PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhou, C; Horstman, D; Carpenter, G; Roberts, MF				Zhou, C; Horstman, D; Carpenter, G; Roberts, MF			Action of phosphatidylinositol-specific phospholipase C gamma 1 on soluble and micellar substrates - Separating effects on catalysis from modulation of the surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SUBSTRATE; X-DOMAIN; Y-DOMAIN; PHOSPHORYLATION; ACTIVATION; MECHANISM; PURIFICATION; ASSOCIATION; EXPRESSION; PROTEINS	(T)he kinetics of PI-PLC gamma 1 toward a water-soluble substrate (inositol 1,2-cyclic phosphate, cIP) and phosphatidylinositol (PI) in detergent mixed micelles were monitored by P-31 NMR spectroscopy. That cIP is also a substrate (K-m = similar to 15 mM) implies a two-step mechanism (intramolecular phosphotransferase reaction to form cIP followed by cyclic phosphodiesterase activity to form inositol-1-phosphate (I-1-P)), PI is cleaved by PI-PLC gamma 1 to form cIP and I-I-P with the enzyme specific activity and ratio of products (cIP/I-1-P) regulated by assay temperature, pH, Ca2+, and other amphiphilic additives, Cleavage of both cIP and PI by the enzyme is optimal at pH 5, The effect of Ca2+ on PI-PLC gamma 1 activity is unique compared with other isozymes enzymes: Ca2+ is necessary for the activity and low Ca2+ activates the enzyme; however, high Ca2+ inhibits PI-PLC gamma 1 hydrolysis of phosphoinositides (but not cIP) with the extent of inhibition dependent on pH, substrate identity (cIP or PI), substrate presentation (e.g. detergent matrix), and substrate surface concentration. This inhibition of PI-PLC gamma 1 by high Ca2+ is proposed to derive from the divalent metal ion-inducing clustering of the PI and reducing its accessibility to the enzyme, Amphiphilic additives such as phosphatidic acid, fatty acid, and sodium dodecylsulfate enhance PI cleavage in micelles at pH 7.5 but not at pH 5.0; they have no effect on cIP hydrolysis at either pH value. These different kinetic patterns are used to propose a model for regulation of the enzyme. A key hypothesis is that there is a pH-dependent conformational change in the enzyme that controls accessibility of the active site to both water-soluble cIP and interfacially organized PI. The low activity enzyme at pH 7.5 can be activated by PA (or phosphorylation by tyrosine kinase), However, this activation requires lipophilic substrate (PI) present because cIP hydrolysis is not enhanced in the presence of PA.	Boston Coll, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA; Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Boston College; Vanderbilt University	Roberts, MF (corresponding author), Boston Coll, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu			NATIONAL CANCER INSTITUTE [R01CA075195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026762] Funding Source: NIH RePORTER; NCI NIH HHS [CA75195] Funding Source: Medline; NIGMS NIH HHS [GM 26762] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BURGESS WH, 1990, MOL CELL BIOL, V10, P4770, DOI 10.1128/MCB.10.9.4770; DENNIS EA, 1973, ARCH BIOCHEM BIOPHYS, V158, P485, DOI 10.1016/0003-9861(73)90540-7; EMORI Y, 1989, J BIOL CHEM, V264, P21885; Essen LO, 1997, BIOCHEMISTRY-US, V36, P1704, DOI 10.1021/bi962512p; FERNALD AW, 1994, BIOCHEM J, V302, P503, DOI 10.1042/bj3020503; GARIGAPATI VR, 1995, J COLLOID INTERF SCI, V169, P486, DOI 10.1006/jcis.1995.1059; GOLDSCHMIDTCLERMONT PJ, 1991, SCIENCE, V251, P1231, DOI 10.1126/science.1848725; Grobler JA, 1996, PROTEIN SCI, V5, P680; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HENDRICKSON HS, 1984, J BIOL CHEM, V259, P5734; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; HORSTMAN DA, 1995, PROTEIN EXPRES PURIF, V6, P278, DOI 10.1006/prep.1995.1036; Horstman DA, 1996, P NATL ACAD SCI USA, V93, P7518, DOI 10.1073/pnas.93.15.7518; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; JONES GA, 1993, J BIOL CHEM, V268, P20845; Kamat Asha, 1997, Cytokine and Growth Factor Reviews, V8, P109, DOI 10.1016/S1359-6101(97)00003-8; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Lomasney JW, 1996, J BIOL CHEM, V271, P25316, DOI 10.1074/jbc.271.41.25316; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MINTA A, 1989, J BIOL CHEM, V264, P8171; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; RHEE SG, 1992, J BIOL CHEM, V267, P12393; Roberts M. F., 1998, PHOSPHOINOSITIDES CH, V718, P137; RYU SH, 1987, J BIOL CHEM, V262, P12511; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0; Wu YQ, 1997, BIOCHEMISTRY-US, V36, P8514, DOI 10.1021/bi970560j; Wu YQ, 1997, BIOCHEMISTRY-US, V36, P356, DOI 10.1021/bi960602o; Wu YQ, 1997, BIOCHEMISTRY-US, V36, P11223, DOI 10.1021/bi971039s; Zhou C, 1997, BIOCHEMISTRY-US, V36, P347, DOI 10.1021/bi960601w	32	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2786	2793		10.1074/jbc.274.5.2786	http://dx.doi.org/10.1074/jbc.274.5.2786			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915811	hybrid			2022-12-27	WOS:000078319500029
J	Alayash, AI; Ryan, BAB; Eich, RF; Olson, JS; Cashon, RE				Alayash, AI; Ryan, BAB; Eich, RF; Olson, JS; Cashon, RE			Reactions of sperm whale myoglobin with hydrogen peroxide - Effects of distal pocket mutations on the formation and stability of the ferryl intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKED HEMOGLOBIN; VASCULAR ENDOTHELIAL-CELLS; SITE-DIRECTED MUTAGENESIS; NITRIC-OXIDE; HISTIDINE RESIDUE; LIGAND-BINDING; OXIDATION; OXYGEN; MECHANISM; BLOOD	Distal pocket mutants of sperm whale oxymyoglobin (oxy-Mb) were reacted with a 2.5-fold excess of hydrogen peroxide (HOOH) in phosphate buffer at pH 7.0, 37 degrees C. We describe a mechanism composed of three instinct steps: 1) initial oxidation of oxy- to ferryl-Mb, 2) autoreduction of the ferryl intermediate to ferric metmyoglobin (metMb), and 3) reaction of metMb with an additional HOOH molecule to regenerate the ferryl intermediate creating a pseudoperoxidase catalytic cycle. Mutation of Leu-29(B10) to Phe slows the initial oxidation reaction 3-fold but has little effect on the rate of ferryl. reduction to ferric met-aquo-myoglobin. In contrast, the Val-68(E11) to Phe mutation causes a small, 60% increase in the initial oxidation reaction and a much larger 2.5-fold increase in the rate of autoreduction. Double insertion of Phe at both the B10- and E11-positions (L29F/V68F) produces a mutant with oxidation characteristics of both single mutants, slow initial oxidation, and rapid autoreduction, but an extraordinarily high affinity for O-2. Replacing His-64(E7) with Gln produces 3-4-fold increases in both processes. Combining the mutation H64Q with L29F results in a myoglobin with enhanced resistance to metMb formation in the absence of antioxidant enzymes (i.e. catalase and superoxide dismutase) due to its own high pseudoperoxidase activity, which rapidly removes any DOOR produced in the initial stages of autoxidation. This double substitution occurs naturally in the myoglobin of Asian elephants, and similar multiple replacements have been used to reduce selectively the rate of nitric oxide (NO)-induced oxidation of both recombinant MbO(2) and HbO(2) blood substitute prototypes without altering O-2 affinity.	US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Univ Maine, Dept Biochem Microbiol & Mol Biol, Orono, ME 04469 USA	US Food & Drug Administration (FDA); Rice University; University of Maine System; University of Maine Orono	Alayash, AI (corresponding author), US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.	Alayash@A1.cber.fda.gov		Olson, John/0000-0002-0760-5403	NHLBI NIH HHS [HL47020] Funding Source: Medline; NIGMS NIH HHS [GM35649, GM08280] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, T32GM008280] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abassi Z, 1997, J LAB CLIN MED, V129, P603, DOI 10.1016/S0022-2143(97)90194-3; ALAYASH AI, 1995, MOL MED TODAY, V1, P122, DOI 10.1016/S1357-4310(95)80089-1; ALAYASH AI, 1993, COMP BIOCHEM PHYS B, V106, P427, DOI 10.1016/0305-0491(93)90324-X; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; ASAHI M, 1995, J BIOL CHEM, V270, P21035, DOI 10.1074/jbc.270.36.21035; BALLA J, 1995, AM J PHYSIOL-LUNG C, V12, pL321; BISIG DA, 1995, J BIOL CHEM, V270, P20754, DOI 10.1074/jbc.270.35.20754; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Brittain T, 1997, BIOCHEM J, V326, P109, DOI 10.1042/bj3260109; CARVER TE, 1992, J BIOL CHEM, V267, P14443; CASHON RE, 1995, ARCH BIOCHEM BIOPHYS, V316, P461, DOI 10.1006/abbi.1995.1061; CHANG TMS, 1997, BLOOD SUBSTITUTES PR, V1; D'Agnillo F, 1998, NAT BIOTECHNOL, V16, P667, DOI 10.1038/nbt0798-667; DarleyUsmar V, 1997, EXP PHYSIOL, V82, P305, DOI 10.1113/expphysiol.1997.sp004026; DarleyUsmar V, 1996, PHARM RES-DORDR, V13, P649, DOI 10.1023/A:1016079012214; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Dou Y, 1996, BIOCHEMISTRY-US, V35, P7107, DOI 10.1021/bi9600299; EGEBERG KD, 1990, J BIOL CHEM, V265, P11788; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; GEORGE P, 1932, BIOCHEM J, V52, P511; Giulivi C, 1998, FREE RADICAL BIO MED, V24, P269, DOI 10.1016/S0891-5849(97)00226-8; Goldman DW, 1998, AM J PHYSIOL-HEART C, V275, pH1046, DOI 10.1152/ajpheart.1998.275.3.H1046; Grisham MB, 1992, REACTIVE METABOLITES; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; HARRISON GJ, 1994, CAN J CARDIOL, V10, P843; JOHN ME, 1982, COMP BIOCHEM PHYS B, V73, P585, DOI 10.1016/0305-0491(82)90079-7; KING NK, 1963, J BIOL CHEM, V238, P1520; KLOEK AP, 1994, J BIOL CHEM, V269, P2377; Krishna MC, 1996, J BIOL CHEM, V271, P26018, DOI 10.1074/jbc.271.42.26018; LEE R, 1995, J APPL PHYSIOL, V79, P236, DOI 10.1152/jappl.1995.79.1.236; MARTIN WJ, 1984, AM REV RESPIR DIS, V130, P209; Matsui T, 1997, J BIOL CHEM, V272, P32735, DOI 10.1074/jbc.272.52.32735; Miller YI, 1997, BIOCHEMISTRY-US, V36, P12189, DOI 10.1021/bi970258a; MOTTERLINI R, 1995, AM J PHYSIOL-HEART C, V269, pH648, DOI 10.1152/ajpheart.1995.269.2.H648; NELSON JD, 1997, BLOOD SUBSTITUTES PR, V2, P39; Olson JS, 1997, ARTIF CELL BLOOD SUB, V25, P227, DOI 10.3109/10731199709118912; OSAWA Y, 1991, P NATL ACAD SCI USA, V88, P7081, DOI 10.1073/pnas.88.16.7081; PANUS PC, 1993, FREE RADICAL BIO MED, V14, P217, DOI 10.1016/0891-5849(93)90013-K; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; RAO SI, 1993, J BIOL CHEM, V268, P803; Reah G, 1997, CRIT CARE MED, V25, P1480, DOI 10.1097/00003246-199709000-00014; RIZZI M, 1994, J MOL BIOL, V244, P86, DOI 10.1006/jmbi.1994.1706; SHARMA AC, 1994, J LAB CLIN MED, V123, P299; SHARMA VS, 1987, BIOCHEMISTRY-US, V26, P3837, DOI 10.1021/bi00387a015; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; SHRAGER RI, 1982, ANAL CHEM, V54, P1147, DOI 10.1021/ac00244a031; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; SUZUKI T, 1987, BIOCHIM BIOPHYS ACTA, V914, P170, DOI 10.1016/0167-4838(87)90060-4; Svistunenko DA, 1997, J CHEM SOC PERK T 2, P2539, DOI 10.1039/a702483e; Svistunenko DA, 1997, J BIOL CHEM, V272, P7114, DOI 10.1074/jbc.272.11.7114; TAJIMA G, 1993, INT J BIOCHEM, V25, P101, DOI 10.1016/0020-711X(93)90495-Z; Vandegriff K D, 1992, Biotechnol Genet Eng Rev, V10, P403; VanDyke BR, 1996, J AM CHEM SOC, V118, P3490, DOI 10.1021/ja954181u; WAZAWA T, 1992, BIOPHYS J, V63, P544, DOI 10.1016/S0006-3495(92)81608-9; WHITBURN KD, 1987, ARCH BIOCHEM BIOPHYS, V253, P419, DOI 10.1016/0003-9861(87)90195-0; YAMAMOTO Y, 1987, ANAL BIOCHEM, V160, P7, DOI 10.1016/0003-2697(87)90606-3; YUSA K, 1987, BIOCHEMISTRY-US, V26, P6684, DOI 10.1021/bi00395a018; ZHAO XF, 1995, J BIOL CHEM, V270, P20763, DOI 10.1074/jbc.270.35.20763	59	86	87	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2029	2037		10.1074/jbc.274.4.2029	http://dx.doi.org/10.1074/jbc.274.4.2029			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890961	hybrid			2022-12-27	WOS:000078185200028
J	Mizuguchi, H; Cook, PF; Tai, CH; Hasemann, CA; Uyeda, K				Mizuguchi, H; Cook, PF; Tai, CH; Hasemann, CA; Uyeda, K			Reaction mechanism of fructose-2,6-bisphosphatase - A mutation of nucleophilic catalyst, histidine 256, induces an alteration in the reaction pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER FRUCTOSE-2,6-BISPHOSPHATASE; 6-PHOSPHOFRUCTO-2-KINASE FRUCTOSE-2,6-BISPHOSPHATASE; HEPATIC FRUCTOSE-2,6-BISPHOSPHATASE; CRYSTAL-STRUCTURE; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE; FRUCTOSE-6-PHOSPHATE; MUTAGENESIS; EXPRESSION; BINDING; DOMAIN	A bifunctional enzyme, fructose-6-phosphate,2-kinase/fructose 2,6-bisphosphatase (Fru-6-P,2-kinase/Fru-2,6-Pase), catalyzes synthesis and degradation of fructose a,6-bisphosphate (Fru-2,6-P-2). Previously, the rat liver Fru-2,6-Pase reaction (Fru-2,6-P-2 --> Fru-6-P + P-i) has been shown to proceed via a phosphoenzyme intermediate with His(258) phosphorylated, and mutation of the histidine to alanine resulted in complete loss of activity (Tauler, A., Lin, K., and Pilkis, S. J. (1990) J. Biol. Chem, 265, 15617-15622). In the present study, it is shown that mutation of the corresponding histidine (His(256)) Of the rat testis enzyme decreases activity by less than a factor of 10 with a k(cat) of 17% compared with the wild type enzyme. Mutation of His(390) (in close proximity to His(256)) to Ala results in a k(cat) of 12.5% compared with the wild type enzyme. Attempts to detect a phosphohistidine intermediate with the H256A mutant enzyme were unsuccessful, but the phosphoenzyme is detected in the wild type, H390A, R255A, R305S, and E325A mutant enzymes. Data demonstrate that the mutation of His(256) induces a change in the phosphatase hydrolytic reaction mechanism. Elimination of the nucleophilic catalyst, H256A, results in a change in mechanism. In the H256A mutant enzyme, His(390) likely acts as a general base to activate water for direct hydrolysis of the a-phosphate of Fru-2,6-P-2. Mutation of Arg(255) and Arg(305) suggests that the arginines probably have a role in neutralizing excess charge on the a-phosphate and polarizing the phosphoryl for subsequent transfer to either His(256) or water. The role of Glu(325) is less certain, but it may serve as a general acid, protonating the leaving 2-hydroxyl of Fru-2,6-P-2.	Dallas Vet Affairs Med Ctr, Res Serv, Dallas, TX 75216 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75216 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75216 USA; Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Oklahoma System; University of Oklahoma - Norman	Uyeda, K (corresponding author), Dallas Vet Affairs Med Ctr, Res Serv, 4500 S Lancaster Rd, Dallas, TX 75216 USA.	kuyeda6400@aol.com	Mizuguchi, Hiroyuki/B-5676-2013	Mizuguchi, Hiroyuki/0000-0001-7055-316X	NIDDK NIH HHS [DK16194] Funding Source: Medline; NIGMS NIH HHS [GM36799] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036799] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; ELMAGHRABI MR, 1986, P NATL ACAD SCI USA, V83, P5005, DOI 10.1073/pnas.83.14.5005; FURUYA E, 1981, J BIOL CHEM, V256, P7109; HAN CH, 1979, J BIOL CHEM, V254, P8836; Hasemann CA, 1996, STRUCTURE, V4, P1017, DOI 10.1016/S0969-2126(96)00109-8; KITAJIMA S, 1984, J BIOL CHEM, V259, P6896; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee YH, 1996, BIOCHEMISTRY-US, V35, P6010, DOI 10.1021/bi9600613; LIN K, 1992, J BIOL CHEM, V267, P19163; LIN K, 1992, J BIOL CHEM, V267, P6556; OKAR DA, 1995, BIOCHEM J, V308, P189, DOI 10.1042/bj3080189; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PILKIS SJ, 1987, J BIOL CHEM, V262, P12672; Sakakibara R, 1997, J BIOCHEM-TOKYO, V122, P122; SAKATA J, 1991, J BIOL CHEM, V266, P15764; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLINACKERG KD, 1991, ENZYMES DEPENDENT PY, P149; STEWART HB, 1985, J BIOL CHEM, V260, P2935; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TAULER A, 1990, J BIOL CHEM, V265, P15617; TOMINAGA N, 1993, J BIOL CHEM, V268, P15951; UYEDA K, 1981, J BIOL CHEM, V256, P8394; UYEDA K, 1991, ENZYME CATALYSIS, V2, P445; Watanabe F, 1996, PROTEIN SCI, V5, P904; WEI YF, 1990, ANAL BIOCHEM, V190, P188, DOI 10.1016/0003-2697(90)90179-D; Yuen MH, 1999, J BIOL CHEM, V274, P2176, DOI 10.1074/jbc.274.4.2176	27	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2166	2175		10.1074/jbc.274.4.2166	http://dx.doi.org/10.1074/jbc.274.4.2166			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890979	hybrid			2022-12-27	WOS:000078185200046
J	Paulding, WR; Czyzyk-Krzeska, MF				Paulding, WR; Czyzyk-Krzeska, MF			Regulation of tyrosine hydroxylase mRNA stability by protein-binding, pyrimidine-rich sequence in the 3 '-untranslated region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; 3' UNTRANSLATED REGION; POSTTRANSCRIPTIONAL REGULATION; ERYTHROID-DIFFERENTIATION; GENE-EXPRESSION; PC12 CELLS; TRANSLATION; COMPLEX; IDENTIFICATION; TRANSCRIPTION	The stability of mRNA for tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis, is regulated by oxygen tension in the pheochromocytoma-derived PC12 cell line. We previously identified a pyrimidine-rich 27-base-long protein-binding sequence in the S'-untranslated region of TH mRNA that is associated with hypoxia-inducible formation of a ribonueleo-protein complex (hypoxia-inducible protein-binding site (HIPBS)), In this study, we show that HIPBS is an mRNA stabilizing element necessary for both constitutive and hypoxia-regulated stability of TH mRNA. The mutations within this sequence that abolish protein binding markedly decrease constitutive TH mRNA stability and ablate its hypoxic regulation. A short fragment of TH mRNA that contains the wild-type HIPBS confers the increased mRNA stability to the reporter chloramphenicol acetyltransferase mRNA However, it is not sufficient to confer hypoxic regulation. The HIPBS element binds two isoforms of a 40-kDa poly(C)binding protein (PCBP). Hypoxia induces expression of the isoform 1, PCBP1, but not the isoform 2, PCBP2, in PC12 cells.	Univ Cincinnati, Coll Med, Dept Cellular & Mol Physiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Czyzyk-Krzeska, MF (corresponding author), Univ Cincinnati, Coll Med, Dept Cellular & Mol Physiol, POB 670576, Cincinnati, OH 45267 USA.				NHLBI NIH HHS [T32 HL07571, HL51078, HL58687] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL051078, R01HL058687, T32HL007571] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; CzyzykKrzeska MF, 1997, KIDNEY INT, V51, P585, DOI 10.1038/ki.1997.84; CzyzykKrzeska MF, 1996, J BIOL CHEM, V271, P3293, DOI 10.1074/jbc.271.6.3293; CZYZYKKRZESKA MF, 1994, J BIOL CHEM, V269, P760; CZYZYKRZESKA MF, 1994, J BIOL CHEM, V269, P9940; FOSSOM LH, 1992, MOL PHARMACOL, V42, P898; Gamarnik AV, 1997, RNA, V3, P882; Holcik M, 1997, P NATL ACAD SCI USA, V94, P2410, DOI 10.1073/pnas.94.6.2410; Kiledjian M, 1997, MOL CELL BIOL, V17, P4870, DOI 10.1128/MCB.17.8.4870; KILEDJIAN M, 1995, EMBO J, V14, P4357, DOI 10.1002/j.1460-2075.1995.tb00110.x; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Maurer JA, 1997, J NEUROSCI, V17, P4552; Morales J, 1997, J BIOL CHEM, V272, P6607, DOI 10.1074/jbc.272.10.6607; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; OSTARECKLEDERER A, 1994, EMBO J, V13, P1476, DOI 10.1002/j.1460-2075.1994.tb06402.x; Russell JE, 1998, MOL CELL BIOL, V18, P2173, DOI 10.1128/MCB.18.4.2173; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; SUMMERHILL EM, 1987, MOL BRAIN RES, V2, P99, DOI 10.1016/0169-328X(87)90002-7; VYAS S, 1990, EMBO J, V9, P3707, DOI 10.1002/j.1460-2075.1990.tb07583.x; WANG XM, 1995, MOL CELL BIOL, V15, P1769; WEISS IM, 1995, MOL CELL BIOL, V15, P2457	21	123	126	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2532	2538		10.1074/jbc.274.4.2532	http://dx.doi.org/10.1074/jbc.274.4.2532			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891025	hybrid			2022-12-27	WOS:000078185200092
J	van den Hazel, HB; Pichler, H; Matta, MAD; Leitner, E; Goffeau, A; Daum, G				van den Hazel, HB; Pichler, H; Matta, MAD; Leitner, E; Goffeau, A; Daum, G			PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; MULTIDRUG-RESISTANCE; SHUTTLE VECTORS; YEAST; MEMBRANE; TRANSCRIPTION; ACID; PHOSPHATIDYLETHANOLAMINE; CHROMATOGRAPHY	The Saccharomyces cerevisiae open reading frame YNL231C was recently found to be controlled by the multiple drug resistance regulator Pdr1p, Here we characterize YNL231C (PDR16) and its homologue YNL264C (PDR17), Deletion of PDR16 resulted in hypersensitivity of yeast to azole inhibitors of ergosterol biosynthesis, While no increase in drug sensitivity was found upon deletion of PDR17 alone, a Delta pdr16,Delta pdr17 double mutant was hypersensitive to a broad range of drugs. Both mutations caused significant changes of the lipid composition of plasma membrane and total cell extracts, Deletion of PDR16 had pronounced effects on the sterol composition, whereas PDR17 deletion mainly affected the phospholipid composition, Thus, Pdr16p and Pdr17p may regulate yeast lipid synthesis like their distant homologue, Sec14p, The azole sensitivity of the PDR16-deleted strain may be the result of imbalanced ergosterol synthesis. Impaired plasma membrane barrier function resulting from a change in the lipid composition appears to cause the increased drug sensitivity of the double mutant strain Delta pdr16,Delta pdr17, The uptake rate of rhodamine-6-G into de-energized cells was shown to be almost 2-fold increased in a Delta pdr16,Delta pdr17 strain as compared with wild-type and Delta pdr5 strains. Collectively, our results indicate that PDR16 and PDR17 control levels of various lipids in various compartments of the cell and thereby provide a mechanism for multidrug resistance unrecognized so far.	Graz Univ Technol, Inst Biochem & Lebensmittelchem, A-8010 Graz, Austria; Catholic Univ Louvain, Unite Biochim Physiol, B-1348 Louvain, Belgium	Graz University of Technology; Universite Catholique Louvain	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem & Lebensmittelchem, Petersgasse 12-2, A-8010 Graz, Austria.	f548daum@mbox.tu-graz.ac.at	Pichler, Harald/B-5398-2013; Leitner, Erich/AAG-8826-2021	Pichler, Harald/0000-0001-6043-2137; Leitner, Erich/0000-0003-2520-2111				ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; BALZI E, 1987, J BIOL CHEM, V262, P16871; BALZI E, 1995, J BIOENERG BIOMEMBR, V27, P71, DOI 10.1007/BF02110333; BALZI E, 1994, BBA-BIOENERGETICS, V1187, P152, DOI 10.1016/0005-2728(94)90102-3; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; BarrettBee K, 1995, ACTA BIOCHIM POL, V42, P465; Broekhuyse R. M., 1968, BIOCHIM BIOPHYS ACTA, V260, P449; Carvajal E, 1997, MOL GEN GENET, V256, P406, DOI 10.1007/s004380050584; Ceolotto C, 1996, BBA-BIOMEMBRANES, V1285, P71, DOI 10.1016/S0005-2736(96)00147-2; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cockcroft S, 1997, FEBS LETT, V410, P44, DOI 10.1016/S0014-5793(97)00414-6; Cockcroft S, 1997, BIOCHEM SOC T, V25, P1125, DOI 10.1042/bst0251125; COMFURIUS P, 1990, J LIPID RES, V31, P1719; Cunningham E, 1996, P NATL ACAD SCI USA, V93, P6589, DOI 10.1073/pnas.93.13.6589; DAUM G, 1982, J BIOL CHEM, V257, P3028; DAUM G, 1984, BIOCHIM BIOPHYS ACTA, V794, P385, DOI 10.1016/0005-2760(84)90004-3; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; DECOTTIGNIES A, 1994, J BIOL CHEM, V269, P12797; DELAVEAU T, 1994, MOL GEN GENET, V244, P501, DOI 10.1007/BF00583901; FOLCH J, 1957, J BIOL CHEM, V226, P497; HAID A, 1983, METHOD ENZYMOL, V96, P192; HERMETTER A, 1989, CHEM PHYS LIPIDS, V50, P57, DOI 10.1016/0009-3084(89)90026-1; HIGGINS JA, 1982, BIOCHIM BIOPHYS ACTA, V693, P151, DOI 10.1016/0005-2736(82)90481-3; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; Kean LS, 1997, J CELL BIOL, V138, P255, DOI 10.1083/jcb.138.2.255; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; KOLACZKOWSKI M, 1998, IN PRESS MICROBIOL D; KRAMER JMH, 1977, BIOCHEMISTRY-US, V16, P3932; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; LEWIS TA, 1987, BIOCHIM BIOPHYS ACTA, V921, P205, DOI 10.1016/0005-2760(87)90020-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCGEE TP, 1994, J CELL BIOL, V124, P273, DOI 10.1083/jcb.124.3.273; Monteoliva L, 1996, YEAST, V12, P1097, DOI 10.1002/(SICI)1097-0061(19960915)12:11<1097::AID-YEA990>3.0.CO;2-E; NES W D, 1989, Steroids, V53, P533, DOI 10.1016/0039-128X(89)90030-5; Nourani A, 1997, MOL GEN GENET, V256, P397, DOI 10.1007/s004380050583; PATTERSON GW, 1971, ANAL CHEM, V43, P1165, DOI 10.1021/ac60304a015; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; RANK GH, 1976, MOL GEN GENET, V144, P281, DOI 10.1007/BF00341726; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; SKINNER HB, 1995, P NATL ACAD SCI USA, V92, P112, DOI 10.1073/pnas.92.1.112; SOMERHARJU P, 1982, CHEM PHYS LIPIDS, V30, P81, DOI 10.1016/0009-3084(82)90009-3; SOMERHARJU PJ, 1987, BIOCHEMISTRY-US, V26, P7193, DOI 10.1021/bi00396a048; SPERKAGOTTLIEB CDM, 1988, BIOCHIM BIOPHYS ACTA, V946, P227, DOI 10.1016/0005-2736(88)90397-5; SZOLDERITS G, 1989, BIOCHIM BIOPHYS ACTA, V986, P301, DOI 10.1016/0005-2736(89)90481-1; THIERRY A, 1990, YEAST, V6, P521, DOI 10.1002/yea.320060609; WINSTON F, 1983, METHOD ENZYMOL, V101, P211; Wolfger H, 1997, FEBS LETT, V418, P269, DOI 10.1016/S0014-5793(97)01382-3; XU SH, 1988, J CHROMATOGR, V452, P377, DOI 10.1016/S0021-9673(01)81462-X; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993	55	128	132	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1934	1941		10.1074/jbc.274.4.1934	http://dx.doi.org/10.1074/jbc.274.4.1934			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890948	hybrid			2022-12-27	WOS:000078185200015
J	Sankarapandi, S; Zweier, JL				Sankarapandi, S; Zweier, JL			Bicarbonate is required for the peroxidase function of Cu,Zn-superoxide dismutase at physiological pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC SUPEROXIDE-DISMUTASE; AMYOTROPHIC-LATERAL-SCLEROSIS; HYDROXYL RADICAL PRODUCTION; HYDROGEN-PEROXIDE; ANION BINDING; COPPER; INACTIVATION; CU,ZN; ENZYME; H2O2	Cu,Zn-superoxide dismutase (SOD1) acts as a peroxidase in the presence of H2O2 at high pH (pH > 9). The high pH species of H2O2, HO2-, was previously implicated as the reactive species. However, recent EPR studies of the enzyme performed in the physiological pH range 7,4-7.6 with the spin trap 5,5'-dimethyl-1-pyrolline-N-oxide attributed the intense EPR signal of 5,5'-dimethyl-1-pyrolline-N-oxide-OH obtained from SOD1 and H2O2 to the peroxidase activity of the enzyme. The present study establishes that this intense signal is obtained only in the presence of bicarbonate. To explore the critical role of HCO3-, a comprehensive EPR investigation of the radical production and redox state of the active site copper was performed. The results indicate that HCO3- competes with other anions for the anion-binding site of SOD1 (Arg(141)) but does not bind directly to the copper. Structurally different anions that bind to Arg(141) did not stimulate, but rather blocked, peroxidase function, ruling out an effect due to mere anion binding. However, the structurally similar anions HSeO3- and HSO3- mimic HCO3- in stimulating peroxidase function. These data suggest that HCO3- bound to Arg(141) anchors the neutral H2O2 molecule at the active site copper, enabling its redox cleavage. Thus, SOD1 acquires peroxidase activity at physiological pH only in the presence of HCO3- or structurally similar anions. Alterations in pH that shift the HCO3-/CO2 equilibrium as occur in disease processes such as ischemia, sepsis, or shock would modulate the peroxidase function of SOD1.	Johns Hopkins Med Inst, Dept Med, Div Cardiol, Mol & Cellular Biophys Labs, Baltimore, MD 21224 USA; Johns Hopkins Med Inst, Electron Paramagnet Resonance Ctr, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Zweier, JL (corresponding author), Johns Hopkins Asthma & Allergy Ctr, Electron Paramagnet Resonance Ctr, Rm LA-14,5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.				NHLBI NIH HHS [HL-38324, HL-52315] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038324, R01HL038324, P50HL052315] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AISEN P, 1978, J BIOL CHEM, V253, P1930; BANCI L, 1989, J BIOL CHEM, V264, P9742; BANNISTER JV, 1987, CRC CR REV BIOCH MOL, V22, P111, DOI 10.3109/10409238709083738; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BERTINI I, 1985, J AM CHEM SOC, V107, P4391, DOI 10.1021/ja00301a004; BLECH DM, 1983, ARCH BIOCHEM BIOPHYS, V224, P579, DOI 10.1016/0003-9861(83)90245-X; BORDERS CL, 1985, ARCH BIOCHEM BIOPHYS, V241, P472, DOI 10.1016/0003-9861(85)90572-7; BRAY RC, 1974, BIOCHEM J, V139, P43, DOI 10.1042/bj1390043; CABELLI DE, 1989, J BIOL CHEM, V264, P9967; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; COCCO D, 1982, FEBS LETT, V150, P303, DOI 10.1016/0014-5793(82)80756-4; DEFREITAS DM, 1984, BIOCHEMISTRY-US, V23, P2079, DOI 10.1021/bi00304a031; DJINOVICCARUGO K, 1994, J MOL BIOL, V240, P179, DOI 10.1006/jmbi.1994.1432; ELROYSTEIN O, 1988, CELL, V52, P259, DOI 10.1016/0092-8674(88)90515-6; FEE JA, 1981, J BIOL CHEM, V256, P1910; FEE JA, 1972, J BIOL CHEM, V247, P60; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; FUCHS HJR, 1983, BIOCHEM BIOPH RES CO, V241, P472; GETZOFF ED, 1983, NATURE, V306, P287, DOI 10.1038/306287a0; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5299, DOI 10.1021/bi00695a011; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010; KUPPUSAMY P, 1992, APPL RADIAT ISOTOPES, V44, P367; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MOTTLEY C, 1982, J BIOL CHEM, V257, P5050; RIGO A, 1977, BIOCHEM BIOPH RES CO, V79, P776, DOI 10.1016/0006-291X(77)91179-2; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTILIO G, 1972, BIOCHEMISTRY-US, V11, P2187, DOI 10.1021/bi00761a028; SALO DC, 1990, J BIOL CHEM, V265, P11919; SATO K, 1992, J BIOL CHEM, V267, P25371; SCOTT MD, 1989, J BIOL CHEM, V264, P2498; SEGEL IH, 1993, ENZYME KINETICS, P250; SETTE M, 1992, BIOCHEMISTRY-US, V31, P12410, DOI 10.1021/bi00164a016; SINET PM, 1981, ARCH BIOCHEM BIOPHYS, V212, P411, DOI 10.1016/0003-9861(81)90382-9; SMITH CA, 1992, BIOCHEMISTRY-US, V31, P4527, DOI 10.1021/bi00133a020; STROTHKAMP KG, 1981, BIOCHEMISTRY-US, V20, P7488, DOI 10.1021/bi00529a025; SYMONYAN MA, 1972, FEBS LETT, V28, P22, DOI 10.1016/0014-5793(72)80667-7; UCHIDA K, 1994, J BIOL CHEM, V269, P2405; VALENTINE JS, 1986, SUPEROXIDE SUPEROXID, P149; VIGLINO P, 1988, BIOCHIM BIOPHYS ACTA, V952, P77, DOI 10.1016/0167-4838(88)90103-3; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Yim HS, 1997, J BIOL CHEM, V272, P8861; YIM MB, 1993, J BIOL CHEM, V268, P4099; YIM MB, 1990, P NATL ACAD SCI USA, V87, P5006, DOI 10.1073/pnas.87.13.5006; ZWEIER J, 1979, J BIOL CHEM, V254, P3512; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804; ZWEIER JL, 1988, J BIOL CHEM, V263, P1353; ZWEIER JL, 1988, P NATL ACAD SCI USA, V85, P4046, DOI 10.1073/pnas.85.11.4046; ZWEIER JL, 1981, BIOCHEMISTRY-US, V20, P3505, DOI 10.1021/bi00515a031	50	76	77	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1226	1232		10.1074/jbc.274.3.1226	http://dx.doi.org/10.1074/jbc.274.3.1226			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880490	hybrid			2022-12-27	WOS:000079956900010
J	Liu, YY; Han, TY; Giuliano, AE; Cabot, MC				Liu, YY; Han, TY; Giuliano, AE; Cabot, MC			Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADIATION-INDUCED APOPTOSIS; NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-C; GENE-EXPRESSION; SPHINGOLIPID SYNTHESIS; MULTIDRUG-RESISTANCE; MAMMALIAN-CELLS; BCL-2; PATHWAY; GROWTH	Multidrug-resistant cancer cells display elevated levels of glucosylceramide (Lavie, Y., Cao, H. T., Volner, A. Lucci, A. Han, T. Y., Geffen, V., Giuliano, A. E., and Cabot, M. C. (1997) J. Biol. Chem. 272, 1682-1687). In this study, we have introduced glucosylceramide synthase (GCS) into wild type MCF-7 breast cancer cells using a retroviral tetracycline-on expression system, and we developed a cell line, MCF-7/GCS. MCF-7/GCS cells expressed an 11-fold higher level of GCS activity compared with the parental cell line. Interestingly, the transfected cells demonstrated strong resistance to adriamycin and to ceramide, whereas both agents were highly cytotoxic to MCF-7 cells. The EC50 values of adriamycin and ceramide were 11-fold (p < 0.0005) and 5-fold (p < 0.005) higher, respectively, in MCF-7/GCS cells compared with MCF-7 cells. Ceramide resistance displayed by MCF-7/GCS cells closely paralleled the activity of expressed GCS with a correlation coefficient of 0.99. In turn, cellular resistance and GCS activity were dependent upon the concentration of the expression mediator doxycycline. Adriamycin resistance in MCF-7/GCS cells was related to the hyperglycosylation of ceramide and was not related to shifts in the levels of either P-glycoprotein or Bcl-2. This work demonstrates that overexpression of GCS, which catalyzes ceramide glycosylation, induces resistance to adriamycin and ceramide in MCF-7 breast cancer cells.	St Johns Hlth Ctr, John Wayne Canc Inst, Santa Monica, CA 90404 USA	John Wayne Cancer Institute	Cabot, MC (corresponding author), St Johns Hlth Ctr, John Wayne Canc Inst, 2200 Santa Monica Blvd, Santa Monica, CA 90404 USA.	cabot@jwci.org		Liu, Yong-Yu/0000-0002-7968-0162				BASU S, 1968, J BIOL CHEM, V243, P5802; Bellamy WT, 1996, ANNU REV PHARMACOL, V36, P161, DOI 10.1146/annurev.pa.36.040196.001113; Bezombes C, 1998, FASEB J, V12, P101, DOI 10.1096/fasebj.12.1.101; Blagosklonny MV, 1996, CANCER RES, V56, P1851; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Cabot MC, 1998, FEBS LETT, V431, P185, DOI 10.1016/S0014-5793(98)00744-3; CABOT MC, 1997, BREAST CANC RES TREA, V46, P293; Cai ZZ, 1997, J BIOL CHEM, V272, P6918, DOI 10.1074/jbc.272.11.6918; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUMA SJ, 1997, CANCER RES, V57, P1270; DATTA SC, 1988, LIPIDS, V23, P508, DOI 10.1007/BF02535529; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Haimovitz-Friedman A, 1997, BRIT MED BULL, V53, P539; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; HALDAR S, 1995, P NATL ACAD SCI USA, V92, P4507, DOI 10.1073/pnas.92.10.4507; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HAREL R, 1993, J BIOL CHEM, V268, P14476; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; JAYADEV S, 1994, J BIOL CHEM, V269, P5757; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Lavie Y, 1997, J BIOL CHEM, V272, P1682, DOI 10.1074/jbc.272.3.1682; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Lucci A, 1998, ANTICANCER RES, V18, P475; MARSH NL, 1995, J CLIN INVEST, V95, P2903, DOI 10.1172/JCI117997; Michael JM, 1997, CANCER RES, V57, P3600; MORTON DL, 1994, PROG BRAIN RES, V101, P251; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; SAMBROOK J, 1989, MOL CLONING LABORATO, V7, P43; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; SCHWARZ A, 1995, J BIOL CHEM, V270, P10990, DOI 10.1074/jbc.270.18.10990; SHAYMAN JA, 1991, J BIOL CHEM, V266, P22968; SHUKLA GS, 1990, ARCH BIOCHEM BIOPHYS, V283, P372, DOI 10.1016/0003-9861(90)90657-K; Smyth M J, 1997, Adv Pharmacol, V41, P133, DOI 10.1016/S1054-3589(08)61057-1; Testi R, 1996, TRENDS BIOCHEM SCI, V21, P468, DOI 10.1016/S0968-0004(96)10056-6; Watanabe R, 1998, J BIOL CHEM, V273, P9651, DOI 10.1074/jbc.273.16.9651; Yang JM, 1996, CANCER RES, V56, P3490; Yin DX, 1996, ANAL BIOCHEM, V235, P195, DOI 10.1006/abio.1996.0112; Zhang JD, 1996, P NATL ACAD SCI USA, V93, P5325, DOI 10.1073/pnas.93.11.5325; ZYAD A, 1994, CANCER RES, V54, P825	45	236	251	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1140	1146		10.1074/jbc.274.2.1140	http://dx.doi.org/10.1074/jbc.274.2.1140			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873062	hybrid			2022-12-27	WOS:000077968500077
J	Propper, C; Huang, XH; Roth, J; Sorg, C; Nacken, WG				Propper, C; Huang, XH; Roth, J; Sorg, C; Nacken, WG			Analysis of the MRP8-MRP14 protein-protein interaction by the two-hybrid system suggests a prominent role of the C-terminal domain of S100 proteins in dimer formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; MOLECULAR-CLONING; DIFFERENTIATION; PHOSPHORYLATION; EXPRESSION; ABUNDANT; MRP-14; MRP14; CAAF1; GENE	Calcium-binding S100 proteins are thought to play a central role in calcium-mediated signal transduction pathways. They consist of two helix-loop-helix, calcium-binding EF-hand domains. A characteristic feature is their tendency to form homo- and/or heterodimeric complexes. This report presents for the first time a functional "in vivo" approach to the analysis of S100 protein dimerization. Using the two-hybrid system we analyzed the dimerization of MRP8 (S100A8) and MRP14 (S100A9), two S100 proteins expressed in myeloid cells. It is reported that the MRP8-MRP14 heteromer is the clearly preferred complex in both man and mouse. The ability to homodimerize, however, appears to be restricted to the murine MRPs. Interaction analysis of chimeric murine/human MRP14 proteins indicates, that the C-terminal EF-hand domain plays a prominent role in MRP8 MRP14 interaction and determines the specificity of dimerization, Site-directed mutagenesis of four evolutionary conserved hydrophobic amino acids, which have been recently supposed to be essential for S100 protein dimerization, suggests that at least one of these, namely the most N-terminal located residue, is not critical for dimerization.	Munster Med Sch, Inst Expt Dermatol, D-48149 Munster, Germany		Nacken, WG (corresponding author), Munster Med Sch, Inst Expt Dermatol, Von Esmarch Str 56, D-48149 Munster, Germany.	nacken@uni-muenster.de						Ausubel F.M., 1994, CURRENT PROTOCOLS MO, V1; EDGEWORTH J, 1989, NATURE, V342, P189, DOI 10.1038/342189a0; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hitomi J, 1996, BIOCHEM BIOPH RES CO, V228, P757, DOI 10.1006/bbrc.1996.1728; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Kilby PM, 1996, STRUCTURE, V4, P1041, DOI 10.1016/S0969-2126(96)00111-6; LACKMANN M, 1993, J IMMUNOL, V150, P2981; LAGASSE E, 1992, BLOOD, V79, P1907; LAGASSE E, 1988, MOL CELL BIOL, V8, P2402, DOI 10.1128/MCB.8.6.2402; Luban Jeremy, 1995, Current Opinion in Biotechnology, V6, P59, DOI 10.1016/0958-1669(95)80010-7; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Miller J.H., 1972, EXPT MOL GENETICS; Niki I, 1996, J BIOCHEM, V120, P685; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; POTTS BCM, 1995, NAT STRUCT BIOL, V2, P790, DOI 10.1038/nsb0995-790; RAFERTY MJ, 1998, J AM SOC MASS SPECTR, V9, P533; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Sorg C, 1992, Behring Inst Mitt, P126; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; vandenBos C, 1996, J IMMUNOL, V156, P1247; Wicki R, 1996, CELL CALCIUM, V20, P459, DOI 10.1016/S0143-4160(96)90087-1; Yamamura T, 1996, BIOCHEM BIOPH RES CO, V221, P356, DOI 10.1006/bbrc.1996.0600	24	70	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					183	188		10.1074/jbc.274.1.183	http://dx.doi.org/10.1074/jbc.274.1.183			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867828	hybrid			2022-12-27	WOS:000077900200028
J	Wilkinson, NC; Navarro, J				Wilkinson, NC; Navarro, J			PU.1 regulates the CXCR1 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; IL-8 RECEPTOR HOMOLOG; INTERLEUKIN-8 RECEPTORS; TRANSCRIPTION FACTOR; MICE LACKING; IDENTIFICATION; GRANULOCYTE; EXPRESSION; NEUTROPHIL; CELLS	The interleukin-8 receptors (CXCR1 and CXCR2) are specifically expressed at high levels in cells of the neutrophil lineage. In this work we identify promoter elements of the CXCR1 gene and the ets family transcription factor PU.1 as a major regulator for activation of the CXCR1 promoter. We first showed that the upstream sequence of CXCR1 (-800 to +86 base pairs (bp)) directs myeloid-specific expression of reporter gene constructs. Second, we showed the presence of negative elements in the sequence from -800 to -128 bp and positive elements from -128 to +50 bp. Third, we demonstrated that the fragment -22 to +14 bp binds PU.1. Fourth, we showed that PU.1 transactivates the CXCR1 promoter. These data are the first demonstration of PU.1-mediated transcriptional regulation of a neutrophil chemoattractant G protein-coupled receptor.	Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Navarro, J (corresponding author), Univ Texas, Med Branch, Dept Physiol & Biophys, Galveston, TX 77550 USA.	jnavarro@utmb.edu		Navarro, Javier/0000-0001-7098-4373	NIAID NIH HHS [AI34031] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034031] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHUJA SK, 1994, J BIOL CHEM, V269, P11065; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; Ausubel FM, 1987, CURRENT PROTOCOLS MO, V1-5; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broxmeyer HE, 1996, J EXP MED, V184, P1825, DOI 10.1084/jem.184.5.1825; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DONG F, 1994, P NATL ACAD SCI USA, V91, P4480, DOI 10.1073/pnas.91.10.4480; Dunstan CAN, 1996, J BIOL CHEM, V271, P32770, DOI 10.1074/jbc.271.51.32770; Ford AM, 1996, P NATL ACAD SCI USA, V93, P10838, DOI 10.1073/pnas.93.20.10838; Heydemann A, 1997, J BIOL CHEM, V272, P29527, DOI 10.1074/jbc.272.47.29527; HOLYOAKE TL, 1993, STEM CELLS, V11, P122, DOI 10.1002/stem.5530110925; JOHN SWM, 1991, NUCLEIC ACIDS RES, V19, P408, DOI 10.1093/nar/19.2.408; JOHNSON DR, 1995, BIOTECHNIQUES, V19, P192; Lenny N, 1997, MOL BIOL REP, V24, P157, DOI 10.1023/A:1006859700409; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Lieschke GJ, 1997, CIBA F SYMP, V204, P60; LLOYD AR, 1995, J BIOL CHEM, V270, P28188; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; MOSER B, 1993, BIOCHEM J, V294, P285, DOI 10.1042/bj2940285; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; PRADO GN, 1994, J BIOL CHEM, V269, P12391; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Sambrook J., 1989, MOL CLONING, P1666; Sanchez X, 1998, J IMMUNOL, V160, P906; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; SPRENGER H, 1994, J IMMUNOL, V153, P2524; SUN ZJ, 1995, J BIOL CHEM, V270, P1462, DOI 10.1074/jbc.270.3.1462; THOMAS KM, 1991, J BIOL CHEM, V266, P14839; TITUS D, 1991, PROMEGA PROTOCOLS AP, P101; VALTIERI M, 1987, J IMMUNOL, V138, P3829; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569	36	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					438	443		10.1074/jbc.274.1.438	http://dx.doi.org/10.1074/jbc.274.1.438			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867862	hybrid			2022-12-27	WOS:000077900200062
J	Chen, E; Hrdlickova, R; Nehyba, J; Longo, DL; Bose, HR; Li, CCH				Chen, E; Hrdlickova, R; Nehyba, J; Longo, DL; Bose, HR; Li, CCH			Degradation of proto-oncoprotein c-Rel by the ubiquitin-proteasome pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; V-REL; IN-VITRO; ONCOGENIC TRANSFORMATION; FAMILY MEMBERS; PEST SEQUENCES; EXPRESSION; ALPHA; PROTEINS; CELLS	The c-rel proto-oncogene product, c-Rel, belongs to the Rel/NF-kappa B transcription factor family, which regulates a large variety of cellular functions. The activation of NF-KB involves the degradation of the inhibitor, I kappa B, through the ubiquitin-proteasome (Ub-Pr)-mediated pathway. Here we report that the turnover of c-Rel is also regulated by the Ub-Pr pathway, thus adding another level of complexity to the regulation of NF-KB. High molecular weight ubiquitinated c-Rel conjugates are detected in cells and accumulate in cells treated with proteasome inhibitors. In a cell-free in vitro degradation assay, c-Rel is degraded specifically through the Ub-Pr pathway. N-terminally truncated c-Rel is readily degraded, implying the dispensability of N-terminal sequence; in contrast, a series of deletion mutants missing C-terminal sequences display a reduced susceptibility to the degradation. Interestingly, the sequence between residues 118 and 171 of c-Rel, i.e. the region immediately following the c-Rel/v-Rel homology domain, appears to play an important role in mediating ubiquitin conjugation and the subsequent degradation. Together with our previous study showing an elevated tumorigenic potential for C-terminally truncated mutants, our data suggest that the C-terminal domain of c-Rel plays an important role in mediating c-Rel degradation and growth control.	NCI, Frederick Canc Res & Dev Ctr, Intramural Res Support Program, SAIC Frederick, Frederick, MD 21702 USA; Univ Texas, Dept Microbiol, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; NIA, Gerontol Res Ctr, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Li, CCH (corresponding author), NCI, Frederick Canc Res & Dev Ctr, Intramural Res Support Program, SAIC Frederick, Frederick, MD 21702 USA.		Longo, Dan L./F-6022-2011		NATIONAL CANCER INSTITUTE [R01CA033192] Funding Source: NIH RePORTER; NCI NIH HHS [CA33192] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABBADIE C, 1993, CELL, V75, P899, DOI 10.1016/0092-8674(93)90534-W; ARIMA N, 1991, J VIROL, V65, P6892, DOI 10.1128/JVI.65.12.6892-6899.1991; BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BOSE HR, 1992, BIOCHIM BIOPHYS ACTA, V1114, P1, DOI 10.1016/0304-419X(92)90002-G; BROWNELL E, 1989, ONCOGENE, V4, P935; BRYAN RG, 1994, MOL CELL BIOL, V14, P7933, DOI 10.1128/MCB.14.12.7933; CAPOBIANCO AJ, 1990, ONCOGENE, V5, P257; Carrasco D, 1996, EMBO J, V15, P3640, DOI 10.1002/j.1460-2075.1996.tb00733.x; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; GILMORE TD, 1991, TRENDS GENET, V7, P318, DOI 10.1016/0168-9525(91)90200-A; GILMORE TD, 1995, FRONTIERS MOL BIOL E, P104; HANNINK M, 1989, MOL CELL BIOL, V9, P4323, DOI 10.1128/MCB.9.10.4323; Hateboer G, 1996, GENE DEV, V10, P2960, DOI 10.1101/gad.10.23.2960; Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/S0968-0004(96)10012-8; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; Hofmann F, 1996, GENE DEV, V10, P2949, DOI 10.1101/gad.10.23.2949; HRDLICKOVA R, 1995, J VIROL, V69, P403; HRDLICKOVA R, 1995, J VIROL, V69, P3369; HRDLICKOVA R, 1994, J VIROL, V68, P2371; KAMENS J, 1990, MOL CELL BIOL, V10, P2840, DOI 10.1128/MCB.10.6.2840; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; LANOIX J, 1994, ONCOGENE, V9, P841; LI CCH, 1995, BIOCHEM BIOPH RES CO, V215, P292, DOI 10.1006/bbrc.1995.2465; LI CCH, 1993, J VIROL, V67, P4205, DOI 10.1128/JVI.67.7.4205-4213.1993; LI CCH, 1994, BIOCHEM J, V303, P499, DOI 10.1042/bj3030499; Luque I, 1997, SEMIN CANCER BIOL, V8, P103, DOI 10.1006/scbi.1997.0061; MacKichan ML, 1996, J BIOL CHEM, V271, P6084, DOI 10.1074/jbc.271.11.6084; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; MOSIALOS G, 1993, ONCOGENE, V8, P721; NEHYBA J, 1994, J VIROL, V68, P2039, DOI 10.1128/JVI.68.4.2039-2050.1994; NISHIZAWA M, 1992, EMBO J, V11, P2433, DOI 10.1002/j.1460-2075.1992.tb05308.x; ORIAN A, 1995, J BIOL CHEM, V270, P21707, DOI 10.1074/jbc.270.37.21707; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PAPAVASSILIOU AG, 1992, SCIENCE, V258, P1941, DOI 10.1126/science.1470918; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; RODRIGUEZ MS, 1995, MOL CELL BIOL, V15, P2413; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Sonenshein GE, 1997, SEMIN CANCER BIOL, V8, P113, DOI 10.1006/scbi.1997.0062; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; TSURUMI C, 1995, MOL CELL BIOL, V15, P5682; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Weil R, 1997, J BIOL CHEM, V272, P9942; Weissman AM, 1997, IMMUNOL TODAY, V18, P189, DOI 10.1016/S0167-5699(97)84666-X; WHITE DW, 1995, ONCOGENE, V10, P857; WHITESIDE ST, 1995, MOL CELL BIOL, V15, P5339; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413	54	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35201	35207		10.1074/jbc.273.52.35201	http://dx.doi.org/10.1074/jbc.273.52.35201			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857058	hybrid			2022-12-27	WOS:000077719700076
J	Ott, VL; Rapraeger, AC				Ott, VL; Rapraeger, AC			Tyrosine phosphorylation of syndecan-1 and -4 cytoplasmic domains in adherent B82 fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; HEPARAN-SULFATE PROTEOGLYCANS; PROTEIN-KINASE-C; SURFACE PROTEOGLYCAN; SIGNAL-TRANSDUCTION; MOLECULAR-BASIS; ADHESION; BINDING; ASSOCIATION; PERVANADATE	The syndecans, a family of cell surface proteoglycans, have highly conserved cytoplasmic domains that bind proteins containing PDZ domains and co-localize with the actin cytoskeleton. The syndecan cytoplasmic domains contain four conserved tyrosine residues, two of which are located within favorable sequences for phosphorylation. Endogenous tyrosine phosphorylation of syndecans-1 and -4 is detected in adherent B82 fibroblasts. Approximately 1.5% of total syndecan is endogenously phosphorylated, while most, if not all, cell surface syndecan is phosphorylated following treatment with the tyrosine phosphatase inhibitor pervanadate. Syndecan phosphorylation is also detected in Raji-S1 and NMuMG cells, but only following treatment with vanadate or pervanadate, suggesting that endogenous phosphorylation is maintained in an "off" state in these cells. Endogenous syndecan phosphorylation in B82 cells is rapidly blocked by genistein (IC50 < 10 mu M) confirming the presence of a constitutively active kinase and a corresponding tyrosine phosphatase. Phosphorylation is also inhibited by herbimycin A (IC50 < 1.0 mu M) and staurosporine (IC50 < 1.0 nM), suggesting a role for Src family kinases in regulating syndecan phosphorylation. Together, these data suggest an important role for tyrosine phosphorylation of the syndecan cytoplasmic domains in regulating downstream signaling events in response to cell adhesion and/or growth factor activity.	Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rapraeger, AC (corresponding author), Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA.	acraprae@facstaff.wisc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R23HD021881, R01HD021881] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21881, HD07477] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS JC, 1993, DEVELOPMENT, V117, P1183; AKIYAMA T, 1991, METHOD ENZYMOL, V201, P362; Asundi VK, 1997, BIOCHEM BIOPH RES CO, V240, P502, DOI 10.1006/bbrc.1997.7684; BACIU PC, 1995, MOL BIOL CELL, V6, P1503, DOI 10.1091/mbc.6.11.1503; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Carey DJ, 1996, J BIOL CHEM, V271, P15253, DOI 10.1074/jbc.271.25.15253; CAREY DJ, 1994, EXP CELL RES, V214, P12, DOI 10.1006/excr.1994.1228; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; DAVID G, 1979, P NATL ACAD SCI USA, V76, P786, DOI 10.1073/pnas.76.2.786; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Grunwald GB, 1993, CURR OPIN CELL BIOL, V5, P797, DOI 10.1016/0955-0674(93)90028-O; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; HECHT D, 1992, BIOCHEM BIOPH RES CO, V188, P773, DOI 10.1016/0006-291X(92)91123-8; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; IIDA J, 1995, CANCER RES, V55, P2177; JALKANEN M, 1987, J CELL BIOL, V105, P3087, DOI 10.1083/jcb.105.6.3087; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; JOHANSSON MW, 1994, J CELL BIOL, V126, P1299, DOI 10.1083/jcb.126.5.1299; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KIEFER MC, 1990, P NATL ACAD SCI USA, V87, P6985, DOI 10.1073/pnas.87.18.6985; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; KODA JE, 1985, J BIOL CHEM, V260, P8157; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; LORIES V, 1989, J BIOL CHEM, V264, P7009; MAINIERO F, 1995, EMBO J, V14, P4470, DOI 10.1002/j.1460-2075.1995.tb00126.x; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; PAWSON T, 1995, NATURE, V373, P477, DOI 10.1038/373477a0; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; RAPRAEGER A, 1986, J CELL BIOL, V103, P2683, DOI 10.1083/jcb.103.6.2683; RAPRAEGER A, 1985, J BIOL CHEM, V260, P4103; Rapraeger AC, 1998, CURR OPIN CELL BIOL, V10, P620, DOI 10.1016/S0955-0674(98)80038-0; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; SALMIVIRTA M, 1991, J BIOL CHEM, V266, P7733; SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423; SCHLAEPFER DD, 1994, NATURE, V372, P786; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; SHWORAK NW, 1994, J BIOL CHEM, V269, P21204; SUN XJ, 1989, J BIOL CHEM, V264, P11288; Vepa S, 1997, FREE RADICAL BIO MED, V22, P25, DOI 10.1016/S0891-5849(96)00241-9; WEISS A, 1995, NATURE, V377, P17, DOI 10.1038/377017a0; WOODS A, 1993, MOL BIOL CELL, V4, P605, DOI 10.1091/mbc.4.6.605; WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; WOODS A, 1992, J CELL SCI, V101, P277; Zhao ZZ, 1996, J BIOL CHEM, V271, P22251, DOI 10.1074/jbc.271.36.22251	54	57	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35291	35298		10.1074/jbc.273.52.35291	http://dx.doi.org/10.1074/jbc.273.52.35291			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857070	hybrid			2022-12-27	WOS:000077719700088
J	Firsov, D; Robert-Nicoud, M; Gruender, S; Schild, L; Rossier, BC				Firsov, D; Robert-Nicoud, M; Gruender, S; Schild, L; Rossier, BC			Mutational analysis of cysteine-rich domains of the epithelium sodium channel (ENaC) - Identification of cysteines essential for channel expression at the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; ALPHA-SUBUNIT; BETA-SUBUNIT; NA+ CHANNEL; ALDOSTERONE	One of the characteristic features of the structure of the epithelial sodium channel family (ENaC) is the presence of two highly conserved cysteine-rich domains (CRD1 and CRD2) in the large extracellular loops of the proteins. We have studied the role of CRDs in the functional expression of rat alpha beta gamma ENaC subunits by systematically mutating cysteine residues (singly or in combinations) into either serine or alanine, In the Xenopus oocyte expression system, mutations of two cysteines in CRD1 of alpha, beta, or gamma ENaC subunits led to a temperature-dependent inactivation of the channel. In CRD1, one of the cysteines of the rat alpha ENaC subunit (Cys(158)) is homologous to Cys(133) Of the corresponding human subunit causing, when mutated to tyrosine (C133Y), pseudohypoaldosteronism type 1, a severe salt-loosing syndrome in neonates. In CRD2, mutation of two cysteines in alpha and beta but not in the gamma subunit also produced a temperature-dependent inactivation of the channel. The main features of the mutant cysteine channels are: (i) a decrease in cell surface expression of channel molecules that parallels the decrease in channel activity and (ii) a normal assembly or rate of degradation as assessed by nondenaturing co-immunoprecipitation of [S-35]methionine-labeled channel protein. These data indicate that the two cysteines in CRD1 and CRD2 are not a prerequisite for subunit assembly and/or intrinsic channel activity. We propose that they play an essential role in the efficient transport of assembled channels to the plasma membrane.	Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Rossier, BC (corresponding author), Univ Lausanne, Inst Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Bernard.Rossier@ipharm.unil.ch	Gründer, Stefan/I-2495-2019	Gründer, Stefan/0000-0002-7635-9883				Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; Beggah AT, 1997, J BIOL CHEM, V272, P10318; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Cheng C, 1998, J BIOL CHEM, V273, P22693, DOI 10.1074/jbc.273.35.22693; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; GEERING K, 1982, J BIOL CHEM, V257, P338; GEERING K, 1985, J BIOL CHEM, V260, P5154; Green WN, 1997, J BIOL CHEM, V272, P20945, DOI 10.1074/jbc.272.33.20945; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Grunder S, 1997, J AM SOC NEPHROL, V8, pA0161; Horisberger JD, 1998, CURR OPIN CELL BIOL, V10, P443, DOI 10.1016/S0955-0674(98)80056-2; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; May A, 1997, J AM SOC NEPHROL, V8, P1813; Mulders SM, 1998, J CLIN INVEST, V102, P57, DOI 10.1172/JCI2605; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Shimkets RA, 1998, P NATL ACAD SCI USA, V95, P3301, DOI 10.1073/pnas.95.6.3301; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329	31	67	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2743	2749		10.1074/jbc.274.5.2743	http://dx.doi.org/10.1074/jbc.274.5.2743			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915805	hybrid			2022-12-27	WOS:000078319500023
J	Calder, RB; Williams, RSB; Ramaswamy, G; Rock, CO; Campbell, E; Unkles, SE; Kinghorn, JR; Jackowski, S				Calder, RB; Williams, RSB; Ramaswamy, G; Rock, CO; Campbell, E; Unkles, SE; Kinghorn, JR; Jackowski, S			Cloning and characterization of a eukaryotic pantothenate kinase gene (panK) from Aspergillus nidulans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A BIOSYNTHESIS; ESCHERICHIA-COLI; RAT-HEART; COAA; PURIFICATION; PEROXISOMES; EXPRESSION; SYNTHETASE; TRANSPORT; SEQUENCE	Pantothenate kinase (PanK) is the key regulatory enzyme in the CoA biosynthetic pathway, The PanK gene from Escherichia coli (coaA) has been previously cloned and the enzyme biochemically characterized; highly related genes exist in other prokaryotes. We isolated a PanK cDNA clone from the eukaryotic fungus Aspergillus nidulans by functional complementation of a temperature-sensitive E. coli PanK mutant. The cDNA clone allowed the isolation of the genomic clone and the characterization of the A. nidulans gene designated panK. The panK gene is located on chromosome (linkage group III), is interrupted by three small introns, and is expressed constitutively. The amino acid sequence of A, nidulans PanK (aPanK) predicted a subunit size of 46.9 kDa and bore little resemblance to its bacterial counterpart, whereas a highly related protein was detected in the genome of Saccharomyces cerevisiae. In contrast to E. coli PanK (bPanK), which is regulated by CoA and to a lesser extent by its thioesters, aPanK activity was selectively and potently inhibited by acetyl-CoA, Acetyl-CoA inhibition of aPanK was competitive with respect to ATP. Thus, the eukaryotic PanK has a distinct primary structure and unique regulatory properties that clearly distinguish it from its prokaryotic counterpart.	St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; Univ St Andrews, Sch Environm & Evolutionary Biol, St Andrews KY16 9TH, Fife, Scotland; Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; Univ Tennessee, Dept Biochem, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of St Andrews; Monash University; University of Tennessee System; University of Tennessee Health Science Center	Jackowski, S (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, 332 N Lauderdale St, Memphis, TN 38105 USA.	suzanne.jackowski@stjude.org	Zhang, Ning/F-1387-2014; Williams, Robin/G-6807-2011; Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429	NIGMS NIH HHS [GM 34496, GM 45737] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045737, R37GM034496, R01GM034496] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abiko Y., 1975, Metabolism of sulphur compounds., P1; Aleshin AE, 1998, STRUCTURE, V6, P39, DOI 10.1016/S0969-2126(98)00006-9; BARBARAT B, 1986, J BIOL CHEM, V261, P4455; BAUMANN P, 1968, BIOCHEMISTRY-US, V7, P3653, DOI 10.1021/bi00850a044; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Dimroth P, 1997, MOL MICROBIOL, V25, P3, DOI 10.1046/j.1365-2958.1997.4611824.x; DIMROTH P, 1976, EUR J BIOCHEM, V64, P269, DOI 10.1111/j.1432-1033.1976.tb10297.x; FALK KL, 1993, ARCH BIOCHEM BIOPHYS, V301, P424, DOI 10.1006/abbi.1993.1166; FISHER MN, 1985, J BIOL CHEM, V260, P5745; FLAKS JG, 1966, COLD SPRING HARB SYM, V31, P623, DOI 10.1101/SQB.1966.031.01.081; FLAMM JA, 1988, GENE, V74, P555, DOI 10.1016/0378-1119(88)90189-8; Gurr SJ, 1987, GENE STRUCTURE EUKAR, P93; HALVORSEN O, 1982, EUR J BIOCHEM, V124, P211, DOI 10.1111/j.1432-1033.1982.tb05927.x; HORIE S, 1986, J BIOCHEM, V99, P1345, DOI 10.1093/oxfordjournals.jbchem.a135602; JACKOWSKI S, 1986, J BACTERIOL, V166, P866, DOI 10.1128/jb.166.3.866-871.1986; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; JACKOWSKI S, 1990, J BACTERIOL, V172, P3842, DOI 10.1128/jb.172.7.3842-3848.1990; Jackowski S., 1996, ESCHERICHIA COLI SAL, P687; KERBEY AL, 1977, BIOCHEM J, V164, P509, DOI 10.1042/bj1640509; LOPASCHUK GD, 1987, J BIOL CHEM, V262, P3615; MACCABE AP, 1991, J BIOL CHEM, V266, P12646; MACCABE AP, 1990, EMBO J, V9, P279, DOI 10.1002/j.1460-2075.1990.tb08106.x; ROBISHAW JD, 1985, AM J PHYSIOL, V248, pE1, DOI 10.1152/ajpendo.1985.248.1.E1; ROBISHAW JD, 1982, J BIOL CHEM, V257, P967; ROBISHAW JD, 1984, AM J PHYSIOL, V246, pH532, DOI 10.1152/ajpheart.1984.246.4.H532; Segel IH, 1975, ENZYME KINETICS, P623; SIEGMUND KD, 1991, BIOCHIM BIOPHYS ACTA, V1076, P123, DOI 10.1016/0167-4838(91)90228-R; SKREDE S, 1979, BIOCHEM BIOPH RES CO, V91, P1536, DOI 10.1016/0006-291X(79)91239-7; SONG WJ, 1994, J BIOL CHEM, V269, P27051; SONG WJ, 1992, J BACTERIOL, V174, P1705, DOI 10.1128/jb.174.5.1705-1706.1992; SONG WJ, 1992, J BACTERIOL, V174, P6411, DOI 10.1128/JB.174.20.6411-6417.1992; VAGELOS RP, 1971, CURR TOP CELL REGUL, V4, P119; VALLARI DS, 1985, J BACTERIOL, V162, P1156, DOI 10.1128/JB.162.3.1156-1161.1985; VALLARI DS, 1987, J BACTERIOL, V169, P5795, DOI 10.1128/jb.169.12.5795-5800.1987; VALLARI DS, 1985, J BACTERIOL, V164, P136, DOI 10.1128/JB.164.1.136-142.1985; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; VANBROEKHOVEN A, 1981, BIOCHEM BIOPH RES CO, V100, P305, DOI 10.1016/S0006-291X(81)80097-6; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	40	77	82	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2014	2020		10.1074/jbc.274.4.2014	http://dx.doi.org/10.1074/jbc.274.4.2014			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890959	hybrid			2022-12-27	WOS:000078185200026
J	Chaturvedi, S; Qi, HL; Coleman, D; Rodriguez, A; Hanson, PI; Striepen, B; Roos, DS; Joiner, KA				Chaturvedi, S; Qi, HL; Coleman, D; Rodriguez, A; Hanson, PI; Striepen, B; Roos, DS; Joiner, KA			Constitutive calcium-independent release of Toxoplasma gondii dense granules occurs through the NSF/SNAP/SNARE/Rab machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITOPHOROUS VACUOLE MEMBRANE; GDP DISSOCIATION INHIBITOR; ADRENAL CHROMAFFIN CELLS; SENSITIVE FUSION PROTEIN; PANCREATIC BETA-CELLS; GTP-BINDING PROTEINS; REGULATED EXOCYTOSIS; AMYLASE RELEASE; INTRACELLULAR PARASITE; GUANINE-NUCLEOTIDES	The signals and the molecular machinery mediating release of dense matrix granules from pathogenic protozoan parasites are unknown. We compared the secretion of the endogenous dense granule marker GRA3 in Toxoplasma gondii with the release of a stably transfected foreign reporter, beta-lactamase, that localizes to parasite dense granules. Both proteins were released constitutively in a calcium-independent fashion, as shown using both intact and streptolysin O-permeabilized parasites. N-Ethylmaleimide and recombinant bovine Rab-guanine dissociation inhibitor inhibited p-lactamase secretion in permeabilized parasites, whereas recombinant hamster N-ethylmaleimide-sensitive fusion protein and bovine alpha-SNAP augmented release. Guanosine 5'-3-O-(thio)triphosphate, but not cAMP, augmented secretion in the presence but not in the absence of ATP. The T. gondii NSF/SNAP/SNARE/Rab machinery participates in dense granule release using parasite protein components that can interact functionally with their mammalian homologues.	Yale Univ, Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Yale University; Yale University; Yale University; University of Pennsylvania	Joiner, KA (corresponding author), Yale Univ, Sch Med, Infect Dis Sect, Dept Internal Med, LCI 808,POB 208022, New Haven, CT 06520 USA.	Keith.Joiner@yale.edu	Joiner, Keith/AAH-1059-2021; Hanson, Phyllis/E-9420-2012	Joiner, Keith/0000-0003-3062-823X; Roos, David Siker/0000-0001-6725-4089; Striepen, Boris/0000-0002-7426-432X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030060] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI30060] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHBAROU A, 1991, PARASITOLOGY, V103, P321, DOI 10.1017/S0031182000059837; Aguado F, 1997, J BIOL CHEM, V272, P26005, DOI 10.1074/jbc.272.41.26005; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; ARVAN P, 1991, J BIOL CHEM, V266, P14171; Arvan Peter, 1992, Trends in Cell Biology, V2, P327; Austin CD, 1996, J BIOL CHEM, V271, P1194, DOI 10.1074/jbc.271.2.1194; Ayad N, 1997, EMBO J, V16, P4497, DOI 10.1093/emboj/16.15.4497; BARROWMAN MM, 1986, NATURE, V319, P504, DOI 10.1038/319504a0; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; BECKERS CJM, 1995, J CLIN INVEST, V95, P367, DOI 10.1172/JCI117665; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Castle AM, 1997, J CELL BIOL, V138, P45, DOI 10.1083/jcb.138.1.45; CESBRONDELAUW MF, 1994, PARASITOL TODAY, V10, P293, DOI 10.1016/0169-4758(94)90078-7; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; DARCY F, 1988, PARASITE IMMUNOL, V10, P553, DOI 10.1111/j.1365-3024.1988.tb00242.x; DeLisle RC, 1996, EUR J CELL BIOL, V71, P62; DUBREMETZ JF, 1993, PARASITOL RES, V79, P402, DOI 10.1007/BF00931830; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; Fensome A, 1996, CURR BIOL, V6, P730, DOI 10.1016/S0960-9822(09)00454-0; Fernandez CJ, 1997, MOL BIOL CELL, V8, P2171, DOI 10.1091/mbc.8.11.2171; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; FRAGA D, 1994, GENE, V147, P145, DOI 10.1016/0378-1119(94)90055-8; FujitaYoshigaki J, 1996, J BIOL CHEM, V271, P13130, DOI 10.1074/jbc.271.22.13130; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; GOMPERTS BD, 1986, FASEB J, V45, P2156; Halonen SK, 1996, J EUKARYOT MICROBIOL, V43, P187, DOI 10.1111/j.1550-7408.1996.tb01389.x; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HOLZ RW, 1991, ANN NY ACAD SCI, V635, P382, DOI 10.1111/j.1749-6632.1991.tb36506.x; HUANG XF, 1994, J BIOL CHEM, V269, P20838; IKONEN E, 1995, CELL, V81, P571, DOI 10.1016/0092-8674(95)90078-0; Karsten V, 1998, J CELL BIOL, V141, P1323, DOI 10.1083/jcb.141.6.1323; Karsten V, 1997, METHODS, V13, P103, DOI 10.1006/meth.1997.0503; KELLY RB, 1993, NEURON S, V10, P43; Kuliawat R, 1997, J CELL BIOL, V137, P595, DOI 10.1083/jcb.137.3.595; KULIAWAT R, 1992, J CELL BIOL, V118, P521, DOI 10.1083/jcb.118.3.521; Lawrence GW, 1996, EUR J BIOCHEM, V236, P877, DOI 10.1111/j.1432-1033.1996.00877.x; Lemons PP, 1997, BLOOD, V90, P1490, DOI 10.1182/blood.V90.4.1490.1490_1490_1500; LERICHE MA, 1991, MOL BIOCHEM PARASIT, V45, P249, DOI 10.1016/0166-6851(91)90092-K; MATSUUCHI L, 1991, J CELL BIOL, V112, P843, DOI 10.1083/jcb.112.5.843; MILLER SG, 1991, J CELL BIOL, V112, P39, DOI 10.1083/jcb.112.1.39; MOLLARD GFV, 1994, TRENDS BIOCHEM SCI, V19, P164; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Moreno SNJ, 1996, BIOCHEM J, V313, P655, DOI 10.1042/bj3130655; MORGAN A, 1995, EMBO J, V14, P232, DOI 10.1002/j.1460-2075.1995.tb06996.x; OCALLAGHAN CH, 1972, ANTIMICROB AGENTS CH, V1, P283, DOI 10.1128/AAC.1.4.283; OSSORIO PN, 1994, J BIOL CHEM, V269, P15350; PERKINS ME, 1992, PARASITOL TODAY, V8, P28, DOI 10.1016/0169-4758(92)90308-O; PETERSON JB, 1991, J PROTOZOOL, V38, P495, DOI 10.1111/j.1550-7408.1991.tb04823.x; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; REGAZZI R, 1995, EMBO J, V14, P2723, DOI 10.1002/j.1460-2075.1995.tb07273.x; RUBIN RP, 1994, J PHARMACOL EXP THER, V268, P600; SamYellowe TY, 1996, PARASITOL TODAY, V12, P308, DOI 10.1016/0169-4758(96)10030-2; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Seeber F, 1996, GENE, V169, P39, DOI 10.1016/0378-1119(95)00786-5; SIBLEY LD, 1994, EXP PARASITOL, V79, P301, DOI 10.1006/expr.1994.1093; SIBLEY LD, 1986, J CELL BIOL, V103, P867, DOI 10.1083/jcb.103.3.867; Silverman J. A., 1996, Host response to intracellular pathogens., P313; Skouri F, 1997, MOL BIOL CELL, V8, P1063; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STEDMAN TT, 1999, PHAGOCYTOSIS PATHOGE; Striepen B, 1998, MOL BIOCHEM PARASIT, V92, P325, DOI 10.1016/S0166-6851(98)00011-5; Striggow F, 1996, CURR OPIN CELL BIOL, V8, P490, DOI 10.1016/S0955-0674(96)80025-1; TAKUMA T, 1994, J BIOL CHEM, V269, P22124; TURNER MD, 1992, J CELL BIOL, V117, P269, DOI 10.1083/jcb.117.2.269; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; ZASTROW MV, 1987, J CELL BIOL, V105, P2675	71	53	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2424	2431		10.1074/jbc.274.4.2424	http://dx.doi.org/10.1074/jbc.274.4.2424			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891012	hybrid			2022-12-27	WOS:000078185200079
J	Shih, SC; Claffey, KP				Shih, SC; Claffey, KP			Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; 3' UNTRANSLATED REGION; AU-RICH ELEMENTS; BINDING-PROTEIN; 3'-UNTRANSLATED REGION; IDENTIFICATION; SEQUENCE; DEGRADATION; VEGF; STABILIZATION	A 126-base region of human vascular endothelial growth factor (VEGF) 3'-untranslated region, which we identified as the hypoxia stability region, forms seven hypoxia-inducible RNA-protein complexes with apparent molecular masses ranging from 40 to 90 kDa in RNA-UV-cross-linking assays. In this study, we show that proteins that form the 60-kDa RNA-protein complex with the hypoxia stability region were present in both cytoplasmic and nuclear compartments We purified the protein associated in the 60-kDa complex and identified it as heterogeneous nuclear ribonucleoprotein L (hnRNP L) by protein sequencing. Removal of hnRNP L by immunoprecipitation specifically abolished formation of the 60-kDa complex. Synthetic deoxyribonucleotide competition studies defined th, RNA-binding site of hnRNP L as a 21-base-long sequence, 5'-CACCCACCCA-CAUACAUACA-3'. Immunoprecipitation of hnRNP L followed by reverse transcription-polymerase chain reaction showed that hnRNP L specifically interacts with VEGF mRNA in hypoxic cells in vivo. Furthermore, when M21 cells transfected with antisense oligodeoxyribonucleotide to the hnRNP L RNA-binding site, the VEGF mRNA half-life was significantly reduced under hypoxic conditions. Thus, we propose that specific association of hnRNP L with VEGF mRNA under hypoxia may play an important role in hypoxia-induced posttranscriptional regulation of VEGF mRNA expression.	Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Claffey, KP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 99 Brookline Ave, Boston, MA 02215 USA.				NCI NIH HHS [CA 64436] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA064436, R01CA064436] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOHJANEN PR, 1992, J BIOL CHEM, V267, P6302; BOHJANEN PR, 1991, MOL CELL BIOL, V11, P3288, DOI 10.1128/MCB.11.6.3288; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; CZYZYKRZESKA MF, 1994, J BIOL CHEM, V269, P9940; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; GILLIS P, 1991, J BIOL CHEM, V266, P3172; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; Kiledjian M, 1997, MOL CELL BIOL, V17, P4870, DOI 10.1128/MCB.17.8.4870; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Levy AP, 1996, J BIOL CHEM, V271, P25492, DOI 10.1074/jbc.271.41.25492; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; LIU XD, 1995, GENE DEV, V9, P1766, DOI 10.1101/gad.9.14.1766; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; PINOLROMA S, 1989, J CELL BIOL, V109, P2575, DOI 10.1083/jcb.109.6.2575; RONDON IJ, 1991, J BIOL CHEM, V266, P16594; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHIMA DT, 1995, FEBS LETT, V370, P203, DOI 10.1016/0014-5793(95)00831-S; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; STEIN I, 1995, MOL CELL BIOL, V15, P5363; VAKALOPOULOU E, 1991, MOL CELL BIOL, V11, P3355, DOI 10.1128/MCB.11.6.3355; White FC, 1995, GROWTH FACTORS, V12, P289, DOI 10.3109/08977199509028967; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	30	177	179	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1359	1365		10.1074/jbc.274.3.1359	http://dx.doi.org/10.1074/jbc.274.3.1359			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880507	hybrid			2022-12-27	WOS:000079956900027
J	Jiang, PH; Lagenaur, CF; Narayanan, V				Jiang, PH; Lagenaur, CF; Narayanan, V			Integrin-associated protein is a ligand for the P84 neural adhesion molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURITE OUTGROWTH; CD47; EXPRESSION; RECEPTOR; BINDING; FAMILY; DOMAIN; GLYCOPROTEIN; SUBSTRATE; MIGRATION	P84 (also known as SHPS-1, BIT, and SIRP) is a heterophilic adhesive membrane protein involved in receptor tyrosine kinase signaling that is found at synapses in the mammalian central nervous system and in non-neural tissues. We have identified a binding partner for P84 using an expression cloning strategy. Here we report that integrin-associated protein (IAP/CD47) is a predominant binding partner of P84. Immunohistochemistry reveals a virtually identical distribution of P84 and IAP in a variety of adult brain regions. Because IAP has been implicated in cell signaling in cells of the immune system, P84 and LAP represent a heterophilic binding pair that is likely to be involved in bi-directional signaling at the synapse and in other tissues.	Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Narayanan, V (corresponding author), Childrens Hosp Pittsburgh, Rm 7151 Rangos Bldg,3705 5th Ave & DeSoto St, Pittsburgh, PA 15213 USA.	nara+@pitt.edu		Narayanan, Vinodh/0000-0002-0658-3847				ABOSCH A, 1993, J NEUROBIOL, V24, P344, DOI 10.1002/neu.480240307; Adams S, 1998, J IMMUNOL, V161, P1853; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; CHUANG W, 1990, DEV BIOL, V137, P219, DOI 10.1016/0012-1606(90)90249-I; Comu S, 1997, J NEUROSCI, V17, P8702; COOPER D, 1995, P NATL ACAD SCI USA, V92, P3978, DOI 10.1073/pnas.92.9.3978; Einheber S, 1996, J COMP NEUROL, V370, P105; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Furusawa T, 1998, J BIOCHEM-TOKYO, V123, P101; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Huang AM, 1998, J NEUROSCI, V18, P4305; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Lindberg FP, 1996, J CELL BIOL, V134, P1313, DOI 10.1083/jcb.134.5.1313; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; LINDBERG FP, 1993, J CELL BIOL, V123, P485, DOI 10.1083/jcb.123.2.485; MAWBY WJ, 1994, BIOCHEM J, V304, P525, DOI 10.1042/bj3040525; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Parkos CA, 1996, J CELL BIOL, V132, P437, DOI 10.1083/jcb.132.3.437; REINHOLD MI, 1995, J CELL SCI, V108, P3419; ROSALES C, 1992, J IMMUNOL, V149, P2759; Sano S, 1997, FEBS LETT, V411, P327, DOI 10.1016/S0014-5793(97)00724-2; SCHNITZER J, 1981, J NEUROIMMUNOL, V1, P429, DOI 10.1016/0165-5728(81)90022-9; SENIOR RM, 1992, J CLIN INVEST, V90, P2251, DOI 10.1172/JCI116111; Ticchioni M, 1997, J IMMUNOL, V158, P677; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Waclavicek M, 1997, J IMMUNOL, V159, P5345	30	255	272	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					559	562		10.1074/jbc.274.2.559	http://dx.doi.org/10.1074/jbc.274.2.559			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872987	hybrid			2022-12-27	WOS:000077968500002
J	Braam, LAM; Goryshin, IY; Reznikoff, WS				Braam, LAM; Goryshin, IY; Reznikoff, WS			A mechanism for Tn5 inhibition - Carboxyl-terminal dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; TRANSPOSASE; MUTANTS	Tn5 is unique among prokaryotic transposable elements in that it encodes a special inhibitor protein identical to the Tn5 transposase except lacking a short NH2-terminal DNA binding sequence. This protein regulates transposition through nonproductive protein-protein interactions with transposase, We have studied the mechanism of Tn5 inhibition in vitro and find that a heterodimeric complex between the inhibitor and transposase is critical for inhibition, probably via a DNA-bound form of transposase. Two dimerization domains are known in the inhibitor/transposase shared sequence, and we show that the COOH-terminal domain is necessary for inhibition, correlating with the ability of the inhibitor protein to homodimerize via this domain. This regulatory complex may provide clues to the structures of functional synaptic complexes. Additionally, we find that NH2- and COOH-terminal regions of transposase or inhibitor are in functional contact. The NH2 terminus appears to occlude transposase homodimerization (hypothetically mediated by the COOH terminus), an effect that might contribute to productive transposition. Conversely, a deletion of the COOH terminus uncovers a secondary DNA binding region in the inhibitor protein which is probably located near the NH2 terminus.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, MD PHD Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Reznikoff, WS (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	reznikoff@biochem.wisc.edu			NIGMS NIH HHS [GM07215, GM50692] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERG DE, 1989, MOBILE DNA, P186; Braam LAM, 1998, J BIOL CHEM, V273, P10908, DOI 10.1074/jbc.273.18.10908; DELACRUZ NB, 1993, J BACTERIOL, V175, P6932, DOI 10.1128/jb.175.21.6932-6938.1993; DELONG A, 1991, P NATL ACAD SCI USA, V88, P6072, DOI 10.1073/pnas.88.14.6072; Goryshin IY, 1998, J BIOL CHEM, V273, P7367, DOI 10.1074/jbc.273.13.7367; KREBS MP, 1988, GENE, V63, P277, DOI 10.1016/0378-1119(88)90531-8; KUNZE R, 1993, P NATL ACAD SCI USA, V90, P7094, DOI 10.1073/pnas.90.15.7094; Lee CC, 1996, MOL CELL BIOL, V16, P5616; MIZUUCHI K, 1992, J BIOL CHEM, V267, P21273; REZNIKOFF WS, 1993, ANNU REV MICROBIOL, V47, P945, DOI 10.1146/annurev.mi.47.100193.004501; REZSOHAZY R, 1993, MOL MICROBIOL, V9, P1283, DOI 10.1111/j.1365-2958.1993.tb01258.x; Schumacher S, 1997, EMBO J, V16, P7532, DOI 10.1093/emboj/16.24.7532; vanPouderoyen G, 1997, EMBO J, V16, P6044, DOI 10.1093/emboj/16.19.6044; WEINREICH MD, 1994, J MOL BIOL, V241, P166, DOI 10.1006/jmbi.1994.1486; WIEGAND TW, 1994, J MOL BIOL, V235, P486, DOI 10.1006/jmbi.1994.1008; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; York D, 1996, NUCLEIC ACIDS RES, V24, P3790, DOI 10.1093/nar/24.19.3790; Zhou M, 1998, J MOL BIOL, V276, P913, DOI 10.1006/jmbi.1997.1579; Zhou M, 1997, J MOL BIOL, V271, P362, DOI 10.1006/jmbi.1997.1188	19	35	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					86	92		10.1074/jbc.274.1.86	http://dx.doi.org/10.1074/jbc.274.1.86			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867814	hybrid			2022-12-27	WOS:000077900200014
J	Erhardt, JA; Hynicka, W; DiBenedetto, A; Shen, N; Stone, N; Paulson, H; Pittman, RN				Erhardt, JA; Hynicka, W; DiBenedetto, A; Shen, N; Stone, N; Paulson, H; Pittman, RN			A novel F box protein, NFB42, is highly enriched in neurons and induces growth arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCES; CELL-CYCLE; S-PHASE; NEUROBLASTOMA-CELLS; KINASE; DIFFERENTIATION; PROTEOLYSIS; PHOSPHORYLATION; EXPRESSION; KINETOCHORE	NFB42 (neural F Box 42 kDa) is a novel gene product that is highly enriched in the nervous system. Its predicted protein contains an F box, a motif recently shown to couple cell cycle regulation to the proteasome pathway (Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J. W., and Elledge, S. (1996) Cell 86, 263-274). NFB42 mRNA and protein are expressed in all major areas of the adult rat brain but are not detected in non-neural tissues. NFB42 protein is localized primarily to the cytoplasm of neurons and does not appear to be present in glia, The presence of an F box in NFB42 suggests that it may be involved in cell cycle regulation; however, its expression in postmitotic neurons indicates that it is not involved in regulating typical cell cycle events. In an initial attempt to characterize the function of this protein, NFB42 was transfected into N1E-115 neuroblastoma and Chinese hamster ovary cells. The expression of full-length NFB42, but not an F box deletion mutant, inhibits proliferation in both cell lines. Additional experiments demonstrate that NFB42 interacts with Skp1p, a component of the proteasome pathway, and deletion of the F box also inhibits this interaction. Overall, the expression pattern of NFB42, along with the presence of an F box domain and the ability to inhibit growth, suggests that it may play a role in maintaining neurons in a postmitotic state.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Erhardt, JA (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032465] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32465] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAI C, 1994, EMBO J, V13, P6087, DOI 10.1002/j.1460-2075.1994.tb06955.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; Erhardt JA, 1998, ONCOGENE, V16, P443, DOI 10.1038/sj.onc.1201577; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Gao CY, 1997, BIOESSAYS, V19, P307, DOI 10.1002/bies.950190408; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; HAYES TE, 1991, NEW BIOL, V3, P259; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Hoyt MA, 1997, CELL, V91, P149, DOI 10.1016/S0092-8674(00)80396-7; INO H, 1994, BRAIN RES, V661, P196, DOI 10.1016/0006-8993(94)91197-5; ISAKSSON A, 1996, BIOCHIM BIOPHYS ACTA, V1288, P21; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; KATAYAMA C, 1990, STRATEGIES MOL BIOL, V4, P56; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; KRANENBURG O, 1995, J CELL BIOL, V131, P227, DOI 10.1083/jcb.131.1.227; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; Poluha W, 1996, MOL CELL BIOL, V16, P1335; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Ross ME, 1996, TRENDS NEUROSCI, V19, P62, DOI 10.1016/0166-2236(96)89622-6; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; THALMANN I, 1993, HEARING RES, V64, P191, DOI 10.1016/0378-5955(93)90005-L; UroCoste E, 1997, NEUROREPORT, V8, P1675, DOI 10.1097/00001756-199705060-00023; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Wuarin J, 1996, CELL, V85, P785, DOI 10.1016/S0092-8674(00)81261-1; YAN GZ, 1995, J NEUROSCI, V15, P6200; YEN SH, 1995, J NEUROCHEM, V65, P2577; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6	33	54	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35222	35227		10.1074/jbc.273.52.35222	http://dx.doi.org/10.1074/jbc.273.52.35222			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857061	hybrid			2022-12-27	WOS:000077719700079
J	Rao-Naik, C; delaCruz, W; Laplaza, JM; Tan, S; Callis, J; Fisher, AJ				Rao-Naik, C; delaCruz, W; Laplaza, JM; Tan, S; Callis, J; Fisher, AJ			The rub family of ubiquitin-like proteins - Crystal structure of arabidopsis Rub1 and expression of multiple rubs in arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; SACCHAROMYCES-CEREVISIAE; ENCODES; GENES; CONJUGATION; REFINEMENT; HOMOLOG; RANGAP1; SUMO-1; AUXIN	Several proteins with significant identity to ubiquitin have been characterized recently. In contrast to ubiquitin's main role in targeting proteins for degradation, a described function of one family of ubiquitin-related proteins, the Rub family, is to serve as a stable posttranslational modification of a complex involved in the G(1)-to-S cell cycle transition. Rub proteins have been found in animals, plants, and fungi and consist of 76 residues with 52-63% identity to ubiquitin. In this study three different RUB proteins within the plant Arabidopsis are identified; two differ by only 1 amino acid, while the third is only 77.6% identical to the other two. Genes encoding all three are expressed in multiple organs. In addition, we report the crystal structure of higher plant RUB1 at 1.7-Angstrom resolution to help elucidate the functional differences between Rub and ubiquitin. RUB1 contains a single globular domain with a flexible COOH-terminal extension. The overall RUB1 structure is very similar to ubiquitin. The majority of the amino acid differences between RUB1 and ubiquitin map to the surface. These changes alter the electrostatic surface potential in two regions and likely confer specificity between ubiquitin and RUB1 and their ubiquitin-activating enzyme (El) or El-like activating enzymes.	Univ Calif Davis, Sect Mol & Cellular Biol, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis	Fisher, AJ (corresponding author), Univ Calif Davis, Sect Mol & Cellular Biol, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	fisher@chem.ucdavis.edu		Fisher, Andrew/0000-0003-3488-6594; Callis, Judy/0000-0002-0622-078X; Delacruz, Wilfred/0000-0001-5363-6975	NIGMS NIH HHS [GM 56774] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056774] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; BRUNGER AT, 1990, XPLOR SYSTEM CRYSTAL; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; CALLIS J, 1995, GENETICS, V139, P921; Chandler JS, 1997, MOL GEN GENET, V255, P302, DOI 10.1007/s004380050501; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; DESHAIES RJ, 1995, EMBO J, V14, P303, DOI 10.1002/j.1460-2075.1995.tb07004.x; ESTELLE M, 1992, BIOESSAYS, V14, P439, DOI 10.1002/bies.950140703; GARRETT KP, 1995, P NATL ACAD SCI USA, V92, P7172, DOI 10.1073/pnas.92.16.7172; GUARINO LA, 1990, P NATL ACAD SCI USA, V87, P409, DOI 10.1073/pnas.87.1.409; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Haas AL, 1996, BIOCHEMISTRY-US, V35, P5385, DOI 10.1021/bi9524981; Haas AL, 1997, FASEB J, V11, P1257; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Johnson PR, 1997, TRENDS CELL BIOL, V7, P408, DOI 10.1016/S0962-8924(97)01132-X; JONES D, 1993, J BIOL CHEM, V268, P19545; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kamitani T, 1997, J BIOL CHEM, V272, P14001, DOI 10.1074/jbc.272.22.14001; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; LINNEN JM, 1993, GENE, V128, P181, DOI 10.1016/0378-1119(93)90561-G; LOEB KR, 1994, MOL CELL BIOL, V14, P8408, DOI 10.1128/MCB.14.12.8408; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Narasimhan J, 1996, J BIOL CHEM, V271, P324, DOI 10.1074/jbc.271.1.324; NAVAZA J, 1993, ACTA CRYSTALLOGR D, V49, P588, DOI 10.1107/S0907444993005141; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OLVERA J, 1993, J BIOL CHEM, V268, P17967; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; RECHSTEINER M, 1998, UBIQUITIN BIOL CELL, P147; ROCHESTER DE, 1986, EMBO J, V5, P451, DOI 10.1002/j.1460-2075.1986.tb04233.x; SAIKI RK, 1990, PCR PROTOCOLS GUIDE, P21; Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X; Schwarz SE, 1998, P NATL ACAD SCI USA, V95, P560, DOI 10.1073/pnas.95.2.560; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; TONIOLO D, 1988, P NATL ACAD SCI USA, V85, P851, DOI 10.1073/pnas.85.3.851; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757	56	75	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34976	34982		10.1074/jbc.273.52.34976	http://dx.doi.org/10.1074/jbc.273.52.34976			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857029	hybrid			2022-12-27	WOS:000077719700047
J	Song, MM; Shuai, K				Song, MM; Shuai, K			The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONALLY ACTIVE STAT1; TYROSINE KINASE; TARGETED DISRUPTION; GAMMA-INTERFERON; PATHWAY; GENE; TRANSDUCTION; ACTIVATION; ALPHA/BETA; GROWTH	The suppressor of cytokine signaling (SOCS) proteins are a family of cytokine-inducible negative regulators of cytokine signaling. Interferon (IFN)-gamma treatment induces the expression of SOCS1, SOCS2, and SOCS3 mRNAs. To examine the effect of SOCS proteins on IFN-mediated Janus-activated kinase/signal transducers and activators of transcription (STAT) signaling, HeLa- and MCF-7-derived stable cell lines expressing SOCS1, SOCS2, and SOCS3 proteins were established, SOCS1 and SOCS3 but not SOCS2 inhibited the tyrosine phosphorylation and nuclear translocation of STAT1 in response to IFN stimulation. The IFN-mediated antiviral and antiproliferative activities were consistently blocked by the constitutive expression of SOCS1 and SOCS3 but not SOCS2 proteins. The maximum inhibitory activities of SOCS1 and SOCS3 proteins toward the activation of STAT1 were observed at very low levels of SOCS protein expression. In addition, SOCS1 exhibited a much stronger inhibitory activity toward the activation of STAT1 than did SOCS3, These results suggest that SOCS1 and SOCS3 but not SOCS2 are inhibitors of IFN-mediated Janus-activated kinase/STAT signaling pathways.	Univ Calif Los Angeles, Inst Mol Biol, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Shuai, K (corresponding author), Div Hematol Oncol, 11-934 Factor Bldg,10833 LeConte Ave, Los Angeles, CA 90095 USA.	Kshuai@mednet.ucla.edu						Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; AMAN JM, 1997, CURR BIOL, V7, pR784; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Demaeyer E., 1988, INTERFERONS OTHER RE; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Horvath CM, 1996, J VIROL, V70, P647, DOI 10.1128/JVI.70.1.647-650.1996; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Minamoto S, 1997, BIOCHEM BIOPH RES CO, V237, P79, DOI 10.1006/bbrc.1997.7080; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Ohya K, 1997, J BIOL CHEM, V272, P27178, DOI 10.1074/jbc.272.43.27178; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; Shuai K, 1996, MOL CELL BIOL, V16, P4932; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x	30	330	351	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35056	35062		10.1074/jbc.273.52.35056	http://dx.doi.org/10.1074/jbc.273.52.35056			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857039	hybrid			2022-12-27	WOS:000077719700057
J	Vriend, G; Berendsen, HJC; van den Burg, B; Venema, G; Eijsink, VGH				Vriend, G; Berendsen, HJC; van den Burg, B; Venema, G; Eijsink, VGH			Early steps in the unfolding of thermolysin-like proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTILIS NEUTRAL PROTEASE; BACILLUS-SUBTILIS; THERMAL-STABILITY; THERMOSTABILITY; SURFACE; STEAROTHERMOPHILUS; MUTATIONS; PROTEINS; LYSOZYME; ENZYMES	Several series of site-directed mutations in thermolysin-like proteases are presented that show remarkable nonadditivity in their effect on thermal stability. A simple model is proposed that relates this nonadditivity to the occurrence of independent partial unfolding processes that occur in parallel at elevated temperatures. To prove this model, a thermolysin-like protease was designed in which two mutations located similar to 35 Angstrom apart in the structure individually exert small stabilizing effects of 2.3 and 4.1 degrees C, respectively, but when combined stabilize the protease by 14.6 degrees C. This overadditivity, which follows directly from the model, confirms that unfolding of this engineered protease starts in parallel at two different regions of the protein.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Univ Groningen, BIOSON Res Inst, NL-9747 AG Groningen, Netherlands; Univ Groningen, Dept Genet, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands; Agr Univ Norway, Dept Biotechnol Sci, N-1432 As, Norway	European Molecular Biology Laboratory (EMBL); University of Groningen; University of Groningen; Norwegian University of Life Sciences	Vriend, G (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	Vriend@EMBL-Heidelberg.DE	Vriend, Gert/D-6730-2011; Vriend, G./H-8112-2014					BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; BRAXTON S, 1992, BIOCHEMISTRY-US, V31, P7796, DOI 10.1021/bi00149a008; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chamberlain AK, 1996, NAT STRUCT BIOL, V3, P782, DOI 10.1038/nsb0996-782; CHRUNYK BA, 1993, PROTEIN ENG, V6, P733, DOI 10.1093/protein/6.7.733; Creighton T.E., 1993, PROTEINS; DAHLQUIST FW, 1976, BIOCHEMISTRY-US, V15, P1103, DOI 10.1021/bi00650a024; Daniel RM, 1996, BIOCHEM J, V317, P1, DOI 10.1042/bj3170001; delPino MMS, 1997, BIOCHEMISTRY-US, V36, P5560, DOI 10.1021/bi963133z; EIJSINK VGH, 1992, PROTEIN ENG, V5, P157, DOI 10.1093/protein/5.2.157; EIJSINK VGH, 1995, NAT STRUCT BIOL, V2, P374, DOI 10.1038/nsb0595-374; EIJSINK VGH, 1992, PROTEIN ENG, V5, P421, DOI 10.1093/protein/5.5.421; EIJSINK VGH, 1991, BIOCHEM INT, V24, P517; EIJSINK VGH, 1992, PROTEIN ENG, V5, P165; EIJSINK VGH, 1992, PROTEINS, V14, P224, DOI 10.1002/prot.340140209; FERSHT AR, 1993, CURR OPIN STRUC BIOL, V3, P75, DOI 10.1016/0959-440X(93)90205-Y; FONTANA A, 1988, BIOPHYS CHEM, V29, P181, DOI 10.1016/0301-4622(88)87038-8; Fontana A, 1997, FOLD DES, V2, pR17, DOI 10.1016/S1359-0278(97)00010-2; Frigerio F, 1996, PROTEIN ENG, V9, P439, DOI 10.1093/protein/9.5.439; FUJII M, 1983, J BACTERIOL, V154, P831, DOI 10.1128/JB.154.2.831-837.1983; HARDY F, 1994, PROTEIN ENG, V7, P425, DOI 10.1093/protein/7.3.425; Heinrikson R L, 1977, Methods Enzymol, V47, P175; KIDOKORO S, 1995, FEBS LETT, V367, P73, DOI 10.1016/0014-5793(95)00537-J; KIEFHABER T, 1995, NATURE, V375, P513, DOI 10.1038/375513a0; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Mansfeld J, 1997, J BIOL CHEM, V272, P11152, DOI 10.1074/jbc.272.17.11152; MARGARIT I, 1992, PROTEIN ENG, V5, P543, DOI 10.1093/protein/5.6.543; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P37, DOI 10.1038/newbio238037a0; MATTHEWS BW, 1995, ADV PROTEIN CHEM, V46, P249, DOI 10.1016/S0065-3233(08)60337-X; MITCHINSON C, 1989, BIOCHEMISTRY-US, V28, P4807, DOI 10.1021/bi00437a043; MITRAKI A, 1989, BIO-TECHNOL, V7, P690, DOI 10.1038/nbt0789-690; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; PERUTZ MF, 1980, PROTEIN FOLDING, P14; STOEVA S, 1989, BIOL CHEM H-S, V370, P1139, DOI 10.1515/bchm3.1989.370.2.1139; VANDENBURG B, 1989, J BIOCHEM BIOPH METH, V18, P209, DOI 10.1016/0165-022X(89)90005-5; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; VRIEND G, 1993, J COMPUT AID MOL DES, V7, P367, DOI 10.1007/BF02337558; Wallenhorst WF, 1997, BIOCHEMISTRY-US, V36, P5795, DOI 10.1021/bi9700476; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001	40	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35074	35077		10.1074/jbc.273.52.35074	http://dx.doi.org/10.1074/jbc.273.52.35074			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857041	hybrid			2022-12-27	WOS:000077719700059
J	Perrella, M; Di Cera, E				Perrella, M; Di Cera, E			CO ligation intermediates and the mechanism of hemoglobin cooperativity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Direct experimental resolution of the ligation intermediates for the reaction of human hemoglobin with CO reveals the distribution of ligated states as a function of saturation. At low saturation, binding of CO occurs with slightly higher affinity to the beta chains, but pairwise interactions are more pronounced between the cu chains. At high saturation, the two chains tend to behave identically. The sequence of CO ligation reconstructed from the distribution of intermediates shows that the overall increase in CO affinity is 588-fold, but it is not distributed uniformly among the ligation steps. The affinity increases 16.5-fold in the second ligation step, 4.6-fold in the third ligation step, and 7.7-fold in the fourth ligation step. This pattern and the detailed distribution of ligated states cannot be immediately reconciled with the predictions of either the concerted allosteric model of Monod-Wyman-Changeux or the sequential model of Koshland-Nemethy-Filmer and underscore a more subtle mechanism for hemoglobin cooperativity.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Univ Milan, Dipartimento Sci & Tecnol Biomed, I-20090 Segrate, Italy	Washington University (WUSTL); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan	Di Cera, E (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	enrico@caesar.wustl.edu			NHLBI NIH HHS [HL49413, HL58141] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL049413, R01HL049413, R01HL058141] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ackers GK, 1998, ADV PROTEIN CHEM, V51, P185; ACKERS GK, 1992, SCIENCE, V255, P54, DOI 10.1126/science.1553532; Adair GS, 1925, J BIOL CHEM, V63, P529; Di Cera E., 1995, THERMODYNAMIC THEORY; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Henry ER, 1997, BIOCHEMISTRY-US, V36, P6511, DOI 10.1021/bi9619177; HO C, 1992, ADV PROTEIN CHEM, V43, P153, DOI 10.1016/S0065-3233(08)60555-0; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; OLSON JS, 1971, J BIOL CHEM, V246, P5919; PERRELLA M, 1990, BIOPHYS CHEM, V37, P211, DOI 10.1016/0301-4622(90)88020-S; PERRELLA M, 1994, METHOD ENZYMOL, V232, P445; Perrella M, 1998, BIOCHEMISTRY-US, V37, P2017, DOI 10.1021/bi971669u; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1	16	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2605	2608		10.1074/jbc.274.5.2605	http://dx.doi.org/10.1074/jbc.274.5.2605			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915786	hybrid			2022-12-27	WOS:000078319500004
J	Sengupta, S; Tripathi, J; Tandon, R; Raje, M; Roy, RP; Basu, SK; Mukhopadhyay, A				Sengupta, S; Tripathi, J; Tandon, R; Raje, M; Roy, RP; Basu, SK; Mukhopadhyay, A			Hemoglobin endocytosis in Leishmania is mediated through a 46-kDa protein located in the flagellar pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; MEXICANA-AMAZONENSIS; TRYPANOSOMA-BRUCEI; BINDING PROTEIN; RECEPTOR; HEME; IDENTIFICATION; TRANSFERRIN; ACQUISITION; PARASITES	Four lines of evidence indicate that a specific high affinity binding site on the surface of Leishmania donovani promastigotes mediates rapid internalization and degradation of hemoglobin. 1) Binding and uptake of I-125-hemoglobin by Leishmania followed saturation kinetics and were competed by unlabeled hemoglobin but not by globin or hemin or other heme- or iron-containing proteins. 2) Immunogold labeling studies revealed that, at 4 degrees C, hemoglobin binding was localized in the flagellar pocket of the promastigotes. Indirect immuno-fluorescence assays showed that, at 37 degrees C, the bound hemoglobin in such cells entered an endocytic compartment within 2 min and dispersed throughout the cell body by 15 min. 3) After incubation with hemoglobin-gold conjugates at 25 degrees C or 37 degrees C, the particles accumulated in discrete intracellular vesicles. 4) A single biotinylated protein of 46-kDa was revealed when solubilized membranes from surface biotinylated intact Leishmania adsorbed by hemoglobin-agarose beads were subjected to SDS-polyacrylamide gel electrophoresis and Western blotting with avidin-horseradish peroxidase, Considered together, these data indicate that this 46-kDa protein on the cell surface of L, donovani promastigotes mediates the binding of hemoglobin and its rapid internalization through a vesicular pathway characteristic of receptor-mediated endocytosis.	Natl Inst Immunol, New Delhi 110067, India; Inst Microbial Technol, Sector 39A, Chandigarh 160014, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Basu, SK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	sandip@nii.res.in	Mukhopadhyay, Asok/C-4051-2009					Bastin P, 1996, MOL BIOCHEM PARASIT, V76, P43, DOI 10.1016/0166-6851(95)02537-5; BASU SK, 1984, J BIOSCIENCES, V6, P535, DOI 10.1007/BF02703904; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Bezkorovainy A, 1987, IRON INFECTION, P27; BRICKMAN MJ, 1995, J CELL SCI, V108, P3611; BUSSON S, 1989, BIOL CELL, V67, P37, DOI 10.1111/j.1768-322X.1989.tb03008.x; CHANG CS, 1985, MOL BIOCHEM PARASIT, V16, P267, DOI 10.1016/0166-6851(85)90069-6; CHANG KP, 1983, INT REV CYTOL, P267; CHANG KP, 1974, SCIENCE, V183, P531, DOI 10.1126/science.183.4124.531; CHANG KP, 1975, P NATL ACAD SCI USA, V72, P2979, DOI 10.1073/pnas.72.8.2979; CHAUDHURI G, 1982, INDIAN J MED RES, V76, P157; Chen CJ, 1996, INFECT IMMUN, V64, P5008, DOI 10.1128/IAI.64.12.5008-5014.1996; COPPENS I, 1987, J PROTOZOOL, V34, P465, DOI 10.1111/j.1550-7408.1987.tb03216.x; DEMEY J, 1986, IMMUNOCYTOCHEMISTRY, P115; Fujimura S, 1996, INFECT IMMUN, V64, P2339, DOI 10.1128/IAI.64.6.2339-2342.1996; GALBRAITH RA, 1988, MOL BIOCHEM PARASIT, V29, P47, DOI 10.1016/0166-6851(88)90118-1; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; HUEBERS HA, 1987, PHYSIOL REV, V67, P520, DOI 10.1152/physrev.1987.67.2.520; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; LWOFF M, 1965, BIOCH PHYSL PROTOZOA, P131; MARSDEN PD, 1984, REV INFECT DIS, V6, P736; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Osborn M, 1994, CELL BIOL LAB HDB, V2, P347; OUAISSI MA, 1986, MOL BIOCHEM PARASIT, V19, P201, DOI 10.1016/0166-6851(86)90002-2; Overath P, 1997, TRENDS CELL BIOL, V7, P27, DOI 10.1016/S0962-8924(97)10046-0; OVERKAMP D, 1988, J IMMUNOASSAY, V9, P51, DOI 10.1080/01971528808053210; Rosenthal PJ, 1996, MOL BIOCHEM PARASIT, V83, P131, DOI 10.1016/S0166-6851(96)02763-6; Roy J.C., 1932, IND J MED RES, V20, P367; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; Tanaka WTH, 1997, BIOCHEM BIOPH RES CO, V232, P350, DOI 10.1006/bbrc.1997.6247; VOYIATZAKI CS, 1992, J BIOL CHEM, V267, P9112; WILEMAN T, 1985, BIOCHEM J, V232, P1; ZURZOLO C, 1994, CELL BIOL LAB HDB, V3, P185	35	63	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2758	2765		10.1074/jbc.274.5.2758	http://dx.doi.org/10.1074/jbc.274.5.2758			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915807	hybrid			2022-12-27	WOS:000078319500025
J	Xiong, XM; Chong, E; Skach, WR				Xiong, XM; Chong, E; Skach, WR			Evidence that endoplasmic reticulum (ER)-associated degradation of cystic fibrosis transmembrane conductance regulator is linked to retrograde translocation from the ER membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; I HEAVY-CHAINS; PROTEIN TRANSLOCATION; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; CULTURED-CELLS; 20S PROTEASOME; MESSENGER-RNA; COMPLEX; CFTR; ATP	The ubiquitin-proteasome pathway has been implicated in the degradation of newly synthesized, misfolded and unassembled proteins in the endoplasmic reticulum (ER), Using a cell-free reticulocyte lysate system we have examined the relationship between biosynthesis and ER-associated degradation of the cystic fibrosis transmembrane conductance regulator (CFTR), a polytopic protein with 12 predicted transmembrane segments. Our results provide direct evidence that length, glycosylated and membrane-integrated CFTR is a substrate for degradation and that degradation involves polyubiquitination and cytosolic proteolytic activity, CFTR ubiquitination was both temperature- and ATP-dependent, Degradation was significantly inhibited by EDTA, apyrase, and the proteasome inhibitors hemin and MG132, Degradation was inhibited to a lesser extent by clasto-lactacystin beta-lactone, ALLN, and N-alpha-tosyl-L-phenylalanine chloromethyl ketone and was relatively unaffected by lactacystin and N-tosyl lysyl chloromethyl ketone. In the presence of hemin, polyubiquitinated CFTR remained tightly associated with ER microsomes. However, membrane-bound ubiquitinated CFTR could be subsequently degraded into trichloroacetic acid-soluble fragments upon incubation in hemin-free, ATP-containing lysate, Thus ER-associated degradation of CFTR occurs via a membrane-bound, rather than cytosolic, intermediate and likely involves recruitment of degradation machinery to the ER membrane, Our data suggest a model in which the degradation of polytopic proteins such as CFTR is coupled to retrograde translocation and removal of the polypeptide from the lipid bilayer.	Univ Penn, Dept Mol & Cellular Engn, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Skach, WR (corresponding author), Oregon Hlth Sci Univ, Div Mol Med, 3181 SW Sam Jackson Pk Rd,NRC-3, Portland, OR 97201 USA.	skachw@ohsu.edu			NIDDK NIH HHS [DK51818] Funding Source: Medline; NIGMS NIH HHS [GM53457] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053457] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315; BEUZARD Y, 1973, P NATL ACAD SCI USA, V70, P1022, DOI 10.1073/pnas.70.4.1022; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Bonifacino Juan S., 1994, V15, P137; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; Dick LR, 1997, J BIOL CHEM, V272, P182; Dick LR, 1996, J BIOL CHEM, V271, P7273, DOI 10.1074/jbc.271.13.7273; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; EDWARDS PA, 1983, J BIOL CHEM, V258, P7272; ETLINGER JD, 1977, P NATL ACAD SCI USA, V74, P54, DOI 10.1073/pnas.74.1.54; EYTAN E, 1993, J BIOL CHEM, V268, P4668; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; HAAS AL, 1981, P NATL ACAD SCI-BIOL, V78, P6845, DOI 10.1073/pnas.78.11.6845; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; HARTL FU, 1994, TRENDS BIOCHEM SCI, V19, P20, DOI 10.1016/0968-0004(94)90169-4; HASEGAWA H, 1992, SCIENCE, V258, P1477, DOI 10.1126/science.1279809; HEGDE R, 1997, CELL, V91, P675; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538; HOUGH R, 1986, J BIOL CHEM, V261, P2400; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnson AE, 1997, TRENDS CELL BIOL, V7, P90, DOI 10.1016/S0962-8924(97)01029-5; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; LENZ JR, 1977, NATURE, V266, P191, DOI 10.1038/266191a0; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Lu Y, 1998, J BIOL CHEM, V273, P568, DOI 10.1074/jbc.273.1.568; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; LYKO F, 1995, J BIOL CHEM, V270, P19873, DOI 10.1074/jbc.270.34.19873; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; MULLINS C, 1995, J BIOL CHEM, V270, P17139, DOI 10.1074/jbc.270.29.17139; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Qu BH, 1996, J BIOL CHEM, V271, P7261, DOI 10.1074/jbc.271.13.7261; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; QU D, 1996, J BIOL CHEM, V271, P22971; RAPOPORT TA, 1990, TRENDS BIOCHEM SCI, V15, P355, DOI 10.1016/0968-0004(90)90076-N; Rapoport TA, 1996, CURR OPIN CELL BIOL, V8, P499, DOI 10.1016/S0955-0674(96)80027-5; RIORDAN JR, 1989, SCIENCE, V245, P1066; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; ROITELMAN J, 1992, J BIOL CHEM, V267, P25264; SASAVAGE NL, 1982, J BIOL CHEM, V257, P678; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Xiong XM, 1997, J CLIN INVEST, V100, P1079, DOI 10.1172/JCI119618; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180	63	94	94	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2616	2624		10.1074/jbc.274.5.2616	http://dx.doi.org/10.1074/jbc.274.5.2616			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915789	hybrid			2022-12-27	WOS:000078319500007
J	Chibalin, AV; Ogimoto, G; Pedemonte, CH; Pressley, TA; Katz, AI; Feraille, E; Berggren, PO; Bertorello, AM				Chibalin, AV; Ogimoto, G; Pedemonte, CH; Pressley, TA; Katz, AI; Feraille, E; Berggren, PO; Bertorello, AM			Dopamine-induced endocytosis of Na+,K+-ATPase is initiated by phosphorylation of Ser-18 in the rat alpha subunit and is responsible for the decreased activity in epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PROXIMAL TUBULE CELLS; K-ATPASE ACTIVITY; INTRACELLULAR NA+; XENOPUS OOCYTES; NA,K-ATPASE; SITE; STIMULATION; ACTIVATION; PATHWAY	Dopamine inhibits Na+,K+-ATPase activity in renal tubule cells. This inhibition is associated with phosphorylation and internalization of the a subunit, both events being protein kinase C-dependent, Studies of purified preparations, fusion proteins with site-directed mutagenesis, and heterologous expression systems have identified two major protein kinase C phosphorylation residues (Ser-11 and Ser-18) in the rat alpha(1) subunit isoform. To identify the phosphorylation site(s) that mediates endocytosis of the subunit in response to dopamine, we have performed site-directed mutagenesis of these residues in the rat alpha(1) subunit and expressed the mutated forms in a renal epithelial cell line. Dopamine inhibited Na+,K+-ATPase activity and increased alpha subunit phosphorylation and clathrin-dependent endocytosis into endosomes in cells expressing the wild type alpha(1) subunit or the S11A alpha(1) mutant, and both effects were blocked by protein kinase C inhibition. In contrast, dopamine did not elicit any of these effects in cells expressing the S18A alpha(1) mutant. While Ser-18 phosphorylation is necessary for endocytosis, it does not affect per se the enzymatic activity: preventing endocytosis with wort-mannin or LY294009 Mocked the inhibitory effect of dopamine on Na+,K+-ATPase activity, although it did not alter the increased alpha subunit phosphorylation induced by this agonist. We conclude that dopamine-induced inhibition of Na+,K+-ATPase activity in rat renal tubule cells requires endocytosis of the alpha subunit into defined intracellular compartments and that phosphorylation of Ser-18 is essential for this process.	Karolinska Hosp, Rolf Luft Ctr Diabet Res, Karolinska Inst, Dept Mol Med, S-17176 Stockholm, Sweden; Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA; Texas Tech Univ, Dept Physiol, Lubbock, TX 79430 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Hop Cantonal Geneva, Div Nephrol, CH-1211 Geneva 14, Switzerland	Karolinska Institutet; Karolinska University Hospital; University of Houston System; University of Houston; Texas Tech University System; Texas Tech University; University of Chicago; University of Geneva	Bertorello, AM (corresponding author), Karolinska Hosp, Rolf Luft Ctr Diabet Res, Karolinska Inst, Dept Mol Med, L6B 01, S-17176 Stockholm, Sweden.	alejan@enk.ks.se		Feraille, Eric/0000-0003-1656-8365; Chibalin, Alexander/0000-0002-6339-6271; Berggren, Per-Olof/0000-0001-8991-413X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK052273] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52273] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Belusa R, 1997, J BIOL CHEM, V272, P20179, DOI 10.1074/jbc.272.32.20179; Beron J, 1997, MOL BIOL CELL, V8, P387, DOI 10.1091/mbc.8.3.387; BERTORELLO A, 1989, AM J PHYSIOL, V256, pF370, DOI 10.1152/ajprenal.1989.256.2.F370; BERTORELLO AM, 1992, J CELL SCI, V101, P343; BERTORELLO AM, 1991, P NATL ACAD SCI USA, V88, P11359, DOI 10.1073/pnas.88.24.11359; BERTORELLO AM, 1993, AM J PHYSIOL, V265, pF743, DOI 10.1152/ajprenal.1993.265.6.F743; BERTORELLO AM, 1999, IN PRESS AM J PHYSL; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; Carranza ML, 1996, AM J PHYSIOL-CELL PH, V271, pC136, DOI 10.1152/ajpcell.1996.271.1.C136; Chibalin AV, 1998, J BIOL CHEM, V273, P8814, DOI 10.1074/jbc.273.15.8814; Chibalin AV, 1997, AM J PHYSIOL-CELL PH, V273, pC1458, DOI 10.1152/ajpcell.1997.273.5.C1458; Chibalin AV, 1998, MOL BIOL CELL, V9, P1209, DOI 10.1091/mbc.9.5.1209; CHIBALIN AV, 1992, J BIOL CHEM, V267, P22378; CourtoisCoutry N, 1997, CELL, V90, P501, DOI 10.1016/S0092-8674(00)80510-3; ERUSALIMSKY JD, 1988, J BIOL CHEM, V263, P19188; FERAILLE E, 1995, AM J PHYSIOL-CELL PH, V268, pC1277, DOI 10.1152/ajpcell.1995.268.5.C1277; FESCHENKO MS, 1994, J BIOL CHEM, V269, P30436; Feschenko MS, 1997, J BIOL CHEM, V272, P17726, DOI 10.1074/jbc.272.28.17726; FESCHENKO MS, 1995, J BIOL CHEM, V270, P14072, DOI 10.1074/jbc.270.23.14072; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; HAMMOND TG, 1994, AM J PHYSIOL, V266, pF554, DOI 10.1152/ajprenal.1994.266.4.F554; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMAZE C, 1995, CURR OPIN CELL BIOL, V7, P573, DOI 10.1016/0955-0674(95)80015-8; Logvinenko NS, 1996, P NATL ACAD SCI USA, V93, P9132, DOI 10.1073/pnas.93.17.9132; LOWNDES JM, 1990, BIOCHIM BIOPHYS ACTA, V1052, P143, DOI 10.1016/0167-4889(90)90069-P; MIDDLETON JP, 1993, J BIOL CHEM, V268, P15958; NESTLER EJ, 1980, P NATL ACAD SCI-BIOL, V77, P7479, DOI 10.1073/pnas.77.12.7479; NISHI A, 1993, ACTA PHYSIOL SCAND, V149, P377, DOI 10.1111/j.1748-1716.1993.tb09633.x; Ominato M, 1996, J MEMBRANE BIOL, V152, P235, DOI 10.1007/s002329900101; Pedemonte CH, 1997, MOL PHARMACOL, V52, P88, DOI 10.1124/mol.52.1.88; PIERCE BMF, 1990, ANN REV CELL BIOL, V6, P151; ROSE JK, 1991, BIOTECHNIQUES, V10, P520; SCHMALZING G, 1990, AM J PHYSIOL, V258, pC179, DOI 10.1152/ajpcell.1990.258.1.C179; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; Vasilets LA, 1997, CELL PHYSIOL BIOCHEM, V7, P1, DOI 10.1159/000154847	40	184	186	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1920	1927		10.1074/jbc.274.4.1920	http://dx.doi.org/10.1074/jbc.274.4.1920			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890946	hybrid			2022-12-27	WOS:000078185200013
J	Jakubik, J; Wess, J				Jakubik, J; Wess, J			Use of a sandwich enzyme-linked immunosorbent assay strategy to study mechanisms of G protein-coupled receptor assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; BETA(2) ADRENERGIC-RECEPTOR; POSITIVE ALLOSTERIC ACTION; SITE-DIRECTED MUTAGENESIS; V2 VASOPRESSIN RECEPTORS; FUNCTIONAL-ROLE; CONFORMATIONAL-CHANGES; TRANSMEMBRANE HELICES; MUTATIONAL ANALYSIS; ANTAGONIST BINDING	All G protein-coupled receptors are predicted to consist of a bundle of seven transmembrane helices (I-VII) that are connected by various extracellular and intracellular loops. At present, little is known about the molecular interactions that are critical for the proper assembly of the transmembrane receptor core. To address this issue, we took advantage of the ability of coexpressed N- and C-terminal m3 muscarinic receptor fragments to form functional receptor complexes (Schoneberg, T. Liu, J., and Wess, J. (1995) J. Biol. Chem. 270, 18000-18006). As a model system, we used two polypeptides, referred to, m3-trunk and m3-tail, that were generated by "splitting'' the m3 muscarinic receptor within the third intracellular loop. We initially demonstrated, by employing a sandwich enzyme-linked immunosorbent assay strategy, that the two receptor fragments directly associate with each other when coexpressed in COS-7 cells. Additional studies with N- and C terminal fragments derived from other G protein-coupled receptors showed that fragment association was highly receptor-specific. In subsequent experiments, the sandwich enzyme-linked immunosorbent assay system was used to identify amino acids that are required for proper fragment (receptor) assembly. Point mutations were introduced into m3-trunk or m3-tail, and the ability of these mutations to interfere with efficient fragment assembly was examined. These studies showed that three highly conserved proline residues (located in transmembrane helices V, VI, and VII) are essential for proper fragment association (receptor assembly). Interestingly, incubation with classical muscarinic agonists and antagonists or allosteric ligands led to significant increases in the efficiency of fragment association (particularly upon substitution of the conserved proline residues), indicating that all of these ligands can act as "anchors" between the m3-trunk and m3-tail fragments. The approach described here should be generally applicable to gain deeper insight into the molecular mechanisms governing G protein-coupled receptor structure and assembly.	NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wess, J (corresponding author), NIDDK, Bioorgan Chem Lab, NIH, Bldg 8A,Rm B1A-05, Bethesda, MD 20892 USA.		Jakubik, Jan/B-7461-2012	Jakubik, Jan/0000-0002-1737-1487				Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BLUML K, 1994, J BIOL CHEM, V269, P11537; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; CLARK AL, 1976, BRIT J PHARMACOL, V58, P323, DOI 10.1111/j.1476-5381.1976.tb07708.x; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; ELLIS J, 1993, MOL PHARMACOL, V44, P5873; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; GETHER U, 1995, J BIOL CHEM, V270, P28268; Grosse R, 1997, MOL ENDOCRINOL, V11, P1305, DOI 10.1210/me.11.9.1305; JAKUBIK J, 1995, J PHARMACOL EXP THER, V274, P1077; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEPPIK RA, 1994, MOL PHARMACOL, V45, P983; Liu J, 1996, J BIOL CHEM, V271, P6172, DOI 10.1074/jbc.271.11.6172; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Maggio R, 1996, J BIOL CHEM, V271, P31055, DOI 10.1074/jbc.271.49.31055; MAGGIO R, 1993, FEBS LETT, V319, P195, DOI 10.1016/0014-5793(93)80066-4; MATSUI H, 1995, MOL PHARMACOL, V47, P88; NEDOMA J, 1985, N-S ARCH PHARMACOL, V329, P176, DOI 10.1007/BF00501209; Nielsen SM, 1998, EUR J BIOCHEM, V251, P217, DOI 10.1046/j.1432-1327.1998.2510217.x; Proska J, 1996, EUR J PHARMACOL, V305, P201, DOI 10.1016/0014-2999(96)00169-0; RIDGE KD, 1995, P NATL ACAD SCI USA, V92, P3204, DOI 10.1073/pnas.92.8.3204; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Schoneberg T, 1996, EMBO J, V15, P1283, DOI 10.1002/j.1460-2075.1996.tb00470.x; Schoneberg T, 1997, J CLIN INVEST, V100, P1547, DOI 10.1172/JCI119678; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; STOCKTON JM, 1983, MOL PHARMACOL, V23, P551; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; TUCEK S, 1995, TRENDS PHARMACOL SCI, V16, P205, DOI 10.1016/S0165-6147(00)89023-9; WATSON S, 1994, G PROTEIN LINKED REC, P1; WESS J, 1992, J BIOL CHEM, V267, P19313; WESS J, 1991, EMBO J, V10, P3729, DOI 10.1002/j.1460-2075.1991.tb04941.x; WESS J, 1993, EMBO J, V12, P331, DOI 10.1002/j.1460-2075.1993.tb05661.x; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; WILLIAMS KA, 1991, BIOCHEMISTRY-US, V30, P8919, DOI 10.1021/bi00101a001; YU HB, 1995, BIOCHEMISTRY-US, V34, P14963, DOI 10.1021/bi00046a002	40	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1349	1358		10.1074/jbc.274.3.1349	http://dx.doi.org/10.1074/jbc.274.3.1349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880506	hybrid			2022-12-27	WOS:000079956900026
J	Kaartinen, MT; Pirhonen, A; Linnala-Kankkunen, A; Maenpaa, PH				Kaartinen, MT; Pirhonen, A; Linnala-Kankkunen, A; Maenpaa, PH			Cross-linking of osteopontin by tissue transglutaminase increases its collagen binding properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE ACIDIC GLYCOPROTEIN-75; HYDROXYAPATITE FORMATION; EXTRACELLULAR-MATRIX; BOVINE OSTEOPONTIN; CRYSTAL-GROWTH; IN-VITRO; PROTEIN; OSTEOCALCIN; INHIBITION; PHOSPHOPROTEINS	Osteopontin, a major noncollagenous bone protein, is an in vitro and in vivo substrate of tissue transglutaminase, which catalyzes formation of cross-linked protein osteopontin are presently not fully understood. In this study we provide evidence that transglutaminase treatment significantly increases the binding of osteopontin to collagen. This was tested with an enzyme-linked immunosorbent assay. The results also show that this increased interaction is clearly calcium-dependent and specific to osteopontin. In dot blot overlay assay 1 mu g of collagen type I was able to bind 420 ng of in vitro prepared and purified polymeric osteopontin and only 83 ng of monomeric osteopontin, indicating that the transglutaminase treatment introduces a 5-fold amount of osteopontin onto collagen. Assays using a reversed situation showed that the collagen binding of the polymeric form of osteopontin appears to be dependent on its conformation in solution. Circular dichroism analysis of monomeric and polymeric osteopontin indicated that transglutaminase treatment induces a conformational change in osteopontin, probably exposing motives relevant to its interactions with other extracellular molecules. This altered collagen binding property of osteopontin may have relevance to its biological functions in tissue repair, bone remodeling, and collagen fibrillogenesis.	Univ Kuopio, Dept Biochem & Biotechnol, FIN-70210 Kuopio, Finland	University of Eastern Finland	Kaartinen, MT (corresponding author), Univ Kuopio, Dept Biochem & Biotechnol, POB 1627, FIN-70211 Kuopio, Finland.	Mari.Kaartinen@uku.fi		Kaartinen, Mari/0000-0003-2999-6502				AESCHLIMANN D, 1995, J CELL BIOL, V129, P881, DOI 10.1083/jcb.129.3.881; AESCHLIMANN D, 1993, J CELL BIOL, V120, P1461, DOI 10.1083/jcb.120.6.1461; AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; BENINATI S, 1994, J BIOCHEM-TOKYO, V115, P675, DOI 10.1093/oxfordjournals.jbchem.a124395; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; BOSKEY AL, 1992, CLIN ORTHOP RELAT R, P244; BOWNESS JM, 1988, BIOCHIM BIOPHYS ACTA, V967, P234; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; CHEN Y, 1992, J BIOL CHEM, V267, P24871; Christensen BM, 1996, J AGR FOOD CHEM, V44, P1943, DOI 10.1021/jf9602131; CURLEYJOSEPH J, 1979, J DENT RES, V58, P1625, DOI 10.1177/00220345790580061201; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; ENDO A, 1989, CONNECT TISSUE RES, V21, P509, DOI 10.3109/03008208909050008; FITZPATRICK LA, 1994, J CLIN INVEST, V94, P1597, DOI 10.1172/JCI117501; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; GIACHELLI CM, 1995, ANN NY ACAD SCI, V760, P109, DOI 10.1111/j.1749-6632.1995.tb44624.x; GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041; GLIMCHER MJ, 1989, ANAT REC, V224, P139, DOI 10.1002/ar.1092240205; GORSKI JP, 1995, ANN NY ACAD SCI, V760, P12, DOI 10.1111/j.1749-6632.1995.tb44616.x; GORSKI JP, 1992, CALCIFIED TISSUE INT, V50, P391, DOI 10.1007/BF00296767; Gorski JP, 1997, J CELL BIOCHEM, V64, P547; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; IKURA K, 1980, AGR BIOL CHEM TOKYO, V44, P1567, DOI 10.1080/00021369.1980.10864171; Jurgensen K, 1997, J BONE JOINT SURG AM, V79A, P185, DOI 10.2106/00004623-199702000-00004; Kaartinen MT, 1997, J BIOL CHEM, V272, P22736, DOI 10.1074/jbc.272.36.22736; KLEMAN JP, 1995, BIOCHEMISTRY-US, V34, P13768, DOI 10.1021/bi00042a007; Liaw L, 1998, J CLIN INVEST, V101, P1468; LIU SH, 1995, CLIN ORTHOP RELAT R, P265; MARK MP, 1987, J HISTOCHEM CYTOCHEM, V35, P707, DOI 10.1177/35.7.3295029; MARK MP, 1988, DIFFERENTIATION, V37, P123, DOI 10.1111/j.1432-0436.1988.tb00804.x; MCKEE MD, 1992, ANAT REC, V234, P479, DOI 10.1002/ar.1092340404; McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W; PRINCE CW, 1991, BIOCHEM BIOPH RES CO, V177, P1205, DOI 10.1016/0006-291X(91)90669-X; ROMBERG RW, 1986, BIOCHEMISTRY-US, V25, P1176, DOI 10.1021/bi00353a035; Sasaki T, 1997, J BIOL CHEM, V272, P9237; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; SORENSEN ES, 1995, ANN NY ACAD SCI, V760, P363, DOI 10.1111/j.1749-6632.1995.tb44658.x; SORENSEN ES, 1994, BIOCHEM J, V304, P13, DOI 10.1042/bj3040013; SORENSEN ES, 1993, J DAIRY RES, V60, P189, DOI 10.1017/S0022029900027503; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; YURCHENCO PD, 1994, METHOD ENZYMOL, V245, P489	43	137	147	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1729	1735		10.1074/jbc.274.3.1729	http://dx.doi.org/10.1074/jbc.274.3.1729			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880554	hybrid			2022-12-27	WOS:000079956900074
J	Milne, KG; Ferguson, MAJ; Englund, PT				Milne, KG; Ferguson, MAJ; Englund, PT			A novel glycosylphosphatidylinositol in African trypanosomes - A possible catabolic intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARIANT SURFACE GLYCOPROTEIN; PHOSPHATIDYLINOSITOL MEMBRANE ANCHORS; DE-N-ACETYLASE; PHOSPHOLIPASE-C; GLYCOLIPID PRECURSORS; RESISTANT GLYCOLIPIDS; MYRISTATE EXCHANGE; INOSITOL-ACYLATION; BIOSYNTHESIS; BRUCEI	The major glycosylphosphatidylinositols (GPIs) in African trypanosomes are glycolipid A, the precursor of the variant surface glycoprotein membrane anchor, and glycolipid C, a species identical to glycolipid A except that it contains an acylated inositol. Both glycolipids A and C contain dimyristoyl glycerol and are efficiently labeled with [H-3]myristate in a cell free system. We now report a novel GPI known as lipid X. This GPI is radio-labeled strongly with [H-3]palmitate (and very poorly with [H-3]myristate or [H-3]stearate) in digitonin-permeabilized cells. The structure of lipid X is Man(1)GlcNAc-(2-O-palmitoyl)-D-myo-inositol-1-HPO4-3(lyso-palmitoylglycerol). Metabolically, lipid X exists as an intermediate, and can be detected only under conditions in which its formation is stimulated (e.g. by EDTA) or its breakdown is inhibited (e.g. by Co2+). Lipid X has not been observed previously because these conditions do not support GPI biosynthesis We speculate that lipid X is an intermediate in the catabolism of conventional trypanosome GPIs possibly deriving from breakdown of glycolipid C.	Univ Dundee, Dept Biochem, Dundee DD1 5EH, Scotland; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	University of Dundee; Johns Hopkins University	Milne, KG (corresponding author), Univ Dundee, Dept Biochem, Wellcome Trust Bldg, Dundee DD1 5EH, Scotland.		Ferguson, Michael A. J./F-7829-2010	Ferguson, Michael A. J./0000-0003-1321-8714	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021334] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 21334] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Buxbaum LU, 1996, P NATL ACAD SCI USA, V93, P1178, DOI 10.1073/pnas.93.3.1178; BUXBAUM LU, 1994, J BIOL CHEM, V269, P30212; CLARKSON AB, 1989, J BIOL CHEM, V264, P17770; COTTAZ S, 1993, J CHEM SOC PERK T 1, P2945, DOI 10.1039/p19930002945; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; DIXON H, 1971, COMP BIOCHEM PHYSIOL, V39, P247, DOI 10.1016/0305-0491(71)90168-4; DOERING TL, 1989, J BIOL CHEM, V264, P11168; DOERING TL, 1993, J BIOL CHEM, V268, P9215; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; Ferguson M. A. J., 1992, LIPID MODIFICATION P, P191; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; FERGUSON MAJ, 1992, BIOCHEM J, V284, P297, DOI 10.1042/bj2840297; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FIELD MC, 1993, LIPID MODIFICATIONS, P83; GUTHER MLS, 1994, J BIOL CHEM, V269, P18694; GUTHER MLS, 1995, EMBO J, V14, P3080, DOI 10.1002/j.1460-2075.1995.tb07311.x; HOLDER AA, 1983, BIOCHEM J, V209, P261, DOI 10.1042/bj2090261; KRAKOW JL, 1986, J BIOL CHEM, V261, P2147; LOW MG, 1989, BIOCHIM BIOPHYS ACTA, V988, P427, DOI 10.1016/0304-4157(89)90014-2; LOW MG, 1988, P NATL ACAD SCI USA, V85, P980, DOI 10.1073/pnas.85.4.980; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MASTERSON WJ, 1991, EMBO J, V10, P2041, DOI 10.1002/j.1460-2075.1991.tb07734.x; MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6; MAYOR S, 1990, J BIOL CHEM, V265, P6164; MAYOR S, 1990, J BIOL CHEM, V265, P6174; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MELLORS A, 1989, PARASITOL TODAY, V5, P239, DOI 10.1016/0169-4758(89)90255-X; MENON AK, 1992, J BIOL CHEM, V267, P15277; MENON AK, 1993, EMBO J, V12, P1907, DOI 10.1002/j.1460-2075.1993.tb05839.x; MENON AK, 1990, J BIOL CHEM, V265, P9033; MENON AK, 1990, EMBO J, V9, P4249, DOI 10.1002/j.1460-2075.1990.tb07873.x; MENSAWILMOT K, 1995, METHOD ENZYMOL, V250, P641; MILNE KG, 1994, J BIOL CHEM, V269, P16403; MILNE KG, 1992, EUR J BIOCHEM, V208, P309, DOI 10.1111/j.1432-1033.1992.tb17188.x; RALTON JE, 1993, J BIOL CHEM, V268, P24183; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; Sharma DK, 1997, BIOCHEM J, V328, P171; Smith TK, 1997, EMBO J, V16, P6667, DOI 10.1093/emboj/16.22.6667; STEVENS VL, 1995, BIOCHEM J, V310, P361, DOI 10.1042/bj3100361; TURRENS JF, 1989, BIOCHEM J, V259, P363, DOI 10.1042/bj2590363	41	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1465	1471		10.1074/jbc.274.3.1465	http://dx.doi.org/10.1074/jbc.274.3.1465			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880521	hybrid			2022-12-27	WOS:000079956900041
J	Steinert, PM; Marekov, LN; Parry, DAD				Steinert, PM; Marekov, LN; Parry, DAD			Molecular parameters of type IV alpha-internexin and type IV-type III alpha-internexin-vimentin copolymer intermediate filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL MOLECULES; TRANSMISSION ELECTRON-MICROSCOPY; EPIDERMAL KERATIN FILAMENTS; NF-L; NEUROFILAMENT PROTEINS; END DOMAINS; INVITRO; PERIPHERIN; EXPRESSION; CELLS	During neuronal development, a dynamic replacement mechanism occurs in which the type VI nestin and type III vimentin intermediate filament proteins are replaced by a series of type IV proteins beginning with alpha-internexin. We have explored molecular details of how the type III to type IV replacement process may occur. First, we have demonstrated by cross linking experiments that bacterially expressed forms of alpha-internexin and vimentin form heterodimer molecules in vitro that assemble into copolymer intermediate filaments. We show using a urea disassembly assay that alpha-internexin molecules are likely to be more stable than those of vimentin. Second, by analyses of the induced cross-links, we have determined the axial lengths of alpha-internexin homodimer and alpha-internexin-vimentin heterodimer molecules and their modes of alignments in filaments. We report that these dimensions are the same as those reported earlier for vimentin homopolymer molecules and, by implication are also the same for the other neuronal type IV proteins. These data suggest that during neuronal development, alpha-internexin molecules are readily assimilated onto the pre-existing vimentin cytoskeletal intermediate filament network because the axial lengths and axial alignments of their molecules are the same. Furthermore, the dynamic replacement process may be driven by a positive equilibrium due to the increased stability of the alpha-internexin network.	NIAMS, Skin Biol Lab, NIH, Bethesda, MD 20892 USA; Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Massey University	Steinert, PM (corresponding author), NIAMS, Skin Biol Lab, NIH, Bldg 6,Rm 425, Bethesda, MD 20892 USA.							ABUMUHOR I, 1997, MOL BIOL CHEM, V8, P278; Athlan ES, 1997, J NEUROSCI RES, V47, P300; Athlan ES, 1997, J BIOL CHEM, V272, P31073, DOI 10.1074/jbc.272.49.31073; Carpenter DA, 1996, J CELL SCI, V109, P2493; CHADAN S, 1994, J NEUROCHEM, V62, P1894; CHIN SSM, 1991, J CELL SCI, V99, P335; CHING GY, 1991, J BIOL CHEM, V266, P19459; CHING GY, 1993, J CELL BIOL, V122, P1323, DOI 10.1083/jcb.122.6.1323; CHUI FC, 1989, NEURON, V2, P1435; COHLBERG JA, 1995, J BIOL CHEM, V270, P9334, DOI 10.1074/jbc.270.16.9334; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; ENGEL A, 1985, J ULTRA MOL STRUCT R, V90, P323, DOI 10.1016/S0022-5320(85)80010-1; FLIEGNER KH, 1994, J COMP NEUROL, V342, P161, DOI 10.1002/cne.903420202; FRASER RDB, 1985, INT J BIOL MACROMOL, V7, P258, DOI 10.1016/0141-8130(85)90024-8; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Goldman R. D., 1990, CELLULAR MOL BIOL IN, P3; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; GOLDMAN RD, 1990, CELLULAR MOL BIOL IN; HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199; HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517; HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485; HISANAGA S, 1990, J MOL BIOL, V211, P857, DOI 10.1016/0022-2836(90)90079-2; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; HOULE J, 1983, DEV BRAIN RES, V9, P189, DOI 10.1016/0165-3806(83)90051-2; IP W, 1985, ANN NY ACAD SCI, V455, P185, DOI 10.1111/j.1749-6632.1985.tb50412.x; IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5; ISENBERG G, 1995, CYTOSKELETAL PROTEIN, P218; Jones LN, 1997, BIOPHYS CHEM, V68, P83, DOI 10.1016/S0301-4622(97)00013-6; KACHINSKY AM, 1995, J HISTOCHEM CYTOCHEM, V43, P843, DOI 10.1177/43.8.7542682; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; KONIGSBERG WH, 1983, METHOD ENZYMOL, V91, P254; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Liem RKH, 1993, CURR OPIN CELL BIOL, V5, P12, DOI 10.1016/S0955-0674(05)80003-1; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; PACHTER JS, 1985, J CELL BIOL, V101, P1316, DOI 10.1083/jcb.101.4.1316; Parry DAD, 1996, INT J BIOL MACROMOL, V19, P45, DOI 10.1016/0141-8130(96)01099-9; PARRY DAD, 1986, BIOCHEM J, V238, P305, DOI 10.1042/bj2380305; PARRY DAD, 1985, BIOCHEM BIOPH RES CO, V127, P1012, DOI 10.1016/S0006-291X(85)80045-0; PARRY DAD, 1995, INTERMEDIATE FILAMEN; PARYSEK LM, 1987, J NEUROSCI, V7, P781; PARYSEK LM, 1991, J NEUROSCI RES, V30, P80, DOI 10.1002/jnr.490300110; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; SOLLNER P, 1985, P NATL ACAD SCI USA, V82, P7929; STEINERT PM, 1978, J MOL BIOL, V123, P49, DOI 10.1016/0022-2836(78)90376-5; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; STEINERT PM, 1991, J STRUCT BIOL, V107, P175, DOI 10.1016/1047-8477(91)90020-W; STEINERT PM, 1993, BIOCHEMISTRY-US, V32, P10046, DOI 10.1021/bi00089a021; STEINERT PM, 1980, P NATL ACAD SCI-BIOL, V77, P4534, DOI 10.1073/pnas.77.8.4534; STEINERT PM, 1990, J BIOL CHEM, V265, P8766; STEINERT PM, 1990, CELL, V60, P521, DOI 10.1016/0092-8674(90)90651-T; STEINERT PM, 1993, J BIOL CHEM, V268, P24916; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; STEINERT PM, 1991, J STRUCT BIOL, V107, P157, DOI 10.1016/1047-8477(91)90019-S; STEINERT PM, 1981, P NATL ACAD SCI-BIOL, V78, P3692, DOI 10.1073/pnas.78.6.3692; STEVEN AC, 1982, P NATL ACAD SCI-BIOL, V79, P3101, DOI 10.1073/pnas.79.10.3101; TAPSCOTT SJ, 1981, DEV BIOL, V86, P40, DOI 10.1016/0012-1606(81)90313-4; VANDENHEUVEL RMM, 1987, J CELL SCI, V88, P475; WONG J, 1990, J NEUROSCI RES, V27, P332, DOI 10.1002/jnr.490270312	59	42	44	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1657	1666		10.1074/jbc.274.3.1657	http://dx.doi.org/10.1074/jbc.274.3.1657			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880545	hybrid			2022-12-27	WOS:000079956900065
J	Fujita, M; Gang, DR; Davin, LB; Lewis, NG				Fujita, M; Gang, DR; Davin, LB; Lewis, NG			Recombinant pinoresinol-lariciresinol reductases from western red cedar (Thuja plicata) catalyze opposite enantiospecific conversions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORSYTHIA-INTERMEDIA; LIGNANS; PHYTOESTROGENS; TOPOISOMERASE; PROTEIN	Although the heartwood of woody plants represents the main source of fiber and solid wood products, essentially nothing is known about how the biological processes leading to its formation are initiated and regulated. Accordingly, a reverse transcription-polymerase chain reaction-guided cloning strategy was employed to obtain genes encoding pinoresinol-lariciresinol reductases from western red cedar (Thuja plicata) as a means to initiate the study of its heartwood formation. (+)-Pinoresinol-(+)-lariciresinol reductase from Forsythia intermedia was used as a template for primer construction for reverse transcription-polymerase chain reaction amplifications, which, when followed by homologous hybridization cloning, resulted in the isolation of two distinct classes of putative pinoresinol-lariciresinol reductase cDNA clones from western red cedar. A representative of each class was expressed as a fusion protein with P-galactosidase and assayed for enzymatic activity. Using both deuterated and radiolabeled (+/-)-pinoresinols as substrates, it was established that each class of cDNA encoded a pinoresinol-lariciresinol reductase of different (opposite) enantiospecificity. Significantly, the protein from one class converted (+)-pinoresinol into (-)-secoisolariciresinol, whereas the other utilized the opposite (-)-enantiomer to give the corresponding (+)-form. This differential substrate specificity raises important questions about the role of each of these individual reductases in heartwood formation, such as whether they are expressed in different cells/tissues or at different stages during heartwood development.	Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Kagawa Univ, Fac Agr, Kagawa 76107, Japan	Washington State University; Kagawa University	Lewis, NG (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lewisn@wsu.edu	Gang, David/B-1001-2013	Lewis, Norman/0000-0001-5742-032X; Davin, Laurence/0000-0002-3248-6485				ADLERCREUTZ H, 1987, J STEROID BIOCHEM, V27, P1135, DOI 10.1016/0022-4731(87)90200-7; ADLERCREUTZ H, 1991, AM J CLIN NUTR, V54, P1093, DOI 10.1093/ajcn/54.6.1093; ADLERCREUTZ H, 1995, ENVIRON HEALTH PERSP, V103, P103, DOI 10.2307/3432518; Ausubel FM., 2006, ENZYMATIC MANIPULATI; Chattaway M. M., 1952, Australian Forestry, V16, P25; CHATTAWAY MM, 1949, AUST J SCI RES SER B, V2, P227; CHU A, 1993, J BIOL CHEM, V268, P27026; Davin L.B., 1995, AN ACAD BRAS CIEN S3, V67, P363; Davin LB, 1997, SCIENCE, V275, P362, DOI 10.1126/science.275.5298.362; Dewick P. M., 1989, STUDIES NATURAL PROD, V5, P459; DinkovaKostova AT, 1996, J BIOL CHEM, V271, P29473, DOI 10.1074/jbc.271.46.29473; Gang DR, 1997, ACS SYM SER, V658, P58; Gang DR, 1998, ACS SYM SER, V697, P389, DOI DOI 10.1021/BK-1998-0697.CH025; GARDNER JAF, 1960, CAN J CHEM, V38, P2387, DOI 10.1139/v60-324; GARDNER JAF, 1966, CAN J CHEMISTRY, V44, P52, DOI 10.1139/v66-009; GARDNER JAF, 1959, CAN J CHEM, V37, P1703, DOI 10.1139/v59-246; Genetic Computer Group, 1994, PROGR MAN WISC PACK; HERGERT HL, 1960, J ORG CHEM, V25, P405, DOI 10.1021/jo01073a026; HERGERT HL, 1977, ACS SYM SER, V48, P227, DOI DOI 10.1021/BK-1977-0048.CH016; Kato MJ, 1998, PHYTOCHEMISTRY, V47, P583, DOI 10.1016/S0031-9422(97)00727-9; KRAHMER RL, 1970, WOOD SCI TECHNOL, V4, P122, DOI 10.1007/BF00365298; Lewinsohn E., 1994, Plant Molecular Biology Reporter, V12, P20, DOI 10.1007/BF02668660; LEWIS NG, 1997, Patent No. 20391; Ludwig CH, 1971, LIGNINS OCCURRENCE F; MACLEAN H, 1967, CAN J CHEMISTRY, V45, P305, DOI 10.1139/v67-054; MACLEAN H, 1967, CAN J CHEMISTRY, V45, P739, DOI 10.1139/v67-120; MACLEAN H, 1966, CAN J CHEMISTRY, V44, P1541, DOI 10.1139/v66-229; MACLEAN H., 1956, Forest Products Journal, V6, P510; MACLEAN H, 1966, CAN J CHEMISTRY, V44, P1827, DOI 10.1139/v66-274; NOSE M, 1995, PHYTOCHEMISTRY, V39, P71, DOI 10.1016/0031-9422(95)95268-Y; RICHTER A, 1987, NUCLEIC ACIDS RES, V15, P3455, DOI 10.1093/nar/15.8.3455; ROSS W, 1984, CANCER RES, V44, P5857; Sambrook J, 1994, MOL CLONING LAB MANU; STAHELIN H, 1973, EUR J CANCER, V9, P215, DOI 10.1016/S0014-2964(73)80021-0; SWAN EP, 1969, PHYTOCHEMISTRY, V8, P345, DOI 10.1016/S0031-9422(00)85430-8; UMEZAWA T, 1990, J CHEM SOC CHEM COMM, P1405, DOI 10.1039/c39900001405; Umezawa T, 1998, ACS SYM SER, V697, P377, DOI [10.1021/bk-1998-0697.ch024, DOI 10.1021/BK-1998-0697.CH024]; [No title captured]	38	73	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					618	627		10.1074/jbc.274.2.618	http://dx.doi.org/10.1074/jbc.274.2.618			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872995	hybrid			2022-12-27	WOS:000077968500010
J	New, L; Zhao, M; Li, YQ; Bassett, WW; Feng, Y; Ludwig, S; Padova, FD; Gram, H; Han, JH				New, L; Zhao, M; Li, YQ; Bassett, WW; Feng, Y; Ludwig, S; Padova, FD; Gram, H; Han, JH			Cloning and characterization of RLPK, a novel RSK-related protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; PHORBOL ESTER; 2 ISOFORMS; RAT-LIVER; ACTIVATION; PHOSPHORYLATION; PP90(RSK); RAPAMYCIN; PP90RSK; DOMAINS	A novel protein kinase whose activity can be stimulated by mitogen in vivo was cloned and characterized. The cDNA of this gene encodes an 802-amino acid protein (termed RLPK) with the highest homology (37% identity) to the two protein kinase families, p90(RSK) and p70(RSK). Like p90(RSR), but not p70(RSK), RLPK also contains two complete nonidentical protein kinase domains. RLPK mRNA is widely expressed in all human tissues examined and is enriched in the brain, heart, and placenta. In HeLa cells, transiently expressed epitope-tagged RLPK can be strongly induced by epidermal growth factor, serum, and phorbol 12-myristate 13-acetate, but only moderately up-regulated by tumor necrosis factor-ct and other stress-related stimuli. The activity of RLPK stimulated by epidermal growth factor was not inhibited by several known protein kinase C inhibitors nor by rapamycin, a known specific inhibitor for p70(RSK), but could be inhibited by herbimycin A, a tyrosine kinase inhibitor, and partially inhibited by PD98059 or SB203580, inhibitors for the mitogen-activated protein kinase pathways. Recombinant RLPK possesses high phosphorylation activity toward histone 2B and the S6 peptide, RRRLSSLRA. Although purified recombinant RLPK can be phosphorylated by ERK2 and p38 alpha in vitro, its activity is not affected by this phosphorylation. Moreover, the treatment of RLPK with acid phosphatase did not reduce its in vitro kinase activity. These data suggest that RLPK is structurally similar to previously isolated RSKs, but its regulatory mechanism may be distinct from either p70(RSK) or p90(RSK)S.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany; Novartis Pharma AG, CH-4002 Basel, Switzerland	Scripps Research Institute; Emory University; Novartis	Han, JH (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Han, J/G-4671-2010	Ludwig, Stephan/0000-0003-4490-3052	NIAID NIH HHS [AI41637] Funding Source: Medline; NIGMS NIH HHS [GM51417] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHN NG, 1991, J BIOL CHEM, V266, P4220; Alessi DR, 1997, FEBS LETT, V402, P121, DOI 10.1016/S0014-5793(96)01510-4; BALLOU LM, 1991, NATURE, V349, P348, DOI 10.1038/349348a0; BANERJEE P, 1990, P NATL ACAD SCI USA, V87, P8550, DOI 10.1073/pnas.87.21.8550; BLENIS J, 1985, P NATL ACAD SCI USA, V82, P7621, DOI 10.1073/pnas.82.22.7621; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; CHEN RH, 1990, MOL CELL BIOL, V10, P3204, DOI 10.1128/MCB.10.6.3204; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; CHUNG J, 1991, P NATL ACAD SCI USA, V88, P4981, DOI 10.1073/pnas.88.11.4981; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; CHUNG JK, 1991, MOL CELL BIOL, V11, P1868, DOI 10.1128/MCB.11.4.1868; COFFER PJ, 1994, BIOCHEM BIOPH RES CO, V198, P780, DOI 10.1006/bbrc.1994.1112; DAVIS IJ, 1993, MOL ENDOCRINOL, V7, P953, DOI 10.1210/me.7.8.953; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; ERIKSON E, 1987, MOL CELL BIOL, V7, P3147, DOI 10.1128/MCB.7.9.3147; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; GROVE JR, 1993, BIOCHEMISTRY-US, V32, P7727, DOI 10.1021/bi00081a018; HSIAO KM, 1994, P NATL ACAD SCI USA, V91, P5480, DOI 10.1073/pnas.91.12.5480; INNIS MA, 1990, PCR PROTOCOLS; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; KOZMA SC, 1989, EMBO J, V8, P4125, DOI 10.1002/j.1460-2075.1989.tb08597.x; KOZMA SC, 1990, P NATL ACAD SCI USA, V87, P7365, DOI 10.1073/pnas.87.19.7365; MOLLER DE, 1994, AM J PHYSIOL, V266, pC351, DOI 10.1152/ajpcell.1994.266.2.C351; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Ohta Y, 1996, J BIOL CHEM, V271, P11858, DOI 10.1074/jbc.271.20.11858; PRICE DJ, 1989, J BIOL CHEM, V264, P13825; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; REINHARD C, 1992, P NATL ACAD SCI USA, V89, P4052, DOI 10.1073/pnas.89.9.4052; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; SCIMECA JC, 1992, J BIOL CHEM, V267, P17369; SUTHERLAND C, 1993, EUR J BIOCHEM, V212, P581, DOI 10.1111/j.1432-1033.1993.tb17696.x; THOMAS G, 1993, BIOCHEM SOC T, V21, P901, DOI 10.1042/bst0210901; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zhao Y, 1996, J BIOL CHEM, V271, P29773, DOI 10.1074/jbc.271.47.29773; ZHAO Y, 1995, MOL CELL BIOL, V15, P4353	43	46	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1026	1032		10.1074/jbc.274.2.1026	http://dx.doi.org/10.1074/jbc.274.2.1026			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873047	hybrid			2022-12-27	WOS:000077968500062
J	Rosenkilde, MM; Kledal, TN; Brauner-Osborne, H; Schwartz, TW				Rosenkilde, MM; Kledal, TN; Brauner-Osborne, H; Schwartz, TW			Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-OPIOID RECEPTOR; NK-1 RECEPTOR; INTERLEUKIN-8 RECEPTOR; NONPEPTIDE ANTAGONISTS; KAPOSIS-SARCOMA; NK1 RECEPTOR; SUBSTANCE-P; BINDING; EXPRESSION; CELLS	A number of CXC chemokines competed with similar, nanomolar affinity against I-125-interleukin-8 (IL-8) binding to ORF-74, a constitutively active seven-transmembrane receptor encoded by human herpesvirus 8. How ever, in competition against I-125-labeled growth-related oncogene (GRO)-alpha, the ORF-74 receptor was highly selective for GRO peptides, with IL-8 being 10,000-fold less potent. The constitutive stimulating activity of ORF-74 on phosphatidylinositol turnover was not influenced by, for example, IL-8 binding. In contrast, GRO peptides acted as potent agonists in stimulating ORF-74 signaling, whereas IP-10 and stromal cell-derived factor-1 alpha surprisingly acted as inverse agonists. These peptides had similar pharmacological properties with regard to enhancing or inhibiting, respectively, the stimulatory effect of ORF-74 on NIH-3T3 cell proliferation. Construction of a high affinity zinc switch through introduction of two His residues at the extracellular end of transmembrane segment V enabled Zn2+ to act as a prototype non-peptide inverse agonist, which eliminated the constitutive signaling. It is concluded that ORF-74, which is believed to be causally involved in the formation of highly vascularized tumors, has been optimized for agonist and inverse agonist modulation by the endogenous angiogenic GRO peptides and angiostatic IP-10 and stromal cell-derived factor-leg respectively. ORF-74 could serve as a target for the development of non-peptide inverse agonist drugs as demonstrated by the effect of Zn2+ on the metal ion site-engineered receptor.	Univ Copenhagen, Panum Inst, Mol Pharmacol Lab, Dept Pharmacol, DK-2200 Copenhagen, Denmark; Royal Danish Sch Pharm, Dept Med Chem, PharmaBiotec Res Ctr, DK-2100 Copenhagen, Denmark	University of Copenhagen; Royal Danish School of Pharmacy	Schwartz, TW (corresponding author), Univ Copenhagen, Panum Inst, Mol Pharmacol Lab, Dept Pharmacol, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.		Bräuner-Osborne, Hans/D-7260-2011	Bräuner-Osborne, Hans/0000-0001-9495-7388; Schwartz, Thue W./0000-0002-0261-6904; Rosenkilde, Mette Marie/0000-0001-9600-3254				Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; AHUJA SK, 1993, J BIOL CHEM, V268, P20691; Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Beisser PS, 1998, J VIROL, V72, P2352, DOI 10.1128/JVI.72.3.2352-2363.1998; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; Betancur C, 1997, TRENDS PHARMACOL SCI, V18, P372, DOI 10.1016/S0165-6147(97)01109-7; Brauner-Osborne H, 1996, EUR J PHARMACOL, V295, P93, DOI 10.1016/0014-2999(95)00639-7; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Dairaghi DJ, 1998, SEMIN VIROL, V8, P377, DOI 10.1006/smvy.1997.0146; Damon I, 1998, P NATL ACAD SCI USA, V95, P6403, DOI 10.1073/pnas.95.11.6403; DavisPoynter NJ, 1997, J VIROL, V71, P1521, DOI 10.1128/JVI.71.2.1521-1529.1997; Elling CE, 1997, FOLD DES, V2, pS76, DOI 10.1016/S1359-0278(97)00068-0; ELLING CE, 1995, NATURE, V374, P74, DOI 10.1038/374074a0; FIELD BN, 1995, FIELDS VIROLOGY; FONG TM, 1995, CAN J PHYSIOL PHARM, V73, P860, DOI 10.1139/y95-118; Geras-Raaka E, 1998, J EXP MED, V187, P801, DOI 10.1084/jem.187.5.801; GETHER U, 1993, NATURE, V362, P345, DOI 10.1038/362345a0; Hastrup H, 1996, FEBS LETT, V399, P264, DOI 10.1016/S0014-5793(96)01337-3; Hesselgesser J, 1998, J BIOL CHEM, V273, P15687, DOI 10.1074/jbc.273.25.15687; Hjorth SA, 1996, MOL PHARMACOL, V50, P977; Horuk R, 1998, NATURE, V393, P524, DOI 10.1038/31116; JOHANSEN TE, 1990, FEBS LETT, V267, P289, DOI 10.1016/0014-5793(90)80947-H; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; LEONG SR, 1994, J BIOL CHEM, V269, P19343; LIM K, 1989, BIOTECHNIQUES, V7, P576; Luan J, 1997, J LEUKOCYTE BIOL, V62, P588, DOI 10.1002/jlb.62.5.588; Maggi CA, 1997, TRENDS PHARMACOL SCI, V18, P351, DOI 10.1016/S0165-6147(97)90663-5; Moore BB, 1998, TRENDS CARDIOVAS MED, V8, P51, DOI 10.1016/S1050-1738(97)00128-X; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; ROSENKILDE MM, 1994, J BIOL CHEM, V269, P28160; Sagan S, 1997, MOL PHARMACOL, V52, P120, DOI 10.1124/mol.52.1.120; SCHWARTZ TW, 1995, CURR PHARM DESIGN, V1, P325; SIMAS JP, 1999, IN PRESS J GEN MICRO; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; STRIETER RM, 1995, BIOCHEM BIOPH RES CO, V210, P51, DOI 10.1006/bbrc.1995.1626; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Thirstrup K, 1996, J BIOL CHEM, V271, P7875, DOI 10.1074/jbc.271.14.7875; Wells TNC, 1997, CURR OPIN BIOTECH, V8, P741, DOI 10.1016/S0958-1669(97)80129-2; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095	42	166	171	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					956	961		10.1074/jbc.274.2.956	http://dx.doi.org/10.1074/jbc.274.2.956			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873037	hybrid			2022-12-27	WOS:000077968500052
J	Santolini, J; Haraux, F; Sigalat, C; Moal, G; Andre, F				Santolini, J; Haraux, F; Sigalat, C; Moal, G; Andre, F			Kinetic analysis of tentoxin binding to chloroplast F-1-ATPase - A model for the overactivation process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F1-ATPASE; ATP SYNTHASE; COUPLING FACTOR-1; OXIDATIVE-PHOSPHORYLATION; SPINACH CHLOROPLAST; EPSILON-SUBUNITS; ROTATION; CF1; SENSITIVITY; MECHANISM	The mechanism of action of tentoxin on the soluble part (chloroplast F-1 H+-ATPase; CF1) of chloroplast ATP synthase was analyzed in the light of new kinetic and equilibrium experiments. Investigations were done regarding the functional state of the enzyme (activation, bound nucleotide, catalytic turnover). Dialysis and binding data, obtained with C-14-tentoxin, fully confirmed the existence of two tentoxin binding sites of distinct dissociation constants consistent with the observed K-inhibition and K-overactivation. This strongly supports a two-site model of tentoxin action on CF1. Kinetic and thermodynamic parameters of tentoxin binding to the first site (K-i = 10 nM; k(on) = 4.7 x 10(4) s(-1).M-1) were determined from time-resolved activity assays. Tentoxin binding to the high affinity site was found independent on the catalytic state of the enzyme, The analysis of the kinetics of tentoxin binding on the low affinity site of the enzyme showed strong evidence for an interaction between this site and the nucleotide binding sites and revealed a complex relationship between the catalytic state and the reactivation process. New catalytic states of CF1 devoid of epsilon-subunit were detected: a transient overstimulated state, and a dead end complex unable to bind a second tentoxin molecule. Our experiments led to a kinetic model for the reactivation phenomenon for which rate constants were determined. The implications of this model are discussed in relation to the previous mechanistic hypotheses on the effect of tentoxin.	CEA Saclay, Sect Bioenerget, Dept Biol Cellulaire & Mol, F-91191 Gif Sur Yvette, France; CEA Saclay, DBCM, CNRS, URA 2096, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Santolini, J (corresponding author), CEA Saclay, Sect Bioenerget, Dept Biol Cellulaire & Mol, F-91191 Gif Sur Yvette, France.	santo@dsvidf.cea.fr	ANDRE, François/E-5555-2015	Santolini, Jerome/0000-0001-8919-112X				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Aggeler R, 1997, J BIOL CHEM, V272, P19621, DOI 10.1074/jbc.272.31.19621; AGGELER R, 1995, J BIOL CHEM, V270, P9185, DOI 10.1074/jbc.270.16.9185; AVNI A, 1992, SCIENCE, V257, P1245, DOI 10.1126/science.1387730; BERGER G, 1987, J LIQ CHROMATOGR, V10, P1507, DOI 10.1080/01483918708066783; BIZOUARN T, 1990, BIOCHIM BIOPHYS ACTA, V1016, P43, DOI 10.1016/0005-2728(90)90004-N; BOYER PD, 1973, P NATL ACAD SCI USA, V70, P2837, DOI 10.1073/pnas.70.10.2837; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; DAHSE I, 1994, J PLANT PHYSIOL, V143, P615, DOI 10.1016/S0176-1617(11)81147-8; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; DURBIN RD, 1977, PHYTOPATHOLOGY, V67, P602, DOI 10.1094/Phyto-67-602; Engelbrecht S, 1997, FEBS LETT, V414, P485, DOI 10.1016/S0014-5793(97)00997-6; FROMME P, 1992, Z NATURFORSCH C, V47, P239; Hu DL, 1997, J BIOL CHEM, V272, P5457, DOI 10.1074/jbc.272.9.5457; HU NM, 1993, J BIOL CHEM, V268, P8536; LIEBERMANN B, 1983, Z ALLG MIKROBIOL, V23, P503, DOI 10.1002/jobm.3630230810; MEYER W L, 1971, Tetrahedron Letters, V25, P2357; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mochimaru M, 1997, FEBS LETT, V419, P23, DOI 10.1016/S0014-5793(97)01421-X; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ogilvie I, 1997, J BIOL CHEM, V272, P16652, DOI 10.1074/jbc.272.26.16652; Pinet E, 1996, FEBS LETT, V395, P217, DOI 10.1016/0014-5793(96)01043-5; REIMER S, 1978, J BIOL CHEM, V253, P7249; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Sabbert D, 1997, P NATL ACAD SCI USA, V94, P4401, DOI 10.1073/pnas.94.9.4401; Santolini J, 1998, J BIOL CHEM, V273, P3343, DOI 10.1074/jbc.273.6.3343; SIGALAT C, 1995, FEBS LETT, V368, P253, DOI 10.1016/0014-5793(95)00664-U; STEELE JA, 1978, BIOCHIM BIOPHYS ACTA, V504, P136, DOI 10.1016/0005-2728(78)90012-9; STEELE JA, 1976, P NATL ACAD SCI USA, V73, P2245, DOI 10.1073/pnas.73.7.2245; STEELE JA, 1978, BIOCHIM BIOPHYS ACTA, V501, P72, DOI 10.1016/0005-2728(78)90096-8; VIK SB, 1994, J BIOL CHEM, V269, P30364; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Zhou YT, 1997, P NATL ACAD SCI USA, V94, P10583, DOI 10.1073/pnas.94.20.10583	34	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					849	858		10.1074/jbc.274.2.849	http://dx.doi.org/10.1074/jbc.274.2.849			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873024	hybrid			2022-12-27	WOS:000077968500039
J	Arnold, I; Pfeiffer, K; Neupert, W; Stuart, RA; Schagger, H				Arnold, I; Pfeiffer, K; Neupert, W; Stuart, RA; Schagger, H			ATP synthase of yeast mitochondria - Isolation of subunit j and disruption of the ATP18 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; BOVINE HEART-MITOCHONDRIA; STRUCTURAL GENE; SACCHAROMYCES-CEREVISIAE; SEQUENCE-ANALYSIS; F1-ATPASE; IMPORT; SIGNAL; SYSTEM	The subunit composition of the mitochondrial ATP synthase from Saccharomyces cerevisiae was analyzed using blue native gel electrophoresis and high resolution SDS-polyacrylamide gel electrophoresis, We report here the identification of a novel subunit of molecular mass of 6,687 Da, termed subunit j (Su j). An open reading frame of 127 base pairs (ATP18), which encodes for Su j, was identified on chromosome XIII. Su j does not display sequence similarity to ATP synthase subunits from other organisms. Data base searches, however, identified a potential homolog from Schizosaccharomyces pombe with 51% identity to Su j of S. cerevisiae. Su j, a small protein of 59 amino acid residues, has the characteristics of an integral inner membrane protein with a single transmembrane segment. Deletion of the ATP18 gene encoding Su j led to a strain (Delta su j) completely deficient in oligomycin-sensitive ATPase activity and unable to grow on nonfermentable carbon sources. The presence of Su j is required for the stable expression of subunits 6 and f of the F-0 membrane sector. In the absence of Su j, spontaneously arising rho(-) cells were observed that lacked also ubiquinol-cytochrome c reductase and cytochrome c oxidase activities. We conclude that Su j is a novel and essential subunit of yeast ATP synthase.	Univ Munich, Inst Physiol Chem, D-80336 Munich, Germany; Univ Frankfurt Klinikum, Zentrum Biol Chem, D-60590 Frankfurt, Germany	University of Munich; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Stuart, RA (corresponding author), Univ Munich, Inst Physiol Chem, D-80336 Munich, Germany.	stuart@bio.med.uni-meunchen.de						Arnold I, 1997, FEBS LETT, V411, P195, DOI 10.1016/S0014-5793(97)00691-1; ARNOLD I, 1998, IN PRESS EMBO J, V17; Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLLINSON IR, 1994, BIOCHEMISTRY-US, V33, P7971, DOI 10.1021/bi00191a026; DAYHOFF MO, 1981, ATLAS PROTEIN SEQUEN, V5, P342; FANG JK, 1984, P NATL ACAD SCI-BIOL, V81, P6603, DOI 10.1073/pnas.81.21.6603; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; Gheorghe MT, 1997, ANAL BIOCHEM, V254, P119, DOI 10.1006/abio.1997.2380; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIRAUD MF, 1994, EUR J BIOCHEM, V222, P851, DOI 10.1111/j.1432-1033.1994.tb18932.x; GUELIN E, 1993, J BIOL CHEM, V268, P161; HELENIUS A, 1972, J BIOL CHEM, V247, P3656; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; ICHIKAWA N, 1990, J BIOL CHEM, V265, P6274; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Law RHP, 1995, METHOD ENZYMOL, V260, P133, DOI 10.1016/0076-6879(95)60135-X; MACINO G, 1979, J BIOL CHEM, V254, P4617; MACINO G, 1980, CELL, V20, P507, DOI 10.1016/0092-8674(80)90637-6; MACREADIE IG, 1983, NUCLEIC ACIDS RES, V11, P4435, DOI 10.1093/nar/11.13.4435; NORAIS N, 1991, J BIOL CHEM, V266, P16541; PAUL MF, 1994, J BIOL CHEM, V269, P26158; PFANNER N, 1988, EUR J BIOCHEM, V175, P205, DOI 10.1111/j.1432-1033.1988.tb14185.x; SCHAGGER H, 1995, ELECTROPHORESIS, V16, P763, DOI 10.1002/elps.11501601125; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHAGGER H, 1994, PRACTICAL GUIDE MEMB, P107; Schagger H., 1994, PRACTICAL GUIDE MEMB, P59; Spannagel C, 1997, EUR J BIOCHEM, V247, P1111, DOI 10.1111/j.1432-1033.1997.01111.x; TAKEDA M, 1985, J BIOL CHEM, V260, P5458; TAKEDA M, 1986, J BIOL CHEM, V261, P5126; Tokatlidis K, 1996, NATURE, V384, P585, DOI 10.1038/384585a0; UH M, 1990, J BIOL CHEM, V265, P19047; VELOURS J, 1988, EUR J BIOCHEM, V170, P637, DOI 10.1111/j.1432-1033.1988.tb13745.x; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Walker JE, 1995, METHOD ENZYMOL, V260, P163, DOI 10.1016/0076-6879(95)60136-8	37	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					36	40		10.1074/jbc.274.1.36	http://dx.doi.org/10.1074/jbc.274.1.36			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867807	hybrid			2022-12-27	WOS:000077900200007
J	Ho, CL; Noji, M; Saito, M; Saito, K				Ho, CL; Noji, M; Saito, M; Saito, K			Regulation of serine biosynthesis in Arabidopsis - Crucial role of plastidic 3-phosphoglycerate dehydrogenase in non-photosynthetic tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEA PISUM-SATIVUM; GLYCINE DECARBOXYLASE COMPLEX; H-PROTEIN; PHOSPHOGLYCERATE DEHYDROGENASE; PHOSPHOSERINE AMINOTRANSFERASE; PHOSPHORYLATED PATHWAY; MOLECULAR-CLONING; ESCHERICHIA-COLI; GENE-EXPRESSION; ORGANIZATION	In plants, Ser is synthesized through a couple of pathways. 3-Phosphoglycerate dehydrogenase (PGDH), the first enzyme that is involved in the phosphorylated pathway of Ser biosynthesis, is responsible for the oxidation of 3-phosphoglycerate to phosphohydroxypyruvate. Here we report the first molecular cloning and characterization of PGDH from Arabidopsis thaliana, Sequence analysis of cDNA and a genomic clone revealed that the PGDH gene is composed of three exons, encoding a 623-amino acid polypeptide (66,453 Da). The deduced protein, containing three of the most conserved regions in the NAD-dependent 2-hydroxyacid dehydrogenase family, has 38-39% identity to its animal and bacterial counterparts. The presence of an N-terminal signal sequence for translocation into plastids was confirmed by particle-gun bombardment experiments using green fluorescence protein as a reporter protein for subcellular localization. Southern hybridization analysis and restriction fragment length polymorphism mapping indicated that PGDH is a single-copy gene that is mapped to the upper arm of chromosome 1. Northern hybridization analysis indicated preferential expression of PGDH mRNA in root tissues of light-grown plants, suggesting that the phosphorylated pathway of Ser biosynthesis plays an important role in supplying Ser to non-photosynthetic tissues. The recombinant enzyme overproduced in Escherichia coli displayed hyperbolic kinetics with respect to 3-phosphoglycerate and NAD(+).	Chiba Univ, Fac Pharmaceut Sci, Res Ctr Medicinal Resources, Lab Mol Biol & Biotechnol,Inage Ku, Chiba 2638522, Japan	Chiba University	Saito, K (corresponding author), Chiba Univ, Fac Pharmaceut Sci, Res Ctr Medicinal Resources, Lab Mol Biol & Biotechnol,Inage Ku, Yayoi Cho 1-33, Chiba 2638522, Japan.	ksaito@p.chiba-u.ac.jp	Saito, Kazuki/D-2670-2009	Saito, Kazuki/0000-0001-6310-5342				Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; BOLAND MJ, 1982, PLANTA, V155, P45, DOI 10.1007/BF00402930; CHEUNG GP, 1968, PLANT PHYSIOL, V43, P1813, DOI 10.1104/pp.43.11.1813; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; DUBROW R, 1977, J BIOL CHEM, V252, P1527; DUNCAN K, 1986, BIOCHEM J, V234, P49, DOI 10.1042/bj2340049; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; GRANT GA, 1981, BIOSCIENCE REP, V1, P733, DOI 10.1007/BF01116472; Ho CL, 1998, PLANT J, V16, P443, DOI 10.1046/j.1365-313x.1998.00313.x; Jaeken J, 1996, ARCH DIS CHILD, V74, P542, DOI 10.1136/adc.74.6.542; KEYS AJ, 1980, BIOCH PLANTS, V5, P359; KIM YH, 1990, J BIOL CHEM, V265, P848; KLECZKOWSKI LA, 1988, J PLANT PHYSIOL, V132, P641, DOI 10.1016/S0176-1617(88)80223-2; KREBBERS E, 1988, PLANT MOL BIOL, V11, P745, DOI 10.1007/BF00019515; LARSSON C, 1979, PHYSIOL PLANTARUM, V45, P7, DOI 10.1111/j.1399-3054.1979.tb01654.x; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; LUND K, 1985, ARCH BIOCHEM BIOPHYS, V237, P186, DOI 10.1016/0003-9861(85)90268-1; LUTCKE HA, 1987, EMBO J, V6, P43, DOI 10.1002/j.1460-2075.1987.tb04716.x; MACHEREL D, 1990, BIOCHEM J, V268, P783, DOI 10.1042/bj2680783; NEUBERGER M, 1986, FEBS LETT, V20, P718; REYNOLDS PHS, 1986, PLANT PHYSIOL, V81, P293, DOI 10.1104/pp.81.1.293; Saito K, 1997, PLANT MOL BIOL, V33, P359, DOI 10.1023/A:1005730725764; Sambrook J., 2002, MOL CLONING LAB MANU; SASKI R, 1975, EUR J BIOCHEM, V51, P415, DOI 10.1111/j.1432-1033.1975.tb03941.x; SCHULLER DJ, 1989, J BIOL CHEM, V264, P2645; SLAUGHTER JC, 1968, BIOCHEM J, V109, P743, DOI 10.1042/bj1090743; SOROKIN A, 1993, MOL MICROBIOL, V10, P385, DOI 10.1111/j.1365-2958.1993.tb02670.x; SRINIVASAN R, 1995, PLANT PHYSIOL, V109, P161, DOI 10.1104/pp.109.1.161; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2081; Takahashi H, 1996, PLANT PHYSIOL, V112, P273, DOI 10.1104/pp.112.1.273; TAKAIWA F, 1985, PLANT MOL BIOL, V4, P355, DOI 10.1007/BF02418257; TOBEY KL, 1986, J BIOL CHEM, V261, P2179; TOLBERT NE, 1980, BIOCH PLANTS, V2, P488; TURNER SR, 1992, J BIOL CHEM, V267, P7745; TURNER SR, 1992, J BIOL CHEM, V267, P5355; TURNER SR, 1993, MOL GEN GENET, V236, P402, DOI 10.1007/BF00277140; TURNER SR, 1992, J BIOL CHEM, V267, P13528; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; WALSH DA, 1966, J BIOL CHEM, V241, P4068; WEIRENGA RK, 1986, J MOL BIOL, V187, P101	41	69	96	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					397	402		10.1074/jbc.274.1.397	http://dx.doi.org/10.1074/jbc.274.1.397			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867856	hybrid			2022-12-27	WOS:000077900200056
J	Du, KY; Leu, JI; Peng, Y; Taub, R				Du, KY; Leu, JI; Peng, Y; Taub, R			Transcriptional up-regulation of the delayed early gene HRS/SRp40 during liver regeneration - Interactions among YY1, GA-binding proteins, and mitogenic signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; PAPILLOMAVIRUS TYPE-18 PROMOTER; SMALL NUCLEAR RIBONUCLEOPROTEIN; SR SPLICING FACTORS; ADENOVIRUS E1A; PREMESSENGER RNA; DISTINCT FUNCTIONS; ALTERNATIVE EXON; IN-VIVO; ETS	Arg-Ser-rich domain-containing proteins (SR proteins), a family of splicing factors, can regulate pre-mRNA alternative splicing in a concentration dependent manner. Thus, the relative expression of various SR proteins may play an important role in alternative splicing regulation. HRS/SRp40, an SR protein and delayed early gene in liver regeneration, can mediate alternative splicing of fibronectin mRNA Here we determined that transcription of the HRS/SRp40 gene is induced about B-fold during liver regeneration, similar to the level of steady-state mRNA. We found that both mouse and human RRS promoters lack TATA and CAAT boxes. The mouse promoter region from -130 to -18, which contains highly conserved GA-binding protein (GABP) and YY1 binding sites, conferred high transcriptional activity. While GABP alpha/GABP beta heterodimer transactivated the HRS promoter, YY1 functioned as a repressor. During liver regeneration, the relative amount of GABP alpha/GABP beta heterodimer increased 3-fold, and YY1 changed little, which could partially account for the increase in HRS gene transcription. Interleukin-6, a critical mitogenic component of liver regeneration, was able to relieve the repressive activity of the YY1 site within the HRS promoter. The combined effect of small changes in the level of existing transcription factors and mitogenic signals may explain the transcriptional activation of the HRS gene during cell growth.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Taub, R (corresponding author), Univ Penn, Sch Med, Dept Genet, 705A Stellar Chance,422 Curie Blvd, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, R01DK044237] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK44237, P50 DK49210] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; BAUKNECHT T, 1992, EMBO J, V11, P4607, DOI 10.1002/j.1460-2075.1992.tb05563.x; Bauknecht T, 1996, J VIROL, V70, P7695, DOI 10.1128/JVI.70.11.7695-7705.1996; BAUKNECHT T, 1995, J VIROL, V69, P1; BOTTINGER EP, 1994, MOL CELL BIOL, V14, P2604; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; CARTER RS, 1992, J BIOL CHEM, V267, P23418; Chabot B, 1997, MOL CELL BIOL, V17, P1776, DOI 10.1128/MCB.17.4.1776; CHABOT B, 1992, NUCLEIC ACIDS RES, V20, P5197, DOI 10.1093/nar/20.19.5197; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; CRESSMAN DE, 1994, J BIOL CHEM, V269, P26594; Crispino JD, 1996, RNA, V2, P664; DIAMOND RH, 1993, J BIOL CHEM, V268, P15185; Du KY, 1997, MOL CELL BIOL, V17, P4096, DOI 10.1128/MCB.17.7.4096; Du KY, 1997, GENE, V204, P243, DOI 10.1016/S0378-1119(97)00552-0; Eckner R, 1996, MOL CELL BIOL, V16, P3454; FU XD, 1995, RNA, V1, P663; Gallego ME, 1997, EMBO J, V16, P1772, DOI 10.1093/emboj/16.7.1772; Genuario R. Robert, 1993, Gene Expression, V3, P279; Genuario RR, 1996, J BIOL CHEM, V271, P4388; GREENBAUM LE, 1995, J CLIN INVEST, V96, P1351, DOI 10.1172/JCI118170; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Higgins GM, 1931, ARCH PATHOL, V12, P186; HIMMELSPACH M, 1995, RNA, V1, P794; HSU JC, 1992, MOL CELL BIOL, V12, P4654, DOI 10.1128/MCB.12.10.4654; Inoue Kunio, 1995, Gene Expression, V4, P177; Kanopka A, 1996, NATURE, V381, P535, DOI 10.1038/381535a0; Kramer A, 1996, ANNU REV BIOCHEM, V65, P367, DOI 10.1146/annurev.biochem.65.1.367; KRAMER A, 1990, METHOD ENZYMOL, V181, P215; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; Lee JS, 1996, MOL CELL BIOL, V16, P4312; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; Lee JS, 1996, J BIOL CHEM, V271, P17666, DOI 10.1074/jbc.271.30.17666; LEWIS BA, 1995, J VIROL, V69, P1628, DOI 10.1128/JVI.69.3.1628-1636.1995; LIN JX, 1993, MOL CELL BIOL, V13, P6201, DOI 10.1128/MCB.13.10.6201; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Markiewicz S, 1996, J BIOL CHEM, V271, P14849, DOI 10.1074/jbc.271.25.14849; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; MOHN KL, 1991, MOL CELL BIOL, V11, P1393, DOI 10.1128/MCB.11.3.1393; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Peng Y, 1998, J BIOL CHEM, V273, P17286, DOI 10.1074/jbc.273.27.17286; POPIELARZ M, 1995, J BIOL CHEM, V270, P17830, DOI 10.1074/jbc.270.30.17830; RAMCHATESINGH J, 1995, MOL CELL BIOL, V15, P4898; ROSMARIN AG, 1995, J BIOL CHEM, V270, P23627, DOI 10.1074/jbc.270.40.23627; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; SCREATON GR, 1995, EMBO J, V14, P4336, DOI 10.1002/j.1460-2075.1995.tb00108.x; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; SHRIVASTAVA A, 1993, SCIENCE, V262, P1889, DOI 10.1126/science.8266081; Somasundaram K, 1997, ONCOGENE, V14, P1047, DOI 10.1038/sj.onc.1201002; Sucharov C, 1995, GENE EXPRESSION, V5, P93; SUREAU A, 1992, P NATL ACAD SCI USA, V89, P11683, DOI 10.1073/pnas.89.24.11683; TARN WY, 1995, P NATL ACAD SCI USA, V92, P2504, DOI 10.1073/pnas.92.7.2504; Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; WANG CY, 1992, J EXP MED, V175, P1391, DOI 10.1084/jem.175.5.1391; WANG J, 1995, RNA, V1, P335; WATANABE H, 1993, MOL CELL BIOL, V13, P1385, DOI 10.1128/MCB.13.3.1385; ZAHLER AM, 1995, P NATL ACAD SCI USA, V92, P2642, DOI 10.1073/pnas.92.7.2642; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799	67	21	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35208	35215		10.1074/jbc.273.52.35208	http://dx.doi.org/10.1074/jbc.273.52.35208			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857059	hybrid			2022-12-27	WOS:000077719700077
J	Ujita, M; McAuliffe, J; Schwientek, T; Almeida, R; Hindsgaul, O; Clausen, H; Fukuda, M				Ujita, M; McAuliffe, J; Schwientek, T; Almeida, R; Hindsgaul, O; Clausen, H; Fukuda, M			Synthesis of poly-N-acetyllactosamine in core 2 branched O-glycans - The requirement of novel beta-1,4-galtactosyltransferase IV and beta-1,3-N-acetylglucosaminyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE-GLYCOPROTEINS; WISKOTT-ALDRICH SYNDROME; LINKED OLIGOSACCHARIDES; L-SELECTIN; CELL-ADHESION; HUMAN GALACTOSYLTRANSFERASE; EXPRESSION CLONING; LEUKEMIC-CELLS; SIALYL LE(X); HL-60 CELLS	Poly-N-acetyllactosamine is a unique carbohydrate composed of N-acetyllactosamine repeats and provides the backbone structure for additional modifications such as sialyl Le(x), Poly-N-acetyllactosamines in mucin-type O-glycans can be formed in core 2 branched oligosaccharides, which are synthesized by core 2 beta-1,6-N-acetylglucosaminyltransferase. Using a beta-1,4-galactosyltransferase (beta 4Gal-TI) present in milk and the recently cloned beta-1,3-N-acetylglucosaminyltransferase, the formation of poly-N-acetyllactosamine was found to be extremely inefficient starting from a core 2 branched oligosaccharide, GlcNAc beta 1-->6-(Gal beta 1-->3)GalNAc alpha-->R. Since the majority of synthesized oligosaccharides contained N-acetylglucosamine at the nonreducing ends, galactosylation was judged to be inefficient, prompting us to test novel members of the beta 4Gal-T gene family for this synthesis. Using various synthetic accepters and recombinant beta 4Gal-Ts, beta 4Gal-TIV was found to be most efficient in the addition of a single galactose residue to GlcNAc beta 1-->6(Gal beta 1-->3)Gal-NAc alpha-->R. Moreover, beta 4Gal-TIV, together with beta-1,3-N-acetylglucosaminyltransferase, was capable of synthesizing poly-N-acetyllactosamine in core 2 branched oligosaccharides. On the other hand, beta 4Gal-TI was found to be most efficient for poly-N-acetyllactosamine synthesis in N-glycans, In contrast to beta 4Gal-TI, the efficiency of beta 4Gal-TIV decreased dramatically as the accepters contained more N-acetyllactosamine repeats, consistent with the fact that core 2 branched O-glycans contain fewer and shorter poly-N-acetyllactosamines than N-glycans in many cells. These results, as a whole, indicate that beta 4Gal-TIV is responsible for poly-N-acetyllactosamine synthesis in core 2 branched O-glycans.	Burnham Inst, Glycobiol Program, Ctr Canc Res, La Jolla, CA 92037 USA; Univ Copenhagen, Sch Dent, DK-2200 Copenhagen, Denmark	Sanford Burnham Prebys Medical Discovery Institute; University of Copenhagen	Ujita, M (corresponding author), Burnham Inst, Glycobiol Program, Ctr Canc Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Almeida, Raquel/B-9647-2012; clausen, henrik/AAD-8016-2021	Almeida, Raquel/0000-0002-5622-1633; 	NATIONAL CANCER INSTITUTE [P01CA071932, R37CA033000, R01CA048737] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA33000, R01 CA48737, P01 CA71932] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; AOKI D, 1990, EMBO J, V9, P3171, DOI 10.1002/j.1460-2075.1990.tb07515.x; ARDMAN B, 1990, J EXP MED, V172, P1151, DOI 10.1084/jem.172.4.1151; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Bakker H, 1997, J BIOL CHEM, V272, P18580, DOI 10.1074/jbc.272.30.18580; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; BELL JE, 1976, J BIOL CHEM, V251, P3003; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; BIERHUIZEN MFA, 1994, J BIOL CHEM, V269, P4473; BROCKHAUSEN I, 1991, CANCER RES, V51, P1257; Cho SK, 1997, J BIOL CHEM, V272, P13622, DOI 10.1074/jbc.272.21.13622; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; FUKUDA M, 1984, J BIOL CHEM, V259, P8260; FUKUDA M, 1986, J BIOL CHEM, V261, P2796; FUKUDA M, 1984, MOL GLYCOBIOLOGY, P1; FUKUDA MN, 1985, J BIOL CHEM, V260, P6623; FUKUDA MN, 1981, J BIOL CHEM, V256, P3900; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; HIGGINS EA, 1991, J BIOL CHEM, V266, P6280; KitazumeKawaguchi S, 1997, P NATL ACAD SCI USA, V94, P3650, DOI 10.1073/pnas.94.8.3650; Komatsu M, 1997, J BIOL CHEM, V272, P33245, DOI 10.1074/jbc.272.52.33245; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; LEE N, 1990, J BIOL CHEM, V265, P20476; LEFEBVRE JC, 1994, J EXP MED, V180, P1609, DOI 10.1084/jem.180.5.1609; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; LOWE JB, 1990, CELL, V63, P475, DOI 10.1016/0092-8674(90)90444-J; MAEMURA K, 1992, J BIOL CHEM, V267, P24379; MAEMURA K, 1994, TETRAHEDRON-ASYMMETR, V5, P2093, DOI 10.1016/S0957-4166(00)86286-2; MANJUNATH N, 1995, NATURE, V377, P535, DOI 10.1038/377535a0; MASRI KA, 1988, BIOCHEM BIOPH RES CO, V157, P657, DOI 10.1016/S0006-291X(88)80300-0; MERKLE RK, 1988, J BIOL CHEM, V263, P16143; MIZOGUCHI A, 1984, J BIOL CHEM, V259, P1949; Nakayama J, 1996, J BIOL CHEM, V271, P1829, DOI 10.1074/jbc.271.4.1829; NARIMATSU H, 1986, P NATL ACAD SCI USA, V83, P4720, DOI 10.1073/pnas.83.13.4720; Nomura T, 1998, J BIOL CHEM, V273, P13570, DOI 10.1074/jbc.273.22.13570; OEHRLEIN R, 1993, CARBOHYD RES, V244, P149, DOI 10.1016/0008-6215(93)80011-3; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; PILLER F, 1991, J EXP MED, V173, P1501, DOI 10.1084/jem.173.6.1501; PILLER F, 1988, J BIOL CHEM, V263, P15146; SAITOH O, 1991, BLOOD, V77, P1491; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Sasaki K, 1997, P NATL ACAD SCI USA, V94, P14294, DOI 10.1073/pnas.94.26.14294; Sato T, 1998, P NATL ACAD SCI USA, V95, P472, DOI 10.1073/pnas.95.2.472; Schwientek T, 1998, J BIOL CHEM, V273, P29331, DOI 10.1074/jbc.273.45.29331; Shaper NL, 1997, J BIOL CHEM, V272, P31389, DOI 10.1074/jbc.272.50.31389; SHAPER NL, 1986, P NATL ACAD SCI USA, V83, P1573, DOI 10.1073/pnas.83.6.1573; Shimodaira K, 1997, CANCER RES, V57, P5201; SPIRO RG, 1974, J BIOL CHEM, V249, P5704; SRIVASTAVA G, 1992, CARBOHYD RES, V224, P83, DOI 10.1016/0008-6215(92)84095-A; Tsuboi S, 1998, J BIOL CHEM, V273, P30680, DOI 10.1074/jbc.273.46.30680; Tsuboi S, 1997, EMBO J, V16, P6364, DOI 10.1093/emboj/16.21.6364; Tsuboi S, 1996, J BIOL CHEM, V271, P27213, DOI 10.1074/jbc.271.44.27213; WALTZ G, 1990, SCIENCE, V250, P1132; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772	55	77	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34843	34849		10.1074/jbc.273.52.34843	http://dx.doi.org/10.1074/jbc.273.52.34843			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857011	hybrid			2022-12-27	WOS:000077719700029
J	Borghaei, RC; Sullivan, C; Mochan, E				Borghaei, RC; Sullivan, C; Mochan, E			Identification of a cytokine-induced repressor of interleukin-1 stimulated expression of stromelysin 1 (MMP-3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL PLASMINOGEN-ACTIVATOR; GENE-EXPRESSION; GROWTH-FACTOR; MATRIX METALLOPROTEINASE-3; TRANSCRIPTIONAL ACTIVATION; CORONARY ATHEROSCLEROSIS; RECEPTOR ANTAGONIST; PROMOTER; AP-1; PROCOLLAGENASE	Stromelysin 1 (MMP-3) is a matrix metalloproteinase with broad substrate specificity that has been Linked to joint and tissue destruction associated with chronic inflammatory diseases such as rheumatoid arthritis and periodontitis. Transcription of the stromelysin gene is induced by inflammatory cytokines such as interleukin 1 (IL-1) and tumor necrosis factor as well as a number of other cytokines and mitogens, but the exact mechanisms involved in its regulation are not fully understood. To identify transcription factors and cis elements potentially involved in the IL-1 induction of stromelysin, the human stromelysin 5'-flanking region was screened by electrophoretic mobility shift assay for IL-1-induced DNA-binding complexes in human synovial and gingival fibroblasts. Here we report the identification of such a complex binding to the region -1614 to -1595 (5'-G(T)TTTTTCCCCCCATCAAAG-3') termed the stromelysin IL-1 responsive element site. Binding to this site is also induced by tumor necrosis factor but not by platelet-derived growth factor or interleukin 4. UV cross-linking demonstrates that there are at least two DNA-binding proteins involved, of approximately 48 and 52 kDa. Transient transfection experiments in human foreskin fibroblasts demonstrate that proteins binding to this site act as a repressor of IL-1-induced expression of the stromelysin gene.	Philadelphia Coll Osteopath Med, Dept Biochem Mol Biol, Philadelphia, PA 19131 USA		Borghaei, RC (corresponding author), Philadelphia Coll Osteopath Med, Dept Biochem Mol Biol, Philadelphia, PA 19131 USA.			Borghaei, Ruth/0000-0003-4206-0231	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE011577, R29DE012096] Funding Source: NIH RePORTER; NIDCR NIH HHS [R03 DE11577-01, R29 DE012096-04, R29 DE12096-02] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Beekman B, 1997, FEBS LETT, V418, P305, DOI 10.1016/S0014-5793(97)01371-9; BIRKEDALHANSEN H, 1993, J PERIODONTAL RES, V28, P500, DOI 10.1111/j.1600-0765.1993.tb02113.x; BORDEN P, 1994, GENE, V151, P315, DOI 10.1016/0378-1119(94)90677-7; Borghaei RC, 1998, ARTHRITIS RHEUM-US, V41, P1398, DOI 10.1002/1529-0131(199808)41:8<1398::AID-ART8>3.0.CO;2-B; BRINCKERHOFF CE, 1990, J BIOL CHEM, V265, P22262; Buisson AC, 1996, LAB INVEST, V74, P658; BUTTICE G, 1991, NUCLEIC ACIDS RES, V19, P3723, DOI 10.1093/nar/19.13.3723; DECHANET J, 1993, J IMMUNOL, V151, P4908; DIAZMECO MT, 1991, J BIOL CHEM, V266, P22597; GAIRE M, 1994, J BIOL CHEM, V269, P2032; Harris ED, 1993, TXB RHEUMATOLOGY, P833; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Kabashima H, 1996, J ORAL PATHOL MED, V25, P449, DOI 10.1111/j.1600-0714.1996.tb00295.x; MAUVIEL A, 1992, J CELL BIOCHEM, V50, P53, DOI 10.1002/jcb.240500110; MOCHAN E, 1986, ARTHRITIS RHEUM, V29, P1078, DOI 10.1002/art.1780290904; MOCHAN E, 1986, J RHEUMATOL, V13, P15; Ni X, 1997, INFLAMM RES, V46, pS124; QUINONES S, 1994, BIOCHEM J, V302, P471, DOI 10.1042/bj3020471; QUINONES S, 1989, J BIOL CHEM, V264, P8339; Reynolds J J, 1994, Adv Dent Res, V8, P312; SANZ L, 1994, J BIOL CHEM, V269, P10044; SANZ L, 1995, MOL CELL BIOL, V15, P3164; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEITZ M, 1994, J IMMUNOL, V152, P2060; SIRUMCONNOLLY K, 1991, NUCLEIC ACIDS RES, V19, P335, DOI 10.1093/nar/19.2.335; Sugiyama E, 1996, ANN RHEUM DIS, V55, P375, DOI 10.1136/ard.55.6.375; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; WASYLYK C, 1991, EMBO J, V10, P1127, DOI 10.1002/j.1460-2075.1991.tb08053.x; Werb Z, 1992, Matrix Suppl, V1, P337; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; YE S, 1995, BRIT HEART J, V73, P209	32	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2126	2131		10.1074/jbc.274.4.2126	http://dx.doi.org/10.1074/jbc.274.4.2126			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890974	Green Accepted, hybrid			2022-12-27	WOS:000078185200041
J	Glaven, JA; Whitehead, I; Bagrodia, S; Kay, R; Cerione, RA				Glaven, JA; Whitehead, I; Bagrodia, S; Kay, R; Cerione, RA			The Dbl-related protein, Lfc, localizes to microtubules and mediates the activation of Rac signaling pathways in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; PLECKSTRIN HOMOLOGY DOMAIN; STRUCTURAL SIMILARITIES; EXPRESSION CLONING; KINASE ACTIVATION; FAMILY; ONCOGENE; CDC42; ACTIN; VAV	The possibility that the Dbl family member Lfc can activate Rad in cells is investigated in this study, Previously, we demonstrated that both Lfc and Lsc, like their closest relative Lbc, can act catalytically in stimulating the guanine nucleotide exchange activity of RhoA in vitro. Neither Lfc nor Lsc stimulated the in vitro exchange activity of Cdc42 or Rad; however, Lfc was capable of forming a tight complex with Rac1 in vitro, We show here that Lfc stimulates c-Jun kinase (JNK) activity in COS-7 cells. This stimulation was blocked by a dominant negative mutant of Rad and somewhat less effectively by dominant negative RhoA, but not by dominant negative Cdc42, Overexpression of Lfc in NIH 3T3 cells induced the formation of actin stress fibers and membrane ruffles, consistent with the activation of both RhoA and Rad signaling pathways, whereas overexpression of Lsc led exclusively to well developed stress fibers. Using a recently developed assay for measuring the cellular activation of Pac, we did not find that expression of Lfc increased the levels of GTP-bound Rad. However, an examination of the cellular localization of Lfc showed that it was localized to microtubules, similar to what has been reported for activated! Rad, the mixed lineage kinase (MLK) and JNK. Moreover, we have found that the Pleckstrin homology (PH) domain of Lfc specifically associates with tubulin, Taken together, these findings suggest a model where the PH domain-mediated localization of Lfc to microtubules enables the recruitment of Rac to a site proximal to its signaling targets, resulting in JNK activation and actin cytoskeletal changes.	Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 4E6, Canada	Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; British Columbia Cancer Agency	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S15GM045478] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45478] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Best A, 1996, J BIOL CHEM, V271, P3756; BROWN JL, 1996, J CURR BIOL, P598; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Glaven JA, 1996, J BIOL CHEM, V271, P27374, DOI 10.1074/jbc.271.44.27374; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HART MJ, 1994, J BIOL CHEM, V269, P62; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; TERRAMOTO H, 1996, J BIOL CHEM, V271, P25731; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; WHITEHEAD I, 1995, J BIOL CHEM, V270, P18388, DOI 10.1074/jbc.270.31.18388; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Whitehead IP, 1996, J BIOL CHEM, V271, P18643, DOI 10.1074/jbc.271.31.18643; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Zheng Y, 1996, J BIOL CHEM, V271, P19017, DOI 10.1074/jbc.271.32.19017	31	136	136	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2279	2285		10.1074/jbc.274.4.2279	http://dx.doi.org/10.1074/jbc.274.4.2279			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890991	hybrid			2022-12-27	WOS:000078185200058
J	Gonzalez-Perez, MM; Ramos, JL; Gallegos, MT; Marques, S				Gonzalez-Perez, MM; Ramos, JL; Gallegos, MT; Marques, S			Critical nucleotides in the upstream region of the XylS-dependent TOL meta-cleavage pathway operon promoter as deduced from analysis of mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARAC-PROTEIN; PSEUDOMONAS-PUTIDA; PLASMID PWWO; DNA-BINDING; PM PROMOTER; GENE XYLS; TRANSCRIPTION; SEQUENCE; IDENTIFICATION; REGULATORS	The Pm promoter, dependent on TOL plasmid XylS regulator, which is activated by benzoate effecters, drives transcription of the meta-cleavage pathway for the metabolism of alkylbenzoates. This promoter is unique in that in vivo transcription is mediated by RNA-polymerase with different sigma factors. In vivo footprinting analysis shows that XylS interacted with nucleotides in the -40 to -70 region, In vivo and in vitro methylation of Pm shows extensive methylation of T at position -42 in the bottom strand, suggesting that it represents a key distortion point that may favor XylS/RNA polymerase interactions. Methylation of T-42 was highest in cells bearing XylS and in the presence of an effector. Gs in the -47 to -61 region appeared to be more protected in cells harboring XylS in the presence than in the absence of the effector. Almost 100 mutants in the Pm region between -41 and -78 were generated; transcriptional analysis of these mutants defined the XylS target as two direct repeats with the sequence TGCAN(6)GGNCA. These motifs cover the -70 to -56 and the -49 to -35 regions. Single point mutations revealed that nucleotides located at -49 to -46 and at -59, -60, -62, and -70 are the most critical for appropriate XylS-Pm interactions.	CSIC, Estac Expt Zaidin, Dept biochem & Mol & Cellular Biol Plants, E-18008 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Ramos, JL (corresponding author), CSIC, Estac Expt Zaidin, Dept biochem & Mol & Cellular Biol Plants, Apartado Correos 419, E-18008 Granada, Spain.	jlramos@eez.csic.es	Marqués, Silvia/B-8079-2012; Gallegos, María-Trinidad M.T./K-6501-2014	Marqués, Silvia/0000-0002-6289-3348; Gallegos, María-Trinidad M.T./0000-0001-7633-8807; Ramos, Juan L./0000-0002-8731-7435				Ausubel FM., 2006, ENZYMATIC MANIPULATI; BRUNELLE A, 1989, J MOL BIOL, V209, P607, DOI 10.1016/0022-2836(89)90598-6; BUSTOS SA, 1993, P NATL ACAD SCI USA, V90, P5638, DOI 10.1073/pnas.90.12.5638; CARRA JH, 1993, EMBO J, V12, P35, DOI 10.1002/j.1460-2075.1993.tb05629.x; CASWELL R, 1992, BIOCHEM J, V287, P493, DOI 10.1042/bj2870493; EGAN SM, 1993, J MOL BIOL, V234, P87, DOI 10.1006/jmbi.1993.1565; EUSTANCE RJ, 1994, J MOL BIOL, V242, P330; FAWCETT WP, 1995, J BACTERIOL, V177, P1742, DOI 10.1128/jb.177.7.1742-1750.1995; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gallegos MT, 1996, J BACTERIOL, V178, P6427, DOI 10.1128/jb.178.22.6427-6434.1996; INOUYE S, 1986, GENE, V44, P235; INOUYE S, 1981, J BACTERIOL, V148, P413, DOI 10.1128/JB.148.2.413-418.1981; Kaldalu N, 1996, MOL MICROBIOL, V20, P569, DOI 10.1046/j.1365-2958.1996.5381060.x; KESSLER B, 1993, J MOL BIOL, V230, P699, DOI 10.1006/jmbi.1993.1189; Li ZY, 1996, MOL MICROBIOL, V20, P937, DOI 10.1111/j.1365-2958.1996.tb02535.x; LOBELL RB, 1991, J MOL BIOL, V218, P45, DOI 10.1016/0022-2836(91)90872-4; LOBELL RB, 1990, SCIENCE, V250, P528, DOI 10.1126/science.2237403; MARQUES S, 1993, BIOCHIM BIOPHYS ACTA, V1216, P227, DOI 10.1016/0167-4781(93)90149-8; MARQUES S, 1999, IN PRESS MOL MICROBI; MENON KP, 1990, P NATL ACAD SCI USA, V87, P3708, DOI 10.1073/pnas.87.10.3708; MERMOD N, 1987, MOL GEN GENET, V207, P349, DOI 10.1007/BF00331600; Niland P, 1996, J MOL BIOL, V264, P667, DOI 10.1006/jmbi.1996.0668; RAMOS JL, 1986, P NATL ACAD SCI USA, V83, P8467, DOI 10.1073/pnas.83.22.8467; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; RAMOS JL, 1987, MOL MICROBIOL, V1, P297; REEDER T, 1993, J MOL BIOL, V231, P205, DOI 10.1006/jmbi.1993.1276; SCHLEIF R, 1992, TRANSCRIPTIONAL REGU, V2, P643; SPOONER RA, 1987, J BACTERIOL, V169, P3581, DOI 10.1128/jb.169.8.3581-3586.1987	29	52	55	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2286	2290		10.1074/jbc.274.4.2286	http://dx.doi.org/10.1074/jbc.274.4.2286			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890992	hybrid			2022-12-27	WOS:000078185200059
J	Ivins, KJ; Ivins, JK; Sharp, JP; Cotman, CW				Ivins, KJ; Ivins, JK; Sharp, JP; Cotman, CW			Multiple pathways of apoptosis in PC12 cells - CrmA inhibits apoptosis induced by beta-amyloid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE NEURONS; CENTRAL-NERVOUS-SYSTEM; CULTURED HIPPOCAMPAL-NEURONS; TUMOR-NECROSIS-FACTOR; A-BETA; ALZHEIMERS-DISEASE; CORTICAL-NEURONS; IN-VITRO; TYROSINE PHOSPHORYLATION; MITOCHONDRIAL-MEMBRANE	Stable transfectants of PC12 cells expressing bcl-2 or crmA were generated and tested for their susceptibility to various apoptotic insults. Bcl-2 expression conferred resistance to apoptosis induced by staurosporine and by oxidative insults including hydrogen peroxide and peroxynitrite, but was less effective in inhibition of:activation-induced programmed cell death induced by concanavalin A. Concanavalin A-induced apoptosis was abated, however, in cells expressing very high levels of bcl-2. In contrast, cells expressing crmA were protected from concanavalin A-induced apoptosis, but were as susceptible as control cells to apoptosis induced by staurosporine and oxidative insults. Therefore, at least two apoptotic pathways in PC12 cells can be discerned by their differential sensitivity to blockade by bcl-2 and crmA, The ability of beta-amyloid (A beta) to induce apoptosis in these cells was assessed. CrmA transfectants were protected from apoptosis induced by A beta(1-42), but only cells expressing very high levels of bcl-2 were similarly protected. These results suggest that the apoptotic pathway activated by A beta(1-42), in PC12 cells can be differentiated from the apoptotic pathway activated by oxidative insults. Gene transfer experiments also demonstrated that expression of crmA in primary cultures of hippocampal neurons is protective against cell death induced by A beta(1-42), Together these results support the hypothesis that A beta-induced apoptosis occurs through activation-induced programmed cell death.	Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ivins, KJ (corresponding author), Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92697 USA.				NATIONAL INSTITUTE ON AGING [R01AG013007] Funding Source: NIH RePORTER; NIA NIH HHS [R01-AG13007] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adachi S, 1997, J BIOL CHEM, V272, P21878, DOI 10.1074/jbc.272.35.21878; Alam MK, 1997, EUR J IMMUNOL, V27, P3485, DOI 10.1002/eji.1830271249; Anderson AJ, 1996, J NEUROSCI, V16, P1710, DOI 10.1523/jneurosci.16-05-01710.1996; ANDERSON AJ, 1995, J NEUROCHEM, V65, P1487; Aragane Y, 1998, J CELL BIOL, V140, P171, DOI 10.1083/jcb.140.1.171; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BEHL C, 1993, BIOCHEM BIOPH RES CO, V197, P949, DOI 10.1006/bbrc.1993.2571; Beyaert R, 1997, J BIOL CHEM, V272, P11694, DOI 10.1074/jbc.272.18.11694; Blacker D, 1998, ARCH NEUROL-CHICAGO, V55, P294, DOI 10.1001/archneur.55.3.294; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573; COTMAN CW, 1996, MOL MECH DEMENTIA, P73; Cribbs DH, 1996, NEUROSCIENCE, V75, P173, DOI 10.1016/0306-4522(96)80001-P; deLuca A, 1996, J NEUROSCI, V16, P4174; Farinelli SE, 1996, J NEUROSCI, V16, P1150, DOI 10.1523/jneurosci.16-03-01150.1996; Frisch SM, 1996, J CELL BIOL, V135, P1377, DOI 10.1083/jcb.135.5.1377; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; GELLER AI, 1990, P NATL ACAD SCI USA, V87, P1149, DOI 10.1073/pnas.87.3.1149; GomezIsla T, 1996, J NEUROSCI, V16, P4491; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041; Keller JN, 1998, J NEUROSCI, V18, P687; KORSMEYER SJ, 1995, BBA-MOL BASIS DIS, V1271, P63, DOI 10.1016/0925-4439(95)00011-R; Kruman I, 1997, J NEUROSCI, V17, P5089; Lawrence MS, 1996, J NEUROSCI, V16, P486; Lim F, 1996, BIOTECHNIQUES, V20, P460; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; LUO YQ, 1995, BRAIN RES, V681, P65, DOI 10.1016/0006-8993(95)00282-U; Mandal M, 1996, J BIOL CHEM, V271, P30354, DOI 10.1074/jbc.271.48.30354; Mark RJ, 1997, J NEUROSCI, V17, P1046; MATTSON M, 1997, BRAIN RES, V77, P147; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; MEMON SA, 1995, J IMMUNOL, V155, P4644; Messam CA, 1998, EXP CELL RES, V238, P389, DOI 10.1006/excr.1997.3845; Moreno MB, 1996, J IMMUNOL, V157, P3845; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; NAKAJIMA M, 1994, BRAIN RES, V641, P350, DOI 10.1016/0006-8993(94)90165-1; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Park DS, 1997, J NEUROSCI, V17, P8975; Pike CJ, 1997, J NEUROCHEM, V69, P1601; PIKE CJ, 1993, J NEUROSCI, V13, P1676; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Ray CA, 1996, VIROLOGY, V217, P384, DOI 10.1006/viro.1996.0128; Schulz JB, 1996, J NEUROSCI, V16, P4696; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Stefanis L, 1996, J BIOL CHEM, V271, P30663, DOI 10.1074/jbc.271.48.30663; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; SU JH, 1994, NEUROREPORT, V5, P2529, DOI 10.1097/00001756-199412000-00031; Taylor J, 1997, J NEUROCHEM, V68, P1598; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; VanderZee CEEM, 1996, SCIENCE, V274, P1729, DOI 10.1126/science.274.5293.1729; Vogel P, 1997, BRAIN RES, V764, P205, DOI 10.1016/S0006-8993(97)00458-7; WATT JA, 1994, BRAIN RES, V661, P147, DOI 10.1016/0006-8993(94)91191-6; Weldon DT, 1998, J NEUROSCI, V18, P2161; WHITTEMORE ER, 1995, NEUROSCIENCE, V67, P921, DOI 10.1016/0306-4522(95)00108-U; WOODS AG, 1995, BRAIN RES, V697, P53, DOI 10.1016/0006-8993(95)00775-L; Wujek JR, 1996, NEUROBIOL AGING, V17, P107, DOI 10.1016/0197-4580(95)02020-9; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; ZHANG C, 1994, J BIOL CHEM, V269, P25247; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	64	92	97	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2107	2112		10.1074/jbc.274.4.2107	http://dx.doi.org/10.1074/jbc.274.4.2107			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890971	hybrid			2022-12-27	WOS:000078185200038
J	Naeger, LK; McKinney, J; Salvekar, A; Hoey, T				Naeger, LK; McKinney, J; Salvekar, A; Hoey, T			Identification of a STAT4 binding site in the interleukin-12 receptor required for signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; TYROSINE PHOSPHORYLATION; T-CELLS; CYTOKINE RECEPTORS; INTERFERON-ALPHA; IFN-ALPHA; TH2 CELLS; IL-12; TRANSCRIPTION; ACTIVATION	The specificity of the various STAT SH2 domains for different tyrosine-containing peptides enables cytokines to activate different signaling pathways rand to induce distinct patterns of gene expression. We show that STAT4 has a unique peptide specificity and binds to the peptide sequence pYLPSNID (where pY represents phosphotyrosine). This motif is found at tyrosine residue 800 in the beta 2 subunit of the interleukin-12 receptor and is required for DNA binding and transcriptional activity of STAT4, Our data demonstrate that transfection of interleukin-12 receptor beta 1 and beta 2 subunits is sufficient for STAT4 activation but not for STAT1 or STAT3 activation.	Tularik Inc, S San Francisco, CA 94080 USA		Hoey, T (corresponding author), Tularik Inc, 2 Corp Dr, S San Francisco, CA 94080 USA.							BACON CM, 1995, J EXP MED, V181, P399, DOI 10.1084/jem.181.1.399; BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cho SS, 1996, J IMMUNOL, V157, P4781; CHUA AO, 1994, J IMMUNOL, V153, P128; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FARRELL G, 1992, INT REV VICTIMOLOGY, V2, P89; Gollob JA, 1998, BLOOD, V91, P1341, DOI 10.1182/blood.V91.4.1341; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; PIGNATA C, 1995, CELL IMMUNOL, V165, P211, DOI 10.1006/cimm.1995.1207; PIGNATA C, 1994, BLOOD, V83, P184; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Romagnani S, 1996, CLIN IMMUNOL IMMUNOP, V80, P225, DOI 10.1006/clin.1996.0118; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schindler U, 1996, GENES CELLS, V1, P507, DOI 10.1046/j.1365-2443.1996.d01-263.x; SCHINDLER U, 1995, IMMUNITY, V2, P689, DOI 10.1016/1074-7613(95)90013-6; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; YAMAMOTO K, 1994, MOL CELL BIOL, V14, P4342, DOI 10.1128/MCB.14.7.4342; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; Yu CR, 1996, J IMMUNOL, V157, P126; ZHONG Z, 1994, P NATL ACAD SCI USA, V91, P4806, DOI 10.1073/pnas.91.11.4806; Zou J, 1997, J BIOL CHEM, V272, P6073, DOI 10.1074/jbc.272.9.6073	35	58	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1875	1878		10.1074/jbc.274.4.1875	http://dx.doi.org/10.1074/jbc.274.4.1875			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890938	hybrid			2022-12-27	WOS:000078185200005
J	Yao, ZB; Zhou, GS; Wang, XHS; Brown, A; Diener, K; Gan, H; Tan, TH				Yao, ZB; Zhou, GS; Wang, XHS; Brown, A; Diener, K; Gan, H; Tan, TH			A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMINAL CENTER KINASE; INDUCED APOPTOSIS; JNK PATHWAY; TRANSDUCTION; ISOFORMS; MEDIATOR; CASCADE; HOMOLOG; DOMAIN; FAMILY	The yeast serine/threonine kinase STE20 activates a signaling cascade that includes STE11 (mitogen-activated protein kinase kinase kinase), STE7 (mitogen-activated protein kinase kinase), and FUS3/KSS1 (mitogen-activated protein kinase) in response to signals from both Cdc42 and the heterotrimeric G proteins associated with transmembrane pheromone receptors. Using degenerate polymerase chain reaction, we have isolated a human cDNA encoding a protein kinase homologous to STE20. This protein kinase, designated HPK/GCK-like kinase (HGK), has nucleotide sequences that encode an open reading frame of 1165 amino acids with 11 kinase subdomains. HGK was a serine/threonine protein kinase that specifically activated the c-Jun N-terminal kinase (JNK) signaling pathway when transfected into 293T cells, but it did not stimulate either the extracellular signal-regulated kinase or p38 kinase pathway. HGK also increased AP-1-mediated transcriptional activity in vivo. HGK-induced JNK activation was inhibited by the dominant-negative MKK4 and MKK7 mutants. The dominant-negative mutant of TAK1, but not MEKK1 or MAPK upstream kinase (MUK), strongly inhibited HGK-induced JNK activation. TNF-alpha activated HGK in 298T sells, as well as the dominant-negative HGK mutants, inhibited TNF-alpha-induced JNK activation. These results indicate that HGK, a novel activator of the JNK pathway, may function through TAK1, and that the HGK --> TAK1 --> MKK4, MKK7 --> JNK kinase cascade may mediate the TNF-alpha signaling pathway.	Baylor Coll Med, Dept Microbiol & Immunol, Houston, TX 77030 USA; Amgen Inc, Boulder, CO 80301 USA	Baylor College of Medicine; Amgen	Tan, TH (corresponding author), Baylor Coll Med, Dept Microbiol & Immunol, M929,1 Baylor Plaza, Houston, TX 77030 USA.	ttan@bcm.tmc.edu	Tan, Tse-Hua/E-3983-2010; Tan, Tse-Hua/ABD-7080-2021	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170	NIAID NIH HHS [R01-AI38649, R01-AI42532] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042532, R01AI038649] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chen YR, 1998, J BIOL CHEM, V273, P1769, DOI 10.1074/jbc.273.3.1769; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; CHEN YR, 1996, J BIOL CHEM, V271, P8971; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; HATZ P, 1994, J BIOL CHEM, V269, P16802; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Hirai S, 1996, ONCOGENE, V12, P641; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; Meyer CF, 1996, J BIOL CHEM, V271, P8971, DOI 10.1074/jbc.271.15.8971; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; Shi CS, 1997, J BIOL CHEM, V272, P32102, DOI 10.1074/jbc.272.51.32102; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Tung RM, 1997, ONCOGENE, V14, P653, DOI 10.1038/sj.onc.1200877; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Wang XHS, 1996, J BIOL CHEM, V271, P31607; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu X, 1996, ONCOGENE, V13, P135; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; YAN MH, 1994, NATURE, V372, P798; Yao ZB, 1997, J BIOL CHEM, V272, P32378, DOI 10.1074/jbc.272.51.32378	35	136	166	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2118	2125		10.1074/jbc.274.4.2118	http://dx.doi.org/10.1074/jbc.274.4.2118			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890973	hybrid			2022-12-27	WOS:000078185200040
J	Yuan, ZM; Huang, YY; Ishiko, T; Nakada, S; Utsugisawa, T; Shioya, H; Utsugisawa, Y; Yokoyama, K; Weichselbaum, R; Shi, Y; Kufe, D				Yuan, ZM; Huang, YY; Ishiko, T; Nakada, S; Utsugisawa, T; Shioya, H; Utsugisawa, Y; Yokoyama, K; Weichselbaum, R; Shi, Y; Kufe, D			Role for p300 in stabilization of p53 in the response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN P300; TRANSCRIPTIONAL ADAPTER; MDM2 EXPRESSION; BINDING; COACTIVATOR; ACTIVATION; CBP; GROWTH; DOMAIN; TARGET	The nuclear p300/CBP proteins function as coactivators of gene transcription. Here, using cells deficient in p300 or CBP, we show that p300, and not CBP, is essential for ionizing radiation-induced accumulation of the p53 tumor suppressor and thereby p53-mediated growth arrest. The results demonstrate that deficiency of p300 results in increased degradation of p53. Our findings suggest that p300 contributes to the stabilization and transactivation function of p53 in the cellular response to DNA damage.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Inst Phys & Chem Res, Tsukuba Life Sci Ctr, Tsukuba, Ibaraki 305, Japan; Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; RIKEN; University of Chicago	Yuan, ZM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.		Utsugisawa, Taiju/ABD-7059-2021					ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; Bex F, 1998, MOL CELL BIOL, V18, P2392, DOI 10.1128/MCB.18.4.2392; Bottger A, 1997, CURR BIOL, V7, P860, DOI 10.1016/S0960-9822(06)00374-5; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; Kawasaki H, 1996, NUCLEIC ACIDS RES, V24, P3010, DOI 10.1093/nar/24.15.3010; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; MIYASHITA T, 1995, CELL, V80, P293; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Woo RA, 1998, NATURE, V394, P700, DOI 10.1038/29343; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	34	80	80	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1883	1886		10.1074/jbc.274.4.1883	http://dx.doi.org/10.1074/jbc.274.4.1883			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890940	hybrid			2022-12-27	WOS:000078185200007
J	Choe, CY; Im, HJ; Ko, JL; Loh, HH				Choe, CY; Im, HJ; Ko, JL; Loh, HH			Mouse mu opioid receptor gene expression - A 34-base pair cis-acting element inhibits transcription of the mu opioid receptor gene from the distal promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; SECONDARY STRUCTURE; REGION; RAT; TRANSLATION; SEQUENCES; CLONING	The 5'-flanking region of the mouse mu opioid receptor (MOR) gene has two promoters, referred to as distal and proximal, and the activities of each in the brain are quite different from each other. The 5'-distal promoter regulatory sequences (5'-DPRS), positioned between these two promoters, have strong inhibitory effects on the reporter gene expression driven by the MOR distal promoter. In our studies, detailed 3' deletion mapping of the 5'-DPRS narrowed down the negative cis-acting element to a 34-base pair (bp) segment (position -721 to -687). This 34-bp cis-acting element functions in both neuronal (NMB) and non-neuronal (CHO and RAW264.7) cultured cells. S1 nuclease protection assays indicated that this 34-bp cis-acting element suppresses distal promoter activity at the transcriptional level. Linker scanning mutagenesis demonstrated that nucleotides around position -721 and -689 in the 34-bp cis-acting element are essential for the regulation of distal promoter activity. Operational characterization of the 34-bp cis-acting element in the homologous MOR distal promoter and the heterologous SV40 promoter showed that its effects are position- and promoter-dependent while being orientation-independent in both promoters. Collectively, these data suggested that this 34-bp segment is a conditional transcriptional cis-acting element that blocks mouse MOR gene expression from the distal promoter.	Univ Minnesota, Dept Pharmacol, Sch Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Choe, CY (corresponding author), Univ Minnesota, Dept Pharmacol, Sch Med, 3-249 Millard Hall,435 Delaware St SE, Minneapolis, MN 55455 USA.	choex003@ec.umn.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA005695, R37DA001583, R01DA001583] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002647] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR053220-04, R01 AR053220] Funding Source: Medline; NIDA NIH HHS [DA-00546, DA-01583, DA-05695] Funding Source: Medline; BLRD VA [I01 BX002647] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); BLRD VA		ARRICK BA, 1991, MOL CELL BIOL, V11, P4306, DOI 10.1128/MCB.11.9.4306; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; BAUMHAKER Y, 1994, BRAIN RES, V665, P94, DOI 10.1016/0006-8993(94)91156-8; BRODSKY M, 1995, NEUROREPORT, V6, P725, DOI 10.1097/00001756-199503270-00005; DELFS JM, 1994, J NEUROCHEM, V63, P777; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Kieffer BL, 1995, CELL MOL NEUROBIOL, V15, P615, DOI 10.1007/BF02071128; KIM SJ, 1992, J BIOL CHEM, V267, P13702; Ko JL, 1997, BIOCHEM BIOPH RES CO, V234, P351, DOI 10.1006/bbrc.1997.6640; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRAUS J, 1995, BIOCHEM BIOPH RES CO, V215, P591, DOI 10.1006/bbrc.1995.2505; LIANG YB, 1995, BRAIN RES, V679, P82, DOI 10.1016/0006-8993(95)00222-C; Liang YB, 1997, BRAIN RES, V769, P372, DOI 10.1016/S0006-8993(97)00854-8; LOH HH, 1990, ANNU REV PHARMACOL, V30, P123; MA CK, 1994, MOL MICROBIOL, V14, P1033, DOI 10.1111/j.1365-2958.1994.tb01337.x; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; MIN BH, 1994, P NATL ACAD SCI USA, V91, P9081, DOI 10.1073/pnas.91.19.9081; Olson GA, 1997, PEPTIDES, V18, P1651, DOI 10.1016/S0196-9781(97)00264-7; PATEL RC, 1992, J BIOL CHEM, V267, P1159; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Ruzicka BB, 1997, NEUROSCIENCE, V79, P517, DOI 10.1016/S0306-4522(96)00669-0; SIMANTOV R, 1989, J NEUROCHEM, V52, P305, DOI 10.1111/j.1471-4159.1989.tb10931.x; SIMANTOV R, 1986, DEV BRAIN RES, V391, P301; SNYDER SH, 1984, SCIENCE, V224, P22, DOI 10.1126/science.6322304; Wendel B, 1998, J MOL MED-JMM, V76, P525, DOI 10.1007/s001090050246; Wittert G, 1996, BIOCHEM BIOPH RES CO, V218, P877, DOI 10.1006/bbrc.1996.0156; YANOFSKY C, 1988, J BIOL CHEM, V263, P609	29	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34926	34932		10.1074/jbc.273.52.34926	http://dx.doi.org/10.1074/jbc.273.52.34926			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857022	Green Accepted, hybrid			2022-12-27	WOS:000077719700040
J	Liang, JS; Wu, XJ; Jiang, HS; Zhou, MY; Yang, HY; Angkeow, PS; Huang, LS; Sturley, SL; Ginsberg, H				Liang, JS; Wu, XJ; Jiang, HS; Zhou, MY; Yang, HY; Angkeow, PS; Huang, LS; Sturley, SL; Ginsberg, H			Translocation efficiency, susceptibility to proteasomal degradation, and lipid responsiveness of apolipoprotein B are determined by the presence of beta sheet domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; HEP G2 CELLS; ENDOPLASMIC-RETICULUM; CONTAINING LIPOPROTEINS; INTRACELLULAR DEGRADATION; PAUSE TRANSFER; APO-B; SECRETION; B100; HEAT-SHOCK-PROTEIN-70	Apolipoprotein (apo) B100 is an atypical secretory protein in that its translocation across the endoplasmic reticulum membrane is inefficient, resulting in the partial translocation and exposure of apoB100 on the cytoplasmic surface of the endoplasmic reticulum. Cytosolic exposure leads to the association of nascent apoB with heat shock protein 70 and to its predisposition to ubiquitination and proteasomal degradation. The basis for the inefficient translocation of apoB100 remains unclear and controversial. To test the hypothesis that beta sheet domains present in apoB100 contribute to its inefficient translocation, we created human apoB chimeric constructs apoB13,16 and apoB13,13,16, which contain amino-terminal cu globular domains but no beta sheet domains, and apoB13,16,beta, which has an amphipathic beta sheet domain of apoB100 inserted into apoB13,16. These constructs, along with carboxyl-terminal truncations of apoB100, apoB34 and apoB42, were used to transfect HepG2 and Chinese hamster ovary cells. In contrast to the lack of effect of proteinase K on apoB13,16 and apoB13,13,16, the levels of apoB34, apoB42, and apoB13,16,beta were decreased by 70-85% after proteinase K-induced proteolysis in both HepG2 and Chinese hamster ovary cells. Either oleic acid or proteasomal inhibitors (N-acetyl-leucinyl-leucinyl-norleucinal and lactacystin) significantly increased the cell levels of apoB13,16,beta, apoB34, apoB42, and full-length apoB100 but had no effect on the cell levels of apoB13,16 and apoB13,13,16. When HepG2 cells were incubated with a microsomal triglyceride transfer protein inhibitor, the cellular levels of apoB13,16,beta, apoB34, and apoB42 were decreased by 70-80%, whereas the levels of apoB13,16 and apoB13,13,16 were unaffected. The effects of microsomal triglyceride transfer protein inhibition were reversed by lactacystin. Our results clearly demonstrate that the translocation efficiency, susceptibility to proteasomal degradation, and lipid responsiveness of apoB were determined by the presence of a lipid binding beta sheet domain. It is possible that beta sheet domains may at least transiently facilitate the interaction of apoB with the lipid bilayer surrounding the translocation channel.	Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA	Columbia University; Columbia University	Ginsberg, H (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA.		Yang, Hongyuan/AAR-1326-2020	Yang, Hongyuan/0000-0002-8482-6031	NHLBI NIH HHS [T32HL07343, HL55638] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055638, T32HL007343] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADELI K, 1994, J BIOL CHEM, V269, P9166; Bakillah A, 1998, BIOCHEMISTRY-US, V37, P3727, DOI 10.1021/bi972629t; Benoist F, 1997, J BIOL CHEM, V272, P20435, DOI 10.1074/jbc.272.33.20435; Chen Y, 1998, J BIOL CHEM, V273, P11887, DOI 10.1074/jbc.273.19.11887; CHUCK SL, 1992, CELL, V68, P9, DOI 10.1016/0092-8674(92)90202-N; CHUCK SL, 1990, NATURE, V346, P382, DOI 10.1038/346382a0; Corsi AK, 1996, J BIOL CHEM, V271, P30299, DOI 10.1074/jbc.271.48.30299; DAVIS RA, 1989, J LIPID RES, V30, P1185; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; DIXON JL, 1992, J CELL BIOL, V117, P1161, DOI 10.1083/jcb.117.6.1161; DIXON JL, 1993, J LIPID RES, V34, P167; DIXON JL, 1991, J BIOL CHEM, V266, P5080; DU EZ, 1994, J BIOL CHEM, V269, P24169; Du EZ, 1996, J LIPID RES, V37, P1309; Du XB, 1998, J CELL BIOL, V141, P585, DOI 10.1083/jcb.141.3.585; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; FURUKAWA S, 1992, J BIOL CHEM, V267, P22630; GINSBERG HN, 1991, DIABETES CARE, V14, P839, DOI 10.2337/diacare.14.9.839; GORDON DA, 1994, P NATL ACAD SCI USA, V91, P7628, DOI 10.1073/pnas.91.16.7628; Haghpassand M, 1996, J LIPID RES, V37, P1468; Hegde RS, 1998, CELL, V92, P621, DOI 10.1016/S0092-8674(00)81130-7; HEINEMANN T, 1994, J LIPID RES, V35, P2200; Hussain MM, 1997, BIOCHEMISTRY-US, V36, P13060, DOI 10.1021/bi971395a; Kivlen MH, 1997, J LIPID RES, V38, P1149; LEIPER JM, 1994, J BIOL CHEM, V269, P21951; Macri J, 1997, J BIOL CHEM, V272, P7328, DOI 10.1074/jbc.272.11.7328; McLeod RS, 1996, J BIOL CHEM, V271, P18445, DOI 10.1074/jbc.271.31.18445; Patel SB, 1996, J BIOL CHEM, V271, P18686, DOI 10.1074/jbc.271.31.18686; PEASE RJ, 1995, J BIOL CHEM, V270, P7261, DOI 10.1074/jbc.270.13.7261; PEASE RJ, 1991, NATURE, V353, P448, DOI 10.1038/353448a0; PULLINGER CR, 1989, J LIPID RES, V30, P1065; Rusinol AE, 1998, J LIPID RES, V39, P1287; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674, DOI 10.1161/01.ATV.14.10.1674; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; STEINBERG D, 1989, CIRCULATION, V80, P719, DOI 10.1161/01.CIR.80.3.719; THRIFT RN, 1992, P NATL ACAD SCI USA, V89, P9161, DOI 10.1073/pnas.89.19.9161; Wang S, 1996, J BIOL CHEM, V271, P14124, DOI 10.1074/jbc.271.24.14124; Wu XJ, 1996, J BIOL CHEM, V271, P10277, DOI 10.1074/jbc.271.17.10277; Yao ZM, 1997, J LIPID RES, V38, P1937; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777; ZHOU MY, 1995, J BIOL CHEM, V270, P25220, DOI 10.1074/jbc.270.42.25220; Zhou MY, 1998, J BIOL CHEM, V273, P24649, DOI 10.1074/jbc.273.38.24649	42	42	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35216	35221		10.1074/jbc.273.52.35216	http://dx.doi.org/10.1074/jbc.273.52.35216			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857060	hybrid			2022-12-27	WOS:000077719700078
J	Urbano, A; McCaffrey, R; Foss, F				Urbano, A; McCaffrey, R; Foss, F			Isolation and characterization of NUC70, a cytoplasmic, hematopoietic apoptotic endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL-ELECTROPHORESIS; DNA FRAGMENTATION; CELL-DEATH; CA2+/MG2+-DEPENDENT ENDONUCLEASE; INTRACELLULAR ACIDIFICATION; ENDO-EXONUCLEASE; RAT THYMOCYTES; JURKAT CELLS; IDENTIFICATION; PURIFICATION	Endonucleolytic DNA fragmentation is the common end point and the prevailing indicator of apoptosis, We have identified a 70-kDa endonuclease (NUC70) that is activated in drug-induced apoptosis of human hematopoietic cells. We purified NUC7O to homogeneity and generated a rabbit polyclonal antibody to distinguish it from previously identified nucleases. Biochemical characterization of isolated NUC70 demonstrates that it is Ca2+/Mg2+-dependent and active over a pH range of 6-8, When incubated with isolated HeLa nuclei, NUC70 was capable of generating internucleosomal DNA fragmentation. This endonucleolytic activity was inhibited by Zn2+, aurintricarboxylic acid, N-ethylnaleimide, spermine, and iodoacetamide. Western immunoblots using the anti-NUC70 antibody and DNA-SDS-polyacrylamide gel electrophoresis assays indicate that NUC70 expression and activity is restricted to human hematopoietic cells. No such activity was detected in human epithelial cell lines or murine hematopoietic cells. We also observed no difference in levels of NUC70 expression between apoptotic and nonapoptotic cells, suggesting that activation of NUC70 may be by posttranslational modification. We demonstrate that NUC70 activity is diminished in cells pretreated with the caspase inhibitors z-DEVD-fmk, z-VAD-fmk, and Z-CH2-Asp-DCB. Time course studies of cytoplasmic and nuclear endonuclease activities during apoptosis show that NUC70 is a cytoplasmic endonuclease that is translocated to the nucleus after the initiation of apoptosis, We confirmed this with immuno staining studies using anti-NUC70 antibody. These results demonstrate that NUC70 is an endogenous cytoplasmic endonuclease that is activated during apoptosis in a caspase-dependent mechanism.	Tufts Univ, New England Med Ctr, Dept Hematol Oncol, Boston, MA 02111 USA; Boston Univ, Dept Pathol, Sch Med, Boston, MA 02111 USA; Boston Univ, Dept Lab Med, Sch Med, Boston, MA 02111 USA; Boston Med Ctr, Dev Therapeut Program, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Boston University; Boston University; Boston Medical Center	Foss, F (corresponding author), Tufts Univ, New England Med Ctr, Dept Hematol Oncol, 750 Washington St, Boston, MA 02111 USA.							ARENDS MJ, 1990, AM J PATHOL, V136, P593; ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; BARRY MA, 1993, CANCER RES, V53, P2349; BARRY MA, 1993, ARCH BIOCHEM BIOPHYS, V300, P440, DOI 10.1006/abbi.1993.1060; Bendjennat M, 1997, J BACTERIOL, V179, P2210, DOI 10.1128/jb.179.7.2210-2220.1997; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARONLESLIE LAM, 1991, J STEROID BIOCHEM, V40, P661, DOI 10.1016/0960-0760(91)90288-G; Chiarugi P, 1997, BIOCHEM BIOPH RES CO, V231, P717, DOI 10.1006/bbrc.1997.6176; CHOW TYK, 1983, J BIOL CHEM, V258, P2010; Collins MKL, 1996, J CELL SCI, V109, P2393; COMPTON MM, 1987, J BIOL CHEM, V262, P8288; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; FLECKENSTEIN E, 1994, LEUKEMIA, V8, P1424; Fraser MJ, 1996, J CELL SCI, V109, P2343; GAIDO ML, 1991, J BIOL CHEM, V266, P18580; GENDIMENICO GJ, 1988, ANAL BIOCHEM, V173, P45, DOI 10.1016/0003-2697(88)90156-X; GIANNAKIS C, 1991, BIOCHEM BIOPH RES CO, V181, P915, DOI 10.1016/0006-291X(91)91278-K; GOTTLIEB RA, 1995, BLOOD, V86, P2414, DOI 10.1182/blood.V86.6.2414.bloodjournal8662414; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P654, DOI 10.1073/pnas.93.2.654; Halenbeck R, 1998, CURR BIOL, V8, P537, DOI 10.1016/S0960-9822(98)79298-X; Kawabata H, 1997, BIOCHEM BIOPH RES CO, V233, P133, DOI 10.1006/bbrc.1997.6362; KERR JFR, 1971, J PATHOL, V105, P13, DOI 10.1002/path.1711050103; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khodarev NN, 1998, INT J RADIAT BIOL, V73, P455; Khodarev NN, 1996, J IMMUNOL, V156, P922; Krueger E, 1998, ANTICANCER RES, V18, P983; Mashima T, 1997, ONCOGENE, V14, P1007, DOI 10.1038/sj.onc.1200919; MCGREW BR, 1990, ANAL BIOCHEM, V189, P68, DOI 10.1016/0003-2697(90)90045-B; Mesner P W Jr, 1997, Adv Pharmacol, V41, P461, DOI 10.1016/S1054-3589(08)61069-8; MONTAGUE JW, 1994, J BIOL CHEM, V269, P18877; Nishikawa A, 1997, BIOCHEM BIOPH RES CO, V231, P305, DOI 10.1006/bbrc.1997.6091; Paddenberg R, 1996, EUR J CELL BIOL, V71, P105; Pandey S, 1997, BIOCHEMISTRY-US, V36, P711, DOI 10.1021/bi962387h; PEITSCH MC, 1993, EMBO J, V12, P371, DOI 10.1002/j.1460-2075.1993.tb05666.x; POLZAR B, 1993, EUR J CELL BIOL, V62, P397; RIBEIRO JM, 1993, BIOCHEMISTRY-US, V32, P9129, DOI 10.1021/bi00086a018; ROSENTHAL AL, 1977, ANAL BIOCHEM, V80, P76, DOI 10.1016/0003-2697(77)90627-3; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; SCHULZEOSTHOFF K, 1994, J CELL BIOL, V127, P15, DOI 10.1083/jcb.127.1.15; Shiokawa D, 1997, ARCH BIOCHEM BIOPHYS, V346, P15, DOI 10.1006/abbi.1997.0275; TAKAUJI R, 1995, JPN J CANCER RES, V86, P677, DOI 10.1111/j.1349-7006.1995.tb02452.x; UCKER DS, 1992, MOL CELL BIOL, V12, P3060, DOI 10.1128/MCB.12.7.3060; Walker PR, 1997, BIOCHEM CELL BIOL, V75, P287, DOI 10.1139/bcb-75-4-287; ZHANG CH, 1995, CELL IMMUNOL, V165, P161, DOI 10.1006/cimm.1995.1201	44	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34820	34827		10.1074/jbc.273.52.34820	http://dx.doi.org/10.1074/jbc.273.52.34820			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857008	hybrid			2022-12-27	WOS:000077719700026
J	Ellinghaus, P; Wolfrum, C; Assmann, G; Spener, F; Seedorf, U				Ellinghaus, P; Wolfrum, C; Assmann, G; Spener, F; Seedorf, U			Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPAR alpha) in sterol carrier protein 2- sterol carrier protein x-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACIDS; BINDING-PROTEIN; RAT-LIVER; HYPOLIPIDEMIC AGENTS; GENE-EXPRESSION; BETA-OXIDATION; LIGAND; EICOSANOIDS; PATHWAY; THIOLASE	We showed recently that a targeted null mutation in the murine sterol carrier protein 2-/sterol carrier protein x-gene (Scp2) leads to defective peroxisomal catabolism of 3,7,11,15-tetramethylhexadecanoic acid (phytanic acid), peroxisome proliferation, hypolipidemia, and enhanced hepatic expression of several genes that have been demonstrated to be transcriptionally regulated by the peroxisome proliferator-activated receptor alpha (PPAR alpha), As a broad range of fatty acids activates PPAR alpha in vitro, we examined whether the latter effects could be because of phytanic acid-induced activation of this transcription factor. Dietary phytol supplementation was used to modulate the concentration of phytanic acid in C57B1/6 and Scp2 (-/-) mice. We found that the serum concentrations of phytanic acid correlated well with the expression of genes encoding peroxisomal beta-oxidation enzymes and liver fatty acid-binding protein, who have all been demonstrated to contain functionally active peroxisome proliferator response elements in their promoter regions. In accordance with these findings, a stimulating effect on acyl-CoA oxidase gene expression was also observed after incubation of the rat hepatoma cell line MH1C1 with phytanic acid. Moreover, reporter gene studies revealed that phytanic acid induces the expression of a peroxisome proliferator response element-driven chloramphenicol transferase reporter gene comparable with strong peroxisome proliferators, In addition, the ability of phytanic acid to act as an inductor of PPAR alpha-dependent gene expression corresponded with high affinity binding of this dietary branched chain fatty acid to recombinant PPAR alpha, We conclude that phytanic acid can be considered as a bona fide physiological ligand of murine PPAR alpha.	Univ Munster, Inst Arterioskleroseforsch, D-48149 Munster, Germany; Univ Munster, Inst Biochem, D-48149 Munster, Germany; Univ Munster, Inst Klin Chem & Lab Med, Zent Lab, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster	Seedorf, U (corresponding author), Univ Munster, Inst Arterioskleroseforsch, Domagkstr 3, D-48149 Munster, Germany.	seedorfu@uni-muenster.de		Wolfrum, Christian/0000-0002-3862-6805				Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; BERTHOU L, 1995, EUR J BIOCHEM, V232, P179, DOI 10.1111/j.1432-1033.1995.tb20797.x; BROCARD C, 1993, BIOL CELL, V77, P37, DOI 10.1016/S0248-4900(05)80172-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Dowell P, 1997, J BIOL CHEM, V272, P2013, DOI 10.1074/jbc.272.3.2013; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; DWIVEDI RS, 1989, TOXICOL PATHOL, V17, P16, DOI 10.1177/01926233890171P103; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Frolov A, 1996, J BIOL CHEM, V271, P31878, DOI 10.1074/jbc.271.50.31878; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; HIJIKATA M, 1990, J BIOL CHEM, V265, P4600; ISSEMANN I, 1992, BIOCHEM SOC T, V20, P824, DOI 10.1042/bst0200824; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Keller H, 1997, BIOL CHEM, V378, P651, DOI 10.1515/bchm.1997.378.7.651; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kitahara K, 1996, J Exp Ther Oncol, V1, P7; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335; Lemotte PK, 1996, EUR J BIOCHEM, V236, P328, DOI 10.1111/j.1432-1033.1996.00328.x; MARCUS SL, 1993, P NATL ACAD SCI USA, V90, P5723, DOI 10.1073/pnas.90.12.5723; OHBA T, 1995, BIOCHEMISTRY-US, V34, P10660, DOI 10.1021/bi00033a042; SCHLENIUS AK, 1995, BIOCHIM BIOPHYS ACTA, V1258, P257; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; SEEDORF U, 1994, J BIOL CHEM, V269, P21277; SEEDORF U, 1991, J BIOL CHEM, V266, P630; Seedorf U, 1998, GENE DEV, V12, P1189, DOI 10.1101/gad.12.8.1189; SHA RS, 1993, J BIOL CHEM, V268, P7885; SINGH H, 1994, J BIOL CHEM, V269, P9514; Steinberg D., 1995, METABOLIC MOL BASES, P2351; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Verhoeven NM, 1998, J LIPID RES, V39, P66; Wanders RJA, 1997, BIOCHEM BIOPH RES CO, V236, P565, DOI 10.1006/bbrc.1997.7007; Wirtz KWA, 1997, BIOCHEM J, V324, P353, DOI 10.1042/bj3240353	40	142	148	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2766	2772		10.1074/jbc.274.5.2766	http://dx.doi.org/10.1074/jbc.274.5.2766			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915808	hybrid			2022-12-27	WOS:000078319500026
J	Venkatachalam, KV; Fuda, H; Koonin, EV; Strott, CA				Venkatachalam, KV; Fuda, H; Koonin, EV; Strott, CA			Site-selected mutagenesis of a conserved nucleotide binding HXGH motif located in the ATP sulfurylase domain of human bifunctional 3 '-phosphoadenosine 5 '-phosphosulfate synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; SULFATE ACTIVATION; SEQUENCE; IDENTIFICATION; ALIGNMENT; PROTEIN; CLONING; REGION; KINASE	3'-Phosphoadenosine-5'-phosphosulfate (PAPS) synthase is a bifunctional protein consisting of an NH,terminal APS kinase and a COOH-terminal ATP sulfurylase. Both catalytic activities require ATP; the APS kinase domain involves cleavage of the beta-gamma phosphodiester bond of ATP, whereas the ATP sulfurylase domain involves cleavage of the alpha-beta phosphodiester bond of ATP. Previous mutational studies have suggested that beta-gamma phosphodiesterase activity involves a highly conserved NTP-binding P-loop motif located in the adenosine-5'-phosphosulfate kinase domain of PAPS syntheses. Sequence alignment analysis of PAPS synthases and the superfamily of TagD-related nucleotidylyltransferases revealed the presence of a highly conserved HXGH motif in the ATP sulfurylase domain of PAPS synthases, a motif implicated in the alpha-beta phosphodiesterase activity of cytidylyltransferases. Thus, site-selected mutagenesis of the HXGH motif in the ATP sulfurylase domain of human PAPS synthase (amino acids 425-428) was performed to examine this possibility. Either H425A or H428A mutation produced an inactive enzyme. In contrast, a N426K mutation resulted in increased enzymatic activity. A G427A single mutant resulted in only a modest 30% reduction in catalytic activity, whereas a G427A/H428A double mutant produced an inactive enzyme. These results suggest an important role for the HXGH histidines in the ATP sulfurylase activity of bifunctional PAPS synthase and support the hypothesis that the highly conserved HXGH motif found in the ATP sulfurylase domain of PAPS synthases is involved in ATP binding and alpha-beta phosphodiesterase activity.	NICHD, Sect Steroid Regulat, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA; NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Strott, CA (corresponding author), NICHD, Sect Steroid Regulat, Endocrinol & Reprod Res Branch, NIH, Bldg 49,Rm 6A36, Bethesda, MD 20892 USA.	chastro@box-c.nih.gov		Venkatachalam, K.V./0000-0001-6692-9099	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000194] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; BORGESWALMSLEY MI, 1995, MOL GEN GENET, V247, P423; BORK P, 1995, PROTEINS, V22, P259, DOI 10.1002/prot.340220306; CHEREST H, 1987, MOL GEN GENET, V210, P307, DOI 10.1007/BF00325699; Deyrup AT, 1998, J BIOL CHEM, V273, P9450, DOI 10.1074/jbc.273.16.9450; FOSTER BA, 1994, J BIOL CHEM, V269, P19777; GREGORY JD, 1960, ANNU REV BIOCHEM, V29, P347, DOI 10.1146/annurev.bi.29.070160.002023; Jullien D, 1997, MECH DEVELOP, V68, P179, DOI 10.1016/S0925-4773(97)00136-6; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; LEUSTEK T, 1994, PLANT PHYSIOL, V105, P897, DOI 10.1104/pp.105.3.897; LEYH TS, 1993, CRIT REV BIOCHEM MOL, V28, P515, DOI 10.3109/10409239309085137; LI H, 1995, J BIOL CHEM, V270, P29453, DOI 10.1074/jbc.270.49.29453; MURILLO M, 1995, ARCH BIOCHEM BIOPHYS, V323, P195, DOI 10.1006/abbi.1995.0026; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; ROSENTHAL E, 1995, GENE, V165, P243, DOI 10.1016/0378-1119(95)00450-K; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Veitch DP, 1998, EUR J BIOCHEM, V255, P227, DOI 10.1046/j.1432-1327.1998.2550227.x; Veitch DP, 1996, BIOCHEMISTRY-US, V35, P10743, DOI 10.1021/bi960402c; Venkatachalam KV, 1998, J BIOL CHEM, V273, P19311, DOI 10.1074/jbc.273.30.19311; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986	24	35	38	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2601	2604		10.1074/jbc.274.5.2601	http://dx.doi.org/10.1074/jbc.274.5.2601			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915785	hybrid			2022-12-27	WOS:000078319500003
J	Arai, T; Wang, N; Bezouevski, M; Welch, C; Tall, AR				Arai, T; Wang, N; Bezouevski, M; Welch, C; Tall, AR			Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SR-BI; HEPATIC LIPASE; A-I; CHOLESTEROL; PLASMA; OVEREXPRESSION; LESIONS; LIVER; DIET; HDL	Scavenger receptor type B class I (SR-BI), initially identified as a receptor that recognizes low density lipoprotein (LDL), was recently shown to mediate the selective uptake of high density lipoprotein (HDL) cholesteryl esters in liver and steroidogenic tissues. To evaluate effects on atherosclerosis, transgenic mice with liver-specific overexpression of SR-BI (SR-BI Tg mice) have been crossed onto LDL receptor-deficient backgrounds, To induce atherosclerosis in a setting of moderate hypercholesterolemia, heterozygous LDL receptor-deficient mice (LDLR1) were fed a high fat/cholesterol/bile salt diet, and homozygous LDL receptor knock-outs (LDLR0) were fed a high fat/cholesterol diet. LDLR1/SRBI Tg mice showed decreases in VLDL, LDL, and HDL cholesterol and a significant 80% decrease in mean lesion area in the aortic root compared with LDLR1 mice (female LDLR1 74, 120 mu m(2) versus LDLR1/SR-BI Tg 12, 667 mu m(2); male 25, 747 mu m(2) versus 5, 448 mu m(2), respectively). LDLR0/SR-BI Tg mice showed decreased LDL and HDL cholesterol but increased VLDL cholesterol and no significant difference in extent of atherosclerosis compared with LDLR0 mice. Combined data analysis showed a strong correlation between atherosclerotic lesion area and the VLDL+LDL cholesterol level but no correlation with HDL level. These studies demonstrate a strong anti-atherogenic potential of hepatic SR-BI overexpression, In mice with marked over-expression of SR-BI, the protective effect appears to be primarily related to the lowering of VLDL and LDL cholesterol levels.	Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA	Columbia University	Tall, AR (corresponding author), Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA.		Tall, Alan/AAT-8528-2021		NHLBI NIH HHS [HL21006, HL54591, HL58033] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054591, P50HL021006, R01HL058033] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; BURSTEIN M, 1970, J LIPID RES, V11, P583; Cao GP, 1997, J BIOL CHEM, V272, P33068, DOI 10.1074/jbc.272.52.33068; Cohen RD, 1997, J CLIN INVEST, V99, P1906, DOI 10.1172/JCI119358; FAN JL, 1994, P NATL ACAD SCI USA, V91, P8724, DOI 10.1073/pnas.91.18.8724; Foger B, 1997, CIRCULATION, V96; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Goldstein J, 1995, FAMILIAL HYPERCHOLES, P1981; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; LI H, 1993, ARTERIOSCLER THROMB, V13, P1814, DOI 10.1161/01.ATV.13.12.1814; Machleder D, 1997, J CLIN INVEST, V99, P1406, DOI 10.1172/JCI119300; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; MasucciMagoulas L, 1997, SCIENCE, V275, P391, DOI 10.1126/science.275.5298.391; Osono Y, 1996, P NATL ACAD SCI USA, V93, P4114, DOI 10.1073/pnas.93.9.4114; PAIGEN B, 1995, AM J CLIN NUTR, V62, p458S, DOI 10.1093/ajcn/62.2.458S; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; SHENG J, 1990, METABOLISM, V39, P155, DOI 10.1016/0026-0495(90)90069-O; Spady DK, 1998, J BIOL CHEM, V273, P126, DOI 10.1074/jbc.273.1.126; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Veniant MM, 1997, J CLIN INVEST, V100, P180, DOI 10.1172/JCI119511; Wang N, 1998, J BIOL CHEM, V273, P32920, DOI 10.1074/jbc.273.49.32920; Wang N, 1996, J BIOL CHEM, V271, P21001, DOI 10.1074/jbc.271.35.21001; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210	30	285	299	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2366	2371		10.1074/jbc.274.4.2366	http://dx.doi.org/10.1074/jbc.274.4.2366			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891004	hybrid			2022-12-27	WOS:000078185200071
J	Ravanti, L; Heino, J; Lopez-Otin, C; Kahari, VM				Ravanti, L; Heino, J; Lopez-Otin, C; Kahari, VM			Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MATRIX METALLOPROTEINASE-13; GENE-EXPRESSION; MESSENGER-RNA; I COLLAGEN; TYROSINE PHOSPHORYLATION; INTEGRIN ALPHA-2-BETA-1; RHEUMATOID-ARTHRITIS; BREAST CARCINOMAS; TISSUE INHIBITOR	Collagenase-3 (matrix metalloproteinase-13, MMP-13) is a recently identified human MMP with an exceptionally wide substrate specificity and restricted tissue-specific expression. Here we show that MMP-13 expression is induced in normal human skin fibroblasts cultured within three-dimensional collagen gel resulting in production and proteolytic activation of MMP-13. Induction of MMP-13 mRNAs by collagen gel was potently inhibited by blocking antibodies against alpha(1) and alpha(2) integrin subunits and augmented by activating antibody against beta(1) integrin subunit, indicating that both alpha(1)beta(1) and alpha(2)beta(1) integrins mediate the MMP-13-inducing cellular signal generated by three-dimensional collagen. Collagen-related induction of MMP-13 expression was dependent on tyrosine kinase activity, as it was abolished by treatment of fibroblasts with tyrosine kinase inhibitors genistein and herbimycin A Contact of fibroblasts to three-dimensional collagen resulted in simultaneous activation of mitogen-activated protein kinases (MAPKs) in three distinct subgroups: extracellular signal-regulated kinase (ERK)1 and ERK2, Jun N-terminal kinase/stress-activated protein kinase, and p38. Induction of MMP-13 expression was inhibited by treatment of fibroblasts with a specific p38 inhibitor, SE 203580, whereas blocking the ERK1,2 pathway (Raf/MEK1,2/ERK1,2) by PD 98059, a selective inhibitor of MEK1,2 activation potently augmented MMP-13 expression. Furthermore, specific activation of ERK1,2 pathway by 12-O-tetradecanoylphorbol-13-acetate markedly suppressed MMP-13 expression in dermal fibroblasts in collagen gel, These results show that collagen-dependent induction of MMP-13 in dermal fibroblasts requires p38 activity, and is inhibited by activation of ERR1,2. Therefore, the balance between the activity of ERK;1,2 and p38 MAPK pathways appears to be crucial in regulation of MMP-13 expression in dermal fibroblasts, suggesting that p38 MAPK may serve as a target for selective inhibition of collagen degradation, e.g. in chronic. dermal ulcers.	Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland; Univ Turku, Dept Biochem Med, FIN-20520 Turku, Finland; Turku Univ, Cent Hosp, Dept Dermatol, Turku, Finland; Univ Jyvaskyla, Dept Biol & Environm Sci, FIN-40351 Jyvaskyla, Finland; Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain	University of Turku; University of Turku; University of Turku; University of Jyvaskyla; University of Oviedo	Kahari, VM (corresponding author), Univ Turku, MediCity Res Lab, Tykistokatu 6A, FIN-20520 Turku, Finland.		López-Otín, Carlos/AAB-2106-2020; Kähäri, Veli-Matti/E-5144-2011; Kahari, Veli-Matti/T-4925-2019	López-Otín, Carlos/0000-0001-6964-1904; Kähäri, Veli-Matti/0000-0003-2421-9368; Kahari, Veli-Matti/0000-0003-2421-9368				Airola K, 1997, J INVEST DERMATOL, V109, P225, DOI 10.1111/1523-1747.ep12319441; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Atula S, 1997, EXP CELL RES, V235, P180, DOI 10.1006/excr.1997.3676; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Broberg A, 1996, EXP CELL RES, V228, P29, DOI 10.1006/excr.1996.0295; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; GIAMBERNARDI TR, 1997, MATRIX BIOL, V16, P483; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Haas TL, 1998, J BIOL CHEM, V273, P3604, DOI 10.1074/jbc.273.6.3604; Heppner KJ, 1996, AM J PATHOL, V149, P273; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; IVARSSON M, 1993, J INVEST DERMATOL, V101, P216, DOI 10.1111/1523-1747.ep12364810; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; Johansson N, 1997, CELL GROWTH DIFFER, V8, P243; Johansson N, 1997, AM J PATHOL, V151, P499; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; KAMATA T, 1994, J BIOL CHEM, V269, P26006; KERN A, 1994, J BIOL CHEM, V269, P22811; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Krane SM, 1996, J BIOL CHEM, V271, P28509, DOI 10.1074/jbc.271.45.28509; Kumar S, 1996, J BIOL CHEM, V271, P30864, DOI 10.1074/jbc.271.48.30451; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Langholz O, 1997, EXP CELL RES, V235, P22, DOI 10.1006/excr.1997.3640; LARJAVA H, 1993, J CELL PHYSIOL, V157, P190, DOI 10.1002/jcp.1041570125; Lindy O, 1997, ARTHRITIS RHEUM-US, V40, P1391, DOI 10.1002/art.1780400806; Lohi J, 1996, EUR J BIOCHEM, V239, P239, DOI 10.1111/j.1432-1033.1996.0239u.x; MAKELA JK, 1988, NUCLEIC ACIDS RES, V16, P349, DOI 10.1093/nar/16.1.349; Messent AJ, 1998, J CELL SCI, V111, P1127; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; Reboul P, 1996, J CLIN INVEST, V97, P2011, DOI 10.1172/JCI118636; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; RIIKONEN T, 1995, BIOCHEM BIOPH RES CO, V209, P205, DOI 10.1006/bbrc.1995.1490; RIIKONEN T, 1995, J BIOL CHEM, V270, P13548, DOI 10.1074/jbc.270.22.13548; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; ROECKEL D, 1994, EXP CELL RES, V211, P42, DOI 10.1006/excr.1994.1056; SAARIALHOKERE UK, 1993, J CLIN INVEST, V92, P2858, DOI 10.1172/JCI116906; SAARIALHOKERE UK, 1992, J CLIN INVEST, V90, P1952, DOI 10.1172/JCI116073; SAUS J, 1988, J BIOL CHEM, V263, P6742; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; StahleBackdahl M, 1997, LAB INVEST, V76, P717; SUDBECK BD, 1994, J BIOL CHEM, V269, P30022; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Uitto VJ, 1998, AM J PATHOL, V152, P1489; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; Uria JA, 1998, AM J PATHOL, V153, P91, DOI 10.1016/S0002-9440(10)65549-6; Uria JA, 1997, CANCER RES, V57, P4882; Vaalamo M, 1998, AM J PATHOL, V152, P1005; Vaalamo M, 1997, J INVEST DERMATOL, V109, P96, DOI 10.1111/1523-1747.ep12276722; Vaalamo M, 1996, BRIT J DERMATOL, V135, P52; Wernicke D, 1996, J RHEUMATOL, V23, P590; Xu JH, 1997, J CELL BIOL, V136, P473, DOI 10.1083/jcb.136.2.473	61	240	248	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2446	2455		10.1074/jbc.274.4.2446	http://dx.doi.org/10.1074/jbc.274.4.2446			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891015	hybrid			2022-12-27	WOS:000078185200082
J	Yang, CS; Skiba, NP; Mazzoni, MR; Hamm, HE				Yang, CS; Skiba, NP; Mazzoni, MR; Hamm, HE			Conformational changes at the carboxyl terminus of G alpha occur during G protein activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; GUANINE-NUCLEOTIDE-BINDING; HETEROTRIMERIC G-PROTEIN; CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; SYNTHETIC PEPTIDES; GAMMA-SUBUNIT; TRANSDUCIN; RECEPTOR; SITES	To understand the dynamics of conformational changes during G protein activation, surface exposed cysteine residues on G alpha were fluorescently labeled. Limited trypsinolysis and mutational analysis of recombinant G alpha(t)/G alpha(il) determined that two cysteines are the major fluorescent labeling sites, Cys(210), located in the switch II region, and Cys(347) at the C terminus. Mutants with serines replacing Cys(210) (Chi6a) and Cy-347 (Chi6b) were single fluorescently labeled with lucifer yellow (LY), while a double mutant (Chi6ab) was no longer labeled. When Chi6b was labeled with LY on Cys(210), AlF4- caused a 220% increase in LY fluorescence, indicating that the fluorescent group at Cys(210) is a reporter of conformational change in the switch II region. Chi6a labeled at Cys(347) also showed an AlF4--dependent increase in LY fluorescence (91%), indicating that G alpha activation leads to a conformational change at the COOH terminus. Preactivation of the protein with AlF4- before labeling led to a decreased incorporation of LY into Cys(347) suggesting that G alpha activation buries Cys347. This COOH-terminal conformational change may provide the structural basis for communication between the GDP-binding site on G alpha and activated receptors, and may contribute to dissociation of activated G alpha subunit from activated receptor.	Northwestern Univ, Inst Neurosci, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; Northwestern Univ, Dept Ophthalmol, Chicago, IL 60611 USA; Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; Univ Pisa, Dept Psychiat Neurobiol Pharmacol & Biotechnol, Neurobiol & Pharmacol Lab, I-56126 Pisa, Italy	Northwestern University; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pisa	Hamm, HE (corresponding author), Northwestern Univ, Inst Neurosci, Dept Mol Pharmacol & Biol Chem, Searle Bldg,Rm 5-555,320 Super St, Chicago, IL 60611 USA.		Hamm, Heidi E/G-2374-2014; Hsiao, Wei-Hung/B-9931-2013; Mazzoni, Maria Rosa/AAA-2366-2022	Mazzoni, Maria Rosa/0000-0003-2612-432X; YANG, CHII-SHEN/0000-0002-2792-6247	NEI NIH HHS [EY10291, EY06062] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010291, R01EY006062] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; Birnbaumer L, 1985, Recent Prog Horm Res, V41, P41; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; DENKER BM, 1992, J BIOL CHEM, V267, P9998; DHANASEKARAN N, 1988, J BIOL CHEM, V263, P17942; DRATZ EA, 1993, NATURE, V363, P276, DOI 10.1038/363276a0; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; FUNG BKK, 1983, J BIOL CHEM, V258, P503; Gilchrist A, 1998, J BIOL CHEM, V273, P14912, DOI 10.1074/jbc.273.24.14912; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HO YK, 1984, J BIOL CHEM, V259, P6694; IYENGAR R, 1980, J BIOL CHEM, V255, P312; KAHLERT M, 1990, J BIOL CHEM, V265, P18928; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Osawa S, 1995, J BIOL CHEM, V270, P31052, DOI 10.1074/jbc.270.52.31052; PANICO J, 1990, J BIOL CHEM, V265, P18922; PFISTER C, 1983, EUR J BIOCHEM, V136, P489, DOI 10.1111/j.1432-1033.1983.tb07767.x; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; SIMONDS WF, 1989, FEBS LETT, V249, P189, DOI 10.1016/0014-5793(89)80622-2; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; SULLIVAN KA, 1987, NATURE, V330, P758, DOI 10.1038/330758a0; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WEST RE, 1985, J BIOL CHEM, V260, P4428; YATSUNAMI K, 1985, P NATL ACAD SCI USA, V82, P4316, DOI 10.1073/pnas.82.13.4316	37	42	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2379	2385		10.1074/jbc.274.4.2379	http://dx.doi.org/10.1074/jbc.274.4.2379			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891006	hybrid			2022-12-27	WOS:000078185200073
J	Bender, AT; Silverstein, AM; Demady, DR; Kanelakis, KC; Noguchi, S; Pratt, WB; Osawa, Y				Bender, AT; Silverstein, AM; Demady, DR; Kanelakis, KC; Noguchi, S; Pratt, WB; Osawa, Y			Neuronal nitric-oxide synthase is regulated by the hsp90-based chaperone system in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; HORMONE-BINDING DOMAIN; GLUCOCORTICOID RECEPTOR; COMPLEX-FORMATION; HSP90; HEME; HETEROCOMPLEX; PURIFICATION; GELDANAMYCIN; INHIBITION	It is established that the multiprotein heat shock protein 90 (hsp90)-based chaperone system acts on the ligand binding domain of the glucocorticoid receptor (GR) to form a GR.hsp90 heterocomplex and to convert the receptor ligand binding domain to the steroid-binding state. Treatment of cells with the hsp90 inhibitor geldanamycin inactivates steroid binding activity and increases the rate of GR turnover. We show here that a portion of neuronal nitric-oxide synthase (nNOS) exists as a molybdate-stabilized nNOS.hsp90 heterocomplex in the cytosolic fraction of human embryonic kidney 293 cells stably transfected with rat nNOS, Treatment of human embryonic kidney 293 cells with geldanamycin both decreases nNOS catalytic activity and increases the rate of nNOS turnover. Similarly, geldanamycin treatment of nNOS-expressing Sf9 cells partially inhibits nNOS activation by exogenous heme, Like the GR, purified heme-free apo-nNOS is activated by the DE52-retained fraction of rabbit reticulocyte lysate, which also assembles nNOS.hsp90 heterocomplexes. However, in contrast to the GR, heterocomplex assembly with hsp90 is not required for increased heme binding and nNOS activation in this cell-free system. We propose that, in vivo, where access by free heme is limited, the complete hsp90-based chaperone machinery is required for sustained opening of the heme binding cleft and nNOS activation, but in the heme containing cell-free nNOS-activating system transient opening of the heme binding cleft without hsp90 is sufficient to facilitate heme binding.	Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Pratt, WB (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031573, R37DK031573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31573] Funding Source: Medline; NIEHS NIH HHS [ES08365] Funding Source: Medline; NIGMS NIH HHS [GM07767] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAEK KJ, 1993, J BIOL CHEM, V268, P21120; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; ERHART JC, 1988, ONCOGENE, V3, P595; Feelisch M., 1996, METHODS NITRIC OXIDE, P455; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gorren ACF, 1997, BIOCHEMISTRY-US, V36, P4360, DOI 10.1021/bi962381s; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hemmens B, 1998, BIOCHEM J, V332, P337, DOI 10.1042/bj3320337; HEVEL JM, 1991, J BIOL CHEM, V266, P22789; HUTCHISON KA, 1992, J BIOL CHEM, V267, P14047; HUTCHISON KA, 1994, J BIOL CHEM, V269, P5043; Joly GA, 1997, FEBS LETT, V403, P40, DOI 10.1016/S0014-5793(97)00004-5; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; Modarress KJ, 1997, J BIOL CHEM, V272, P23986, DOI 10.1074/jbc.272.38.23986; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; OLKEN NM, 1994, BIOCHEMISTRY-US, V33, P14784, DOI 10.1021/bi00253a017; OMURA T, 1964, J BIOL CHEM, V239, P2370; OSAWA Y, 1989, CHEM RES TOXICOL, V2, P131, DOI 10.1021/tx00009a001; OSAWA Y, 1994, CYTOCHROME P450, P459; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; PRATT WB, 1993, STEROID HORMONE ACTI, P64; RICHARDS MK, 1994, BIOCHEMISTRY-US, V33, P14723, DOI 10.1021/bi00253a010; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; SCHMIDT HHHW, 1992, MOL PHARMACOL, V41, P615; SIMONS SS, 1989, J BIOL CHEM, V264, P14493; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; Stancato LF, 1996, J BIOL CHEM, V271, P8831, DOI 10.1074/jbc.271.15.8831; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Sugiyama K, 1997, P NATL ACAD SCI USA, V94, P796, DOI 10.1073/pnas.94.3.796; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Xu M, 1998, J BIOL CHEM, V273, P13918, DOI 10.1074/jbc.273.22.13918	45	139	143	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1472	1478		10.1074/jbc.274.3.1472	http://dx.doi.org/10.1074/jbc.274.3.1472			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880522	hybrid			2022-12-27	WOS:000079956900042
J	Cox, D; Tseng, CC; Bjekic, G; Greenberg, S				Cox, D; Tseng, CC; Bjekic, G; Greenberg, S			A requirement for phosphatidylinositol 3-kinase in pseudopod extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; FC-GAMMA RECEPTOR; GUANINE-NUCLEOTIDE EXCHANGE; GTPASE-ACTIVATING PROTEIN; PHOSPHOINOSITIDE 3-KINASE; TYROSINE KINASE; ACTIN POLYMERIZATION; PLASMA-MEMBRANE; SIGNAL-TRANSDUCTION; MOUSE MACROPHAGES	Phagocytosis requires actin assembly and pseudopod extension, two cellular events that coincide spatially and temporally. The signal transduction events underlying both processes may be distinct. We tested whether phagocytic signaling resembles that of growth factor receptors, which induce actin polymerization via activation of phosphatidylinositol 3-kinase (PI 3-kinase). Fc gamma receptor-mediated phagocytosis was accompanied by a rapid increase in the accumulation of phosphatidylinositol 3,4,5-trisphosphate in vivo, and addition of wortmannin (WM) or LY294002, two inhibitors of PI 3-kinase(s), inhibited phagocytosis but not Fc gamma receptor-directed actin polymerization. However, both compounds prevented maximal pseudopod extension, suggesting that PI 3-kinase inhibition produced a limitation in membrane required for pseudopod extension. Availability of plasma membrane was not limiting for phagocytosis, because blockade of ingestion in the presence of WM was not overcome by reducing the number of particles adhering to macrophages. However, decreasing bead size, and hence the magnitude of pseudopod extension required for particle engulfment, relieved the inhibition of phagocytosis in the presence of WM or LY294002 by up to 80%. The block in phagocytosis of large particles occurred before phagosomal closure, because both compounds inhibited spreading of macrophages on substrate-bound IgG. Macrophage spreading on IgG was accompanied by exocytic insertion of membrane from an intracellular source, as measured by the dye FM1-43. These results indicate that one or more isoforms of PI 3 kinase are required for maximal pseudopod extension but not phagocytosis per se. We suggest that PI 3-kinase is required for coordinating exocytic membrane insertion and pseudopod extension.	Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University	Greenberg, S (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA.	greenberg@cuccfa.ccc.columbia.edu		Cox, Dianne/0000-0002-0591-9767				Angleson JK, 1997, TRENDS NEUROSCI, V20, P281, DOI 10.1016/S0166-2236(97)01083-7; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; BARKER SA, 1995, MOL BIOL CELL, V6, P1145, DOI 10.1091/mbc.6.9.1145; BONNEMA JD, 1994, J EXP MED, V180, P1427, DOI 10.1084/jem.180.4.1427; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; BROWN WJ, 1995, J CELL BIOL, V130, P781, DOI 10.1083/jcb.130.4.781; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chacko GW, 1996, J BIOL CHEM, V271, P10775, DOI 10.1074/jbc.271.18.10775; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; Cox D, 1996, J BIOL CHEM, V271, P16597, DOI 10.1074/jbc.271.28.16597; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; CROSS MJ, 1995, J BIOL CHEM, V270, P25352, DOI 10.1074/jbc.270.43.25352; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; GREENBERG S, 1993, J EXP MED, V177, P529, DOI 10.1084/jem.177.2.529; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; GREENBERG S, 1991, J IMMUNOL METHODS, V139, P115, DOI 10.1016/0022-1759(91)90358-M; Hackam DJ, 1998, P NATL ACAD SCI USA, V95, P11691, DOI 10.1073/pnas.95.20.11691; Hackam DJ, 1996, J IMMUNOL, V156, P4377; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; HARTLEY D, 1995, J BIOL CHEM, V270, P18260, DOI 10.1074/jbc.270.31.18260; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Heldman AW, 1996, CIRC RES, V78, P312, DOI 10.1161/01.RES.78.2.312; Hirasawa N, 1997, CELL SIGNAL, V9, P305, DOI 10.1016/S0898-6568(96)00189-1; HOPKINS CR, 1994, J CELL BIOL, V125, P1265, DOI 10.1083/jcb.125.6.1265; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; JONES AT, 1995, BIOCHEM J, V311, P31, DOI 10.1042/bj3110031; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V208, P985, DOI 10.1006/bbrc.1995.1431; KOVACSOVICS TJ, 1995, J BIOL CHEM, V270, P11358, DOI 10.1074/jbc.270.19.11358; Koval M, 1998, EXP CELL RES, V242, P265, DOI 10.1006/excr.1998.4110; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; LENNARTZ MR, 1991, J IMMUNOL, V147, P621; Lennartz MR, 1997, J CELL SCI, V110, P2041; LI GP, 1995, P NATL ACAD SCI USA, V92, P10207, DOI 10.1073/pnas.92.22.10207; Lowry MB, 1998, J EXP MED, V187, P161, DOI 10.1084/jem.187.2.161; Malide D, 1997, J CELL SCI, V110, P2795; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Martys JL, 1996, J BIOL CHEM, V271, P10953, DOI 10.1074/jbc.271.18.10953; Matsuo T, 1996, FEBS LETT, V382, P11, DOI 10.1016/0014-5793(96)00122-6; Melendez AJ, 1998, P NATL ACAD SCI USA, V95, P2169, DOI 10.1073/pnas.95.5.2169; MOTTO DG, 1994, J BIOL CHEM, V269, P21608; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; NINOMIYA N, 1994, J BIOL CHEM, V269, P22732; PLEIMAN CM, 1993, MOL CELL BIOL, V13, P5877, DOI 10.1128/MCB.13.9.5877; PRASAD KVS, 1993, P NATL ACAD SCI USA, V90, P7366, DOI 10.1073/pnas.90.15.7366; Reaves BJ, 1996, J CELL SCI, V109, P749; SALMON JE, 1991, J IMMUNOL, V146, P997; Sesaki H, 1997, J CELL SCI, V110, P809; SHEPHERD PR, 1995, BIOCHEM BIOPH RES CO, V211, P535, DOI 10.1006/bbrc.1995.1846; Shepherd PR, 1996, TRENDS CELL BIOL, V6, P92, DOI 10.1016/0962-8924(96)80998-6; Shibata H, 1997, J BIOL CHEM, V272, P14542, DOI 10.1074/jbc.272.23.14542; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; Tapper H, 1997, J IMMUNOL, V159, P409; VLAHOS CJ, 1995, J IMMUNOL, V154, P2413; Walters RJ, 1996, FEBS LETT, V392, P66, DOI 10.1016/0014-5793(96)00679-5; WANG J, 1995, J BIOL CHEM, V270, P12774, DOI 10.1074/jbc.270.21.12774; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; WENNSTROM S, 1994, ONCOGENE, V9, P651; Wiedemann C, 1998, NATURE, V394, P426, DOI 10.1038/28752; WYMANN M, 1994, BIOCHEM J, V298, P517, DOI 10.1042/bj2980517; YANAGI S, 1994, EUR J BIOCHEM, V224, P329, DOI 10.1111/j.1432-1033.1994.00329.x; YANO H, 1993, J BIOL CHEM, V268, P25846; YOUNG AT, 1995, P NATL ACAD SCI USA, V92, P11613, DOI 10.1073/pnas.92.25.11613; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977	75	319	325	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1240	1247		10.1074/jbc.274.3.1240	http://dx.doi.org/10.1074/jbc.274.3.1240			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880492	hybrid			2022-12-27	WOS:000079956900012
J	Niv, H; Gutman, O; Henis, YI; Kloog, Y				Niv, H; Gutman, O; Henis, YI; Kloog, Y			Membrane interactions of a constitutively active GFP-Ki-Ras 4B and their role in signaling - Evidence from lateral mobility studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CELL-GROWTH; INFLUENZA HEMAGGLUTININ; PLASMA-MEMBRANE; STRUCTURAL REQUIREMENTS; PHOTOBLEACHING RECOVERY; TRANSFORMED-CELLS; COATED PITS; PROTEIN; FLUORESCENCE; KINETICS	Membrane anchorage of Ras proteins in the inner leaflet of the plasma membrane is an important factor in their signaling and oncogenic potential. Despite these important roles, the precise mode of Ras-membrane interactions is not yet understood. It is especially important to characterize these interactions at the surface of intact cells, To investigate Ras-membrane interactions in live cells, we employed studies on the lateral mobility of a constitutively active Ras isoform to characterize its membrane dynamics, and examined the effects of the Ras-displacing antagonist S-trans,trans-farnesylthiosalicylic acid (FTS) (Haklai, R., Gana-Weisz, M., Elad, G., Paz, A., Marciano, D., Egozi, Y., Ben-Baruch, G., and Kloog, Y. (1998) Biochemistry 37, 1306-1314) on these parameters. A green fluorescent protein (GFP) was fused to the N terminus of constitutively active Ki-Ras 4B(12V) to generate GFP-Ki-Ras(12V). When stably expressed in Rat-1 cells, this protein was preferentially localized to the plasma membrane and displayed transforming activity. The lateral mobility studies demonstrated that GFP-Ki-Ras(12V) undergoes fast lateral diffusion at the plasma membrane, rather than exchange between membrane bound and unbound states. Treatment of the cells with FTS had a biphasic effect on GFP-Ki-Ras(12V) lateral mobility. At the initial phase, the lateral diffusion rate of GFP-Ki-Ras(12V) was elevated, suggesting that it is released from some constraints on its lateral mobility. This was followed by dislodgment of the protein into the cytoplasm, and a reduction in the diffusion rate of the fraction of GFP-Ki-Ras(12V) that remained associated with the plasma membrane. Control experiments with other S-prenyl analogs showed that these effects are specific for FTS. These results have implications for the interactions of Ki-Ras with specific membrane anchorage domains or sites.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel	Tel Aviv University	Kloog, Y (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Tel Aviv, Israel.	kloog@post.tau.ac.il		Henis, Yoav/0000-0002-1408-3877				Aharonson Z, 1998, BBA-MOL BASIS DIS, V1406, P40, DOI 10.1016/S0925-4439(97)00077-X; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOS JL, 1995, EUR J CANCER, V31A, P1051, DOI 10.1016/0959-8049(95)00168-I; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; COX AD, 1992, MOL CELL BIOL, V12, P2606, DOI 10.1128/MCB.12.6.2606; Cox Adrienne D., 1992, Current Opinion in Cell Biology, V4, P1008, DOI 10.1016/0955-0674(92)90133-W; EDIDIN M, 1991, J CELL BIOL, V112, P1143, DOI 10.1083/jcb.112.6.1143; Edidin M., 1992, STRUCTURE BIOL MEMBR, P539; ELSON EL, 1979, J SUPRAMOL STR CELL, V12, P481, DOI 10.1002/jss.400120408; ELSON EL, 1985, ANNU REV PHYS CHEM, V36, P379, DOI 10.1146/annurev.physchem.36.1.379; FIRE E, 1995, J BIOL CHEM, V270, P21075, DOI 10.1074/jbc.270.36.21075; FIRE E, 1991, J CELL BIOL, V115, P1585, DOI 10.1083/jcb.115.6.1585; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HAKLAI R, 1909, BIOCHEMISTRY-US, V37, P1306; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HENIS YI, 1983, BIOCHIM BIOPHYS ACTA, V762, P281, DOI 10.1016/0167-4889(83)90082-4; HENIS YI, 1988, BIOPOLYMERS, V27, P123, DOI 10.1002/bip.360270110; HENIS YI, 1993, BIOMEMBRANES PHYSICA, V1, P279; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; ISHIHARA A, 1987, P NATL ACAD SCI USA, V84, P1290, DOI 10.1073/pnas.84.5.1290; JACOBSON K, 1995, SCIENCE, V268, P1441, DOI 10.1126/science.7770769; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; KATO K, 1992, P NATL ACAD SCI USA, V89, P6403, DOI 10.1073/pnas.89.14.6403; KEMBLE GW, 1993, J CELL BIOL, V122, P1253, DOI 10.1083/jcb.122.6.1253; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; KOPPEL DE, 1976, BIOPHYS J, V16, P1315, DOI 10.1016/S0006-3495(76)85776-1; Kusumi A, 1996, CURR OPIN CELL BIOL, V8, P566, DOI 10.1016/S0955-0674(96)80036-6; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; LOWRY DR, 1993, ANNU REV BIOCHEM, V62, P851; MARCIANO D, 1995, J MED CHEM, V38, P1267, DOI 10.1021/jm00008a004; Marciano D, 1997, BIOORG MED CHEM LETT, V7, P1709, DOI 10.1016/S0960-894X(97)00294-1; MAROM M, 1995, J BIOL CHEM, V270, P22263, DOI 10.1074/jbc.270.38.22263; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; MORRIS SJ, 1989, J BIOL CHEM, V264, P3972; PETERSEN NO, 1981, J SUPRAMOL STR CELL, V17, P213, DOI 10.1002/jsscb.380170303; Petersen NO, 1986, HDB EXPT IMMUNOLOGY; PRENDERGAST GC, 1994, MOL CELL BIOL, V14, P4193, DOI 10.1128/MCB.14.6.4193; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCHOOTEMEIJER A, 1994, EUR J BIOCHEM, V224, P423, DOI 10.1111/j.1432-1033.1994.00423.x; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Sheets ED, 1997, BIOCHEMISTRY-US, V36, P12449, DOI 10.1021/bi9710939; Siddiqui AA, 1998, J BIOL CHEM, V273, P3712, DOI 10.1074/jbc.273.6.3712; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Symons M, 1996, TRENDS BIOCHEM SCI, V21, P178, DOI 10.1016/S0968-0004(96)10022-0; Yokoe E, 1996, NAT BIOTECHNOL, V14, P1252, DOI 10.1038/nbt1096-1252	52	106	107	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1606	1613		10.1074/jbc.274.3.1606	http://dx.doi.org/10.1074/jbc.274.3.1606			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880539	hybrid			2022-12-27	WOS:000079956900059
J	Solecki, D; Wimmer, E; Lipp, M; Bernhardt, G				Solecki, D; Wimmer, E; Lipp, M; Bernhardt, G			Identification and characterization of the cis-acting elements of human CD155 gene core promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN POLIOVIRUS RECEPTOR; TRANSCRIPTION FACTOR AP-2; AMINO-ACID-RESIDUES; IMMUNOGLOBULIN SUPERFAMILY; BINDING-SITE; CELLULAR RECEPTOR; MOLECULAR-CLONING; MAMMALIAN-CELLS; VIRUS BINDING; DNA-BINDING	The CD155 protein is the founding member of a new group or related molecules within the immunoglobulin superfamily sharing a V-C2-C2 domain structure and significant amino acid identity, We have recently isolated the promoter of the CD155 gene so that we may determine the transcription factors that regulate its expression and possibly gain insight into the cell biology of this gene. Here we report the mapping of three cis-elements within the CD155 core promoter, designated FPI, II, and III. The results of linker scanning mutagenesis suggest that all three of these cis elements are required in varying degrees for the promoter activity of the core promoter fragment. The relative contribution of each region ranked in the following order: III > II > I. Interestingly, footprint and electrophoretic mobility shift assays show that FPIII binding activity is much reduced in a human cell line that does not express CD155, Additionally, protein binding to FPI and FPII was also investigated. DNase I footprinting using recombinant hAP-2 alpha indicated that this transcription factor hound to both the FPI and FPII regions of the CD155 core promoter fragment. Electrophoretic mobility shift assays and supershift analysis confirmed the binding of AP-2 from crude nuclear extracts to FPI and to FPII. Lastly, cotransfection of the CD155 promoter with an AP-2 alpha expression vector indicates that overexpression of AP-2 alpha modulated the promoter activity of a CD155 promoter construct.	Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany; SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bernhardt, G (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13122 Berlin, Germany.		Bernhardt, Günter/F-6946-2012; Lipp, Martin/G-2235-2010; Solecki, David/N-8080-2018	Bernhardt, Günter/0000-0002-0510-2853; Lipp, Martin/0000-0002-0087-2672	NIAID NIH HHS [AI39485] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039485, R01AI039485] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aoki J, 1997, EXP CELL RES, V235, P374, DOI 10.1006/excr.1997.3685; AOKI J, 1994, J BIOL CHEM, V269, P8431; BERNHARDT G, 1994, VIROLOGY, V203, P344, DOI 10.1006/viro.1994.1493; BERNHARDT G, 1994, VIROLOGY, V199, P105, DOI 10.1006/viro.1994.1102; BIBB JA, 1994, VIROLOGY, V201, P107, DOI 10.1006/viro.1994.1270; BIBB JA, 1994, J GEN VIROL, V75, P1875, DOI 10.1099/0022-1317-75-8-1875; BIBB JA, 1994, J VIROL, V68, P6111, DOI 10.1128/JVI.68.9.6111-6115.1994; Bosher JM, 1996, ONCOGENE, V13, P1701; Chadeneau C, 1996, MAMM GENOME, V7, P636, DOI 10.1007/s003359900194; Chadeneau C, 1996, INT J CANCER, V68, P817; CHADENEAU C, 1994, J BIOL CHEM, V269, P15601; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; DUAN CM, 1995, J BIOL CHEM, V270, P24844, DOI 10.1074/jbc.270.42.24844; DYNAN WS, 1987, GENETIC ENG PRINCIPL, V9, P75; EBERLE F, 1995, GENE, V159, P267, DOI 10.1016/0378-1119(95)00180-E; FREISTADT M, 1994, COLD SPRING HARBOR M, P445; Freistadt MS, 1997, MOL IMMUNOL, V34, P1247, DOI 10.1016/S0161-5890(98)00003-0; FREISTADT MS, 1991, J VIROL, V65, P3873, DOI 10.1128/JVI.65.7.3873-3876.1991; GAO B, 1995, J BIOL CHEM, V270, P5614, DOI 10.1074/jbc.270.10.5614; GROMEIER M, 1995, MICROB PATHOGENESIS, V18, P253, DOI 10.1016/S0882-4010(05)80002-6; Harber J, 1995, VIROLOGY, V214, P559, DOI 10.1006/viro.1995.0067; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; KANNAN F, 1994, GENE DEV, V8, P1258, DOI 10.1101/gad.8.11.1258; KOIKE S, 1991, P NATL ACAD SCI USA, V88, P4104, DOI 10.1073/pnas.88.10.4104; KOIKE S, 1994, COLD SPRING HARBOR M, P463; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; KOIKE S, 1991, P NATL ACAD SCI USA, V88, P951, DOI 10.1073/pnas.88.3.951; KOIKE S, 1992, J VIROL, V66, P7059, DOI 10.1128/JVI.66.12.7059-7066.1992; Kraus RJ, 1996, NUCLEIC ACIDS RES, V24, P1531, DOI 10.1093/nar/24.8.1531; Lee BS, 1997, J BIOL CHEM, V272, P174; LOPEZ M, 1995, GENE, V155, P261, DOI 10.1016/0378-1119(94)00842-G; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MORRISON ME, 1992, J VIROL, V66, P2807, DOI 10.1128/JVI.66.5.2807-2813.1992; MORRISON ME, 1994, J VIROL, V68, P2578, DOI 10.1128/JVI.68.4.2578-2588.1994; MOSER M, 1995, DEVELOPMENT, V121, P2779; NOBIS P, 1985, J GEN VIROL, V66, P2563, DOI 10.1099/0022-1317-66-12-2563; OuladAbdelghani M, 1996, EXP CELL RES, V225, P338, DOI 10.1006/excr.1996.0184; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SELINKA HC, 1991, P NATL ACAD SCI USA, V88, P3598, DOI 10.1073/pnas.88.9.3598; Solecki D, 1997, J BIOL CHEM, V272, P5579, DOI 10.1074/jbc.272.9.5579; WILLIAMS T, 1991, SCIENCE, V251, P1067, DOI 10.1126/science.1998122; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; WIMMER E, 1994, COLD SPRING HARBOR M, P101; ZIBERT A, 1992, VIRUS RES, V25, P51, DOI 10.1016/0168-1702(92)90099-U; ZIBERT A, 1991, VIROLOGY, V182, P250, DOI 10.1016/0042-6822(91)90668-2	51	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1791	1800		10.1074/jbc.274.3.1791	http://dx.doi.org/10.1074/jbc.274.3.1791			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880562	hybrid			2022-12-27	WOS:000079956900082
J	Verheijen, MHG; Wolthuis, RMF; Bos, JL; Defize, LHK				Verheijen, MHG; Wolthuis, RMF; Bos, JL; Defize, LHK			The Ras/Erk pathway induces primitive endoderm but prevents parietal endoderm differentiation of F9 embryonal carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HORMONE-RELATED PEPTIDE; TERATOCARCINOMA STEM-CELLS; NUCLEOTIDE-GATED CHANNELS; PARATHYROID-HORMONE; RETINOIC ACID; GROWTH-FACTORS; RAS ONCOGENES; MESSENGER-RNA; MONOCLONAL-ANTIBODIES	The formation of parietal endoderm (PE) is one of the first differentiation processes during mouse development and can be studied in vitro using F9 embryonal carcinoma (EC) cells. Treatment of F9 EC cells with retinoic acid (RA) induces differentiation toward primitive endoderm (PrE), while differentiation toward PE is induced by subsequent addition of parathyroid hormone (PTH) or PTH-related peptide (PTRrP). The signal transduction mechanisms involved in this two-step process are largely unclear. We show that the RA-induced differentiation toward PrE is accompanied by a sustained increase in Ras activity and that ectopic expression of oncogenic Ha-Ras is sufficient to induce PrE differentiation Ras activity subsequently decreases upon PTH-induced differentiation toward PE. This is a necessary event, since expression of oncogenic Ha-Ras in PrE like cells prevents PTH-induced PE differentiation. Expression of active PKA in PrE-like F9 cells mimics PTH-induced PE differentiation and is again prevented by oncogenic Ha-Ras. The effect of oncogenic Ras on both differentiation steps is abolished by the MEK inhibitor PD98059 and can be mimicked by constitutively active forms of Raf and MEK. In conclusion, our data suggest that activation of the Ras/Erk is sufficient to induce differentiation to PrE and to prevent subsequent differentiation toward PE. Activation of PISA down-regulates Ras activity, resulting in disappearance of this blockade and transmission of signal(s) triggering PE differentiation.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Univ Utrecht, Physiol Chem Lab, NL-3584 CG Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University	Verheijen, MHG (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.		Verheijen, Mark/AAD-8112-2019; Verheijen, Mark/GQY-5157-2022	Verheijen, Mark/0000-0002-3739-3755; Wolthuis, Rob/0000-0002-3109-1588				ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; AVVEDIMENTO VE, 1991, GENE DEV, V5, P22, DOI 10.1101/gad.5.1.22; BENITO M, 1991, SCIENCE, V253, P565, DOI 10.1126/science.1857988; BREWER LM, 1992, ANAT REC, V234, P443, DOI 10.1002/ar.1092340314; BRUNET A, 1994, ONCOGENE, V9, P3379; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; CHAN SDH, 1990, MOL ENDOCRINOL, V4, P638, DOI 10.1210/mend-4-4-638; Clifford J, 1996, EMBO J, V15, P4142, DOI 10.1002/j.1460-2075.1996.tb00789.x; DEGROOT RP, 1990, NUCLEIC ACIDS RES, V18, P3195, DOI 10.1093/nar/18.11.3195; DEGROOT RP, 1990, EMBO J, V9, P1837; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; DUPREY P, 1985, P NATL ACAD SCI USA, V82, P8535, DOI 10.1073/pnas.82.24.8535; Gao P, 1996, J BIOL CHEM, V271, P9002, DOI 10.1074/jbc.271.15.9002; HER JH, 1993, BIOCHEM J, V296, P25, DOI 10.1042/bj2960025; IMADA M, 1987, DEV BIOL, V122, P483, DOI 10.1016/0012-1606(87)90312-5; Izawa I, 1996, FEBS LETT, V382, P53, DOI 10.1016/0014-5793(96)00137-8; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karperien M, 1996, INT J DEV BIOL, V40, P599; KARPERIEN M, 1994, MECH DEVELOP, V47, P29, DOI 10.1016/0925-4773(94)90093-0; Kastner P, 1997, DEVELOPMENT, V124, P313; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; KEMLER R, 1981, J EMBRYOL EXP MORPH, V64, P45; KENNEL SJ, 1987, EXP MOL PATHOL, V47, P110, DOI 10.1016/0014-4800(87)90012-8; KONIECZNY SF, 1989, ONCOGENE, V4, P473; LEDER A, 1975, CELL, V5, P319, DOI 10.1016/0092-8674(75)90107-5; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MEDEMA RH, 1991, MOL CELL BIOL, V11, P5963, DOI 10.1128/MCB.11.12.5963; MENINI A, 1995, BIOPHYS CHEM, V55, P185, DOI 10.1016/0301-4622(94)00153-B; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; MULLER R, 1984, NATURE, V311, P438, DOI 10.1038/311438a0; MUMMERY CL, 1990, CELL DIFFER DEV, V30, P1, DOI 10.1016/0922-3371(90)90069-9; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; Offermanns S, 1996, MOL ENDOCRINOL, V10, P566, DOI 10.1210/me.10.5.566; ORELLANA SA, 1990, J BIOL CHEM, V265, P3048; PIPER RC, 1993, J BIOL CHEM, V268, P16557; RIZZINO A, 1993, INT J DEV BIOL, V37, P61; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; SCHAAP D, 1993, J BIOL CHEM, V268, P20232; SHEN S, 1993, MECH DEVELOP, V40, P177, DOI 10.1016/0925-4773(93)90075-9; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; VANDESTOLPE A, 1993, J CELL BIOL, V120, P235, DOI 10.1083/jcb.120.1.235; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; VERHEIJEN MHG, 1995, ENDOCRINOLOGY, V136, P3331, DOI 10.1210/en.136.8.3331; Verheijen MHG, 1997, J BIOL CHEM, V272, P3423, DOI 10.1074/jbc.272.6.3423; WeilerGuettler H, 1996, DEVELOPMENT, V122, P2271; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; YAMAGUCHIIWAI Y, 1990, P NATL ACAD SCI USA, V87, P8670, DOI 10.1073/pnas.87.21.8670; YANG-YEN H-F, 1990, New Biologist, V2, P351	55	46	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1487	1494		10.1074/jbc.274.3.1487	http://dx.doi.org/10.1074/jbc.274.3.1487			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880524	hybrid			2022-12-27	WOS:000079956900044
J	Caceres, C; Gimenez-Bonafe, P; Ribes, E; Wouters-Tyrou, D; Martinage, A; Kouach, M; Sautiere, P; Muller, S; Palau, J; Subirana, JA; Cornudella, L; Chiva, M				Caceres, C; Gimenez-Bonafe, P; Ribes, E; Wouters-Tyrou, D; Martinage, A; Kouach, M; Sautiere, P; Muller, S; Palau, J; Subirana, JA; Cornudella, L; Chiva, M			DNA-interacting proteins in the spermiogenesis of the mollusc Murex brandaris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; NUCLEOPROTAMINE STRUCTURE; CHROMATIN FIBERS; BASIC-PROTEINS; PROTAMINE; SPERM; SPERMATOGENESIS; NUCLEOPLASMIN; COMPLEXES; FISH	Sperm chromatin of Murex brandaris (a neogastropod mollusc) undergoes a series of structural transitions during spermiogenesis. The DNA-interacting proteins responsible for these changes as well as the mature protamines present in the ripe sperm nucleus have been characterized. The results reveal that spermiogenic nuclear proteins are protamine precursors that are subjected to a substantial number of small N-terminal deletions that gradually modify their overall charge. The composition of mature protamines is remarkably simple in turn, promoting an efficient and extremely tight packaging of DNA. The pattern of spermiogenic chromatin condensation in IM. brandaris clearly departs from that corresponding to vertebrate chromatin.	Univ Politecn Cataluna, ETSEIB, Dept Engn Quim, E-08028 Barcelona, Spain; Univ Barcelona, Fac Biol, Dept Biol Cellular Anim Vegetal, E-08028 Barcelona, Spain; Inst Pasteur, CNRS, URA 1309, F-59019 Lille, France; Inst Biol Mol & Cellulaire, CNRS, UPR 9021, F-67084 Strasbourg, France; Univ Rovira & Virgili, Fac Ciencies, Dept Engn Quim Bioquim, Tarragona 43005, Spain; CSIC, Ctr Invest Desarrollo, Dept Mol Cellular Biol, E-08028 Barcelona, Spain	Universitat Politecnica de Catalunya; University of Barcelona; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universitat Rovira i Virgili; Consejo Superior de Investigaciones Cientificas (CSIC)	Chiva, M (corresponding author), Univ Politecn Cataluna, ETSEIB, Dept Engn Quim, Diagonal 647, E-08028 Barcelona, Spain.	chiva@eq.upc.es	Muller, Sylviane/J-5319-2014; Subirana, juan/L-7192-2014	Subirana, juan/0000-0002-1706-9341; Gimenez-Bonafe, Pepita/0000-0002-4713-903X				AMOR MJ, 1990, MOL REPROD DEV, V25, P348, DOI 10.1002/mrd.1080250407; AUSIO J, 1995, ADV SPERMATOZOAL TAX, V166, P447; Ausio J., 1995, ADV SPERMATOZOAL TAX, V166, P501; BALHORN R, 1991, BIOCHEMISTRY-US, V30, P175, DOI 10.1021/bi00215a026; BALHORN R, 1982, MOL BIOL CHROMOSOME, P366; BUCKLANDNICKS J, 1982, CELL TISSUE RES, V227, P235, DOI 10.1007/BF00210883; BUCKLANDNICKS JA, 1976, CELL TISSUE RES, V170, P455, DOI 10.1007/BF00361704; Buesa C, 1998, COMP BIOCHEM PHYS B, V119, P145, DOI 10.1016/S0305-0491(97)00297-6; CACERES C, 1994, MOL REPROD DEV, V38, P440, DOI 10.1002/mrd.1080380412; CASAS MT, 1993, EXP CELL RES, V204, P192, DOI 10.1006/excr.1993.1024; CHAUVIERE M, 1995, EUR J BIOCHEM, V204, P759; CHIVA M, 1987, FEBS LETT, V215, P237, DOI 10.1016/0014-5793(87)80153-9; CHIVA M, 1988, J EXP ZOOL, V245, P304, DOI 10.1002/jez.1402450311; CHIVA M, 1983, FEBS LETT, V162, P324, DOI 10.1016/0014-5793(83)80781-9; CHRISTENSEN ME, 1982, DEV BIOL, V93, P404, DOI 10.1016/0012-1606(82)90127-0; DABAN M, 1995, J MOL EVOL, V40, P663, DOI 10.1007/BF00160515; DEBARLE M, 1995, MOL REPROD DEV, V40, P84, DOI 10.1002/mrd.1080400111; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; FITA I, 1983, J MOL BIOL, V167, P157, DOI 10.1016/S0022-2836(83)80039-4; FORNELLS M, 1983, J MOL BIOL, V166, P249, DOI 10.1016/S0022-2836(83)80012-6; GUSSE M, 1983, BIOCHIM BIOPHYS ACTA, V748, P93, DOI 10.1016/0167-4838(83)90031-6; Harlow E., 1988, ANTIBODIES LAB MANUA; HEALY JM, 1992, NAUTILUS, V106, P1; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; HURLEY CK, 1977, ANAL BIOCHEM, V80, P624, DOI 10.1016/0003-2697(77)90687-X; JARAMILLO R, 1986, VELIGER, V29, P217; Kasinsky H. E., 1989, HISTONES OTHER BASIC, P73; LASKEY RA, 1993, PHILOS T ROY SOC B, V339, P263, DOI 10.1098/rstb.1993.0024; LENO GH, 1993, JOHN INN S, P135; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LOUIE AJ, 1972, J BIOL CHEM, V247, P7962; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; OLIVA R, 1982, NUCLEIC ACIDS RES, V10, P8049, DOI 10.1093/nar/10.24.8049; Oliva R, 1995, ADV SPERMATOZOAL TAX, V166, P537; OLIVA R, 1990, NUCLEIC ACIDS RES, V188, P2789; PANYIM S, 1969, ARCH BIOCHEM BIOPHYS, V130, P337, DOI 10.1016/0003-9861(69)90042-3; RuizLara SA, 1996, EUR J BIOCHEM, V240, P186, DOI 10.1111/j.1432-1033.1996.0186h.x; SAPERAS N, 1994, J MOL EVOL, V39, P282, DOI 10.1007/BF00160152; SAPERAS N, 1993, BIOL BULL-US, V185, P186, DOI 10.2307/1541999; SUAU P, 1977, J MOL BIOL, V117, P909, DOI 10.1016/S0022-2836(77)80005-3; SUBIRANA JA, 1992, FEBS LETT, V302, P105, DOI 10.1016/0014-5793(92)80416-E; SUBIRANA JA, 1993, SPERM CELL, P197; SUZUKI M, 1988, J MOL BIOL, V204, P653, DOI 10.1016/0022-2836(88)90362-2; WILLMITZER L, 1980, BIOPHYS STRUCT MECH, V6, P95, DOI 10.1007/BF00535747; WOUTERSTYROU D, 1995, BIOCHEM J, V309, P529, DOI 10.1042/bj3090529	45	24	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					649	656		10.1074/jbc.274.2.649	http://dx.doi.org/10.1074/jbc.274.2.649			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872998	hybrid, Green Published			2022-12-27	WOS:000077968500013
J	Chen, G; Cizeau, J; Velde, CV; Park, JH; Bozek, G; Bolton, J; Shi, L; Dubik, D; Greenberg, A				Chen, G; Cizeau, J; Velde, CV; Park, JH; Bozek, G; Bolton, J; Shi, L; Dubik, D; Greenberg, A			Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURVIVAL-PROMOTING PROTEINS; DEATH GENE CED-3; BCL-X-L; CELL-DEATH; BH3 DOMAIN; ELEGANS; INTERACTS; INDUCTION; ENCODES; COMMON	We have identified Nix, a homolog of the E1B 19K/Bcl-2 binding and pro-apoptotic protein Nip3, Human and murine Nix have a 56 and 53% amino acid identity to human and murine Nip3, respectively. The carboxyl terminus of Nix, including a transmembrane domain, is highly homologous to Nip3 but it bears a longer and distinct asparagine/proline-rich N terminus. Human Nip3 maps to chromosome 14q11.2-q12, whereas Nix/BNip3L was found on 8q21, Nix encodes a 23.8-kDa protein but it is expressed as a 48-kDa protein, suggesting that it homodimerizes similarly to Nip3, Following transfection, Nix protein undergoes progressive proteolysis to an 11-kDa C-terminal fragment, which is blocked by the proteasome inhibitor lactacystin, Nix colocalizes with the mitochondrial matrix protein HSP60, and removal of the putative transmembrane domain (TM) results in general cytoplasmic and nuclear expression. When transiently expressed, Nix and Nip3 but not TM deletion mutants rapidly activate apoptosis, Nix can overcome the suppressers Bcl-2 and Bcl-X-L, although high levels of Bcl-X-L expression will inhibit apoptosis, We propose that Nix and Nip3 form a new subfamily of pro-apoptotic mitochondrial proteins.	Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada	University of Manitoba	Greenberg, A (corresponding author), Univ Manitoba, Manitoba Inst Cell Biol, 100 Olivia St, Winnipeg, MB R3E 0V9, Canada.		Velde, Christine Vande/AAB-8828-2020; Vande Velde, Christine/F-2721-2016	Vande Velde, Christine/0000-0001-5926-1529				BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; BOYD JM, 1995, ONCOGENE, V11, P1921; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Han J, 1996, MOL CELL BIOL, V16, P5857; HENGARTNER MO, 1994, CURR OPIN GENET DEV, V4, P581, DOI 10.1016/0959-437X(94)90076-F; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Matsushima M, 1998, GENE CHROMOSOME CANC, V21, P230, DOI 10.1002/(SICI)1098-2264(199803)21:3<230::AID-GCC7>3.0.CO;2-0; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Yasuda M, 1998, J BIOL CHEM, V273, P12415, DOI 10.1074/jbc.273.20.12415; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	19	224	238	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					7	10		10.1074/jbc.274.1.7	http://dx.doi.org/10.1074/jbc.274.1.7			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867803	hybrid			2022-12-27	WOS:000077900200003
J	Chen, SH; Zhou, SH; Sarkar, M; Spence, AM; Schachter, H				Chen, SH; Zhou, SH; Sarkar, M; Spence, AM; Schachter, H			Expression of three Caenorhabditis elegans N-acetylglucosaminyltransferase I genes during development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT GLYCOPROTEIN-SYNDROME; ASPARAGINE-LINKED OLIGOSACCHARIDES; C-ELEGANS; INSECT CELLS; PHOSPHOMANNOMUTASE DEFICIENCY; CARBOHYDRATE MOIETY; LYMNAEA-STAGNALIS; GLYCAN SYNTHESIS; SUGAR CHAINS; COMPLEX	UDP-N-acetylglucosamine:alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I (GnT I) is a key enzyme in the synthesis of Asn-linked complex and hybrid glycans. Studies on mice with a null mutation in the GnT I gene have indicated that N-glycans play critical roles in mammalian morphogenesis. This paper presents studies on N-glycans during the development of the nematode Caenorhabditis elegans, We have cloned cDNAs for three predicted C. elegans genes homologous to mammalian GnT I (designated gly-12, gly-13, and gly-14), All three cDNAs encode proteins (467, 449, and 437 amino acids, respectively) with the domain structure typical of previously cloned Golgi-type glycosyltransferases. Expression in both insect cells and transgenic worms showed that gly-12 and gly-14, but not gly-13, encode active GnT I. All three genes were expressed throughout worm development (embryo, larval stages L1-L4, and adult worms). The gly-12 and gly-13 promoters were expressed from embryogenesis to adulthood in many tissues. The gly-14 promoter was expressed only in gut cells from L1 to adult developmental stages. Transgenic worms that overexpress any one of the three genes show no obvious phenotypic defects. The data indicate that C. elegans is a suitable model for further study of the role of complex N-glycans in development.	Hosp Sick Children, Dept Struct Biol & Biochem, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Schachter, H (corresponding author), Hosp Sick Children, Dept Struct Biol & Biochem, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	harry@sickkids.on.ca						ALTMANN F, 1993, GLYCOBIOLOGY, V3, P619, DOI 10.1093/glycob/3.6.619; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BAKKER H, 1994, J BIOL CHEM, V269, P30326; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Campbell R, 1997, GLYCOBIOLOGY, V7, P143; CHARUK JHM, 1995, EUR J BIOCHEM, V230, P797; Chen S, 1997, GLYCOBIOLOGY, V7, P113; CHURCH DL, 1995, DEVELOPMENT, V121, P2525; DIECKMANNSCHUPPERT A, 1996, N COMP BIOC, V30, P125; Dixon M., 1964, ENZYMES, V2nd; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; FIRE A, 1992, GENET ANAL-BIOMOL E, V9, P151, DOI 10.1016/1050-3862(92)90042-4; FREEZE HH, 1997, N COMP BIOC B, V29, P89; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gaudet J, 1996, MOL BIOL CELL, V7, P1107, DOI 10.1091/mbc.7.7.1107; GOMEZ L, 1994, P NATL ACAD SCI USA, V91, P1829, DOI 10.1073/pnas.91.5.1829; Hagen FK, 1998, J BIOL CHEM, V273, P8268, DOI 10.1074/jbc.273.14.8268; Haslam SM, 1996, J BIOL CHEM, V271, P30561, DOI 10.1074/jbc.271.48.30561; Haslam SM, 1997, MOL BIOCHEM PARASIT, V85, P53, DOI 10.1016/S0166-6851(96)02807-1; HAYES BK, 1996, N COMP BIOC, V30, P99; HONDA S, 1990, ANAL BIOCHEM, V191, P228, DOI 10.1016/0003-2697(90)90212-R; Inoue S., 1997, N COMP BIOC B, P143; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; JAEKEN J, 1994, ARCH DIS CHILD, V71, P123, DOI 10.1136/adc.71.2.123; Jaeken J, 1997, J INHERIT METAB DIS, V20, P447, DOI 10.1023/A:1005331523477; JAEKEN J, 1993, GLYCOBIOLOGY, V3, P423, DOI 10.1093/glycob/3.5.423; JEYAPRAKASH A, 1985, EXP PARASITOL, V59, P90, DOI 10.1016/0014-4894(85)90061-X; Kamerling JP, 1997, N COMP BIOC B, P123; Kelly WG, 1997, GENETICS, V146, P227; KHOO K-H, 1991, Glycobiology, V1, P163, DOI 10.1093/glycob/1.2.163; Krause M, 1995, METHOD CELL BIOL, V48, P483; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehle L., 1995, GLYCOPROTEINS A, V29a, P475; LINK CD, 1992, GENETICS, V131, P867; LINK CD, 1988, DEVELOPMENT, V103, P485; MARZ L, 1995, GLYCOPROTEINS A, V29, P543; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; MULDER H, 1995, EUR J BIOCHEM, V232, P272, DOI 10.1111/j.1432-1033.1995.tb20809.x; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; NISHIKAWA Y, 1988, J BIOL CHEM, V263, P8270; NYAME K, 1989, J BIOL CHEM, V264, P3235; PALCIC MM, 1988, GLYCOCONJUGATE J, V5, P49, DOI 10.1007/BF01048331; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; REASON AJ, 1994, GLYCOBIOLOGY, V4, P593, DOI 10.1093/glycob/4.5.593; RECK F, 1994, CARBOHYD RES, V259, P93, DOI 10.1016/0008-6215(94)84200-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sarkar M, 1998, GLYCOCONJUGATE J, V15, P193, DOI 10.1023/A:1006928624913; SARKAR M, 1994, GLYCOCONJUGATE J, V11, P204, DOI 10.1007/BF00731219; Sarkar M, 1997, GLYCOBIOLOGY, V7, P116; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schachter H, 1997, BIOCHEM SOC T, V25, P875, DOI 10.1042/bst0250875; Schachter H, 1998, ADV EXP MED BIOL, V435, P9; SRIVATSAN J, 1992, GLYCOBIOLOGY, V2, P445, DOI 10.1093/glycob/2.5.445; STURM A, 1995, GLYCOPROTEINS A, V29, P521; SUMPER M, 1995, GLYCOPROTEINS NEW A, V29, P455; TAI T, 1977, J BIOL CHEM, V252, P6687; Tan J, 1996, AM J HUM GENET, V59, P810; TAN J, 1995, EUR J BIOCHEM, V231, P317, DOI 10.1111/j.1432-1033.1995.tb20703.x; TURCO SJ, 1996, N COMP BIOC, V30, P113; VANDAM GJ, 1996, N COMP BIOC, V30, P159; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; Wood WB, 1988, NEMATODE CAENORHABDI; Xie GF, 1995, GENET ANAL-BIOMOL E, V12, P95, DOI 10.1016/1050-3862(95)00112-3; YAMASHITA K, 1978, J BIOL CHEM, V253, P3862; YAMASHITA K, 1982, J BIOL CHEM, V257, P2809; Yip B, 1997, BIOCHEM J, V321, P465, DOI 10.1042/bj3210465; Zhou S, 1997, GLYCOBIOLOGY, V7, P115	78	67	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					288	297		10.1074/jbc.274.1.288	http://dx.doi.org/10.1074/jbc.274.1.288			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867843	hybrid			2022-12-27	WOS:000077900200043
J	Hays, WS; VanderJagt, DJ; Bose, B; Serianni, AS; Glew, RH				Hays, WS; VanderJagt, DJ; Bose, B; Serianni, AS; Glew, RH			Catalytic mechanism and specificity for hydrolysis and transglycosylation reactions of cytosolic beta-glucosidase from guinea pig liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; GALACTOSIDASE; SPECTROSCOPY; NUCLEOPHILE; EXPRESSION; GLU-461; BINDING	Cytosolic beta-glucosidase (CBG) from mammalian Liver is known for its broad substrate specificity and has been implicated in the transformation of xenobiotic glycosides, CBG also catalyzes a variety of transglycosylation reactions, which have been been shown with other glycosylhydrolases to function in synthetic and genetic regulatory pathways. We investigated the catalytic mechanism, substrate specificity, and transglycosylation acceptor specificity of guinea pig liver CBG by several methods. These studies indicate that CBG employs a two-step catalytic mechanism with the formation of a covalent enzyme-sugar intermediate and that CBG mill transfer sugar residues to primary hydroxyls and equatorial but not axial C-4 hydroxyls of aldopyranosyl sugars, Kinetic studies revealed that correction for transglycosylation reactions is necessary to derive correct kinetic parameters for CBG. Further analyses revealed that for aldopyranosyl substrates, the activation energy barrier is affected most by the presence of a C-6 carbon and by the configuration of the C-2 hydroxyl, whereas the binding energy is affected modestly by the configuration and substituents at C-2, C-4, and C-5. These data indicate that the transglycosylation activity of CBG derives from the formation of a covalently linked enzyme-sugar intermediate and that the specificity of CBG; for transglycosylation reactions is different from its specificity for hydrolysis reactions.	Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of Notre Dame	Glew, RH (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA.	rglew@salud.unm.edu						BADER DE, 1988, BIOCHEM BIOPH RES CO, V153, P301, DOI 10.1016/S0006-291X(88)81222-1; BAX A, 1986, J MAGN RESON, V67, P565, DOI 10.1016/0022-2364(86)90395-1; BOCK K, 1983, ADV CARBOHYD CHEM BI, V41, P27, DOI 10.1016/S0065-2318(08)60055-4; DINTER A, 1995, ADV EXP MED BIOL, V376, P53; GEBLER JC, 1992, J BIOL CHEM, V267, P11126; GLEW RH, 1993, ACS SYM SER, V533, P83; GOPALAN V, 1992, J BIOL CHEM, V267, P14027; GOPALAN V, 1992, J BIOL CHEM, V267, P9629; GOPALAN V, 1989, J BIOL CHEM, V264, P15418; GRACE ME, 1994, J BIOL CHEM, V269, P2283; Hays WS, 1996, BIOCHEM J, V319, P829, DOI 10.1042/bj3190829; JOBE A, 1972, J MOL BIOL, V69, P397, DOI 10.1016/0022-2836(72)90253-7; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; LEGLER G, 1988, ARCH BIOCHEM BIOPHYS, V260, P427, DOI 10.1016/0003-9861(88)90466-3; LEGLER G, 1988, ARCH BIOCHEM BIOPHYS, V260, P437, DOI 10.1016/0003-9861(88)90467-5; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; MCCARTER JD, 1992, BIOCHEM J, V286, P721, DOI 10.1042/bj2860721; MIAO SC, 1994, J BIOL CHEM, V269, P10975; POCSI I, 1988, BIOCHEM J, V256, P139, DOI 10.1042/bj2560139; PODLASEK CA, 1995, J AM CHEM SOC, V117, P8635, DOI 10.1021/ja00138a020; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; STREET IP, 1992, BIOCHEMISTRY-US, V31, P9970, DOI 10.1021/bi00156a016; Thompson JE, 1997, BIOCHEM J, V327, P699; WALSH C, 1979, ENZYMATIC REACTION M, P267	24	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34941	34948		10.1074/jbc.273.52.34941	http://dx.doi.org/10.1074/jbc.273.52.34941			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857024	hybrid			2022-12-27	WOS:000077719700042
J	Scheumann, V; Schoch, S; Rudiger, W				Scheumann, V; Schoch, S; Rudiger, W			Chlorophyll a formation in the chlorophyll b reductase reaction requires reduced ferredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORDEUM-VULGARE L; POLYACRYLAMIDE GELS; CUCUMBER ETIOPLASTS; FORMYL-GROUP; IN-VITRO; CONVERSION; CHLOROPLASTS; APOPROTEINS; COTYLEDONS; PROTEINS	The reduction of chlorophyllide b and its analogue zinc pheophorbide b in etioplasts of barley (Hordeum vulgare L.) was investigated in detail. In intact etioplasts, the reduction proceeds to chlorophyllide a and zinc pheophorbide a or, if incubated together with phytyldiphosphate, to chlorophyll a and zinc pheophytin a, respectively. In lysed etioplasts supplied with NADPH, the reduction stops at the intermediate step of 7(1)-OH-chlorophyll(ide) and Zn-7(1)-OH-pheophorbide or Zn-7(1)OH-pheophytin. However, the final reduction is achieved when reduced ferredoxin is added to the lysed etioplasts, suggesting that ferredoxin is the natural cofactor for reduction of chlorophyll b to chlorophyll a. The reduction to chlorophyll a requires ATP in intact etioplasts but not in lysed etioplasts when reduced ferredoxin is supplied. The role of ATP and the significance of two cofactors for the two steps of reduction are discussed.	Univ Munich, Inst Bot, D-80638 Munich, Germany	University of Munich	Rudiger, W (corresponding author), Univ Munich, Inst Bot, Menzingerstr 67, D-80638 Munich, Germany.							Adamson HY, 1997, J PHOTOCH PHOTOBIO B, V41, P201, DOI 10.1016/S1011-1344(97)00105-X; ARGYROUDIAKOYUNOGLOU JH, 1982, PLANT PHYSIOL, V70, P1242, DOI 10.1104/pp.70.5.1242; BENZ J, 1984, PLANTA, V162, P215, DOI 10.1007/BF00397442; BENZ J, 1980, THESIS U MUNCHEN; CRAMER F, 1959, ANGEW CHEM INT EDIT, V71, P775, DOI 10.1002/ange.19590712405; Eichacker LA, 1996, J BIOL CHEM, V271, P32174, DOI 10.1074/jbc.271.50.32174; Eichacker LA, 1996, PLANT PHYSIOL, V112, P633, DOI 10.1104/pp.112.2.633; GAFNI Y, 1979, ANAL BIOCHEM, V92, P248, DOI 10.1016/0003-2697(79)90653-5; GIERLOFFEMDEN HG, 1989, FERNERKUNDUNGSKARTOG, P1; HELFRICH M, 1994, EUR J BIOCHEM, V219, P267, DOI 10.1111/j.1432-1033.1994.tb19938.x; HELFRICH M, 1995, THESIS U MUNCHEN; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; HORTENSTEINER S, 1995, NEW PHYTOL, V129, P237, DOI 10.1111/j.1469-8137.1995.tb04293.x; IRIYAMA K, 1979, J LIQ CHROMATOGR, V2, P255, DOI 10.1080/01483917908060061; ITO H, 1994, J BIOL CHEM, V269, P22034; ITO H, 1993, ARCH BIOCHEM BIOPHYS, V306, P148, DOI 10.1006/abbi.1993.1492; Ito H, 1996, J BIOL CHEM, V271, P1475, DOI 10.1074/jbc.271.3.1475; Ito H, 1996, PLANT PHYSIOL BIOCH, V34, P35; Kropat J, 1997, P NATL ACAD SCI USA, V94, P14168, DOI 10.1073/pnas.94.25.14168; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDSTEN A, 1990, PHYSIOL PLANTARUM, V80, P277, DOI 10.1111/j.1399-3054.1990.tb04408.x; LUTZ C, 1981, Z NATURFORSCH C, V36, P58; MATILE P, 1992, PLANTA, V187, P230, DOI 10.1007/BF00201944; Matile P, 1995, CHEM UNSERER ZEIT, V29, P298, DOI 10.1002/ciuz.19950290603; MCFEETERS RF, 1971, PLANT PHYSIOL, V47, P609, DOI 10.1104/pp.47.5.609; Ohtsuka T, 1997, PLANT PHYSIOL, V113, P137, DOI 10.1104/pp.113.1.137; Perez-Ruzafa A, 1996, SCI MAR, V60, P19; Popperl G, 1997, Z NATURFORSCH C, V52, P144; Porra RJ, 1997, PHOTOCHEM PHOTOBIOL, V65, P492, DOI 10.1111/j.1751-1097.1997.tb08596.x; PORRA RJ, 1993, FEBS LETT, V323, P31, DOI 10.1016/0014-5793(93)81442-3; Reinbothe S, 1996, EUR J BIOCHEM, V237, P323, DOI 10.1111/j.1432-1033.1996.00323.x; Rudiger W, 1997, PHYTOCHEMISTRY, V46, P1151, DOI 10.1016/S0031-9422(97)80003-9; Scheumann V, 1996, EUR J BIOCHEM, V242, P163, DOI 10.1111/j.1432-1033.1996.0163r.x; Scheumann V, 1996, Z NATURFORSCH C, V51, P185; SCHMIDT H, 1990, P NATL ACAD SCI USA, V87, P9477, DOI 10.1073/pnas.87.23.9477; SCHNEEGURT MA, 1992, BIOCHEMISTRY-US, V31, P11677, DOI 10.1021/bi00162a002; STAHL E, 1967, DUNNSCHICHTCHROMATOG, P816; TANAKA A, 1981, PLANT PHYSIOL, V68, P567, DOI 10.1104/pp.68.3.567; TANAKA A, 1991, PLANT CELL PHYSIOL, V32, P195, DOI 10.1093/oxfordjournals.pcp.a078064; TERRY MJ, 1991, J BIOL CHEM, V266, P22215; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VEZITSKII AY, 1988, PHOTOSYNTHETICA, V22, P184; WILLSTATTER R, 1913, UNTERSUCHUNGEN CHLOR, P206	43	47	51	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35102	35108		10.1074/jbc.273.52.35102	http://dx.doi.org/10.1074/jbc.273.52.35102			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857045	hybrid			2022-12-27	WOS:000077719700063
J	Whitby, FG; Xia, G; Pickart, CM; Hill, CP				Whitby, FG; Xia, G; Pickart, CM; Hill, CP			Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; MULTIUBIQUITIN CHAIN; CONJUGATING ENZYME; CARRIER PROTEIN; SACCHAROMYCES-CEREVISIAE; IDENTIFICATION; POLYUBIQUITIN; PROTEOLYSIS; DEGRADATION; PROTEASOME	The NEDD8/Rub1 class of ubiquitin-like proteins has been implicated in progression of the cell cycle from G(1) into S phase. These molecules undergo a metabolism that parallels that of ubiquitin and involves specific interactions with many different proteins. We report here the crystal structure of recombinant human NEDD8 refined at 1.6-Angstrom resolution to an R factor of 21.9%. As expected from the high sequence similarity (57% identical), the NEDD8 structure closely resembles that reported previously for ubiquitin, We also show that recombinant human NEDD8 protein is activated, albeit inefficiently, by the ubiquitin-activating (El) enzyme and that NEDD8 can be transferred from El to the ubiquitin conjugating enzyme E2-25K, E2-25K adds NEDD8 to a polyubiquitin chain with an efficiency similar to that of ubiquitin, A chimeric tetramer composed of three ubiquitins and one histidine-tagged NEDD8 binds to the 26 S proteasome with an affinity similar to that of tetraubiquitin. Seven residues that differ from the corresponding residues in ubiquitin, but are conserved between NEDD8 orthologs, are candidates for mediating interactions with NEDD8-specific partners. One such residue, Ala-72 (Arg in ubiquitin), is shown to perform a key role in selecting against reaction with the ubiquitin El enzyme, thereby acting to prevent the inappropriate diversion of NEDD8 into ubiquitin-specific pathways.	Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biochem, Baltimore, MD 21205 USA	Utah System of Higher Education; University of Utah; Johns Hopkins University	Hill, CP (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA.	chris@snowbird.med.utah.edu			NIDDK NIH HHS [DK46984] Funding Source: Medline; NIGMS NIH HHS [GM50163] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050163] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Beal RE, 1998, BIOCHEMISTRY-US, V37, P2925, DOI 10.1021/bi972514p; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; BURCH TJ, 1994, BIOCHEMISTRY-US, V33, P7300, DOI 10.1021/bi00189a035; CALLIS J, 1995, GENETICS, V139, P921; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; COOK WJ, 1992, J BIOL CHEM, V267, P16467; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Deshaies RJ, 1997, CURR OPIN GENET DEV, V7, P7, DOI 10.1016/S0959-437X(97)80103-7; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GREGORI L, 1990, J BIOL CHEM, V265, P8354; HAAS AL, 1985, J BIOL CHEM, V260, P2464; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Liu Z, 1996, J BIOL CHEM, V271, P2817, DOI 10.1074/jbc.271.5.2817; LOEB KR, 1994, MOL CELL BIOL, V14, P8408, DOI 10.1128/MCB.14.12.8408; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mastrandrea LD, 1998, BIOCHEMISTRY-US, V37, P9784, DOI 10.1021/bi9800911; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; PICKART CM, 1992, J BIOL CHEM, V267, P14418; PICKART CM, 1988, J BIOL CHEM, V263, P12028; PICKART CM, 1998, UBIQUITIN BIOL CELL, P19; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; RECHSTEINER M, 1998, UBIQUITIN BIOL CELL, P147; REISS Y, 1989, J BIOL CHEM, V264, P10378; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Schwarz SE, 1998, P NATL ACAD SCI USA, V95, P560, DOI 10.1073/pnas.95.2.560; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; WILKINSON KD, 1988, UBIQUITIN, P5; Wilkinson KD, 1998, UBIQUITIN BIOL CELL, P99	61	173	180	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34983	34991		10.1074/jbc.273.52.34983	http://dx.doi.org/10.1074/jbc.273.52.34983			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857030	hybrid			2022-12-27	WOS:000077719700048
J	Khursigara, G; Orlinick, JR; Chao, MV				Khursigara, G; Orlinick, JR; Chao, MV			Association of the p75 neurotrophin receptor with TRAF6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; NF-KAPPA-B; DEATH DOMAIN; TNF RECEPTOR; P75(NTR); INDUCTION; PROTEINS; ACTIVATION; APOPTOSIS; EXPRESSION	In addition to the Trk tyrosine kinase receptors, neurotrophins also bind to a second receptor, p75, a member of the tumor necrosis factor receptor superfamily. Several signaling pathways have been implicated for p75 in the absence of Trk receptors, including induction of NF-kappa B and c-Jun kinase activities and increased production of ceramide, However, to date, the mechanisms by which the p75 receptor initiates intracellular signal transduction have not been defined. Here we report a specific interaction between p75 and TRAF6 (tumor necrosis factor receptor-associated factor-6) after transient transfection in HEK293T cells. The interaction was ligand-dependent and maximal at 100 ng/ml of nerve growth factor (NGF). Other neurotrophins also promoted the association of TRAF6 with p75 but to a lesser extent. The binding of TRAF6 was localized to the juxtamembrane region of p75 by co-immunoprecipitation and Western blotting. To assess the functional significance of this interaction, we have tested responses in cultured Schwann cells that express p75 and TRAF6. An NGF-mediated increase in the nuclear localization of the p65 subunit of NF-kappa B could be blocked by the introduction of a dominant negative form of TRAF6 in Schwann cells. These results indicate that TRAF6 can potentially function as a signal transducer for NGF actions through the p75 receptor.	NYU, Med Ctr, Skirball Inst, Mol Neurobiol Program, New York, NY 10016 USA	New York University	Chao, MV (corresponding author), NYU, Med Ctr, Skirball Inst, Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.			Chao, Moses/0000-0002-6969-3744				ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Bothwell M, 1996, SCIENCE, V272, P506, DOI 10.1126/science.272.5261.506; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brojatsch J, 1996, CELL, V87, P845, DOI 10.1016/S0092-8674(00)81992-3; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Carter BD, 1997, NEURON, V18, P187, DOI 10.1016/S0896-6273(00)80259-7; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; CHAO MV, 1994, J NEUROBIOL, V25, P1373, DOI 10.1002/neu.480251106; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Dechant G, 1997, CURR OPIN NEUROBIOL, V7, P413, DOI 10.1016/S0959-4388(97)80071-2; DOBROWSKY RT, 1995, J BIOL CHEM, V270, P22135, DOI 10.1074/jbc.270.38.22135; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; Frade JM, 1996, NATURE, V383, P166; HOFMANN K, 1995, FEBS LETT, V371, P321, DOI 10.1016/0014-5793(95)00931-X; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEE KF, 1994, DEVELOPMENT, V120, P1027; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; SEILHEIMER B, 1987, EMBO J, V6, P1611, DOI 10.1002/j.1460-2075.1987.tb02408.x; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; VanderZee CEEM, 1996, SCIENCE, V274, P1729, DOI 10.1126/science.274.5293.1729; Yeo TT, 1997, J NEUROSCI, V17, P7594; Yoon SO, 1998, J NEUROSCI, V18, P3273	40	200	207	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2597	2600		10.1074/jbc.274.5.2597	http://dx.doi.org/10.1074/jbc.274.5.2597			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915784	hybrid			2022-12-27	WOS:000078319500002
J	Zhang, BL; Zhang, YQ; Collins, CC; Johnson, DI; Zheng, Y				Zhang, BL; Zhang, YQ; Collins, CC; Johnson, DI; Zheng, Y			A built-in arginine finger triggers the self-stimulatory GTPase-activating activity of Rho family GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE ANALOG; CDC42; PROTEINS; GENE; RAS; HYDROLYSIS; HOMOLOG; COMPLEX; BINDING; GAP	Signal transduction through the Rho family GTPases requires regulated cycling of the GTPases between the active GTP-bound state and the inactive GDP-bound state. Rho family members containing an arginine residue at position 186 in the C-terminal polybasic region were found to possess a self-stimulatory GTPase-activating protein (GAP) activity through homophilic interaction, resulting in significantly enhanced intrinsic GTPase activities. This arginine residue functions effectively as an "arginine finger" in the GTPase activating reaction to confer the catalytic GAP activity but is not essential for the homophilic binding interactions of Rho family proteins. The arginine 186-mediated negative regulation seems to be absent from Cdc42, a Rho family member important for cell-division cycle regulation, of lower eukaryotes, yet appears to be a part of the turn-off machinery of Cdc42 from higher eukaryotes, Introduction of the arginine 186 mutation into S, cerevisiae CDC42 led to phenotypes consistent with down-regulated CDC42 function. Thus, specific Rho family GTPases may utilize a built-in arginine finger, in addition to RhoGAPs, for negative regulation.	Univ Tennessee, Dept Biochem, Memphis, TN 38163 USA; Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Vermont	Zheng, Y (corresponding author), Univ Tennessee, Dept Biochem, Memphis, TN 38163 USA.	yzheng@utmem.edu	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074				Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Bourne HR, 1997, NATURE, V389, P673, DOI 10.1038/39470; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CHEN WN, 1993, J BIOL CHEM, V268, P13280; Eby JJ, 1998, CURR BIOL, V8, P967, DOI 10.1016/S0960-9822(98)00398-4; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Li R, 1997, J BIOL CHEM, V272, P32830, DOI 10.1074/jbc.272.52.32830; Li R, 1997, J BIOL CHEM, V272, P4671, DOI 10.1074/jbc.272.8.4671; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; Noel JP, 1997, NAT STRUCT BIOL, V4, P677, DOI 10.1038/nsb0997-677; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; SHINJO K, 1990, P NATL ACAD SCI USA, V87, P9853, DOI 10.1073/pnas.87.24.9853; Sprang SR, 1997, SCIENCE, V277, P329, DOI 10.1126/science.277.5324.329; Tanaka K, 1998, CURR OPIN CELL BIOL, V10, P112, DOI 10.1016/S0955-0674(98)80093-8; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tjandra H, 1998, CURR BIOL, V8, P991, DOI 10.1016/S0960-9822(07)00419-8; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vitale N, 1998, J BIOL CHEM, V273, P2553, DOI 10.1074/jbc.273.5.2553; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999; Zhang BL, 1998, J BIOL CHEM, V273, P25728, DOI 10.1074/jbc.273.40.25728; Zhang BL, 1998, BIOCHEMISTRY-US, V37, P5249, DOI 10.1021/bi9718447; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169	26	41	41	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2609	2612		10.1074/jbc.274.5.2609	http://dx.doi.org/10.1074/jbc.274.5.2609			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915787	hybrid			2022-12-27	WOS:000078319500005
J	Cherry, L; Menhart, N; Fung, LWM				Cherry, L; Menhart, N; Fung, LWM			Interactions of the alpha-spectrin N-terminal region with beta-spectrin - Implications for the spectrin tetramerization reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ERYTHROCYTE SPECTRIN; RED-CELL MEMBRANE; SELF-ASSOCIATION; BINDING-SITE; I DOMAIN; SKELETON; PEPTIDES; ELLIPTOCYTOSIS; VISUALIZATION; TEMPERATURE	Spectrin of the erythrocyte membrane skeleton is composed of alpha- and beta-spectrin, which associate to, form heterodimers and tetramers. It has been suggested that a fractional domain (helix C) in the amino-terminal region of alpha-spectrin (N alpha region) bundles with another fractional domain in the carboxyl-terminal region of beta-spectrin (C beta region) to yield a triple alpha-helical bundle and that this helical bundling is largely responsible for tetramer formation. However, there are certain objections to assigning a preeminent role to this helical bundling in the tetramerization reactions. We prepared several recombinant peptides of alpha-spectrin fragments spanning only the N alpha region (lacking the dimer nucleation site) and quantitatively studied their interaction with beta-spectrin, We found that a majority of the interactions were localized, as expected, in the N alpha-helix C region but that there was also some contribution from the nonhomologous region. More importantly, the temperature and ionic strength dependence of this interaction in our model peptides was different from that in intact spectrin, We suggest that, although the regions involving the putative helical bundling in alpha- and beta-spectrin undoubtedly play a significant role in tetramerization, regions distal to the N alpha-helix C region in spectrin are also involved in tetramer formation. Structural flexibility and lateral interactions may play a role in spectrin tetramerization.	Loyola Univ, Dept Chem, Chicago, IL 60626 USA	Loyola University Chicago	Fung, LWM (corresponding author), Loyola Univ, Dept Chem, 6525 N Sheridan Rd, Chicago, IL 60626 USA.	lfung@luc.edu						Ausubel FM, 1998, CURRENT PROTOCOLS MO; BAKLOUTI F, 1992, BLOOD, V79, P2464; Begg GE, 1997, BIOCHEMISTRY-US, V36, P6977, DOI 10.1021/bi970186n; BENNETT V, 1991, J CLIN INVEST, V87, P1483, DOI 10.1172/JCI115157; BUSSO N, 1994, J CELL BIOL, V126, P259, DOI 10.1083/jcb.126.1.259; BYERS TJ, 1985, P NATL ACAD SCI USA, V82, P6153, DOI 10.1073/pnas.82.18.6153; CALVERT R, 1980, EUR J BIOCHEM, V107, P363; Chabin RM, 1996, BIOCHEMISTRY-US, V35, P9567, DOI 10.1021/bi960476o; COLE N, 1992, BIOCHIM BIOPHYS ACTA, V1121, P23, DOI 10.1016/0167-4838(92)90332-8; DELAUNAY J, 1995, CRIT REV ONCOL HEMAT, V19, P79, DOI 10.1016/1040-8428(94)00139-K; DESILVA TM, 1992, BIOCHEMISTRY-US, V31, P10872, DOI 10.1021/bi00159a030; Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817; GALLAGHER PG, 1993, SEMIN HEMATOL, V30, P4; GALLAGHER PG, 1998, HEMATOLOGY INFANCY C, P544; GARBARZ M, 1990, BLOOD, V75, P1691; GOLDBERG ME, 1993, CURR OPIN IMMUNOL, V5, P278, DOI 10.1016/0952-7915(93)90018-N; Hassoun H, 1996, BLOOD REV, V10, P129, DOI 10.1016/S0268-960X(96)90021-1; HENNIKER A, 1994, BIOPHYS CHEM, V52, P251, DOI 10.1016/0301-4622(94)00094-Z; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; KNOWLES W, 1983, SEMIN HEMATOL, V20, P159; Kohn WD, 1997, J MOL BIOL, V267, P1039, DOI 10.1006/jmbi.1997.0930; KOTULA L, 1993, J BIOL CHEM, V268, P14788; LABRAKE CC, 1993, BIOCHEMISTRY-US, V32, P10296, DOI 10.1021/bi00090a004; LEBERMAN R, 1995, NATURE, V378, P364, DOI 10.1038/378364a0; LIU SC, 1987, J CELL BIOL, V104, P527, DOI 10.1083/jcb.104.3.527; LIU SC, 1982, P NATL ACAD SCI-BIOL, V79, P2072, DOI 10.1073/pnas.79.6.2072; LUSITANI DM, 1994, J BIOL CHEM, V269, P25955; Lux SE, 1995, BLOOD PRINCIPLES PRA, P1701; Menhart N, 1996, J BIOL CHEM, V271, P30410, DOI 10.1074/jbc.271.48.30410; MORLE L, 1990, J CLIN INVEST, V86, P548, DOI 10.1172/JCI114743; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; Pascual J, 1997, J MOL BIOL, V273, P740, DOI 10.1006/jmbi.1997.1344; RALSTON GB, 1991, BIOCHEMISTRY-US, V30, P4179, DOI 10.1021/bi00231a011; RALSTON GB, 1978, J SUPRAMOL STR CELL, V8, P361, DOI 10.1002/jss.400080313; SAHR KE, 1990, J BIOL CHEM, V265, P4434; SEGAL IH, 1975, ENZYME KINETICS, P100; SHOTTON DM, 1979, J MOL BIOL, V131, P303, DOI 10.1016/0022-2836(79)90078-0; SPEICHER DW, 1983, J BIOL CHEM, V258, P4938; SPEICHER DW, 1992, J BIOL CHEM, V267, P14775; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; SPEICHER DW, 1993, J BIOL CHEM, V268, P4227; SPEICHER DW, 1982, J BIOL CHEM, V257, P9093; TANG LH, 1977, BIOPHYS CHEM, V7, P121, DOI 10.1016/0301-4622(77)80005-7; TSE WT, 1990, J CLIN INVEST, V86, P909, DOI 10.1172/JCI114792; UNGEWICKELL E, 1978, EUR J BIOCHEM, V88, P379, DOI 10.1111/j.1432-1033.1978.tb12459.x; Ursitti JA, 1996, J BIOL CHEM, V271, P6636, DOI 10.1074/jbc.271.12.6636; VERTESSY BG, 1989, BIOPHYS J, V55, P255, DOI 10.1016/S0006-3495(89)82800-0; Wu SM, 1996, ARCH BIOCHEM BIOPHYS, V326, P39, DOI 10.1006/abbi.1996.0044; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Zahedi K, 1996, J BIOL CHEM, V271, P14897, DOI 10.1074/jbc.271.25.14897	50	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2077	2084		10.1074/jbc.274.4.2077	http://dx.doi.org/10.1074/jbc.274.4.2077			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890967	hybrid			2022-12-27	WOS:000078185200034
J	Lavie, J; Dandre, F; Louis, H; Lamaziere, JMD; Bonnet, J				Lavie, J; Dandre, F; Louis, H; Lamaziere, JMD; Bonnet, J			Vascular cell adhesion molecule-1 gene expression during human smooth muscle cell differentiation is independent of NF-kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; BINDING-PROTEINS; INTEGRIN VLA-4; VCAM-1; ALPHA; ENHANCER; PROMOTER; MODULATION; CLONING	Vascular cell adhesion molecule-1 (VCAM-1) gene expression in cytokine-activated cells depends on two kappa B elements. Since VCAM-1 expression appears developmentally regulated and cytokine-inducible in smooth muscle cells (SMCs), we have studied the role of NF-kappa B in differentiated SMC VCAM-1 expression. Confluent SMCs were cultured either in a serum-free medium in order to induce differentiation, or in medium with serum, stimulated or not by tumor necrosis factor alpha (TNF-alpha). The expression of smooth muscle myosin heavy chain, a SMC marker, and VCAM-1 was induced concomitantly in serum-free medium, whereas only VCAM-1 expression was induced by cytokine-treatment. We showed that the p50 and p65 subunits of NF-kappa B were localized in the cytoplasm of differentiating SMCs, whereas they were translocated into the nucleus of TNF-alpha-activated SMCs. Electrophoretic mobility shift assays with VCAM-1 gene kappa B elements failed to detect any induction of DNA-protein complex with nuclear extracts of differentiating SMCs in contrast to the cytokine-activated SMC nuclear extracts. Furthermore, VCAM-1 mRNA induction was inhibited in TNF-alpha-stimulated SMCs, but not in differentiating SMCs, by pyrrolidine dithiocarbamate, an inhibitor of NF-kappa B protein activation. Taken together, these findings suggest that in contrast to TNF-alpha activation, NF-kappa B is not involved in VCAM-1 gene expression during SMC differentiation.	INSERM U441, Atherosclerose, F-33600 Pessac, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Bonnet, J (corresponding author), INSERM U441, Atherosclerose, Ave Haut Leveque, F-33600 Pessac, France.			Lavie, Julie/0000-0002-7208-3154				ARIMA N, 1991, J VIROL, V65, P6892, DOI 10.1128/JVI.65.12.6892-6899.1991; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BELLAS RE, 1995, J CLIN INVEST, V96, P2521, DOI 10.1172/JCI118313; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN M, 1995, J MOL CELL CARDIOL, V27, P2571, DOI 10.1006/jmcc.1995.0044; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN L, 1992, J CELL PHYSIOL, V152, P10, DOI 10.1002/jcp.1041520103; COUFFINHAL T, 1994, CIRC RES, V74, P225, DOI 10.1161/01.RES.74.2.225; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; DAVIES M, 1993, J PATHOL, V3, P223; Duplaa C, 1997, CIRC RES, V80, P159; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; FRID MG, 1992, DEV BIOL, V153, P185, DOI 10.1016/0012-1606(92)90104-O; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; IADEMARCO MF, 1993, P NATL ACAD SCI USA, V90, P3943, DOI 10.1073/pnas.90.9.3943; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; IADEMARCO MF, 1995, J CLIN INVEST, V95, P264, DOI 10.1172/JCI117650; Jesse TL, 1998, J CELL BIOL, V140, P1265, DOI 10.1083/jcb.140.5.1265; Katoh Y, 1998, J BIOL CHEM, V273, P1511, DOI 10.1074/jbc.273.3.1511; KATOH Y, 1994, J BIOL CHEM, V269, P30589; KWEE L, 1995, DEVELOPMENT, V121, P489; LARSON DM, 1984, J CELL BIOL, V99, P1582, DOI 10.1083/jcb.99.5.1582; Lehtinen SK, 1996, BIOCHEM BIOPH RES CO, V229, P36, DOI 10.1006/bbrc.1996.1754; LI HM, 1993, AM J PATHOL, V143, P1551; LI ZL, 1993, J BIOL CHEM, V268, P10403; LIBBY P, 1983, J CELL PHYSIOL, V115, P217, DOI 10.1002/jcp.1041150217; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; MARUI N, 1993, J CLIN INVEST, V92, P1866, DOI 10.1172/JCI116778; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; NAGAI R, 1988, P NATL ACAD SCI USA, V85, P1047, DOI 10.1073/pnas.85.4.1047; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; Obata H, 1996, BIOCHEM BIOPH RES CO, V224, P27, DOI 10.1006/bbrc.1996.0979; OBRIEN KD, 1993, J CLIN INVEST, V92, P945, DOI 10.1172/JCI116670; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; OWENS GK, 1986, J CELL BIOL, V102, P343, DOI 10.1083/jcb.102.2.343; RICE GE, 1990, J EXP MED, V171, P1369, DOI 10.1084/jem.171.4.1369; ROSEN GD, 1992, CELL, V69, P1107, DOI 10.1016/0092-8674(92)90633-N; Sambrook J., 2002, MOL CLONING LAB MANU; SCHEIMNAM RI, 1993, MOL CELL BIOL, V13, P6039; SCHMID RM, 1991, NATURE, V352, P733, DOI 10.1038/352733a0; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHEPPARD AM, 1995, J BIOL CHEM, V270, P3710, DOI 10.1074/jbc.270.8.3710; SHEPPARD AM, 1994, CELL ADHES COMMUN, V2, P27, DOI 10.3109/15419069409014200; SHIMIZU RT, 1995, J BIOL CHEM, V270, P7631, DOI 10.1074/jbc.270.13.7631; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; SUZUKI E, 1995, MOL CELL BIOL, V15, P3415; Suzuki E, 1996, GENOMICS, V38, P283, DOI 10.1006/geno.1996.0630; THYBERG J, 1983, DIFFERENTIATION, V25, P156; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328	58	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2308	2314		10.1074/jbc.274.4.2308	http://dx.doi.org/10.1074/jbc.274.4.2308			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890996	hybrid			2022-12-27	WOS:000078185200063
J	McGregor, A; Murray, JB; Adams, CJ; Stockley, PG; Connolly, BA				McGregor, A; Murray, JB; Adams, CJ; Stockley, PG; Connolly, BA			Secondary structure mapping of an RNA ligand that has high affinity for the MetJ repressor protein and interference modification analysis of the protein-RNA complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI METHIONINE REPRESSOR; HIV-1 REVERSE-TRANSCRIPTASE; ESCHERICHIA-COLI; CIRCULAR-DICHROISM; OPERATOR COMPLEX; ARC REPRESSOR; DNA; RECOGNITION; BINDING; OLIGODEOXYRIBONUCLEOTIDE	The secondary structure of an RNA aptamer, which has a high affinity for the Escherichia coli MetJ repressor protein, has been mapped using ribonucleases and with diethyl pyrocarbonate. The RNA ligand is composed of a stem-loop with a highly structured internal loop. Interference modification showed that the bases within the internal loop, and those directly adjacent to it, are important in the binding of the RNA ligand to MetJ. Most of the terminal stem-loop could be removed with little effect on the binding. Ethylation interference suggests that none of the phosphate groups are absolutely essential for tight binding. The data suggest that the MetJ binding site on the aptamer is distinct from that of the natural DNA target, the 8-base pair Met box.	Newcastle Univ, Dept Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	Newcastle University - UK; University of Leeds	Connolly, BA (corresponding author), Newcastle Univ, Dept Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	b.a.connolly@ncl.ac.uk		Stockley, Peter/0000-0002-1360-2751				ADAMS CJ, 1994, TETRAHEDRON LETT, V35, P765, DOI 10.1016/S0040-4039(00)75812-6; BORER PN, 1995, BIOCHEMISTRY-US, V34, P6488, DOI 10.1021/bi00019a030; BROWN BM, 1990, BIOCHEMISTRY-US, V29, P11189, DOI 10.1021/bi00503a006; BURGERING MJM, 1995, BIOPOLYMERS, V35, P217, DOI 10.1002/bip.360350210; Burke DH, 1996, J MOL BIOL, V264, P650, DOI 10.1006/jmbi.1996.0667; CONNELL GJ, 1998, BIOCHEMISTRY-US, V32, P5497; Convery MA, 1998, NAT STRUCT BIOL, V5, P133, DOI 10.1038/nsb0298-133; CONWAY L, 1989, METHOD ENZYMOL, V180, P369; DURAND M, 1990, NUCLEIC ACIDS RES, V18, P6353, DOI 10.1093/nar/18.21.6353; EADIE JS, 1987, ANAL BIOCHEM, V165, P442, DOI 10.1016/0003-2697(87)90294-6; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; GRAY DM, 1995, METHOD ENZYMOL, V246, P19; GREEN L, 1995, J MOL BIOL, V247, P60, DOI 10.1006/jmbi.1994.0122; HE YY, 1992, NATURE, V359, P431, DOI 10.1038/359431a0; He YY, 1996, J MOL BIOL, V255, P55, DOI 10.1006/jmbi.1996.0006; Heus HA, 1997, NAT STRUCT BIOL, V4, P597, DOI 10.1038/nsb0897-597; JOHNSON CM, 1992, BIOCHEMISTRY-US, V31, P9717, DOI 10.1021/bi00155a027; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P400; McGregor A, 1996, NUCLEIC ACIDS RES, V24, P3173, DOI 10.1093/nar/24.16.3173; NIKIFOROV TT, 1992, NUCLEIC ACIDS RES, V20, P1209, DOI 10.1093/nar/20.6.1209; NIKIFOROV TT, 1992, TETRAHEDRON LETT, V33, P2379, DOI 10.1016/S0040-4039(00)74217-1; PARSONS I, 1996, THESIS U LEEDS UK; PARSONS ID, 1995, NUCLEIC ACIDS RES, V23, P211, DOI 10.1093/nar/23.2.211; PHILLIPS K, 1994, STRUCTURE, V2, P309, DOI 10.1016/S0969-2126(00)00032-0; PHILLIPS SEV, 1989, NATURE, V341, P711, DOI 10.1038/341711a0; RYAN PC, 1989, BIOCHEMISTRY-US, V28, P9949, DOI 10.1021/bi00452a012; SAINTGIRONS I, 1984, J BIOL CHEM, V259, P4282; SAINTGIRONS I, 1988, CRIT REV BIOCHEM MOL, V23, pS1, DOI 10.3109/10409238809083374; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; SCHNEIDER D, 1992, J MOL BIOL, V228, P862, DOI 10.1016/0022-2836(92)90870-P; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; TUERK C, 1992, P NATL ACAD SCI USA, V89, P6988, DOI 10.1073/pnas.89.15.6988; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Valegard K, 1997, J MOL BIOL, V270, P724, DOI 10.1006/jmbi.1997.1144; VLASSOV VV, 1981, EUR J BIOCHEM, V119, P51, DOI 10.1111/j.1432-1033.1981.tb05575.x; ZUKER M, 1989, METHOD ENZYMOL, V180, P51	37	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2255	2262		10.1074/jbc.274.4.2255	http://dx.doi.org/10.1074/jbc.274.4.2255			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890988	hybrid			2022-12-27	WOS:000078185200055
J	Seol, DW; Billiar, TR				Seol, DW; Billiar, TR			A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERTING-ENZYME; PROTEASE CASCADE; CD95 FAS/APO-1; DEATH DOMAIN; NITRIC-OXIDE; CYTOCHROME-C; CELL-DEATH; MEDIATOR; COMPLEX; FAMILY	It is likely that endogenous inhibitors of the apical caspases such as caspase-9 exist to prevent undesirable activation of caspase cascades. A naturally occurring variant of caspase-9 named caspase-9S was cloned from human liver. Caspase-9S is missing most of the large subunit of caspase-9, including the catalytic site, but has the intact prodomain and small subunit. Caspase-9S did not show apoptotic: activity in transfection analysis. Overexpression of caspase-9S inhibited apoptosis induced by caspase-9, indicating that caspase-9S is an endogenous dominant-negative of caspase-9S. Moreover, caspase-9S inhibited apoptosis induced by tumor necrosis factor(TNF)-alpha, TNF factor-related apoptosis-inducing ligand (TRAIL), Bar, or Fas-associated death domain-containing protein (FADD) as well as the combination of Apaf-1 and caspase-9, In vitro binding assays demonstrated that caspase-9S binds to Apaf-1 and blocks the binding of caspase-9 to Apaf-1. Coexpression of caspase-9 and caspase-9S mRNA was identified in various cell lines. Thus, caspase-9S acts as a dominant-negative inhibitor of caspase-9 activation, at least in part, by blocking Apaf-1-caspase-9 interaction.	Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Seol, DW (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, BST W1503,200 Lothrop St, Pittsburgh, PA 15261 USA.				NIGMS NIH HHS [GM44100] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM044100, R01GM044100, R37GM044100] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Duan HJ, 1996, J BIOL CHEM, V271, P16720, DOI 10.1074/jbc.271.28.16720; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kim YM, 1998, J BIOL CHEM, V273, P31437, DOI 10.1074/jbc.273.47.31437; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mittl PRE, 1997, J BIOL CHEM, V272, P6539, DOI 10.1074/jbc.272.10.6539; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Ohta T, 1997, J BIOL CHEM, V272, P23111, DOI 10.1074/jbc.272.37.23111; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Seol DW, 1998, BBA-GENE STRUCT EXPR, V1395, P252, DOI 10.1016/S0167-4781(97)00202-9; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Srinivasula SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/jbc.271.43.27099; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0	37	152	159	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2072	2076		10.1074/jbc.274.4.2072	http://dx.doi.org/10.1074/jbc.274.4.2072			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890966	hybrid			2022-12-27	WOS:000078185200033
J	Takayama, Y; Tanaka, S; Nagai, K; Okada, M				Takayama, Y; Tanaka, S; Nagai, K; Okada, M			Adenovirus-mediated overexpression of C-terminal Src kinase (Csk) in type I astrocytes interferes with cell spreading and attachment to fibronectin - Correlation with tyrosine phosphorylations of paxillin and FAK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; SIGNAL-TRANSDUCTION; FAMILY KINASES; BINDING-SITE; FYN; ACTIVATION; EXPRESSION; RECEPTOR; MICE; LOCALIZATION	To examine the role of C-terminal Src kinase (Csk), a negative regulatory kinase of Src family tyrosine kinases, in the cell adhesion mechanism of the nervous system, wild-type Csk (Csk), and a kinase-deficient mutant of Csk (Csk-Delta K) were overexpressed in primary cultured type I astrocytes by infecting them with the recombinant adenovirus, Overexpression of Csk repressed the in vitro kinase activity of Src to as little as 10% that of control cells and interfered with cell spreading and cell attachment to fibronectin. Focal adhesion assembly and the organization of actin stress fibers were also disrupted in cells overexpressing Csk. On the other hand, overexpression of Csk-Delta K induced tyrosine phosphorylation of cellular proteins, including the paxillin and focal adhesion kinase (FAK) and enhanced to some extent the cytoskeletal organization and the rate of cell spreading on fibronectin, indicating that Src or its relatives was functionally activated in the cells. Paxillin was also tyrosine-phosphorylated in Csk-overexpressing cells, indicating that it can serve as a substrate of Csk, The phosphorylation state of paxillin in cells overexpressing Csk was indistinguishable from that in cells expressing Csk-Delta K in that both phosphorylated paxillins bound equally to SH2 domain of Csk and were co-immunoprecipitated with Csk, In contrast, tyrosine phosphorylation of FAK and its in vitro autophosphorylation activity were increased only in cells expressing Csk-Delta K, In Csk-expressing cells, the kinase activity of FAK was substantially decreased to 20-30% that of control cells, even though the expression level of FAK: was rather increased. These findings suggest that Csk regulates Src family tyrosine kinases that play essential roles in the regulation of cell adhesion via a FAK-dependent mechanism and that the tyrosine phosphorylation of paxillin alone may not be sufficient for the regulation of the cell adhesion mechanism in astrocytes.	Osaka Univ, Inst Prot Res, Inst Prot Metab, Suita, Osaka 5650871, Japan; Univ Tokyo, Fac Med, Dept Orthoped Surg, Bunkyo Ku, Tokyo 113, Japan	Osaka University; University of Tokyo	Takayama, Y (corresponding author), Osaka Univ, Inst Prot Res, Inst Prot Metab, Suita, Osaka 5650871, Japan.	ytaka@protein.osaka-u.ac.jp	Takayama, Yoshiharu/E-3662-2010; Tanaka, Sakae/Y-3061-2019; Takayama, Yoshiharu/M-8826-2019	Takayama, Yoshiharu/0000-0003-4532-7114; Tanaka, Sakae/0000-0001-9210-9414; Takayama, Yoshiharu/0000-0003-4532-7114				BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Cary LA, 1996, J CELL SCI, V109, P1787; CHEN YH, 1994, J BIOL CHEM, V269, P27372; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; Gelderloos JA, 1998, J BIOL CHEM, V273, P5908, DOI 10.1074/jbc.273.10.5908; GRANT SGN, 1995, GENE DEV, V9, P1909, DOI 10.1101/gad.9.15.1909; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; IGRELZI MAJ, 1994, NEURON, V12, P873; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; Khan MA, 1996, EUR J BIOCHEM, V235, P579, DOI 10.1111/j.1432-1033.1996.00579.x; KOBAYASHI N, 1993, P NATL ACAD SCI USA, V90, P4201, DOI 10.1073/pnas.90.9.4201; LIEBL EC, 1992, ONCOGENE, V7, P2417; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; NADA S, 1994, ONCOGENE, V9, P3571; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOMURA S, 1995, NATURE, V377, P539; OKADA M, 1991, J BIOL CHEM, V266, P24249; PARSONS JT, 1989, CURR TOP MICROBIOL, V147, P79; RALSTON R, 1985, P NATL ACAD SCI USA, V82, P7845, DOI 10.1073/pnas.82.23.7845; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; SABE H, 1992, MOL CELL BIOL, V12, P4706, DOI 10.1128/MCB.12.10.4706; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SCHLAEPFER DD, 1994, NATURE, V372, P786; Takayama Y, 1997, FEBS LETT, V406, P11, DOI 10.1016/S0014-5793(97)00224-X; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; Tobe K, 1996, MOL CELL BIOL, V16, P4765; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0	35	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2291	2297		10.1074/jbc.274.4.2291	http://dx.doi.org/10.1074/jbc.274.4.2291			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890993	hybrid			2022-12-27	WOS:000078185200060
J	Uchida, K; Shiraishi, M; Naito, Y; Torii, Y; Nakamura, Y; Osawa, T				Uchida, K; Shiraishi, M; Naito, Y; Torii, Y; Nakamura, Y; Osawa, T			Activation of stress signaling pathways by the end product of lipid peroxidation - 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-HYDROXYNONENAL PROTEIN ADDUCTS; AMYLOID BETA-PEPTIDE; C-JUN; MAP KINASE; GENE-EXPRESSION; GROWTH-FACTOR; ALDEHYDIC PRODUCT; TYROSINE PHOSPHORYLATION; TRANSDUCTION PATHWAY; OXIDATIVE STRESS	In the present study, we studied the signal transduction mechanism that is involved in the expression of c-Jun protein evident after exposure of rat liver epithelial RL34 cells to the major end product of oxidized fatty acid metabolism, 4-hydroxy-2-nonenal (HNE). HNE treatment of the cells resulted in depletion of intracellular glutathione (GSH) and in the formation of protein-bound HNE in plasma membrane. In addition, HNE strongly induced intracellular peroxide production, suggesting that HNE exerted oxidative stress on the cells. Potent expression of c-Jun occurred within 30 min of HNE treatment, which was accompanied by a time-dependent increase in activator protein-1 (AP-1) DNA binding activity. We found that HNE caused an immediate increase in tyrosine phosphorylation in RL34 cells, In addition, HNE strongly induced phosphorylation of c-Jun N-terminal kinases (JNK) and p38 mitogen-activated protein kinases and also moderately induced phosphorylation of extracellular signal-regulated kinases. The phosphorylation of JNK was accompanied by a rapid and transient increase in JNK and p38 activities, whereas changes in the activity of extracellular signal-regulated kinase were scarcely observed. GSH depletion by L-buthionine-S,R-sulfoximine, a specific inhibitor of GSH biosynthesis, only slightly enhanced peroxide production and JNK activation, suggesting that HNE exerted these effects independent of GSH depletion. This and the findings that (i) HNE strongly induced intracellular peroxide production, (ii) HNE-induced JNK activation was inhibited by pretreatment of the cells with a thiol antioxidant, N-acetylcysteine, and (iii) H2O2 significantly activated JNK support the hypothesis that pro-oxidants play a crucial role in the HNE-induced activation of stress signaling pathways. In addition, we found that, among the inhibitors of tyrosine kinases, cyclooxygenase, and Ca2+ influx, only quercetin exerted a significant inhibitory effect on HNE-induced JNK activation. In light of the JNK-dependent induction of c-jun transcription and the AP-1-induced transcription of xenobiotic-metabolizing enzymes, these data may show a potential critical role for JNK in the induction of a cellular defense program against toxic products generated from lipid peroxidation.	Nagoya Univ, Lab Food & Biodynam, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; Kyoto Univ, Div Appl Sci, Grad Sch Agr, Kyoto 6068502, Japan	Nagoya University; Kyoto University	Uchida, K (corresponding author), Nagoya Univ, Lab Food & Biodynam, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Torii, Yasuyoshi/G-7800-2016	Uchida, Koji/0000-0003-3894-5299				ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Ando Y, 1997, BIOCHEM BIOPH RES CO, V232, P497, DOI 10.1006/bbrc.1996.5997; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Barrera G, 1996, BIOCHEM BIOPH RES CO, V227, P589, DOI 10.1006/bbrc.1996.1550; Blanc EM, 1997, J NEUROCHEM, V69, P570; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Cahill MA, 1996, CURR BIOL, V6, P16, DOI 10.1016/S0960-9822(02)00410-4; Carini R, 1996, BIOCHEM BIOPH RES CO, V218, P772, DOI 10.1006/bbrc.1996.0137; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Clark GJ, 1997, J BIOL CHEM, V272, P1677, DOI 10.1074/jbc.272.3.1677; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; De Montarby L., 1988, TETRAHEDRON LETT, V29, P3895; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DEVARY Y, 1992, CELL, V71, P1081, DOI 10.1016/S0092-8674(05)80058-3; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FAZIO VM, 1992, CANCER RES, V52, P4866; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Fukuda A, 1997, BIOCHEM BIOPH RES CO, V236, P505, DOI 10.1006/bbrc.1997.6585; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GOULD KL, 1988, MOL CELL BIOL, V8, P3345, DOI 10.1128/MCB.8.8.3345; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; HAN JH, 1993, J BIOL CHEM, V268, P25009; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonarduzzi G, 1997, FASEB J, V11, P851, DOI 10.1096/fasebj.11.11.9285483; LI Y, 1992, J BIOL CHEM, V267, P15097; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Mark RJ, 1997, J NEUROSCI, V17, P1046; Mark RJ, 1997, J NEUROCHEM, V68, P255; Mattson MP, 1997, NEUROREPORT, V8, P2275, DOI 10.1097/00001756-199707070-00036; MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290; MILTENBERGER RJ, 1993, J BIOL CHEM, V268, P15674; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Morikawa S, 1997, BIOCHEM MOL BIOL INT, V41, P767; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; OKAMOTO K, 1994, INT J CANCER, V58, P825, DOI 10.1002/ijc.2910580613; OKUDA A, 1989, J BIOL CHEM, V264, P16919; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; PAROLA M, 1993, BIOCHEM BIOPH RES CO, V194, P1044, DOI 10.1006/bbrc.1993.1927; POLI G, 1987, CHEM PHYS LIPIDS, V45, P117, DOI 10.1016/0009-3084(87)90063-6; Rao GN, 1996, J BIOL CHEM, V271, P27760, DOI 10.1074/jbc.271.44.27760; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; ROSSI MA, 1990, BIOCHEM PHARMACOL, V39, P1715, DOI 10.1016/0006-2952(90)90116-3; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHREIBER M, 1995, EMBO J, V14, P5338, DOI 10.1002/j.1460-2075.1995.tb00218.x; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; Spycher S, 1996, BIOCHEM BIOPH RES CO, V226, P512, DOI 10.1006/bbrc.1996.1386; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; Tournier C, 1997, EUR J BIOCHEM, V244, P587, DOI 10.1111/j.1432-1033.1997.00587.x; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P5611, DOI 10.1073/pnas.89.12.5611; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; Uchida K, 1995, ARCH BIOCHEM BIOPHYS, V324, P241, DOI 10.1006/abbi.1995.0036; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; WHITMARSH AJ, 1995, SCIENCE, V269, P1760; Wilmer WA, 1997, J BIOL CHEM, V272, P10877; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YAMADA M, 1987, CELL STRUCT FUNCT, V12, P53, DOI 10.1247/csf.12.53; YAN MH, 1994, NATURE, V372, P798; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696	79	481	490	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2234	2242		10.1074/jbc.274.4.2234	http://dx.doi.org/10.1074/jbc.274.4.2234			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890986	hybrid			2022-12-27	WOS:000078185200053
J	Feng, X; Teitelbaum, SL; Quiroz, ME; Towler, DA; Ross, FP				Feng, X; Teitelbaum, SL; Quiroz, ME; Towler, DA; Ross, FP			Cloning of the murine beta(5) integrin subunit promoter - Identification of a novel sequence mediating granulocyte-macrophage colony-stimulating factor-dependent repression of beta(5) integrin gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-RESORPTION; OSTEOCLAST PRECURSORS; SIGNAL-TRANSDUCTION; CELL-ADHESION; RECEPTOR; EXPRESSION; PROTEINS; DIFFERENTIATION; INTERLEUKIN-3; ACTIVATION	We previously noted that the initial receptor by which murine osteoclast precursors bind matrix is the integrin alpha(v)beta(5) and that granulocyte-macrophage colony-stimulating factor (GM-CSF) decreases expression of this heterodimer by suppressing transcription of the beta(5) gene. We herein report cloning of the beta(5) integrin gene promoter and identification of a GM-CSF-responsive sequence. A 13-kilobase (kb) genomic fragment containing part of the beta(5) gene was isolated by screening a mouse genomic library with a probe derived from the most 5'-end of a murine beta(5) cDNA. A combination of primer extension and S1 nuclease studies identifies two transcriptional start sites, with the major one designated +1. A 1-kb subclone containing sequence -875 to + 110 is transcriptionally active in a murine myeloid cell line. This 1-kb fragment contains consensus binding sequences for basal (Sp1), lineage-specific (PU.1), and regulatable (signal transducer and activator of transcription) transcription factors. Reflecting our earlier findings, promoter activity is repressed in transfected myeloid cells treated with GM-CSF. Using deletion mutants, we localized a 109-base pair (bp) promoter region responsible for GM-CSF-inhibited beta(5) transcription. We further identified a 19-bp sequence within the 109-bp region that binds GM-CSF-induced nuclear proteins by gel shift/competition assays. Mutation of the 19-bp sequence not only ablates its capacity to bind nuclear proteins from GM-CSF-treated cells, in vitro, but the same mutation, when introduced in the 1-kb promoter, abolishes its ability to respond to GM-CSF treatment. Northern analysis demonstrates that cycloheximide treatment abrogates the capacity of GM-CSF to decrease beta(5) mRNA levels. In summary, we have identified a 19-bp cis-element mediating GM-CSF-induced down-regulation of beta(5) by a mechanism requiring protein synthesis.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Ross, FP (corresponding author), Washington Univ, Sch Med, Barnes Jewish Hosp N, Dept Pathol, 216 S Kingshighway, St Louis, MO 63110 USA.			Towler, Dwight/0000-0003-2107-7923; Teitelbaum, Steven/0000-0002-4054-6679				ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; BARON R, 1986, AM J PATHOL, V122, P363; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; CAO X, 1993, J BIOL CHEM, V268, P27371; CHODOSH LA, 1994, CURRENT PROTOCOLS MO; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FALLON MD, 1983, LAB INVEST, V49, P159; GLINIAK BC, 1990, CELL, V63, P1073, DOI 10.1016/0092-8674(90)90510-L; GLOWACKI J, 1986, J BONE MINER RES, V1, P327; GRONER B, 1995, CURR OPIN GENET DEV, V5, P587, DOI 10.1016/0959-437X(95)80027-1; Hara T, 1996, STEM CELLS, V14, P605, DOI 10.1002/stem.140605; HORTON MA, 1991, EXP CELL RES, V195, P368, DOI 10.1016/0014-4827(91)90386-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; INOUE M, 1998, IN PRESS MOL ENDOCRI; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Matayoshi A, 1996, P NATL ACAD SCI USA, V93, P10785, DOI 10.1073/pnas.93.20.10785; MCHUGH K, 1994, J BONE MINER RES, V9, pS248; MCLEAN JW, 1990, J BIOL CHEM, V265, P17126; MIMURA H, 1994, ENDOCRINOLOGY, V134, P1061, DOI 10.1210/en.134.3.1061; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; RAMASWAMY H, 1990, EMBO J, V9, P1561, DOI 10.1002/j.1460-2075.1990.tb08275.x; RANSOM DG, 1993, DEV BIOL, V160, P265, DOI 10.1006/dbio.1993.1304; ROSEN GD, 1991, P NATL ACAD SCI USA, V88, P4094, DOI 10.1073/pnas.88.10.4094; ROSS FP, 1993, J BIOL CHEM, V268, P9901; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO M, 1990, J CELL BIOL, V111, P1713, DOI 10.1083/jcb.111.4.1713; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SHINAR DM, 1993, J BONE MINER RES, V8, P403; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; SUZUKI S, 1990, P NATL ACAD SCI USA, V87, P5354, DOI 10.1073/pnas.87.14.5354; TEITELBAUM SL, 1995, J CELL BIOCHEM, V59, P1, DOI 10.1002/jcb.240590102; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; VILLAGARCIA M, 1994, BLOOD, V83, P668, DOI 10.1182/blood.V83.3.668.bloodjournal833668; Welham MJ, 1997, J BIOL CHEM, V272, P1377, DOI 10.1074/jbc.272.2.1377; XIAO JH, 1987, EMBO J, V6, P3005, DOI 10.1002/j.1460-2075.1987.tb02606.x; ZIMRIN AB, 1990, J BIOL CHEM, V265, P8590; Ziober BL, 1996, J BIOL CHEM, V271, P22915, DOI 10.1074/jbc.271.37.22915; ZUTTER MM, 1994, J BIOL CHEM, V269, P463	42	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1366	1374		10.1074/jbc.274.3.1366	http://dx.doi.org/10.1074/jbc.274.3.1366			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880508	hybrid			2022-12-27	WOS:000079956900028
J	Kim, CY; Shen, BH; Park, MS; Olah, GA				Kim, CY; Shen, BH; Park, MS; Olah, GA			Structural changes measured by x-ray scattering from human flap endonuclease-1 complexed with Mg2+ and flap DNA substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; PURIFIED PROTEINS; REPLICATION FORK; MAMMALIAN-CELLS; YEAST; FEN-1; BINDING; EXONUCLEASE	Human flap endonuclease-1 (FEN-1) is a member of the structure-specific endonuclease family and is essential in DNA replication and repair. FEN-1 has specific endonuclease activity for repairing nicked double-stranded DNA substrates that have the 5'-end of the nick expanded into a single-stranded tail, and it is involved in processing Okazaki fragments during DNA replication. Magnesium is a cofactor required for nuclease activity. We used small-angle x-ray scattering to obtain global structural information pertinent to nuclease activity from FEN-1, the D181A mutant, the wild-type FEN-1.34-mer DNA flap complex, and the D181A 34-mer DNA flap complex. The D181A mutant, which has Asp-181 replaced by Ala, selectively binds to the flap structure, but has lost its cleaving activity. Asp-181 is thought to be involved in Mg2+ binding at the active site (Shen, B., Nolan, J. P., Sklar, L. A. and Park, M. S. (1996) J. Biol. Chem. 271, 9173-9176). Our data indicate that PEN-1 and the D181A mutant each have a radius of gyration of similar to 26 Angstrom and the effect of Mg2+ on the scattering from the proteins alone is insignificant. The 34-mer DNA fragment was constructed such that it readily forms a 5'-flap structure. The formation of the flap conformation of the DNA substrate was evident by both the extrapolated I-o scattering and radius of gyration and was supported by NMR spectrum and nuclease assays. In the absence of magnesium, the FEN-1.34-mer DNA flap complex has an R-g value of similar to 34 Angstrom whereas the D181A 34-mer DNA flap complex self-associates, suggesting that a significant protein conformational change occurs by addition of the flap DNA substrate and that Asp-181 is crucial for proper binding of the protein to the DNA substrate. A time course change in the scattering profiles arising from magnesium activation of the FEN-1.34-mer DNA flap complex is consistent with the protein completely releasing the DNA substrate after cleavage.	Univ Calif Los Alamos Natl Lab, Div Life Sci, Los Alamos, NM 87545 USA; Univ Calif Los Alamos Natl Lab, Chem Sci & Technol Div, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Olah, GA (corresponding author), Oklahoma State Univ, Coll Vet Med, 110 Vet Med, Stillwater, OK 74078 USA.		Park, Min Sung/HCH-2207-2022; Prakash, Surya/AFC-8224-2022; Prakash, Surya/AAF-1756-2022	Shen, Binghui/0000-0002-4408-407X; Kim, Chang-Yub/0000-0001-9353-5909	NCI NIH HHS [CA73764] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073764, R29CA073764] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Biswas EE, 1997, BIOCHEMISTRY-US, V36, P5955, DOI 10.1021/bi962890u; BLECHNER SL, 1992, BIOCHEMISTRY-US, V31, P11326, DOI 10.1021/bi00161a010; BLOMMERS MJJ, 1987, NATO ASI SER E, V133, P78; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; DOETSCH PW, 1995, TRENDS BIOCHEM SCI, V20, P384, DOI 10.1016/S0968-0004(00)89084-2; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; GUTMAN PD, 1993, NUCLEIC ACIDS RES, V21, P4406, DOI 10.1093/nar/21.18.4406; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; HARRINGTON JJ, 1995, J BIOL CHEM, V270, P4503, DOI 10.1074/jbc.270.9.4503; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; HEIDORN DB, 1988, BIOCHEMISTRY-US, V27, P909, DOI 10.1021/bi00403a011; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; LYAMICHEV V, 1993, SCIENCE, V260, P778, DOI 10.1126/science.7683443; Mecklenburg SL, 1997, J MOL BIOL, V270, P739, DOI 10.1006/jmbi.1997.1126; MOORE PB, 1980, J APPL CRYSTALLOGR, V13, P168, DOI 10.1107/S002188988001179X; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; MURANTE RS, 1994, J BIOL CHEM, V269, P1191; Murante RS, 1996, J BIOL CHEM, V271, P25888, DOI 10.1074/jbc.271.42.25888; MURRAY JM, 1994, MOL CELL BIOL, V14, P4878, DOI 10.1128/MCB.14.7.4878; Nolan JP, 1996, BIOCHEMISTRY-US, V35, P11668, DOI 10.1021/bi952840+; PONTKINGDON G, 1993, EMBO J, V12, P23, DOI 10.1002/j.1460-2075.1993.tb05628.x; REAGAN MS, 1995, J BACTERIOL, V177, P365; ROBINS P, 1994, J BIOL CHEM, V269, P28535; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; SANCAR A, 1995, J BIOL CHEM, V270, P15915, DOI 10.1074/jbc.270.27.15915; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; TURCHI JJ, 1993, J BIOL CHEM, V268, P15136; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; VALLEN EA, 1995, MOL CELL BIOL, V15, P4291; VERMEULEN W, 1993, AM J HUM GENET, V53, P185; WAGA S, 1994, J BIOL CHEM, V269, P10923; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036	45	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1233	1239		10.1074/jbc.274.3.1233	http://dx.doi.org/10.1074/jbc.274.3.1233			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880491	hybrid			2022-12-27	WOS:000079956900011
J	Herson, PS; Lee, K; Pinnock, RD; Hughes, J; Ashford, MLJ				Herson, PS; Lee, K; Pinnock, RD; Hughes, J; Ashford, MLJ			Hydrogen peroxide induces intracellular calcium overload by activation of a non-selective cation channel in an insulin-secreting cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED PANCREATIC-ISLETS; OXYGEN-FREE-RADICALS; OXIDATIVE STRESS; BETA-CELLS; SUPEROXIDE-DISMUTASE; PYRIDINE-NUCLEOTIDES; ALLOXAN; CA2+; RAT; FLUORESCENCE	Fura-2 fluorescence was used to investigate the effects of H(2)O(2) on [Ca(2+)](i) in the insulin-secreting cell line CRI-G1. H(2)O(2) (1-10 mM) caused a biphasic increase in free [Ca(2+)](i), an initial rise observed within 3 min and a second, much larger rise following a 30-min exposure. Extracellular calcium removal blocked the late, but not the initial, rise in [Ca(2+)](i), Thapsigargin did not affect either response to H(2)O(2), but activated capacitive calcium entry, an action abolished by 10 mu M La(3+), Simultaneous recordings of membrane potential and [Ca(2+)](i) demonstrated the same biphasic [Ca(2+)](i) response to H(2)O(2) and showed that the late increase in [Ca(2+)](i) coincided temporally with cell membrane potential collapse. Buffering Ca(i)(2+) to low nanomolar levels prevented both phases of increased [Ca(2+)](i) and the H(2)O(2)-induced depolarization. The H(2)O(2)-induced late rise in [Ca(2+)](i) was prevented by extracellular application of 100 mu M La(3+). La(3+) (100 mu M) inhibited the H(2)O(2)-induced cation current and NAD-activated cation (NS(NAD)) channel activity in these cells. H(2)O(2) increased the NAD/NADH ratio in intact CRI-G1 cells, consistent with increased cellular [NAD], These data suggest that H(2)O(2) increases [NAD], which, coupled with increased [Ca(2+)](i), activates NS(NAD), channels, causing unregulated Ca(2+) entry and consequent cell death.	Univ Aberdeen, Inst Med Sci, Dept Biomed Sci, Aberdeen AB25 2ZD, Scotland; Univ Cambridge, Parke Davis Neurosci Res Ctr, Cambridge CB2 2QB, England	University of Aberdeen; University of Cambridge	Ashford, MLJ (corresponding author), Univ Aberdeen, Inst Med Sci, Dept Biomed Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland.	mike.ashford@abdn.ac.uk		Ashford, Michael/0000-0002-0861-7676				ALBANO E, 1991, BIOCHIM BIOPHYS ACTA, V1091, P310, DOI 10.1016/0167-4889(91)90194-3; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bielefeldt K, 1997, AM J PHYSIOL-GASTR L, V272, pG1439, DOI 10.1152/ajpgi.1997.272.6.G1439; BOQUIST L, 1977, ACTA PATH MICRO IM A, V85, P219; BOQUIST L, 1984, DIABETOLOGIA, V27, P379, DOI 10.1007/BF00304854; CARRINGTON CA, 1996, J ENDOCRINOL, V109, P193; CLAGUE JR, 1994, J MOL CELL CARDIOL, V26, P11, DOI 10.1006/jmcc.1994.1003; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DEAN PM, 1972, DIABETOLOGIA, V8, P173, DOI 10.1007/BF01212257; Dunn JS, 1943, LANCET, V1, P484; FAVERO TG, 1995, J BIOL CHEM, V270, P25557, DOI 10.1074/jbc.270.43.25557; FISCHER LJ, 1980, DIABETES, V29, P213, DOI 10.2337/diabetes.29.3.213; GRANKVIST K, 1979, BIOCHEM J, V182, P17, DOI 10.1042/bj1820017; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gutteridge J. M. C., 1996, NEUROS PER, P1; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Herson PS, 1998, J PHYSIOL-LONDON, V507P, p15P; Herson PS, 1997, J PHYSIOL-LONDON, V505, P65, DOI 10.1111/j.1469-7793.1997.065bc.x; Herson PS, 1997, J PHYSIOL-LONDON, V501, P59, DOI 10.1111/j.1469-7793.1997.059bo.x; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; JABR RI, 1993, CIRC RES, V72, P1229, DOI 10.1161/01.RES.72.6.1229; JUNTTIBERGGREN L, 1993, SCIENCE, V261, P86, DOI 10.1126/science.7686306; KANEKO M, 1994, MOL CELL BIOCHEM, V135, P99, DOI 10.1007/BF00925965; KANEKO M, 1989, AM J PHYSIOL, V256, pH368, DOI 10.1152/ajpheart.1989.256.2.H368; KIM HR, 1994, BBA-MOL BASIS DIS, V1227, P87, DOI 10.1016/0925-4439(94)90111-2; KlonowskiStumpe H, 1997, AM J PHYSIOL-GASTR L, V272, pG1489, DOI 10.1152/ajpgi.1997.272.6.G1489; Leech CA, 1998, DIABETES, V47, P1066, DOI 10.2337/diabetes.47.7.1066; Leist M, 1998, REV PHYSIOL BIOCH P, V132, P79, DOI 10.1007/BFb0004986; Miura Y, 1997, J PHYSIOL-LONDON, V503, P387, DOI 10.1111/j.1469-7793.1997.387bh.x; MUNNS PL, 1995, FREE RADICAL BIO MED, V18, P467, DOI 10.1016/0891-5849(94)00163-E; NICOTERA P, 1992, ANNU REV PHARMACOL, V32, P449, DOI 10.1146/annurev.pa.32.040192.002313; NICOTERA P, 1994, MOL CELL BIOCHEM, V135, P89, DOI 10.1007/BF00925964; OKAMOTO H, 1985, BIOESSAYS, V2, P15, DOI 10.1002/bies.950020106; OLANOW CW, 1992, ANN NEUROL, V32, pS2, DOI 10.1002/ana.410320703; PANTEN U, 1973, DIABETOLOGIA, V9, P477, DOI 10.1007/BF00461692; Preuss KD, 1997, BIOCHEM BIOPH RES CO, V240, P167, DOI 10.1006/bbrc.1997.7528; REALE V, 1994, J MEMBRANE BIOL, V142, P299; RICHARDSON JS, 1993, ANN NY ACAD SCI, V695, P73, DOI 10.1111/j.1749-6632.1993.tb23031.x; ROJANASAKUL Y, 1993, AM J RESP CELL MOL, V8, P377, DOI 10.1165/ajrcmb/8.4.377; ROVERI A, 1992, ARCH BIOCHEM BIOPHYS, V297, P265, DOI 10.1016/0003-9861(92)90671-I; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; WILLIAMS DA, 1990, CELL CALCIUM, V11, P75, DOI 10.1016/0143-4160(90)90061-X; WORLEY JF, 1994, J BIOL CHEM, V269, P14359; WORLEY JF, 1994, J BIOL CHEM, V269, P32055; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139; ZHANG H, 1995, DIABETOLOGIA, V38, P635, DOI 10.1007/BF00401832	49	98	106	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					833	841		10.1074/jbc.274.2.833	http://dx.doi.org/10.1074/jbc.274.2.833			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873022	hybrid			2022-12-27	WOS:000077968500037
J	Macfarlane, WM; McKinnon, CM; Felton-Edkins, ZA; Cragg, H; James, RFL; Docherty, K				Macfarlane, WM; McKinnon, CM; Felton-Edkins, ZA; Cragg, H; James, RFL; Docherty, K			Glucose stimulates translocation of the homeodomain transcription factor PDX1 from the cytoplasm to the nucleus in pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INSULIN-GENE; ACTIVATED PROTEIN-KINASE; BINDING-PROTEINS; PORE COMPLEX; ISLET CELLS; FACTOR IUF1; MAP KINASE; EXPRESSION; ENHANCER; PATHWAY	One of the mechanisms whereby glucose stimulates insulin gene transcription in pancreatic beta-cells involves activation of the homeodomain transcription factor PDX1 (pancreatic/duodenal homeobox-1) via a stress-activated pathway involving stress-activated protein kinase 2 (SAPK2, also termed RK/p38, CSBP, and Mxi2). In the present study we show, by Western blotting and electrophoretic mobility shift assay, that in human islets of Langerhans incubated in low glucose (3 mM) PDX1 exists as an inactive 31-kDa protein localized exclusively in the cytoplasm. Transfer of the islets to high (16 mM) glucose results in rapid (within 10 min) conversion of PDX1 to an active 46-kDa form that was present predominantly in the nucleus. Activation of PDX1 appears to involve phosphorylation, as shown by incorporation of P-32(i) into the 46-kDa form of the protein. These effects of glucose could be mimicked by chemical stress (sodium arsenite), or by overexpression of SAPK2 in the beta-cell line MIN6. Overexpression of SAPK2 also stimulated PDX1-dependent transcription of a -50 to -250 region of the human insulin gene promoter linked to a firefly luciferase reporter gene. The effects of glucose were inhibited by the SAPK2 inhibitor SB 203580, and by wortmannin and LY 294002, which inhibit phosphatidylinositol-3-kinase, although the effects of stress (arsenite) were inhibited only by SE 203580, These results demonstrate that glucose regulates the insulin gene promoter through activation and nuclear translocation of PDX1 via the SAPK2 pathway.	Inst Med Sci, Dept Mol & Cell Biol, Aberdeen AB25 2ZD, Scotland; Univ Leicester, Leicester Royal Infirm, Dept Surg, Leicester LE2 7LX, Leics, England	University of Aberdeen; University of Leicester	Docherty, K (corresponding author), Inst Med Sci, Dept Mol & Cell Biol, Aberdeen AB25 2ZD, Scotland.			Docherty, Kevin/0000-0001-6765-2060				BOAM DSW, 1989, BIOCHEM J, V264, P233, DOI 10.1042/bj2640233; BOAM DSW, 1990, J BIOL CHEM, V265, P8285; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CLARK AR, 1993, FEBS LETT, V329, P139, DOI 10.1016/0014-5793(93)80210-L; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; DUVERGER E, 1995, J CELL SCI, V108, P1325; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; GUZ Y, 1995, DEVELOPMENT, V121, P11; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kajimoto Y, 1997, J CLIN INVEST, V100, P1840, DOI 10.1172/JCI119712; Kim SJ, 1997, BIOCHEM J, V323, P621, DOI 10.1042/bj3230621; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; LEONARD J, 1993, MOL ENDOCRINOL, V7, P1275, DOI 10.1210/me.7.10.1275; Macfarlane WM, 1997, FEBS LETT, V413, P304, DOI 10.1016/S0014-5793(97)00874-0; MACFARLANE WM, 1994, BIOCHEM J, V303, P625, DOI 10.1042/bj3030625; Macfarlane WM, 1997, J BIOL CHEM, V272, P20936, DOI 10.1074/jbc.272.33.20936; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Marshak S, 1996, P NATL ACAD SCI USA, V93, P15057, DOI 10.1073/pnas.93.26.15057; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MELLOUL D, 1993, P NATL ACAD SCI USA, V90, P3865, DOI 10.1073/pnas.90.9.3865; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; PEERS B, 1994, MOL ENDOCRINOL, V8, P1798, DOI 10.1210/me.8.12.1798; PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465; Rafiq I, 1998, J BIOL CHEM, V273, P23241, DOI 10.1074/jbc.273.36.23241; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Serup P, 1996, P NATL ACAD SCI USA, V93, P9015, DOI 10.1073/pnas.93.17.9015; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351	31	187	222	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1011	1016		10.1074/jbc.274.2.1011	http://dx.doi.org/10.1074/jbc.274.2.1011			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873045	hybrid			2022-12-27	WOS:000077968500060
J	Tillmann-Bogush, M; Heaton, JH; Gelehrter, TD				Tillmann-Bogush, M; Heaton, JH; Gelehrter, TD			Cyclic nucleotide regulation of PAI-1 mRNA stability - Identification of cytosolic proteins that interact with an A-rich sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; PLASMINOGEN-ACTIVATOR-INHIBITOR; RAT HEPATOMA-CELLS; PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; AGONIST-INDUCED DESTABILIZATION; 3'-UNTRANSLATED REGION; BINDING PROTEIN; GENE-TRANSCRIPTION; DOWN-REGULATION; SERTOLI CELLS	Incubation of HTC rat hepatoma cells with the cyclic nucleotide analogue 8-bromo-cAMP results in a 3-fold increase in the rate of degradation of type-1 plasminogen activator-inhibitor (PAI-1) mRNA. Previous studies utilizing HTC cells stably transfected with beta-globin: PAI-1 chimeric constructs demonstrated that at least two regions within the PAI-1 3'-untranslated region mediate the cyclic nucleotide-induced destabilization of PAI-1 mRNA; one of these regions is the 3'-most 134 nucleotides (nt) of the PAI-1 mRNA (Heaton, J. H., Tillmann-Bogush, M. Leff, N. S., and Gelehrter, T. D. (1998) J. Biol Chem. 273, 14261-14268). In the present study, ultraviolet cross-linking analyses of this region demonstrate HTC cell cytosolic mRNA-binding proteins ranging from 38 to 76 kDa, with a major complex migrating at similar to 50 kDa. RNA electrophoretic mobility shift analyses demonstrate high molecular weight multiprotein complexes that specifically interact with the 134-nt cyclic nucleotide-responsive sequence. The 50, 61, and 76 kDa and multiprotein complexes form with an A-rich sequence at the 3' end of the cyclic nucleotide-responsive region; a 38-kDa complex forms with a U-rich region at the 5' end of the 134 nt sequence. Mutation of the A-rich region prevents both the binding of the 50-, 61-, and 76-bDa proteins and formation of the multiprotein complexes, as well as cyclic nucleotide-regulated degradation of chimeric globin:PAI-1 transcripts in HTC cells. These data suggest that the proteins identified in this report play an important role in the cyclic nucleotide regulation of PAI-1 mRNA stability.	Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gelehrter, TD (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, M4708 MSII-0618,1301 Catherine St, Ann Arbor, MI 48109 USA.	tdgum@umich.edu			NATIONAL CANCER INSTITUTE [R37CA022729, R01CA022729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009437] Funding Source: NIH RePORTER; NCI NIH HHS [CA22729] Funding Source: Medline; NIDDK NIH HHS [DK09437] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDREASEN PA, 1990, MOL CELL ENDOCRINOL, V68, P1, DOI 10.1016/0303-7207(90)90164-4; Ausubel FM, 1988, MOL REPROD DEV; BLOK LJ, 1992, ENDOCRINOLOGY, V131, P1343, DOI 10.1210/en.131.3.1343; BRENTANO ST, 1992, P NATL ACAD SCI USA, V89, P4099, DOI 10.1073/pnas.89.9.4099; BREWER G, 1990, METHOD ENZYMOL, V181, P202; CHEN M, 1993, J BIOL CHEM, V268, P24138; Chung SM, 1997, J BIOL CHEM, V272, P6593, DOI 10.1074/jbc.272.10.6593; Danner S, 1998, J BIOL CHEM, V273, P3223, DOI 10.1074/jbc.273.6.3223; FOSSOM LH, 1992, MOL PHARMACOL, V42, P898; FUH VL, 1989, MOL ENDOCRINOL, V3, P1148, DOI 10.1210/mend-3-7-1148; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; HEATON JH, 1990, MOL ENDOCRINOL, V4, P171, DOI 10.1210/mend-4-1-171; HEATON JH, 1989, MOL ENDOCRINOL, V3, P349, DOI 10.1210/mend-3-2-349; HEATON JH, 1992, MOL ENDOCRINOL, V6, P53, DOI 10.1210/me.6.1.53; HEATON JH, 1989, MOL ENDOCRINOL, V3, P185, DOI 10.1210/mend-3-1-185; Heaton JH, 1998, J BIOL CHEM, V273, P14261, DOI 10.1074/jbc.273.23.14261; HOD Y, 1988, J BIOL CHEM, V263, P7747; HUANG DL, 1995, MOL ENDOCRINOL, V9, P994, DOI 10.1210/me.9.8.994; Irwin N, 1997, NUCLEIC ACIDS RES, V25, P1281, DOI 10.1093/nar/25.6.1281; Jain RG, 1997, MOL CELL BIOL, V17, P954, DOI 10.1128/MCB.17.2.954; KAESTNER KH, 1991, P NATL ACAD SCI USA, V88, P1933, DOI 10.1073/pnas.88.5.1933; Kash JC, 1998, J BIOL CHEM, V273, P10658, DOI 10.1074/jbc.273.17.10658; KNUTSEN HK, 1991, ENDOCRINOLOGY, V129, P2496, DOI 10.1210/endo-129-5-2496; KRUITHOF EKO, 1988, ENZYME, V40, P113, DOI 10.1159/000469153; Laterza OF, 1997, J BIOL CHEM, V272, P22481, DOI 10.1074/jbc.272.36.22481; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; NACHALIEL N, 1993, J BIOL CHEM, V268, P24203; NODA M, 1988, J BIOL CHEM, V263, P18574; Pande A, 1996, J BIOL CHEM, V271, P8493, DOI 10.1074/jbc.271.14.8493; Ross J, 1996, TRENDS GENET, V12, P171, DOI 10.1016/0168-9525(96)10016-0; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; SAKAUE M, 1991, J BIOL CHEM, V266, P5743; SMITH JD, 1988, EMBO J, V7, P3711, DOI 10.1002/j.1460-2075.1988.tb03254.x; STEPHENS JM, 1992, J BIOL CHEM, V267, P8336; STOCKERT RJ, 1993, J BIOL CHEM, V268, P19540; THEMMEN APN, 1991, MOL CELL ENDOCRINOL, V78, pR7, DOI 10.1016/0303-7207(91)90130-K; THOLANIKUNNEL BG, 1995, J BIOL CHEM, V270, P12787, DOI 10.1074/jbc.270.21.12787; Tholanikunnel BG, 1997, J BIOL CHEM, V272, P11471; VANMEIJER M, 1995, FIBRINOLYSIS, V9, P263, DOI 10.1016/S0268-9499(95)80015-8; VASSALLI JD, 1994, NATURE, V370, P14, DOI 10.1038/370014a0; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Wang XF, 1997, MOL PHARMACOL, V52, P781, DOI 10.1124/mol.52.5.781; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24000; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24007; ZEHEB R, 1988, GENE, V73, P459, DOI 10.1016/0378-1119(88)90510-0	45	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1172	1179		10.1074/jbc.274.2.1172	http://dx.doi.org/10.1074/jbc.274.2.1172			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873066	hybrid			2022-12-27	WOS:000077968500081
J	Fraser, CS; Pain, VM; Morley, SJ				Fraser, CS; Pain, VM; Morley, SJ			The association of initiation factor 4F with Poly(A)-binding protein is enhanced in serum-stimulated Xenopus kidney cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-DEPENDENT TRANSLATION; MESSENGER-RNA TRANSLATION; FACTOR EIF 4G; FACTOR 4E; PHAS-I; BINDING-PROTEIN; KINASE-C; PHOSPHORYLATION SITES; REPRESSES TRANSLATION; 4E-BINDING PROTEINS	Serum stimulation of cultured Xenopus kidney cells results in enhanced phosphorylation of the translational initiation factor (eIF) 4E and promotes a 2.8-fold increase in the binding of the adapter protein eIF4G to eIF4E, to form the functional initiation factor complex eIF4F. Here we demonstrate the serum-stimulated coisolation of the poly(A)-binding protein (PABP) with the eIF4F complex. This apparent interaction of PABP with eIF4F suggests that a mechanism shown to be important in the control of translation in the yeast Saccharomyces cerevisiae also operates in vertebrate cells. We also present evidence that the signaling pathways modulating eIF4E phosphorylation and function in Xenopus kidney cells differ from those in several mammalian cell types studied previously. Experiments with the immunosuppressant rapamycin suggest that the mTOR signaling pathway is involved in serum-promoted eIF4E phosphorylation and association with eIF4G. Moreover, we could find little evidence for regulation of eIF4E function via interaction with the specific binding proteins 4E-BP1 or 4E-BP2 in these cells. Although rapamycin abrogated serum-enhanced rates of protein synthesis and the interaction of eIF4G with eIF4E, it did not prevent the increase in association of eIF4G with PABP. This suggests that serum stimulates the interaction between eIF4G and PABP by a distinct mechanism that is independent of both the mTOR pathway and the enhanced association of eIF4G with eIF4E.	Univ Sussex, Sch Biol Sci, Biochem Lab, Brighton BN1 9QG, E Sussex, England	University of Sussex	Morley, SJ (corresponding author), Univ Sussex, Sch Biol Sci, Biochem Lab, Brighton BN1 9QG, E Sussex, England.	s.j.morley@sussex.ac.uk	Fraser, Christopher/H-9186-2013					Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; BU X, 1993, J BIOL CHEM, V268, P4975; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Diggle TA, 1996, BIOCHEM J, V316, P447, DOI 10.1042/bj3160447; Fadden P, 1997, J BIOL CHEM, V272, P10240; Feigenblum D, 1996, MOL CELL BIOL, V16, P5450; Flynn A, 1996, CANCER SURV, V27, P293; Flynn A, 1996, FEBS LETT, V389, P162, DOI 10.1016/0014-5793(96)00564-9; Flynn A, 1996, EUR J BIOCHEM, V236, P40, DOI 10.1111/j.1432-1033.1996.00040.x; GALLIE DR, 1994, J BIOL CHEM, V269, P7174; GALLIE DR, 1994, J BIOL CHEM, V269, P17166; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gallie DR, 1996, PLANT MOL BIOL, V32, P145, DOI 10.1007/BF00039381; Gradi A, 1998, MOL CELL BIOL, V18, P334, DOI 10.1128/MCB.18.1.334; GRAVES LM, 1995, P NATL ACAD SCI USA, V92, P7222, DOI 10.1073/pnas.92.16.7222; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Jacobson A., 1996, TRANSLATIONAL CONTRO, P451; JEFFERIES HBJ, 1994, J BIOL CHEM, V269, P4367; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1998, AM J PHYSIOL-CELL PH, V274, pC221, DOI 10.1152/ajpcell.1998.274.1.C221; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; Le H, 1997, EUR J BIOCHEM, V243, P350, DOI 10.1111/j.1432-1033.1997.0350a.x; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lin TA, 1996, J BIOL CHEM, V271, P30199, DOI 10.1074/jbc.271.47.30199; LIN TA, 1995, J BIOL CHEM, V270, P18531, DOI 10.1074/jbc.270.31.18531; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; LORENI F, 1992, EUR J BIOCHEM, V205, P1027, DOI 10.1111/j.1432-1033.1992.tb16870.x; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mendez R, 1996, MOL CELL BIOL, V16, P2857; Merrick WC., 1996, TRANSLATION CONTROL, P31; MINICH WB, 1994, P NATL ACAD SCI USA, V91, P7668, DOI 10.1073/pnas.91.16.7668; MORLEY SJ, 1991, J BIOL CHEM, V266, P4669; MORLEY SJ, 1995, J CELL SCI, V108, P1751; MORLEY SJ, 1990, J BIOL CHEM, V265, P10611; Morley SJ, 1997, RNA, V3, P1085; Morley SJ, 1997, J BIOL CHEM, V272, P17887, DOI 10.1074/jbc.272.28.17887; Morley SJ, 1997, FEBS LETT, V418, P327, DOI 10.1016/S0014-5793(97)01405-1; MORLEY SJ, 1995, BIOCHEM J, V312, P627, DOI 10.1042/bj3120627; MORLEY SJ, 1993, EUR J BIOCHEM, V218, P39, DOI 10.1111/j.1432-1033.1993.tb18349.x; MORLEY SJ, 1996, PROTEIN PHOSPHORYLAT, P197; Ohlmann T, 1997, EMBO J, V16, P844, DOI 10.1093/emboj/16.4.844; Ohlmann T, 1996, EMBO J, V15, P1371, DOI 10.1002/j.1460-2075.1996.tb00479.x; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Rau M, 1996, J BIOL CHEM, V271, P8983, DOI 10.1074/jbc.271.15.8983; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; ROWLANDS AG, 1988, EUR J BIOCHEM, V175, P93, DOI 10.1111/j.1432-1033.1988.tb14170.x; Sachs AB, 1997, TRENDS BIOCHEM SCI, V22, P189, DOI 10.1016/S0968-0004(97)01051-7; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; Tarun SZ, 1997, MOL CELL BIOL, V17, P6876, DOI 10.1128/MCB.17.12.6876; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; TERADA N, 1995, J IMMUNOL, V155, P3418; vonManteuffel SR, 1996, P NATL ACAD SCI USA, V93, P4076, DOI 10.1073/pnas.93.9.4076; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; WAKIYAMA M, 1995, FEBS LETT, V360, P191, DOI 10.1016/0014-5793(95)00081-J; WELSH GI, 1993, FEBS LETT, V316, P241, DOI 10.1016/0014-5793(93)81300-O; Whalen SG, 1996, J BIOL CHEM, V271, P11831, DOI 10.1074/jbc.271.20.11831; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3	76	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					196	204		10.1074/jbc.274.1.196	http://dx.doi.org/10.1074/jbc.274.1.196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867830	hybrid			2022-12-27	WOS:000077900200030
J	Hitoshi, S; Kusunoki, S; Kanazawa, I; Tsuji, S				Hitoshi, S; Kusunoki, S; Kanazawa, I; Tsuji, S			Dorsal root ganglia neuron specific promoter activity of the rabbit beta-galactoside alpha 1,2-fucosyltransferase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUCOSYL GM1 ANTIBODY; ALPHA-2,6-SIALYLTRANSFERASE GENE; MOLECULAR-CLONING; SPINAL-CORD; EXPRESSION; CELLS; ORGANIZATION; PROTEIN; ELEMENT; ALPHA-1,2-FUCOSYL-TRANSFERASE	The rabbit H-blood type alpha 1,2-flucosyltransferase (RFT-I), gene and its biosynthetic products, H antigens (Fuc alpha 1,2Gal beta), are abundantly expressed in a subset of dorsal root ganglia (DRG) neurons. To investigate the regulatory mechanisms for the RFT-I gene expression, we determined the genomic structure and promoter activity of this gene. PCR amplification of the 5' cDNA end analysis revealed two transcriptional start sites, 498 and 82 nucleotides upstream of the translational initiation codon, the latter site yielding a major 3.1-kb transcript specifically expressed in DRG, as revealed by Northern blotting. Promoter analysis of the 5'-flanking region of the RFT-I gene using a luciferase gene reporter system demonstrated strong promoter activity in PC12 cells, which express the rat H-type alpha 1,2-fucosyltransferase gene, and Neuro2a mouse neuroblastoma cells. Deletion analysis revealed the 704-base pair minimal promoter region flanking the translational initiation codon, for which two distinct promoter activities were detected and differentially used in PC12 and Neuro2a cells, The minimal promoter region contained a GC-rich domain (GC content 80%), in which a Spl binding sequence and a GSG-like nerve growth factor-responsive element were found, but lacked TATA- and CAAT-boxes. Promoter analysis with a primary culture of DRG neurons demonstrated that the minimal promoter region of the RFT-I gene was sufficient for the expression of a reporter gene in DRG neurons. We conclude that the TATA-less GC-rich minimal promoter region of the RFT-I gene controls DRG small neuron-specific expression of the RFT-I gene.	RIKEN, Inst Phys & Chem Res, Frontier Res Program, Wako, Saitama 3510198, Japan; Univ Tokyo, Fac Med, Grad Sch, Div Neurosci,Dept Neurol,Bunkyo Ku, Tokyo 113, Japan	RIKEN; University of Tokyo	Tsuji, S (corresponding author), RIKEN, Inst Phys & Chem Res, Frontier Res Program, Wako, Saitama 3510198, Japan.							AASHEIM HC, 1993, EUR J BIOCHEM, V213, P467, DOI 10.1111/j.1432-1033.1993.tb17783.x; CAMERON HS, 1995, J BIOL CHEM, V270, P20112, DOI 10.1074/jbc.270.34.20112; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; FENDERSON BA, 1986, DEV BIOL, V114, P12, DOI 10.1016/0012-1606(86)90379-9; FROTHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998; Furukawa K, 1996, J BIOL CHEM, V271, P20836, DOI 10.1074/jbc.271.34.20836; GILLOYZAGA P, 1989, CELL TISSUE RES, V257, P17; HARDUINLEPERS A, 1993, J BIOL CHEM, V268, P14348; Hitoshi S, 1998, J NEUROCHEM, V70, P2174; Hitoshi S, 1996, J BIOL CHEM, V271, P16975, DOI 10.1074/jbc.271.28.16975; HITOSHI S, 1995, J BIOL CHEM, V270, P8844, DOI 10.1074/jbc.270.15.8844; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Koda Y, 1997, J BIOL CHEM, V272, P7501, DOI 10.1074/jbc.272.11.7501; KUSUNOKI S, 1992, NEUROSCI RES, V15, P74, DOI 10.1016/0168-0102(92)90019-9; KUSUNOKI S, 1991, NEUROSCI LETT, V126, P159, DOI 10.1016/0304-3940(91)90543-3; KUSUNOKI S, 1989, BRAIN RES, V494, P391, DOI 10.1016/0006-8993(89)90611-2; KUSUNOKI S, 1994, BBA-LIPID LIPID MET, V1214, P27, DOI 10.1016/0005-2760(94)90005-1; MASUDA ES, 1993, MOL CELL BIOL, V13, P7399, DOI 10.1128/MCB.13.12.7399; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MOLLICONE R, 1986, J NEUROIMMUNOL, V10, P255, DOI 10.1016/0165-5728(86)90106-2; MOLLICONE R, 1985, DEV BRAIN RES, V17, P275, DOI 10.1016/0165-3806(85)90154-3; MORI K, 1987, NEUROSCI RES, V4, P291; MORI K, 1986, BRAIN RES, V365, P404, DOI 10.1016/0006-8993(86)91659-8; MU XJ, 1993, J NEUROSCI, V13, P4029; Prieto PA, 1997, J BIOL CHEM, V272, P2089; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; SAITO H, 1995, EUR J BIOCHEM, V233, P18, DOI 10.1111/j.1432-1033.1995.018_1.x; SARNESTO A, 1992, J BIOL CHEM, V267, P2737; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; SVENNERHOLM L, 1964, J LIPID RES, V5, P145; SZULMAN AE, 1962, J EXP MED, V115, P977, DOI 10.1084/jem.115.5.977; SZULMAN AE, 1964, J EXP MED, V119, P503, DOI 10.1084/jem.119.4.503; WANG XC, 1993, J BIOL CHEM, V268, P4355; Watkins W M, 1980, Adv Hum Genet, V10, P1; WEN DX, 1992, J BIOL CHEM, V267, P2512	38	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					389	396		10.1074/jbc.274.1.389	http://dx.doi.org/10.1074/jbc.274.1.389			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867855	hybrid			2022-12-27	WOS:000077900200055
J	Vaillier, J; Arselin, G; Graves, PV; Camougrand, N; Velours, J				Vaillier, J; Arselin, G; Graves, PV; Camougrand, N; Velours, J			Isolation of supernumerary yeast ATP synthase subunits e and i - Characterization of subunit i and disruption of its structural gene ATP18	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; SACCHAROMYCES-CEREVISIAE; ADENOSINE-TRIPHOSPHATASE; F1-ATPASE; PROTEIN; F1F0-ATPASE; SEQUENCE; LACKING; COMPLEX; TRANSLOCATION	Two subunits of the yeast ATP synthase have been isolated. Subunit e was found loosely associated to the complex. Triton X-100 at a 1% concentration removed this subunit from the ATP synthase, The N-terminal sequencing of subunit i has been performed. The data are in agreement with the sequence of the predicted product of a DNA fragment of Saccharomyces cerevisiae chromosome XIII, The ATP18 gene encodes subunit i, which is 59 amino acids long and corresponds to a calculated mass of 6687 Da, Its pi is 9.73, It is an amphiphilic protein having a hydrophobic N-terminal part and a hydrophilic C-terminal part. It is not apparently related to any subunit described in other ATP synthases, The null mutant showed low growth on nonfermentable medium. Mutant mitochondria display a low ADP/O ratio and a decrease with time in proton pumping after ATP addition. Subunit i is associated with the complex; it is not a structural component of the enzyme but rather is involved in the oxidative phosphorylations. Similar amounts of ATP synthase were measured for wild-type and null mutant mitochondria. Because a fold less specific ATPase activity was measured for the null mutant than for the wild-type mitochondria, we make the hypothesis that the observed decrease in the turnover of the mutant enzyme could be linked to a proton translocation defect through F-0.	Univ Victor Segalen, Inst Biochim & Genet Cellulaires, CNRS, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Velours, J (corresponding author), Univ Victor Segalen, Inst Biochim & Genet Cellulaires, CNRS, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	jean.veloura@ibgc.u-bordeaux2.fr						ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AKASHI A, 1988, J BIOCHEM, V104, P526, DOI 10.1093/oxfordjournals.jbchem.a122504; ANSORGE W, 1983, ELECTROPHORESIS, V82, P235; Arnold I, 1997, FEBS LETT, V411, P195, DOI 10.1016/S0014-5793(97)00691-1; ARSELIN G, 1991, J BIOL CHEM, V266, P723; Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284; Belogrudov GI, 1996, J BIOL CHEM, V271, P20340, DOI 10.1074/jbc.271.34.20340; Bowman S, 1997, NATURE, V387, P90, DOI 10.1038/387s090; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; COLLINSON IR, 1994, BIOCHEMISTRY-US, V33, P7971, DOI 10.1021/bi00191a026; DECHATEAUBODEAU GA, 1976, BIOCHIMIE PARIS, V58, P601; EBNER E, 1973, J BIOL CHEM, V248, P5379; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Guerin B, 1979, Methods Enzymol, V55, P149; ICHIKAWA N, 1990, J BIOL CHEM, V265, P6274; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANG B, 1977, ANAL BIOCHEM, V77, P110, DOI 10.1016/0003-2697(77)90295-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; NORAIS N, 1991, J BIOL CHEM, V266, P16541; PAUL MF, 1992, EUR J BIOCHEM, V205, P163, DOI 10.1111/j.1432-1033.1992.tb16764.x; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; Pedersen PL, 1996, J BIOENERG BIOMEMBR, V28, P389, DOI 10.1007/BF02113979; PRESCOTT M, 1997, YEAST, V13, P82; RAZAKAJOLLY D, 1994, BIOCHEMISTRY-US, V33, P9684, DOI 10.1021/bi00198a038; RIGOULET M, 1979, FEBS LETT, V102, P18, DOI 10.1016/0014-5793(79)80919-9; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sabbert D, 1997, P NATL ACAD SCI USA, V94, P4401, DOI 10.1073/pnas.94.9.4401; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHWERZMANN K, 1986, ARCH BIOCHEM BIOPHYS, V250, P1, DOI 10.1016/0003-9861(86)90695-8; SOMLO M, 1968, EUR J BIOCHEM, V5, P276, DOI 10.1111/j.1432-1033.1968.tb00368.x; Spannagel C, 1998, BIOCHEMISTRY-US, V37, P615, DOI 10.1021/bi9714971; Spannagel C, 1997, EUR J BIOCHEM, V247, P1111, DOI 10.1111/j.1432-1033.1997.01111.x; TODD RD, 1980, J BIOL CHEM, V255, P5461; Tokatlidis K, 1996, NATURE, V384, P585, DOI 10.1038/384585a0; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; UH M, 1990, J BIOL CHEM, V265, P19047; WALKER JE, 1991, BIOCHEMISTRY-US, V30, P5369, DOI 10.1021/bi00236a007; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; YOSHIDA Y, 1990, EUR J BIOCHEM, V192, P49, DOI 10.1111/j.1432-1033.1990.tb19193.x; Zhou YT, 1997, P NATL ACAD SCI USA, V94, P10583, DOI 10.1073/pnas.94.20.10583	44	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					543	548		10.1074/jbc.274.1.543	http://dx.doi.org/10.1074/jbc.274.1.543			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867878	hybrid			2022-12-27	WOS:000077900200078
J	Yoshikawa, F; Iwasaki, H; Michikawa, T; Furuichi, T; Mikoshiba, K				Yoshikawa, F; Iwasaki, H; Michikawa, T; Furuichi, T; Mikoshiba, K			Trypsinized cerebellar inositol 1,4,5-trisphosphate receptor - Structural and functional coupling of cleaved ligand binding and channel domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; RECONSTITUTED LIPID VESICLES; CA2+ RELEASE CHANNEL; CENTRAL-NERVOUS-SYSTEM; RYANODINE RECEPTOR; CALCIUM-RELEASE; TRISPHOSPHATE RECEPTOR; MOUSE CEREBELLUM; PURKINJE-CELLS; COMPLEX-FORMATION	The type 1 inositol 1,4,5-trisphosphate receptor (IP(3)R1) is a tetrameric intracellular inositol 1,4,5-trisphosphate (IP3)-gated Ca2+ release channel (calculated molecular mass = similar to 313 kDa/subunit). We studied structural and functional coupling in this protein complex by limited (controlled) trypsinization of membrane fractions from mouse cerebellum, the predominant site for IP(3)R1. Mouse IP(3)R1 (mIP(3)R1) was trypsinized into five major fragments (I-V) that were positioned on the entire mIP(3)R1 sequence by immune-probing with 11 site-specific antibodies and by micro-sequencing of the N termini. Four fragments I-TV were derived from the N-terminal cytoplasmic region where the IP3-binding region extended over two fragments I (40/37 kDa) and II (64 kDa). The C-terminal fragment V (91 kDa) included the membrane-spanning channel region. All five fragments were pelleted by centrifugation as were membrane proteins. Furthermore, after solubilizing with 1% Triton X-100, all were co-immunoprecipitated with the C terminus-specific monoclonal antibody that recognized only the fragment V. These data suggested that the native mIP(3)R1-channel is an assembly of four subunits, each of which is constituted by non-covalent interactions of five major, well folded structural components I-V that are not susceptible to attack by mild trypsinolysis. Ca2+ release experiments further revealed that even the completely fragmented mIP(3)R1 retained significant IP3-induced Ca2+ release activity. These data suggest that structural coupling among five split components conducts functional coupling for IP3-induced Ca2+ release, despite the loss of peptide linkages. We propose structural-functional coupling in the mIP(3)R1, that is neighboring coupling between components I and II for IP3 binding and long-distant coupling between the IP3 binding region and the channel region (component V) beyond trypsinized gaps for ligand gating.	Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 1088639, Japan; RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan	University of Tokyo; RIKEN	Furuichi, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tfuruich@ims.u-tokyo.ac.jp	Mikoshiba, Katsuhiko/N-7943-2015; Furuichi, Teiichi/B-5086-2014	Furuichi, Teiichi/0000-0002-9676-1888				BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bhat MB, 1997, BIOPHYS J, V73, P1329, DOI 10.1016/S0006-3495(97)78166-9; BRANDT NR, 1992, J MEMBRANE BIOL, V127, P35; CALLAWAY C, 1994, J BIOL CHEM, V269, P15876; Cameron AM, 1997, J BIOL CHEM, V272, P27582, DOI 10.1074/jbc.272.44.27582; CHEN SRW, 1993, J BIOL CHEM, V268, P13414; CHEN SRW, 1993, J BIOL CHEM, V268, P22642; CHU A, 1988, BIOCHEMISTRY-US, V27, P2827, DOI 10.1021/bi00408a025; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; FURUICHI T, 1995, J NEUROCHEM, V64, P953, DOI 10.1046/j.1471-4159.1995.64030953.x; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; GILCHRIST JSC, 1992, J BIOL CHEM, V267, P20857; GYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HIROTA J, 1995, J BIOL CHEM, V270, P19046, DOI 10.1074/jbc.270.32.19046; Joseph SK, 1997, J BIOL CHEM, V272, P1579, DOI 10.1074/jbc.272.3.1579; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; Katayama E, 1996, EMBO J, V15, P4844, DOI 10.1002/j.1460-2075.1996.tb00865.x; KOMALAVILAS P, 1994, J BIOL CHEM, V269, P8701; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; MAEDA N, 1991, J BIOL CHEM, V266, P1109; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; MAEDA N, 1989, DEV BIOL, V133, P67, DOI 10.1016/0012-1606(89)90297-2; MAGNUSSON A, 1993, FEBS LETT, V323, P229, DOI 10.1016/0014-5793(93)81345-Z; Manjunatha B, 1997, J GEN PHYSIOL, V110, P749, DOI 10.1085/jgp.110.6.749; MARANTO AR, 1994, J BIOL CHEM, V269, P1222; MARKS AR, 1990, J BIOL CHEM, V265, P13143; MCPHERSON PS, 1993, J BIOL CHEM, V268, P13765; MEISSNER G, 1989, J BIOL CHEM, V264, P1715; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; NAKADE S, 1994, J BIOL CHEM, V269, P6735; NAKADE S, 1991, BIOCHEM J, V277, P125, DOI 10.1042/bj2770125; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; NUCIFORA FC, 1995, MOL BRAIN RES, V32, P291, DOI 10.1016/0169-328X(95)00089-B; OHMI S, 1994, CELL BIOTECHNOLOGY P; PRICE NC, 1989, PROTEOLYTIC ENZYMES, P163; RARDON DP, 1990, CIRC RES, V67, P84, DOI 10.1161/01.RES.67.1.84; Sayers LG, 1997, BIOCHEM J, V323, P273, DOI 10.1042/bj3230273; SHOSHANBARMATZ V, 1988, J BIOL CHEM, V263, P16772; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Taniuchi H, 1986, Methods Enzymol, V131, P185; WORLEY PF, 1987, NATURE, V325, P159, DOI 10.1038/325159a0; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083; YAMADA N, 1994, BIOCHEM J, V302, P781, DOI 10.1042/bj3020781; YAMAMOTOHINO M, 1995, NEUROREPORT, V6, P273, DOI 10.1097/00001756-199501000-00012; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277	57	89	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					316	327		10.1074/jbc.274.1.316	http://dx.doi.org/10.1074/jbc.274.1.316			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867846	hybrid			2022-12-27	WOS:000077900200046
J	Dumoulin, A; Padovan, JC; Manning, LR; Popowicz, A; Winslow, RM; Chait, BT; Manning, JM				Dumoulin, A; Padovan, JC; Manning, LR; Popowicz, A; Winslow, RM; Chait, BT; Manning, JM			The N-terminal sequence affects distant helix interactions in hemoglobin - Implications for mutant proteins from studies on recombinant hemoglobin felix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYHEMOGLOBIN; COOPERATIVITY; RESOLUTION; TETRAMER	The N-terminal 18-amino acid sequence of the beta-chain of hemoglobin, as far as the end of the A helix, has been replaced by the corresponding sequence of the gamma-chain of fetal hemoglobin with the remaining sequence of the beta-chain retained (helices B through H), The gamma-beta-chain had the correct mass, and its entire sequence was established by mass spectrometric analysis of its tryptic peptides; the alpha-chain also had the correct mass. This recombinant hemoglobin (named Hb Felix) retains cooperativity and has an oxygen affinity like that of HbA both in the presence and absence of the allosteric regulators, 2,3-diphosphoglycerate or chloride but differs from HbF in its 2,3-diphosphoglycerate response. However, Hb Felix has some features that resemble fetal hemoglobin, i.e. its significantly decreased tetramer-dimer dissociation and its circular dichroism spectrum, which measure the strength of the tetramer-dimer interface in the oxy conformation and its rearrangement to the deoxy conformation, respectively. Even though Hb Felix contains the HbA amino acids at its tetramer-dimer interface, which is located at a distance from the substitution sites, its interface properties resemble those of HbF, Therefore, the N-terminal sequence and not just those amino acids directly involved at the subunit interface contacts with alpha-chains must have a strong influence on this region of the molecule. The results reinforce the concept of fluid long range relationships among various parts of the hemoglobin tetramer (Dumoulin, A. Manning, L. R., Jenkins, W. T., Winslow, R. M., and Manning, J. M. (1997) J, Biol. Chem. 272, 31326-31332) and demonstrate the importance of the N-terminal sequence, especially in some mutant hemoglobins, in influencing its overall structure by affecting the relationship between helices.	Northeastern Univ, Dept Biol, Boston, MA 02115 USA; Rockefeller Univ, New York, NY 10021 USA; Univ Calif San Diego, San Diego, CA 92161 USA	Northeastern University; Rockefeller University; University of California System; University of California San Diego	Manning, JM (corresponding author), Northeastern Univ, Dept Biol, Mugar Life Sci Bldg,Rm 414,360 Huntington Ave, Boston, MA 02115 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P60HL015157, R37HL018819, R01HL018819, P01HL048018] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-48018, HL-18819, HL-15157] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Beavis RC, 1996, METHOD ENZYMOL, V270, P519; BUNN HF, 1970, J CLIN INVEST, V49, P1088, DOI 10.1172/JCI106324; DELLANO JJM, 1994, PROTEIN SCI, V3, P1206, DOI 10.1002/pro.5560030806; DESANCTIS G, 1994, P NATL ACAD SCI USA, V91, P11507, DOI 10.1073/pnas.91.24.11507; Dumoulin A, 1997, J BIOL CHEM, V272, P31326, DOI 10.1074/jbc.272.50.31326; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FRIER JA, 1977, J MOL BIOL, V112, P97, DOI 10.1016/S0022-2836(77)80158-7; FRONTICELLI C, 1994, BIOPHYS CHEM, V51, P53, DOI 10.1016/0301-4622(94)00028-X; Harrington DJ, 1997, J MOL BIOL, V272, P398, DOI 10.1006/jmbi.1997.1253; Hirsch RE, 1996, J BIOL CHEM, V271, P372, DOI 10.1074/jbc.271.1.372; HO C, 1992, ADV PROTEIN CHEM, V43, P153, DOI 10.1016/S0065-3233(08)60555-0; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; Huisman T. H. J., 1996, SYLLABUS HUMAN HEMOG; Lesecq S, 1996, J BIOL CHEM, V271, P17211, DOI 10.1074/jbc.271.29.17211; Manning JM, 1998, J BIOL CHEM, V273, P19359, DOI 10.1074/jbc.273.31.19359; Manning LR, 1996, PROTEIN SCI, V5, P775; MUKERJI I, 1994, BIOCHEMISTRY-US, V33, P13132, DOI 10.1021/bi00248a024; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; PERUTZ MF, 1974, BIOCHEMISTRY-US, V13, P2174, DOI 10.1021/bi00707a027; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; TURNER GJ, 1992, PROTEINS, V14, P333, DOI 10.1002/prot.340140303; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; WIND M, 1976, BIOCHEMISTRY-US, V15, P5161, DOI 10.1021/bi00668a033	25	19	19	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35032	35038		10.1074/jbc.273.52.35032	http://dx.doi.org/10.1074/jbc.273.52.35032			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857036	hybrid, Green Published			2022-12-27	WOS:000077719700054
J	Wargnier, A; Lafaurie, C; Legros-Maida, S; Bourge, JF; Sigaux, F; Sasportes, M; Paul, P				Wargnier, A; Lafaurie, C; Legros-Maida, S; Bourge, JF; Sigaux, F; Sasportes, M; Paul, P			Down-regulation of human granzyme B expression by glucocorticoids - Dexamethasone inhibits binding to the Ikaros and AP-1 regulatory elements of the granzyme B promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL GROWTH-FACTOR; ACTIVATED T-CELLS; VERSUS-HOST DISEASE; TRANSCRIPTION FACTOR; HUMAN-LYMPHOCYTES; GENE-EXPRESSION; ACUTE REJECTION; DNA-BINDING; HEART-TRANSPLANTATION	The serine protease granzyme B is an essential component of the granule exocytosis pathway, a major apoptotic mechanism used by cytotoxic T lymphocytes and natural killer cells to induce target cell apoptosis, Granzyme B gene transcription is induced in activated lymphocytes upon antigenic stimulation, and several regulatory regions including CBF, AP-1, and Ikaros binding sites have been shown to be essential in the control of granzyme B promoter activation. Dexamethasone, a glucocorticoid that is widely used as an immunomodulatory and anti-inflammatory agent, inhibits granzyme B mRNA transcript in phytohemagglutinin-activated peripheral blood mononuclear cells. Transfection of a reporter construct containing the -148 to +60 region of the human granzyme B promoter demonstrated that this region was the target for dexamethasone repression. Mutation of Ikaros or AP-1 binding sites in the context of the granzyme B promoter demonstrated that both sites participate in dexamethasone-mediated inhibition of the granzyme B promoter activity. Electromobility shift assay revealed that dexamethasone abolished the binding of nuclear transcription factors to the Ikaros binding site and reduced AP-1 binding activity. These results indicate that dexamethasone is able to abrogate the transcriptional activity of the human granzyme B gene promoter by inhibiting the binding of nuclear factors at the AP-1 and Ikaros sites.	Hop St Louis, INSERM, CEA, U462,Inst Hematol, F-75010 Paris, France; Hop St Louis, Serv Rech Hemato Immunol, CEA, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; UDICE-French Research Universities; Universite Paris Cite	Wargnier, A (corresponding author), Hop St Louis, INSERM, CEA, U462,Inst Hematol, 1 Ave Claude Vellefaux, F-75010 Paris, France.	wargnier@chu-stlouis.fr	PAUL, Pascale/AAI-1772-2020; PAUL, Pascale/R-1484-2016	PAUL, Pascale/0000-0002-6734-4479; PAUL, Pascale/0000-0002-6734-4479				ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ARYA SK, 1984, J IMMUNOL, V133, P273; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Babichuk CK, 1996, J BIOL CHEM, V271, P16485, DOI 10.1074/jbc.271.28.16485; Babichuk CK, 1997, J BIOL CHEM, V272, P18564, DOI 10.1074/jbc.272.30.18564; Baus E, 1996, J IMMUNOL, V156, P4555; BEUTLER B, 1986, SCIENCE, V232, P977, DOI 10.1126/science.3754653; BOUMPAS DT, 1991, CLIN EXP RHEUMATOL, V9, P413; CAPUTO A, 1988, J BIOL CHEM, V263, P6363; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEMENT MV, 1991, INT IMMUNOL, V3, P1175, DOI 10.1093/intimm/3.11.1175; CLEMENT MV, 1990, RES IMMUNOL, V141, P477, DOI 10.1016/0923-2494(90)90017-S; CLEMENT MV, 1994, TRANSPLANTATION, V57, P322, DOI 10.1097/00007890-199402150-00002; CLEMENT MV, 1990, HUM IMMUNOL, V28, P159, DOI 10.1016/0198-8859(90)90013-F; Darmon AJ, 1996, J BIOL CHEM, V271, P21709, DOI 10.1074/jbc.271.36.21709; DROUIN J, 1993, FRONTIERS MOL BIOL S, P118; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; GILLIS S, 1979, J IMMUNOL, V123, P1624; GILLIS S, 1979, J IMMUNOL, V123, P1632; Graubert TA, 1996, BLOOD, V87, P1232, DOI 10.1182/blood.V87.4.1232.bloodjournal8741232; Graubert TA, 1997, J CLIN INVEST, V100, P904, DOI 10.1172/JCI119606; HADDAD P, 1993, EUR J IMMUNOL, V23, P625, DOI 10.1002/eji.1830230307; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; HEUSEL JW, 1991, J BIOL CHEM, V266, P6152; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Lanza L, 1996, CLIN EXP IMMUNOL, V103, P482; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; LEGROSMAIDA S, 1994, EUR J IMMUNOL, V24, P229, DOI 10.1002/eji.1830240136; LUCIBELLO FC, 1990, EMBO J, V9, P2827, DOI 10.1002/j.1460-2075.1990.tb07471.x; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MINER JN, 1992, GENE DEV, V6, P2491, DOI 10.1101/gad.6.12b.2491; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Molnar A, 1996, J IMMUNOL, V156, P585; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Mori A, 1997, BLOOD, V89, P2891, DOI 10.1182/blood.V89.8.2891; MUKAIDA N, 1992, IMMUNOLOGY, V75, P674; NAKAJIMA H, 1995, J EXP MED, V181, P1037, DOI 10.1084/jem.181.3.1037; NORTHROP JP, 1992, J EXP MED, V175, P1235, DOI 10.1084/jem.175.5.1235; Ohtsuka T, 1996, J BIOL CHEM, V271, P1651, DOI 10.1074/jbc.271.3.1651; PALIOGIANNI F, 1993, J IMMUNOL, V151, P4081; PALIOGIANNI F, 1995, J IMMUNOL, V155, P1809; PALIOGIANNI F, 1993, J CLIN INVEST, V91, P1481, DOI 10.1172/JCI116353; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; Quan LT, 1996, P NATL ACAD SCI USA, V93, P1972, DOI 10.1073/pnas.93.5.1972; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SHI LF, 1992, J EXP MED, V176, P1521, DOI 10.1084/jem.176.6.1521; SHIVER JW, 1992, CELL, V71, P315, DOI 10.1016/0092-8674(92)90359-K; SHULZ M, 1995, EUR J IMMUNOL, V25, P474, DOI 10.1002/eji.1830250225; Strehlau J, 1997, P NATL ACAD SCI USA, V94, P695, DOI 10.1073/pnas.94.2.695; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Talanian RV, 1997, J EXP MED, V186, P1323, DOI 10.1084/jem.186.8.1323; VACCA A, 1992, J EXP MED, V175, P637, DOI 10.1084/jem.175.3.637; WARGNIER A, 1995, P NATL ACAD SCI USA, V92, P6930, DOI 10.1073/pnas.92.15.6930; Wisniewska M, 1997, CELL BIOL INT, V21, P127, DOI 10.1006/cbir.1996.0124; WU CY, 1991, EUR J IMMUNOL, V21, P2645, DOI 10.1002/eji.1830211053; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V	63	49	51	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35326	35331		10.1074/jbc.273.52.35326	http://dx.doi.org/10.1074/jbc.273.52.35326			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857074	hybrid			2022-12-27	WOS:000077719700092
J	Czarny, M; Lavie, Y; Fiucci, G; Liscovitch, M				Czarny, M; Lavie, Y; Fiucci, G; Liscovitch, M			Localization of phospholipase D in detergent-insoluble, caveolin-rich membrane domains - Modulation by caveolin-1 expression and caveolin-1(82-101)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; SACCHAROMYCES-CEREVISIAE; ANCHORED PROTEINS; PLASMA-MEMBRANE; CELL-SURFACE; RAT-BRAIN; IN-VITRO	The activation of cellular phospholipase D (PLD) is implicated in vesicular trafficking and signal transduction, Two mammalian PLD forms, designated PLD1 and PLD2, have been cloned, but their cellular localization and function are not fully understood. Here, we report that in HaCaT human keratinocytes, as well as other cell lines, PLD activity is highly enriched in low density, Triton X-100-insoluble membrane domains that contain the caveolar marker protein caveolin-l. Similar to other PLDs, the PLD activity in these membrane domains is stimulated by phosphatidylinositol 4,5-bisphosphate and is inhibited by neomycin, Immunoblot analysis indicated that caveolin-rich membrane domains do not contain the PLD1 isoform, Stable transfection of mouse PLD2 in Chinese hamster ovary cells greatly increased PLD activity in these domains compared with PLD activity in control Chinese hamster ovary cells transfected with vector alone. PLD activity is enriched in low density Triton-insoluble membrane domains also in U937 promonocytes, even though these cells do not express caveolin-l. In U937 cells, also, PLD1 is largely excluded from low density Triton-insoluble membrane domains. Expression of recombinant caveolin-l in v-Src-transformed NIH-3T3 cells resulted in up-regulation of PLD activity in the caveolin-containing membrane domains. The caveolin scaffolding peptide (caveolin-l(82-101)) modulated the caveolar PLD activity, causing stimulation at concentration of 1-10 mu M and inhibition at concentrations >10 mu M. We conclude that a PLD activity, which is likely to represent PLD2, is enriched in low density Triton-insoluble membrane domains. The effects of caveolin-l expression and of the caveolin scaffolding peptide suggest that in cells that express caveolin-l, PLD may be targeted to caveolae, The possible functions of PLD in the dynamics of caveolae and related domains and in signal transduction processes are discussed.	Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Liscovitch, M (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	lhliscov@weizmann.weizmann.ac.il						BENAV P, 1993, EUR J BIOCHEM, V215, P455, DOI 10.1111/j.1432-1033.1993.tb18054.x; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; Bouillot C, 1996, J BIOL CHEM, V271, P7640, DOI 10.1074/jbc.271.13.7640; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; DANIN M, 1993, LIPID METABOLISM SIG, P14; Ella KM, 1996, BIOCHEM J, V314, P15, DOI 10.1042/bj3140015; Exton JH, 1997, J BIOL CHEM, V272, P15579, DOI 10.1074/jbc.272.25.15579; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Fielding CJ, 1997, J LIPID RES, V38, P1503; FRA AM, 1994, J BIOL CHEM, V269, P30745; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; KASZKIN M, 1991, CANCER RES, V51, P4328; Kodaki T, 1997, J BIOL CHEM, V272, P11408; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; Lavie Y, 1997, FASEB J, V11, pA1346; LEE YH, 1994, J BIOL CHEM, V269, P26842; LISANTI MP, 1995, MOL MEMBR BIOL, V12, P121, DOI 10.3109/09687689509038506; LISANTI MP, 1995, METHOD ENZYMOL, V250, P655; LISCOVITCH M, 1989, J BIOL CHEM, V264, P11762; Liscovitch M, 1996, CHEM PHYS LIPIDS, V80, P37, DOI 10.1016/0009-3084(96)02544-3; LISCOVITCH M, 1991, BIOCHEM J, V279, P319, DOI 10.1042/bj2790319; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; LISCOVITCH M, 1994, SIGNAL ACTIVATED PHO, P31; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Liu YM, 1998, BIOCHEM BIOPH RES CO, V245, P684, DOI 10.1006/bbrc.1998.8329; Mayr JA, 1996, FEBS LETT, V393, P236, DOI 10.1016/0014-5793(96)00893-9; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; Morris AJ, 1996, TRENDS PHARMACOL SCI, V17, P182, DOI 10.1016/0165-6147(96)10016-X; Natarajan V, 1996, CHEM PHYS LIPIDS, V80, P1, DOI 10.1016/0009-3084(96)02540-6; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Park SK, 1997, J BIOL CHEM, V272, P29263, DOI 10.1074/jbc.272.46.29263; Parolini I, 1996, BLOOD, V87, P3783, DOI 10.1182/blood.V87.9.3783.bloodjournal8793783; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; PERTILE P, 1995, J BIOL CHEM, V270, P5130, DOI 10.1074/jbc.270.10.5130; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Ponting CP, 1996, PROTEIN SCI, V5, P914; Ribbes G, 1996, BIOCHEM BIOPH RES CO, V224, P206, DOI 10.1006/bbrc.1996.1008; Rose K, 1995, P NATL ACAD SCI USA, V92, P12151, DOI 10.1073/pnas.92.26.12151; Schmidt M, 1996, EUR J BIOCHEM, V240, P707, DOI 10.1111/j.1432-1033.1996.0707h.x; SEVERS NJ, 1988, J CELL SCI, V90, P341; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398; Waksman M, 1996, J BIOL CHEM, V271, P2361, DOI 10.1074/jbc.271.5.2361; Waksman M, 1997, J BIOL CHEM, V272, P36; WANG XM, 1994, J BIOL CHEM, V269, P20312; Wang XM, 1997, TRENDS PLANT SCI, V2, P261, DOI 10.1016/S1360-1385(97)86348-0; Waugh MG, 1998, J BIOL CHEM, V273, P17115, DOI 10.1074/jbc.273.27.17115; YEO EJ, 1995, J BIOL CHEM, V270, P3980, DOI 10.1074/jbc.270.8.3980; YEO EJ, 1994, J BIOL CHEM, V269, P27823; Yokozeki T, 1996, J NEUROCHEM, V66, P1234	64	100	101	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2717	2724		10.1074/jbc.274.5.2717	http://dx.doi.org/10.1074/jbc.274.5.2717			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915802	hybrid			2022-12-27	WOS:000078319500020
J	Antognoni, F; Del Duca, S; Kuraishi, A; Kawabe, E; Fukuchi-Shimogori, T; Kashiwagi, K; Igarashi, K				Antognoni, F; Del Duca, S; Kuraishi, A; Kawabe, E; Fukuchi-Shimogori, T; Kashiwagi, K; Igarashi, K			Transcriptional inhibition of the operon for the spermidine uptake system by the substrate-binding protein PotD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; PREFERENTIAL UPTAKE SYSTEM; PUTRESCINE TRANSPORT-SYSTEM; POLYAMINE TRANSPORT; ORNITHINE DECARBOXYLASE; GENE; GROWTH; EXPRESSION; IDENTIFICATION; DEHYDROGENASE	Inhibition of spermidine uptake in Escherichia coli, which occurs in the presence of accumulated polyamines, has been studied using the spermidine uptake operon consisting of the potA, -B, -C, and -D genes. Transcription of the potABCD operon was inhibited by PotD, a spermidine-binding protein usually found in the periplasm, and the inhibitory effect of PotD was increased by spermidine, Transcription was not affected by bovine serum albumin, PotA, or PotF, suggesting that the effects of PotD are specific to the PotD protein. In the presence of 8 mM spermidine, a 50% inhibition of transcription was observed with a molar ratio of approximately 1:500 of template DNA:PotD. It was found that PotD bound to regions -258 to -209 nucleotides upstream and +66 to +135 nucleotides downstream of the ATG initiation codon of the potA gene. Binding of PotD to the downstream site was stimulated by spermidine. Overexpression of PotD in Escherichia coli DH5 alpha inhibited the uptake of spermidine, the synthesis of Pot-ABCD mRNA, and expression of a lacZ reporter gene fused downstream of a potA gene containing the PotD binding sites. In cells overexpressing PotD, a large amount of PotD existed as PotD precursor in spheroplasts. Our results indicate that PotD precursor can also inhibit spermidine transport. The amino acid residues in PotD that are involved in its interaction with the potABCD operon were determined using mutated PotD proteins. Thr-35 and Ser-85 of PotD were found to be important for this interaction. These results suggest that transcription of the spermidine transport (potABCD) operon is inhibited in vivo by PotD precursor rather than PotD through its binding to two regions close to the transcriptional initiation site of the operon.	Chiba Univ, Fac Pharmaceut Sci, Inage Ku, Chiba 2638522, Japan	Chiba University	Igarashi, K (corresponding author), Chiba Univ, Fac Pharmaceut Sci, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	iga16077@p.chiba-u.ac.jp	Shimogori, Tomomi/L-2893-2013; Del Duca, Stefano/K-5980-2017	Shimogori, Tomomi/0000-0002-6931-5401; Del Duca, Stefano/0000-0002-5981-520X; Igarashi, Kazuei/0000-0003-3751-3187; ANTOGNONI, FABIANA/0000-0002-5928-9027				AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; HIGGINS CF, 1995, CELL, V82, P693, DOI 10.1016/0092-8674(95)90465-4; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Igarashi K, 1997, J BIOL CHEM, V272, P4058, DOI 10.1074/jbc.272.7.4058; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; KAJITANI M, 1983, NUCLEIC ACIDS RES, V11, P671, DOI 10.1093/nar/11.3.671; KAKEGAWA T, 1991, J BIOCHEM, V109, P627, DOI 10.1093/oxfordjournals.jbchem.a123431; KASHIWAGI K, 1994, BIOCHEM BIOPH RES CO, V200, P591, DOI 10.1006/bbrc.1994.1489; KASHIWAGI K, 1990, J BIOL CHEM, V265, P20893; KASHIWAGI K, 1993, J BIOL CHEM, V268, P19358; KASHIWAGI K, 1991, J BIOL CHEM, V266, P20922; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; Kashiwagi K, 1996, J BIOL CHEM, V271, P12205, DOI 10.1074/jbc.271.21.12205; KASHIWAGI K, 1986, J BACTERIOL, V165, P972, DOI 10.1128/jb.165.3.972-977.1986; KASHIWAGI K, 1995, J BIOL CHEM, V270, P25377, DOI 10.1074/jbc.270.43.25377; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANNA D, 1994, J BACTERIOL, V176, P5378, DOI 10.1128/JB.176.17.5378-5384.1994; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; Miller J. H, 1972, EXPT MOL GENETICS; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; MUROPASTOR AM, 1995, J BIOL CHEM, V270, P9819, DOI 10.1074/jbc.270.17.9819; NEWMAN EB, 1992, CELL, V68, P617, DOI 10.1016/0092-8674(92)90135-Y; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; OLIVER DB, 1982, CELL, V30, P311, DOI 10.1016/0092-8674(82)90037-X; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; OWENHUGHES TA, 1992, CELL, V71, P255, DOI 10.1016/0092-8674(92)90354-F; PARK YW, 1995, J BIOL CHEM, V270, P28433; PEGG AE, 1988, CANCER RES, V48, P759; PISTOCCHI R, 1993, J BIOL CHEM, V268, P146; SAMBROOK J, 1989, MOL CLONING LAB MANU, pA1; Sambrook J., 2002, MOL CLONING LAB MANU; SCHMID MB, 1990, CELL, V63, P451, DOI 10.1016/0092-8674(90)90438-K; Sugiyama S, 1996, J BIOL CHEM, V271, P9519, DOI 10.1074/jbc.271.16.9519; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1966, J BIOL CHEM, V241, P3714; UEGUCHI C, 1993, MOL GEN GENET, V236, P171, DOI 10.1007/BF00277109; Vassylyev DG, 1998, J BIOL CHEM, V273, P17604, DOI 10.1074/jbc.273.28.17604; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WANG Q, 1993, EMBO J, V12, P2495, DOI 10.1002/j.1460-2075.1993.tb05904.x; XU JM, 1995, J BACTERIOL, V177, P3166, DOI 10.1128/jb.177.11.3166-3175.1995	45	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1942	1948		10.1074/jbc.274.4.1942	http://dx.doi.org/10.1074/jbc.274.4.1942			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890949	hybrid			2022-12-27	WOS:000078185200016
J	Haile, DT; Parvin, JD				Haile, DT; Parvin, JD			Activation of transcription in vitro by the BRCA1 carboxyl-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; GENE-TRANSCRIPTION; PROMOTER DNA; PROTEIN; BASAL; HOLOENZYME; TFIIA; PURIFICATION; REQUIREMENT; BINDING	The breast and ovarian specific tumor suppressor protein, BRCA1, has been shown to be a transcription factor because its carboxyl terminus, when fused to the GAL4 DNA binding domain, activates gene expression in cells. In this study, purified GAL4-BRCA1 protein functions in transcriptional activation assays using a minimal in vitro system. When compared with a standard activator, GAL4-VP16, the levels of activation produced by the BRCA1 fusion protein were stronger when in the presence of certain coactivators. The transcriptional activation by BRCA1 is maximal when in the presence of the PC4 (positive component 4) coactivator but not HMG2 (high mobility group protein 2) and when the template is negatively supercoiled. By contrast, transcriptional activation by VP16 was highest in the presence of HMG2 as well as PC4 and when DNA templates had linear topology. Activation by VP16 was largely unaffected by the concentration of TFIIH, whereas activation by BRCA1 was strongly affected by TFIIH concentrations. The differing cofactor and template requirements suggest that GAL4-BRCA1 and GAL4-VP16 regulate different steps in the pathways that lead to transcriptional activation.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Dept Cellular & Mol Biol, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University	Parvin, JD (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.		Parvin, Jeffrey D/C-8955-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053504] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53504] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; BURATOWSKI S, 1988, NATURE, V334, P37, DOI 10.1038/334037a0; Chao DM, 1996, NATURE, V380, P82, DOI 10.1038/380082a0; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; CHASMAN DI, 1989, MOL CELL BIOL, V9, P4746, DOI 10.1128/MCB.9.11.4746; CHIANG CM, 1993, PEPTIDE RES, V6, P62; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; DEJONG J, 1995, P NATL ACAD SCI USA, V92, P3313, DOI 10.1073/pnas.92.8.3313; DEJONG J, 1993, GENE DEV, V7, P2220, DOI 10.1101/gad.7.11.2220; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; HOLSTEGE FCP, 1995, EMBO J, V14, P810, DOI 10.1002/j.1460-2075.1995.tb07059.x; Kim J, 1996, J BIOL CHEM, V271, P18405, DOI 10.1074/jbc.271.31.18405; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; MANLEY JL, 1983, METHOD ENZYMOL, V101, P568; MEISTERERNST M, 1991, CELL, V66, P981, DOI 10.1016/0092-8674(91)90443-3; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Pan GH, 1997, J BIOL CHEM, V272, P24563, DOI 10.1074/jbc.272.39.24563; PAN GH, 1994, J BIOL CHEM, V269, P30101; PARVIN JD, 1992, CELL, V68, P1135, DOI 10.1016/0092-8674(92)90084-P; Parvin JD, 1998, CURR OPIN GENET DEV, V8, P565, DOI 10.1016/S0959-437X(98)80012-9; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PIL PM, 1993, P NATL ACAD SCI USA, V90, P9465, DOI 10.1073/pnas.90.20.9465; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; SHYKIND BM, 1995, GENE DEV, V9, P1354, DOI 10.1101/gad.9.11.1354; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; TANTIN D, 1994, J BIOL CHEM, V269, P17397; THOMPSON NE, 1990, J BIOL CHEM, V265, P7069; Werten S, 1998, EMBO J, V17, P5103, DOI 10.1093/emboj/17.17.5103; Werten S, 1998, J MOL BIOL, V276, P367, DOI 10.1006/jmbi.1997.1534; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932	44	71	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2113	2117		10.1074/jbc.274.4.2113	http://dx.doi.org/10.1074/jbc.274.4.2113			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890972	hybrid			2022-12-27	WOS:000078185200039
J	Kato, I; Yamamoto, Y; Fujimura, M; Noguchi, N; Takasawa, S; Okamoto, H				Kato, I; Yamamoto, Y; Fujimura, M; Noguchi, N; Takasawa, S; Okamoto, H			CD38 disruption impairs glucose-induced increases in cyclic ADP-ribose, [Ca2+](i), and insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; LEUKOCYTE ANTIGEN CD38; PHYSIOLOGICAL SIGNIFICANCE; PROINSULIN SYNTHESIS; TRANSGENIC MICE; MOUSE ISLETS; HYDROLYSIS; RELEASE; CYCLASE; GENE	Increases in [Ca2+](i) in pancreatic beta cells, resulting from Ca2+ mobilization from intracellular stores as well as Ca2+ influx from extracellular sources, are important in insulin secretion by glucose. Cyclic ADP-ribose (cADPR), accumulated in beta cells by glucose stimulation, has been postulated to serve as a second messenger for intracellular Ca2+ mobilization for insulin secretion, and CD38 is thought to be involved in the cADPR accumulation (Takasawa, S,, Tohgo, k, Noguchi, N,, Koguma, T,, Nata, K,, Sugimoto, T,, Yonekura, H.,, and Okamoto, H, (1993) J. Biol. Chem, 268, 26052-26054), Here we created "knockout" (CD38(-/-)) mice by homologous recombination, CD38(-/-) mice developed normally but showed no increase in their glucose-induced production of cADPR in pancreatic islets, The glucose-induced [Ca2+](i) rise and insulin secretion were both severely impaired in CD38(-/-) islets, whereas CD38(-/-) islets responded normally to the extracellular Ca2+ influx stimulants tolbutamide and KCl, CD38(-/-) mice showed impaired glucose tolerance, and the serum insulin level was lower than control, and these impaired phenotypes were rescued by beta cell-specific expression of CD38 cDNA These results indicate that CD38 plays an essential role in intracellular Ca2+ mobilization by cADPR for insulin secretion.	Tohoku Univ, Sch Med, Dept Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan	Tohoku University	Okamoto, H (corresponding author), Tohoku Univ, Sch Med, Dept Biochem, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.							ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; ASHCROFT FM, 1992, INSULIN MOL BIOL PAT, P97; BOER PH, 1990, BIOCHEM GENET, V28, P299, DOI 10.1007/BF02401419; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; GOTO Y, 1975, P JPN ACAD, V51, P80, DOI 10.2183/pjab1945.51.80; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HARADA N, 1993, J IMMUNOL, V151, P3111; HERMANS MP, 1987, DIABETOLOGIA, V30, P659; HIRATA Y, 1994, FEBS LETT, V356, P244, DOI 10.1016/0014-5793(94)01279-2; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Ikehata F, 1998, J CLIN INVEST, V102, P395, DOI 10.1172/JCI1656; ITOH N, 1980, NATURE, V283, P100, DOI 10.1038/283100a0; KARASAWA T, 1995, FEMS MICROBIOL LETT, V130, P201; KATO I, 1994, J BIOL CHEM, V269, P21223; KATO I, 1995, J BIOL CHEM, V270, P30045, DOI 10.1074/jbc.270.50.30045; LEE HC, 1989, J BIOL CHEM, V264, P1608; MATSUOKA TA, 1995, BIOCHEM BIOPH RES CO, V214, P239, DOI 10.1006/bbrc.1995.2280; Meszaros LG, 1997, BIOCHEM BIOPH RES CO, V234, P252, DOI 10.1006/bbrc.1997.6620; MOSS J, 1976, P NATL ACAD SCI USA, V73, P4424, DOI 10.1073/pnas.73.12.4424; Noguchi N, 1997, J BIOL CHEM, V272, P3133, DOI 10.1074/jbc.272.6.3133; OKAMOTO H, 1981, MOL CELL BIOCHEM, V37, P43, DOI 10.1007/BF02355886; Okamoto H, 1997, METHOD ENZYMOL, V280, P306; Okamoto H, 1997, DIABETOLOGIA, V40, P1485, DOI 10.1007/s001250050854; OKAMOTO H, 1995, BIOCHIMIE, V77, P356, DOI 10.1016/0300-9084(96)88146-6; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; ROE MW, 1993, J BIOL CHEM, V268, P9953; ROJAS E, 1994, ENDOCRINOLOGY, V134, P1771, DOI 10.1210/en.134.4.1771; Takasawa S, 1998, J BIOL CHEM, V273, P2497, DOI 10.1074/jbc.273.5.2497; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; Takasawa S, 1995, J BIOL CHEM, V270, P30257, DOI 10.1074/jbc.270.51.30257; TOHGO A, 1994, J BIOL CHEM, V269, P28555; Tohgo A, 1997, J BIOL CHEM, V272, P3879, DOI 10.1074/jbc.272.7.3879; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yagui K, 1998, DIABETOLOGIA, V41, P1024, DOI 10.1007/s001250051026	37	184	190	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1869	1872		10.1074/jbc.274.4.1869	http://dx.doi.org/10.1074/jbc.274.4.1869			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890936	hybrid			2022-12-27	WOS:000078185200003
J	Kraft, S; Diefenbach, B; Mehta, R; Jonczyk, A; Luckenbach, GA; Goodman, SL				Kraft, S; Diefenbach, B; Mehta, R; Jonczyk, A; Luckenbach, GA; Goodman, SL			Definition of an unexpected ligand recognition motif for alpha nu beta 6 integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CARCINOMA CELLS; PHAGE DISPLAY LIBRARY; ALPHA-V-INTEGRINS; FIBRONECTIN RECEPTOR; PEPTIDE LIGANDS; HUMAN-MELANOMA; ADHESION; VITRONECTIN; BINDING; ATTACHMENT	Integrin interactions with extracellular matrix proteins are mediated by brief oligopeptide recognition sequences, and synthetic peptides containing such sequences can inhibit integrin binding to the matrix. The RGD peptide motif is recognized by many integrins including alpha v beta 6, a specific receptor for fibronectin thought to support epithelial cell proliferation during wound healing and carcinoma progression. We report here the discovery of an unexpected non-RGD recognition motif for integrin alpha v beta 6. We compared the recognition profiles of recombinant alpha v beta 6 and alpha v beta 3 integrins by using phage display screening employing 7-mer and 12-mer peptide libraries. As predicted, phages binding strongly to alpha v beta 3 contained ubiquitous RGD sequences.:However, on alpha v beta 6, in addition to RGD- containing phages, one-quarter of the population from the 12-mer library contained the distinctive consensus motif DLXXL, A synthetic DLXXL peptide, RTDLDSLRTYTL, selected from the phage sequences (clone-l) was a selective inhibitor of RGD-dependent ligand binding to alpha v beta 6 in isolated receptor assays (IC50 = 20 nM), and in cell adhesion assays (IC50 = 50 mu M). DLXXL peptides were highly specific inhibitors of alpha v beta 6-fibronectin interaction as synthetic scrambled or reversed DLXXL peptides were inactive. NH2- and COOH-terminal modifications of the flanking amino acids suggested that the preceding two and a single trailing amino acid were also involved in interaction with alpha v beta 6. The DLXXL sequence is present in several matrix components and in the beta chain of many integrins. Although there is as yet no precise biological role known for DLXXL, it is clearly a specific inhibitory sequence for integrin alpha v beta 6 which has been unrecognized previously.	Merck KGaA, Dept Biomed Res Immunol Oncol, D-64271 Darmstadt, Germany; Merck KGaA, Dept Med Chem, D-64271 Darmstadt, Germany; Merck London, MRC, Ctr Collaborat, London NW7 1AD, England	Merck KGaA; Merck KGaA	Goodman, SL (corresponding author), Merck KGaA, Dept Biomed Res Immunol Oncol, D-64271 Darmstadt, Germany.	goodman@merck.de						AGREZ M, 1994, J CELL BIOL, V127, P547, DOI 10.1083/jcb.127.2.547; BREUSS JM, 1995, J CELL SCI, V108, P2241; BREUSS JM, 1993, J HISTOCHEM CYTOCHEM, V41, P1521, DOI 10.1177/41.10.8245410; BUSK M, 1992, J BIOL CHEM, V267, P5790; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; GOODMAN SL, 1987, J CELL BIOL, V105, P589, DOI 10.1083/jcb.105.1.589; Haubner R, 1996, J AM CHEM SOC, V118, P7461, DOI 10.1021/ja9603721; HEALY JM, 1995, BIOCHEMISTRY-US, V34, P3948, DOI 10.1021/bi00012a012; KAZAL LA, 1963, P SOC EXP BIOL MED, V113, P989; Kemperman H, 1997, EXP CELL RES, V234, P156, DOI 10.1006/excr.1997.3599; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Liu YK, 1997, J BIOCHEM-TOKYO, V121, P961; Marshall JF, 1996, SEMIN CANCER BIOL, V7, P129, DOI 10.1006/scbi.1996.0018; Mehta RJ, 1998, BIOCHEM J, V330, P861; MITJANS F, 1995, J CELL SCI, V108, P2825; ONEIL KT, 1992, PROTEINS, V14, P509, DOI 10.1002/prot.340140411; PRIETO AL, 1993, P NATL ACAD SCI USA, V90, P10154, DOI 10.1073/pnas.90.21.10154; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; RUOSLAHTI E, 1994, KIDNEY INT, V45, pS17; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; Sahu A, 1996, J IMMUNOL, V157, P884; SCHNAPP LM, 1995, J BIOL CHEM, V270, P23196, DOI 10.1074/jbc.270.39.23196; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SMITH JW, 1990, J BIOL CHEM, V265, P11008; TUCKWELL DS, 1993, SYM SOC EXP BIOL, V47, P107; VOGEL BE, 1990, J BIOL CHEM, V265, P5934; WEINACKER A, 1994, J BIOL CHEM, V269, P6940; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281	36	120	137	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1979	1985		10.1074/jbc.274.4.1979	http://dx.doi.org/10.1074/jbc.274.4.1979			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890954	hybrid			2022-12-27	WOS:000078185200021
J	Wolff, EA; Greenfield, B; Taub, DD; Murphy, WJ; Bennett, KL; Aruffo, A				Wolff, EA; Greenfield, B; Taub, DD; Murphy, WJ; Bennett, KL; Aruffo, A			Generation of artificial proteoglycans containing glycosaminoglycan-modified CD44 - Demonstration of the interaction between RANTES and chondroitin sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE HOMING RECEPTOR; T-CELL ACTIVATION; FIBROBLAST GROWTH-FACTOR; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; HEPARAN-SULFATE; SPLICED EXONS; BINDING; ADHESION; HYALURONATE	All CD44 isoforms are modified with chondroitin sulfate (CS), while only those containing variably spliced exon V3 are modified with both CS and heparan sulfate (HS). The CS is added to a serine-glycine (SG) site in CD44 exon E5, while NS and CS are added to the SGSG site in exon V3, Site-directed mutagenesis and other molecular biology techniques were used to determine the minimal motifs responsible for the addition of CS and HS to CD44 (see accompanying paper (Greenfield, B,, Wang, W,-C,, Marquardt, W., Piepkorn, RI., Wolff, E. A., Aruffo, A., and Bennett, K. L, (1999) J, Biol. Chem. 274, 2511-2517)). We have used this information to generate artificial proteoglycans containing the extracellular domain of the cell adhesion protein lymphocyte function-associated antigen-3 (LFA-3)(CD58) and CD44 motifs modified with CS or a combination of CS and HS. Analysis of the CD44-modified LFA-3 protein showed that it retains the ability to engage and trigger the function of its natural ligand CD2, resulting in T cell activation. In addition, the glycosaminoglycan-modified artificial proteoglycan is capable of binding the chemokine RANTES (regulated upon activation, normally T cell expressed and Secreted) and delivering it to human T cells, resulting in enhanced T cell activation. These data demonstrate that artificial proteoglycans can be;engineered with functional domains that have enhanced activity by codelivering glyaosaminoglycan-binding molecules. The artificial proteoglycans were also used as a model system to explore the glycosaminoglycan binding properties of basic-fibroblast growth factor and the chemokine RANTES. While basic-fibroblast growth factor was shown to bind BS alone, this model revealed that RANTES binds not only HS, as has been demonstrated in the past, but also CS. Thus, artificial proteoglycans can be used for studying the glycosaminoglycan binding patterns of growth factors and chemokines and provide a means to manipulate the levels, types, and activity of glycosaminoglycan-binding proteins in vitro and in vivo.	Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ 08543 USA; NIA, Clin Immunol Sect, NIH, Baltimore, MD 21224 USA; NCI, Frederick Canc Res & Dev Ctr, NIH, Frederick, MD 21702 USA	Bristol-Myers Squibb; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Wolff, EA (corresponding author), Bristol Myers Squibb Pharmaceut Res Inst, POB 4000, Princeton, NJ 08543 USA.				NATIONAL INSTITUTE ON AGING [Z01AG000764, ZIAAG000764] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARCH R, 1992, SCIENCE, V257, P682, DOI 10.1126/science.1496383; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BENNETT KL, 1995, J CELL BIOL, V131, P1623, DOI 10.1083/jcb.131.6.1623; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; CULTY M, 1990, J CELL BIOL, V111, P2765, DOI 10.1083/jcb.111.6.2765; DENNING SM, 1990, J IMMUNOL, V144, P7; GALANDRINI R, 1994, J IMMUNOL, V153, P21; Gilat D, 1996, IMMUNOL TODAY, V17, P16, DOI 10.1016/0167-5699(96)80563-9; GILAT D, 1994, J IMMUNOL, V153, P4899; GOLDSTEIN LA, 1989, CELL, V56, P1063, DOI 10.1016/0092-8674(89)90639-9; Greenfield B, 1999, J BIOL CHEM, V274, P2511, DOI 10.1074/jbc.274.4.2511; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; HAYNES BF, 1989, IMMUNOL TODAY, V10, P423, DOI 10.1016/0167-5699(89)90040-6; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; HUET S, 1989, J IMMUNOL, V143, P798; JACKSON DG, 1992, J BIOL CHEM, V267, P4732; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; JACOBSSON KG, 1986, BIOCHEM J, V240, P625, DOI 10.1042/bj2400625; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; KANNER SB, 1992, J IMMUNOL, V148, P2023; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; KINSELLA MG, 1986, J CELL BIOL, V102, P679, DOI 10.1083/jcb.102.3.679; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; Lindahl U., 1989, HEPARIN, P159; MANN DM, 1990, J BIOL CHEM, V265, P5317; MIYAKE K, 1990, J EXP MED, V172, P69, DOI 10.1084/jem.172.1.69; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; Piepkorn M, 1997, BIOCHEM J, V327, P499, DOI 10.1042/bj3270499; ROT A, 1992, IMMUNOL TODAY, V13, P291, DOI 10.1016/0167-5699(92)90039-A; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; SHIMIZU Y, 1989, J IMMUNOL, V143, P2457; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; TANAKA Y, 1993, IMMUNOL TODAY, V14, P111, DOI 10.1016/0167-5699(93)90209-4; Taub DD, 1996, J IMMUNOL, V156, P2095; VANSEVENTER GA, 1991, J EXP MED, V174, P901, DOI 10.1084/jem.174.4.901; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295; ZHAO XM, 1995, J IMMUNOL, V155, P3904	46	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2518	2524		10.1074/jbc.274.4.2518	http://dx.doi.org/10.1074/jbc.274.4.2518			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891023	hybrid			2022-12-27	WOS:000078185200090
J	Fabbro, C; Braghetta, P; Girotto, D; Piccolo, S; Volpin, D; Bressan, GM				Fabbro, C; Braghetta, P; Girotto, D; Piccolo, S; Volpin, D; Bressan, GM			Cell type-specific transcription of the alpha 1(VI) collagen gene - Role of the AP1 binding site and of the core promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; EXPRESSION; IDENTIFICATION; ENHANCER; SEQUENCE; MOUSE; ACTIVATION; CHROMATIN; REGIONS; SYNERGY	Analysis of the chromatin of different cell types has identified four DNase I-hypersensitive sites in the 5'-flanking region of the alpha 1(VI) collagen gene, mapping at -4.6, -4,4, -2,5, and -0.1 kilobase (kb) from the RNA start site. The site at -2.5 kb was independent from, whereas the other three sites could be related to, alpha 1(VI) mRNA expression, The site at -0.1 kb was present in cells expressing (NIH3T3 and C2C12) but absent in cells not expressing (EL4) the mRNA; the remaining two sites were apparently related with high levels of mRNA. DNase I footprinting and gel-shift assays with NIH3T3 and C2C12 nuclear extracts have located a binding site for transcription factor AP1 (activator protein 1) between nucleotides -104 and -73, When nuclear extracts from EL4 lymphocytes were used, the AP1 site-containing sequence was bound by proteins not related to AP1, The existence of the hypersensitive site at -0.1 kb may be related to the binding of AP1 and of additional factors to the core promoter (Piccolo, S,, Bonaldo, P,, Vitale, P., Volpin, D,, and Bressan, G, M, (1995) J. Biol, Chem. 270, 19583-19590), The function of the AP1 binding site and of the core promoter in the transcriptional regulation of the Col6a1 gene was investigated by expressing several promoter-reporter gene constructs in transgenic mice and in cell cultures. The results indicate that regulation of transcription of the Col6a1 gene by different cis-acting elements (core promoter, AP1 binding site and enhancers) is not completely modular, but the final output depends on the specific interactions among the three elements in a defined cell type.	Univ Padua, Inst Histol & Embryol, I-35100 Padua, Italy	University of Padua	Bressan, GM (corresponding author), Univ Padua, Inst Histol & Embryol, Via G Colombo 3, I-35100 Padua, Italy.	bressan@civ.bio.unipd.it	Braghetta, Paola/K-5478-2016	Braghetta, Paola/0000-0003-2547-8679; PICCOLO, STEFANO/0000-0002-2037-0004				Arnone MI, 1997, DEVELOPMENT, V124, P1851; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Barrett TJ, 1996, RECEPT SIGNAL TRANS, V6, P179; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; BELLARD M, 1989, METHOD ENZYMOL, V170, P317; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; BONALDO P, 1993, MATRIX, V13, P223, DOI 10.1016/S0934-8832(11)80006-5; BouGharios G, 1996, J CELL BIOL, V134, P1333, DOI 10.1083/jcb.134.5.1333; Braghetta P, 1997, EUR J BIOCHEM, V247, P200, DOI 10.1111/j.1432-1033.1997.00200.x; Braghetta P, 1996, J CELL BIOL, V135, P1163, DOI 10.1083/jcb.135.4.1163; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; Fraser P, 1998, CURR OPIN CELL BIOL, V10, P361, DOI 10.1016/S0955-0674(98)80012-4; GROSSCHEDL R, 1995, CURR OPIN CELL BIOL, V7, P362, DOI 10.1016/0955-0674(95)80091-3; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Jobsis GJ, 1996, NAT GENET, V14, P113, DOI 10.1038/ng0996-113; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; LISKA DJ, 1994, J CELL BIOL, V125, P695, DOI 10.1083/jcb.125.3.695; Martin DIK, 1996, CURR OPIN GENET DEV, V6, P488, DOI 10.1016/S0959-437X(96)80072-4; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PAVLIN D, 1992, J CELL BIOL, V116, P227, DOI 10.1083/jcb.116.1.227; PICCOLO S, 1995, J BIOL CHEM, V270, P19583, DOI 10.1074/jbc.270.33.19583; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rossert JA, 1996, P NATL ACAD SCI USA, V93, P1027, DOI 10.1073/pnas.93.3.1027; SAITTA B, 1995, EUR J BIOCHEM, V234, P542, DOI 10.1111/j.1432-1033.1995.542_b.x; SalimiTari P, 1997, GENE, V198, P61, DOI 10.1016/S0378-1119(97)00293-X; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WILLIMANN TE, 1994, J BIOL CHEM, V269, P332; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277	33	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1759	1766		10.1074/jbc.274.3.1759	http://dx.doi.org/10.1074/jbc.274.3.1759			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880558	hybrid			2022-12-27	WOS:000079956900078
J	Stefan, CJ; Blumer, KJ				Stefan, CJ; Blumer, KJ			A syntaxin homolog encoded by VAM3 mediates down-regulation of a yeast G protein-coupled receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; SACCHAROMYCES-CEREVISIAE; BETA(2)-ADRENERGIC RECEPTOR; PLASMA-MEMBRANE; ALPHA-FACTOR; ENDOCYTIC PATHWAY; VACUOLAR; TRANSPORT; RESENSITIZATION; SEQUESTRATION	G protein-coupled receptors that transduce signals for many hormones, neurotransmitters, and inflammatory mediators are internalized and subsequently recycled to the plasma membrane, or down-regulated by targetting to lysosomes for degradation. Here we have characterized yeast alpha-factor receptors tagged with green fluorescent protein (Ste2-GFP) and used them to obtain mutants defective in receptor down-regulation. In wild type cells, Ste2-GFP was functional and localized to the plasma membrane and endocytic compartments. Although GFP was fused to the cytoplasmic tail of the receptor, GFP also accumulated in the lumen of the vacuole, suggesting that the receptor's extracellular and cytoplasmic domain are degraded within the vacuole lumen. Transposon mutagenesis and a visual screen were used to identify mutants displaying aberrant localization of Ste2-GFP. Mutants that accumulated Ste2-GFP in numerous intracellular vesicles carried disruptions of the VAM3/PTH1 gene, which encodes a syntaxin homolog (t-SNARE) required for homotypic vacuole membrane fusion, autophagy and fusion of biosynthetic transport vesicles with the vacuole. We provide evidence that Vam3 is required for the delivery of alpha-factor receptor-ligand complexes to the vacuole. Vam3 homologs in mammalian cells may mediate late steps in the down-regulation and lysosomal degradation pathways of various G protein-coupled receptors.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Blumer, KJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	kblumer@cellbio.wustl.edu	Blumer, Kendall J/C-5268-2012	Stefan, Christopher/0000-0002-4118-5721	NIGMS NIH HHS [GM44592] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044592] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; Chun KT, 1996, GENETICS, V142, P39; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; DULIC V, 1991, METHOD ENZYMOL, V194, P697; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; HEIN L, 1994, J BIOL CHEM, V269, P27719; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hicke L, 1997, MOL BIOL CELL, V8, P13, DOI 10.1091/mbc.8.1.13; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; JENNESS DD, 1986, CELL, V46, P345, DOI 10.1016/0092-8674(86)90655-0; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; Krueger KM, 1997, J BIOL CHEM, V272, P5; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Prescianotto-Baschong C, 1998, MOL BIOL CELL, V9, P173, DOI 10.1091/mbc.9.1.173; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; Riezman H, 1998, SEMIN CELL DEV BIOL, V9, P129, DOI 10.1006/scdb.1997.0217; Riezman H, 1996, EXPERIENTIA, V52, P1033, DOI 10.1007/BF01952099; Riezman H, 1997, CELL, V91, P731, DOI 10.1016/S0092-8674(00)80461-4; Rossi G, 1997, J BIOL CHEM, V272, P16610, DOI 10.1074/jbc.272.26.16610; SINGER B, 1990, J CELL BIOL, V110, P1911, DOI 10.1083/jcb.110.6.1911; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Stefan CJ, 1998, MOL BIOL CELL, V9, P885, DOI 10.1091/mbc.9.4.885; STEWART A, 1995, BIOTECH HISTOCHEM, V70, P57, DOI 10.3109/10520299509108318; Tarasova NI, 1997, J BIOL CHEM, V272, P14817, DOI 10.1074/jbc.272.23.14817; WADA Y, 1992, J BIOL CHEM, V267, P18665; Wada Y, 1997, J CELL SCI, V110, P1299; Waddle JA, 1996, J CELL BIOL, V132, P861, DOI 10.1083/jcb.132.5.861	37	56	58	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1835	1841		10.1074/jbc.274.3.1835	http://dx.doi.org/10.1074/jbc.274.3.1835			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880567	hybrid			2022-12-27	WOS:000079956900087
J	Dreher, TW; Uhlenbeck, OC; Browning, KS				Dreher, TW; Uhlenbeck, OC; Browning, KS			Quantitative assessment of EF-1 alpha center dot GTP binding to aminoacyl-tRNAs, aminoacyl-viral RNA, and tRNA shows close correspondence to the RNA binding properties of EF-Tu	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-TU; MOSAIC-VIRUS RNA; WHEAT-GERM; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; PROTEIN-BIOSYNTHESIS; TERNARY COMPLEX; 3' END; GTP; VALINE	A ribonuclease protection assay was used to determine the equilibrium dissociation constants (K-d) for the binding of various RNAs by wheat germ EF-1 alpha.GTP. Aminoacylated fully modified tRNAs and unmodified tRNA transcripts of four specificities (valyl, methionyl, alanyl, and phenylalanyl) hom higher plants or Escherichia coli were bound with K-d values between 0.8 and 10 nM. A valylated 3'-fragment of turnip yellow mosaic virus RNA, which has a pseudoknotted amino acid acceptor stem, was bound with affinity similar to that of Val-tRNA(Val). Uncharged tRNA and initiator Met-tRNA(Met) from wheat germ, RNAs that are normally excluded from the ribosomal A site in vivo, bound weakly. The discrimination against wheat germ initiator Met-tRNA(Met) was almost entirely due to the 2'-phosphoribosyl modification at nucleotide G64, since removal resulted in tight binding by EF-1 alpha.GTP. A 44-nucleotide RNA representing a kinked acceptor/T arm obtained by in vitro selection to bacterial EF-Tu formed an Ala-RNA EF1 alpha.GTP complex with a K-d of 29 nM, indicating that much of the binding affinity for aminoacylated tRNA is derived from interaction with the acceptor/T half of the molecule. The pattern of tRNA interaction observed for EF-1 alpha (eEF1A) therefore closely resembles that of bacterial EF-Tu (EF1A).	Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA	Oregon State University; University of Colorado System; University of Colorado Boulder; University of Texas System; University of Texas Austin	Dreher, TW (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037552, R01GM054610] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-33907] Funding Source: Medline; NIGMS NIH HHS [GM-37552, GM-54610] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARCISZEWSKA M, 1987, NUCLEIC ACIDS RES, V15, P1333, DOI 10.1093/nar/15.3.1333; BARCISZEWSKA M, 1983, BIOCHEM BIOPH RES CO, V114, P1161, DOI 10.1016/0006-291X(83)90684-8; BARCISZEWSKI J, 1994, FEBS LETT, V351, P137, DOI 10.1016/0014-5793(94)00770-5; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; CARVALHO MDD, 1984, ARCH BIOCHEM BIOPHYS, V234, P603, DOI 10.1016/0003-9861(84)90310-2; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; DREHER TW, 1992, BIOCHEMISTRY-US, V31, P9183, DOI 10.1021/bi00153a010; DREHER TW, 1988, BIOCHIMIE, V70, P1719, DOI 10.1016/0300-9084(88)90030-2; Dreher TW, 1996, P NATL ACAD SCI USA, V93, P12212, DOI 10.1073/pnas.93.22.12212; England T E, 1980, Methods Enzymol, V65, P65; FORSTER C, 1993, NUCLEIC ACIDS RES, V21, P5679; GHOSH HP, 1982, NUCLEIC ACIDS RES, V10, P3241, DOI 10.1093/nar/10.10.3241; GLASSER AL, 1991, NUCLEIC ACIDS RES, V19, P5199, DOI 10.1093/nar/19.19.5199; GRASMUK H, 1977, FEBS LETT, V82, P237, DOI 10.1016/0014-5793(77)80592-9; JANIAK F, 1990, BIOCHEMISTRY-US, V29, P4268, DOI 10.1021/bi00470a002; JOSHI RL, 1986, EMBO J, V5, P1143, DOI 10.1002/j.1460-2075.1986.tb04339.x; KIESEWETTER S, 1990, NUCLEIC ACIDS RES, V18, P4677, DOI 10.1093/nar/18.16.4677; KIM SH, 1981, TOPICS NUCLEIC ACID, V1, P83; KINZY TG, 1992, J BIOL CHEM, V267, P1623; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Kolk MH, 1998, SCIENCE, V280, P434, DOI 10.1126/science.280.5362.434; LAX SR, 1986, METHOD ENZYMOL, V118, P109; LOUIE A, 1985, BIOCHEMISTRY-US, V24, P6433, DOI 10.1021/bi00344a019; LOUIE A, 1984, J BIOL CHEM, V259, P5010; MANS RMW, 1991, EUR J BIOCHEM, V201, P303, DOI 10.1111/j.1432-1033.1991.tb16288.x; MORL M, 1995, NUCLEIC ACIDS RES, V23, P3380, DOI 10.1093/nar/23.17.3380; NAGATA S, 1976, ARCH BIOCHEM BIOPHYS, V172, P168, DOI 10.1016/0003-9861(76)90063-1; NAZARENKO IA, 1994, EMBO J, V13, P2464, DOI 10.1002/j.1460-2075.1994.tb06531.x; NAZARENKO IA, 1995, BIOCHEMISTRY-US, V34, P2545, DOI 10.1021/bi00008a019; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; OTT G, 1990, BIOCHIM BIOPHYS ACTA, V1050, P222, DOI 10.1016/0167-4781(90)90170-7; PINCK M, 1970, NATURE, V226, P954, DOI 10.1038/226954a0; Rajbhandary Uttam L., 1995, P511; RAVEL JM, 1973, ARCH BIOCHEM BIOPHYS, V155, P332, DOI 10.1016/0003-9861(73)90122-7; RICHTER D, 1970, BIOCHEM BIOPH RES CO, V38, P864, DOI 10.1016/0006-291X(70)90800-4; RIETVELD K, 1983, EMBO J, V2, P1079, DOI 10.1002/j.1460-2075.1983.tb01549.x; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; RUDINGER J, 1994, BIOCHEMISTRY-US, V33, P5682, DOI 10.1021/bi00185a003; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; TSAI CH, 1993, BIOTECHNIQUES, V14, P58; TSURUI H, 1994, ANAL BIOCHEM, V221, P166, DOI 10.1006/abio.1994.1393	42	56	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					666	672		10.1074/jbc.274.2.666	http://dx.doi.org/10.1074/jbc.274.2.666			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873000	hybrid			2022-12-27	WOS:000077968500015
J	Yagi, K; Goto, D; Hamamoto, T; Takenoshita, S; Kato, M; Miyazono, K				Yagi, K; Goto, D; Hamamoto, T; Takenoshita, S; Kato, M; Miyazono, K			Alternatively spliced variant of Smad2 lacking exon 3 - Comparison with wild-type Smad2 and Smad3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; TUMOR-SUPPRESSOR; PHOSPHORYLATION; ACTIVATION; COMPLEX; PROTEIN; SMAD4/DPC4; MUTATIONS; SER(465); PATHWAY	An alternatively spliced variant of Smad2 with a deletion of exon 3 (Smad2 Delta exon3) is found in various cell types. Here, we studied the function of Smad2 Delta exon3 and compared it with those of wild-type Smad2 containing exon 3 (Smad2(wt)) and Smad3. When transcriptional activity was measured using the p3TP-lux construct, Smad2 Delta exon3 was more potent than Smad2(wt), and had activity similar to Smad3. Transcriptional activation of the activin-responsive element (ARE) of Mix.2 gene promoter by Smad2 Delta hexon3 was also similar to that by Smad3, and slightly less potent than that by Smad2(wt). Phosphorylation by the activated transforming growth factor-beta type I receptor and heteromer formation with Smad4 occurred to similar extents in Smad2 Delta exon3, Smad2(wt), and Smad3. However, DNA binding to the activating protein-1 sites of p3TP-lux was observed in Smad2 Delta exon3 as well as in Smad3, but not in Smad2(wt). In contrast, Smad2(wt), Smad2 Delta exon3, and Smad3 efficiently formed ARE-binding complexes with Smad4 and FAST1, although Smad2(wt) did not directly bind to ARE. These results suggest that exon 3 of Smad2 interferes with the direct DNA binding of Smad2, and modifies the function of Smad2 in transcription of certain target genes.	Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Toshima Ku, Tokyo 1708455, Japan; Japan Soc Promot Sci, Res Future Program, Toshima Ku, Tokyo 1708455, Japan; Gunma Univ, Sch Med, Dept Surg 1, Gunma 3718511, Japan	Japanese Foundation for Cancer Research; Japan Society for the Promotion of Science; Gunma University	Kato, M (corresponding author), Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Toshima Ku, 1-37-1 Kami Ikebukuro, Tokyo 1708455, Japan.							Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Attisano L, 1998, CURR OPIN CELL BIOL, V10, P188, DOI 10.1016/S0955-0674(98)80141-5; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; CARCAMO J, 1995, MOL CELL BIOL, V15, P1573; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 1997, TRENDS CELL BIOL, V7, P187, DOI 10.1016/S0962-8924(97)01036-2; Meersseman G, 1997, MECH DEVELOP, V61, P127, DOI 10.1016/S0925-4773(96)00629-6; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nishihara A, 1998, GENES CELLS, V3, P613, DOI 10.1046/j.1365-2443.1998.00217.x; Shimizu A, 1998, GENES CELLS, V3, P125, DOI 10.1046/j.1365-2443.1998.00174.x; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Takenoshita S, 1998, GENOMICS, V48, P1, DOI 10.1006/geno.1997.5149; Topper JN, 1998, P NATL ACAD SCI USA, V95, P9506, DOI 10.1073/pnas.95.16.9506; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu RY, 1997, MOL CELL BIOL, V17, P2521, DOI 10.1128/MCB.17.5.2521; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3	41	198	208	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					703	709		10.1074/jbc.274.2.703	http://dx.doi.org/10.1074/jbc.274.2.703			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873005	hybrid			2022-12-27	WOS:000077968500020
J	Mu, J; Roach, PJ				Mu, J; Roach, PJ			Characterization of human glycogenin-2, a self-glucosylating initiator of liver glycogen metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; ENDOGENOUS RENAL ACCEPTOR; DNA-BINDING DOMAINS; COS CELLS; XYLOSYL TRANSFER; LEUCINE-ZIPPER; BIOSYNTHESIS; PROTEINS; BIOGENESIS; IDENTIFICATION	Glycogenin-a is a recently described self-glucosylating protein potentially involved in the initiation of glycogen biosynthesis (Mu, J., Skurat, A. V., and Roach, P. J. (1997) J. Biol. Chem. 272, 27589-27597). In human liver extracts, most of the glycogenin-2 was only detectable after treatment with alpha-amylase. Similarly, purifed high M-r glycogen was only detected after release by alpha-amylase treatment. Based on analysis by polymerase chain reaction, the predominant isoform in liver was glycogenin-2 beta. Glycogenin-a was found in Ewing's sarcoma RD-ES cells where, however, it was not associated with high M-r carbohydrate. Both human liver and human RD-ES cell extracts also contained glycogenin-l. Glycogenin-l and glycogenin-2 interact with one another, based on in vitro interactions and co-immunoprecipitation from liver and cell extracts. Mutation of Tyr-196 in glycogenin-a to a Phe residue abolished the ability of glycogenin-g to self-glucosylate but not to interact with glycogenin-l. Stable overexpression of glycogenin-2 alpha in Rat-1 fibroblast cells resulted in a 5-fold increase in the level of glycogen present in the low speed pellet but little change in the low speed supernatant. This result is important since it indicates that the level of glycogenin-2 can determine glycogen accumulation and hence has the potential to control glycogen synthesis.	Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Roach, PJ (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.			Mu, James/0000-0001-8081-2401	NIDDK NIH HHS [DK27221, DK20542] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027221, R37DK027221, P60DK020542, R56DK027221] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALONSO MD, 1994, FEBS LETT, V342, P38, DOI 10.1016/0014-5793(94)80580-6; ALONSO MD, 1995, FASEB J, V9, P1126, DOI 10.1096/fasebj.9.12.7672505; Baque S, 1997, FEBS LETT, V417, P355, DOI 10.1016/S0014-5793(97)01299-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; CAO YJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P293, DOI 10.1006/abbi.1995.1295; CAO YJ, 1993, J BIOL CHEM, V268, P14687; ELLENBERGER T, 1994, CURR OPIN STRUC BIOL, V4, P12, DOI 10.1016/S0959-440X(94)90054-X; ERCAN N, 1994, J BIOL CHEM, V269, P22328; GANNON MC, 1996, TRENDS GLYCOSCI GLYC, V8, P163; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Harris Robert A., 1997, P267; KOVAR H, 1990, ONCOGENE, V5, P1067; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LOMAKO J, 1988, FASEB J, V2, P3097, DOI 10.1096/fasebj.2.15.2973423; MEEZAN E, 1994, J BIOL CHEM, V269, P11503; Mu J, 1997, J BIOL CHEM, V272, P27589, DOI 10.1074/jbc.272.44.27589; Mu J, 1996, J BIOL CHEM, V271, P26554, DOI 10.1074/jbc.271.43.26554; Pathak D., 1992, CURR OPIN STRUC BIOL, V2, P116, DOI [10.1016/0959-440X(92)90186-B, DOI 10.1016/0959-440X(92)90186-B]; PITCHER J, 1988, EUR J BIOCHEM, V176, P391, DOI 10.1111/j.1432-1033.1988.tb14294.x; RAPPOLD GA, 1993, HUM GENET, V92, P315, DOI 10.1007/BF01247327; Roach PJ, 1997, PROG NUCLEIC ACID RE, V57, P289, DOI 10.1016/S0079-6603(08)60284-6; RODEN L, 1994, J BIOL CHEM, V269, P11509; RODRIGUEZ IR, 1988, ARCH BIOCHEM BIOPHYS, V260, P628, DOI 10.1016/0003-9861(88)90491-2; ROSEN G, 1997, CANC MED, V2, P2503; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Skurat Alexander V., 1996, P213; SKURAT AV, 1994, J BIOL CHEM, V269, P25534; SKURAT AV, 1993, J BIOL CHEM, V268, P14701; Skurat AV, 1996, ARCH BIOCHEM BIOPHYS, V328, P283, DOI 10.1006/abbi.1996.0174; Skurat AV, 1997, EUR J BIOCHEM, V245, P147, DOI 10.1111/j.1432-1033.1997.t01-1-00147.x; SMYTHE C, 1989, EUR J BIOCHEM, V183, P205, DOI 10.1111/j.1432-1033.1989.tb14914.x; SMYTHE C, 1990, EUR J BIOCHEM, V189, P199, DOI 10.1111/j.1432-1033.1990.tb15477.x; STALMANS W, 1987, Diabetes Metabolism Reviews, V3, P127; Trempe G L, 1976, Recent Results Cancer Res, P33	36	30	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34850	34856		10.1074/jbc.273.52.34850	http://dx.doi.org/10.1074/jbc.273.52.34850			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857012	hybrid			2022-12-27	WOS:000077719700030
J	Rangan, VS; Joshi, AK; Smith, S				Rangan, VS; Joshi, AK; Smith, S			Fatty acid synthase dimers containing catalytically active beta-ketoacyl synthase or malony/acetyltransferase domains in only one subunit can support fatty acid synthesis at the acyl carrier protein domains of both subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT MAMMARY-GLAND; ESCHERICHIA-COLI; MULTIFUNCTIONAL ENZYME; IN-VITRO; SYNTHETASE; EXPRESSION; THIOESTERASE; COMPLEMENTATION; CONSTRUCTION; PURIFICATION	A double-tagging, dual affinity chromatographic procedure, which permits isolation of dimers independently mutated in each subunit, has been exploited to probe the functional topology of the animal fatty acid synthase, Dimers were engineered in which the chain-terminating thioesterase reaction was compromised by mutation of the (active-site) serine residue in both subunits; these dimers assembled two long-chain fatty acyl moieties, which remained covalently linked to the 4'-phosphopantetheine residues of the two acyl carrier protein domains. Significantly, dimers that contained an additional mutation that compromised the activity of either the beta-ketoacyl synthase or malonyl/acetyltransferase activity in only one subunit also assembled two long-chain acyl moieties, In contrast, in a control experiment, introduction of an additional mutation that compromised the function of the acyl carrier protein domain in only one subunit resulted in the assembly of only one long-chain acyl moiety per dimer, Because the beta-ketoacyl synthase and malonyl/acetyltransferase domains are located near the amino terminus of the polypeptide and the acyl carrier protein domain near the carboxyl terminus, these results support a modified model for the animal fatty acid synthase in which head-to-tail functional contacts are possible both within as well as between subunits.	Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Smith, S (corresponding author), Childrens Hosp, Oakland Res Inst, 747 52nd St, Oakland, CA 94609 USA.	ssmith@lanminds.com			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016073] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK16073] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHANG SI, 1990, ACCOUNTS CHEM RES, V23, P363, DOI 10.1021/ar00179a003; Joshi AK, 1998, BIOCHEMISTRY-US, V37, P2515, DOI 10.1021/bi971886v; JOSHI AK, 1993, BIOCHEM J, V296, P143, DOI 10.1042/bj2960143; Joshi AK, 1998, J BIOL CHEM, V273, P4937, DOI 10.1074/jbc.273.9.4937; JOSHI AK, 1993, J BIOL CHEM, V268, P22508; Joshi AK, 1997, BIOCHEMISTRY-US, V36, P2316, DOI 10.1021/bi9626968; KIM IC, 1977, ARCH BIOCHEM BIOPHYS, V178, P475, DOI 10.1016/0003-9861(77)90218-1; KUMAR S, 1972, J BIOL CHEM, V247, P4749; LIBERTINI LJ, 1979, ARCH BIOCHEM BIOPHYS, V192, P47, DOI 10.1016/0003-9861(79)90070-5; LIBERTINI LJ, 1978, J BIOL CHEM, V253, P1393; NAGGERT J, 1991, BIOCHEM J, V273, P787, DOI 10.1042/bj2730787; NAGGERT J, 1991, J BIOL CHEM, V266, P11044; Rangan VS, 1996, J BIOL CHEM, V271, P31749, DOI 10.1074/jbc.271.49.31749; SINGH N, 1984, J BIOL CHEM, V259, P3605; Smith S, 1975, Methods Enzymol, V35, P65, DOI 10.1016/0076-6879(75)35139-2; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; SMITH S, 1985, EUR J BIOCHEM, V152, P547, DOI 10.1111/j.1432-1033.1985.tb09230.x; SMITH S, 1971, J BIOL CHEM, V246, P6428; STERN A, 1982, J BIOL CHEM, V257, P799; STOOPS JK, 1979, J BIOL CHEM, V254, P7418; STOOPS JK, 1981, J BIOL CHEM, V256, P5128; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Witkowski A, 1996, BIOCHEMISTRY-US, V35, P10569, DOI 10.1021/bi960910m; Witkowski A, 1997, BIOCHEMISTRY-US, V36, P16338, DOI 10.1021/bi972242q	24	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34949	34953		10.1074/jbc.273.52.34949	http://dx.doi.org/10.1074/jbc.273.52.34949			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857025	hybrid			2022-12-27	WOS:000077719700043
J	Shaham, S				Shaham, S			Identification of multiple Caenorhabditis elegans caspases and their potential roles in proteolytic cascades	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; PROGRAMMED CELL-DEATH; C-ELEGANS; CYSTEINE PROTEASE; CYTOCHROME-C; APOPTOSIS; CED-3; ACTIVATION; MEMBRANES; COLICINS	Proteases of the caspase family play a central role in the execution of programmed cell death in all metazoans examined. The Caenorhabditis elegans caspase CED-3 is essential for programmed cell death in this organism. Three additional C. elegans caspase-related genes, csp-l (caspase homolog-(1) under bar), which encodes the csp-1A, csp-1B, and csp-1C RNA species; csp-2, which encodes the csp-2A and csp-2B RNA species; and csp-3 are identified. CSP-1A, CSP-1B, CSP-2A, and CSP-BB proteins are similar in sequence to caspase proproteins. CSP-1C is similar only to large caspase subunits, and CSP-3 is similar only to small caspase subunits. CSP-IB can be activated to become a cysteine protease by processing at internal aspartate residues. Activated CSP-IB can cleave the CSP-1B, CED-3, and CSP-BE proproteins, and activated CED-3 can cleave the CED-3 and CSP-2B proproteins. Inhibitor and synthetic substrate studies further suggest that activated CSP-1B and activated CED-3 have different substrate specificities. These results suggest that C. elegans encodes several caspases that might act in proteolytic cascades to regulate processes such as programmed cell death.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Shaham, S (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 513 Parnassus Ave, San Francisco, CA 94143 USA.							Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chinnaiyan AM, 1997, NATURE, V388, P728, DOI 10.1038/41913; Coulson A, 1996, BIOCHEM SOC T, V24, P289, DOI 10.1042/bst0240289; Elkins P, 1997, STRUCTURE, V5, P443, DOI 10.1016/S0969-2126(97)00200-1; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; FAUCHEU C, 1995, EMBO J, V14, P1914, DOI 10.1002/j.1460-2075.1995.tb07183.x; Fraser AG, 1997, EMBO J, V16, P2805, DOI 10.1093/emboj/16.10.2805; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HORVITZ HR, 1994, COLD SPRING HARB SYM, V59, P377, DOI 10.1101/SQB.1994.059.01.042; HUIBREGTSE JM, 1991, GUIDE YEAST GENETICS, P552; HUNKAPILLER MW, 1983, SCIENCE, V219, P650, DOI 10.1126/science.6687410; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; LAKEY JH, 1994, TOXICOLOGY, V87, P85, DOI 10.1016/0300-483X(94)90156-2; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; McCall K, 1998, SCIENCE, V279, P230, DOI 10.1126/science.279.5348.230; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NELSON DW, 1989, NUCLEIC ACIDS RES, V17, P8657, DOI 10.1093/nar/17.21.8657; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P168; RILEY MA, 1993, MOL BIOL EVOL, V10, P1380; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sambrook J., 2002, MOL CLONING LAB MANU; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; SULSTON J, 1988, NEMATODE CAENORHABDI, P604; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Xue D, 1996, GENE DEV, V10, P1073, DOI 10.1101/gad.10.9.1073; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	35	71	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35109	35117		10.1074/jbc.273.52.35109	http://dx.doi.org/10.1074/jbc.273.52.35109			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857046	Green Published, hybrid			2022-12-27	WOS:000077719700064
J	Arnold, JJ; Cameron, CE				Arnold, JJ; Cameron, CE			Poliovirus RNA-dependent RNA polymerase (3D(pol)) is sufficient for template switching in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; ESCHERICHIA-COLI; REVERSE-TRANSCRIPTASE; KINETIC-ANALYSIS; PROTEIN 3AB; VIRAL-RNA; DNA; RECOMBINATION; REPLICATION; IDENTIFICATION	We have performed a systematic, quantitative analysis of the kinetics of nucleotide incorporation catalyzed by poliovirus RNA-dependent RNA polymerase, 3D(pol.) Homopolymeric primer/templates of defined length were used to evaluate the contribution of primer and template length and sequence to the efficiency of nucleotide incorporation without the complication of RNA structure. Interestingly, thermodynamic stability of the duplex region of these primer/templates was more important for efficient nucleotide incorporation than either primer or template length. Surprisingly, products greater than unit length formed in all reactions regardless of length or sequence. Neither a distributive nor a processive slippage mechanism could be used to explain completely the formation of long products. Rather, the data were consistent with a template-switching mechanism. All of the nucleotide could be polymerized during the course of the reaction. However, very few primers could be extended, suggesting an inverse correlation between the efficiency of primer utilization and that of nucleotide incorporation, Therefore, the greatest fraction of incorporated nucleotide derives from a small fraction of enzyme when radioactive nucleotide and homopolymeric primer/template substrates are employed. The impact of these results on mechanistic studies of 3D(pol)-catalyzed nucleotide incorporation and RNA recombination are discussed.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cameron, CE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.				NATIONAL CANCER INSTITUTE [K01CA075118] Funding Source: NIH RePORTER; NCI NIH HHS [CA75118] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Benkovic SJ, 1995, METHOD ENZYMOL, V262, P257; BRYANT FR, 1983, BIOCHEMISTRY-US, V22, P3537, DOI 10.1021/bi00284a001; Buck KW, 1996, ADV VIRUS RES, V47, P159, DOI 10.1016/S0065-3527(08)60736-8; BUISER RG, 1991, J BIOL CHEM, V266, P13103; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; Carroll SS, 1996, METHOD ENZYMOL, V275, P365; COUCH RB, 1996, FIELDS VIROLOGY, V1, P713; DEHASETH PL, 1995, MOL MICROBIOL, V16, P817, DOI 10.1111/j.1365-2958.1995.tb02309.x; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; DORSCHHASLER K, 1975, J VIROL, V16, P1512; Duggal R, 1997, P NATL ACAD SCI USA, V94, P13786, DOI 10.1073/pnas.94.25.13786; ERIE DA, 1992, ANNU REV BIOPH BIOM, V21, P379, DOI 10.1146/annurev.bb.21.060192.002115; FALVEY AK, 1976, NUCLEIC ACIDS RES, V3, P79, DOI 10.1093/nar/3.1.79; FLANEGAN JB, 1979, J VIROL, V32, P155, DOI 10.1128/JVI.32.1.155-161.1979; Gamarnik AV, 1996, EMBO J, V15, P5988, DOI 10.1002/j.1460-2075.1996.tb00985.x; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; HARRIS KS, 1994, J BIOL CHEM, V269, P27004; Hope DA, 1997, J VIROL, V71, P9490, DOI 10.1128/JVI.71.12.9490-9498.1997; HOUGHTON M, 1996, FIELDS VIROLOGY, V1, P1035; HUBER HE, 1989, J BIOL CHEM, V264, P4669; ISHIHAMA A, 1994, ARCH VIROL, V134, P235, DOI 10.1007/BF01310564; JARVIS TC, 1991, TRENDS GENET, V7, P186, DOI 10.1016/0168-9525(91)90434-R; KATI WM, 1992, J BIOL CHEM, V267, P25988; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; LUBINSKI JM, 1987, J VIROL, V61, P2997, DOI 10.1128/JVI.61.10.2997-3003.1987; Nagy PD, 1997, VIROLOGY, V235, P1, DOI 10.1006/viro.1997.8681; NEUFELD KL, 1991, J BIOL CHEM, V266, P24212; PATA JD, 1995, RNA, V1, P466; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; PAUL AV, 1994, J BIOL CHEM, V269, P29173; PLOTCH SJ, 1989, J VIROL, V63, P216, DOI 10.1128/JVI.63.1.216-225.1989; REARDON JE, 1993, J BIOL CHEM, V268, P8743; Richards OC, 1998, J BIOL CHEM, V273, P12832, DOI 10.1074/jbc.273.21.12832; RUECKERT RR, 1996, FIELDS VIROLOGY, V1, P609; SANKAR S, 1992, J BIOL CHEM, V267, P10168; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Serra MJ, 1995, METHOD ENZYMOL, V259, P242; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tan KL, 1996, BIOCHEM J, V315, P727, DOI 10.1042/bj3150727; Tang RS, 1997, RNA, V3, P624; Vazquez AL, 1998, J VIROL, V72, P2999; Xiang WK, 1995, RNA, V1, P892; Xiang WK, 1997, SEMIN VIROL, V8, P256, DOI 10.1006/smvy.1997.0128; YOGO Y, 1974, BIOCHEM BIOPH RES CO, V61, P1101, DOI 10.1016/S0006-291X(74)80397-9	47	85	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2706	2716		10.1074/jbc.274.5.2706	http://dx.doi.org/10.1074/jbc.274.5.2706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915801	hybrid			2022-12-27	WOS:000078319500019
J	Enke, DA; Kaldis, P; Holmes, JK; Solomon, MJ				Enke, DA; Kaldis, P; Holmes, JK; Solomon, MJ			The CDK-activating kinase (Cak1p) from budding yeast has an unusual ATP-binding pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CRYSTAL-STRUCTURE; TYROSINE KINASE; CATALYTIC SUBUNIT; SACCHAROMYCES-CEREVISIAE; MAP KINASE; CDC28 MUTATION; EGF RECEPTOR; BETA-SUBUNIT; SITE	Cak1p is an essential protein kinase that phosphorylates and thereby activates the major cyclin-dependent kinase in budding yeast, Cdc28p, The sequence of Cak1p differs from other members of the protein kinase superfamily in several conserved regions. Cak1p lacks the highly conserved glycine loop motif (GXGXXG) that is found in the nucleotide binding fold of virtually all protein kinases and also lacks a number of conserved amino acids found at sites throughout the protein kinase core sequence. We have used kinetic and mutagenic analyses to investigate whether these sequence differences affect the nucleotide-binding properties of Cak1p, Although Cak1p differs dramatically from other protein kinases, it binds ATP with a reasonable affinity, with a K-M of 4.8 mu M. Mutations of the putative invariant lysine in Cak1p (Lys-31), homologous to a residue required for activity in virtually all protein kinases and that interacts with the ATP phosphates, moderately reduced the ability of Cak1p to bind ATP but did not dramatically affect the catalytic rate of the kinase. Similarly, Cak1p is insensitive to the ATP analog 5'-fluorosulfonylbenzoyladenosine, which inhibits most protein kinases through covalent modification of the invariant lysine, We found that Cak1p is tolerant of mutations within its glycine loop region. Remarkably, Cak1p remains functional even following truncation of its first 31 amino acids, including the glycine loop region and the invariant lysine. We conclude that the Cak1p nucleotide-binding pocket differs significantly from those of most other protein kinases and therefore might provide a specific target for an inhibitory drug.	Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Solomon, MJ (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA.	Mark.Solomon@yale.edu	Kaldis, Philipp/G-2714-2010	Kaldis, Philipp/0000-0002-7247-7591	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047830] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47830] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS PD, 1992, J BIOL CHEM, V267, P13135; ARMSTRONG RN, 1979, P NATL ACAD SCI USA, V76, P722, DOI 10.1073/pnas.76.2.722; ATHERTONFESSLER S, 1993, MOL CELL BIOL, V13, P1675, DOI 10.1128/MCB.13.3.1675; Boerner RJ, 1995, BIOCHEMISTRY-US, V34, P16419, DOI 10.1021/bi00050a024; BOOHER R, 1986, MOL CELL BIOL, V6, P3523, DOI 10.1128/MCB.6.10.3523; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; CHOU CK, 1987, J BIOL CHEM, V262, P1842; Chun KT, 1997, MOL GEN GENET, V256, P365, DOI 10.1007/s004380050580; CISMOWSKI MJ, 1995, MOL CELL BIOL, V15, P2983; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; DESAI D, 1992, MOL BIOL CELL, V3, P571, DOI 10.1091/mbc.3.5.571; DESHAIES RJ, 1995, P NATL ACAD SCI USA, V92, P1182, DOI 10.1073/pnas.92.4.1182; ELLEDGE SJ, 1991, EMBO J, V10, P2653, DOI 10.1002/j.1460-2075.1991.tb07808.x; ERIKSON E, 1989, J BIOL CHEM, V264, P19577; ESCH FS, 1978, J BIOL CHEM, V253, P6100; Espinoza FH, 1996, SCIENCE, V273, P1714, DOI 10.1126/science.273.5282.1714; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; Graaff IVDZ, 1997, BBA-BIOENERGETICS, V1318, P123, DOI 10.1016/S0005-2728(96)00149-1; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hartog AF, 1997, BBA-BIOENERGETICS, V1318, P107, DOI 10.1016/S0005-2728(96)00110-7; HATHAWAY GM, 1981, J BIOL CHEM, V256, P1442; Hemmer W, 1997, J BIOL CHEM, V272, P16946, DOI 10.1074/jbc.272.27.16946; HERMAN PK, 1991, CELL, V64, P425, DOI 10.1016/0092-8674(91)90650-N; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; HU SH, 1994, NATURE, V369, P581, DOI 10.1038/369581a0; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kaldis P, 1996, CELL, V86, P553, DOI 10.1016/S0092-8674(00)80129-4; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; KAMPS MP, 1984, NATURE, V310, P589, DOI 10.1038/310589a0; KING MM, 1988, ARCH BIOCHEM BIOPHYS, V267, P467, DOI 10.1016/0003-9861(88)90052-5; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kobe B, 1996, EMBO J, V15, P6810, DOI 10.1002/j.1460-2075.1996.tb01072.x; KOMATSU H, 1993, BIOCHEM J, V296, P53, DOI 10.1042/bj2960053; LEE JH, 1992, BIOCHEMISTRY-US, V31, P10616, DOI 10.1021/bi00158a026; Lew J, 1997, BIOCHEMISTRY-US, V36, P6717, DOI 10.1021/bi963164u; Lim HH, 1996, MOL CELL BIOL, V16, P4573; LoGrasso PV, 1997, BIOCHEMISTRY-US, V36, P10422, DOI 10.1021/bi9706778; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Narayana N, 1997, BIOCHEMISTRY-US, V36, P4438, DOI 10.1021/bi961947+; Nelson JW, 1996, J BIOL CHEM, V271, P17021, DOI 10.1074/jbc.271.29.17021; NINOMIYATSUJI J, 1991, P NATL ACAD SCI USA, V88, P9006, DOI 10.1073/pnas.88.20.9006; ODAWARA M, 1989, SCIENCE, V245, P66, DOI 10.1126/science.2544998; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Russo AA, 1997, METHOD ENZYMOL, V283, P3; RUSSO MW, 1985, J BIOL CHEM, V260, P5205; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Solomon M J, 1998, Results Probl Cell Differ, V22, P79; SOLOMON MJ, 1993, EMBO J, V12, P3133, DOI 10.1002/j.1460-2075.1993.tb05982.x; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; TAYLOR SS, 1992, ANNU REV CELL BIOL, V8, P429, DOI 10.1146/annurev.cb.08.110192.002241; Thuret JY, 1996, CELL, V86, P565, DOI 10.1016/S0092-8674(00)80130-0; WEINMASTER G, 1986, EMBO J, V5, P69, DOI 10.1002/j.1460-2075.1986.tb04179.x; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; WYATT JL, 1977, BIOCHEMISTRY-US, V16, P1333, DOI 10.1021/bi00626a015; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZOLLER MJ, 1979, J BIOL CHEM, V254, P8363; ZOLLER MJ, 1981, J BIOL CHEM, V256, P837	63	17	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1949	1956		10.1074/jbc.274.4.1949	http://dx.doi.org/10.1074/jbc.274.4.1949			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890950	hybrid			2022-12-27	WOS:000078185200017
J	Thomas, JC; Passaquet, C				Thomas, JC; Passaquet, C			Characterization of a phycoerythrin without alpha-subunits from a unicellular red alga	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE ANALYSIS; CYANOBACTERIUM MASTIGOCLADUS-LAMINOSUS; II-CONTAINING PHYCOBILISOME; BILIN ATTACHMENT SITES; AMINO-ACID-SEQUENCE; RHODELLA-VIOLACEA; C-PHYCOCYANIN; R-PHYCOERYTHRIN; PORPHYRIDIUM-CRUENTUM; ANGSTROM RESOLUTION	We describe here the spectral and biochemical properties of a novel biliprotein belonging to the phycoerythrin family, purified from the phycobilisome of a unicellular red alga, Rhodella reticulata strain R6, This biliprotein is assembled from a unique beta-type subunit, chloroplast-encoded, whose hexameric or dodecameric aggregates are stabilized by unusually large linkers (87 and 60 kDa) encoded by the nuclear genome. Although each beta-type subunit bears two phycoerythrobilins and one phycocyanobilin per chain, the linker polypeptides are non-chromophorylated. The apoprotein of the beta-subunit of the R reticulata R6 phycoerythrin is specified by a monocistronic rpeB chloroplast gene that is split into three exons. We discuss the relationships between R6 beta-phycoerythrin and the previously published polypeptide sequences, the structural consequences due to the absence of an alpha-subunit, and its evolutionary implications.	Ecole Normale Super, Lab Photoregulat, CNRS, Unite Rech Associee 1810,GDR 1002, F-75230 Paris 05, France; Ecole Normale Super, Lab Photoregulat & Dynam Membranes Vegetales, CNRS, Unite Rech Associee 1810,GDR 1002, F-75230 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Thomas, JC (corresponding author), Ecole Normale Super, Lab Photoregulat, CNRS, Unite Rech Associee 1810,GDR 1002, 46 Rue Ulm, F-75230 Paris 05, France.	jcthomas@biologie.ens.fr						ANDERSON LK, 1990, J BACTERIOL, V172, P1297, DOI 10.1128/jb.172.3.1297-1305.1990; [Anonymous], [No title captured]; APT KE, 1993, J BIOL CHEM, V268, P16208; APT KE, 1995, J MOL BIOL, V248, P79, DOI 10.1006/jmbi.1995.0203; APT KE, 1993, PLANT MOL BIOL, V21, P27, DOI 10.1007/BF00039615; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bernard C, 1996, J PHYCOL, V32, P265, DOI 10.1111/j.0022-3646.1996.00265.x; BERNARD C, 1992, P NATL ACAD SCI USA, V89, P9564, DOI 10.1073/pnas.89.20.9564; BREJC K, 1995, J MOL BIOL, V249, P424, DOI 10.1006/jmbi.1995.0307; BROWN AS, 1979, J BIOL CHEM, V254, P7803; Bryant D. A., 1991, CELL CULTURE SOMATIC, P257; CAPUANO V, 1993, J BIOL CHEM, V268, P8277; CAPUANO V, 1991, J BIOL CHEM, V266, P7239; Chang WR, 1996, J MOL BIOL, V262, P721, DOI 10.1006/jmbi.1996.0547; Cohen-Bazire G., 1982, BOTANICAL MONOGRAPHS, V19, P143; DEBRECZENY MP, 1993, J PHYS CHEM-US, V97, P9852, DOI 10.1021/j100140a050; DEMARSAC NT, 1993, FEMS MICROBIOL LETT, V104, P119; DOUGLAS SE, 1991, NATURE, V350, P148, DOI 10.1038/350148a0; DUCRET A, 1994, EUR J BIOCHEM, V221, P563, DOI 10.1111/j.1432-1033.1994.tb18769.x; DUERRING M, 1991, J MOL BIOL, V217, P577, DOI 10.1016/0022-2836(91)90759-Y; DUERRING M, 1990, J MOL BIOL, V211, P633, DOI 10.1016/0022-2836(90)90270-V; EGELHOFF T, 1983, P NATL ACAD SCI-BIOL, V80, P3339, DOI 10.1073/pnas.80.11.3339; FICNER R, 1993, EUR J BIOCHEM, V218, P103, DOI 10.1111/j.1432-1033.1993.tb18356.x; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; FRESNEL J, 1989, PLANT SYST EVOL, V164, P253, DOI 10.1007/BF00940441; Fritsch EF, 1986, MOL CLONING LAB MANU, V2nd; GANTT E, 1986, J PHYCOL, V22, P480, DOI 10.1111/j.1529-8817.1986.tb02491.x; GANTT E, 1986, ENCY PLANT PHYSL, V19, P260; GARNIER F, 1994, PLANT PHYSIOL, V106, P747, DOI 10.1104/pp.106.2.747; GIBBS SP, 1981, ANN NY ACAD SCI, V361, P193; GILLOTT MA, 1980, J PHYCOL, V16, P558; GLAUSER M, 1992, EUR J BIOCHEM, V205, P907, DOI 10.1111/j.1432-1033.1992.tb16857.x; Glazer A.N., 1987, CYANOBACTERIA, P69; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.bb.14.060185.000403; GLAZER AN, 1977, J BIOL CHEM, V252, P32; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Glazer AN, 1997, J PHYCOL, V33, P617, DOI 10.1111/j.0022-3646.1997.00617.x; Glazer AN, 1995, PHOTOSYNTH RES, V46, P93, DOI 10.1007/BF00020420; Grossman AR, 1995, ANNU REV GENET, V29, P231, DOI 10.1146/annurev.ge.29.120195.001311; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Hess WR, 1996, P NATL ACAD SCI USA, V93, P11126, DOI 10.1073/pnas.93.20.11126; JENKINS J, 1990, FEBS LETT, V273, P191, DOI 10.1016/0014-5793(90)81082-Y; JUDD RC, 1990, METHOD ENZYMOL, V182, P613; KARSHIKOV A, 1991, PROTEIN ENG, V4, P681, DOI 10.1093/protein/4.6.681; KLOTZ AV, 1987, J BIOL CHEM, V262, P17350; KLOTZ AV, 1985, J BIOL CHEM, V260, P4856; KOLLER KP, 1977, ARCH MICROBIOL, V112, P61, DOI 10.1007/BF00446655; LUNDELL DJ, 1981, J BIOL CHEM, V256, P3580; LUNDELL DJ, 1984, J BIOL CHEM, V259, P5472; MacColl R., 1987, P1; MARTIN CD, 1987, BIOCHIM BIOPHYS ACTA, V923, P88, DOI 10.1016/0304-4165(87)90130-9; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MAZEL D, 1986, NUCLEIC ACIDS RES, V14, P8279, DOI 10.1093/nar/14.21.8279; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MORSCHEL E, 1980, ARCH MICROBIOL, V125, P43, DOI 10.1007/BF00403196; MUCKLE G, 1978, H-S Z PHYSIOL CHEM, V359, P345; NEWMAN J, 1994, PLANT MOL BIOL, V24, P679, DOI 10.1007/BF00023564; ONG LJ, 1991, J BIOL CHEM, V266, P9515; ONG LJ, 1987, J BIOL CHEM, V262, P6323; PASSAQUET C, 1995, PLANT MOL BIOL, V29, P135, DOI 10.1007/BF00019125; REITH M, 1993, PLANT CELL, V5, P465, DOI 10.1105/tpc.5.4.465; Richaud C, 1997, P NATL ACAD SCI USA, V94, P11736, DOI 10.1073/pnas.94.21.11736; ROELL MK, 1993, PLANT MOL BIOL, V21, P47, DOI 10.1007/BF00039617; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHIRMER T, 1985, J MOL BIOL, V184, P257, DOI 10.1016/0022-2836(85)90379-1; SCHIRMER T, 1986, J MOL BIOL, V188, P651, DOI 10.1016/S0022-2836(86)80013-4; SCHIRMER T, 1987, J MOL BIOL, V196, P677, DOI 10.1016/0022-2836(87)90040-4; SIDLER W, 1989, BIOL CHEM H-S, V370, P115, DOI 10.1515/bchm3.1989.370.1.115; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; STARR RC, 1978, J PHYCOL, V14, P47, DOI 10.1111/j.1529-8817.1978.tb02507.x; WEHRMEYER W, 1993, EUR J CELL BIOL, V60, P203; WILBANKS SM, 1991, J BIOL CHEM, V266, P9535; WILBANKS SM, 1993, J BIOL CHEM, V268, P1236; WILBANKS SM, 1993, J BIOL CHEM, V268, P1226; YAMANAKA G, 1978, J BIOL CHEM, V253, P8303; YU MH, 1982, J BIOL CHEM, V257, P3429; YU MH, 1981, J BIOL CHEM, V256, P3130; ZUBER H, 1987, NEW COMPR BIOCH, V15, P233	78	19	20	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2472	2482		10.1074/jbc.274.4.2472	http://dx.doi.org/10.1074/jbc.274.4.2472			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891018	hybrid			2022-12-27	WOS:000078185200085
J	Murata, T; Yamaguchi, M				Murata, T; Yamaguchi, M			Promoter characterization of the rat gene for Ca(2+)-binding protein regucalcin - Transcriptional regulation by signaling factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; DEOXYRIBONUCLEIC-ACID; 5'-FLANKING REGION; C-FOS; BINDING; CALCIUM; EXPRESSION; LIVER; INSULIN; TRANSDUCTION	To understand the mechanism underlying the regulation of the Ca(2+)-binding protein regucalcin gene expression, we characterized the 5'-flanking region of the rat regucalcin gene. The transcriptional start site of the rat regucalcin gene was determined by the cap site hunting method with rat liver cap site cDNA. The 5'-flanking region of the rat regucalcin gene ligated to a luciferase reporter gene possessed functional promoter activity in rat H4-II-E hepatoma cells. 3'- and 5'-deletion analyses indicated the sequence required for basal functional promoter activity of the rat regucalcin gene. The promoter activity of the rat regucalcin gene was enhanced by treatment with Bay K 8644, dibutyryl cAMP, phorbol esters, insulin, and dexamethasone. Using gel mobility shift assays, we found that nuclear proteins from H4-II-E cells specifically bind to the 5'-flanking region of the rat regucalcin gene. Moreover, gel mobility shift assays revealed that Bay K 8644, dibutyryl cAMP, phorbol esters, and insulin stimulated the binding of nuclear factors to the 5'-flanking region of the rat regucalcin gene in H4-II-E cells. These results suggest that Bay K 8644-, dibutyryl cAMP-, phorbol ester-, and insulin-inducible nuclear factors mediate the stimulatory effect of each regulator on promoter activity of the rat regucalcin gene.	Univ Shizuoka, Grad Sch Nutr Sci, Lab Endocrinol & Mol Metab, Shizuoka 4228526, Japan	University of Shizuoka	Yamaguchi, M (corresponding author), Univ Shizuoka, Grad Sch Nutr Sci, Lab Endocrinol & Mol Metab, 52-1 Yada, Shizuoka 4228526, Japan.	yamaguch@fns.1.u-shizuoka-ken.ac.jp						BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ESTEVE L, 1995, NEUROPHARMACOLOGY, V34, P439, DOI 10.1016/0028-3908(95)00006-R; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; KIM SJ, 1994, J BIOL CHEM, V269, P11887; Kurota H, 1996, MOL CELL BIOCHEM, V155, P105; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; Murata T, 1998, BIOCHEM J, V329, P157, DOI 10.1042/bj3290157; Murata T, 1997, MOL CELL BIOCHEM, V175, P163, DOI 10.1023/A:1006844815743; Murata T, 1998, MOL CELL BIOCHEM, V178, P305, DOI 10.1023/A:1006867531428; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; RAHMSDORF HJ, 1990, PHARMACOL THERAPEUT, V48, P157, DOI 10.1016/0163-7258(90)90079-H; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; SHIMOKAWA N, 1995, MOL CELL BIOCHEM, V151, P157, DOI 10.1007/BF01322338; SHIMOKAWA N, 1995, MOL CELL BIOCHEM, V143, P67, DOI 10.1007/BF00925928; SHIMOKAWA N, 1992, FEBS LETT, V305, P151, DOI 10.1016/0014-5793(92)80884-J; SHIMOKAWA N, 1993, FEBS LETT, V316, P79, DOI 10.1016/0014-5793(93)81740-Q; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; WASSERMAN RH, 1991, NOVEL CALCIUM BINDIN, P7; YAMAGUCHI M, 1991, FEBS LETT, V279, P281, DOI 10.1016/0014-5793(91)80168-3; YAMAGUCHI M, 1991, MOL CELL BIOCHEM, V106, P25; YAMAGUCHI M, 1995, MOL CELL BIOCHEM, V143, P137, DOI 10.1007/BF01816947; Yamaguchi M, 1996, MOL CELL BIOCHEM, V165, P145; YAMAGUCHI M, 1995, MOL CELL BIOCHEM, V142, P35, DOI 10.1007/BF00928911; YMAGUCHI M, 1992, CALCIUM INHIBITION, P19; [No title captured]	29	75	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1277	1285		10.1074/jbc.274.3.1277	http://dx.doi.org/10.1074/jbc.274.3.1277			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880496	hybrid			2022-12-27	WOS:000079956900016
J	Kim, MH; Lu, M; Lim, EJ; Chai, YG; Hersh, LB				Kim, MH; Lu, M; Lim, EJ; Chai, YG; Hersh, LB			Mutational analysis of aspartate residues in the transmembrane regions and cytoplasmic loops of rat vesicular acetylcholine transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORPEDO SYNAPTIC VESICLES; MONOAMINE TRANSPORTER; PROTEIN-KINASE; CHOLINE-ACETYLTRANSFERASE; CAENORHABDITIS-ELEGANS; SUBSTRATE RECOGNITION; ACTIVE-TRANSPORT; ESCHERICHIA-COLI; EXPRESSION; GENE	The vesicular acetylcholine transporter (VAChT) is responsible for the transport of the neuotransmitter acetylcholine (ACh) into synaptic vesicles using an electrochemical gradient to drive transport, Rat VAChT has a number of aspartate residues within its predicted transmembrane domains (TM) and cytoplasmic loops, which may play important structural or functional roles in acetylcholine transport. In order to identify functional charged residues, site-directed mutagenesis of rVAChT was undertaken. No effect on ACh transport was observed when any of the five aspartate residues in the cytoplasmic loop were converted to asparagine, Similarly, changing Asp-46 (D46N) in TM1 or Asp-255 (D255N) in TM6 had no effect on ACh transport or vesamicol. binding, However, replacement of Asp-398 in TM10 with Asn completely eliminated both ACh transport and vesamicol binding. The conservative mutant D398E retained transport activity, but not vesamicol binding, suggesting this residue is critical for transport. Mutation of Asp-193 in TM4 did not affect ACh transport activity; however, vesamicol binding was dramatically reduced. With mutant D425N of TM11 transport activity for ACh was completely blocked, without an effect on vesamicol binding. Activity was not restored in the conservative mutant D425E, suggesting the side chain as well as the negative charge of Asp-425 is important for substrate binding. These mutants, as well as mutant D193N, clearly dissociated ACh binding and transport from vesamicol binding. These data suggest that Asp-398 in TM10 and Asp-425 in TM11 are important for ACh binding and transport, while Asp-193 and Asp-398 in TM4 and TM10, respectively, me involved in vesamicol binding.	Univ Kentucky, Albert B Chandler Med Ctr, Dept Biochem, Lexington, KY 40536 USA; Hanyang Univ, Dept Biochem, Ansan 425791, South Korea	University of Kentucky; Hanyang University	Hersh, LB (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, Dept Biochem, 800 Rose st, Lexington, KY 40536 USA.	lhersh@pop.uky.edu			NATIONAL INSTITUTE ON AGING [R55AG005893, R01AG005893, P50AG005144] Funding Source: NIH RePORTER; NIA NIH HHS [AG05144, AG05893] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; BAHR BA, 1992, BIOCHEMISTRY-US, V31, P5752, DOI 10.1021/bi00140a010; BAHR BA, 1986, P NATL ACAD SCI USA, V83, P2267, DOI 10.1073/pnas.83.7.2267; BAHR BA, 1986, J NEUROCHEM, V46, P1214, DOI 10.1111/j.1471-4159.1986.tb00640.x; BEJANIN S, 1994, J BIOL CHEM, V269, P21944; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; CLARKSON ED, 1993, J NEUROCHEM, V61, P22, DOI 10.1111/j.1471-4159.1993.tb03534.x; CORRELL LA, 1989, J BIOL CHEM, V264, P16672; DIEBLER MF, 1989, J NEUROCHEM, V52, P813, DOI 10.1111/j.1471-4159.1989.tb02526.x; Eiden LE, 1998, J NEUROCHEM, V70, P2227; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; Gilmor ML, 1996, J NEUROSCI, V16, P2179; GINTY DD, 1991, J BIOL CHEM, V266, P15325; HAIGH JR, 1994, NEUROREPORT, V5, P773, DOI 10.1097/00001756-199403000-00009; INOUE H, 1995, J NEUROCHEM, V64, P985; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; MCMURRY LM, 1992, J BACTERIOL, V174, P6294, DOI 10.1128/JB.174.19.6294-6297.1992; MERICKEL A, 1995, J BIOL CHEM, V270, P25798, DOI 10.1074/jbc.270.43.25798; Merickel A, 1997, J BIOL CHEM, V272, P5403, DOI 10.1074/jbc.272.9.5403; MORIYAMA Y, 1989, J BIOL CHEM, V264, P3577; Nguyen ML, 1996, PROG BRAIN RES, V109, P97; NGUYEN ML, 1995, J NEUROCHEM, V64, P1137; PARSONS SM, 1993, INT REV NEUROBIOL, V35, P279, DOI 10.1016/S0074-7742(08)60572-3; ROGHANI A, 1994, P NATL ACAD SCI USA, V91, P10620, DOI 10.1073/pnas.91.22.10620; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shimojo M, 1998, J NEUROCHEM, V71, P1118; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; SteinerMordoch S, 1996, J BIOL CHEM, V271, P13048, DOI 10.1074/jbc.271.22.13048; USDIN TB, 1995, TRENDS NEUROSCI, V18, P218, DOI 10.1016/0166-2236(95)93906-E; Varoqui H, 1998, J BIOL CHEM, V273, P9094, DOI 10.1074/jbc.273.15.9094; Varoqui H, 1997, MOL NEUROBIOL, V15, P165, DOI 10.1007/BF02740633; VAROQUI H, 1994, FEBS LETT, V342, P97, DOI 10.1016/0014-5793(94)80592-X; Varoqui H, 1996, J BIOL CHEM, V271, P27229, DOI 10.1074/jbc.271.44.27229; WEIGH E, 1996, P NATL ACAD SCI USA, V93, P3547; YAMAGUCHI A, 1992, BIOCHEMISTRY-US, V31, P8344, DOI 10.1021/bi00150a031; YAMAGUCHI A, 1992, J BIOL CHEM, V267, P7490	40	40	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					673	680		10.1074/jbc.274.2.673	http://dx.doi.org/10.1074/jbc.274.2.673			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873001	hybrid			2022-12-27	WOS:000077968500016
J	Eichenberg, K; Kunkel, T; Kretsch, T; Speth, V; Schafer, E				Eichenberg, K; Kunkel, T; Kretsch, T; Speth, V; Schafer, E			In vivo characterization of chimeric phytochromes in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT-NEGATIVE SUPPRESSION; PHYCOCYANOBILIN ADDUCTS; REGULATORY ACTIVITY; TERMINAL-DOMAIN; ARABIDOPSIS; LIGHT; SEEDLINGS; EXPRESSION; SEQUENCES; PROTEIN	Phytochromes are plant photoreceptors that play a major role in photomorphogenesis. Two members of the phytochrome family have been characterized in some detail. Phytochrome A, which controls very low fluence and high irradiance responses, is rapidly degraded in the light, forms sequestered areas of phytochrome (SAPs), and does not exhibit dark reversion in monocotyledonous seedlings. Phytochrome B mediates red! far-red reversible responses, is stable in the light, and does not form SAPs, We report on the behavior in yeast of the phytochrome apoproteins of rice PHYA, tobacco PHYB, and chimeric PHYAB and PHYBA and on the behavior of the respective holoprotein adducts after assembly with phycocyanobilin chromophore (PHY*). SAP-like formation in yeast was not observed for PHYB but was detectable for PHYA, PHYAB, and PHYBA. Rice PHYA* did not undergo dark reversion in yeast. Surprisingly, all other tested phytochrome constructs did exhibit dark reversion, including chimeric phytochromes with a short N-terminal part of tobacco PHYB or parsley PHYA fused to rice PHYA. Furthermore, the proportion of phytochrome undergoing dark reversion and the rate of reversion were increased for both the N terminus-swapped constructs and PHYBA*, These results are discussed with respect to structure/function analysis of phytochromes A and B.	Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany	University of Freiburg	Schafer, E (corresponding author), Univ Freiburg, Inst Biol 2, Schanzlestr 1, D-79104 Freiburg, Germany.	schaegen@ruf.uni-freiburg.de						ABE A, 1988, AGR BIOL CHEM TOKYO, V52, P2035; Aukerman MJ, 1997, PLANT CELL, V9, P1317, DOI 10.1105/tpc.9.8.1317; BOYLAN M, 1994, PLANT CELL, V6, P449, DOI 10.1105/tpc.6.3.449; BROCKMANN J, 1987, PLANT CELL ENVIRON, V10, P105, DOI 10.1111/1365-3040.ep11602037; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; COLE WJ, 1967, J AM CHEM SOC, V89, P3643, DOI 10.1021/ja00990a055; Elich TD, 1997, PLANT CELL, V9, P2271, DOI 10.1105/tpc.9.12.2271; EMMLER K, 1995, PLANTA, V197, P103, DOI 10.1007/BF00239945; Furuya M, 1996, TRENDS PLANT SCI, V1, P301; Furuya Masaki, 1994, P29; Furuya Masaki, 1994, P105; Gross J, 1984, TECHNIQUES PHOTOMORP, P131; HEIM B, 1981, PHOTOCHEM PHOTOBIOL, V34, P89; HOFMANN E, 1991, PLANTA, V183, P265, DOI 10.1007/BF00197798; JABBEN M, 1983, PHOTOMORPHOGENESIS, P704; KAY SA, 1989, NUCLEIC ACIDS RES, V17, P2865, DOI 10.1093/nar/17.7.2865; KENDRICK RE, 1971, AM J BOT, V58, P424, DOI 10.2307/2441134; Kendrick RE, 1994, PHOTOMORPHOGENESIS P; KERN R, 1993, PLANT PHYSIOL, V102, P1363, DOI 10.1104/pp.102.4.1363; Kunkel T, 1996, PLANT J, V10, P625, DOI 10.1046/j.1365-313X.1996.10040625.x; KUNKEL T, 1995, J BIOL CHEM, V270, P20193, DOI 10.1074/jbc.270.34.20193; KUNKEL T, 1993, EUR J BIOCHEM, V215, P587, DOI 10.1111/j.1432-1033.1993.tb18069.x; LI LM, 1994, P NATL ACAD SCI USA, V91, P12535, DOI 10.1073/pnas.91.26.12535; LI LM, 1992, J BIOL CHEM, V267, P19204; Mancinelli Alberto L., 1994, P211; MARME D, 1971, PLANTA, V100, P331, DOI 10.1007/BF00385197; MORISHIMA N, 1990, J BIOL CHEM, V265, P15189; NAGATANI A, 1993, PLANT PHYSIOL, V102, P269, DOI 10.1104/pp.102.1.269; PARKS BM, 1993, PLANT CELL, V5, P39, DOI 10.1105/tpc.5.1.39; POPOV N, 1975, ACTA BIOL MED GER, V34, P1441; POPPE C, 1994, PLANT MOL BIOL, V26, P481, DOI 10.1007/BF00039558; Pratt Lee H., 1994, P163; PRATT LH, 1978, PHOTOCHEM PHOTOBIOL, V27, P81, DOI 10.1111/j.1751-1097.1978.tb07569.x; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Ruddat A, 1997, BIOCHEMISTRY-US, V36, P103, DOI 10.1021/bi962012w; SCHAFER E, 1974, PLANTA, V116, P257, DOI 10.1007/BF00390231; SCHAFER E, 1975, PHOTOCHEM PHOTOBIOL, V22, P193, DOI 10.1111/j.1751-1097.1975.tb06736.x; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; SPETH V, 1987, PLANTA, V171, P332, DOI 10.1007/BF00398678; Vierstra Richard D., 1994, P141; Wagner D, 1996, P NATL ACAD SCI USA, V93, P4011, DOI 10.1073/pnas.93.9.4011; WAGNER D, 1995, P NATL ACAD SCI USA, V92, P8596, DOI 10.1073/pnas.92.19.8596; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; XU Y, 1995, PLANT CELL, V7, P1433, DOI 10.1105/tpc.7.9.1433; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	46	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					354	359		10.1074/jbc.274.1.354	http://dx.doi.org/10.1074/jbc.274.1.354			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867850	hybrid			2022-12-27	WOS:000077900200050
J	Hani, J; Schelbert, B; Bernhardt, A; Domdey, H; Fischer, G; Wiebauer, K; Rahfeld, JU				Hani, J; Schelbert, B; Bernhardt, A; Domdey, H; Fischer, G; Wiebauer, K; Rahfeld, JU			Mutations in a peptidylprolyl-cis/trans-isomerase gene lead to a defect in 3 '-end formation of a pre-mRNA in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERASES; T7 RNA-POLYMERASE; POLYADENYLATION SITES; TERMINAL DOMAIN; CYCLOPHILIN-A; PROTEINS; EXPRESSION; TRANSCRIPTION; MUTAGENESIS; HOMOLOGY	In a genetic screen aimed at the identification of trans acting factors involved in mRNA 3'-end processing of budding yeast, we have previously isolated two temperature-sensitive mutants with an apparent defect in the 3'-end formation of a plasmid-derived pre-mRNA Surprisingly, both mutants were rescued by the essential gene ESS1/PTF1 that encoded a putative peptidylprolyl-cis/trans-isomerase (PPIase) (Hani, J., Stumpf, G., and Domdey, H. (1995) FFBS Lett, 365, 198-202), Such enzymes, which catalyze the cis/trans-interconversion of peptide bonds N-terminal of prolines, are suggested to play a role in protein folding or trafficking. Here we report that Ptf1p shows PPIase activity in vitro, displaying an unusual substrate specificity for peptides with phosphorylated serine and threonine residues preceding proline, Both mutations were found to result in amino acid substitutions of highly conserved residues within the PPIase domain, causing a marked decrease in PPIase activity of the mutant enzymes. Our results are suggestive of a so far unknown involvement of a PPIase in mRNA 3'-end formation in Saccharomyces cerevisiae.	Univ Munich, Genzentrum, D-81377 Munich, Germany; Max Planck Gesell Forderung Wissensch EV, Forsch Stelle Enzymol Prot Faltung, D-06120 Halle, Germany	University of Munich; Max Planck Society	Wiebauer, K (corresponding author), Univ Munich, Genzentrum, Feodor Lynen Str 25, D-81377 Munich, Germany.			Hernandez Alvarez, Birte/0000-0003-0635-8698				ALTINGMEES MA, 1989, NUCLEIC ACIDS RES, V17, P9494, DOI 10.1093/nar/17.22.9494; [Anonymous], 1997, NATURE, V387, pS; Bourquin JP, 1997, NUCLEIC ACIDS RES, V25, P2055, DOI 10.1093/nar/25.11.2055; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; BUTLER JS, 1990, MOL CELL BIOL, V10, P2599, DOI 10.1128/MCB.10.6.2599; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; DOMDEY H, 1984, CELL, V39, P611, DOI 10.1016/0092-8674(84)90468-9; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1994, ANGEW CHEM INT EDIT, V33, P1415, DOI 10.1002/anie.199414151; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; GARCIAECHEVERRIA C, 1993, BIOCHEM BIOPH RES CO, V191, P70, DOI 10.1006/bbrc.1993.1185; Haber J E, 1975, Methods Cell Biol, V11, P45, DOI 10.1016/S0091-679X(08)60316-7; HAID A, 1983, METHOD ENZYMOL, V96, P6921; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; HANI J, 1995, FEBS LETT, V365, P198, DOI 10.1016/0014-5793(95)00471-K; HEIDMANN S, 1992, MOL CELL BIOL, V12, P4215, DOI 10.1128/MCB.12.9.4215; Horowitz DS, 1997, RNA, V3, P1374; IRNIGER S, 1991, MOL CELL BIOL, V11, P3060, DOI 10.1128/MCB.11.6.3060; JOHNSON PF, 1983, NATURE, V302, P381; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE CW, 1991, METHOD ENZYMOL, V194, P273; LIN RJ, 1985, J BIOL CHEM, V260, P4780; Lu KP, 1996, NATURE, V380, P544; LU KP, 1995, CELL, V81, P413, DOI 10.1016/0092-8674(95)90394-1; Maleszka R, 1997, GENE, V203, P89, DOI 10.1016/S0378-1119(97)00522-2; Maleszka R, 1996, P NATL ACAD SCI USA, V93, P447, DOI 10.1073/pnas.93.1.447; MANNINGKRIEG UC, 1994, FEBS LETT, V352, P98, DOI 10.1016/0014-5793(94)00927-9; MYERS AM, 1987, J BIOL CHEM, V262, P3388; RAHFELD JU, 1994, FEBS LETT, V352, P180, DOI 10.1016/0014-5793(94)00932-5; RAHFELD JU, 1994, FEBS LETT, V343, P65, DOI 10.1016/0014-5793(94)80608-X; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; RUSSNAK R, 1995, MOL CELL BIOL, V15, P1689; RUSSO P, 1989, P NATL ACAD SCI USA, V86, P8348, DOI 10.1073/pnas.86.21.8348; SCHMID FX, 1993, ADV PROTEIN CHEM, V44, P25, DOI 10.1016/S0065-3233(08)60563-X; Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z; SHERMAN F, 1991, METHOD ENZYMOL, V194, P21; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Teigelkamp S, 1998, RNA, V4, P127; Zhao YD, 1997, STRUCTURE, V5, P139, DOI 10.1016/S0969-2126(97)00172-X	48	89	90	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					108	116		10.1074/jbc.274.1.108	http://dx.doi.org/10.1074/jbc.274.1.108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867817	hybrid			2022-12-27	WOS:000077900200017
J	Kovacic, B; Ilic, D; Damsky, CH; Gardner, DG				Kovacic, B; Ilic, D; Damsky, CH; Gardner, DG			c-Src activation plays a role in endothelin-dependent hypertrophy of the cardiac myocyte	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-FACTOR; PROTEIN-KINASE-C; FAMILY TYROSINE KINASES; SERUM RESPONSE FACTOR; SIGNAL-TRANSDUCTION PATHWAYS; FIBROBLAST GROWTH-FACTORS; MUSCLE CELL HYPERTROPHY; FOCAL ADHESION KINASE; ALPHA-ACTIN PROMOTER; FOS GENE-EXPRESSION	Activation of the atrial natriuretic peptide (ANP) gene is regarded as one of the earliest and most reliable markers of hypertrophy in the ventricular cardiac myocyte. We have examined the role of the nonreceptor tyrosine kinases in the signaling mechanism(s) leading to hypertrophy using human ANP gene promoter activity as a marker. Endothelin (ET), a well known hypertrophic agonist, increased activity of c-Src, c-Yes, and Fyn within minutes and promoted a selective redistribution of each of these kinases within the cell. Overexpression of c-Src effected a significant increase in activity of a cotransfected human ANP promoter-driven chloramphenicol acetyl transferase reporter, while expression of either c-Yes or Fyn was considerably less effective in this regard. ET-dependent stimulation of the human ANP gene promoter was partially inhibited by co-transfection with dominant negative Ras or dominant negative Src or Csk or by treatment with the potent Src family-selective tyrosine kinase inhibitor PPI, suggesting that the Src family kinases are involved in signaling ET-dependent activation of this promoter. Both ET- and Src-dependent activation of the ANP promoter required the presence of a CArG motif in a serum response element-like structure between -422 and -413 but did not appear to require assembly of a ternary complex for full activity. These findings support a role for Src in the activation of ANP gene expression and suggest that this kinase may contribute in an important way to the signaling mechanisms that activate hypertrophy in the cardiac myocyte.	Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kovacic, B (corresponding author), Univ Calif San Francisco, Metab Res Unit, Box 0540, San Francisco, CA 94143 USA.	branka@itsa.ucsf.edu		ILIC, DUSKO/0000-0003-1647-0026	NHLBI NIH HHS [HL 35753] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035753] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARDATI A, 1993, EMBO J, V12, P5131, DOI 10.1002/j.1460-2075.1993.tb06208.x; BAUER RF, 1976, IN VITRO CELL DEV B, V12, P558; BAXTER JD, 1988, BIO-TECHNOL, V6, P529, DOI 10.1038/nbt0588-529; BOGOYEVITCH MA, 1995, J BIOL CHEM, V270, P26303, DOI 10.1074/jbc.270.44.26303; BOGOYEVITCH MA, 1994, J BIOL CHEM, V269, P1110; Cazaubon S, 1997, J NEUROSCI, V17, P6203; CHENG HC, 1992, J BIOL CHEM, V267, P9248; CHIEN KR, 1993, ANNU REV PHYSIOL, V55, P77, DOI 10.1146/annurev.ph.55.030193.000453; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; GARDNER DG, 1986, P NATL ACAD SCI USA, V83, P6697, DOI 10.1073/pnas.83.18.6697; GARDNER DG, 1987, P NATL ACAD SCI USA, V84, P2175, DOI 10.1073/pnas.84.8.2175; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HERMAN WH, 1995, J BIOL CHEM, V270, P11654, DOI 10.1074/jbc.270.19.11654; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; IRONS CE, 1993, J BIOL CHEM, V268, P23417; KARIYA K, 1994, J BIOL CHEM, V269, P3775; KARNS LR, 1995, J BIOL CHEM, V270, P410, DOI 10.1074/jbc.270.1.410; Kawakatsu H, 1996, J BIOL CHEM, V271, P5680, DOI 10.1074/jbc.271.10.5680; KNOWLTON KU, 1991, J BIOL CHEM, V266, P7759; KOVACICMILIVOJEVIC B, 1992, MOL CELL BIOL, V12, P292, DOI 10.1128/MCB.12.1.292; Kuppuswamy D, 1997, J BIOL CHEM, V272, P4500, DOI 10.1074/jbc.272.7.4500; LAPOINTE MC, 1988, J BIOL CHEM, V263, P9075; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MACLELLAN WR, 1994, J BIOL CHEM, V269, P16754; McDonough PM, 1997, J BIOL CHEM, V272, P24046, DOI 10.1074/jbc.272.38.24046; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; PARKER TG, 1990, P NATL ACAD SCI USA, V87, P7066, DOI 10.1073/pnas.87.18.7066; PARKER TG, 1992, J BIOL CHEM, V267, P3343; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; RodriguezFernandez JL, 1996, J BIOL CHEM, V271, P27895, DOI 10.1074/jbc.271.44.27895; SADOSHIMA J, 1993, CIRC RES, V73, P424, DOI 10.1161/01.RES.73.3.424; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; Sadoshima J, 1996, EMBO J, V15, P5535, DOI 10.1002/j.1460-2075.1996.tb00938.x; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Sadoshima J, 1996, EMBO J, V15, P775, DOI 10.1002/j.1460-2075.1996.tb00413.x; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; Simonson MS, 1996, J BIOL CHEM, V271, P77, DOI 10.1074/jbc.271.1.77; Simonson MS, 1996, AM J PHYSIOL-RENAL, V270, pF790, DOI 10.1152/ajprenal.1996.270.5.F790; SPRENKLE AB, 1995, CIRC RES, V77, P1060, DOI 10.1161/01.RES.77.6.1060; SUPERTIFURGA G, 1993, EMBO J, V12, P2625, DOI 10.1002/j.1460-2075.1993.tb05923.x; THORBURN A, 1993, J BIOL CHEM, V268, P2244; THORBURN J, 1994, BIOCHEM BIOPH RES CO, V202, P1586, DOI 10.1006/bbrc.1994.2113; Thuerauf DJ, 1997, J BIOL CHEM, V272, P7464, DOI 10.1074/jbc.272.11.7464; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; TWAMLEYSTEIN GM, 1993, P NATL ACAD SCI USA, V90, P7696, DOI 10.1073/pnas.90.16.7696; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; WU JP, 1991, MOL ENDOCRINOL, V5, P1311, DOI 10.1210/mend-5-9-1311; ZACHARY I, 1993, J BIOL CHEM, V268, P22060; Zou YZ, 1996, J BIOL CHEM, V271, P33592, DOI 10.1074/jbc.271.52.33592	56	60	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35185	35193						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857056				2022-12-27	WOS:000077719700074
J	Morsomme, P; Dambly, S; Maudoux, O; Boutry, M				Morsomme, P; Dambly, S; Maudoux, O; Boutry, M			Single point mutations distributed in 10 soluble and membrane regions of the Nicotiana plumbaginifolia plasma membrane PMA2 H+-ATPase activate the enzyme and modify the structure of the C-terminal region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PLANT DEFENSE RESPONSE; SARCOPLASMIC-RETICULUM; SCANNING MUTAGENESIS; DELETION ANALYSIS; FUNGAL PATHOGENS; GENE; IDENTIFICATION; DOMAIN; LYSOPHOSPHATIDYLCHOLINE	The Nicotiana plumbaginifolia pma2 (plasma membrane H+-ATPase) gene is capable of functionally replacing the H+-ATPase genes of the yeast Saccharomyces cerevisiae, provided that the external pH is kept above 5.0, Single point mutations within the pma2 gene were previously identified that improved H+-ATPase activity and allowed yeast growth at pH 4.0. The aim of the present study was to identify most of the PMA2 positions, the mutation of which would lead to improved growth and to determine whether all these mutations result in similar enzymatic and structural modifications. We selected additional mutants in total 42 distinct point mutations localized in 30 codons, They were distributed in 10 soluble and membrane regions of the enzyme. Most mutant PMA2 H+-ATPases were characterized by a higher specific activity, lower inhibition by ADP, and lower stimulation by lysophosphatidylcholine than wild-type PMA2. The mutants thus seem to be constitutively activated. Partial tryptic digestion and immunodetection showed that the PMA2 mutants had a conformational change making the C-terminal region more accessible. These data therefore support the hypothesis that point mutations in various H+-ATPase parts displace the inhibitory C-terminal region, resulting in enzyme activation. The high density of mutations within the first half of the C-terminal region suggests that this part is involved in the interaction between the inhibitory C-terminal region and the rest of the enzyme.	Catholic Univ Louvain, Unite Biochim Physiol, B-1348 Louvain, Belgium	Universite Catholique Louvain	Boutry, M (corresponding author), Catholic Univ Louvain, Unite Biochim Physiol, Pl Croix Sud 2-20, B-1348 Louvain, Belgium.	boutry@fysa.ucl.ac.be	Morsomme, Pierre/AAD-9600-2019	Boutry, Marc/0000-0002-2315-6900; Morsomme, Pierre/0000-0001-7780-7230				Ambesi A, 1996, J BIOL CHEM, V271, P22999, DOI 10.1074/jbc.271.38.22999; ANAND S, 1995, BBA-BIOMEMBRANES, V1234, P127, DOI 10.1016/0005-2736(94)00281-S; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; ERASO P, 1994, J BIOL CHEM, V269, P10393; EWING NN, 1994, PLANT PHYSIOL, V106, P547, DOI 10.1104/pp.106.2.547; Fullone MR, 1998, J BIOL CHEM, V273, P7698, DOI 10.1074/jbc.273.13.7698; GABER RF, 1992, INT REV CYTOL, V137A, P299; GOFFEAU A, 1981, BIOCHIM BIOPHYS ACTA, V639, P197, DOI 10.1016/0304-4173(81)90010-0; GOFFEAU A, 1988, METHOD ENZYMOL, V157, P528; Gomes E, 1996, FEBS LETT, V398, P48, DOI 10.1016/S0014-5793(96)01218-5; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jahn T, 1997, PLANT CELL, V9, P1805, DOI 10.1105/tpc.9.10.1805; JOHANSSON F, 1993, PLANT CELL, V5, P321, DOI 10.2307/3869599; JOSEPHSON L, 1977, BIOCHEMISTRY-US, V16, P4572, DOI 10.1021/bi00640a006; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MICHELET B, 1995, PLANT PHYSIOL, V108, P1, DOI 10.1104/pp.108.1.1; MONK BC, 1994, J BIOENERG BIOMEMBR, V26, P101, DOI 10.1007/BF00763222; MORIAU L, 1993, PLANT MOL BIOL, V21, P955, DOI 10.1007/BF00023594; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Oecking C, 1997, PLANT J, V12, P441, DOI 10.1046/j.1365-313X.1997.12020441.x; PALMGREN MG, 1988, PHYSIOL PLANTARUM, V74, P11, DOI 10.1111/j.1399-3054.1988.tb04934.x; PALMGREN MG, 1994, J BIOL CHEM, V269, P3027; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Portillo F, 1997, FEBS LETT, V402, P136, DOI 10.1016/S0014-5793(96)01515-3; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; RAO R, 1996, MYCOTA, V3, P29; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Rice WJ, 1996, J BIOL CHEM, V271, P31412, DOI 10.1074/jbc.271.49.31412; SCHALLER GE, 1988, PLANTA, V173, P508; SCHLESSER A, 1988, J BIOL CHEM, V263, P19480; SERRANO R, 1989, ANNU REV PLANT PHYS, V40, P61; SetoYoung D, 1996, J BIOL CHEM, V271, P581, DOI 10.1074/jbc.271.1.581; SUPPLY P, 1993, J BIOL CHEM, V268, P19744; SUSSMAN MR, 1994, ANNU REV PLANT PHYS, V45, P211, DOI 10.1146/annurev.pp.45.060194.001235; TRECO DA, 1989, CURRENT PROTOCOLS MO; VERAESTRELLA R, 1994, PLANT PHYSIOL, V104, P209, DOI 10.1104/pp.104.1.209; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WACH A, 1990, EUR J BIOCHEM, V189, P675, DOI 10.1111/j.1432-1033.1990.tb15536.x; WACH A, 1992, J BIOENERG BIOMEMBR, V24, P309; Wang GF, 1996, J BIOL CHEM, V271, P25438, DOI 10.1074/jbc.271.41.25438; Xing T, 1996, PLANT CELL, V8, P555, DOI 10.2307/3870332	43	108	116	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34837	34842		10.1074/jbc.273.52.34837	http://dx.doi.org/10.1074/jbc.273.52.34837			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857010	hybrid			2022-12-27	WOS:000077719700028
J	Wakamori, M; Yamazaki, K; Matsunodaira, H; Teramoto, T; Tanaka, I; Niidome, T; Sawada, K; Nishizawa, Y; Sekiguchi, N; Mori, E; Mori, Y; Imoto, K				Wakamori, M; Yamazaki, K; Matsunodaira, H; Teramoto, T; Tanaka, I; Niidome, T; Sawada, K; Nishizawa, Y; Sekiguchi, N; Mori, E; Mori, Y; Imoto, K			Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CA2+ CHANNELS; BETA-SUBUNIT; ALPHA(1) SUBUNIT; CHARGE MOVEMENT; SKELETAL-MUSCLE; PURKINJE-CELLS; MUTANT MICE; NEURONS; ATAXIA; BRAIN	Recent genetic and molecular biological analyses have revealed many forms of inherited channelopathies. Homozygous ataxic mice, tottering (tg) and leaner (tg(1a)) mice, have mutations in the P/Q-type Ca2+ channel alpha(1A) subunit gene. Although their clinical phenotypes, histological changes, and locations of gene mutations are known, it remains unclear what phenotypes the mutant Ca2+ channels manifest, or whether the altered channel properties are the primary consequence of the mutations. To address these questions, we have characterized the electrophysiological properties of Ca2+ channels in cerebellar Purkinje cells, where the P-type is the dominant Ca2+ channel, dissociated from the normal, tg, and tg(1a) mice, and compared them with the properties of the wild-type and mutant alpha(1A) channels recombinantly expressed with the alpha(2) and beta subunits in baby hamster kidney cells. The most striking feature of Ca2+ channel currents of mutant Purkinje cells was a marked reduction in current density, being reduced to similar to 60 and similar to 40% of control in tg and tg(1a) mice, respectively, without changes of cell size. The Ca2+ channel currents in the tg Purkinje cells showed a relative increase in non-inactivating component in voltage-dependent inactivation. Besides the same change, those of the tg(1a) mice showed a more distinct change in voltage dependence of activation and inactivation, being shifted in the depolarizing direction by similar to 10 mV, with a broader voltage dependence of inactivation. In the recombinant expression system, the tg channel with a missense mutation (P601L) and one form of the two possible tg(1a) aberrant splicing products, tg(1a) (short) channel, showed a significant reduction in current density, while the other form of the tg(1a) channels, tg(1a) (long), had a current density comparable to the normal control. On the other hand, the shift in voltage dependence of activation and inactivation was observed only for the tg(1a) (long) channel. Comparison of properties of the native and recombinant mutant channels suggests that single tottering mutations are directly responsible for the neuropathic phenotypes of reduction in current density and deviations in gating behavior, which lead to neuronal death and cerebellar atrophy.	Natl Inst Physiol Sci, Dept Informat Physiol, Okazaki, Aichi 4448585, Japan; Eisai Tsukuba Res Labs, Tsukuba, Ibaraki 3002635, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Eisai Co Ltd	Imoto, K (corresponding author), Natl Inst Physiol Sci, Dept Informat Physiol, Okazaki, Aichi 4448585, Japan.	Keiji@nips.ac.jp	Wakamori, Minoru/AAE-2661-2019	Wakamori, Minoru/0000-0001-8574-3310; Imoto, Keiji/0000-0002-2861-5985				AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; Dickie MM, 1964, MOUSE NEWS LETT, V30, P31; Doroshenko PA, 1997, NEUROPHARMACOLOGY, V36, P865, DOI 10.1016/S0028-3908(97)00032-4; DUNG HC, 1972, TEX REP BIOL MED, V30, P23; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; GALLI C, 1995, J NEUROSCI, V15, P1172; GLOSSMANN H, 1990, REV PHYSL BIOCH PHAR, V114, P1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HECKROTH JA, 1994, BRAIN RES, V658, P93, DOI 10.1016/S0006-8993(09)90014-2; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Kamp TJ, 1996, J PHYSIOL-LONDON, V492, P89, DOI 10.1113/jphysiol.1996.sp021291; KLOCKNER U, 1995, J BIOL CHEM, V270, P17306, DOI 10.1074/jbc.270.29.17306; KOH JY, 1992, BRAIN RES, V587, P233, DOI 10.1016/0006-8993(92)91002-V; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P363, DOI 10.1002/mus.880100414; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; Lorenzon NM, 1998, J NEUROSCI, V18, P4482; MEIER H, 1971, J HERED, V62, P297, DOI 10.1093/oxfordjournals.jhered.a108176; Melliti K, 1996, J PHYSIOL-LONDON, V490, P363, DOI 10.1113/jphysiol.1996.sp021150; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NIIDOME T, 1994, BIOCHEM BIOPH RES CO, V203, P1821, DOI 10.1006/bbrc.1994.2399; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; RANDALL A, 1995, J NEUROSCI, V15, P2995; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; Sidman RL., 1965, CATALOG NEUROLOGICAL, DOI [10.4159/harvard.9780674424326, DOI 10.4159/HARVARD.9780674424326]; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; TANAKA O, 1995, MOL BRAIN RES, V30, P1, DOI 10.1016/0169-328X(94)00265-G; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; VAGHY PL, 1988, TRENDS PHARMACOL SCI, V9, P398, DOI 10.1016/0165-6147(88)90066-1; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; Wakamori M, 1998, J NEUROPHYSIOL, V79, P622, DOI 10.1152/jn.1998.79.2.622; WAKAMORI M, 1993, BIOCHEM BIOPH RES CO, V196, P1170, DOI 10.1006/bbrc.1993.2374; WAKAMORI M, 1993, J PHYSIOL-LONDON, V463, P585, DOI 10.1113/jphysiol.1993.sp019612; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; Yue Q, 1997, AM J HUM GENET, V61, P1078, DOI 10.1086/301613; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	58	174	178	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34857	34867		10.1074/jbc.273.52.34857	http://dx.doi.org/10.1074/jbc.273.52.34857			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857013	hybrid			2022-12-27	WOS:000077719700031
J	Gueydan, C; Droogmans, L; Chalon, P; Huez, G; Caput, D; Kruys, V				Gueydan, C; Droogmans, L; Chalon, P; Huez, G; Caput, D; Kruys, V			Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEGRADATION; SEQUENCE	In monocyte/macrophages, the translation of tumor necrosis factor alpha (TNF-alpha) mRNA is tightly regulated. In unstimulated cells, translation of TNF-alpha mRNA is blocked. Upon stimulation with lipopolysaccharides, this repression is overcome, and the mRNA becomes efficiently translated. The key element in this regulation is the AU-rich element (ARE). We have previously reported the binding of two cytosolic protein complexes to the TNF-cu mRNA ARE. One of these complexes (complex 1) forms with extracts of both unstimulated and lipopolysaccharide-stimulated macrophages and requires a large fragment of the ARE containing clustered AUUUA pentamers, The other complex (complex 2) is only detected after cell activation, binds to a minimal UUAUUUAUU nonamer, and is composed of a 55-kDa protein. Here, we report the identification of the RNA-binding protein TIAR as a protein involved in complex 1. The RNA sequence bound by TIAR and the cytoplasmic localization of this protein in macrophages argue for an involvement of TIAR in TNF mRNA posttranscriptional regulation.	Free Univ Brussels, Chim Biol Lab, B-1640 Rhode St Genese, Belgium; Sanofi Elf Biorech, F-31676 Labege, France	Sanofi-Aventis	Gueydan, C (corresponding author), Free Univ Brussels, Chim Biol Lab, 67 Rue Chevaux, B-1640 Rhode St Genese, Belgium.		Kruys, Veronique I/N-6613-2018	Kruys, Veronique/0000-0002-3144-5403; Gueydan, Cyril/0000-0003-3097-7667				Beck ARP, 1996, NUCLEIC ACIDS RES, V24, P3829, DOI 10.1093/nar/24.19.3829; BEUTLER B, 1992, TUMOR NECROSIS FACTO, P485; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Gueydan C, 1996, MOL MED, V2, P479, DOI 10.1007/BF03401907; Han J, 1990, Eur Cytokine Netw, V1, P71; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; HAN JH, 1991, BIOCHIM BIOPHYS ACTA, V1090, P22, DOI 10.1016/0167-4781(91)90032-H; JARZEMBOWSKI JA, 1997, CYTOPLASMIC FATE MES, P141; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Lee K, 1996, MOL CELL BIOL, V16, P3023; Lewis T, 1998, J BIOL CHEM, V273, P13781, DOI 10.1074/jbc.273.22.13781; NAMBRU C, 1997, J BIOL CHEM, V272, P32061; QIAN ZW, 1994, NUCLEIC ACIDS RES, V22, P2334, DOI 10.1093/nar/22.12.2334; Sambrook J., 2002, MOL CLONING LAB MANU; TAUPIN JL, 1995, P NATL ACAD SCI USA, V92, P1629, DOI 10.1073/pnas.92.5.1629; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611	22	222	228	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2322	2326		10.1074/jbc.274.4.2322	http://dx.doi.org/10.1074/jbc.274.4.2322			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890998	hybrid			2022-12-27	WOS:000078185200065
J	Nighorn, A; Byrnes, KA; Morton, DB				Nighorn, A; Byrnes, KA; Morton, DB			Identification and characterization of a novel beta subunit of soluble guanylyl cyclase that is active in the absence of a second subunit and is relatively insensitive to nitric oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; CYCLIC-GMP; MOLECULAR-CLONING; MANDUCA-SEXTA; CGMP LEVELS; RAT LUNG; INHIBITION; INDUCTION; HORMONE; FORM	Previously characterized soluble guanylyl cyclases form alpha-beta heterodimers that can be activated by the gaseous messenger, nitric oxide. In mammals, four subunits have been cloned, named alpha 1, alpha 2, beta 1, and beta 2. We have identified a novel soluble guanylyl cyclase isoform from the nervous system of the insect Manduca sexta that we have named M. sexta guanylyl cyclase beta 3 (MsGC-beta 3). It is most closely related to the mammalian beta subunits but has several features that distinguish it from previously identified soluble cyclases. Most importantly, MsGC-beta 3 does not need to form heterodimers to form an active enzyme because guanylyl cyclase activity can be measured when it is expressed alone in COS-7 cells. Moreover, this activity is only weakly enhanced in the presence of the nitric oxide donor, sodium nitroprusside. Several of the amino acids in rat beta 1 subunits, previously identified as being important in heme binding or necessary for nitric oxide activation, are substituted with nonsimilar amino acids in MsGC-beta 3. There are also an additional 315 amino acids C-terminal to the catalytic domain of MsGC-beta 3 that have no sequence similarity to any known protein. Northern blot analysis shows that MsGC-beta 3 is primarily expressed in the nervous system of Manduca.	Oregon Hlth & Sci Univ, Dept Biol Struct & Funct, Sch Dent, Portland, OR 97201 USA; Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA	Oregon Health & Science University; University of Arizona	Nighorn, A (corresponding author), Oregon Hlth & Sci Univ, Dept Biol Struct & Funct, Sch Dent, 611 SW Campus Dr,SD, Portland, OR 97201 USA.	mortonda@ohsu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS029740, R01NS029740] Funding Source: NIH RePORTER; NINDS NIH HHS [NS29740] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; DREWETT JG, 1994, ENDOCR REV, V15, P135, DOI 10.1210/er.15.2.135; EWER J, 1994, J NEUROSCI, V14, P7704; Friebe A, 1997, BIOCHEMISTRY-US, V36, P1194, DOI 10.1021/bi962047w; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Gupta G, 1997, J CLIN INVEST, V100, P1488, DOI 10.1172/JCI119670; Hartell NA, 1996, J NEUROSCI, V16, P2881; HARTENECK C, 1991, FEBS LETT, V292, P217, DOI 10.1016/0014-5793(91)80871-Y; KOESLING D, 1990, FEBS LETT, V266, P128, DOI 10.1016/0014-5793(90)81523-Q; KOESLING D, 1988, FEBS LETT, V239, P29, DOI 10.1016/0014-5793(88)80539-8; LINCOLN TM, 1989, PHARMACOL THERAPEUT, V41, P479, DOI 10.1016/0163-7258(89)90127-7; LINDEN DJ, 1995, J NEUROSCI, V15, P5098; Morton DB, 1995, J COMP PHYSIOL B, V165, P417, DOI 10.1007/BF00261295; Morton DB, 1996, J NEUROBIOL, V29, P341, DOI 10.1002/(SICI)1097-4695(199603)29:3<341::AID-NEU6>3.3.CO;2-E; MORTON DB, 1992, J NEUROCHEM, V59, P1522, DOI 10.1111/j.1471-4159.1992.tb08469.x; Morton DB, 1997, ANN NY ACAD SCI, V814, P40, DOI 10.1111/j.1749-6632.1997.tb46143.x; NAKANE M, 1988, BIOCHEM BIOPH RES CO, V157, P1139, DOI 10.1016/S0006-291X(88)80992-6; NAKANE M, 1990, J BIOL CHEM, V265, P16841; Nighorn A, 1998, J NEUROSCI, V18, P7244; Schrammel A, 1996, MOL PHARMACOL, V50, P1; SIMPSON PJ, 1999, IN PRESS J BIOL CHEM; STONE JR, 1995, BIOCHEMISTRY-US, V34, P14668, DOI 10.1021/bi00045a007; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; TREMBLAY J, 1988, ADV SEC MESS PHOSPH, V22, P319; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; WEDEL B, 1995, J BIOL CHEM, V270, P24871, DOI 10.1074/jbc.270.42.24871; WILSON EM, 1995, BIOCHEMISTRY-US, V34, P4696, DOI 10.1021/bi00014a025; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; YUEN PST, 1990, BIOCHEMISTRY-US, V29, P10872, DOI 10.1021/bi00501a002; Zitnan D, 1996, SCIENCE, V271, P88, DOI 10.1126/science.271.5245.88	30	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2525	2531		10.1074/jbc.274.4.2525	http://dx.doi.org/10.1074/jbc.274.4.2525			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891024	hybrid			2022-12-27	WOS:000078185200091
J	Pikuleva, IA; Cao, C; Waterman, MR				Pikuleva, IA; Cao, C; Waterman, MR			An additional electrostatic interaction between adrenodoxin and P450c27 (CYP27A1) results in tighter binding than between adrenodoxin and P450scc (CYP11A1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN CLEAVAGE CYTOCHROME-P450; SIDE-CHAIN; BILE-ACIDS; SITE; CHOLESTEROL; IDENTIFICATION; MITOCHONDRIA; SPECIFICITY; EXPRESSION; REDUCTASE	Mitochondrial cytochrome P450c27 (product of the CYP27A1 gene) is found to have significantly higher affinity for the common redox partner adrenodoxin than another mitochondrial P450, P450scc (product of the CYP11A1 gene). To investigate the basis of the similar to 30-fold difference in adrenodoxin binding, two sets of P450c27 mutants were generated, expressed in Escherichia coli, and purified. Mutations of one set were within the putative adrenodoxin-binding site containing conserved lysine residues also crucial in P450scc for binding adrenodoxin, The second set included mutations within a sequence aligning with the "meander region" of P450BM-3 proposed to be a site of redox-partner interactions in P450s (Hasemann, C. A. Kurumbail, R. G., Boddupalli, S. S., Peterson, J. A. and Deisenhofer, J. (1995) Structure 3, 41-62), Mutation of the :P450c27 conserved lysines (K354A and K358A) led to a similar to 20-fold increase in apparent K-s for adrenodoxin, confirming that these two positively charged residues conserved in mitochondrial P450s are important for adrenodoxin binding. Mutation of Arg-418, conserved in the CYP27A1 family, to serine also decreased the affinity for adrenodoxin similar to 20-fold. This residue is predicted to be located in the meander region. A triple K354A/K358A/R418S mutation profoundly reduced adrenodoxin binding. Thus, in contrast to P450scc, where mutation of the two conserved positively charged residues results in virtually complete inhibition of adrenodoxin binding, in P450c27 there are three of such residues (Lys-354, Lys-358, and Arg-418) important for adrenodoxin interaction.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Pikuleva, IA (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.	pikuleva@toxicology.mc.vanderbilt.edu		Pikuleva, Irina/0000-0001-9742-6232	NIEHS NIH HHS [P30 ES00267] Funding Source: Medline; NIGMS NIH HHS [GM37942] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037942, R01GM037942] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON KE, 1972, J CLIN INVEST, V51, P112, DOI 10.1172/JCI106780; Beckert V, 1997, J BIOL CHEM, V272, P4883, DOI 10.1074/jbc.272.8.4883; BJORKHEM I, 1992, J LIPID RES, V33, P455; COGHLAN VM, 1991, J BIOL CHEM, V266, P18606; CUPP JR, 1989, J BIOL CHEM, V264, P1602; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; HANUKOGLU I, 1981, J BIOL CHEM, V256, P4321, DOI 10.1016/S0021-9258(19)69436-6; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; Muller A, 1998, STRUCTURE, V6, P269, DOI 10.1016/S0969-2126(98)00031-8; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; OMURA T, 1964, J BIOL CHEM, V239, P2370; PIKULEVA IA, 1995, ARCH BIOCHEM BIOPHYS, V322, P189, DOI 10.1006/abbi.1995.1451; Pikuleva IA, 1997, ARCH BIOCHEM BIOPHYS, V343, P123, DOI 10.1006/abbi.1997.0142; SAGARA Y, 1992, FEBS LETT, V300, P208, DOI 10.1016/0014-5793(92)80847-A; SAGARA Y, 1993, BIOL PHARM BULL, V16, P627; TSUBAKI M, 1989, BIOCHEMISTRY-US, V28, P6899, DOI 10.1021/bi00443a019; TULS J, 1989, J BIOL CHEM, V264, P16421; UHLMANN H, 1994, J BIOL CHEM, V269, P22557; WADA A, 1992, J BIOL CHEM, V267, P22877; WELLS JA, 1987, P NATL ACAD SCI USA, V84, P1219, DOI 10.1073/pnas.84.5.1219; WIKVALL K, 1984, J BIOL CHEM, V259, P3800; YAMAZAKI T, 1993, MOL CELL ENDOCRINOL, V95, P1, DOI 10.1016/0303-7207(93)90023-D	22	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2045	2052		10.1074/jbc.274.4.2045	http://dx.doi.org/10.1074/jbc.274.4.2045			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890963	hybrid			2022-12-27	WOS:000078185200030
J	Ravindranath, RMH; Moradian-Oldak, J; Fincham, AG				Ravindranath, RMH; Moradian-Oldak, J; Fincham, AG			Tyrosyl motif in amelogenins binds N-acetyl-D-glucosamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SPECIFIC LECTIN; WHEAT-GERM-AGGLUTININ; ENAMEL-MATRIX PROTEINS; DNA-SEQUENCE; SIALIC-ACID; DENTIN PHOSPHOPROTEIN; TOOTH DEVELOPMENT; BOVINE; PURIFICATION; CLEAVAGE	Ameloblasts secrete amelogenins on the pre-existing enamel matrix glycoproteins at the dentine-enamel junction. The hypothesis that amelogenins may interact with enamel matrix glycoproteins is tested by hemagglutination of purified, native (porcine) and recombinant murine amelogenins (rM179 and rM166) and hemaggIutination inhibition with sugars. Amelogenin agglutination of murine erythrocytes was specifically inhibited by N-acetylglucosamine (GlcNAc), chitobiose, and chitotetraose and by ovalbumin with terminal GlcNAc. The GlcNAc affinity was confirmed by dosimetric binding of rM179 with [C-14]GlcNAc, specific binding in relation to varying concentrations of GlcNAc, Scatchard plot analysis and competitive inhibition with Gold GlcNAc, The hemagglutination activity and [C-14]GlcNAc affinity were retained by the NH2-terminal tyrosine-rich amelogenin peptide (TRAP) but not by the leucine-rich amelogenin peptide, LRAP (a polypeptide sharing 33 amino acid residues of TRAP), or by the C-terminal 13 residue polypeptide of amelogenin (rM179). Since TRAP but not the 33-residue sequence of the TRAP shared by LRAP bound to [C-14]GlcNAc, we inferred that the GlcNAc binding motif was located in the 13-residue tyrosyl C-terminal domain of TRAP (PYPSYGYEPMGGW), which was absent from LRAP, [C-14]GlcNAc did indeed bind to this '"amelogenin tyrosyl motif peptide" but not when the tyrosyl residues were substituted with phenylalanine or when the third proline was replaced by threonine. Significantly, this latter modification mimics a point mutation identified in a case of human X-linked amelogenesis imperfecta. The amelogenin tyrosyl motif peptide sequence showed a similarity to the secondary GlcNAc-binding site of wheat germ agglutinin.	Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA	University of Southern California	Ravindranath, RMH (corresponding author), Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St, Los Angeles, CA 90033 USA.				NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE002848] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE-02848] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AKITA H, 1992, ARCH ORAL BIOL, V37, P953, DOI 10.1016/0003-9969(92)90067-I; Belogortseva N, 1998, BBA-GEN SUBJECTS, V1380, P249, DOI 10.1016/S0304-4165(97)00150-5; BHAVANANDAN VP, 1979, J BIOL CHEM, V254, P4000; BONASS WA, 1994, BIOCHEM BIOPH RES CO, V198, P755, DOI 10.1006/bbrc.1994.1109; Boskey AL, 1997, J CELL BIOCHEM, V64, P632, DOI 10.1002/(SICI)1097-4644(19970315)64:4<632::AID-JCB11>3.0.CO;2-E; CHUNG CC, 1985, CALCIFIED TISSUE INT, V37, P395; CLARK RD, 1965, BIOCHIM BIOPHYS ACTA, V101, P267, DOI 10.1016/0926-6534(65)90004-7; Collier PM, 1997, ARCH ORAL BIOL, V42, P235, DOI 10.1016/S0003-9969(96)00099-4; CROWLEY JF, 1984, ARCH BIOCHEM BIOPHYS, V231, P524, DOI 10.1016/0003-9861(84)90417-X; CUERVO LA, 1973, CALC TISS RES, V13, P1, DOI 10.1007/BF02015390; DASILVA MLC, 1995, ARCH BIOCHEM BIOPHYS, V318, P465, DOI 10.1006/abbi.1995.1255; DEUTSCH D, 1991, J BIOL CHEM, V266, P16021; DOI Y, 1984, TOOTH ENAMEL, V4, P19; EASTOE JE, 1979, J DENT RES, V58, P753, DOI 10.1177/00220345790580022701; EASTOE JE, 1963, ARCH ORAL BIOL, V8, P633, DOI 10.1016/0003-9969(63)90078-5; ELWOOD WK, 1975, CALC TISS RES, V17, P337, DOI 10.1007/BF02546605; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; FINCHAM AG, 1981, BIOSCIENCE REP, V1, P771, DOI 10.1007/BF01114799; FINCHAM AG, 1992, INT CONGR SER, V1002, P187; FINCHAM AG, 1982, CARIES RES, V16, P64, DOI 10.1159/000260578; FINCHAM AG, 1991, ARCH ORAL BIOL, V36, P305, DOI 10.1016/0003-9969(91)90101-Y; FINCHAM AG, 1990, CALCIFIED TISSUE INT, V47, P105, DOI 10.1007/BF02555993; FINCHAM AG, 1983, BIOCHEM J, V211, P149, DOI 10.1042/bj2110149; FINCHAM AG, 1993, BIOCHEM BIOPH RES CO, V197, P248, DOI 10.1006/bbrc.1993.2468; Fukae M, 1996, Adv Dent Res, V10, P111; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Goldstein I J, 1978, Adv Carbohydr Chem Biochem, V35, P127; GOMORI G, 1955, METHOD ENZYMOL, V1, P138, DOI 10.1016/0076-6879(55)01020-3; Hu CC, 1997, J DENT RES, V76, P1720, DOI 10.1177/00220345970760110201; KELLEY KW, 1981, ARCH ORAL BIOL, V26, P893, DOI 10.1016/0003-9969(81)90148-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU EC, 1992, BIOCHEM BIOPH RES CO, V197, P248; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; MENANTEAU J, 1988, CALCIFIED TISSUE INT, V42, P196, DOI 10.1007/BF02556334; MENANTEAU J, 1998, CALCIFIED TISSUE INT, V42, P196; MERCY PD, 1993, EUR J BIOCHEM, V215, P697, DOI 10.1111/j.1432-1033.1993.tb18081.x; MERRIFIELD B, 1986, SCIENCE, V232, P341, DOI 10.1126/science.3961484; MILLER RL, 1987, METHOD ENZYMOL, V138, P527; MoradianOldak J, 1996, CONNECT TISSUE RES, V35, P231, DOI 10.3109/03008209609029196; NAKAMURA M, 1994, ANAT RECORD, V238, P383, DOI 10.1002/ar.1092380313; OVERALL CM, 1988, BIOCHEM J, V256, P965, DOI 10.1042/bj2560965; PETERS BP, 1979, BIOCHEMISTRY-US, V18, P5505, DOI 10.1021/bi00591a038; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; RAVINDRANATH MH, 1985, J BIOL CHEM, V260, P8850; RICHARD AG, 1955, INTEGUMENT ARTHROPOD; ROBINSON C, 1977, CALC TISS RES, V23, P19, DOI 10.1007/BF02012762; ROBINSON C, 1979, J DENT RES, V58, P871, DOI 10.1177/00220345790580024101; Sasaki S, 1991, MECH PHYLOGENY MINER, P79; SASAKI S, 1995, DENTAL ENAMEL FORMAT, P85; SEYER J, 1969, BIOCHIM BIOPHYS ACTA, V184, P509, DOI 10.1016/0304-4165(69)90265-7; SIGAL MJ, 1984, J HISTOCHEM CYTOCHEM, V32, P872, DOI 10.1177/32.8.6379038; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; SMITH CE, 1995, CALCIFIED TISSUE INT, V57, P133, DOI 10.1007/BF00298434; SNEAD ML, 1985, BIOCHEM BIOPH RES CO, V129, P812, DOI 10.1016/0006-291X(85)91964-3; SUGA S, 1970, ARCH ORAL BIOL, V15, P597, DOI 10.1016/0003-9969(70)90129-9; TAKAGI T, 1984, BIOCHEM BIOPH RES CO, V121, P592, DOI 10.1016/0006-291X(84)90223-7; Tan J, 1998, J DENT RES, V77, P1388, DOI 10.1177/00220345980770060301; TANABE T, 1992, CALCIFIED TISSUE INT, V51, P213, DOI 10.1007/BF00334549; TERMINE JD, 1980, J BIOL CHEM, V255, P9769; THESLEFF I, 1981, DIFFERENTIATION, V18, P75, DOI 10.1111/j.1432-0436.1981.tb01107.x; TRAVIS DF, 1964, J CELL BIOL, V23, P447, DOI 10.1083/jcb.23.3.447; WALTZ G, 1990, SCIENCE, V250, P1132; WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998; WRIGHT CS, 1984, J MOL BIOL, V178, P91, DOI 10.1016/0022-2836(84)90232-8; YAMAKOSHI Y, 1994, CALCIFIED TISSUE INT, V54, P69, DOI 10.1007/BF00316293; YAMAKOSHI Y, 1995, CALCIFIED TISSUE INT, V56, P323, DOI 10.1007/BF00318054; Yamamoto K, 1980, J Osaka Univ Dent Sch, V20, P119; YAMAMOTO K, 1992, J BIOCHEM-TOKYO, V111, P436, DOI 10.1093/oxfordjournals.jbchem.a123775; YAMASHITA K, 1987, J BIOL CHEM, V262, P1602; ZEICHNERDAVID M, 1995, INT J DEV BIOL, V39, P69	73	73	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2464	2471		10.1074/jbc.274.4.2464	http://dx.doi.org/10.1074/jbc.274.4.2464			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891017	hybrid			2022-12-27	WOS:000078185200084
J	Venditti, S; Vega-Palas, MA; Di Mauro, E				Venditti, S; Vega-Palas, MA; Di Mauro, E			Heterochromatin organization of a natural yeast telomere - Recruitment of Sir3p through interaction with histone H4 M terminus is required for the establishment of repressive structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTONOMOUSLY REPLICATING SEQUENCES; SILENT MATING LOCI; SACCHAROMYCES-CEREVISIAE; CHROMATIN STRUCTURE; LENGTH REGULATION; MOLECULAR-MODEL; NUCLEOSOME CORE; N-TERMINI; DNA; TRANSCRIPTION	The chromatin organization of eukaryotic telomeres is essential for telomeric function and is currently receiving great attention. In yeast, the structural organization of telomeres involves a complex interplay of telomeric proteins that results in the formation of heterochromatin. This telomeric heterochromatin involves homotypic and heterotypic protein interactions that have been summarized in a general model. Recent analyses have focused on the study of the structural complexity at yeast telomeres to the level of specific nucleosomes and of the distribution of protein complexes in a natural telomeric region (LIII). In this report, we further analyze the structural complexity of Lm and the implication of this structure on telomeric silencing. It. is shown that the establishment of repressive heterochromatin structures at LIII requires the recruitment of Sir3p through interaction with the N terminus of histone H4, The establishment of such structures does not require acetylation of any of four lysines located in the H4 N terminus (lysines 5, 8, 12, and 16).	Univ Rome La Sapienza, Dipartimento Genet & Biol Mol, Fdn Ist Pasteu, Fdn Cenci Bolognetti, I-00185 Rome, Italy; CNR, Ctr Acidi Nucl, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR)	Di Mauro, E (corresponding author), Univ Rome La Sapienza, Dipartimento Genet & Biol Mol, Fdn Ist Pasteu, Fdn Cenci Bolognetti, Ple Aldo Moro 5, I-00185 Rome, Italy.		Palas, Miguel Angel Vega/K-6424-2014	Palas, Miguel Angel Vega/0000-0003-1841-540X				APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; BUTTINELLI M, 1993, P NATL ACAD SCI USA, V90, P9315, DOI 10.1073/pnas.90.20.9315; CASERTA M, 1996, BIOESSAYS, V18, P947; CHAN CSM, 1983, J MOL BIOL, V168, P505, DOI 10.1016/S0022-2836(83)80299-X; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; EBRALIDSE KK, 1988, NATURE, V331, P365, DOI 10.1038/331365a0; FISHERADAMS G, 1995, EMBO J, V14, P1468, DOI 10.1002/j.1460-2075.1995.tb07133.x; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Guarente L, 1996, CELL, V86, P9, DOI 10.1016/S0092-8674(00)80072-0; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; LONGTINE MS, 1989, CURR GENET, V16, P225, DOI 10.1007/BF00422108; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; LOUIS EJ, 1994, GENETICS, V136, P789; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MEERSSEMAN G, 1992, EMBO J, V11, P2951, DOI 10.1002/j.1460-2075.1992.tb05365.x; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; Rhodes D, 1997, NATURE, V389, P231, DOI 10.1038/38386; ROTH SY, 1992, GENE DEV, V6, P411, DOI 10.1101/gad.6.3.411; SHAMPAY J, 1988, P NATL ACAD SCI USA, V85, P534, DOI 10.1073/pnas.85.2.534; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; THOMA F, 1992, BIOCHIM BIOPHYS ACTA, V1130, P1, DOI 10.1016/0167-4781(92)90455-9; THOMPSON JS, 1994, NATURE, V369, P245, DOI 10.1038/369245a0; Vega-Palas MA, 1998, J BIOL CHEM, V273, P9388, DOI 10.1074/jbc.273.16.9388; VegaPalas MA, 1997, NAT GENET, V15, P232, DOI 10.1038/ng0397-232; VENDITTI S, 1994, MOL GEN GENET, V242, P3811; WOLFFE AP, 1994, TRENDS BIOCHEM SCI, V19, P240, DOI 10.1016/0968-0004(94)90148-1; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; WRIGHT JH, 1995, NUCLEIC ACIDS RES, V23, P1454, DOI 10.1093/nar/23.9.1454; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	44	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1928	1933		10.1074/jbc.274.4.1928	http://dx.doi.org/10.1074/jbc.274.4.1928			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890947	hybrid			2022-12-27	WOS:000078185200014
J	Yamauchi, J; Kaziro, Y; Itoh, H				Yamauchi, J; Kaziro, Y; Itoh, H			Differential regulation of mitogen-activated protein kinase kinase 4 (MKK4) and 7 (MKK7) by signaling from G protein beta gamma subunit in human embryonal kidney 293 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; C-JUN KINASE; HETEROTRIMERIC G-PROTEINS; COUPLED RECEPTORS; TYROSINE KINASE; TERMINAL KINASE; MAP KINASE; PATHWAY; RAS; G-ALPHA(12)	Heterotrimeric G protein beta gamma subunit (G beta gamma) mediates signals to two types of stress-activated protein kinases, c-Jun NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase, in mammalian cells. To investigate the signaling mechanism whereby G beta gamma regulates the activity of JNK, we transfected kinase-deficient mutants of two JNK kinases, mitogen-activated protein kinase kinase 4 (MKK4) and 7 (MKK7), into human embryonal kidney 293 cells. G beta gamma-induced JNK activation was blocked by kinase-deficient MKK4 and to a lesser extent by kinase-deficient MKK7. Moreover, G beta gamma increased MKK4 activity by Q-fold and MKK7 activity by 2-fold. MKK4 activation by G beta gamma was blocked by dominant-negative Rho and Cdc42, whereas MKK7 activation was blocked by dominant-negative Rac. In addition, GP gamma-mediated MKK4 activation, but not MKK7 activation, was inhibited completely by specific tyrosine kinase inhibitors PP2 and PP1. These results indicate that G beta gamma induces JNK activation mainly through MKK4 activation dependent on Rho, Cdc42, and tyrosine kinase, and to a lesser extent through MKK7 activation dependent on Rac.	Tokyo Inst Technol, Fac Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Itoh, H (corresponding author), Tokyo Inst Technol, Fac Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.							Collins LR, 1996, J BIOL CHEM, V271, P17349, DOI 10.1074/jbc.271.29.17349; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; COSO OA, 1995, J BIOL CHEM, V270, P5620, DOI 10.1074/jbc.270.10.5620; Coso OA, 1996, J BIOL CHEM, V271, P3963; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Heasley LE, 1996, MOL CELL BIOL, V16, P648; Higashita R, 1997, J BIOL CHEM, V272, P25845, DOI 10.1074/jbc.272.41.25845; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; ITO A, 1995, FEBS LETT, V368, P183, DOI 10.1016/0014-5793(95)00643-N; Jho EH, 1997, J BIOL CHEM, V272, P24468, DOI 10.1074/jbc.272.39.24468; Kawakami Y, 1997, P NATL ACAD SCI USA, V94, P3938, DOI 10.1073/pnas.94.8.3938; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; LAHGHANSRAJASEK.SA, 1995, P NATL ACAD SCI USA, V92, P8601; Lawler S, 1997, FEBS LETT, V414, P153, DOI 10.1016/S0014-5793(97)00990-3; Lopez-Ilasaca M, 1998, J BIOL CHEM, V273, P2505, DOI 10.1074/jbc.273.5.2505; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MITCHELL FM, 1995, BIOCHEM J, V309, P381, DOI 10.1042/bj3090381; Mitsui H, 1997, J BIOL CHEM, V272, P4904, DOI 10.1074/jbc.272.8.4904; Moriguchi T, 1997, EMBO J, V16, P7045, DOI 10.1093/emboj/16.23.7045; Nagao M, 1998, J BIOL CHEM, V273, P22892, DOI 10.1074/jbc.273.36.22892; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; PRASAD MVVSV, 1995, J BIOL CHEM, V270, P18655, DOI 10.1074/jbc.270.31.18655; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; VoynoYasenetskaya TA, 1996, J BIOL CHEM, V271, P21081, DOI 10.1074/jbc.271.35.21081; Yamauchi J, 1997, J BIOL CHEM, V272, P7602, DOI 10.1074/jbc.272.12.7602; YAMAUCHI J, 1995, BIOCHEM BIOPH RES CO, V214, P694, DOI 10.1006/bbrc.1995.2341; Yamauchi JJ, 1997, J BIOL CHEM, V272, P27771, DOI 10.1074/jbc.272.44.27771; Yao ZB, 1997, J BIOL CHEM, V272, P32378, DOI 10.1074/jbc.272.51.32378	41	52	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1957	1965		10.1074/jbc.274.4.1957	http://dx.doi.org/10.1074/jbc.274.4.1957			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890951	hybrid			2022-12-27	WOS:000078185200018
J	Conyers, GB; Bessman, MJ				Conyers, GB; Bessman, MJ			The gene, ialA, associated with the invasion of human erythrocytes by Bartonella bacilliformis, designates a nudix hydrolase active on dinucleoside 5 '-polyphosphates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MUTT FAMILY; SURAMIN; PURIFICATION; PROTEINS; ENZYMES; CLONING; MEMBER; NADH	iaLA, one of two genes associated with the invasion of human red blood cells by Bartonella bacilliformis, the causative agent of several diseases, has been cloned and depressed in Escherichia coli. The protein, IalA, contains an amino acid array characteristic of a family of enzymes, the Nudix hydrolases, active on a variety of nucleoside diphosphate derivatives. IalA has been purified, identified, and characterized as an enzyme catalyzing the hydrolysis of members of a class of signaling nucleotides, the dinucleoside polyphosphates, with its highest activity on adenosine 5'-tetraphospho-5'-adenosine (Ap(4)A), but also hydrolyzing Ap(5)A, Ap(6)A, Gp(4)G, and Gp(5)G. In each case, a pyrophosphate linkage is cleaved yielding a nucleoside triphosphate and the remaining nucleotide moiety.	Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Johns Hopkins Univ, McCollum Pratt Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Bessman, MJ (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	zoot@jhu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM017178] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-17178, GM 18649] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMES BN, 1960, J BIOL CHEM, V235, P769; Andersson SGE, 1998, BBA-BIOENERGETICS, V1365, P105, DOI 10.1016/S0005-2728(98)00050-4; BAXI MD, 1995, J PHARMACOL TOX MET, V33, P121, DOI 10.1016/1056-8719(94)00127-P; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; BHATNAGAR SK, 1991, J BIOL CHEM, V266, P9050; Cartwright JL, 1997, BIOCHEM SOC T, V25, pS580, DOI 10.1042/bst025s580; FRICK DN, 1995, J BIOL CHEM, V270, P1529, DOI 10.1074/jbc.270.4.1529; FRICK DN, 1995, J BIOL CHEM, V270, P24086, DOI 10.1074/jbc.270.41.24086; GUPTA RS, 1995, MOL MICROBIOL, V15, P1, DOI 10.1111/j.1365-2958.1995.tb02216.x; HOURANI SMO, 1992, BRIT J PHARMACOL, V105, P453, DOI 10.1111/j.1476-5381.1992.tb14274.x; Ihler GM, 1996, FEMS MICROBIOL LETT, V144, P1, DOI [10.1016/0378-1097(96)00307-2, 10.1111/j.1574-6968.1996.tb08501.x]; LAZEWSKA D, 1993, PROTEIN EXPRES PURIF, V4, P45, DOI 10.1006/prep.1993.1007; Maksel D, 1998, BIOCHEM J, V329, P313, DOI 10.1042/bj3290313; MALLARD N, 1992, EUR J PHARMACOL, V220, P1, DOI 10.1016/0014-2999(92)90004-N; MARKHAM R, 1952, BIOCHEM J, V52, P552, DOI 10.1042/bj0520552; MATHEW N, 1995, BIOCHEM J, V311, P717, DOI 10.1042/bj3110717; Minnick MF, 1996, TRENDS MICROBIOL, V4, P343, DOI 10.1016/0966-842X(96)10055-X; MITCHELL SJ, 1995, INFECT IMMUN, V63, P1552, DOI 10.1128/IAI.63.4.1552-1562.1995; O'Handley SF, 1998, J BIOL CHEM, V273, P3192, DOI 10.1074/jbc.273.6.3192; OHandley SF, 1996, J BIOL CHEM, V271, P24649, DOI 10.1074/jbc.271.40.24649; OHNO N, 1993, EUR J PHARMACOL, V249, P121, DOI 10.1016/0014-2999(93)90671-4; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Rotllan P, 1998, FEBS LETT, V429, P143, DOI 10.1016/S0014-5793(98)00579-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vartanian A, 1997, FEBS LETT, V415, P160, DOI 10.1016/S0014-5793(97)01086-7; VIALE AM, 1994, FEBS LETT, V341, P146, DOI 10.1016/0014-5793(94)80446-X; WEBER DJ, 1992, J BIOL CHEM, V267, P16939	28	63	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1203	1206		10.1074/jbc.274.3.1203	http://dx.doi.org/10.1074/jbc.274.3.1203			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880487	hybrid			2022-12-27	WOS:000079956900007
J	Timmusk, T; Palm, K; Lendahl, U; Metsis, M				Timmusk, T; Palm, K; Lendahl, U; Metsis, M			Brain-derived neurotrophic factor expression in vivo is under the control of neuron-restrictive silencer element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATORY ELEMENT; TISSUE-SPECIFIC EXPRESSION; CELL-ADHESION MOLECULE; BETA-HYDROXYLASE GENE; SODIUM-CHANNEL GENE; RAT-BRAIN; SYNAPTIC TRANSMISSION; TRANSGENIC MICE; BDNF-GENE; TRANSCRIPTION	Neuron-restrictive silencer element (NRSE) has been identified in multiple neuron-specific genes. This element has been shown to mediate repression of neuronal gene transcription in nonneuronal cells. A palindromic NRSE (NRSEBDNF) is present in the proximal, region of brain-derived neurotrophic factor (BDNF) promoter II. Using in vitro binding assays, we establish that the upper half-site is largely responsible for the NRSEBDNF activity. To delineate the in vivo role of NRSE in the regulation of rat BDNF gene, promoter constructs with intact and mutated NRSEBDNF were introduced into transgenic mice. Our data show that NRSEBDNF is controlling the activity of BDNF promoters I and II in the brain, thymus, and lung, i.e. in the tissues in which the intact reporter gene and endogenous BDNF mRNAs are expressed. Mutation of NRSEBDNF did not lead to the ectopic activation of the reporter gene in any other nonneural tissues. In the brain, NRSEBDNF is involved in the repression of basal and kainic acid-induced expression from BDNF promoters I and II in neurons. However, NRSEBDNF does not control the activity of the BDNF gene in nonneuronal cells of brain.	Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17177 Stockholm, Sweden; Uppsala Univ, Ctr Biomed, Dept Dev Neurosci, S-75123 Uppsala, Sweden; Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Inst Chem Phys & Biophys, EE-0026 Tallinn, Estonia; Tallinn Univ Technol, Ctr Gene Technol, EE-0026 Tallinn, Estonia	Karolinska Institutet; Uppsala University; Karolinska Institutet; National Institute of Chemical Physics & Biophysics (NICPB); Tallinn University of Technology	Timmusk, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17177 Stockholm, Sweden.	tonis.timmusk@mun.uu.se	Schweitzer, Mary/V-8143-2019; Metsis, Madis/F-7080-2016; schweitzer, mary h/A-6756-2010; Timmusk, Tonis/H-4889-2015	Metsis, Madis/0000-0003-1667-677X; schweitzer, mary h/0000-0002-0427-3829; Timmusk, Tonis/0000-0002-1015-3348; Lendahl, Urban/0000-0001-9543-8141				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bai G, 1998, J BIOL CHEM, V273, P1086, DOI 10.1074/jbc.273.2.1086; Belluardo N, 1997, J COMP NEUROL, V379, P226; Berninger B, 1996, CURR OPIN NEUROBIOL, V6, P324, DOI 10.1016/S0959-4388(96)80115-2; Bessis A, 1997, P NATL ACAD SCI USA, V94, P5906, DOI 10.1073/pnas.94.11.5906; BISHOP JF, 1994, MOL BRAIN RES, V26, P225, DOI 10.1016/0169-328X(94)90094-9; Bishop JF, 1997, MOL BRAIN RES, V50, P154, DOI 10.1016/S0169-328X(97)00180-0; Bonhoeffer T, 1996, CURR OPIN NEUROBIOL, V6, P119, DOI 10.1016/S0959-4388(96)80017-1; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Cellerino A, 1996, PROG NEUROBIOL, V49, P53, DOI 10.1016/0301-0082(96)00008-1; CHIARAMELLO A, 1995, MOL CELL BIOL, V15, P6036; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Gall CM, 1995, WENN GR INT, V67, P275; Gan L, 1996, J BIOL CHEM, V271, P5859, DOI 10.1074/jbc.271.10.5859; Giesen K, 1997, DEVELOPMENT, V124, P2307; Hayes VY, 1997, MOL BRAIN RES, V45, P189, DOI 10.1016/S0169-328X(96)00254-9; Ishiguro H, 1995, MOL BRAIN RES, V34, P251, DOI 10.1016/0169-328X(95)00170-W; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Kallunki P, 1998, P NATL ACAD SCI USA, V95, P3233, DOI 10.1073/pnas.95.6.3233; KALLUNKI P, 1995, J BIOL CHEM, V270, P21291, DOI 10.1074/jbc.270.36.21291; Kallunki P, 1997, J CELL BIOL, V138, P1343, DOI 10.1083/jcb.138.6.1343; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Labouesse M, 1996, DEVELOPMENT, V122, P2579; Lee S, 1997, MOL BRAIN RES, V47, P183, DOI 10.1016/S0169-328X(97)00043-0; LEINGARTNER A, 1994, EUR J NEUROSCI, V6, P1149, DOI 10.1111/j.1460-9568.1994.tb00613.x; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lindvall O, 1995, WENN GR INT, V67, P417; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; Lonnerberg P, 1996, J BIOL CHEM, V271, P33358, DOI 10.1074/jbc.271.52.33358; METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Murray KD, 1998, EUR J NEUROSCI, V10, P377, DOI 10.1046/j.1460-9568.1998.00019.x; NAKAYAMA M, 1994, MOL BRAIN RES, V21, P206, DOI 10.1016/0169-328X(94)90251-8; Palm K, 1998, J NEUROSCI, V18, P1280; PATHAK BG, 1994, NUCLEIC ACIDS RES, V22, P4748, DOI 10.1093/nar/22.22.4748; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Salin T, 1997, MOL CELL NEUROSCI, V9, P264, DOI 10.1006/mcne.1997.0625; Schoch S, 1996, J BIOL CHEM, V271, P3317, DOI 10.1074/jbc.271.6.3317; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; SCHOENHERR CJ, 1995, CURR OPIN NEUROBIOL, V5, P566, DOI 10.1016/0959-4388(95)80060-3; Scholl T, 1996, J IMMUNOL, V156, P1448; SHASKUS J, 1995, J NEUROCHEM, V64, P52; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SLOAN JH, 1992, J IMMUNOL, V148, P2591; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TIMMUSK T, 1995, J CELL BIOL, V128, P185, DOI 10.1083/jcb.128.1.185; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O	56	108	114	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1078	1084						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873054				2022-12-27	WOS:000077968500069
J	Hsueh, YP; Sheng, M				Hsueh, YP; Sheng, M			Requirement of N-terminal cysteines of PSD-95 for PSD-95 multimerization and ternary complex formation, but not for binding to potassium channel Kv1.4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY PROTEIN PSD-95; NMDA RECEPTOR SUBUNITS; GUANYLATE KINASES; PDZ DOMAINS; CLUSTERING ACTIVITY; FASCICLIN-II; K+ CHANNELS; SHAKER; FAMILY; RECOGNITION	The PSD-95 family of PSD-95/Discs large/ZO-1 (PDZ) domain-containing proteins plays a role in the clustering and localization of specific ion channels and receptors at synapses. Previous studies have shown that PSD-95 forms multimers through an N-terminal region (termed the N-segment) and that the multimerization of PSD-95 is critical for its ability to cluster Shaker-type potassium channel Kv1.4 in heterologous cells. We show here that the PSD-95 N-segment functions as a multimerization domain only when located at the N-terminal end of a heterologous protein. A pair of N-terminal cysteines, Cys(3) and Cys(5), is essential for the ability of PSD-95 to self-associate and to form cell surface clusters with Kv1.4. However, PSD-95 mutants lacking these cysteine residues retain their ability to associate with membranes and to bind to Kv1.4, Unlike wild type PSD-95, the cysteine mutant of PSD-95 cannot form a ternary complex with Kv1.4 and the cell adhesion molecule Fas-ciclin II. These results suggest that the N-terminal cysteines are essential for PSD-95 multimerization and that multimerization is required for simultaneous binding of multiple membrane protein ligands by PSD-95.	Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheng, M (corresponding author), Howard Hughes Med Inst, Boston, MA 02114 USA.		Hsueh, Yi-Ping/ABH-5052-2020	Hsueh, Yi-Ping/0000-0002-0866-6275; Sheng, Morgan/0000-0002-8703-5366				Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Kim E, 1996, NEUROPHARMACOLOGY, V35, P993, DOI 10.1016/0028-3908(96)00093-7; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Niethammer M, 1996, J NEUROSCI, V16, P2157; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Sheng M, 1996, CURR OPIN NEUROBIOL, V6, P602, DOI 10.1016/S0959-4388(96)80091-2; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	25	74	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					532	536		10.1074/jbc.274.1.532	http://dx.doi.org/10.1074/jbc.274.1.532			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867876	hybrid			2022-12-27	WOS:000077900200076
J	Knauer, MF; Crisp, RJ; Kridel, SJ; Knauer, DJ				Knauer, MF; Crisp, RJ; Kridel, SJ; Knauer, DJ			Analysis of a structural determinant in thrombin-protease nexin 1 complexes that mediates clearance by the low density lipoprotein receptor-related protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-BINDING DOMAIN; HUMAN ANTITHROMBIN-III; ALPHA(2)-MACROGLOBULIN RECEPTOR; CELLULAR INTERNALIZATION; UROKINASE RECEPTOR; SERINE PROTEASES; DEGRADATION; IDENTIFICATION; ACTIVATION; MECHANISM	We recently identified a synthetic peptide, pro(47)-Ile(58), derived from the mature protease nexin 1 (PN1) sequence, that inhibited the low density lipoprotein receptor-related protein (LRP)-mediated internalization of thrombin-PN1 (Th-PN1) complexes, Presently, we have analyzed this sequence in Th-PN1 complex catabolism using two independent approaches: 1) An antibody was generated against pro(47)-Ile(58), which inhibited complex degradation by 70% but had no effect on the binding of the complexes to cell surface heparins. This places the structural determinant in PN1 mediating complex internalization by the LRP outside of the heparin-binding site. 2) Site-directed genetic variants of PN1 with a single Ala substitution at His(48), or two Ala substitutions, one at His48 and another at Asp(49), Were expressed in Sf9 insect cells. The catabolic rate of complexes formed between Th and the singly substituted and doubly substituted variants was lowered to 50 and 15%, respectively, when compared with the catabolic rate of native Th-PN1 complexes. This is the first analysis of a structural determinant in a serine protease inhibitor (SERPIN) required for LRP-mediated internalization and in part may explain the cryptic nature of this site in the unreacted serine protease inhibitor.	Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Burnham Inst, La Jolla, CA 92037 USA	University of California System; University of California Irvine; Sanford Burnham Prebys Medical Discovery Institute	Knauer, DJ (corresponding author), Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92697 USA.				NIGMS NIH HHS [R01GM34001-12] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034001] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER JB, 1980, CELL, V21, P37, DOI 10.1016/0092-8674(80)90112-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COHEN AB, 1977, P NATL ACAD SCI USA, V74, P4311, DOI 10.1073/pnas.74.10.4311; CONESE M, 1994, J BIOL CHEM, V269, P17886; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; DONOVAN FM, 1994, J BIOL CHEM, V269, P17199; HOWARD EW, 1987, J CELL PHYSIOL, V131, P276, DOI 10.1002/jcp.1041310219; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; KNAUER DJ, 1983, J CELL PHYSIOL, V117, P385, DOI 10.1002/jcp.1041170314; Knauer MF, 1997, J BIOL CHEM, V272, P12261, DOI 10.1074/jbc.272.19.12261; Knauer MF, 1997, J BIOL CHEM, V272, P29039, DOI 10.1074/jbc.272.46.29039; Kounnas MZ, 1996, J BIOL CHEM, V271, P6523, DOI 10.1074/jbc.271.11.6523; Kridel SJ, 1997, J BIOL CHEM, V272, P7656, DOI 10.1074/jbc.272.12.7656; Kridel SJ, 1996, J BIOL CHEM, V271, P20935, DOI 10.1074/jbc.271.34.20935; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE DA, 1995, J BIOL CHEM, V270, P25309, DOI 10.1074/jbc.270.43.25309; LOW DA, 1981, P NATL ACAD SCI-BIOL, V78, P2340, DOI 10.1073/pnas.78.4.2340; Mikhailenko I, 1997, J BIOL CHEM, V272, P6784, DOI 10.1074/jbc.272.10.6784; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; Nielsen MS, 1997, J BIOL CHEM, V272, P5821, DOI 10.1074/jbc.272.9.5821; PERLMUTTER DH, 1988, J CLIN INVEST, V81, P1774, DOI 10.1172/JCI113519; SCOTT RW, 1985, J BIOL CHEM, V260, P7029; SHIEH BH, 1989, J BIOL CHEM, V264, P13420; SMITH JW, 1990, BIOCHEMISTRY-US, V29, P8950, DOI 10.1021/bi00490a010; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; STONE SR, 1994, BIOCHEMISTRY-US, V33, P7731, DOI 10.1021/bi00190a028; Wells MJ, 1997, J BIOL CHEM, V272, P28574, DOI 10.1074/jbc.272.45.28574; Wells MJ, 1998, J BIOL CHEM, V273, P23440, DOI 10.1074/jbc.273.36.23440	28	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					275	281		10.1074/jbc.274.1.275	http://dx.doi.org/10.1074/jbc.274.1.275			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867841	hybrid			2022-12-27	WOS:000077900200041
J	Utz, PJ; Hottelet, M; Le, TM; Kim, SJ; Geiger, ME; van Venrooij, WJ; Anderson, P				Utz, PJ; Hottelet, M; Le, TM; Kim, SJ; Geiger, ME; van Venrooij, WJ; Anderson, P			The 72-kDa component of signal recognition particle is cleaved during apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; PROGRAMMED CELL-DEATH; POLY(ADP-RIBOSE) POLYMERASE; PROTEIN TRANSLOCATION; ENDOPLASMIC-RETICULUM; HUMAN AUTOANTIBODIES; 7S RNA; BCL-2; KERATINOCYTES; AUTOANTIGENS	Proteins cleaved by apoptotic caspases are commonly recognized by autoantibodies found in the serum of patients with rheumatic disease. We report that the 72-kDa signal recognition particle (SRP) protein, a rare target of autoantibodies found in the serum of patients with dermatomyositis and systemic lupus erythematosus, is rapidly cleaved in Jurkat T cells treated with apoptotic (i.e. Pas ligation, treatment with gamma or ultraviolet radiation, or co-culture with anisomycin or staurosporine) but not proliferative (CD3 cross-linking) stimuli. Cleavage of SRP 72 produces a 66-kDa amino-terminal fragment and a 6-kDa carboxyl-terminal fragment that is selectively phosphorylated on serine residues. Cleavage of SRP 72 is prevented by chemical and peptide caspase inhibitors, and by overexpression of bcl-2, an inhibitor of apoptotic cell death. Analysis of the carboxyl terminus of SRP 72 has identified a putative cleavage site (SELD/A) for group III caspases, and carboxyl-terminal serine residues that are highly conserved in phylogeny, Both serine phosphorylation and caspase cleavage of SRP 72 are observed in cells derived from human, dog, rat, and mouse. Canine SRP 72 is cleaved in vitro by recombinant caspase 3 but retains the ability to mediate transport of a signal peptide-containing protein into the endoplasmic reticulum lumen. The 72-kDa component of the SRP joins a growing list of autoantigens that undergo post-translational modifications during programmed cell death.	Brigham & Womens Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Univ Nijmegen, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	Harvard University; Brigham & Women's Hospital; Radboud University Nijmegen	Utz, PJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Smith 608,1 Jimmy Fund Way, Boston, MA 02115 USA.	pjutz@rics.bwh.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA067929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI033600, R01AI033600] Funding Source: NIH RePORTER; NCI NIH HHS [CA67929] Funding Source: Medline; NIAID NIH HHS [K08AI101521, AI33600] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boise L H, 1995, Curr Top Microbiol Immunol, V200, P107; BROWN JD, 1994, EMBO J, V13, P4390, DOI 10.1002/j.1460-2075.1994.tb06759.x; CASCIOLAROSEN LA, 1994, J BIOL CHEM, V269, P30757; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; CASCIOLAROSEN LA, 1995, J EXP MED, V182, P1625, DOI 10.1084/jem.182.6.1625; Casiano CA, 1996, J EXP MED, V184, P765, DOI 10.1084/jem.184.2.765; Clemens MJ, 1997, INT J BIOCHEM CELL B, V29, P945, DOI 10.1016/S1357-2725(96)00169-0; COLIGAN JE, 1994, CURRENT PROTOCOLS IM, V3; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; GOLAN TD, 1992, J CLIN INVEST, V90, P1067, DOI 10.1172/JCI115922; Haneji N, 1997, SCIENCE, V276, P604, DOI 10.1126/science.276.5312.604; ITOH N, 1993, J IMMUNOL, V151, P621; JACOBSON MD, 1994, EMBO J, V13, P1899, DOI 10.1002/j.1460-2075.1994.tb06459.x; KARWAN R, 1991, GENE DEV, V5, P1264, DOI 10.1101/gad.5.7.1264; KAUFMANN SH, 1993, CANCER RES, V53, P3976; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEFEBER WP, 1984, J CLIN INVEST, V74, P1545, DOI 10.1172/JCI111569; Li HL, 1997, J BIOL CHEM, V272, P21010, DOI 10.1074/jbc.272.34.21010; LUTCKE H, 1993, J CELL BIOL, V121, P977, DOI 10.1083/jcb.121.5.977; MARIN S, 1995, J BIOL CHEM, V270, P6425; MCNAIR A, 1995, PARASITOL RES, V81, P175, DOI 10.1007/BF00931628; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; OKADA N, 1987, J IMMUNOL, V138, P3219; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Proud CG, 1996, TRENDS BIOCHEM SCI, V21, P181, DOI 10.1016/0968-0004(96)10016-5; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; REEVES WH, 1986, P NATL ACAD SCI USA, V83, P9507, DOI 10.1073/pnas.83.24.9507; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; TARGOFF IN, 1990, ARTHRITIS RHEUM, V33, P1361, DOI 10.1002/art.1780330908; Utz PJ, 1998, ARTHRITIS RHEUM, V41, P1152, DOI 10.1002/1529-0131(199807)41:7<1152::AID-ART3>3.0.CO;2-L; Utz PJ, 1998, J EXP MED, V187, P547, DOI 10.1084/jem.187.4.547; Utz PJ, 1997, J EXP MED, V185, P843, DOI 10.1084/jem.185.5.843; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; WALTER P, 1983, CELL, V34, P525, DOI 10.1016/0092-8674(83)90385-9; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; WANG XD, 1995, J BIOL CHEM, V270, P18044, DOI 10.1074/jbc.270.30.18044; Waterhouse N, 1996, J BIOL CHEM, V271, P29335, DOI 10.1074/jbc.271.46.29335; Weaver VM, 1996, J CELL SCI, V109, P45; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0	44	58	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35362	35370		10.1074/jbc.273.52.35362	http://dx.doi.org/10.1074/jbc.273.52.35362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857079	hybrid			2022-12-27	WOS:000077719700097
J	Chen, XZ; Zhu, T; Smith, DE; Hediger, MA				Chen, XZ; Zhu, T; Smith, DE; Hediger, MA			Stoichiometry and kinetics of the high-affinity H+-coupled peptide transporter PepT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-GLUCOSE COTRANSPORTER; BETA-LACTAM ANTIBIOTICS; XENOPUS-LAEVIS OOCYTES; RABBIT SMALL-INTESTINE; OLIGOPEPTIDE TRANSPORTER; EXPRESSION CLONING; MEMBRANE; DIPEPTIDES; DEPENDENCE; SYMPORTER	Proton-coupled peptide transporters mediate the absorption of a large variety of di- and tripeptides as well as peptide-like pharmacologically active compounds. We report a kinetic analysis of the rat kidney high-affinity peptide transporter PepT2 expressed in Xenopus oocytes. By use of simultaneous radioactive uptake and current measurements under voltage-clamp condition, the charge to substrate uptake ratio was found to be close to 2 for both D-Phe-L-Ala and D-Phe-L-Glu, indicating that the H+:substrate stoichiometry is 2:1 and 3:1 for neutral and anionic dipeptides, respectively. The higher stoichiometry for anionic peptides suggests that they are transported in the protonated form. For D-Phe-L-Lys, the charge:uptake ratio averaged 2.4 from pooled experiments, suggesting that Phe-Lys crosses the membrane via PepT2 either in its deprotonated (neutral) or its positively charged form, averaging a H+:Phe-Lys stoichiometry of 1.4:1, These findings led to the overall con elusion that PepT2 couples transport of one peptide molecule to two H+; This is in contrast to the low-affinity transporter PepT1 that couples transport of one peptide to one H+. Quinapril inhibited PepT2-mediated currents in presence or in absence of external substrates, Oocytes expressing PepT2 exhibited quinapril-sensitive outward currents. In the absence of external substrate, a quinapril-sensitive proton inward current (proton leak) was also observed which, together with the observed pH-dependent PepT2-specific presteady-state currents (I-pss), indicates that at least one H+ binds to the transporter prior to substrate. PepT2 exhibited I-pss in response to hyperpolarization at pH 6.5-8.0. However, contrary to previous observations on various transporters, 1) no significant currents were observed corresponding to voltage jumps returning from hyperpolarization, and 2) at reduced extracellular pH, no significant I-pss were observed in either direction. Together with observed lower substrate affinities and decreased PepT2-mediated currents at hyperpolarized V-m, our data are consistent with the concept that hyperpolarization exerts inactivation effects on the transporter which are enhanced by low pH, Our studies revealed distinct properties of PepT2, compared with PepT1 and other ion-coupled transporters.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal, Boston, MA 02115 USA; Univ Michigan, Upjohn Ctr Clin Pharmacol, Ann Arbor, MI 48109 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Michigan System; University of Michigan	Hediger, MA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal, Boston, MA 02115 USA.	mhediger@rics.bwh.harvard.edu		Hediger, Matthias/0000-0003-1946-027X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035498] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK43171] Funding Source: Medline; NIGMS NIH HHS [GM35498] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE M, 1987, J PHYSIOL-LONDON, V394, P481, DOI 10.1113/jphysiol.1987.sp016882; ADIBI SA, 1973, J CLIN INVEST, V52, P1586, DOI 10.1172/JCI107335; Amasheh S, 1997, J MEMBRANE BIOL, V155, P247, DOI 10.1007/s002329900177; Amasheh S, 1997, J PHYSIOL-LONDON, V504, P169, DOI 10.1111/j.1469-7793.1997.169bf.x; BOLL M, 1994, PFLUG ARCH EUR J PHY, V429, P146, DOI 10.1007/BF02584043; Chen XZ, 1998, J BIOL CHEM, V273, P20972, DOI 10.1074/jbc.273.33.20972; Chen XZ, 1997, BIOPHYS J, V73, P2503, DOI 10.1016/S0006-3495(97)78278-X; Chen XZ, 1995, BIOPHYS J, V69, P2405, DOI 10.1016/S0006-3495(95)80110-4; Chen XZ, 1996, BIOPHYS J, V71, P2544, DOI 10.1016/S0006-3495(96)79447-X; DANIEL H, 1991, J BIOL CHEM, V266, P19917; Daniel H, 1996, J MEMBRANE BIOL, V154, P197, DOI 10.1007/s002329900144; Daniel H, 1997, AM J PHYSIOL-RENAL, V273, pF1, DOI 10.1152/ajprenal.1997.273.1.F1; DANTZIG AH, 1994, SCIENCE, V264, P430, DOI 10.1126/science.8153632; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; Fei YJ, 1998, BIOCHEM J, V332, P565, DOI 10.1042/bj3320565; Fei YJ, 1998, PROG NUCLEIC ACID RE, V58, P239; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; Ganapathy V, 1996, Curr Opin Nephrol Hypertens, V5, P395, DOI 10.1097/00041552-199609000-00003; GANAPATHY V, 1986, AM J PHYSIOL, V251, pF945, DOI 10.1152/ajprenal.1986.251.6.F945; HEDIGER MA, 1995, J PHYSIOL-LONDON, V482P, pS7; KRAMER W, 1992, EUR J BIOCHEM, V204, P923, DOI 10.1111/j.1432-1033.1992.tb16713.x; LISTER N, 1995, J PHYSIOL-LONDON, V484, P173, DOI 10.1113/jphysiol.1995.sp020656; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Mackenzie B, 1998, J MEMBRANE BIOL, V162, P101, DOI 10.1007/s002329900347; Mackenzie B, 1996, J BIOL CHEM, V271, P5430, DOI 10.1074/jbc.271.10.5430; MIYAMOTO Y, 1988, BIOCHEM J, V249, P247, DOI 10.1042/bj2490247; Nussberger S, 1996, BIOPHYS J, V70, P998, DOI 10.1016/S0006-3495(96)79643-1; NUSSBERGER S, 1995, EXP NEPHROL, V3, P211; Nussberger S, 1997, J BIOL CHEM, V272, P7777, DOI 10.1074/jbc.272.12.7777; Saadi I, 1998, KIDNEY INT, V54, P48, DOI 10.1046/j.1523-1755.1998.00956.x; Saito H, 1996, BBA-BIOMEMBRANES, V1280, P173, DOI 10.1016/0005-2736(96)00024-7; Segel I. H., 1975, ENZYME KINETICS, P884; Smith DE, 1998, PHARM RES-DORDR, V15, P1244, DOI 10.1023/A:1011996009332; Steel A, 1997, J PHYSIOL-LONDON, V498, P563, DOI 10.1113/jphysiol.1997.sp021883; TEMPLE CS, 1995, PFLUG ARCH EUR J PHY, V430, P825, DOI 10.1007/BF00386182; Temple CS, 1996, J PHYSIOL-LONDON, V494, P795, DOI 10.1113/jphysiol.1996.sp021533; THWAITES DT, 1993, PFLUG ARCH EUR J PHY, V425, P178, DOI 10.1007/BF00374520; THWAITES DT, 1993, BIOCHEM BIOPH RES CO, V194, P432, DOI 10.1006/bbrc.1993.1838; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	39	58	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2773	2779		10.1074/jbc.274.5.2773	http://dx.doi.org/10.1074/jbc.274.5.2773			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915809	hybrid			2022-12-27	WOS:000078319500027
J	Salvemini, F; Franze, A; Iervolino, A; Filosa, S; Salzano, S; Ursini, MV				Salvemini, F; Franze, A; Iervolino, A; Filosa, S; Salzano, S; Ursini, MV			Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; ENCODING GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; TRANSCRIPTION FACTOR; FLOW-CYTOMETRY; CELLS; ACTIVATION; APOPTOSIS; GENE; INHIBITION	Glucose-6-phosphate dehydrogenase (G6PD) is the key enzyme of the pentose phosphate pathway that is responsible for the generation of NADPH, which is required in many detoxifying reactions. We have recently demonstrated that G6PD expression is induced by a variety of chemical agents acting at different steps in the biochemical pathway controlling the intracellular redox status. Although we obtained evidence that the oxidative stress-mediated enhancement of G6PD expression is a general phenomenon, the functional significance of such G6PD induction after oxidant insult is still poorly understood. In this report, we used a GSH-depleting drug that determines a marked decrease in the intracellular pool of reduced glutathione and a gradual but notable increase in G6PD expression. Both effects are seen soon after drug addition. Once G6PD activity has reached the maximum, the GSH pool is restored. We suggest and also provide the first direct evidence that G6PD induction serves to maintain and regenerate the intracellular GSH pool. We used HeLa cell clones stably transfected with the human G6PD gene that display higher G6PD activity than the parent HeLa cells. Although the activities of glutathione peroxidase, glutathione reductase, and catalase were comparable in all strains, the concentrations of GSH were significantly higher in G6PD-overexpressing clones. A direct consequence of GSH increase in these cells is a decreased reactive oxygen species production, which makes these cells less sensitive to the oxidative burst produced by external stimuli. Indeed, all clones that constitutively overexpress G6PD exhibited strong protection against oxidants-mediated cell killing. We also observe that NF-kappa B activation, in response to tumor necrosis factor-alpha treatment, is strongly reduced in human HeLa cells overexpressing G6PD.	CNR, Int Inst Genet & Biophys, I-80125 Naples, Italy; CNR, Ctr Endocrinol & Expt Oncol, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Consiglio Nazionale delle Ricerche (CNR)	Ursini, MV (corresponding author), CNR, Int Inst Genet & Biophys, Via Guglielmo Marconi 12, I-80125 Naples, Italy.	usini@iigbna.iigb.na.cnr.it	Filosa, Stefania/A-4609-2014; Franze', Annamaria/H-2539-2012; Franzè, Annamaria/V-3837-2019	Franzè, Annamaria/0000-0002-4392-9739; Filosa, Stefania/0000-0003-2896-3362				AEBI H, 1984, METHOD ENZYMOL, V105, P121; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Banki K, 1996, J BIOL CHEM, V271, P32994, DOI 10.1074/jbc.271.51.32994; BATTISTUZZI G, 1985, P NATL ACAD SCI USA, V82, P1465, DOI 10.1073/pnas.82.5.1465; BENATTI U, 1981, FEBS LETT, V128, P225, DOI 10.1016/0014-5793(81)80086-5; BEUTLER E, 1996, HUM GENET, V29, P49; BEUTLER E, 1981, HUM GENET, V29, P225; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; CHEN EY, 1991, GENOMICS, V10, P792, DOI 10.1016/0888-7543(91)90465-Q; CLANCY RM, 1994, P NATL ACAD SCI USA, V91, P3680, DOI 10.1073/pnas.91.9.3680; COHEN G, 1963, BIOCHEMISTRY-US, V2, P1420, DOI 10.1021/bi00906a038; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; GAETANI GF, 1989, BLOOD, V73, P334; HANSEN SK, 1994, MOL CELL BIOL, V14, P2593, DOI 10.1128/MCB.14.4.2593; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KIRKMAN HN, 1987, J BIOL CHEM, V262, P660; KIRKMAN HN, 1978, P NATL ACAD SCI USA, V81, P4343; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; KOSOWER EM, 1969, NATURE, V224, P117, DOI 10.1038/224117a0; KretzRemy C, 1996, J CELL BIOL, V133, P1083, DOI 10.1083/jcb.133.5.1083; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lioi MB, 1998, ENVIRON MOL MUTAGEN, V32, P39; Lioi MB, 1998, MUTAT RES-FUND MOL M, V403, P13, DOI 10.1016/S0027-5107(98)00010-4; LUZZATTO L, 1995, METABOLIC MOL BASES, P3367; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; Martini G, 1996, BIOESSAYS, V18, P631, DOI 10.1002/bies.950180806; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; NISHIKI K, 1976, BIOCHEM J, V160, P343, DOI 10.1042/bj1600343; NOBEL CSI, 1995, J BIOL CHEM, V270, P26202, DOI 10.1074/jbc.270.44.26202; NOGAE I, 1990, GENE, V96, P161, DOI 10.1016/0378-1119(90)90248-P; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SCHRECK R, 1994, METHOD ENZYMOL, V234, P151; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SHERWOOD SW, 1995, METHOD CELL BIOL, V46, P77; TIAN WN, 1994, J BIOL CHEM, V269, P14798; TOWN M, 1990, SOMAT CELL MOLEC GEN, V16, P97, DOI 10.1007/BF01233040; Ursini MV, 1997, BIOCHEM J, V323, P801, DOI 10.1042/bj3230801; URSINI MV, 1993, VIROLOGY, V196, P338, DOI 10.1006/viro.1993.1485; VULLIAMY T, 1992, TRENDS GENET, V8, P138, DOI 10.1016/0168-9525(92)90372-B; Wendel A, 1981, Methods Enzymol, V77, P325; ZIEGLER DM, 1991, OXIDATIVE STRESS OXI, P85	48	266	281	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2750	2757		10.1074/jbc.274.5.2750	http://dx.doi.org/10.1074/jbc.274.5.2750			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915806	hybrid			2022-12-27	WOS:000078319500024
J	Blasioli, J; Paust, S; Thomas, ML				Blasioli, J; Paust, S; Thomas, ML			Definition of the sites of interaction between the protein tyrosine phosphatase SHP-1 and CD22	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; CD22-DEFICIENT MICE; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; B-CELLS; ASSOCIATION; 1C; ACTIVATION; INHIBITION; DOMAINS	CD22 phosphorylation is an early event of B cell antigen receptor engagement and results in the recruitment of the negative regulatory tyrosine phosphatase, SHP-1. Peptides representing the potential phosphorylation sites within the cytoplasmic domain of CD22 have been used to stimulate SHP-1 catalytic activity and to inhibit the binding of SHP-1 to CD22 (Doody, G., Justement, L., Delibrias, C., Matthews, R., Lin, J., Thomas, Ra., and Fearon, D. (1995) Science 269, 242-244). However, the sites of phosphorylation within the cytoplasmic domain of CD22 and the importance of each for the recruitment and activation of SHP-1 remain unknown. Here we demonstrate that there are multiple sites within the cytoplasmic domain of CD22 that interact with the Src homology 2 domains of SHP-1, Nevertheless, a minimum of two tyrosines in CD22 is required for the association with SHP-1. Furthermore, both Src homology a domains of SHP-1 are necessary for efficient binding to CD22.	Washington Univ, Sch Med, Dept Pathol & Mol Microbiol, Howard Hughes Med Inst,Ctr Immunol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Thomas, ML (corresponding author), Washington Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, 660 S Euclid Ave,Box 8118, St Louis, MO 63110 USA.			Paust, Silke/0000-0002-0526-3999	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056455] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56455] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; CAMPBELL MA, 1995, EUR J IMMUNOL, V25, P1573, DOI 10.1002/eji.1830250616; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Cyster JG, 1997, IMMUNITY, V6, P509, DOI 10.1016/S1074-7613(00)80339-8; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Gupta N, 1997, J EXP MED, V186, P473, DOI 10.1084/jem.186.3.473; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; MCFARLAND EDC, 1995, J BIOL CHEM, V270, P28103; McFarland EDC, 1997, BIOCHEMISTRY-US, V36, P7169, DOI 10.1021/bi970013y; Nishizumi H, 1998, J EXP MED, V187, P1343, DOI 10.1084/jem.187.8.1343; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Pei DH, 1996, P NATL ACAD SCI USA, V93, P1141, DOI 10.1073/pnas.93.3.1141; PEI DH, 1994, BIOCHEMISTRY-US, V33, P15483, DOI 10.1021/bi00255a030; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; ROY G, 1995, ADV PROTEIN PHOSPHAT, V9, P121; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Smith KGC, 1998, J EXP MED, V187, P807, DOI 10.1084/jem.187.5.807; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; TOWNLEY R, 1993, BIOCHEMISTRY-US, V32, P13414, DOI 10.1021/bi00212a006; Tuscano JM, 1996, EUR J IMMUNOL, V26, P1246, DOI 10.1002/eji.1830260610; Vely F, 1997, EUR J IMMUNOL, V27, P1994, DOI 10.1002/eji.1830270825	31	57	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2303	2307		10.1074/jbc.274.4.2303	http://dx.doi.org/10.1074/jbc.274.4.2303			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890995	hybrid			2022-12-27	WOS:000078185200062
J	Chen, YR; Larimer, FW; Serpersu, EH; Hartman, FC				Chen, YR; Larimer, FW; Serpersu, EH; Hartman, FC			Identification of a catalytic aspartyl residue of D-ribulose 5-phosphate 3-epimerase by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; TRIOSEPHOSPHATE ISOMERASE; PROTON ABSTRACTION; MANDELATE RACEMASE; TRANSITION-STATES; CARBON ACIDS; MECHANISM; ENZYMES	Guided by comparative sequence considerations, we have examined the possibility of a catalytic role of Asp(186) Of D-ribulose B-phosphate epimerase by site-directed mutagenesis of the recombinant spinach enzyme. Accordingly, D186A, D186N, and D186E mutants of the epimerase were constructed, purified, and characterized; as judged by their electrophoretic mobilities the mutants are properly assembled into octamers like the wild-type enzyme. Based on the extent of internal quenching of Trp fluorescence, the conformational integrity of the wild-type enzyme is preserved in the mutants. The wild-type k(cat) of 7.1 x 10(3) s(-1) is lowered to 3.3 x 10(-4) s(-1) in D186A, 0.13 s(-1) in D186N, and 1.1 s(-1) in D186E; as gauged by D186A, altogether lacking a functional side chain at position 186, the beta-carboxyl of Asp(186) facilitates catalysis by >10(7)-fold. Relative to the wildtype enzyme, the K-m for D-ribulose fi-phosphate is essentially unaltered with D186N and D186E but increased 10-fold with D186A, Apart from their impairments in epimerase activity, the mutants are unable to catalyze exchange between solvent protons and the C3 proton of substrates. This deficiency and the differential alterations of kinetic parameters among the mutants are consistent with Asp(186) serving as an electrophile to facilitate alpha-proton abstraction. This study is the first to identify a catalytic group of the epimerase.	Oak Ridge Natl Lab, Div Life Sci, Prot Engn Program, Oak Ridge, TN 37831 USA; Univ Tennessee, Grad Sch Biomed Sci, Oak Ridge, TN 37831 USA; Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Hartman, FC (corresponding author), Oak Ridge Natl Lab, Div Life Sci, Prot Engn Program, POB 2009, Oak Ridge, TN 37831 USA.			Serpersu, Engin H./0000-0003-1420-455X				ALAGONA G, 1995, J AM CHEM SOC, V117, P9855, DOI 10.1021/ja00144a011; Babbitt PC, 1997, J BIOL CHEM, V272, P30591, DOI 10.1074/jbc.272.49.30591; BASH PA, 1991, BIOCHEMISTRY-US, V30, P5826, DOI 10.1021/bi00238a003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDEN C, 1987, CRYSTALLOGRAPHY MOL, P359; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P43; Chen YR, 1998, PLANT PHYSIOL, V118, P199, DOI 10.1104/pp.118.1.199; Cho HS, 1998, BIOCHEMISTRY-US, V37, P8325, DOI 10.1021/bi9801614; DAVIS L, 1972, J BIOL CHEM, V247, P5862; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; FARBER GK, 1990, TRENDS BIOCHEM SCI, V15, P228, DOI 10.1016/0968-0004(90)90035-A; GERLT JA, 1993, BIOCHEMISTRY-US, V32, P11943, DOI 10.1021/bi00096a001; GERLT JA, 1993, J AM CHEM SOC, V115, P11552, DOI 10.1021/ja00077a062; HOSOMI S, 1986, BIOCHEM J, V239, P739, DOI 10.1042/bj2390739; KIELY ME, 1973, BIOCHIM BIOPHYS ACTA, V293, P534, DOI 10.1016/0005-2744(73)90360-4; LANDRO JA, 1994, BIOCHEMISTRY-US, V33, P635, DOI 10.1021/bi00169a003; LARIMER FW, 1990, PROTEIN ENG, V3, P227, DOI 10.1093/protein/3.3.227; LODI PJ, 1991, BIOCHEMISTRY-US, V30, P6948, DOI 10.1021/bi00242a020; MITRA B, 1995, BIOCHEMISTRY-US, V34, P2777, DOI 10.1021/bi00009a006; PORTER MA, 1986, ARCH BIOCHEM BIOPHYS, V245, P14, DOI 10.1016/0003-9861(86)90185-2; PORTER MA, 1988, J BIOL CHEM, V263, P123; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Sambrook J., 1989, MOL CLONING LABORATO, V3, pA3; Teige M, 1998, EUR J BIOCHEM, V252, P237, DOI 10.1046/j.1432-1327.1998.2520237.x; Thornburg LD, 1998, BIOCHEMISTRY-US, V37, P10499, DOI 10.1021/bi980099a; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Wu ZR, 1997, SCIENCE, V276, P415, DOI 10.1126/science.276.5311.415	28	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2132	2136		10.1074/jbc.274.4.2132	http://dx.doi.org/10.1074/jbc.274.4.2132			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890975	hybrid			2022-12-27	WOS:000078185200042
J	Iyer, SS; Kusner, DJ				Iyer, SS; Kusner, DJ			Association of phospholipase D activity with the detergent-insoluble cytoskeleton of U937 promonocytic leukocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION-FACTOR; CELL-FREE SYSTEM; BOTULINUM C3 EXOENZYME; FILAMENT BARBED ENDS; PROTEIN-KINASE-C; HUMAN NEUTROPHILS; SIGNAL-TRANSDUCTION; PHOSPHATIDIC-ACID; TYROSINE KINASE; PLASMA-MEMBRANE	Phospholipase D (PLD) regulates cytoskeletal-dependent antimicrobial responses of myeloid leukocytes, including phagocytosis and oxidant generation. However, the mechanisms responsible for this association between PLD activity and the actin cytoskeleton are unknown. We utilized a cell-free system from. U937 promonocytes to test the hypothesis that stimulation of PLD results in stable association of the activated lipase with the detergent-insoluble membrane skeleton. Plasma membrane and cytosol were incubated +/- guanosine 5'-3-O-(thio)triphosphate (GTP gamma S), followed by re-isolation and extraction of the washed membranes with octyl glucoside. The detergent-insoluble fraction derived from membranes incubated with GTP gamma S (DIFGTP gamma S) exhibited 22-fold greater PLD activity than that derived front control membranes (DIF0), when both were assayed in the presence of GTP gamma S, The DIF contained PLD1, RhoA, and ARF, and the level of each was increased by GTP gamma S in a dose-dependent manner. The DIF also contained F-actin, vinculin, talin, paxillin, and alpha-actinin, consistent with its identification as the membrane skeleton. The physiologic relevance of these findings was demonstrated by a similar increase in DIF-associated PLD activity after stimulation of intact U937 cells with opsonized zymosan. These results indicate that stimulation of PLD1 is accompanied by stable association of the activated Lipase, RhoA, and ADP-ribosylation factor with the actin-based membrane skeleton.	Univ Iowa, Dept Med, Iowa City, IA 52242 USA; Univ Iowa, Inflammat Program, Iowa City, IA 52242 USA; Univ Iowa, Grad Program Immunol, Iowa City, IA 52242 USA; Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Kusner, DJ (corresponding author), Univ Iowa, Dept Internal Med, Div Infect Dis, 200 Hawkins Dr SW 34-I,GH, Iowa City, IA 52242 USA.	david-kusner@uiowa.edu						Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; Barkalow K, 1996, J CELL BIOL, V134, P389, DOI 10.1083/jcb.134.2.389; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN HA, 1995, J BIOL CHEM, V270, P14935, DOI 10.1074/jbc.270.25.14935; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Chung JK, 1997, J BIOL CHEM, V272, P15980, DOI 10.1074/jbc.272.25.15980; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Cowin P, 1996, CURR OPIN CELL BIOL, V8, P56, DOI 10.1016/S0955-0674(96)80049-4; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; Deckert M, 1996, J CELL BIOL, V133, P791, DOI 10.1083/jcb.133.4.791; DUBYAK GR, 1993, BIOCHEM J, V292, P121, DOI 10.1042/bj2920121; Exton JH, 1997, J BIOL CHEM, V272, P15579, DOI 10.1074/jbc.272.25.15579; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; FALLMAN M, 1992, J BIOL CHEM, V267, P2656; Fleming IN, 1996, J BIOL CHEM, V271, P33067, DOI 10.1074/jbc.271.51.33067; FOX JEB, 1993, J BIOL CHEM, V268, P25973; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; FUKAMI K, 1992, J BIOL CHEM, V267, P10988; HA KS, 1993, J CELL BIOL, V123, P1789, DOI 10.1083/jcb.123.6.1789; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; HOULE MG, 1995, J BIOL CHEM, V270, P22795, DOI 10.1074/jbc.270.39.22795; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; KANAHO Y, 1991, J IMMUNOL, V146, P3536; KLOTZ KN, 1994, J IMMUNOL, V152, P801; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; KURIBARA H, 1995, J BIOL CHEM, V270, P25667, DOI 10.1074/jbc.270.43.25667; Kusner DJ, 1996, J EXP MED, V184, P585, DOI 10.1084/jem.184.2.585; KUSNER DJ, 1994, BIOCHEM J, V304, P485, DOI 10.1042/bj3040485; KUSNER DJ, 1993, J BIOL CHEM, V268, P19973; Lee CH, 1997, J BIOL CHEM, V272, P15986, DOI 10.1074/jbc.272.25.15986; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; Liscovitch M, 1996, J LIPID MEDIAT CELL, V14, P215, DOI 10.1016/0929-7855(96)00528-7; Lukowski S, 1996, J BIOL CHEM, V271, P24164, DOI 10.1074/jbc.271.39.24164; Malcolm KC, 1996, J BIOL CHEM, V271, P13135, DOI 10.1074/jbc.271.22.13135; Marcil J, 1997, J BIOL CHEM, V272, P20660, DOI 10.1074/jbc.272.33.20660; Morgan CP, 1997, BIOCHEM J, V325, P581, DOI 10.1042/bj3250581; MORITZ A, 1992, J BIOL CHEM, V267, P7207; ODA A, 1992, J BIOL CHEM, V267, P20075; Ohguchi K, 1997, J BIOL CHEM, V272, P1990, DOI 10.1074/jbc.272.3.1990; OLSON SC, 1991, J BIOL CHEM, V266, P17236; Olson SC, 1996, CHEM PHYS LIPIDS, V80, P3, DOI 10.1016/0009-3084(96)02541-8; Parolini I, 1996, BLOOD, V87, P3783, DOI 10.1182/blood.V87.9.3783.bloodjournal8793783; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; Pestonjamasp KN, 1997, J CELL BIOL, V139, P1255, DOI 10.1083/jcb.139.5.1255; Provost JJ, 1996, BIOCHEM J, V319, P285, DOI 10.1042/bj3190285; QUALLIOTINEMANN D, 1993, J BIOL CHEM, V268, P23843; Rose K, 1995, P NATL ACAD SCI USA, V92, P12151, DOI 10.1073/pnas.92.26.12151; SHARIFF A, 1992, SCIENCE, V256, P245, DOI 10.1126/science.1373523; SINGER WD, 1995, J BIOL CHEM, V270, P14944, DOI 10.1074/jbc.270.25.14944; Stow JL, 1998, TRENDS CELL BIOL, V8, P138, DOI 10.1016/S0962-8924(98)01238-0; Valderrama F, 1998, EUR J CELL BIOL, V76, P9, DOI 10.1016/S0171-9335(98)80012-5; WANG PY, 1995, INFLAMMATION, V47, P126; Whatmore J, 1996, BIOCHEM J, V320, P785, DOI 10.1042/bj3200785; XIE MS, 1991, BIOCHEM J, V278, P81, DOI 10.1042/bj2780081; XIE MS, 1991, J CLIN INVEST, V88, P45, DOI 10.1172/JCI115303; YAN SR, 1995, J LEUKOCYTE BIOL, V58, P595, DOI 10.1002/jlb.58.5.595; ZHOU MJ, 1995, J BIOL CHEM, V270, P13553, DOI 10.1074/jbc.270.22.13553; Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0	59	53	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2350	2359		10.1074/jbc.274.4.2350	http://dx.doi.org/10.1074/jbc.274.4.2350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891002	hybrid			2022-12-27	WOS:000078185200069
J	Ramakers, GMJ; Gerendasy, DD; de Graan, PNE				Ramakers, GMJ; Gerendasy, DD; de Graan, PNE			Substrate phosphorylation in the protein kinase C gamma knockout mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; MUTANT MICE; RC3/NEUROGRANIN; NEUROGRANIN; B-50/GAP-43; ANTIBODIES; RELEASE; BRAIN; STATE	The phosphorylation state of three identified neural-specific protein kinase C substrates (RC3, GAP-43/B-50, and MARCKS) was monitored in hippocampal slices of mice lacking the gamma-subtype of protein kinase C and wildtype controls by quantitative immunoprecipitation following P-32(i) labeling. Depolarization with potassium, activation of glutamate receptors with glutamate, or direct stimulation of protein kinase C: with a phorbol ester increased RC3 phosphorylation in wild-type animals but failed to affect RC3 phosphorylation in mice lacking the gamma-subtype of protein kinase C. Our results suggests the following biochemical pathway: activation of a postsynaptic (metabotropic) glutamate receptor stimulates the gamma-subtype of protein kinase C, which in turn phosphorylates RC3. The inability to increase RC3 phosphorylation in mice lacking the gamma-subtype of protein kinase C by membrane depolarization or glutamate receptor activation may contribute to the spatial learning deficits and impaired hippocampal LTP observed in these mice.	Rudolf Magnus Inst Neurosci, Dept Med Pharmacol, NL-3584 CG Utrecht, Netherlands; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA	Utrecht University; Utrecht University Medical Center; Scripps Research Institute	Ramakers, GMJ (corresponding author), Univ Oslo, Dept Physiol, Inst Basal Med Sci, PB 1103 Blindern, N-0317 Oslo, Norway.			Ramakers, Geert/0000-0001-7499-6996	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035831] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-32355] Funding Source: Medline; NINDS NIH HHS [NS-35831] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; DEGRAAN PNE, 1993, BIOCHEM SOC T, V21, P406, DOI 10.1042/bst0210406; DEKKER LV, 1989, NATURE, V342, P74, DOI 10.1038/342074a0; FEDOROV NB, 1995, EUR J NEUROSCI, V7, P819, DOI 10.1111/j.1460-9568.1995.tb00685.x; GERENDASY DD, 1994, J BIOL CHEM, V269, P22420; GERENDASY DD, 1995, J BIOL CHEM, V270, P6741, DOI 10.1074/jbc.270.12.6741; Gerendasy DD, 1997, MOL NEUROBIOL, V15, P131, DOI 10.1007/BF02740632; Ramakers GMJ, 1997, PROG NEURO-PSYCHOPH, V21, P455, DOI 10.1016/S0278-5846(97)00013-4; RAMAKERS GMJ, 1995, J BIOL CHEM, V270, P13892, DOI 10.1074/jbc.270.23.13892; REPRESA A, 1990, J NEUROSCI, V10, P3782, DOI 10.1523/JNEUROSCI.10-12-03782.1990; WATSON JB, 1990, J NEUROSCI RES, V26, P397, DOI 10.1002/jnr.490260402	13	40	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1873	1874		10.1074/jbc.274.4.1873	http://dx.doi.org/10.1074/jbc.274.4.1873			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890937	hybrid			2022-12-27	WOS:000078185200004
J	Saci, A; Pain, S; Rendu, F; Bachelot-Loza, C				Saci, A; Pain, S; Rendu, F; Bachelot-Loza, C			Fc receptor-mediated platelet activation is dependent on phosphatidylinositol 3-kinase activation and involves p120(cbl)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; C-CBL PROTOONCOGENE; STIMULATES TYROSINE PHOSPHORYLATION; PHOSPHOTYROSINE-BINDING DOMAIN; HUMAN HEMATOPOIETIC-CELLS; PROTEIN PRODUCT; PHOSPHOINOSITIDE 3-KINASE; ADAPTER PROTEINS; ANTIGEN RECEPTOR; GAMMA RECEPTOR	The platelet receptor for the Fc domain of IgGs (Fc gamma RIIa) triggers intracellular signaling through protein tyrosine phosphorylations leading to platelet aggregation. In this study, we focused on the adaptor protein p120(cbl) (Cbl), which became tyrosine-phosphorylated after platelet activation induced by antibodies. Cbl phosphorylation was dependent on Fc receptor engagement. An association of Cbl with the p85 subunit of phosphatidylinositol 3-kinase (PI 3-K) occurred in parallel with Cbl tyrosine phosphorylation. We showed by in vitro experiments that Cbl/p85 association was mediated by the Src homology 3 domain of p85/PI 3-K and the proline-rich region of Cbl. Inhibition of PI 3-K activity by wort-mannin led to the blockade of both platelet aggregation and serotonin release mediated by Fc gamma RIIa engagement, whereas it only partly inhibited those induced by thrombin. Thus, PI 3-K may play a crucial role in the initiation of platelet responses after Fc gamma RIIa engagement. Our results suggest that Cbl is involved in platelet signal transduction by the recruitment of PI 3-K to the Fc gamma RIIa pathway, possibly by increasing PI 3-K activity.	Univ Paris 05, Fac Pharm, INSERM U428, F-75270 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bachelot-Loza, C (corresponding author), Univ Paris 05, Fac Pharm, INSERM U428, 4 Ave Observ, F-75270 Paris, France.	bachelot@pharmacie.univ-paris5.fr		Bachelot-Loza, Christilla/0000-0002-6264-902X				Andoniou CE, 1996, ONCOGENE, V12, P1981; ANDONIOU CE, 1994, EMBO J, V13, P4515, DOI 10.1002/j.1460-2075.1994.tb06773.x; Bachelot C, 1995, THROMB HAEMOSTASIS, V74, P1557; Barber DL, 1997, BLOOD, V89, P3166, DOI 10.1182/blood.V89.9.3166; Beckwith M, 1996, BLOOD, V88, P3502, DOI 10.1182/blood.V88.9.3502.bloodjournal8893502; BLAKE TJ, 1991, ONCOGENE, V6, P653; BLAKE TJ, 1993, EMBO J, V12, P2017, DOI 10.1002/j.1460-2075.1993.tb05851.x; Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; BOUCHEIX C, 1983, FEBS LETT, V161, P289, DOI 10.1016/0014-5793(83)81027-8; BOWTELL DDL, 1995, ONCOGENE, V11, P1561; Buday L, 1996, J BIOL CHEM, V271, P6159, DOI 10.1074/jbc.271.11.6159; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; Chacko GW, 1996, J BIOL CHEM, V271, P10775, DOI 10.1074/jbc.271.18.10775; CLARK MR, 1989, J IMMUNOL, V143, P1731; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; Hartley D, 1996, J BIOL CHEM, V271, P21939, DOI 10.1074/jbc.271.36.21939; Hunter S, 1997, MOL ENDOCRINOL, V11, P1213, DOI 10.1210/me.11.9.1213; Jain SK, 1997, ONCOGENE, V14, P2217, DOI 10.1038/sj.onc.1201049; KAPELLER R, 1994, J BIOL CHEM, V269, P1927; KIM TJ, 1995, J BIOL CHEM, V270, P27504, DOI 10.1074/jbc.270.46.27504; Kitanaka A, 1996, BLOOD, V88, P590, DOI 10.1182/blood.V88.2.590.bloodjournal882590; KOVACSOVICS TJ, 1995, J BIOL CHEM, V270, P11358, DOI 10.1074/jbc.270.19.11358; LANGDON WY, 1989, J VIROL, V63, P5420, DOI 10.1128/JVI.63.12.5420-5424.1989; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Manie SN, 1997, EXP HEMATOL, V25, P45; MARCILLA A, 1995, J BIOL CHEM, V270, P9115, DOI 10.1074/jbc.270.16.9115; Marengere LEM, 1997, J IMMUNOL, V159, P70; MEISNER H, 1995, J BIOL CHEM, V270, P25332, DOI 10.1074/jbc.270.43.25332; Naccache PH, 1997, J LEUKOCYTE BIOL, V62, P901, DOI 10.1002/jlb.62.6.901; ODAI H, 1995, J BIOL CHEM, V270, P10800, DOI 10.1074/jbc.270.18.10800; Ojaniemi M, 1997, J BIOL CHEM, V272, P3780, DOI 10.1074/jbc.272.6.3780; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Qi RM, 1996, J IMMUNOL, V157, P5638; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; Rellahan BL, 1997, J BIOL CHEM, V272, P30806, DOI 10.1074/jbc.272.49.30806; Ribon V, 1997, BIOCHEM J, V324, P839, DOI 10.1042/bj3240839; Rittenhouse SE, 1996, BLOOD, V88, P4401, DOI 10.1182/blood.V88.12.4401.bloodjournal88124401; RUBINSTEIN E, 1995, SEMIN THROMB HEMOST, V21, P10, DOI 10.1055/s-2007-1000375; Sattler M, 1997, J CELL PHYSIOL, V171, P28; Sattler M, 1996, ONCOGENE, V12, P839; Sattler M, 1997, J BIOL CHEM, V272, P14320, DOI 10.1074/jbc.272.22.14320; SAVAGE PD, 1991, CYTOGENET CELL GENET, V56, P112, DOI 10.1159/000133062; Soltoff SP, 1996, J BIOL CHEM, V271, P563, DOI 10.1074/jbc.271.1.563; TANAKA S, 1995, J BIOL CHEM, V270, P14347, DOI 10.1074/jbc.270.24.14347; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Ueno H, 1998, BLOOD, V91, P46, DOI 10.1182/blood.V91.1.46.46_46_53; Wisniewski D, 1996, LEUKEMIA, V10, P1436; YANAGA F, 1995, BIOCHEM J, V311, P471, DOI 10.1042/bj3110471; Zhang J, 1996, J BIOL CHEM, V271, P6265, DOI 10.1074/jbc.271.11.6265; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	55	42	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1898	1904		10.1074/jbc.274.4.1898	http://dx.doi.org/10.1074/jbc.274.4.1898			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890943	hybrid			2022-12-27	WOS:000078185200010
J	Tarn, C; Bilodeau, ML; Hullinger, RL; Andrisani, OM				Tarn, C; Bilodeau, ML; Hullinger, RL; Andrisani, OM			Differential immediate early gene expression in conditional hepatitis B virus pX-transforming versus nontransforming hepatocyte cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; HUMAN HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR-ALPHA; MAP KINASE KINASE; RNA-POLYMERASE-II; X-PROTEIN; HBX PROTEIN; TRANSCRIPTION FACTORS; LIVER-REGENERATION	We report construction and characterization of tetracycline-controlled hepatitis B virus pX-expressing hepatocyte (AML12) cell lines. These cell lines were constructed in AML12 clonal isolates (clones 3 and 4), which express constitutively the tetracycline-controlled transactivator. Since pX is implicated in HCC, this immortalized hepatocyte model system was used to investigate the mechanism of pX in transformation. Clonal isolates of 3pX and 4pX lineages display conditional synthesis of pX mRNA and protein and a 2-fold increase in growth saturation density following tetracycline removal, implicating pX in monolayer overgrowth. Interestingly, only 3pX clones display pX-dependent anchorage independence. Clone 3 lineages express hepatocyte nuclear factor-1 alpha and hepatocyte-specific marker genes; clone 4 lineages express hepatocyte nuclear factor-1 beta and reduced levels of hepatocyte-specific marker genes, suggesting the importance of the differentiated hepatocyte in pX-mediated oncogenic transformation. Importantly, 3pX and 4pX lineages display differential expression of immediate early genes c-fos and ATP3;The pX-transforming 3pX lineage displays early, pX-dependent induction of ATF3 and prolonged induction of c-fos. The nontransforming 4pX cells display an absence of pX-dependent ATF3 induction and transient induction of c-fos. Our results support the direct link of pX expression to oncogenic transformation in 3pX lineage clones and underscore the advantage of this conditional cellular model system for studying mechanisms of pX-mediated oncogenesis.	Purdue Univ, Sch Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Andrisani, OM (corresponding author), Purdue Univ, Sch Vet Med, Dept Basic Med Sci, 1246 Lynn Hall, W Lafayette, IN 47907 USA.	oma@vet.purdue.edu		Andrisani, Ourania/0000-0002-6230-0303	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044533, R29DK044533] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK44533] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANDRISANI OM, 1988, MOL CELL BIOL, V8, P1947, DOI 10.1128/MCB.8.5.1947; Barnabas S, 1997, J BIOL CHEM, V272, P20684, DOI 10.1074/jbc.272.33.20684; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BEASLEY RP, 1981, LANCET, V2, P1129; BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Benn J, 1996, J VIROL, V70, P4978, DOI 10.1128/JVI.70.8.4978-4985.1996; BIRCHMEIER W, 1993, J CELL SCI, P159; BRECHOT C, 1980, NATURE, V286, P533, DOI 10.1038/286533a0; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; CASSELMANN WH, 1996, ADV VIRUS RES, V47, P253; CEREGHINI S, 1988, GENE DEV, V2, P957, DOI 10.1101/gad.2.8.957; CHAKRABORTY PR, 1980, NATURE, V286, P531, DOI 10.1038/286531a0; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; CHEONG JH, 1995, EMBO J, V14, P143, DOI 10.1002/j.1460-2075.1995.tb06984.x; Chirillo P, 1997, P NATL ACAD SCI USA, V94, P8162, DOI 10.1073/pnas.94.15.8162; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; COX AD, 1994, METHOD ENZYMOL, V238, P277; CRABTREE GR, 1992, TRANSCRIPTIONAL REGU, V2, P1063; CROSS JC, 1993, P NATL ACAD SCI USA, V90, P8078, DOI 10.1073/pnas.90.17.8078; Dandri M, 1996, J VIROL, V70, P5246, DOI 10.1128/JVI.70.8.5246-5254.1996; DESCHATRETTE J, 1974, BIOCHIMIE, V56, P1603; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DORIA M, 1995, EMBO J, V14, P4747, DOI 10.1002/j.1460-2075.1995.tb00156.x; DUFLOT A, 1995, HEPATOLOGY, V21, P1483, DOI 10.1016/0270-9139(95)90448-4; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hagmeyer BM, 1996, ONCOGENE, V12, P1025; Haviv I, 1998, MOL CELL BIOL, V18, P1562, DOI 10.1128/MCB.18.3.1562; Haviv I, 1996, EMBO J, V15, P3413, DOI 10.1002/j.1460-2075.1996.tb00707.x; HOHNE M, 1990, EMBO J, V9, P1137, DOI 10.1002/j.1460-2075.1990.tb08220.x; KAY A, 1985, EMBO J, V4, P1287, DOI 10.1002/j.1460-2075.1985.tb03774.x; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim H, 1998, J BIOL CHEM, V273, P381, DOI 10.1074/jbc.273.1.381; KINCH MS, 1995, BIOCHEM SOC T, V23, P446, DOI 10.1042/bst0230446; KOIKE K, 1994, J CLIN INVEST, V94, P44, DOI 10.1172/JCI117343; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEVRERO M, 1990, J VIROL, V64, P3082, DOI 10.1128/JVI.64.6.3082-3086.1990; Liang GS, 1996, J BIOL CHEM, V271, P1695, DOI 10.1074/jbc.271.3.1695; Lin Y, 1997, J BIOL CHEM, V272, P7132, DOI 10.1074/jbc.272.11.7132; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MEAD JE, 1989, P NATL ACAD SCI USA, V86, P1558, DOI 10.1073/pnas.86.5.1558; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819; MORIARTY AM, 1985, SCIENCE, V227, P429, DOI 10.1126/science.2981434; NATOLI G, 1994, MOL CELL BIOL, V14, P989, DOI 10.1128/MCB.14.2.989; Oguey D, 1996, HEPATOLOGY, V24, P1024, DOI 10.1002/hep.510240508; POPPER H, 1987, P NATL ACAD SCI USA, V84, P866, DOI 10.1073/pnas.84.3.866; Qadri I, 1996, P NATL ACAD SCI USA, V93, P10578, DOI 10.1073/pnas.93.20.10578; RUPP RAW, 1991, CELL, V65, P927, DOI 10.1016/0092-8674(91)90545-A; RUSSELL ME, 1994, J CLIN INVEST, V94, P722, DOI 10.1172/JCI117391; Servillo G, 1997, ONCOGENE, V14, P1601, DOI 10.1038/sj.onc.1200996; SETO E, 1988, P NATL ACAD SCI USA, V85, P8286, DOI 10.1073/pnas.85.21.8286; SETO E, 1990, NATURE, V344, P72, DOI 10.1038/344072a0; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; SIDDIQUI A, 1987, P NATL ACAD SCI USA, V84, P2513, DOI 10.1073/pnas.84.8.2513; SIDDIQUI A, 1989, VIROLOGY, V169, P479, DOI 10.1016/0042-6822(89)90177-3; Su F, 1997, P NATL ACAD SCI USA, V94, P8744, DOI 10.1073/pnas.94.16.8744; Terradillos O, 1997, ONCOGENE, V14, P395, DOI 10.1038/sj.onc.1200850; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; TWU JS, 1990, VIROLOGY, V177, P406, DOI 10.1016/0042-6822(90)90501-H; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674	68	62	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2327	2336		10.1074/jbc.274.4.2327	http://dx.doi.org/10.1074/jbc.274.4.2327			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890999	hybrid			2022-12-27	WOS:000078185200066
J	Wei, Z; Swiedler, SJ				Wei, Z; Swiedler, SJ			Functional analysis of conserved cysteines in heparan sulfate N-deacetylase-N-sulfotransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; MOLECULAR-CLONING; BINDING; BIOSYNTHESIS; EXPRESSION; RECEPTOR; MOUSE; REQUIREMENTS; PROTEOGLYCAN; FGF-2	N-Deacetylase-N-sulfotransferases (NDANST) catalyze the two initial modifications of the polysaccharide precursor in the biosynthesis of heparin and heparan sulfate, These modifications are the gating steps in establishing growth factor protein-binding domains of these glycosaminoglycans. We have undertaken a structure-activity analysis of the 841-amino acid Golgi-luminal portion of the rat liver NDANST to localize the two enzymatic functions. Each activity can be assayed in vitro independently of the other when provided with the appropriate substrate, and N-ethylmaleimide treatment selectively inactivates the deacetylase activity. In this study, dithiothreitol treatment of the rat liver NDANST was shown to inactivate the sulfotransferase function, while stimulating deacetylase activity 2-3-fold over the native protein. Site-directed mutagenesis of the eight cysteine (Cys) residues in the rat liver NDANST that are conserved in the mouse mastocytoma protein produced three important findings regarding the localization of each enzymatic function: 1) derivatization of Cys(486) With N-ethylmaleimide resulted in total inactivation of the deacetylase activity based on steric hindrance of the active site (this residue was shown not to be involved in enzymatic catalysis), 2) substitution of either Cys(159) or Cys486 With alanine resulted in enhanced activity of the deacetylase to the level obtained by dithiothreitol treatment, and 3) alanine substitution of Cys(818) or Cys(828) completely inactivated the sulfotransferase activity, while substitution of Cys(586) or Cys(601) resulted in a 90% loss in activity, These findings suggest that the two enzymatic domains within the NDANST localize to different portions of the protein, with two disulfide pairs toward the COOH-terminal half of the protein necessary for the sulfotransferase activity, and Cys residues within the NH2-terminal half influencing or located near the active site of the deacetylase functionality.	Glycomed Inc, Alameda, CA 94501 USA; Univ Calif Davis, Mol Biol Grad Program, Davis, CA 95616 USA	University of California System; University of California Davis	Wei, Z (corresponding author), ChemoCentryx, 1539 Ind Rd, San Carlos, CA 94070 USA.							ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; AVIEZER D, 1994, J BIOL CHEM, V269, P114; BAME KJ, 1991, J BIOL CHEM, V266, P10287; Conrad H. E., 1998, HEPARIN BINDING PROT; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; ISHIHARA M, 1992, ANAL BIOCHEM, V206, P400, DOI 10.1016/0003-2697(92)90385-K; ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P451, DOI 10.1093/glycob/4.4.451; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KOMATSU K, 1994, BIOCHEM BIOPH RES CO, V204, P1178, DOI 10.1006/bbrc.1994.2587; LINDAHL U, 1986, TRENDS BIOCHEM SCI, V11, P221, DOI 10.1016/0968-0004(86)90011-3; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; Marshall AD, 1997, J BIOL CHEM, V272, P9153; NAVIA JL, 1983, ANAL BIOCHEM, V135, P134, DOI 10.1016/0003-2697(83)90741-8; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; Oravecz T, 1997, J IMMUNOL, V159, P4587; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; SEED B, 1987, P NATL ACAD SCI USA, V84, P8565; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Stringer SE, 1997, J BIOL CHEM, V272, P20508, DOI 10.1074/jbc.272.33.20508; WEI Z, 1993, P NATL ACAD SCI USA, V90, P3885, DOI 10.1073/pnas.90.9.3885; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	26	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1966	1970		10.1074/jbc.274.4.1966	http://dx.doi.org/10.1074/jbc.274.4.1966			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890952	hybrid			2022-12-27	WOS:000078185200019
J	Du, EZ; Fleming, JF; Wang, SL; Spitsen, GM; Davis, RA				Du, EZ; Fleming, JF; Wang, SL; Spitsen, GM; Davis, RA			Translocation-arrested apolipoprotein B evades proteasome degradation via a sterol-sensitive block in ubiquitin conjugation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LOW-DENSITY LIPOPROTEIN; ENDOPLASMIC-RETICULUM; INTRACELLULAR DEGRADATION; HEPG2 CELLS; BILE-ACIDS; SECRETION; ABETALIPOPROTEINEMIA; PROTEOLYSIS; PATHWAY	In this study, we explored how sterol metabolism altered by the expression of cholesterol-7-alpha-hydroxylase NADPH:oxygen oxidoreductase (7 alpha-hydroxylase) affects the ubiquitin-dependent proteasome degradation of translocation-arrested apoB53 in Chinese hamster ovary cells. Stable expression of two different plasmids that encode either rat or human 7 alpha-hydroxylase inhibited the ubiquitin conjugation of apoB and its subsequent degradation by the proteasome. Oxysterols (25-hydroxycholesterol and 7-ketocholesterol) reversed the inhibition of apoB degradation caused by 7 alpha-hydroxylase, The combined results suggest that the normally rapid proteasome degradation of translocation-arrested apoB can be regulated by a sterol-sensitive polyubiquitin conjugation step in the endoplasmic reticulum. flocked ubiquitin-dependent proteasome degradation caused translocation-arrested apoB to become sequestered in segregated membrane domains. Our results described for the first time a novel mechanism through which the "quality control" proteasome endoplasmic reticulum degradative pathway of translocation-arrested apoB is linked to sterol metabolism. Sterol-sensitive blocked ubiquitin conjugation appears to selectively inhibit the proteasome degradation of apoB, but not 7 alpha-hydroxylase protein, with no impairment of cell vitality or function. Our findings may help to explain why the hepatic production of lipoproteins is increased when familial hypertriglyceridemic patients are treated with drugs that activate 7 alpha-hydroxylase (e.g, bile acid-binding resins).	San Diego State Univ, Dept Biol, Mammalian Cell & Mol Biol Lab, San Diego, CA 92182 USA; San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Davis, RA (corresponding author), San Diego State Univ, Dept Biol, Mammalian Cell & Mol Biol Lab, San Diego, CA 92182 USA.				NHLBI NIH HHS [HL52005, HL-51648] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051648, R01HL052005] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANGELIN B, 1978, J LIPID RES, V19, P1004; ANGELIN B, 1987, P NATL ACAD SCI USA, V84, P5434, DOI 10.1073/pnas.84.15.5434; BEIL U, 1982, METABOLISM, V31, P438, DOI 10.1016/0026-0495(82)90231-1; Benoist F, 1997, J BIOL CHEM, V272, P20435, DOI 10.1074/jbc.272.33.20435; BLOCHLINGER K, 1984, MOL CELL BIOL, V4, P2929, DOI 10.1128/MCB.4.12.2929; BONNARDEL JA, 1995, J BIOL CHEM, V270, P28892, DOI 10.1074/jbc.270.48.28892; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; BREUER O, 1993, EUR J BIOCHEM, V215, P705, DOI 10.1111/j.1432-1033.1993.tb18082.x; CAMARRI E, 1978, BIOMED EXPRESS, V29, P193; CHAIT A, 1980, EUR J CLIN INVEST, V10, P17, DOI 10.1111/j.1365-2362.1980.tb00004.x; CLADARAS C, 1986, EMBO J, V5, P3495, DOI 10.1002/j.1460-2075.1986.tb04675.x; CORRELL CC, 1994, J BIOL CHEM, V269, P633; DANIELSSON H, 1972, STEROIDS, V20, P63, DOI 10.1016/0039-128X(72)90118-3; Davis R A, 1993, Subcell Biochem, V21, P169; DAVIS RA, 1996, N COMP BIOC, V31, P473; DU EZ, 1994, J BIOL CHEM, V269, P24169; Du EZ, 1996, J LIPID RES, V37, P1309; Duane WC, 1997, J LIPID RES, V38, P183; EDWARDS PA, 1996, N COMP BIOC, V31, P341; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; Gordon DA, 1996, J BIOL CHEM, V271, P33047, DOI 10.1074/jbc.271.51.33047; Gregg Richard E., 1994, Current Opinion in Lipidology, V5, P81, DOI 10.1097/00041433-199404000-00003; HAMPTON RY, 1996, CELL, P2029; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Innerarity TL, 1996, J BIOL CHEM, V271, P2353, DOI 10.1074/jbc.271.5.2353; INNERARITY TL, 1987, J CLIN INVEST, V80, P1794, DOI 10.1172/JCI113273; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; Macri J, 1997, J BIOL CHEM, V272, P7328, DOI 10.1074/jbc.272.11.7328; MARCEL YL, 1987, ARTERIOSCLEROSIS, V7, P166, DOI 10.1161/01.ATV.7.2.166; McGee TP, 1996, J BIOL CHEM, V271, P25630, DOI 10.1074/jbc.271.41.25630; Meigs TE, 1996, J BIOL CHEM, V271, P7916, DOI 10.1074/jbc.271.14.7916; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Okura T, 1996, J IMMUNOL, V157, P4277; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; ROITELMAN J, 1992, J BIOL CHEM, V267, P25264; Rustaeus S, 1998, J BIOL CHEM, V273, P5196, DOI 10.1074/jbc.273.9.5196; SAKATA N, 1993, J BIOL CHEM, V268, P22967; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; SINENSKY M, 1981, J BIOL CHEM, V256, P1774; THRIFT RN, 1992, P NATL ACAD SCI USA, V89, P9161, DOI 10.1073/pnas.89.19.9161; TRAWICK JD, 1996, J LIPID RES, V37, P24169; VALETTI C, 1991, J CELL BIOL, V115, P983, DOI 10.1083/jcb.115.4.983; VENKATESAN S, 1993, ARTERIOSCLER THROMB, V13, P1110, DOI 10.1161/01.ATV.13.7.1110; Wang S, 1996, J BIOL CHEM, V271, P14124, DOI 10.1074/jbc.271.24.14124; Wang SL, 1997, J BIOL CHEM, V272, P19351, DOI 10.1074/jbc.272.31.19351; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WETTERAU JR, 1992, SCIENCE, V258, P999; Wetterau JR, 1997, BBA-LIPID LIPID MET, V1345, P136, DOI 10.1016/S0005-2760(96)00168-3; YANG CY, 1986, NATURE, V323, P738, DOI 10.1038/323738a0; Yao ZM, 1997, J LIPID RES, V38, P1937; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777	57	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1856	1862		10.1074/jbc.274.3.1856	http://dx.doi.org/10.1074/jbc.274.3.1856			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880570	hybrid			2022-12-27	WOS:000079956900090
J	Hallmann, A				Hallmann, A			Enzymes in the extracellular matrix of Volvox: an inducible, calcium-dependent phosphatase with a modular composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN-ALGA VOLVOX; ALKALINE-PHOSPHATASE; CARTERI; GENE; PROTEIN; PURIFICATION; PHOSPHOTYROSINE; TRANSFORMATION; SEQUENCE; FAMILY	The volvocine algae provide the unique opportunity for exploring development of an extracellular matrix. Volvox is the most advanced member of this family and represents the simplest multicellular organism, with differentiated cells, a complete division of labor, and a complex extracellular matrix, which serves structural and enzymatic functions. In Volvox carteri a glycosylated extracellular phosphatase was identified, which is partially released from the extracellular matrix into the growth medium. The phosphatase is synthesized in response to inorganic phosphate starvation and is strictly to inorganic phosphate starvation and is strictly calcium-dependent. The metalloenzyme has been purified to homogeneity and characterized. Its gene and cDNA have been cloned. Comparisons of genomic and cDNA sequences revealed an extremely intron-rich gene (32 introns), With an apparent molecular mass of 160 kDa the Volvox extracellular phosphatase is the largest phosphatase cloned, with no sequence similarity to any other phosphatase. This enzyme exhibits a modular composition. There are two large domains and a small one. The large domains are highly homologous to each other and therefore most likely originated from gene duplication and fusion. At least one EF-hand motif for calcium binding was identified in this extracellular protein Volvox extracellular phosphatase is the first calcium-dependent extracellular phosphatase to be cloned.	Univ Regensburg, Lehrstuhl Biochem 1, D-93053 Regensburg, Germany	University of Regensburg	Hallmann, A (corresponding author), Univ Regensburg, Lehrstuhl Biochem 1, Univ Str 31, D-93053 Regensburg, Germany.	armin.hallmann@vkl.uni-regensburg.de	Hallmann, Armin/G-5823-2011	Hallmann, Armin/0000-0001-5977-6143				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amon P, 1998, PLANT CELL, V10, P781; BLOCK MA, 1988, PLANT PHYSIOL, V86, P1179, DOI 10.1104/pp.86.4.1179; BRADSHAW RA, 1981, P NATL ACAD SCI-BIOL, V78, P3473, DOI 10.1073/pnas.78.6.3473; CATHALA G, 1975, J BIOL CHEM, V250, P6040; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; DAUWALDER M, 1980, J ULTRA MOL STRUCT R, V70, P318, DOI 10.1016/S0022-5320(80)80015-3; ERTL H, 1989, J CELL BIOL, V109, P3493, DOI 10.1083/jcb.109.6.3493; FISHMAN WH, 1970, CLIN CHIM ACTA, V29, P339, DOI 10.1016/0009-8981(70)90057-4; FORTUNA R, 1979, BIOCHIM BIOPHYS ACTA, V570, P291, DOI 10.1016/0005-2744(79)90149-9; FOULKES JG, 1983, J BIOL CHEM, V258, P431; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FRUENHAUF AM, 1983, J MOL BIOL, V170, P827; GILLES R, 1983, NATURWISSENSCHAFTEN, V70, P571, DOI 10.1007/BF00376679; Godl K, 1997, EMBO J, V16, P25, DOI 10.1093/emboj/16.1.25; GOLDMAN S, 1990, J BACTERIOL, V172, P7065, DOI 10.1128/jb.172.12.7065-7070.1990; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; GRUBER H, 1992, GENE, V120, P75, DOI 10.1016/0378-1119(92)90011-D; HALLMANN A, 1994, P NATL ACAD SCI USA, V91, P11562, DOI 10.1073/pnas.91.24.11562; HALLMANN A, 1994, EUR J BIOCHEM, V221, P143, DOI 10.1111/j.1432-1033.1994.tb18723.x; Hallmann A, 1997, P NATL ACAD SCI USA, V94, P7469, DOI 10.1073/pnas.94.14.7469; Hallmann A, 1996, P NATL ACAD SCI USA, V93, P669, DOI 10.1073/pnas.93.2.669; Halstead R. L., 1975, Soil Biology and Biochemistry. Volume 4 (Paul, E.A.; McLaren, A.D., Editors)., P31; HARPER JF, 1988, MOL GEN GENET, V213, P315, DOI 10.1007/BF00339597; HOLST O, 1989, EUR J BIOCHEM, V181, P345, DOI 10.1111/j.1432-1033.1989.tb14730.x; Horne A.J., 1994, LIMNOLOGY; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; KIRK DL, 1986, J CELL SCI, V80, P207; KIRK DL, 1998, DEV CELL BIOL SERIES, P56; KIRK MM, 1985, CELL, V41, P419, DOI 10.1016/S0092-8674(85)80015-5; MOSS B, 1973, J ECOL, V61, P193, DOI 10.2307/2258927; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; OWENS OVH, 1976, ANNU REV PLANT PHYS, V27, P461, DOI 10.1146/annurev.pp.27.060176.002333; Provasoli L., 1960, Special Publications Pymatuning Laboratory of Field Ecology, VNo. 2, P84; Quisel JD, 1996, PLANT PHYSIOL, V111, P839, DOI 10.1104/pp.111.3.839; RAY JM, 1991, J BACTERIOL, V173, P4297, DOI 10.1128/JB.173.14.4297-4309.1991; ROUND FE, 1981, ECOLOGY ALGAE, P479; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIEDLMEIER B, 1994, P NATL ACAD SCI USA, V91, P5080, DOI 10.1073/pnas.91.11.5080; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Schlesinger WH., 1998, BIOGEOCHEMISTRY ANAL, V73, P353, DOI 10.1016/0016-7037(92)90106-s; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Smith GM, 1918, AM J BOT, V5, P178, DOI 10.2307/2435005; SOMMER U, 1986, LIMNOL OCEANOGR, V31, P650, DOI 10.4319/lo.1986.31.3.0650; SPARKS JW, 1985, J BIOL CHEM, V260, P2042; Starr R. C., 1969, Archiv fuer Protistenkunde, V111, P204; STARR RC, 1974, P NATL ACAD SCI USA, V71, P1050, DOI 10.1073/pnas.71.4.1050; STARR RC, 1970, DEVELOP BIOL       S, V4, P59; STRYER L, 1995, BIOCHEMISTRY-US, P434; Sumper M, 1998, INT REV CYTOL, V180, P51; SUMPER M, 1980, FEBS LETT, V114, P307, DOI 10.1016/0014-5793(80)81140-9; SWARUP G, 1981, J BIOL CHEM, V256, P8197; Utermohl H., 1925, Archiv Hydrobiol Stuttgart Suppl Bd, V5, P1; UTERMOHL H, 1924, SCHRIFT SUSSWASSER M, V9, P731; VARNER JE, 1989, CELL, V56, P231, DOI 10.1016/0092-8674(89)90896-9; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; WENZL S, 1981, P NATL ACAD SCI-BIOL, V78, P3716, DOI 10.1073/pnas.78.6.3716	58	30	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1691	1697		10.1074/jbc.274.3.1691	http://dx.doi.org/10.1074/jbc.274.3.1691			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880549	hybrid			2022-12-27	WOS:000079956900069
J	Ortega-Barria, E; Boothroyd, JC				Ortega-Barria, E; Boothroyd, JC			A Toxoplasma lectin-like activity specific for sulfated polysaccharides is involved in host cell infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-D-XYLOSIDE; HEPARAN-SULFATE; PLASMODIUM-FALCIPARUM; BORRELIA-BURGDORFERI; GONDII TACHYZOITES; BINDING PROTEIN; PROTEOGLYCANS; INVASION; HEMAGGLUTINATION; IDENTIFICATION	Toxoplasma gondii is one of the most widespread parasites of humans and animals. The parasite has a remarkable ability to invade a broad range of cells within its mammalian hosts by mechanisms that are poorly understood at the molecular level. This broad host cell specificity suggests that adhesion should involve the recognition of ubiquitous surface-exposed host molecules or, alternatively, the presence of various parasite attachment molecules able to recognize different host cell receptors. We have discovered a sugar-binding activity (lectin) in tachyzoites of T. gondii that plays a role in vitro in erythrocyte agglutination and infection of human fibroblasts and epithelial cells. The ability to agglutinate erythrocytes can be reversed by a variety of soluble glycoconjugates, of which heparin, fucoidan, and dextran sulfate were the most effective. Interestingly, infectivity of tachyzoites for human foreskin fibroblasts, cells that are commonly used to grow T. gondii in vitro, was increased by low concentrations of the sulfated glycoconjugates that inhibited hemagglutination activity (i.e. dextran sulfate and fucoidan) whereas high concentrations inhibited parasite infection. Furthermore, inhibition of glycosaminoglycan biosynthesis and sulfation on the host cells reduced Toxoplasma infectivity. Finally, Toxoplasma tachyzoites showed a reduced ability to infect epithelial cell mutants deficient in the biosynthesis of surface proteoglycans The probable identity of the hemagglutinin(s) was investigated by 1) direct binding of red blood cells to filter blots of Toxoplasma proteins separated by polyacrylamide gel electrophoresis, and 2) binding of metabolically labeled parasite proteins to fixed mammalian cells. Three parasite bands were thus identified as candidate adhesins. These results suggest that attachment of T. gondii to its target cell is mediated by parasite lectins and that sulfated sugars on the surface of host cells may function as a key parasite receptor.	Stanford Univ, Lucille Packard Childrens Hosp, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Lucille Packard Childrens Hosp, Sch Med, Div Pediat Infect Dis, Stanford, CA 94305 USA	Lucile Packard Children's Hospital (LPCH); Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University	Boothroyd, JC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Sherman Fairchild Sci Bldg,D-305, Stanford, CA 94305 USA.	jboothr@leland.stanford.edu		Boothroyd, John C./0000-0001-9719-745X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001286, R01AI021423, R37AI021423] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 21423, K08 AI 01286] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAME KJ, 1989, J BIOL CHEM, V264, P8059; BRENNAN J, 1995, J BIOL CHEM, V270, P9691, DOI 10.1074/jbc.270.17.9691; BUTCHER BA, 1992, J IMMUNOL, V148, P2879; CASU B, 1985, ADV CARBOHYD CHEM BI, V43, P51, DOI 10.1016/S0065-2318(08)60067-0; DEANGELIS PL, 1987, J BIOL CHEM, V262, P13946; DECARVALHO L, 1991, J PARASITOL, V77, P156, DOI 10.2307/3282574; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; ESKO JD, 1987, J BIOL CHEM, V262, P12189; EVANS DJ, 1979, INFECT IMMUN, V23, P336, DOI 10.1128/IAI.23.2.336-346.1979; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; FREVERT U, 1994, EXP PARASITOL, V79, P206, DOI 10.1006/expr.1994.1082; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; FURTADO GC, 1992, INFECT IMMUN, V60, P2337, DOI 10.1128/IAI.60.6.2337-2342.1992; GOLDHAR J, 1994, METHOD ENZYMOL, V236, P211; GOLDHAR J, 1995, METHOD ENZYMOL, V253, P43; GROSS U, 1993, PARASITOL RES, V79, P191, DOI 10.1007/BF00931891; HERRERA EM, 1994, MOL BIOCHEM PARASIT, V65, P73, DOI 10.1016/0166-6851(94)90116-3; HUMPHRIES DE, 1988, BIOCHEM BIOPH RES CO, V154, P365, DOI 10.1016/0006-291X(88)90694-8; ISAACS RD, 1994, J CLIN INVEST, V93, P809, DOI 10.1172/JCI117035; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KOPPE JG, 1986, LANCET, V1, P254; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKY LA, 1994, N HORIZ TH, P37; LEONG JM, 1995, INFECT IMMUN, V63, P874, DOI 10.1128/IAI.63.3.874-883.1995; LEVY RM, 1985, J NEUROSURG, V62, P475, DOI 10.3171/jns.1985.62.4.0475; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; MARK MP, 1990, CELL DIFFER DEV, V32, P1, DOI 10.1016/0922-3371(90)90094-D; MCCABE R, 1988, NEW ENGL J MED, V318, P313, DOI 10.1056/NEJM198802043180509; MINEO JR, 1993, J IMMUNOL, V150, P3951; NADER HB, 1987, P NATL ACAD SCI USA, V84, P3565, DOI 10.1073/pnas.84.11.3565; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; ORTEGABARRIA E, 1992, TROP MED PARASITOL, V43, P186; ORTEGABARRIA E, 1991, CELL, V67, P411, DOI 10.1016/0092-8674(91)90192-2; OSSORIO PN, 1992, MOL BIOCHEM PARASIT, V50, P1, DOI 10.1016/0166-6851(92)90239-G; PARISH CR, 1988, J IMMUNOL, V141, P3498; PATANKAR MS, 1993, J BIOL CHEM, V268, P21770; PFEFFERKORN ER, 1977, J PROTOZOOL, V24, P449, DOI 10.1111/j.1550-7408.1977.tb04774.x; Remington JS., 1990, INFECT DIS FETUS NEW, V3, P89; ROBERT R, 1991, INFECT IMMUN, V59, P4670, DOI 10.1128/IAI.59.12.4670-4673.1991; Rostand KS, 1997, INFECT IMMUN, V65, P1; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; Schwartzman Joseph D., 1992, V18, P333; SIBLEY LD, 1995, TRENDS CELL BIOL, V5, P129, DOI 10.1016/S0962-8924(00)88964-3; WERK R, 1985, REV INFECT DIS, V7, P449; WILSON CB, 1980, PEDIATRICS, V66, P767; ZHANG JP, 1992, CELL, V69, P861, DOI 10.1016/0092-8674(92)90296-O	47	96	100	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1267	1276		10.1074/jbc.274.3.1267	http://dx.doi.org/10.1074/jbc.274.3.1267			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880495	hybrid			2022-12-27	WOS:000079956900015
J	Zhang, HM; Huang, DR; Cramer, WA				Zhang, HM; Huang, DR; Cramer, WA			Stoichiometrically bound beta-carotene in the cytochrome b(6)f complex of oxygenic photosynthesis protects against oxygen damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS-REINHARDTII; CRYSTAL-STRUCTURE; PHOTOSYSTEM-II; BC(1) COMPLEX; CHLOROPHYLL-A; SUBUNIT; POLYPEPTIDE; MEMBRANES; DIMER; ACID	The cytochrome b(6)f complex of oxygenic photosynthesis carries out "dark reactions" of electron transfer that link are light-driven reactions of the reaction centers, and coupled proton transfer that generates part of the electrochemical potential utilized for ATP synthesis. In contrast to the bc(1) complex of the respiratory chain, with which there are many structural and functional homologies, the b(6)f complex contains bound pigment molecules. Along with the specifically bound chlorophyll a previously found to be bound stoichiometrically in the dimeric b(6)f complex, it was found in the present study that beta-carotene is also present in the b(6)f complex at stoichiometric levels or nearly so, Chlorophyll and carotenoid pigments were quantitatively extracted from b(6)f complex purified from (i) the thermophilic cyanobacterium, Mastigocladus laminosus, (ii) spinach chloroplasts, and (iii) the green alga, Chlamydomonas reinhardtii, Visible and mass spectra showed the carotenoid to be a beta-carotene of molecular weight = 536, with a stoichiometry of 1.0:1 relative to cytochrome f in the highly active M. laminosus complex but somewhat lower stoichiometries, 0.77 and 0.55, in the b(6)f complex obtained from spinach chloroplasts and C, reinhardtii, A photoprotective function for the beta-carotene was inferred from the findings that the rate of photobleaching of tho chlorophyll a bound in the complex was found to vary inversely with beta-carotene content and to decrease markedly in the presence of ambient N-2 instead of air. The presence of beta-carotene in the b(6)f complex, and not in the related be, complexes of the mitochondrial respiratory chain and photosynthetic bacteria, suggests that an additional function is to protect the protein complexes in oxygenic photosynthetic membranes against toxic effects of intramembrane singlet O-2.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cramer, WA (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	wac@bilbo.bio.purdue.edu			NIGMS NIH HHS [GM-38323] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038323, R56GM038323] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALFONSO M, 1994, BIOCHEMISTRY-US, V33, P10494, DOI 10.1021/bi00200a034; Bald D., 1992, P629; BERTHOLD DA, 1995, J BIOL CHEM, V270, P29293, DOI 10.1074/jbc.270.49.29293; Breyton C, 1997, J BIOL CHEM, V272, P21892, DOI 10.1074/jbc.272.35.21892; Britton G., 1993, CAROTENOIDS PHOTOSYN, P409, DOI [10.1007/978-94-011-2124-8_10, DOI 10.1007/978-94-011-2124-8_10]; Carrell CJ, 1997, STRUCTURE, V5, P1613, DOI 10.1016/S0969-2126(97)00309-2; Cramer WA, 1997, PHYSIOL PLANTARUM, V100, P852, DOI 10.1111/j.1399-3054.1997.tb00011.x; Cramer WA, 1996, ANNU REV PLANT PHYS, V47, P477, DOI 10.1146/annurev.arplant.47.1.477; deVitry C, 1996, J BIOL CHEM, V271, P10667, DOI 10.1074/jbc.271.18.10667; Frank H. A., 1993, CAROTENOIDS PHOTOSYN, P253; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; FRANK HA, 1996, ANOXYGENIC PHOTOSYNT, P373; GILMORE AM, 1991, J CHROMATOGR, V543, P137, DOI 10.1016/S0021-9673(01)95762-0; HALEY J, 1989, P NATL ACAD SCI USA, V86, P1534, DOI 10.1073/pnas.86.5.1534; HUANG D, 1994, BIOCHEMISTRY-US, V33, P4401, DOI 10.1021/bi00180a038; HUANG D, 1998, IN PRESS P 11 INT C; HURT E, 1981, EUR J BIOCHEM, V117, P591; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Joliot A, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL II, P615; Koyama Y., 1993, CAROTENOIDS PHOTOSYN, P327, DOI 10.1007/978-94-011-2124-8_9; LAVERGNE J, 1991, TRENDS BIOCHEM SCI, V16, P129, DOI 10.1016/0968-0004(91)90054-Y; Marquardt J, 1998, J PLANT PHYSIOL, V152, P372, DOI 10.1016/S0176-1617(98)80250-2; Martinez SE, 1996, PROTEIN SCI, V5, P1081; MARTINEZ SE, 1994, STRUCTURE, V2, P95, DOI 10.1016/S0969-2126(00)00012-5; Metzger SU, 1997, BBA-BIOENERGETICS, V1319, P233, DOI 10.1016/S0005-2728(96)00164-8; PALOZZA P, 1992, METHOD ENZYMOL, V213, P403; Patzlaff JS, 1996, BIOCHEMISTRY-US, V35, P7802, DOI 10.1021/bi960056z; Peterman EJG, 1998, BIOPHYS J, V75, P389, DOI 10.1016/S0006-3495(98)77523-X; Pierre Y, 1997, J BIOL CHEM, V272, P21901, DOI 10.1074/jbc.272.35.21901; PIERRE Y, 1995, J BIOL CHEM, V270, P29342, DOI 10.1074/jbc.270.49.29342; Poggese C, 1997, FEBS LETT, V414, P585, DOI 10.1016/S0014-5793(97)01078-8; Porra RJ., 1991, CHLOROPHYLLS, P31; RYBEK JF, 1985, SINGLET O2 POLYM BIO, V4, P1; SEELY GR, 1966, CHLOROPHYLLS, P523; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Takahashi Y, 1996, EMBO J, V15, P3498, DOI 10.1002/j.1460-2075.1996.tb00718.x; TELFER A, 1994, BIOCHEMISTRY-US, V33, P14469, DOI 10.1021/bi00252a013; VANDERMEER BW, 1993, BIOMEMBRANE, V2, P97; WHITMARSH J, 1986, ENCY PLANT PHYSL, P509; WIDGER WR, 1984, P NATL ACAD SCI-BIOL, V81, P674, DOI 10.1073/pnas.81.3.674; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; 1993, CAROTENOIDS PHOTOSYN, P253	43	90	93	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1581	1587		10.1074/jbc.274.3.1581	http://dx.doi.org/10.1074/jbc.274.3.1581			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880536	hybrid			2022-12-27	WOS:000079956900056
J	Han, YQ; Meng, T; Murray, NR; Field, AP; Brasier, AR				Han, YQ; Meng, T; Murray, NR; Field, AP; Brasier, AR			Interleukin-1-induced nuclear factor-kappa B-I kappa B alpha autoregulatory feedback loop in hepatocytes - A role for protein kinase C alpha in post-transcriptional regulation of I kappa B alpha resynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION; MESSENGER-RNA; FAMILY; CELLS; TRANSACTIVATOR; INHIBITION; ACTIVATION; INDUCTION; MECHANISM	The I kappa B inhibitors regulate the activity of the potent transcription factor nuclear factor-kappa B (NF-kappa B). Following signal-induced I kappa B proteolysis, NF-kappa B translocates into the nucleus to activate transcription of target genes, including I kappa B alpha itself, initiating the "NF-kappa B-I kappa B alpha autoregulatory feedback loop." Upon I kappa B alpha resynthesis, NF-kappa B is subsequently inactivated and redistributed back into the cytoplasm. We have previously reported a robust NF-kappa B-I kappa B alpha autoregulatory feedback loop in HepG2 hepatocytes. Sixty minutes after tumor necrosis factor (TNF-alpha) stimulation, I kappa B alpha is resynthesized to similar to 2-fold greater level than in control cells and completely inhibits NF-kappa B binding. Here we investigate the mechanism for I kappa B alpha resynthesis comparing the effect of stimulation of TNF-alpha with that of interleukin-1 (IL-1 alpha). Although either TNF-alpha or IL-1 alpha stimulation of protein kinase C (PKC)-down-regulated cells equivalently induces NF-kappa B translocation, the kinetics of I kappa B alpha resynthesis is slowed, Moreover, pretreatment with selective calcium-dependent PKC inhibitors selectively slowed the kinetics of the IL-1 alpha-induced overshoot without affecting that produced by TNF-alpha. Down-regulation of PKC alpha by antisense phosphorothioate oligonucleotides and expression vectors selectively blocked the IL-1 alpha-induced I kappa B alpha overshoot. In the absence of PKC alpha, although IL-1 alpha induced similar amounts of I kappa B alpha transcription and changes in steady-state mRNA, a greater component of I kappa B alpha mRNA was retained in the nucleus. These data indicate a selective role for PKC alpha in IL-1 alpha-induced I kappa B alpha resynthesis, which is mediated, at least in part, by post-transcriptional control of mRNA export.	Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Onclol & Hematol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Brasier, AR (corresponding author), Univ Texas, Med Branch, Dept Internal Med, 301 Univ Blvd, Galveston, TX 77555 USA.	arbrasie@utmb.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NIEHS NIH HHS [P30 ES06676] Funding Source: Medline; PHS HHS [1RO1 55630-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BIRCH HE, 1986, J BIOL CHEM, V261, P8077; Brasier AR, 1996, HYPERTENSION, V27, P1009, DOI 10.1161/01.HYP.27.4.1009; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; BRASIER AR, 1990, EMBO J, V9, P3933, DOI 10.1002/j.1460-2075.1990.tb07614.x; Brasier AR, 1996, HYPERTENSION, V27, P465, DOI 10.1161/01.HYP.27.3.465; BRASIER AR, 1990, CURRENT PROTOCOLS MO; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; CHENG Q, 1994, J BIOL CHEM, V269, P13551; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; DEAN NM, 1994, J BIOL CHEM, V269, P16416; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Ducher L, 1995, BIOCHEM BIOPH RES CO, V217, P546, DOI 10.1006/bbrc.1995.2810; Han YQ, 1997, J BIOL CHEM, V272, P9825; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; Jamaluddin M, 1998, J VIROL, V72, P4849, DOI 10.1128/JVI.72.6.4849-4857.1998; Klement JF, 1996, MOL CELL BIOL, V16, P2341; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; LOFQUIST AK, 1995, MOL CELL BIOL, V15, P1737; Maniatis T, 1997, SCIENCE, V278, P818, DOI 10.1126/science.278.5339.818; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MEICHLE A, 1990, J BIOL CHEM, V265, P8339; MURRAY NR, 1993, J BIOL CHEM, V268, P15847; PADMANABHAN R, 1993, METHOD ENZYMOL, V218, P637; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; Rzymkiewicz DM, 1996, J BIOL CHEM, V271, P17241, DOI 10.1074/jbc.271.29.17241; Smith CL, 1997, J BIOL CHEM, V272, P14227, DOI 10.1074/jbc.272.22.14227; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; YOUNG S, 1987, BIOCHEM J, V244, P775, DOI 10.1042/bj2440775; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P	36	70	72	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					939	947		10.1074/jbc.274.2.939	http://dx.doi.org/10.1074/jbc.274.2.939			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873035	hybrid			2022-12-27	WOS:000077968500050
J	Janulis, M; Silberman, S; Ambegaokar, A; Gutkind, JS; Schultz, RM				Janulis, M; Silberman, S; Ambegaokar, A; Gutkind, JS; Schultz, RM			Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASE MATRILYSIN; HUMAN UROKINASE ENHANCER; RAT EMBRYO CELLS; C-HA-RAS; PLASMINOGEN-ACTIVATOR; SIGNALING PATHWAY; PROMOTER ACTIVITY; BINDING-SITES; CANCER CELLS; JUN	Ras activates a multitude of downstream activities with roles in cellular proliferation, invasion and metastasis, differentiation, and programmed cell death. In this work we have evaluated the requirement of extracellular signal-regulated protein kinase (ERK), c-Jun NH2-terminal kinase kinase (JNKK), and c-Jun/AP-1 activities in transformation and extracellular matrix invasion of ras oncogene expressing NIH 3T3 fibroblasts by expressing stable mutant genes that constitutively inhibit these activities. Whereas the inhibition of ERK activity reverts the transformed and invasive phenotype, the inhibition of the JNK pathway and AP-1 transactivating activities by JNKK[K129R] and c-Jun(TAM67) had no effect on the ability of the ras oncogene-expressing cells to grow in soft agar or invade Matrigel basement membrane. Thus an elevated JNK activity and/or c-Jun/AP-1 trans-activating activity are not absolute requirements for ras transformation or invasion through basement membrane, and the dependence on AP-1 activity for transformation is cell-specific. However, inhibition of JNH kinase (JNKK) in ras-transformed cells with normally elevated JNK activity switches the protease-dependent invasive phenotype from a urokinase plasminogen activator (uPA)-dependent to a cathepsin L (CL)-dependent invasive phenotype. Conversely, treatment of ras-transformed cells of low constitutive JNK activity with the JNH stimulator, anisomycin, converts the protease mRNA levels from those characteristic of a CL-dependent to a uPA-dependent phenotype, These protease phenotypes can be duplicated in untransformed NIH 3T3 cells that express platelet-derived growth factor receptors and mi muscarinic receptors that selectively stimulate the ERK or JNK pathways, respectively. It is concluded that high ERK activity is required for both protease phenotypes, whereas the JNK pathway and c-Jun/AP-1 activity are not required for transformation but regulate a switch between uPA and CL protease phenotypes in both transformed and untransformed cells. In ras-transformed NIH 3T3 fibroblasts, the uPA- and CL-dependent protease phenotypes are redundant in their ability to invade through basement membrane.	Loyola Univ, Stritch Sch Med, Dept Mol & Cellular Biochem, Maywood, IL 60153 USA; Loyola Univ, Stritch Sch Med, Dept Pathol, Maywood, IL 60153 USA; NIDR, Mol Signaling Unit, Cellular Dev & Oncol Lab, NIH, Bethesda, MD 20892 USA	Loyola University Chicago; Loyola University Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Schultz, RM (corresponding author), Loyola Univ, Stritch Sch Med, Dept Mol & Cellular Biochem, 2160 S 1st Ave, Maywood, IL 60153 USA.	rschult@luc.edu	Gutkind, J. Silvio/J-1201-2016; Gutkind, J. Silvio/A-1053-2009	Gutkind, J. Silvio/0000-0002-5150-4482; 				ALANI R, 1991, MOL CELL BIOL, V11, P6286, DOI 10.1128/MCB.11.12.6286; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ANGEL P, 1994, FOS JUN FAMILIES TRA, P3; BONINI JA, 1991, BIOTECHNIQUES, V11, P708; BRADLEY MO, 1986, P NATL ACAD SCI USA, V83, P5277, DOI 10.1073/pnas.83.14.5277; BROWN PH, 1994, ONCOGENE, V9, P791; BROWN PH, 1993, ONCOGENE, V8, P877; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; CASTELLAZZI M, 1990, ONCOGENE, V5, P1541; Chen TK, 1996, MOL CARCINOGEN, V15, P215, DOI 10.1002/(SICI)1098-2744(199603)15:3<215::AID-MC7>3.0.CO;2-G; CLARK GJ, 1995, METHOD ENZYMOL, V255, P395; COSO OA, 1995, J BIOL CHEM, V270, P5620, DOI 10.1074/jbc.270.10.5620; DECESARE D, 1995, ONCOGENE, V11, P365; DEFEOJONES D, 1985, SCIENCE, V228, P179, DOI 10.1126/science.3883495; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; GAIRE M, 1994, J BIOL CHEM, V269, P2032; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P2674, DOI 10.1073/pnas.81.9.2674; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; HAUSER CA, 1995, METHOD ENZYMOL, V255, P412; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Kane S E, 1990, Semin Cancer Biol, V1, P127; KHOSRAVIFAR R, 1994, CANCER METAST REV, V13, P67, DOI 10.1007/BF00690419; Kirstein M, 1996, J BIOL CHEM, V271, P18231, DOI 10.1074/jbc.271.30.18231; KOBAYASHI H, 1994, THROMB HAEMOSTASIS, V71, P474; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEE JS, 1994, J BIOL CHEM, V269, P2887; Lengyel E, 1996, J BIOL CHEM, V271, P23176, DOI 10.1074/jbc.271.38.23176; LENGYEL E, 1995, J BIOL CHEM, V270, P23007, DOI 10.1074/jbc.270.39.23007; Lengyel E, 1996, J CELL BIOCHEM, V61, P430, DOI 10.1002/(SICI)1097-4644(19960601)61:3<430::AID-JCB10>3.0.CO;2-N; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; MARSHALLHEYMAN H, 1994, ONCOGENE, V9, P3655; MCDONNELL S, 1994, BIOCHEM SOC T, V22, P58, DOI 10.1042/bst0220058; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; NERLOV C, 1991, ONCOGENE, V6, P1583; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; REICH R, 1988, CANCER RES, V48, P3307; REPESH LA, 1989, INVAS METAST, V9, P192; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SCHUTTE J, 1989, P NATL ACAD SCI USA, V86, P2257, DOI 10.1073/pnas.86.7.2257; Silberman S, 1997, J BIOL CHEM, V272, P5927, DOI 10.1074/jbc.272.9.5927; Simon C, 1996, CANCER RES, V56, P5369; SUN H, 1994, SCIENCE, V266, P285, DOI 10.1126/science.7939666; TERRANOVA VP, 1986, P NATL ACAD SCI USA, V83, P465, DOI 10.1073/pnas.83.2.465; TROPPMAIR J, 1994, J BIOL CHEM, V269, P7030; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; Vandel L, 1996, MOL CELL BIOL, V16, P1881; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; VOGT PK, 1994, FOS JUN FAMILIES TRA, P203; WASYLYK C, 1994, ONCOGENE, V9, P3665; WESTWICK JK, 1994, P NATL ACAD SCI USA, V91, P6030, DOI 10.1073/pnas.91.13.6030; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; YAMAMOTO H, 1995, J CLIN LAB ANAL, V9, P297, DOI 10.1002/jcla.1860090504; ZHANG JY, 1992, CANCER RES, V52, P6682	63	56	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					801	813		10.1074/jbc.274.2.801	http://dx.doi.org/10.1074/jbc.274.2.801			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873019	hybrid			2022-12-27	WOS:000077968500034
J	Tone, M; Diamond, LE; Walsh, LA; Tone, Y; Thompson, SAJ; Shanahan, EM; Logan, JS; Waldmann, H				Tone, M; Diamond, LE; Walsh, LA; Tone, Y; Thompson, SAJ; Shanahan, EM; Logan, JS; Waldmann, H			High level transcription of the complement regulatory protein CD59 requires an enhancer located in intron 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE ATTACK COMPLEX; HYPERSENSITIVE SITES; GENE; MOLECULES; CELLS; ACTIVATION; EXPRESSION; C9	CD59 is a complement regulatory protein and may also act as a signal-transducing molecule. CD59 transgenic mice have been generated using a CD59 minigene (CD59 minigene-1). Although this minigene contained a 4.6-kilobase pair 5'-flanking region from the human CD59 gene as a promoter, the expression levels of the CD59 mRNA were substantially lower than those observed in humans, suggesting that CD59 gene expression might also require other transcriptional regulatory elements such as an enhancer. To investigate the transcriptional regulation of the CD59 gene, we used three cell lines that express CD59 at different levels. We have identified DNase 1-hypersensitive sites in intron 1 in HeLa cells, which express CD59 at high levels, but not in Jurkat (intermediate level) or Raji cells (low level). Furthermore, cell line-specific enhancer activity was detected in a fragment containing these DNase 1-hypersensitive sites. The CD59 enhancer was mapped to between -1155 and -888 upstream of the 5'-end of exon 2. To investigate the enhancer activity in vivo, a new CD59 minigene was constructed by the addition of the enhancer fragment, into CD59 minigene-1, High expressor CD59 transgenic mice were generated using the new minigene.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Nextran Inc, Princeton, NJ 08540 USA; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Oxford; University of Cambridge	Tone, M (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	mtone@molbiol.ox.ac.uk	waldmann, herman/F-7412-2011; Shanahan, Michael/ABE-5543-2020; waldmann, herman/W-8051-2019	Waldmann, Herman/0000-0001-7519-6720				DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; Diamond L E, 1995, Transpl Immunol, V3, P305, DOI 10.1016/0966-3274(95)80016-6; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; GHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156; GHOSH D, 1993, NUCLEIC ACIDS RES, V21, P3117, DOI 10.1093/nar/21.13.3117; Holguin MH, 1996, J IMMUNOL, V157, P1659; Jones J, 1995, IMMUNOLOGY, V86, P651; KOOYMAN DL, 1995, SCIENCE, V269, P89, DOI 10.1126/science.7541557; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MCCURRY KR, 1995, NAT MED, V1, P423, DOI 10.1038/nm0595-423; MERI S, 1990, IMMUNOLOGY, V71, P1; MORGAN BP, 1993, EUR J IMMUNOL, V23, P2841, DOI 10.1002/eji.1830231118; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; TONE M, 1992, J MOL BIOL, V227, P971, DOI 10.1016/0022-2836(92)90239-G; WALSH LA, 1992, TISSUE ANTIGENS, V40, P213, DOI 10.1111/j.1399-0039.1992.tb02048.x; WALSH LA, 1991, EUR J IMMUNOL, V21, P847, DOI 10.1002/eji.1830210349; WU C, 1989, METHOD ENZYMOL, V170, P269; ZHAO J, 1991, J BIOL CHEM, V266, P13418	22	12	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					710	716		10.1074/jbc.274.2.710	http://dx.doi.org/10.1074/jbc.274.2.710			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873006	hybrid			2022-12-27	WOS:000077968500021
J	Blom, AM; Morgelin, M; Oyen, M; Jarvet, J; Fries, E				Blom, AM; Morgelin, M; Oyen, M; Jarvet, J; Fries, E			Structural characterization of inter-alpha-inhibitor - Evidence for an extended shape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URINARY TRYPSIN-INHIBITOR; CUMULUS EXTRACELLULAR-MATRIX; HYALURONAN-BINDING PROTEIN; COVALENTLY CROSS-LINKS; AMINO-ACID-SEQUENCE; HEAVY-CHAINS; LIMITED PROTEOLYSIS; ELECTRON-MICROSCOPY; IN-VIVO; SERUM	Inter-alpha-inhibitor (I alpha I) is a 180-kDa serum protein consisting of three polypeptides, Two of these, the heavy chains 1 and 2 (H1 and H2), are of 75-80 kDa and have similar amino acid sequences. The third polypeptide, bikunin, has a molecular mass of 25 kDa and contains a 7-kDa chondroitin sulfate chain that is covalently linked to the C-terminal amino acid residues of H1 and H2, I alpha I has been shown to be required for the formation of the hyaluronan-containing extracellular matrix of certain cell types. How I alpha I exerts this function is not known, but it appears that upon interaction with cells, the heavy chains are released and become covalently linked to hyaluronan, Our results indicate that I alpha I and its heavy chains are extended molecules; thus, upon electron microscopy, I alpha I appeared to consist of two globular domains connected by a thin structure 31-nm long and the isolated heavy chains of a globular domain and a "tail" about 15-nm long. Analysis of the heavy chains by partial proteolysis showed that the C-terminal halves are particularly sensitive to hydrolysis indicating that they are loosely folded. Furthermore, electron microscopy showed that partially degraded heavy chains lacked the extended regions. Taken together, these results suggest that the N-terminal half of the heavy chains forms a globular domain, whereas the other half has an extended and loosely folded structure.	Univ Uppsala, Dept Med Biochem & Microbiol, Ctr Biomed, S-75123 Uppsala, Sweden; Univ Lund, Dept Cell & Mol Biol, S-22100 Lund, Sweden; Stockholm Univ, Dept Biophys, S-10691 Stockholm, Sweden	Uppsala University; Lund University; Stockholm University	Fries, E (corresponding author), Univ Uppsala, Dept Med Biochem & Microbiol, Ctr Biomed, Box 575, S-75123 Uppsala, Sweden.	Erik.Fries@medkem.uu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022; Jarvet, Jüri/A-7330-2008	Blom, Anna/0000-0002-1348-1734; Jarvet, Jüri/0000-0002-7863-1887				BALDUYCK M, 1989, BIOL CHEM H-S, V370, P329, DOI 10.1515/bchm3.1989.370.1.329; BALDUYCK M, 1993, BIOL CHEM H-S, V374, P895, DOI 10.1515/bchm3.1993.374.7-12.895; BANERJEE SD, 1992, J CELL BIOL, V119, P643, DOI 10.1083/jcb.119.3.643; BLOM A, 1995, J BIOL CHEM, V270, P9698, DOI 10.1074/jbc.270.17.9698; BOURGUIGNON J, 1993, EUR J BIOCHEM, V212, P771, DOI 10.1111/j.1432-1033.1993.tb17717.x; CHEN L, 1992, J BIOL CHEM, V267, P12380; CHEN L, 1994, J BIOL CHEM, V269, P28282; Chen L, 1996, J BIOL CHEM, V271, P19409, DOI 10.1074/jbc.271.32.19409; ENGEL J, 1987, EXTRACELLULAR MATRIX, P3; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; FONTANA A, 1986, BIOCHEMISTRY-US, V25, P1847, DOI 10.1021/bi00356a001; FOWLER WE, 1979, J MOL BIOL, V134, P241, DOI 10.1016/0022-2836(79)90034-2; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; HOCHSTRASSER K, 1977, KLIN WOCHENSCHR, V55, P337, DOI 10.1007/BF01488112; HUANG L, 1993, J BIOL CHEM, V268, P26725; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; JESSEN TE, 1994, BIOL CHEM H-S, V375, P521, DOI 10.1515/bchm3.1994.375.8.521; Kobayashi H, 1996, J BIOL CHEM, V271, P11362, DOI 10.1074/jbc.271.19.11362; LEE GM, 1993, J CELL BIOL, V123, P1899, DOI 10.1083/jcb.123.6.1899; Lindstrom KE, 1997, KIDNEY INT, V51, P1053, DOI 10.1038/ki.1997.147; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MORELLE W, 1994, EUR J BIOCHEM, V221, P881, DOI 10.1111/j.1432-1033.1994.tb18803.x; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; Olsen EHN, 1998, BIOCHEMISTRY-US, V37, P408, DOI 10.1021/bi971137d; POTEMPA J, 1989, J BIOL CHEM, V264, P15109; Salier JP, 1996, BIOCHEM J, V315, P1, DOI 10.1042/bj3150001; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHOTTON DM, 1979, J MOL BIOL, V131, P303, DOI 10.1016/0022-2836(79)90078-0; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SJOBERG EM, 1992, ARCH BIOCHEM BIOPHYS, V295, P217, DOI 10.1016/0003-9861(92)90509-U; STEINBUCH M, 1961, NATURE, V192, P1196, DOI 10.1038/1921196a0; THOGERSEN IB, 1995, J BIOL CHEM, V270, P18700; TOYODA H, 1993, BIOL PHARM BULL, V16, P945; TYLER JM, 1980, J ULTRA MOL STRUCT R, V71, P95, DOI 10.1016/S0022-5320(80)90098-2; WACHTER E, 1981, H-S Z PHYSIOL CHEM, V362, P1351, DOI 10.1515/bchm2.1981.362.2.1351; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; YONEDA M, 1990, J BIOL CHEM, V265, P5247; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657	41	46	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					298	304		10.1074/jbc.274.1.298	http://dx.doi.org/10.1074/jbc.274.1.298			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867844	hybrid			2022-12-27	WOS:000077900200044
J	Lang, T; Kessler, D				Lang, T; Kessler, D			Evidence for cysteine persulfide as reaction product of L-Cyst(e)ine C-S-Lyase (C-DES) from Synechocystis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AZOTOBACTER-VINELANDII; ESCHERICHIA-COLI; NIFS GENE; FERREDOXIN; RHODANESE; SEQUENCE; CLUSTER; SULFURTRANSFERASE; CONTAINS; PROTEIN	The pyridoxal phosphate-dependent monomeric L-cysteine/cystine C-S-lyase (C-DES), previously isolated from Synechocystis PCC 6714 by its capacity to direct [2Fe-2S] cluster assembly of ferredoxin in vitro (Leibrecht, I., and Kessler, D, (1997) J, Biol, Chem, 272, 10442-10447), has now been cloned, sequenced, and overexpressed in Escherichia cell. The amino acid sequence of C-DES was found to be nearly identical (92% identity) to the open reading frame slr2143 of Synechocystis PCC 6803 and showed a more distant relationship to the NifS family of proteins (about 27% identity). Recombinant C-DES displayed activities equal to the isolate from Synechocystis in terms of the cyst(e)ine lyase reaction and holoferre-doxin formation which recommended its use for functional and mechanistic studies. Investigation of the substrate spectrum for beta-elimination found L-cysteine to be a poor substrate (k(cat) approximate to 0.15 s(-1)) in contrast to L-cystine (k(cat) = 36 s(-1)) and several related compounds. Of these compounds, desaminocystine (S-(carboxyethylthio)-L-cysteine) was used for C-DES-mediated persulfide generation. Stabilization of the linear persulfide 3-(disulfanyl)-propionic acid was achieved by cyclization as a novel intramolecular trapping reaction; this yielded 1,2-dithiolan-3-one which was isolated and identified by chemical analyses.	Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Kessler, D (corresponding author), Max Planck Inst Med Forsch Gemeinschaft, D-69120 Heidelberg, Germany.	fb8@sun0.urz.uni-heidelberg.de						Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; CERLETTI P, 1986, TRENDS BIOCHEM SCI, V11, P369, DOI 10.1016/0968-0004(86)90206-9; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; ENDO T, 1975, CHEM LETT, P813, DOI 10.1246/cl.1975.813; EVERETT SA, 1995, METHOD ENZYMOL, V251, P55, DOI 10.1016/0076-6879(95)51110-5; FLAVIN M, 1962, J BIOL CHEM, V237, P768; Flint DH, 1996, J BIOL CHEM, V271, P16068; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Kaneko T, 1996, DNA Res, V3, P109; Kemper MA, 1997, J BIOL CHEM, V272, P15620, DOI 10.1074/jbc.272.25.15620; LANG T, 1997, BIOL CHEM S, V378, pS118; LANGER HJ, 1973, CAN J CHEM, V51, P3403, DOI 10.1139/v73-508; Leibrecht I, 1997, J BIOL CHEM, V272, P10442; Loring HS, 1933, J BIOL CHEM, V102, P287; METZLER DE, 1957, J AM CHEM SOC, V79, P485, DOI 10.1021/ja01559a068; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Nagahara N, 1996, J BIOL CHEM, V271, P27395, DOI 10.1074/jbc.271.44.27395; OGATA K, 1990, J BIOL CHEM, V265, P8087; OUZOUNIS C, 1993, FEBS LETT, V322, P159, DOI 10.1016/0014-5793(93)81559-I; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sazuka T, 1996, DNA Res, V3, P225, DOI 10.1093/dnares/3.4.225; SCHJANBERG E, 1942, CHEM BER, V75, P468; SCHOBERL A, 1958, LIEBIGS ANN CHEM, V617, P71; TANIGUCHI T, 1974, BIOCHIM BIOPHYS ACTA, V364, P284, DOI 10.1016/0005-2744(74)90014-X; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	29	40	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					189	195		10.1074/jbc.274.1.189	http://dx.doi.org/10.1074/jbc.274.1.189			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867829	hybrid			2022-12-27	WOS:000077900200029
J	Li, L; Yuan, HD; Xie, W; Mao, JH; Caruso, AM; McMahon, A; Sussman, DJ; Wu, DQ				Li, L; Yuan, HD; Xie, W; Mao, JH; Caruso, AM; McMahon, A; Sussman, DJ; Wu, DQ			Dishevelled proteins lead to two signaling pathways - Regulation of LEF-1 and c-Jun N-terminal kinase in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; TISSUE POLARITY; TRANSCRIPTIONAL ACTIVATION; AXIS FORMATION; DROSOPHILA; WINGLESS; FAMILY; BINDING; APC; CDC42HS	Dishevelled (Dsh/Dvl) proteins are known to mediate Wnt signaling by up-regulating beta-catenin levels and stimulating T cell factor (TCF)LEF-1-dependent transcription. We have identified a new Dvl-mediated signaling pathway in that mouse Dvl proteins, when expressed in COS-7 cells, stimulate c-Jun-dependent transcription activity and the kinase activity of the c-Jun N-terminal kinase (JNK), The DEP domain of Dvl1 is essential for JNK activation. By contrast, all three conserved domains of Dvl, including DIX, PDZ, and DEP, are required for up-regulation of beta-catenin and for stimulation of LEF-1-mediated transcription in mammalian cells. Thus, Dvl can lead to two different signaling pathways. Furthermore, the small G proteins of Cdc42 or Rad, which are involved in JNK activation by many stimuli, do not appear to play a major role in Dvl-mediated JNK activation, because the dominant negative mutants of Cdc42 and Rad could not inhibit Dv1-induced JNK activation. This suggests that Dvl may activate JNK via novel pathways.	Univ Rochester, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; Univ Rochester, Dept Oncol, Rochester, NY 14642 USA; Chinese Acad Sci, Shanghai Inst Biochem, Shanghai, Peoples R China; Harvard Univ, Cambridge, MA 02163 USA; Univ Maryland, Dept Obstet & Gynecol, Baltimore, MD 21250 USA	University of Rochester; University of Rochester; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; University System of Maryland; University of Maryland Baltimore	Wu, DQ (corresponding author), Univ Rochester, Dept Pharmacol & Physiol, 601 Elmwood Ave, Rochester, NY 14642 USA.				NCI NIH HHS [CA63929] Funding Source: Medline; NIGMS NIH HHS [GM53162, GM54167] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA063929, R01CA063929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM053162] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; ADLER PN, 1992, BIOESSAYS, V14, P735, DOI 10.1002/bies.950141103; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CHAN SDH, 1992, J BIOL CHEM, V267, P25202; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Dale TC, 1998, BIOCHEM J, V329, P209; Dickinson ME, 1992, CURR OPIN GENET DEV, V2, P562, DOI 10.1016/S0959-437X(05)80172-8; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fahmy O. G., 1959, DIS, V33, P83; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Klingensmith J, 1996, MECH DEVELOP, V58, P15, DOI 10.1016/S0925-4773(96)00549-7; KLINGENSMITH J, 1994, DEV BIOL, V166, P396, DOI 10.1006/dbio.1994.1325; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krasnow RE, 1995, DEVELOPMENT, V121, P4095; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Minden A., 1997, BIOCHIM BIOPHYS ACTA, V1333, P85, DOI DOI 10.1016/S0304-419X(97)00018-8; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; PERRIMON N, 1994, CELL, V76, P781, DOI 10.1016/0092-8674(94)90351-4; POLAKIS P, 1997, BIOCHIM BIOPHYS ACTA, V1332, P127; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; THEISEN H, 1994, DEVELOPMENT, V120, P347; Tsang M, 1996, DEV DYNAM, V207, P253, DOI 10.1002/(SICI)1097-0177(199611)207:3<253::AID-AJA2>3.0.CO;2-G; Wang YS, 1996, J BIOL CHEM, V271, P4468; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	43	252	257	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					129	134		10.1074/jbc.274.1.129	http://dx.doi.org/10.1074/jbc.274.1.129			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867820	hybrid			2022-12-27	WOS:000077900200020
J	Sung, TC; Altshuller, YM; Morris, AJ; Frohman, MA				Sung, TC; Altshuller, YM; Morris, AJ; Frohman, MA			Molecular analysis of mammalian phospholipase d2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CHOLERA-TOXIN; ARF PROTEINS; RAT-BRAIN; D DEFINES; ACTIVATION; FAMILY; PHOSPHATIDYLCHOLINE; SUPERFAMILY	The mammalian phosphatidylcholine-specific phospholipase D (PLD) enzymes PLD1 and PLDS have been proposed to play roles in signal transduction and membrane vesicular trafficking in distinct subcellular compartments. PLD1 is activated in a synergistic manner in vitro by protein kinase C-alpha, ADP-ribosylation factor 1 (ARF1), and Rho family members. In contrast, PLD2 is constitutively active in vitro. We describe here molecular analysis of PLDS, We show that the NH2-terminal 308 amino acids are required for PLD2's characteristic high basal activity. Unexpectedly, PLDS lacking this region becomes highly responsive to ARF proteins and displays a modest preference for activation by ARF5. Chimeric analysis of PLD1 and PLD2 suggests that the ARF-responsive region is in the PLD carboxyl terminus. We also inserted into PLDS a region of sequence unique to PLD1 known as the "loop" region, which had been proposed initially to mediate effector stimulation but that subsequently was shown instead to be required in part for the very low basal activity characteristic of PLD1. The insertion decreased PLDS activity, consistent with the latter finding. Finally, we show that the critical role undertaken by the conserved carboxyl terminus is unlikely to involve promoting PLD association with membrane surfaces.	SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; SUNY Stony Brook, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Frohman, MA (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.		Morris, Andrew/B-7869-2010		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050388, R01GM054813] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50388, GM54813] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chung JK, 1997, J BIOL CHEM, V272, P15980, DOI 10.1074/jbc.272.25.15980; Colley WC, 1997, BIOCHEM J, V326, P745, DOI 10.1042/bj3260745; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; FROHMAN MA, 1999, IN PRESS PHOSPHOLIPA; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Katayama K, 1998, BIOCHEM J, V329, P647, DOI 10.1042/bj3290647; Kodaki T, 1997, J BIOL CHEM, V272, P11408; Koonin EV, 1996, TRENDS BIOCHEM SCI, V21, P242, DOI 10.1016/0968-0004(96)30024-8; Liang JO, 1997, J BIOL CHEM, V272, P33001, DOI 10.1074/jbc.272.52.33001; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; Morris AJ, 1996, TRENDS PHARMACOL SCI, V17, P182, DOI 10.1016/0165-6147(96)10016-X; MOSS J, 1995, J BIOL CHEM, V270, P12327, DOI 10.1074/jbc.270.21.12327; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Ponting CP, 1996, PROTEIN SCI, V5, P914; REDINA O, 1998, IN PRESS GENE AMST; Redina OE, 1998, BIOCHEM J, V331, P845, DOI 10.1042/bj3310845; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Rudge SA, 1998, J CELL BIOL, V140, P81, DOI 10.1083/jcb.140.1.81; SLAABY R, 1998, IN PRESS J BIOL CHEM, V273; Steed PM, 1998, FASEB J, V12, P1309, DOI 10.1096/fasebj.12.13.1309; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; VANBLITTERSWIJK WJ, 1993, EMBO J, V12, P2655, DOI 10.1002/j.1460-2075.1993.tb05926.x; WAKELAM MJO, 1991, BIOCHEM SOC T, V19, P321, DOI 10.1042/bst0190321; Wang XM, 1997, TRENDS PLANT SCI, V2, P261, DOI 10.1016/S1360-1385(97)86348-0; West MA, 1997, J CELL BIOL, V138, P1239, DOI 10.1083/jcb.138.6.1239; ZHANG GF, 1995, J BIOL CHEM, V270, P21, DOI 10.1074/jbc.270.1.21	32	133	138	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					494	502		10.1074/jbc.274.1.494	http://dx.doi.org/10.1074/jbc.274.1.494			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867870	hybrid			2022-12-27	WOS:000077900200070
J	Garofalo, T; Sorice, M; Misasi, R; Cinque, B; Giammatteo, M; Pontieri, GM; Cifone, MG; Pavan, A				Garofalo, T; Sorice, M; Misasi, R; Cinque, B; Giammatteo, M; Pontieri, GM; Cifone, MG; Pavan, A			A novel mechanism of CD4 down-modulation induced by monosialoganglioside GM3 - Involvement of serine phosphorylation and protein kinase C delta translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; GANGLIOSIDE-MEDIATED MODULATION; T-CELL RECEPTOR; TYROSINE PHOSPHORYLATION; LYMPHOCYTES; ACTIVATION; INHIBITOR; DIFFERENTIATION; DISSOCIATION; MEMBRANE	In this report the molecular mechanism(s) involved in the rapid and selective endocytosis of cell surface glycoprotein CD4 induced by exogenous monosialoganglioside GM3 in human peripheral blood lymphocytes have been investigated. Inhibition of the GM3-induced CD4 down-modulation was observed in the presence of specific protein kinase C (PKC) inhibitors. Scanning confocal microscopy revealed the translocation and clustering on the cell surface of PKC isozymes delta and theta (more evidently than alpha and beta) after GM3 treatment, suggesting the involvement of these isozymes in the ganglioside-induced CD4 down-modulation. Exogenous GM3 induced phosphorylation of CD4 molecule, which then dissociated from p56(lck), as early as after 5 min. Moreover, addition of GM3 resulted in a rapid (1 min) cytosolic phospholipase A(2) activation with consequent arachidonic acid release, whereas no phosphatidylinositol-phospholipase C activity was observed. Both PKC translocation and CD4 down-modulation were blocked by the trifluoromethylketone analog of arachidonic acid, a selective inhibitor of cytosolic phospholipase A(2) and by mitogen-activated protein kinase inhibitor PD98059. Taken together, these findings strongly suggest that GM3 may trigger a novel mechanism of modulation of the CD4 surface expression through the activation of enzyme(s) involved in the regulation of cellular functions.	Univ Aquila, Dipartimento Med Sperimentale, I-67100 Laquila, Italy; Univ Rome La Sapienza, Dipartimento Med Sperimentale & Patol, I-00161 Rome, Italy; Univ Aquila, Ctr Microscopia, I-67100 Laquila, Italy	University of L'Aquila; Sapienza University Rome; University of L'Aquila	Pavan, A (corresponding author), Univ Aquila, Dipartimento Med Sperimentale, Via Vetoio,Coppito 2, I-67100 Laquila, Italy.		Sorice, Maurizio/Q-5079-2019; Cifone, Maria Grazia/ABH-1984-2021; Sousa, Maria/HCI-9642-2022; Cifone, Maria Grazia/I-3750-2019	Cifone, Maria Grazia/0000-0002-9923-5445; Sorice, Maurizio/0000-0003-3534-1502; Cinque, Benedetta/0000-0003-4510-9416; Garofalo, Tina/0000-0003-0645-2510				ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANDERSON P, 1987, J IMMUNOL, V139, P678; BALDARI CT, 1992, J BIOL CHEM, V267, P4289; BASU SK, 1986, BIOCHEMISTRY-US, V25, P2577, DOI 10.1021/bi00357a044; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BREMER EG, 1984, J BIOL CHEM, V259, P6818; BREMER EG, 1986, J BIOL CHEM, V261, P2434; BREMER EG, 1994, CURR TOP MEMBR, V40, P387, DOI 10.1016/S0070-2161(08)60989-2; BREMER EG, 1982, BIOCHEM BIOPH RES CO, V106, P711, DOI 10.1016/0006-291X(82)91769-7; CHIECOBIANCHI L, 1989, AIDS, V3, P501, DOI 10.1097/00002030-198908000-00003; Chigorno V, 1985, GLYCOCONJUGATE J, VV2, P279; CINEK T, 1992, J IMMUNOL, V149, P2262; COLE JA, 1989, J IMMUNOL, V143, P397; CUMAR FA, 1978, BIOCHEM BIOPH RES CO, V84, P65, DOI 10.1016/0006-291X(78)90263-2; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; FISHMAN PH, 1982, J MEMBRANE BIOL, V69, P85, DOI 10.1007/BF01872268; GOUY H, 1995, J IMMUNOL, V155, P5160; GOUY H, 1994, J IMMUNOL, V152, P3271; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; HA KS, 1993, J BIOL CHEM, V268, P10534; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HURLEY TR, 1989, SCIENCE, V245, P407, DOI 10.1126/science.2787934; Iwabuchi K, 1998, J BIOL CHEM, V273, P9130, DOI 10.1074/jbc.273.15.9130; KIGUCHI K, 1990, J BIOCHEM-TOKYO, V107, P8, DOI 10.1093/oxfordjournals.jbchem.a123016; KIGUCHI K, 1986, CANCER RES, V46, P3027; KNIEP B, 1994, BIOCHEM BIOPH RES CO, V203, P1069, DOI 10.1006/bbrc.1994.2291; Knutson KL, 1996, J CELL BIOCHEM, V62, P543, DOI 10.1002/(SICI)1097-4644(19960915)62:4<543::AID-JCB11>3.3.CO;2-Q; KREUTTER D, 1987, J BIOL CHEM, V262, P1633; LEIBERSPERGER H, 1990, J BIOL CHEM, V265, P16108; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Marsh M, 1996, CURR TOP MICROBIOL, V205, P107; MATSUMOTO H, 1989, BIOCHEM BIOPH RES CO, V158, P105, DOI 10.1016/S0006-291X(89)80183-4; MISASI R, 1993, CLIN IMMUNOL IMMUNOP, V67, P216, DOI 10.1006/clin.1993.1068; MUTOH T, 1995, P NATL ACAD SCI USA, V92, P5087, DOI 10.1073/pnas.92.11.5087; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; OFFNER H, 1987, J IMMUNOL, V139, P3295; Olshefski R, 1996, EUR J BIOCHEM, V241, P47, DOI 10.1111/j.1432-1033.1996.0047t.x; OWENS T, 1987, P NATL ACAD SCI USA, V84, P9209, DOI 10.1073/pnas.84.24.9209; REPKE H, 1992, J IMMUNOL, V149, P2585; RIVAS A, 1988, J IMMUNOL, V140, P2912; SAGGIORO D, 1993, J BIOL CHEM, V268, P1368; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHOJI M, 1986, BIOCHEM BIOPH RES CO, V135, P1144, DOI 10.1016/0006-291X(86)91047-8; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; SONG WX, 1993, BIOCHEMISTRY-US, V32, P8602, DOI 10.1021/bi00084a030; Sorice M, 1996, J ACQ IMMUN DEF SYND, V12, P112, DOI 10.1097/00042560-199606010-00003; SORICE M, 1995, SCAND J IMMUNOL, V41, P148, DOI 10.1111/j.1365-3083.1995.tb03547.x; SORICE M, 1997, J LIPID RES, V38, P98; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; USUKI S, 1988, J BIOL CHEM, V263, P10595; VANBLITTERSWIJK WJ, 1994, CURR TOP MEMBR, V40, P413, DOI 10.1016/S0070-2161(08)60990-9; VanBrocklyn JR, 1997, J NEUROCHEM, V69, P116; WILLIAMS MA, 1980, J NEUROCHEM, V35, P266, DOI 10.1111/j.1471-4159.1980.tb12515.x; ZENG GC, 1995, P NATL ACAD SCI USA, V92, P8670, DOI 10.1073/pnas.92.19.8670; ZHOU QG, 1994, J BIOL CHEM, V269, P1959	61	43	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35153	35160		10.1074/jbc.273.52.35153	http://dx.doi.org/10.1074/jbc.273.52.35153			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857052	hybrid			2022-12-27	WOS:000077719700070
J	Imagawa, K; Numata, Y; Katsuura, G; Sakaguchi, I; Morita, A; Kikuoka, S; Matumoto, Y; Tsuji, T; Tamaki, M; Sasakura, K; Teraoka, H; Hosoda, K; Ogawa, Y; Nakao, K				Imagawa, K; Numata, Y; Katsuura, G; Sakaguchi, I; Morita, A; Kikuoka, S; Matumoto, Y; Tsuji, T; Tamaki, M; Sasakura, K; Teraoka, H; Hosoda, K; Ogawa, Y; Nakao, K			Structure-function studies of human leptin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBESE GENE-PRODUCT; FOOD-INTAKE; OB PROTEIN; BODY-WEIGHT; OB/OB MICE; RECEPTOR; RATS; LOCALIZATION; HYPOTHALAMUS; EXPRESSION	To elucidate the structural requirement of human leptin for its functions, the mild-type, mutant type, C-terminal deletion, and N-terminal deletion were expressed in Escherichia coli and purified in soluble forms. These leptin analogs were intracerebroventrically injected into C57BL/6J ob/ob mice, and their in vivo biological activities were evaluated. The mutant-type leptin lacking a C-terminal disulfide bond reduced food intake at doses of more than 15 pmol/mouse, which was as effective as the wild-type leptin, C-terminal deletion without the loop structure, also significantly, but to a lesser extent, reduced food intake at doses of more than 90 pmol/mouse. However, N-terminal deletions showed no effect on food intake. We also evaluated the effects of the leptin analogs on radiolabeled leptin binding to its receptor in the choroid plexus using autoradiography. An excess of unlabeled mutant-type leptin as well as wildtype leptin led to complete inhibition of binding. C-terminal deletions led to weak inhibitory activity, whereas N-terminal deletions caused no inhibitory activity. These results clearly demonstrate that the N-terminal region of leptin is essential for both its biological and receptor binding activities. The amino acid sequence of the C-terminal loop structure is also important for enhancing these actions, whereas the C-terminal disulfide bond is not needed.	Shionogi & Co Ltd, Res & Dev Diagnost Sci Div, Osaka 566, Japan; Shionogi & Co Ltd, CNS Res Labs, Osaka 566, Japan; Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto 6068507, Japan	Shionogi & Company Limited; Shionogi & Company Limited; Kyoto University	Numata, Y (corresponding author), Shionogi & Co Ltd, Res & Dev Diagnost Sci Div, 2-5-1 Mishima, Osaka 566, Japan.	yoshito.numata@shionogi.co.jp		Ogawa, Yoshihiro/0000-0002-0834-2836				CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cohen SL, 1996, NATURE, V382, P589, DOI 10.1038/382589a0; Devos R, 1996, P NATL ACAD SCI USA, V93, P5668, DOI 10.1073/pnas.93.11.5668; Gavrilova O, 1997, J BIOL CHEM, V272, P30546, DOI 10.1074/jbc.272.48.30546; Giese K, 1996, MOL MED, V2, P50, DOI 10.1007/BF03402202; Grasso P, 1997, ENDOCRINOLOGY, V138, P1413, DOI 10.1210/en.138.4.1413; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; MASUZAKI H, 1995, DIABETES, V44, P855, DOI 10.2337/diabetes.44.7.855; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Muller G, 1997, J BIOL CHEM, V272, P10585, DOI 10.1074/jbc.272.16.10585; OGAWA Y, 1995, J CLIN INVEST, V96, P1647, DOI 10.1172/JCI118204; Pace C N, 1986, Methods Enzymol, V131, P266; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; RENTSCH J, 1995, BIOCHEM BIOPH RES CO, V214, P131, DOI 10.1006/bbrc.1995.2266; Samson WK, 1996, ENDOCRINOLOGY, V137, P5182, DOI 10.1210/en.137.11.5182; Satoh N, 1997, ENDOCRINOLOGY, V138, P947, DOI 10.1210/en.138.3.947; Satoh N, 1997, NEUROSCI LETT, V224, P149, DOI 10.1016/S0304-3940(97)00163-8; Sinha MK, 1996, J CLIN INVEST, V98, P1277, DOI 10.1172/JCI118913; Takaya K, 1996, NAT GENET, V14, P130, DOI 10.1038/ng1096-130; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	24	61	73	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35245	35249		10.1074/jbc.273.52.35245	http://dx.doi.org/10.1074/jbc.273.52.35245			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857064	hybrid			2022-12-27	WOS:000077719700082
J	Johnson, JL; Park, JW; El Benna, J; Faust, LP; Inanami, O; Babior, BM				Johnson, JL; Park, JW; El Benna, J; Faust, LP; Inanami, O; Babior, BM			Activation of p47(PHOX), a cytosolic subunit of the leukocyte NADPH oxidase - Phosphorylation of Ser-359 or Ser-370 precedes phosphorylation at other sites and is required for activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; CHRONIC GRANULOMATOUS-DISEASE; PROTEIN-KINASE-C; CELL-FREE SYSTEM; HUMAN-NEUTROPHILS; SUPEROXIDE PRODUCTION; COMPONENTS P47(PHOX); KDA PROTEINS; TRANSLOCATION; P67(PHOX)	The leukocyte NADPH oxidase catalyzes the reduction of oxygen to superoxide (O-2(radical anion) at the expense of NADPH in phagocytes and B lymphocytes, The enzyme is dormant in resting cells but becomes active when the cells are exposed to appropriate stimuli. During oxidase activation, the highly basic cytosolic oxidase component p47(PHOX) becomes phosphorylated on several serines and migrates to the plasma membrane. We report here that p47(PHOX)-deficient B lymphoblasts expressing the p47(PHOX) S359A/S370A or p47PHOX S359K/S370K double mutation show dramatically reduced levels of enzyme activity and phosphorylation of p47PHOX as compared with the same cells expressing wild type p47PHOX. I, addition, these mutant p47PHOX proteins fails to translocate to the plasma membrane when the cells are stimulated. In contrast, normal phosphorylation and translocation are seen in mutants containing aspartate or glutamate at positions 359 and 370, but oxidase activity is still greatly reduced. These results imply that a negative charge at position 359 and/or 370 is sufficient to allow the phosphorylation and translocation of p47(PHOX) to take place but that features unique to a phosphorylated hydroxyamino acid are required to support O-2(radical anion) production. These findings, plus those from an earlier study (Inanami, O., Johnson, J, L., McAdara, J. K., El Benna, J., Faust, L. P., Newburger, P, E., and Babior, B, M. (1998) J. Biol. Chem. 273, 9539-9543), suggest that oxidase activation requires 1) the sequential phosphorylation of at least two serines on p47(PHOX): Ser-359 or Ser-370, followed by Ser-303 or Ser-304; and 2) the translocation of p47(PHOX) to the membrane at some point after the first phosphorylation takes place.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Kyungpook Natl Univ, Taegu 702701, South Korea; CHU X Bichat, INSERM U294, F-75018 Paris, France	Scripps Research Institute; Kyungpook National University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Johnson, JL (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.		Inanami, Osamu/A-5197-2012	Inanami, Osamu/0000-0001-7895-3918	NCRR NIH HHS [RR-00833] Funding Source: Medline; NIAID NIH HHS [AI-28479, AI-24227] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028479, R37AI024227, R01AI024227] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABIOR BM, 1984, CLIN RES, V32, P550; CALDWELL SE, 1988, J CLIN INVEST, V81, P1485, DOI 10.1172/JCI113480; CHANOCK SJ, 1994, J BIOL CHEM, V269, P24519; CHANOCK SJ, 1992, P NATL ACAD SCI USA, V89, P10174, DOI 10.1073/pnas.89.21.10174; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COX JA, 1985, J CLIN INVEST, V76, P1932, DOI 10.1172/JCI112190; CROWLEY CA, 1980, NEW ENGL J MED, V302, P1163, DOI 10.1056/NEJM198005223022102; Dusi S, 1996, BIOCHEM J, V314, P409, DOI 10.1042/bj3140409; ElBenna J, 1995, BLOOD CELL MOL DIS, V21, P201, DOI 10.1006/bcmd.1995.0023; ElBenna J, 1996, J BIOL CHEM, V271, P6374; ELBENNA J, 1994, J BIOL CHEM, V269, P6729; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; FAUST LP, 1995, J CLIN INVEST, V96, P1499, DOI 10.1172/JCI118187; HAYAKAWA T, 1986, J BIOL CHEM, V261, P9109; HEYWORTH PG, 1990, BIOCHIM BIOPHYS ACTA, V1052, P299, DOI 10.1016/0167-4889(90)90225-3; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; Inanami O, 1998, ARCH BIOCHEM BIOPHYS, V350, P36, DOI 10.1006/abbi.1997.0484; Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539; KLEINBERG ME, 1990, J BIOL CHEM, V265, P15577; OHTSUKA T, 1986, BIOCHIM BIOPHYS ACTA, V888, P332, DOI 10.1016/0167-4889(86)90233-8; OKAMURA N, 1988, J BIOL CHEM, V263, P6777; PARK JW, 1994, BIOCHEMISTRY-US, V33, P2907, DOI 10.1021/bi00176a021; PARK JW, 1992, J BIOL CHEM, V267, P17327; Park JW, 1997, J BIOL CHEM, V272, P11035; PARK JW, 1997, BIOCHEMISTRY-US, V36, P8484; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; Sambrook J., 2002, MOL CLONING LAB MANU; SEGAL AW, 1985, NATURE, V316, P547, DOI 10.1038/316547a0; SOMEYA A, 1993, FEBS LETT, V330, P215, DOI 10.1016/0014-5793(93)80276-Z; STEINBECK MJ, 1991, J BIOL CHEM, V266, P16336; THRASHER A, 1992, BLOOD, V80, P1125	34	123	125	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35147	35152		10.1074/jbc.273.52.35147	http://dx.doi.org/10.1074/jbc.273.52.35147			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857051	hybrid			2022-12-27	WOS:000077719700069
J	Leicher, T; Bahring, R; Isbrandt, D; Pongs, O				Leicher, T; Bahring, R; Isbrandt, D; Pongs, O			Coexpression of the KCNA3B gene product with Kv1.5 leads to a novel A-type potassium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL BETA-SUBUNIT; SHAKER K+ CHANNEL; RAT-BRAIN; FUNCTIONAL-CHARACTERIZATION; ALPHA-SUBUNITS; HUMAN HEART; EXPRESSION; INACTIVATION; LOCALIZATION; EUKARYOTES	Shaker-related voltage-gated potassium (Rv) channels may be heterooligomers consisting of membrane-integral cu-subunits associated with auxiliary cytoplasmic p-subunits, In this study we have cloned the human Kv beta 3.1 subunit and the corresponding KCNA3B gene. Identification of sequence-tagged sites in the gene mapped KCNA3B to band p13.1 of human chromosome 17. Comparison of the KCNA1B, KCNA2B, and KCNA3B gene structures showed that the three Kv beta genes have very disparate lengths varying from greater than or equal to 350 kb (KCNA1B) to similar to 7 kb (KCNA3B). Yet, the exon patterns of the three genes, which code for the seven known mammalian Kv beta subunits, are very similar. The Kv beta 1 and Kv beta 2 splice variants are generated by alternative use of 5'-exons. Mouse Rv beta 4, a potential splice variant of Kv beta 3, is a read-through product where the open reading frame starts within the sequence intervening between Kv beta 3 exons 7 and 8, The human KCNA3B sequence does not contain a mouse Kv beta 4-like open reading frame. Human Kv beta 3 mRNA is specifically expressed in the brain, where it is predominantly detected in the cerebellum. The heterologous coexpression of human Kv1.5 and Kv beta 3.1 subunits in Chinese hamster ovary cells yielded a novel Ky channel mediating very fast inactivating (A-type) outward currents upon depolarization. Thus, the expression of Kv beta 3.1 subunits potentially extends the possibilities to express diverse A-type Kv channels in the human brain.	Zentrum Mol Neurobiol, Inst Neurale Signalverarbeitung, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Pongs, O (corresponding author), Zentrum Mol Neurobiol, Inst Neurale Signalverarbeitung, Martinistr 52, D-20246 Hamburg, Germany.	pointuri@uke.uni-hamburg.de	Bähring, Robert/F-7146-2010	Isbrandt, Dirk/0000-0002-4720-1016; Bahring, Robert/0000-0002-0406-5958				Accili EA, 1997, J BIOL CHEM, V272, P25824, DOI 10.1074/jbc.272.41.25824; BALCIUNIENE J, 1995, GENOMICS, V30, P281, DOI 10.1006/geno.1995.9876; CHANDY KG, 1995, HDB RECEPTORS CHANNE, V2, P1; CHOUINARD SW, 1995, P NATL ACAD SCI USA, V92, P6763, DOI 10.1073/pnas.92.15.6763; CHRISTIE MJ, 1990, NEURON, V2, P405; DeBiasi M, 1997, AM J PHYSIOL-HEART C, V272, pH2932, DOI 10.1152/ajpheart.1997.272.6.H2932; ENGLAND SK, 1995, J BIOL CHEM, V270, P28531, DOI 10.1074/jbc.270.48.28531; ENGLAND SK, 1995, P NATL ACAD SCI USA, V92, P6309, DOI 10.1073/pnas.92.14.6309; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fink M, 1996, J BIOL CHEM, V271, P26341, DOI 10.1074/jbc.271.42.26341; Heinemann SH, 1995, FEBS LETT, V377, P383, DOI 10.1016/0014-5793(95)01377-6; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; Hille B., 1992, IONIC CHANNELS EXCIT; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Kelsell RE, 1997, HUM MOL GENET, V6, P597, DOI 10.1093/hmg/6.4.597; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; KLOCKE R, 1993, GENOMICS, V18, P568, DOI 10.1016/S0888-7543(05)80358-1; Leicher T, 1996, NEUROPHARMACOLOGY, V35, P787, DOI 10.1016/0028-3908(96)00133-5; LEICHER T, 1998, THESIS HAMBURG U; LOCK LF, 1994, GENOMICS, V20, P354, DOI 10.1006/geno.1994.1188; MAJUMDER K, 1995, FEBS LETT, V361, P13, DOI 10.1016/0014-5793(95)00120-X; MCCORMACK K, 1995, FEBS LETT, V370, P32, DOI 10.1016/0014-5793(95)00785-8; MORALES MJ, 1995, J BIOL CHEM, V270, P6272, DOI 10.1074/jbc.270.11.6272; Morales MJ, 1996, P NATL ACAD SCI USA, V93, P15119, DOI 10.1073/pnas.93.26.15119; OLIVEIRA L, 1994, GENOMICS, V22, P478, DOI 10.1006/geno.1994.1415; PARCEJ DN, 1992, BIOCHEMISTRY-US, V31, P11084, DOI 10.1021/bi00160a018; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; PONGS O, 1995, SEMIN NEUROSCI, V7, P137, DOI 10.1006/smns.1995.0015; PONGS O, 1992, PHYSL REV S4, V72, P69; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rhodes KJ, 1996, J NEUROSCI, V16, P4846; Roeper J, 1997, J NEUROSCI, V17, P3379; Roeper J, 1998, NATURE, V391, P390, DOI 10.1038/34916; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schultz D, 1996, GENOMICS, V31, P389, DOI 10.1006/geno.1996.0065; Sewing S, 1996, NEURON, V16, P455, DOI 10.1016/S0896-6273(00)80063-X; Shamotienko OG, 1997, BIOCHEMISTRY-US, V36, P8195, DOI 10.1021/bi970237g; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; SNYDERS DJ, 1993, J GEN PHYSIOL, V101, P513, DOI 10.1085/jgp.101.4.513; Stathakis DG, 1997, GENOMICS, V44, P71, DOI 10.1006/geno.1997.4848; Uebele VN, 1996, J BIOL CHEM, V271, P2406, DOI 10.1074/jbc.271.5.2406; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Wilson GF, 1998, J BIOL CHEM, V273, P6389, DOI 10.1074/jbc.273.11.6389; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	49	59	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35095	35101		10.1074/jbc.273.52.35095	http://dx.doi.org/10.1074/jbc.273.52.35095			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857044	hybrid			2022-12-27	WOS:000077719700062
J	Reddy, KB; Gascard, P; Price, MG; Negrescu, EV; Fox, JEB				Reddy, KB; Gascard, P; Price, MG; Negrescu, EV; Fox, JEB			Identification of an interaction between the M-band protein skelemin and beta-integrin subunits - Colocalization of a skelemin-like protein with beta(1)- and beta(3)-integrins in non-muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; CYTOPLASMIC DOMAIN MUTANTS; ACTIN STRESS FIBERS; SARCOMERIC M-BAND; FOCAL ADHESIONS; SIGNAL-TRANSDUCTION; TYROSINE PHOSPHORYLATION; EXTRACELLULAR-MATRIX; FIBRONECTIN RECEPTOR; ALPHA-ACTININ	Signaling across integrins is regulated by interaction of these receptors with cytoskeletal proteins and signaling molecules. To identify molecules interacting with the cytoplasmic domain of the beta(3)-integrin subunit (glycoprotein ma), a placental cDNA library was screened in the yeast two-hybrid system. Two identical clones coding for a 96-amino acid sequence were identified. This sequence was 100% identical to a sequence in skelemin, a protein identified previously in skeletal muscle. Skelemin is a member of a superfamily of cytoskeletal proteins that contain fibronectin-type ill-like motifs and immunoglobulin CB-like motifs and that regulate the organization of myosin filaments in muscle. The amino acid residues in the isolated clones encompassed C2 motifs 4 and 5 of skelemin. A recombinant skelemin protein consisting of C2 motifs 3-7 interacted with beta(1)- and beta(3)-integrin cytoplasmic domains expressed as glutathione S-transferase (GST) fusion proteins, but not with GST-beta(2)-integrin cytoplasmic tail or GST alone. The skelemin-binding region was in the membrane proximal cytoplasmic domains of the integrins, Full-length skelemin interacted with integrin in intact cells as demonstrated by the colocalization of hemagglutinin-tagged skelemin in Chinese hamster ovary (CHO) cells containing alpha(IIb)beta(3)-integrin and by the finding that microinjection of C2 motif 4 of skelemin into C2C12 mouse myoblast cells caused spread cells to round up. A skelemin-like protein was detected in CHO cells, endothelial cells, and platelets, and this protein colocalized with beta(1)- and beta(3)-integrins in CHO cells. This study suggests the presence of a skelemin-like protein in non-muscle cells and provides evidence that it may be involved in linking integrins to the cytoskeleton.	Cleveland Clin Fdn, JJ Jacobs Ctr Thrombosis & Vasc Biol, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	Cleveland Clinic Foundation; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Baylor College of Medicine	Fox, JEB (corresponding author), Cleveland Clin Fdn, JJ Jacobs Ctr Thrombosis & Vasc Biol, Lerner Res Inst, Dept Mol Cardiol, FF2-04, Cleveland, OH 44195 USA.			Gascard, Philippe/0000-0001-5912-5228	NHLBI NIH HHS [HL56264, HL30657] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R23HL030657, R01HL030657, R37HL030657, R01HL056264] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; AYMESOUTHGATE A, 1991, P NATL ACAD SCI USA, V88, P7973, DOI 10.1073/pnas.88.18.7973; Bantle S, 1996, J BIOL CHEM, V271, P19042, DOI 10.1074/jbc.271.32.19042; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chang DD, 1997, J CELL BIOL, V138, P1149, DOI 10.1083/jcb.138.5.1149; CHEN YP, 1994, BLOOD, V84, P1857; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; EILERTSEN KJ, 1994, J CELL BIOL, V126, P1201, DOI 10.1083/jcb.126.5.1201; FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fox JEB, 1996, J BIOL CHEM, V271, P7004, DOI 10.1074/jbc.271.12.7004; FOX JEB, 1982, J BIOL CHEM, V257, P4120; FOX JEB, 1993, J CELL BIOL, V120, P1501, DOI 10.1083/jcb.120.6.1501; FOX JEB, 1991, J BIOL CHEM, V266, P13289; FOX JEB, 1993, J BIOL CHEM, V268, P25973; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FURST DO, 1992, J CELL SCI, V102, P769; GOLDEN A, 1990, J CELL BIOL, V111, P3117, DOI 10.1083/jcb.111.6.3117; GROVE BK, 1984, J CELL BIOL, V98, P518, DOI 10.1083/jcb.98.2.518; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; HAYASHI Y, 1990, J CELL BIOL, V110, P175, DOI 10.1083/jcb.110.1.175; HIBBS ML, 1991, J EXP MED, V174, P1227, DOI 10.1084/jem.174.5.1227; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; HUANG MM, 1993, J CELL BIOL, V122, P473, DOI 10.1083/jcb.122.2.473; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; Kashiwagi H, 1997, J CELL BIOL, V137, P1433, DOI 10.1083/jcb.137.6.1433; Kazmierski ST, 1996, MOL BIOL CELL, V7, P1166; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Knezevic I, 1996, J BIOL CHEM, V271, P16416, DOI 10.1074/jbc.271.27.16416; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; KOUNS WC, 1990, J BIOL CHEM, V265, P20594; LABEIT S, 1990, NATURE, V345, P273, DOI 10.1038/345273a0; Labeit S, 1997, CIRC RES, V80, P290, DOI 10.1161/01.RES.80.2.290; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; LEWIS JM, 1995, MOL BIOL CELL, V6, P151, DOI 10.1091/mbc.6.2.151; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; LOPEZ JA, 1992, J BIOL CHEM, V267, P12851; LUKASHEV ME, 1994, J BIOL CHEM, V269, P18311; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; MASAKI T, 1974, J BIOCHEM, V75, P367, DOI 10.1093/oxfordjournals.jbchem.a130403; MEYER S, 1995, THROMB HAEMOSTASIS, V73, P1201; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOGUCHI J, 1992, J BIOL CHEM, V267, P20302; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; OLSON NJ, 1990, P NATL ACAD SCI USA, V87, P2284, DOI 10.1073/pnas.87.6.2284; OTEY CA, 1993, J BIOL CHEM, V268, P21193; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Parsons JT, 1996, CURR OPIN CELL BIOL, V8, P146, DOI 10.1016/S0955-0674(96)80059-7; PRICE MG, 1987, J CELL BIOL, V104, P1325, DOI 10.1083/jcb.104.5.1325; PRICE MG, 1993, J BIOL CHEM, V268, P21800; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; ROJIANI MV, 1991, BIOCHEMISTRY-US, V30, P9859, DOI 10.1021/bi00105a008; ROSALES C, 1995, J LEUKOCYTE BIOL, V57, P189, DOI 10.1002/jlb.57.2.189; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SCHWARTZ MA, 1994, MOL BIOL CELL, V5, P389, DOI 10.1091/mbc.5.4.389; SHATTIL SJ, 1995, J CELL BIOL, V131, P807, DOI 10.1083/jcb.131.3.807; SMALL JV, 1992, EUR J BIOCHEM, V208, P559, DOI 10.1111/j.1432-1033.1992.tb17220.x; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMYTH SS, 1993, BLOOD, V81, P2827; TRINICK J, 1994, TRENDS BIOCHEM SCI, V19, P405, DOI 10.1016/0968-0004(94)90088-4; VINKEMEIER U, 1993, J CELL SCI, V106, P319; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223	78	41	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35039	35047		10.1074/jbc.273.52.35039	http://dx.doi.org/10.1074/jbc.273.52.35039			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857037	hybrid			2022-12-27	WOS:000077719700055
J	Okun, JG; Lummen, P; Brandt, U				Okun, JG; Lummen, P; Brandt, U			Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH : ubiquinone oxidoreductase)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; PHOTOSYNTHETIC REACTION CENTER; H-3 DIHYDROROTENONE BINDING; PROTON-TRANSLOCATING NADH; ELECTRON-TRANSPORT CHAIN; RESPIRATORY-CHAIN; SUBMITOCHONDRIAL PARTICLES; ESCHERICHIA-COLI; COENZYME-Q; REDUCTASE	We have developed two independent methods to measure equilibrium binding of inhibitors to membrane bound and partially purified NADH:ubiquinone oxidoreductase (complex I) to characterize the binding sites for the great variety of hydrophobic compounds acting on this large and complicated enzyme. Taking advantage of a partial quench of fluorescence upon binding of the fenazaquin-type inhibitor 2-decyl-4-quinazolinyl amine to complex I in bovine submitochondrial particles, we determined a K-d of 17 +/- 3 nM and one binding site per complex I. Equilibrium binding studies with [H-3]dihydrorotenone and the aminopyrimidine [H-3]AE F119209 (4(cis-4-[H-3]isopropyl cyclohexylamino)-5-chloro-6-ethyl pyrimidine) using partially purified complex I from Musca domestica exhibited little unspecific binding and allowed reliable determination of dissociation constants. Competition experiments consistently demonstrated that all tested hydrophobic inhibitors of complex I share a common binding domain with partially overlapping sites. Although the rotenone site overlaps with both the piericidin A and the capsaicin site, the latter two sites do not overlap. This is in contrast to the interpretation of enzyme kinetics that have previously been used to define three classes of complex I inhibitors. The existence of only one large inhibitor binding pocket in the hydrophobic part of complex I is discussed in the light of possible mechanisms of proton translocation.	Univ Frankfurt Klinikum, Inst Biochem 1, D-60590 Frankfurt, Germany; Hoechst Schering AgrEvo GMBH, Biochem Res, D-65926 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Sanofi-Aventis	Brandt, U (corresponding author), Univ Frankfurt Klinikum, Inst Biochem 1, ZBC Theodor Stern Kai 7,Haus 25B, D-60590 Frankfurt, Germany.	brandt@zbc.klinik.uni-frankfurt.de	Brandt, Ulrich/GLV-1242-2022; Brandt, Ulrich/C-4406-2008	Brandt, Ulrich/0000-0003-1869-6811; Brandt, Ulrich/0000-0003-1869-6811				Albracht SPJ, 1997, BBA-BIOENERGETICS, V1318, P92, DOI 10.1016/S0005-2728(96)00153-3; BLANDINI F, 1995, ANAL BIOCHEM, V230, P16, DOI 10.1006/abio.1995.1430; Brandt U, 1997, BBA-BIOENERGETICS, V1318, P79, DOI 10.1016/S0005-2728(96)00141-7; BRANDT U, 1991, EUR J BIOCHEM, V195, P163, DOI 10.1111/j.1432-1033.1991.tb15690.x; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; BRANDT U, 1998, IN PRESS BIOFACTORS; Buchanan SK, 1996, BIOCHEM J, V318, P343, DOI 10.1042/bj3180343; BURBAEV DS, 1989, FEBS LETT, V254, P47, DOI 10.1016/0014-5793(89)81007-5; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CREMONA T, 1964, J BIOL CHEM, V239, P2328; Darrouzet E, 1997, BBA-BIOENERGETICS, V1319, P1, DOI 10.1016/S0005-2728(97)00009-1; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Dutton PL, 1998, BBA-BIOENERGETICS, V1364, P245, DOI 10.1016/S0005-2728(98)00031-0; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; ESPOSTI MD, 1994, BIOCHEM J, V301, P161, DOI 10.1042/bj3010161; ESPOSTI MD, 1994, BBA-BIOENERGETICS, V1187, P116, DOI 10.1016/0005-2728(94)90095-7; Esposti MD, 1996, BIOCHEM J, V313, P327, DOI 10.1042/bj3130327; Fato R, 1996, BIOCHEMISTRY-US, V35, P2705, DOI 10.1021/bi9516034; FINEL M, 1994, FEBS LETT, V339, P142, DOI 10.1016/0014-5793(94)80402-8; FRIEDRICH T, 1994, BIOCHEM SOC T, V22, P226, DOI 10.1042/bst0220226; FRIEDRICH T, 1994, EUR J BIOCHEM, V219, P691, DOI 10.1111/j.1432-1033.1994.tb19985.x; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Guenebaut V, 1997, J MOL BIOL, V265, P409, DOI 10.1006/jmbi.1996.0753; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; GUTMAN M, 1970, J BIOL CHEM, V245, P1992; GUTMAN M, 1970, BIOCHEMISTRY-US, V9, P2678, DOI 10.1021/bi00815a016; GUTMAN M, 1980, BIOCHIM BIOPHYS ACTA, V594, P53, DOI 10.1016/0304-4173(80)90013-0; Higgins DS, 1996, J NEUROSCI, V16, P3807; HOFHAUS G, 1991, J MOL BIOL, V221, P1027, DOI 10.1016/0022-2836(91)80190-6; HOLLINGWORTH RM, 1994, BIOCHEM SOC T, V22, P230, DOI 10.1042/bst0220230; HORGAN DJ, 1968, J BIOL CHEM, V243, P834; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JEWESS PJ, 1994, BIOCHEM SOC T, V22, P247, DOI 10.1042/bst0220247; KIM SJ, 1987, BIOCHIM BIOPHYS ACTA, V894, P270, DOI 10.1016/0005-2728(87)90196-4; Lenaz G, 1998, BBA-BIOENERGETICS, V1364, P207, DOI 10.1016/S0005-2728(98)00028-0; Lummen P, 1998, BBA-BIOENERGETICS, V1364, P287, DOI 10.1016/S0005-2728(98)00034-6; Nedergaard J, 1979, Methods Enzymol, V55, P3; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohshima M, 1998, BIOCHEMISTRY-US, V37, P6436, DOI 10.1021/bi9800202; Satoh T, 1996, BBA-BIOENERGETICS, V1273, P21, DOI 10.1016/0005-2728(95)00131-X; SCHULTE U, 1994, BBA-BIOENERGETICS, V1187, P121, DOI 10.1016/0005-2728(94)90096-5; SINGER TP, 1992, MOL MECHANISMS BIOEN, P145; SINNING I, 1992, TRENDS BIOCHEM SCI, V17, P150, DOI 10.1016/0968-0004(92)90324-3; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; SUZUKI H, 1983, J BIOL CHEM, V258, P352; THIERBACH G, 1981, BIOCHIM BIOPHYS ACTA, V638, P282, DOI 10.1016/0005-2728(81)90238-3; UENO H, 1994, EUR J BIOCHEM, V225, P411, DOI 10.1111/j.1432-1033.1994.00411.x; Ueno H, 1996, BBA-BIOENERGETICS, V1276, P195, DOI 10.1016/0005-2728(96)00078-3; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; VINOGRADOV AD, 1995, FEBS LETT, V370, P83, DOI 10.1016/0014-5793(95)00803-H; WAN YP, 1975, BIOCHEM BIOPH RES CO, V63, P11, DOI 10.1016/S0006-291X(75)80003-9; WEIDNER U, 1993, J MOL BIOL, V233, P109, DOI 10.1006/jmbi.1993.1488; WEILAND GA, 1981, LIFE SCI, V29, P313, DOI 10.1016/0024-3205(81)90324-6; WEISS H, 1991, J BIOENERG BIOMEMBR, V23, P743, DOI 10.1007/BF00785999; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; YAGI T, 1993, J BIOENERG BIOMEMBR, V25, P339, DOI 10.1007/BF00762459; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	58	284	297	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2625	2630		10.1074/jbc.274.5.2625	http://dx.doi.org/10.1074/jbc.274.5.2625			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915790	hybrid			2022-12-27	WOS:000078319500008
J	Kameya, S; Miyagoe, Y; Nonaka, I; Ikemoto, T; Endo, M; Hanaoka, K; Nabeshima, Y; Takeda, S				Kameya, S; Miyagoe, Y; Nonaka, I; Ikemoto, T; Endo, M; Hanaoka, K; Nabeshima, Y; Takeda, S			alpha 1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE-MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; POSTSYNAPTIC PROTEIN; STEM-CELLS; ASSOCIATION; SYNTROPHIN; DIVERSITY; BETA-2-SYNTROPHIN; LOCALIZATION; GLYCOPROTEIN	alpha 1-Syntrophin is a member of the family of dystrophin-associated proteins and is strongly expressed in the sarcolemma and the neuromuscalar junctions. All three syntrophin isoforms have a PDZ domain that appears to participate in protein-protein interactions at the plasma membrane. alpha 1-Syntrophin has additionally been shown to associate with neuronal nitric-oxide synthase (nNOS) through PDZ domains in vitro. These observations suggest that alpha 1-syntrophin may work as a modular adaptor protein that can link nNOS or other signaling enzyme to the sarcolemmal dystrophin complex. In the sarcolemma, nNOS regulates the homeostasis of reactive free radical species and may contribute to the oxidative damage to muscle protein in muscle disease such as Duchenne muscular dystrophy. In this study, we generated alpha 1-syntrophin knockout mice to clarify the interaction between alpha 1-syntrophin and nNOS in the skeletal muscle. We observed that nNOS, normally expressed in the sarcolemma, was largely absent from the sarcolemma, but considerably remained in the cytosol of the knock-out mice. Even though the distribution of nNOS was altered, the knock-out mice displayed no gross histological changes in the skeletal muscle. We also discovered that muscle contractile properties have not been influenced in the knock-out mice.	Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Genet, Kodaira, Tokyo 1878502, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Kodaira, Tokyo 1878502, Japan; Saitama Med Sch, Dept Pharmacol, Moroyama, Saitama 35004, Japan; Kitasato Univ, Sch Sci, Dept Biosci, Sagamihara, Kanagawa 228, Japan; Osaka Univ, Inst Mol & Cellular Biol, Suita, Osaka 565, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Saitama Medical University; Kitasato University; Osaka University	Takeda, S (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Genet, 4-1-1 Ogawa Higashi, Kodaira, Tokyo 1878502, Japan.			Kameya, Shuhei/0000-0003-3962-3099				ADAMS ME, 1995, J BIOL CHEM, V270, P25859, DOI 10.1074/jbc.270.43.25859; ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; Aghdasi B, 1997, J BIOL CHEM, V272, P25462, DOI 10.1074/jbc.272.41.25462; Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; Blake DJ, 1996, J BIOL CHEM, V271, P7802, DOI 10.1074/jbc.271.13.7802; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; BUTLER MH, 1992, J BIOL CHEM, V267, P6213; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CARTAUD A, 1993, J BIOL CHEM, V268, P13019; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; FROEHNER SC, 1987, J CELL BIOL, V104, P1633, DOI 10.1083/jcb.104.6.1633; Galler S, 1997, PFLUG ARCH EUR J PHY, V434, P242, DOI 10.1007/s004240050391; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; Haycock JW, 1996, NEUROREPORT, V8, P357, DOI 10.1097/00001756-199612200-00070; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; Kusner LL, 1996, BRAIN RES, V730, P238; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NATHAN C, 1994, J BIOL CHEM, V269, P13725; OGURA T, 1993, BIOCHEM BIOPH RES CO, V193, P1014, DOI 10.1006/bbrc.1993.1726; PETERS MF, 1994, NEUROREPORT, V5, P1577, DOI 10.1097/00001756-199408150-00009; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P102, DOI 10.1016/S0968-0004(00)88973-2; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	29	149	151	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2193	2200		10.1074/jbc.274.4.2193	http://dx.doi.org/10.1074/jbc.274.4.2193			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890982	hybrid			2022-12-27	WOS:000078185200049
J	O'Rourke, JF; Tian, YM; Ratcliffe, PJ; Pugh, CW				O'Rourke, JF; Tian, YM; Ratcliffe, PJ; Pugh, CW			Oxygen-regulated and transactivating domains in endothelial PAS protein 1: Comparison with hypoxia-inducible factor-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; FACTOR 1-ALPHA; ERYTHROPOIETIN GENE; ALPHA-SUBUNIT; FACTOR-I; ACTIVATION; RECEPTOR; CELLS; ARNT	Endothelial PAS protein 1 (EPAS1) is a basic helix-loop-helix Per-AHR-ARNT-Sim transcription factor related to hypoxia-inducible factor-1 alpha (HIF-1 alpha), To analyze EPAS1 domains responsible for transactivation and oxygen-regulated function, we constructed chimeric fusions of EPAS1 with a GAL4 DNA binding domain, plus or minus the VP16 activation domain. Two transactivation domains were defined in EPAS1; a C-terminal domain (amino acids 828-870), and a larger internal domain (amino acids 517-682). These activation domains were interspersed by functionally repressive sequences, several of which independently conveyed oxygen-regulated activity. Two types of activity were defined, Sequences lying N-terminal to and overlapping the internal transactivation domain conferred regulated repression on the VP16 transactivator, Sequences lying C-terminal to this internal domain conveyed repression and oxygen-regulated activity on the native EPAS1 C-terminal activation domain, but not the Gal/VP16 fusion, Fusions containing internal but not C-terminal regulatory domains manifested regulation of fusion protein level, Comparison of EPAS1 with HIF-1 alpha demonstrated a similar organization for both proteins, and for the C terminus defined a conserved RLL motif critical for inducibility. Overall, EPAS1 sequences were less inducible than those of HIF-1 alpha; and inducibility was strikingly reduced as their expression level was increased. Despite these quantitative differences, EPAS1 regulation appeared similar to HIF-1 alpha, conforming to a model involving the modulation of both protein level and activity, through distinct internal and C-terminal domains.	John Radcliffe Hosp, Inst Mol Med, Erythropoietin Grp, Oxford OX3 9DS, England	University of Oxford	Pugh, CW (corresponding author), John Radcliffe Hosp, Inst Mol Med, Erythropoietin Grp, Room 425, Oxford OX3 9DS, England.			Ratcliffe, Peter/0000-0002-2853-806X; Pugh, Chris/0000-0002-5170-1662				Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; DECHASSEVAL R, 1992, NUCLEIC ACIDS RES, V20, P245, DOI 10.1093/nar/20.2.245; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Flamme I, 1997, MECH DEVELOP, V63, P51, DOI 10.1016/S0925-4773(97)00674-6; Flamme I, 1998, AM J PATHOL, V153, P25, DOI 10.1016/S0002-9440(10)65541-1; Gleadle JM, 1998, MOL MED TODAY, V4, P122, DOI 10.1016/S1357-4310(97)01198-2; GLEADLE JM, 1995, AM J PHYSIOL-CELL PH, V268, pC1362, DOI 10.1152/ajpcell.1995.268.6.C1362; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; Pugh CW, 1997, J BIOL CHEM, V272, P11205; SALEEDA S, 1997, J BIOL CHEM, V272, P22642; Semenza GL, 1998, J LAB CLIN MED, V131, P207, DOI 10.1016/S0022-2143(98)90091-9; SRINIVAS V, 1998, BIOCHEM BIOPH RES CO, V273, P18019; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1995, BIOCHEM BIOPH RES CO, V212, P550, DOI 10.1006/bbrc.1995.2005; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WEBSTER N, 1988, CELL, V52, P169, DOI 10.1016/0092-8674(88)90505-3; Wenger RH, 1997, EUR J BIOCHEM, V246, P155, DOI 10.1111/j.1432-1033.1997.t01-1-00155.x; WHITELAW ML, 1994, MOL CELL BIOL, V14, P8343, DOI 10.1128/MCB.14.12.8343; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; WOOD WM, 1989, J BIOL CHEM, V264, P14840	32	188	193	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2060	2071		10.1074/jbc.274.4.2060	http://dx.doi.org/10.1074/jbc.274.4.2060			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890965	hybrid			2022-12-27	WOS:000078185200032
J	Vazquez, F; Rodriguez-Manzaneque, JC; Lydon, JP; Edwards, DP; O'Malley, BW; Iruela-Arispe, ML				Vazquez, F; Rodriguez-Manzaneque, JC; Lydon, JP; Edwards, DP; O'Malley, BW; Iruela-Arispe, ML			Progesterone regulates proliferation of endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN REPLACEMENT THERAPY; CORONARY HEART-DISEASE; RECEPTOR SUPERFAMILY; ARTERIAL INJURY; EXPERIMENTAL ATHEROSCLEROSIS; CELLULAR PROLIFERATION; RETINOBLASTOMA PROTEIN; POSTMENOPAUSAL WOMEN; MOLECULAR-CLONING; BREAST-CANCER	The use of steroid hormones in postmenopausal replacement therapy has been associated with prevention of cardiovascular disease. Although the contribution of estradiol to endothelial cell function has been addressed, little information is available on the effect of progestins on this cell type. Here, we provide direct evidence for the presence of functional nuclear progesterone receptor in endothelial cells and demonstrate that physiological levels of progesterone inhibit proliferation through a nuclear receptor-mediated mechanism. The effects of progesterone were blocked by pretreatment with a progesterone receptor antagonist, and progesterone receptor-deficient endothelial cells failed to respond to the hormone. We evaluated the effect of progesterone by analysis of aorta re-endothelialization experiments in wild-type and progesterone receptor knockout mice. The rate of re-endothelialization was significantly decreased in wild-type mice when in the presence of progesterone, whereas there was no difference between control and progesterone-treated progesterone receptor knockout mice. FACS analysis showed that progestins arrest endothelial cell cycle in G(1). The lag in cell cycle progression involved reduction in cyclin-dependent kinase activity, as shown by down-regulation in retinoblastoma protein phosphorylation. In addition, treatment of endothelial cells with progestins altered the expression of cyclin E and A in accordance with G(1) arrest. These results have important implications to our current knowledge of the effect of steroids on endothelial cell function and to the overall contribution of progesterone to vascular repair.	Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Baylor College of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Iruela-Arispe, ML (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Cell & Dev Biol, R559,611 Circle Dr E, Los Angeles, CA 90095 USA.	arispe@mbi.ucla.edu	Iruela-Arispe, M. Luisa/AAJ-1297-2020; Rodriguez-Manzaneque, Juan Carlos/F-3899-2012	Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Rodriguez-Manzaneque, Juan Carlos/0000-0001-5951-7029	NATIONAL CANCER INSTITUTE [R03CA070559] Funding Source: NIH RePORTER; NCI NIH HHS [R03CA70559-01, R29CA63356-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apostolakis EM, 1996, MOL ENDOCRINOL, V10, P1595, DOI 10.1210/me.10.12.1595; CHRISTENSEN BC, 1977, ACTA PATH MICRO IM A, V85, P297; CLOWES AW, 1978, LAB INVEST, V39, P141; CLOWES AW, 1983, LAB INVEST, V49, P327; COLBURN P, 1978, SCIENCE, V201, P817, DOI 10.1126/science.684408; DETMAR M, 1990, J INVEST DERMATOL, V95, pS219, DOI 10.1111/1523-1747.ep12875807; EDWARDS DP, 1995, J STEROID BIOCHEM, V53, P449, DOI 10.1016/0960-0760(95)00091-D; ELASHRY D, 1989, MOL ENDOCRINOL, V3, P1545, DOI 10.1210/mend-3-10-1545; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FOUSER L, 1991, J BIOL CHEM, V266, P18345; FRASER IS, 1980, ENDOMETRIAL BLEEDING, P384; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Groshong SD, 1997, MOL ENDOCRINOL, V11, P1593, DOI 10.1210/me.11.11.1593; Hanke H, 1996, ATHEROSCLEROSIS, V121, P129, DOI 10.1016/0021-9150(95)05710-2; Hanke H, 1996, CIRCULATION, V94, P175, DOI 10.1161/01.CIR.94.2.175; HORWITZ KB, 1992, ENDOCR REV, V13, P146, DOI 10.1210/er.13.2.146; INGEGNO MD, 1988, LAB INVEST, V59, P353; IRUELAARISPE ML, 1993, J CELL BIOCHEM, V52, P414, DOI 10.1002/jcb.240520406; IruelaArispe ML, 1996, J CLIN INVEST, V97, P403, DOI 10.1172/JCI118429; IRUELAARISPE ML, 1999, IN PRESS MICROCIRCUL; Ishida Y, 1997, BONE, V20, P17, DOI 10.1016/S8756-3282(96)00315-8; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Krasinski K, 1997, CIRCULATION, V95, P1768; Lee SH, 1997, DEV DYNAM, V209, P342, DOI 10.1002/(SICI)1097-0177(199708)209:4<342::AID-AJA2>3.0.CO;2-I; Lee WS, 1997, NAT MED, V3, P1005, DOI 10.1038/nm0997-1005; Levine RL, 1996, CIRCULATION, V94, P2221, DOI 10.1161/01.CIR.94.9.2221; LOBO RA, 1990, OBSTET GYNECOL, V75, pS18; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MACQUEO M, 1980, ENDOMETRIAL BLEEDING, P138; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Musgrove EA, 1998, MOL CELL BIOL, V18, P1812, DOI 10.1128/MCB.18.4.1812; Nair SC, 1997, MOL CELL BIOL, V17, P594, DOI 10.1128/MCB.17.2.594; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; PERROTAPPLANAT M, 1988, ENDOCRINOLOGY, V123, P1511, DOI 10.1210/endo-123-3-1511; Prapapanich V, 1998, MOL CELL BIOL, V18, P944, DOI 10.1128/MCB.18.2.944; Prapapanich V, 1996, MOL ENDOCRINOL, V10, P420, DOI 10.1210/me.10.4.420; Rao BR, 1997, ANTICANCER RES, V17, P1019; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rossouw JE, 1996, CIRCULATION, V94, P2982, DOI 10.1161/01.CIR.94.11.2982; Said TK, 1997, ENDOCRINOLOGY, V138, P3933, DOI 10.1210/en.138.9.3933; Segnitz B, 1997, J BIOL CHEM, V272, P18694, DOI 10.1074/jbc.272.30.18694; SHOUPE D, 1991, OBSTET GYNECOL, V77, P256, DOI 10.1097/00006250-199102000-00018; SIVIN I, 1988, STUD FAMILY PLANN, V19, P81, DOI 10.2307/1966493; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; STEMERMAN MB, 1977, AM J PATHOL, V87, P125; Sullivan Jay M., 1996, Cardiology Clinics, V14, P105; Sullivan JM, 1996, CIRCULATION, V94, P2699, DOI 10.1161/01.CIR.94.11.2699; SULLIVAN JM, 1995, PROG CARDIOVASC DIS, V38, P211, DOI 10.1016/S0033-0620(95)80013-1; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WHITEHEAD M, 1988, LANCET, V2, P1243; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	52	111	113	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2185	2192		10.1074/jbc.274.4.2185	http://dx.doi.org/10.1074/jbc.274.4.2185			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890981	hybrid			2022-12-27	WOS:000078185200048
J	Chiabrando, C; Valagussa, A; Rivalta, C; Durand, T; Guy, A; Zuccato, E; Villa, P; Rossi, JC; Fanelli, R				Chiabrando, C; Valagussa, A; Rivalta, C; Durand, T; Guy, A; Zuccato, E; Villa, P; Rossi, JC; Fanelli, R			Identification and measurement of endogenous beta-oxidation metabolites of 8-epi-prostaglandin F2 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS IN-VIVO; OXIDANT STRESS; URINARY-EXCRETION; FEMALE SUBJECTS; METHYL-ESTER; RAT; ISOPROSTANES; SMOKERS; HUMANS; INDEX	F-2-isoprostanes are prostaglandin-like compounds derived from nonenzymatic free radical-catalyzed peroxidation of arachidonic acid. 8-epi-Prostaglandin (PG) F-2 alpha, a major component of the F-2-isoprostane family, can be conveniently measured in urine to assess noninvasively lipid peroxidation in vivo. Measurement of major metabolites of endogenous 8-epi PGF(2 alpha), in addition to the parent compound, may be useful to better define its formation in vivo. 2,3-dinor-5,6-dihydro-8-epi-PGF(2 alpha) is the only identified metabolite of 8-epi-PGF(2 alpha) in man, but its endogenous levels are unknown. In addition to this metabolite, we have identified another major endogenous metabolite, 2,3-dinor-8-epi PGF(2 alpha), in human and rat urine. The identity of these compounds, present at the pg/ml level in urine, was proven by a number of complementary approaches, based on: (a) immunoaffinity chromatography for selective extraction; (b) gas chromatography-mass spectrometry for structural analysis; (c) in vitro metabolism in isolated rat hepatocytes; and (d) chemical synthesis of the enantiomer of 2,3-dinor-5,6-dihydro-8-epi-PGF(2 alpha) as reference standard. In humans, the urinary excretion rate of both diner metabolites is comparable with that of 8-epi-PGF(2 alpha). Both metabolites increase in parallel with the parent compound in cigarette smokers, and they are not reduced during cyclooxygenase inhibition. Another beta-oxidation product, 2,3,4,5-tetranor-8-epi-PGF(2 alpha), was identified as a major product of rat hepatocyte metabolism. In conclusion, at least two major beta-oxidation products of 8-epi-PGF(2 alpha) are present in urine, which may be considered as additional analytical targets to evaluate 8-epi-PGF(2 alpha) formation and degradation in vivo.	Ist Ric Farmacol Mario Negri, Dept Environm Hlth Sci, I-20157 Milan, Italy; Fac Pharm, CNRS, UPRES A 5074, F-34060 Montpellier, France	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Chiabrando, C (corresponding author), Ist Ric Farmacol Mario Negri, Dept Environm Hlth Sci, Via Eritrea 62, I-20157 Milan, Italy.		Zuccato, Ettore/AAB-2116-2020	Zuccato, Ettore/0000-0003-2094-2305				AWAD JA, 1993, J BIOL CHEM, V268, P4161; Bachi A, 1997, BRIT J PHARMACOL, V121, P1770, DOI 10.1038/sj.bjp.0701321; Bachi A, 1996, FREE RADICAL BIO MED, V20, P619, DOI 10.1016/0891-5849(95)02087-X; CHIABRANDO C, 1987, ANAL BIOCHEM, V163, P255, DOI 10.1016/0003-2697(87)90121-7; CHIABRANDO C, 1993, PROSTAGLANDINS, V45, P401, DOI 10.1016/0090-6980(93)90117-P; CHIABRANDO C, 1994, PROSTAGLANDINS, V47, P409, DOI 10.1016/0090-6980(94)90042-6; Delanty N, 1996, BRIT J CLIN PHARMACO, V42, P15, DOI 10.1046/j.1365-2125.1996.03804.x; GRANSTRO.E, 1971, J BIOL CHEM, V246, P7470; GRANSTROM E, 1971, J BIOL CHEM, V246, P5254; GREEN K, 1971, BIOCHIM BIOPHYS ACTA, V231, P419, DOI 10.1016/0005-2760(71)90111-1; Guy A, 1998, TETRAHEDRON LETT, V39, P6181, DOI 10.1016/S0040-4039(98)01290-8; Guy A, 1997, TETRAHEDRON LETT, V38, P1543, DOI 10.1016/S0040-4039(97)00100-7; MORROW JD, 1994, BBA-LIPID LIPID MET, V1210, P244, DOI 10.1016/0005-2760(94)90128-7; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Morrow JD, 1996, BIOCHEM PHARMACOL, V51, P1, DOI 10.1016/0006-2952(95)02072-1; OSBORNE DJ, 1979, PROSTAGLANDINS, V17, P863, DOI 10.1016/0090-6980(79)90058-3; Patrono C, 1997, ARTERIOSCL THROM VAS, V17, P2309, DOI 10.1161/01.ATV.17.11.2309; PRTAICO D, 1998, P NATL AACAD SCI US, V59, P3449; Reilly M, 1996, CIRCULATION, V94, P19, DOI 10.1161/01.CIR.94.1.19; Roberts LJ, 1996, J BIOL CHEM, V271, P20617, DOI 10.1074/jbc.271.34.20617; Roland A, 1996, B SOC CHIM FR, V133, P1149; SAGO T, 1986, BIOCHIM BIOPHYS ACTA, V879, P330	22	89	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1313	1319		10.1074/jbc.274.3.1313	http://dx.doi.org/10.1074/jbc.274.3.1313			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880501	hybrid			2022-12-27	WOS:000079956900021
J	Ribeiro, A; Pastier, D; Kardassis, D; Chambaz, J; Cardot, P				Ribeiro, A; Pastier, D; Kardassis, D; Chambaz, J; Cardot, P			Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE RECEPTOR SUPERFAMILY; DNA-BINDING; FACTOR USF; CARBOHYDRATE REGULATION; PROMOTER ELEMENTS; ENHANCER ACTIVITY; MULTIPLE FORMS; E-BOX; EXPRESSION; PROTEIN	The activity of the human apoA-II promoter is controlled by a Synergistic interaction of the distal enhancer and the proximal promoter. An important role in apoA II promoter activity is exerted by a transcription factor, designated CIIIB1, which binds to the proximal element AB and the distal elements of the enhancer, K and L. In the present communication we establish that CIIIB1 corresponds to the previously described factor, upstream stimulatory factor (USF) using the following criteria. (a) Purification of CIIIB1 by affinity chromatography provided a heat-stable protein with an apparent molecular mass of 45 kDa that cross-reacted with anti-USF1 and -USF2a antibodies; (b) CIIIB1 bound to the elements AB, K, and L was supershifted by these antibodies; (c) the heterodimer USF1/2a is the predominant form that corresponds to CIIIB1. Cotransfection experiments in HepG2 cells established the functional significance of USF in apoA-II transcription It Was found that the minimal promoter AB was transactivated by USF2a. In addition, all three E-box motifs present in elements AB, K and L are necessary for maximum transactivation by USF2a. A dominant negative form of USF2a inhibits the activity of apoA-II promoter The USF1/2a heterodimer, which is naturally expressed in the liver, is as efficient as the USF2a homodimer in the transactivation of apoA-II promoter/enhancer constructs. Cotransfection experiments in COS-l cells showed that hepatic nuclear factor 4 (HNF-4) synergized with USF2a in the transactivation of the apoA-II promoter. In addition, we showed that HNF-4 and USF2a bind to the enhancer cooperatively. This may account for the transcriptional synergism observed between USF and HNF-4 in the transactivation of the apoA-II promoter.	Univ Paris 06, Inst Cordeliers, INSERM, U505, F-75006 Paris, France; Univ Crete, Sch Hlth Sci, Dept Basic Sci, Div Med, Iraklion 71110, Greece	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Crete	Ribeiro, A (corresponding author), Univ Paris 06, Inst Cordeliers, INSERM, U505, 15 Rue Ecole Med, F-75006 Paris, France.		Ribeiro, Agnès/Q-9702-2017	Ribeiro, Agnès/0000-0003-2063-6084				BECKMANN H, 1991, GENE DEV, V5, P1057, DOI 10.1101/gad.5.6.1057; BENDALL AJ, 1994, NUCLEIC ACIDS RES, V22, P2801, DOI 10.1093/nar/22.14.2801; BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; CARDOT P, 1993, BIOCHEMISTRY-US, V32, P9080, DOI 10.1021/bi00086a013; CARDOT P, 1994, BIOCHEMISTRY-US, V33, P12139, DOI 10.1021/bi00206a017; CARDOT P, 1991, J BIOL CHEM, V266, P24460; CARR CS, 1990, MOL CELL BIOL, V10, P4384, DOI 10.1128/MCB.10.8.4384; CARTHEW RW, 1987, GENE DEV, V1, P973, DOI 10.1101/gad.1.9.973; CHAMBAZ J, 1991, J BIOL CHEM, V266, P11676; DESBOIS C, 1992, TRENDS GENET, V8, P300, DOI 10.1016/0168-9525(92)90260-B; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; EISENBERG S, 1984, J LIPID RES, V25, P1017; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUERRA MJMD, 1993, MOL CELL BIOL, V13, P7725, DOI 10.1128/MCB.13.12.7725; HADZOPOULOUCLADARAS M, 1993, BIOCHEMISTRY-US, V32, P9657, DOI 10.1021/bi00088a018; HALLE JP, 1995, J BIOL CHEM, V270, P21307, DOI 10.1074/jbc.270.36.21307; HENRION AA, 1995, GENOMICS, V25, P36, DOI 10.1016/0888-7543(95)80107-W; HUANG YD, 1995, ARTERIOSCL THROM VAS, V15, P1412, DOI 10.1161/01.ATV.15.9.1412; HUSSAIN MM, 1990, BIOCHEMISTRY-US, V29, P209, DOI 10.1021/bi00453a029; IKEWAKI K, 1995, ARTERIOSCL THROM VAS, V15, P306, DOI 10.1161/01.ATV.15.3.306; Ikewaki K, 1996, J LIPID RES, V37, P399; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kan HY, 1997, CIRCULATION, V96, P2708; Kaytor EN, 1997, J BIOL CHEM, V272, P7525, DOI 10.1074/jbc.272.11.7525; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Lacorte JM, 1996, BIOCHEM J, V318, P681, DOI 10.1042/bj3180681; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Beyec J, 1998, TRANSGENICS, V2, P211; LEFRANCOISMARTINEZ AM, 1995, J BIOL CHEM, V270, P2640, DOI 10.1074/jbc.270.6.2640; LIU ZR, 1995, BIOCHEM J, V308, P105, DOI 10.1042/bj3080105; OGAMI K, 1990, J BIOL CHEM, V265, P9808; OGAMI K, 1991, J BIOL CHEM, V266, P9640; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; PUCHOIS P, 1987, ATHEROSCLEROSIS, V68, P35, DOI 10.1016/0021-9150(87)90091-8; RAYMONDJEAN M, 1988, P NATL ACAD SCI USA, V85, P757, DOI 10.1073/pnas.85.3.757; SAWADOGO M, 1988, J BIOL CHEM, V263, P11994; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; Sieweke MH, 1998, EMBO J, V17, P1728, DOI 10.1093/emboj/17.6.1728; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; TIMCHENKO N, 1995, MOL CELL BIOL, V15, P1192; Vallet VS, 1997, J BIOL CHEM, V272, P21944, DOI 10.1074/jbc.272.35.21944; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; Viollet B, 1996, J BIOL CHEM, V271, P1405, DOI 10.1074/jbc.271.3.1405; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; Weng W, 1996, P NATL ACAD SCI USA, V93, P14788, DOI 10.1073/pnas.93.25.14788; Yang YS, 1997, NUCLEIC ACIDS RES, V25, P2284, DOI 10.1093/nar/25.12.2284; YANG YS, 1993, MOL CELL BIOL, V13, P5593, DOI 10.1128/MCB.13.9.5593	54	62	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1216	1225		10.1074/jbc.274.3.1216	http://dx.doi.org/10.1074/jbc.274.3.1216			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880489	hybrid			2022-12-27	WOS:000079956900009
J	Niewmierzycka, A; Clarke, S				Niewmierzycka, A; Clarke, S			S-adenosylmethionine-dependent methylation in Saccharomyces cerevisiae - Identification of a novel protein arginine methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUINONE BIOSYNTHESIS; CRYSTAL-STRUCTURE; SEQUENCE MOTIFS; RIBOSOMAL-RNA; N-METHYLTRANSFERASE; TRANSCRIPTIONAL ACTIVATOR; CARBOXYL METHYLATION; GENE DISRUPTION; BOVINE BRAIN; COQ5 GENE	We used sequence moths conserved in S-adenosylmethionine-dependent methyltransferases to identify 26 putative methyltransferases from the complete genome of the yeast Saccharomyces cerevisiae. Seven sequences with the best matches to the methyltransferase consensus motifs were selected for further study. We prepared yeast disruption mutants of each of the genes encoding these sequences, and we found that disruption of the YJL125c gene is lethal, whereas disruptions of YCR047c and YDR140w lead to slow growth phenotypes. Normal growth was observed when the YDL201w, YDR465c, YHR209w, and YOR240w genes were disrupted. Initial analysis of protein methylation patterns of all mutants by amino acid analysis revealed that the YDR465c mutant has a defect in the methylation of the delta-nitrogen atom of arginine residues. We propose that YDR465c codes for the methyltransferase responsible for this recently characterized type of protein methylation, and we designate the enzyme as Rmt2 (protein a (r) under bar ginine (m) under bar ethyl (t) under bar ransferase). In addition, we show that the methylation of susceptible residues in Rmt2 substrates is likely to take place on nascent polypeptide chains and that these substrates exist in the cell as fully methylated species. Interestingly, Rmt2 has 27% sequence identity over 138 amino acids to the mammalian guanidinoacetate N-methyltransferase, an enzyme responsible for methylating the delta-nitrogen of the small molecule guanidinoacetate.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, S (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Box 951570, Los Angeles, CA 90095 USA.	clarke@ewald.mbi.ucla.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042, R01GM026020, R37GM026020] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26020, GM08042] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1997, NATURE, V387, pS; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; Bussiere DE, 1998, BIOCHEMISTRY-US, V37, P7103, DOI 10.1021/bi973113c; CAVALLIUS J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P75, DOI 10.1016/0167-4838(93)90281-U; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CLARKE CF, 1991, J BIOL CHEM, V266, P16636; Clarke S, 1993, CURR OPIN CELL BIOL, V5, P977, DOI 10.1016/0955-0674(93)90080-A; Cuesta R, 1998, GENETICS, V148, P1007; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dibrov E, 1997, J BIOL CHEM, V272, P9175; Djordjevic S, 1998, NAT STRUCT BIOL, V5, P446, DOI 10.1038/nsb0698-446; Dujon B, 1998, ELECTROPHORESIS, V19, P617, DOI 10.1002/elps.1150190427; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; ELLIS SR, 1986, J BIOL CHEM, V261, P9703; FAROOQUI J, 1980, J BIOL CHEM, V255, P4468; Fu ZJ, 1996, BIOCHEMISTRY-US, V35, P11985, DOI 10.1021/bi961068n; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9; Hamahata A, 1996, BIOCHEM J, V317, P141, DOI 10.1042/bj3170141; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Hansen J, 1997, FEBS LETT, V401, P20, DOI 10.1016/S0014-5793(96)01423-8; HARASHIMA S, 1986, MOL CELL BIOL, V6, P3990, DOI 10.1128/MCB.6.11.3990; HARDWICK KG, 1994, YEAST, V10, P265, DOI 10.1002/yea.320100213; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0; HRYCYNA CA, 1993, BIOCHEMISTRY-US, V32, P11293, DOI 10.1021/bi00093a005; HRYCYNA CA, 1994, BIOCHEMISTRY-US, V33, P9806, DOI 10.1021/bi00198a053; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Hsu AY, 1996, BIOCHEMISTRY-US, V35, P9797, DOI 10.1021/bi9602932; INGROSSO D, 1989, J BIOL CHEM, V264, P20131; Isbrandt D, 1995, BBA-GENE STRUCT EXPR, V1264, P265, DOI 10.1016/0167-4781(95)00184-0; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; KLIMASAUSKAS S, 1989, NUCLEIC ACIDS RES, V17, P9823, DOI 10.1093/nar/17.23.9823; KLOOTWIJK J, 1973, EUR J BIOCHEM, V39, P325, DOI 10.1111/j.1432-1033.1973.tb03130.x; KODAKI T, 1987, J BIOL CHEM, V262, P15428; LABAHN J, 1994, P NATL ACAD SCI USA, V91, P10957, DOI 10.1073/pnas.91.23.10957; LAFONTAINE D, 1994, J MOL BIOL, V241, P492, DOI 10.1006/jmbi.1994.1525; LAUSTER R, 1989, J MOL BIOL, V206, P305, DOI 10.1016/0022-2836(89)90480-4; LIAO HH, 1979, J BACTERIOL, V138, P853, DOI 10.1128/JB.138.3.853-860.1979; LOBET Y, 1989, BIOCHIM BIOPHYS ACTA, V997, P224, DOI 10.1016/0167-4838(89)90191-X; LUSSIER M, 1993, YEAST, V9, P1057, DOI 10.1002/yea.320091004; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; MAO XD, 1995, MOL CELL BIOL, V15, P4167; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; Palermo LM, 1997, CURR GENET, V32, P93, DOI 10.1007/s002940050252; PARKS LW, 1985, METHOD ENZYMOL, V111, P333; POSFAI J, 1989, NUCLEIC ACIDS RES, V17, P2421, DOI 10.1093/nar/17.7.2421; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Rieger KJ, 1997, YEAST, V13, P1547, DOI 10.1002/(SICI)1097-0061(199712)13:16<1547::AID-YEA230>3.3.CO;2-P; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROLFES RJ, 1993, MOL CELL BIOL, V13, P5099, DOI 10.1128/MCB.13.8.5099; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SCHLUCKEBIER G, 1995, J MOL BIOL, V247, P16, DOI 10.1006/jmbi.1994.0117; SHAPIRO SK, 1965, J BIOL CHEM, V240, P2512; SHERMAN F, 1991, METHOD ENZYMOL, V194, P21; SINDHUPHAK T, 1985, BIOCHIM BIOPHYS ACTA, V824, P66, DOI 10.1016/0167-4781(85)90030-2; SIRUMCONNOLLY K, 1993, SCIENCE, V262, P1886, DOI 10.1126/science.8266080; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; WELIHINDA AA, 1994, BBA-BIOMEMBRANES, V1193, P107, DOI 10.1016/0005-2736(94)90339-5; XIE HY, 1993, J BIOL CHEM, V268, P13364; XIE HY, 1994, J BIOL CHEM, V269, P1981; Yu LP, 1997, NAT STRUCT BIOL, V4, P483, DOI 10.1038/nsb0697-483; Zobel-Thropp P, 1998, J BIOL CHEM, V273, P29283, DOI 10.1074/jbc.273.45.29283	68	185	197	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					814	824		10.1074/jbc.274.2.814	http://dx.doi.org/10.1074/jbc.274.2.814			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873020	hybrid			2022-12-27	WOS:000077968500035
J	Piston, DW; Knobel, SM; Postic, C; Shelton, KD; Magnuson, MA				Piston, DW; Knobel, SM; Postic, C; Shelton, KD; Magnuson, MA			Adenovirus-mediated knockout of a conditional glucokinase gene in isolated pancreatic islets reveals an essential role for proximal metabolic coupling events in glucose-stimulated insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL GLUCOKINASE; RECOMBINANT ADENOVIRUS; HEXOKINASE-I; B-CELLS; HETEROGENEITY; EXPRESSION; OVEREXPRESSION; LANGERHANS; MODULATION; INVIVO	The relationship between glucokinase (GK) and glucose-stimulated metabolism, and the potential for metabolic coupling between beta cells, was examined in isolated mouse islets by using a recombinant adenovirus that expresses Cre recombinase (AdenoCre) to inactivate a conditional GK gene allele (gk(lox)). Analysis of AdenoCre-treated islets indicated that the gk(lox) allele in similar to 30% of islet cells was converted to a nonexpressing variant (gk(del)). This resulted in a heterogeneous population of beta cells where GK was absent in some cells. Quantitative two-photon excitation imaging of NAD(P)H autofluorescence was then used to measure glucose-stimulated metabolic responses of individual islet beta cells from gk(lox/lox) mice. In AdenoCre-infected islets, approximately one-third of the beta cells showed markedly lower NAD(P)H responses. These cells also exhibited glucose dose responses consistent with the loss of GK. Glucose dose responses of the low-responding cells were not sigmoidal and reached a maximum at similar to 5 mM glucose, In contrast, the normal response cells showed a sigmoidal response with an KcatS0.5 of similar to 8 mM. These data provide direct evidence that GK is essential for glucose-stimulated metabolic responses in beta cells within intact islets and that intercellular coupling within the islet plays little or no role in glucose-stimulated metabolic responses.	Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Piston, DW (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 702 Light Hall, Nashville, TN 37232 USA.	dave.piston@mcmail.vanderbilt.edu; mark.magnuson@mcmail.vanderbilt.edu	Magnuson, Mark/AAY-7172-2021; Postic, Catherine/P-2271-2017; Magnuson, Mark A/B-1335-2009	Magnuson, Mark/0000-0002-8824-6499; Postic, Catherine/0000-0002-1875-6960; Magnuson, Mark A/0000-0002-8824-6499	NIDDK NIH HHS [DK42612, DK42502, DK53434] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053434, R01DK042612] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; BALI D, 1995, J BIOL CHEM, V270, P21464, DOI 10.1074/jbc.270.37.21464; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Becker TC, 1996, J BIOL CHEM, V271, P390, DOI 10.1074/jbc.271.1.390; BECKER TC, 1994, J BIOL CHEM, V269, P21234; Bennett BD, 1996, J BIOL CHEM, V271, P3647; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; GYLFE E, 1991, CELL CALCIUM, V12, P229, DOI 10.1016/0143-4160(91)90023-8; ISHIHARA H, 1995, FEBS LETT, V371, P329, DOI 10.1016/0014-5793(95)00932-Y; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LERNMARK A, 1974, DIABETOLOGIA, V10, P431, DOI 10.1007/BF01221634; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; MEDA P, 1990, J CLIN INVEST, V86, P759, DOI 10.1172/JCI114772; MEDA P, 1991, EXP CELL RES, V192, P469, DOI 10.1016/0014-4827(91)90066-4; MEDA P, 1984, Q J EXP PHYSIOL CMS, V69, P719; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Noma Y, 1996, ENDOCRINOLOGY, V137, P1485, DOI 10.1210/en.137.4.1485; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; PISTON DW, 1995, J MICROSC SOC AM, V1, P25; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; SCHARP DW, 1973, TRANSPLANTATION, V16, P686, DOI 10.1097/00007890-197312000-00028; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; STEFAN Y, 1987, J CLIN INVEST, V80, P175, DOI 10.1172/JCI113045; Sweet IR, 1996, AM J PHYSIOL-ENDOC M, V271, pE606, DOI 10.1152/ajpendo.1996.271.3.E606; VISCHER U, 1997, BIOCHEM J, V241, P249; Wang HY, 1997, P NATL ACAD SCI USA, V94, P4372, DOI 10.1073/pnas.94.9.4372; YIN L, 1992, DIABETES, V41, P792	32	51	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1000	1004		10.1074/jbc.274.2.1000	http://dx.doi.org/10.1074/jbc.274.2.1000			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873043	hybrid			2022-12-27	WOS:000077968500058
J	Tscherne, JS; Nurse, K; Popienick, P; Ofengand, J				Tscherne, JS; Nurse, K; Popienick, P; Ofengand, J			Purification, cloning, and characterization of the 16 S RNA m(2)G1201 methyltransferase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECODING SITE C1400; 23S RIBOSOMAL-RNA; SEQUENCE; PROTEIN; 30S; METHYLATION; MUTATIONS; SUBUNIT	The methyltransferase that forms m(2)G1207 in Escherichia coli small subunit rRNA has been purified, cloned, and characterized. The gene was identified from the N-terminal sequence of the purified enzyme as the open reading frame yjjT (SWISS-PROT accession number P39406), The gene, here renamed rsmC in view of its newly established function, codes for a 343-amino acid protein that has homologs in prokaryotes, Archaea, and possibly also in lower eukaryotes. The enzyme reacted well with 30 S subunits reconstituted from 16 S RNA transcripts and 30 S proteins but was almost inactive with the corresponding free RNA. By hybridization and protection of appropriate segments of 16 S RNA that had been extracted from 30 S subunits methylated by the enzyme, it was shown that of the three naturally occurring m(2)G residues, only m2G1207 was formed. Whereas close to unit stoichiometry of methylation could be achieved at 0.9 mn Mg2+, both 2 mM EDTA and 6 mM Mg2+ markedly reduced the level of methylation, suggesting that the optimal substrate may be a ribonucleoprotein particle less structured than a 30 S ribosome but more so than free RNA.	Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Ofengand, J (corresponding author), Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA.							Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAKIN A, 1994, NUCLEIC ACIDS RES, V22, P3681, DOI 10.1093/nar/22.18.3681; BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; BJORK GR, 1996, ESCHERICHIA COLI SAL, P861; CUNNINGHAM PR, 1991, BIOCHIMIE, V73, P789, DOI 10.1016/0300-9084(91)90058-9; DENMAN R, 1989, BIOCHEMISTRY-US, V28, P1002, DOI 10.1021/bi00429a013; DENMAN R, 1989, BIOCHEMISTRY-US, V28, P1012, DOI 10.1021/bi00429a014; Green R, 1996, RNA, V2, P1011; INGROSSO D, 1989, J BIOL CHEM, V264, P20131; KOONIN EV, 1995, P NATL ACAD SCI USA, V92, P11921, DOI 10.1073/pnas.92.25.11921; KRZYZOSIAK W, 1987, BIOCHEMISTRY-US, V26, P2353, DOI 10.1021/bi00382a042; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; McCloskey JA, 1998, NUCLEIC ACIDS RES, V26, P196, DOI 10.1093/nar/26.1.196; MOINE H, 1994, J MOL BIOL, V243, P402, DOI 10.1006/jmbi.1994.1668; Murgola EJ, 1995, BIOCHEM CELL BIOL, V73, P925, DOI 10.1139/o95-100; NEGRE D, 1990, UCLA SYM BI, V128, P1; NEGRE D, 1989, P NATL ACAD SCI USA, V86, P4902, DOI 10.1073/pnas.86.13.4902; POLDERMANS B, 1979, J BIOL CHEM, V254, P9094; RAUE HA, 1988, PROG BIOPHYS MOL BIO, V51, P77, DOI 10.1016/0079-6107(88)90011-9; RINKEAPPEL J, NUCL ACIDS RES, V21, P2853; Sergiev PV, 1997, RNA, V3, P464; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; van Knippenberg PH, 1986, STRUCTURE FUNCTION G, P412; VANBUUL CPJJ, 1985, GENE, V38, P65, DOI 10.1016/0378-1119(85)90204-5; WEITZMANN C, 1991, NUCLEIC ACIDS RES, V19, P7089, DOI 10.1093/nar/19.25.7089; WRZESINSKI J, 1995, BIOCHEMISTRY-US, V34, P8904, DOI 10.1021/bi00027a043	26	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					924	929		10.1074/jbc.274.2.924	http://dx.doi.org/10.1074/jbc.274.2.924			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873033	hybrid			2022-12-27	WOS:000077968500048
J	Browning, DD; Windes, ND; Ye, RD				Browning, DD; Windes, ND; Ye, RD			Activation of p38 mitogen-activated protein kinase by lipopolysaccharide in human neutrophils requires nitric oxide-dependent cGMP accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED HUMAN-NEUTROPHILS; CYCLIC-GMP; CHEMOTACTIC PEPTIDE; INFLAMMATORY CYTOKINES; PREDOMINANT ISOFORM; KAPPA-B; LEU-PHE; STRESS; PHOSPHORYLATION; PATHWAYS	This study examined the signal transduction pathway(s) leading to phosphorylation of p38 in human neutrophils stimulated with lipopolysaccharide and formyl peptides. Blockade of the nitric oxide (NO) pathway in neutrophils with the NO synthase inhibitor N-nitro-L-argnine methyl ester or by treatment with the NO scavenger 2-phenyl-tetramethylimidazoline-1-oxyl-3-oxide attenuated phosphorylation of the mitogen-activated protein kinase p38 in response to lipopolysaccharide but not fMet-Leu-Phe. Using the NO releasing agents S-nitroso-N-acetylpenicillamine and sodium nitroprusside it was determined that nitric oxide is sufficient to cause an increase in phosphorylation of p38. Increasing cellular cGMP with phosphodiesterase inhibitors, by stimulation of soluble guanylyl cyclase with YC-1 or with exogenous dibutyryl cGMP resulted in mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 3,6 (MEK3,6) activation and phosphorylation of p38, This phenomenon was specific for MEK3,6, because these agents had no effect on the phosphorylation state of MEK1.2. A role for protein kinase G but not protein kinase A downstream of lipopolysaccharide but not formylmethionylleucylphenylalanine was shown using the specific inhibitors KT5823 and H89, respectively. These data indicate that activation of p38 by fMet-Leu-Phe and lipopolysaccharide involve different mechanisms, and that activation of protein kinase G by NO-dependent stimulation of guanylyl cyclase is necessary and sufficient for phosphorylation of p38 downstream of lipopolysaccharide.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Ye, RD (corresponding author), Univ Illinois, Dept Pharmacol MC 868, 835 S Wolcott Ave, Chicago, IL 60612 USA.		Ye, Richard/ABF-2413-2020; Ye, Richard/O-5223-2016	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620; Browning, Darren/0000-0003-0497-7620	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033503, R56AI033503, R01AI040176, R56AI040176] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40176, AI33503] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Avdi NJ, 1996, J BIOL CHEM, V271, P33598, DOI 10.1074/jbc.271.52.33598; BELENKY SN, 1993, J LAB CLIN MED, V122, P388; Bhat NR, 1998, J NEUROSCI, V18, P1633; BLUMER KJ, 1994, TRENDS BIOCHEM SCI, V19, P236, DOI 10.1016/0968-0004(94)90147-3; Browning DD, 1997, J BIOL CHEM, V272, P7995, DOI 10.1074/jbc.272.12.7995; Corriveau CC, 1998, J INFECT DIS, V177, P116, DOI 10.1086/513829; Cuthbertson BH, 1997, BRIT J ANAESTH, V78, P714, DOI 10.1093/bja/78.6.714; DaSilva J, 1997, J BIOL CHEM, V272, P28373, DOI 10.1074/jbc.272.45.28373; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; Downey GP, 1996, J BIOL CHEM, V271, P21005, DOI 10.1074/jbc.271.35.21005; ElBenna J, 1996, ARCH BIOCHEM BIOPHYS, V334, P395; Elferink JGR, 1996, GEN PHARMACOL-VASC S, V27, P387, DOI 10.1016/0306-3623(95)00070-4; Fierro IM, 1996, IMMUNOLOGY, V89, P295, DOI 10.1046/j.1365-2567.1996.d01-742.x; Foey AD, 1998, J IMMUNOL, V160, P920; Frasch SC, 1998, J BIOL CHEM, V273, P8389, DOI 10.1074/jbc.273.14.8389; GRADY PG, 1986, BIOCHIM BIOPHYS ACTA, V885, P282, DOI 10.1016/0167-4889(86)90243-0; GRINSTEIN S, 1994, J BIOL CHEM, V269, P19313; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Han JH, 1997, FEBS LETT, V403, P19, DOI 10.1016/S0014-5793(97)00021-5; Hobbs AJ, 1997, TRENDS PHARMACOL SCI, V18, P484, DOI 10.1016/S0165-6147(97)01137-1; Hogaboam CM, 1997, J IMMUNOL, V159, P5585; Kankaanranta H, 1997, MOL PHARMACOL, V51, P882, DOI 10.1124/mol.51.5.882; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; Krump E, 1997, J BIOL CHEM, V272, P937, DOI 10.1074/jbc.272.2.937; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; Lander HM, 1996, J BIOL CHEM, V271, P19705, DOI 10.1074/jbc.271.33.19705; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; LANDER HM, 1995, J BIOL CHEM, V270, P21195, DOI 10.1074/jbc.270.36.21195; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; Nahas N, 1996, BIOCHEM J, V318, P247, DOI 10.1042/bj3180247; Nath J, 1997, J LEUKOCYTE BIOL, V62, P805, DOI 10.1002/jlb.62.6.805; Nick JA, 1997, J CLIN INVEST, V99, P975, DOI 10.1172/JCI119263; Nick JA, 1996, J IMMUNOL, V156, P4867; Numata M, 1998, J IMMUNOL, V160, P3031; Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9; Pryzwansky Katherine B., 1998, Cell Biochemistry and Biophysics, V28, P251, DOI 10.1007/BF02737813; PRYZWANSKY KB, 1995, BLOOD, V85, P222, DOI 10.1182/blood.V85.1.222.bloodjournal851222; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rane MJ, 1997, J IMMUNOL, V159, P5070; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; SCHMIDT HHHW, 1989, FEBS LETT, V244, P357, DOI 10.1016/0014-5793(89)80562-9; Schnyder B, 1998, BIOCHEM J, V331, P489, DOI 10.1042/bj3310489; SCHUDT C, 1991, N-S ARCH PHARMACOL, V344, P682; TavaresMurta BM, 1996, BRAZ J MED BIOL RES, V29, P381; Vaandrager AB, 1996, MOL CELL BIOCHEM, V157, P23, DOI 10.1007/BF00227877; VANDERVORT AL, 1994, J IMMUNOL, V152, P4102; VILLARETE LH, 1995, BIOCHEM BIOPH RES CO, V211, P671, DOI 10.1006/bbrc.1995.1864; Wanikiat P, 1997, BRIT J PHARMACOL, V122, P1135, DOI 10.1038/sj.bjp.0701477; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; WYATT TA, 1991, J BIOL CHEM, V266, P21274; WYATT TA, 1993, AM J PHYSIOL, V265, pC201, DOI 10.1152/ajpcell.1993.265.1.C201; Zu YL, 1998, J IMMUNOL, V160, P1982	56	55	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					537	542		10.1074/jbc.274.1.537	http://dx.doi.org/10.1074/jbc.274.1.537			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867877	hybrid			2022-12-27	WOS:000077900200077
J	Egea, J; Espinet, C; Comella, JX				Egea, J; Espinet, C; Comella, JX			Calcium influx activates extracellular-regulated kinase/mitogen-activated protein kinase pathway through a calmodulin-sensitive mechanism in PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; MAP-KINASE; NEURONAL SURVIVAL; NEUROTROPHIC FACTORS; PHOSPHOLIPASE-C; EGF RECEPTOR; BINDING-SITE; RAS	Evidence suggests that membrane depolarization is able to promote neuronal survival through a sustained, although moderate, increase in the intracellular calcium. We have used the PC12 cell line to study the possible intracellular pathways that can be activated by calcium influx. Previously, we observed that membrane depolarization-induced calcium influx was able to activate the extracellular-regulated kinase (ERK)/mitogen-activated protein kinase pathway and most of this activation was calmodulin-dependent. We demonstrated that a part of the ERK activation is due to the phosphorylation of the epidermal growth factor receptor. Here, we show that both the epidermal growth factor receptor phosphorylation and the Shc-Grb2-Ras activation are not calmodulin-modulated. Moreover, dominant negative mutant Ha-ras (Asn-17) prevents the activation on ERKs by membrane depolarization, suggesting that Pas and calmodulin are both necessaries to activate ERKs by membrane depolarization. We failed to observe any significant induction and/or modulation of the A-Raf, B-Raf or c-Raf-l kinase activities, thus suggesting the existence of a MEK kinase different from the classical Raf kinases that directly or indirectly can be modulated by Ca2+/calmodulin.	Univ Lleida, Dept Ciencies Med Basiques, Grp Neurobiol Mol, E-25198 Lleida, Catalonia, Spain	Universitat de Lleida	Comella, JX (corresponding author), Univ Lleida, Dept Ciencies Med Basiques, Grp Neurobiol Mol, Rovira Roure 44, E-25198 Lleida, Catalonia, Spain.	Joan.Comella@cmb.UdL.es	Egea, Joaquim/A-7501-2010; Comella, Joan/GQA-4279-2022; Espinet, Came/AGY-9582-2022; Comella, Joan X/D-7333-2012; Egea, Joaquim/AAT-1984-2021; Espinet, Carme/A-7950-2010	Comella, Joan X/0000-0002-6218-0786; Egea Navarro, Joaquim/0000-0002-1164-8377; EspinetMestre, Carme/0000-0001-7172-3407				AHN NG, 1992, J NEUROCHEM, V59, P147, DOI 10.1111/j.1471-4159.1992.tb08885.x; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; COLLINS F, 1989, BRAIN RES, V502, P99, DOI 10.1016/0006-8993(89)90465-4; D'Mello SR, 1997, J NEUROSCI, V17, P1548; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Downward J, 1998, SCIENCE, V279, P673, DOI 10.1126/science.279.5351.673; Egea J, 1998, J NEUROCHEM, V70, P2554; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; FAURE M, 1995, MOL BIOL CELL, V6, P1025, DOI 10.1091/mbc.6.8.1025; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P500; GIETZEN K, 1982, BIOCHEM J, V207, P637, DOI 10.1042/bj2070637; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Hemmings BA, 1997, SCIENCE, V277, P534, DOI 10.1126/science.277.5325.534; HIDAKA H, 1983, METHOD ENZYMOL, V102, P185; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; HU JR, 1993, NEUROREPORT, V4, P198, DOI 10.1097/00001756-199302000-00021; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Klinghoffer RA, 1996, MOL CELL BIOL, V16, P5905; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; LARMET Y, 1992, NEURON, V9, P563, DOI 10.1016/0896-6273(92)90193-H; Lee RB, 1996, IEEE MICRO, V16, P6, DOI 10.1109/MM.1996.526920; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MASSOM L, 1990, BIOCHEMISTRY-US, V29, P671, DOI 10.1021/bi00455a012; Miller TM, 1997, J BIOL CHEM, V272, P9847; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SOLEM M, 1995, J NEUROSCI, V15, P5966; Soler RM, 1998, J NEUROSCI, V18, P1230; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; TANAKA T, 1980, J BIOL CHEM, V255, P1078; Tatsuta M, 1996, CANCER LETT, V107, P179, DOI 10.1016/0304-3835(96)04353-4; TENG KK, 1993, J NEUROSCI, V13, P3124; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; Wixler V, 1996, FEBS LETT, V385, P131, DOI 10.1016/0014-5793(96)00363-8; YAMAGUCHI K, 1995, BIOCHEM BIOPH RES CO, V210, P639, DOI 10.1006/bbrc.1995.1708; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zwick E, 1997, J BIOL CHEM, V272, P24767, DOI 10.1074/jbc.272.40.24767	63	89	89	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					75	85		10.1074/jbc.274.1.75	http://dx.doi.org/10.1074/jbc.274.1.75			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867813	hybrid			2022-12-27	WOS:000077900200013
J	Inohara, N; Koseki, T; Chen, S; Benedict, MA; Nunez, G				Inohara, N; Koseki, T; Chen, S; Benedict, MA; Nunez, G			Identification of regulatory and catalytic domains in the apoptosis nuclease DFF40/CAD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; PROTEIN	The DNA fragmentation factor (DFF) is composed of two subunits, the 40-kDa caspase-3-activated nuclease (DFF40/CAD) and its 45-kDa inhibitor (DFF45/ICAD), During apoptosis, DFF-40/CAD is activated by caspase-3-mediated cleavage of DFF45/ICAD, Mutational analysis of DFF40/CAD revealed that DFF40/CAD is composed of a C-terminal catalytic domain and an N-terminal regulatory domain. Deletion of the catalytic domain (residues 290-345) abrogated the caspase-3-induced nuclease activity of DFF40/CAD but not its ability to interact with DFF45/ICAD, Conversely, removal of the regulatory domain (residues 1-83) yielded a constitutively active DFF40/CAD nuclease that neither bound to its inhibitor nor required caspase-3 for activation. Amino acid alignment revealed that the regulatory domain of DFF40/CAD has homology to the N-terminal region of mammalian and Drosophila DFF45/ICAD and CIDE-N, a regulatory domain previously identified in pro-apoptotic CIDE proteins. Mutational analysis of the N-terminal region revealed mutants with diminished nuclease activity but with intact ability to bind DFF45/ICAD, Thus, CIDE-N represents a new type of domain that is associated with the regulation of the apoptosis/DNA fragmentation pathway.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.		Nuñez, Gabriel/A-7160-2014		NCI NIH HHS [CA-64421, CA-64556] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA064556, K04CA064421] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; DUAN H, 1998, J BIOL CHEM, V271, P16720; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Halenbeck R, 1998, CURR BIOL, V8, P537, DOI 10.1016/S0960-9822(98)79298-X; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Mukae N, 1998, P NATL ACAD SCI USA, V95, P9123, DOI 10.1073/pnas.95.16.9123; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214	13	69	74	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					270	274		10.1074/jbc.274.1.270	http://dx.doi.org/10.1074/jbc.274.1.270			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867840	hybrid			2022-12-27	WOS:000077900200040
J	Sulli, C; Fang, ZW; Muchhal, U; Schwartzbach, SD				Sulli, C; Fang, ZW; Muchhal, U; Schwartzbach, SD			Topology of Euglena chloroplast protein precursors within endoplasmic reticulum to Golgi to chloroplast transport vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A/B-BINDING-PROTEIN; LHCP-II APOPROTEIN; POLYPROTEIN PRECURSOR; PHOTOSYSTEM-II; EUBACTERIAL ORIGIN; CDNA CLONE; CHLOROPHYLL; MEMBRANES; GRACILIS; IMPORT	Euglena chloroplast protein precursors are transported as integral membrane proteins from the endoplasmic reticulum (ER) to the Golgi apparatus prior to chloroplast localization. All Euglena chloroplast protein precursors have functionally similar bipartite presequences composed of an N-terminal signal peptide domain and a stromal targeting domain containing a hydrophobic region approximately 60 amino acids from the predicted signal peptidase cleavage site. Asparagine-Linked glycosylation reporters and presequence deletion constructs of the precursor to the Euglena light-harvesting chlorophyll a/b-binding protein of photosystem II (pLHCPII) were used to identify presequence regions translocated into the ER lumen and stop transfer membrane anchor domains. An asparagine-linked glycosylation site present at amino acid 148 of pLHCPII near the N terminus of mature LHCPII was not glycosylated in vitro by canine microsomes while an asparagine-linked glycosylation site inserted at amino acid 40 was. The asparagine at amino acid 148 was glycosylated upon deletion of amino acids 46-146, which contain the stromal targeting domain, indicating that the hydrophobic region within this domain functions as a stop transfer membrane anchor sequence. Protease protection assays indicated that for all constructs, mature LHCPII, was not translocated across the microsomal membrane. Taken together with the structural similarity of all Euglena presequences, these results demonstrate that chloroplast precursors are anchored within ER and Golgi transport vesicles by the stromal targeting domain hydrophobic region oriented with the presequence N terminus formed by signal peptidase cleavage in the vesicle lumen and the mature protein in the cytoplasm.	Univ Nebraska, Sch Biol Sci, Beadle Ctr E 207, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Schwartzbach, SD (corresponding author), Univ Nebraska, Sch Biol Sci, Beadle Ctr E 207, Lincoln, NE 68588 USA.	schwartz@biocomp.unl.edu						APT KE, 1993, J BIOL CHEM, V268, P16208; APT KE, 1995, PLANT PHYSIOL, V109, P339; BHAYA D, 1991, MOL GEN GENET, V229, P400, DOI 10.1007/BF00267462; CHAN RL, 1990, EMBO J, V9, P333, DOI 10.1002/j.1460-2075.1990.tb08115.x; Cline K, 1996, ANNU REV CELL DEV BI, V12, P1, DOI 10.1146/annurev.cellbio.12.1.1; Corsi AK, 1996, J BIOL CHEM, V271, P30299, DOI 10.1074/jbc.271.48.30299; DODGE J D, 1975, Phycologia, V14, P253, DOI 10.2216/i0031-8884-14-4-253.1; Enomoto T, 1997, PLANT CELL PHYSIOL, V38, P743, DOI 10.1093/oxfordjournals.pcp.a029229; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gafvelin G, 1997, J BIOL CHEM, V272, P6119, DOI 10.1074/jbc.272.10.6119; GIBBS SP, 1978, CAN J BOT, V56, P2883, DOI 10.1139/b78-345; GIBBS SP, 1981, ANN NY ACAD SCI, V361, P193; GIBBS SP, 1981, INT REV CYTOL, V72, P49, DOI DOI 10.1016/S0074-7696(08)61194-8; HAUBER MM, 1994, BOT ACTA, V107, P383; HENZE K, 1995, P NATL ACAD SCI USA, V92, P9122, DOI 10.1073/pnas.92.20.9122; High S, 1997, J BIOL CHEM, V272, P11622; HOWE G, 1993, P NATL ACAD SCI USA, V90, P1862, DOI 10.1073/pnas.90.5.1862; Jakowitsch J, 1996, FEBS LETT, V381, P153, DOI 10.1016/0014-5793(96)00102-0; KISHORE R, 1993, P NATL ACAD SCI USA, V90, P11845, DOI 10.1073/pnas.90.24.11845; KISHORE R, 1992, PLANT SCI, V85, P79, DOI 10.1016/0168-9452(92)90096-5; KOHORN BD, 1991, J BIOL CHEM, V266, P12048; Lang M, 1998, J BIOL CHEM, V273, P30973, DOI 10.1074/jbc.273.47.30973; Le QH, 1997, MOL GEN GENET, V255, P595, DOI 10.1007/s004380050533; LEFORTTRAN M, 1980, J ULTRA MOL STRUCT R, V73, P44, DOI 10.1016/0022-5320(80)90115-X; LIN Q, 1994, J BIOL CHEM, V269, P9436; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; MELKONIAN M, 1996, VERH DTSCH ZOOL GES, P71; MUCHHAL US, 1992, PLANT MOL BIOL, V18, P287, DOI 10.1007/BF00034956; MUCHHAL US, 1994, NUCLEIC ACIDS RES, V22, P5737, DOI 10.1093/nar/22.25.5737; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NORRIS BJ, 1994, PLANT MOL BIOL, V24, P673, DOI 10.1007/BF00023563; OSAFUNE T, 1991, EXP CELL RES, V193, P320, DOI 10.1016/0014-4827(91)90103-2; OSAFUNE T, 1991, J ELECTRON MICROSC, V40, P41; Plaumann M, 1997, CURR GENET, V31, P430, DOI 10.1007/s002940050226; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; SCHNELL DJ, 1993, J CELL BIOL, V120, P103, DOI 10.1083/jcb.120.1.103; Schwartzbach SD, 1998, PLANT MOL BIOL, V38, P247, DOI 10.1023/A:1006029919283; SHARIF AL, 1989, EUR J BIOCHEM, V184, P353, DOI 10.1111/j.1432-1033.1989.tb15026.x; Sharples FP, 1996, BBA-BIOENERGETICS, V1276, P117, DOI 10.1016/0005-2728(96)00066-7; Sulli C, 1996, PLANT CELL, V8, P43; SULLI C, 1995, J BIOL CHEM, V270, P13084, DOI 10.1074/jbc.270.22.13084; SWEENEY BM, 1981, J PHYCOL, V17, P95, DOI 10.1111/j.1529-8817.1981.tb00824.x; SZCZESNASKORUPA E, 1988, P NATL ACAD SCI USA, V85, P738, DOI 10.1073/pnas.85.3.738; VONHEIJNE G, 1988, BIOCHIM BIOPHYS ACTA, V947, P307, DOI 10.1016/0304-4157(88)90013-5	46	83	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					457	463		10.1074/jbc.274.1.457	http://dx.doi.org/10.1074/jbc.274.1.457			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867865	hybrid			2022-12-27	WOS:000077900200065
J	Carter, RE; Sorkin, A				Carter, RE; Sorkin, A			Endocytosis of functional epidermal growth factor receptor-green fluorescent protein chimera	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA A431 CELLS; COATED PIT ADAPTINS; KINASE-ACTIVITY; EGF-RECEPTOR; TRANSFERRIN RECEPTOR; DOWN-REGULATION; INTERNALIZATION; BINDING; PHOSPHORYLATION; DEGRADATION	A chimera of the epidermal growth factor receptor (EGFR) and green fluorescent protein (GFP) has been engineered by fusing GFP to the carboxyl terminus of EGFR. Data are provided to demonstrate that the GFP moiety does not affect the expected functioning of EGFR. EGFR-GFP becomes phosphorylated at tyrosine residues in response to EGF and is capable of phosphorylating endogenous substrates and initiating signaling cascades. EGF-dependent association of the chimeric receptor with the clathrin adaptor protein AP-2, involved in endocytosis, and with Shc adaptor protein, which binds in close proximity to the fusion point, is not affected by the GFP moiety. Receptor down-regulation and internalization occur at rates similar to those in cells expressing wild-type EGFR. Western blot analysis reveals that lysosomal degradation of EGFR-GFP proceeds from the extracellular domain and that GFP is not preferentially cleaved. Time-dependent co-localization of EGFR-GFP and Texas Red-conjugated EGF in living cells using digital deconvolution microscopy demonstrates the trafficking of ligand-receptor complexes through the early and multivesicular endosomes followed by segregation of the ligand and receptor at the late stages of endocytosis. Time-lapse optical analysis of the early stages of endocytosis reveals localization of EGFR-GFP in the tubular-vesicular endosomal compartments. Rapid dynamics of membrane movement and fusion within these compartments were observed. This approach and the fidelity of the biochemical properties of the EGFR-GFP demonstrate that real-time visualization of trafficking and protein interactions of tyrosine kinase receptors in the presence or absence of the ligand are feasible.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Sorkin, A (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, 4200 E 9th Ave, Denver, CO 80262 USA.	alexander.sorkin@uchsc.edu		Sorkin, Alexander/0000-0002-4446-1920	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046817] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46817] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; BERTICS PJ, 1988, J BIOL CHEM, V263, P3610; BERTICS PJ, 1985, J CELL BIOCHEM, V29, P195, DOI 10.1002/jcb.240290304; BOLL W, 1995, CURR BIOL, V5, P1168, DOI 10.1016/S0960-9822(95)00233-8; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; DEBRABANDER M, 1988, CELL MOTIL CYTOSKEL, V9, P30, DOI 10.1002/cm.970090105; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; HOPKINS CR, 1992, TRENDS BIOCHEM SCI, V17, P27, DOI 10.1016/0968-0004(92)90423-7; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; HOPKINS CR, 1990, NATURE, V346, P335, DOI 10.1038/346335a0; HOPKINS CR, 1985, J CELL SCI, P173; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; LAI WH, 1989, J CELL BIOL, V109, P2751, DOI 10.1083/jcb.109.6.2751; MILLER K, 1986, J CELL BIOL, V102, P500, DOI 10.1083/jcb.102.2.500; NESTEROV A, 1995, P NATL ACAD SCI USA, V92, P8719, DOI 10.1073/pnas.92.19.8719; NESTEROV A, 1995, J BIOL CHEM, V270, P6320, DOI 10.1074/jbc.270.11.6320; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; SCHLESSINGER J, 1978, P NATL ACAD SCI USA, V75, P2659, DOI 10.1073/pnas.75.6.2659; SOLER C, 1994, J BIOL CHEM, V269, P12320; SORKIN A, 1991, J BIOL CHEM, V266, P23453; SORKIN A, 1991, J BIOL CHEM, V266, P8355; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; SORKIN A, 1991, J CELL BIOL, V112, P469, DOI 10.1083/jcb.112.3.469; SORKIN A, 1991, J CELL BIOL, V112, P55, DOI 10.1083/jcb.112.1.55; SORKIN AD, 1988, EXP CELL RES, V175, P192, DOI 10.1016/0014-4827(88)90266-2; STOSCHECK CM, 1984, J CELL PHYSIOL, V120, P296, DOI 10.1002/jcp.1041200306; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; WILEY HS, 1991, J BIOL CHEM, V266, P11083	36	183	186	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35000	35007		10.1074/jbc.273.52.35000	http://dx.doi.org/10.1074/jbc.273.52.35000			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857032	hybrid			2022-12-27	WOS:000077719700050
J	Araki, M; Nanri, H; Ejima, K; Murasato, Y; Fujiwara, T; Nakashima, Y; Ikeda, M				Araki, M; Nanri, H; Ejima, K; Murasato, Y; Fujiwara, T; Nakashima, Y; Ikeda, M			Antioxidant function of the mitochondrial protein SP-22 in the cardiovascular system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	71st Scientific Session of the American-Heart-Association	NOV 08-12, 1998	DALLAS, TX	Amer Heart Assoc			MYOCARDIAL REPERFUSION INJURY; DEPENDENT PEROXIDE REDUCTASE; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; HYDROGEN-PEROXIDE; FREE-RADICALS; NITRIC-OXIDE; INDUCTION; CATALASE	The mitochondrial protein SP-22 has recently been reported to be a member of the thioredoxin-dependent peroxide reductase family, suggesting that it may be one of the antioxidant systems in mitochondria, which are the major site of reactive oxygen intermediate generation, The aim of this study was to examine whether SP-22 is involved in mitochondrial antioxidant mechanisms and whether its expression is induced by oxidative stresses, particularly those in mitochondria. The expression of SP-22 protein was enhanced by about 1.5-4.6-fold when bovine aortic endothelial cells (BAEC) were exposed to various oxidative stresses, including mitochondrial respiratory inhibitors which increased the superoxide generation in BAEC mitochondria. The expression of SP-22 mRNA increased 2.0-3.5-fold with a peak at 3-6 h after exposure to Fe2+/dithiothreitol or a respiratory inhibitor, antimycin A. BAEC with an increased level of SP-22 protein caused by pretreatment with mild oxidative stress became tolerant to subsequent intense oxidative stress. On the other hand, BAEC that had been depleted of SP-22 with an antisense oligodeoxynucleotide against SP-22 mRNA became more labile to oxidative stress than control BAEC. The induction of SP-22 protein by oxidative stress in vivo was demonstrated in an experimental model of myocardial infarction in rat heart. These findings indicate that SP-22 functions as an antioxidant in mitochondria of the cardiovascular system.	Univ Occupat & Environm Hlth, Dept Hlth Dev, Yahatanishi Ku, Kitakyushu, Fukuoka 807, Japan; Univ Occupat & Environm Hlth, Dept Internal Med 2, Kitakyushu, Fukuoka 8078555, Japan; Univ Occupat & Environm Hlth, Dept Syst Physiol, Kitakyushu, Fukuoka 8078555, Japan; Fukuoka Univ, Sch Med, Dept Biochem, Fukuoka 8140180, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Fukuoka University	Nanri, H (corresponding author), Univ Occupat & Environm Hlth, Dept Hlth Dev, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 807, Japan.	nanrih@med.uoeh-u.ac.jp						BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Cahill A, 1997, BIOCHEM BIOPH RES CO, V235, P286, DOI 10.1006/bbrc.1997.6774; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; FANTONE JC, 1982, AM J PATHOL, V107, P397; FERNANDO MR, 1992, EUR J BIOCHEM, V209, P917, DOI 10.1111/j.1432-1033.1992.tb17363.x; FERRARI R, 1995, AM J CARDIOL, V76, pB17; FLOHE L, 1976, GLUTATHIONE METABOLI, P115; FORMAN HJ, 1982, FREE RADICAL BIO MED, V5, P65; FREEMAN BA, 1982, LAB INVEST, V47, P412; FREEMAN ML, 1988, RADIAT RES, V115, P461, DOI 10.2307/3577295; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; HASEGAWA E, 1990, BIOCHEM BIOPH RES CO, V170, P1049, DOI 10.1016/0006-291X(90)90498-C; ISHII T, 1993, J BIOL CHEM, V268, P18633; JOLLY SR, 1984, CIRC RES, V54, P277, DOI 10.1161/01.RES.54.3.277; Kaku Y, 1997, BBA-MOL CELL RES, V1356, P43, DOI 10.1016/S0167-4889(96)00156-5; KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; KIM IH, 1989, P NATL ACAD SCI USA, V86, P6018, DOI 10.1073/pnas.86.16.6018; Kowaltowski AJ, 1998, J BIOL CHEM, V273, P12766, DOI 10.1074/jbc.273.21.12766; KWAK HS, 1995, P NATL ACAD SCI USA, V92, P4582, DOI 10.1073/pnas.92.10.4582; LESKO SA, 1980, BIOCHEMISTRY-US, V19, P3023, DOI 10.1021/bi00554a029; LEVINSON W, 1980, BIOCHIM BIOPHYS ACTA, V606, P170, DOI 10.1016/0005-2787(80)90108-2; LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4; MACLEAN D, 1978, J CLIN INVEST, V61, P541, DOI 10.1172/JCI108965; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; MCCORD JM, 1978, FEBS LETT, V86, P139, DOI 10.1016/0014-5793(78)80116-1; RADI R, 1991, J BIOL CHEM, V266, P22028; SATO H, 1993, BIOCHIM BIOPHYS ACTA, V1148, P127, DOI 10.1016/0005-2736(93)90169-Z; SHAU HY, 1993, CELL IMMUNOL, V147, P1, DOI 10.1006/cimm.1993.1043; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SHULL S, 1991, J BIOL CHEM, V266, P24398; SIOW RCM, 1995, FEBS LETT, V368, P239, DOI 10.1016/0014-5793(95)00650-X; Solzbach U, 1997, CIRCULATION, V96, P1513, DOI 10.1161/01.CIR.96.5.1513; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129; TARTAGLIA LA, 1990, J BIOL CHEM, V265, P10535; THOMPSONGORMAN SL, 1990, J BIOL CHEM, V265, P6656; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; WATABE S, 1995, BIOCHEM BIOPH RES CO, V213, P1010, DOI 10.1006/bbrc.1995.2229; WATABE S, 1994, J BIOCHEM, V115, P648, DOI 10.1093/oxfordjournals.jbchem.a124390; Watabe S, 1997, EUR J BIOCHEM, V249, P52, DOI 10.1111/j.1432-1033.1997.t01-1-00052.x; WERNS SW, 1986, CIRCULATION, V74, P1, DOI 10.1161/01.CIR.74.1.1; WERNS SW, 1985, CIRC RES, V56, P895, DOI 10.1161/01.RES.56.6.895; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; YAMAMOTO T, 1989, GENE, V80, P337	54	111	116	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2271	2278		10.1074/jbc.274.4.2271	http://dx.doi.org/10.1074/jbc.274.4.2271			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	159QL	9890990	hybrid			2022-12-27	WOS:000078185200057
J	Gupta, S; Rajvanshi, P; Sokhi, RP; Vaidya, S; Irani, AN; Gorla, GR				Gupta, S; Rajvanshi, P; Sokhi, RP; Vaidya, S; Irani, AN; Gorla, GR			Position-specific gene expression in the liver lobule is directed by the microenvironment and not by the previous cell differentiation state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV-DEFICIENT RAT; PERIVENOUS HEPATOCYTES; INSITU HYBRIDIZATION; ALBUMIN GENE; MOUSE-LIVER; IN-VIVO; MODULATION; TRANSPLANTATION; ETHANOL; SUBPOPULATIONS	Mechanisms directing position-specific liver gene regulation are incompletely understood. To establish whether this aspect of hepatic gene expression is an inveterate phenomenon, we used transplanted hepatocytes as reporters in dipeptidyl peptidase IV-deficient F344 rats. After integration in liver parenchyma, the position of transplanted cells was shifted from periportal to perivenous areas by targeted hepatic ablations with carbon tetrachloride, In controls, transplanted cells showed greater glucose-6-phosphatase and lesser glycogen content in periportal areas. This pattern was reversed when transplanted cells shifted from periportal to perivenous areas. Transplanted hepatocytes in perivenous areas exhibited inducible cytochrome P450 activity, which was deficient in periportal hepatocytes, Moreover, cytochrome P450 activity was rapidly extinguished in activated hepatocytes when these cells were transplanted into the nonpermissive river of suckling rat pups, In cells isolated from the normal F344 rat liver, cytochrome P450 inducibility was originally greater in perivenous hepatocytes; however, periportal cells rapidly acquired this facility in culture conditions. These findings indicate that the liver microenvironment exerts supremacy over prior differentiation state of cells in directing position-specific gene expression. Therefore, persistence of specialized hepatocellular function will require interactions with regulatory signals and substrate availability, which bears upon further analysis of liver gene regulation, including in progenitor and/or stem cells.	Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Canc Res Ctr, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Gupta, S (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Ullmann 625,1300 Morris Pk Ave, Bronx, NY 10461 USA.				NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, R01DK046952] Funding Source: NIH RePORTER; NCI NIH HHS [P30-CA13330] Funding Source: Medline; NIDDK NIH HHS [P33 DK41296, R01 DK46952] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENGTSSON G, 1987, J PHARMACOL EXP THER, V240, P663; BERKOWITZ CM, 1995, HEPATOLOGY, V21, P1658, DOI 10.1002/hep.1840210626; BERTHOUD VM, 1992, AM J PHYSIOL, V263, pG650, DOI 10.1152/ajpgi.1992.263.5.G650; BILIR BM, 1993, J BIOL CHEM, V268, P19776; BURGER HJ, 1989, HEPATOLOGY, V9, P22, DOI 10.1002/hep.1840090105; CEREGHINI S, 1987, CELL, V50, P627, DOI 10.1016/0092-8674(87)90036-5; Coleman WB, 1997, AM J PATHOL, V151, P353; DONATO MT, 1993, ANAL BIOCHEM, V213, P29, DOI 10.1006/abio.1993.1381; Fang C, 1998, HEPATOLOGY, V27, P1304, DOI 10.1002/hep.510270516; GROOTHUIS GMM, 1992, ENZYME, V46, P94, DOI 10.1159/000468780; Gupta S, 1996, Prog Liver Dis, V14, P199; GUPTA S, 1995, P NATL ACAD SCI USA, V92, P5860, DOI 10.1073/pnas.92.13.5860; GUPTA S, 1991, HEPATOLOGY, V14, P144, DOI 10.1002/hep.1840140124; GUPTA S, 1999, IN PRESS AM J PHYSL; INGELMANSUNDBERG M, 1988, BIOCHEM BIOPH RES CO, V157, P55, DOI 10.1016/S0006-291X(88)80010-X; JUNGERMANN K, 1992, ENZYME, V46, P33, DOI 10.1159/000468777; Kietzmann T, 1997, CELL BIOL TOXICOL, V13, P243, DOI 10.1023/A:1007427206391; KLINGER W, 1988, EXP PATHOL-JENA, V33, P213, DOI 10.1016/S0232-1513(88)80075-6; KOHLER T, 1991, EXP PATHOL-JENA, V42, P159; KUO FC, 1991, MOL CELL BIOL, V11, P6050, DOI 10.1128/MCB.11.12.6050; LINDROS KO, 1990, HEPATOLOGY, V12, P1092, DOI 10.1002/hep.1840120503; LINDROS KO, 1997, CELL BIOL TOXICOL, V13, P57; Oinonen T, 1996, BIOCHEM PHARMACOL, V51, P1379, DOI 10.1016/0006-2952(96)00064-0; OMIECINSKI CJ, 1990, MOL PHARMACOL, V38, P462; OSYPIW JC, 1994, BIOCHEM J, V304, P617, DOI 10.1042/bj3040617; Overturf K, 1997, AM J PATHOL, V151, P1273; POLIARD AM, 1986, J CELL BIOL, V103, P777, DOI 10.1083/jcb.103.3.777; Rajvanshi P, 1996, HEPATOLOGY, V23, P482; Rajvanshi P, 1998, EXP CELL RES, V244, P405, DOI 10.1006/excr.1998.4223; REID LM, 1992, HEPATOLOGY, V15, P1198, DOI 10.1002/hep.1840150635; RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734; ROJKIND M, 1995, AM J PATHOL, V146, P1508; SANCHOTELLO M, 1987, VIRCHOWS ARCH B, V54, P170, DOI 10.1007/BF02899209; SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205; SIGAL SH, 1992, AM J PHYSIOL, V263, P139; TAL M, 1990, J CLIN INVEST, V86, P986, DOI 10.1172/JCI114801; Tateishi T, 1997, LIFE SCI, V61, P2567, DOI 10.1016/S0024-3205(97)01011-4; VAANANEN H, 1985, ALCOHOL CLIN EXP RES, V9, P315, DOI 10.1111/j.1530-0277.1985.tb05551.x; WAGENAAR GTM, 1993, HEPATOLOGY, V18, P1144; WOJCIK E, 1988, J CLIN INVEST, V82, P658, DOI 10.1172/JCI113645; YAMAUCHI M, 1988, HEPATOLOGY, V8, P243, DOI 10.1002/hep.1840080209	41	53	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2157	2165		10.1074/jbc.274.4.2157	http://dx.doi.org/10.1074/jbc.274.4.2157			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890978	hybrid			2022-12-27	WOS:000078185200045
J	Rani, MRS; Gauzzi, C; Pellegrini, S; Fish, EN; Wei, T; Ransohoff, RM				Rani, MRS; Gauzzi, C; Pellegrini, S; Fish, EN; Wei, T; Ransohoff, RM			Induction of beta-R1/I-TAC by interferon-beta requires catalytically active TYK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; GAMMA SIGNAL-TRANSDUCTION; ALPHA-INTERFERON; IFN-ALPHA; ANTIVIRAL ACTIONS; GENE-EXPRESSION; RECEPTOR; PHOSPHORYLATION; TRANSCRIPTION; ACTIVATION	The beta-R1/I-TAC (interferon-inducible T-cell alpha-chemoattractant) gene encodes an alpha-chemokine that is a potent chemoattractant for activated T-cells. We previously reported that beta-R1 was selectively induced by interferon (IFN)-beta compared with IFN-alpha and that the canonical type I IFN transcription factor interferon-stimulated gene factor 3 (ISGF3) was necessary but not sufficient for beta-R1 induction by IFN-beta. These findings suggested that beta-R1 induction by IFN-beta required an accessory component. To begin characterizing this signaling pathway, we examined the function of TYK2 protein in the IFN-beta-mediated induction of beta-R1. This study was motivated by the observation that beta-R1 could not be induced in TYK2-deficient U1 cells by IFN-beta (Rani, M, R, S., Foster, G;. R,, Leung, S,, Leaman, D,, Stark, G. R,, and Ransohoff, R. IM, (1996) J. Biol. Chem. 271, 22878-22884), an unexpected result because IFN-beta evokes substantial expression of IFN-stimulated genes (ISGs) in U1 cells through a TYK2-independent pathway. We now report beta-R1 expression patterns in U1 cells complemented with wild-type or mutant TYK2 proteins. Complementation with wild-type TYK2 rescued IFN-beta-inducible expression of beta-R1. Cells expressing kinase-deficient deletion or point mutants of TYK2 were refractory to induction of beta-R1 by IFN-beta despite robust expression of other ISGs. Transient transfection analysis of a beta-R1 promoter-reporter confirmed that transcriptional activation of beta-R1 by IFN-beta required competent TYK2 kinase, These studies indicate that the catalytic function of TYK2 is required for IFN-beta-mediated induction of beta-R1, Catalytic TYK2 is the first identified component in an accessory signaling pathway that supplements ISGF3/interferon-stimulated response element signaling for gene induction by type I IFNs.	Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; Inst Pasteur, INSERM U276, F-75724 Paris 15, France; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 3E2, Canada	Cleveland Clinic Foundation; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Toronto	Ransohoff, RM (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, NC30, Cleveland, OH 44195 USA.	ransohr@cesmtp.ccf.org	Pellegrini, Sandra/Y-6351-2019; Pellegrini, Sandra -/G-5546-2015; Gauzzi, Maria Cristina/N-7038-2017	Pellegrini, Sandra/0000-0001-5837-7589; Pellegrini, Sandra -/0000-0001-5837-7589; Gauzzi, Maria Cristina/0000-0002-2996-5231	OAPP OPHS HHS [PPG IPOICAG2220] Funding Source: Medline	OAPP OPHS HHS		ABRAMOVICH C, 1994, EMBO J, V13, P5871, DOI 10.1002/j.1460-2075.1994.tb06932.x; ACKRILL AM, 1991, NUCLEIC ACIDS RES, V19, P591, DOI 10.1093/nar/19.3.591; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLAMONICI O, 1994, MOL CELL BIOL, V14, P8133, DOI 10.1128/MCB.14.12.8133; COLAMONICI OR, 1994, J BIOL CHEM, V269, P3518; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Croze E, 1996, J BIOL CHEM, V271, P33165, DOI 10.1074/jbc.271.52.33165; DAMELL JE, 1994, SCIENCE, V264, P1415; Domanski P, 1998, J BIOL CHEM, V273, P3144, DOI 10.1074/jbc.273.6.3144; Domanski Paul, 1996, Cytokine and Growth Factor Reviews, V7, P143, DOI 10.1016/1359-6101(96)00017-2; Foster GR, 1996, J INTERF CYTOK RES, V16, P1027, DOI 10.1089/jir.1996.16.1027; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; GHISLAIN J, 1995, J BIOL CHEM, V270, P21785, DOI 10.1074/jbc.270.37.21785; GRESSER I, 1990, J INVEST DERMATOL, V95, P665; Gupta S, 1996, EMBO J, V15, P1075, DOI 10.1002/j.1460-2075.1996.tb00445.x; HARPUR AG, 1992, ONCOGENE, V7, P1347; HELM MH, 1995, SCIENCE, V267, P1347; Leaman DW, 1996, MOL CELL BIOL, V16, P369; Li XX, 1996, J BIOL CHEM, V271, P5790, DOI 10.1074/jbc.271.10.5790; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; PEILEGRINI S, 1989, MOL CELL BIOL, V9, P4605; Pellegrini S, 1997, EUR J BIOCHEM, V248, P615, DOI 10.1111/j.1432-1033.1997.00615.x; PLATANIAS LC, 1994, J BIOL CHEM, V269, P17761; Rani MRS, 1996, J BIOL CHEM, V271, P22878, DOI 10.1074/jbc.271.37.22878; SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O; SEN GC, 1993, ADV VIRUS RES, V42, P57, DOI 10.1016/S0065-3527(08)60083-4; SEN GC, 1992, J BIOL CHEM, V267, P5017; STARK GR, 1992, J INTERFERON RES, V12, P147, DOI 10.1089/jir.1992.12.147; UZE G, 1995, J INTERF CYTOK RES, V15, P3, DOI 10.1089/jir.1995.15.3; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; VELAZQUEZ L, 1995, J BIOL CHEM, V270, P3327, DOI 10.1074/jbc.270.7.3327; WEIL J, 1983, NATURE, V301, P437, DOI 10.1038/301437a0; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x	37	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1891	1897		10.1074/jbc.274.4.1891	http://dx.doi.org/10.1074/jbc.274.4.1891			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890942	hybrid			2022-12-27	WOS:000078185200009
J	Wang, J; Giacomini, KM				Wang, J; Giacomini, KM			Serine 318 is essential for the pyrimidine selectivity of the N2 Na+-nucleoside transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL EXPRESSION; XENOPUS-LAEVIS; PURINE; PROTEIN; RESIDUES; OOCYTES	Molecular cloning has isolated two subtypes of Na+-nucleoside transporters; one is pyrimidine-selective (N2), and the other is purine-selective (N1). Using chimeric rat N2/N1 transporters, we previously demonstrated that transmembrane domains (TM) 8 and 9 are the major sites for substrate binding and discrimination. Interestingly, when TM8 of N2 was replaced by that of N1, the resulting chimera, T8, lost the pyrimidine selectivity of N2 and accepted both purine and pyrimidine nucleosides, Five residues differ between rat N2 and N1 in TM8, To identify the critical residues responsible for transport selectivity, the five residues in N2 were systematically changed to their equivalents in N1, Replacing the serine residue at position 318 to its equivalent N1 residue, glycine, caused N2 to lose its selectivity for pyrimidine nucleosides and accept purine nucleosides as substrates. In contrast, replacing the other four residues did not, change the pyrimidine selectivity of N2. Furthermore, when glycine 318 in chimera T8 was changed back to serine, the chimeric transporter regained pyrimidine selectivity. These observations suggest that serine 318 is located in the nucleoside permeation pathway and is responsible for the substrate selectivity of N2. An adjacent residue, glutamine 319, was found to be important in modulating the apparent affinity for nucleosides.	Univ Calif San Francisco, Dept Biopharmaceut Sci & Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Giacomini, KM (corresponding author), Univ Calif San Francisco, Dept Biopharmaceut Sci & Cellular & Mol Pharmacol, S-926,513 Parnassus Ave, San Francisco, CA 94143 USA.		Giacomini, Kathleen/AEF-2452-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042230] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM42230] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELT JA, 1993, ADV ENZYME REGUL, V33, P235; BUCK KJ, 1994, P NATL ACAD SCI USA, V91, P12584, DOI 10.1073/pnas.91.26.12584; CASS CE, 1995, DRUG TRANSPORT ANTIM, P403; CHE MX, 1995, J BIOL CHEM, V270, P13596, DOI 10.1074/jbc.270.23.13596; EISENBERG D, 1986, J CELL BIOCHEM, V31, P11, DOI 10.1002/jcb.240310103; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; HUANG QQ, 1994, J BIOL CHEM, V269, P17757; HUANG QQ, 1993, J BIOL CHEM, V268, P20613; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; Kaback HR, 1997, P NATL ACAD SCI USA, V94, P5539, DOI 10.1073/pnas.94.11.5539; Merickel A, 1997, J BIOL CHEM, V272, P5403, DOI 10.1074/jbc.272.9.5403; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Schaner ME, 1997, PHARMACEUT RES, V14, P1316, DOI 10.1023/A:1012148016794; Wang J, 1997, J BIOL CHEM, V272, P28845, DOI 10.1074/jbc.272.46.28845; Wang J, 1997, AM J PHYSIOL-RENAL, V273, pF1058, DOI 10.1152/ajprenal.1997.273.6.F1058; Wang J, 1997, PHARM RES-DORDR, V14, P1524, DOI 10.1023/A:1012113931332; WU XC, 1992, J BIOL CHEM, V267, P8813; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973; Yao SYM, 1996, MOL PHARMACOL, V50, P388; Zeng H, 1996, BIOPHYS J, V70, P14, DOI 10.1016/S0006-3495(96)79560-7	20	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2298	2302		10.1074/jbc.274.4.2298	http://dx.doi.org/10.1074/jbc.274.4.2298			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890994	hybrid			2022-12-27	WOS:000078185200061
J	Bonafe, CFS; Matsukuma, AY; Matsuura, MSA				Bonafe, CFS; Matsukuma, AY; Matsuura, MSA			ATP-induced tetramerization and cooperativity in hemoglobin of lower vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIOPHIS-MILIARIS; LIGAND-BINDING; TEMPERATURE; EXPRESSION; ADAPTATION	The importance of intraerythrocytic organic phosphates in the allosteric control of oxygen binding to vertebrate hemoglobin (Hb) is well recognized and is correlated with conformational changes of the tetramer, ATP is a major allosteric effector of snake Hbt since the absence of this nucleotide abolishes the Hb cooperativity. This effect may be related to the molecular weight of about 32,000 for this Hb, which is compatible with the dimeric form. ATP induces a pH-dependent tetramerization of deoxyHb that leads to the recovery of cooperativity, This phenomenon may be partially explained by two amino acid replacements in the beta chains (CD2 Glu-43 --> Thr and G3 Glu-101 --> Val), which result in the loss of two negative charges at the alpha(1)beta(2) interface and favors the dissociation into dimers, The ATP-dependent dimer <-> tetramer may be physiologically important among ancient animal groups that have similar mutations and display variations in blood pH that are governed by these animals' metabolic state. The enormous loss of free energy of association that accompanies Hb oxygenation, and which is also observed at a much lower intensity in higher vertebrate Hbs, must be taken into consideration in allosteric models. We propose that the transition from a myoglobin-like protein to an allosteric one may be of evolutionary significance.	Univ Estadual Campinas, Inst Biol, Dept Bioquim, BR-13083970 Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Matsuura, MSA (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Bioquim, BR-13083970 Campinas, SP, Brazil.							ABBASI A, 1991, BIOL CHEM H-S, V372, P473, DOI 10.1515/bchm3.1991.372.2.473; ABBASI A, 1988, BIOL CHEM H-S, V369, P755, DOI 10.1515/bchm3.1988.369.2.755; ANTONINI E, 1964, J BIOL CHEM, V239, P907; ANTONINI E, 1971, N HOLLAND RES MONOGR, V21, P153; BENESCH RE, 1969, BIOCHEMISTRY-US, V8, P2567, DOI 10.1021/bi00834a046; BRIEHL RW, 1963, J BIOL CHEM, V238, P2361; BRITTAIN T, 1989, COMP BIOCHEM PHYS B, V93, P549, DOI 10.1016/0305-0491(89)90374-X; BRUNORI M, 1964, J BIOL CHEM, V239, P2340; BRUNORI M, 1969, BIOCHEMISTRY-US, V8, P2880, DOI 10.1021/bi00835a028; Clark W. M., 1960, OXIDATION REDUCTION; GORR T, 1991, BIOL CHEM H-S, V372, P599, DOI 10.1515/bchm3.1991.372.2.599; HEWITT JA, 1972, P NATL ACAD SCI USA, V69, P203, DOI 10.1073/pnas.69.1.203; KILMARTIN JV, 1973, BIOCHEM J, V133, P725, DOI 10.1042/bj1330725; MALAN A, 1976, RESP PHYSIOL, V28, P29, DOI 10.1016/0034-5687(76)90083-9; MARUYAMA T, 1980, J BIOL CHEM, V255, P3285; MATSUURA MSA, 1987, COMP BIOCHEM PHYS A, V86, P683, DOI 10.1016/0300-9629(87)90624-4; MATSUURA MSA, 1989, J BIOL CHEM, V264, P5515; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Perutz M. F., 1970, NATURE, V228, P734; PERUTZ MF, 1983, MOL BIOL EVOL, V1, P1; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; Riggs A., 1981, Methods in Enzymology, V76, P5; RIGGS AF, 1956, J GEN PHYSIOL, V39, P585, DOI 10.1085/jgp.39.4.585; ROSSIFANELLI A, 1958, ARCH BIOCHEM BIOPHYS, V77, P428; RUCKNAGEL KP, 1988, BIOL CHEM H-S, V369, P1143, DOI 10.1515/bchm3.1988.369.2.1143; SANTUCCI R, 1984, BIOCHIM BIOPHYS ACTA, V789, P20, DOI 10.1016/0167-4838(84)90055-4; Stinner JN, 1996, J EXP BIOL, V199, P815; WEBER G, 1984, P NATL ACAD SCI-BIOL, V81, P7098, DOI 10.1073/pnas.81.22.7098; WEBER RE, 1988, AANN REV PHYSL, V50, P181; WLD G, 1951, J GEN PHYSIOL, V24, P1269; WOOD SC, 1980, AM ZOOL, V20, P163	31	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1196	1198		10.1074/jbc.274.3.1196	http://dx.doi.org/10.1074/jbc.274.3.1196			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880485	hybrid			2022-12-27	WOS:000079956900005
J	Chapman-Smith, A; Morris, TW; Wallace, JC; Cronan, JE				Chapman-Smith, A; Morris, TW; Wallace, JC; Cronan, JE			Molecular recognition in a post-translational modification of exceptional specificity - Mutants of the biotinylated domain of acetyl-CoA carboxylase defective in recognition by biotin protein ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE MULTIENZYME COMPLEX; ACYL CARRIER PROTEIN; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; POSTTRANSLATIONAL MODIFICATION; LIPOYL DOMAIN; 3-DIMENSIONAL STRUCTURE; H-PROTEIN; PURIFICATION; SUBUNIT	We have used localized mutagenesis of the biotin domain of the Escherichia coli biotin carboxyl carrier protein coupled with a genetic selection to identify regions of the domain having a role in interactions with the modifying enzyme, biotin protein ligase, We purified several singly substituted mutant biotin domains that showed reduced biotinylation in vivo and characterized these proteins in vitro. This approach has allowed us to distinguish putative biotin protein ligase interaction mutations from structurally defective proteins. Two mutant proteins with glutamate to lysine substitutions (at residues 119 or 147) behaved as authentic ligase interaction mutants. The E119K protein was virtually inactive as a substrate for biotin protein ligase, whereas the E147K protein could be biotinylated, albeit poorly. Neither substitution affected the overall structure of the domain, assayed by disulfide dimer formation and trypsin resistance. Substitutions of the highly conserved glycine residues at positions 133 and 143 or at a key hydrophobic core residue, Val-146, gave structurally unstable proteins.	Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, Urbana, IL 61801 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Univ Adelaide, Dept Biochem, Adelaide, SA 5005, Australia	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Adelaide	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.		Cronan, John/V-6626-2019; , John/AAP-5150-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER; NIAID NIH HHS [AI15650] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Athappilly FK, 1995, STRUCTURE, V3, P1407, DOI 10.1016/S0969-2126(01)00277-5; BROSIUS J, 1984, P NATL ACAD SCI-BIOL, V81, P6929, DOI 10.1073/pnas.81.22.6929; CHAMBERS SP, 1988, GENE, V68, P139, DOI 10.1016/0378-1119(88)90606-3; ChapmanSmith A, 1997, J BIOL CHEM, V272, P26017, DOI 10.1074/jbc.272.41.26017; CHAPMANSMITH A, 1994, BIOCHEM J, V302, P881, DOI 10.1042/bj3020881; CRONAN JE, 1995, FEMS MICROBIOL LETT, V130, P221, DOI 10.1016/0378-1097(95)00210-V; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; CRONAN JE, 1988, J BIOL CHEM, V263, P10332; DARDEL F, 1993, J MOL BIOL, V229, P1037, DOI 10.1006/jmbi.1993.1103; DAVIS RW, 1980, ADV BACTERIAL GENET, P202; del Campillo-Campbell A, 1979, Methods Enzymol, V62, P379; Fontana A, 1997, J MOL BIOL, V266, P223, DOI 10.1006/jmbi.1996.0787; FUJIWARA K, 1991, FEBS LETT, V293, P115, DOI 10.1016/0014-5793(91)81164-4; GRABAU C, 1989, J BIOL CHEM, V264, P12510; GREEN DE, 1995, BIOCHEM J, V309, P853, DOI 10.1042/bj3090853; GREEN JDF, 1995, J MOL BIOL, V248, P328, DOI 10.1006/jmbi.1995.0225; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; KADONAGA JT, 1985, NUCLEIC ACIDS RES, V13, P1733, DOI 10.1093/nar/13.5.1733; KALDERON D, 1982, NUCLEIC ACIDS RES, V10, P5161, DOI 10.1093/nar/10.17.5161; KEATING DH, 1995, J BIOL CHEM, V270, P22229, DOI 10.1074/jbc.270.38.22229; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEE H, 1971, BIOCHIM BIOPHYS ACTA, V242, P519, DOI 10.1016/0005-2744(71)90144-6; LEONDELRIO A, 1995, P NATL ACAD SCI USA, V92, P4626, DOI 10.1073/pnas.92.10.4626; LEONDELRIO A, 1994, J BIOL CHEM, V269, P22964; LI SJ, 1992, J BIOL CHEM, V267, P855; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; MCALLISTER HC, 1966, J BIOL CHEM, V241, P2855; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; Miller JH, 1972, EXPT MOL GENETICS, P201; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; MORRIS TW, 1994, THESIS U ILLINOIS UR; Nenortas E, 1996, J BIOL CHEM, V271, P7559, DOI 10.1074/jbc.271.13.7559; PARES S, 1994, P NATL ACAD SCI USA, V91, P4850, DOI 10.1073/pnas.91.11.4850; RAWLINGS M, 1992, J BIOL CHEM, V267, P5751; Reche P, 1998, BIOCHEM J, V329, P589, DOI 10.1042/bj3290589; REED KE, 1991, J BIOL CHEM, V266, P11425; ROCK CO, 1980, ANAL BIOCHEM, V102, P362, DOI 10.1016/0003-2697(80)90168-2; Sambrook J., 1982, MOL CLONING LAB MANU, V1; SAMOLS D, 1988, J BIOL CHEM, V263, P6461; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; SHENOY BC, 1992, J BIOL CHEM, V267, P18407; SHENOY BC, 1988, FASEB J, V2, P2505, DOI 10.1096/fasebj.2.9.3131174; WALLIS NG, 1994, J MOL BIOL, V236, P209, DOI 10.1006/jmbi.1994.1130; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; XU Y, 1994, BIOCHEMISTRY-US, V33, P7354, DOI 10.1021/bi00189a041; Yao X, 1997, BIOCHEMISTRY-US, V36, P15089, DOI 10.1021/bi971485f	47	58	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1449	1457		10.1074/jbc.274.3.1449	http://dx.doi.org/10.1074/jbc.274.3.1449			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880519	hybrid			2022-12-27	WOS:000079956900039
J	Forgac, M				Forgac, M			The vacuolar H+-Pase of clathrin-coated vesicles is reversibly inhibited by S-nitrosoglutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; MUTATIONAL ANALYSIS; CYTOPLASMIC PH; NITRIC-OXIDE; SUBUNIT-A; V-ATPASES; PUMP; ACIDIFICATION; (H+)-ATPASE; SYNTHASES	It has been previously demonstrated that the vacuolar H+-ATPase (V-ATPase) of clathrin-coated vesicles is reversibly inhibited by disulfide bond formation between conserved cysteine residues at the catalytic site on the A subunit (Feng, Y., and Forgac, M (1994) J Biol. Chem. 269,13224-13230). Proton transport and ATPase activity of the purified, reconstituted V-ATPase are now shown to be inhibited by the nitric oxide-generating reagent S-nitrosoglutathione (SNG). The K-0.5 for inhibition by SNG following incubation for 30 min at 37 degrees C is 200-400 mu M. As with disulfide bond formation at the catalytic site, inhibition by SNG is reversed upon treatment with 100 mM dithiothreitol and is partially protected in the presence of ATP. Also as with disulfide bond formation, treatment of the V-ATPase with SNG protects activity from subsequent inactivation by N-ethylmaleimide, as demonstrated by restoration of activity by dithiothreitol following sequential treatment of the V-ATPase with SNG and N-ethylmaleimide. Moreover, inhibition by SNG is readily reversed by dithiothreitol but not by the reduced form of glutathione, suggesting that the disulfide bond formed at the catalytic site of the V-ATPase may not be immediately reduced under intracellular conditions. These results suggest that SNG inhibits the V-ATPase through disulfide bond formation between cysteine residues at the catalytic site and that nitric oxide (or nitrosothiols) might act as a negative regulator of V-ATPase activity in vivo.	Tufts Univ, Sch Med, Dept Cellular & Mol Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Cellular & Mol Physiol, 136 Harrison Ave, Boston, MA 02111 USA.				NIDDK NIH HHS [DK34928] Funding Source: Medline; NIGMS NIH HHS [R01 GM034478, GM 34478] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI I, 1990, J BIOL CHEM, V265, P967; Allison WS, 1996, J BIOENERG BIOMEMBR, V28, P433, DOI 10.1007/BF02113985; ANRAKU Y, 1992, J BIOENERG BIOMEMBR, V24, P395, DOI 10.1007/BF00762532; ARAI H, 1987, BIOCHEMISTRY-US, V26, P6632, DOI 10.1021/bi00395a011; ARAI H, 1988, J BIOL CHEM, V263, P8796; BOWMAN BJ, 1992, J BIOENERG BIOMEMBR, V24, P361, DOI 10.1007/BF00762529; Capaldi RA, 1996, J BIOENERG BIOMEMBR, V28, P397, DOI 10.1007/BF02113980; CHATTERJEE D, 1992, P NATL ACAD SCI USA, V89, P6257, DOI 10.1073/pnas.89.14.6257; Cross RL, 1996, J BIOENERG BIOMEMBR, V28, P403, DOI 10.1007/BF02113981; DSCHIDA WJA, 1995, J BIOL CHEM, V270, P1557, DOI 10.1074/jbc.270.4.1557; FENG Y, 1992, J BIOL CHEM, V267, P5817; FENG Y, 1992, J BIOL CHEM, V267, P19769; FENG Y, 1994, J BIOL CHEM, V269, P13224; Fillingame RH, 1997, J EXP BIOL, V200, P217; FORGAC M, 1992, J BIOENERG BIOMEMBR, V24, P341, DOI 10.1007/BF00762527; Futai M, 1996, J BIOENERG BIOMEMBR, V28, P409, DOI 10.1007/BF02113982; GLUCK SL, 1992, J BIOENERG BIOMEMBR, V24, P351, DOI 10.1007/BF00762528; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; JANSEN A, 1992, J PHARMACOL EXP THER, V261, P154; KANE PM, 1992, J BIOENERG BIOMEMBR, V24, P383, DOI 10.1007/BF00762531; KIBAK H, 1992, J BIOENERG BIOMEMBR, V24, P415, DOI 10.1007/BF00762534; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; MULBERG AE, 1991, J BIOL CHEM, V266, P20590; NELSON N, 1992, J BIOENERG BIOMEMBR, V24, P407, DOI 10.1007/BF00762533; Oluwatosin YE, 1997, J BIOL CHEM, V272, P28149, DOI 10.1074/jbc.272.44.28149; Pedersen PL, 1996, J BIOENERG BIOMEMBR, V28, P389, DOI 10.1007/BF02113979; SHINUKI K, 1991, NATURE, V349, P326; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SWALLOW CJ, 1991, J EXP MED, V174, P1009, DOI 10.1084/jem.174.5.1009; SWALLOW CJ, 1990, J BIOL CHEM, V265, P7645; SZE H, 1992, J BIOENERG BIOMEMBR, V24, P371, DOI 10.1007/BF00762530; TOJO A, 1994, AM J PHYSIOL-RENAL, V267, pF509, DOI 10.1152/ajprenal.1994.267.4.F509; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; WIECZOREK H, 1991, J BIOL CHEM, V266, P15340; ZHANG JM, 1995, J BIOL CHEM, V270, P15494, DOI 10.1074/jbc.270.26.15494	38	48	48	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1301	1305		10.1074/jbc.274.3.1301	http://dx.doi.org/10.1074/jbc.274.3.1301			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880499	hybrid			2022-12-27	WOS:000079956900019
J	Hughes, FJ; Buttery, LDK; Hukkanen, MVJ; O'Donnell, A; Maclouf, J; Polak, JM				Hughes, FJ; Buttery, LDK; Hukkanen, MVJ; O'Donnell, A; Maclouf, J; Polak, JM			Cytokine-induced prostaglandin E-2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-FORMATION INVITRO; CELL-LINE MC3T3-E1; ALKALINE-PHOSPHATASE; FUNCTIONAL-ROLE; SYNTHASE; RESORPTION; INTERLEUKIN-1-BETA; INHIBITION; EXPRESSION; MOUSE	Osteoblasts respond to stimulation with interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-alpha), and interferon-gamma (IFN-gamma) by production of nitric oxide and prostaglandins (PGs), In this study the relationship between nitric oxide and PG synthesis was investigated after cytokine stimulation of cultured rat osteoblasts. IL-1, TNF-alpha, IFN-gamma, and exogenous sodium nitroprusside, a nitric oxide donor, all stimulated PGE(2) production in a dose-dependent manner. PGE(2) production was blocked-by L-nitro-arginine methyl ester, an inhibitor of nitric oxide production, after IFN-gamma stimulation and was partially blocked after TNF-alpha stimulation. However, IL-1-induced PGE(2) was unaffected. Similarly, expression of the cyclooxygenase-2 protein was stimulated by cytokines, and IFN-gamma-induced expression was again blocked by L-nitro-arginine methyl ester, In contrast, all cytokines induced the cyclooxygenase-2 mRNA expression independently of nitric oxide production, although exogenous sodium nitroprusside was able to induce the cyclooxygenase-a mRNA in the absence of cytokines, The results show that nitric oxide can induce PG synthesis and cyclooxygenase 2 expression and may regulate cyclooxygenase-a expression at both transcriptional and post-transcriptional levels. In addition, the data show the existence of both nitric oxide-dependent and -independent pathways of PG synthesis after cytokine stimulation of osteoblasts. The results suggest that nitric oxide may be an important mediator of PG production in inflammatory bone diseases.	Imperial Coll Sch Med, Dept Histochem, London W12 0NN, England; St Bartholomews & Royal London Sch Med & Dent, Fac Clin Dent, Dept Periodontol, London E1, England; Hop Lariboisiere, INSERM, U384, F-75475 Paris, France	Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Buttery, LDK (corresponding author), Imperial Coll Sch Med, Dept Histochem, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.		Buttery, Lee/C-5627-2015	Buttery, Lee/0000-0003-3808-6770; Hughes, Francis/0000-0001-9073-8962; Hukkanen, Mika/0000-0001-9687-9571				AKATSU T, 1991, J BONE MINER RES, V6, P183; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0; BRANDI ML, 1995, P NATL ACAD SCI USA, V92, P2954, DOI 10.1073/pnas.92.7.2954; DAMOULIS PD, 1994, BIOCHEM BIOPH RES CO, V201, P924, DOI 10.1006/bbrc.1994.1790; DAVIDGE ST, 1995, CIRC RES, V77, P274, DOI 10.1161/01.RES.77.2.274; DEBRUMFERNANDES AJ, 1994, BIOCHEM BIOPH RES CO, V198, P955, DOI 10.1006/bbrc.1994.1136; ELLIES L G, 1990, Cytokine, V2, P430, DOI 10.1016/1043-4666(90)90052-U; EVANS DB, 1990, BIOCHEM BIOPH RES CO, V166, P208, DOI 10.1016/0006-291X(90)91932-I; EVANS DB, 1990, BIOCHEM BIOPH RES CO, V167, P194, DOI 10.1016/0006-291X(90)91750-M; FRANCHI AM, 1994, P NATL ACAD SCI USA, V91, P539, DOI 10.1073/pnas.91.2.539; GOWEN M, 1986, J BONE MINER RES, V1, P469; GOWEN M, 1983, NATURE, V306, P378, DOI 10.1038/306378a0; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; HABIB A, 1993, J BIOL CHEM, V268, P23448; HANAZAWA S, 1986, FEBS LETT, V203, P279, DOI 10.1016/0014-5793(86)80758-X; HUKKANEN M, 1995, ENDOCRINOLOGY, V136, P5445, DOI 10.1210/en.136.12.5445; IKEDA E, 1988, CALCIFIED TISSUE INT, V43, P162, DOI 10.1007/BF02571314; KAWAGUCHI H, 1994, ENDOCR RES, V20, P219, DOI 10.1080/07435809409035860; KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822; LOWIK CW, 1990, J CLIN INVEST, V93, P1465; MACINTYRE I, 1991, P NATL ACAD SCI USA, V88, P2936, DOI 10.1073/pnas.88.7.2936; MILANO S, 1995, PROSTAG OTH LIPID M, V49, P105, DOI 10.1016/0090-6980(94)00004-G; OHMORI Y, 1988, BIOCHIM BIOPHYS ACTA, V970, P22, DOI 10.1016/0167-4889(88)90218-2; Pitsillides AA, 1995, FASEB J, V9, P1614, DOI 10.1096/fasebj.9.15.8529841; RAISZ LG, 1984, BONE MINERAL RES ANN, V2, P286; RALSTON SH, 1994, ENDOCRINOLOGY, V135, P330, DOI 10.1210/en.135.1.330; Ralston SH, 1996, BONE, V19, P29, DOI 10.1016/8756-3282(96)00101-9; RIANCHO JA, 1995, J BONE MINER RES, V10, P439; RIANCHO JA, 1995, MOL CELL ENDOCRINOL, V107, P87, DOI 10.1016/0303-7207(94)03428-V; SAITO S, 1991, J DENT RES, V70, P27, DOI 10.1177/00220345910700010401; SALVEMINI D, 1994, J CLIN INVEST, V93, P1940, DOI 10.1172/JCI117185; SALVEMINI D, 1995, J CLIN INVEST, V96, P301, DOI 10.1172/JCI118035; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; SMITH DD, 1987, ENDOCRINOLOGY, V120, P2494, DOI 10.1210/endo-120-6-2494; STASHENKO P, 1987, J BONE MINER RES, V2, P559; TAICHMAN RS, 1992, INFLAMMATION, V16, P587, DOI 10.1007/BF00919342; TETSUKA T, 1994, P NATL ACAD SCI USA, V91, P12168, DOI 10.1073/pnas.91.25.12168; THOMSON BM, 1986, J EXP MED, V164, P104, DOI 10.1084/jem.164.1.104; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167; YONEDA T, 1994, CELLULAR MOL BIOL BO, P376	42	94	99	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1776	1782		10.1074/jbc.274.3.1776	http://dx.doi.org/10.1074/jbc.274.3.1776			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880560	hybrid			2022-12-27	WOS:000079956900080
J	Tjalsma, H; Kontinen, VP; Pragai, Z; Wu, HY; Meima, R; Venema, G; Bron, S; Sarvas, M; van Dijl, JM				Tjalsma, H; Kontinen, VP; Pragai, Z; Wu, HY; Meima, R; Venema, G; Bron, S; Sarvas, M; van Dijl, JM			The role of lipoprotein processing by signal peptidase II in the Gram-positive eubacterium Bacillus subtilis - Signal peptidase II is required for the efficient secretion of alpha-amylase, a non-lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPORALLY CONTROLLED EXPRESSION; OUTER-MEMBRANE LIPOPROTEIN; SPORE GERMINATION GENE; ESCHERICHIA-COLI; PROTEIN EXPORT; MODIFICATION SITE; TRANSPORT-SYSTEM; IDENTIFICATION; SPORULATION; SEQUENCE	Computer-assisted analyses indicate that Bacillus subtilis contains approximately 300 genes for exported proteins with an amino-terminal signal peptide. About 114 of these are lipoproteins, which are retained in the cytoplasmic membrane. We have investigated the importance of lipoprotein processing by signal peptidase II (SPase II) for cellular homeostasis, using cells lacking SPase II. The results show that lipoprotein processing is important for cell viability at low and high temperatures, suggesting that lipoproteins are essential for growth under these conditions. Although certain lipoproteins are required for the development of genetic competence, sporulation, and germination, these developmental processes were not affected in the absence of SPase II. Cells lacking SPase II accumulated lipid-modified precursor and mature-like forms of PrsA, a folding catalyst for secreted proteins. These forms of PrsA seem to have a reduced activity, as the secretion of alpha-amylase was strongly impaired. Unexpectedly, type I signal peptidases, which process secretory preproteins, were not involved in alternative amino-terminal processing of pre-PrsA in the absence of SPase II. In conclusion, processing of Lipoproteins by SPase II in B, subtilis is not strictly required for lipoprotein function, which is surprising as lipoproteins and type II SPases seem to be conserved in all eubacteria.	Univ Groningen, Dept Pharmaceut Biol, NL-9713 AV Groningen, Netherlands; Groningen Biomol Sci & Biotechnol Inst, Dept Genet, NL-9751 NN Haren, Netherlands; Natl Publ Hlth Inst, Vaccine Dev Lab, SF-00300 Helsinki, Finland; Univ Newcastle Upon Tyne, Sch Med, Dept Microbiol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Groningen; University of Groningen; Finland National Institute for Health & Welfare; Newcastle University - UK	van Dijl, JM (corresponding author), Univ Groningen, Dept Pharmaceut Biol, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.		Tjalsma, Harold/I-7146-2012; Kontinen, Vesa P/A-2260-2012; van Dijl, Jan Maarten/G-1205-2013					Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bolhuis A, 1996, MOL MICROBIOL, V22, P605, DOI 10.1046/j.1365-2958.1996.d01-4676.x; Bolhuis A, 1998, J BIOL CHEM, V273, P21217, DOI 10.1074/jbc.273.33.21217; BRON S, 1972, MUTAT RES, V15, P1, DOI 10.1016/0027-5107(72)90086-3; CORFE BM, 1994, MICROBIOL-UK, V140, P471, DOI 10.1099/00221287-140-3-471; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; Dartois V, 1997, MOL MICROBIOL, V26, P1097, DOI 10.1046/j.1365-2958.1997.6542024.x; Duong F, 1997, CELL, V91, P567, DOI 10.1016/S0092-8674(00)80444-4; ERRINGTON J, 1992, J GEN MICROBIOL, V138, P2609, DOI 10.1099/00221287-138-12-2609; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; GIAM CZ, 1984, EUR J BIOCHEM, V141, P331, DOI 10.1111/j.1432-1033.1984.tb08196.x; HASTRUP S, 1990, GENETICS BIOTECHNOLO, P33; HAYASHI S, 1984, J BIOL CHEM, V259, P448; HAYASHI S, 1983, J BACTERIOL, V156, P773, DOI 10.1128/JB.156.2.773-777.1983; HAYASHI S, 1986, J BACTERIOL, V165, P678, DOI 10.1128/jb.165.3.678-681.1986; INUKAI M, 1978, J ANTIBIOT, V31, P1203, DOI 10.7164/antibiotics.31.1203; JACOBS M, 1993, MOL MICROBIOL, V8, P957, DOI 10.1111/j.1365-2958.1993.tb01640.x; KEMP EH, 1991, J BACTERIOL, V173, P4646, DOI 10.1128/jb.173.15.4646-4652.1991; KOIDE A, 1994, MOL MICROBIOL, V13, P417, DOI 10.1111/j.1365-2958.1994.tb00436.x; KONST F, 1997, NATURE, V390, P249; KONTINEN VP, 1993, MOL MICROBIOL, V8, P727, DOI 10.1111/j.1365-2958.1993.tb01616.x; KONTINEN VP, 1991, MOL MICROBIOL, V5, P1273, DOI 10.1111/j.1365-2958.1991.tb01901.x; KONTINEN VP, 1988, J GEN MICROBIOL, V134, P2333; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; MATHIOPOULOS C, 1991, MOL MICROBIOL, V5, P1903, DOI 10.1111/j.1365-2958.1991.tb00814.x; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; Matsuyama S, 1997, EMBO J, V16, P6947, DOI 10.1093/emboj/16.23.6947; Miller J. H., 1982, EXPT MOL GENETICS; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; PALVA I, 1982, GENE, V19, P81, DOI 10.1016/0378-1119(82)90191-3; POGLIANO KJ, 1993, GENETICS, V133, P763; POQUET I, 1993, MOL MICROBIOL, V9, P1061, DOI 10.1111/j.1365-2958.1993.tb01235.x; Pragai Z, 1997, MICROBIOL-UK, V143, P1327, DOI 10.1099/00221287-143-4-1327; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Sambrook J., 2002, MOL CLONING LAB MANU; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; SANKARAN K, 1994, SIGNAL PEPTIDASES, P17; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; SLYNN GM, 1994, FEMS MICROBIOL LETT, V121, P315, DOI 10.1016/0378-1097(94)90310-7; SUTCLIFFE IC, 1995, J BACTERIOL, V177, P1123, DOI 10.1128/jb.177.5.1123-1128.1995; Tjalsma H, 1997, J BIOL CHEM, V272, P25983, DOI 10.1074/jbc.272.41.25983; Tjalsma H, 1998, GENE DEV, V12, P2318, DOI 10.1101/gad.12.15.2318; TOKUNAGA M, 1982, P NATL ACAD SCI USA, V79, P2253; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; VANDIJL JM, 1991, MOL GEN GENET, V227, P40, DOI 10.1007/BF00260704; VANDIJL JM, 1992, EMBO J, V11, P2819, DOI 10.1002/j.1460-2075.1992.tb05349.x; VANDIJL JM, 1995, J BIOL CHEM, V270, P3611, DOI 10.1074/jbc.270.8.3611; VANDIJL JM, 1991, J GEN MICROBIOL, V137, P2073, DOI 10.1099/00221287-137-9-2073; VANHOY BE, 1990, J BACTERIOL, V172, P1306, DOI 10.1128/jb.172.3.1306-1311.1990; VONHEIJNE G, 1989, PROTEIN ENG, V2, P531, DOI 10.1093/protein/2.7.531; WERTMAN KF, 1986, GENE, V49, P253, DOI 10.1016/0378-1119(86)90286-6; WU HC, 1986, CURR TOP MICROBIOL, V125, P127; YAMAGATA H, 1982, J BACTERIOL, V152, P1163; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6; Yamane K, 1996, MICROBIOL-SGM, V142, P3047, DOI 10.1099/13500872-142-11-3047; YANSURA DG, 1984, GENETICS BIOCH BACIL, P249; ZUBERI AR, 1987, GENE, V51, P1, DOI 10.1016/0378-1119(87)90468-9	59	104	115	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1698	1707		10.1074/jbc.274.3.1698	http://dx.doi.org/10.1074/jbc.274.3.1698			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880550	hybrid			2022-12-27	WOS:000079956900070
J	Hsu, PY; Tsai, AL; Kulmacz, RJ; Wang, LH				Hsu, PY; Tsai, AL; Kulmacz, RJ; Wang, LH			Expression, purification, and spectroscopic characterization of human thromboxane synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; FERRIC CYTOCHROME P-450-CAM; MAGNETIC CIRCULAR-DICHROISM; ESCHERICHIA-COLI; LIGAND COMPLEXES; HUMAN-PLATELETS; ENZYME; INHIBITORS; SEQUENCE; CHLOROPEROXIDASE	Thromboxane A(2) (TXA(2)) is a potent inducer of vasoconstriction and platelet aggregation. Large scale expression of TXA(2) synthase (TXAS) is very useful for studies of the reaction mechanism, structural/functional relationships, and drug interactions. We report here a heterologous system for overexpression of human TXAS. The TXAS cDNA was modified by replacing the sequence encoding the first 28 amino acid residues with a CYP17 amino-terminal sequence and by adding a polyhistidine tag sequence prior to the stop codon; the cDNA was inserted into the pCW vector and co-expressed with chaperonins groES and groEL in Escherichia coli. The resulting recombinant protein was purified to electrophoretic homogeneity by affinity, ion exchange, and hydrophobic chromatography. UV-visible absorbance (UV-Vis), magnetic circular dichroism (MCD), and electron paramagnetic resonance (EPR) spectra indicate that TXAS has a typical low spin cytochrome P450 heme with an oxygen-based distal ligand. The UV-Vis and EPR spectra of recombinant TXAS were essentially identical to those of TXAS isolated from human platelets, except that a more homogenous EPR spectrum was observed for the recombinant TXAS. The recombinant protein had a heme:protein molar ratio of 0.7:1 and a specific activity of 12 mu mol of TXA(2)/min/mg of protein at 23 degrees C. Furthermore, it catalyzed formation of TXA(2), 12-hydroxy-5,8,10-heptadecatrienoic acid, and malondialdehyde in a molar ratio of 0.94:1.0:0.93. Spectral binding titrations showed that bulky heme ligands such as clotrimazole bound strongly to TXAS (K-d similar to 0.5 mu M), indicating ample space at the distal face of the heme iron, Analysis of MCD and EPR spectra showed that TXAS was a typical low spin hemoprotein with a proximal thiolate ligand and had a very hydrophobic distal ligand binding domain.	Univ Texas, Ctr Hlth Sci, Div Hematol, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Wang, LH (corresponding author), Univ Texas, Ctr Hlth Sci, Div Hematol, Dept Internal Med, 6431 Fannin, Houston, TX 77030 USA.	lhwang@heart.med.uth.tmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023327] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-44911] Funding Source: Medline; NINDS NIH HHS [NS-23327] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Berka V, 1996, J BIOL CHEM, V271, P33293, DOI 10.1074/jbc.271.52.33293; Berka V, 1998, BIOCHEMISTRY-US, V37, P6136, DOI 10.1021/bi980133l; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Blumberg WE, 1971, PROBES STRUCTURE FUN, V2, P215; CHAUDHARY AK, 1994, SCIENCE, V265, P1580, DOI 10.1126/science.8079172; DAWSON JH, 1982, J BIOL CHEM, V257, P3606; DAWSON VL, 1989, SOC COGNITION, V7, P1, DOI 10.1521/soco.1989.7.1.1; GEGNER JA, 1991, P NATL ACAD SCI USA, V88, P750, DOI 10.1073/pnas.88.3.750; GILLAM EMJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P123, DOI 10.1006/abbi.1993.1401; GONZALEZ FJ, 1995, ANNU REV PHARMACOL, V35, P369, DOI 10.1146/annurev.pa.35.040195.002101; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; HAURAND M, 1985, J BIOL CHEM, V260, P5059; HECKER M, 1987, ARCH BIOCHEM BIOPHYS, V254, P124, DOI 10.1016/0003-9861(87)90088-9; HECKER M, 1989, J BIOL CHEM, V264, P141; HECKER M, 1986, EUR J BIOCHEM, V157, P217, DOI 10.1111/j.1432-1033.1986.tb09659.x; HOLMQUIS.B, 1973, BIOCHEMISTRY-US, V12, P4409, DOI 10.1021/bi00746a018; IMAI T, 1993, J BIOL CHEM, V268, P19681; JONES DA, 1991, J BIOL CHEM, V266, P23510; KULMACZ RJ, 1990, BIOCHEMISTRY-US, V29, P8760, DOI 10.1021/bi00489a037; MAJERUS PW, 1983, J CLIN INVEST, V72, P1521, DOI 10.1172/JCI111110; MANLEY PW, 1987, J MED CHEM, V30, P1588, DOI 10.1021/jm00392a011; NUSING R, 1990, ARCH BIOCHEM BIOPHYS, V280, P325, DOI 10.1016/0003-9861(90)90337-X; OHASHI K, 1992, J BIOL CHEM, V267, P789; Okamoto N, 1997, ARCH BIOCHEM BIOPHYS, V337, P338, DOI 10.1006/abbi.1996.9786; RICHARDSON TH, 1993, ARCH BIOCHEM BIOPHYS, V300, P510, DOI 10.1006/abbi.1993.1069; RICHARDSON TH, 1995, ARCH BIOCHEM BIOPHYS, V323, P87, DOI 10.1006/abbi.1995.0013; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; RUAN KH, 1993, J BIOL CHEM, V268, P19483; SANDHU P, 1994, ARCH BIOCHEM BIOPHYS, V309, P168, DOI 10.1006/abbi.1994.1099; SHEN RF, 1994, GENE, V140, P261, DOI 10.1016/0378-1119(94)90555-X; SHEN RF, 1986, J BIOL CHEM, V261, P1592; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SONO M, 1982, J BIOL CHEM, V257, P5496; SONO M, 1995, J BIOL CHEM, V270, P19943, DOI 10.1074/jbc.270.34.19943; SONO M, 1991, BIOCHIM BIOPHYS ACTA, V1078, P351, DOI 10.1016/0167-4838(91)90156-T; TAI HH, 1980, ARCH BIOCHEM BIOPHYS, V203, P758, DOI 10.1016/0003-9861(80)90236-2; TANOUCHI T, 1981, J MED CHEM, V24, P1149, DOI 10.1021/jm00142a006; TONE Y, 1994, FEBS LETT, V340, P241, DOI 10.1016/0014-5793(94)80146-0; Tsai AL, 1996, J BIOL CHEM, V271, P32563, DOI 10.1074/jbc.271.51.32563; VICKERY LE, 1978, METHOD ENZYMOL, V65, P284; Waterman MR, 1995, TOXICOL LETT, V82-3, P807, DOI 10.1016/0378-4274(95)03597-4; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531; WU KK, 1981, J CLIN INVEST, V67, P1801, DOI 10.1172/JCI110221; XIA ZN, 1995, ARCH BIOCHEM BIOPHYS, V321, P531, DOI 10.1006/abbi.1995.1427; YASUKAWA T, 1995, J BIOL CHEM, V270, P25328, DOI 10.1074/jbc.270.43.25328; YOKAYAMA C, 1991, BIOCHEM BIOPH RES CO, V178, P1479; YOKOYAMA C, 1993, FEBS LETT, V318, P91, DOI 10.1016/0014-5793(93)81335-W; ZHANG LQ, 1993, BIOCHEM BIOPH RES CO, V194, P741, DOI 10.1006/bbrc.1993.1884	49	36	37	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					762	769		10.1074/jbc.274.2.762	http://dx.doi.org/10.1074/jbc.274.2.762			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873013	hybrid			2022-12-27	WOS:000077968500028
J	Ohmitsu, M; Fukunaga, K; Yamamoto, H; Miyamoto, E				Ohmitsu, M; Fukunaga, K; Yamamoto, H; Miyamoto, E			Phosphorylation of myristoylated alanine-rich protein kinase C substrate by mitogen-activated protein kinase in cultured rat hippocampal neurons following stimulation of glutamate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; CEREBELLAR GRANULE CELLS; GROWTH-FACTORS; TYROSINE PHOSPHORYLATION; CELLULAR SUBSTRATE; BRAIN SYNAPTOSOMES; PYRAMIDAL NEURONS; PLASMA-MEMBRANE; PHORBOL ESTERS; ACTIN FILAMENT	Glutamate induced phosphorylation of myristoylated alanine-rich protein kinase C substrate (MARCKS) was investigated in cultured rat hippocampal neurons. In P-32-labeled hippocampal neurons, exposure to 10 mu M glutamate induced a long lasting increase in phosphorylation of MARCKS, The long lasting increase in MARCKS phosphorylation mainly required activation of the N-methyl-D-aspartate receptor. Unexpectatively, the MARCKS phosphorylation after the 10-min incubation with glutamate was not inhibited by treatment with calphostin C, a potent inhibitor for protein kinase C (PKC), or down-regulation of PKC but was largely prevented by PD098059, a selective inhibitor for mitogen-activated protein (MAP) kinase kinase. In contrast, the phosphorylation following the short exposure to glutamate was prevented by a combination of PD098059 and calphostin C. The phosphopeptide mapping and immunoblotting analyses confirmed that PKC-dependent phosphorylation of MARCKS was transient and the MAP kinase-dependent phosphorylation was relatively persistent. Investigations of the functional properties also showed that the MARCKS phosphorylation by MAP kinase regulates its calmodulin-binding ability and its interaction with F-actin as seen in the PKC-dependent phosphorylation. These results suggest that glutamate causes a long lasting increase in MARCKS phosphorylation through activation of the N-methyl-D-aspartate receptor and subsequent activation of MAP kinase in the hippocampal neurons.	Kumamoto Univ, Sch Med, Dept Pharmacol, Kumamoto 8600811, Japan	Kumamoto University	Fukunaga, K (corresponding author), Kumamoto Univ, Sch Med, Dept Pharmacol, 2-2-1 Honjo, Kumamoto 8600811, Japan.							ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; ADEREM AA, 1988, NATURE, V332, P362, DOI 10.1038/332362a0; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; BLACKSHEAR PJ, 1986, J BIOL CHEM, V261, P1459; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang S, 1996, J BIOL CHEM, V271, P1174, DOI 10.1074/jbc.271.2.1174; CREUZET C, 1995, J NEUROCHEM, V64, P1541; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; FUKUNAGA K, 1989, J BIOL CHEM, V264, P21830; FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119, DOI 10.1074/jbc.270.11.6119; Goodall AR, 1997, J NEUROCHEM, V68, P392; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; GRAHAM ME, 1993, EUR J NEUROSCI, V5, P575, DOI 10.1111/j.1460-9568.1993.tb00523.x; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HEEMSKERK FMJ, 1993, BIOCHEM BIOPH RES CO, V190, P236, DOI 10.1006/bbrc.1993.1036; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; HERGET T, 1992, EUR J BIOCHEM, V209, P7, DOI 10.1111/j.1432-1033.1992.tb17255.x; HISANAGA S, 1993, J BIOL CHEM, V268, P15056; HOSOI T, 1995, J BIOCHEM, V117, P741, DOI 10.1093/oxfordjournals.jbchem.a124771; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; KIM JY, 1994, BIOPHYS J, V67, P227, DOI 10.1016/S0006-3495(94)80473-4; KURINO M, 1995, J NEUROCHEM, V65, P1282; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI JX, 1992, CELL, V70, P791, DOI 10.1016/0092-8674(92)90312-Z; Marsh HN, 1996, J NEUROCHEM, V67, P952; McNamara RK, 1997, J COMP NEUROL, V379, P48; MORIOKA M, 1995, J NEUROCHEM, V64, P2132; Muller U, 1997, BRAIN RES, V757, P24, DOI 10.1016/S0006-8993(96)01435-7; NAIRN AC, 1992, CIBA F SYMP, V164, P145; NICHOLS RA, 1987, J NEUROCHEM, V48, P615, DOI 10.1111/j.1471-4159.1987.tb04137.x; OUIMET CC, 1990, J NEUROSCI, V10, P1683; PATEL J, 1987, J BIOL CHEM, V262, P16686; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; SCHOLZ WK, 1991, J NEUROSCI, V11, P2422; Schonwasser DC, 1996, FEBS LETT, V395, P1; Seki K, 1996, ARCH BIOCHEM BIOPHYS, V326, P193, DOI 10.1006/abbi.1996.0065; SHAFFER LM, 1993, DEV BRAIN RES, V73, P133, DOI 10.1016/0165-3806(93)90055-F; Spizz G, 1996, J BIOL CHEM, V271, P553, DOI 10.1074/jbc.271.1.553; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; TANIGUCHI H, 1993, J BIOL CHEM, V268, P9960; TANIGUCHI H, 1994, J BIOL CHEM, V269, P18299; THELEN M, 1990, P NATL ACAD SCI USA, V87, P5603, DOI 10.1073/pnas.87.15.5603; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; TUCKER MS, 1993, J NEUROCHEM, V61, P1376, DOI 10.1111/j.1471-4159.1993.tb13631.x; UMEKAGE T, 1991, FEBS LETT, V286, P147, DOI 10.1016/0014-5793(91)80961-2; WANG JKT, 1989, P NATL ACAD SCI USA, V86, P2253, DOI 10.1073/pnas.86.7.2253; WOOD JG, 1993, NEUROREPORT, V4, P599, DOI 10.1097/00001756-199305000-00036; WOOTEN MW, 1987, EUR J BIOCHEM, V164, P461, DOI 10.1111/j.1432-1033.1987.tb11079.x; WU WCS, 1982, P NATL ACAD SCI-BIOL, V79, P5249, DOI 10.1073/pnas.79.17.5249; YAMAMOTO H, 1995, J NEUROCHEM, V65, P802; Yamauchi E, 1998, J BIOL CHEM, V273, P4367, DOI 10.1074/jbc.273.8.4367	61	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					408	417		10.1074/jbc.274.1.408	http://dx.doi.org/10.1074/jbc.274.1.408			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867858	hybrid			2022-12-27	WOS:000077900200058
J	Foster, KA; Correia, JJ; Gilbert, SP				Foster, KA; Correia, JJ; Gilbert, SP			Equilibrium binding studies of non-claret disjunctional protein (Ncd) reveal cooperative interactions between the motor domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-KINESIN ATPASE; CRYOELECTRON MICROSCOPY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DROSOPHILA; HEAD; SEDIMENTATION; PURIFICATION; MECHANISM; MOVEMENT	Non-claret disjunctional protein (Ncd) is a minus end-directed microtubule motor required for normal spindle assembly and integrity during Drosophila oogenesis. We have pursued equilibrium binding experiments to examine the affinity of Ncd for microtubules in the presence of the ATP nonhydrolyzable analog 5'-adenylyl-beta,gamma-imidodiphosphate (AMP-PNP), ADP, or ADP + P-i using both dimeric (MC1) and monomeric (MC6) Ncd constructs expressed in Escherichia coli. Both MC1 and MC6 sediment with microtubules in the absence of added nucleotide as well as in the presence of either ADP or AMPPNP. Yet, in the presence of ADP + P-i, there is a decrease in the affinity of both MC1 and MC6 for microtubules, The data for dimeric MC1 show that release of the dimer to the supernatant is sigmoidal with the apparent K-d(Pi) for the two phosphate sites at 23.3 and 1.9 parent mM, respectively. The results indicate that binding at the first phosphate site enhances binding at the second site, thus cooperatively stimulating release. Stopped-flow kinetics indicate that MgATP promotes dissociation of the Mt.MC1 complex at 14 s(-1), yet AMP-PNP has no effect on the Mt.MC1 complex. These results are consistent with a model for the ATPase cycle in which ATP hydrolysis occurs on the microtubule followed by detachment as the Ncd.ADP.P-i intermediate.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Mississippi; University of Mississippi Medical Center	Gilbert, SP (corresponding author), Univ Pittsburgh, Dept Biol Sci, 518 Langley Hall, Pittsburgh, PA 15260 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054141, R01GM054141] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054141, GM 54141] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; Arnal I, 1996, CURR BIOL, V6, P1265, DOI 10.1016/S0960-9822(02)70712-4; BERLINER E, 1994, J BIOL CHEM, V269, P8610; BLOOM GS, 1994, PROTEIN PROFILE, V1, P1059; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; CHANDRA R, 1993, J BIOL CHEM, V268, P9005; CORREIA JJ, 1995, BIOCHEMISTRY-US, V34, P4898, DOI 10.1021/bi00014a047; Crevel IMTC, 1996, J MOL BIOL, V257, P66, DOI 10.1006/jmbi.1996.0147; Endow SA, 1997, J CELL BIOL, V137, P1321, DOI 10.1083/jcb.137.6.1321; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; GILBERT SP, 1994, BIOCHEMISTRY-US, V33, P1951, DOI 10.1021/bi00173a044; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HARRISON BC, 1993, NATURE, V362, P73, DOI 10.1038/362073a0; Hirose K, 1996, P NATL ACAD SCI USA, V93, P9539, DOI 10.1073/pnas.93.18.9539; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Hoenger A, 1998, J CELL BIOL, V141, P419, DOI 10.1083/jcb.141.2.419; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEE JC, 1981, J BIOL CHEM, V256, P7193; LOCKHART A, 1995, J MOL BIOL, V249, P763, DOI 10.1006/jmbi.1995.0335; LOCKHART A, 1995, FEBS LETT, V368, P531, DOI 10.1016/0014-5793(95)00723-M; LOCKHART A, 1994, EMBO J, V13, P751, DOI 10.1002/j.1460-2075.1994.tb06317.x; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13242, DOI 10.1021/bi00040a040; Ma YZ, 1997, J BIOL CHEM, V272, P717, DOI 10.1074/jbc.272.2.717; Matthies HJG, 1996, J CELL BIOL, V134, P455, DOI 10.1083/jcb.134.2.455; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; Moore JD, 1996, EMBO J, V15, P3306, DOI 10.1002/j.1460-2075.1996.tb00695.x; Moyer ML, 1996, BIOCHEMISTRY-US, V35, P6321, DOI 10.1021/bi960017n; Moyer ML, 1998, BIOCHEMISTRY-US, V37, P800, DOI 10.1021/bi9711184; Pechatnikova E, 1997, J BIOL CHEM, V272, P30735, DOI 10.1074/jbc.272.49.30735; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; Rosenfeld SS, 1996, J BIOL CHEM, V271, P30212, DOI 10.1074/jbc.271.47.30212; Rosenfeld SS, 1996, J BIOL CHEM, V271, P9473, DOI 10.1074/jbc.271.16.9473; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; SHIMIZU T, 1995, BIOCHEMISTRY-US, V34, P13259, DOI 10.1021/bi00040a042; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; STEWART RJ, 1993, P NATL ACAD SCI USA, V90, P5209, DOI 10.1073/pnas.90.11.5209; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; WONG I, 1992, SCIENCE, V256, P350, DOI 10.1126/science.256.5055.350; YANG JT, 1990, SCIENCE, V249, P42, DOI 10.1126/science.2142332	53	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35307	35318		10.1074/jbc.273.52.35307	http://dx.doi.org/10.1074/jbc.273.52.35307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857072	hybrid			2022-12-27	WOS:000077719700090
J	Jarmuszkiewicz, W; Almeida, AM; Sluse-Goffart, CM; Sluse, FE; Vercesi, AE				Jarmuszkiewicz, W; Almeida, AM; Sluse-Goffart, CM; Sluse, FE; Vercesi, AE			Linoleic acid-induced activity of plant uncoupling mitochondrial protein in purified tomato fruit mitochondria during resting, phosphorylating, and progressively uncoupled respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVE OXIDASE; OXIDATIVE-PHOSPHORYLATION; MECHANISM; TRANSPORT	An uncoupling protein was recently discovered in plant mitochondria and demonstrated to function similarly to the uncoupling protein of brown adipose tissue. In this work, green tomato fruit mitochondria were purified on a self-generating Percoll gradient in the presence of 0.5% bovine serum albumin to deplete mitochondria of endogenous free fatty acids. The uncoupling protein activity was induced by the addition of linoleic acid during the resting state, and in the progressively uncoupled state, as well as during phosphorylating respiration in the presence of benzohydroxamic acid, an inhibitor of the alternative oxidase and with succinate (+ rotenone) as oxidizable substrate. Linoleic acid strongly stimulated the resting respiration in fatty acid-depleted mitochondria but had no effect on phosphorylating respiration, suggesting no activity of the uncoupling protein in this respiratory state. Progressive uncoupling of state 4 respiration decreased the stimulation by linoleic acid. The similar respiratory rates in phosphorylating and fully uncoupled respiration in the presence and absence of linoleic acid suggested that a rate-limiting step on the dehydrogenase side of the respiratory chain was responsible for the insensitivity of phosphorylating respiration to Linoleic acid. Indeed, the ADP/O ratio determined by ADP/O pulse method was decreased by linoleic acid, indicating that uncoupling protein was active during phosphorylating respiration and was able to divert energy from oxidative phosphorylation. Moreover, the respiration rates appeared to be determined by membrane potential independently of the presence of linoleic acid, indicating that linoleic acid-induced stimulation of respiration is due to a pure protonophoric activity without any direct effect on the electron transport chain.	Univ Estadual Campinas, Dept Patol Clin, Fac Ciencias Med, NMCE, BR-13083970 Campinas, SP, Brazil; Adam Mickiewicz Univ, Dept Bioenerget, PL-61701 Poznan, Poland; Univ Liege, Lab Bioenerget, Ctr Oxygen Biochem, Inst Chem B6, B-4000 Liege, Belgium	Universidade Estadual de Campinas; Adam Mickiewicz University; University of Liege	Vercesi, AE (corresponding author), Univ Estadual Campinas, Dept Patol Clin, Fac Ciencias Med, NMCE, CP 6111, BR-13083970 Campinas, SP, Brazil.		Vercesi, Aníbal E/C-8767-2012; de Almeida, Andrea Miyasaka/AAY-7847-2020	Miyasaka Almeida, Andrea/0000-0002-5848-0874; Vercesi, Anibal Eugenio/0000-0001-6671-7125; Jarmuszkiewicz, Wieslawa/0000-0001-8550-8337				CRUZHERNANDEZ A, 1995, PLANTA, V197, P569, DOI 10.1007/BF00191562; DAY DA, 1980, BIOCH PLANTS, V2, P197; Garlid KD, 1996, J BIOL CHEM, V271, P2615, DOI 10.1074/jbc.271.5.2615; Gomall A. G, 1949, J BIOL CHEM, V177, P751; Jarmuszkiewicz W, 1998, J BIOL CHEM, V273, P10174, DOI 10.1074/jbc.273.17.10174; JENSEN BD, 1986, ARCH BIOCHEM BIOPHYS, V248, P305, DOI 10.1016/0003-9861(86)90427-3; Jezek P, 1997, J BIOL CHEM, V272, P24272, DOI 10.1074/jbc.272.39.24272; Jezek P, 1996, J BIOL CHEM, V271, P32743, DOI 10.1074/jbc.271.51.32743; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; KLINGENBERG M, 1990, TRENDS BIOCHEM SCI, V15, P108, DOI 10.1016/0968-0004(90)90194-G; Kramer R, 1996, KIDNEY INT, V49, P947, DOI 10.1038/ki.1996.133; LEE CP, 1989, BIOCHIM BIOPHYS ACTA, V1000, P371, DOI 10.1016/S0006-3002(89)80032-0; Meesue BJD, 1975, ANNU REV PLANT PHYS, V26, P117; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; VANDENBERGEN CWM, 1994, EUR J BIOCHEM, V226, P1071; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; VERCESI A, 1978, J BIOL CHEM, V253, P6379; Vercesi A. E., 1997, Recent Research Developments in Plant Physiology, V1, P85; VERCESI AE, 1995, NATURE, V375, P24, DOI 10.1038/375024a0; Wagner AM, 1997, BIOSCIENCE REP, V17, P319, DOI 10.1023/A:1027388729586	21	54	54	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34882	34886		10.1074/jbc.273.52.34882	http://dx.doi.org/10.1074/jbc.273.52.34882			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857016	Green Published, hybrid			2022-12-27	WOS:000077719700034
J	Lim, EK; Roberts, MR; Bowles, DJ				Lim, EK; Roberts, MR; Bowles, DJ			Biochemical characterization of tomato annexin p35 - Independence of calcium binding and phosphatase activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; PHOSPHOLIPID-BINDING; CRYSTAL-STRUCTURE; MEMBRANE-BINDING; PLANT ANNEXINS; PROTEIN; SEQUENCE; CHANNEL; IMMUNOLOCALIZATION; PURIFICATION	Tomato annexin p35 has been cloned and used in a site directed mutagenesis study to explore the phospholipid binding and catalytic properties of the protein in detail. Analysis of the cDNA sequence of p35 reveals that the annexin has only two typical endonexin folds, corresponding to repeats I and IV. Expression of recombinant p35 in Escherichia coli confirmed both phospholipid binding and a nucleotide phosphatase activity that could be inhibited on interaction of the recombinant annexin with phospholipids. Site-directed mutagenesis in which the acidic residues Glu-68 (repeat I), and Asp-297 (repeat IV) were changed to Asn, generated two mutant forms, E68N and D297N, respectively. Both mutant forms of the annexin continued to express catalytic activity. Changing repeat I had little effect on phospholipid binding, whereas the change to repeat IV abolished this property. These data show that, in this plant annexin, repeat TV plays a more critical role in calcium-dependent phospholipid binding than repeat I, and that the catalytic and phospholipid binding activity of the protein can be separated experimentally.	Univ York, Dept Biol, Plant Lab, York YO10 5YW, N Yorkshire, England	University of York - UK	Bowles, DJ (corresponding author), Univ York, Dept Biol, Plant Lab, POB 373, York YO10 5YW, N Yorkshire, England.	djb32@york.ac.uk	Roberts, Michael R/H-2664-2012	Roberts, Michael R/0000-0002-1441-7363				Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; ANDRAWIS A, 1993, PLANT J, V3, P763, DOI 10.1111/j.1365-313X.1993.00763.x; BandorowiczPikula J, 1997, FEBS LETT, V409, P300, DOI 10.1016/S0014-5793(97)00534-6; Benz J, 1997, BIOL CHEM, V378, P177; BLACKBOURN HD, 1992, PLANT PHYSIOL, V99, P864, DOI 10.1104/pp.99.3.864; BURGER A, 1994, J MOL BIOL, V237, P479, DOI 10.1006/jmbi.1994.1249; BURGOYNE RD, 1989, CELL CALCIUM, V10, P1, DOI 10.1016/0143-4160(89)90038-9; Calvert CM, 1996, PLANT CELL, V8, P333, DOI 10.1105/tpc.8.2.333; CHEN JM, 1993, J BIOMOL STRUCT DYN, V10, P1067, DOI 10.1080/07391102.1993.10508696; CLARK GB, 1992, PLANTA, V187, P1, DOI 10.1007/BF00201617; CLARK GB, 1995, PLANTA, V197, P376, DOI 10.1007/BF00202660; CLARK GB, 1994, ADV SPACE RES, V14, P341, DOI 10.1016/0273-1177(94)90421-9; Cohen BE, 1995, FEBS LETT, V377, P444, DOI 10.1016/0014-5793(95)01395-4; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; CREUTZ CE, 1979, J BIOL CHEM, V254, P553; Delmer DP, 1997, CELL MOL LIFE SCI, V53, P546, DOI 10.1007/s000180050070; ETO M, 1990, J BIOCHEM-TOKYO, V108, P499, DOI 10.1093/oxfordjournals.jbchem.a123228; GAO ZH, 1993, J BIOL CHEM, V268, P20096; GERKE V, 1985, EMBO J, V4, P2917, DOI 10.1002/j.1460-2075.1985.tb04023.x; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; Gidrol X, 1996, P NATL ACAD SCI USA, V93, P11268, DOI 10.1073/pnas.93.20.11268; GLENNEY J, 1986, P NATL ACAD SCI USA, V83, P4258, DOI 10.1073/pnas.83.12.4258; HOSHINO T, 1995, BIOCHEM MOL BIOL INT, V35, P749; HOSOYA H, 1992, CELL MOTIL CYTOSKEL, V22, P200, DOI 10.1002/cm.970220307; HUANG KS, 1986, CELL, V46, P191, DOI 10.1016/0092-8674(86)90736-1; Hung CH, 1996, P NATL ACAD SCI USA, V93, P10797, DOI 10.1073/pnas.93.20.10797; JONES PG, 1992, J BIOL CHEM, V267, P13993; JOST M, 1994, BIOCHEM J, V298, P553, DOI 10.1042/bj2980553; LEWITBENTLEY A, 1992, EUR J BIOCHEM, V210, P73, DOI 10.1111/j.1432-1033.1992.tb17392.x; Liemann S, 1997, CELL MOL LIFE SCI, V53, P516, DOI 10.1007/s000180050065; MCCLUNG AD, 1994, BIOCHEM J, V303, P709, DOI 10.1042/bj3030709; MEERS P, 1993, BIOCHEMISTRY-US, V32, P5411, DOI 10.1021/bi00071a016; Morgan RO, 1997, CELL MOL LIFE SCI, V53, P508, DOI 10.1007/s000180050064; Moss S. E, 1992, ANNEXINS; Moss SE, 1997, TRENDS CELL BIOL, V7, P87, DOI 10.1016/S0962-8924(96)10049-0; NELSON MR, 1995, BIOCHEMISTRY-US, V34, P3121, DOI 10.1021/bi00009a044; PIRCK M, 1994, PLANT PHYSIOL, V104, P1463, DOI 10.1104/pp.104.4.1463; Proust J, 1996, FEBS LETT, V383, P208, DOI 10.1016/0014-5793(96)00252-9; RAVANAT C, 1992, J MOL BIOL, V226, P1271, DOI 10.1016/0022-2836(92)91066-X; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; REEVES JP, 1969, J CELL PHYSIOL, V73, P49, DOI 10.1002/jcp.1040730108; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHLAEPFER DD, 1987, J BIOL CHEM, V262, P6931; SMALLWOOD M, 1990, BIOCHEM J, V270, P157, DOI 10.1042/bj2700157; SOPKOVA J, 1993, J MOL BIOL, V234, P816, DOI 10.1006/jmbi.1993.1627; SUZUKI R, 1987, J BIOL CHEM, V262, P11410; SWAIRJO MA, 1994, ANNU REV BIOPH BIOM, V23, P193, DOI 10.1146/annurev.bb.23.060194.001205; WALKER JH, 1983, J NEUROCHEM, V41, P139, DOI 10.1111/j.1471-4159.1983.tb11825.x; WENG XW, 1993, PROTEIN SCI, V2, P448	49	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34920	34925		10.1074/jbc.273.52.34920	http://dx.doi.org/10.1074/jbc.273.52.34920			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857021	hybrid			2022-12-27	WOS:000077719700039
J	Shimomura, I; Shimano, H; Korn, BS; Bashmakov, Y; Horton, JD				Shimomura, I; Shimano, H; Korn, BS; Bashmakov, Y; Horton, JD			Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; STEAROYL-COA DESATURASE; LEUCINE ZIPPER PROTEIN; ATP-CITRATE-LYASE; TRANSCRIPTIONAL REGULATION; ADIPOCYTE DETERMINATION; 3T3-L1 PREADIPOCYTES; RECEPTOR ACTIVITY; CULTURED-CELLS; MESSENGER-RNA	Previous studies have shown that the rate of fatty acid synthesis is elevated by more than 20-fold in livers of transgenic mice that express truncated nuclear forms of sterol regulatory element-binding proteins (SREBPs). This was explained in part by an increase in the levels of mRNA for the two major enzymes of fatty acid synthesis, acetyl-CoA carboxylase and fatty acid synthase, whose transcription is stimulated by SREBPs. Fatty acid synthesis also requires a source of acetyl-CoA and NADPH. In the current studies we show that the levels of mRNA for ATP citrate lyase, the enzyme that produces acetyl-CoA, are also elevated in the transgenic livers. In addition, we found marked elevations in the mRNAs for malic enzyme, glucose-6-phosphate dehydrogenase, and 6-phosphogluconate dehydrogenase, all of which produce NADPH. Finally, we found that overexpressing two of the SREBPs (la and 2) led to elevated mRNAs for stearoyl-CoA desaturase 1 (SCD1), an isoform that is detectable in nontransgenic livers, and SCD2, an isoform that is not detected in nontransgenic livers. This stimulation led to an increase in total SCD activity in liver microsomes, Together, all of these changes would be expected to lead to a marked increase in the concentration of monounsaturated fatty acids in the transgenic livers, and this was confirmed chromatographically. We conclude that expression of nuclear SREBPs is capable of activating the entire coordinated program of unsaturated fatty acid biosynthesis in mouse liver.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Horton, JD (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, 5323 Harry Hines Blvd,Rm L5-238, Dallas, TX 75235 USA.		Shimano, Hitoshi/AAI-5648-2020; Shimano, Hitoshi/V-1761-2019	Shimano, Hitoshi/0000-0002-5562-5572; Bashmakov, Yuriy/0000-0002-2265-3817	NHLBI NIH HHS [HL-20948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSEN JM, 1978, J BIOL CHEM, V253, P9024; BAGCHI S, 1986, ANN NY ACAD SCI, V478, P77, DOI 10.1111/j.1749-6632.1986.tb15522.x; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; DAUMERIE CM, 1992, P NATL ACAD SCI USA, V89, P10797, DOI 10.1073/pnas.89.22.10797; DIXON JL, 1991, J BIOL CHEM, V266, P5080; ELSHOURBAGY NA, 1992, EUR J BIOCHEM, V204, P491, DOI 10.1111/j.1432-1033.1992.tb16659.x; ELSHOURBAGY NA, 1990, J BIOL CHEM, V265, P1430; Ericsson J, 1996, P NATL ACAD SCI USA, V93, P945, DOI 10.1073/pnas.93.2.945; Ericsson J, 1997, J BIOL CHEM, V272, P7298, DOI 10.1074/jbc.272.11.7298; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; Guan GM, 1997, J BIOL CHEM, V272, P10295; GURR M I, 1968, Febs Letters, V1, P320, DOI 10.1016/0014-5793(68)80144-9; HAMILTON JG, 1988, LIPIDS, V23, P1146, DOI 10.1007/BF02535281; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47, DOI 10.1152/physrev.1995.75.1.47; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; JUMP DB, 1984, J BIOL CHEM, V259, P2789; KAESTNER KH, 1989, J BIOL CHEM, V264, P14755; KIM JB, 1995, MOL CELL BIOL, V15, P2582; LEPAGE G, 1986, J LIPID RES, V27, P114; LIAW CW, 1984, J BIOL CHEM, V259, P7253; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magana MM, 1997, J LIPID RES, V38, P1630; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; NTAMBI JM, 1995, PROG LIPID RES, V34, P139, DOI 10.1016/0163-7827(94)00010-J; OSHINO N, 1966, BIOCHIM BIOPHYS ACTA, V128, P13, DOI 10.1016/0926-6593(66)90137-8; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; RAJU PK, 1972, BIOCHIM BIOPHYS ACTA, V280, P267, DOI 10.1016/0005-2760(72)90093-8; ROGNSTAD R, 1979, J BIOL CHEM, V254, P1969; Rudel LL, 1997, J CLIN INVEST, V100, P74, DOI 10.1172/JCI119524; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; SOMERS DO, 1992, BIOCHEM J, V288, P1061, DOI 10.1042/bj2881061; STJOHN LC, 1991, J ANIM SCI, V69, P1064; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Vallett SM, 1996, J BIOL CHEM, V271, P12247, DOI 10.1074/jbc.271.21.12247; WOOLLETT LA, 1992, J CLIN INVEST, V89, P1133, DOI 10.1172/JCI115694; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zollo M, 1993, DNA Seq, V3, P319, DOI 10.3109/10425179309020830	44	297	316	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35299	35306		10.1074/jbc.273.52.35299	http://dx.doi.org/10.1074/jbc.273.52.35299			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857071	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000077719700089
J	Gillotte, KL; Zaiou, M; Lund-Katz, S; Anantharamaiah, GM; Holvoet, P; Dhoest, A; Palgunachari, MN; Segrest, JP; Weisgraber, KH; Rothblat, GH; Phillips, MC				Gillotte, KL; Zaiou, M; Lund-Katz, S; Anantharamaiah, GM; Holvoet, P; Dhoest, A; Palgunachari, MN; Segrest, JP; Weisgraber, KH; Rothblat, GH; Phillips, MC			Apolipoprotein-mediated plasma membrane microsolubilization - Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; A-I MUTANTS; ACYLTRANSFERASE ACTIVATION; RECEPTOR-BINDING; ELEVATED LEVELS; PROTEIN; CELLS; MACROPHAGES; TRANSPORT; PEPTIDES	Lipid-free apolipoprotein (apo) A-I contributes to the reverse transport of cholesterol from the periphery to the liver by solubilizing plasma membrane phospholipid and cholesterol. The features of the apolipoprotein required for this process are not understood and are addressed in the current study, Membrane nnicrosolubilization of human fibroblasts is not specific for apo A-I; unlipidated apos A-II, C, and E incubated with the fibroblast monolayers at a saturating concentration of 50 mu g/ml are all able to release cholesterol and phospholipid similarly. To determine the properties of the apolipoprotein that drive the process, apo A-I peptides spanning the entire sequence of the protein were utilized; the peptides correspond to the 11- and 22-residue amphipathic cu-helical segments, as well as adjacent combinations of the helices. Of the 20 helical peptides examined, only peptides representing the N- and C-terminal portions of the protein had the ability to solubilize phospholipid and cholesterol, Cholesterol efflux to the most effective peptides, 44-65 and 209-241, was approximately 50 and 70%, respectively, of that to intact apo A-I. Deletion mutants of apo E and apo A-I were constructed that have reduced lipid binding affinities as compared with the intact molecule. The proteins, apo A-I (Delta 222-243), apo A-I (Delta 190-243), apo E3 (Delta 192-299) and apo E4 (Delta 192-299) all exhibited a decreased ability to remove cellular cholesterol and phospholipid. These decreases correlated with the reduced ability of these proteins to penetrate into a phospholipid monomolecular film, Overall, the results indicate that insertion of amphipathic cu-helices between the plasma membrane phospholipid molecules is a required step in the mechanism of apolipoprotein-mediated cellular lipid afflux. Therefore the lipid binding ability of the apolipoprotein is critical for efficient membrane microsolubilization.	Med Coll Penn & Hahnemann Univ, Dept Biochem, Philadelphia, PA 19129 USA; Univ Alabama, Birmingham Med Ctr, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Birmingham Med Ctr, Dept Biochem, Birmingham, AL 35294 USA; Univ Alabama, Birmingham Med Ctr, Dept Mol Genet, Birmingham, AL 35294 USA; Univ Alabama, Birmingham Med Ctr, Atherosclerosis Res Unit, Birmingham, AL 35294 USA; Catholic Univ Louvain, Ctr Mol & Vasc Biol, B-3000 Louvain, Belgium; Univ Calif San Francisco, Cardiovasc Res Inst, Gladstone Fdn Labs Cardiovasc Dis, Dept Pathol, San Francisco, CA 94140 USA	Drexel University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Universite Catholique Louvain; University of California System; University of California San Francisco; The J David Gladstone Institutes	Phillips, MC (corresponding author), Med Coll Penn & Hahnemann Univ, Dept Biochem, 2900 Queen Ln, Philadelphia, PA 19129 USA.		Zaiou, Mohamed/AAG-8923-2019; HOLVOET, PAUL/T-8434-2017	HOLVOET, PAUL/0000-0001-9201-0772; Phillips, Michael/0000-0002-7147-8007; ZAIOU, Mohamed/0000-0002-4113-4350	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056083, T32HL007443, P01HL022633] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07443, HL56083, HL22633] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANANTHARAMAIAH GM, 1986, METHOD ENZYMOL, V128, P627; BARRANS A, 1994, J BIOL CHEM, V269, P11572; Barter PJ, 1996, CURR OPIN LIPIDOL, V7, P82, DOI 10.1097/00041433-199604000-00006; BIELICKI JK, 1992, J LIPID RES, V33, P1699; BIELICKI JK, 1991, BIOCHIM BIOPHYS ACTA, V1085, P7, DOI 10.1016/0005-2760(91)90225-7; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CLAY MA, 1992, BIOCHIM BIOPHYS ACTA, V1124, P52, DOI 10.1016/0005-2760(92)90125-F; DAVIDSON WS, 1994, J BIOL CHEM, V269, P22975; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Dong LM, 1996, NAT STRUCT BIOL, V3, P718, DOI 10.1038/nsb0896-718; FIELDING CJ, 1995, J LIPID RES, V36, P211; Gillotte KL, 1998, J LIPID RES, V39, P1918; GLOMSET JA, 1968, J LIPID RES, V9, P155; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; HARA H, 1992, LIPIDS, V27, P302, DOI 10.1007/BF02536480; HARA H, 1991, J BIOL CHEM, V266, P3080; HOLVOET P, 1995, BIOCHEMISTRY-US, V34, P13334, DOI 10.1021/bi00041a009; JOHNSON WJ, 1986, J BIOL CHEM, V261, P5766; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; KOSHLAND D, 1980, CELL, V20, P749, DOI 10.1016/0092-8674(80)90321-9; KUNITAKE ST, 1992, J LIPID RES, V33, P1807; Laccotripe M, 1997, J BIOL CHEM, V272, P17511, DOI 10.1074/jbc.272.28.17511; Li QQ, 1995, BBA-LIPID LIPID MET, V1259, P227, DOI 10.1016/0005-2760(95)00165-4; LIANG HQ, 1994, J LIPID RES, V35, P1187; LUNDKATZ S, 1986, BIOCHEMISTRY-US, V25, P1562, DOI 10.1021/bi00355a016; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MCCLOSKEY HM, 1987, BIOCHIM BIOPHYS ACTA, V921, P320, DOI 10.1016/0005-2760(87)90033-6; MENDEZ AJ, 1994, J CLIN INVEST, V94, P1698, DOI 10.1172/JCI117515; MINNICH A, 1992, J BIOL CHEM, V267, P16553; Mishra VK, 1998, BIOCHEMISTRY-US, V37, P10313, DOI 10.1021/bi980042o; Oram JF, 1996, J LIPID RES, V37, P2473; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Phillips MC, 1998, ATHEROSCLEROSIS, V137, pS13, DOI 10.1016/S0021-9150(97)00312-2; PHILLIPS MC, 1987, BIOCHIM BIOPHYS ACTA, V906, P223, DOI 10.1016/0304-4157(87)90013-X; PHILLIPS MC, 1975, NATURE, V254, P154, DOI 10.1038/254154a0; RALL SC, 1986, METHOD ENZYMOL, V128, P273; ROSS AC, 1984, J BIOL CHEM, V259, P815; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; SCANU AM, 1971, ANAL BIOCHEM, V44, P576, DOI 10.1016/0003-2697(71)90247-8; SCHMIDT HHJ, 1995, J BIOL CHEM, V270, P5469, DOI 10.1074/jbc.270.10.5469; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; SEGREST JP, 1992, J LIPID RES, V33, P141; STEIN O, 1973, BIOCHIM BIOPHYS ACTA, V326, P232, DOI 10.1016/0005-2760(73)90249-X; Sviridov D, 1996, J BIOL CHEM, V271, P33277, DOI 10.1074/jbc.271.52.33277; VENKATACHALAPATHI YV, 1993, PROTEINS, V15, P349, DOI 10.1002/prot.340150403; vonEckardstein A, 1996, CURR OPIN LIPIDOL, V7, P308, DOI 10.1097/00041433-199610000-00009; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; YANCEY PG, 1995, BIOCHEMISTRY-US, V34, P7955, DOI 10.1021/bi00024a021; Yokoyama S, 1998, BBA-LIPID LIPID MET, V1392, P1, DOI 10.1016/S0005-2760(98)00032-0	52	164	171	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2021	2028		10.1074/jbc.274.4.2021	http://dx.doi.org/10.1074/jbc.274.4.2021			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890960	hybrid			2022-12-27	WOS:000078185200027
J	Li, JF; Pak, JH; Huang, FL; Huang, KP				Li, JF; Pak, JH; Huang, FL; Huang, KP			N-methyl-D-aspartate induces neurogranin/RC3 oxidation in rat brain slices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; LONG-TERM POTENTIATION; CALMODULIN-BINDING DOMAIN; NITRIC-OXIDE MODIFICATION; SIGNAL-TRANSDUCTION; SUBSTRATE RC3; PHOSPHORYLATION SITE; NMDA RECEPTORS; NEUROMODULIN; SUPEROXIDE	Neurogranin/RC3 (Ng), a postsynaptic neuronal protein kinase C (PRC) substrate, binds calmodulin (CaM) at low level of Ca2+. In vitro, rat brain Ng can be oxidized by nitric oxide (NO) donors and by oxidants to form an intramolecular disulfide bond with resulting downward mobility shift on nonreducing SDS-polyacrylamide gel electrophoresis. The oxidized Ng, as compared with the reduced form, is a poorer substrate of PKC but like the PKC-phosphorylated Ng has a lower affinity for CaM than the reduced form. To investigate the physiological relevance of Ng oxidation, we tested the effects of neurotransmitter, N-methyl-D-aspartate (NMDA), NO donors, and other oxidants such as hydrogen peroxide and oxidized glutathione on the oxidation of this protein in rat brain slices. Western blot analysis showed that the NMDA-induced oxidation of Ng was rapid and transient, it reached maximum within 3-5 min and declined to base line in 30 min. The response was dose-dependent (EC50 similar to 100 mu M) and could be blocked by NMDA-receptor antagonist 2-amino-5-phosphonovaleric acid and by NO synthase inhibitor N-G-nitro-L-arginine methyl ester and N-G-monomethyl-L-arginine. Ng was oxidized by NO donors, sodium nitroprusside, S-nitroso-N-acetylpenicillamine, and S-nitrosoglutathione, and H2O2 at concentrations less than 0.5 mM. Oxidation of Ng in brain slices induced by sodium nitroprusside could be reversed by dithiothreitol, ascorbic acid, or reduced glutathione. Reversible oxidation and reduction of Ng were also observed in rat brain extracts, in which oxidation was enhanced by Ca2+ and the oxidized Ng could be reduced by NADPH or reduced glutathione. These results suggest that redox of Ng is involved in the NMDA-mediated signaling pathway and that there are enzymes catalyzing the oxidation and reduction of Ng in the brain. We speculate that the redox state of Ng, similar to the state of phosphorylation of this protein, may regulate the level of CaM, which in turn modulates the activities of CaM-dependent enzymes in the neurons.	NICHHD, Metab Regulat Sect, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Huang, KP (corresponding author), NICHHD, Metab Regulat Sect, Endocrinol & Reprod Res Branch, NIH, Bldg 49,Rm 6A36,49 Convent Dr,MSC 4510, Bethesda, MD 20892 USA.		Li, Junfa/H-8707-2013	Li, Junfa/0000-0002-1930-9724	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000187] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000187] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALEXANDER KA, 1988, J BIOL CHEM, V263, P7544; ALUAREZBOLADO G, 1996, NEUROSCIENCE, V73, P565; ANDERSON MT, 1994, P NATL ACAD SCI USA, V91, P11527, DOI 10.1073/pnas.91.24.11527; APEL ED, 1990, BIOCHEMISTRY-US, V29, P2330, DOI 10.1021/bi00461a017; BAUDIER J, 1991, J BIOL CHEM, V266, P229; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; CARTER WO, 1994, J LEUKOCYTE BIOL, V55, P253; CERENDASY DD, 1997, MOL NEUROBIOL, V15, P131; CHAPMAN ER, 1991, J BIOL CHEM, V266, P207; Chen SJ, 1997, BRAIN RES, V749, P181, DOI 10.1016/S0006-8993(96)01159-6; COHEN RW, 1993, BRAIN RES, V627, P147, DOI 10.1016/0006-8993(93)90758-F; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; FEDOROV NB, 1995, EUR J NEUROSCI, V7, P819, DOI 10.1111/j.1460-9568.1995.tb00685.x; FIALKOW L, 1994, J BIOL CHEM, V269, P31234; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1986, THIOREDOXIN GLUTARED, P1; HUANG KP, 1993, ARCH BIOCHEM BIOPHYS, V305, P570, DOI 10.1006/abbi.1993.1463; KLANN E, 1993, P NATL ACAD SCI USA, V90, P8337, DOI 10.1073/pnas.90.18.8337; KLANN E, 1992, J NEUROCHEM, V58, P1576, DOI 10.1111/j.1471-4159.1992.tb11382.x; LANDER HM, 1995, J BIOL CHEM, V270, P21195, DOI 10.1074/jbc.270.36.21195; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Mahoney CW, 1996, J BIOL CHEM, V271, P28798, DOI 10.1074/jbc.271.46.28798; MARTZEN MR, 1995, J NEUROCHEM, V64, P92; MEISTER A, 1988, J BIOL CHEM, V263, P17205; NOACK E, 1991, OXIDATIVE STRESS OXI, P445; ODONNELL ME, 1983, J BIOL CHEM, V258, P3795; PERKEL DJ, 1993, NEURON, V11, P817, DOI 10.1016/0896-6273(93)90111-4; POU S, 1992, J BIOL CHEM, V267, P24173; RADI R, 1991, J BIOL CHEM, V266, P4244; RAMAKERS GMJ, 1995, J BIOL CHEM, V270, P13892, DOI 10.1074/jbc.270.23.13892; REPRESA A, 1990, J NEUROSCI, V10, P3782, DOI 10.1523/JNEUROSCI.10-12-03782.1990; RodriguezSanchez P, 1997, NEUROSCI LETT, V221, P137, DOI 10.1016/S0304-3940(96)13309-7; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SEKI K, 1995, ARCH BIOCHEM BIOPHYS, V316, P673, DOI 10.1006/abbi.1995.1090; Sheu FS, 1996, J BIOL CHEM, V271, P22407, DOI 10.1074/jbc.271.37.22407; Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; STAAL FJT, 1994, P NATL ACAD SCI USA, V91, P3619, DOI 10.1073/pnas.91.9.3619; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; WARDMAN P, 1995, METHOD ENZYMOL, V251, P31, DOI 10.1016/0076-6879(95)51108-3; WATSON JB, 1992, P NATL ACAD SCI USA, V89, P8581, DOI 10.1073/pnas.89.18.8581; WATSON JB, 1990, J NEUROSCI RES, V26, P397, DOI 10.1002/jnr.490260402; Wink DA, 1997, J BIOL CHEM, V272, P11147; WINTERBOURN CC, 1995, METHOD ENZYMOL, V251, P81, DOI 10.1016/0076-6879(95)51112-1; YAN SD, 1994, J BIOL CHEM, V269, P9889	53	55	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1294	1300		10.1074/jbc.274.3.1294	http://dx.doi.org/10.1074/jbc.274.3.1294			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880498	hybrid			2022-12-27	WOS:000079956900018
J	MacKichan, ML; DeFranco, AL				MacKichan, ML; DeFranco, AL			Role of ceramide in lipopolysaccharide (LPS)-induced signaling - LPS increases ceramide rather than acting as a structural homolog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; N-TERMINAL KINASE; TRANSCRIPTION FACTOR ATF2; CELL-CYCLE ARREST; BACTERIAL LIPOPOLYSACCHARIDE; TYROSINE PHOSPHORYLATION; MURINE MACROPHAGES; INDUCED APOPTOSIS; PHOSPHOLIPASE-C	Ceramide and ceramide activated enzymes have been implicated in responses to bacterial lipopolysaccharide (LPS) and the proinflammatory cytokines tumor necrosis factor-alpha (TNF) and interleukin-1 beta (IL-1). Although TNF and IL-1 cause elevation of cellular ceramide, which is thought to act as a second messenger, LPS has been proposed to signal by virtue of structural similarity to ceramide. We have investigated the relationship between ceramide and LPS by comparing the effects of a cell-permeable ceramide analog (C-2-ceramide) and LPS on murine macrophage cell lines and by measuring ceramide levels in macrophages exposed to LPS, We found that while both C-2-ceramide and LPS activated c-Jun N-terminal kinase (JNK), only LPS also activated extracellular signal-regulated kinases (ERKs). C-2-ceramide was also unable to activate NF-kappa B, a transcription factor important for LPS-induced gene expression. Upon measurement of cellular ceramide in macrophage lines, we observed a small but rapid rise in ceramide, similar to that seen upon IL-1 or TNF treatment, suggesting LPS induces an increase in ceramide rather than interacting directly with ceramide-responsive enzymes. We found that C-2-ceramide activated JNK and induced growth arrest in macrophages cell lines from both normal mice (Lps(n)) and mice genetically unresponsive to LPS (Lps(d)), whereas only Lps(n) macrophages made these responses to LPS. Surprisingly, LPS treatment of Lps(d) macrophages induced a rise in ceramide similar to that observed in LPS-responsive cells. These results indicate that the wild type Lps allele is not required for LPS-induced ceramide generation and suggest that ceramide elevation alone is insufficent stimulus for most responses to LPS.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, GW Hooper Fdn, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	DeFranco, AL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	defranco@socrates.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033442] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33442] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barber SA, 1996, INFECT IMMUN, V64, P3397, DOI 10.1128/IAI.64.8.3397-3400.1996; BARBER SA, 1995, J IMMUNOL, V155, P2303; BETTS JC, 1994, J BIOL CHEM, V269, P8455; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Bilderback TR, 1997, J BIOL CHEM, V272, P10922; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; CIFONE MG, 1995, EMBO J, V14, P5859, DOI 10.1002/j.1460-2075.1995.tb00274.x; Coroneos E, 1996, BIOCHEM J, V316, P13, DOI 10.1042/bj3160013; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; DBAIBO GS, 1995, P NATL ACAD SCI USA, V92, P1347, DOI 10.1073/pnas.92.5.1347; DEFRANCO AL, 1997, ENDOTOXIN SEPSIS MOL; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DING A, 1993, J IMMUNOL, V151, P5596; DONG ZY, 1993, J EXP MED, V177, P1071, DOI 10.1084/jem.177.4.1071; FISHBEIN JD, 1993, J BIOL CHEM, V268, P9255; Grassme H, 1997, CELL, V91, P605, DOI 10.1016/S0092-8674(00)80448-1; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; HAMBLETON J, 1995, J EXP MED, V182, P147, DOI 10.1084/jem.182.1.147; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Hedlund M, 1996, J EXP MED, V183, P1037, DOI 10.1084/jem.183.3.1037; Hofmeister R, 1997, J BIOL CHEM, V272, P27730, DOI 10.1074/jbc.272.44.27730; Hooper NM, 1998, CURR BIOL, V8, pR114, DOI 10.1016/S0960-9822(98)70984-4; Ilangumaran S, 1996, TRENDS CELL BIOL, V6, P163, DOI 10.1016/0962-8924(96)20012-1; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Joneson T, 1998, J BIOL CHEM, V273, P7743, DOI 10.1074/jbc.273.13.7743; JOSEPH CK, 1994, J BIOL CHEM, V269, P17606; Kitchens RL, 1998, J IMMUNOL, V160, P1920; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; LAULEDERKIND SJF, 1995, J EXP MED, V182, P599, DOI 10.1084/jem.182.2.599; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; LUTZ MB, 1994, J IMMUNOL METHODS, V174, P269, DOI 10.1016/0022-1759(94)90031-0; MANTHEY CL, 1992, J IMMUNOL, V149, P2459; Masamune A, 1996, J BIOL CHEM, V271, P9368, DOI 10.1074/jbc.271.16.9368; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; Nakabo Y, 1997, IMMUNOLOGY, V90, P477, DOI 10.1046/j.1365-2567.1997.d01-2189.x; NAKANO M, 1992, BACTERIAL ENDOTOXIC, V1, P311; PAGE DM, 1990, MOL CELL BIOL, V10, P3003, DOI 10.1128/MCB.10.6.3003; Paul A, 1997, BRIT J PHARMACOL, V120, P1439, DOI 10.1038/sj.bjp.0701070; Perera PY, 1997, J IMMUNOL, V158, P4422; PIRAMI L, 1991, P NATL ACAD SCI USA, V88, P7543, DOI 10.1073/pnas.88.17.7543; PREISS J, 1986, J BIOL CHEM, V261, P8597; Pugin J, 1998, INFECT IMMUN, V66, P1174, DOI 10.1128/IAI.66.3.1174-1180.1998; RAINES MA, 1993, J BIOL CHEM, V268, P14572; RIGHI M, 1991, ONCOGENE, V6, P103; Ruiz-Arguello MB, 1998, J BIOL CHEM, V273, P22977, DOI 10.1074/jbc.273.36.22977; Sanghera JS, 1996, J IMMUNOL, V156, P4457; SASSANO M, 1994, ONCOGENE, V9, P1473; SAWAI H, 1995, J BIOL CHEM, V270, P27326, DOI 10.1074/jbc.270.45.27326; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Stevens VL, 1997, J BIOL CHEM, V272, P18020, DOI 10.1074/jbc.272.29.18020; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Thieblemont N, 1997, J EXP MED, V185, P2095, DOI 10.1084/jem.185.12.2095; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Vadiveloo PK, 1996, ONCOGENE, V13, P599; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; WEINSTEIN SL, 1993, J IMMUNOL, V151, P3829; Welsh N, 1996, J BIOL CHEM, V271, P8307, DOI 10.1074/jbc.271.14.8307; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; WRIGHT SD, 1995, IMMUNOL TODAY, V16, P297, DOI 10.1016/0167-5699(95)80185-5; Wurfel MM, 1997, J IMMUNOL, V158, P3925; YANG ZH, 1993, J BIOL CHEM, V268, P20520; YAO B, 1995, NATURE, V378, P307, DOI 10.1038/378307a0; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	80	88	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1767	1775		10.1074/jbc.274.3.1767	http://dx.doi.org/10.1074/jbc.274.3.1767			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880559	hybrid			2022-12-27	WOS:000079956900079
J	Pellicer, MT; Fernandez, C; Badia, J; Aguilar, J; Lin, ECC; Baldoma, L				Pellicer, MT; Fernandez, C; Badia, J; Aguilar, J; Lin, ECC; Baldoma, L			Cross-induction of glc and ace operons of Escherichia coli attributable to pathway intersection - Characterization of the glc promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATION HOST FACTOR; GLYOXYLATE BYPASS OPERON; DNA-BINDING; PROPANEDIOL OXIDOREDUCTASE; REGULATOR PROTEIN; L-RHAMNOSE; EXPRESSION; GENE; CLONING; ARCA	The metabolic pathways specified by the glc and ace operons in Escherichia coli yield glyoxylate as a common intermediate, which is acted on by two malate synthase isoenzymes: one encoded by glcB and the other by aceB. Null mutations in either gene exhibit no phenotype, because of cross-induction of the ace operon by glycolate and the glc operon by acetate. In this study, the regulation of the glc operon, comprising the structural genes glcDEFGB, was analyzed at the molecular level. This operon, activated by growth on glycolate, is transcribed as a single message and is under the positive control of GlcC encoded by a divergent gene. Expression of the glc operon is strongly dependent on the integration host factor (IHF) and is repressed by the global respiratory regulator ArcA-P, In vitro gel-shift experiments demonstrated direct binding of the promoter DNA to IHF and ArcA-P. Mutant analysis indicated that cross-induction of the glc operon by acetate is mediated by the GlcC protein that recognizes the compound as an alternative effector. The similar pattern of regulation of the Glc and Ace systems by IHF and ArcA-P ensures their effective cross-induction.	Univ Barcelona, Sch Pharm, Dept Biochem, E-08028 Barcelona, Spain; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	University of Barcelona; Harvard University; Harvard Medical School	Baldoma, L (corresponding author), Univ Barcelona, Sch Pharm, Dept Biochem, Diagonal 643, E-08028 Barcelona, Spain.	baldoma@farmacia.far.ub.es	Baldomà, Laura/G-7301-2015; Badia, Josefa/G-7292-2015	Baldomà, Laura/0000-0002-7678-269X; Badia, Josefa/0000-0003-0768-5033	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040993, R01GM039693] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-39693, GM-40993] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSUBEL FM, 1991, CURRENT PROTOCOLS MO, V2; BALDOMA L, 1987, J BIOL CHEM, V262, P13991; BELASCO JG, 1985, CELL, V40, P171, DOI 10.1016/0092-8674(85)90320-4; BORONAT A, 1981, J BACTERIOL, V147, P181, DOI 10.1128/JB.147.1.181-185.1981; BORONAT A, 1979, J BACTERIOL, V140, P320, DOI 10.1128/JB.140.2.320-326.1979; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CHUNG T, 1988, J BACTERIOL, V170, P386, DOI 10.1128/jb.170.1.386-392.1988; Clark D. P., 1996, ESCHERICHIA COLI SAL, P343; CORTAY JC, 1991, EMBO J, V10, P675, DOI 10.1002/j.1460-2075.1991.tb07996.x; ELLIOTT T, 1992, J BACTERIOL, V174, P245, DOI 10.1128/jb.174.1.245-253.1992; FALMAGNE P, 1965, BIOCHIM BIOPHYS ACTA, V99, P246, DOI 10.1016/S0926-6593(65)80121-7; GOODRICH JA, 1990, NUCLEIC ACIDS RES, V18, P4993, DOI 10.1093/nar/18.17.4993; GRANSTON AE, 1993, J MOL BIOL, V234, P45, DOI 10.1006/jmbi.1993.1562; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; IUCHI S, 1989, J BACTERIOL, V171, P2889, DOI 10.1128/jb.171.5.2889-2893.1989; IUCHI S, 1994, J BACTERIOL, V176, P1695, DOI 10.1128/jb.176.6.1695-1701.1994; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Jovanovic G, 1997, MOL MICROBIOL, V25, P473, DOI 10.1046/j.1365-2958.1997.4791844.x; KORNBERG HL, 1966, BIOCHEM J, V99, P1; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LANGE R, 1995, J BACTERIOL, V177, P4676, DOI 10.1128/jb.177.16.4676-4680.1995; LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynch AS, 1996, J BACTERIOL, V178, P6238, DOI 10.1128/JB.178.21.6238-6249.1996; MALOY SR, 1982, J BACTERIOL, V149, P173, DOI 10.1128/JB.149.1.173-180.1982; MOLINA I, 1994, EUR J BIOCHEM, V224, P541, DOI 10.1111/j.1432-1033.1994.00541.x; MORALEJO P, 1993, J BACTERIOL, V175, P5585, DOI 10.1128/JB.175.17.5585-5594.1993; MOZOLA MA, 1985, VIROLOGY, V140, P313, DOI 10.1016/0042-6822(85)90368-X; MUDD EA, 1990, MOL MICROBIOL, V4, P2127, DOI 10.1111/j.1365-2958.1990.tb00574.x; Nash Howard A., 1996, P149; NUNOSHIBA T, 1992, J BACTERIOL, V174, P6054, DOI 10.1128/JB.174.19.6054-6060.1992; ORNSTON LN, 1969, J BACTERIOL, V98, P1098, DOI 10.1128/JB.98.3.1098-1108.1969; Pellicer MT, 1996, J BACTERIOL, V178, P2051, DOI 10.1128/jb.178.7.2051-2059.1996; Resnik E, 1996, J BACTERIOL, V178, P2715, DOI 10.1128/jb.178.9.2715-2717.1996; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHRODER I, 1993, J BIOL CHEM, V268, P771; SHENG J, 1998, MOL MICROBIOL, V26, P223; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SUNNARBORG A, 1990, J BACTERIOL, V172, P2642, DOI 10.1128/jb.172.5.2642-2649.1990; VANDERWI.E, 1968, EUR J BIOCHEM, V5, P81, DOI 10.1111/j.1432-1033.1968.tb00340.x; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; ZAREMBINSKI CM, 1991, CURR MICROBIOL, V22, P65, DOI 10.1007/BF02106215	43	56	60	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1745	1752		10.1074/jbc.274.3.1745	http://dx.doi.org/10.1074/jbc.274.3.1745			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880556	hybrid			2022-12-27	WOS:000079956900076
J	Scaffidi, C; Schmitz, I; Krammer, PH; Peter, ME				Scaffidi, C; Schmitz, I; Krammer, PH; Peter, ME			The role of c-FLIP in modulation of CD95-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN; INDUCED CELL-DEATH; RECEPTOR-1 SIGNALING COMPLEX; T-CELL; REGULATES APOPTOSIS; BCL-X; FAS; ACTIVATION; FADD; INTERACTS	Upon stimulation, CD95 (APO-1/Fas) recruits the adapted molecule Fas-associated death domain protein (FADD/MORT1 and caspase-8 (FADD-like interleukin-1 beta-converting enzyme (FLICE)/MACH/MCH5) into the death-inducing signaling complex (DISC). Recently, a molecule with sequence homology to caspase-8 was identified, termed cellular FLICE-inhibitory protein (c-FLIP). c-FLIP has been controversially reported to possess apoptosis-promoting and -inhibiting functions. Using c-FLIP-specific monoclonal antibodies, we now show that c-FLIP is expressed in two isoforms, both of which, like FADD and caspase-8, are recruited to the CD95 DISC in a stimulation-dependent fashion. In stably transfected BJAB cells, c-FLIP blocks caspase-8 activation at the DISC and thereby inhibits CD95-mediated apoptosis. During this process, both caspase-8 and c-FLIP undergo cleavage between the p18 and p10 subunits, generating two stable intermediates of 43 kDa that stay bound to the DISC. c-FLIP has been suggested to play a role in protecting activated peripheral T cells from CD95-mediated apoptosis (Irmler, M., Theme, M, Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J. L., Schroter, M., Burns, K., Mattmann, C., Rimoldi, D., French, L. E., and Tschopp, J. (1997) Nature 388, 180-195). In contrast to this hypothesis, neither caspase-8 nor c-FLIP were cleaved in these cells, ruling out c-FLIP as the main factor regulating DISC activity. Moreover, recruitment of FADD, caspase-8, and c-FLIP to the DISC was strongly reduced in the apoptosis-resistant but readily detectable in the apoptosis-sensitive T cells.	German Canc Res Ctr, Tumor Immunol Program, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Peter, ME (corresponding author), German Canc Res Ctr, Tumor Immunol Program, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	m.peter@dkfz-heidelberg.de	Watzl, Carsten/B-4911-2013; Schmitz, Ingo/G-2093-2013	Watzl, Carsten/0000-0001-5195-0995; Schmitz, Ingo/0000-0002-5360-0419; Peter, Marcus Ernst/0000-0003-3216-036X				ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BROOME HE, 1995, J IMMUNOL, V155, P2311; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DITA RM, 1998, CELL DEATH DIFFER, V5, P271; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Han DKM, 1997, P NATL ACAD SCI USA, V94, P11333, DOI 10.1073/pnas.94.21.11333; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hu SM, 1997, J BIOL CHEM, V272, P9621; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; KLAS C, 1993, INT IMMUNOL, V5, P625, DOI 10.1093/intimm/5.6.625; KRAMMER PH, 1994, IMMUNOL REV, V142, P175, DOI 10.1111/j.1600-065X.1994.tb00889.x; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; OWENSCHAUB LB, 1992, CELL IMMUNOL, V140, P197, DOI 10.1016/0008-8749(92)90187-T; Penninger JM, 1998, ADV IMMUNOL, V68, P51, DOI 10.1016/S0065-2776(08)60558-1; Peter ME, 1997, EUR J IMMUNOL, V27, P1207, DOI 10.1002/eji.1830270523; PETER ME, 1995, INT IMMUNOL, V7, P1873, DOI 10.1093/intimm/7.11.1873; PETER ME, 1998, APOPTOSIS PROBLEMS D, P25; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; SCAFFIDI C, 1999, IN PRESS METHODS ENZ; SCAFFIDI C, 1999, IN PRESS METHODS COM; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; TEWARI M, 1995, J BIOL CHEM, V270, P3255, DOI 10.1074/jbc.270.7.3255; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; Yang XF, 1997, IMMUNITY, V7, P629, DOI 10.1016/S1074-7613(00)80384-2; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	52	677	695	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1541	1548		10.1074/jbc.274.3.1541	http://dx.doi.org/10.1074/jbc.274.3.1541			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880531	hybrid			2022-12-27	WOS:000079956900051
J	Alvarez, B; Ferrer-Sueta, G; Freeman, BA; Radi, R				Alvarez, B; Ferrer-Sueta, G; Freeman, BA; Radi, R			Kinetics of peroxynitrite reaction with amino acids and human serum albumin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BLOOD-PLASMA; NITRIC-OXIDE; CARBON-DIOXIDE; CATALYZED OXIDATION; MEDIATED OXIDATION; PROTEIN OXIDATION; ONE-ELECTRON; THIOL-GROUPS; SUPEROXIDE; DECOMPOSITION	An initial rate approach was used to study the reaction of peroxynitrite with human serum albumin (HSA) through stopped-flow spectrophotometry. At pH 7.4 and 37 degrees C, the second order rate constant for peroxynitrite reaction with HSA was 9.1 +/- 1.1 x 10(3) M-1 s(-1). The rate constants for sulfhydryl-blocked HSA and for the single sulfhydryl were 5.9 +/- 0.3 and 3.8 +/- 0.8 x 10(3) M-1 s(-1), respectively. The corresponding values for bovine serum albumin were also determined. The reactivity of sulfhydryl-blocked HSA increased at acidic pH, whereas plots of the rate constant with the sulfhydryl versus pH were bell-shaped. The kinetics of peroxynitrite reaction with all free L-amino acids were determined under pseudo first order conditions. The most reactive amino acids were cysteine, methionine, and tryptophan. Histidine, leucine, and phenylalanine (and by extension tyrosine) did not affect peroxynitrite decay rate, whereas for the remaining amino acids plots of k(obs) versus concentration were hyperbolic. The sum of the contributions of the constituent amino acids of the protein to HSA reactivity was comparable to the experimentally determined rate constant, where cysteine and methionine (seven residues in 585) accounted for an estimated 65% of the reactivity. Nitration of aromatic amino acids occurred in HSA following peroxynitrite reaction, with nitration of sulfhydryl-blocked HSA 2-fold higher than native HSA, Carbon dioxide accelerated peroxynitrite decomposition, enhanced aromatic amino acid nitration, and partially inhibited sulfhydryl oxidation of HSA. Nitration in the presence of carbon dioxide increased when the sulfhydryl was blocked. Thus, cysteine 34 was a preferential. target of peroxynitrite both in the presence and in the absence of carbon dioxide.	Fac Med, Dept Bioquim, Montevideo 11800, Uruguay; Fac Ciencias, Enzymol Lab, Unidad Asociada Enzimol, Montevideo 11800, Uruguay; Fac Ciencias, Dept Fisquim Biol, Montevideo 11800, Uruguay; Univ Alabama, Dept Anesthesiol, Birmingham, AL 35233 USA; Univ Alabama, Dept Biochem, Birmingham, AL 35233 USA; Univ Alabama, Ctr Free Rad Biol, Birmingham, AL 35233 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Radi, R (corresponding author), Fac Med, Dept Bioquim, Av Gen flores 2125, Montevideo 11800, Uruguay.	rradi@lobbm.fmed.edu.uy	Ferrer-Sueta, Gerardo/C-3316-2011	Ferrer-Sueta, Gerardo/0000-0002-8663-8480; Alvarez, Beatriz/0000-0001-6911-3132				Alvarez B, 1998, FREE RADICAL BIO MED, V24, P1331, DOI 10.1016/S0891-5849(98)00005-7; Alvarez B, 1996, CHEM RES TOXICOL, V9, P390, DOI 10.1021/tx950133b; ALVAREZ B, 1995, CHEM RES TOXICOL, V8, P859, DOI 10.1021/tx00048a006; AUGUSTO O, 1994, ARCH BIOCHEM BIOPHYS, V310, P118, DOI 10.1006/abbi.1994.1147; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BUNK DM, 1996, ANAL CHEM, V69, P2457; CASTRO L, 1994, J BIOL CHEM, V269, P29409; CHEN RF, 1967, J BIOL CHEM, V242, P173; CROW JP, 1995, BIOCHEMISTRY-US, V34, P3544, DOI 10.1021/bi00011a008; DAVIES MJ, 1993, FREE RADICAL RES COM, V18, P353, DOI 10.3109/10715769309147502; Dean RT, 1997, BIOCHEM J, V324, P1; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; ELLMAN G, 1979, ANAL BIOCHEM, V93, P98, DOI 10.1016/S0003-2697(79)80122-0; GATTI RM, 1994, FEBS LETT, V348, P287, DOI 10.1016/0014-5793(94)00625-3; Gow A, 1996, ARCH BIOCHEM BIOPHYS, V333, P42, DOI 10.1006/abbi.1996.0362; HUGHES MN, 1968, J CHEM SOC A, P450, DOI 10.1039/j19680000450; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; KEITH WG, 1969, J CHEM SOC A, V90; KOOY NW, 1994, ARCH BIOCHEM BIOPHYS, V310, P352, DOI 10.1006/abbi.1994.1178; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; LYMAR SV, 1995, J AM CHEM SOC, V117, P8867, DOI 10.1021/ja00139a027; Lymar SV, 1996, BIOCHEMISTRY-US, V35, P7855, DOI 10.1021/bi960331h; Lymar SV, 1998, INORG CHEM, V37, P294, DOI 10.1021/ic970946i; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; MEUCCI E, 1991, J BIOL CHEM, V266, P4692; PETERS T, 1996, ALL ALBUMIN BIOCH GE, P57; Pietraforte D, 1997, BIOCHEM J, V321, P743, DOI 10.1042/bj3210743; Pietraforte D, 1997, BIOCHEM J, V325, P675, DOI 10.1042/bj3250675; Pryor WA, 1997, FREE RADICAL BIO MED, V23, P331, DOI 10.1016/S0891-5849(97)00121-4; PRYOR WA, 1994, P NATL ACAD SCI USA, V91, P11173, DOI 10.1073/pnas.91.23.11173; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; Putnam E., 1975, 3 SERUM ALBUMIN, VSecond, P133, DOI [10.1016/B978-0-12-568401-9.50010-4, DOI 10.1016/B978-0-12-568401-9.50010-4]; Quijano C, 1997, BIOCHEM J, V322, P167, DOI 10.1042/bj3220167; RADI R, 1991, J BIOL CHEM, V266, P4244; Radi R, 1996, METHOD ENZYMOL, V269, P354; Radi R, 1999, METHOD ENZYMOL, V301, P353; Radi R, 1996, CHEM RES TOXICOL, V9, P828, DOI 10.1021/tx950176s; RAMEZANIAN MS, 1996, CHEM RES TOXICOL, V9, P160; RUBBO H, 1994, J BIOL CHEM, V269, P26066; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; THOMSON L, 1995, ARCH BIOCHEM BIOPHYS, V319, P491, DOI 10.1006/abbi.1995.1321; TORCHINSKY YM, 1981, SULFUR PROTEINS, P3; Wada Y, 1996, J MASS SPECTROM, V31, P263, DOI 10.1002/(SICI)1096-9888(199603)31:3<263::AID-JMS292>3.0.CO;2-2; WILSON JM, 1980, J AM CHEM SOC, V102, P359, DOI 10.1021/ja00521a058; Zhang HW, 1997, ARCH BIOCHEM BIOPHYS, V339, P183, DOI 10.1006/abbi.1996.9863	51	224	231	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					842	848		10.1074/jbc.274.2.842	http://dx.doi.org/10.1074/jbc.274.2.842			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873023	hybrid			2022-12-27	WOS:000077968500038
J	Fish, EN; Uddin, S; Korkmaz, M; Majchrzak, B; Druker, BJ; Platanias, LC				Fish, EN; Uddin, S; Korkmaz, M; Majchrzak, B; Druker, BJ; Platanias, LC			Activation of a CrkL-Stat5 signaling complex by type I interferons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATES TYROSINE PHOSPHORYLATION; DEPENDENT ACTIVATION; SUPPRESSOR ACTIVITY; GENE; PROTEINS; CELLS; TRANSFORMATION; BINDING; CRKL; RAP1	Type I interferons (IFN alpha and IFN beta) transduce signals by inducing tyrosine phosphorylation of Jaks and Stats, as well as the CrkL adapter, an SH2/SH3-containing protein which provides a link to downstream pathways that mediate growth inhibition. We report that Stat5 interacts constitutively with the IFN receptor-associated Tyk-2 kinase, and during IFN alpha stimulation its tyrosine-phosphorylated form acts as a docking site for the SH2 domain of CrkL. CrkL and Stat5 then form a complex that translocates to the nucleus. This IFN-inducible CrkL-Stat5 complex binds in vitro to the TTCTAGGAA palindromic element found in the promoters of a subset of IFN-stimulated genes. Thus, during activation of the Type I IFN receptor, CrkL functions as a nuclear adapter protein and, in association with Stat5, regulates gene transcription through DNA binding.	Univ Illinois, Hematol Oncol Sect, MBRB, Chicago, IL 60607 USA; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 3E2, Canada; W Side Vet Affairs Hosp, Chicago, IL 60607 USA; Oregon Hlth Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Toronto; Oregon Health & Science University	Platanias, LC (corresponding author), Univ Illinois, Hematol Oncol Sect, MBRB, MC-734,Rm 3150,900 S Ashland Ave, Chicago, IL 60607 USA.	Lplatani@UIC.Edu		Druker, Brian/0000-0001-8331-8206; Uddin, Shahab/0000-0003-1886-6710	NATIONAL CANCER INSTITUTE [R01CA077816] Funding Source: NIH RePORTER; NCI NIH HHS [CA77816] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad S, 1997, J BIOL CHEM, V272, P29991, DOI 10.1074/jbc.272.48.29991; BARAHMANDPOUR F, 1995, FEBS LETT, V360, P29, DOI 10.1016/0014-5793(95)00072-H; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Burfoot MS, 1997, J BIOL CHEM, V272, P24183, DOI 10.1074/jbc.272.39.24183; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; EILERS A, 1994, MOL CELL BIOL, V14, P1364, DOI 10.1128/MCB.14.2.1364; Ghislain JJ, 1996, J BIOL CHEM, V271, P12408, DOI 10.1074/jbc.271.21.12408; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Heaney C, 1997, BLOOD, V89, P297, DOI 10.1182/blood.V89.1.297.297_297_306; Ingham RJ, 1996, J BIOL CHEM, V271, P32306, DOI 10.1074/jbc.271.50.32306; KITAYAMA H, 1990, P NATL ACAD SCI USA, V87, P4284, DOI 10.1073/pnas.87.11.4284; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Koval AP, 1998, J BIOL CHEM, V273, P14780, DOI 10.1074/jbc.273.24.14780; Meinke A, 1996, MOL CELL BIOL, V16, P6937; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Platanias LC, 1996, J BIOL CHEM, V271, P278, DOI 10.1074/jbc.271.1.278; Platanias Leonidas C., 1995, Current Opinion in Oncology, V7, P560, DOI 10.1097/00001622-199511000-00015; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; SAWASDIKOSOL S, 1995, J BIOL CHEM, V270, P2893, DOI 10.1074/jbc.270.7.2893; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; UDDIN S, 1995, J BIOL CHEM, V270, P7712, DOI 10.1074/jbc.270.13.7712	23	116	122	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					571	573		10.1074/jbc.274.2.571	http://dx.doi.org/10.1074/jbc.274.2.571			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872990	hybrid			2022-12-27	WOS:000077968500005
J	Uchiumi, T; Sato, N; Wada, A; Hachimori, A				Uchiumi, T; Sato, N; Wada, A; Hachimori, A			Interaction of the sarcin/ricin domain of 23 S ribosomal RNA with proteins L3 and L6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RIBOSOME; ELONGATION FACTOR-G; RICIN-A-CHAIN; ANTIBIOTIC THIOSTREPTON; BINDING-SITES; CROSS-LINKING; GTPASE CENTER; ALPHA-SARCIN; 50S SUBUNIT; FACTOR TU	We investigated interaction of an RNA domain covering the target;site of alpha-sarcin and ricin (sarcin/ricin domain) of Escherichia coli 23 S rRNA with ribosomal proteins. RNA fragments comprising residues 2630-2788 (Tox-1) and residues 2840-2774 (Tox-2) of 23 S rRNA were transcribed in vitro and used to analyze the binding proteins by gel shift and filter binding. Protein L6 ;bound to both Tox-1 (K-d: 0.31 mu M) and Tox-2 (K-d: 0.18 mu M), and L3 bound only to Tox-1 (K-d: 0.069 mu M) in a solution containing 10 mM MgCl2 and 175 mM KCl at 0 degrees C. Footprinting studies were performed using the chemical probe dimethyl sulfate on full-length 23 S rRNA, Binding of L6 protected a single base, A-2757, and strongly enhanced reactivity of C-2752, A direct role of A-2757 in the L6 binding was verified by site-directed mutagenesis; replacements of A-2757 with G and C impaired the 1.6 binding. On the other hand, binding of L3 protected A-2632, A-2634, A-2635, A-2675, A-2726, A-2733, A-2749, and A-2750. Interestingly, binding of L6 and L3 together protected additional bases A-2657, A-2662, C-2666, and C-2667 in the sarcin/ricin loop, in addition to A-2740, A-2741, A-2748, A-2753, A-2764, A-2765, and A-2766 in the other stem-loop. This appears to be due to cooperative interaction of L3 and L6 with the RNA. The results are discussed with respect to conformational modulation of the sarcin/ricin domain by the protein binding.	Shinshu Univ, Fac Text Sci & Technol, Inst High Polymer Res, Ueda, Nagano 3868567, Japan; Osaka Med Coll, Dept Phys, Takatsuki, Osaka 5690084, Japan	Shinshu University; Osaka Medical College	Uchiumi, T (corresponding author), Shinshu Univ, Fac Text Sci & Technol, Inst High Polymer Res, Ueda, Nagano 3868567, Japan.	uchiumi@giptc.shinshu-u.ac.jp						Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; BEAUCLERK AAD, 1984, J BIOL CHEM, V259, P6559; DRAPER DE, 1988, METHOD ENZYMOL, V164, P203; EGEBJERG J, 1990, J MOL BIOL, V213, P275, DOI 10.1016/S0022-2836(05)80190-1; ENDO Y, 1988, J BIOL CHEM, V263, P8735; ENDO Y, 1982, J BIOL CHEM, V257, P9054; GIRSHOVICH AS, 1981, FEBS LETT, V130, P54, DOI 10.1016/0014-5793(81)80664-3; GIRSHOVICH AS, 1986, FEBS LETT, V197, P192, DOI 10.1016/0014-5793(86)80325-8; GOLDEN BL, 1993, EMBO J, V12, P4901, DOI 10.1002/j.1460-2075.1993.tb06184.x; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; HARDY SJS, 1969, BIOCHEMISTRY-US, V8, P2897, DOI 10.1021/bi00835a031; HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; LEFFERS H, 1988, J MOL BIOL, V204, P507, DOI 10.1016/0022-2836(88)90351-8; MILLER SP, 1991, NUCLEIC ACIDS RES, V19, P1657, DOI 10.1093/nar/19.7.1657; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; Munishkin A, 1997, P NATL ACAD SCI USA, V94, P12280, DOI 10.1073/pnas.94.23.12280; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; NOWOTNY V, 1982, P NATL ACAD SCI-BIOL, V79, P7238, DOI 10.1073/pnas.79.23.7238; ROSENDAHL G, 1993, J MOL BIOL, V234, P1013, DOI 10.1006/jmbi.1993.1655; RYAN PC, 1991, J MOL BIOL, V221, P1257, DOI 10.1016/0022-2836(91)80125-E; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMIDT FJ, 1981, J BIOL CHEM, V256, P2301; SKOLD SE, 1982, EUR J BIOCHEM, V127, P225, DOI 10.1111/j.1432-1033.1982.tb06859.x; SPIERER P, 1975, EUR J BIOCHEM, V52, P459, DOI 10.1111/j.1432-1033.1975.tb04014.x; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; STOFFLERMEILICKE M, 1983, P NATL ACAD SCI-BIOL, V80, P6780, DOI 10.1073/pnas.80.22.6780; SZEWCZAK AA, 1995, J MOL BIOL, V247, P81, DOI 10.1006/jmbi.1994.0124; SZEWCZAK AA, 1993, P NATL ACAD SCI USA, V90, P9581, DOI 10.1073/pnas.90.20.9581; TRAUT RR, 1985, STRUCTURE FUNCTION G, P286; UCHIUMI T, 1995, J BIOL CHEM, V270, P29889; UCHIUMI T, 1991, J BIOL CHEM, V266, P2054; VATER CA, 1995, J BIOL CHEM, V270, P12933, DOI 10.1074/jbc.270.21.12933; WADA A, 1986, J BIOCHEM, V100, P1583, DOI 10.1093/oxfordjournals.jbchem.a121866; WALLECZEK J, 1988, EMBO J, V7, P3571, DOI 10.1002/j.1460-2075.1988.tb03234.x; Wilson KS, 1998, CELL, V92, P131, DOI 10.1016/S0092-8674(00)80905-8; WOWER I, 1981, NUCLEIC ACIDS RES, V9, P4285, DOI 10.1093/nar/9.17.4285	39	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					681	686		10.1074/jbc.274.2.681	http://dx.doi.org/10.1074/jbc.274.2.681			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873002	hybrid			2022-12-27	WOS:000077968500017
J	Wickner, RB; Edskes, HK; Maddelein, ML; Taylor, KL; Moriyama, H				Wickner, RB; Edskes, HK; Maddelein, ML; Taylor, KL; Moriyama, H			Prions of yeast and fungi - Proteins as genetic material	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SACCHAROMYCES-CEREVISIAE; RNA VIRUSES; SUP35 GENE; PSI; URE3; INCOMPATIBILITY; MUTATION; PRODUCT; ANALOG		NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wickner, RB (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bldg 8,Rm 225,,8 Ctr Dr,MSC 0830, Bethesda, MD 20892 USA.	wickner@helix.nih.gov	Moriyama, Hiromitsu/F-9256-2013; MADDELEIN, Marie-Lise/G-5395-2010		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK024943] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; BEGUERET J, 1994, TRENDS GENET, V10, P441, DOI 10.1016/0168-9525(94)90115-5; BEISSON J, 1965, P NATL ACAD SCI USA, V53, P275, DOI 10.1073/pnas.53.2.275; Beisson-Schecroun J, 1962, ANN GENET-PARIS, V4, P3; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Cooper T. G., 1982, MOL BIOL YEAST SACCH, V2, P39; COSCHIGANO PW, 1991, MOL CELL BIOL, V11, P822, DOI 10.1128/MCB.11.2.822; COURCHESNE WE, 1988, J BACTERIOL, V170, P708, DOI 10.1128/jb.170.2.708-713.1988; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Cox Brian, 1993, P219; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; DOEL SM, 1994, GENETICS, V137, P659; DRILLIEN R, 1973, BIOCHEM BIOPH RES CO, V53, P367, DOI 10.1016/0006-291X(73)90671-2; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Grimes G.W., 1991, CELLULAR ASPECTS PAT; Kushnirov VV, 1998, CELL, V94, P13, DOI 10.1016/S0092-8674(00)81216-7; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; Liebman SW, 1999, J BIOL CHEM, V274, P1181, DOI 10.1074/jbc.274.3.1181; Lindquist S, 1997, CELL, V89, P495, DOI 10.1016/S0092-8674(00)80231-7; LUND PM, 1981, GENET RES, V37, P173, DOI 10.1017/S0016672300020140; MAGASANIK B, 1992, MOL CELLULAR BIOL YE, V2, P283; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; MITCHELL AP, 1984, MOL CELL BIOL, V4, P2758, DOI 10.1128/MCB.4.12.2758; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1996, FIELDS VIROLOGY, V2, P2901; RAI R, 1987, J BACTERIOL, V169, P3521, DOI 10.1128/jb.169.8.3521-3524.1987; RIZET GEORGES, 1952, REV CYTOL ET BIOL VEG, V13, P51; SCHOUN J, 1969, CR ACAD SCI D NAT, V269, P1412; SINGH A, 1979, P NATL ACAD SCI USA, V76, P1952, DOI 10.1073/pnas.76.4.1952; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TUITE MF, 1981, GENETICS, V98, P691; TUROSCY V, 1987, J BACTERIOL, V169, P2598, DOI 10.1128/jb.169.6.2598-2600.1987; Weissmann C, 1999, J BIOL CHEM, V274, P3, DOI 10.1074/jbc.274.1.3; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1996, CURR TOP MICROBIOL, V207, P147; Wickner RB, 1996, ANNU REV GENET, V30, P109, DOI 10.1146/annurev.genet.30.1.109; Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996	40	64	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					555	558		10.1074/jbc.274.2.555	http://dx.doi.org/10.1074/jbc.274.2.555			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872986	hybrid			2022-12-27	WOS:000077968500001
J	Yang, WC; Ghiotto, M; Barbarat, B; Olive, D				Yang, WC; Ghiotto, M; Barbarat, B; Olive, D			The role of Tec protein-tyrosine kinase in T cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; GTPASE-ACTIVATING PROTEIN; SRC FAMILY KINASES; ANTIGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; CROSS-LINKING; COSTIMULATORY RECEPTOR; SH3 DOMAINS; PH DOMAIN; CD28	The Tec protein-tyrosine kinase family includes Btk, Itk/Tsk/Emt, Tee, Rlk/Txk, and Bmx which are involved in signals mediated by various cytokines or antigen receptors. Itk is expressed primarily in T cells and activated by TCR/CD3, CD28, and CD2. However, the defect in T cell signaling in itk-deficient mice is very modest. Thus, we looked for other Tec family kinases that could be expressed in lymphoid cells and involved in T cell signal transduction. Here, we demonstrate that Tee, expressed in T cells, is activated following TCR/CD3 or CD28 ligation and interacts with CD28 receptor in an activation-dependent manner. This interaction involves the Tec SH3 domain and the proline-rich motifs in CD28. We also show that Tec can phosphorylate p62(dok), one CD28-specific substrate, whereas Itk cannot. Overexpression of Tec but not Itk can enhance the interleukin-2 promoter activity mediated by TCR/CD3 or CD28 stimulation and introduction of a kinase-dead Tec but not Itk can suppress interleukin-2 expression, indicating that Tec is directly involved in T cell activation. Altogether, these data demonstrate that Tec kinase is an integral component of T cell signaling and that the two Tec family kinases, Tec and Itk, have distinct roles in T cell activation.	INSERM, U119, F-13009 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Olive, D (corresponding author), INSERM, U119, 27 Blvd Lei Roure, F-13009 Marseille, France.		Barbarat, Bernadette/R-2881-2016; Yang, Wen-Chin/D-3441-2015	Barbarat, Bernadette/0000-0002-8578-980X; Yang, Wen-Chin/0000-0001-6410-2581				Afar DEH, 1996, MOL CELL BIOL, V16, P3465; ANDREA L, 1995, TRENDS GENET, V11, P216; Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; AUGUST A, 1994, BIOCHEM BIOPH RES CO, V199, P1466, DOI 10.1006/bbrc.1994.1396; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; BOLEN JB, 1995, CURR OPIN IMMUNOL, V7, P306, DOI 10.1016/0952-7915(95)80103-0; BUDAY L, 1994, J BIOL CHEM, V269, P9019; Bunnell SC, 1996, J BIOL CHEM, V271, P25646, DOI 10.1074/jbc.271.41.25646; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; CHENG GH, 1994, P NATL ACAD SCI USA, V91, P8152, DOI 10.1073/pnas.91.17.8152; DANIELIAN S, 1992, EUR J IMMUNOL, V22, P2915, DOI 10.1002/eji.1830221124; DECLUE JE, 1993, MOL CELL BIOL, V13, P6799, DOI 10.1128/MCB.13.11.6799; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; ELLIS C, 1991, ONCOGENE, V6, P895; Gibson S, 1996, J IMMUNOL, V156, P2716; Gibson S, 1996, J BIOL CHEM, V271, P7079, DOI 10.1074/jbc.271.12.7079; GIBSON S, 1993, BLOOD, V82, P1561; GOTOH A, 1994, LEUKEMIA, V8, P115; HEYECK SD, 1993, P NATL ACAD SCI USA, V90, P669, DOI 10.1073/pnas.90.2.669; HUBERT P, 1993, J EXP MED, V178, P1587, DOI 10.1084/jem.178.5.1587; HUTCHCROFT JE, 1994, P NATL ACAD SCI USA, V91, P3260, DOI 10.1073/pnas.91.8.3260; KAWAKAMI Y, 1995, J IMMUNOL, V155, P3556; King PD, 1997, J IMMUNOL, V158, P580; King PD, 1996, INT IMMUNOL, V8, P1707, DOI 10.1093/intimm/8.11.1707; Kitanaka A, 1998, BLOOD, V91, P940, DOI 10.1182/blood.V91.3.940.940_940_948; Li TJ, 1997, ONCOGENE, V15, P1375, DOI 10.1038/sj.onc.1201308; LI TJ, 1995, IMMUNITY, V2, P451, DOI 10.1016/1074-7613(95)90026-8; Li ZM, 1997, P NATL ACAD SCI USA, V94, P13820, DOI 10.1073/pnas.94.25.13820; Liao XC, 1997, J EXP MED, V186, P221, DOI 10.1084/jem.186.2.221; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; LU YL, 1992, J IMMUNOL, V149, P24; LU YL, 1994, EUR J IMMUNOL, V24, P2732, DOI 10.1002/eji.1830241124; MACHIDE M, 1995, ONCOGENE, V11, P619; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; MANO H, 1995, BLOOD, V85, P343; MANO H, 1994, ONCOGENE, V9, P3205; MANO H, 1993, ONCOGENE, V8, P417; Mano H, 1996, FASEB J, V10, P637, DOI 10.1096/fasebj.10.5.8621063; Marengere LEM, 1997, J IMMUNOL, V159, P3220; MATSUDA T, 1995, BLOOD, V85, P627, DOI 10.1182/blood.V85.3.627.bloodjournal853627; Miyazato A, 1996, CELL GROWTH DIFFER, V7, P1135; NUNES J, 1993, INT IMMUNOL, V5, P311, DOI 10.1093/intimm/5.3.311; Nunes JA, 1996, J BIOL CHEM, V271, P1591, DOI 10.1074/jbc.271.3.1591; NUNES JA, 1994, J EXP MED, V180, P1067, DOI 10.1084/jem.180.3.1067; Ohya K, 1997, J BIOL CHEM, V272, P27178, DOI 10.1074/jbc.272.43.27178; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Pages F, 1996, J BIOL CHEM, V271, P9403, DOI 10.1074/jbc.271.16.9403; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Rawlings D J, 1995, Semin Immunol, V7, P237, DOI 10.1006/smim.1995.0028; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; REIF K, 1994, J BIOL CHEM, V269, P14081; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; SILICIANO JD, 1992, P NATL ACAD SCI USA, V89, P11194, DOI 10.1073/pnas.89.23.11194; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Tanaka N, 1997, EUR J IMMUNOL, V27, P834; TANAKA N, 1993, FEBS LETT, V324, P1, DOI 10.1016/0014-5793(93)81520-A; TANG B, 1994, MOL CELL BIOL, V14, P8432, DOI 10.1128/MCB.14.12.8432; TSYGANKOV AY, 1992, J BIOL CHEM, V267, P18259; VANDENBERGHE P, 1992, J EXP MED, V175, P951, DOI 10.1084/jem.175.4.951; VIHINEN M, 1994, FEBS LETT, V350, P263, DOI 10.1016/0014-5793(94)00783-7; Ward SG, 1996, IMMUNOL TODAY, V17, P187, DOI 10.1016/0167-5699(96)80618-9; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yamashita Y, 1998, BLOOD, V91, P1496, DOI 10.1182/blood.V91.5.1496.1496_1496_1507; Yamashita Y, 1997, EXP HEMATOL, V25, P211; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	71	84	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					607	617		10.1074/jbc.274.2.607	http://dx.doi.org/10.1074/jbc.274.2.607			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872994	hybrid			2022-12-27	WOS:000077968500009
J	Zhang, MC; He, L; Giro, M; Yong, SL; Tiller, GE; Davidson, JM				Zhang, MC; He, L; Giro, M; Yong, SL; Tiller, GE; Davidson, JM			Cutis laxa arising from frameshift mutations in exon 30 of the elastin gene (ELN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	Meetin on Elastin and Elastic Tissue	OCT 17-20, 1996	MARATEA, ITALY				SUPRAVALVULAR AORTIC-STENOSIS; SKIN FIBROBLAST-CULTURES; MARFAN-SYNDROME; WILLIAMS-SYNDROME; POINT MUTATIONS; FIBRILLIN GENE; ECTOPIA LENTIS; EXPRESSION; DISEASE; CDNA	Congenital cutis laxa, a rare syndrome with marked skin laxity and pulmonary and cardiovascular compromise, is due to defective elastic fiber formation. In several cases, skin fibroblast tropoelastin production is markedly reduced yet reversed in vitro by transforming growth factor-beta treatment. We previously showed that this reversal was due to elastin mRNA stabilization in one cell strain, and here this behavior was confirmed in skin fibroblasts from two generations of a second family. cDNA sequencing and heteroduplex analysis of elastin gene transcripts from three fibroblast strains in two kindreds now identify two frameshift mutations (2012 Delta G and 2039 Delta C) in elastin gene exon 30, thus leading to missense C termini. No other mutations were present in the ELN cDNA sequences of all three affected individuals. Transcripts from both alleles in each kindred were unstable and responsive to transforming growth factor-beta. Exons 22, 23, 26A, and 32 were always absent. Since exon 30 underwent alternative splicing in fibroblasts, we speculate that a differential splicing pattern could conceivably lead to phenotypic rescue. These two dominant-acting, apparently de novo mutations in the elastin gene appear to be responsible for qualitative and quantitative defects in elastin, resulting in the cutis laxa phenotype.	Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Dept Vet Affairs Med Ctr, Res Serv, Nashville, TN 37212 USA; Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of British Columbia	Davidson, JM (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol, C-3321 MCN, Nashville, TN 37232 USA.		xu, tao/K-6631-2016		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037387] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR44431] Funding Source: Medline; NIGMS NIH HHS [GM37387] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASHIR M, 1990, ELASTIN CHEM BIOL AS, P45; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Bittar, 1993, ADV MOL CELL BIOL, P133, DOI [10.1016/S1569-2558(08)60201-5, DOI 10.1016/S1569-2558(08)60201-5]; BROWN PL, 1992, BIOCHEM BIOPH RES CO, V186, P549, DOI 10.1016/S0006-291X(05)80843-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRAWFORD SW, 1985, BIOCHEM J, V227, P491, DOI 10.1042/bj2270491; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; DAMKIER A, 1991, CLIN GENET, V39, P321; Davidson JM, 1995, CIBA F SYMP, V192, P81; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; EWART AK, 1994, J CLIN INVEST, V93, P1071, DOI 10.1172/JCI117057; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; FAZIO MJ, 1988, J INVEST DERMATOL, V91, P458, DOI 10.1111/1523-1747.ep12476591; FRISCH SM, 1985, MOL CELL BIOL, V5, P253, DOI 10.1128/MCB.5.1.253; GIRO MG, 1985, J CLIN INVEST, V75, P672, DOI 10.1172/JCI111746; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; INDIK Z, 1987, CONNECT TISSUE RES, V16, P197, DOI 10.3109/03008208709006976; INDIK Z, 1990, EXTRACELLULAR MATRIX, P221; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; KEATING MT, 1995, CIRCULATION, V92, P142, DOI 10.1161/01.CIR.92.1.142; KITANO Y, 1989, J AM ACAD DERMATOL, V21, P378, DOI 10.1016/S0190-9622(89)80039-8; KOTZOT D, 1995, EUR J PEDIATR, V154, P477, DOI 10.1007/BF02029360; LEE B, 1991, NATURE, V352, P334; Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021; LOWERY MC, 1995, AM J HUM GENET, V57, P49; MARIGO V, 1994, BIOCHEM BIOPH RES CO, V199, P1049, DOI 10.1006/bbrc.1994.1335; MARTORANA PA, 1993, LAB INVEST, V68, P233; Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281; MORISAKI H, 1993, J CLIN INVEST, V91, P2275, DOI 10.1172/JCI116455; Neldner K H, 1988, Clin Dermatol, V6, P1; OLSEN DR, 1988, J BIOL CHEM, V263, P6465; PACHTER JS, 1987, CELL, V51, P283, DOI 10.1016/0092-8674(87)90155-3; PASQUALIRONCHETTI I, 1994, EXP MOL PATHOL, V61, P36, DOI 10.1006/exmp.1994.1024; PIERCE RA, 1990, BIOCHEMISTRY-US, V29, P9677, DOI 10.1021/bi00493a024; PYERITZ RE, 1993, CONNECTIVE TISSUE IT, P436; SEPHEL GC, 1989, J INVEST DERMATOL, V93, P147, DOI 10.1111/1523-1747.ep12277389; Tassabehji M, 1997, HUM MOL GENET, V6, P1029, DOI 10.1093/hmg/6.7.1029; Tassabehji M, 1998, HUM MOL GENET, V7, P1021, DOI 10.1093/hmg/7.6.1021; TROMP G, 1991, NUCLEIC ACIDS RES, V19, P4314, DOI 10.1093/nar/19.15.4314-a; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; UITTO J, 1989, J AM ACAD DERMATOL, V21, P614, DOI 10.1016/S0190-9622(89)70228-0; Uitto Jouni, 1993, P409; WOLFE BL, 1993, J BIOL CHEM, V268, P12418; ZHANG MC, 1995, J CLIN INVEST, V95, P986, DOI 10.1172/JCI117808	44	113	117	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					981	986		10.1074/jbc.274.2.981	http://dx.doi.org/10.1074/jbc.274.2.981			6	Biochemistry & Molecular Biology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873040	hybrid			2022-12-27	WOS:000077968500055
J	Hackeng, CM; Pladet, MW; Akkerman, JWN; van Rijn, HJM				Hackeng, CM; Pladet, MW; Akkerman, JWN; van Rijn, HJM			Low density lipoprotein phosphorylates the focal adhesion-associated kinase p125(FAK) in human plate independent of integrin alpha(IIb)beta(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE GLYCOPROTEIN-VI; TYROSINE PHOSPHORYLATION; LYSOPHOSPHATIDIC-ACID; ACTIVATED PLATELETS; MEDIATED ACTIVATION; CYTOPLASMIC DOMAIN; BLOOD-PLATELETS; PROTEIN-KINASE; MAP KINASE; C-SRC	Low density lipoprotein (LDL) is known to sensitize platelets to agonists via integrin mediated outside-in signaling (Hackeng, C, M,, Huigsloot, M,, Pladet, M, W,, Nieuwenhuis, H. K., Rijn, H, J. M, v,, and Akkerman, J, W, N, (1999) Arterioscler, Thromb, Vase, Biol,, in press). As outside in signaling is associated with phosphorylation of p125(FAK), the effect of LDL on p125FAK phosphorylation in platelets was investigated. LDL induced p125FAK phosphorylation in a dose- and time- dependent manner. The phosphorylation was independent of ligand binding to integrin alpha(IIb)beta(3) and aggregation, such in contrast to Lu-thrombin-induced p125FAK phosphorylation, that critically depended on platelet aggregation, Platelets from patients with Glanzmann's thrombastenia showed the same LDL- induced phosphorylation of p125(FAK) as control platelets, whereas alpha-thrombin completely failed to phosphorylate the kinase in the patients platelets. LDL signaling to p125FAK was independent of integrin alpha(2)beta(1), the Fc gamma RII receptor, and the lysophosphatidic acid receptor and not affected by inhibitors of cyclooxygenase, protein kinase C, ERK1/2 or p38(MAPK). Phosphorylation of p125(FAK) by LDL was strongly inhibited by cyclic AMP, These observations indicate that LDL is a unique platelet agonist, as it phosphorylates p125(FAK) in platelet suspensions, under unstirred conditions and independent of integrin alpha(IIb)beta(3).	Univ Utrecht Hosp, Dept Haematol, NL-3508 GA Utrecht, Netherlands; Univ Utrecht Hosp, Dept Clin Chem, NL-3508 GA Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University	Akkerman, JWN (corresponding author), Univ Utrecht Hosp, Dept Haematol, POB 85500, NL-3508 GA Utrecht, Netherlands.							ANDREWS HE, 1987, BIOCHEM J, V242, P559, DOI 10.1042/bj2420559; ARDLIE NG, 1989, ATHEROSCLEROSIS, V76, P117, DOI 10.1016/0021-9150(89)90094-4; BLOCK LH, 1988, P NATL ACAD SCI USA, V85, P885, DOI 10.1073/pnas.85.3.885; CALALB MB, 1995, MOL CELL BIOL, V15, P954; DUNN RC, 1988, FEBS LETT, V238, P357, DOI 10.1016/0014-5793(88)80512-X; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; ELSAADANI M, 1989, J LIPID RES, V30, P627; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; HACKENG CM, IN PRESS ARTERIOSCLE; HAFFNER C, 1995, EMBO J, V14, P19, DOI 10.1002/j.1460-2075.1995.tb06971.x; HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868; Haimovich B, 1996, BLOOD, V87, P152, DOI 10.1182/blood.V87.1.152.bloodjournal871152; Haimovich B, 1996, J BIOL CHEM, V271, P16332, DOI 10.1074/jbc.271.27.16332; Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; HORSTRUP K, 1994, EUR J BIOCHEM, V225, P21, DOI 10.1111/j.1432-1033.1994.00021.x; HUANG MM, 1993, J CELL BIOL, V122, P473, DOI 10.1083/jcb.122.2.473; Ichinohe T, 1997, J BIOL CHEM, V272, P63; ICHINOHE T, 1995, J BIOL CHEM, V270, P28029; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Imamura F, 1996, INT J CANCER, V65, P627, DOI 10.1002/(SICI)1097-0215(19960301)65:5<627::AID-IJC12>3.0.CO;2-4; Jacobs D. S., 1996, LAB TEST HDB; JALINK K, 1995, BIOCHEM J, V307, P609, DOI 10.1042/bj3070609; KNORR M, 1988, EUR J BIOCHEM, V172, P753, DOI 10.1111/j.1432-1033.1988.tb13953.x; LEONG L, 1995, J CELL SCI, V108, P3817; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Lin TH, 1997, J CELL BIOL, V136, P1385, DOI 10.1083/jcb.136.6.1385; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; Lyman S, 1997, J BIOL CHEM, V272, P22538, DOI 10.1074/jbc.272.36.22538; Negrier C, 1998, BRIT J HAEMATOL, V100, P33, DOI 10.1046/j.1365-2141.1998.00515.x; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nofer JR, 1997, CIRCULATION, V95, P1370; OLEARY VJ, 1992, BIOCHEM J, V282, P631, DOI 10.1042/bj2820631; POLANOWSKAGRABOWSKA R, 1993, BIOCHEM J, V296, P543, DOI 10.1042/bj2960543; Polte TR, 1997, J BIOL CHEM, V272, P5501, DOI 10.1074/jbc.272.9.5501; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; SCHLAEPFER DD, 1994, NATURE, V372, P786; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; SHATTIL SJ, 1994, J BIOL CHEM, V269, P14738; SHATTIL SJ, 1988, PLATELET MEMBRANE RE, P345; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; SURYA II, 1993, AM HEART J, V125, P272, DOI 10.1016/0002-8703(93)90096-R; SURYA II, 1992, BIOCHIM BIOPHYS ACTA, V1165, P19, DOI 10.1016/0005-2760(92)90070-C; THOMAS CE, 1991, J PHARMACOL EXP THER, V256, P1182; VANWILLIGEN G, 1994, ARTERIOSCLER THROMB, V14, P41, DOI 10.1161/01.ATV.14.1.41; Wang F, 1997, BIOCHEM J, V324, P481, DOI 10.1042/bj3240481; Wang RG, 1997, J CLIN INVEST, V100, P2393, DOI 10.1172/JCI119780; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; ZHAO B, 1995, AM J HEMATOL, V49, P177, DOI 10.1002/ajh.2830490302	55	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					384	388		10.1074/jbc.274.1.384	http://dx.doi.org/10.1074/jbc.274.1.384			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867854	hybrid			2022-12-27	WOS:000077900200054
J	Johansson, L; Thomsen, JS; Damdimopoulos, AE; Spyrou, G; Gustafsson, JA; Treuter, E				Johansson, L; Thomsen, JS; Damdimopoulos, AE; Spyrou, G; Gustafsson, JA; Treuter, E			The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ER alpha and ER beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; RETINOID-X-RECEPTOR; LIGAND-BINDING DOMAIN; HISTONE ACETYLTRANSFERASE; DNA-BINDING; ALLOSTERIC CONTROL; CO-REPRESSOR; COACTIVATOR; ACTIVATION; CBP	SHP (short heterodimer partner) is an unusual orphan nuclear receptor that contains a putative ligand-binding domain but lacks a conserved DNA-binding domain, Although no conventional receptor function has yet been identified, SHP has been proposed to act as a negative regulator of nuclear receptor signaling pathways, because it interacts with and inhibits DNA binding and transcriptional activity of various nonsteroid receptors, including thyroid hormone and retinoid receptors, We show here that SHP interacts directly with agonist-bound estrogen receptors, ER alpha and ER beta, and inhibits ER-mediated transcriptional activation. SHP specifically targets the ligand-regulated activation domain AF-2 and competes for binding of coactivators such as TIF2. Thus, SHP may represent a new category of negative coregulators for ligand-activated nuclear receptors. SHP mRNA is widely expressed in rat tissues including certain estrogen target tissues, and subcellular localization studies demonstrate that SHP is a nuclear protein, suggesting a biological significance of the SHP interactions with ERs. Taken together, these results identify ERs as novel SHP targets and suggest that competition for coactivator-binding is a novel mechanism by which SHP may inhibit nuclear receptor activation.	Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden	Karolinska Institutet	Treuter, E (corresponding author), Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden.			Damdimopoulos, Anastasios/0000-0003-4425-1189; Treuter, Eckardt/0000-0002-4147-8989; thomsen, jane/0000-0002-9336-5695				Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chang KH, 1997, P NATL ACAD SCI USA, V94, P9040, DOI 10.1073/pnas.94.17.9040; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chu RY, 1996, J BIOL CHEM, V271, P27670, DOI 10.1074/jbc.271.44.27670; Collingwood TN, 1997, J BIOL CHEM, V272, P13060, DOI 10.1074/jbc.272.20.13060; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; Crawford PA, 1998, MOL CELL BIOL, V18, P2949, DOI 10.1128/MCB.18.5.2949; Enmark E, 1996, MOL ENDOCRINOL, V10, P1293, DOI 10.1210/me.10.11.1293; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Kalkhoven E, 1998, EMBO J, V17, P232, DOI 10.1093/emboj/17.1.232; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; Lee HK, 1998, J BIOL CHEM, V273, P14398, DOI 10.1074/jbc.273.23.14398; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Masuda N, 1997, BBA-GENE STRUCT EXPR, V1350, P27, DOI 10.1016/S0167-4781(96)00196-0; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Norris JD, 1998, J BIOL CHEM, V273, P6679, DOI 10.1074/jbc.273.12.6679; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; ONATE SA, 1995, SCIENCE, V270, P1354; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; Schulman IG, 1997, GENE DEV, V11, P299, DOI 10.1101/gad.11.3.299; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Seol W, 1997, MOL CELL BIOL, V17, P7126, DOI 10.1128/MCB.17.12.7126; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Thompson PD, 1998, J BIOL CHEM, V273, P8483, DOI 10.1074/jbc.273.14.8483; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; White R, 1997, EMBO J, V16, P1427, DOI 10.1093/emboj/16.6.1427; Wiebel FF, 1997, MOL CELL BIOL, V17, P3977, DOI 10.1128/MCB.17.7.3977; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zazopoulos E, 1997, NATURE, V390, P311, DOI 10.1038/36899; Zhang X, 1998, MOL ENDOCRINOL, V12, P513, DOI 10.1210/me.12.4.513	61	157	161	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					345	353		10.1074/jbc.274.1.345	http://dx.doi.org/10.1074/jbc.274.1.345			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867849	hybrid			2022-12-27	WOS:000077900200049
J	Oliveira, L; Bouton, C; Drapier, JC				Oliveira, L; Bouton, C; Drapier, JC			Thioredoxin activation of iron regulatory proteins - Redox regulation of RNA binding after exposure to nitric oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR MESSENGER-RNA; RESPONSIVE ELEMENT; CYTOSOLIC ACONITASE; SULFUR CLUSTER; MODULATION; SYNTHASE; FERRITIN; PHOSPHORYLATION; PEROXYNITRITE; DEGRADATION	Iron regulatory proteins (IRP1 and IRP2) are redox-sensitive RNA-binding proteins that modulate the expression of several genes encoding key proteins of iron metabolism. IRP1 can also exist as an aconitase containing a [4Fe-4S] cluster bound to three cysteines at the active site. We previously showed that biosynthesis of nitric oxide (NO) induces the transition of IRP1 from aconitase to apoprotein able to bind RNA. This switch is also observed when cytosolic extracts are exposed to NO donors. However, the activation of IRP1 under these conditions is far from maximal. In this study we examined the capacity of physiological reducing systems to cooperate with NO in the activation of IRP1. Cytosolic extracts from the macrophage cell line RAW 264.7 or purified IRP1 were incubated with NO donors and subsequently exposed to glutathione or to thioredoxin (Trx), a strong protein disulfide reductase, Trx was the most effective, inducing a 2-6-fold enhancement of the RNA binding activity of NO-treated IRP1. Furthermore, the effect of NO on IRP1 from cytosolic extracts was abolished in the presence of anti-Trx antibodies. We also studied the combined effect of NO and Trx on IRP2, which exhibits constitutive RNA binding activity. We observed an inhibition of IRP2 activity following exposure to NO donors which was restored by Trx. Collectively, these results point to a crucial role of Trx as a modulator of IRP activity in situations of NO production.	CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Drapier, JC (corresponding author), CNRS, Inst Chim Subst Nat, Ave de la Terrasse, F-91198 Gif Sur Yvette, France.	Jean-Claude.Drapier@icsn.cnrs-gif.fr	Bouton, Cecile/J-8663-2013					BEINERT H, 1993, FASEB J, V7, P1442, DOI 10.1096/fasebj.7.15.8262329; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Bouton C, 1996, J BIOL CHEM, V271, P2300, DOI 10.1074/jbc.271.4.2300; Bouton C, 1997, J BIOL CHEM, V272, P19969, DOI 10.1074/jbc.272.32.19969; CAIRO G, 1995, EUR J BIOCHEM, V232, P358, DOI 10.1111/j.1432-1033.1995.tb20819.x; Cairo G, 1996, FASEB J, V10, P1326, DOI 10.1096/fasebj.10.11.8836047; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; CROW JP, 1995, BIOCHEMISTRY-US, V34, P3544, DOI 10.1021/bi00011a008; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; EISENSTEIN RS, 1993, J BIOL CHEM, V268, P27363; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; GUO B, 1994, J BIOL CHEM, V269, P24252; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; Henderson BR, 1996, BIOESSAYS, V18, P739, DOI 10.1002/bies.950180909; HENDERSON BR, 1993, J BIOL CHEM, V268, P27327; HENDERSON BR, 1995, J BIOL CHEM, V270, P20509, DOI 10.1074/jbc.270.35.20509; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; JacquierSarlin MR, 1996, BIOCHEM J, V318, P187, DOI 10.1042/bj3180187; JAFFREY SR, 1994, P NATL ACAD SCI USA, V91, P12994, DOI 10.1073/pnas.91.26.12994; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KIM HY, 1995, J BIOL CHEM, V270, P4983, DOI 10.1074/jbc.270.10.4983; KLAUSNER RD, 1993, MOL BIOL CELL, V4, P1; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; KUHN LC, 1992, J INORG BIOCHEM, V47, P183, DOI 10.1016/0162-0134(92)84064-T; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Makino Y, 1996, J CLIN INVEST, V98, P2469, DOI 10.1172/JCI119065; MARTINS EAL, 1995, ARCH BIOCHEM BIOPHYS, V316, P128, DOI 10.1006/abbi.1995.1019; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; MULLNER EW, 1992, EUR J BIOCHEM, V208, P597, DOI 10.1111/j.1432-1033.1992.tb17224.x; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; PACKER L, 1996, FASEB J, V10, P709; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Patel JM, 1996, AM J RESP CELL MOL, V15, P410, DOI 10.1165/ajrcmb.15.3.8810647; Phillips JD, 1996, BIOCHEMISTRY-US, V35, P15704, DOI 10.1021/bi960653l; PHILPOTT CC, 1993, J BIOL CHEM, V268, P17655; PIGIET VP, 1986, P NATL ACAD SCI USA, V83, P7643, DOI 10.1073/pnas.83.20.7643; RADI R, 1991, J BIOL CHEM, V266, P4244; Recalcati S, 1998, BLOOD, V91, P1059, DOI 10.1182/blood.V91.3.1059.1059_1059_1066; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Schalinske KL, 1997, P NATL ACAD SCI USA, V94, P10681, DOI 10.1073/pnas.94.20.10681; Schalinske KL, 1997, BIOCHEMISTRY-US, V36, P3950, DOI 10.1021/bi9624447; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; SCHENK H, 1994, P NATL ACAD SCI USA, V91, P1672, DOI 10.1073/pnas.91.5.1672; Smith MA, 1998, BRAIN RES, V788, P232, DOI 10.1016/S0006-8993(98)00002-X; Theil EC, 1998, MET IONS BIOL SYST, V35, P403; TOTH I, 1995, J BIOL CHEM, V270, P19540, DOI 10.1074/jbc.270.33.19540; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x	57	42	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					516	521		10.1074/jbc.274.1.516	http://dx.doi.org/10.1074/jbc.274.1.516			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867873	hybrid			2022-12-27	WOS:000077900200073
J	Verma, AK; Paszty, K; Filoteo, AG; Penniston, JT; Enyedi, A				Verma, AK; Paszty, K; Filoteo, AG; Penniston, JT; Enyedi, A			Protein kinase C phosphorylates plasma membrane Ca2+ pump isoform 4a at its calmodulin binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-PUMP; REGION; 4B	Phosphorylation by protein kinase C of isoform 4a of the human plasma membrane Ca2+ pump (hPMCA4a) was studied using the COS cell expression system. Phosphorylation of several truncated mutants of hPMCA4a indicated that a single phosphorylation site lies in a region between residues 1113 and 1125, This region is within the calmodulin binding domain and contains a single phosphorylatable residue, serine 1115, Converting this serine to an alanine diminished phosphorylation greatly. Phosphorylation, done in the absence of calmodulin, did not affect subsequent calmodulin binding, but previous binding of calmodulin did inhibit phosphorylation, Moreover, no significant shift in the calmodulin response curve of hPMCA4a was observed when phosphorylation was mimicked by converting serine 1115 to an acidic residue. The calmodulin binding domain of hPMCA4a is much longer than other calmodulin binding domains and has been suggested to consist of two binding lobes interrupted by a short nonbinding region. The findings of this study indicate that serine 1115 is the residue phosphorylated by protein kinase C, and that it lies within the nonbinding region of the calmodulin binding domain.	Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Natl Inst Haematol & Immunol, H-1113 Budapest, Hungary	Mayo Clinic	Enyedi, A (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, 200 1st S W, Rochester, MN 55905 USA.		Pászty, Katalin/X-3785-2019; Enyedi, Agnes/N-9742-2013	Enyedi, Agnes/0000-0002-7366-9376; Paszty, Katalin/0000-0003-2457-8555	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055514, R01GM028835] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55514, GM28835] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARIK S, 1993, PCR PROTOCOLS CURREN, P277; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; Enyedi A, 1997, J BIOL CHEM, V272, P27525, DOI 10.1074/jbc.272.44.27525; Enyedi A, 1996, J BIOL CHEM, V271, P32461, DOI 10.1074/jbc.271.50.32461; ENYEDI A, 1994, J BIOL CHEM, V269, P41; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157; PENNISTON JT, 1998, ADV MOL CEL A&B, V23, P249; STREHLER EE, 1991, J MEMBRANE BIOL, V120, P1, DOI 10.1007/BF01868586; VERGHESE GM, 1994, J BIOL CHEM, V269, P9361; Verma AK, 1996, J BIOL CHEM, V271, P3714; VERMA AK, 1994, J BIOL CHEM, V269, P1687	13	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					527	531		10.1074/jbc.274.1.527	http://dx.doi.org/10.1074/jbc.274.1.527			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867875	hybrid			2022-12-27	WOS:000077900200075
J	Wu, SY; Perez, MD; Puyol, P; Sawyer, L				Wu, SY; Perez, MD; Puyol, P; Sawyer, L			beta-lactoglobulin binds palmitate within its central cavity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-INDUCED INTERACTIONS; FATTY-ACID; ALPHA-LACTALBUMIN; PROTEIN; RETINOL; BOVINE; RESOLUTION; MILK; DENATURATION; REFINEMENT	Bovine beta-lactoglobulin (beta-Lg) has been studied extensively in both the isolated and the naturally occurring states. It is a commercially important whey protein of obvious nutritional value but, so far, one that has no clearly identified biological function. In common with many of the other members of the lipocalin family to which it belongs, beta-Lg binds hydrophobic ligands, and it appears possible that there are at least two distinct binding sites per monomer for a variety of ligands, By comparison with other members of the family, there is a probable binding site in the central cavity of the molecule that is formed by the eight antiparallel beta-strands that are typical of the lipocalins, We have now cocrystallized beta-Lg with palmitic acid, and the refined structure (R = 0.204, R-free = 0.240 for 6,888 reflections to 2.5-Angstrom resolution) reveals that the ligand binds in the central cavity in a manner similar to the binding of retinol to the related lipocalin, serum retinol-binding protein. The carboxyl group binds to both Lys-60 and Lys-69 at the entrance to the cavity. The hydrophobic tail stretches in an almost fully extended conformation into the center of the protein. This is the first direct observation of a ligand binding to beta-Lg.	Univ Edinburgh, Struct Biochem Grp, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Zaragoza, Fac Vet, E-50013 Zaragoza, Spain	University of Edinburgh; University of Zaragoza	Sawyer, L (corresponding author), Univ Edinburgh, Struct Biochem Grp, Swann Bldg,Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	L.Sawyer@ed.ac.uk	Wu, Su-Ying/C-1370-2010; Pérez, María D/B-6919-2017					BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; Brownlow S, 1997, STRUCTURE, V5, P481, DOI 10.1016/S0969-2126(97)00205-0; CHEN RF, 1967, J BIOL CHEM, V242, P173; CHO YJ, 1994, J BIOL CHEM, V269, P11102; Ducruix A., 1992, CRYSTALLIZATION NUCL, P73; Flower DR, 1996, BIOCHEM J, V318, P1; FOX PF, 1995, HEAT INDUCED CHANGES; FRAPIN D, 1993, J PROTEIN CHEM, V12, P443, DOI 10.1007/BF01025044; Gezimati J, 1997, J AGR FOOD CHEM, V45, P1130, DOI 10.1021/jf960564f; Hambling S. G., 1992, ADV DAIRY CHEM, V1, P141; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P2278, DOI 10.1021/bi962018l; Iametti S, 1996, EUR J BIOCHEM, V237, P106, DOI 10.1111/j.1432-1033.1996.0106n.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LYSTER RLJ, 1972, J DAIRY RES, V39, P279, DOI 10.1017/S0022029900014114; MONACO HL, 1987, J MOL BIOL, V197, P695, DOI 10.1016/0022-2836(87)90476-1; Narayan M, 1997, BIOCHEMISTRY-US, V36, P1906, DOI 10.1021/bi9621526; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NEWCOMER ME, 1984, EMBO J, V3, P1451, DOI 10.1002/j.1460-2075.1984.tb01995.x; NOH B, 1989, J FOOD SCI, V54, P889, DOI 10.1111/j.1365-2621.1989.tb07906.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAPIZ MZ, 1986, NATURE, V324, P383, DOI 10.1038/324383a0; PEREZ MD, 1992, BIOCHIM BIOPHYS ACTA, V1123, P151, DOI 10.1016/0005-2760(92)90105-5; PEREZ MD, 1989, J BIOCHEM-TOKYO, V106, P1094, DOI 10.1093/oxfordjournals.jbchem.a122971; PEREZ MD, 1995, J DAIRY SCI, V78, P978, DOI 10.3168/jds.S0022-0302(95)76713-3; PUYOL P, 1994, J DAIRY SCI, V77, P1494, DOI 10.3168/jds.S0022-0302(94)77088-0; PUYOL P, 1991, AGR BIOL CHEM TOKYO, V55, P2515, DOI 10.1080/00021369.1991.10871001; Qi XL, 1997, BIOCHEM J, V324, P341, DOI 10.1042/bj3240341; Qin BY, 1998, BIOCHEMISTRY-US, V37, P14014, DOI 10.1021/bi981016t; Ragona L, 1997, FOLD DES, V2, P281, DOI 10.1016/S1359-0278(97)00039-4; Rocha TL, 1996, J DAIRY RES, V63, P575, DOI 10.1017/S0022029900032118; ROEFS SPFM, 1994, EUR J BIOCHEM, V226, P883, DOI 10.1111/j.1432-1033.1994.00883.x; SACCHETTINI JC, 1992, J BIOL CHEM, V267, P23534; Sawyer L, 1998, INT DAIRY J, V8, P65, DOI 10.1016/S0958-6946(98)00021-1; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; TANFORD C, 1959, J AM CHEM SOC, V81, P4032, DOI 10.1021/ja01524a054; Tilley J. M. A., 1960, Dairy Science Abstracts, V22, P111	37	283	289	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					170	174		10.1074/jbc.274.1.170	http://dx.doi.org/10.1074/jbc.274.1.170			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867826	hybrid			2022-12-27	WOS:000077900200026
J	Chen, SY; Smith, DF				Chen, SY; Smith, DF			Hop as an adaptor in the heat shock protein 70 (Hsp70) and Hsp90 chaperone machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT RETICULOCYTE LYSATE; PROGESTERONE-RECEPTOR; MOLECULAR CHAPERONE; GLUCOCORTICOID RECEPTOR; BINDING DOMAINS; P60; P23; RECONSTITUTION; IDENTIFICATION; HETEROCOMPLEX	Hop, an abundant and conserved protein of unresolved function, binds concomitantly with heat shock protein 70 (Hsp70) and Hsp90, participates with heat shock proteins at an intermediate stage of progesterone receptor assembly, and is required for efficient assembly of mature receptor complexes in vitro, A largely untested hypothesis is that Hop functions as an adaptor that targets Hsp90- to Hsp70-substrate complexes; if true, then loss of either Hsp70 binding or Hsp90 binding by Hop should equally disrupt its ability to promote assembly of mature receptor complexes. To generate Hop mutants that selectively disrupt heat shock protein interactions, highly conserved amino acids in the previously mapped Hsp70 and Hsp90 binding domains of Hop and in a conserved C-terminal domain were targeted for small substitutions and deletions. In co-precipitation assays, these mutants displayed selective loss of association with heat shock proteins. In assays using Hop-depleted rabbit reticulocyte lysate for the cell-free assembly of receptor complexes, none of the Hop mutants inhibited Hsp70 binding to receptor, but all mutants were defective in supporting Hsp90-receptor interactions. Thus, Hop has a novel role in the chaperone machinery as an adaptor that can integrate Hsp70 and Hsp90 interactions.	Univ Nebraska, Med Ctr, Dept Pharmacol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Smith, DF (corresponding author), Univ Nebraska, Med Ctr, Dept Pharmacol, 600 S 42nd St, Omaha, NE 68198 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048218] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK48218] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barent RL, 1998, MOL ENDOCRINOL, V12, P342, DOI 10.1210/me.12.3.342; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Dittmar KD, 1997, J BIOL CHEM, V272, P13047, DOI 10.1074/jbc.272.20.13047; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Fung KL, 1996, J BIOL CHEM, V271, P21559, DOI 10.1074/jbc.271.35.21559; Gebauer M, 1997, FEBS LETT, V417, P109, DOI 10.1016/S0014-5793(97)01267-2; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Gross M, 1996, J BIOL CHEM, V271, P16833, DOI 10.1074/jbc.271.28.16833; HOEHFELD J, 1995, CELL, V83, P589; HUTCHISON KA, 1995, J BIOL CHEM, V270, P18841, DOI 10.1074/jbc.270.32.18841; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; JOHNSON JL, 1995, MOL ENDOCRINOL, V9, P670, DOI 10.1210/me.9.6.670; Lassle M, 1997, J BIOL CHEM, V272, P1876, DOI 10.1074/jbc.272.3.1876; NICOLET CM, 1989, MOL CELL BIOL, V9, P3638, DOI 10.1128/MCB.9.9.3638; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Prapapanich V, 1998, MOL CELL BIOL, V18, P944, DOI 10.1128/MCB.18.2.944; Prapapanich V, 1996, MOL CELL BIOL, V16, P6200; Prapapanich V, 1996, MOL ENDOCRINOL, V10, P420, DOI 10.1210/me.10.4.420; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; SCHERRER LC, 1990, J BIOL CHEM, V265, P21397; SMITH DF, 1992, J BIOL CHEM, V267, P1350; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Thulasiraman V, 1996, BIOCHEMISTRY-US, V35, P13443, DOI 10.1021/bi9615396	32	265	273	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35194	35200		10.1074/jbc.273.52.35194	http://dx.doi.org/10.1074/jbc.273.52.35194			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857057	hybrid			2022-12-27	WOS:000077719700075
J	Hynds, PJ; Robinson, D; Robinson, C				Hynds, PJ; Robinson, D; Robinson, C			The Sec-independent twin-arginine translocation system can transport both tightly folded and malfolded proteins across the thylakoid membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; PRECURSOR PROTEIN; CHLOROPLAST ENVELOPES; ENERGY-REQUIREMENTS; PEA-CHLOROPLASTS; PROTON GRADIENT; CONTACT SITES; IMPORT; PATHWAY; BINDING	A subset of lumen proteins is transported across the thylakoid membrane by a Sec-independent translocase that recognizes a twin-arginine motif in the targeting signal. A related system operates in bacteria, apparently for the export of redox cofactor-containing proteins. In this report we describe a key feature of this system, the ability to transport folded proteins. The thylakoidal system is able to transport dihydrofolate reductase (DHFR) when an appropriate signal is attached, and the transport efficiency is almost undiminished by the binding of folate analogs such as methotrexate that cause the protein to fold very tightly. The system is moreover able to transport DHFR into the lumen with methotrexate bound in the active site, demonstrating that the Delta pH-driven transport of large, native structures is possible by this pathway. However, correct folding is not a prerequisite for transport. Truncated, malfolded DHFR can be translocated by this system, as can physiological substrates that are severely malfolded by the incorporation of amino acid analogs.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Robinson, C (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.							AMERICA T, 1994, PLANT MOL BIOL, V24, P283, DOI 10.1007/BF00020168; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; BROCK IW, 1993, PLANT MOL BIOL, V23, P717, DOI 10.1007/BF00021527; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Clark SA, 1997, MOL BIOL CELL, V8, P923, DOI 10.1091/mbc.8.5.923; CLINE K, 1992, J BIOL CHEM, V267, P2688; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; CREIGHTON AM, 1995, J BIOL CHEM, V270, P1663, DOI 10.1074/jbc.270.4.1663; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; ENDO T, 1994, EUR J BIOCHEM, V225, P403, DOI 10.1111/j.1432-1033.1994.00403.x; GUERA A, 1993, PLANT MOL BIOL, V23, P309, DOI 10.1007/BF00029007; HENRY R, 1994, J BIOL CHEM, V269, P10189; KLOSGEN RB, 1992, PLANT MOL BIOL, V18, P1031, DOI 10.1007/BF00019226; LAIDLER V, 1995, J BIOL CHEM, V270, P17664, DOI 10.1074/jbc.270.30.17664; MANT A, 1994, J BIOL CHEM, V269, P27303; MEADOWS JW, 1989, FEBS LETT, V253, P244, DOI 10.1016/0014-5793(89)80968-8; MOULD RM, 1991, J BIOL CHEM, V266, P12189; MULLER G, 1988, EMBO J, V7, P639, DOI 10.1002/j.1460-2075.1988.tb02858.x; NAKAI M, 1994, J BIOL CHEM, V269, P31338; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; RASSOW J, 1990, FEBS LETT, V275, P190, DOI 10.1016/0014-5793(90)81469-5; ROBINSON C, 1994, EMBO J, V13, P279, DOI 10.1002/j.1460-2075.1994.tb06260.x; Robinson C, 1998, PLANT MOL BIOL, V38, P209, DOI 10.1023/A:1006041917853; ROBINSON C, 1985, EUR J BIOCHEM, V152, P67, DOI 10.1111/j.1432-1033.1985.tb09164.x; Roffey RA, 1996, PLANT PHYSIOL, V111, P1329, DOI 10.1104/pp.111.4.1329; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; SCHNELL DJ, 1993, J CELL BIOL, V120, P103, DOI 10.1083/jcb.120.1.103; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; VOELKER R, 1995, EMBO J, V14, P3905, DOI 10.1002/j.1460-2075.1995.tb00062.x; WALES R, 1989, PLANT MOL BIOL, V13, P573, DOI 10.1007/BF00027317; WALTON PA, 1995, MOL BIOL CELL, V3, P186; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; YUAN JG, 1994, SCIENCE, V266, P796, DOI 10.1126/science.7973633	36	136	146	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34868	34874		10.1074/jbc.273.52.34868	http://dx.doi.org/10.1074/jbc.273.52.34868			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857014	hybrid			2022-12-27	WOS:000077719700032
J	Ricken, S; Leipziger, J; Greger, R; Nitschke, R				Ricken, S; Leipziger, J; Greger, R; Nitschke, R			Simultaneous measurements of cytosolic and mitochondrial Ca2+ transients in HT29 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT CARDIAC MYOCYTES; COLON-CARCINOMA CELLS; ENDOTHELIAL-CELLS; FREE CALCIUM; CONFOCAL MICROSCOPY; FREE CA-2+; FLUORESCENCE; FURA-2; PH; SUSPENSIONS	Loading of HT29 cells with the Ca2+ dye fura-2/AM resulted in an nonhomogeneous intracellular distribution of the dye. Cellular compartments with high fura-2 concentrations were identified by correlation with mitochondrial markers, cellular autofluorescence induced by UV, and dynamic measurement of autofluorescence after inhibition of oxidative phosphorylation. Stimulation with carbachol (10(-4) mol/liter) increased cytosolic, nuclear, and mitochondrial Ca2+ activity ([Ca2+](c), [Ca2+](n), and [Ca2+](m), respectively) measured by UV confocal and conventional imaging. Similar results were obtained with a prototype two-photon microscope (Zeiss, Jena, Germany) allowing for fura-2 excitation. The increase of [Ca2+](m) lagged behind that of [Ca2+](c) and [Ca2+](n) by 10-20 s, and after removing the agonist, [Ca2+](m) also decreased with a delay. A strong increase of [Ca2+](m) occurred only when a certain threshold of [Ca2+](c) (around 1 mu mol/liter) was exceeded. In a very similar way, ATP, neurotensin, and thapsigargin increased [Ca2+](c) and [Ca2+](m). Carbonyl cyanide p-trifluoromethoxyphenylhyrdrazone reversibly reduced the increase of [Ca2+](m). The source of the mitochondrial Ca2+ increase had intra- and extracellular components, as revealed by experiments in low extracellular Ca2+. We conclude that agonist-induced Ca2+ signals are transduced into mitochondria, 1) Mitochondria could serve as a Ca2+ sink, 2) mitochondria could allow the modulation of [Ca2+](c) and [Ca2+](n) signals, and 3) [Ca2+](m) may serve as a stimulatory metabolic signal when a cell is highly stimulated.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany	University of Freiburg	Nitschke, R (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.		Nitschke, Roland/F-9525-2010	Nitschke, Roland/0000-0002-9397-8475; Leipziger, Jens/0000-0002-6719-7034				Benning N, 1996, PFLUG ARCH EUR J PHY, V432, P126, DOI 10.1007/s004240050114; Chacon E, 1996, FEBS LETT, V382, P31, DOI 10.1016/0014-5793(96)00138-X; CHACON E, 1992, BIOCHEM J, V281, P871, DOI 10.1042/bj2810871; CHACON E, 1994, BIOPHYS J, V66, P942, DOI 10.1016/S0006-3495(94)80904-X; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; Donnadieu E, 1996, CELL CALCIUM, V20, P53, DOI 10.1016/S0143-4160(96)90050-0; ENG J, 1989, BIOPHYS J, V55, P621, DOI 10.1016/S0006-3495(89)82859-0; Griffiths EJ, 1997, CELL CALCIUM, V21, P321, DOI 10.1016/S0143-4160(97)90120-2; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER TE, 1988, AM J PHYSIOL, V255, P304; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HOFER AM, 1993, P NATL ACAD SCI USA, V90, P2598, DOI 10.1073/pnas.90.7.2598; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; KERST G, 1995, PFLUG ARCH EUR J PHY, V430, P653, DOI 10.1007/BF00386159; KOPP R, 1989, EUR J PHARM-MOLEC PH, V172, P397, DOI 10.1016/0922-4106(89)90021-7; KOTTGEN M, 1994, PFLUG ARCH EUR J PHY, V428, P179, DOI 10.1007/BF00374856; Lawrie AM, 1996, J BIOL CHEM, V271, P10753, DOI 10.1074/jbc.271.18.10753; LEIPZIGER J, 1991, Cellular Physiology and Biochemistry, V1, P273, DOI 10.1159/000154615; LUKACS GL, 1987, BIOCHEM J, V248, P609, DOI 10.1042/bj2480609; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; MILLS LR, 1994, 3 DIMENSIONAL CONFOC, P253; MIYATA H, 1991, AM J PHYSIOL, V261, pH1123, DOI 10.1152/ajpheart.1991.261.4.H1123; NATHANSON MH, 1992, CELL CALCIUM, V13, P89, DOI 10.1016/0143-4160(92)90002-A; NICHOLS BJ, 1995, MOL CELL BIOCHEM, V149, P203, DOI 10.1007/BF01076578; NITSCHKE R, 1993, PFLUG ARCH EUR J PHY, V423, P519, DOI 10.1007/BF00374950; NITSCHKE R, 1991, PFLUG ARCH EUR J PHY, V417, P622, DOI 10.1007/BF00372961; Nitschke R, 1997, PFLUG ARCH EUR J PHY, V434, P466, DOI 10.1007/s004240050422; Nitschke R, 1997, PFLUG ARCH EUR J PHY, V433, P653, DOI 10.1007/s004240050327; POENIE M, 1985, NATURE, V315, P147, DOI 10.1038/315147a0; Purkiss JR, 1996, CELL CALCIUM, V20, P21, DOI 10.1016/S0143-4160(96)90047-0; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; REERS M, 1989, BIOCHEM J, V257, P131, DOI 10.1042/bj2570131; RINK TJ, 1985, CELL CALCIUM, V6, P133, DOI 10.1016/0143-4160(85)90040-5; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Rutter GA, 1996, P NATL ACAD SCI USA, V93, P5489, DOI 10.1073/pnas.93.11.5489; SHEU SS, 1994, J BIOENERG BIOMEMBR, V26, P487, DOI 10.1007/BF00762733; SHIMOMURA O, 1989, BIOCHEM J, V261, P913, DOI 10.1042/bj2610913; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; STEINBERG SF, 1987, AM J PHYSIOL, V253, pC744, DOI 10.1152/ajpcell.1987.253.5.C744; WILLIFORD DJ, 1990, CIRC RES, V66, P234	42	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34961	34969		10.1074/jbc.273.52.34961	http://dx.doi.org/10.1074/jbc.273.52.34961			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857027	hybrid			2022-12-27	WOS:000077719700045
J	Hunter, S; Burton, EA; Wu, SC; Anderson, SM				Hunter, S; Burton, EA; Wu, SC; Anderson, SM			Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; EPIDERMAL GROWTH-FACTOR; GAMMA SIGNAL-TRANSDUCTION; PROLACTIN PRL RECEPTOR; CRK ADAPTER PROTEINS; IN-VIVO ASSOCIATION; C-CBL; PROTOONCOGENE PRODUCT; EGF RECEPTOR; KINASE JAK2	We have investigated the interaction between Cbl and the Src-related tyrosine kinase Fyn. Fyn was observed to be constitutively associated with Cbl in lysates of several different cell types including the interleukin-3-dependent murine myeloid cell line 32Dc13, and the prolactin-dependent rat thymoma cell line Nb2. Binding studies indicated that Cbl could bind to glutathione S-transferase (GST) fusion proteins encoding the unique, Src homology domain 3 (SH3), and SH2 domains of Fyn, Hck, or Lyn, Fusion proteins encoding either the SH3 or SH2 domains of Fyn bound to Cbl as effectively as the fusion protein encoding the unique, SH3, and SH2 domains of Fyn. The Fyn SH2 domain bound to both tyrosine-phosphorylated and nonphosphorylated Cbl, implying that this interaction might be phosphotyrosine-independent. Binding of the Fyn SH2 domain to Cbl was not disrupted by the addition of phosphotyrosine, phosphoserine, or phosphothreonine. A GST fusion protein encoding the proline-rich region of Cbl bound to Fyn present in a total cell lysate. Far Western blot analysis also indicated that the SH3 domain of Fyn bound preferentially to the proline-rich region of Cbl. The addition of [gamma-P-32]ATP to either anti-Cbl immunoprecipitates or anti-Fyn immunoprecipitates resulted in the phosphorylation of both Cbl and Fyn as demonstrated by immunoprecipitation of the phosphorylated proteins with specific antisera. Fyn directly phosphorylated a GST fusion protein containing the C-terminal region of Cbl (GST-CBL-LZIP). In contrast, immunoprecipitated JAK2 was not able to phosphorylate this same region of Cbl. The GST-CBL-LZIP fusion protein contains a binding site for the SH2 domain of the p85 subunit of phosphatidylinositol 3-kinase, which mapped to Tyr(731), which is present in the sequence YEAM. Mutation of Tyr(731) in GST-CBL-LZIP eliminated binding of the p85 subunit of phosphatidylinositol 3-kinase and substantially reduced the phosphorylation of this fusion protein by Fyn, despite the presence of four other tyrosine residues in this fusion protein. These data are consistent with the hypothesis that Cbl represents a substrate for Src-like kinases that are activated in response to the engagement of cell surface receptors, and that Src-like kinases are responsible for the phosphorylation of a tyrosine residue in Cbl that may regulate activation of phosphatidylinositol 3-kinase.	Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Anderson, SM (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pathol, 4200 E 9th Ave, Denver, CO 80262 USA.	steve.anderson@uchsc.edu			NATIONAL CANCER INSTITUTE [R01CA045241, R29CA045241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048845] Funding Source: NIH RePORTER; NCI NIH HHS [CA45241] Funding Source: Medline; NIDDK NIH HHS [DK48878, DK48845] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; ANDERSON SM, 1995, J IMMUNOL, V155, P1660; Anderson SM, 1997, J BIOL CHEM, V272, P739, DOI 10.1074/jbc.272.2.739; Barber DL, 1997, BLOOD, V89, P3166, DOI 10.1182/blood.V89.9.3166; BLAKE TJ, 1991, ONCOGENE, V6, P653; Burnham MR, 1996, ONCOGENE, V12, P2467; Burton EA, 1997, J BIOL CHEM, V272, P16189, DOI 10.1074/jbc.272.26.16189; CAMPBELL KS, 1991, P NATL ACAD SCI USA, V88, P3982, DOI 10.1073/pnas.88.9.3982; CHEADLE C, 1994, J BIOL CHEM, V269, P24034; CLEVENGER CV, 1994, MOL ENDOCRINOL, V8, P674, DOI 10.1210/me.8.6.674; DASILVA L, 1994, J BIOL CHEM, V269, P18267; Datta K, 1996, J BIOL CHEM, V271, P30835, DOI 10.1074/jbc.271.48.30835; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DAVID M, 1994, P NATL ACAD SCI USA, V91, P7174, DOI 10.1073/pnas.91.15.7174; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; delPeso L, 1997, SCIENCE, V278, P687; DombroskyFerlan PM, 1997, ONCOGENE, V14, P2019, DOI 10.1038/sj.onc.1201031; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; FitzerAttas CJ, 1997, J BIOL CHEM, V272, P8551, DOI 10.1074/jbc.272.13.8551; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141, DOI 10.1074/jbc.270.32.19141; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; Gao J, 1996, MOL ENDOCRINOL, V10, P847, DOI 10.1210/me.10.7.847; GILMOUR KC, 1994, P NATL ACAD SCI USA, V91, P6850, DOI 10.1073/pnas.91.15.6850; HANNEMANN J, 1995, MOL CELL BIOL, V15, P2402; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Hartley D, 1996, J BIOL CHEM, V271, P21939, DOI 10.1074/jbc.271.36.21939; Hunter S, 1997, MOL ENDOCRINOL, V11, P1213, DOI 10.1210/me.11.9.1213; Ingham RJ, 1996, J BIOL CHEM, V271, P32306, DOI 10.1074/jbc.271.50.32306; Joung I, 1996, P NATL ACAD SCI USA, V93, P5991, DOI 10.1073/pnas.93.12.5991; KAWAKAMI Y, 1989, ONCOGENE, V4, P389; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Khwaja A, 1996, ONCOGENE, V12, P2491; KLIPPEL A, 1992, MOL CELL BIOL, V12, P1451, DOI 10.1128/MCB.12.4.1451; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; LEBRUN JJ, 1994, J BIOL CHEM, V269, P14021; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Luo XM, 1997, J BIOL CHEM, V272, P12221, DOI 10.1074/jbc.272.18.12221; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; MARCILLA A, 1995, J BIOL CHEM, V270, P9115, DOI 10.1074/jbc.270.16.9115; MATSUDA M, 1997, J BIOL CHEM, V271, P14468; MEISNER H, 1995, MOL CELL BIOL, V15, P3571; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; ODAI H, 1995, J BIOL CHEM, V270, P10800, DOI 10.1074/jbc.270.18.10800; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Park I, 1995, P NATL ACAD SCI USA, V92, P12338, DOI 10.1073/pnas.92.26.12338; Parrizas M, 1997, J BIOL CHEM, V272, P154; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; Raffel GD, 1996, J BIOL CHEM, V271, P4640; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; RICKLES RJ, 1994, EMBO J, V13, P5598, DOI 10.1002/j.1460-2075.1994.tb06897.x; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; RUI H, 1994, J BIOL CHEM, V269, P5364; SAKAI R, 1994, J BIOL CHEM, V269, P32740; Sattler M, 1997, J BIOL CHEM, V272, P10248; Sattler M, 1996, ONCOGENE, V12, P839; Sawasdikosol S, 1996, J IMMUNOL, V157, P110; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; Smit L, 1996, ONCOGENE, V13, P381; Soltoff SP, 1996, J BIOL CHEM, V271, P563, DOI 10.1074/jbc.271.1.563; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; SPARKS AB, 1994, J BIOL CHEM, V269, P23853; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; TANAKA S, 1995, J BIOL CHEM, V270, P14347, DOI 10.1074/jbc.270.24.14347; TORIGOE T, 1992, BLOOD, V80, P617; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WHITE MF, 1994, J BIOL CHEM, V269, P1; YamamotoHonda R, 1996, J BIOL CHEM, V271, P28677, DOI 10.1074/jbc.271.45.28677; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	85	116	117	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2097	2106		10.1074/jbc.274.4.2097	http://dx.doi.org/10.1074/jbc.274.4.2097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890970	hybrid			2022-12-27	WOS:000078185200037
J	Reiners, JJ; Clift, RE				Reiners, JJ; Clift, RE			Aryl hydrocarbon receptor regulation of ceramide-induced apoptosis in murine hepatoma 1c1c7 cells - A function independent of aryl hydrocarbon receptor nuclear translocator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DAUNORUBICIN-INDUCED APOPTOSIS; C57BL/6N MOUSE EMBRYO; AH RECEPTOR; DEVELOPMENTAL EXPRESSION; TRANSCRIPTION FACTORS; ALPHA-NAPHTHOFLAVONE; SIGNAL-TRANSDUCTION; PERMEABLE CERAMIDE; DIOXIN RECEPTOR	The relationship between aryl hydrocarbon receptor (AHR) content and susceptibility to apoptosis was examined in the murine hepatoma 1c1c7 cell line and a series of variants having different levels of AHR expression. Exposure of 1c1c7 cultures to N-acetylsphingosine (C-2-ceramide) caused a concentradion-dependent inhibition of cell proliferation, loss of viability, and induction of apoptosis as monitored by analyses of DNA fragmentation and caspase activation. A variant cell line (Tao) having similar to 10% of the AHR content of 1c1c7 cells also arrested following exposure to C-2-ceramide, but did not undergo apoptosis, Modulation of 1c1c7 and Tao AHR contents by transfection of Ahr antisense and sense constructs, respectively, confirmed the relationship between AHR content and susceptibility to C-2-ceramide-indueed apoptosis. C-2-ceramide also induced the apoptosis of an AHR-containing cell line lacking the aryl hydrocarbon receptor nuclear translocator protein. ABR ligands (Le. 2,3,7,8-tetrachlorodibenzo-p-dioxin and alpha-naphthoflavone) neither induced apoptosis nor modulated the development of apoptosis in C-2-ceramide-treated 1c1c7 cultures, AHR content did not affect staurosporine- or doxorubicin-induced apoptosis. These results suggest the ABR modulates aspects of ceramide signaling associated with the induction of apoptosis but not cell cycle arrest, and does so by a mechanism that is independent of its interaction with aryl hydrocarbon receptor nuclear translocator and exogenous AHR ligands.	Wayne State Univ, Inst Chem Toxicol, Detroit, MI 48201 USA	Wayne State University	Reiners, JJ (corresponding author), Wayne State Univ, Inst Chem Toxicol, 2727 2nd Ave,Rm 4000, Detroit, MI 48201 USA.	john.reiners.jr@wayne.edu			NATIONAL CANCER INSTITUTE [R01CA034469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639] Funding Source: NIH RePORTER; NCI NIH HHS [CA34469] Funding Source: Medline; NIEHS NIH HHS [P30 ES06639] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABBOTT BD, 1995, DEV DYNAM, V204, P144, DOI 10.1002/aja.1002040205; ABBOTT BD, 1995, DEV DYNAM, V204, P133, DOI 10.1002/aja.1002040204; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHREST FJ, 1993, CYTOMETRY, V14, P883, DOI 10.1002/cyto.990140806; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Crawford RB, 1997, MOL PHARMACOL, V52, P921, DOI 10.1124/mol.52.6.921; DBAIBO GS, 1995, P NATL ACAD SCI USA, V92, P1347, DOI 10.1073/pnas.92.5.1347; Decaudin D, 1998, INT J ONCOL, V12, P141; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Ge NL, 1998, J BIOL CHEM, V273, P22708, DOI 10.1074/jbc.273.35.22708; GILLNER M, 1993, MOL PHARMACOL, V44, P336; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Herr I, 1997, EMBO J, V16, P6200, DOI 10.1093/emboj/16.20.6200; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jaeschke H, 1998, J IMMUNOL, V160, P3480; Jaffrezou JP, 1996, EMBO J, V15, P2417, DOI 10.1002/j.1460-2075.1996.tb00599.x; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jarvis WD, 1997, MOL PHARMACOL, V52, P935, DOI 10.1124/mol.52.6.935; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; KAFAFI SA, 1992, CARCINOGENESIS, V13, P1599, DOI 10.1093/carcin/13.9.1599; Kamath AB, 1997, TOXICOL APPL PHARM, V142, P367, DOI 10.1006/taap.1996.8049; Kimura C, 1998, EXP CELL RES, V239, P411, DOI 10.1006/excr.1997.3912; Kuroki J, 1996, LEUKEMIA, V10, P1950; Lavie Y, 1997, J BIOL CHEM, V272, P1682, DOI 10.1074/jbc.272.3.1682; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Lawrence BP, 1996, TOXICOL APPL PHARM, V138, P275, DOI 10.1006/taap.1996.0126; LIU J, 1994, J BIOL CHEM, V269, P3047; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; LOZANO J, 1994, J BIOL CHEM, V269, P19200; Lu YF, 1996, BIOCHEM PHARMACOL, V51, P1077, DOI 10.1016/0006-2952(96)00063-9; Ma Q, 1996, MOL CELL BIOL, V16, P2144; MILLER AG, 1983, J BIOL CHEM, V258, P3523; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Mitamura S, 1998, BIOCHEM BIOPH RES CO, V243, P480, DOI 10.1006/bbrc.1998.8122; MULLER G, 1995, EMBO J, V14, P1961, DOI 10.1002/j.1460-2075.1995.tb07188.x; NEBERT DW, 1994, BIOCHEM PHARMACOL, V47, P25, DOI 10.1016/0006-2952(94)90434-0; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; PASCHER I, 1976, BIOCHIM BIOPHYS ACTA, V455, P433, DOI 10.1016/0005-2736(76)90316-3; Pastorino JG, 1996, J BIOL CHEM, V271, P29792, DOI 10.1074/jbc.271.47.29792; POLLENZ RS, 1994, MOL PHARMACOL, V45, P428; Reiners JJ, 1997, MOL CARCINOGEN, V19, P91, DOI 10.1002/(SICI)1098-2744(199707)19:2<91::AID-MC4>3.0.CO;2-O; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; SANTOSTEFANO M, 1993, MOL PHARMACOL, V43, P200; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; SCHOLLER A, 1994, MOL PHARMACOL, V45, P944; Scott DW, 1996, J IMMUNOL, V156, P2352; SHAH J, 1995, J LIPID RES, V36, P1936; Su X, 1996, J IMMUNOL, V156, P4198; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; WEIB C, 1996, EXP CELL RES, V226, P154; WHITLOCK JP, 1984, J BIOL CHEM, V259, P980; WILHELMSSON A, 1994, J BIOL CHEM, V269, P19028; WOLFF RA, 1994, J BIOL CHEM, V269, P19605; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; YAO B, 1995, NATURE, V378, P307, DOI 10.1038/378307a0; Yue TL, 1998, J MOL CELL CARDIOL, V30, P495, DOI 10.1006/jmcc.1997.0614; Zaher H, 1998, MOL PHARMACOL, V54, P313, DOI 10.1124/mol.54.2.313; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	71	50	53	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2502	2510		10.1074/jbc.274.4.2502	http://dx.doi.org/10.1074/jbc.274.4.2502			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891021	hybrid			2022-12-27	WOS:000078185200088
J	Rouvinen, J; Rautiainen, J; Virtanen, T; Zeiler, T; Kauppinen, J; Taivainen, A; Mantyjarvi, R				Rouvinen, J; Rautiainen, J; Virtanen, T; Zeiler, T; Kauppinen, J; Taivainen, A; Mantyjarvi, R			Probing the molecular basis of allergy - Three-dimensional structure of the bovine lipocalin allergen Bos d 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIRCH POLLEN PROFILIN; X-RAY; BETA-LACTOGLOBULIN; CRYSTAL-STRUCTURE; BINDING-PROTEIN; IGE-EPITOPE; ASSOCIATION; RESOLUTION; REFINEMENT; CLONING	The three-dimensional structure of the major bovine allergen Bos d 2 has been determined by using x-ray diffraction at 1.8-Angstrom resolution, Structurally Bos d 2 is a member of the lipocalin family comprising proteins with transport functions. There is a flat small cavity inside the Bos d 2 protein core suitable for ligand binding, and it is possible that Glu(115) and Asn(37) inside the core are able to make hydrogen bonds with the ligand. Many allergens from different animals belong to the lipocalin family. The amino acid residue similarities between these lipocalins indicate putative regions for IgE binding. Comparison with the available allergen structures from other sources suggests that these allergens are roughly the same size and that their shape is more spherical than elliptical.	Univ Joensuu, Dept Chem, FIN-80101 Joensuu, Finland; Univ Kuopio, Dept Clin Microbiol, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Pulm Dis, FIN-70211 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital	Rouvinen, J (corresponding author), Univ Joensuu, Dept Chem, POB 111, FIN-80101 Joensuu, Finland.	juha.rouvinen@joensuu.fi						Arruda LK, 1995, J BIOL CHEM, V270, P31196, DOI 10.1074/jbc.270.52.31196; BALL G, 1994, CLIN EXP ALLERGY, V24, P758, DOI 10.1111/j.1365-2222.1994.tb00987.x; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Brownlow S, 1997, STRUCTURE, V5, P481, DOI 10.1016/S0969-2126(97)00205-0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Fedorov AA, 1997, INT ARCH ALLERGY IMM, V113, P109, DOI 10.1159/000237520; Fedorov AA, 1997, STRUCTURE, V5, P33, DOI 10.1016/S0969-2126(97)00164-0; Flower DR, 1996, BIOCHEM J, V318, P1; FRANCESCHI G, 1989, J ANTIMICROB CHEMOTH, V23, P1; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gregoire C, 1996, J BIOL CHEM, V271, P32951, DOI 10.1074/jbc.271.51.32951; Ichikawa S, 1998, J BIOL CHEM, V273, P356, DOI 10.1074/jbc.273.1.356; ISLAM SA, 1995, PROTEIN ENG, V8, P513, DOI 10.1093/protein/8.6.513; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Konieczny A, 1997, IMMUNOLOGY, V92, P577, DOI 10.1046/j.1365-2567.1997.00386.x; Liebers V, 1996, CLIN EXP ALLERGY, V26, P494, DOI 10.1111/j.1365-2222.1996.tb00570.x; LORUSSO JR, 1986, J ALLERGY CLIN IMMUN, V78, P928, DOI 10.1016/0091-6749(86)90242-3; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MIYAMOTO T, 1992, ADVANCES IN ALLERGOLOGY AND CLINICAL IMMUNOLOGY, P343; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishiyama C, 1995, MOL IMMUNOL, V32, P1021, DOI 10.1016/0161-5890(95)00091-7; OTWINOWSKI Z, 1993, P CCP4 STUD WEEK DAT; Rautiainen J, 1998, BIOCHEM BIOPH RES CO, V247, P746, DOI 10.1006/bbrc.1998.8851; Rautiainen J, 1998, J ALLERGY CLIN IMMUN, V101, P349, DOI 10.1016/S0091-6749(98)70247-7; SANTA H, J PROTEIN CHEM, V17, P663; SCHWARTZ RH, 1985, ANNU REV IMMUNOL, V3, P237, DOI 10.1146/annurev.iy.03.040185.001321; Stewart GA, 1996, CLIN EXP ALLERGY, V26, P1020, DOI 10.1111/j.1365-2222.1996.tb00641.x; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Thorn KS, 1997, STRUCTURE, V5, P19, DOI 10.1016/S0969-2126(97)00163-9; YLONEN J, 1994, ALLERGY, V49, P707, DOI 10.1111/j.1398-9995.1994.tb02091.x; Zeiler T, 1997, J ALLERGY CLIN IMMUN, V100, P721, DOI 10.1016/S0091-6749(97)70264-1	35	73	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2337	2343		10.1074/jbc.274.4.2337	http://dx.doi.org/10.1074/jbc.274.4.2337			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891000	hybrid			2022-12-27	WOS:000078185200067
J	Yuen, MH; Mizuguchi, H; Lee, YH; Cook, PF; Uyeda, K; Hasemann, CA				Yuen, MH; Mizuguchi, H; Lee, YH; Cook, PF; Uyeda, K; Hasemann, CA			Crystal structure of the H256A mutant of rat testis fructose-6-phosphate,2-kinase/fructose-2,6-bisphosphatase - Fructose 6-phosphate in the active site leads to mechanisms for both mutant and wild type bisphosphatase activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC 6-PHOSPHOFRUCTO-2-KINASE FRUCTOSE-2,6-BISPHOSPHATASE; PHOSPHOGLYCERATE MUTASE; LIVER FRUCTOSE-2,6-BISPHOSPHATASE; BIFUNCTIONAL ENZYME; ACID-PHOSPHATASE; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE; INTERMEDIATE; DOMAIN; 2,6-BISPHOSPHATASE; PHOSPHOHISTIDINE	Fructose-6-phosphate,2-kinase/fructose-2 phatase (Fru-6-P,2-kinase/Fru-2,6-Pase) is a bifunctional enzyme, catalyzing the interconversion of beta-D-fructose-6-phosphate (Fru-6-P) and fructose-2,6-bisphosphate (Fru-2,6-P-2) at distinct active sites. A mutant rat testis isozyme with an alanine replacement for the catalytic histidine (H256A) in the Fru-2,6-Pase domain retains 17% of the wild type activity (Mizuguchi, H., Cook, P. F., Tai, C-H., Hasemann, C.A., and Uyeda, K. (1998) J. Biol Chem. 274, 2166-2175), We have solved the crystal structure of H256A to a resolution of 2.4 Angstrom by molecular replacement. Clear electron density for Fru-6-P is found at the Fru-2,6-Pase active site, revealing the important interactions in substrate/product binding. A superposition of the H256A structure with the RT2K-Wo structure reveals no significant reorganization of the active site resulting from the binding of Fru-6-P or the H256A mutation. Using this superposition, we have built a view of the Fru-2,6-P-2-bound enzyme and identify the residues responsible for catalysis. This analysis yields distinct catalytic mechanisms for the wild type and mutant proteins. The wild type mechanism would lead to an inefficient transfer of a proton to the leaving group Fru-6-P, which is consistent with a view of this event being rate-limiting, explaining the extremely slow turnover (0.032 s(-1)) of the Fru-2,6-Pase in all Fru-6-P,2-kinase/Fru-2,6-Pase isozymes.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA; Dept Vet Affairs Med Ctr, Res Serv, Dallas, TX 75216 USA; Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Oklahoma System; University of Oklahoma - Norman	Hasemann, CA (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.		Mizuguchi, Hiroyuki/B-5676-2013	Mizuguchi, Hiroyuki/0000-0001-7055-316X	NIDDK NIH HHS [DK16194] Funding Source: Medline; NIGMS NIH HHS [GM36799] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036799] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BERRY RS, 1960, J CHEM PHYS, V32, P933, DOI 10.1063/1.1730820; BLATTLER WA, 1980, BIOCHEMISTRY-US, V19, P738; Bodansky O, 1972, Adv Clin Chem, V15, P43, DOI 10.1016/S0065-2423(08)60159-6; Brunger A.T., 1993, X PLOR VERSION 3 1 S; DENNIS EA, 1966, J AM CHEM SOC, V88, P3432, DOI 10.1021/ja00966a046; FOTHERGILLGILMORE LA, 1989, ADV ENZYMOL RAMB, V62, P227; Hasemann CA, 1996, STRUCTURE, V4, P1017, DOI 10.1016/S0969-2126(96)00109-8; ISTVAN ES, 1995, PROTEIN SCI, V4, P2439, DOI 10.1002/pro.5560041125; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lee YH, 1997, NAT STRUCT BIOL, V4, P615, DOI 10.1038/nsb0897-615; Lee YH, 1996, BIOCHEMISTRY-US, V35, P6010, DOI 10.1021/bi9600613; LI L, 1992, J BIOL CHEM, V267, P21588; LI L, 1992, J BIOL CHEM, V267, P16669; LIN K, 1992, J BIOL CHEM, V267, P19163; LIN K, 1992, J BIOL CHEM, V267, P6556; LIN K, 1994, J BIOL CHEM, V269, P16953; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mizuguchi H, 1999, J BIOL CHEM, V274, P2166, DOI 10.1074/jbc.274.4.2166; OKAR DA, 1995, BIOCHEM J, V308, P189, DOI 10.1042/bj3080189; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PILKIS SJ, 1983, J BIOL CHEM, V258, P6135; PILKIS SJ, 1984, J BIOL CHEM, V259, P949; PILKIS SJ, 1995, ANNU REV BIOCHEM, V64, P799, DOI 10.1146/annurev.bi.64.070195.004055; PILKIS SJ, 1987, J BIOL CHEM, V262, P12672; QUIOCHO FA, 1998, BIOCHEM SOC T, V21, P442; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; ROSE ZB, 1970, ARCH BIOCHEM BIOPHYS, V140, P508, DOI 10.1016/0003-9861(70)90095-0; ROUSSEAU GG, 1993, PROG NUCLEIC ACID RE, V45, P99, DOI 10.1016/S0079-6603(08)60868-5; SCHNEIDER G, 1993, EMBO J, V12, P2609, DOI 10.1002/j.1460-2075.1993.tb05921.x; STEWART HB, 1985, J BIOL CHEM, V260, P2935; STEWART HB, 1986, J BIOL CHEM, V261, P8793; TAULER A, 1990, J BIOL CHEM, V265, P15617; TOMINAGA N, 1993, J BIOL CHEM, V268, P15951; UYEDA K, 1991, STUDY ENZYMES, V2, P445; VANETTEN RL, 1977, ARCH BIOCHEM BIOPHYS, V183, P250, DOI 10.1016/0003-9861(77)90438-6; Vyas NK, 1991, CURR OPIN STRUC BIOL, V1, P732, DOI 10.1016/0959-440X(91)90172-P; Watanabe F, 1996, PROTEIN SCI, V5, P904; WINN SI, 1981, PHILOS T ROY SOC B, V293, P121, DOI 10.1098/rstb.1981.0066	41	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2176	2184		10.1074/jbc.274.4.2176	http://dx.doi.org/10.1074/jbc.274.4.2176			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890980	hybrid			2022-12-27	WOS:000078185200047
J	Hornstein, E; Git, A; Braunstein, I; Avni, D; Meyuhas, O				Hornstein, E; Git, A; Braunstein, I; Avni, D; Meyuhas, O			The expression of poly(A)-binding protein gene is translationally regulated in a growth-dependent fashion through a 5 '-terminal oligopyrimidine tract motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) BINDING-PROTEIN; MESSENGER-RNA; XENOPUS-LAEVIS; IN-VITRO; ELONGATION FACTOR-1-ALPHA; NUCLEOTIDE-SEQUENCE; PYRIMIDINE TRACT; PROMOTER; YEAST; ELEMENTS	Poly(A) binding protein (PABP) is an important regulator of gene expression that has been implicated in control of translation initiation. Here we report the isolation and the initial structural and functional characterization of the human PABP gene. Delineation of the promoter region revealed that it directs the initiation of transcription at consecutive C residues within a stretch of pyrimidines. A study of the translational behavior of the corresponding mRNA demonstrates that it is translationally repressed upon growth arrest of cultured mouse fibroblasts and translationally activated in regenerating rat liver. Furthermore, transfection experiments show that the first 32 nucleotides of PABP mRNA are sufficient to confer growth-dependent translational control on a heterologous mRNA. Substitution of the C residue at the cap site by purines abolishes the translational control of the chimeric mRNA. These features have established PABP mRNA as a new member of the terminal oligopyrimidine tract mRNA family. Members of this family are known to encode for components of the translational apparatus and to contain an oligopyrimidine tract at the 5' terminus (5'TOP), This motif mediates their translational control in a growth-dependent manner.	Hebrew Univ Jerusalem, Sch Med, Dept Biochem, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Meyuhas, O (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Biochem, POB 12272, IL-91120 Jerusalem, Israel.	meyuhas@cc.huji.ac.il	Avni, Dror/GRE-8325-2022; HORNSTEIN, ERAN/K-1340-2012	HORNSTEIN, ERAN/0000-0002-5534-1924; Avni, Dror/0000-0002-8738-1840				ALONI R, 1992, MOL CELL BIOL, V12, P2203, DOI 10.1128/MCB.12.5.2203; Amrani N, 1997, MOL CELL BIOL, V17, P3694, DOI 10.1128/MCB.17.7.3694; Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; AVNI D, 1994, MOL CELL BIOL, V14, P3822, DOI 10.1128/MCB.14.6.3822; Bag J, 1996, EUR J BIOCHEM, V237, P143, DOI 10.1111/j.1432-1033.1996.0143n.x; BERNSTEIN P, 1989, MOL CELL BIOL, V9, P659, DOI 10.1128/MCB.9.2.659; Biberman Y, 1997, FEBS LETT, V405, P333, DOI 10.1016/S0014-5793(97)00234-2; CARDINALI B, 1993, NUCLEIC ACIDS RES, V21, P2301, DOI 10.1093/nar/21.10.2301; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; DUDOV KP, 1984, CELL, V37, P457, DOI 10.1016/0092-8674(84)90376-3; GRANGE T, 1987, NUCLEIC ACIDS RES, V15, P4771, DOI 10.1093/nar/15.12.4771; GU W, 1995, MOL REPROD DEV, V40, P273, DOI 10.1002/mrd.1080400303; HARIHARAN N, 1989, GENE DEV, V3, P1789, DOI 10.1101/gad.3.11.1789; HARIHARAN N, 1990, P NATL ACAD SCI USA, V87, P1526, DOI 10.1073/pnas.87.4.1526; Higgins GM, 1931, ARCH PATHOL, V12, P186; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JEFFERIES HBJ, 1996, TRANSLATIONAL CONTRO, P389; KASPAR RL, 1992, J BIOL CHEM, V267, P508; KIOUSSIS D, 1979, P NATL ACAD SCI USA, V76, P4370, DOI 10.1073/pnas.76.9.4370; LEVY S, 1991, P NATL ACAD SCI USA, V88, P3319, DOI 10.1073/pnas.88.8.3319; MAUNDRELL K, 1983, J BIOL CHEM, V258, P1387; MEYUHAS O, 1987, MOL CELL BIOL, V7, P2691, DOI 10.1128/MCB.7.8.2691; Meyuhas Oded, 1996, P65; Meyuhas Oded, 1996, V30, P363; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; NAKANISHI T, 1988, J BIOL CHEM, V263, P6384; NETO OPD, 1995, NUCLEIC ACIDS RES, V23, P2198, DOI 10.1093/nar/23.12.2198; NIELSEN FC, 1995, NATURE, V377, P358, DOI 10.1038/377358a0; NIETFELD W, 1990, EMBO J, V9, P3699, DOI 10.1002/j.1460-2075.1990.tb07582.x; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Pellizzoni L, 1996, J MOL BIOL, V259, P904, DOI 10.1006/jmbi.1996.0368; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Pellizzoni L, 1998, J MOL BIOL, V281, P593, DOI 10.1006/jmbi.1998.1961; Proweller A, 1996, J BIOL CHEM, V271, P10859, DOI 10.1074/jbc.271.18.10859; RAIZIS AM, 1993, BIOCHEM J, V289, P133, DOI 10.1042/bj2890133; SACHS AB, 1992, CELL, V70, P961, DOI 10.1016/0092-8674(92)90246-9; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIBLER U, 1978, CELL, V15, P1495, DOI 10.1016/0092-8674(78)90072-7; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SEVERSON WE, 1995, EUR J BIOCHEM, V229, P426, DOI 10.1111/j.1432-1033.1995.tb20483.x; TERADA N, 1994, P NATL ACAD SCI USA, V91, P11477, DOI 10.1073/pnas.91.24.11477; THOMAS G, 1986, J CELL BIOL, V103, P2137, DOI 10.1083/jcb.103.6.2137; THOMAS G, 1981, P NATL ACAD SCI-BIOL, V78, P5712, DOI 10.1073/pnas.78.9.5712; UETSUKI T, 1989, J BIOL CHEM, V264, P5791; WAKABAYASHIITO N, 1994, J BIOL CHEM, V269, P29831; WANG MY, 1992, NUCLEIC ACIDS RES, V20, P3519, DOI 10.1093/nar/20.13.3519; WIEDEMANN LM, 1984, MOL CELL BIOL, V4, P2518, DOI 10.1128/MCB.4.11.2518; Wormington M, 1996, EMBO J, V15, P900, DOI 10.1002/j.1460-2075.1996.tb00424.x; ZELUS BD, 1989, MOL CELL BIOL, V9, P2756, DOI 10.1128/MCB.9.6.2756	54	66	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1708	1714		10.1074/jbc.274.3.1708	http://dx.doi.org/10.1074/jbc.274.3.1708			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880551	hybrid			2022-12-27	WOS:000079956900071
J	Maingret, F; Fosset, M; Lesage, F; Lazdunski, M; Honore, E				Maingret, F; Fosset, M; Lesage, F; Lazdunski, M; Honore, E			TRAAK is a mammalian neuronal mechano-gated K+ channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APLYSIA S-CHANNEL; ION CHANNELS; STRETCH ACTIVATION; ARACHIDONIC-ACID; FATTY-ACIDS; TRANSDUCTION; EXPRESSION; CLONING; TWIK-1; CELLS	The novel structural class of mammalian channels with four transmembrane segments and two pore regions comprise background K+ channels (TWIK-1, TREK-1, TRAAK, TASK, and TASK-2) with unique physiological functions (1-6). Unlike its counterparts, TRAAK is only expressed in neuronal tissues, including brain, spinal cord, and retina (1). This report shows that TRAAK, which was known to be activated by arachidonic acid (3), is also opened by membrane stretch. Mechanical activation of TRAAK is induced by a convex curvature of the plasma membrane and can be mimicked by the amphipathic membrane crenator trinitrophenol. Cytoskeletal elements are negative tonic regulators of TRAAK. Membrane depolarization and membrane cremation synergize with stretch-induced channel opening. Finally, TRAAK is reversibly blocked by micromolar concentrations of gadolinium, a well known blocker of stretch-activated channels. Mechanical activation of TRAAK in the central nervous system may play an important role during growth cone motility and neurite elongation.	CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Lazdunski, M (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UPR 411,660 Route Lucioles, F-06560 Valbonne, France.		Lesage, Florian/D-5097-2011; Lesage, Florian/P-9780-2019	Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106; HONORE, Eric/0000-0002-8007-0919				Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Hamill OP, 1996, PHARMACOL REV, V48, P231; KIM DH, 1995, J PHYSIOL-LONDON, V484, P643, DOI 10.1113/jphysiol.1995.sp020693; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; MARTINAC B, 1992, THERMODYNAMICS CELL, P327; MERTINAE B, 1990, NATURE, V348, P261; MORRIS CE, 1990, J MEMBRANE BIOL, V113, P93, DOI 10.1007/BF01872883; ORDWAY RW, 1995, J PHYSIOL-LONDON, V484, P331, DOI 10.1113/jphysiol.1995.sp020668; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cb.04.110188.000431; SACHS F, 1988, CRIT REV BIOMED ENG, V16, P141; Sachs F, 1997, SOC GEN PHY, V52, P209; SACKIN H, 1995, ANNU REV PHYSIOL, V57, P333, DOI 10.1146/annurev.ph.57.030195.002001; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; SIGURDSON WJ, 1989, J NEUROSCI, V9, P2801; SUKHAREV SI, 1997, ANNU REV PHYSIOL, V59, P638; VANDORPE DH, 1992, J MEMBRANE BIOL, V127, P205; VANDORPE DH, 1994, BIOPHYS J, V66, P46, DOI 10.1016/S0006-3495(94)80749-0	23	267	288	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1381	1387		10.1074/jbc.274.3.1381	http://dx.doi.org/10.1074/jbc.274.3.1381			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880510	hybrid			2022-12-27	WOS:000079956900030
J	Park, YG; Nesterova, M; Agrawal, S; Cho-Chung, YS				Park, YG; Nesterova, M; Agrawal, S; Cho-Chung, YS			Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide - Gene-specific inhibition of tumor growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CAMP-MEDIATED INDUCTION; SOMATOSTATIN GENE; DOMINANT REPRESSOR; REGULATORY SUBUNIT; BINDING-PROTEINS; TRANS-ACTIVATOR; EXPRESSION; PROMOTER; CELLS	Alteration of gene transcription by inhibition of specific transcriptional regulatory proteins has important therapeutic potential. Synthetic double-stranded phosphorothioate oligonucleotides with high affinity for a target transcription factor can be introduced into cells as decoy cis elements to bind the factors and alter gene expression. The CRE (cyclic AMP response element)-transcription factor complex is a pleiotropic activator that participates in the induction of a wide variety of cellular and viral genes. Because the CRE cis-element, TGACGTCA, is palindromic, a synthetic single-stranded oligonucleotide composed of the CRE sequence self;hybridizes to form a duplex/hairpin. Herein we report that the CRE-palindromic oligonucleotide can penetrate into cells, compete with CRE enhancers for binding transcription factors, and specifically interfere with CRE- and AP-1-directed transcription in vivo. These oligonucleotides restrained tumor cell proliferation, without affecting the growth of noncancerous cells. This decoy oligonucleotide approach offers great promise as a tool for defining cellular regulatory processes and treating cancer and other diseases.	NCI, Cellular Biochem Sect, Tumor Immunol & Biol Lab, NIH, Bethesda, MD 20892 USA; Hybridon Inc, Milford, MA 01757 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cho-Chung, YS (corresponding author), NCI, Cellular Biochem Sect, Tumor Immunol & Biol Lab, NIH, Bldg 10,Rm 5B05, Bethesda, MD 20892 USA.			Agrawal, Sudhir/0000-0003-4275-2510				BALTIMORE D, 1988, NATURE, V335, P395, DOI 10.1038/335395a0; BIELINSKA A, 1990, SCIENCE, V250, P997, DOI 10.1126/science.2237444; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BROWN M, 1987, CELL, V49, P603, DOI 10.1016/0092-8674(87)90536-8; CHRIVIA JC, 1988, J BIOL CHEM, V263, P5739; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ELLIS MJC, 1995, J MOL ENDOCRINOL, V14, P191, DOI 10.1677/jme.0.0140191; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6506; FRIEDMAN AD, 1988, NATURE, V335, P452, DOI 10.1038/335452a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HU MCT, 1987, CELL, V48, P555, DOI 10.1016/0092-8674(87)90234-0; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; MAHER LJ, 1989, SCIENCE, V245, P725, DOI 10.1126/science.2549631; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MORISHITA R, 1995, P NATL ACAD SCI USA, V92, P5855, DOI 10.1073/pnas.92.13.5855; Nesterova M, 1996, EUR J BIOCHEM, V235, P486, DOI 10.1111/j.1432-1033.1996.00486.x; NOWAK I, 1987, EUR J BIOCHEM, V167, P27, DOI 10.1111/j.1432-1033.1987.tb13300.x; PADMAPRIYA AA, 1994, ANTISENSE RES DEV, V4, P185, DOI 10.1089/ard.1994.4.185; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; SHORT JM, 1986, J BIOL CHEM, V261, P9721; STEIN CA, 1995, NAT MED, V1, P1119, DOI 10.1038/nm1195-1119; TASKEN KA, 1991, MOL ENDOCRINOL, V5, P21, DOI 10.1210/mend-5-1-21; TRONO D, 1989, CELL, V59, P113, DOI 10.1016/0092-8674(89)90874-X; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; WANG XF, 1986, CELL, V47, P241, DOI 10.1016/0092-8674(86)90446-0; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	33	116	135	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1573	1580		10.1074/jbc.274.3.1573	http://dx.doi.org/10.1074/jbc.274.3.1573			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880535	hybrid			2022-12-27	WOS:000079956900055
J	Shigemitsu, K; Tsujishita, Y; Hara, K; Nanahoshi, M; Avruch, J; Yonezawa, K				Shigemitsu, K; Tsujishita, Y; Hara, K; Nanahoshi, M; Avruch, J; Yonezawa, K			Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways - Possible involvement of autophagy in cultured hepatoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; ISOLATED RAT HEPATOCYTES; P70 S6 KINASE; PROTEIN-DEGRADATION; 3-KINASE INHIBITORS; PHAS-I; PHOSPHORYLATION; INSULIN; INITIATION; LIVER	Amino acid deprivation of Chinese hamster ovary cells overexpressing human insulin receptors results in deactivation of p70 S6 kinase (p70) and dephosphorylation of eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), which become unresponsive to insulin readdition of amine acids restores these responses in a rapamycin-sensitive manner, suggesting that amino acids and mammalian target of rapamycin signal through common effecters. Contrarily, withdrawal of medium amino acids from the hepatoma cell line H4IIE does not abolish the ability of insulin to stimulate p70 and 4E-BP1. The addition of 3-methyladenine (3MA) to H4IIE cells deprived of amino acids inhibited the increment in protein degradation caused by amino acid withdrawal nearly completely at 10 mM and also strongly inhibited the ability of insulin to stimulate p70 and 4E-BP1 at 10 mM. Treatment of H4IIE cells with 3MA did not alter the ability of insulin to activate tyrosine phosphorylation, phosphoinositide 3-kinase, or mitogen-activated protein kinase. In conclusion, the ability of H4IIE cells to maintain the insulin responsiveness of the mammalian target of rapamycin-dependent signaling pathways impinging on p70 and 4E-BP1 without exogenous amino acids reflects the generation of amino acids endogenously through a 3MA-sensitive process, presumably autophagy, a major mechanism of facultative protein degradation in liver.	Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02129 USA; Massachusetts Gen Hosp, Med Serv, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA	Kobe University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Yonezawa, K (corresponding author), Kobe Univ, Biosignal Res Ctr, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.							Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; BIOMMAART EFC, 1995, J BIOL CHEM, V270, P2320; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; BURGERING BM, 1995, NATURE, V376, P553; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; ENDEMANN G, 1990, J BIOL CHEM, V265, P396; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HIRSIMAKI P, 1983, PATHOBIOLOGY CELL ME, P201; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; LIN TA, 1995, J BIOL CHEM, V270, P18531, DOI 10.1074/jbc.270.31.18531; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105; MORTIMORE GE, 1987, J BIOL CHEM, V262, P16322; NEMENOFF RA, 1986, ARCH BIOCHEM BIOPHYS, V245, P196, DOI 10.1016/0003-9861(86)90205-5; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; SCHWORER CM, 1981, J BIOL CHEM, V256, P7652; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; SOMMERCORN JM, 1981, J BIOL CHEM, V256, P4816; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; Svanberg E, 1997, AM J PHYSIOL-ENDOC M, V272, pE841, DOI 10.1152/ajpendo.1997.272.5.E841; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; Xu G, 1998, J BIOL CHEM, V273, P4485, DOI 10.1074/jbc.273.8.4485	38	170	173	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1058	1065		10.1074/jbc.274.2.1058	http://dx.doi.org/10.1074/jbc.274.2.1058			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873051	Green Published, hybrid			2022-12-27	WOS:000077968500066
J	Balboa, MA; Balsinde, J; Dillon, DA; Carman, GM; Dennis, EA				Balboa, MA; Balsinde, J; Dillon, DA; Carman, GM; Dennis, EA			Proinflammatory macrophage-activating properties of the novel phospholipid diacylglycerol pyrophosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ARACHIDONIC-ACID MOBILIZATION; CATHARANTHUS-ROSEUS CELLS; P388D(1) MACROPHAGES; SIGNAL-TRANSDUCTION; SACCHAROMYCES-CEREVISIAE; LYSOPHOSPHATIDIC ACID; PHOSPHATIDATE KINASE; CELLULAR-RESPONSES; ESCHERICHIA-COLI	We have found that the novel phospholipid diacylglycerol pyrophosphate (DGPP), identified in bacteria, yeast, and plants, but not in mammalian cells, is able to potently activate macrophages for enhanced secretion of arachidonate metabolites, a key event in the immunoinflammatory response of leukocytes. Macrophage responses to DGPP are specific and are not mediated by its conversion into other putative lipid mediators such as phosphatidic acid, lysophosphatidic acid, or diacylglycerol, The responses to DGPP are compatible with a receptor-recognition event because they are blocked by suramin. Intracellular signaling initiated by DGPP includes phosphorylation and activation of the Group TV cytosolic phospholipase A(2) and of the extracellular-signal regulated p42 mitogen-activated protein kinase (MAPK) and p44 MAPK, and membrane translocation of the protein kinase C isoenzymes alpha, epsilon, delta. These results establish DGPP as a novel macrophage-activating factor and suggest a potential role for this compound in triggering homeostatic cellular responses.	Univ Calif San Diego, Sch Med, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Revelle Coll, La Jolla, CA 92093 USA; Rutgers State Univ, New Jersey Agr Expt Stn, Dept Food Sci, New Brunswick, NJ 08901 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rutgers State University New Brunswick	Dennis, EA (corresponding author), Univ Calif San Diego, Sch Med, Dept Chem & Biochem, La Jolla, CA 92093 USA.	edennis@ucsd.edu	Balboa, María A./V-9493-2018; Balsinde, Jesús/C-7833-2018; Dennis, Edward A./M-5554-2019	Balboa, María A./0000-0002-2130-5298; Balsinde, Jesús/0000-0002-4157-6714; Dennis, Edward A./0000-0003-3738-3140	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 26171] Funding Source: Medline; NIGMS NIH HHS [GM 20501, GM 28140] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; ASMIS R, 1994, BIOCHEM J, P543; Balboa MA, 1996, J BIOL CHEM, V271, P32381, DOI 10.1074/jbc.271.50.32381; Balsinde J, 1997, BIOCHEM J, V321, P805, DOI 10.1042/bj3210805; BALSINDE J, 1994, P NATL ACAD SCI USA, V91, P11060, DOI 10.1073/pnas.91.23.11060; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P4449, DOI 10.1074/jbc.273.8.4449; Brindley DN, 1996, CHEM PHYS LIPIDS, V80, P45, DOI 10.1016/0009-3084(96)02545-5; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Dillon DA, 1997, J BIOL CHEM, V272, P10361; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Guo Z, 1996, P NATL ACAD SCI USA, V93, P14367, DOI 10.1073/pnas.93.25.14367; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Munnik T, 1996, J BIOL CHEM, V271, P15708, DOI 10.1074/jbc.271.26.15708; Munnik T, 1998, BBA-LIPID LIPID MET, V1389, P222, DOI 10.1016/S0005-2760(97)00158-6; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Riedel B, 1997, PLANT SCI, V128, P1, DOI 10.1016/S0168-9452(97)00120-9; Serhan CN, 1996, FASEB J, V10, P1147, DOI 10.1096/fasebj.10.10.8751717; WISSING JB, 1993, PLANT PHYSIOL, V102, P1243, DOI 10.1104/pp.102.4.1243; WISSING JB, 1993, FEBS LETT, V315, P95, DOI 10.1016/0014-5793(93)81141-L; WISSING JB, 1994, PLANT PHYSIOL, V105, P903, DOI 10.1104/pp.105.3.903; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868	31	58	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					522	526		10.1074/jbc.274.1.522	http://dx.doi.org/10.1074/jbc.274.1.522			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867874	Green Published, hybrid			2022-12-27	WOS:000077900200074
J	Cederberg, A; Hulander, M; Carlsson, P; Enerback, S				Cederberg, A; Hulander, M; Carlsson, P; Enerback, S			The kidney-expressed winged helix transcription factor FREAC-4 is regulated by Ets-1 - A possible role in kidney development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FORKHEAD GENE; DNA-BINDING MOTIF; WILD-TYPE P53; ALVEOLAR RHABDOMYOSARCOMA; DIFFERENTIAL EXPRESSION; CAENORHABDITIS-ELEGANS; MOUSE EMBRYO; HEAD DOMAIN; FAMILY; PROTEIN	In this paper we show that the kidney-expressed winged helix transcription factor FREAC-4 is regulated by Ets-l, another kidney-expressed transcription factor. Through transfection experiments three Ets-l cis-elements are identified within the first 152 nucleotides upstream of the transcription start in the freac-4 promoter. These sites are confirmed in a DNase I in vitro protection assay using recombinant Ets-l protein. In cotransfection experiments using an Ets-l expression vector, the induction of freac-4 reporter gene activity is attenuated approximately B-fold when the three Ets-l binding sites are mutated. Furthermore, we demonstrate that overexpression of Ets-l in the human embryonic kidney cell line 293 is sufficient to increase freac-4 mRNA levels. These results are compatible with the hypothesis that Ets-l acts as an upstream regulator of FREAC-4 expression during kidney development.	Univ Gothenburg, Lundberg Lab, Dept Biol Mol, S-41390 Gothenburg, Sweden; Chalmers Univ Technol, Dept Phys Chem, Unit Biotechnol, S-41296 Gothenburg, Sweden	University of Gothenburg; Chalmers University of Technology	Enerback, S (corresponding author), Univ Gothenburg, Lundberg Lab, Dept Biol Mol, Medicinareg 9C, S-41390 Gothenburg, Sweden.	enerback@molbio.gu.se	Carlsson, Peter/B-5551-2008	Carlsson, Peter/0000-0001-6535-5927				ALTABA ARI, 1993, MECH DEVELOP, V44, P91, DOI 10.1016/0925-4773(93)90060-B; ANG SL, 1993, DEVELOPMENT, V119, P1301; BATH NK, 1989, J IMMUNOL, V142, P672; BRADFORD AP, 1995, MOL CELL BIOL, V15, P2849; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; DONALDSON LW, 1994, BIOCHEMISTRY-US, V33, P13509, DOI 10.1021/bi00250a001; DOWNING JR, 1995, AM J PATHOL, V146, P626; ENERBACK S, 1992, MOL CELL BIOL, V12, P4622, DOI 10.1128/MCB.12.10.4622; Ernstsson S, 1997, GENOMICS, V46, P78, DOI 10.1006/geno.1997.4986; Ernstsson S, 1996, J BIOL CHEM, V271, P21094, DOI 10.1074/jbc.271.35.21094; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Godley LA, 1996, GENE DEV, V10, P836, DOI 10.1101/gad.10.7.836; HACKER U, 1992, P NATL ACAD SCI USA, V89, P8754, DOI 10.1073/pnas.89.18.8754; HATINI V, 1994, J NEUROBIOL, V25, P1293, DOI 10.1002/neu.480251010; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Hellqvist M, 1996, J BIOL CHEM, V271, P4482; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; Iotsova V, 1996, ONCOGENE, V13, P2331; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; KOLA I, 1993, P NATL ACAD SCI USA, V90, P7588, DOI 10.1073/pnas.90.16.7588; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; Lambert PF, 1997, MOL BIOL CELL, V8, P313, DOI 10.1091/mbc.8.2.313; Lehmann M, 1996, EMBO J, V15, P4825, DOI 10.1002/j.1460-2075.1996.tb00863.x; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; LI J, 1993, P NATL ACAD SCI USA, V90, P4490, DOI 10.1073/pnas.90.10.4490; LIANG H, 1994, P NATL ACAD SCI USA, V91, P11655, DOI 10.1073/pnas.91.24.11655; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MACLEOD K, 1992, TRENDS BIOCHEM SCI, V17, P251, DOI 10.1016/0968-0004(92)90404-W; MAROULAKOU IG, 1994, ONCOGENE, V9, P1551; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; NUNN MF, 1983, NATURE, V306, P391, DOI 10.1038/306391a0; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; PARRY P, 1994, GENE CHROMOSOME CANC, V11, P79, DOI 10.1002/gcc.2870110203; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; QUEVA C, 1993, ONCOGENE, V8, P2511; RADKE K, 1982, CELL, V31, P643, DOI 10.1016/0092-8674(82)90320-8; SASAKI H, 1993, DEVELOPMENT, V118, P47; SCHMID P, 1991, DEVELOPMENT, V113, P857; SHAPIRO DN, 1993, CANCER RES, V53, P5108; THOMPSON CB, 1992, MOL CELL BIOL, V12, P1043, DOI 10.1128/MCB.12.3.1043; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yuasa J, 1996, NATURE, V382, P632, DOI 10.1038/382632a0	51	28	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					165	169		10.1074/jbc.274.1.165	http://dx.doi.org/10.1074/jbc.274.1.165			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867825	hybrid			2022-12-27	WOS:000077900200025
J	Ho, YD; Joyal, JL; Li, ZG; Sacks, DB				Ho, YD; Joyal, JL; Li, ZG; Sacks, DB			IQGAP1 integrates Ca2+/calmodulin and Cdc42 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS; REGULATORY DOMAIN; CALMODULIN; ACTIN; RAS; GTPASES; FILOPODIA; RHO; IDENTIFICATION; LAMELLIPODIA	Calmodulin regulates diverse Ca2+-dependent cellular processes, including cell cycle progression and cytoskeletal rearrangement. A recently identified calmodulin-binding protein, IQGAP1, interacts with both actin and Cdc42, In this study, evidence is presented that, in the absence of Ca2+, IQGAP1 bound to Cdc42, which maintained Cdc42 in the active GTP-bound state. Addition of Ca2+ both directly abrogated the effect of IQGAP1 on the intrinsic GTPase activity of Cdc42 and, in the presence of calmodulin, dissociated Cdc42 from IQGAP1. In addition, in vitro binding assays revealed that calmodulin associated with both the calponin homology domain and the IQ motifs of IQGAP1. Moreover, F-actin competed with Ca2+/calmodulin for binding to the calponin homology domain, but not the IQ motifs, of IQGAP1, Analysis of cell lysates revealed that calmodulin bound to IQGAP1 in a ternary complex with Cdc42, Increasing the Ca2+ concentration enhanced the interaction between calmodulin and IQGAP1, with a concomitant decrease in the association of IQGAP1 with Cdc42. Our data suggest that IQGAP1 functions as a scaffolding protein, providing a molecular link between Ca2+/calmodulin and Cdc42 signaling.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sacks, DB (corresponding author), Brigham & Womens Hosp, Dept Pathol, Thorn 530,75 Francis St, Boston, MA 02115 USA.			Sacks, David/0000-0003-3100-0735				AYMESOUTHGATE A, 1989, J CELL BIOL, V108, P521, DOI 10.1083/jcb.108.2.521; BARBACID M, 1990, EUR J CLIN INVEST, V20, P225, DOI 10.1111/j.1365-2362.1990.tb01848.x; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; CHOW MM, 1996, CELL, V85, P573; COHEN P, 1988, CALMDULIN; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; HART MF, 1996, EMBO J, V15, P2887; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kozma R, 1996, MOL CELL BIOL, V16, P5069; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; MEZGUELDI M, 1995, J BIOL CHEM, V270, P8867, DOI 10.1074/jbc.270.15.8867; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; RASMUSSEN CD, 1992, CELL MOTIL CYTOSKEL, V21, P45, DOI 10.1002/cm.970210106; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; SINGER AL, 1976, CANCER RES, V36, P60; STOWERS L, 1995, P NATL ACAD SCI USA, V92, P5027, DOI 10.1073/pnas.92.11.5027; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Symons M, 1996, TRENDS BIOCHEM SCI, V21, P178, DOI 10.1016/S0968-0004(96)10022-0; VANELDIK LJ, 1983, J BIOL CHEM, V258, P4539; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	28	174	180	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					464	470		10.1074/jbc.274.1.464	http://dx.doi.org/10.1074/jbc.274.1.464			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867866	hybrid			2022-12-27	WOS:000077900200066
J	Kwon, HS; Kim, MS; Edenberg, HJ; Hur, MW				Kwon, HS; Kim, MS; Edenberg, HJ; Hur, MW			Sp3 and Sp4 can repress transcription by competing with Sp1 for the core cis-elements on the human ADH5/FDH minimal promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX-BINDING-PROTEINS; ALCOHOL-DEHYDROGENASE; DNA-BINDING; BIOCHEMICAL-CHARACTERIZATION; FORMALDEHYDE DEHYDROGENASE; REGULATORY PROTEINS; ACTIVATION DOMAINS; MOLECULAR-CLONING; GENE-EXPRESSION; CPG ISLANDS	The human alcohol dehydrogenase 5 gene (also known as the formaldehyde dehydrogenase gene, ADH5/FDH) has a CC-rich promoter with many sites at which transcription factors bind. A minimal promoter extending from -34 base pairs (bp) to +61 bp directs high levels of transcription in several different cells, consistent with the ubiquitous expression of the gene. Nearly the entire minimal promoter can be bound by Spl, We analyzed the transcriptional regulation of ADH5/FDH by members of the Spl multigene family. Two core cis-elements (-22 bp to +22 bp) had the highest affinity for Spl, Mutagenesis revealed that these cis-elements are critical for transcriptional activation. The zinc-finger domains of Sp3 and Sp4 also bind selectively to the core cis-elements. In Drosophila SL2 cells, which lack endogenous Spl, the minimal promoter cannot drive transcription. Introduction of Spl activated transcription over 50-fold, suggesting that Spl is critical in the initiation of transcription. Neither Sp3 nor Sp4 was able to activate transcription in those cells, and transcriptional activation by Spl was repressed by Sp3 or Sp4, These data suggest that Sp3 and Sp4 can repress transcription by competing with Spl for binding to the core cis-elements, The content of Spl, Sp3, and Sp4 in different cells may be critical factors regulating transcription of the ADH5/FDH gene.	Yonsei Univ, Sch Med, Inst Genet Sci, Dept Biochem & Mol Biol,SeoDaeMoon Ku, Seoul 120752, South Korea; Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Yonsei University; Indiana University System; Indiana University-Purdue University Indianapolis	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Inst Genet Sci, Dept Biochem & Mol Biol,SeoDaeMoon Ku, 134 ShinChon Dong, Seoul 120752, South Korea.	mwhur@shinbiro.co.kr		Hur, Man-Wook/0000-0002-3416-1334; Edenberg, Howard/0000-0003-0344-9690				ADINOLFI A, 1984, ANN HUM GENET, V48, P1, DOI 10.1111/j.1469-1809.1984.tb00828.x; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CHEN JL, 1994, CELL, V79, P93, DOI 10.1016/0092-8674(94)90403-0; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; COUREY AJ, 1992, TRANSCRIPTIONAL REGU, P743; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; Dennig J, 1996, EMBO J, V15, P5659, DOI 10.1002/j.1460-2075.1996.tb00950.x; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DULEY JA, 1985, ALCOHOL CLIN EXP RES, V9, P263, DOI 10.1111/j.1530-0277.1985.tb05747.x; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; HUR MW, 1995, J BIOL CHEM, V270, P9002, DOI 10.1074/jbc.270.15.9002; HUR MW, 1992, GENE, V121, P305, DOI 10.1016/0378-1119(92)90135-C; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; JORNVALL H, 1995, ADV EXP MED BIOL, V372, P281; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; LI BY, 1994, J BIOL CHEM, V269, P7756; MAJELLO B, 1994, NUCLEIC ACIDS RES, V22, P4914, DOI 10.1093/nar/22.23.4914; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; MIMORI T, 1986, J BIOL CHEM, V261, P2274; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Prowse DM, 1997, J BIOL CHEM, V272, P1308, DOI 10.1074/jbc.272.2.1308; REEVES WH, 1989, J BIOL CHEM, V264, P5047; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; UDVADIA AJ, 1995, P NATL ACAD SCI USA, V92, P3953, DOI 10.1073/pnas.92.9.3953; UOTILA L, 1974, J BIOL CHEM, V249, P7653; WAGNER FW, 1984, BIOCHEMISTRY-US, V23, P2193, DOI 10.1021/bi00305a014; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; Zhao LY, 1997, J BIOL CHEM, V272, P4869, DOI 10.1074/jbc.272.8.4869	43	96	97	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					20	28		10.1074/jbc.274.1.20	http://dx.doi.org/10.1074/jbc.274.1.20			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867805	hybrid			2022-12-27	WOS:000077900200005
J	Marks, DL; Wu, KJ; Paul, P; Kamisaka, Y; Watanabe, R; Pagano, RE				Marks, DL; Wu, KJ; Paul, P; Kamisaka, Y; Watanabe, R; Pagano, RE			Oligomerization and topology of the Golgi membrane protein glucosylceramide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER; CERAMIDE GLUCOSYLTRANSFERASE; RETENTION; GALACTOSYLTRANSFERASE; DIMERIZATION; ANTIBODIES; FRACTIONS; RECEPTORS; APPARATUS; BINDING	Glucosylceramide synthase (GCS) catalyzes the transfer of glucose from UDP-glucose to ceramide to form glucosylceramide, the precursor of most higher order glycosphingolipids. Recently, we characterized GCS activity in highly enriched fractions from rat liver Golgi membranes (Paul, P., Kamisaka, Y., Marks, D. L., and Pagano, R. E. (1996) J. Biol. Chem. 271, 2287-2293), and human GCS was cloned by others (Ichikawa, S., Sakiyama, H., Suzuki, G., Hidari, K. I.-P, J., and Hirabayashi, Y, (1996) Proc. Natl. Acad. Sci. U. S, A. 93, 4638-4643). However, the polypeptide responsible for GCS activity has never been identified or characterized. In this study, we made polyclonal antibodies against peptides based on the predicted amino acid sequence of human GCS and used these antibodies to characterize the GCS polypeptide in rat liver Gels membranes. Western blotting of rat liver Golgi membranes, human cells, and recombinant rat GCS expressed in bacteria showed that GCS migrates as an similar to 38-kDa protein on SDS-polyacrylamide gels. Trypsinization and immunoprecipitation studies with Golgi membranes showed that both the C terminus and a hydrophilic loop near the N terminus of GCS are accessible from the cytosolic face of the Golgi membrane. Treatment of Golgi membranes with N-hydroxysuccinimide ester based cross-linking reagents yielded an similar to 50-kDa polypeptide recognized by anti-GCS antibodies; however, treatment of similar to 10,000-fold purified Golgi GCS with the same reagents did not yield cross-linked GCS forms. These results suggest that GCS forms a dimer or oligomer with another protein in the Golgi membrane. The migration of solubilized Golgi GCS in glycerol gradients was also consistent with a predominantly oligomeric organization of GCS.	Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Thorac Dis Res Unit, Rochester, MN 55905 USA	Mayo Clinic	Pagano, RE (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Thorac Dis Res Unit, Guggenheim 621-C,200 1st St SW, Rochester, MN 55905 USA.				NIGMS NIH HHS [GM22942] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022942, R37GM022942] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASU S, 1973, J BIOL CHEM, V248, P1388; BERGERON JJM, 1982, J CELL BIOL, V92, P139, DOI 10.1083/jcb.92.1.139; Boldin S, 1997, J NEUROCHEM, V68, P882; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKE J, 1994, J BIOL CHEM, V269, P12049; CAMBRON LD, 1994, MOL CELL BIOCHEM, V130, P173, DOI 10.1007/BF01457398; COSTE H, 1986, BIOCHIM BIOPHYS ACTA, V858, P6, DOI 10.1016/0005-2736(86)90285-3; Dan N, 1997, J BIOL CHEM, V272, P14214, DOI 10.1074/jbc.272.22.14214; EHRENREICH JH, 1973, J CELL BIOL, V59, P45, DOI 10.1083/jcb.59.1.45; FISHBURN CS, 1994, BIOCHEM BIOPH RES CO, V205, P1460, DOI 10.1006/bbrc.1994.2829; FLEISCHER B, 1993, BIOCHEMISTRY-US, V32, P2076, DOI 10.1021/bi00059a027; FUTERMAN AH, 1992, METHOD ENZYMOL, V209, P437; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; HAKOMORI S, 1994, PROG BRAIN RES, V101, P241; HARLOWE E, 1988, ANTIBODIES LAB MANUA, P427; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Kaneda K, 1997, INFECT IMMUN, V65, P3180, DOI 10.1128/IAI.65.8.3180-3185.1997; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARKIN JM, 1991, J CELL SCI, V98, P205; LOCKER JK, 1995, J BIOL CHEM, V270, P8815, DOI 10.1074/jbc.270.15.8815; Meech R, 1997, J BIOL CHEM, V272, P26913, DOI 10.1074/jbc.272.43.26913; MUTOH T, 1995, P NATL ACAD SCI USA, V92, P5087, DOI 10.1073/pnas.92.11.5087; Paul P, 1996, J BIOL CHEM, V271, P2287, DOI 10.1074/jbc.271.4.2287; Sandvig K, 1996, MOL BIOL CELL, V7, P1391, DOI 10.1091/mbc.7.9.1391; Sevier CS, 1998, BIOCHEMISTRY-US, V37, P185, DOI 10.1021/bi971782k; TEASDALE RD, 1994, GLYCOBIOLOGY, V4, P917, DOI 10.1093/glycob/4.6.917; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSANG VCW, 1991, J IMMUNOL METHODS, V138, P291, DOI 10.1016/0022-1759(91)90178-I; Watanabe R, 1998, J BIOL CHEM, V273, P9651, DOI 10.1074/jbc.273.16.9651; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Zhu GF, 1997, GLYCOBIOLOGY, V7, P987, DOI 10.1093/glycob/7.7.987	33	74	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					451	456		10.1074/jbc.274.1.451	http://dx.doi.org/10.1074/jbc.274.1.451			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867864	hybrid			2022-12-27	WOS:000077900200064
J	Subramaniam, PS; Mujtaba, MG; Paddy, MR; Johnson, HM				Subramaniam, PS; Mujtaba, MG; Paddy, MR; Johnson, HM			The carboxyl terminus of interferon-gamma contains a functional polybasic nuclear localization sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-GAMMA; BIOLOGICAL-ACTIVITY; MEMBRANE-RECEPTORS; BINDING; PEPTIDE; IMPORT; IDENTIFICATION; MACROPHAGES; EXPRESSION; TRANSPORT	Cytokines such as interferon-gamma (IFN-gamma), which utilize the well studied JAK/STAT pathway for nuclear signal transduction, are themselves translocated to the nucleus. The exact mechanism for the nuclear import of IFN-gamma or the functional role of the nuclear translocation of ligand in signal transduction is unknown, We show in this study that nuclear localization of IFN-gamma is driven by a simple polybasic nuclear localization sequence (NLS) in its COOH terminus, as verified by its ability to specify nuclear import of a heterologous protein allophycocyanin (APC) in standard import assays in digitonin-permeabilized cells. Similar to other nuclear import signals, we show that a peptide representing amino acids 95-132 of IFN-gamma (IFN-gamma(95-132)) containing the polybasic sequence (RKRKRSR132)-R-126 was capable of specifying nuclear uptake of the autofluorescent protein, APC, in an energy-dependent fashion that required both ATP and GTP, Nuclear import was abolished when the above polybasic sequence was deleted. Moreover, deletions immediately NH2-terminal of this sequence did not affect the nuclear import. Thus, the sequence (RKRKRSR132)-R-126 is necessary and sufficient for nuclear localization. FurthePmore, nuclear import was strongly blocked by competition with the cognate peptide IFN-gamma(95-132) but Plot the peptide IFN-gamma(95-125), which is deleted in the polybasic sequence, further confirming that the NLS properties were contained in this sequence. A peptide containing the prototypical polybasic NLS sequence of the SV40 large T-antigen was also able to inhibit the nuclear import mediated by IFN-gamma(95-132), This observation suggests that the NLS in IFN-gamma may function through the components of the Ran/importin pathway utilized by the SV40 T-NLS, Finally, we show that intact IFN-gamma, when coupled to APC, was also able to mediate its nuclear import. Again, nuclear import was blocked by the peptide IFN-gamma(95-132) and the SV40 T-NLS peptide, suggesting that intact IFN-gamma was also transported into the nucleus through the Ran/importin pathway. Previous studies have suggested a direct intracellular role for IFN-gamma in the induction of its biological activities. Based on our data in this study, we suggest that a key intracellular site of interaction of IFN-gamma is the one with the nuclear transport mechanism that occurs via the NLS in the COOH terminus of lFN-gamma.	Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Subramaniam, PS (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Rm 1052,Bldg 981,POB 110700, Gainesville, FL 32611 USA.	prem@micro.ifas.ufl.edu			NATIONAL CANCER INSTITUTE [R01CA038587, R43CA069956] Funding Source: NIH RePORTER; NCI NIH HHS [CA38587, CA69956] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAM SA, 1992, METHOD ENZYMOL, V219, P97; ARAKAWA T, 1986, J BIOL CHEM, V261, P8534; Arakawa T, 1989, Drug Des Deliv, V4, P217; BADER T, 1994, P NATL ACAD SCI USA, V91, P11831, DOI 10.1073/pnas.91.25.11831; DOBELI H, 1988, J BIOTECHNOL, V7, P199, DOI 10.1016/0168-1656(88)90052-1; FIDLER IJ, 1985, J IMMUNOL, V135, P4289; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Green MM, 1998, BIOCHEM BIOPH RES CO, V243, P170, DOI 10.1006/bbrc.1998.8077; Jans DA, 1997, FEBS LETT, V410, P368, DOI 10.1016/S0014-5793(97)00622-4; Jans DA, 1998, BIOESSAYS, V20, P400, DOI 10.1002/(SICI)1521-1878(199805)20:5<400::AID-BIES7>3.0.CO;2-R; Jans DA, 1997, FEBS LETT, V406, P315, DOI 10.1016/S0014-5793(97)00293-7; JANS DA, 1994, FASEB J, V8, P841, DOI 10.1096/fasebj.8.11.8070633; Johnson HM, 1998, BIOCHEM BIOPH RES CO, V244, P607, DOI 10.1006/bbrc.1998.8254; KUSHNARYOV VM, 1988, BIOCHEM BIOPH RES CO, V157, P109, DOI 10.1016/S0006-291X(88)80019-6; Leaman DW, 1996, FASEB J, V10, P1578, DOI 10.1096/fasebj.10.14.9002549; LUNDELL D, 1991, PROTEIN ENG, V4, P335, DOI 10.1093/protein/4.3.335; MACDONALD HS, 1986, BIOCHEM BIOPH RES CO, V138, P254, DOI 10.1016/0006-291X(86)90273-1; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; Rutherford MN, 1996, J INTERF CYTOK RES, V16, P507, DOI 10.1089/jir.1996.16.507; SANCEAU J, 1987, P NATL ACAD SCI USA, V84, P2906, DOI 10.1073/pnas.84.9.2906; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; Sekimoto T, 1996, J BIOL CHEM, V271, P31017, DOI 10.1074/jbc.271.49.31017; SLODOWSKI O, 1991, EUR J BIOCHEM, V202, P1133, DOI 10.1111/j.1432-1033.1991.tb16481.x; SMITH MR, 1990, J IMMUNOL, V144, P1777; SZENTE BE, 1994, BIOCHEM BIOPH RES CO, V201, P215, DOI 10.1006/bbrc.1994.1691; Szente BE, 1996, J INTERF CYTOK RES, V16, P813, DOI 10.1089/jir.1996.16.813; SZENTE BE, 1994, BIOCHEM BIOPH RES CO, V203, P1645, DOI 10.1006/bbrc.1994.2375; SZENTE BE, 1995, J IMMUNOL, V155, P5617; WESSENDORF JHM, 1993, J BIOL CHEM, V268, P22100; WETZEL R, 1990, PROTEIN ENG, V3, P611, DOI 10.1093/protein/3.7.611	30	60	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					403	407		10.1074/jbc.274.1.403	http://dx.doi.org/10.1074/jbc.274.1.403			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867857	hybrid			2022-12-27	WOS:000077900200057
J	Yoshikawa, F; Iwasaki, H; Michikawa, T; Furuichi, T; Mikoshiba, K				Yoshikawa, F; Iwasaki, H; Michikawa, T; Furuichi, T; Mikoshiba, K			Cooperative formation of the ligand-binding site of the inositol 1,4,5-trisphosphate receptor by two separable domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRISPHOSPHATE RECEPTOR; EXPRESSION; PROTEIN; PURIFICATION; LOCALIZATION; BRAIN	Limited trypsin digestion of mouse cerebellar membrane fractions leads to fragmentation of the type 1 inositol 1,4,5-trisphosphate receptor (IP(3)R1) into five major components (Yoshikawa, F., Iwasaki, H., Michikawa, T., Furuichi, T., and Mikoshiba, K, (1999) J, Biol. Chem. 274, 316-327), Here we report that trypsin-fragmented mouse IP(3)R1 (mIP(3)R1) retains significant inositol 1,4,5-trisphosphate (IP,) binding activity that is comparable to the intact receptor in affinity, capacity, and specificity. This is despite the fact that the IP,binding core (residues 226-578), which is close to the minimum for high affinity binding, is completely split into two tryptic fragments at the Arg-343 and/or Arg-345, around the center of the core. Furthermore, we have examined whether binding activity could be complemented in vitro by mixing two distinct glutathione S-transferase (GST) fusion proteins, which were respectively composed of residues 1-343 and 341-604, almost corresponding to two split binding components, and separately expressed in Escherichia coli. The GST-fused residues 1-343 (GN) showed no binding affinity for IF,, whereas the GST-fused residues 341-604 (GC) displayed weak but definite activity with an affinity >100-fold lower than that of the native receptor. Upon mixing of both GN and GC, a high affinity site comparable to the native site appeared, We suggest that the IP3-binding pocket consists of two non-covalently but tightly associated structural domains each of which has a discrete function: the C-terminal domain alone has low affinity for IF,, whereas the N-terminal one alone is incapable of binding but is capable of potentiating binding affinity.	Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 1088639, Japan; RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan	University of Tokyo; RIKEN	Furuichi, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tfuruich@ims.u-tokyo.ac.jp	Mikoshiba, Katsuhiko/N-7943-2015; Furuichi, Teiichi/B-5086-2014	Furuichi, Teiichi/0000-0002-9676-1888; Iwasaki, Hirohide/0000-0002-7432-5938				BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; FURUICHI T, 1995, J NEUROCHEM, V64, P953, DOI 10.1046/j.1471-4159.1995.64030953.x; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; MAEDA N, 1991, J BIOL CHEM, V266, P1109; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; NAHORSKI SR, 1989, TRENDS PHARMACOL SCI, V10, P139, DOI 10.1016/0165-6147(89)90165-X; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; WORLEY PF, 1987, NATURE, V325, P159, DOI 10.1038/325159a0; YAMADA N, 1994, BIOCHEM J, V302, P781, DOI 10.1042/bj3020781; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316	18	59	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					328	334		10.1074/jbc.274.1.328	http://dx.doi.org/10.1074/jbc.274.1.328			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867847	hybrid			2022-12-27	WOS:000077900200047
J	Bannerman, DD; Sathyamoorthy, M; Goldblum, SE				Bannerman, DD; Sathyamoorthy, M; Goldblum, SE			Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CADHERIN-CATENIN COMPLEX; ALBUMIN FLUX INVITRO; TO-CELL JUNCTIONS; BETA-CATENIN; MOLECULAR-ORGANIZATION; EXTRACELLULAR-MATRIX; IN-VITRO; APOPTOSIS; ENDOTOXIN	Bacterial lipopolysaccharide or endotoxin induces actin reorganization, increased paracellular permeability, and endothelial cell detachment from the underlying extracellular matrix in vitro. We studied the effect of endotoxin on transendothelial albumin flux and detachment of endothelial cells cultured on gelatin-impregnated filters. The endotoxin-induced changes in endothelial barrier function and detachment occurred at doses and times that were compatible with endotoxin-induced apoptosis. Since the actin cytoskeleton and cell-cell and cell-matrix adhesion all participate in the regulation of the paracellular pathway and cell-matrix interactions, we studied whether protein components of the actin-linked adherens junctions were modified in response to endotoxin. Components of cell-cell (beta- and gamma-catenin) and cell-matrix (focal adhesion kinase and p130(Cas)) adherens junctions were cleaved by caspases activated during apoptosis with dose and time requirements that paralleled those seen for barrier dysfunction and detachment. Cleavage of focal adhesion kinase led to its dissociation from the focal adhesion-associated signaling protein, paxillin, resulting in reduced paxillin tyrosine phosphorylation. Inhibition of caspase-mediated cleavage of these proteins protected against detachment but not opening of the paracellular pathway. Therefore, endotoxin-induced disruption of endothelial monolayer integrity and survival signaling events is mediated, in part, through caspase cleavage of adherens junction proteins.	Univ Maryland, Sch Med, Dept Vet Affairs Med Ctr, Dept Pathol,Div Infect Dis,Med Serv 111, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Vet Affairs Med Ctr, Dept Med,Div Infect Dis, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Goldblum, SE (corresponding author), Univ Maryland, Sch Med, Dept Vet Affairs Med Ctr, Dept Pathol,Div Infect Dis,Med Serv 111, Rm 5D-139,10 N Greene St, Baltimore, MD 21201 USA.							Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; ABERLE H, 1994, J CELL SCI, V107, P3655; ALBELDA SM, 1991, AM J RESP CELL MOL, V4, P195, DOI 10.1165/ajrcmb/4.3.195; Armstrong RC, 1996, J BIOL CHEM, V271, P16850, DOI 10.1074/jbc.271.28.16850; Bannerman DD, 1998, INFECT IMMUN, V66, P1400, DOI 10.1128/IAI.66.4.1400-1407.1998; Bannerman DD, 1997, AM J PHYSIOL-LUNG C, V273, pL217, DOI 10.1152/ajplung.1997.273.1.L217; Barth AI, 1997, CURR OPIN CELL BIOL, V9, P683, DOI 10.1016/S0955-0674(97)80122-6; Brancolini C, 1997, J CELL BIOL, V139, P759, DOI 10.1083/jcb.139.3.759; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; BUTZ S, 1992, SCIENCE, V257, P1142, DOI 10.1126/science.257.5073.1142-a; CAMPBELL WN, 1992, AM J PHYSIOL, V263, pL128, DOI 10.1152/ajplung.1992.263.1.L128; Campbell WN, 1997, AM J PHYSIOL-LUNG C, V273, pL31, DOI 10.1152/ajplung.1997.273.1.L31; Choi KB, 1998, J BIOL CHEM, V273, P20185, DOI 10.1074/jbc.273.32.20185; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; Dejana E, 1996, J CLIN INVEST, V98, P1949, DOI 10.1172/JCI118997; DEJANA E, 1995, THROMB HAEMOSTASIS, V74, P309; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; DESCH CE, 1989, INFECT IMMUN, V57, P1612, DOI 10.1128/IAI.57.5.1612-1614.1989; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Frey EA, 1998, MICROB PATHOGENESIS, V24, P101, DOI 10.1006/mpat.1997.0178; Gervais FG, 1998, J BIOL CHEM, V273, P17102, DOI 10.1074/jbc.273.27.17102; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; GOLDBLUM SE, 1990, AM J PHYSIOL, V258, pL57, DOI 10.1152/ajplung.1990.258.2.L57; GOLDBLUM SE, 1989, INFECT IMMUN, V57, P1218, DOI 10.1128/IAI.57.4.1218-1226.1989; GOLDBLUM SE, 1993, J CELL PHYSIOL, V157, P13, DOI 10.1002/jcp.1041570103; GOLDBLUM SE, 1994, J CLIN INVEST, V93, P692, DOI 10.1172/JCI117022; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; HARLAN JM, 1983, THROMB RES, V29, P15, DOI 10.1016/0049-3848(83)90121-4; HARLAN JM, 1983, LAB INVEST, V48, P269; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; KAWANISHI J, 1995, MOL CELL BIOL, V15, P1175; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Levkau B, 1998, J EXP MED, V187, P579, DOI 10.1084/jem.187.4.579; MAHER PA, 1985, P NATL ACAD SCI USA, V82, P6576, DOI 10.1073/pnas.82.19.6576; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; MEYRICK BO, 1986, FASEB J, V45, P19; MEYRICK BO, 1986, AM J PATHOL, V122, P140; Munemitsu S, 1996, MOL CELL BIOL, V16, P4088; OLSON NC, 1995, BRIT VET J, V151, P489, DOI 10.1016/S0007-1935(05)80023-5; PAULSEN DB, 1989, AM J VET RES, V50, P1633; RAUBER P, 1986, BIOCHEM J, V239, P633, DOI 10.1042/bj2390633; Redl H., 1994, Arzneimittel-Forschung, V44, P443; Retta SF, 1996, EXP CELL RES, V229, P307, DOI 10.1006/excr.1996.0376; RIETSCHEL ET, 1993, IMMUNOBIOLOGY, V187, P169, DOI 10.1016/S0171-2985(11)80338-4; RUBENSTEIN HS, 1962, P SOC EXP BIOL MED, V111, P458, DOI 10.3181/00379727-111-27824; Ruoslahti E, 1997, SCIENCE, V276, P1345, DOI 10.1126/science.276.5317.1345; SALOMON RN, 1995, DIAGN MOL PATHOL, V4, P235, DOI 10.1097/00019606-199512000-00002; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; Schumann RR, 1998, BLOOD, V91, P577, DOI 10.1182/blood.V91.2.577.577_577_584; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Stromblad S, 1996, J CLIN INVEST, V98, P426, DOI 10.1172/JCI118808; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; TURNER CE, 1994, BIOESSAYS, V16, P47, DOI 10.1002/bies.950160107; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; ULEVITCH RJ, 1975, J EXP MED, V142, P1570, DOI 10.1084/jem.142.6.1570; Wen LP, 1997, J BIOL CHEM, V272, P26056, DOI 10.1074/jbc.272.41.26056; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; WOODS A, 1988, COLLAGEN REL RES, V8, P155; Xu LH, 1996, CELL GROWTH DIFFER, V7, P413	66	156	163	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35371	35380		10.1074/jbc.273.52.35371	http://dx.doi.org/10.1074/jbc.273.52.35371			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857080	hybrid			2022-12-27	WOS:000077719700098
J	Goldberg, IJ; Wagner, WD; Pang, L; Paka, L; Curtiss, LK; DeLozier, JA; Shelness, GS; Young, CSH; Pillarisetti, S				Goldberg, IJ; Wagner, WD; Pang, L; Paka, L; Curtiss, LK; DeLozier, JA; Shelness, GS; Young, CSH; Pillarisetti, S			The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; AMINO-TERMINAL DOMAIN; PLASMA LOW-DENSITY; HEPARIN-BINDING; ATHEROSCLEROTIC LESIONS; ENDOTHELIAL-CELLS; HEPATIC LIPASE; APO-B; IDENTIFICATION; PROTEOGLYCANS	An initial event in atherosclerosis is the retention of lipoproteins within the intima of the vessel wall. The co-localization of apolipoprotein (apo) B and proteoglycans within lesions has suggested that retention is due to Lipoprotein interaction with these highly electronegative glycoconjugates. Both apoB100- and apoB48-eontaining lipoproteins, i.e. low density lipoproteins (LDLs) and chylomicron remnants, are atherogenic, This suggests that retention is due to determinants in the initial 48% of apoB, To test this, the interaction of an apoB fragment (apoB17), and apoB48- and apoB100- containing lipoproteins with heparin, subendothelial matrix, and artery wall purified proteoglycans was studied. ApoB100-containing LDL from humans and human apoB transgenic mice and apoB48-containing LDLs from apoE knockout mice were used. Despite the lack of the carboxyl-terminal 52% of apoB, the apoB48-LDL bound to heparin-affinity gel as well as did apoB100-LDL, An NH2-terminal fragment containing 17% of full-length apoB was made using a recombinant adenovirus; apoB17 bound to heparin as well as did LDL, Monoclonal antibodies against the NH2-terminal region of apoB decreased apoB100 LDL binding to heparin, whereas antibodies against the LDL receptor-binding region did not alter LDL-heparin interaction. The role of the NH2-terminal region of apoB in LDL interaction with matrix molecules was also assessed. Media containing apoB17 decreased LDL binding to subendothelial matrix by 42%, Moreover, removal of the apoB17 by immunoprecipitation abrogated the inhibitory effect of these media, Antibodies to the NH2-terminal region decreased LDL binding to matrix and dermatan sulfate proteoglycans. Purified apoB17 effectively competed for binding of LDL to artery derived decorin and to subendothelial matrix. Thus, despite the presence of multiple basic amino acids near the LDL receptor-binding domain of LDL, the NH2-terminal region of apoB is sufficient for the interaction of lipoproteins with glycoconjugates produced by endothelial and smooth muscle cells. The presence of a proteoglycan-binding site in the NH2-terminal region of apoB may explain why apoB48- and apoB100-containing lipoproteins are equally atherogenic.	Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; Wake Forest Univ, Sch Med, Dept Pathol, Winston Salem, NC 27157 USA; Scripps Res Inst, La Jolla, CA 92037 USA	Columbia University; Columbia University; Wake Forest University; Scripps Research Institute	Goldberg, IJ (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA.	IJG3@columbia.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056984, R01HL025161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031452] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56984, HL25161] Funding Source: Medline; NIGMS NIH HHS [GM31452] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELLOSTA S, 1995, J CLIN INVEST, V96, P2170, DOI 10.1172/JCI118271; BERRYMAN DE, 1993, J BIOL CHEM, V268, P3272; BIHARIVARGA M, 1967, BIOCHIM BIOPHYS ACTA, V144, P202, DOI 10.1016/0005-2760(67)90150-6; Boren J, 1998, J CLIN INVEST, V101, P2658, DOI 10.1172/JCI2265; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; CAMEJO G, 1988, ARTERIOSCLEROSIS, V8, P368, DOI 10.1161/01.ATV.8.4.368; CAMEJO G, 1989, ATHEROSCLEROSIS, V79, P121, DOI 10.1016/0021-9150(89)90116-0; Cardin A D, 1988, Adv Exp Med Biol, V243, P157; CHEN GC, 1989, J BIOL CHEM, V264, P14369; CHEN GC, 1991, J BIOL CHEM, V266, P12581; CONRAD HE, 1998, HEPARIN BINDING PROT, P402; DAVIS RC, 1992, J BIOL CHEM, V267, P21499; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; GIANTURCO SH, 1995, CIRCULATION, V92, P3313; GOLDBERG IJ, 1982, J CLIN INVEST, V70, P1184, DOI 10.1172/JCI110717; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gretch DG, 1996, J BIOL CHEM, V271, P8682, DOI 10.1074/jbc.271.15.8682; Guyton JR, 1996, ARTERIOSCL THROM VAS, V16, P4, DOI 10.1161/01.ATV.16.1.4; HATA A, 1993, J BIOL CHEM, V268, P8447; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HOFF HF, 1986, ATHEROSCLEROSIS, V61, P231, DOI 10.1016/0021-9150(86)90143-7; HOFF HF, 1982, ATHEROSCLEROSIS, V42, P273, DOI 10.1016/0021-9150(82)90157-5; HOFF HF, 1977, EXP MOL PATHOL, V26, P214, DOI 10.1016/0014-4800(77)90051-X; HurtCamejo E, 1997, ARTERIOSCL THROM VAS, V17, P1011, DOI 10.1161/01.ATV.17.6.1011; Ingram MF, 1997, J BIOL CHEM, V272, P10279; IVERIUS PH, 1972, J BIOL CHEM, V247, P2607; Kreuzer J, 1997, J LIPID RES, V38, P324; Lovry O.H., 1951, J BIOL CHEM, V193, P265; MA YH, 1994, J LIPID RES, V35, P2049; MAHLEY RW, 1991, JAMA-J AM MED ASSOC, V265, P78, DOI 10.1001/jama.265.1.78; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; OBUNIKE JC, 1994, J BIOL CHEM, V269, P13129; PEASE RJ, 1990, J BIOL CHEM, V265, P553; Pillarisetti S, 1997, J CLIN INVEST, V100, P867, DOI 10.1172/JCI119602; REGISTER TC, 1993, ATHEROSCLEROSIS, V98, P99, DOI 10.1016/0021-9150(93)90227-L; SCHONFELD G, 1985, ADV EXP MED BIOL, V183, P135; SCHWENKE DC, 1989, ARTERIOSCLEROSIS, V9, P908, DOI 10.1161/01.ATV.9.6.908; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674, DOI 10.1161/01.ATV.14.10.1674; SHEPHERD J, 1976, CLIN CHIM ACTA, V66, P97, DOI 10.1016/0009-8981(76)90376-4; SIVARAM P, 1995, J BIOL CHEM, V270, P29760; Sivaram P, 1996, J BIOL CHEM, V271, P15261, DOI 10.1074/jbc.271.25.15261; SIVARAM P, 1994, J BIOL CHEM, V269, P9409; STEINER G, 1993, ANN MED, V25, P431, DOI 10.3109/07853899309147307; Veniant MM, 1997, J CLIN INVEST, V100, P180, DOI 10.1172/JCI119511; WAGNER WD, 1985, ANN NY ACAD SCI, V454, P52, DOI 10.1111/j.1749-6632.1985.tb11844.x; WAGNER WD, 1989, ATHEROSCLEROSIS, V75, P49, DOI 10.1016/0021-9150(89)90206-2; WEISGRABER KH, 1987, J BIOL CHEM, V262, P11097; WONG H, 1991, P NATL ACAD SCI USA, V88, P11290, DOI 10.1073/pnas.88.24.11290; YOMANTAS S, 1984, ARCH PATHOL LAB MED, V108, P374; YOUNG CSH, 1998, METHODS MOL MED, V20, P61; YOUNG SG, 1986, P NATL ACAD SCI USA, V83, P1101, DOI 10.1073/pnas.83.4.1101	51	44	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35355	35361		10.1074/jbc.273.52.35355	http://dx.doi.org/10.1074/jbc.273.52.35355			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857078	hybrid			2022-12-27	WOS:000077719700096
J	Mateer, SC; Fedorov, SA; Mumby, MC				Mateer, SC; Fedorov, SA; Mumby, MC			Identification of structural elements involved in the interaction of simian virus 40 small tumor antigen with protein phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-T ANTIGEN; POLYOMAVIRUS MIDDLE-T; 3-DIMENSIONAL STRUCTURE; SECONDARY STRUCTURE; CATALYTIC SUBUNIT; BINDING-PROTEIN; NEURAL NETWORKS; CELL-GROWTH; ZINC IONS; A-SUBUNIT	SV40 small tumor antigen (small-t) was used as a model to identify structural elements involved in the interactions between regulatory proteins and protein phosphatase 2A (PP2A), Using mutant proteins and synthetic peptides, we identified a small domain within small-t that is a major site for interaction with the dimeric form of PP2A A series of small-t truncation mutants identified a region surrounding the first of two conserved cysteine clusters that was critical for interaction with PP2A These mutants also identified additional regions of small-t that contribute to high affinity interaction. Deletion of residues 110-119, which encompass the first cysteine cluster, resulted in a protein that failed to bind to PP2A, Synthetic peptides that contained residues 105-122 of small-t blocked binding of small-t to PP2A These peptides also inhibited the phosphatase activity of PP2A in a manner analogous to full-length small-t, The active small-t peptides adopt a beta-strand structure that was essential for high affinity interaction with the PP2A dimer, Based on circular dichroism measurements, the same cysteine cluster-containing peptides that bind to PP2A also interact with zinc. Interaction with zinc required the conserved cysteines but was not required for interaction with PP2A.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Mumby, MC (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	marc.mumby@email.swmed.edu			NIGMS NIH HHS [GM49505] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049505] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGOSTINIS P, 1992, EUR J BIOCHEM, V205, P241, DOI 10.1111/j.1432-1033.1992.tb16774.x; Bliss C.I, 1970, STAT BIOL; CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; GLENN GM, 1995, J VIROL, V69, P3729, DOI 10.1128/JVI.69.6.3729-3736.1995; GOSWAMI R, 1992, J VIROL, V66, P1746, DOI 10.1128/JVI.66.3.1746-1751.1992; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HENDRIX P, 1993, J BIOL CHEM, V268, P15267; HERSHMAN KM, 1993, BIOTECHNIQUES, V15, P790; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; JOG P, 1990, J VIROL, V64, P2895, DOI 10.1128/JVI.64.6.2895-2900.1990; KAMIBAYASHI C, 1994, J BIOL CHEM, V269, P20139; Kelley WL, 1997, P NATL ACAD SCI USA, V94, P3679, DOI 10.1073/pnas.94.8.3679; KELLEY WL, 1994, TRENDS BIOCHEM SCI, V19, P277, DOI 10.1016/0968-0004(94)90003-5; MARTIN RG, 1979, J VIROL, V31, P596, DOI 10.1128/JVI.31.3.596-607.1979; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; MUMBY M, 1995, SEMIN CANCER BIOL, V6, P229, DOI 10.1006/scbi.1995.0030; MUMBY MC, 1987, J BIOL CHEM, V262, P6257; MUMBY MC, 1985, J BIOL CHEM, V260, P3763; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; MUNGRE S, 1994, J VIROL, V68, P1675, DOI 10.1128/JVI.68.3.1675-1681.1994; OMICHINSKI JG, 1990, BIOCHEMISTRY-US, V29, P9324, DOI 10.1021/bi00492a004; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; PIPAS JM, 1992, J VIROL, V66, P3979, DOI 10.1128/JVI.66.7.3979-3985.1992; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rost B, 1996, METHOD ENZYMOL, V266, P525; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; SLEIGH MJ, 1978, CELL, V14, P79, DOI 10.1016/0092-8674(78)90303-3; Sontag E, 1997, EMBO J, V16, P5662, DOI 10.1093/emboj/16.18.5662; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; Summers MD, 1987, TEXAS AGR EXPT STATI; TURK B, 1993, J VIROL, V67, P3671, DOI 10.1128/JVI.67.6.3671-3673.1993; UMI H, 1988, J BIOL CHEM, V263, P3752; VALLEE BL, 1991, P NATL ACAD SCI USA, V88, P999, DOI 10.1073/pnas.88.3.999; Watanabe G, 1996, P NATL ACAD SCI USA, V93, P12861, DOI 10.1073/pnas.93.23.12861; YANG JT, 1986, METHOD ENZYMOL, V130, P208; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988	42	32	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35339	35346		10.1074/jbc.273.52.35339	http://dx.doi.org/10.1074/jbc.273.52.35339			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857076	hybrid			2022-12-27	WOS:000077719700094
J	Moolenaar, GF; Bazuine, M; van Knippenberg, IC; Visse, R; Goosen, N				Moolenaar, GF; Bazuine, M; van Knippenberg, IC; Visse, R; Goosen, N			Characterization of the Escherichia coli damage-independent UvrBC endonuclease activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; (A)BC EXCINUCLEASE; ENZYMATIC-PROPERTIES; UVRABC ENDONUCLEASE; PREINCISION COMPLEX; CATALYTIC SITE; 5' INCISION; DNA; PROTEIN; SUBUNITS	Incision of damaged DNA templates by UvrBC in Escherichia coli depends on UvrA, which loads UvrB on the site of the damage. A 50-base pair 3' prenicked DNA substrate containing a cholesterol lesion is incised by UvrABC at two positions 5' to the lesion, the first incision at the eighth and the second at the 15th phosphodiester bond, Analysis of a 5' prenicked cholesterol substrate revealed that the second 5' incision is efficiently produced by UvrBC independent of UvrA This UvrBC incision was also found on the same substrate without a lesion and, with an even higher efficiency, on a DNA substrate containing a 5' single strand overhang. Incision occurred in the presence of ATP or ADP but not in the absence of cofactor. We could show an interaction between UvrB and UvrC in solution and subsequent binding of this complex to the substrate with a 5' single strand overhang. Analysis of mutant UvrB and UvrC proteins revealed that the damage-independent nuclease activity requires the protein-protein interaction do; mains, which are exclusively needed for the 3' incision on damaged substrates, However, the UvrBC incision uses the catalytic site in UvrC which makes the 5' incision on damaged DNA substrates.	Leiden Univ, Gorlaeus Labs, Leiden Inst Chem, Genet Mol Lab, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Goosen, N (corresponding author), Leiden Univ, Gorlaeus Labs, Leiden Inst Chem, Genet Mol Lab, POB 9502, NL-2300 RA Leiden, Netherlands.	N.Goosen@chem.Leidenuniv.nl						BERTRANDBURGGRAF E, 1991, J MOL BIOL, V219, P27, DOI 10.1016/0022-2836(91)90854-Y; Crowley DJ, 1998, J BACTERIOL, V180, P3345, DOI 10.1128/JB.180.13.3345-3352.1998; FREIDBERG EC, 1995, DNA REPAIR MUTAGENES; GOOSEN N, 1998, NUCL ACID M, V12, P103; Gordienko I, 1998, EMBO J, V17, P626, DOI 10.1093/emboj/17.2.626; HSU DS, 1995, J BIOL CHEM, V270, P8319, DOI 10.1074/jbc.270.14.8319; Lin CLG, 1997, NUCLEIC ACIDS RES, V25, P3151, DOI 10.1093/nar/25.15.3151; LIN JJ, 1992, J BIOL CHEM, V267, P17693; LIN JJ, 1992, J BIOL CHEM, V267, P17688; MATSUNAGA T, 1995, J BIOL CHEM, V270, P20862, DOI 10.1074/jbc.270.35.20862; Moolenaar GF, 1998, NUCLEIC ACIDS RES, V26, P462, DOI 10.1093/nar/26.2.462; Moolenaar GF, 1997, MUTAT RES-DNA REPAIR, V385, P195, DOI 10.1016/S0921-8777(97)00042-6; Moolenaar GF, 1995, J BIOL CHEM, V270, P30508, DOI 10.1074/jbc.270.51.30508; MOOLENAAR GF, 1994, J MOL BIOL, V240, P294, DOI 10.1006/jmbi.1994.1447; ORREN DK, 1989, P NATL ACAD SCI USA, V86, P5237, DOI 10.1073/pnas.86.14.5237; ORREN DK, 1990, J BIOL CHEM, V265, P15796; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SHIZUYA H, 1972, J BACTERIOL, V112, P676, DOI 10.1128/JB.112.2.676-681.1972; VANHOUTEN B, 1987, J BIOL CHEM, V262, P13180; VANHOUTEN B, 1990, MICROBIOL REV, V54, P18, DOI 10.1128/MMBR.54.1.18-51.1990; VISSE R, 1992, J BIOL CHEM, V267, P6736; VISSE R, 1991, J BIOL CHEM, V266, P7609; YEUNG AT, 1983, P NATL ACAD SCI-BIOL, V80, P6157, DOI 10.1073/pnas.80.20.6157; Zou Y, 1997, J BIOL CHEM, V272, P4820, DOI 10.1074/jbc.272.8.4820	25	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34896	34903		10.1074/jbc.273.52.34896	http://dx.doi.org/10.1074/jbc.273.52.34896			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857018	hybrid, Green Published			2022-12-27	WOS:000077719700036
J	Vaillancourt, FH; Han, S; Fortin, PD; Bolin, JT; Eltis, LD				Vaillancourt, FH; Han, S; Fortin, PD; Bolin, JT; Eltis, LD			Molecular basis for the stabilization and inhibition of 2,3-dihydroxybiphenyl 1,2-dioxygenase by t-butanol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRADIOL CATECHOL DIOXYGENASES; SUBSTRATE-SPECIFICITY; PSEUDOMONAS-PUTIDA; PROTOCATECHUATE 3,4-DIOXYGENASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; 2,3-DIOXYGENASE; MECHANISM; PURIFICATION; PSEUDOALCALIGENES	The steady-state cleavage of catechols by 2,3-dihydroxybiphenyl 1,2-dioxygenase (DHBD), the extradiol dioxygenase of the biphenyl biodegradation pathway, was investigated using a highly active, anaerobically purified preparation of enzyme, The kinetic data obtained using 2,3-dihydroxybiphenyl (DHB) fit a compulsory order ternary complex mechanism in which substrate inhibition occurs. The K-m for dioxygen was 1280 +/- 70 mu M, which is at least 2 orders of magnitude higher than that reported for catechol 2,3-dioxygenases, K-m and K-d for DHB were 22 +/- 2 and 8 +/- 1 mu M, respectively, DI-IBD was subject to reversible substrate inhibition and mechanism-based inactivation. In air-saturated buffer, the partition ratios of catecholic substrates substituted at C-3 were inversely related to their apparent specificity constants, Small organic molecules that stabilized DHBD most effectively also inhibited the cleavage reaction most strongly. The steady-state kinetic data and crystallographic results suggest that the stabilization and inhibition are due to specific interactions between the organic molecule and the active site of the enzyme. t-Butanol stabilized the enzyme and inhibited the cleavage of DHB in a mixed fashion, consistent with the distinct binding sites occupied by t-butanol in the crystal structures of the substrate-free form of the enzyme and the enzyme-DHB complex. In contrast, crystal structures of complexes with catechol and 3-methylcatechol revealed relationships between the binding of these smaller substrates and t-butanol that are consistent with the observed competitive inhibition.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Univ Laval, Dept Biochem, Quebec City, PQ G1K 7P4, Canada	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Laval University	Eltis, LD (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.		Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158; Fortin, Pascal/0000-0001-9796-791X	NIGMS NIH HHS [GM-52381] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS RH, 1992, APPL ENVIRON MICROB, V58, P647, DOI 10.1128/AEM.58.2.647-654.1992; Arras T, 1998, J BACTERIOL, V180, P2133, DOI 10.1128/JB.180.8.2133-2136.1998; ASTURIAS JA, 1994, J BIOL CHEM, V269, P7807; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergdoll M, 1998, PROTEIN SCI, V7, P1661, DOI 10.1002/pro.5560070801; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; CERDAN P, 1994, J BACTERIOL, V176, P6074, DOI 10.1128/jb.176.19.6074-6081.1994; CERDAN P, 1995, EUR J BIOCHEM, V229, P113, DOI 10.1111/j.1432-1033.1995.0113l.x; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; Elgren TE, 1997, BIOCHEMISTRY-US, V36, P11504, DOI 10.1021/bi970691k; Eltis LD, 1996, J BACTERIOL, V178, P5930, DOI 10.1128/jb.178.20.5930-5937.1996; ELTIS LD, 1993, J BIOL CHEM, V268, P2727; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FERSHT A, 1985, ENZYM STRUCTURE MECH, P325; FURUKAWA K, 1987, J BACTERIOL, V169, P924, DOI 10.1128/jb.169.2.924-927.1987; HAIGLER BE, 1990, J BACTERIOL, V172, P457, DOI 10.1128/JB.172.1.457-464.1990; HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976; HAPPE B, 1993, J BACTERIOL, V175, P7313, DOI 10.1128/JB.175.22.7313-7320.1993; HEISS G, 1995, J BACTERIOL, V177, P5865, DOI 10.1128/jb.177.20.5865-5871.1995; HORI K, 1973, J BIOCHEM, V74, P375; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; KOBAYASHI T, 1995, J BIOCHEM, V117, P614, DOI 10.1093/oxfordjournals.jbchem.a124753; Kukor JJ, 1996, APPL ENVIRON MICROB, V62, P1728, DOI 10.1128/AEM.62.5.1728-1740.1996; Lendenmann U, 1996, J BACTERIOL, V178, P6227, DOI 10.1128/jb.178.21.6227-6232.1996; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; MABROUK PA, 1991, J AM CHEM SOC, V113, P4053, DOI 10.1021/ja00011a001; NOZAKI M, 1963, BIOCHEM Z, V338, P582; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PASCAL RA, 1987, J AM CHEM SOC, V109, P2854, DOI 10.1021/ja00243a065; POLISSI A, 1993, EMBO J, V12, P3339, DOI 10.1002/j.1460-2075.1993.tb06004.x; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; SANVOISIN J, 1995, J AM CHEM SOC, V117, P7836, DOI 10.1021/ja00134a041; Senda T, 1996, J MOL BIOL, V255, P735, DOI 10.1006/jmbi.1996.0060; SHU LJ, 1995, BIOCHEMISTRY-US, V34, P6649, DOI 10.1021/bi00020a010; SMITH TJ, 1995, J MOL GRAPHICS, V13, P122, DOI 10.1016/0263-7855(94)00019-O; Spence EL, 1996, J BACTERIOL, V178, P5249, DOI 10.1128/jb.178.17.5249-5256.1996; Spence EL, 1996, J AM CHEM SOC, V118, P8336, DOI 10.1021/ja9607704; WHITTAKER JW, 1990, METHOD ENZYMOL, V188, P82	42	80	81	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34887	34895		10.1074/jbc.273.52.34887	http://dx.doi.org/10.1074/jbc.273.52.34887			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857017	hybrid			2022-12-27	WOS:000077719700035
J	Wang, SSQ; Mahendran, R; Miller, DL				Wang, SSQ; Mahendran, R; Miller, DL			Editing of cytochrome b mRNA in Physarum mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; POLYCEPHALUM; DNA; SEQUENCE; GENE; ORGANIZATION	The reading frame in the mRNA for the cytochrome b apoprotein in mitochondria of Physarum polycephalum is created by the insertion of 43 nucleotides in the mRNA relative to the mtDNA sequence encoding it (RNA editing), Most of these insertions (31) are single cytidines; however, single uridines are inserted at six sites, and the dinucleotides, CU and GC, are inserted at two sites and one site, respectively. These insertions create a 392-codon reading frame in the mature mRNA, The amino acid sequence inferred from this reading frame has similarity to cytochrome b apoproteins encoded by other mtDNAs, The insertions are quite evenly distributed throughout the length of the reading frame with an average spacing of 27 nucleotides, This mRNA has the highest percentage (23%) of noncytidine insertions of any Physarum RNA characterized to date. cDNAs corresponding to partially edited RNAs can be enriched by selective amplification, Some cDNAs that lack the GC dinucleotide insertion are fully edited at sites flanking the GC dinucleotide insertion site. Similarly some cDNAs lack the CT dinucleotide insertion or have a CC or TT insertion flanked by a fully edited sequence. These results imply that dinucleotide editing occurs by a process separate from the global insertion of cytidines.	Univ Texas, Dept Mol & Cell Biol FO3 1, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas	Miller, DL (corresponding author), Univ Texas, Dept Mol & Cell Biol FO3 1, 2601 N Floyd Rd, Richardson, TX 75080 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044223] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 44223] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antes T, 1998, MOL CELL BIOL, V18, P7521, DOI 10.1128/MCB.18.12.7521; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Daniel J. W., 1964, METHOD CELL PHYSIOL, P9; DAWSON AJ, 1984, EMBO J, V3, P2107, DOI 10.1002/j.1460-2075.1984.tb02098.x; GOTT JM, 1993, J BIOL CHEM, V268, P25483; JONES EP, 1990, CURR GENET, V17, P331, DOI 10.1007/BF00314881; LOCKER J, 1979, ANAL BIOCHEM, V98, P358, DOI 10.1016/0003-2697(79)90154-4; MAHENDRAN R, 1991, NATURE, V349, P434, DOI 10.1038/349434a0; MAHENDRAN R, 1994, EMBO J, V13, P232, DOI 10.1002/j.1460-2075.1994.tb06253.x; Miller D. L., 1993, RNA EDITING ALTERATI, P53; Miller Dennis, 1993, Seminars in Cell Biology, V4, P261, DOI 10.1006/scel.1993.1031; Miller Dennis L., 1993, P53; NOBREGA FG, 1980, J BIOL CHEM, V255, P9828; QUEEN C, 1984, NUCLEIC ACIDS RES, V12, P581, DOI 10.1093/nar/12.1Part2.581; RUNDQUIST BA, 1995, MOL GEN GENET, V247, P306, DOI 10.1007/BF00293198; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; VisomirskiRobic LM, 1997, P NATL ACAD SCI USA, V94, P4324, DOI 10.1073/pnas.94.9.4324; VisomirskiRobic LM, 1997, RNA, V3, P821	21	19	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2725	2731		10.1074/jbc.274.5.2725	http://dx.doi.org/10.1074/jbc.274.5.2725			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915803	hybrid			2022-12-27	WOS:000078319500021
J	Hansen, JB; Petersen, RK; Larsen, BM; Bartkova, J; Alsner, J; Kristiansen, K				Hansen, JB; Petersen, RK; Larsen, BM; Bartkova, J; Alsner, J; Kristiansen, K			Activation of peroxisome proliferator-activated receptor gamma bypasses the function of the retinoblastoma protein in adipocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING-PROTEIN; SKELETAL-MUSCLE CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; PPAR-GAMMA; GLUCOCORTICOID RECEPTOR; ECTOPIC EXPRESSION; RESTRICTION POINT; CYCLE; ALPHA	The retinoblastoma protein (pRB) is an important regulator of development, proliferation, and cellular differentiation. pRB was recently shown to play a pivotal role in adipocyte differentiation, to interact physically with adipogenic CCAAT/enhancer-binding proteins (C/EBPs), and to positively regulate transactivation by C/EBP beta. We show that PPAR gamma-mediated transactivation is pRB-independent, and that ligand-induced transactivation by PPAR gamma 1 present in RB+/+ and RB-/- mouse embryo fibroblasts is sufficient to bypass the differentiation block imposed by the absence of pRB. The differentiated RB-/- cells accumulate lipid and express adipocyte markers, including C/EBP alpha and PPAR gamma 2, Interestingly, adipose conversion of pRB-deficient cells occurs in the absence of compensatory up-regulations of the other pRB family members p107 and p130. RB+/+ as well as RB-/- cells efficiently exit from. the cell cycle after completion of clonal expansion following stimulation with adipogenic inducers. We conclude that ligand-induced activation of endogenous PPAR gamma 1 in mouse embryo fibroblasts is sufficient to initiate a transcriptional cascade resulting in induction of PPAR gamma 2 and C/EBP alpha expression, withdrawal from the cell cycle, and terminal differentiation in the absence of a functional pRB.	Odense Univ, Dept Mol Biol, DK-5230 Odense M, Denmark; Danish Canc Soc, Div Canc Biol, DK-2100 Copenhagen, Denmark; Aarhus Univ Hosp, Dept Expt Clin Oncol, DK-8000 Aarhus C, Denmark	University of Southern Denmark; Danish Cancer Society; Aarhus University	Kristiansen, K (corresponding author), Odense Univ, Dept Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark.		Kristiansen, Karsten/J-5148-2014; Alsner, Jan/A-3056-2009; Hansen, Jacob B/F-3775-2010	Kristiansen, Karsten/0000-0002-6024-0917; Alsner, Jan/0000-0002-5395-3193; Hansen, Jacob B/0000-0001-5249-2586				Alcalay M, 1998, MOL CELL BIOL, V18, P1084, DOI 10.1128/MCB.18.2.1084; Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Bartek J, 1996, CURR OPIN CELL BIOL, V8, P805, DOI 10.1016/S0955-0674(96)80081-0; Brun RP, 1996, CURR OPIN CELL BIOL, V8, P826, DOI 10.1016/S0955-0674(96)80084-6; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chang KH, 1997, P NATL ACAD SCI USA, V94, P9040, DOI 10.1073/pnas.94.17.9040; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chen PL, 1996, P NATL ACAD SCI USA, V93, P465, DOI 10.1073/pnas.93.1.465; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P56; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; GAO X, 1991, BIOCHEM BIOPH RES CO, V179, P280, DOI 10.1016/0006-291X(91)91366-K; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; HENDRICKSTAYLOR LR, 1995, NUCLEIC ACIDS RES, V23, P4726, DOI 10.1093/nar/23.22.4726; Herrera RE, 1996, MOL CELL BIOL, V16, P2402; Higgins C, 1996, J VIROL, V70, P745, DOI 10.1128/JVI.70.2.745-752.1996; Jensen J, 1996, J BIOL CHEM, V271, P18749, DOI 10.1074/jbc.271.31.18749; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; LEGRAVEREND C, 1993, NUCLEIC ACIDS RES, V21, P1735, DOI 10.1093/nar/21.8.1735; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; LIAO K, 1995, J BIOL CHEM, V270, P12123, DOI 10.1074/jbc.270.20.12123; Livneh E, 1996, ONCOGENE, V12, P1545; LUKAS J, 1995, MOL CELL BIOL, V15, P2600; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; Mandrup S, 1998, J BIOL CHEM, V273, P23897, DOI 10.1074/jbc.273.37.23897; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Richon VM, 1997, J BIOL CHEM, V272, P10117, DOI 10.1074/jbc.272.15.10117; RILEY DJ, 1994, ANNU REV CELL BIOL, V10, P1, DOI 10.1146/annurev.cb.10.110194.000245; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; SINGH P, 1995, NATURE, V374, P562, DOI 10.1038/374562a0; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang J, 1997, CANCER RES, V57, P351; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051	54	124	125	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2386	2393		10.1074/jbc.274.4.2386	http://dx.doi.org/10.1074/jbc.274.4.2386			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891007	hybrid			2022-12-27	WOS:000078185200074
J	Kennedy, ME; Nemec, J; Corey, S; Wickman, K; Clapham, DE				Kennedy, ME; Nemec, J; Corey, S; Wickman, K; Clapham, DE			GIRK4 confers appropriate processing and cell surface localization to G-protein-gated potassium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING K+-CHANNEL; BETA-GAMMA-SUBUNITS; INWARD RECTIFIER; XENOPUS OOCYTES; I-KACH; LINKED OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; MESSENGER-RNAS; ADULT-RAT; EXPRESSION	GIRK1 and GIRK4 subunits combine to form the heterotetrameric acetylcholine-activated potassium current (I-KACh) channel in pacemaker cells of the heart. The channel is activated by direct binding of G-protein G(beta gamma) subunits, The GIRK1 subunit is atypical in the GIRK family in having a unique (similar to 125-amino acid) domain in its distal C terminus. GIRK1 cannot form functional channels by itself but must combine with another GIRK family member (GIRK2, GIRK3, or GIRK4), which are themselves capable of forming functional homotetramers. Here we show, using an extracellularly Flag-tagged GIRK1 subunit, that GIRK1 requires association with GIRK4 for cell surface localization. Furthermore, GIRK1 homomultimers reside in core-glycosylated and nonglycosylated states. Coexpression of GIRK4 caused the appearance of the mature glycosylated form of GIRK1. [S-35]Methionine pulse-labeling experiments demonstrated that GIRK4 associates with GIRK1 either during or shortly after subunit synthesis. Mutant and chimeric channel subunits were utilized to identify domains responsible for GIRK1 localization. Truncation of the unique C-terminal domain of Delta 374-501 resulted in an intracellular GIRK1 subunit that produced normal I-KACh-like channels when coexpressed with GIRK4. Chimeras containing the C-terminal domain of GIRK1 from amino acid 194 to 501 were intracellularly localized, whereas chimeras containing the C terminus of GIRK4 localized to the cell surface. Deletion analysis of the GIRK4 C terminus identified a 25-amino acid region required for cell surface targeting of GIRK1/GIRK4 heterotetramers and a 25-amino acid region required for cell surface localization of GIRK4 homotetramers. GIRK1 appeared intracellular in atrial myocytes isolated from GIRK4 knockout mice and was not maturely glycosylated, supporting an essential role for GIRK4 in the processing and cell surface localization of I,,, in vivo.	Howard Hughes Med Inst, Childrens Hosp, Boston, MA 02115 USA; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA; Harvard Univ, Sch Med, Dept Cardiol, Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Mayo Clinic; Harvard University; Boston Children's Hospital; Harvard Medical School	Clapham, DE (corresponding author), Howard Hughes Med Inst, Childrens Hosp, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.	clapham@rascal.med.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428; Wickman, Kevin/0000-0002-5179-9540	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007572] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32HL07572-13] Funding Source: Medline; PHS HHS [34873] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Corey S, 1998, J BIOL CHEM, V273, P5271, DOI 10.1074/jbc.273.9.5271; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; INANOBE A, 1995, BIOCHEM BIOPH RES CO, V212, P1022, DOI 10.1006/bbrc.1995.2072; Isomoto S, 1996, BIOCHEM BIOPH RES CO, V218, P286, DOI 10.1006/bbrc.1996.0050; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; Karschin C, 1996, J NEUROSCI, V16, P3559; KENDALL JM, 1994, ANAL BIOCHEM, V221, P173, DOI 10.1006/abio.1994.1394; Kennedy ME, 1996, NEUROPHARMACOLOGY, V35, P831, DOI 10.1016/0028-3908(96)00132-3; KIM DH, 1993, CIRC RES, V73, P89, DOI 10.1161/01.RES.73.1.89; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; Kofuji P, 1996, J PHYSIOL-LONDON, V490, P633, DOI 10.1113/jphysiol.1996.sp021173; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P28777, DOI 10.1074/jbc.270.48.28777; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; Luchian T, 1997, J PHYSIOL-LONDON, V505, P13, DOI 10.1111/j.1469-7793.1997.013bc.x; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Navarro B, 1996, SCIENCE, V272, P1950, DOI 10.1126/science.272.5270.1950; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Silverman SK, 1996, P NATL ACAD SCI USA, V93, P15429, DOI 10.1073/pnas.93.26.15429; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; Stevens EB, 1997, J PHYSIOL-LONDON, V503, P547, DOI 10.1111/j.1469-7793.1997.547bg.x; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; TAKAO K, 1994, NEURON, V13, P747, DOI 10.1016/0896-6273(94)90041-8; Velimirovic BM, 1996, FEBS LETT, V379, P31, DOI 10.1016/0014-5793(95)01465-9; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Woodward R, 1997, J BIOL CHEM, V272, P10823	56	69	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2571	2582		10.1074/jbc.274.4.2571	http://dx.doi.org/10.1074/jbc.274.4.2571			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891030	hybrid			2022-12-27	WOS:000078185200097
J	Orzech, E; Schlessinger, K; Weiss, A; Okamoto, CT; Aroeti, B				Orzech, E; Schlessinger, K; Weiss, A; Okamoto, CT; Aroeti, B			Interactions of the AP-1 Golgi adaptor with the polymeric immunoglobulin receptor and their possible role in mediating brefeldin A-sensitive basolateral targeting from the trans-Golgi network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED EPITHELIAL-CELLS; ADP-RIBOSYLATION FACTOR; MANNOSE 6-PHOSPHATE RECEPTOR; HIGH-AFFINITY INTERACTION; CANINE KIDNEY-CELLS; MDCK CELLS; CYTOPLASMIC DOMAIN; PHOSPHOLIPASE-D; SORTING SIGNAL; SELECTIVE TRANSPORT	We provide morphological, biochemical, and functional evidence suggesting that the AP-1 clathrin adaptor complex of the trans-Golgi network interacts with the polymeric immunoglobulin receptor in transfected Madin-Darby canine kidney cells. Our results indicate that immunofluorescently labeled gamma-adaptin subunit of the adaptor complex and the polymeric immunoglobulin receptor partially co-localize in polarized and semi-polarized cells. gamma-Adaptin is co-immunoisolated with membranes expressing the wild-type receptor. The entire AP-1 adaptor complex could be chemically cross-linked to the receptor in filter-grown cells. gamma-Adaptin could be co-immunoprecipitated with the wild-type receptor, with reduced efficiency with receptor mutant whose basolateral sorting motif has been deleted, and not with receptor lacking its cytoplasmic tail. Co-immunoprecipitation of gamma-adaptin was inhibited by brefeldin A. Mutation of cytoplasmic serine 726 inhibited receptor interactions with AP-1 but did not abrogate the fidelity of its basolateral targeting from the trans-Golgi network. However, the kinetics of receptor delivery to the basolateral cell surface were slowed by the mutation. Although surface delivery of the wild-type receptor was inhibited by brefeldin A, the delivery of the mutant receptor was insensitive to the drug. Our results are consistent with a working model in which phosphorylated cytoplasmic serine modulates the recruitment of the polymeric immunoglobulin receptor into AP-1/clathrin-coated areas in the trans-Golgi network. This process may regulate the efficiency of receptor targeting from the trans-Golgi network.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Anim Biol, IL-91904 Jerusalem, Israel; Univ So Calif, Sch Pharm, Dept Pharmaceut Sci, Los Angeles, CA 90033 USA	Hebrew University of Jerusalem; University of Southern California	Aroeti, B (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Anim Biol, IL-91904 Jerusalem, Israel.	aroeti@cc.huji.ac.il						Alonso MA, 1997, J BIOL CHEM, V272, P30748, DOI 10.1074/jbc.272.49.30748; ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; APODACA G, 1993, J BIOL CHEM, V268, P20380; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Aridor M, 1996, TRENDS CELL BIOL, V6, P315, DOI 10.1016/0962-8924(96)10027-1; AROETI B, 1993, J CELL BIOL, V123, P1149, DOI 10.1083/jcb.123.5.1149; Aroeti B, 1998, BBA-REV BIOMEMBRANES, V1376, P57, DOI 10.1016/S0304-4157(98)00005-7; AROETI B, 1994, EMBO J, V13, P2297, DOI 10.1002/j.1460-2075.1994.tb06513.x; BARROSO M, 1994, J CELL BIOL, V124, P83, DOI 10.1083/jcb.124.1.83; BOLL W, 1991, P NATL ACAD SCI USA, V88, P8592, DOI 10.1073/pnas.88.19.8592; BREITFELD PP, 1989, METHOD CELL BIOL, V32, P329; Bremnes T, 1998, J BIOL CHEM, V273, P8638, DOI 10.1074/jbc.273.15.8638; BREWER CB, 1994, METHOD CELL BIOL, V43, P233; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; DEMATTEIS MA, 1993, NATURE, V364, P818, DOI 10.1038/364818a0; Dietrich J, 1997, J CELL BIOL, V138, P271, DOI 10.1083/jcb.138.2.271; Distel B, 1998, J BIOL CHEM, V273, P186, DOI 10.1074/jbc.273.1.186; DONALDSON JG, 1994, CURR OPIN CELL BIOL, V6, P527, DOI 10.1016/0955-0674(94)90072-8; Fire E, 1997, J BIOL CHEM, V272, P29538, DOI 10.1074/jbc.272.47.29538; FUTTER CE, 1995, J BIOL CHEM, V270, P10999, DOI 10.1074/jbc.270.18.10999; Futter CE, 1998, J CELL BIOL, V141, P611, DOI 10.1083/jcb.141.3.611; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Gut A, 1998, EMBO J, V17, P1919, DOI 10.1093/emboj/17.7.1919; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; HUNZIKER W, 1991, CELL, V57, P1; JOHNSON KF, 1992, J BIOL CHEM, V267, P17110; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; LeBorgne R, 1996, J BIOL CHEM, V271, P2162; LEITINGER B, 1995, P NATL ACAD SCI USA, V92, P10109, DOI 10.1073/pnas.92.22.10109; Lewin DA, 1998, BBA-MOL CELL RES, V1401, P129, DOI 10.1016/S0167-4889(97)00130-4; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LISCOVITCH M, 1995, CELL, V81, P659, DOI 10.1016/0092-8674(95)90525-1; Luton F, 1998, MOL BIOL CELL, V9, P1787, DOI 10.1091/mbc.9.7.1787; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; Mauxion F, 1996, J BIOL CHEM, V271, P2171, DOI 10.1074/jbc.271.4.2171; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; MOSTOV KE, 1986, CELL, V47, P359, DOI 10.1016/0092-8674(86)90592-1; MOSTOV KE, 1995, BIOESSAYS, V17, P129, DOI 10.1002/bies.950170208; Musch A, 1997, J CELL BIOL, V138, P291, DOI 10.1083/jcb.138.2.291; NARULA N, 1992, J CELL BIOL, V117, P27, DOI 10.1083/jcb.117.1.27; NELSON WJ, 1992, SCIENCE, V258, P948, DOI 10.1126/science.1439806; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; OKAMOTO CT, 1994, J BIOL CHEM, V269, P15676; PAGE LJ, 1995, J CELL BIOL, V131, P619, DOI 10.1083/jcb.131.3.619; Ponnambalam S, 1996, CURR BIOL, V6, P1076, DOI 10.1016/S0960-9822(02)70669-6; Reich V, 1996, J CELL SCI, V109, P2133; Robinson MS, 1997, TRENDS CELL BIOL, V7, P99, DOI 10.1016/S0962-8924(96)10048-9; Rodionov DG, 1998, J BIOL CHEM, V273, P6005, DOI 10.1074/jbc.273.11.6005; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; SOLARI R, 1985, J BIOL CHEM, V260, P1141; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; THOMAS DC, 1993, J BIOL CHEM, V268, P3313; Tong X, 1998, J VIROL, V72, P476, DOI 10.1128/JVI.72.1.476-482.1998; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Weimbs T, 1997, TRENDS CELL BIOL, V7, P393, DOI 10.1016/S0962-8924(97)01130-6; West MA, 1997, J CELL BIOL, V138, P1239, DOI 10.1083/jcb.138.6.1239; WONG DH, 1992, J CELL BIOL, V117, P1171, DOI 10.1083/jcb.117.6.1171; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929	73	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2201	2215		10.1074/jbc.274.4.2201	http://dx.doi.org/10.1074/jbc.274.4.2201			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890983	hybrid			2022-12-27	WOS:000078185200050
J	Barber, KR; McClintock, KA; Jamieson, GA; Dimlich, RVW; Shaw, GS				Barber, KR; McClintock, KA; Jamieson, GA; Dimlich, RVW; Shaw, GS			Specificity and Zn2+ enhancement of the S100B binding epitope TRTK-12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ACTIN CAPPING PROTEIN; HUMAN-BRAIN S100B; CALCIUM-BINDING; CA2+-DEPENDENT MANNER; GUANYLATE-CYCLASE; CATION-BINDING; SMOOTH-MUSCLE; S-100 PROTEIN; HIGH-AFFINITY	The calcium-binding protein S100B (an S100 dimer composed of two S100 beta monomers) is proposed to act as a calcium-sensory protein through interactions with a variety of proteins. While the nature of the exact targets for S100B has yet to be defined, random bacteriophage peptide mapping experiments have elucidated a calcium-sensitive "epitope" (TRTK-12) for S100B recognition. In this work, interactions of TRTK-12 with S100B have been shown to be calcium-sensitive. In addition, the interactions are enhanced by zinc binding to S100B, resulting in an approximate 5-fold decrease in the TRTK-12/S100B dissociation constant. Moreover, Zn2+ binding alone has little effect. TRTK-12 showed Little evidence for binding to another S100 protein, S100A11 or to a peptide derived from the N terminus of S100B, indicating both a level of specificity for TRTK-12 recognition by S100B and that the N-terminal region of S100B is probably not involved in protein-protein interactions. NMR spectroscopy revealed residues most responsive to TRTK-12 binding that could be mapped to the surface of the three-dimensional structure of calcium-saturated S100B, revealing a common region indicative of a binding site.	Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; Univ Western Ontario, McLaughlin Macromol Struct Facil, London, ON N6A 5C1, Canada; Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Anat Cell Biol & Neurobiol, Cincinnati, OH 45267 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Shaw, GS (corresponding author), Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada.		Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625				Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Allen BG, 1996, BIOCHEM CELL BIOL, V74, P687, DOI 10.1139/o96-075; BAUDIER J, 1983, BIOCHEMISTRY-US, V22, P3360, DOI 10.1021/bi00283a009; BAUDIER J, 1986, J BIOL CHEM, V261, P8192; BAUDIER J, 1988, J BIOL CHEM, V263, P5876; BAUDIER J, 1983, BIOCHEM BIOPH RES CO, V114, P1138, DOI 10.1016/0006-291X(83)90681-2; BAUDIER J, 1984, BIOCHIM BIOPHYS ACTA, V790, P164, DOI 10.1016/0167-4838(84)90220-6; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; BAUDIER J, 1987, BIOCHEMISTRY-US, V26, P2886, DOI 10.1021/bi00384a033; Bianchi R, 1996, BBA-MOL CELL RES, V1313, P258, DOI 10.1016/0167-4889(96)00098-5; BIANCHI R, 1993, J BIOL CHEM, V268, P12669; DEDMAN JR, 1993, J BIOL CHEM, V268, P23025; DELLANGELICA EC, 1994, J BIOL CHEM, V269, P28929; DONALDSON C, 1995, PROTEIN SCI, V4, P765; DONATO R, 1991, CELL CALCIUM, V12, P713, DOI 10.1016/0143-4160(91)90040-L; DONATO R, 1988, J BIOL CHEM, V263, P106; Drohat AC, 1998, BIOCHEMISTRY-US, V37, P2729, DOI 10.1021/bi972635p; FILIPEK A, 1990, FEBS LETT, V264, P263, DOI 10.1016/0014-5793(90)80263-I; FOHR UG, 1995, J BIOL CHEM, V270, P21056, DOI 10.1074/jbc.270.36.21056; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; Heierhorst J, 1996, NATURE, V380, P636, DOI 10.1038/380636a0; HEIZMANN CW, 1991, TRENDS BIOCHEM SCI, V16, P98, DOI 10.1016/0968-0004(91)90041-S; HILT DC, 1991, NOVEL CALCIUM BINDIN, P65; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; IVANENKOV VV, 1995, J BIOL CHEM, V270, P14651, DOI 10.1074/jbc.270.24.14651; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kilby PM, 1997, PROTEIN SCI, V6, P2494; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; LEMASTER DM, 1988, BIOCHEMISTRY-US, V27, P142, DOI 10.1021/bi00401a022; LIN LH, 1994, MOL BRAIN RES, V25, P297, DOI 10.1016/0169-328X(94)90165-1; Matsumura H, 1998, STRUCTURE, V6, P233, DOI 10.1016/S0969-2126(98)00024-0; McKay RT, 1997, J BIOL CHEM, V272, P28494, DOI 10.1074/jbc.272.45.28494; OGOMA Y, 1992, INT J BIOL MACROMOL, V14, P279, DOI 10.1016/S0141-8130(05)80041-8; POTTS BCM, 1995, NAT STRUCT BIOL, V2, P790, DOI 10.1038/nsb0995-790; Pozdnyakov N, 1997, BIOCHEMISTRY-US, V36, P14159, DOI 10.1021/bi971792l; Pozdnyakov N, 1998, BIOCHEMISTRY-US, V37, P10701, DOI 10.1021/bi9802115; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Schonekess BO, 1997, BIOCHEM CELL BIOL, V75, P771, DOI 10.1139/bcb-75-6-771; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Smith SP, 1997, J BIOMOL NMR, V10, P77, DOI 10.1023/A:1018397213369; Smith SP, 1996, BIOCHEMISTRY-US, V35, P8805, DOI 10.1021/bi952698c; Smith SP, 1998, STRUCTURE, V6, P211, DOI 10.1016/S0969-2126(98)00022-7; SMITH SP, 1998, IN PRESS BIOCH CELL; VANELDIK LJ, 1994, BBA-MOL CELL RES, V1223, P398, DOI 10.1016/0167-4889(94)90101-5; Wilder PT, 1998, PROTEIN SCI, V7, P794, DOI 10.1002/pro.5560070330; ZHAN Q, 1991, J BIOL CHEM, V266, P21810; ZHANG MJ, 1994, BIOCHEMISTRY-US, V33, P1163, DOI 10.1021/bi00171a016	48	43	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1502	1508		10.1074/jbc.274.3.1502	http://dx.doi.org/10.1074/jbc.274.3.1502			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880526	hybrid			2022-12-27	WOS:000079956900046
J	Patel, CV; Sharangpani, R; Bandyopadhyay, S; DiCorleto, PE				Patel, CV; Sharangpani, R; Bandyopadhyay, S; DiCorleto, PE			Endothelial cells express a novel, tumor necrosis factor-alpha-regulated variant of HOXA9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MOUSE HOMEOBOX GENE; E-SELECTIN PROMOTER; TARGETED DISRUPTION; DROSOPHILA-MELANOGASTER; DEVELOPMENTAL DEFECTS; VASCULAR ENDOTHELIUM; TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEIN; AXIAL SKELETON	The expression of the class 1 homeobox (HOX) family of "master control" transcription factors has been studied principally in embryogenesis and neoplasia in which HOX genes play a critical role in cell proliferation, migration, and differentiation. We wished to test whether HOX family members were also involved in a differentiation-like process occurring in normal, diploid adult cells, that is, cytokine-induced activation of endothelial cells (EC). Screening of a human EC cDNA library yielded several members of the A add B groups of HOX transcription factors. One clone represented a novel, alternatively spliced variant of the human HOXA9 gene containing a new exon and the expression of which was driven by a novel promoter. This variant termed HOXA9EC appeared restricted to cells of endothelial lineage, i.e. expressed by human EC from multiple sources, but not by fibroblasts, smooth muscle cells, or several transformed cell lines. HOXA9EC mRNA was rapidly down-regulated in EC in response to tumor necrosis factor-alpha due to an apparent reduction in transcriptional rate. Reporter construct studies showed that the 400 base pairs of genomic DNA directly 5' to the transcription initiation site of HOXA9EC contained the information required for both up-regulation in response to cotransfection with a HOXA9EC expression vector and tumor necrosis factor-alpha-dependent down-regulation of this gene. These results provide evidence of a novel HOX family member that may participate in either the suppression or the genesis of EC activation.	Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol NC10, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	DiCorleto, PE (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol NC10, 9500 Euclid Ave, Cleveland, OH 44195 USA.				NHLBI NIH HHS [HL 34727] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034727] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARBA P, 1993, ADV EXP MED BIOL, V348, P45; BARON A, 1987, EMBO J, V6, P2977, DOI 10.1002/j.1460-2075.1987.tb02603.x; BENSON GV, 1995, MOL CELL BIOL, V15, P1591; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; Boudreau N, 1997, J CELL BIOL, V139, P257, DOI 10.1083/jcb.139.1.257; Boulet AM, 1996, DEV BIOL, V177, P232, DOI 10.1006/dbio.1996.0159; BUSTURIA A, 1990, EMBO J, V9, P3551, DOI 10.1002/j.1460-2075.1990.tb07565.x; Care A, 1996, MOL CELL BIOL, V16, P4842; Chen F, 1997, DEV BIOL, V181, P186, DOI 10.1006/dbio.1996.8440; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; CIANETTI L, 1990, NUCLEIC ACIDS RES, V18, P4361, DOI 10.1093/nar/18.15.4361; CILLO C, 1994, INVAS METAST, V14, P38; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; CONDIE BG, 1990, MOL CELL BIOL, V10, P3376, DOI 10.1128/MCB.10.7.3376; CONDIE BG, 1993, DEVELOPMENT, V119, P579; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; DICORLETO PE, 1993, AM J HYPERTENS, V6, pS314; DICORLETO PE, 1996, ATHEROSCLEROSIS CORO, V22, P387; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; ENOCH T, 1986, MOL CELL BIOL, V6, P801, DOI 10.1128/MCB.6.3.801; Favier B, 1996, DEVELOPMENT, V122, P449; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Fujimoto S, 1998, GENE, V209, P77, DOI 10.1016/S0378-1119(98)00014-6; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; Gaunt SJ, 1996, DEV DYNAM, V207, P270, DOI 10.1002/(SICI)1097-0177(199611)207:3<270::AID-AJA4>3.0.CO;2-E; GAVIS ER, 1991, DEVELOPMENT, V112, P1077; GAY NJ, 1988, NUCLEIC ACIDS RES, V16, P6637, DOI 10.1093/nar/16.14.6637; GIMBRONE MA, 1995, ANN NY ACAD SCI, V748, P122; GORSKI DH, 1993, TRENDS CARDIOVAS MED, V3, P184, DOI 10.1016/1050-1738(93)90004-P; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HONG YS, 1995, GENE, V159, P209, DOI 10.1016/0378-1119(95)92712-G; IZPISUABELMONTE JC, 1991, EMBO J, V10, P2279, DOI 10.1002/j.1460-2075.1991.tb07764.x; Janicke RU, 1996, MOL CELL BIOL, V16, P5245; KASZUBSKA W, 1993, MOL CELL BIOL, V13, P7180, DOI 10.1128/MCB.13.11.7180; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5; LEWIS H, 1994, MOL CELL BIOL, V14, P5701, DOI 10.1128/MCB.14.9.5701; LU QA, 1995, MOL CELL BIOL, V15, P3786; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; Lyons GE, 1996, CURR OPIN GENET DEV, V6, P454, DOI 10.1016/S0959-437X(96)80067-0; MAK A, 1993, GENE DEV, V7, P1862, DOI 10.1101/gad.7.10.1862; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; Newman CS, 1997, MECH DEVELOP, V66, P83, DOI 10.1016/S0925-4773(97)00092-0; PATEL CV, 1992, J BIOL CHEM, V267, P26085; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; RAMIREZSOLIS R, 1993, CELL, V73, P279, DOI 10.1016/0092-8674(93)90229-J; READ MA, 1994, J EXP MED, V179, P503, DOI 10.1084/jem.179.2.503; RINGEISEN F, 1993, J BIOL CHEM, V268, P25706; ROBBINS J, 1996, CARDIOVASC RES, V31, P2; ROGINA B, 1995, BIOCHEM MOL BIOL INT, V35, P825; Rubin M R, 1990, DNA Seq, V1, P115, DOI 10.3109/10425179009016039; RUBIN MR, 1987, MOL CELL BIOL, V7, P3836, DOI 10.1128/MCB.7.10.3836; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; SELSER SJ, 1993, GENE DEV, V7, P1714; SHAM MH, 1992, EMBO J, V11, P1825, DOI 10.1002/j.1460-2075.1992.tb05234.x; SHARPE PT, 1988, DEVELOPMENT, V102, P397; SHEN WF, 1991, NUCLEIC ACIDS RES, V19, P539, DOI 10.1093/nar/19.3.539; Shen WF, 1997, MOL CELL BIOL, V17, P6448, DOI 10.1128/MCB.17.11.6448; STROEHER VL, 1986, MOL CELL BIOL, V6, P4667, DOI 10.1128/MCB.6.12.4667; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; WHELAN J, 1991, NUCLEIC ACIDS RES, V19, P2645, DOI 10.1093/nar/19.10.2645; Whelan J, 1996, TRENDS BIOCHEM SCI, V21, P65, DOI 10.1016/0968-0004(96)80868-1; ZAPPAVIGNA V, 1994, GENE DEV, V8, P732, DOI 10.1101/gad.8.6.732; ZAPPAVIGNA V, 1996, EMBO J, V15, P49811	69	34	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1415	1422		10.1074/jbc.274.3.1415	http://dx.doi.org/10.1074/jbc.274.3.1415			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880515	hybrid			2022-12-27	WOS:000079956900035
J	Tanudji, M; Sjoling, S; Glaser, E; Whelan, J				Tanudji, M; Sjoling, S; Glaser, E; Whelan, J			Signals required for the import and processing of the alternative oxidase into mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-ORNITHINE TRANSCARBAMYLASE; LIVER ALDEHYDE DEHYDROGENASE; PROTEIN IMPORT; TARGETING PEPTIDES; PRECURSOR PROTEINS; PLANT-MITOCHONDRIA; CYTOSOLIC FACTORS; CLEAVAGE SITES; LEADER PEPTIDE; BC(1) COMPLEX	The critical residues involved in targeting and processing of the soybean alternative oxidase to plant and animal mitochondria was investigated. Import of various site-directed mutants into soybean mitochondria indicated that positive residues throughout the length of the presequence were important for import, not just those in the predicted region of amphiphilicity. The position of the positive residues in the C-terminal end of the presequence was also important for import. Processing assays of the various constructs with purified spinach mitochondrial processing peptidase showed that all the -2-position mutants had a drastic effect on processing. In contrast to the import assay, the position of the positive residue could be changed for processing. Deletion mutants confirmed the site-directed mutagenesis data in that an amphiphilic alpha-helix was not the only determinant of mitochondrial import in this homologous plant system. Import of these constructs into rat liver mitochondria indicated that the degree of inhibition differed and that the predicted region of amphiphilic alpha-helix was more important with rat liver mitochondria. Processing with a rat liver matrix fraction showed little inhibition. These results are discussed with respect to targeting specificity in plant cells and highlight the need to carry out homologous studies and define the targeting requirements to plant mitochondria.	Univ Western Australia, Dept Biochem, Nedlands, WA 6907, Australia; Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem, S-10694 Stockholm, Sweden	University of Western Australia; Stockholm University	Whelan, J (corresponding author), Univ Western Australia, Dept Biochem, Nedlands, WA 6907, Australia.	seamus@cyllene.uwa.edu.au	Whelan, James/F-6402-2011	Whelan, James/0000-0001-5754-025X				BEDWELL DM, 1989, MOL CELL BIOL, V9, P1014, DOI 10.1128/MCB.9.3.1014; BRAUN HP, 1995, TRENDS BIOCHEM SCI, V20, P171, DOI 10.1016/S0968-0004(00)88999-9; BRINKS S, 1994, J BIOL CHEM, V269, P16478; Brunner M., 1994, SIGNAL PEPTIDASES, P73; CHAUMONT F, 1994, PLANT MOL BIOL, V24, P631, DOI 10.1007/BF00023559; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CONBOY JG, 1982, BIOCHEM BIOPH RES CO, V105, P1, DOI 10.1016/S0006-291X(82)80002-8; DAY DA, 1995, AUST J PLANT PHYSIOL, V22, P497, DOI 10.1071/PP9950497; DAY DA, 1985, AUST J PLANT PHYSIOL, V12, P219, DOI 10.1071/PP9850219; Dessi P, 1997, FEBS LETT, V415, P173, DOI 10.1016/S0014-5793(97)01116-2; ELTHON TE, 1989, PLANT PHYSIOL, V89, P1311, DOI 10.1104/pp.89.4.1311; ERIKSSON AC, 1994, BBA-BIOENERGETICS, V1186, P221, DOI 10.1016/0005-2728(94)90181-3; FILHO MDS, 1997, J BIOL CHEM, V272, P15264; Finnegan PM, 1997, PLANT PHYSIOL, V114, P455, DOI 10.1104/pp.114.2.455; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; GLASER E, 1994, FEBS LETT, V346, P83, DOI 10.1016/0014-5793(94)00312-2; GLICK B, 1991, ANNU REV GENET, V25, P21; Hammen PK, 1996, J BIOL CHEM, V271, P21041, DOI 10.1074/jbc.271.35.21041; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; Haucke V, 1997, J BIOENERG BIOMEMBR, V29, P11, DOI 10.1023/A:1022451520203; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; Hiser C, 1996, PLANT PHYSIOL, V110, P277, DOI 10.1104/pp.110.1.277; HORWICH AL, 1986, CELL, V44, P451, DOI 10.1016/0092-8674(86)90466-6; ISAYA G, 1991, J CELL BIOL, V113, P65, DOI 10.1083/jcb.113.1.65; ISAYA G, 1994, SIGNAL PEPTIDASES, P87; LITHGOW T, 1993, FEBS LETT, V329, P1, DOI 10.1016/0014-5793(93)80179-X; Mihara K, 1996, EXPERIENTIA, V52, P1063, DOI 10.1007/BF01952103; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; NISHI T, 1989, J BIOL CHEM, V264, P6044; Rickwood D, 1987, MITOCHONDRIA PRACTIC; Roise D, 1997, J BIOENERG BIOMEMBR, V29, P19, DOI 10.1023/A:1022403604273; ROISE D, 1993, AAMPHIPATHIC HELIX; Schneider G, 1998, PROTEINS, V30, P49, DOI 10.1002/(SICI)1097-0134(19980101)30:1<49::AID-PROT5>3.3.CO;2-P; Sjoling S, 1998, TRENDS PLANT SCI, V3, P136, DOI 10.1016/S1360-1385(98)01212-6; SJOLING S, 1994, J BIOL CHEM, V269, P32059; Szigyarto C, 1998, PLANT MOL BIOL, V36, P171, DOI 10.1023/A:1005977716814; SZTUL ES, 1987, J CELL BIOL, V105, P2631, DOI 10.1083/jcb.105.6.2631; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Waltner M, 1996, J BIOL CHEM, V271, P21226, DOI 10.1074/jbc.271.35.21226; WANG Y, 1993, J BIOL CHEM, V268, P4759; Whelan J, 1996, BBA-MOL CELL RES, V1312, P48, DOI 10.1016/0167-4889(96)00014-6; WHELAN J, 1995, PLANT PHYSIOL, V107, P1469, DOI 10.1104/pp.107.4.1469; WHITE JA, 1989, P NATL ACAD SCI USA, V86, P3534, DOI 10.1073/pnas.86.10.3534; ZHOU JZ, 1995, J BIOL CHEM, V270, P16689, DOI 10.1074/jbc.270.28.16689	45	56	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1286	1293		10.1074/jbc.274.3.1286	http://dx.doi.org/10.1074/jbc.274.3.1286			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880497	hybrid			2022-12-27	WOS:000079956900017
J	Townsend, KJ; Zhou, P; Qian, LP; Bieszczad, CK; Lowrey, CH; Yen, A; Craig, RW				Townsend, KJ; Zhou, P; Qian, LP; Bieszczad, CK; Lowrey, CH; Yen, A; Craig, RW			Regulation of MCL1 through a serum response factor Elk-1 mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; TERNARY COMPLEX FACTORS; ACTIVATED PROTEIN-KINASE; NERVE GROWTH-FACTOR; C-FOS; TRANSCRIPTION FACTOR; B-CELLS; CSF-1 RECEPTOR; IN-VIVO; APOPTOSIS	Proliferation, differentiation, and apoptosis are tightly regulated during hematopoiesis, allowing amplification along specific lineages while preventing excessive proliferation of immature cells. The MCL1 member of the BCL2 family is up-regulated during the induction of monocytic differentiation (similar to 10-fold with 12-O-tetradecanoylphorbol 13-acetate (TPA)), MCL1 has effects similar to those of BCL2, up-regulation promoting viability, but differs from BCL2 in its rapid inducibility and its pattern of expression. Nuclear factors that regulate MCLI transcription have now been identified, extending the previous demonstration of signal transduction through mitogen activated protein kinase, A 162-base pair segment of the human MCLI 5'-flank was found to direct luciferase reporter activity, allowing similar to 10-fold induction with TPA that was suppressible upon inhibition of the extracellular signal-regulated kinase (ERK) pathway. Serum response factor (SRF), Elk-1, and Sp1 bound to cownate sites within this segment, SRF and Elk-1 acting coordinately to affect both basal activity and TPA inducibility, whereas Sp1 affected basal activity only, Thus, the mechanism of the TPA-induced increase in MCL1 expression seen in myelomonocytic cells at early stages of differentiation involves signal transduction through ERKs and transcriptional activation through SRF/Elk-1, This finding provides a parallel to early response genes (e.g. c-FOS and EGR1) that affect maturation commitment in these cells and therefore suggests a means through which enhancement of cell viability may be linked to the induction of differentiation.	Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA; Cornell Univ, Dept Pathol, Canc Biol Labs, Ithaca, NY 14853 USA	Dartmouth College; Dartmouth College; Cornell University	Craig, RW (corresponding author), Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA.				NCI NIH HHS [R01 CA057359, CA57359] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057359] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Altmeyer A, 1997, IMMUNITY, V7, P667, DOI 10.1016/S1074-7613(00)80387-8; BHATIA M, 1994, LEUKEMIA, V8, P1744; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; BRADBURY D, 1994, LEUKEMIA, V8, P786; BRASIER AR, 1995, CURRENT PROTOCOLS MO; Chao JR, 1998, MOL CELL BIOL, V18, P4883, DOI 10.1128/MCB.18.8.4883; CHEN HM, 1993, J BIOL CHEM, V268, P8230; CHEN HM, 1995, MOL CELL BIOL, V15, P3840; CHENG T, 1994, J BIOL CHEM, V269, P30848; Cohen DM, 1996, J BIOL CHEM, V271, P12903, DOI 10.1074/jbc.271.22.12903; CRAIG RW, 1984, CANCER RES, V44, P2421; DEFRANCO C, 1993, MOL ENDOCRINOL, V7, P365, DOI 10.1210/me.7.3.365; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FISCH MW, 1987, J PRE-RAPHAELITE AES, V7, P1; Gajate C, 1996, BIOCHEM BIOPH RES CO, V218, P267, DOI 10.1006/bbrc.1996.0047; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Grillot DAM, 1997, J IMMUNOL, V158, P4750; Hashimoto S, 1997, BLOOD, V89, P315, DOI 10.1182/blood.V89.1.315.315_315_321; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; HIPSKIND RA, 1994, GENE DEV, V8, P1803, DOI 10.1101/gad.8.15.1803; Hu L, 1996, J IMMUNOL, V157, P3804; Ivanov VN, 1997, J BIOL CHEM, V272, P8558; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Jehn BM, 1997, CRIT REV EUKAR GENE, V7, P179, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.100; KATO JY, 1989, MOL CELL BIOL, V9, P4069, DOI 10.1128/MCB.9.9.4069; KINOSHITA T, 1995, EMBO J, V14, P266, DOI 10.1002/j.1460-2075.1995.tb07000.x; KINOSHITA T, 1995, ONCOGENE, V10, P2207; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; KOZOPAS KM, 1990, J CELL PHYSIOL, V145, P575, DOI 10.1002/jcp.1041450326; KRAJEWSKI S, 1995, AM J PATHOL, V146, P1309; KRISHNARAJU K, 1995, MOL CELL BIOL, V15, P5499; LATINKIC BV, 1994, J BIOL CHEM, V269, P23163; Li L, 1997, CELL IMMUNOL, V178, P33, DOI 10.1006/cimm.1997.1129; Liebermann DA, 1998, INT J ONCOL, V12, P685; Lomo J, 1997, BLOOD, V89, P4415; Lomo J, 1996, CANCER RES, V56, P40; LORD KA, 1993, MOL CELL BIOL, V13, P841, DOI 10.1128/MCB.13.2.841; LOWREY CH, 1992, P NATL ACAD SCI USA, V89, P1143, DOI 10.1073/pnas.89.3.1143; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Mils V, 1997, ONCOGENE, V14, P1555, DOI 10.1038/sj.onc.1200991; MIYASHITA T, 1994, ONCOGENE, V9, P1799; MIYASHITA T, 1994, CANCER RES, V54, P3131; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; PAHL HL, 1991, EXP HEMATOL, V19, P1038; Preston GA, 1996, MOL CELL BIOL, V16, P211; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; Price MA, 1996, PHILOS T ROY SOC B, V351, P551, DOI 10.1098/rstb.1996.0054; QU, 1995, NUCL ACIDS RES, V23, P4878; Reynolds JE, 1996, EXP CELL RES, V225, P430, DOI 10.1006/excr.1996.0194; REYNOLDS JE, 1994, CANCER RES, V54, P6348; RofflerTarlov S, 1996, DEVELOPMENT, V122, P1; Townsend KJ, 1998, ONCOGENE, V17, P1223, DOI 10.1038/sj.onc.1202035; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; VASSILIADIS S, 1991, LEUKEMIA RES, V15, P943, DOI 10.1016/0145-2126(91)90171-O; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang S, 1996, CANCER RES, V56, P4610; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Yen A, 1996, EXP CELL RES, V229, P111, DOI 10.1006/excr.1996.0349; YEN A, 1993, J CELL PHYSIOL, V157, P379, DOI 10.1002/jcp.1041570222; Yen A, 1997, CANCER RES, V57, P2020; YOUNG RL, 1993, MOL CELL BIOL, V13, P3686, DOI 10.1128/MCB.13.6.3686; Zhan QM, 1997, ONCOGENE, V14, P1031, DOI 10.1038/sj.onc.1200927; ZHAN QM, 1994, ONCOGENE, V9, P3743; ZHANG DE, 1994, J BIOL CHEM, V269, P11425; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630; Zhou P, 1998, BLOOD, V92, P3226, DOI 10.1182/blood.V92.9.3226.421k49_3226_3239; ZINCK R, 1993, EMBO J, V12, P2377, DOI 10.1002/j.1460-2075.1993.tb05892.x	72	115	117	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1801	1813		10.1074/jbc.274.3.1801	http://dx.doi.org/10.1074/jbc.274.3.1801			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880563	hybrid			2022-12-27	WOS:000079956900083
J	Wang, XX; Driscoll, DM; Morton, RE				Wang, XX; Driscoll, DM; Morton, RE			Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTERYL ESTER TRANSFER; LIPOPROTEIN-DEFICIENT PLASMA; LOW-DENSITY-LIPOPROTEIN; A-I; TRANSGENIC MICE; HUMAN-SERUM; PURIFICATION; HYPERTRIGLYCERIDEMIA; TRIGLYCERIDE; MECHANISM	Published studies demonstrate that lipid transfer inhibitor protein (LTIP) is an important regulator of cholesteryl ester transfer protein (CETP) activity. Although LTIP inhibits CETP activity among different lipoprotein classes, it preferentially suppresses transfer events involving low density lipoprotein (LDL), whereas transfers involving high density lipoprotein as donor are less affected. In this study, we report the purification of LTIP and the expression of its cDNA in cultured cells. Purification of LTIP, in contrast to other published protocols, took advantage of the tight association of this protein with LDL. Ultracentrifugally isolated LDL was further purified on anti-apoE and apoA-I affinity columns. Affinity purified LDL was delipidated by tetramethylurea, and the tetramethylurea-soluble proteins were separated by SDS-polyacrylamide gel electrophoresis, The protein migrating at a molecular mass of similar to 33 kDa was excised from the gel and its N-terminal amino acid sequence determined. The 14-amino acid sequence obtained showed complete homology with the sequence deduced for apolipoprotein F (apoF) cDNA isolated from Hep G2 cells. On Western blots, peptide-specific antibodies raised against synthetic fragments of apoF reacted with the same 33 kDa protein in LTIP-containing fractions purified from LDL and from lipoprotein-deficient plasma. In contrast to that previously reported, apoF was shown to be associated almost exclusively with LDL, identical to the distribution of LTIP activity. The cDNA for apoF was cloned from a human liver cDNA Library, ligated into a mammalian expression vector, and transiently transfected into COS-7 cells. Conditioned media containing secreted apoF demonstrated CETP inhibitor activity, whereas cells transfected with vector alone did not. This CETP inhibitor activity was efficiently removed from the media by nickel-Sepharose, consistent with the 6-His tag incorporated into recombinant apoF. By Western blot, the 6-His-tagged protein had a molecular weight slightly larger than native apoF, The CETP inhibitor activity of recombinant apoF possessed the same LDL specificity, oleate sensitivity, and dependence on lipoprotein concentration as previously noted for LTIP, We conclude that LTIP and apoF are identical.	Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Morton, RE (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, NC10,9500 Euclid Ave, Cleveland, OH 44195 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL29582] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BURSTEIN M, 1970, J LIPID RES, V11, P583; Connolly DT, 1996, BBA-LIPID LIPID MET, V1304, P145, DOI 10.1016/S0005-2760(96)00115-4; DAY JR, 1994, BIOCHEM BIOPH RES CO, V203, P1146, DOI 10.1006/bbrc.1994.2302; Edelstein C., 1986, BIOCH BIOL PLASMA LI, P495; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; FIELDING PE, 1980, P NATL ACAD SCI-BIOL, V77, P3327, DOI 10.1073/pnas.77.6.3327; GUYARDDANGREMONT V, 1994, J LIPID RES, V35, P982; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HAYEK T, 1992, J CLIN INVEST, V90, P505, DOI 10.1172/JCI115887; HOFF HF, 1992, J BIOL CHEM, V267, P602; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P399; JAUHIAINEN MS, 1982, CLIN CHIM ACTA, V122, P85, DOI 10.1016/0009-8981(82)90099-7; KANE JP, 1975, J CLIN INVEST, V56, P1622, DOI 10.1172/JCI108245; KOREN E, 1982, BIOCHEMISTRY-US, V21, P5347, DOI 10.1021/bi00264a035; KUSHWAHA RS, 1993, J LIPID RES, V34, P1285; LAGROST L, 1994, J BIOL CHEM, V269, P3189; Lee LG, 1997, NUCLEIC ACIDS RES, V25, P2816, DOI 10.1093/nar/25.14.2816; LEGRENDRE N, 1993, PRACTICAL GUIDE PROT, P71; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANN CJ, 1991, J CLIN INVEST, V88, P2059, DOI 10.1172/JCI115535; MCCONATHY WJ, 1986, METHOD ENZYMOL, V128, P297; MILNER TG, 1991, BIOCHIM BIOPHYS ACTA, V1082, P71, DOI 10.1016/0005-2760(91)90301-W; MORTON RE, 1985, J BIOL CHEM, V260, P2593; MORTON RE, 1994, J LIPID RES, V35, P836; MORTON RE, 1982, J LIPID RES, V23, P1058; MORTON RE, 1994, J LIPID RES, V35, P2094; Morton RE, 1997, ARTERIOSCL THROM VAS, V17, P3041, DOI 10.1161/01.ATV.17.11.3041; MORTON RE, 1993, ARTERIOSCLER THROMB, V13, P1843, DOI 10.1161/01.ATV.13.12.1843; MORTON RE, 1981, J BIOL CHEM, V256, P1992; MORTON RE, 1981, BIOCHIM BIOPHYS ACTA, V663, P350, DOI 10.1016/0005-2760(81)90220-4; MORTON RE, 1997, CIRCULATION, V96, P108; MOULIN P, 1994, J LIPID RES, V35, P793; MURAKAMI T, 1995, ARTERIOSCL THROM VAS, V15, P1819, DOI 10.1161/01.ATV.15.11.1819; NISHIDE T, 1989, J LIPID RES, V30, P149; NISHIKAWA O, 1988, J BIOCHEM, V103, P188, DOI 10.1093/oxfordjournals.jbchem.a122229; OHNISHI T, 1993, BIOCHEMISTRY-US, V32, P5029, DOI 10.1021/bi00070a009; PATTNAIK NM, 1978, BIOCHIM BIOPHYS ACTA, V530, P428, DOI 10.1016/0005-2760(78)90163-7; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Serdyuk AP, 1997, ARTERIOSCL THROM VAS, V17, P1716, DOI 10.1161/01.ATV.17.9.1716; SON YSC, 1984, BIOCHIM BIOPHYS ACTA, V795, P473; TOLLEFSON JH, 1988, J LIPID RES, V29, P1593; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ZHONG SB, 1994, J CLIN INVEST, V94, P2457, DOI 10.1172/JCI117614	43	75	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1814	1820		10.1074/jbc.274.3.1814	http://dx.doi.org/10.1074/jbc.274.3.1814			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880564	hybrid			2022-12-27	WOS:000079956900084
J	Xiao, Z; Yao, YH; Long, Y; Devreotes, P				Xiao, Z; Yao, YH; Long, Y; Devreotes, P			Desensitization of G-protein-coupled receptors - Agonist-induced phosphorylation of the chemoattractant receptor cAR1 lowers its intrinsic affinity for cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; DICTYOSTELIUM; CHEMOTAXIS; RESPONSES; SIGNAL; DOMAIN; CELLS; STATE	Agonist-induced phosphorylation of G-protein-coupled receptors has been shown to facilitate the desensitization processes, such as receptor internalization, decreased efficiency of coupling to G-proteins, or decreased ligand affinity. The lowered affinity may be an intrinsic property of the phosphorylated receptor or it may be the result of altered interactions between the modified receptor and downstream components such as G-proteins or arrestins, To address this issue, we puri fled cAR1, the major chemoattractant receptor of Dictyostelium discoideum by a strategy that is independent of the ligand binding capacity-of the receptor. To our knowledge, this represents the first successful purification of a chemoattractant receptor. The hexyl-histidine-tagged receptor was solubilized from a highly enriched plasma membrane preparation and purified by Ni2+-chelating chromatography, The protocol offers a simple way to purify 100-500 mu g of a G-protein coupled receptor that can be targeted to the plasma membrane of D. discoideum. The K-d value for the purified cAR1 was about 200 nM, consistent with that of receptors that are not coupled to G-proteins in intact cells. In contrast, the affinity of phosphorylated cAR1, purified from desensitized cells, was about three times lower. Treatment of the phosphorylated receptor with protein phosphatases caused dephosphorylation and parallel restoration of higher affinity. We propose that ligand-induced phosphorylation of G-protein-coupled receptors causes decrease in intrinsic affinity and may be useful in maintaining the receptor's sensitivity at high agonist levels. This affinity decrease may precede other processes such as receptor internalization or uncoupling from G-proteins.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Devreotes, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.				NIGMS NIH HHS [GM34933] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034933] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENOVIC JL, 1985, J BIOL CHEM, V260, P7094; BOULAY G, 1994, ENDOCRINOLOGY, V135, P2130, DOI 10.1210/en.135.5.2130; BOUNDY VA, 1995, MOL PHARMACOL, V48, P956; BURGESS WH, 1980, BIOCHIM BIOPHYS ACTA, V623, P257, DOI 10.1016/0005-2795(80)90254-8; CATERINA MJ, 1995, J BIOL CHEM, V270, P8667, DOI 10.1074/jbc.270.15.8667; DEVREOTES PN, 1994, NEURON, V12, P235, DOI 10.1016/0896-6273(94)90267-4; GEORGE ST, 1985, PREP BIOCHEM, V15, P349, DOI 10.1080/00327488508062451; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; HERELD D, 1994, J BIOL CHEM, V269, P7036; Kim JY, 1997, J BIOL CHEM, V272, P2060; Kim JY, 1997, J BIOL CHEM, V272, P27313, DOI 10.1074/jbc.272.43.27313; LOHSE MJ, 1990, SCIENCE, V248, P4962; PARINI A, 1989, ANAL BIOCHEM, V176, P375, DOI 10.1016/0003-2697(89)90327-8; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; REPASKE MG, 1987, J BIOL CHEM, V363, P12381; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; STRULOVICI B, 1984, SCIENCE, V225, P837, DOI 10.1126/science.6089331; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Xiao Z, 1997, MOL BIOL CELL, V8, P855, DOI 10.1091/mbc.8.5.855	22	32	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1440	1448		10.1074/jbc.274.3.1440	http://dx.doi.org/10.1074/jbc.274.3.1440			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880518	hybrid			2022-12-27	WOS:000079956900038
J	Zitzer, A; Zitzer, O; Bhakdi, S; Palmer, M				Zitzer, A; Zitzer, O; Bhakdi, S; Palmer, M			Oligomerization of Vibrio cholerae cytolysin yields a pentameric pore and has a dual specificity for cholesterol and sphingolipids in the target membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCAL ALPHA-HEMOLYSIN; HEPTAMERIC TRANSMEMBRANE PORE; STRUCTURAL GENE HLYA; SEMLIKI-FOREST-VIRUS; EL-TOR CYTOLYSIN; SUBUNIT STOICHIOMETRY; NUCLEOTIDE-SEQUENCE; PROTECTIVE ANTIGEN; CRYSTAL-STRUCTURE; TOXIN	Vibrio cholerae cytolysin permeabilizes animal cell membranes Upon binding to the target lipid bilayer, the protein assembles into homo oligomeric pores of an as yet unknown stoichiometry Pore formation has been observed with model liposomes consisting of phosphatidylcholine and cholesterol, but the latter were much less susceptible to the cytolysin than were erythrocytes or intestinal epithelial cells. We here show that liposome permeabilization is strongly promoted if cholesterol is combined with sphingolipids, whereby the most pronounced effects are observed with monohexosylceramides and free ceramide. These two lipid species are prevalent in mammalian intestinal brush border membranes. We therefore propose that, on its natural target membranes, the cytolysin has a dual specificity for both cholesterol and ceramides. To assess the stoichiometry of the pore, we generated hybrid oligomers of two naturally occurring variants of the toxin that differ in molecular weight. On SDS-polyacrylamide gel electrophoresis, the mixed oligomers formed a pattern of six distinct bands. Ordered by decreasing electrophoretic mobility, the six oligomer species must comprise 0 to 5 subunits of the larger form; the pore thus is a pentamer, Due to both lipid specificity and pore stoichiometry, V. cholerae cytolysin represents a novel prototype in the class of bacterial pore-forming toxins.	Johannes Gutenberg Univ Mainz, Inst Med Microbiol, D-55101 Mainz, Germany	Johannes Gutenberg University of Mainz	Palmer, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Med Microbiol, Augustuspl, D-55101 Mainz, Germany.							ALM RA, 1988, MOL MICROBIOL, V2, P481; ARCHIBALD DD, 1992, BIOCHEMISTRY-US, V31, P9045, DOI 10.1021/bi00152a048; ARKIN IT, 1994, EMBO J, V13, P4757, DOI 10.1002/j.1460-2075.1994.tb06801.x; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; BJORK S, 1987, J BIOL CHEM, V262, P6758; BOUHOURS JF, 1976, BIOCHIM BIOPHYS ACTA, V441, P123, DOI 10.1016/0005-2760(76)90287-3; BRASITUS TA, 1980, BIOCHEMISTRY-US, V19, P2763, DOI 10.1021/bi00553a035; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; CURATOLO W, 1986, J BIOL CHEM, V261, P7177; DITTMER JC, 1974, METHOD ENZYMOL, V35, P482; FINKELSTEIN RA, 1985, PHARMACOL THERAPEUT, V27, P37, DOI 10.1016/0163-7258(85)90063-4; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; GRONBERG L, 1990, BIOCHEMISTRY-US, V29, P3173, DOI 10.1021/bi00465a003; HALL RH, 1990, INFECT IMMUN, V58, P3375, DOI 10.1128/IAI.58.10.3375-3379.1990; HIRONO I, 1993, MICROB PATHOGENESIS, V15, P269, DOI 10.1006/mpat.1993.1077; HONDA SI, 1988, LANCET, V2, P1486; HUGHES JM, 1978, ANN INTERN MED, V88, P602, DOI 10.7326/0003-4819-88-5-602; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; Ikigai H, 1996, INFECT IMMUN, V64, P2968, DOI 10.1128/IAI.64.8.2968-2973.1996; KRASILNIKOV OV, 1992, BIOCHIM BIOPHYS ACTA, V1111, P7, DOI 10.1016/0005-2736(92)90268-Q; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MCCARDELL BA, 1985, CAN J MICROBIOL, V31, P711, DOI 10.1139/m85-135; MCINTYRE OR, 1965, B WORLD HEALTH ORGAN, V32, P627; Miyoshi S, 1997, MICROB PATHOGENESIS, V23, P235, DOI 10.1006/mpat.1997.0149; MOESBY L, 1995, BIOCHEMISTRY-US, V34, P10319, DOI 10.1021/bi00033a001; MORRIS JG, 1984, J CLIN MICROBIOL, V19, P296, DOI 10.1128/JCM.19.2.296-297.1984; Nagamune K, 1996, INFECT IMMUN, V64, P4655, DOI 10.1128/IAI.64.11.4655-4658.1996; Nagamune K, 1997, J BIOL CHEM, V272, P1338, DOI 10.1074/jbc.272.2.1338; NIEVA JL, 1994, EMBO J, V13, P2797, DOI 10.1002/j.1460-2075.1994.tb06573.x; Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; RADER AE, 1988, INFECT IMMUN, V56, P1414, DOI 10.1128/IAI.56.6.1414-1419.1988; Saha N, 1997, J BIOL CHEM, V272, P162, DOI 10.1074/jbc.272.1.162; SLOTTE JP, 1993, BIOCHEMISTRY-US, V32, P7886, DOI 10.1021/bi00082a008; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; WEDRYCHOWSKI A, 1986, ANAL BIOCHEM, V159, P323, DOI 10.1016/0003-2697(86)90349-0; YAMAMOTO K, 1986, INFECT IMMUN, V51, P927, DOI 10.1128/IAI.51.3.927-931.1986; YAMAMOTO K, 1990, INFECT IMMUN, V58, P4106, DOI 10.1128/IAI.58.12.4106-4116.1990; YAMAMOTO K, 1990, INFECT IMMUN, V58, P2706, DOI 10.1128/IAI.58.8.2706-2709.1990; ZHANG RG, 1995, J MOL BIOL, V251, P550, DOI 10.1006/jmbi.1995.0455; Zitzer A, 1997, INFECT IMMUN, V65, P1293, DOI 10.1128/IAI.65.4.1293-1298.1997; ZITZER A, 1995, MED MICROBIOL IMMUN, V184, P37, DOI 10.1007/BF00216788; Zitzer A, 1997, EUR J BIOCHEM, V247, P209, DOI 10.1111/j.1432-1033.1997.00209.x; ZITZER AO, 1993, ZBL BAKT-INT J MED M, V279, P494, DOI 10.1016/S0934-8840(11)80421-4	44	89	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1375	1380		10.1074/jbc.274.3.1375	http://dx.doi.org/10.1074/jbc.274.3.1375			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880509	hybrid			2022-12-27	WOS:000079956900029
J	Bernstein, EM; Quick, MW				Bernstein, EM; Quick, MW			Regulation of gamma-aminobutyric acid (GABA) transporters by extracellular GABA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RAT HIPPOCAMPAL SLICE; DORSAL RAPHE NUCLEUS; MESSENGER-RNA; GLUTAMATE TRANSPORTERS; XENOPUS-OOCYTES; PHORBOL ESTERS; NITRIC-OXIDE; BRAIN; INHIBITION	gamma-Aminobutyric acid (GABA) transporters on neurons and glia at or near the synapse function to remove GABA from the synaptic cleft. Recent evidence suggests that GABA transporter function can be regulated, although the initial triggers for such regulation are not known. One hypothesis is that transporter function is modulated by extracellular GABA concentration, thus providing a feedback mechanism for the control of neurotransmitter levels at the synapse. To test this hypothesis, GABA uptake assays were performed on primary dissociated rat hippocampal cultures that endogenously express GABA transporters and on mammalian cells stably expressing the cloned rat brain GABA transporter GAT1, In both experimental systems, extracellular GABA induces chronic changes in GABA transport that occur in a dose-dependent and time-dependent manner. In addition to GABA, ACHC and nipecotic acid, both substrates of GAT1, up-regulate transport; GAT1 transport inhibitors that are not transporter substrates down-regulate transport, These changes occur in the presence of blockers of both GABA(A) and GABA(B) receptors, occur in the presence of protein synthesis inhibitors, and are not influenced by intracellular GABA, Surface biotinylation experiments reveal that the increase in transport is correlated with an increase in surface transporter expression. This increase in surface expression is due, at least in part, to a slowing of GAT1 internalization in the presence of extracellular GABA, These data suggest that the GABA transporter fine-tunes its function in response to extracellular GABA and would act to maintain a constant level of neurotransmitter at the synaptic cleft.	Univ Alabama, CIRC 446, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Quick, MW (corresponding author), Univ Alabama, CIRC 446, Dept Neurobiol, 1719 6th Ave, Birmingham, AL 35294 USA.				NATIONAL INSTITUTE ON DRUG ABUSE [R29DA010509, R01DA010509] Funding Source: NIH RePORTER; NIDA NIH HHS [DA10509] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Beckman ML, 1998, J NEUROSCI, V18, P6103; Beckman ML, 1998, J MEMBRANE BIOL, V164, P1; BERG DK, 1974, SCIENCE, V184, P473, DOI 10.1126/science.184.4135.473; BOWERY NG, 1976, NATURE, V264, P281, DOI 10.1038/264281a0; CASADO M, 1993, J BIOL CHEM, V268, P27313; Conradt M, 1997, J NEUROCHEM, V68, P1244, DOI 10.1046/j.1471-4159.1997.68031244.x; COREY JL, 1994, MOL MEMBR BIOL, V11, P23, DOI 10.3109/09687689409161026; COREY JL, 1994, J BIOL CHEM, V269, P14759; Davis KE, 1998, J NEUROSCI, V18, P2475; DINGLEDINE R, 1985, J PHYSIOL-LONDON, V366, P387, DOI 10.1113/jphysiol.1985.sp015804; DURING MJ, 1995, NATURE, V376, P174, DOI 10.1038/376174a0; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Gegelashvili G, 1997, MOL PHARMACOL, V52, P6, DOI 10.1124/mol.52.1.6; Gegelashvili G, 1996, NEUROREPORT, V8, P261, DOI 10.1097/00001756-199612200-00052; GOMEZA J, 1991, BIOCHEM J, V275, P435, DOI 10.1042/bj2750435; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Huff RA, 1997, J NEUROCHEM, V68, P225; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; IVERSEN LL, 1975, HDB PSYCHOPHARMACOLO, P381; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; LARSSON OM, 1988, J NEUROCHEM, V50, P818, DOI 10.1111/j.1471-4159.1988.tb02986.x; LAUNAY JM, 1994, AM J PHYSIOL, V266, pR526, DOI 10.1152/ajpregu.1994.266.2.R526; LEWIN L, 1992, NEUROCHEM RES, V17, P333, DOI 10.1007/BF00974574; Martin D.L., 1976, GABA NERVOUS SYSTEM, P347; MILLER KJ, 1994, J BIOL CHEM, V269, P27351; Neumaier JF, 1996, NEUROPSYCHOPHARMACOL, V15, P515, DOI 10.1016/S0893-133X(96)00095-4; OSAWA I, 1994, NEUROSCI RES, V19, P287, DOI 10.1016/0168-0102(94)90041-8; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; Quick MW, 1997, J NEUROSCI, V17, P2967; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; RATTRAY M, 1994, EUR J PHARM-MOLEC PH, V268, P439, DOI 10.1016/0922-4106(94)90070-1; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; SATO K, 1995, FEBS LETT, V375, P99, DOI 10.1016/0014-5793(95)01191-G; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; SOLIS JM, 1992, J NEUROSCI, V12, P3466; THOMSEN C, 1995, EPILEPSY RES, V21, P79, DOI 10.1016/0920-1211(95)00010-8; XIA Y, 1992, J NEUROCHEM, V59, P1179, DOI 10.1111/j.1471-4159.1992.tb08365.x; Ye ZC, 1996, NEUROREPORT, V7, P2181, DOI 10.1097/00001756-199609020-00025; YU AQ, 1995, BRAIN RES, V688, P209, DOI 10.1016/0006-8993(95)00539-3; YUNGER LM, 1984, J PHARMACOL EXP THER, V228, P109; Zhu MY, 1998, J NEUROCHEM, V70, P1547	44	127	134	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					889	895		10.1074/jbc.274.2.889	http://dx.doi.org/10.1074/jbc.274.2.889			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873028	hybrid			2022-12-27	WOS:000077968500043
J	Dong, MQ; Wang, Y; Pinon, DI; Hadac, EM; Miller, LJ				Dong, MQ; Wang, Y; Pinon, DI; Hadac, EM; Miller, LJ			Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; HORMONE (PTH)/PTH-RELATED PEPTIDE; PROTEIN-LINKED RECEPTOR; PARATHYROID-HORMONE; CALCITONIN RECEPTOR; CYSTEINE RESIDUES; AGONIST-BINDING; LIGAND-BINDING; CHOLECYSTOKININ RECEPTOR; EXTRACELLULAR DOMAINS	An understanding of the molecular basis of hormonal activation of receptors provides important insights for drug design, Toward this end, intrinsic photoaffinity labeling is a powerful tool to directly identify the Ligand-binding domain. We have developed a new radioiodinatable agonist ligand of the secretin receptor that incorporates a photolabile p-benzoyl-L-phenylalanine (Bpa) into the position of Leu(22) and have utilized this to identify the adjacent receptor domain. The rat [Tyr(10),Bpa(22)]secretin-27 probe was a fully efficacious agonist, with a potency to stimulate cAMP accumulation by Chinese hamster ovary SecR cells similar to that of natural secretin (EC50 = 68 +/- 22 pM analogue and 95 +/- 25 pM secretin), It bound specifically and with high affinity (K-i = 5.0 +/- 1.1 nM) and covalently labeled the M-r = 57,000-62,000 secretin receptor. Cyanogen bromide cleavage of the receptor yielded a major labeled fragment of apparent M-r = 19,000 that shifted to M-r = 9,000 after deglycosylation. This was most consistent with either of two glycosylated domains within the amino-terminal tail of the receptor. Immunoprecipitation with antibody directed to epitope tags incorporated into each of the candidate domains established that the fragment at the amino terminus of the receptor was the site of labeling. This was further localized to the amino-terminal 30 residues of the receptor by additional proteolysis of this fragment with endoproteinase Lys-C. This provides the first direct demonstration of a contact between a secretin-like agonist and its receptor and will contribute a useful constraint to the modeling of this interaction.	Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA	Mayo Clinic	Miller, LJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Ctr Basic Res Digest Dis, Guggenheim 17, Rochester, MN 55905 USA.				NIDDK NIH HHS [DK46577] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046577, R01DK046577] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aquino CJ, 1996, J MED CHEM, V39, P562, DOI 10.1021/jm950626d; BODANSZKY M, 1986, PEPTIDES, V7, P43, DOI 10.1016/0196-9781(86)90162-2; CAO YJ, 1995, BIOCHEM BIOPH RES CO, V212, P673, DOI 10.1006/bbrc.1995.2021; CLORE GM, 1988, EUR J BIOCHEM, V171, P479, DOI 10.1111/j.1432-1033.1988.tb13814.x; Donnelly D, 1997, FEBS LETT, V409, P431, DOI 10.1016/S0014-5793(97)00546-2; Ganguli SC, 1998, J PHARMACOL EXP THER, V286, P593; GAUDIN P, 1995, BIOCHEM BIOPH RES CO, V211, P901, DOI 10.1006/bbrc.1995.1897; Gaudin P, 1996, ANN NY ACAD SCI, V805, P585; Gourlet P, 1996, EUR J BIOCHEM, V239, P349, DOI 10.1111/j.1432-1033.1996.0349u.x; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; GRONENBORN AM, 1987, FEBS LETT, V215, P88, DOI 10.1016/0014-5793(87)80119-9; Hadac EM, 1998, J BIOL CHEM, V273, P12988, DOI 10.1074/jbc.273.21.12988; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Holtmann MH, 1996, J BIOL CHEM, V271, P14944, DOI 10.1074/jbc.271.25.14944; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; Ji ZS, 1997, J BIOL CHEM, V272, P24393, DOI 10.1074/jbc.272.39.24393; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; JUPPNER H, 1994, ENDOCRINOLOGY, V134, P879, DOI 10.1210/en.134.2.879; KAUER JC, 1986, J BIOL CHEM, V261, P695; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CW, 1994, ENDOCRINOLOGY, V135, P1488, DOI 10.1210/en.135.4.1488; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; Mannstadt M, 1998, J BIOL CHEM, V273, P16890, DOI 10.1074/jbc.273.27.16890; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Pantaloni C, 1996, J BIOL CHEM, V271, P22146, DOI 10.1074/jbc.271.36.22146; PEARSON RK, 1987, J BIOL CHEM, V262, P13850; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; ROBBERECHT P, 1984, BIOCHIM BIOPHYS ACTA, V773, P271, DOI 10.1016/0005-2736(84)90091-9; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Schwartz TW, 1996, TRENDS PHARMACOL SCI, V17, P213, DOI 10.1016/0165-6147(96)10017-1; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; SERVANT G, 1993, MOL PHARMACOL, V43, P677; SHOELSON SE, 1993, J BIOL CHEM, V268, P4085; Stroop SD, 1996, ENDOCRINOLOGY, V137, P4752, DOI 10.1210/en.137.11.4752; Suva LJ, 1997, J PHARMACOL EXP THER, V283, P876; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Ulrich CD, 1998, GASTROENTEROLOGY, V114, P382, DOI 10.1016/S0016-5085(98)70491-3; Vilardaga JP, 1997, EUR J BIOCHEM, V246, P173, DOI 10.1111/j.1432-1033.1997.00173.x; Vilardaga JP, 1996, BIOCHEM BIOPH RES CO, V218, P842, DOI 10.1006/bbrc.1996.0150; VILARDAGA JP, 1995, BIOCHEM BIOPH RES CO, V211, P885, DOI 10.1006/bbrc.1995.1895; Wong SS, 1991, CHEM PROTEIN CONJUGA; Zhou AT, 1997, P NATL ACAD SCI USA, V94, P3644, DOI 10.1073/pnas.94.8.3644	46	81	87	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					903	909		10.1074/jbc.274.2.903	http://dx.doi.org/10.1074/jbc.274.2.903			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873030	hybrid			2022-12-27	WOS:000077968500045
J	Bilderback, TR; Gazula, VR; Lisanti, MP; Dobrowsky, RT				Bilderback, TR; Gazula, VR; Lisanti, MP; Dobrowsky, RT			Caveolin interacts with Trk A and p75(NTR) and regulates neurotrophin signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; TYROSINE PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; SPHINGOMYELIN HYDROLYSIS; CELL-SURFACE; RECEPTOR; MEMBRANE; LOCALIZATION; TRANSDUCTION; IDENTIFICATION	Neurotrophins signal through Trk tyrosine kinase receptors and the low-affinity neurotrophin receptor p75(NTR). We have shown previously that activation of Trk A tyrosine kinase activity can inhibit p75(NTR)-dependent sphingomyelin hydrolysis, that caveolae are a localized site for p75NTR signaling, and that caveolin can directly interact with p75NTR. Th, ability of caveolin to also interact with tyrosine kinase receptors and inhibit their activity led us to hypothesize that caveolin expression may modulate interactions between neurotrophin signaling pathways. PC12 cells were transfected with caveolin that was expressed efficiently and targeted to the appropriate membrane domains. Upon exposure to nerve growth factor (NGF), caveolin-PC12 cells were unable to develop extensive neuritic processes. Caveolin expression in PC12 cells was found to diminish the magnitude and duration of Trk A activation in vivo. This inhibition may be due to a direct interaction of caveolin with Trk A, because Trk A co-immunoprecipitated with caveolin from Cav-Trk A-PC12 cells, and a glutathione S-transferase-caveolin fusion protein bound to Trk A and inhibited NGF-induced autophosphorylation in vitro. Furthermore, the in vivo kinetics of the inhibition of Trk A tyrosine kinase activity by caveolin expression correlated with an increased ability of NGF to induce sphingomyelin hydrolysis through p75(NTR). In summary, our results suggest that the interaction of caveolin with neurotrophin receptors may have functional consequences in regulating signaling through p75NTR and Trk A in neuronal and glial cell populations.	Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	University of Kansas; Yeshiva University; Albert Einstein College of Medicine	Dobrowsky, RT (corresponding author), Univ Kansas, Dept Pharmacol & Toxicol, 5064 Malott Hall, Lawrence, KS 66045 USA.	dobrowsky@hbc.ukans.edu	Lisanti, Michael/B-6131-2018; Lisanti, Michael P/C-6866-2013	Lisanti, Michael/0000-0003-2034-1382; 				Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Bilderback TR, 1997, J BIOL CHEM, V272, P10922; Bredesen DE, 1997, TRENDS NEUROSCI, V20, P287, DOI 10.1016/S0166-2236(96)01049-1; Cameron PL, 1997, J NEUROSCI, V17, P9520; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; CHAO MV, 1994, J NEUROBIOL, V25, P1373, DOI 10.1002/neu.480251106; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; DOBROWSKY RT, 1995, J BIOL CHEM, V270, P22135, DOI 10.1074/jbc.270.38.22135; Frade JM, 1996, NATURE, V383, P166; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Galbiati F, 1998, P NATL ACAD SCI USA, V95, P10257, DOI 10.1073/pnas.95.17.10257; Glass David J., 1993, Trends in Cell Biology, V3, P262, DOI 10.1016/0962-8924(93)90054-5; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; Henke RC, 1996, J NEUROSCI RES, V45, P617, DOI 10.1002/(SICI)1097-4547(19960901)45:5<617::AID-JNR11>3.3.CO;2-L; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; JAYADEV S, 1994, J BIOL CHEM, V269, P5757; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; LAMBALLE F, 1993, EMBO J, V12, P3083, DOI 10.1002/j.1460-2075.1993.tb05977.x; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; VanderZee CEEM, 1996, SCIENCE, V274, P1729, DOI 10.1126/science.274.5293.1729; Venema VJ, 1997, J BIOL CHEM, V272, P28187, DOI 10.1074/jbc.272.45.28187; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Yoon SO, 1998, J NEUROSCI, V18, P3273	51	138	140	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					257	263		10.1074/jbc.274.1.257	http://dx.doi.org/10.1074/jbc.274.1.257			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867838	hybrid			2022-12-27	WOS:000077900200038
J	Cho, HP; Nakamura, MT; Clarke, SD				Cho, HP; Nakamura, MT; Clarke, SD			Cloning, expression, and nutritional regulation of the mammalian Delta-6 desaturase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; STEAROYL-COA DESATURASE; RAT-LIVER; ARACHIDONIC-ACID; GENE-EXPRESSION; LINOLEIC-ACID; DOCOSAHEXAENOIC ACID; PRETERM INFANTS; METABOLISM; BIOSYNTHESIS	Arachidonic acid (20:4(n-6)) and docosahexaenoic acid (22:6(n-3)) have a variety of physiological functions that include being the major component of membrane phospholipid in brain and retina, substrates for eicosanoid production, and regulators of nuclear transcription factors. The rate-limiting step in the production of 20:4(n-6) and 22:6(n-3) is the desaturation of 18:2(n-6) and 18:3(n-3) by Delta-6 desaturase, In this report, we describe the cloning, characterization, and expression of a mammalian Delta-6 desaturase, The open reading frames for mouse and human Delta-6 desaturase each encode a 444-amino acid peptide, and the two peptides share an 87% amino acid homology. The amino acid sequence predicts that the peptide contains two membrane-spanning domains as well as a cytochrome b(5)-like domain that is characteristic of nonmammalian Delta-6 desaturases. Expression of the open reading frame in rat hepatocytes and Chinese hamster ovary cells instilled in these cells the ability to convert 18:2(n-6) and 18:3(n-3) to their respective products, 18:3(n-6) and 18:4(n-3), When mice were fed a diet containing 10% fat, hepatic enzymatic activity and mRNA abundance for hepatic Delta-6 desaturase in mice fed corn oil were 70 and 50% lower than in mice fed triolein, Finally, Northern analysis revealed that the brain contained an amount of Delta-6 desaturase mRNA that was several times greater than that found in other tissues including the liver, lung, heart, and skeletal muscle. The RNA abundance data indicate that prior conclusions regarding the low level of Delta-6 desaturase expression in nonhepatic tissues may need to be reevaluated.	Univ Texas, Nutr Sci Program, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Clarke, SD (corresponding author), Univ Texas, Nutr Sci Program, 115 GEA, Austin, TX 78712 USA.	stevedclarke@mail.utexas.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052573] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 52573] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARMSTRONG MK, 1991, BIOCHEM BIOPH RES CO, V177, P1056, DOI 10.1016/0006-291X(91)90645-N; Birch EE, 1998, PEDIATR RES, V44, P201, DOI 10.1203/00006450-199808000-00011; BOURRE JM, 1990, LIPIDS, V25, P354, DOI 10.1007/BF02544347; Brenner R., 1989, R FACTORS INFLUENCIN, VVolume 1989, P45; CARLSON SE, 1993, P NATL ACAD SCI USA, V90, P1073, DOI 10.1073/pnas.90.3.1073; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLANDININ MT, 1985, BIOCHEM J, V226, P305, DOI 10.1042/bj2260305; CLARKE SD, 1994, ANNU REV NUTR, V14, P83, DOI 10.1146/annurev.nu.14.070194.000503; Clarke SD, 1997, ANN NY ACAD SCI, V827, P178, DOI 10.1111/j.1749-6632.1997.tb51833.x; Crawford MA, 1997, AM J CLIN NUTR, V66, P1032, DOI 10.1093/ajcn/66.4.1032S; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Horrobin DF, 1997, DIABETES, V46, pS90, DOI 10.2337/diab.46.2.S90; IGAL RA, 1991, MOL CELL ENDOCRINOL, V77, P217, DOI 10.1016/0303-7207(91)90077-6; KAWASHIMA Y, 1990, J BIOL CHEM, V265, P9170; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; LANDS WEM, 1991, ANNU REV NUTR, V11, P41, DOI 10.1146/annurev.nu.11.070191.000353; LEDERER F, 1994, BIOCHIMIE, V76, P674, DOI 10.1016/0300-9084(94)90144-9; MARTINEZ M, 1992, J PEDIATR-US, V120, pS129, DOI 10.1016/S0022-3476(05)81247-8; Marzo I, 1996, BBA-LIPID LIPID MET, V1301, P263, DOI 10.1016/0005-2760(96)00051-3; Melin T, 1997, PROSTAG LEUKOTR ESS, V56, P437, DOI 10.1016/S0952-3278(97)90596-2; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Nakamura MT, 1996, LIPIDS, V31, P139, DOI 10.1007/BF02522612; Napier JA, 1998, BIOCHEM J, V330, P611; NEURINGER M, 1994, J PEDIATR-US, V125, pS39, DOI 10.1016/S0022-3476(06)80735-3; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; OKAYASU T, 1981, ARCH BIOCHEM BIOPHYS, V206, P21, DOI 10.1016/0003-9861(81)90061-8; PELUFFO RO, 1976, BIOCHIM BIOPHYS ACTA, V441, P25, DOI 10.1016/0005-2760(76)90277-0; Piomelli D, 1993, CURR OPIN CELL BIOL, V5, P274, DOI 10.1016/0955-0674(93)90116-8; POISSON JPG, 1991, J NUTR BIOCHEM, V2, P60, DOI 10.1016/0955-2863(91)90030-9; REDDY AS, 1993, PLANT MOL BIOL, V22, P293, DOI 10.1007/BF00014936; SAMUELSSON B, 1983, BIOSCIENCE REP, V3, P791, DOI 10.1007/BF01133779; SAMUELSSON B, 1992, BIOSCIENCE REP, V120, pS129; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sayanova O, 1997, P NATL ACAD SCI USA, V94, P4211, DOI 10.1073/pnas.94.8.4211; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; SPRECHER H, 1981, Progress in Lipid Research, V20, P13, DOI 10.1016/0163-7827(81)90009-6; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; UAUY R, 1992, J PEDIATR-US, V120, pS168, DOI 10.1016/S0022-3476(05)81252-1; Uauy R, 1996, LIPIDS, V31, pS167, DOI 10.1007/BF02637071; VOSS A, 1991, J BIOL CHEM, V266, P19995; Werkman SH, 1996, LIPIDS, V31, P91, DOI 10.1007/BF02522417; WOLF BA, 1986, J BIOL CHEM, V261, P3501	44	512	550	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					471	477		10.1074/jbc.274.1.471	http://dx.doi.org/10.1074/jbc.274.1.471			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867867	hybrid			2022-12-27	WOS:000077900200067
J	Panetti, TS; Kudryk, BJ; Mosher, DF				Panetti, TS; Kudryk, BJ; Mosher, DF			Interaction of recombinant procollagen and properdin modules of thrombospondin-1 with heparin and fibrinogen/fibrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLATELET THROMBOSPONDIN; MELANOMA CELL-ADHESION; FIBRIN CROSS-LINKING; N-TERMINAL DOMAIN; FACTOR-XIIIA; COMPLEX-FORMATION; BINDING PEPTIDES; ALPHA-CHAIN; I REPEATS; FIBRONECTIN	Many properties have been assigned to the procollagen and properdin (Type I) modules of thrombospondin-1 (TSP1) based on activities of large proteolytic fragments of TSP1 or peptides containing TSP1-derived sequences. To examine the activities of the modules more exactly, we expressed the first properdin module (P1); the third properdin module (P3); the first and second properdin modules (P12); the first, second, and third properdin modules (P123); and the procollagen module with the first, second, and third properdin modules (CP123) in the GELEX expression vector (GE1) using the baculovirus system. GE1 encodes the pre-pro sequence, the transglutaminase cross-linking site(s), the protease-sensitive site, and the gelatin binding domain from the amino terminus of rat fibronectin. All five recombinant proteins were expressed by insect cells, secreted into the culture medium, and purified by gelatin-agarose affinity chromatography, P123 shared with TSP1 a resistance to trypsin unless reduced and alkylated. P12/GE1, P123/GE1, and CP123/GE1 bound poorly to heparin-agarose except in the absence of sodium chloride, whereas peptides based on P2 are known to bind to heparin in up to 150 mM sodium chloride. In cross-linking experiments employing activated recombinant factor XIII and the transglutaminase cross-linking site in the fibronectin-derived sequence, P12/GE1, P123/GE1, CP123/GE1, and P3/GE1 but not P1/GE1 became incorporated into a fibrin clot more than GE1 alone. Analysis of the complex indicated that cross-linking was to the portion of the fibrin alpha-chain remaining in the D-dimer of plasmin digests. P123 also cross-linked to the Aa-chain of unclotted fibrinogen. P123 competed for I-125-TSP1 incorporation into the fibrin clot. P123 did not crosslink to plasminogen, histidine-rich glycoprotein, fibronectin, or plasma globulins other than fibrinogen/ fibrin, These results indicate that the properdin modules of TSP1 specifically interact with fibrinogen/ fibrin but not with heparin under physiologic conditions.	Univ Wisconsin, Dept Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Blood Coagulat Biochem, New York, NY 10021 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; New York Blood Center	Panetti, TS (corresponding author), Univ Wisconsin, Dept Med, 1300 Univ Ave, Madison, WI 53706 USA.	tpanetti@facstaff.wisc.edu			NHLBI NIH HHS [HL54462, HL09150] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054462, F32HL009150] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASAKURA S, 1992, J CELL BIOL, V116, P465, DOI 10.1083/jcb.116.2.465; ASCH AS, 1993, SCIENCE, V262, P1436, DOI 10.1126/science.7504322; ASTERMARK J, 1994, J BIOL CHEM, V269, P3690; BACONBAGULEY T, 1990, J BIOL CHEM, V265, P2317; BACONBAGULEY T, 1987, J BIOL CHEM, V262, P1927; BALE MD, 1985, J BIOL CHEM, V260, P7502; BALE MD, 1987, SEMIN THROMB HEMOST, V13, P326, DOI 10.1055/s-2007-1003508; BALE MD, 1986, J BIOL CHEM, V261, P862; BALE MD, 1986, BIOCHEMISTRY-US, V25, P5667, DOI 10.1021/bi00367a048; Clezardin P, 1997, BIOCHEM J, V321, P819, DOI 10.1042/bj3210819; Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999; DARDIK R, 1989, EUR J BIOCHEM, V185, P581, DOI 10.1111/j.1432-1033.1989.tb15153.x; DIXIT VM, 1984, J BIOL CHEM, V259, P100; FRAZIER WA, 1987, SEMIN THROMB HEMOST, V13, P255, DOI 10.1055/s-2007-1003500; Frazier WA, 1991, CURR OPIN CELL BIOL, V3, P792, DOI 10.1016/0955-0674(91)90052-Z; GAFFNEY PJ, 1983, ANN NY ACAD SCI, V408, P407, DOI 10.1111/j.1749-6632.1983.tb23261.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; GUO NH, 1992, J BIOL CHEM, V267, P19349; GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040; HENSCHEN A, 1980, HAEMATOLOGICA, V65, P535; HESSEL B, 1975, THROMB RES, V7, P75, DOI 10.1016/0049-3848(75)90126-7; HOGG PJ, 1992, BIOCHEMISTRY-US, V31, P265, DOI 10.1021/bi00116a036; HOMANDBERG GA, 1987, THROMB RES, V48, P329, DOI 10.1016/0049-3848(87)90445-2; Hynes RO, 1990, FIBRONECTINS; Incardona F, 1996, J CELL BIOCHEM, V62, P431, DOI 10.1002/(SICI)1097-4644(19960915)62:4<431::AID-JCB1>3.0.CO;2-N; LAHAV J, 1984, EUR J BIOCHEM, V145, P151, DOI 10.1111/j.1432-1033.1984.tb08534.x; LAWLER J, 1986, ANN NY ACAD SCI, V485, P273, DOI 10.1111/j.1749-6632.1986.tb34589.x; LAWLER J, 1985, J BIOL CHEM, V260, P3762; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LEGRAND C, 1992, BLOOD, V79, P1995; LEUNG LLK, 1984, J CLIN INVEST, V73, P5, DOI 10.1172/JCI111206; LEUNG LLK, 1982, J CLIN INVEST, V70, P542, DOI 10.1172/JCI110646; LORAND L, 1962, NATURE, V195, P911, DOI 10.1038/195911b0; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Merle B, 1997, J CELL BIOCHEM, V67, P75; MOSHER DF, 1975, J BIOL CHEM, V250, P6614; MOSHER DF, 1983, ANN NY ACAD SCI, V408, P583, DOI 10.1111/j.1749-6632.1983.tb23275.x; MOSHER DF, 1990, ANNU REV MED, V41, P85; MOSHER DF, 1993, ADV MOL CELL BIOL, V6, P115; Nehls V, 1996, MICROVASC RES, V51, P347, DOI 10.1006/mvre.1996.0032; PARAMESWARAN KN, 1990, P NATL ACAD SCI USA, V87, P8472, DOI 10.1073/pnas.87.21.8472; POTTS JR, 1995, NAT STRUCT BIOL, V2, P946, DOI 10.1038/nsb1195-946; PROCYK R, 1991, BLOOD, V77, P1469; PROCYK R, 1993, THROMB RES, V71, P127, DOI 10.1016/0049-3848(93)90179-R; ROBERTS DD, 1988, CANCER RES, V48, P6785; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26783; SILVERSTEIN RL, 1984, J CLIN INVEST, V74, P1625, DOI 10.1172/JCI111578; Sobel JH, 1996, J BIOL CHEM, V271, P19288, DOI 10.1074/jbc.271.32.19288; SOTTILE J, 1993, BIOCHEMISTRY-US, V32, P1641, DOI 10.1021/bi00057a031; SOTTILE J, 1991, BIOCHEMISTRY-US, V30, P6556, DOI 10.1021/bi00240a028; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; TAKAGI J, 1993, J BIOL CHEM, V268, P15544; TUSZYNSKI GP, 1994, LAB INVEST, V70, P228; TUSZYNSKI GP, 1985, J BIOL CHEM, V260, P2240; WOLF FW, 1990, GENOMICS, V6, P685, DOI 10.1016/0888-7543(90)90505-O; Yamada KM, 1989, FIBRONECTIN, P47; Zhang QH, 1996, J BIOL CHEM, V271, P33284, DOI 10.1074/jbc.271.52.33284	59	37	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					430	437		10.1074/jbc.274.1.430	http://dx.doi.org/10.1074/jbc.274.1.430			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867861	hybrid			2022-12-27	WOS:000077900200061
J	Kawano, S; Kuruma, A; Hirayama, Y; Hiraoka, M				Kawano, S; Kuruma, A; Hirayama, Y; Hiraoka, M			Anion permeability and conduction of adenine nucleotides through a chloride channel in cardiac sarcoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; GLUCOSE-REGULATED PROTEIN; PLANAR LIPID BILAYERS; ENDOPLASMIC-RETICULUM; ADENOSINE-TRIPHOSPHATE; KINASE-A; ATP; TRANSPORT; VDAC	Cardiac sarcoplasmic reticulum (SR) membrane contains several chloride (Cl-) channels. We have characterized a 116-pS Cl- channel (500 mM cis, 50 mM trans Cl-) in cardiac SR that is activated by protein kinase A-dependent phosphorylation. To understand its function further, we examined the permeation of various anions and adenine nucleotides using the planar lipid bilayer-vesicle fusion technique. This Cl- channel showed a high selectivity to anions and its permeability sequence was Br- > Cl- > I- > NO3- > F-. When all anions were replaced with ATP in the cis solution, channel activity persisted. The conductance was 78 pS with 200 mM ATP and 68 pS with 100 mM ATP. The reversal potentials were +63 mV and +41 mV in 200 mM ATP and in 100 mM ATP, respectively. With 100 mM ADP or AMP in the cis solution, channel activities were also observed. The conductances were 87 pS with 100 mM ADP and 115 pS with 100 mM AMP. The apparent adenine selectivity of this channel was ATP > ADP > AMP, assuming that they exist as divalent anions. These results suggest that the SR Cl- channel in cardiac cells may serve as a transporter for the movement of adenine nucleotides between cytosol and SR lumen.	Tokyo Med & Dent Univ, Med Res Inst, Dept Cardiovasc Dis, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU)	Kawano, S (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Cardiovasc Dis, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	seiko.card@mri.tmd.ac.jp						ABRAHAM EH, 1993, P NATL ACAD SCI USA, V90, P312, DOI 10.1073/pnas.90.1.312; BENZ R, 1988, FEBS LETT, V231, P75, DOI 10.1016/0014-5793(88)80706-3; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; CORONADO R, 1982, NATURE, V298, P849, DOI 10.1038/298849a0; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; ENDO M, 1985, CURR TOP MEMBR TRANS, V25, P181; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; GADSBY DC, 1995, ANNU REV PHYSIOL, V57, P387; GELLERICH FN, 1993, BIOCHIM BIOPHYS ACTA, V1142, P217, DOI 10.1016/0005-2728(93)90150-E; Grygorczyk R, 1996, J MEMBRANE BIOL, V151, P139, DOI 10.1007/s002329900065; GUILLEN E, 1995, BIOCHEMISTRY-US, V34, P5472, DOI 10.1021/bi00016a018; HALS GD, 1989, J GEN PHYSIOL, V93, P385, DOI 10.1085/jgp.93.3.385; Hanrahan John W., 1993, P93; HENDERSHOT LM, 1988, MOL CELL BIOL, V8, P4250, DOI 10.1128/MCB.8.10.4250; JUNGE D, 1976, NERVE MUSCLE EXCITAT, P101; KAWANO S, 1993, CIRC RES, V73, P751, DOI 10.1161/01.RES.73.4.751; KAWANO S, 1992, CIRC RES, V71, P585, DOI 10.1161/01.RES.71.3.585; Kawano S, 1998, BIOPHYS J, V74, pA98; LEE AC, 1994, J BIOL CHEM, V269, P30974; LEUSTEK T, 1991, ARCH BIOCHEM BIOPHYS, V289, P256, DOI 10.1016/0003-9861(91)90469-Y; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Linsdell P, 1998, J GEN PHYSIOL, V111, P601, DOI 10.1085/jgp.111.4.601; LIU MY, 1992, BIOCHIM BIOPHYS ACTA, V1098, P255, DOI 10.1016/S0005-2728(05)80344-5; MAYINGER P, 1995, J CELL BIOL, V131, P1377, DOI 10.1083/jcb.131.6.1377; MCMANUS ML, 1995, NEW ENGL J MED, V333, P1260, DOI 10.1056/NEJM199511093331906; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Pasyk EA, 1997, J BIOL CHEM, V272, P7746, DOI 10.1074/jbc.272.12.7746; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; QUEMENEUR E, 1994, J BIOL CHEM, V269, P5485; Reddy MM, 1996, SCIENCE, V271, P1876, DOI 10.1126/science.271.5257.1876; REISIN IL, 1994, J BIOL CHEM, V269, P20584; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 1998, BIOPHYS J, V74, P2365, DOI 10.1016/S0006-3495(98)77945-7; ROUSSEAU E, 1989, J MEMBRANE BIOL, V110, P39, DOI 10.1007/BF01870991; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; Sugita M, 1998, EMBO J, V17, P898, DOI 10.1093/emboj/17.4.898; Tabcharani JA, 1997, J GEN PHYSIOL, V110, P341, DOI 10.1085/jgp.110.4.341; TANIFUJI M, 1987, J MEMBRANE BIOL, V99, P103, DOI 10.1007/BF01871230; WRIGHT EM, 1977, PHYSIOL REV, V57, P109, DOI 10.1152/physrev.1977.57.1.109	40	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2085	2092		10.1074/jbc.274.4.2085	http://dx.doi.org/10.1074/jbc.274.4.2085			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890968	hybrid			2022-12-27	WOS:000078185200035
J	Haan, S; Hemmann, U; Hassiepen, U; Schaper, F; Schneider-Mergener, J; Wollmer, A; Heinrich, PC; Grotzinger, J				Haan, S; Hemmann, U; Hassiepen, U; Schaper, F; Schneider-Mergener, J; Wollmer, A; Heinrich, PC; Grotzinger, J			Characterization and binding specificity of the monomeric STAT3-SH2 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TRANSDUCER GP130; PHASE RESPONSE FACTOR/STAT3; DIFFERENTIAL ACTIVATION; CYTOPLASMIC DOMAIN; FLUORESCENCE DECAY; CRYSTAL-STRUCTURE; PI 3-KINASE; INTERLEUKIN-6; SH2; TRYPTOPHAN	Signal transducers and activators of transcription (STATs) are important mediators of cytokine signal transduction. STAT factors are recruited to phosphotyrosine-containing motifs of activated receptor chains via their SH2 domains. The subsequent tyrosine phosphorylation of the STATs leads to their dissociation from the receptor, dimerization, and translocation to the nucleus. Here we describe the expression, purification, and refolding of the STAT3-SH2 domain. Proper folding of the isolated protein was proven by circular dichroism and fluorescence spectroscopy. The STAT3-SH2 domain undergoes a conformational change upon dimerization. Using an enzyme-linked immunosorbent assay we demonstrate that the monomeric domain binds to specific phosphotyrosine peptides. The specificity of binding to phosphotyrosine peptides was assayed with the tyrosine motif encompassing Tyr(705) Of STAT3 and with all tyrosine motifs present in the cytoplasmic tail of the signal transducer gp130.	Rhein Westfal TH Aachen, Inst Biochem, D-52074 Aachen, Germany; Humboldt Univ, Klinikum Charite, Inst Med Immunol, D-10098 Berlin, Germany	RWTH Aachen University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Heinrich, PC (corresponding author), Rhein Westfal TH Aachen, Inst Biochem, Pauwelsstr 30, D-52074 Aachen, Germany.	heinrich@rwth-aachen.de	Schaper, Fred/F-1403-2013	Schaper, Fred/0000-0002-8899-5414				Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; CHEN GC, 1977, ANAL LETT, V10, P1195, DOI 10.1080/00032717708067855; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; FU XY, 1993, CELL, V74, P1135, DOI 10.1016/0092-8674(93)90734-8; Gerhartz C, 1996, J BIOL CHEM, V271, P12991, DOI 10.1074/jbc.271.22.12991; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; HEIM MH, 1995, SCIENCE, V267, P1347, DOI 10.1126/science.7871432; Hemmann U, 1996, J BIOL CHEM, V271, P12999, DOI 10.1074/jbc.271.22.12999; KUNZ D, 1989, NUCLEIC ACIDS RES, V17, P1121, DOI 10.1093/nar/17.3.1121; LEENDERS HRM, 1990, EUR BIOPHYS J, V18, P43, DOI 10.1007/BF00185419; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; PANAYOTOU G, 1992, EMBO J, V11, P4261, DOI 10.1002/j.1460-2075.1992.tb05524.x; PAWSON T, 1994, ADV CANCER RES, V64, P87, DOI 10.1016/S0065-230X(08)60835-0; Reineke U, 1996, MOL DIVERS, V1, P141, DOI 10.1007/BF01544952; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHOELSON SE, 1993, EMBO J, V12, P795, DOI 10.1002/j.1460-2075.1993.tb05714.x; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Stancato LF, 1996, J BIOL CHEM, V271, P4134; SZABO AG, 1980, J AM CHEM SOC, V102, P554, DOI 10.1021/ja00522a020; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; WAXMAN E, 1993, ANAL BIOCHEM, V210, P425, DOI 10.1006/abio.1993.1220; WEGENKA UM, 1994, MOL CELL BIOL, V14, P3186, DOI 10.1128/MCB.14.5.3186; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	28	39	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1342	1348		10.1074/jbc.274.3.1342	http://dx.doi.org/10.1074/jbc.274.3.1342			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880505	hybrid			2022-12-27	WOS:000079956900025
J	Kawasaki, K; Kuge, O; Chang, SC; Heacock, PN; Rho, M; Suzuki, K; Nishijima, M; Dowhan, W				Kawasaki, K; Kuge, O; Chang, SC; Heacock, PN; Rho, M; Suzuki, K; Nishijima, M; Dowhan, W			Isolation of a Chinese hamster ovary (CHO) cDNA encoding phosphatidylglycerophosphate (PGP) synthase, expression of which corrects the mitochondrial abnormalities of a PGP synthase-defective mutant of CHO-K1 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLSERINE SYNTHASE; CARDIOLIPIN SYNTHASE; ESCHERICHIA-COLI; CONTACT SITES; PEL1 GENE; PHOSPHOLIPIDS; BIOSYNTHESIS; SEQUENCE	Phosphatidylglycerophosphate (PGP) synthase catalyzes the first step in the cardiolipin (CL) branch of phospholipid biosynthesis in mammalian cells. In this study, we isolated a Chinese hamster ovary (CHO) cDNA encoding a putative protein similar in sequence to the yeast PGS1 gene product, PGP synthase, The gene for the isolated CHO cDNA was named PGS1, Expression of the CHO PGS1 cDNA in CHO-K1 cells and production of a recombinant CHO PGS1 protein with a N-terminal extension in Escherichia coli resulted in 15-fold and 90-fold increases of PGP synthase specific activity, respectively, establishing that CHO PGS1 encodes PGP synthase, A PGP synthase-defective CHO mutant, PGS-S, isolated previously (Ohtsuka, T., Nishijima, M,, and Akamatsu, Y, (1993) J, Biol. Chem. 268, 22908-22913) exhibits striking reductions in biosynthetic rate and cellular content of phosphatidylglycerol (PG) and CL and shows mitochondrial morphological and functional abnormalities. The CHO PGS-S mutant transfected with the CHO PGS1 cDNA exhibited 620-fold and 7-fold higher PGP synthase activity than mutant PGS-S and wild type CHO-K1 cells, respectively, and had a normal cellular content and rate of biosynthesis of PG and CL, In contrast to mutant PGS-S, the transfectant had morphologically normal mitochondria, When the transfectant and mutant PGS-S cells were cultivated in a glucose depleted medium, in which cellular energy production mainly depends on mitochondrial function, the transformant but not mutant PGS-S was capable of growth. These results demonstrated that the morphological and functional defects displayed by the PGS-S mutant are due directly to the reduced ability to make normal levels of PG and/or CL.	Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA; Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	University of Texas System; National Institute of Infectious Diseases (NIID)	Nishijima, M (corresponding author), Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA.			Kuge, Osamu/0000-0003-4962-3519	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020478, R01GM056389, R37GM020478] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM20478, GM56389] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS MD, 1995, NATURE, V377, P3; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; AWASTHI YC, 1971, BIOCHIM BIOPHYS ACTA, V226, P42, DOI 10.1016/0005-2728(71)90176-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; DARNELL JE, 1983, SCI AM, V249, P72; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Dryden SC, 1996, J BACTERIOL, V178, P1030, DOI 10.1128/jb.178.4.1030-1038.1996; FINE JB, 1982, J LIPID RES, V23, P660; GUN D, 1989, BIOCHIM BIOPHYS ACTA, P34; HALLMAN M, 1975, BIOCHIM BIOPHYS ACTA, V409, P172, DOI 10.1016/0005-2760(75)90152-6; HAM RG, 1965, P NATL ACAD SCI USA, V53, P288, DOI 10.1073/pnas.53.2.288; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; HEACOCK PN, 1987, J BIOL CHEM, V262, P13044; Hostetler K. Y., 1982, PHOSPHOLIPIDS, V4, P215; Janitor M, 1996, FEMS MICROBIOL LETT, V140, P43; JANITOR M, 1993, CURR GENET, V24, P307, DOI 10.1007/BF00336781; JELSEMA CL, 1978, J BIOL CHEM, V253, P7960; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; KIYASU JY, 1963, J BIOL CHEM, V238, P2293; Koonin EV, 1996, TRENDS BIOCHEM SCI, V21, P242, DOI 10.1016/0968-0004(96)30024-8; KREBS JJR, 1979, J BIOL CHEM, V254, P5308; Kuge O, 1997, J BIOL CHEM, V272, P19133, DOI 10.1074/jbc.272.31.19133; MCMURRAY WC, 1978, CAN J BIOCHEM CELL B, V56, P414, DOI 10.1139/o78-065; Murray NR, 1998, J BIOL CHEM, V273, P11514, DOI 10.1074/jbc.273.19.11514; NICHOLSON DW, 1986, BIOCHIM BIOPHYS ACTA, V856, P515, DOI 10.1016/0005-2736(86)90143-4; NIKAWA J, 1987, J BIOL CHEM, V262, P4876; NISHIJIMA M, 1986, J BIOL CHEM, V261, P5784; Nishijima M, 1997, TRENDS CELL BIOL, V7, P324, DOI 10.1016/S0962-8924(97)01084-2; NOEL H, 1986, EUR J BIOCHEM, V155, P99, DOI 10.1111/j.1432-1033.1986.tb09463.x; OHTSUKA T, 1993, J BIOL CHEM, V268, P22914; OHTSUKA T, 1993, J BIOL CHEM, V268, P22908; OU W, 1988, J BIOCH, P589; OU WJ, 1988, J BIOCHEM-TOKYO, V103, P589, DOI 10.1093/oxfordjournals.jbchem.a122312; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; REATZ CRH, 1987, BIOCHEMISTRY-US, V26, P4022; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; RIETVELD A, 1983, EMBO J, V2, P907, DOI 10.1002/j.1460-2075.1983.tb01520.x; Rose K, 1995, P NATL ACAD SCI USA, V92, P12151, DOI 10.1073/pnas.92.26.12151; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; SIMONSEN CC, 1983, MOL CELL BIOL, V3, P2250, DOI 10.1128/MCB.3.12.2250; TOUCHSTONE JC, 1985, LIPIDS, V20, P869, DOI 10.1007/BF02534770; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1	45	75	79	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1828	1834		10.1074/jbc.274.3.1828	http://dx.doi.org/10.1074/jbc.274.3.1828			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880566	hybrid			2022-12-27	WOS:000079956900086
J	Eskew, JD; Vanacore, RM; Sung, L; Morales, PJ; Smith, A				Eskew, JD; Vanacore, RM; Sung, L; Morales, PJ; Smith, A			Cellular protection mechanisms against extracellular heme - Heme-hemopexin, but not free heme, activates the N-terminal c-Jun kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METALLOTHIONEIN GENE-EXPRESSION; RECEPTOR-MEDIATED UPTAKE; KAPPA-B; OXYGENASE-1 HSP32; GROWTH ARREST; TRANSCRIPTION FACTORS; ISCHEMIA REPERFUSION; OXIDATIVE DAMAGE; PROTEIN-KINASES; HEPATOMA-CELLS	Hemopexin protects cells lacking hemopexin receptors by tightly binding heme abrogating its deleterious effects and preventing nonspecific heme uptake, whereas cells with hemopexin receptors undergo a series of cellular events upon encountering heme-hemopexin. The biochemical responses to heme-hemopexin depend on its extracellular concentration and range from stimulation of cell growth at low levels to cell survival at otherwise toxic levels of heme. High (2-10 mu M) but not low (0.01-1 mu M) concentrations of heme-hemopexin increase, albeit transiently, the protein carbonyl content of mouse hepatoma (Hepa) cells. This is due to events associated with heme transport since cobalt-protoporphyrin IX-hemopexin, which binds to the receptor and activates signaling pathways without tetrapyrrole transport, does not increase carbonyl content. The N-terminal c-Jun kinase (JNK) is rapidly activated by 2-10 mu M heme-hemopexin, yet the increased intracellular heme levels are neither toxic nor apoptotic. After 24 h exposure to 10 mu M heme-hemopexin, Hepa cells become refractory to the growth stimulation seen with 0.1-0.75 mu M heme-hemopexin but HO-1 remains responsive to induction by heme-hemopexin, Since free heme does not induce JNK, the signaling events, like phosphorylation of c-Jun via activation of JNK as well as the nuclear translocation of NF kappa B, G(2)/M arrest, and increased expression of p53 and of the cell cycle inhibitor p21(WAF1/CIP1/SDI1) generated by heme-hemopexin appear to be of paramount importance in cellular protection by heme-hemopexin.	Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Smith, A (corresponding author), Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, 5007 Rockhill Rd, Kansas City, MO 64110 USA.	smithan@umkc.edu	Vanacore, Roberto/AAD-6399-2020; Vanacore, Roberto/C-9763-2012	Vanacore, Roberto/0000-0002-2886-0606; Vanacore, Roberto/0000-0002-2886-0606	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037463] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 37463] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AFT RL, 1984, J BIOL CHEM, V259, P301; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; ALAM J, 1992, J BIOL CHEM, V267, P16379; ALAM J, 1994, J BIOL CHEM, V269, P25049; AMES BN, 1992, ANN NY ACAD SCI, V663, P85, DOI 10.1111/j.1749-6632.1992.tb38652.x; BALLA G, 1992, J BIOL CHEM, V267, P18148; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Bergeron M, 1997, J CEREBR BLOOD F MET, V17, P647; CHUBATSU LS, 1993, BIOCHEM J, V291, P193, DOI 10.1042/bj2910193; DAVIES DM, 1979, BIOCHEM BIOPH RES CO, V91, P1504, DOI 10.1016/0006-291X(79)91235-X; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; Elbirt KK, 1998, J BIOL CHEM, V273, P8922, DOI 10.1074/jbc.273.15.8922; Fischer EH, 1998, P NATL ACAD SCI USA, V95, P3333, DOI 10.1073/pnas.95.7.3333; Fornari FA, 1996, BIOCHEM PHARMACOL, V51, P931, DOI 10.1016/0006-2952(96)00050-0; FRIEDMANMOR Z, 1978, J TRAUMA, V18, P104, DOI 10.1097/00005373-197802000-00005; Guo JH, 1998, BIOCHEM BIOPH RES CO, V242, P39, DOI 10.1006/bbrc.1997.7910; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; Hunt RC, 1996, J CELL PHYSIOL, V168, P71, DOI 10.1002/(SICI)1097-4652(199607)168:1<71::AID-JCP9>3.0.CO;2-5; IMBRA RJ, 1987, MOL CELL BIOL, V7, P1358, DOI 10.1128/MCB.7.4.1358; Karin M, 1998, CANCER J SCI AM, V4, pS92; Kelly EJ, 1996, NAT GENET, V13, P219, DOI 10.1038/ng0696-219; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEDFORD BE, 1983, J BIOL CHEM, V258, P3304; Lee PJ, 1996, P NATL ACAD SCI USA, V93, P10393, DOI 10.1073/pnas.93.19.10393; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lin FB, 1998, ARCH BIOCHEM BIOPHYS, V352, P51, DOI 10.1006/abbi.1998.0588; LYSKO PG, 1994, STROKE, V25, P2476, DOI 10.1161/01.STR.25.12.2476; MADORE N, 1994, J NEUROSCI RES, V39, P186, DOI 10.1002/jnr.490390209; MAINES MD, 1993, J PHARMACOL EXP THER, V264, P457; Meldrum DR, 1997, J SURG RES, V69, P268, DOI 10.1006/jsre.1997.5023; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miller YI, 1996, BIOCHEMISTRY-US, V35, P13112, DOI 10.1021/bi960737u; Morgan W T, 1989, J Mol Recognit, V2, P122, DOI 10.1002/jmr.300020304; MORGAN WT, 1993, J BIOL CHEM, V268, P6256; MORRIS CM, 1993, NEUROSCI LETT, V149, P141, DOI 10.1016/0304-3940(93)90756-B; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; PALLER MS, 1988, AM J PHYSIOL, V255, pF539, DOI 10.1152/ajprenal.1988.255.3.F539; POMBO CM, 1994, J BIOL CHEM, V269, P26546; Raju VS, 1996, J PHARMACOL EXP THER, V277, P1814; REN YF, 1995, J BIOL CHEM, V270, P23988, DOI 10.1074/jbc.270.41.23988; RUSSO T, 1995, J BIOL CHEM, V270, P29386, DOI 10.1074/jbc.270.49.29386; SEARS DA, 1970, J CLIN INVEST, V49, P5, DOI 10.1172/JCI106222; Shim J, 1996, NATURE, V381, P804, DOI 10.1038/381804a0; SMITH A, 1979, BIOCHEM J, V182, P47, DOI 10.1042/bj1820047; Smith A, 1997, EXP CELL RES, V232, P246, DOI 10.1006/excr.1997.3526; SMITH A, 1990, EUR J CELL BIOL, V53, P234; SMITH A, 1978, BIOCHEM BIOPH RES CO, V84, P151, DOI 10.1016/0006-291X(78)90276-0; SMITH A, 1984, J BIOL CHEM, V259, P2049; SMITH A, 1993, J BIOL CHEM, V268, P7365; SMITH A, 1988, BIOCHEM J, V256, P941, DOI 10.1042/bj2560941; Smith A., 1990, BIOSYNTHESIS HEME CH, P435; Tacchini L, 1997, HEPATOLOGY, V26, P186; TAKETANI S, 1986, BIOCHEM INT, V13, P307; Terry CM, 1998, AM J PHYSIOL-HEART C, V274, pH883, DOI 10.1152/ajpheart.1998.274.3.H883; Venters HD, 1997, BRAIN RES, V764, P93, DOI 10.1016/S0006-8993(97)00425-3; VINCENT SH, 1988, ARCH BIOCHEM BIOPHYS, V265, P539, DOI 10.1016/0003-9861(88)90159-2; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wu Y, 1997, P NATL ACAD SCI USA, V94, P8982, DOI 10.1073/pnas.94.17.8982; Zheng H, 1996, TOXICOL LETT, V87, P139, DOI 10.1016/0378-4274(96)03770-8; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	66	80	82	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					638	648		10.1074/jbc.274.2.638	http://dx.doi.org/10.1074/jbc.274.2.638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872997	hybrid			2022-12-27	WOS:000077968500012
J	Franke, I; Meiss, G; Pingoud, A				Franke, I; Meiss, G; Pingoud, A			On the advantage of being a dimer, a case study using the dimeric Serratia nuclease and the monomeric nuclease from Anabaena sp. strain PCC 71209	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MARCESCENS NUCLEASE; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL NUCLEASE; STRANDED DNA; ENDONUCLEASE; GENE; EXPRESSION; IDENTIFICATION; PURIFICATION	The extracellular endonucleases from Serratia marcescens and Anabaena sp. are members of a family of nonspecific endonucleases. In contrast to the monomeric Anabaena nuclease, the Serratia nuclease is a dimer of two identical subunits, To find out whether the two active sites of the Serratia nuclease function independently of each other and what the advantage of being a dimer for this enzyme might be, we produced (i) dimers in which the two subunits were cross-linked, (ii) heterodimers consisting of a wild type and an inactive mutant subunit which were also cross-linked, and (iii) monomeric variants which are unable to dimerize, The monomeric H184R variant and the cross-linked S140C variant exhibit the same activity as the wild type enzyme, while the cross-linked heterodimer with one inactive subunit shows only half of the activity of the wild type enzyme, demonstrating functional independence of the two subunits of the Serratia nuclease, On the other hand at low enzyme and substrate concentrations dimeric forms of the Serratia nuclease are relatively more active than monomeric forms or the monomeric Anabaena nuclease in cleaving polynucleotides, not, however, oligonucleotides, which is correlated with the ability of dimeric forms of the Serratia nuclease to form large enzyme-substrate networks with high molecular weight DNA and to cleave polynucleotides in a processive manner, We conclude that in the natural habitat of Serratia marcescens where the supply of nutrients may become growth limiting the dimeric nuclease can fulfil its nutritive function more efficiently than a monomeric enzyme.	Univ Giessen, Inst Biochem, Fachbereich Biol, D-35392 Giessen, Germany	Justus Liebig University Giessen	Pingoud, A (corresponding author), Univ Giessen, Inst Biochem, Fachbereich Biol, Heinrich Buff Ring 58, D-35392 Giessen, Germany.	alfred.m.pingoud@chemie.bio.uni-giessen.de						BALL TK, 1992, NUCLEIC ACIDS RES, V20, P4971, DOI 10.1093/nar/20.19.4971; BALL TK, 1987, GENE, V57, P183, DOI 10.1016/0378-1119(87)90121-1; Benedik MJ, 1998, FEMS MICROBIOL LETT, V165, P1; Bernardi G., 1971, HYDROLYSIS, P271; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BRAUN V, 1980, ARCH MICROBIOL, V124, P55, DOI 10.1007/BF00407028; BRONKE BJ, 1979, CAN J MICROBIOL, V25, P47; CHEN LY, 1993, ARCH BIOCHEM BIOPHYS, V303, P51, DOI 10.1006/abbi.1993.1254; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; DAKE E, 1988, J BIOL CHEM, V263, P7691; EAVES GN, 1963, J BACTERIOL, V85, P273, DOI 10.1128/JB.85.2.273-278.1963; FILIMONOVA M N, 1981, Biokhimiya, V46, P1660; Franke I, 1998, FEBS LETT, V425, P517, DOI 10.1016/S0014-5793(98)00279-8; FRANKE I, 1999, IN PRESS J PROT CHEM; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FRIEDHOFF P, 1994, NUCLEIC ACIDS RES, V22, P3280, DOI 10.1093/nar/22.16.3280; Friedhoff P, 1996, EUR J BIOCHEM, V241, P572, DOI 10.1111/j.1432-1033.1996.00572.x; FRIEDHOFF P, 1994, PROTEIN EXPRES PURIF, V5, P37, DOI 10.1006/prep.1994.1005; Friedhoff P, 1996, NUCLEIC ACIDS RES, V24, P2632, DOI 10.1093/nar/24.14.2632; GERDES W, 1998, BIOSPEKTRUM, V1, P73; GIVSKOV M, 1988, J BACTERIOL, V170, P5855, DOI 10.1128/jb.170.12.5855-5862.1988; HELLER KB, 1979, J BACTERIOL, V140, P1120, DOI 10.1128/JB.140.3.1120-1122.1979; Ikeda S, 1996, BIOCHEM MOL BIOL INT, V40, P1017; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989; JONES JDG, 1986, EMBO J, V5, P467, DOI 10.1002/j.1460-2075.1986.tb04235.x; KINDLER B, 1997, THESIS U HANNOVER; Kolmes B, 1996, FEBS LETT, V397, P343, DOI 10.1016/S0014-5793(96)01210-0; KUNITZ M, 1950, J GEN PHYSIOL, V33, P349, DOI 10.1085/jgp.33.4.349; LACKS S, 1975, J BACTERIOL, V124, P1321, DOI 10.1128/JB.124.3.1321-1329.1975; LI XY, 1995, APPL ENVIRON MICROB, V61, P2674, DOI 10.1128/AEM.61.7.2674-2680.1995; Lunin VY, 1997, FEBS LETT, V412, P217, DOI 10.1016/S0014-5793(97)00512-7; MEISS G, 1995, BIOCHEMISTRY-US, V34, P11979, DOI 10.1021/bi00037a040; Meiss G, 1998, EUR J BIOCHEM, V251, P924, DOI 10.1046/j.1432-1327.1998.2510924.x; Miller MD, 1996, PROTEIN SCI, V5, P24; MILLER MD, 1994, NAT STRUCT BIOL, V1, P461, DOI 10.1038/nsb0794-461; MONREAL J, 1969, CAN J MICROBIOL, V15, P689, DOI 10.1139/m69-122; MUROPASTOR AM, 1994, J BACTERIOL, V176, P1093, DOI 10.1128/JB.176.4.1093-1098.1994; MUROPASTOR AM, 1992, MOL MICROBIOL, V6, P3021, DOI 10.1111/j.1365-2958.1992.tb01760.x; MuroPastor AM, 1997, J MOL BIOL, V268, P589, DOI 10.1006/jmbi.1997.0985; Pingoud A, 1997, EUR J BIOCHEM, V246, P1, DOI 10.1111/j.1432-1033.1997.t01-6-00001.x; Prats E, 1997, DNA CELL BIOL, V16, P1111, DOI 10.1089/dna.1997.16.1111; PUYET A, 1990, J MOL BIOL, V213, P727, DOI 10.1016/S0022-2836(05)80259-1; Roberts R, 1993, NUCLEASES, P35; ROSENTHAL AL, 1977, ANAL BIOCHEM, V80, P76, DOI 10.1016/0003-2697(77)90627-3; Sambrook J., 2002, MOL CLONING LAB MANU; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TIRANTI V, 1995, GENOMICS, V25, P559, DOI 10.1016/0888-7543(95)80058-T; VINCENT RD, 1988, NUCLEIC ACIDS RES, V16, P3297, DOI 10.1093/nar/16.8.3297; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; YONEMURA K, 1983, J BIOCHEM-TOKYO, V93, P1287, DOI 10.1093/oxfordjournals.jbchem.a134262; ZABEAU M, 1982, EMBO J, V1, P1217, DOI 10.1002/j.1460-2075.1982.tb00016.x; ZASSENHAUS HP, 1988, NUCLEIC ACIDS RES, V16, P3283, DOI 10.1093/nar/16.8.3283	54	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					825	832		10.1074/jbc.274.2.825	http://dx.doi.org/10.1074/jbc.274.2.825			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873021	hybrid			2022-12-27	WOS:000077968500036
J	Gross, A; Yin, XM; Wang, K; Wei, MC; Jockel, J; Millman, C; Erdjument-Bromage, H; Tempst, P; Korsmeyer, SJ				Gross, A; Yin, XM; Wang, K; Wei, MC; Jockel, J; Millman, C; Erdjument-Bromage, H; Tempst, P; Korsmeyer, SJ			Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-X-L prevents this release but not tumor necrosis factor-R1/Fas death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-FAS ANTIBODY; SURVIVAL-PROMOTING PROTEINS; PROGRAMMED CELL-DEATH; SIGNALING COMPLEX; POSITIVE CHARGES; ION-CHANNEL; BH3 DOMAIN; APOPTOSIS; BAX; BCL-X(L)	"BH3 domain only" members of the BCL-2 family including the pro-apoptotic molecule BID represent candidates to connect with proximal signal transduction. Tumor necrosis factor alpha (TNF alpha) treatment induced a caspase-mediated cleavage of cytosolic, inactive p22 BID at internal Asp sites to yield a major p15 and minor p13 and p11 fragments. p15 BID translocates to mitochondria as an integral membrane protein. p15 BID within cytosol targeted normal mitochondria and released cytochrome c. Immunodepletion of p15 BID prevents cytochrome c release, in vivo, anti-Fas Ab results in the appearance of p15 BID in the cytosol of hepatocytes which translocates to mitochondria where it releases cytochrome c. Addition of activated caspase-8 to normal cytosol generates p15 BID which is also required in this system for release of cytochrome c. In the presence of BCL-X-L/BCL-2, TNF alpha still induced BID cleavage and p15 BID became an integral mitochondrial membrane protein. However, BCC X-L/BCL-2 prevented the release of cytochrome c, yet other aspects of mitochondrial dysfunction still transpired and cells died nonetheless. Thus, while BID appears to be required for the release of cytochrome c in the TNF death pathway, the release of cytochrome c may not be required for cell death.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Memorial Sloan Kettering Cancer Center	Korsmeyer, SJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Smith 758,1 Jimmy Fund Way, Boston, MA 02115 USA.	stanley_korsmeyer@dfci.harvard.edu		Erdjument-Bromage, Hediye/0000-0003-0224-3594				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Boise LH, 1997, P NATL ACAD SCI USA, V94, P3759, DOI 10.1073/pnas.94.8.3759; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; BOYD JM, 1995, ONCOGENE, V11, P1921; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; FALNES PO, 1992, J BIOL CHEM, V267, P12284; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hegde R, 1998, J BIOL CHEM, V273, P7783, DOI 10.1074/jbc.273.14.7783; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kuwana T, 1998, J BIOL CHEM, V273, P16589, DOI 10.1074/jbc.273.26.16589; Lacronique V, 1996, NAT MED, V2, P80, DOI 10.1038/nm0196-80; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MCBRIDE HM, 1995, BBA-BIOMEMBRANES, V1237, P162, DOI 10.1016/0005-2736(95)00088-K; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; Nagata S, 1996, CURR BIOL, V6, P1241, DOI 10.1016/S0960-9822(02)70706-9; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Rodriguez I, 1996, J EXP MED, V183, P1031, DOI 10.1084/jem.183.3.1031; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Wallach D, 1998, CURR OPIN IMMUNOL, V10, P279, DOI 10.1016/S0952-7915(98)80166-0; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	60	894	923	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1156	1163		10.1074/jbc.274.2.1156	http://dx.doi.org/10.1074/jbc.274.2.1156			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873064	hybrid			2022-12-27	WOS:000077968500079
J	Yanagidani, J; Tamura, T; Inagaki, K; Soda, K; Tanaka, H				Yanagidani, J; Tamura, T; Inagaki, K; Soda, K; Tanaka, H			Purification and characterization of NAD : penicillamine ADP transferase from Bacillus sphaericus - A novel NAD-dependent enzyme catalyzing phosphoramide bond formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITION; MYELOPEROXIDASE; PROTEIN	A strain of Bacillus sphaericus isolated from a local soil sample has been found to use beta,beta-dimethyl-DL-cysteine (DL-penicillamine) as the sole nitrogen source, Crude cell extract of the bacterium showed potent penicillamine-consuming activity only in the presence of NAD, which, however, was not used as an electron ac ceptor, Characterization of reaction products revealed that penicillamine was derivatized to a phosphoramide adduct with the ADP moiety of NAD, whereas the nicotinamide-ribose group was released and hydrolyzed spontaneously to ribose and nicotinamide, The phosphoramide product, ADP-penicillamine, caused potent product inhibition on the purified enzyme, and adenylate deaminase was found to be effective in converting the inhibitory product into inosine-diphosphate-penicillamine and thereby maintained the catalysis for several hours, The novel enzyme, termed as NAD:penicillamine ADP transferase, showed a single band on SDS-polyacrylamide gel electrophoresis with a mass of approximately 42 kDa, The native enzyme was monomeric. The enzyme showed high substrate specificity to NAD (K-m = 13.0 mM) and L-penicillamine (K-m = 6.5 mM); other nucleotides such as NADP, NAD(P)H, AMP, ADP, and ADP-ribose did not substitute for NAD, and L-valine, L-cysteine, L-homocysteine, L-cystine, L-leucine, and L-isoleucine did not serve as the substrate. Kinetic studies suggested an Ordered Bi Bi mechanism, with NAD as the first substrate to bind and ADP-L-penicillamine as the last product released, The novel NAD-dependent enzyme may catalyze the first step in penicillamine degradation in the strain of B. sphaericus.	Okayama Univ, Fac Agr, Dept Bioresource Chem, Okayama 7008530, Japan; Kansai Univ, Fac Engn, Dept Biotechnol, Osaka, Japan	Okayama University; Kansai University	Tanaka, H (corresponding author), Okayama Univ, Fac Agr, Dept Bioresource Chem, 1-1-1 Tsushimanaka, Okayama 7008530, Japan.	htanaka@cc.okayama-u.ac.jp						APOSHIAN HV, 1960, BIOCHEM PHARMACOL, V3, P38; ASATOOR AM, 1964, NATURE, V203, P1382, DOI 10.1038/2031382b0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANDRA A, 1988, FEBS LETT, V236, P282, DOI 10.1016/0014-5793(88)80038-3; CHWALINSKASADOWSKA H, 1976, J CLIN INVEST, V58, P871, DOI 10.1172/JCI108540; Cleland W. W, 1970, ENZYMES, V2, P1; CUPERUS RA, 1983, BIOCHIM BIOPHYS ACTA, V749, P18, DOI 10.1016/0167-4838(83)90145-0; CUPERUS RA, 1987, BIOCHIM BIOPHYS ACTA, V912, P124, DOI 10.1016/0167-4838(87)90255-X; DUVIGNEAUD C, 1957, BIOCHIM BIOPHYS ACTA, V69, P130; Evered D. F., 1969, BIOCHEM J, V111, P15; GOLDBERG A, 1963, BRIT MED J, P1270, DOI 10.1136/bmj.1.5340.1270; GUIJARRO JI, 1995, J BIOL CHEM, V270, P23520, DOI 10.1074/jbc.270.40.23520; HEYL D, 1948, J AM CHEM SOC, V70, P3429, DOI 10.1021/ja01190a061; JENCKS WP, 1965, J AM CHEM SOC, V87, P3199, DOI 10.1021/ja01092a035; KATUNUMA N, 1958, ARCH BIOCHEM BIOPHYS, V76, P547, DOI 10.1016/0003-9861(58)90179-6; KOSHLAND DE, 1952, J AM CHEM SOC, V74, P2286, DOI 10.1021/ja01129a035; KUSHINSKAS EJ, 1957, ARCH BIOCH, V68, P69; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHMAN IR, 1974, SCIENCE, V186, P790; LELOIR LF, 1985, METHOD ENZYMOL, V115, P843; LIPSKY PE, 1984, J CLIN INVEST, V73, P53, DOI 10.1172/JCI111207; NAKADA HI, 1964, J BIOL CHEM, V239, P468; NUSSRALLAH BA, 1989, BIOCHEMISTRY-US, V28, P6245, DOI 10.1021/bi00441a016; PERRY TL, 1965, NATURE, V206, P895, DOI 10.1038/206895a0; ROSSOMANDO EF, 1987, DIFFERENTIATION, V35, P88, DOI 10.1111/j.1432-0436.1987.tb00154.x; SEGAL HL, 1970, METHODS ENZYMOLOGY A, V17, P153; Smith E.L., 1975, ENZYMES, P293, DOI DOI 10.1016/S1874-6047(08)60213-9; UEDA K, 1960, J BIOCHEM-TOKYO, V48, P584, DOI 10.1093/oxfordjournals.jbchem.a127206; WALSHE JM, 1956, AM J MED, V21, P487, DOI 10.1016/0002-9343(56)90066-3	29	1	1	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					795	800		10.1074/jbc.274.2.795	http://dx.doi.org/10.1074/jbc.274.2.795			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873018	hybrid			2022-12-27	WOS:000077968500033
J	Morris, AE; Remmele, RL; Klinke, R; Macduff, BM; Fanslow, WC; Armitage, RJ				Morris, AE; Remmele, RL; Klinke, R; Macduff, BM; Fanslow, WC; Armitage, RJ			Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL PROLIFERATION; LIGHT-SCATTERING; LEUCINE-ZIPPER; LIGAND; RECEPTOR; IDENTIFICATION; SUPERFAMILY; INVOLVEMENT; INHIBITION; MUTANTS	Recent progress in the understanding of immune function indicates that the interaction of CD40L with its receptor, CD40, plays a pivotal role in both humoral immunity and cell-mediated defense against pathogens. Functional studies of this interaction on both dendritic cells and malignant cells have demonstrated that CD40L also plays an important role in immune surveillance and anti-tumor immunity. CD40L exists in nature predominantly as a membrane-anchored molecule. To develop CD40L as a potential therapeutic, it is important to optimize soluble forms of this molecule that could be used in a clinical setting. Several reports have shown that soluble forms of CD40L, like CD40 antibodies, are biologically active. In the present report we demonstrate that the incorporation of an isoleucine zipper trimerization motif significantly enhances the biological activity of soluble CD40L.	Immunex Corp, Seattle, WA 98101 USA	Immunex Corporation	Morris, AE (corresponding author), Immunex Corp, 51 Univ St, Seattle, WA 98101 USA.							ARAKAWA T, 1992, ANAL BIOCHEM, V203, P53, DOI 10.1016/0003-2697(92)90042-6; ARMITAGE RJ, 1992, EUR J IMMUNOL, V22, P2071, DOI 10.1002/eji.1830220817; ARMITAGE RJ, 1994, CURR OPIN IMMUNOL, V6, P407, DOI 10.1016/0952-7915(94)90119-8; ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; BAJORATH J, 1995, BIOCHEMISTRY-US, V34, P1833, DOI 10.1021/bi00006a003; Fanslow W C, 1994, Semin Immunol, V6, P267, DOI 10.1006/smim.1994.1035; FANSLOW WC, 1997, LEUCOCYTE TYPING, V6, P101; FUNAKOSHI S, 1994, BLOOD, V83, P2787, DOI 10.1182/blood.V83.10.2787.2787; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Grewal IS, 1997, IMMUNOL RES, V16, P59, DOI 10.1007/BF02786323; GRUSS HJ, 1995, BLOOD, V85, P3378, DOI 10.1182/blood.V85.12.3378.bloodjournal85123378; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8; MAZZEI GJ, 1995, J BIOL CHEM, V270, P7025, DOI 10.1074/jbc.270.13.7025; MOORE S, 1958, ANAL CHEM, V30, P1185, DOI 10.1021/ac60139a005; Morris AE, 1997, ANIMAL CELL TECHNOLOGY, P529; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; PECCEU F, 1991, GENE, V97, P253, DOI 10.1016/0378-1119(91)90059-K; PEITSCH MC, 1993, INT IMMUNOL, V5, P233, DOI 10.1093/intimm/5.2.233; Seyama K, 1998, BLOOD, V92, P2421, DOI 10.1182/blood.V92.7.2421.2421_2421_2434; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; SUMIMOTO SI, 1994, J IMMUNOL, V153, P2488; URLAUB G, 1980, P NATL ACAD SCI-BIOL, V77, P4216, DOI 10.1073/pnas.77.7.4216; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; WEN J, 1996, TECHNIQUES PROTEIN C, V7, P23	28	88	105	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					418	423		10.1074/jbc.274.1.418	http://dx.doi.org/10.1074/jbc.274.1.418			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867859	hybrid			2022-12-27	WOS:000077900200059
J	Banky, P; Huang, LJS; Taylor, SS				Banky, P; Huang, LJS; Taylor, SS			Dimerization/docking domain of the type I alpha regulatory subunit of cAMP-dependent protein kinase - Requirements for dimerization and docking are distinct but overlapping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A ANCHORING PROTEIN; RI-ALPHA; CATALYTIC SUBUNIT; N-TERMINUS; BINDING; LOCALIZATION; MUTAGENESIS; CLONING; MUSCLE; CELLS	Based on increasing evidence that the type I R subunits as well as the type LT:R subunits localize to specific subcellular sites, we have carried out an extensive characterization of the stable dimerization domain at the N terminus of RI alpha. Deletion mutants as well as alanine scanning mutagenesis were used to delineate critical regions as well as particular amino acids that are required for homodimerization. A set of nested deletion mutants defined a minimum core required for dimerization, Two single site mutations on the C37H template, RI alpha(F47A) and RI alpha(F52A), were sufficient to abolish dimerization. In addition to serving as a dimerization motif, this domain also serves as a docking surface for binding to dual specificity anchoring proteins (D-AKAPs) (Huang, L. J., Durick, H., Weiner, J. A., Chun, J., and Taylor, S. S. (1997) J. Biol. Chem. 272, 8057-8064; Huang, L. J., Durick, K., Weiner, J. A, Chun, J., and Taylor, S. S. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 11184-11189). A similar strategy was used to map the sequence requirements for anchoring of RI alpha to D-AKAP1. Although dimerization appears to be essential for anchoring to D-AKAP1, anchoring can also be abolished by the following single site mutations: C37H, V20A, and I25A. These sites define "hot spots" for the anchoring surface since each of these dimeric proteins are deficient in binding to D-AKAP1. In contrast to earlier predictions, the alignment of the dimerization/docking domains of RI(U and RII show striking similarities yet subtle differences not only in their secondary structure (Newlon, M. G., Boy, M., Hausken, Z. E., Scott, J. D., and Jennings, P. A. (1997) J. Biol. Chem. 272, 23637-23644) but also in the distribution of residues important for both docking and dimerization functions.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biochem & Chem, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	staylor@ucsd.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034921, T32GM007240] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32GM07240-21A1, GM 34921] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEEBE SJ, 1986, ENZYMES, V17, P43; BUBIS J, 1987, J BIOL CHEM, V262, P14961; BUBIS J, 1987, PROTEIN STRUCTURE DE, P401; BUECHLER YJ, 1993, J BIOL CHEM, V268, P16495; BUECHLER YJ, 1991, J BIOL CHEM, V266, P3491; CARR DW, 1992, J BIOL CHEM, V267, P16816; CARR DW, 1992, J BIOL CHEM, V267, P13376; CARR DW, 1991, J BIOL CHEM, V266, P14188; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; CORBIN JD, 1975, ADV CYCLIC NUCLEOTID; DellAcqua ML, 1997, J BIOL CHEM, V272, P12881, DOI 10.1074/jbc.272.20.12881; Eide T, 1998, EXP CELL RES, V238, P305, DOI 10.1006/excr.1997.3855; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; HERBERG FW, 1994, BIOCHEMISTRY-US, V33, P7485, DOI 10.1021/bi00189a057; HOFMANN F, 1975, J BIOL CHEM, V250, P7795; HUANG LJH, 1997, THESIS U CALIFORNIA; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; ImaizumiScherrer T, 1996, J CELL BIOL, V134, P1241, DOI 10.1083/jcb.134.5.1241; KLANCK TM, 1996, SCIENCE, V271, P1589; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leon DA, 1997, J BIOL CHEM, V272, P28431, DOI 10.1074/jbc.272.45.28431; Lester LB, 1997, RECENT PROG HORM RES, V52, P409; Levy FO, 1996, EUR J IMMUNOL, V26, P1290, DOI 10.1002/eji.1830260617; LI Y, 1995, J BIOL CHEM, V270, P1935, DOI 10.1074/jbc.270.4.1935; Li Y, 1996, J BIOL CHEM, V271, P16862, DOI 10.1074/jbc.271.28.16862; LIN RY, 1995, J BIOL CHEM, V270, P27804, DOI 10.1074/jbc.270.46.27804; LUO ZJ, 1990, J BIOL CHEM, V265, P21804; MUTZEL R, 1987, P NATL ACAD SCI USA, V84, P6, DOI 10.1073/pnas.84.1.6; Newlon MG, 1997, J BIOL CHEM, V272, P23637, DOI 10.1074/jbc.272.38.23637; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; POTTER RL, 1979, J BIOL CHEM, V254, P2413; REIMANN EM, 1986, BIOCHEMISTRY-US, V25, P119, DOI 10.1021/bi00349a018; Rosen O M, 1975, Adv Cyclic Nucleotide Res, V5, P253; RUBIN CS, 1972, J BIOL CHEM, V247, P6135; RUBIN CS, 1994, BIOCHIM BIOPHYS ACTA, V1224, P407; SARASWAT LD, 1988, METHOD ENZYMOL, V159, P325; SCOTT JD, 1994, MOL ENDOCRINOL, V8, P5, DOI 10.1210/me.8.1.5; SCOTT JD, 1990, J BIOL CHEM, V265, P21561; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SKALHEGG BS, 1994, SCIENCE, V263, P84, DOI 10.1126/science.8272870; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Tortora G, 1997, ONCOGENE, V14, P923, DOI 10.1038/sj.onc.1200906; Walsh D.A., 2018, PEPT PROT PHOSPH, P43; WALSH DA, 1968, J BIOL CHEM, V243, P3763; WEBER W, 1979, BIOCHEM BIOPH RES CO, V90, P1073, DOI 10.1016/0006-291X(79)91935-1; WELDON SL, 1985, J BIOL CHEM, V260, P4203	52	61	105	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35048	35055		10.1074/jbc.273.52.35048	http://dx.doi.org/10.1074/jbc.273.52.35048			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857038	hybrid			2022-12-27	WOS:000077719700056
J	Raffioni, S; Zhu, YZ; Bradshaw, RA; Thompson, LM				Raffioni, S; Zhu, YZ; Bradshaw, RA; Thompson, LM			Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells - A model for the control of receptor tyrosine kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSPLASIA TYPE-II; THANATOPHORIC DYSPLASIA; CROUZON-SYNDROME; ACANTHOSIS NIGRICANS; RECURRENT MUTATION; ACHONDROPLASIA; FGFR3; DIFFERENTIATION; DWARFISM; PROTEIN	The effect of six point mutations causing various human skeletal dysplasias, occurring in the transmembrane (TM) and kinase domains (KD) of fibroblast growth factor receptor 3, were introduced into a chimera composed of the extracellular domain of human platelet-derived growth factor beta and the TM and intracellular domains of hFGFR3, Stable transfectants in rat PC12 cells showed distinct differences in the two classes of mutations. The cells containing TM mutants displayed normal expression and activation but higher responsiveness to lower doses of ligand, The KD mutants showed significantly altered expression patterns. Normal amounts of a lower M-r receptor (p130) reflecting incomplete glycosylation, but only greatly decreased amounts of the mature (p170) form, were observed. However, the latter material showed normal ligand-dependent activation. In contrast, the p130 form, which is regularly observed in the expression of both native and chimeric receptors, exhibits strong ligand-independent tyrosine phosphorylation, particularly with the K650E mutation. Expression of two of the KD mutants (K650M and K650E), under control of an inducible metallothionein promoter, indicated that this receptor was sufficiently autoactivated to produce at least partial differentiation and, in the case of the K650E mutation, to induce ligand-independent neurite outgrowth. A model is presented that suggests that the low IM, (p130) KD mutants can, under the right conditions, signal intracellularly, but when they are fully glycosylated and move to the cell surface they adopt a normal, inhibited conformation, in the form of ligand-independent dimers, that neutralizes the effects of the mutations. When ligands bind, these dimeric receptors are activated in a normal manner. This model suggests that unliganded dimers may be a common intermediate in receptor tyrosine kinase signaling.	Univ Calif Irvine, Dept Biol Chem, Coll Med, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Physiol & Biophys, Coll Med, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Anat & Neurobiol, Coll Med, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Thompson, LM (corresponding author), Univ Calif Irvine, Dept Biol Chem, Coll Med, D240 Med Sci 1, Irvine, CA 92697 USA.	lmthomps@uci.edu	Bradshaw, Ralph A/K-1515-2013		NIA NIH HHS [AG09735] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline; NINDS NIH HHS [NS25631] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009735] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; BONAVENTURE J, 1996, AM J MED GENET, V63, P145; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P505; Burke D, 1998, TRENDS BIOCHEM SCI, V23, P59, DOI 10.1016/S0968-0004(97)01170-5; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COLVIN JS, 1996, NAT GENET, V12, P290; Cook DM, 1996, ONCOGENE, V13, P1789; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; FOEHR ED, 1998, IN PRESS IMMUNOL CEL, V76; Galvin BD, 1996, P NATL ACAD SCI USA, V93, P7894, DOI 10.1073/pnas.93.15.7894; Green PJ, 1996, BIOESSAYS, V18, P639, DOI 10.1002/bies.950180807; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; JONES KL, 1997, SMITHS RECOGNIZABLE, P338; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; KUNAI M, 1997, J BIOL CHEM, V272, P13007; Legeai-Mallet L, 1998, J BIOL CHEM, V273, P13007, DOI 10.1074/jbc.273.21.13007; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Meyers GA, 1996, AM J HUM GENET, V58, P491; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Neilson KM, 1996, J BIOL CHEM, V271, P25049, DOI 10.1074/jbc.271.40.25049; Nguyen HB, 1997, HUM MOL GENET, V6, P681, DOI 10.1093/hmg/6.5.681; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Omura T, 1997, J BIOL CHEM, V272, P12676, DOI 10.1074/jbc.272.19.12676; Ong SH, 1996, BIOCHEM BIOPH RES CO, V225, P1021, DOI 10.1006/bbrc.1996.1288; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; RABIN SJ, 1993, MOL CELL BIOL, V13, P2203, DOI 10.1128/MCB.13.4.2203; RIMOIN DL, 1993, MCKUSICKS HERITABLE, P557; Rousseau F, 1996, HUM MOL GENET, V5, P509, DOI 10.1093/hmg/5.4.509; ROUSSEAU F, 1995, NAT GENET, V10, P11, DOI 10.1038/ng0595-11; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; SUPERTIFURGA A, 1995, EUR J PEDIATR, V154, P215, DOI 10.1007/BF01954274; Tanner KG, 1997, BIOCHEMISTRY-US, V36, P14889, DOI 10.1021/bi9706834; TAVORMINA PL, 1995, HUM MOL GENET, V4, P2175, DOI 10.1093/hmg/4.11.2175; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; TAVORMINA PL, 1998, IN PRESS AM J HUM GE; THOMPSON LM, 1991, GENOMICS, V11, P1133, DOI 10.1016/0888-7543(91)90041-C; Thompson LM, 1997, MOL CELL BIOL, V17, P4169, DOI 10.1128/MCB.17.7.4169; Wang JK, 1996, ONCOGENE, V13, P721; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; Webster MK, 1997, TRENDS GENET, V13, P178, DOI 10.1016/S0168-9525(97)01131-1; Webster MK, 1996, MOL CELL BIOL, V16, P4081; Wilcox WR, 1998, AM J MED GENET, V78, P274, DOI 10.1002/(SICI)1096-8628(19980707)78:3<274::AID-AJMG14>3.0.CO;2-C; Wilkes D, 1996, J MED GENET, V33, P744, DOI 10.1136/jmg.33.9.744	54	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35250	35259		10.1074/jbc.273.52.35250	http://dx.doi.org/10.1074/jbc.273.52.35250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857065	hybrid			2022-12-27	WOS:000077719700083
J	Chandran, UR; Warren, BS; Baumann, CT; Hager, GL; DeFranco, DB				Chandran, UR; Warren, BS; Baumann, CT; Hager, GL; DeFranco, DB			The glucocorticoid receptor is tethered to DNA-bound Oct-1 at the mouse gonadotropin-releasing hormone distal negative glucocorticoid response element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL HYPOTHALAMIC-AMENORRHEA; PROTEIN-PROTEIN-INTERACTION; NEURONAL CELL-LINES; POU-SPECIFIC DOMAIN; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MEDIATED REPRESSION; PROMOTER ACTIVITY; KINASE-C; LUTEINIZING-HORMONE	An element required for glucocorticoid repression of mouse gonadotropin-releasing hormone (GnRH) gene transcription, the distal negative glucocorticoid response element (nGRE), is not bound directly by glucocorticoid receptors (GRs) but is recognized by Oct-1 present in GT1-7 cell nuclear extracts or by Oct-1 purified from HeLa cells. Furthermore, purified full-length GRs interact directly with purified Oct-1 bound to the distal nGRE. Increasing the extent of distal nGRE: match to an Oct-1 consensus site not only increases the affinity of Oct-1 binding, but also alters the conformation of DNA-bound Oct-1 and the pattern of protein DNA complexes formed in vitro with GT1-7 cell nuclear extracts. In addition, the interaction of purified GR with DNA-bound Oct-1 is altered when Oct-1 is bound to the consensus Oct-1 site. Mutation of the distal nGRE to a consensus Oct-1 site is also associated with reduced glucocorticoid repression in transfected GT1-7 cells. Furthermore, repression of GnRN gene transcription by 12-O-tetradecanoylphorbol-13-acetate, which utilizes sequences that overlap with the nGRE, is reversed by this distal nGRE mutation leading to activation of GnRH: gene transcription. Thus, changes in the assembly of multi-protein complexes at the distal nGRE can influence the regulation of GnRN gene transcription.	Univ Pittsburgh, Dept Sci Biol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15260 USA; NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	DeFranco, DB (corresponding author), Univ Pittsburgh, Dept Sci Biol, Pittsburgh, PA 15260 USA.				NATIONAL CANCER INSTITUTE [Z01BC005450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047938] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK47938] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHIMA RS, 1992, NEUROENDOCRINOLOGY, V56, P845, DOI 10.1159/000126315; [Anonymous], 1982, MOL CLONING LAB MANU; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Belsham DD, 1996, EMBO J, V15, P538, DOI 10.1002/j.1460-2075.1996.tb00386.x; BERGA SL, 1989, J CLIN ENDOCR METAB, V68, P301, DOI 10.1210/jcem-68-2-301; BRANN DW, 1991, BIOL REPROD, V44, P1005, DOI 10.1095/biolreprod44.6.1005; Bruder JM, 1996, MOL ENDOCRINOL, V10, P35, DOI 10.1210/me.10.1.35; BRUDER JM, 1992, ENDOCRINOLOGY, V131, P2552, DOI 10.1210/en.131.6.2552; Chandran UR, 1996, J BIOL CHEM, V271, P20412, DOI 10.1074/jbc.271.34.20412; CHANDRAN UR, 1994, ENDOCRINOLOGY, V134, P1467, DOI 10.1210/en.134.3.1467; CHIANG CM, 1993, PEPTIDE RES, V6, P62; DELAESCALERA G, 1995, NEUROENDOCRINOLOGY, V61, P310, DOI 10.1159/000126853; DELAESCALERA GM, 1994, NEUROENDOCRINOLOGY, V59, P420, DOI 10.1159/000126687; DELAESCALERA GM, 1992, ENDOCRINOLOGY, V131, P1397; DELAESCALERA GM, 1992, ENDOCRINOLOGY, V131, P2965; Delhase M, 1996, J BIOL CHEM, V271, P32349, DOI 10.1074/jbc.271.50.32349; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DROUIN J, 1993, EMBO J, V12, P145, DOI 10.1002/j.1460-2075.1993.tb05640.x; DUBEY AK, 1985, BIOL REPROD, V33, P423, DOI 10.1095/biolreprod33.2.423; ERALY SA, 1995, MOL ENDOCRINOL, V9, P848, DOI 10.1210/me.9.7.848; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GONZALEZMANCHON C, 1991, NEUROENDOCRINOLOGY, V54, P373, DOI 10.1159/000125916; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; HOLLOWAY JM, 1995, GENE DEV, V9, P1992, DOI 10.1101/gad.9.16.1992; Huang CC, 1996, MOL CELL BIOL, V16, P2967; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KEPA JK, 1994, ENDOCRINE, V2, P947; KIM MH, 1995, J BIOL CHEM, V270, P27823, DOI 10.1074/jbc.270.46.27823; KRISTIE TM, 1990, GENE DEV, V4, P2382; Kusk P, 1996, J BIOL CHEM, V271, P31269, DOI 10.1074/jbc.271.49.31269; KUTOH E, 1992, MOL CELL BIOL, V12, P4960, DOI 10.1128/MCB.12.11.4960; LIU M, 1994, MOL ENDOCRINOL, V8, P1593, DOI 10.1210/me.8.12.1593; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Misra V, 1996, MOL CELL BIOL, V16, P4404; Mittal V, 1996, MOL CELL BIOL, V16, P1955; MORETTO M, 1993, ENDOCRINOLOGY, V133, P2399, DOI 10.1210/en.133.5.2399; MURPHY S, 1989, CELL, V59, P1071, DOI 10.1016/0092-8674(89)90763-0; Murphy S, 1997, NUCLEIC ACIDS RES, V25, P2068, DOI 10.1093/nar/25.11.2068; PADMANABHAN V, 1983, ENDOCRINOLOGY, V112, P1782, DOI 10.1210/endo-112-5-1782; REAME NE, 1985, J CLIN ENDOCR METAB, V61, P301; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; Scarlett CO, 1997, DNA CELL BIOL, V16, P45, DOI 10.1089/dna.1997.16.45; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Strom AC, 1996, NUCLEIC ACIDS RES, V24, P1981, DOI 10.1093/nar/24.11.1981; STURM R, 1987, GENE DEV, V1, P1147, DOI 10.1101/gad.1.10.1147; SUH BY, 1988, J CLIN ENDOCR METAB, V66, P733, DOI 10.1210/jcem-66-4-733; Truss M, 1995, CIBA F SYMP, V191, P7; Warren BS, 1996, J BIOL CHEM, V271, P11434, DOI 10.1074/jbc.271.19.11434; Wegner M, 1993, CURR OPIN CELL BIOL, V5, P488, DOI 10.1016/0955-0674(93)90015-I; WETSEL WC, 1993, ENDOCRINOLOGY, V132, P2360, DOI 10.1210/en.132.6.2360; Wood JR, 1998, MOL CELL BIOL, V18, P1927, DOI 10.1128/MCB.18.4.1927; Wu GD, 1997, J BIOL CHEM, V272, P2396; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YU KL, 1994, MOL CELL ENDOCRINOL, V102, P85, DOI 10.1016/0303-7207(94)90101-5	58	70	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2372	2378		10.1074/jbc.274.4.2372	http://dx.doi.org/10.1074/jbc.274.4.2372			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891005	hybrid			2022-12-27	WOS:000078185200072
J	Olefsky, JM				Olefsky, JM			Insulin-stimulated glucose transport minireview series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Univ Calif San Diego, Dept Med, Sch Med, La Jolla, CA 92093 USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, Sch Med, La Jolla, CA 92093 USA.								0	37	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1863	1863		10.1074/jbc.274.4.1863	http://dx.doi.org/10.1074/jbc.274.4.1863			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890934	hybrid			2022-12-27	WOS:000078185200001
J	Yamauchi, S; Hirahara, Y; Usui, H; Takeda, Y; Hoshino, M; Fukuta, M; Kimura, JH; Habuchi, O				Yamauchi, S; Hirahara, Y; Usui, H; Takeda, Y; Hoshino, M; Fukuta, M; Kimura, JH; Habuchi, O			Purification and characterization of chondroitin 4-sulfotransferase from the culture medium of a rat chondrosarcoma cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICK-EMBRYO CHONDROCYTES; HAMSTER OVARY CELLS; SULFATE PROTEOGLYCAN; NEURITE OUTGROWTH; MOLECULAR-CLONING; 6-SULFOTRANSFERASE; OLIGOSACCHARIDES; GLYCOSAMINOGLYCANS; EXPRESSION; CARTILAGE	Chondroitin I-sulfotransferase, which transfers sulfate from 3'-phosphoadenosine 5'-phosphosulfate to position 4 of N-acetylgalactosamine in chondroitin, was purified 1900-fold to apparent homogeneity with 6.1% yield from the serum-free culture medium of rat chondrosarcoma cells by affinity chromatography on heparin-Sephharose CL-GB, Matrex gel red A-agarose, 3',5'-ADP-agarose, and the second heparin-Sepharose CL-GB. SDS-polyacrylamide gel electrophoresis of the purified enzyme showed two protein bands. Molecular masses of these protein were 60 and 64 kDa under reducing conditions and 50 and 54 kDa under nonreducing conditions. Both the protein bands coeluted with chondroitin 4-sulfotransferase activity from Toyopearl HW-55 around the position of 50 kDa, indicating that the active form of chondroitin Li-sulfotransferase is a monomer. Dithiothreitol activated the purified chondroitin 4-sulfotransferase. The purified enzyme transferred sulfate to chondroitin and desulfated dermatan sulfate. Chondroitin sulfate A and chondroitin sulfate C were poor accepters. Chondroitin sulfate E from squid cartilage, dermatan sulfate, heparan sulfate, and completely desulfated N-resulfated heparin hardly served as accepters of the sulfotransferase. The transfer of sulfate to the desulfated dermatan sulfate occurred preferentially at position 4 of the N-acetylgalactosamine residues flanked with glucuronic acid residues on both reducing and nonreducing sides.	Aichi Univ Educ, Dept Life Sci, Aichi 4488542, Japan; Henry Ford Hosp, Ctr Bone & Joint, Detroit, MI 48202 USA	Aichi University Education; Henry Ford Health System; Henry Ford Hospital	Habuchi, O (corresponding author), Aichi Univ Educ, Dept Life Sci, Aichi 4488542, Japan.	ohabuchi@auecc.aichi-edu.ac.jp						ADANY R, 1990, J BIOL CHEM, V265, P11389; Albertini R, 1997, FEBS LETT, V403, P154, DOI 10.1016/S0014-5793(97)00043-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN AH, 1946, ARCH BIOCHEM, V11, P269; Chaiyaroj SC, 1996, AM J TROP MED HYG, V55, P76, DOI 10.4269/ajtmh.1996.55.76; DELFERT DM, 1985, ANAL BIOCHEM, V148, P303, DOI 10.1016/0003-2697(85)90233-7; DELFERT DM, 1985, J BIOL CHEM, V260, P4446; Dou CL, 1995, J NEUROSCI, V15, P8053; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; FELLINI SA, 1981, J BIOL CHEM, V256, P7883; FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669; FUKUTA M, 1995, J BIOL CHEM, V270, P18575, DOI 10.1074/jbc.270.31.18575; HABUCHI H, 1986, J BIOL CHEM, V261, P1031; Habuchi H, 1998, J BIOL CHEM, V273, P9208, DOI 10.1074/jbc.273.15.9208; HABUCHI H, 1995, J BIOL CHEM, V270, P4172, DOI 10.1074/jbc.270.8.4172; Habuchi O, 1996, GLYCOBIOLOGY, V6, P51, DOI 10.1093/glycob/6.1.51; HABUCHI O, 1980, BIOCHIM BIOPHYS ACTA, V616, P208, DOI 10.1016/0005-2744(80)90139-4; HABUCHI O, 1977, J BIOL CHEM, V252, P4570; HABUCHI O, 1993, J BIOL CHEM, V268, P21968; HABUCHI O, 1982, BIOCHIM BIOPHYS ACTA, V717, P414, DOI 10.1016/0304-4165(82)90282-3; Habuchi O, 1997, GLYCOBIOLOGY, V7, P405, DOI 10.1093/glycob/7.3.405; HABUCHI O, 1991, BIOCHIM BIOPHYS ACTA, V1133, P9; HOOPER LV, 1995, J BIOL CHEM, V270, P16327, DOI 10.1074/jbc.270.27.16327; KIMATA K, 1973, MOL CELL BIOCHEM, V1, P211, DOI 10.1007/BF01659331; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Kobayashi M, 1996, J BIOL CHEM, V271, P7645, DOI 10.1074/jbc.271.13.7645; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; MCQUILLAN DJ, 1989, J BIOL CHEM, V264, P13245; MIDURA RJ, 1995, J BIOL CHEM, V270, P8009, DOI 10.1074/jbc.270.14.8009; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; NAGASAWA K, 1979, J BIOCHEM-TOKYO, V86, P1323, DOI 10.1093/oxfordjournals.jbchem.a132648; OEGEMA TR, 1975, J BIOL CHEM, V250, P6151; OOHIRA A, 1991, J NEUROSCI, V11, P822; Pettway Z, 1996, EXP CELL RES, V225, P195, DOI 10.1006/excr.1996.0170; Rogerson SJ, 1997, PARASITOL TODAY, V13, P70, DOI 10.1016/S0169-4758(96)10081-8; Sartipy P, 1996, J BIOL CHEM, V271, P26307, DOI 10.1074/jbc.271.42.26307; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; SKELTON TP, 1991, J BIOL CHEM, V266, P17142; SUGIURA N, 1993, J BIOL CHEM, V268, P15779; Yamada H, 1997, J NEUROSCI, V17, P7784; YAMAGATA M, 1989, J BIOL CHEM, V264, P8012	42	44	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2456	2463		10.1074/jbc.274.4.2456	http://dx.doi.org/10.1074/jbc.274.4.2456			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891016	hybrid			2022-12-27	WOS:000078185200083
J	Emoto, N; Nurhantari, Y; Alimsardjono, H; Xie, J; Yamada, T; Yanagisawa, M; Matsuo, M				Emoto, N; Nurhantari, Y; Alimsardjono, H; Xie, J; Yamada, T; Yanagisawa, M; Matsuo, M			Constitutive lysosomal targeting and degradation of bovine endothelin-converting enzyme-1a mediated by novel signals in its alternatively spliced cytoplasmic tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIG ENDOTHELIN-1; P-SELECTIN; METALLOPROTEINASE INHIBITOR; RECEPTOR ANTAGONIST; BLOOD-PRESSURE; HEART-FAILURE; B RECEPTOR; MEMBRANE; CELLS; EXPRESSION	Endothelin-converting enzyme-1 (ECE-1) is a type II membrane protein that catalyzes the proteolytic activation of big endothelin-1 to endothelin-1 (ET-1), The subcellular distribution of ECE-1, and hence the exact site of physiological activation of big ET-1, remains controversial. Here, we demonstrate with several complementary methods that the two alternatively spliced bovine ECE-1 Isoforms, ECE-1a and ECE-1b, differing only in the first 30 amino acids of their N-terminal cytoplasmic tails, exhibit strikingly distinct intracellular sorting patterns. Bovine ECE-1a, which is responsible for the intracellular cleavage of big ET-1 in endothelial cells, is constitutively recruited into the lysosome, where it is rapidly degraded. In contrast, bovine ECE-1b, the isoform found in cultured smooth muscle cells, is transported to the plasma membrane by a default pathway and functions as an ectoenzyme, Mutational analyses reveal that the N-terminal tip of the cytoplasmic domain of bovine ECE-1a contains novel proline containing signals that mediate constitutive lysosomal targeting. Analyses of chimeric ECE-1/transferrin receptors demonstrate that the cytoplasmic tail of bovine ECE-1a is sufficient for the lysosomal delivery and rapid degradation. Our results suggest that the distinct intracellular targeting of bovine ECE-1 isoforms may provide new insights into functional aspect of the endothelin system and that the cell permeability of ECE inhibitor compounds should be carefully considered during their pharmacological development.	Kobe Univ, Sch Med, Int Ctr Med Res, Div Genet, Kobe, Hyogo 6500017, Japan; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA	Kobe University; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Emoto, N (corresponding author), Kobe Univ, Sch Med, Int Ctr Med Res, Div Genet, 7-5-1 Kusunoki, Kobe, Hyogo 6500017, Japan.			Xie, Jian/0000-0001-9454-1358; Emoto, Noriaki/0000-0001-6673-2616; Nurhantari, Yudha/0000-0003-1200-2014				ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; Barnes K, 1997, J NEUROCHEM, V68, P570; Barnes K, 1998, HYPERTENSION, V31, P3, DOI 10.1161/01.HYP.31.1.3; Barnes K, 1996, J CELL SCI, V109, P919; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Blagoveshchenskaya AD, 1998, J BIOL CHEM, V273, P2729, DOI 10.1074/jbc.273.5.2729; Casteels KM, 1998, ENDOCRINOLOGY, V139, P95, DOI 10.1210/en.139.1.95; Clouthier DE, 1998, DEVELOPMENT, V125, P813; CLOZEL M, 1993, NATURE, V365, P759, DOI 10.1038/365759a0; EMOTO N, 1995, J BIOL CHEM, V270, P15262, DOI 10.1074/jbc.270.25.15262; GREEN SA, 1994, J CELL BIOL, V124, P435, DOI 10.1083/jcb.124.4.435; GUI GJ, 1993, J CARDIOVASC PHARM, V22, pS53, DOI 10.1097/00005344-199322008-00016; HARRISON VJ, 1995, P NATL ACAD SCI USA, V92, P6344, DOI 10.1073/pnas.92.14.6344; HEMSEN A, 1995, REGUL PEPTIDES, V55, P287, DOI 10.1016/0167-0115(94)00119-I; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; IKEGAWA R, 1990, BIOCHEM BIOPH RES CO, V171, P669, DOI 10.1016/0006-291X(90)91198-2; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; KIOWSKI W, 1995, LANCET, V346, P732, DOI 10.1016/S0140-6736(95)91504-4; Krum H, 1998, NEW ENGL J MED, V338, P784, DOI 10.1056/NEJM199803193381202; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; Luoh SM, 1997, J MOL ENDOCRINOL, V18, P77, DOI 10.1677/jme.0.0180077; MATSUMURA Y, 1990, EUR J PHARMACOL, V185, P103, DOI 10.1016/0014-2999(90)90216-S; Minamino T, 1997, CIRCULATION, V95, P221, DOI 10.1161/01.CIR.95.1.221; PELHAM HRB, 1993, CELL, V75, P603, DOI 10.1016/0092-8674(93)90479-A; Sakai S, 1996, NATURE, V384, P353, DOI 10.1038/384353a0; SAKAMOTO A, 1993, J BIOL CHEM, V268, P8547; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SCHMIDT M, 1994, FEBS LETT, V356, P238, DOI 10.1016/0014-5793(94)01277-6; Schweizer A, 1997, BIOCHEM J, V328, P871, DOI 10.1042/bj3280871; SETIADI H, 1995, J BIOL CHEM, V270, P26818, DOI 10.1074/jbc.270.45.26818; SHIMADA K, 1994, J BIOL CHEM, V269, P18275; SHIMADA K, 1995, FEBS LETT, V371, P140, DOI 10.1016/0014-5793(95)00886-E; SUZUKI N, 1990, J IMMUNOL METHODS, V127, P165, DOI 10.1016/0022-1759(90)90065-4; TAKAHASHI M, 1995, BIOCHEM J, V311, P657, DOI 10.1042/bj3110657; Turner AJ, 1997, FASEB J, V11, P355, DOI 10.1096/fasebj.11.5.9141502; VALDENAIRE O, 1995, J BIOL CHEM, V270, P29794; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	39	41	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1509	1518		10.1074/jbc.274.3.1509	http://dx.doi.org/10.1074/jbc.274.3.1509			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880527	hybrid			2022-12-27	WOS:000079956900047
J	Hache, RJG; Tse, R; Reich, T; Savory, JGA; Lefebvre, YA				Hache, RJG; Tse, R; Reich, T; Savory, JGA; Lefebvre, YA			Nucleocytoplasmic trafficking of steroid-free glucocorticoid receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; HUMAN ANDROGEN RECEPTOR; NUCLEAR-LOCALIZATION SIGNALS; MOUSE LYMPHOMA-CELLS; SV40 T-ANTIGEN; PROGESTERONE-RECEPTOR; C-ABL; SACCHAROMYCES-CEREVISIAE; SUBNUCLEAR TRAFFICKING; CYTOPLASMIC RETENTION	Glucocorticoid receptor (GR) recycles between an inactive form complexed with heat shock proteins (hsps) and localized to the cytoplasm and a free Liganded form that regulates specific gene transcription in the nucleus. We report here that, contrary to previous assumptions, association of GR into hsp-containing complexes is not sufficient to prevent the shuttling or trafficking of the GR across the nuclear membrane. Following the withdrawal of treatment with cortisol or the hormone antagonist RU486, GRs recycled rapidly into hsp associated, hormone-responsive complexes. However, cortisol-withdrawn receptors redistributed to the cytoplasm very slowly (t(1/2) = 8-9 h) and RU486-withdrawn receptors not at all. Persistent localization of these GRs to the nucleus was not due to a gross defect in export, since in both instances the complexed nuclear GRs transferred efficiently between heterokaryon nuclei. Moreover, the addition of a nuclear retention signal to the N terminus of GR induced the transfer of naive receptor to the nucleus in the absence of steroid. These results suggest that the localization of GR to the cytoplasm is determined by fine control of the rates of transfer of GR across the nuclear membrane and/or by active retention that occurs independently from the association of GR with hsps.	Univ Ottawa, Ottawa Hosp, Loeb Hlth Res Inst, Dept Med, Ottawa, ON K1Y 4E9, Canada; Univ Ottawa, Ottawa Hosp, Loeb Hlth Res Inst, Dept Biochem Microbiol & Immunol, Ottawa, ON K1Y 4E9, Canada; Univ Ottawa, Ottawa Hosp, Loeb Hlth Res Inst, Grad Program Biochem, Ottawa, ON K1Y 4E9, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Lefebvre, YA (corresponding author), Univ Ottawa, Ottawa Hosp, Loeb Hlth Res Inst, Dept Med, 725 Parkdale Ave, Ottawa, ON K1Y 4E9, Canada.	lefebvre@civich.ottawa.on.ca						BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; CADEPOND F, 1992, EXP CELL RES, V201, P99, DOI 10.1016/0014-4827(92)90352-9; CADEPOND F, 1991, J BIOL CHEM, V266, P5834; CATELLI MG, 1985, EMBO J, V4, P3131, DOI 10.1002/j.1460-2075.1985.tb04055.x; CATO ACB, 1988, J CELL BIOL, V106, P2119, DOI 10.1083/jcb.106.6.2119; CZAR MJ, 1995, MOL ENDOCRINOL, V9, P1549, DOI 10.1210/me.9.11.1549; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; DAUVOIS S, 1993, J CELL SCI, V106, P1377; DIKSTEIN R, 1992, CELL, V69, P751, DOI 10.1016/0092-8674(92)90287-M; Dingwall C, 1996, NATURE, V384, P210, DOI 10.1038/384210a0; DISTELHORST CW, 1987, J STEROID BIOCHEM, V26, P59, DOI 10.1016/0022-4731(87)90031-8; DISTELHORST CW, 1990, J STEROID BIOCHEM, V36, P25, DOI 10.1016/0022-4731(90)90110-E; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; GUIOCHONMANTEL A, 1992, ANN BIOL CLIN-PARIS, V50, P387; GUIOCHONMANTEL A, 1991, EMBO J, V10, P3851, DOI 10.1002/j.1460-2075.1991.tb04954.x; HOECK W, 1989, J BIOL CHEM, V264, P14396; HSU SC, 1995, J BIOL CHEM, V270, P3359, DOI 10.1074/jbc.270.7.3359; Hu JM, 1997, MOL ENDOCRINOL, V11, P305, DOI 10.1210/me.11.3.305; HU LM, 1994, J BIOL CHEM, V269, P6571; HUTCHISON KA, 1993, ANN NY ACAD SCI, V684, P35, DOI 10.1111/j.1749-6632.1993.tb32269.x; HUTCHISON KA, 1992, J BIOL CHEM, V267, P14047; JACKSON P, 1993, EMBO J, V12, P2809, DOI 10.1002/j.1460-2075.1993.tb05942.x; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; JENSTER G, 1993, BIOCHEM J, V293, P761, DOI 10.1042/bj2930761; JEWELL CM, 1995, J STEROID BIOCHEM, V55, P135, DOI 10.1016/0960-0760(95)00174-X; Krstic MD, 1997, MOL CELL BIOL, V17, P3947, DOI 10.1128/MCB.17.7.3947; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; LI XX, 1994, J CELL BIOL, V124, P7, DOI 10.1083/jcb.124.1.7; LITWACK G, 1978, BIOCHEM J, V169, P445, DOI 10.1042/bj1690445; MADAN AP, 1993, P NATL ACAD SCI USA, V90, P3588, DOI 10.1073/pnas.90.8.3588; MARTINS VR, 1991, MOL ENDOCRINOL, V5, P217, DOI 10.1210/mend-5-2-217; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; MUNCK A, 1984, J BIOL CHEM, V259, P820; ORTI E, 1989, J BIOL CHEM, V264, P9728; ORTI E, 1993, J BIOL CHEM, V268, P7779; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prefontaine GG, 1998, MOL CELL BIOL, V18, P3416, DOI 10.1128/MCB.18.6.3416; PRESS MF, 1988, ENDOCRINOLOGY, V122, P1165, DOI 10.1210/endo-122-3-1165; PUCA GA, 1986, ANN NY ACAD SCI, V464, P168, DOI 10.1111/j.1749-6632.1986.tb16003.x; QI M, 1990, MOL ENDOCRINOL, V4, P455, DOI 10.1210/mend-4-3-455; QI M, 1989, MOL ENDOCRINOL, V3, P1279, DOI 10.1210/mend-3-8-1279; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; RODATSKY I, 1998, P NATL ACAD SCI USA, V95, P2050; Sackey FNA, 1996, MOL ENDOCRINOL, V10, P1191, DOI 10.1210/me.10.10.1191; SANCHEZ ER, 1990, J BIOL CHEM, V265, P20123; SCHERRER LC, 1990, J BIOL CHEM, V265, P21397; SIDOROVA J, 1993, MOL CELL BIOL, V13, P1069, DOI 10.1128/MCB.13.2.1069; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; Tang YT, 1996, MOL CELL BIOL, V16, P1989; Tang YT, 1997, MOL BIOL CELL, V8, P795, DOI 10.1091/mbc.8.5.795; THOIE HH, 1994, J STEROID BIOCHEM, V48, P463; TRAISH AM, 1984, ENDOCRINOLOGY, V114, P1761, DOI 10.1210/endo-114-5-1761; URDA LA, 1989, MOL ENDOCRINOL, V3, P251, DOI 10.1210/mend-3-2-251; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; VANSTEENSEL B, 1995, J CELL SCI, V108, P3003; VANSTEENSEL B, 1995, J CELL BIOCHEM, V57, P465, DOI 10.1002/jcb.240570312; Webster JC, 1997, J BIOL CHEM, V272, P9287; WEIL PA, 1979, CELL, V18, P469; Yang J, 1997, J CELL BIOL, V137, P523, DOI 10.1083/jcb.137.3.523; YLIKOMI T, 1992, EMBO J, V11, P3681, DOI 10.1002/j.1460-2075.1992.tb05453.x	69	97	100	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1432	1439		10.1074/jbc.274.3.1432	http://dx.doi.org/10.1074/jbc.274.3.1432			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880517	hybrid			2022-12-27	WOS:000079956900037
J	Hwang, SR; Steineckert, B; Kohn, A; Palkovits, M; Hook, VYH				Hwang, SR; Steineckert, B; Kohn, A; Palkovits, M; Hook, VYH			Molecular studies define the primary structure of alpha(1)-antichymotrypsin (ACT) protease inhibitor in Alzheimer's disease brains - Comparison of ACT in hippocampus and liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING ENZYME; BOVINE ADRENAL-MEDULLA; HUMAN ALPHA-1-ANTICHYMOTRYPSIN; AMYLOID DEPOSITS; CLONING; PURIFICATION; ISOFORMS; ALPHA-1-ANTITRYPSIN; SERPINS; PEPTIDE	An alpha(1)-antichymotrypsin-like serpin has been implicated in Alzheimer's disease (AD) based on immunochemical detection of alpha(1)-antichymotrypsin (ACT) in amyloid plaques from the hippocampus of AD brains. The presence of neuroendocrine isoforms of ACTs and reported variations in human liver ACT cDNA sequences raise the question of the molecular identity of ACT in brain. In this study, direct reverse transcription-polymerase chain reaction and cDNA sequencing indicate that the hippocampus ACT possesses the reactive site loop that is characteristic of serpins, with Leu as the predicted P1 residue interacting with putative chymotrypsin-like target proteases, The deduced primary sequence of the human hippocampus ACT possesses more than 90% homology with reported primary sequences br the human liver ACT. Moreover, identical ACT primary sequences deduced from the cDNAs were demonstrated in the hippocampus of control and AD brains. Northern blots showed that ACT mRNA expression in hippocampus was 900 times lower than that in liver. Also, hippocampus and liver ACT proteins demonstrated differential sensitivities to deglycosylation. Overall, reverse transcription polymerase chain reaction combined with cDNA and primary sequence analyses have defined the molecular identity of human hippocampus ACT in control and AD brains. The determined reactive site loop domain of hippocampus ACT will allow prediction of potential target proteases inhibited by ACT in AD.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA; Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20892 USA; Semmelweis Univ Med, Dept Anat 1, H-1085 Budapest, Hungary	University of California System; University of California San Diego; University of California System; University of California San Diego; Uniformed Services University of the Health Sciences - USA; Semmelweis University	Hook, VYH (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr 0822, La Jolla, CA 92093 USA.		Palkovits, Miklos/F-2707-2013	Palkovits, Miklos/0000-0003-0578-0387				ABRAHAM CR, 1990, NEUROBIOL AGING, V11, P123, DOI 10.1016/0197-4580(90)90045-2; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; AKAABOUNE M, 1994, J NEUROBIOL, V25, P503, DOI 10.1002/neu.480250505; AZARYAN AV, 1995, J BIOL CHEM, V270, P8201, DOI 10.1074/jbc.270.14.8201; BAO JJ, 1987, BIOCHEMISTRY-US, V26, P7755, DOI 10.1021/bi00398a033; BAUMANN U, 1991, J MOL BIOL, V218, P595, DOI 10.1016/0022-2836(91)90704-A; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; CHANDRA T, 1983, BIOCHEMISTRY-US, V22, P5055, DOI 10.1021/bi00291a001; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; HILL RE, 1984, NATURE, V311, P175, DOI 10.1038/311175a0; HOOK VYH, 1993, J BIOL CHEM, V268, P20570; HOOK VYH, 1985, P NATL ACAD SCI USA, V82, P4745, DOI 10.1073/pnas.82.14.4745; HWANG SR, 1994, P NATL ACAD SCI USA, V91, P9579, DOI 10.1073/pnas.91.20.9579; HWANG SR, 1995, FEBS LETT, V368, P471, DOI 10.1016/0014-5793(95)00709-I; KIDD VJ, 1986, PROTEINASE INHIBITOR, P421; LINDMARK B, 1989, BIOCHIM BIOPHYS ACTA, V997, P90, DOI 10.1016/0167-4838(89)90139-8; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; RUBIN H, 1990, J BIOL CHEM, V265, P1199; SCHILLER MR, 1995, BIOCHEMISTRY-US, V34, P7988, DOI 10.1021/bi00025a004; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1997, BRIT MED BULL, V53, P478; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; TSUDA M, 1992, HUM GENET, V90, P467; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	26	23	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1821	1827		10.1074/jbc.274.3.1821	http://dx.doi.org/10.1074/jbc.274.3.1821			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880565	hybrid			2022-12-27	WOS:000079956900085
J	Mouratou, B; Kasper, P; Gehring, H; Christen, P				Mouratou, B; Kasper, P; Gehring, H; Christen, P			Conversion of tyrosine phenol-lyase to dicarboxylic amino acid beta-lyase, an enzyme not found in nature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; COLI ASPARTATE-AMINOTRANSFERASE; SUBSTRATE-SPECIFICITY; CITROBACTER-FREUNDII; PYRIDOXAL-5'-PHOSPHATE-DEPENDENT ENZYME; EVOLUTIONARY RELATIONSHIPS; SUBTILISIN BPN'; MECHANISM; RACEMIZATION; DEHYDROGENASE	Tyrosine phenol-lyase (TPL), which catalyzes the beta-elimination reaction of L-tyrosine, and aspartate aminotransferase (AspAT), which catalyzes the reversible transfer of an amino group from dicarboxylic amino acids to oxo acids, both belong to the alpha-family of vitamin B-6-dependent enzymes. To switch the substrate specificity of TPL from L-tyrosine to dicarboxylic amino acids, two amino acid residues of AspAT, thought to be important for the recognition of dicarboxylic substrates, were grafted into the active site of TPL. Homology modeling and molecular dynamics identified Val-283 in TPL to match Arg-292 in AspAT, which binds the distal carboxylate group of substrates and is conserved among all known AspATs. Arg-100 in TPL was found to correspond to Thr-109 in AspAT, which interacts with the phosphate group of the coenzyme. The double mutation R100T/V283R of TPL increased the beta-elimination activity to ward dicarboxylic amino acids at least 10(4)-fold. Dicarboxylic amino acids (L-aspartate, L-glutamate, and L-2-aminoadipate) were degraded to pyruvate, ammonia, and the respective monocarboxylic acids, e.g. formate in the case of L-aspartate. The activity toward L-aspartate (k(cat) = 0.21 s(-1)) was two times higher than that toward L-tyrosine. beta-Elimination and transamination as a minor side reaction (k(cat) = 0.001 s(-1)) were the only reactions observed. Thus, TPL R100T/V283R accepts dicarboxylic amino acids as substrates without significant change in its reaction specificity dicarboxylic amino acid beta-lyase is an enzyme not found in nature.	ETH Zurich, Inst Biochem, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Christen, P (corresponding author), ETH Zurich, Inst Biochem, Winterthurerstr 190, CH-8092 Zurich, Switzerland.							ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; ANTSON AA, 1993, BIOCHEMISTRY-US, V32, P4195, DOI 10.1021/bi00067a006; ANTSON AA, 1992, FEBS LETT, V302, P256, DOI 10.1016/0014-5793(92)80454-O; BALLINGER MD, 1995, BIOCHEMISTRY-US, V34, P13312, DOI 10.1021/bi00041a006; Ballinger MD, 1996, BIOCHEMISTRY-US, V35, P13579, DOI 10.1021/bi961543h; BONE R, 1989, NATURE, V339, P191, DOI 10.1038/339191a0; CHEN HY, 1995, BIOCHEMISTRY-US, V34, P12276, DOI 10.1021/bi00038a023; CHEN HY, 1995, EUR J BIOCHEM, V229, P540, DOI 10.1111/j.1432-1033.1995.tb20496.x; CHEN HY, 1993, BIOCHEMISTRY-US, V32, P11591, DOI 10.1021/bi00094a016; CRONIN CN, 1988, BIOCHEMISTRY-US, V27, P4572, DOI 10.1021/bi00412a052; DEMIDKINA TV, 1987, EUR J BIOCHEM, V170, P311, DOI 10.1111/j.1432-1033.1987.tb13701.x; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; FALEEV NG, 1988, EUR J BIOCHEM, V177, P395, DOI 10.1111/j.1432-1033.1988.tb14388.x; GRABER R, 1995, EUR J BIOCHEM, V232, P686, DOI 10.1111/j.1432-1033.1995.tb20861.x; GREEN DW, 1993, J BIOL CHEM, V268, P7792; HANSEN SA, 1976, J CHROMATOGR, V124, P123, DOI 10.1016/S0021-9673(00)87851-6; HAYASHI H, 1989, BIOCHEM BIOPH RES CO, V159, P337, DOI 10.1016/0006-291X(89)92443-1; Hayashi H, 1996, BIOCHEMISTRY-US, V35, P6754, DOI 10.1021/bi960390v; HENDERSON GB, 1991, P NATL ACAD SCI USA, V88, P8769, DOI 10.1073/pnas.88.19.8769; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; HUBER B, 1996, EVOLUTIONARY RELATIO; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; JOHN RA, 1995, BBA-PROTEIN STRUCT M, V1248, P81, DOI 10.1016/0167-4838(95)00025-P; KAZAKOV V K, 1987, Biokhimiya, V52, P1319; KHOURI HE, 1991, BIOCHEMISTRY-US, V30, P8929, DOI 10.1021/bi00101a003; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; KOCHHAR S, 1992, EUR J BIOCHEM, V203, P563, DOI 10.1111/j.1432-1033.1992.tb16584.x; KOCHHAR S, 1988, EUR J BIOCHEM, V175, P433, DOI 10.1111/j.1432-1033.1988.tb14213.x; KUMAGAI H, 1969, BIOCHEM BIOPH RES CO, V34, P266, DOI 10.1016/0006-291X(69)90826-2; KUMAGAI H, 1970, BIOCHEM BIOPH RES CO, V39, P796, DOI 10.1016/0006-291X(70)90393-1; KUMAGAI H, 1970, J BIOL CHEM, V245, P1767; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; MALASHKEVICH VN, 1995, NAT STRUCT BIOL, V2, P548, DOI 10.1038/nsb0795-548; MEHTA PK, 1989, EUR J BIOCHEM, V186, P249, DOI 10.1111/j.1432-1033.1989.tb15202.x; Morino Y, 1970, METHODS ENZYMOLOGY A, V17, P439; NOVOGRODSKY A, 1963, J BIOL CHEM, V238, P1903; ONUFFER JJ, 1995, PROTEIN SCI, V4, P1750, DOI 10.1002/pro.5560040910; PETERSON EA, 1954, J AM CHEM SOC, V76, P169, DOI 10.1021/ja01630a045; PHILLIPS RS, 1987, ARCH BIOCHEM BIOPHYS, V256, P302, DOI 10.1016/0003-9861(87)90450-4; ROBERTS E, 1951, J BIOL CHEM, V190, P505; SEVILLE M, 1988, BIOCHEMISTRY-US, V27, P8344, DOI 10.1021/bi00422a009; Sundararaju B, 1997, BIOCHEMISTRY-US, V36, P6502, DOI 10.1021/bi962917+; UENO T, 1970, BIOCHIM BIOPHYS ACTA, V206, P476, DOI 10.1016/0005-2744(70)90163-4; Vacca RA, 1997, J BIOL CHEM, V272, P21932, DOI 10.1074/jbc.272.35.21932; WILKS HM, 1988, SCIENCE, V242, P1541, DOI 10.1126/science.3201242; Yano T, 1998, P NATL ACAD SCI USA, V95, P5511, DOI 10.1073/pnas.95.10.5511	47	19	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1320	1325		10.1074/jbc.274.3.1320	http://dx.doi.org/10.1074/jbc.274.3.1320			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880502	hybrid, Green Accepted			2022-12-27	WOS:000079956900022
J	Vito, P; Pellegrini, L; Guiet, C; D'Adamio, L				Vito, P; Pellegrini, L; Guiet, C; D'Adamio, L			Cloning of AIP1, a novel protein that associates with the apoptosis-linked gene ALG-2 in a Ca2+-dependent reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; PROGRAMMED CELL-DEATH; IL-1-BETA-CONVERTING ENZYME; SIGNAL-TRANSDUCTION; T-CELLS; ACTIVATION; CED-3; STIMULATION; CALCINEURIN; THYMOCYTES	ALG-2 is a 22-kDa calcium-binding protein necessary for cell death induced by different stimuli in 3DO T-cell hybridoma 3DO cell clones depleted of ALG-2 protein exhibit normal caspases activation, suggesting that ALG-2 function is required downstream or is independent of caspase proteases activity for apoptosis to occur. Using the yeast two-hybrid screening system, we have isolated and characterized the mouse cDNA encoding for ALG-2 interacting protein 1 (AIP1), a novel protein that interacts with ALG-2. ALG-2 and AIP1 colocalize in the cytosol and the presence of calcium is an indispensable requisite for their association. Sequence align ment shows that AIP1 is highly similar to BRO1, a yeast protein related to components of the Pkc1p-MAP kinase cascade. Overexpression of a truncated form of AIP1 protects two different cell types from death induced by trophic factors withdrawal; thus, our data indicate that AIP1 cooperates with ALG-1 in executing the calcium-dependent requirements along the cell death pathway.	Basel Inst Immunol, CH-4005 Basel, Switzerland		Vito, P (corresponding author), NIAID, Cellular & Mol Immunol Lab, Tcell Mol Biol Unit, NIH, Bethesda, MD 20892 USA.	vito@mail.bii.ch	vito, pasquale/ABF-5505-2020	vito, pasquale/0000-0002-5721-7716; D'Adamio, Luciano/0000-0002-2204-9441; Pellegrini, Luca/0000-0002-4235-7708; D'Adamio, Luciano/0000-0002-9820-4882				ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; BERGERON L, 1996, GENE DEV, V12, P1304; Che SL, 1997, BBA-GENE STRUCT EXPR, V1354, P231, DOI 10.1016/S0167-4781(97)00112-7; Chinnaiyan A M, 1997, Semin Immunol, V9, P69, DOI 10.1006/smim.1996.0055; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; COHEN JJ, 1984, J IMMUNOL, V132, P38; D'Adamio L, 1997, Semin Immunol, V9, P17, DOI 10.1006/smim.1996.0057; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; Khan AA, 1996, SCIENCE, V273, P503, DOI 10.1126/science.273.5274.503; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; Lacana E, 1997, J IMMUNOL, V158, P5129; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; MCCONKEY DJ, 1989, J IMMUNOL, V143, P1801; Miossec C, 1997, J BIOL CHEM, V272, P13459, DOI 10.1074/jbc.272.21.13459; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; NAKAYAMA T, 1992, SCIENCE, V257, P96, DOI 10.1126/science.1621102; NegreteUrtasun S, 1997, J BACTERIOL, V179, P1832, DOI 10.1128/jb.179.5.1832-1835.1997; Nickas ME, 1996, MOL CELL BIOL, V16, P2585; OSHIMI Y, 1995, J IMMUNOL, V154, P599; PEITSCH MC, 1993, EMBO J, V12, P371, DOI 10.1002/j.1460-2075.1993.tb05666.x; SHIBASAKI F, 1995, J CELL BIOL, V131, P735, DOI 10.1083/jcb.131.3.735; Shibasaki F, 1997, NATURE, V386, P728, DOI 10.1038/386728a0; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Wilhelm S, 1998, EUR J IMMUNOL, V28, P891, DOI 10.1002/(SICI)1521-4141(199803)28:03<891::AID-IMMU891>3.3.CO;2-O; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112	31	199	203	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1533	1540		10.1074/jbc.274.3.1533	http://dx.doi.org/10.1074/jbc.274.3.1533			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880530	hybrid			2022-12-27	WOS:000079956900050
J	Friedrich, T; Breiderhoff, T; Jentsch, TJ				Friedrich, T; Breiderhoff, T; Jentsch, TJ			Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE CHLORIDE CHANNEL; FUNCTIONAL EXPRESSION; VOLTAGE-DEPENDENCE; XENOPUS OOCYTES; HUMAN MYOTONIA; CL CHANNEL; PROTEIN; DOMINANT; GENE; CLONING	ClC-4 and ClC-5, together with ClC-3, form a distinct branch of the CLC chloride channel family. Although ClC-5 was shown to be mainly expressed in endocytotic vesicles, expression of ClC-5 in Xenopus oocytes elicited chloride currents. We now show that ClC-4 also gives rise to strongly outwardly rectifying anion currents when expressed in oocytes. They closely resemble ClC-5 currents with which they share a NO3- > Cl- > Br- > I- conductance sequence that differs from that reported for the highly homologous ClC-3. Both ClC-4 and ClC-5 currents are reduced by lowering extracellular pH We could measure similar currents after expressing either channel in HEK293 cells. To demonstrate that these currents are directly mediated by the channel proteins, we introduced several point mutations that change channel characteristics. In ClC-5, several point mutations alter the kinetics of activation but leave macroscopic rectification and ion selectivity unchanged. A mutation (N565K) equivalent to a mutation reported to have profound effects on ClC-3 does not have similar effects on ClC-5. Moreover, a mutation at the end of D2 (S168T in ClC-5) changes ion selectivity, and a mutation at the end of D3 (E211A in ClC-5 and E224A in ClC-4) changes voltage dependence and ion selectivity. This shows that ClC-4 and ClC-5 can directly mediate plasma membrane currents.	Univ Hamburg, ZMNH, D-20246 Hamburg, Germany	University of Hamburg	Jentsch, TJ (corresponding author), Univ Hamburg, ZMNH, Martinistr 52, D-20246 Hamburg, Germany.	jentsch@plexus.uke.uni-hamburg.de	Breiderhoff, Tilman/X-9364-2019; Friedrich, Thomas/AAA-3418-2022	Breiderhoff, Tilman/0000-0002-1676-7498; Jentsch, Thomas/0000-0002-3509-2553				BORSANI G, 1995, GENOMICS, V27, P131, DOI 10.1006/geno.1995.1015; Buyse G, 1997, J BIOL CHEM, V272, P3615, DOI 10.1074/jbc.272.6.3615; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Fahlke C, 1997, P NATL ACAD SCI USA, V94, P2729, DOI 10.1073/pnas.94.6.2729; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Furukawa T, 1998, AM J PHYSIOL-CELL PH, V274, pC500, DOI 10.1152/ajpcell.1998.274.2.C500; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hille B., 1992, IONIC CHANNELS EXCIT; IGARASHI T, 1998, IN PRESS KIDNEY INT, V54; JENTSCH TJ, 1995, J PHYSIOL-LONDON, V482P, pS19; Jentsch TJ, 1997, BIOESSAYS, V19, P117, DOI 10.1002/bies.950190206; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Jordt SE, 1997, EMBO J, V16, P1582, DOI 10.1093/emboj/16.7.1582; KAWASAKI M, 1995, NEURON, V14, P1285, DOI 10.1016/0896-6273(95)90275-9; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Lindenthal S, 1997, AM J PHYSIOL-CELL PH, V273, pC1176, DOI 10.1152/ajpcell.1997.273.4.C1176; Lloyd SE, 1997, J CLIN INVEST, V99, P967, DOI 10.1172/JCI119262; Lloyd SE, 1997, HUM MOL GENET, V6, P1233, DOI 10.1093/hmg/6.8.1233; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1997, J PHYSIOL-LONDON, V498, P691, DOI 10.1113/jphysiol.1997.sp021893; Ludewig U, 1997, J GEN PHYSIOL, V110, P165, DOI 10.1085/jgp.110.2.165; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; MORAN O, 1992, FEBS LETT, V302, P21, DOI 10.1016/0014-5793(92)80275-L; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rychkov GY, 1996, J PHYSIOL-LONDON, V497, P423, DOI 10.1113/jphysiol.1996.sp021778; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Sakamoto H, 1996, J BIOL CHEM, V271, P10210, DOI 10.1074/jbc.271.17.10210; Scheinman SJ, 1998, KIDNEY INT, V53, P3, DOI 10.1046/j.1523-1755.1998.00718.x; SchmidtRose T, 1997, P NATL ACAD SCI USA, V94, P7633, DOI 10.1073/pnas.94.14.7633; Schmieder S, 1998, J PHYSIOL-LONDON, V511, P379, DOI 10.1111/j.1469-7793.1998.379bh.x; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; STEINMEYER K, 1994, EMBO J, V13, P737, DOI 10.1002/j.1460-2075.1994.tb06315.x; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; VANSLEGTENHORST MA, 1994, HUM MOL GENET, V3, P547	46	204	209	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					896	902		10.1074/jbc.274.2.896	http://dx.doi.org/10.1074/jbc.274.2.896			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873029	hybrid			2022-12-27	WOS:000077968500044
J	Lee, TC; Ziff, EB				Lee, TC; Ziff, EB			Mxi1 is a repressor of the c-myc promoter and reverses activation by USF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR USF; ORNITHINE DECARBOXYLASE EXPRESSION; MAX-ASSOCIATED PROTEINS; RNA-POLYMERASE-II; CELL-PROLIFERATION; GROWTH ARREST; NEGATIVE AUTOREGULATION; EPIDERMAL DIFFERENTIATION; RAS COTRANSFORMATION; HISTONE DEACETYLASE	The basic region/helix-loop-helix/leucine zipper (B-HLH-LZ) oncoprotein c-Myc is abundant in proliferating cells and forms heterodimers with Max protein that bind to E-box sites in DNA and stimulate genes required for proliferation. A second B-HLH-LZ protein, Mxi1, is induced during terminal differentiation, and forms heterodimers with Max that also bind E-boxes but tether the mSin3 transcriptional repressor protein along with histone deacetylase thereby antagonizing Myc-dependent activation, We show that Mxi1 also antagonizes Myc by a second pathway, repression of transcription from the major c-myc promoter, P2. Repression was independent of Mxi1 binding to mSin3 but dependent on the Mxi1 LZ and COOH-terminal sequences, including putative casein kinase II phosphorylation sites. Repression targeted elements of the myc P2 promoter core (-35/ +10), where it reversed transactivation by the constitutive transcription factor, USF, We show that Zn2+ induction of a stably transfected, metallothionein promoter-regulated mxi1 gene blocked the ability of serum to induce transcription of the endogenous c-myc gene and cell entry into S phase. Thus, induction of Mxi1 in terminally differentiating cells may block Myc function by repressing the c-myc gene P2 promoter, as well as by antagonizing Myc-dependent transactivation through E-boxes.	NYU, Med Ctr, Howard Hughes Med Inst, Dept Biochem, New York, NY 10016 USA; NYU, Med Ctr, Kaplan Canc Ctr, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University	Lee, TC (corresponding author), NYU, Med Ctr, Howard Hughes Med Inst, Dept Biochem, 550 1st Ave, New York, NY 10016 USA.			Ziff, Edward/0000-0001-7389-8649	NCI NIH HHS [CA-01713] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K12CA001713] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; Ayer DE, 1996, MOL CELL BIOL, V16, P5772; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; AYER DE, 1993, GENE DEV, V7, P2110, DOI 10.1101/gad.7.11.2110; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x; BLACKWOOD EM, 1991, COLD SPRING HARB SYM, V56, P109; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; CERNI C, 1995, ONCOGENE, V11, P587; CHEN J, 1995, NAT MED, V1, P638, DOI 10.1038/nm0795-638; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; DU H, 1993, EMBO J, V12, P501, DOI 10.1002/j.1460-2075.1993.tb05682.x; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Facchini LM, 1997, MOL CELL BIOL, V17, P100, DOI 10.1128/MCB.17.1.100; FREYTAG SO, 1988, MOL CELL BIOL, V8, P1614, DOI 10.1128/MCB.8.4.1614; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; GAUBATZ S, 1994, MOL CELL BIOL, V14, P3853, DOI 10.1128/MCB.14.6.3853; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GRIGNANI F, 1990, EMBO J, V9, P3913, DOI 10.1002/j.1460-2075.1990.tb07612.x; GU W, 1993, P NATL ACAD SCI USA, V90, P2935, DOI 10.1073/pnas.90.7.2935; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Hopewell R, 1995, J CELL SCI, P85; HURLIN PJ, 1995, EMBO J, V14, P5646, DOI 10.1002/j.1460-2075.1995.tb00252.x; Hurlin PJ, 1995, ONCOGENE, V11, P2487; HURLIN PJ, 1994, COLD SPRING HARB SYM, V59, P109, DOI 10.1101/SQB.1994.059.01.014; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KOSKINEN PJ, 1995, CELL GROWTH DIFFER, V6, P623; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; LAHOZ EG, 1994, P NATL ACAD SCI USA, V91, P5503, DOI 10.1073/pnas.91.12.5503; LARSSON LG, 1994, ONCOGENE, V9, P1247; Lee LA, 1996, J CLIN INVEST, V97, P1687, DOI 10.1172/JCI118595; Lee TC, 1997, P NATL ACAD SCI USA, V94, P12886, DOI 10.1073/pnas.94.24.12886; Lemaitre JM, 1996, ADV CANCER RES, V70, P95, DOI 10.1016/S0065-230X(08)60873-8; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; LOKE SL, 1988, CURR TOP MICROBIOL, V141, P282; LUCAS JM, 1993, BIOCHEM BIOPH RES CO, V194, P1446, DOI 10.1006/bbrc.1993.1987; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; MAI S, 1995, NUCLEIC ACIDS RES, V23, P1, DOI 10.1093/nar/23.1.1; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Marhin WW, 1997, ONCOGENE, V14, P2825, DOI 10.1038/sj.onc.1201138; OFIR R, 1990, NATURE, V348, P80, DOI 10.1038/348080a0; PENA A, 1995, J CELL PHYSIOL, V162, P234, DOI 10.1002/jcp.1041620209; PENA A, 1993, J BIOL CHEM, V268, P27277; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; PENN LJZ, 1990, MOL CELL BIOL, V10, P4961, DOI 10.1128/MCB.10.9.4961; PHILIPP A, 1994, MOL CELL BIOL, V14, P4032, DOI 10.1128/MCB.14.6.4032; PRENDERGAST GC, 1992, TRENDS GENET, V8, P91, DOI 10.1016/0168-9525(92)90196-B; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; RABBITTS PH, 1985, EMBO J, V4, P2009, DOI 10.1002/j.1460-2075.1985.tb03885.x; Roussel MF, 1996, MOL CELL BIOL, V16, P2796; ROY AL, 1993, NATURE, V365, P359, DOI 10.1038/365359a0; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; Roy AL, 1997, EMBO J, V16, P7091, DOI 10.1093/emboj/16.23.7091; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schreiber-Agus N, 1998, NATURE, V393, P483, DOI 10.1038/31008; SCHREIBERAGUS N, 1995, CELL, V80, P777, DOI 10.1016/0092-8674(95)90356-9; SCHREIBERAGUS N, 1994, ONCOGENE, V9, P3167; SIEBENLIST U, 1988, MOL CELL BIOL, V8, P867, DOI 10.1128/MCB.8.2.867; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; SKERKA C, 1993, ONCOGENE, V8, P2135; SPENCER CA, 1991, ADV CANCER RES, V56, P1; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; THOMPSON CB, 1985, NATURE, V314, P363, DOI 10.1038/314363a0; VASTRIK I, 1995, J CELL BIOL, V128, P1197, DOI 10.1083/jcb.128.6.1197; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x; WATERS CM, 1991, ONCOGENE, V6, P797; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	79	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					595	606		10.1074/jbc.274.2.595	http://dx.doi.org/10.1074/jbc.274.2.595			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872993	hybrid			2022-12-27	WOS:000077968500008
J	Pavoine, C; Magne, S; Sauvadet, A; Pecker, F				Pavoine, C; Magne, S; Sauvadet, A; Pecker, F			Evidence for a beta(2)-adrenergic arachidonic acid pathway in ventricular cardiomyocytes - Regulation by the beta(1)-adrenergic/cAMP pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE STIMULATION; CYTOSOLIC PHOSPHOLIPASE A(2); SENSITIVE G-PROTEIN; HEART-CELLS; BETA-2-ADRENERGIC RECEPTORS; CARDIAC MYOCYTES; MINI-GLUCAGON; KINASE-A; MYOCARDIUM; BETA	The signaling pathway mediating the contractile effect of beta(2)-adrenergic receptors (beta(2)-AR) in the heart is still matter of debate. By using embryonic chick ventricular cardiomyocytes that express both functional beta(1)-and beta(2)-ARs, me show here that the specific beta(2)-AR agonist, zinterol, increases the amplitude of Ca2+ transients and cell contraction of electrically stimulated cells. Zinterol, up to 10 mu M, did not stimulate adenylyl cyclase activity, and its effect on Ca2+ transients was unmodified by the specific cAMP antagonist, (Rp)-cAMPS. In contrast, zinterol (10-100 nM) triggered arachidonic acid (AA) release from [H-3]AA-loaded cells via the activation of the cytosolic phospholipase A(2) (cPLA(2)). Stimulation of the Ca2+ transients by zinterol was abolished by the cPLA(2) inhibitor, AACOCF(3), and was mimicked by AA (0.3-3 mu M). Both stimulations of [H-3]AA release and of [Ca2+](i) cycling by zinterol were abolished after treatment of the cardiomyocytes with pertussis toxin. Although cell responses to beta(2)-AR stimulation were mediated by AA,they were under cAMP control as follows: (i) the beta(1)-AR stimulation exerted a cAMP-mediated negative constraint on the beta(2)-AR/cPLA(2) pathway; (ii) cAMP potentiated AA action downstream beta-AR stimulation. We conclude that, in cardiomyocytes, beta(2)-AR is coupled to cPLA(2) activation via a pertussis toxin-sensitive G protein. These results demonstrate the involvement of the cPLA(2)/AA pathway in mediating positive inotropic effects, which could potentially compensate for a defective cAMP pathway.	Hop Henri Mondor, INSERM, U99, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Pavoine, C (corresponding author), Hop Henri Mondor, INSERM, U99, F-94010 Creteil, France.		Pavoine, Catherine/N-4405-2018	Pavoine, Catherine/0000-0002-0598-5545				ALTSCHULD RA, 1995, CIRCULATION, V92, P1612, DOI 10.1161/01.CIR.92.6.1612; BELL D, 1994, J MOL CELL CARDIOL, V26, P1439, DOI 10.1006/jmcc.1994.1163; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BRECHLER V, 1992, J BIOL CHEM, V267, P15496; BRISTOW MR, 1989, MOL PHARMACOL, V35, P295; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; BRODDE OE, 1988, AM J CARDIOL, V62, pC24, DOI 10.1016/S0002-9149(88)80063-8; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; deJonge HW, 1996, MOL CELL BIOCHEM, V157, P199, DOI 10.1007/BF00227899; DEJONGE HW, 1995, J MOL CELL CARDIOL, V27, P93, DOI 10.1016/S0022-2828(08)80010-7; DELMONTE F, 1993, CIRCULATION, V88, P854, DOI 10.1161/01.CIR.88.3.854; DONNADIEU E, 1992, J BIOL CHEM, V267, P25864; GREEN SA, 1992, MOL PHARMACOL, V41, P889; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HSUEH W, 1977, PROSTAGLANDINS, V13, P1073, DOI 10.1016/0090-6980(77)90135-6; KAUMANN AJ, 1987, N-S ARCH PHARMACOL, V335, P403, DOI 10.1007/BF00165555; LEVISTRE R, 1995, BIOCHEM J, V306, P765, DOI 10.1042/bj3060765; LEVY FO, 1993, P NATL ACAD SCI USA, V90, P10798, DOI 10.1073/pnas.90.22.10798; LOKUTA AJ, 1994, J BIOL CHEM, V269, P4832; MARSH JD, 1985, MOL PHARMACOL, V27, P10; MATZUOKA I, 1985, THROMB RES, V37, P185; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; Nakamura F, 1996, HYPERTENSION, V28, P444, DOI 10.1161/01.HYP.28.3.444; PRASAD MR, 1991, BIOCHEM BIOPH RES CO, V174, P952, DOI 10.1016/0006-291X(91)91511-A; REITHMANN C, 1988, EUR J PHARMACOL, V154, P99, DOI 10.1016/0014-2999(88)90370-6; Sauvadet A, 1997, J BIOL CHEM, V272, P12437, DOI 10.1074/jbc.272.19.12437; Sauvadet A, 1996, CIRC RES, V78, P102, DOI 10.1161/01.RES.78.1.102; SAUVADET A, 1995, CELL CALCIUM, V18, P76, DOI 10.1016/0143-4160(95)90047-0; Skeberdis VA, 1997, J PHARMACOL EXP THER, V283, P452; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; VANBILSEN M, 1995, CARDIOVASC RES, V30, P518, DOI 10.1016/0008-6363(95)00098-4; WAELBROECK M, 1983, MOL PHARMACOL, V24, P174; White A A, 1974, Methods Enzymol, V38, P41; XIAO RP, 1994, J BIOL CHEM, V269, P19151; XIAO RP, 1993, CIRC RES, V73, P286, DOI 10.1161/01.RES.73.2.286; XIAO RP, 1995, MOL PHARMACOL, V47, P322; XIAO RP, 1996, MOL CELLULAR MECHANI, P291; Zhou YY, 1997, AM J PHYSIOL-HEART C, V273, pH1611, DOI 10.1152/ajpheart.1997.273.3.H1611	38	59	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					628	637		10.1074/jbc.274.2.628	http://dx.doi.org/10.1074/jbc.274.2.628			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872996	hybrid			2022-12-27	WOS:000077968500011
J	Skerjanc, IS; Petropoulos, H; Ridgeway, AG; Wilton, S				Skerjanc, IS; Petropoulos, H; Ridgeway, AG; Wilton, S			Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; TRANSCRIPTION FACTOR MEF2C; MYOSIN HEAVY-CHAIN; BONE MORPHOGENETIC PROTEINS; MUSCLE GENE-EXPRESSION; HEART TUBE FORMATION; HELIX-LOOP-HELIX; CARDIAC-MUSCLE; MADS-BOX; VENTRAL MORPHOGENESIS	The Nkx2-5 homeodomain protein plays a key role in cardiomyogenesis. Ectopic expression in frog and zebrafish embryos results in an enlarged myocardium; however, expression of Nkx2-5 in fibroblasts was not able to trigger the development of beating cardiac muscle. In order to examine the ability of Nkx2-5 to modulate endogenous cardiac specific gene expression in cells undergoing early stages of differentiation, P19 cell Lines overexpressing Nkx2-5 were differentiated in the absence of Me2SO. Nkx2-5 expression induced cardiomyogenesis in these cultures aggregated without Me2SO. During differentiation into cardiac muscle, Nkx2-5 expression resulted in the activation of myocyte enhancer factor 2C (MEF2C), but not MEF2A, -B, or -D. In order to compare the abilities of Nkx2-5 and MEF2C to induce cellular differentiation, P19 cells overexpressing MEF2C were aggregated in the absence of Me2SO. Similar to Nkx2-5, MEF2C expression initiated cardiomyogenesis, resulting in the up-regulation of Brachyury T, bone morphogenetic protein-4, Nkx2-5, GATA-4, cardiac cu-actin, and myosin heavy chain expression. These findings indicate the presence of a positive regulatory network between Nkx2-5 and MEF2C and show that both factors can direct early stages of cell differentiation into a cardiomyogenic pathway.	Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Skerjanc, IS (corresponding author), Univ Western Ontario, Dept Biochem, Med Sci Bldg, London, ON N6A 5C1, Canada.		Skerjanc, Ilona/AAN-3318-2020					ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; AMACHER SL, 1993, MOL CELL BIOL, V13, P2753, DOI 10.1128/MCB.13.5.2753; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Black BL, 1996, J BIOL CHEM, V271, P26659, DOI 10.1074/jbc.271.43.26659; BODMER R, 1993, DEVELOPMENT, V118, P719; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chen JN, 1996, DEVELOPMENT, V122, P3809; Cleaver OB, 1996, DEVELOPMENT, V122, P3549; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Durocher D, 1998, DEV GENET, V22, P250, DOI 10.1002/(SICI)1520-6408(1998)22:3<250::AID-DVG7>3.0.CO;2-5; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; EDWARDS MKS, 1983, MOL CELL BIOL, V3, P2280, DOI 10.1128/MCB.3.12.2280; Evans T, 1997, TRENDS CARDIOVAS MED, V7, P75, DOI 10.1016/S1050-1738(97)00010-8; Fishman MC, 1997, CELL, V91, P153, DOI 10.1016/S0092-8674(00)80397-9; Fishman MC, 1997, DEVELOPMENT, V124, P2099; FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; Gajewski K, 1997, EMBO J, V16, P515, DOI 10.1093/emboj/16.3.515; Grepin C, 1997, DEVELOPMENT, V124, P2387; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; HIDAKA K, 1995, BIOCHEM BIOPH RES CO, V213, P555, DOI 10.1006/bbrc.1995.2167; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Huang WY, 1998, BIOCHEM J, V330, P871, DOI 10.1042/bj3300871; IANNELLO RC, 1991, J BIOL CHEM, V266, P3309; IP HS, 1994, MOL CELL BIOL, V14, P7517, DOI 10.1128/MCB.14.11.7517; JOHNSON JE, 1992, DEVELOPMENT, V114, P75; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; KAUSHAL S, 1994, SCIENCE, V266, P1236, DOI 10.1126/science.7973707; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; LEIFER D, 1994, NEUROSCIENCE, V63, P1067, DOI 10.1016/0306-4522(94)90573-8; LEIFER D, 1993, P NATL ACAD SCI USA, V90, P1546, DOI 10.1073/pnas.90.4.1546; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Mao ZX, 1996, J BIOL CHEM, V271, P14371, DOI 10.1074/jbc.271.24.14371; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647, DOI 10.1128/MCB.14.3.1647; MARTIN JF, 1993, P NATL ACAD SCI USA, V90, P5282, DOI 10.1073/pnas.90.11.5282; MCBURNEY MW, 1994, SOMAT CELL MOLEC GEN, V20, P529, DOI 10.1007/BF02255843; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; Mohun T, 1997, CURR OPIN GENET DEV, V7, P628, DOI 10.1016/S0959-437X(97)80010-X; MOLKENTIN JD, 1993, J BIOL CHEM, V268, P19512; Molkentin JD, 1996, MOL CELL BIOL, V16, P3814; Molkentin JD, 1996, J BIOL CHEM, V271, P17199, DOI 10.1074/jbc.271.29.17199; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; NAIDU PS, 1995, MOL CELL BIOL, V15, P2707; NAVANKASATTUSAS S, 1992, MOL CELL BIOL, V12, P1469, DOI 10.1128/MCB.12.4.1469; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; Papaioannou VE, 1997, TRENDS GENET, V13, P212, DOI 10.1016/S0168-9525(97)01144-X; RANGANAYAKULU G, 1995, DEV BIOL, V171, P169, DOI 10.1006/dbio.1995.1269; RUDNICKI MA, 1990, DEV BIOL, V138, P348, DOI 10.1016/0012-1606(90)90202-T; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Schulz RA, 1996, ONCOGENE, V12, P1827; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; SKERJANC IS, 1994, MOL CELL BIOL, V1464, P8451; THUERAUF DJ, 1994, J BIOL CHEM, V269, P17772; VIDRICAIRE G, 1994, DEVELOPMENT, V120, P115; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; Zou YM, 1997, DEVELOPMENT, V124, P793	75	115	131	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34904	34910		10.1074/jbc.273.52.34904	http://dx.doi.org/10.1074/jbc.273.52.34904			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857019	hybrid			2022-12-27	WOS:000077719700037
J	Bown, JA; Owens, JT; Meares, CF; Fujita, N; Ishihama, A; Busby, SJW; Minchin, SD				Bown, JA; Owens, JT; Meares, CF; Fujita, N; Ishihama, A; Busby, SJW; Minchin, SD			Organization of open complexes at Escherichia coli promoters - Location of promoter DNA sites close to region 2.5 of the sigma(70) subunit of RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMAL-ENERGY REQUIREMENT; TRANSCRIPTION INITIATION; STRAND SEPARATION; GALACTOSE OPERON; ALPHA-SUBUNIT; SEQUENCES; PROTEIN; RECOGNITION; CONTACTS; SIGMA-70	A cysteine-tethered DNA cleavage agent has been used to locate the position of region 2.5 of sigma(70) in transcriptionally competent complexes between Escherichia coli RNA polymerase and promoters. In this study we have engineered sigma(70) to introduce a unique cysteine residue at a number of positions in region 2.5. Mutant proteins were purified, and in each case, the single cysteine residue used as the target for covalent coupling of the DNA cleavage agent p-bromoacetamidobenzyl-EDTA . Fe (FeBABE). RNA polymerase core reconstituted with tagged a derivatives was shown to be transcriptionally active. Hydroxyl radical-based DNA cleavage mediated by tethered FeBABE was observed for each derivative of RNA polymerase in the open complex. Our results show that region 2.5 is in close proximity to promoter DNA just upstream of the -10 hexamer. This positioning is independent of promoter sequence. A model for the interaction of this region of a with promoter DNA is discussed.	Univ Birmingham, Sch Biochem, Birmingham B15 2TT, W Midlands, England; Univ Calif Davis, Dept Chem, Livermore, CA 95616 USA; Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 411, Japan	University of Birmingham; University of California System; University of California Davis; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Minchin, SD (corresponding author), Univ Birmingham, Sch Biochem, POB 363, Birmingham B15 2TT, W Midlands, England.	s.d.minchin@bham.ac.uk	Meares, Claude/K-3843-2019; Meares, Claude F/A-8345-2011					Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; BARNE KA, 1997, THESIS U BIRMINGHAM; Bashyam MD, 1998, J BACTERIOL, V180, P2568, DOI 10.1128/JB.180.9.2568-2573.1998; BINGHAM AHA, 1986, GENE, V41, P67, DOI 10.1016/0378-1119(86)90268-4; BUCKLE M, 1994, TRANSCRIPTION MECH R, P207; BURNS H, 1994, NUCLEIC ACIDS RES, V22, P3840, DOI 10.1093/nar/22.19.3840; Burns HD, 1996, BIOCHEM J, V317, P305, DOI 10.1042/bj3170305; Busby S, 1994, Methods Mol Biol, V30, P397; CHAN B, 1989, GENE, V84, P227, DOI 10.1016/0378-1119(89)90496-4; CHAN B, 1990, FEBS LETT, V267, P46, DOI 10.1016/0014-5793(90)80284-P; Chen YF, 1997, J MOL BIOL, V267, P47, DOI 10.1006/jmbi.1996.0853; DEHASETH PL, 1995, MOL MICROBIOL, V16, P817, DOI 10.1111/j.1365-2958.1995.tb02309.x; Fujita N, 1996, METHOD ENZYMOL, V273, P121; GRAVES MC, 1986, J BIOL CHEM, V261, P1409; Greiner DP, 1997, BIOCONJUGATE CHEM, V8, P44, DOI 10.1021/bc9600731; GRIMES E, 1991, NUCLEIC ACIDS RES, V19, P6113, DOI 10.1093/nar/19.22.6113; Gross CA, 1996, PHILOS T R SOC B, V351, P475, DOI 10.1098/rstb.1996.0045; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; HEILEK GM, 1995, P NATL ACAD SCI USA, V92, P1113, DOI 10.1073/pnas.92.4.1113; HELMANN JD, 1995, NUCLEIC ACIDS RES, V23, P2351, DOI 10.1093/nar/23.13.2351; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; JUANG YL, 1995, BIOCHEMISTRY-US, V34, P8465, DOI 10.1021/bi00026a030; KUMAR A, 1993, J MOL BIOL, V232, P406, DOI 10.1006/jmbi.1993.1400; Lilley, 1997, NUCL ACIDS MOL BIOL, P41, DOI 10.1007/978-3-642-60691-5_4; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; MINCHIN S, 1993, BIOCHEM J, V289, P771, DOI 10.1042/bj2890771; Murakami K, 1997, P NATL ACAD SCI USA, V94, P11274, DOI 10.1073/pnas.94.21.11274; Murakami K, 1997, P NATL ACAD SCI USA, V94, P1709, DOI 10.1073/pnas.94.5.1709; Owens JT, 1998, BIOCHEMISTRY-US, V37, P7670, DOI 10.1021/bi980188n; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; PEREZMARTIN J, 1994, MICROBIOL REV, V58, P268; PERRIN S, 1990, NUCLEIC ACIDS RES, V18, P7433, DOI 10.1093/nar/18.24.7433; SABELNIKOV AG, 1995, J MOL BIOL, V250, P144, DOI 10.1006/jmbi.1995.0366; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; Severinova E, 1996, J MOL BIOL, V263, P637, DOI 10.1006/jmbi.1996.0604; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; SPASSKY A, 1988, EMBO J, V7, P1871, DOI 10.1002/j.1460-2075.1988.tb03020.x; SUNDBERG MW, 1974, NATURE, V250, P587, DOI 10.1038/250587a0; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; WALDBURGER C, 1990, J MOL BIOL, V215, P267, DOI 10.1016/S0022-2836(05)80345-6	42	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2263	2270		10.1074/jbc.274.4.2263	http://dx.doi.org/10.1074/jbc.274.4.2263			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890989	hybrid			2022-12-27	WOS:000078185200056
J	Finucane, DM; Bossy-Wetzel, E; Waterhouse, NJ; Cotter, TG; Green, DR				Finucane, DM; Bossy-Wetzel, E; Waterhouse, NJ; Cotter, TG; Green, DR			Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CANCER MCF-7 CELLS; IN-VIVO; PERMEABILITY TRANSITION; LIVER-MITOCHONDRIA; DNA FRAGMENTATION; MAMMALIAN-CELLS; FLOW-CYTOMETRY; ION-CHANNEL; P53 STATUS	A growing body of evidence supports a role for mitochondria and mitochondria-derived factors in the cell death process. In particular, much attention has focused on cytochrome c, a key component of the electron transport chain, that has been reported to translocate from the mitochondria to the cytosol in cells undergoing apoptosis. The mechanism for this release is, as yet, unknown. Here we report that ectopic expression of Bax induces apoptosis with an early release of cytochrome c preceding many apoptosis-associated morphological alterations as well as caspase activation and subsequent substrate proteolysis, A loss of mitochondrial transmembrane potential was detected in vivo, although no mitochondrial swelling or loss of transmembrane potential was observed in isolated mitochondria treated with Bax in vitro. Caspase inhibitors, such as endogenous XIAP and synthetic peptide benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (zVAD-fmk), although capable of altering the kinetics and perhaps mode of cell death, had no influence on this release, suggesting that if cytochrome c plays a role in caspase activation it must precede this step in the apoptotic process. Mitochondrial permeability transition was also shown to be significantly prevented by caspase inhibition, indicating that the translocation of cytochrome c from mitochondria to cytosol is not a consequence of events requiring mitochondrial membrane depolarization, In contrast, Bcl-xL was capable of preventing cytochrome c release while also significantly inhibiting cell death. It would therefore appear that the mitochondrial release of factors such as cytochrome c represents a critical step in committing a cell to death, and this release is independent of permeability transition and caspase activation but is inhibited by Bcl-xL.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Natl Univ Ireland Univ Coll Cork, Dept Biochem, Tumor Biol Lab, Cork, Ireland	La Jolla Institute for Immunology; University College Cork	Green, DR (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	dgreen5240@aol.com	Waterhouse, Nigel/I-9813-2016; Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417; Cotter, Thomas/0000-0003-4626-5613	NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646] Funding Source: NIH RePORTER; NCI NIH HHS [CA69381] Funding Source: Medline; NIAID NIH HHS [AI40646] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alnemri ES, 1997, J CELL BIOCHEM, V64, P33, DOI 10.1002/(SICI)1097-4644(199701)64:1<33::AID-JCB6>3.0.CO;2-0; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Chinnaiyan AM, 1996, CURR BIOL, V6, P555; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Duckett CS, 1998, MOL CELL BIOL, V18, P608, DOI 10.1128/MCB.18.1.608; Findley HW, 1997, BLOOD, V89, P2986, DOI 10.1182/blood.V89.8.2986; HALESTRAP AP, 1986, BIOCHEM J, V236, P779, DOI 10.1042/bj2360779; Han JH, 1996, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; Henkart PA, 1996, IMMUNITY, V4, P195, DOI 10.1016/S1074-7613(00)80428-8; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hughes PE, 1996, NEUROSCIENCE, V74, P1143, DOI 10.1016/S0306-4522(96)00174-1; Ishibashi Y, 1998, BIOCHEM BIOPH RES CO, V243, P609, DOI 10.1006/bbrc.1998.8145; JACOBSON MD, 1994, EMBO J, V13, P1899, DOI 10.1002/j.1460-2075.1994.tb06459.x; Jacobson MD, 1996, J CELL BIOL, V133, P1041, DOI 10.1083/jcb.133.5.1041; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kantrow SP, 1997, BIOCHEM BIOPH RES CO, V232, P669, DOI 10.1006/bbrc.1997.6353; Kato Mitsuo V., 1997, Leukemia (Basingstoke), V11, P389; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kharbanda S, 1997, P NATL ACAD SCI USA, V94, P6939, DOI 10.1073/pnas.94.13.6939; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Loddick SA, 1996, NEUROREPORT, V7, P1465, DOI 10.1097/00001756-199606170-00004; Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; MARTIN SJ, 1990, J IMMUNOL, V145, P1859; MILLIGAN CE, 1995, NEURON, V15, P385, DOI 10.1016/0896-6273(95)90042-X; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pan GH, 1998, FEBS LETT, V426, P151, DOI 10.1016/S0014-5793(98)00330-5; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; PETIT PX, 1990, EUR J BIOCHEM, V194, P389, DOI 10.1111/j.1432-1033.1990.tb15632.x; PINES J, 1995, TRENDS GENET, V11, P326, DOI 10.1016/S0168-9525(00)89092-7; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Rodriguez I, 1996, J EXP MED, V184, P2067, DOI 10.1084/jem.184.5.2067; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sakakura C, 1997, SURG TODAY, V27, P676, DOI 10.1007/BF02388231; Sakakura C, 1996, INT J CANCER, V67, P101, DOI 10.1002/(SICI)1097-0215(19960703)67:1<101::AID-IJC17>3.0.CO;2-H; Schlesinger PH, 1997, P NATL ACAD SCI USA, V94, P11357, DOI 10.1073/pnas.94.21.11357; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Vaux DL, 1997, CELL, V90, P389, DOI 10.1016/S0092-8674(00)80497-3; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YIN XM, 1994, COLD SPRING HARB SYM, V59, P387, DOI 10.1101/SQB.1994.059.01.043; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zarotti M., 1995, BIOCHIM BIOPHYS ACTA, V1241, P139; Zha HB, 1996, MOL CELL BIOL, V16, P6494; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; ZHAN QM, 1994, ONCOGENE, V9, P3743; Zhivotovsky B, 1998, NATURE, V391, P449, DOI 10.1038/35060; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	70	640	662	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2225	2233		10.1074/jbc.274.4.2225	http://dx.doi.org/10.1074/jbc.274.4.2225			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890985	hybrid			2022-12-27	WOS:000078185200052
J	Flaumenhaft, R; Croce, K; Chen, E; Furie, B; Furie, BC				Flaumenhaft, R; Croce, K; Chen, E; Furie, B; Furie, BC			Proteins of the exocytotic core complex mediate platelet alpha-granule secretion - Roles of vesicle-associated membrane protein, SNAP-23, and syntaxin 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; NONNEURONAL TISSUES; VAMP SYNAPTOBREVIN; ZYMOGEN GRANULES; CHROMAFFIN CELLS; PLASMA-MEMBRANE; FUSION PROTEIN; LIGHT-CHAIN; IDENTIFICATION; TETANUS	To understand the molecular basis of granule release from platelets, we examined the role of vesicle-associated membrane protein, SNAP-23, and syntaxin 4 in alpha-granule secretion. A vesicle-associated membrane protein, SNAP-23, and syntaxin 4 were detected in platelet lysate. These proteins form a SDS-resistant complex that disassembles upon platelet activation, To determine whether these proteins are involved in alpha-granule secretion, we developed a streptolysin O-permeabilized platelet model of alpha-granule secretion Streptolysin O-permeabilized platelets released alpha-granules, as measured by surface expression of beta-selectin, in response to Ca2+ up to 120 min after permeabilization. Incubation of streptolysin O-permeabilized platelets with an antibody directed against vesicle-associated membrane protein completely inhibited Ca2+-induced alpha-granule release. Tetanus toxin cleaved platelet vesicle-associated membrane protein and inhibited Ca2+-induced alpha-granule secretion from streptolysin O-perneabilized platelets. An antibody to syntaxin 4 also inhibited Ca2+-induced alpha-granule release by approximately 75% in this system. These results show that vesicle-associated membrane protein, SNAP-23, and syntaxin 4 form a heterotrimeric complex in platelets that disassembles with activation and demonstrate that alpha-granule release is dependent on vesicle SNAP receptor-target SNAP receptor (vSNARE-tSNARE) interactions.	Beth Israel Deaconess Med Ctr, Ctr Hemostasis & Thrombosis Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; Howard Hughes Med Inst, Boston, MA 02111 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Tufts University; Howard Hughes Medical Institute	Flaumenhaft, R (corresponding author), RE 318,Res E,POB 15732, Boston, MA 02215 USA.				NHLBI NIH HHS [HL51926, HL57140] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057140, R01HL051926] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENISTANT C, 1990, BIOCHEM J, V269, P489, DOI 10.1042/bj2690489; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BRAUN JEA, 1994, J BIOL CHEM, V269, P5328; BRUMELL JH, 1995, J IMMUNOL, V155, P5750; BUCKLEY KM, 1994, J MEMBRANE BIOL, V139, P75; CAIN CC, 1992, J BIOL CHEM, V267, P11681; CHONG BH, 1994, BLOOD, V83, P1535; CROVELLO CS, 1993, J BIOL CHEM, V268, P14590; ESCOLAR G, 1991, BLOOD CELLS, V17, P467; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; Foster LJ, 1998, BIOCHEMISTRY-US, V37, P11089, DOI 10.1021/bi980253t; GAISANO HY, 1994, J BIOL CHEM, V269, P17062; Hackam DJ, 1996, J IMMUNOL, V156, P4377; Hao JC, 1997, J NEUROSCI, V17, P1596; HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HERREROS J, 1995, BRAIN RES, V699, P165, DOI 10.1016/0006-8993(95)00739-D; HohneZell B, 1997, ENDOCRINOLOGY, V138, P5518, DOI 10.1210/en.138.12.5518; JACOBSSON G, 1994, P NATL ACAD SCI USA, V91, P12487, DOI 10.1073/pnas.91.26.12487; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE GW, 1994, EUR J BIOCHEM, V222, P325, DOI 10.1111/j.1432-1033.1994.tb18871.x; LEFEBVRE P, 1993, EUR J CELL BIOL, V62, P194; Lemons PP, 1997, BLOOD, V90, P1490, DOI 10.1182/blood.V90.4.1490.1490_1490_1500; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Linial M, 1997, J NEUROCHEM, V69, P1781; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Mizuta M, 1997, DIABETES, V46, P2002, DOI 10.2337/diabetes.46.12.2002; Mollinedo F, 1997, BIOCHEM BIOPH RES CO, V231, P808, DOI 10.1006/bbrc.1997.6196; MORGENSTERN E, 1987, EUR J CELL BIOL, V43, P273; MORIMOTO T, 1990, J CELL BIOL, V111, P79, DOI 10.1083/jcb.111.1.79; NIELSEN S, 1995, J CLIN INVEST, V96, P1834, DOI 10.1172/JCI118229; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; PADFIELD PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG647, DOI 10.1152/ajpgi.1995.269.5.G647; PATEL S, 1991, BIOCHEM J, V273, P561, DOI 10.1042/bj2730561; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Plow Edward F., 1995, P1524; RASMUSSEN UB, 1993, J BIOL CHEM, V268, P14322; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Rossetto O, 1996, J CELL BIOL, V132, P167, DOI 10.1083/jcb.132.1.167; SARAFIAN T, 1987, J BIOL CHEM, V262, P16671; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; SHATTIL SJ, 1992, J BIOL CHEM, V267, P18424; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sollner TH, 1996, EXPERIENTIA, V52, P1021; STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VOLCHUK A, 1994, BIOCHEM J, V304, P139, DOI 10.1042/bj3040139; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; WHEELERJONES CPD, 1992, BIOCHEM J, V281, P465, DOI 10.1042/bj2810465; WHITE JG, 1979, AM J CLIN PATHOL, V71, P363, DOI 10.1093/ajcp/71.4.363; WHITE JG, 1983, AM J PATHOL, V112, P207; WHITE JG, 1982, BLOOD, V60, P474	57	119	120	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2492	2501		10.1074/jbc.274.4.2492	http://dx.doi.org/10.1074/jbc.274.4.2492			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891020	Green Published, hybrid			2022-12-27	WOS:000078185200087
J	Pizzi, S; Dieci, G; Frigeri, P; Piccoli, G; Stocchi, V; Ottonello, S				Pizzi, S; Dieci, G; Frigeri, P; Piccoli, G; Stocchi, V; Ottonello, S			Domain organization and functional properties of yeast transcription factor IIIA species with different zinc stoichiometries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-III; COLI ASPARTATE TRANSCARBAMOYLASE; INTERNAL CONTROL REGION; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; DNA-BINDING; FACTOR TFIIIA; GENE; FINGERS; PROTEIN	Transcription factor IIIA (TFIIIA) binds to the 5S rRNA gene through its zinc finger domain and directs the assembly of a multiprotein complex that promotes transcription initiation by RNA polymerase III. Limited proteolysis of TFIIIA forms with different zinc stoichiometries, in combination with DNA binding and in vitro transcription analyses, have been used herein to investigate the domain organization and zinc requirements of Saccharomyces cerevisiae TFIIIA, Species containing either nine, six, or three zinc equivalents were produced by reductive resaturation and controlled metal depletion of recombinant TFIIIA, Partial digestion of the metal-saturated, 9 Zn2+-liganded factor yields a stable intermediate comprising the eight N-terminal zinc fingers, and a less stable fragment corresponding to a C-terminal portion including the ninth finger. Proteolyzed TFIIIA has the same 5 S DNA binding ability of the intact protein yet no longer supports in vitro 5S rRNA synthesis. Both the structural compactness and the 5 S DNA binding ability of the TFIIIA form only containing 3 zinc ions are severely compromised. In contrast, the 6 Zn2+-liganded species was found to be indistinguishable from metal-saturated TFIIIA. By demonstrating the existence of three classes of zinc-binding sites contributing differently to yeast TFIIIA structure and function, the present study provides new evidence for the remarkable flexibility built into this complex transcription factor.	Univ Parma, Inst Biochem Sci, I-43100 Parma, Italy; Univ Urbino, Inst Biol Chem, I-60129 Urbino, Italy	University of Parma; University of Urbino	Ottonello, S (corresponding author), Univ Parma, Inst Biochem Sci, I-43100 Parma, Italy.	simone@irisbioc.bio.unipr.it	Frigeri, Paola/B-9471-2015; Dieci, Giorgio/B-3434-2012	Dieci, Giorgio/0000-0002-8792-3961; PICCOLI, Giovanni/0000-0001-8114-7888				ARCHAMBAULT J, 1992, J BIOL CHEM, V267, P3282; Berg JM, 1997, ANNU REV BIOPH BIOM, V26, P357, DOI 10.1146/annurev.biophys.26.1.357; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN BR, 1992, J MOL BIOL, V228, P1063, DOI 10.1016/0022-2836(92)90315-B; BRAUN BR, 1989, P NATL ACAD SCI USA, V86, P2530, DOI 10.1073/pnas.86.8.2530; Chen XH, 1998, BIOCHEMISTRY-US, V37, P11152, DOI 10.1021/bi980843r; Choo Y, 1998, NAT STRUCT BIOL, V5, P253, DOI 10.1038/nsb0498-253; DELRIO S, 1993, J MOL BIOL, V233, P567, DOI 10.1006/jmbi.1993.1536; DELRIO S, 1991, NUCLEIC ACIDS RES, V19, P6197; DELRIO S, 1993, P NATL ACAD SCI USA, V90, P168, DOI 10.1073/pnas.90.1.168; DIAKUN GP, 1986, NATURE, V324, P698, DOI 10.1038/324698a0; DIECI G, 1995, J BIOL CHEM, V270, P13476, DOI 10.1074/jbc.270.22.13476; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; DIECI G, 1993, J BIOL CHEM, V268, P11199; ENGELKE DR, 1980, CELL, V19, P717, DOI 10.1016/S0092-8674(80)80048-1; Foster MP, 1997, NAT STRUCT BIOL, V4, P605, DOI 10.1038/nsb0897-605; FRANKEL AD, 1987, P NATL ACAD SCI USA, V84, P4841, DOI 10.1073/pnas.84.14.4841; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; HAN MK, 1990, J BIOL CHEM, V265, P13792; HANAS JS, 1992, PROG NUCLEIC ACID RE, V43, P205, DOI 10.1016/S0079-6603(08)61048-X; HANAS JS, 1983, J BIOL CHEM, V258, P4120; HAYES J, 1989, J BIOL CHEM, V264, P6009; Huet J, 1996, METHOD ENZYMOL, V273, P249; HUNT JB, 1984, J BIOL CHEM, V259, P4793; HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; KASSAVETIS GA, 1992, CELL, V71, P1055, DOI 10.1016/0092-8674(92)90399-W; Kehres DG, 1997, J BIOL CHEM, V272, P20152, DOI 10.1074/jbc.272.32.20152; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; LIAO XB, 1992, J MOL BIOL, V223, P857, DOI 10.1016/0022-2836(92)90248-I; MAKOWSKI GS, 1992, J INORG BIOCHEM, V48, P107, DOI 10.1016/0162-0134(92)80020-V; MAO XZ, 1993, MOL CELL BIOL, V13, P7496, DOI 10.1128/MCB.13.12.7496; MICHAEL SF, 1992, P NATL ACAD SCI USA, V89, P4796, DOI 10.1073/pnas.89.11.4796; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MILNE CA, 1993, J BIOL CHEM, V268, P11364; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; OTTONELLO S, 1994, BIOCHEM BIOPH RES CO, V203, P1217, DOI 10.1006/bbrc.1994.2312; PIELER T, 1993, TRENDS BIOCHEM SCI, V18, P226, DOI 10.1016/0968-0004(93)90194-R; RISOEN PA, 1995, PROTEIN EXPRES PURIF, V6, P272, DOI 10.1006/prep.1995.1035; Rowland O, 1996, J BIOL CHEM, V271, P12103, DOI 10.1074/jbc.271.20.12103; Rowland O, 1998, MOL CELL BIOL, V18, P420, DOI 10.1128/MCB.18.1.420; Ruth J, 1996, EMBO J, V15, P1941, DOI 10.1002/j.1460-2075.1996.tb00545.x; SEGALL J, 1986, J BIOL CHEM, V261, P1578; SHANG ZG, 1989, BIOCHEMISTRY-US, V28, P9790, DOI 10.1021/bi00451a037; Shastry BS, 1996, J CELL SCI, V109, P535; SHASTRY BS, 1993, EXPERIENTIA, V49, P831, DOI 10.1007/BF01952592; SMITH DR, 1984, CELL, V37, P645, DOI 10.1016/0092-8674(84)90396-9; STRUKSNES K, 1991, NUCLEIC ACIDS RES, V19, P565, DOI 10.1093/nar/19.3.565; VRANA KE, 1988, MOL CELL BIOL, V8, P1684, DOI 10.1128/MCB.8.4.1684; WANG CK, 1989, J BIOL CHEM, V264, P1092; WHITE RJ, 1994, RNA POLYMERASE 3 TRA; WOYCHIK NA, 1992, P NATL ACAD SCI USA, V89, P3999, DOI 10.1073/pnas.89.9.3999; WU FYH, 1990, STRUCTURE AND FUNCTION OF NUCLEIC ACIDS AND PROTEINS, P37; Wuttke DS, 1997, J MOL BIOL, V273, P183, DOI 10.1006/jmbi.1997.1291; ZENG J, 1991, P NATL ACAD SCI USA, V88, P9984, DOI 10.1073/pnas.88.22.9984	56	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2539	2548		10.1074/jbc.274.4.2539	http://dx.doi.org/10.1074/jbc.274.4.2539			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891026	hybrid			2022-12-27	WOS:000078185200093
J	Fernandez, JA; Keshvara, LM; Peters, JD; Furlong, MT; Harrison, ML; Geahlen, RL				Fernandez, JA; Keshvara, LM; Peters, JD; Furlong, MT; Harrison, ML; Geahlen, RL			Phosphorylation- and activation-independent association of the tyrosine kinase Syk and the tyrosine kinase substrates Cbl and Vav with tubulin in B-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECEPTOR; PROTOONCOGENE PRODUCT; ALPHA-TUBULIN; SH2 DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; T-LYMPHOCYTES; CROSS-LINKING; IN-VIVO; PROTEIN; STIMULATION	Aggregation of the B-cell antigen receptor leads to the activation of the 72-kDa Syk protein-tyrosine kinase and the phosphorylation of tubulin on tyrosine, To explore the requirement of Syk catalytic activity for tubulin phosphorylation, tubulin was isolated from cytosolic fractions from anti-IgM-activated B-cells (DT40) that lacked endogenous Syk and immunoblotted with antiphosphotyrosine antibodies. Tubulin was not tyrosine-phosphorylated in Syk(-) B-cells, Phosphorylation could be restored by the expression of wild-type, but not catalytically inactive, Syk. However, both catalytically inactive and wild-type Syk were capable of constitutive association with tubulin, indicating that tubulin phosphorylation is not required for this interaction. Anti-phosphotyrosine antibody immunoblotting of proteins adsorbed to colchicine-agarose revealed the presence of three major tubulin-associated phosphoproteins of 110, 90, and 74 kDa, the phosphorylation of which was dependent on Syk expression. The proteins of 110 and 90 kDa were identified as Cbl and Vav, two proto-oncogene products known to become prominently phosphorylated following receptor engagement. Both proteins were shown to be constitutively associated with tubulin.	Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Geahlen, RL (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, Hansen Life Sci Res Bldg, W Lafayette, IN 47907 USA.			Geahlen, Robert/0000-0001-8400-2924	NCI NIH HHS [CA37372] Funding Source: Medline; NIGMS NIH HHS [3 F31 GM18062-01S1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM018062] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson SM, 1997, J BIOL CHEM, V272, P739, DOI 10.1074/jbc.272.2.739; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; BOLLAG G, 1993, EMBO J, V12, P1923, DOI 10.1002/j.1460-2075.1993.tb05841.x; BURG DL, 1994, J BIOL CHEM, V269, P28136; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; BUSTELO XR, 1992, SCIENCE, V256, P1196, DOI 10.1126/science.256.5060.1196; CAMPBELL MA, 1992, MOL CELL BIOL, V12, P2315, DOI 10.1128/MCB.12.5.2315; CORY GOC, 1995, J EXP MED, V182, P611, DOI 10.1084/jem.182.2.611; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DARBY C, 1994, J IMMUNOL, V152, P5429; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; DEFRANCO AL, 1995, CURR OPIN CELL BIOL, V7, P163, DOI 10.1016/0955-0674(95)80024-7; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DILDROP R, 1989, EMBO J, V8, P1121, DOI 10.1002/j.1460-2075.1989.tb03482.x; GULBINS E, 1994, J IMMUNOL, V152, P2123; Huby RDJ, 1995, J BIOL CHEM, V270, P30241, DOI 10.1074/jbc.270.51.30241; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; Itoh T, 1996, J BIOL CHEM, V271, P27931, DOI 10.1074/jbc.271.44.27931; KAPELLER R, 1995, J BIOL CHEM, V270, P25985, DOI 10.1074/jbc.270.43.25985; KATZAV S, 1994, J BIOL CHEM, V269, P32579; Keshvara LM, 1997, J BIOL CHEM, V272, P10377; KIENER PA, 1993, J BIOL CHEM, V268, P24442; LEY SC, 1994, EUR J IMMUNOL, V24, P99, DOI 10.1002/eji.1830240116; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MarieCardine A, 1995, EUR J IMMUNOL, V25, P3290, DOI 10.1002/eji.1830251214; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; OFFRINGA R, 1993, J BIOL CHEM, V268, P4979; Ota Y, 1996, J EXP MED, V184, P1713, DOI 10.1084/jem.184.5.1713; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; Peters JD, 1996, J BIOL CHEM, V271, P4755; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Schmitt H, 1974, Methods Enzymol, V34, P623; Song JS, 1996, J BIOL CHEM, V271, P26962, DOI 10.1074/jbc.271.43.26962; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; VASILE S, 1994, MOL IMMUNOL, V31, P419, DOI 10.1016/0161-5890(94)90061-2; VERLHAC MH, 1993, DEV BIOL, V158, P330, DOI 10.1006/dbio.1993.1192; WANG N, 1990, J BIOL CHEM, V265, P1239; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; ZHOU R, 1991, CELL GROWTH DIFFER, V2, P257; ZHOU RP, 1992, MOL CELL BIOL, V12, P3583, DOI 10.1128/MCB.12.8.3583; ZIONCHECK TF, 1986, J BIOL CHEM, V261, P5637	43	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1401	1406		10.1074/jbc.274.3.1401	http://dx.doi.org/10.1074/jbc.274.3.1401			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880513	hybrid			2022-12-27	WOS:000079956900033
J	Liu, CE; Liu, PQ; Wolf, A; Lin, E; Ames, GFL				Liu, CE; Liu, PQ; Wolf, A; Lin, E; Ames, GFL			Both lobes of the soluble receptor of the periplasmic histidine permease, an ABC transporter (traffic ATPase), interact with the membrane-bound complex - Effect of different ligands and consequences for the mechanism of action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-BINDING PROTEIN; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; CYSTIC-FIBROSIS; MULTIDRUG-RESISTANCE; DEPENDENT TRANSPORT; ARGININE-BINDING; LYSINE-BINDING; SPECIFICITY; COMPONENT	The histidine permease of Salmonella typhimurium is an ABC transporter (traffic ATPase), The liganded soluble receptor, the histidine-binding protein HisJ, interacts with the membrane-bound complex HisQMP(2) and stimulates its ATPase activity, which results in histidine translocation. In this study, we utilized HisJ proteins with mutations in either of the two lobes and wild type HisJ liganded with different substrates to show that each lobe carries an interaction site and that both lobes are involved in inducing (stimulating) the ATPase activity. We suggest that the spatial relationship between the lobes is one of the factors recognized by the membrane-bound complex in dictating the efficiency of the induction signal and of translocation, Several of the key residues involved have been identified, In addition, using constitutive ATPase mutants, we show that the binding protein provides some additional essential function(s) in translocation that is independent of the stimulation of ATP hydrolysis, and one possible mechanism is proposed, which includes the notion that liganded HisJ has different optimal conformations for signaling and for translocation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ames, GFL (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem & Mol Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	giovanna@uclink4.berkeley.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK012121, R01DK012121] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK12121] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMES GF, 1990, FEMS MICROBIOL LETT, V75, P429, DOI 10.1016/S0168-6445(05)80008-7; AMES GF, 1992, FASEB J, V6, P2660, DOI 10.1096/fasebj.6.9.1377140; AMES GFL, 1972, J BIOL CHEM, V247, P4309; Ames GFL, 1996, J BIOL CHEM, V271, P14264, DOI 10.1074/jbc.271.24.14264; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; AMES GFL, 1977, J BACTERIOL, V129, P1289, DOI 10.1128/JB.129.3.1289-1297.1977; BAICHWAL V, 1993, P NATL ACAD SCI USA, V90, P620, DOI 10.1073/pnas.90.2.620; BOOS W, 1996, ESCHERICHIA COLI SAL, P1176; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; DOIGE CA, 1993, ANNU REV MICROBIOL, V47, P291, DOI 10.1146/annurev.micro.47.1.291; FERROLUZZIAMES G, 1976, P NATL ACAD SCI USA, V73, P1877, DOI 10.1073/pnas.73.6.1877; FURLONG CE, 1987, ESCHERICHIA COLI SAL, P768; Hall JA, 1997, J BIOL CHEM, V272, P17615, DOI 10.1074/jbc.272.28.17615; HIGGINS CF, 1982, NATURE, V298, P723, DOI 10.1038/298723a0; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIGGINS CF, 1981, P NATL ACAD SCI-BIOL, V78, P6038, DOI 10.1073/pnas.78.10.6038; HOR LI, 1993, J MOL BIOL, V233, P659, DOI 10.1006/jmbi.1993.1543; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; KANG CH, 1991, J BIOL CHEM, V266, P23893; KUSTU SG, 1974, J BIOL CHEM, V249, P6976; Liu CE, 1997, J BIOL CHEM, V272, P21883, DOI 10.1074/jbc.272.35.21883; Liu CE, 1997, J BIOL CHEM, V272, P859, DOI 10.1074/jbc.272.2.859; LIU CE, 1996, THESIS U CALIFORNIA; NIKAIDO K, 1992, J BIOL CHEM, V267, P20706; Nikaido K, 1997, J BIOL CHEM, V272, P27745, DOI 10.1074/jbc.272.44.27745; OH BH, 1993, J BIOL CHEM, V268, P11348; OH BH, 1994, J BIOL CHEM, V269, P4135; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PETRONILLI V, 1991, J BIOL CHEM, V266, P16293; PROSSNITZ E, 1988, J BIOL CHEM, V263, P17917; PROSSNITZ E, 1989, THESIS U CALIFORNIA; QUIOCHO FA, 1989, NATURE, V340, P404, DOI 10.1038/340404a0; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; SPEISER DM, 1991, J BACTERIOL, V173, P1444, DOI 10.1128/jb.173.4.1444-1451.1991; TREPTOW NA, 1985, J BACTERIOL, V163, P654, DOI 10.1128/JB.163.2.654-660.1985; VYAS MN, 1994, BIOCHEMISTRY-US, V33, P4762, DOI 10.1021/bi00182a003; WOLF A, 1995, J BIOL CHEM, V270, P16097, DOI 10.1074/jbc.270.27.16097; Wolf A, 1996, J BIOL CHEM, V271, P21243, DOI 10.1074/jbc.271.35.21243; YAO NH, 1994, BIOCHEMISTRY-US, V33, P4769, DOI 10.1021/bi00182a004	41	35	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					739	747		10.1074/jbc.274.2.739	http://dx.doi.org/10.1074/jbc.274.2.739			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873010	hybrid			2022-12-27	WOS:000077968500025
J	Poommipanit, PB; Chen, B; Oltvai, ZN				Poommipanit, PB; Chen, B; Oltvai, ZN			Interleukin-3 induces the phosphorylation of a distinct fraction of Bcl-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; ANTI-APOPTOSIS FUNCTION; CYCLE ENTRY; IN-VIVO; PROTEIN; BAX; MEMBRANE; BCL-X(L); SUPPRESSION; FAMILY	Bcl-2-related proteins (i.e. Bcl-2 and Bax) regulate the effector stage of apoptosis and can modulate the entry of quiescent cells into the cell cycle. Phosphorylation of Bcl-2 is presumed to modify its apoptosis-inhibitory function. By utilizing an interleukin-3 (IL-3)-dependent hematopoietic cell line, we examined the structural requirements of Bcl-2 phosphorylation and the correlation of this post-translational modification with its function. In the presence of IL-3, constitutively expressed Bcl-2 was phosphorylated on serine residue(s), and phospho rylated Bcl-2 lost its capacity to heterodimerize with Bax. Whereas the majority of Bcl-2 resided in mitochondria, phosphorylation only affected a minor pool of total Bcl-2 that selectively partitioned into a soluble fraction. Cytosolic targeting of Bcl-2 greatly increased its ratio of phosphorylation. Bcl-2 phosphorylation was reduced during IL-3 deprivation, and its phosphorylation was also delayed after transient cytokine deprivation. This pattern of phosphorylation temporally correlated with the accelerated exit and delayed reentry of Bcl-2-expressing cells into the cell cycle upon transient IL-3 deprivation and subsequent cytokine restimulation. Thus, IL-3-induced phosphorylation of a distinct pool of Bcl-2 may contribute to the inactivation of its antiproliferative function.	Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA	Northwestern University	Oltvai, ZN (corresponding author), Northwestern Univ, Sch Med, Dept Pathol, Ward Bldg 6-204,W127,303 E Chicago Ave, Chicago, IL 60611 USA.				NCI NIH HHS [CA71890, CA72535] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA071890, R29CA072535] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; Blagosklonny MV, 1997, CANCER RES, V57, P130; Blagosklonny MV, 1996, CANCER RES, V56, P1851; BORNER C, 1994, J CELL BIOL, V126, P1059, DOI 10.1083/jcb.126.4.1059; Brady HJM, 1996, EMBO J, V15, P6991, DOI 10.1002/j.1460-2075.1996.tb01091.x; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; DEJONG D, 1994, CANCER RES, V54, P256; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; HALDAR S, 1995, P NATL ACAD SCI USA, V92, P4507, DOI 10.1073/pnas.92.10.4507; Haldar S, 1996, CANCER RES, V56, P1253; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Horiuchi M, 1997, J BIOL CHEM, V272, P19022, DOI 10.1074/jbc.272.30.19022; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Huang DCS, 1997, EMBO J, V16, P4628, DOI 10.1093/emboj/16.15.4628; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; KINOSHITA T, 1995, EMBO J, V14, P266, DOI 10.1002/j.1460-2075.1995.tb07000.x; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Lewis S, 1998, PROTEIN EXPRES PURIF, V13, P120, DOI 10.1006/prep.1997.0871; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Mahajan NP, 1998, NAT BIOTECHNOL, V16, P547, DOI 10.1038/nbt0698-547; MARVEL J, 1994, ONCOGENE, V9, P1117; MAY WS, 1994, J BIOL CHEM, V269, P26865; Miyajima Atsushi, 1997, Leukemia (Basingstoke), V11, P418; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; NGUYEN M, 1994, J BIOL CHEM, V269, P16521; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; OReilly LA, 1997, J IMMUNOL, V159, P2301; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; PIETENPOL JA, 1994, CANCER RES, V54, P3714; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Srivastava RK, 1998, MOL CELL BIOL, V18, P3509, DOI 10.1128/MCB.18.6.3509; StClair EG, 1997, J BIOL CHEM, V272, P29347; TANAKA S, 1993, J BIOL CHEM, V268, P10920; VEIS DJ, 1993, J IMMUNOL, V151, P2546; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zamzami N, 1998, ONCOGENE, V16, P2265, DOI 10.1038/sj.onc.1201989; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	48	44	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1033	1039		10.1074/jbc.274.2.1033	http://dx.doi.org/10.1074/jbc.274.2.1033			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873048	hybrid			2022-12-27	WOS:000077968500063
J	Rizzo, MA; Shome, K; Vasudevan, C; Stolz, DB; Sung, TC; Frohman, MA; Watkins, SC; Romero, G				Rizzo, MA; Shome, K; Vasudevan, C; Stolz, DB; Sung, TC; Frohman, MA; Watkins, SC; Romero, G			Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent Raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; BREFELDIN-A; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; GUANINE-NUCLEOTIDE; D DEFINES; RAS; CELLS; INSULIN	The primary known function of phospholipase D (PLD) is to generate phosphatidic acid (PA) via the hydrolysis of phosphatidylcholine. However, the functional role of PA is not well understood. We report here evidence that links the activation of PLD by insulin and the subsequent generation of PA to the activation of the Raf-1-mitogen-activated protein kinase (MAPK) cascade. Brefeldin A (BFA), an inhibitor of the activation of ADP-ribosylation factor proteins, inhibited insulin-dependent production of PA and MAPK phosphorylation. The addition of PA reversed the inhibition of MAPK activation by BFA. Overexpression of a catalytically inactive variant of PLD2, but not PLD1, blocked insulin-dependent activation of PLD and phosphorylation of MAPK Real time imaging analysis showed that insulin induced Raf-1 translocation to cell membranes by a process that was inhibited by BFA. PA addition reversed the effects of BFA on Raf-1 translocation. However, PA did not activate Raf-1 in vitro or in vivo, suggesting that the primary function of PA is to enhance the recruitment of Raf-1 to the plasma membrane where other factors may activate it. Finally, we found that the recruitment of Raf-1 to the plasma membrane was transient. but Raf-1 remained bound to endocytic vesicles.	Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15261 USA; SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; SUNY Stony Brook, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Romero, G (corresponding author), Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA.	ggr+@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K02DK002465, R01DK051183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008424] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK02465, DK51183] Funding Source: Medline; NIGMS NIH HHS [5-T320GM08424-04] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APP H, 1991, MOL CELL BIOL, V11, P913, DOI 10.1128/MCB.11.2.913; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BENAV P, 1993, EUR J BIOCHEM, V215, P455, DOI 10.1111/j.1432-1033.1993.tb18054.x; Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Chung JK, 1997, J BIOL CHEM, V272, P15980, DOI 10.1074/jbc.272.25.15980; CLARK S, 1991, BIOCHEM J, V276, P27, DOI 10.1042/bj2760027; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DONCHENKO V, 1994, BBA-MOL CELL RES, V1222, P492, DOI 10.1016/0167-4889(94)90059-0; English D, 1996, CELL SIGNAL, V8, P341, DOI 10.1016/0898-6568(95)00076-3; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; Frohman MA, 1996, CURR BIOL, V6, P945, DOI 10.1016/S0960-9822(02)00634-6; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; HA KS, 1993, J CELL BIOL, V123, P1789, DOI 10.1083/jcb.123.6.1789; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Hu CD, 1997, J BIOL CHEM, V272, P11702, DOI 10.1074/jbc.272.18.11702; Huwiler A, 1996, P NATL ACAD SCI USA, V93, P6959, DOI 10.1073/pnas.93.14.6959; JONES GA, 1993, J BIOL CHEM, V268, P20845; Karnam P, 1997, J BIOL CHEM, V272, P6136, DOI 10.1074/jbc.272.10.6136; Kodaki T, 1997, J BIOL CHEM, V272, P11408; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; LISCOVITCH M, 1995, CELL, V81, P659, DOI 10.1016/0092-8674(95)90525-1; Luo ZJ, 1997, MOL CELL BIOL, V17, P46, DOI 10.1128/MCB.17.1.46; MALCOLM KC, 1994, J BIOL CHEM, V269, P25951; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MARTIN TFJ, 1989, METHOD ENZYMOL, V168, P225; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mineo C, 1997, J BIOL CHEM, V272, P10345; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; PRICE BD, 1989, BIOCHEM J, V264, P509, DOI 10.1042/bj2640509; RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555; REINHOLD SL, 1990, FASEB J, V4, P208, DOI 10.1096/fasebj.4.2.2105252; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Roy S, 1997, J BIOL CHEM, V272, P20139, DOI 10.1074/jbc.272.32.20139; Shome K, 1997, CURR BIOL, V7, P387, DOI 10.1016/S0960-9822(06)00186-2; SHOME K, 1995, FEBS LETT, V357, P109, DOI 10.1016/0014-5793(94)01310-W; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; TRAVERSE S, 1993, ONCOGENE, V8, P3175; TSAI MH, 1989, SCIENCE, V243, P522, DOI 10.1126/science.2536192; TURNER B, 1991, P NATL ACAD SCI USA, V88, P1227, DOI 10.1073/pnas.88.4.1227; van Dijk MCM, 1998, CURR BIOL, V8, P386, DOI 10.1016/S0960-9822(98)70157-5; vanDijk MCM, 1997, BIOCHEM J, V323, P693, DOI 10.1042/bj3230693; YEO EJ, 1995, J BIOL CHEM, V270, P3980, DOI 10.1074/jbc.270.8.3980; ZHAO ZH, 1993, P NATL ACAD SCI USA, V90, P4251, DOI 10.1073/pnas.90.9.4251	54	267	271	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1131	1139		10.1074/jbc.274.2.1131	http://dx.doi.org/10.1074/jbc.274.2.1131			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873061	hybrid			2022-12-27	WOS:000077968500076
J	Vancurova, I; Choi, JH; Lin, HY; Kuret, J; Vancura, A				Vancurova, I; Choi, JH; Lin, HY; Kuret, J; Vancura, A			Regulation of phosphatidylinositol 4-phosphate 5-kinase from Schizosaccharomyces pombe by casein kinase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE DILUTION KINETICS; GTPASE-ACTIVATING PROTEIN; ADP-RIBOSYLATION FACTOR; SACCHAROMYCES-CEREVISIAE; MIXED MICELLES; INOSITOL TRISPHOSPHATE; ACID PHOSPHOLIPIDS; BUDDING YEAST; PHOSPHORYLATION; CELL	Phosphatidylinositol (4)P 5-kinase (PtdIns(4)P B-kinase) catalyzes the last step in the synthesis of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2). PtdIns(4,B)P-2 is a precursor of diacylglycerol and inositol 1,45-trisphosphate and is also involved in regulation of actin cytoskeleton remodeling and membrane traffic. To satisfy such varied demands in several aspects of cell physiology, synthesis of PdIns(4,5)P-2 must be stringently regulated. In this paper we describe extraction, purification, and characterization of PtdIns(4)P 5-kinase from the plasma membranes of Schizosaccharomyces pombe. We also provide evidence that PtdIns(4)P 5-kinase is phosphorylated and inactivated by Cki1, the S. pombe homolog of casein kinase I. Phosphorylation by Cki1 in vitro decreases the activity of PtdIns(4)P 5-kinase. In addition, and most importantly, overexpression of Cki1 in S. pombe results in a reduced synthesis of PtdIns(4,5)P-2 and in a lower activity of PtdIns(4)P 5-kinase associated with the plasma membrane, These results suggest that PtdIns(4)P 5-kinase is a target of Cki1 in S. pombe and that Cki1 is involved in regulation of PtdIns(4, 5)P-2 synthesis by phosphorylating and inactivating PtdIns(4)P 5-kinase.	St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA; Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Saint John's University; Northwestern University	Vancura, A (corresponding author), St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA.	vancuraa@stjohns.edu		Vancura, Ales/0000-0002-5895-1218				Alfa C, 1993, EXPT FISSION YEAST L; BAELEE M, 1990, J BIOL CHEM, V265, P7221; BAZENET CE, 1990, J BIOL CHEM, V265, P18012; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BOON AM, 1985, BIOCHEM BIOPH RES CO, V129, P431, DOI 10.1016/0006-291X(85)90169-X; BORONENKOV IV, 1995, J BIOL CHEM, V270, P2881, DOI 10.1074/jbc.270.7.2881; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUXEDA RJ, 1993, J BIOL CHEM, V268, P6248; BUXEDA RJ, 1991, J BIOL CHEM, V266, P13859; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; CEGIELSKA A, 1994, J VIROL, V68, P269, DOI 10.1128/JVI.68.1.269-275.1994; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; DAHMUS ME, 1981, J BIOL CHEM, V256, P3332; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; DEGROOT RP, 1993, EMBO J, V12, P3903, DOI 10.1002/j.1460-2075.1993.tb06068.x; DENNIS EA, 1973, ARCH BIOCHEM BIOPHYS, V158, P485, DOI 10.1016/0003-9861(73)90540-7; Dennis EA, 1983, ENZYMES, P307; DIVECHA N, 1995, BIOCHEM J, V309, P715, DOI 10.1042/bj3090715; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; Dubois T, 1997, J BIOL CHEM, V272, P28882, DOI 10.1074/jbc.272.46.28882; Estrada E, 1996, J BIOL CHEM, V271, P32064, DOI 10.1074/jbc.271.50.32064; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; FLOTOW H, 1989, J BIOL CHEM, V264, P9126; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; HOEKSTRA MF, 1991, SCIENCE, V253, P1031, DOI 10.1126/science.1887218; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; KATO H, 1989, J BIOL CHEM, V264, P3116; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; LIN YP, 1990, J BIOL CHEM, V265, P166; LING LE, 1989, J BIOL CHEM, V264, P5080; LISCHWE MA, 1977, J BIOL CHEM, V252, P4976; LUO KX, 1991, METHOD ENZYMOL, V201, P149; MAJERUS PW, 1990, CELL, V63, P459, DOI 10.1016/0092-8674(90)90442-H; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; MILNE DM, 1992, ONCOGENE, V7, P1361; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Panek HR, 1997, EMBO J, V16, P4194, DOI 10.1093/emboj/16.14.4194; PARKER PJ, 1994, TRENDS BIOCHEM SCI, V19, P54, DOI 10.1016/0968-0004(94)90031-0; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28; ROWLES J, 1991, P NATL ACAD SCI USA, V88, P9548, DOI 10.1073/pnas.88.21.9548; RUSSO GL, 1992, J BIOL CHEM, V267, P20317; TERUI T, 1994, J BIOL CHEM, V269, P28130; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; VANCURA A, 1993, ARCH BIOCHEM BIOPHYS, V305, P47, DOI 10.1006/abbi.1993.1391; VANCURA A, 1994, J BIOL CHEM, V269, P19271; WANG PC, 1992, MOL BIOL CELL, V3, P275, DOI 10.1091/mbc.3.3.275; WANG PC, 1994, J BIOL CHEM, V269, P12014; Wang XM, 1996, MOL CELL BIOL, V16, P5375; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; YOSHIDA S, 1994, MOL GEN GENET, V242, P631, DOI 10.1007/BF00283416; ZHAI LM, 1995, J BIOL CHEM, V270, P12717, DOI 10.1074/jbc.270.21.12717; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756	64	22	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1147	1155		10.1074/jbc.274.2.1147	http://dx.doi.org/10.1074/jbc.274.2.1147			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873063	hybrid			2022-12-27	WOS:000077968500078
J	Carballo, M; Marquez, G; Conde, M; Martin-Nieto, J; Monteseirin, J; Conde, J; Pintado, E; Sobrino, F				Carballo, M; Marquez, G; Conde, M; Martin-Nieto, J; Monteseirin, J; Conde, J; Pintado, E; Sobrino, F			Characterization of calcineurin in human neutrophils - Inhibitory effect of hydrogen peroxide on its enzyme activity and on NF-kappa B DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE PHOSPHATASE INHIBITORS; DEPENDENT PROTEIN PHOSPHATASE; TRANSCRIPTION FACTOR; NUCLEAR FACTOR; CYCLOSPORINE-A; T-CELLS; INTRACELLULAR CALCIUM; SIGNAL-TRANSDUCTION; CELLULAR-REGULATION; OXIDATIVE STRESS	We describe here a specific calcineurin activity in neutrophil lysates, which is dependent on Ca2+, inhibited by trifluoroperazine, and insensitive to okadaic acid. Immunoblotting experiments using a specific antiserum recognized both the A and B chains of calcineurin, Neutrophils treated with cyclosporin A or FK 506 showed a dose-dependent inhibition of calcineurin activity. The effect of oxidant compounds on calcineurin activity was also investigated. Neutrophils treated with hydrogen peroxide (H2O2), where catalase was inhibited with aminotriazole, exhibited a specific inhibition of calcineurin activity. However, the addition of reducing agents to neutrophil extracts partially reversed the inhibition caused by H2O2. A similar inhibitory effect of H2O2 on calcineurin activity was observed to occur in isolated lymphocytes, This is the first demonstration that redox agents modulate calcineurin activity in a cellular system. In addition, electrophoretic mobility shift assays revealed that lipopolysaccharide-induced activation of NF-kappa B in human neutrophils is inhibited by cell pretreatment with H2O2 in a dose-dependent manner. These data indicate that calcineurin activity regulates the functional activity of lipopolysaccharide-induced NF-kappa B/Rel proteins in human neutrophils, These data indicate a role of peroxides in the modulation of calcineurin activity and that the H2O2-dependent NF-kappa B inactivation in neutrophils occurs in concert with inhibition of calcineurin.	Fac Med, Dept Bioquim Med & Biol Mol, Seville 41009, Spain; Univ Seville, Dept Med, Serv Reg Inmunol & Alergia, Hosp Univ Virgen Macarena, E-41009 Seville, Spain; Univ Alicante, Dept Biotecnol, E-03080 Alicante, Spain	University of Sevilla; Hospital Universitario Virgen Macarena; University of Sevilla; Universitat d'Alacant	Sobrino, F (corresponding author), Fac Med, Dept Bioquim Med & Biol Mol, Ave Sanchez Pizjuan 4, Seville 41009, Spain.	fsobrino@cica.es	MARTÍN-NIETO, JOSÉ/R-5428-2018	MARTÍN-NIETO, JOSÉ/0000-0002-7815-6887; Sobrino, Francisco/0000-0002-4503-5739; Pintado, Elizabeth/0000-0002-5237-5045				AITKEN A, 1984, EUR J BIOCHEM, V139, P663, DOI 10.1111/j.1432-1033.1984.tb08055.x; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN P, 1995, BIOCHIM BIOPHYS ACTA, V1260, P1670; Browning DD, 1997, J BIOL CHEM, V272, P7995, DOI 10.1074/jbc.272.12.7995; Carballo M, 1997, BIOCHEM J, V328, P559, DOI 10.1042/bj3280559; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; delArco PG, 1996, J BIOL CHEM, V271, P26335; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; GARCIARUIZ C, 1995, MOL PHARMACOL, V48, P825; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Gualberto A, 1998, J BIOL CHEM, V273, P7088, DOI 10.1074/jbc.273.12.7088; HASHIMOTO Y, 1988, P NATL ACAD SCI USA, V85, P7001, DOI 10.1073/pnas.85.18.7001; Hendey B, 1996, BLOOD, V87, P2038; HENDEY B, 1993, BLOOD CELLS, V19, P143; HENDEY B, 1992, SCIENCE, V258, P296, DOI 10.1126/science.1384129; HODGSON M, 1989, J BIOLUM CHEMILUM, V3, P21, DOI 10.1002/bio.1170030105; HUBBARD MJ, 1991, MOL NEUROBIOL, P135; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; KING MM, 1984, J BIOL CHEM, V259, P8847; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; KLEE CB, 1978, BIOCHEMISTRY-US, V17, P120, DOI 10.1021/bi00594a017; Krejsa CM, 1997, J BIOL CHEM, V272, P11541; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Liu BQ, 1996, J IMMUNOL, V157, P160; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LIU J, 1992, BIOCHEMISTRY-US, V31, P3896, DOI 10.1021/bi00131a002; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; MARGOLIASH E, 1960, BIOCHEM J, V74, P339, DOI 10.1042/bj0740339; MartinezMartinez S, 1997, MOL CELL BIOL, V17, P6437, DOI 10.1128/MCB.17.11.6437; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; Monteseirin J, 1996, J EXP MED, V183, P2571, DOI 10.1084/jem.183.6.2571; Nottet HSLM, 1997, J LEUKOCYTE BIOL, V61, P33, DOI 10.1002/jlb.61.1.33; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; PERRINO BA, 1995, J BIOL CHEM, V270, P340, DOI 10.1074/jbc.270.1.340; POSNER BI, 1994, J BIOL CHEM, V269, P4596; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; SCHMIDT A, 1990, J VIROL, V64, P4037, DOI 10.1128/JVI.64.8.4037-4041.1990; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schreck R, 1991, Trends Cell Biol, V1, P39, DOI 10.1016/0962-8924(91)90072-H; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; SIKKINK R, 1995, BIOCHEMISTRY-US, V34, P8348, DOI 10.1021/bi00026a016; Stemmer P, 1991, Curr Opin Neurobiol, V1, P53, DOI 10.1016/0959-4388(91)90010-5; STEMMER PM, 1995, FEBS LETT, V374, P237, DOI 10.1016/0014-5793(95)01095-V; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; STEWART AA, 1983, EUR J BIOCHEM, V132, P289, DOI 10.1111/j.1432-1033.1983.tb07361.x; SUZUKI Y, 1995, BIOCHEM BIOPH RES CO, V40, P537; SUZUKI YJ, 1994, J IMMUNOL, V153, P5008; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; Wang DZ, 1995, ANN NY ACAD SCI, V766, P182, DOI 10.1111/j.1749-6632.1995.tb26661.x; Wang XT, 1996, NATURE, V383, P434, DOI 10.1038/383434a0; WHISLER RL, 1995, ARCH BIOCHEM BIOPHYS, V319, P23, DOI 10.1006/abbi.1995.1263; WHITE EH, 1964, J AM CHEM SOC, V86, P940, DOI 10.1021/ja01059a050; WOODROW M, 1993, J EXP MED, V178, P1517, DOI 10.1084/jem.178.5.1517	59	92	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					93	100		10.1074/jbc.274.1.93	http://dx.doi.org/10.1074/jbc.274.1.93			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867815	Green Published, hybrid			2022-12-27	WOS:000077900200015
J	Dean, JLE; Brook, M; Clark, AR; Saklatvala, J				Dean, JLE; Brook, M; Clark, AR; Saklatvala, J			p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; ENDOPEROXIDE SYNTHASE-2 GENE; PROSTAGLANDIN-H SYNTHASE-2; HEAT-SHOCK PROTEINS; MAP KINASE; CELLULAR STRESSES; RESPONSE ELEMENT; NUCLEAR FACTOR; RABBIT LIVER	p38 mitogen-activated protein kinase (MAPK) is activated by inflammatory stimuli such as bacterial lipopolysaccharide (LPS), interleukin-1, and tumor necrosis factor. We have previously shown that the pyridinyl imidazole SE 203580, which inhibits it, blocks the interleukin-1 induction of cyclooxygenase-2 (COX-2) and matrix metalloproteinase 1 and 3 mRNAs in fibroblasts. Here we explore the role of p38 MAPK in the response of human monocytes to LPS, 0.1 mu M SB 203580 significantly inhibited the LPS induction of COX-2 and tumor necrosis factor protein and mRNAs. The activity of MAPK-activated protein kinase-2 (a substrate of p38 MAPK) in the cells was commensurately reduced. Some isoforms of c-jun N-terminal kinase (which is also activated by LPS) are sensitive to SE 203580; the inhibitor had little effect on monocyte c-jun N-terminal kinases up to 2 mu m We investigated the mechanism of inhibition of COX-2 induction. Transcription (measured by a nuclear run-on assay) was 60% inhibited by SE 203580 (2 mu M.), Importantly, we found that p38 MAPK was essential for stabilizing COX-2 mRNA: when cells stimulated for 4 h with LPS were treated with actinomycin D, COX-2 mRNA decayed slowly. Treatment of stimulated cells with 2 mu M SE 203580 caused a rapid disappearance of COX-2 mRNA, even with actinomycin D present. We conclude p38 MAPK plays a role in the transcription and stabilization of COX-2 mRNA.	Kennedy Inst Rheumatol, London W6 8LH, England	University of Oxford	Dean, JLE (corresponding author), Kennedy Inst Rheumatol, 1 Aspenlea Rd, London W6 8LH, England.		Brook, Matthew/I-5828-2019; Clark, Andrew/AAN-4043-2021	Brook, Matthew/0000-0003-1245-7385; Clark, Andy/0000-0003-4996-8322; Dean, Jonathan/0000-0002-0703-2756				Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; BROWN T, 1997, CURRENT PROTOCOLS MO, V1; Clerk A, 1998, FEBS LETT, V426, P93, DOI 10.1016/S0014-5793(98)00324-X; Crawley JB, 1997, J BIOL CHEM, V272, P15023, DOI 10.1074/jbc.272.23.15023; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; DAcquisto F, 1997, FEBS LETT, V418, P175, DOI 10.1016/S0014-5793(97)01377-X; Finch A, 1997, FEBS LETT, V418, P144, DOI 10.1016/S0014-5793(97)01364-1; Foey AD, 1998, J IMMUNOL, V160, P920; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HEMPEL SL, 1994, J BIOL CHEM, V269, P32979; Hwang D, 1997, BIOCHEM PHARMACOL, V54, P87, DOI 10.1016/S0006-2952(97)00154-8; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; Inoue H, 1998, BIOCHEM BIOPH RES CO, V244, P143, DOI 10.1006/bbrc.1998.8222; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; KRACHT M, 1994, J EXP MED, V180, P2017, DOI 10.1084/jem.180.6.2017; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Mendelson KG, 1996, P NATL ACAD SCI USA, V93, P12908, DOI 10.1073/pnas.93.23.12908; Mertens S, 1996, FEBS LETT, V383, P273, DOI 10.1016/0014-5793(96)00255-4; Pouliot M, 1997, J IMMUNOL, V158, P4930; PRICHETT W, 1995, J INFLAMM, V45, P97; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Ridley SH, 1997, J IMMUNOL, V158, P3165; Ristimaki A, 1996, BIOCHEM J, V318, P325, DOI 10.1042/bj3180325; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Sambrook J., 2002, MOL CLONING LAB MANU; SIROIS J, 1993, J BIOL CHEM, V268, P21931; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Wang XS, 1997, J BIOL CHEM, V272, P23668, DOI 10.1074/jbc.272.38.23668; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wesselborg S, 1997, J BIOL CHEM, V272, P12422, DOI 10.1074/jbc.272.19.12422; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; XIE WL, 1995, J BIOL CHEM, V270, P27622, DOI 10.1074/jbc.270.46.27622; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Yamaoka K, 1998, J IMMUNOL, V160, P838; Yang XH, 1997, BBA-GENE STRUCT EXPR, V1350, P287, DOI 10.1016/S0167-4781(96)00225-4; YOUNG P, 1993, AGENTS ACTIONS, V39, pC67, DOI 10.1007/BF01972723	52	444	454	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					264	269		10.1074/jbc.274.1.264	http://dx.doi.org/10.1074/jbc.274.1.264			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867839	hybrid			2022-12-27	WOS:000077900200039
J	John, SA; Kondo, R; Wang, SY; Goldhaber, JI; Weiss, JN				John, SA; Kondo, R; Wang, SY; Goldhaber, JI; Weiss, JN			Connexin-43 hemichannels opened by metabolic inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTIONAL CHANNELS; NONJUNCTIONAL PLASMA-MEMBRANE; PIG VENTRICULAR MYOCYTES; XENOPUS-OOCYTES; HORIZONTAL CELLS; HALOTHANE; MECHANISM; PROTEIN; RETINA	The cause of altered ionic homeostasis leading to cell death during ischemia and metabolic inhibition is unclear. Hemichannels, which are precursors to gap junctions, are nonselective ion channels that are permeable to molecules of less than M-r 1000. We show that hemichannels open upon exposure to calcium-free solutions when they are either heterologously overexpressed in HEK293 cells or endogenously expressed in cardiac ventricular myocytes, In the presence of normal extracellular calcium, hemichannels open during metabolic inhibition. During ischemia and other forms of metabolic inhibition, activation of relatively few hemichannels will seriously compromise the cell's ability to maintain ionic homeostasis, which is an essential step promoting cell death.	Univ Calif Los Angeles, Sch Med, Dept Med Cardiol, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Weiss, JN (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med Cardiol, Cardiovasc Res Lab, 675 Circle Dr S, Los Angeles, CA 90095 USA.	jweiss@mednet.ucla.edu		Goldhaber, Joshua/0000-0001-8413-5719; John, Scott/0000-0002-1232-9140	NHLBI NIH HHS [P01 HL52319, R01 HL36729, R01 HL44880] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044880, P50HL052319, R01HL036729] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CHEN CA, 1988, BIOTECHNIQUES, V6, P632; DEVRIES SH, 1992, J PHYSIOL-LONDON, V445, P201, DOI 10.1113/jphysiol.1992.sp018920; Ebihara L, 1996, BIOPHYS J, V71, P742, DOI 10.1016/S0006-3495(96)79273-1; EBIHARA L, 1995, BIOPHYS J, V68, P1796, DOI 10.1016/S0006-3495(95)80356-5; EBIHARA L, 1993, J GEN PHYSIOL, V102, P59, DOI 10.1085/jgp.102.1.59; FLAGGNEWTON J, 1979, SCIENCE, V205, P404, DOI 10.1126/science.377490; GOLDHABER JI, 1991, J PHYSIOL-LONDON, V443, P371, DOI 10.1113/jphysiol.1991.sp018838; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kondo RP, 1997, CIRCULATION, V96, P2007; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 1996, J BIOENERG BIOMEMBR, V28, P311, DOI 10.1007/BF02110107; LAZRAK A, 1994, BIOPHYS J, V67, P1052, DOI 10.1016/S0006-3495(94)80570-3; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; MALCHOW RP, 1993, J NEUROSCI RES, V35, P237, DOI 10.1002/jnr.490350303; MANJUNATH CK, 1985, AM J PHYSIOL, V248, pH783, DOI 10.1152/ajpheart.1985.248.6.H783; MANJUNATH CK, 1985, J MEMBRANE BIOL, V85, P159, DOI 10.1007/BF01871268; MITRA R, 1986, AM J PHYSIOL, V249, pH1056; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; RODRIGO GC, 1991, J PHYSIOL-LONDON, V434, P627, DOI 10.1113/jphysiol.1991.sp018490; SEVERS NJ, 1990, J MUSCLE RES CELL M, V11, P154, DOI 10.1007/BF01766494; Shivkumar K, 1997, J CLIN INVEST, V100, P1782, DOI 10.1172/JCI119705; Siegmund B, 1997, CIRCULATION, V96, P4372; Toyofuku T, 1998, J BIOL CHEM, V273, P1519, DOI 10.1074/jbc.273.3.1519; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; WILDE AAM, 1995, CARDIOVASC RES, V29, P1	25	225	231	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					236	240		10.1074/jbc.274.1.236	http://dx.doi.org/10.1074/jbc.274.1.236			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867835	hybrid			2022-12-27	WOS:000077900200035
J	Suzuki, T; Fujii, Y; Miyano, M; Chen, LY; Takahashi, T; Watanabe, K				Suzuki, T; Fujii, Y; Miyano, M; Chen, LY; Takahashi, T; Watanabe, K			cDNA cloning, expression, and mutagenesis study of liver-type prostaglandin F synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALDOSE REDUCTASE; 3-ALPHA-HYDROXYSTEROID DIHYDRODIOL DEHYDROGENASE; ACID-BINDING PROTEIN; RAT-LIVER; BOVINE LIVER; CRYSTAL-STRUCTURE; MULTIPLE FORMS; DNA-SYNTHESIS; PURIFICATION; LUNG	Prostaglandin (PG) F synthase catalyzes the reduction of PGD(2) to 9 alpha,11 beta-PGF(2) and that of PGH(2) to PGF(2 alpha) on the same molecule. PGF synthase has at least two isoforms, the lung-type enzyme (K-m value of 120 mu M for PGD, (Watanabe, K., Yoshida, R., Shimizu, T., and Hayaishi, O. (1985) J. Biol. Chem. 260, 7035-7041) and the liver-type one (K-m value of 10 mu M for PGD(2) (Chen, L. -Y., Watanabe, K., and Hayaishi, O. (1992) Arch. Biochem. Biophys. 296, 17-26)). The liver-type enzyme was presently found to consist of a 969-base pair open reading frame coding for a 323-amino acid polypeptide with a M-r of 36,742. Sequence analysis indicated that the bovine liver PGF synthase had 87, 79, 77, and 76% identity with the bovine lung PGF synthase and human liver dihydrodiol dehydrogenase (DD) isozymes DD1, DD2, and DD4, respectively. Moreover, the amino acid sequence of the liver-type PGF synthase was identical with that of bo vine liver DD3. The liver-type PGF synthase was expressed in COS-7 cells, and its recombinant enzyme had almost the same properties as the native enzyme. Furthermore, to investigate the nature of catalysis and/or substrate binding of PGF synthase, we constructed and characterized various mutant enzymes as follows: R27E, R91Q, H170C, R223L, K225S, S301R, and N306Y. Although the reductase activities toward PGH, and phenanthrenequinone (PQ) of almost all mutants were not inactivated, the Ii, values of R27E, R91Q, H170C, R223L, and N306Y for PGD, were increased from 15 to 110, 145, 75, 180, and 100 mu M, respectively, indicating that Arg(27), Arg(91), His(170), Arg(223), and Asn(306) are essential to give a low Ii, value for PGD, of the liver-type PGF synthase and that these amino acid residues serve in the binding of PGD,. Moreover, the R223L mutant among these seven mutants especially has a profound effect on k(cat) for PGD(2) reduction. The K-m values of R223L, K225S, and S301R for PQ were about 2-10-fold lower than the wild-type value, indicating that the amino acid residues at 223, 225 and 301 serve in the binding of PQ to the enzyme. On the other hand, the K-m value of H170C for PGH(2) was 8-fold lower than that of the wild type, indicating that the amino acid residue at 170 is related to the binding of PGH(2) to the enzyme and that Cys(170) confer high affinity for PGH,. Additionally, the B-fold increase in k(cat)/K-m value of the N306Y mutant for PGH(2) compared with the wild-type value suggests that the amino acid at 306 plays an important role in catalytic efficiency for PGH(2).	Osaka Biosci Inst, Dept 2, Osaka 5650874, Japan; Fukui Med Sch, Fukui 9101103, Japan; Japan Tobacco Inc, Cent Pharmaceut Res Inst, Osaka 5691125, Japan; Cardiovasc Inst, Dept Biochem, Beijing 100037, Peoples R China; Fu Wai Hosp, Beijing 100037, Peoples R China; Mochida Pharmaceut Co, Biosci Res Lab, Tokyo 1150043, Japan	University of Fukui; Japan Tobacco Inc.; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Mochida Pharmaceutical Co Ltd	Watanabe, K (corresponding author), Osaka Biosci Inst, Dept 2, 6-2-4 Furuedai, Osaka 5650874, Japan.	watanaki@obisun1.obi.or.jp	Miyano, Masashi/R-2785-2016	Miyano, Masashi/0000-0003-2253-6175; Fujii, Yutaka/0000-0001-6357-3795				ATHARI A, 1994, HEPATOLOGY, V20, P142, DOI 10.1016/0270-9139(94)90146-5; BECKH K, 1994, HEPATOLOGY, V19, P1208, DOI 10.1002/hep.1840190519; BOHREN KM, 1994, BIOCHEMISTRY-US, V33, P2021, DOI 10.1021/bi00174a007; BOHREN KM, 1992, J BIOL CHEM, V267, P20965; BOLCSAK LE, 1983, J BIOL CHEM, V258, P7252; CHEN LY, 1992, ARCH BIOCHEM BIOPHYS, V296, P17, DOI 10.1016/0003-9861(92)90539-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dajani OF, 1996, J CELL PHYSIOL, V168, P608, DOI 10.1002/(SICI)1097-4652(199609)168:3<608::AID-JCP13>3.0.CO;2-V; DEYASHIKI Y, 1994, BIOCHEM J, V299, P545, DOI 10.1042/bj2990545; DEYASHIKI Y, 1992, BIOCHEM J, V282, P741, DOI 10.1042/bj2820741; Hara A, 1996, BIOCHEM J, V313, P373, DOI 10.1042/bj3130373; HARA A, 1990, J BIOCHEM-TOKYO, V108, P250, DOI 10.1093/oxfordjournals.jbchem.a123189; HOOG SS, 1994, P NATL ACAD SCI USA, V91, P2517, DOI 10.1073/pnas.91.7.2517; HYMAN AL, 1969, J PHARMACOL EXP THER, V165, P267; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jez JM, 1996, J BIOL CHEM, V271, P30190, DOI 10.1074/jbc.271.47.30190; JONES DH, 1990, NATURE, V344, P793, DOI 10.1038/344793a0; KLEIN J, 1992, EUR J BIOCHEM, V205, P1155, DOI 10.1111/j.1432-1033.1992.tb16885.x; KUCHINKE W, 1992, BIOCHEM BIOPH RES CO, V183, P1238, DOI 10.1016/S0006-291X(05)80323-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATHE AA, 1977, PROSTAGLANDINS, V3, P169; MATSUURA K, 1987, BIOCHIM BIOPHYS ACTA, V912, P270, DOI 10.1016/0167-4838(87)90097-5; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; NANJO H, 1995, BBA-GEN SUBJECTS, V1244, P53, DOI 10.1016/0304-4165(94)00195-4; OLEG AB, 1996, BIOCHEMISTRY-US, V35, P14276; PENNING TM, 1984, BIOCHEM J, V222, P601, DOI 10.1042/bj2220601; REFSNES M, 1994, J CELL PHYSIOL, V159, P35, DOI 10.1002/jcp.1041590106; RONDEAU JM, 1992, NATURE, V355, P469, DOI 10.1038/355469a0; STOLZ A, 1993, J BIOL CHEM, V268, P10448; STOLZ A, 1989, ANNU REV PHYSIOL, V51, P161, DOI 10.1146/annurev.ph.51.030189.001113; TERADA T, 1996, ADV EXP MED BIOL, V414, P545; VOGEL K, 1980, J BIOL CHEM, V255, P9621; WATANABE K, 1986, P NATL ACAD SCI USA, V83, P1583, DOI 10.1073/pnas.83.6.1583; WATANABE K, 1985, J BIOL CHEM, V260, P7035; WATANABE K, 1988, P NATL ACAD SCI USA, V85, P11, DOI 10.1073/pnas.85.1.11; WILSON DK, 1992, SCIENCE, V257, P81, DOI 10.1126/science.1621098; YOSHIMOTO T, 1977, J BIOL CHEM, V252, P5871	37	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					241	248		10.1074/jbc.274.1.241	http://dx.doi.org/10.1074/jbc.274.1.241			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867836	hybrid			2022-12-27	WOS:000077900200036
J	Zhang, XA; Hemler, ME				Zhang, XA; Hemler, ME			Interaction of the integrin beta(1) cytoplasmic domain with ICAP-1 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; MONOCLONAL-ANTIBODIES; FIBRONECTIN RECEPTOR; SIGNAL-TRANSDUCTION; ADHESION; EXPRESSION; KINASE; SUBUNIT; ACTIVATION; PEPTIDES	In a yeast two-hybrid screen, a protein named ICAP-1 (beta(1) integrin cytoplasmic domain associated protein) associated with the integrin beta(1) cytoplasmic tail but not with tails from three other integrin beta subunits (beta(2), beta(3), and beta(5)) or from seven different a subunits, Likewise in human cells, ICAP-1 associated specifically with the beta(1) but not beta(2), beta(3), Or beta(5) tails. The carboxyl-terminal 14 amino acids of beta(1) were critical for ICAP-1 interaction. ICAP-1 is a ubiquitously expressed protein of 27 and 31 kDa, with the smaller form being preferentially solubilized by Triton X-100. Phosphorylation of both 27- and 31-kDa forms was constitutive but was increased by 1.5-2-fold upon cell spreading on fibronectin, compared with poly-L-lysine. Also, ICAP-1 contributes to beta(1) integrin-dependent migration because (i) ICAP-1 transfection markedly increased chemotactic migration of COS7 cells through fibronectin-coated but not vitronectin-coated porous filters, and (ii) support of beta(1)-dependent cell migration (in Chinese hamster ovary cells transfected with various wild type and mutant beta(1) forms) correlated with ICAP-1 association. In summary, ICAP-1 (i) associates specifically with beta(1) integrins, (ii) is phosphorylated upon beta(1) integrin-mediated adhesion, and (iii) may regulate beta(1) dependent cell migration.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Hemler, ME (corresponding author), Dana Farber Canc Inst, Rm D-1410,44 Binney St, Boston, MA 02115 USA.	Hemler@dfci.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046526] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46526] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Assoian RK, 1997, J CELL BIOL, V136, P1, DOI 10.1083/jcb.136.1.1; AUSUBEL FM, CURRENT PROTOCOLS MO, P94; BALZAC F, 1993, J CELL BIOL, V121, P171, DOI 10.1083/jcb.121.1.171; BALZAC F, 1994, J CELL BIOL, V127, P557, DOI 10.1083/jcb.127.2.557; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Bazzoni G, 1996, J CLIN INVEST, V98, P521, DOI 10.1172/JCI118820; Belkin AM, 1996, J CELL BIOL, V132, P211, DOI 10.1083/jcb.132.1.211; Berditchevski F, 1997, J BIOL CHEM, V272, P29174, DOI 10.1074/jbc.272.46.29174; BROWN PJ, 1988, EXP CELL RES, V177, P303, DOI 10.1016/0014-4827(88)90464-8; BUYON JP, 1990, J IMMUNOL, V144, P191; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chang DD, 1997, J CELL BIOL, V138, P1149, DOI 10.1083/jcb.138.5.1149; CHEN YP, 1994, J BIOL CHEM, V269, P18307; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; Crommie D, 1998, J CELL BIOCHEM, V71, P63, DOI 10.1002/(SICI)1097-4644(19981001)71:1<63::AID-JCB7>3.0.CO;2-#; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; FAULL RJ, 1995, STEM CELLS, V13, P38, DOI 10.1002/stem.5530130106; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GLASS DB, 1986, J BIOL CHEM, V261, P2987; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; HAYASHI Y, 1990, J CELL BIOL, V110, P175, DOI 10.1083/jcb.110.1.175; Hemler M.E, 1994, INTEGRINS BIOL PROBL, P1; HEMLER ME, 1983, J IMMUNOL, V131, P334; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; KAUFMAN RJ, 1982, J MOL BIOL, V159, P601, DOI 10.1016/0022-2836(82)90103-6; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAFLAMME SE, 1994, J CELL BIOL, V126, P1287, DOI 10.1083/jcb.126.5.1287; LANGUINO LR, 1992, J BIOL CHEM, V267, P7116; LEMKE H, 1978, NATURE, V271, P249, DOI 10.1038/271249a0; LEWIS JM, 1995, MOL BIOL CELL, V6, P151, DOI 10.1091/mbc.6.2.151; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; LUB M, 1995, IMMUNOL TODAY, V16, P479, DOI 10.1016/0167-5699(95)80031-X; LUKASHEV ME, 1994, J BIOL CHEM, V269, P18311; MARCANTONIO EE, 1990, CELL REGUL, V1, P597, DOI 10.1091/mbc.1.8.597; MEREDITH J, 1995, SCIENCE, V269, P1570, DOI 10.1126/science.7545312; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; OTEY CA, 1993, J BIOL CHEM, V268, P21193; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; PASQUALINI R, 1994, J CELL BIOL, V125, P447, DOI 10.1083/jcb.125.2.447; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; PuzonMcLaughlin W, 1996, J BIOL CHEM, V271, P16580, DOI 10.1074/jbc.271.28.16580; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0; Sastry SK, 1993, CURR OPIN CELL BIOL, V5, P819, DOI 10.1016/0955-0674(93)90031-K; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SHATTIL SJ, 1995, J CELL BIOL, V131, P807, DOI 10.1083/jcb.131.3.807; Shattil SJ, 1997, J CLIN INVEST, V100, P1, DOI 10.1172/JCI119500; Shimizu Y, 1996, IMMUNOL TODAY, V17, P565, DOI 10.1016/S0167-5699(96)10061-X; SMILENOV L, 1994, MOL BIOL CELL, V5, P1215, DOI 10.1091/mbc.5.11.1215; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; Tanaka T, 1996, FEBS LETT, V399, P53, DOI 10.1016/S0014-5793(96)01280-X; VanNhieu GT, 1996, J BIOL CHEM, V271, P7665, DOI 10.1074/jbc.271.13.7665; Williams Michael J., 1994, Trends in Cell Biology, V4, P109, DOI 10.1016/0962-8924(94)90059-0; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; Zheng DQ, 1997, KIDNEY INT, V51, P1434, DOI 10.1038/ki.1997.196	66	76	80	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					11	19		10.1074/jbc.274.1.11	http://dx.doi.org/10.1074/jbc.274.1.11			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867804	hybrid			2022-12-27	WOS:000077900200004
J	Hood, JK; Silver, PA				Hood, JK; Silver, PA			Cse1p is required for export of Srp1p/importin-alpha from the nucleus in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; MESSENGER-RNA EXPORT; BINDING-PROTEINS; IMPORTIN-BETA; PORE COMPLEX; CHROMOSOME CONDENSATION; TRANSPORT FACTORS; RAN/TC4 HOMOLOG; POLY(A)(+) RNA; YEAST MUTANT	In metazoan cells, the CAS protein has been shown to function as a recycling factor for the importin-alpha subunit of the classical nuclear localization signal receptor, exporting importin-alpha from the nucleus to allow its participation in multiple rounds of nuclear import. CAS is a member of a family of proteins that bear homology to the larger subunit of the nuclear localization signal receptor, importin-beta, and that are found in all eukaryotes from yeast to humans. Sequence similarity identifies the product of the Saccharomyces cerevisiae CSE1 gene as a potential CAS homologue. Here we present evidence that Cse1p is the functional homologue of GAS: Cse1p is required to prevent accumulation of Srplp/importin-a: in the nucleus, it localizes to the nuclear envelope in a pattern typical of nuclear transport receptors, and it associates in vivo with Srp1p in a nucleotide-specific manner. We show further that mutations in CSE1 and SRP1 have specific effects on their association and on the intracellular localization of Cse1p.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Silver, PA (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	pamela_silver@dfci.harvard.edu						ADAM EJH, 1994, J CELL BIOL, V125, P547, DOI 10.1083/jcb.125.3.547; AEBI M, 1990, MOL GEN GENET, V224, P72, DOI 10.1007/BF00259453; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; AMBERG DC, 1993, EMBO J, V12, P233, DOI 10.1002/j.1460-2075.1993.tb05649.x; ATKINSON NS, 1985, MOL CELL BIOL, V5, P907, DOI 10.1128/MCB.5.5.907; Ausubel FM, 1998, CURRENT PROTOCOLS MO; BECKER J, 1995, J BIOL CHEM, V270, P11860, DOI 10.1074/jbc.270.20.11860; BELHUMEUR P, 1993, MOL CELL BIOL, V13, P2152, DOI 10.1128/MCB.13.4.2152; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; Chi NC, 1997, J BIOL CHEM, V272, P6818, DOI 10.1074/jbc.272.10.6818; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Corbett AH, 1997, MICROBIOL MOL BIOL R, V61, P193, DOI 10.1128/.61.2.193-211.1997; CORBETT AH, 1995, J CELL BIOL, V130, P1017, DOI 10.1083/jcb.130.5.1017; DAVIS LI, 1990, CELL, V61, P965, DOI 10.1016/0092-8674(90)90062-J; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; FLEISCHMANN M, 1991, MOL GEN GENET, V227, P417, DOI 10.1007/BF00273932; GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; IMAMOTO N, 1995, EMBO J, V14, P3617, DOI 10.1002/j.1460-2075.1995.tb00031.x; Izaurralde E, 1998, RNA, V4, P351; KADOWAKI T, 1992, P NATL ACAD SCI USA, V89, P2312, DOI 10.1073/pnas.89.6.2312; KADOWAKI T, 1993, EMBO J, V12, P2929, DOI 10.1002/j.1460-2075.1993.tb05955.x; Koepp DM, 1996, J CELL BIOL, V133, P1163, DOI 10.1083/jcb.133.6.1163; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI O, 1995, MOL BIOL CELL, V6, P401, DOI 10.1091/mbc.6.4.401; LOEB JDJ, 1995, P NATL ACAD SCI USA, V92, P7647, DOI 10.1073/pnas.92.17.7647; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P2008, DOI 10.1073/pnas.92.6.2008; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; SCHLENSTEDT G, 1995, P NATL ACAD SCI USA, V92, P225, DOI 10.1073/pnas.92.1.225; Schlenstedt G, 1997, EMBO J, V16, P6237, DOI 10.1093/emboj/16.20.6237; Seedorf M, 1997, P NATL ACAD SCI USA, V94, P8590, DOI 10.1073/pnas.94.16.8590; Simos G, 1996, EMBO J, V15, P2270, DOI 10.1002/j.1460-2075.1996.tb00580.x; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Taura T, 1998, P NATL ACAD SCI USA, V95, P7427, DOI 10.1073/pnas.95.13.7427; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3; XIAO ZX, 1993, MOL CELL BIOL, V13, P4691, DOI 10.1128/MCB.13.8.4691; YANO R, 1994, P NATL ACAD SCI USA, V91, P6880, DOI 10.1073/pnas.91.15.6880	46	105	108	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35142	35146		10.1074/jbc.273.52.35142	http://dx.doi.org/10.1074/jbc.273.52.35142			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857050	hybrid			2022-12-27	WOS:000077719700068
J	McCarthy, GM; Augustine, JA; Baldwin, AS; Christopherson, PA; Cheung, HS; Westfall, PR; Scheinman, RI				McCarthy, GM; Augustine, JA; Baldwin, AS; Christopherson, PA; Cheung, HS; Westfall, PR; Scheinman, RI			Molecular mechanism of basic calcium phosphate crystal-induced activation of human fibroblasts - Role of nuclear factor kappa B, activator protein 1, and protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTION FACTOR; HYDROXYAPATITE CRYSTALS; GLUCOCORTICOID RECEPTOR; NEUTROPHIL ACTIVATION; COLLAGENASE GENE; DNA-BINDING; INDUCTION; JUN	Synovial fluid basic calcium phosphate (BCP) crystals are markers of severe joint degeneration in osteoarthritis. BCP crystals cause mitogenesis of articular cells and stimulate matrix metalloprotease production, thus promoting degradation of articular tissues. Previous work suggested that BCP crystal-induced cell activation required intracellular crystal dissolution induction of proto-oncogene expression, and activation of signal transduction pathways involving protein kinase C and mitogen-activated protein kinases. Here we further elucidate the mechanisms of BCP crystal-induced cell activation as ECP crystals activate transcription factors nuclear factor KB and activator protein 1 in human fibroblasts. We confirm the role of protein kinase C in BCP crystal-induced mitogenesis in human fibroblasts. In contrast, we demonstrate that BCP crystals do not activate signal transduction pathways involving protein tyrosine kinases or phosphatidylinositol S-kinase. These data further define the mechanism of cell activation by BCP crystals and confirm its selectivity, an observation that may have therapeutic implications.	Med Coll Wisconsin, Dept Med Rheumatol, Milwaukee, WI 53226 USA; Blood Res Inst, Milwaukee, WI 53226 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Miami, FL 33125 USA; Univ Miami, Sch Med, Dept Med Arthrit, Miami, FL 33125 USA; Univ Colorado, Hlth Sci Ctr, Sch Pharm, Denver, CO 80262 USA	Medical College of Wisconsin; Versiti Blood Center of Wisconsin; University of North Carolina; University of North Carolina Chapel Hill; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Miami; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	McCarthy, GM (corresponding author), Royal Coll Surgeons Ireland, Dept Clin Pharmacol, 123 St Stephens Green, Dublin 2, Ireland.		McCarthy, Geraldine/AFQ-5733-2022	McCarthy, Geraldine/0000-0003-4078-8499	NIAMS NIH HHS [AR-38421, AR-01953] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001953, R01AR038421] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALBERTS B, 1994, MOL BIOL CELL, P721; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; AUBLE DT, 1991, BIOCHEMISTRY-US, V30, P4629, DOI 10.1021/bi00232a039; AUGUSTINE JA, 1991, MOL CELL BIOL, V11, P4431, DOI 10.1128/MCB.11.9.4431; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BALDWIN AS, 1991, MOL CELL BIOL, V11, P4943, DOI 10.1128/MCB.11.10.4943; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; CARROLL GJ, 1991, J RHEUMATOL, V18, P861; CASE JP, 1990, J IMMUNOL, V145, P3755; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEUNG HS, 1984, ARTHRITIS RHEUM-US, V27, P668, DOI 10.1002/art.1780270610; Cheung HS, 1996, BBA-MOL BASIS DIS, V1315, P105, DOI 10.1016/0925-4439(95)00106-9; CHEUNG HS, 1985, EXP CELL RES, V157, P63, DOI 10.1016/0014-4827(85)90152-1; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; DAVIS LG, 1986, BASIC METHODS MOL BI, P143; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; EVANS RW, 1984, CALCIFIED TISSUE INT, V36, P645, DOI 10.1007/BF02405384; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAUDRY M, 1993, J CLIN INVEST, V91, P1649, DOI 10.1172/JCI116373; Gescher A, 1995, TOXICOL LETT, V82-3, P159, DOI 10.1016/0378-4274(95)03475-7; GUSOVSKY F, 1991, MOL PHARMACOL, V39, P124; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; HALVERSON PB, 1986, ANN RHEUM DIS, V45, P603, DOI 10.1136/ard.45.7.603; HALVERSON PB, 1997, ARTHRITIS ALLIED CON, P2127; HANNUN YA, 1985, J BIOL CHEM, V260, P39; Jackson JK, 1997, J RHEUMATOL, V24, P341; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Jones A, 1996, ANN RHEUM DIS, V55, P829, DOI 10.1136/ard.55.11.829; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUCIBELLO FC, 1990, EMBO J, V9, P2827, DOI 10.1002/j.1460-2075.1990.tb07471.x; MCCARTHY GM, 1991, ARTHRITIS RHEUM-US, V34, P1021, DOI 10.1002/art.1780340812; MCCARTHY GM, 1992, J CELL PHYSIOL, V153, P140, DOI 10.1002/jcp.1041530118; McCarthy GM, 1998, OSTEOARTHR CARTILAGE, V6, P205, DOI 10.1053/joca.1998.0113; McCarthy GM, 1997, ARTHRITIS RHEUM-US, V40, P103; McCarthy GM, 1998, ANN RHEUM DIS, V57, P56, DOI 10.1136/ard.57.1.56; MCCARTY DJ, 1981, ARTHRITIS RHEUM, V24, P464, DOI 10.1002/art.1780240303; MCDONNELL SE, 1990, MOL CELL BIOL, V10, P4284, DOI 10.1128/MCB.10.8.4284; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MITCHELL PG, 1989, J BIOL CHEM, V264, P14071; MITCHELL PG, 1992, ARTHRITIS RHEUM, V35, P343, DOI 10.1002/art.1780350314; MITCHELL PG, 1993, BIOCHEM BIOPH RES CO, V196, P1133, DOI 10.1006/bbrc.1993.2369; Nair D, 1997, J BIOL CHEM, V272, P18920, DOI 10.1074/jbc.272.30.18920; RIMM AA, 1980, BASIC BIOSTATISTICS, P267; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; ROTHENBERG RJ, 1988, AM J PHYSIOL, V254, pC554, DOI 10.1152/ajpcell.1988.254.4.C554; SCHEINMAN RI, 1993, MOL CELL BIOL, V13, P6089, DOI 10.1128/MCB.13.10.6089; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; TAMAOKI T, 1991, METHOD ENZYMOL, V201, P340; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; ZHANG BP, 1992, ARTHRITIS RHEUM, V35, pS49	64	55	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35161	35169		10.1074/jbc.273.52.35161	http://dx.doi.org/10.1074/jbc.273.52.35161			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857053	hybrid			2022-12-27	WOS:000077719700071
J	Pearce, SFA; Roy, P; Nicholson, AC; Hajjar, DP; Febbraio, M; Silverstein, RL				Pearce, SFA; Roy, P; Nicholson, AC; Hajjar, DP; Febbraio, M; Silverstein, RL			Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; CHAIN FATTY-ACIDS; ENDOTHELIAL-CELLS; ATHEROSCLEROTIC LESIONS; MEMBRANE-PROTEIN; GLYCOPROTEIN-IV; POTENTIAL ROLE; HUMAN CD36; MALARIAL CYTOADHERENCE; ANIONIC PHOSPHOLIPIDS	CD36 is a multifunctional cell-surface receptor that binds adhesion molecules such as thrombospondin-l and collagen and modified lipids and/or lipoproteins. It participates in cellular uptake of photoreceptor outer segments and scavenging of apoptotic cells and oxidized low density lipoprotein (Ox-LDL). Recognition and internalization of Ox-LDL by mononuclear phagocytes may play an important role in the development of atherosclerotic lesions. We have utilized a series of recombinant bacterial glutathione S-transferase/CD36 fusion proteins that span nearly all of the CD36 molecule to characterize the structural domain on CD36 that recognizes Ox-LDL, We found that the Ox-LDL-binding domain is different from the thrombospondin-l-binding domain located at amino acids 93-120. A fusion protein containing the region extending from amino acids 5 to 143 formed specific, saturable, and reversible complexes with Ox-LDL, As with intact CD36, binding was blocked by excess unlabeled Ox-LDL and antibodies to CD36. The stoichiometry and affinity of the fusion protein for Ox-LDL were similar to those of the intact protein. We also demonstrated that this fusion protein competitively inhibited binding of Ox-LDL to purified platelet CD36 and to CD36 expressed on peripheral blood monocytes and CD36 cDNA-transfected melanoma cells, The use of smaller peptides and fusion proteins including those spanning amino acids 28-93 and 5-93 has further narrowed the binding site to a region from amino acids 28 to 93, although participation of a sequence in the noncontiguous region 120-155 cannot be excluded, This study, for the first time, demonstrates unique regions of the scavenger receptor CD36 that bind the Ox-LDL ligand, Our structural analysis of the receptor provides information as to potential control of the trafficking of modified Lipoproteins into the blood vessel wall.	Cornell Univ, Coll Med, Div Hematol Oncol, Dept Med, New York, NY 10021 USA; Cornell Univ, Coll Med, Dept Pathol, New York, NY 10021 USA	Cornell University; Cornell University	Pearce, SFA (corresponding author), Cornell Univ, Coll Med, Div Hematol Oncol, Dept Med, Rm C606,1300 York Ave, New York, NY 10021 USA.		Eckhardt, Erik/G-1567-2010		NCRR NIH HHS [RR00085] Funding Source: Medline; NHLBI NIH HHS [HL 52540, HL 46403] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046403] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; ACTON S, 1994, J BIOL CHEM, V260, P21003; ALESSIO M, 1993, BLOOD, V82, P3637; Argos Patrick, 1994, Current Opinion in Biotechnology, V5, P361, DOI 10.1016/0958-1669(94)90044-2; ASCH AS, 1992, BIOCHEM BIOPH RES CO, V182, P1208, DOI 10.1016/0006-291X(92)91860-S; ASCH AS, 1991, J BIOL CHEM, V266, P1740; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; ASCH AS, 1993, SCIENCE, V262, P1436, DOI 10.1126/science.7504322; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; BARNWELL JW, 1985, J IMMUNOL, V135, P3494; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BRITTAIN HA, 1993, BLOOD, V81, P2137; CLEMETSON KJ, 1985, PLATELET MEMBRANE GL, P51; CLEZARDIN P, 1993, CANCER RES, V53, P1421; CLINTON SK, 1992, AM J PATHOL, V140, P301; Crombie R, 1998, J BIOL CHEM, V273, P4855, DOI 10.1074/jbc.273.9.4855; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; DAVIET L, 1995, BIOCHEM J, V305, P221, DOI 10.1042/bj3050221; Daviet L, 1997, EUR J BIOCHEM, V243, P344, DOI 10.1111/j.1432-1033.1997.0344a.x; Daviet L, 1996, PLATELETS, V7, P117, DOI 10.3109/09537109609023570; Deigner HP, 1996, FEBS LETT, V385, P149, DOI 10.1016/0014-5793(96)00371-7; EDELMAN P, 1986, BLOOD, V67, P56; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; FAGIOTTO A, 1984, ARTERIOSCLEROSIS, V4, P323; FEI HH, 1993, ARTERIOSCLER THROMB, V13, P1711, DOI 10.1161/01.ATV.13.11.1711; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GREENWALT DE, 1990, BIOCHEMISTRY-US, V29, P7054, DOI 10.1021/bi00482a015; HANDUNNETTI SM, 1992, BLOOD, V80, P2097; HAVEL RJ, 1962, J LIPID RES, V3, P297; Huh HY, 1996, BLOOD, V87, P2020; KATSUDA S, 1993, AM J PATHOL, V142, P1787; KHAN BV, 1995, J CLIN INVEST, V95, P1262, DOI 10.1172/JCI117776; KNOWLES DM, 1984, J IMMUNOL, V132, P2170; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; LEATHERBARROW RJ, ENZFITTER; LEUNG LLK, 1992, J BIOL CHEM, V267, P18244; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; MCMURRAY HF, 1993, J CLIN INVEST, V92, P1004, DOI 10.1172/JCI116605; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Navazo MDP, 1996, J BIOL CHEM, V271, P15381, DOI 10.1074/jbc.271.26.15381; Navazo MDP, 1996, ARTERIOSCL THROM VAS, V16, P1033, DOI 10.1161/01.ATV.16.8.1033; NICHOLSON AC, 1995, ARTERIOSCLER THOMB V, V15, P1; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; OTTNAD E, 1995, P NATL ACAD SCI USA, V92, P1391, DOI 10.1073/pnas.92.5.1391; PARTHASARATHY S, 1987, P NATL ACAD SCI USA, V84, P537, DOI 10.1073/pnas.84.2.537; PARTHASARATHY S, 1992, ANNU REV MED, V43, P219, DOI 10.1146/annurev.me.43.020192.001251; PEARCE SFA, 1995, J BIOL CHEM, V270, P2981, DOI 10.1074/jbc.270.7.2981; QUINN MT, 1987, P NATL ACAD SCI USA, V84, P2995, DOI 10.1073/pnas.84.9.2995; RAJAVASHISTH T, 1990, NATURE, V345, P254; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; RhinehartJones T, 1996, ARCH BIOCHEM BIOPHYS, V326, P115, DOI 10.1006/abbi.1996.0054; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Ryeom SW, 1996, J CELL SCI, V109, P387; Ryeom SW, 1996, J BIOL CHEM, V271, P20536, DOI 10.1074/jbc.271.34.20536; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; SILVERSTEIN RL, 1987, J CLIN INVEST, V79, P867, DOI 10.1172/JCI112896; SILVERSTEIN RL, 1989, J CLIN INVEST, V84, P546, DOI 10.1172/JCI114197; SILVERSTEIN RL, 1992, J BIOL CHEM, V267, P16607; SMITH RF, 1992, PROTEIN ENG, V5, P35, DOI 10.1093/protein/5.1.35; STANTON LW, 1992, J BIOL CHEM, V267, P22446; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; TANDON NN, 1989, J BIOL CHEM, V264, P7576; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; VEGA MA, 1991, J BIOL CHEM, V266, P16818; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; WRIGHT SD, 1982, J EXP MED, V156, P1149, DOI 10.1084/jem.156.4.1149; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Yoshida H, 1998, ARTERIOSCL THROM VAS, V18, P794, DOI 10.1161/01.ATV.18.5.794	73	51	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34875	34881		10.1074/jbc.273.52.34875	http://dx.doi.org/10.1074/jbc.273.52.34875			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857015	hybrid			2022-12-27	WOS:000077719700033
J	Viswanathan, M; Dower, KW; Lovett, ST				Viswanathan, M; Dower, KW; Lovett, ST			Identification of a potent DNase activity associated with RNase T of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECJ GENE; PURIFICATION; POLYMERASE; PROCESSIVITY; MECHANISM; END	RNase T was first identified as an enzyme responsible for end turnover of tRNA in Escherichia coli, Its activity, specific for tRNA-C-C-A, catalyzes the release of tRNA-C-C and AMP. RNase T, along with several other RNases, plays a role in maturation of several other RNA species by a similar limited nuclease activity. In previous work, we identified the gene for RNase T, mt, as a high copy suppressor of the UV sensitivity conferred by deficiency in three single-strand DNA-specific exonucleases, RecJ, exonuclease I, and exonuclease VII, This suggested that RNase T may process DNA substrates as well. In this work, we show that purified RNase T possesses a potent 3' to 5' single-strand DNA-specific exonucleolytic activity. Its K-m for single-strand DNA substrates is many orders of magnitude lower than that for tRNA, suggesting that single-strand DNA may be a natural biological substrate for RNase T, We suggest that the DNase activity of RNase T may play a role in end trimming reactions during DNA recombination and/or DNA repair.	Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Lovett, ST (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.		Lovett, Susan/AAC-1810-2021	Lovett, Susan/0000-0003-2792-1857	NIGMS NIH HHS [GM07122, R01 GM43889] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043889, T32GM007122] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM, 1989, SHORT PROTOCOLS MOL; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRODY RS, 1986, J BIOL CHEM, V261, P7136; CHASE JW, 1974, J BIOL CHEM, V249, P4553; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; DEUTSCHER MP, 1985, P NATL ACAD SCI USA, V82, P6427, DOI 10.1073/pnas.82.19.6427; DEUTSCHER MP, 1985, J BIOL CHEM, V260, P7067; GUTMAN PD, 1993, NUCLEIC ACIDS RES, V21, P4406, DOI 10.1093/nar/21.18.4406; Haggerty TJ, 1997, J BACTERIOL, V179, P6705, DOI 10.1128/jb.179.21.6705-6713.1997; HOLLINGSWORTH HC, 1991, J BIOL CHEM, V266, P1888; KOONIN EV, 1997, CURR BIOL, V7, P604; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; LI ZW, 1995, P NATL ACAD SCI USA, V92, P6883, DOI 10.1073/pnas.92.15.6883; Li ZW, 1996, J BIOL CHEM, V271, P1133, DOI 10.1074/jbc.271.2.1133; LI ZW, 1994, J BIOL CHEM, V269, P6064; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; PADMANABHA KP, 1991, J BACTERIOL, V173, P1376, DOI 10.1128/jb.173.4.1376-1381.1991; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; THOMAS KR, 1978, J BIOL CHEM, V253, P424; Viswanathan M, 1998, GENETICS, V149, P7	23	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35126	35131		10.1074/jbc.273.52.35126	http://dx.doi.org/10.1074/jbc.273.52.35126			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857048	hybrid			2022-12-27	WOS:000077719700066
J	Doyle, MP; Apostol, I; Kerwin, BA				Doyle, MP; Apostol, I; Kerwin, BA			Glutaraldehyde modification of recombinant human hemoglobin alters its hemodynamic properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKED HEMOGLOBIN; POLYMERIZED PYRIDOXYLATED HEMOGLOBIN; STROMA-FREE HEMOGLOBIN; BLOOD SUBSTITUTE; SYSTEMIC HEMODYNAMICS; NITRIC-OXIDE; REGIONAL CIRCULATION; EXCHANGE-TRANSFUSION; ESCHERICHIA-COLI; RATS	Many cell-free hemoglobin solutions designed as oxygen-carrying therapeutics produce a hypertensive effect in animals. The response is likely due to oxidation of nitric oxide by hemoglobin. Since the site of oxidation may lie outside the vascular compartment, we tested the hypothesis that polymerization of hemoglobin, rHb1.1, by glutaraldehyde would attenuate the hypertensive response. Two products of the cross-linking reaction were isolated, a glutaraldehyde-derivatized monomer (mono-glxrHb) and a glutaraldehyde cross-linked polymer (poly-glxrHb), and evaluated for their effects on systemic hemodynamics in conscious rats. Administration of rHb1.1 caused a mean arterial pressure elevation of approximately 20 mm Hg and an increase in total peripheral resistance of approximately 30%. Administration of mono-glxrHb induced changes in mean arterial pressure and vascular resistance that were significantly diminished relative to those observed with rHb1.1. Poly-glxrHb elicited a mean arterial pressure response that was further reduced compared with that obtained with mono-glxrHb and a change in vascular resistance that was the same as the response to mono-glxrHb. These results suggest that rHb peripheral vasoconstriction elicited by rHb1.1 is significantly attenuated by glutaraldehyde modification of the hemoglobin monomer and that the effect of glutaraldehyde polymerization is likely due to surface modification and/or intramolecular cross-linking, rather than an increase in molecular size.	Baxter Healthcare Corp, Boulder, CO 80301 USA	Baxter International Inc	Kerwin, BA (corresponding author), Amgen Inc, 1 Amgen Ctr Dr,MS 8-1-C, Thousand Oaks, CA 91320 USA.							Abassi Z, 1997, J LAB CLIN MED, V129, P603, DOI 10.1016/S0022-2143(97)90194-3; ANDERSEN ME, 1971, J BIOL CHEM, V246, P2796; Apostol I, 1997, J BIOL CHEM, V272, P28980, DOI 10.1074/jbc.272.46.28980; Barve A, 1997, ARTIF CELL BLOOD SUB, V25, P75, DOI 10.3109/10731199709118899; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; BUNN HF, 1969, J EXP MED, V129, P909, DOI 10.1084/jem.129.5.909; Bunn HF, 1986, HEMOGLOBIN MOL GENET; DEVENUTO F, 1983, J SURG RES, V34, P205, DOI 10.1016/0022-4804(83)90061-6; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; DOYLE MP, 1991, AM J PHYSIOL, V260, pR1114, DOI 10.1152/ajpregu.1991.260.6.R1114; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Evelyn KA, 1938, J BIOL CHEM, V126, P655; FREAS W, 1995, J LAB CLIN MED, V125, P762; GARDINER SM, 1990, AM J PHYSIOL, V259, pH448, DOI 10.1152/ajpheart.1990.259.2.H448; GEOGHEGAN KF, 1981, INT J PEPT PROT RES, V17, P345; GOULD SA, 1990, ANN SURG, V211, P394, DOI 10.1097/00000658-199004000-00003; Gould SA, 1996, WORLD J SURG, V20, P1200; GULATI A, 1994, LIFE SCI, V55, P827, DOI 10.1016/0024-3205(94)00566-4; HABEEB AFS, 1968, ARCH BIOCHEM BIOPHYS, V126, P16, DOI 10.1016/0003-9861(68)90554-7; HAMILTON PB, 1947, J EXP MED, V86, P477, DOI 10.1084/jem.86.6.477; HOFFMAN SJ, 1990, P NATL ACAD SCI USA, V87, P8521, DOI 10.1073/pnas.87.21.8521; KATSUYAMA SS, 1994, ARTIF CELL BLOOD SUB, V22, P1, DOI 10.3109/10731199409117396; KEIPERT P, 1982, INT J ARTIF ORGANS, V5, P383, DOI 10.1177/039139888200500612; KEIPERT PE, 1993, TRANSFUSION, V33, P701, DOI 10.1046/j.1537-2995.1993.33994025016.x; KEIPERT PE, 1992, OXYGEN TRANSPORT TIS, V14, P43; KIDA Y, 1995, ARTIF ORGANS, V19, P511, DOI 10.1111/j.1525-1594.1995.tb02371.x; Kroeger KS, 1997, STRUCTURE, V5, P227, DOI 10.1016/S0969-2126(97)00181-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lippincott J, 1997, ANAL BIOCHEM, V252, P314, DOI 10.1006/abio.1997.2334; LOOKER D, 1992, NATURE, V356, P258, DOI 10.1038/356258a0; MACDONALD SL, 1994, METHOD ENZYMOL, V231, P287; MACDONALD VW, 1994, ARTIF CELL BLOOD SUB, V22, P565, DOI 10.3109/10731199409117885; March J., 1977, ADV ORGANIC CHEM REA; Migita R, 1997, J APPL PHYSIOL, V82, P1995, DOI 10.1152/jappl.1997.82.6.1995; MILICI AJ, 1987, J CELL BIOL, V105, P2603, DOI 10.1083/jcb.105.6.2603; MONCADA S, 1991, PHARMACOL REV, V43, P109; MOTTERLINI R, 1993, J APPL PHYSIOL, V75, P2224, DOI 10.1152/jappl.1993.75.5.2224; NAGEL RL, 1971, J BIOL CHEM, V246, P69; Predescu SA, 1997, AM J PHYSIOL-HEART C, V272, pH937, DOI 10.1152/ajpheart.1997.272.2.H937; RABINER SF, 1967, J EXP MED, V126, P1127, DOI 10.1084/jem.126.6.1127; RIOUX F, 1994, J CARDIOVASC PHARM, V24, P229, DOI 10.1097/00005344-199424020-00006; SCHNITZER JE, 1994, J BIOL CHEM, V269, P6072; SEHGAL LR, 1984, SURGERY, V95, P433; SHARMA AC, 1994, J LAB CLIN MED, V123, P299; SHARMA AC, 1995, AM J PHYSIOL-HEART C, V269, pH1379, DOI 10.1152/ajpheart.1995.269.4.H1379; SNYDER SR, 1991, BIOTECHNOLOGY BLOOD, P101; Tedgui A, 1996, PROSTAG LEUKOTR ESS, V54, P27, DOI 10.1016/S0952-3278(96)90077-0; Tentori L, 1981, Methods Enzymol, V76, P707, DOI 10.1016/0076-6879(81)76152-4; TSUCHIDA E, 1995, ARTIFICIAL RED CELLS, P1; VANDEGRIFF KD, 1995, BLOOD SUBSTITUTES, P143; VELKY TS, 1987, ARCH SURG-CHICAGO, V122, P355; Winslow R.M, 1992, HEMOGLOBIN BASED RED; WINSLOW RM, 1989, RED CELL, P305; WITKOWSKA HE, 1993, HEMOGLOBIN, V17, P227, DOI 10.3109/03630269308998897	55	47	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2583	2591		10.1074/jbc.274.4.2583	http://dx.doi.org/10.1074/jbc.274.4.2583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891031	hybrid			2022-12-27	WOS:000078185200098
J	Lerea, KM; Cordero, KP; Sakariassen, KS; Kirk, RI; Fried, VA				Lerea, KM; Cordero, KP; Sakariassen, KS; Kirk, RI; Fried, VA			Phosphorylation sites in the integrin beta(3) cytoplasmic domain in intact platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; SURFACE-BOUND FIBRINOGEN; PHOSPHATASE INHIBITORS; PROTEIN PHOSPHATASE-1; OKADAIC ACID; CALYCULIN-A; RECEPTOR; AGGREGATION; ACTIVATION; BINDING	Protein seryl/threonyl phosphatase inhibitors such as calyculin A block inside-out and outside-in platelet signaling. Our studies demonstrate that the addition of calyculin A blocks platelet adhesion and spreading on fibrinogen, responses that depend on integrin alpha(IIb)beta(3) signaling. We hypothesized that this reflects a change in alpha(IIb)beta(3) structure caused by a specific state of phosphorylation. We show that addition of calyculin A leads to increased phosphorylation of the beta(3) subunit, and phosphoamino acid analysis reveals that only threonine residues become phosphorylated; sequence analysis by Edman degradation established that threonine 753 became stoichiometrically phosphorylated during inhibition of platelet phosphatases by calyculin A. This region of beta(3) is linked to outside-in signaling such as platelet spreading responses. The effect of calyculin A on platelet adhesion and spreading and on the phosphorylation of T-753 in beta(3) is reversed by the calcium ionophore A23187, demonstrating that these effects of calyculin A are not generally toxic ones. We propose that phosphorylation of beta(3) on threonine 753, a region of beta(3) linked to outside-in signaling, may be a mechanism by which integrin alpha(IIb)beta(3) function is regulated.	New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; Univ Oslo, Dept Biol, N-0317 Oslo, Norway	New York Medical College; University of Oslo	Lerea, KM (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Basic Sci Bldg, Valhalla, NY 10595 USA.	ken_lerea@nymc.edu	Lerea, Ken/GWU-8597-2022		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL044893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029542] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL4489301] Funding Source: Medline; NINDS NIH HHS [NS29542] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEUMER S, 1994, BLOOD, V84, P3724, DOI 10.1182/blood.V84.11.3724.bloodjournal84113724; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CHEN YP, 1994, BLOOD, V84, P1857; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; CHIANG TM, 1993, ARCH BIOCHEM BIOPHYS, V302, P56, DOI 10.1006/abbi.1993.1180; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; GOTO S, 1995, J BIOL CHEM, V270, P23352, DOI 10.1074/jbc.270.40.23352; HILLERY CA, 1991, J BIOL CHEM, V266, P14663; HOYT CH, 1995, BIOCHEMISTRY-US, V34, P9565, DOI 10.1021/bi00029a033; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; KIRCHHOFER D, 1990, J BIOL CHEM, V265, P18525; KOIKE Y, 1994, CELL CALCIUM, V15, P381, DOI 10.1016/0143-4160(94)90013-2; Kroll MH, 1996, BLOOD, V88, P1525; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; LEREA KM, 1992, BIOCHEMISTRY-US, V31, P6553, DOI 10.1021/bi00143a027; LEREA KM, 1991, BIOCHEMISTRY-US, V30, P6819, DOI 10.1021/bi00242a003; MURATA K, 1993, J CELL BIOCHEM, V51, P442, DOI 10.1002/jcb.2400510409; NISHIKAWA M, 1994, CELL SIGNAL, V6, P59, DOI 10.1016/0898-6568(94)90061-2; PARISE LV, 1990, BLOOD, V75, P2363; PASQUALINI R, 1994, J CELL BIOL, V125, P447, DOI 10.1083/jcb.125.2.447; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Rosenfeld SJ, 1997, ACTA HAEMATOL-BASEL, V97, P118; Ruggeri ZM, 1997, THROMB HAEMOSTASIS, V78, P611; SAKARIASSEN KS, 1990, ARTERIOSCLEROSIS, V10, P276, DOI 10.1161/01.ATV.10.2.276; SAKON M, 1993, BIOCHEM BIOPH RES CO, V195, P139, DOI 10.1006/bbrc.1993.2021; SAVAGE B, 1991, J BIOL CHEM, V266, P11227; SIESS W, 1989, PHYSIOL REV, V69, P58, DOI 10.1152/physrev.1989.69.1.58; TALLANT EA, 1985, J BIOL CHEM, V260, P7744; TALMADGE K, 1980, P NATL ACAD SCI-BIOL, V77, P3988, DOI 10.1073/pnas.77.7.3988; vanWilligen G, 1996, BIOCHEM J, V314, P769, DOI 10.1042/bj3140769; YANO Y, 1994, BIOCHEM J, V299, P303, DOI 10.1042/bj2990303; Zaidi TN, 1996, BLOOD, V88, P2967, DOI 10.1182/blood.V88.8.2967.bloodjournal8882967	33	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1914	1919		10.1074/jbc.274.4.1914	http://dx.doi.org/10.1074/jbc.274.4.1914			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890945	hybrid			2022-12-27	WOS:000078185200012
J	Matsumoto, K; Ebihara, K; Yamamoto, H; Tabuchi, H; Fukunaga, K; Yasunami, M; Ohkubo, H; Shichiri, M; Miyamoto, E				Matsumoto, K; Ebihara, K; Yamamoto, H; Tabuchi, H; Fukunaga, K; Yasunami, M; Ohkubo, H; Shichiri, M; Miyamoto, E			Cloning from insulinoma cells of synapsin I associated with insulin secretory granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; SYNAPTIC VESICLE PHOSPHOPROTEINS; NEURON-RESTRICTIVE SILENCER; PANCREATIC BETA-CELLS; SODIUM-CHANNEL GENE; BINDING-PROTEIN; CHROMOGRANIN-A; MIN6 CELLS; EXPRESSION; ISLETS	Synapsin I is a synaptic vesicle-associated protein involved in neurotransmitter release. The functions of this protein are apparently regulated by Ca2+/calmodulin-dependent protein kinase II (CaM kinase II). We reported evidence for CaM kinase II and a synapsin I-like protein present in mouse insulinoma MIN6 cells (Matsumoto, K., Fukunaga, K., Miyazaki, J., Shichiri, M., and Miyamoto, E. (1995) Endocrinology 136, 3784-3793), Phosphorylation of the synapsin I-like protein in these cells correlated with the activation of CaM kinase II and insulin secretion. In the present study, we screened the MING cDNA library with the full-length cDNA probe of rat brain synapsin Ia and obtained seven positive clones; the largest one was then sequenced. The largest open reading frame deduced from the cDNA sequence of 3695 base pairs encoded a polypeptide of 670 amino acids, which exhibited significant sequence similarity to rat synapsin Ib, The cDNA contained the same sequence as the first exon of the mouse synapsin I gene. These results indicate that synapsin Ib is present in MING cells. Synapsin I was expressed in normal rat islets, as determined by reverse transcriptase-polymerase chain reaction analysis. Immunoblot analysis after subcellular fractionation of MING cells demonstrated that synapsin Ib and delta subunit of CaM kinase II co-localized with insulin secretory granules. By analogy concerning regulation of neurotransmitter release, our results suggest that phosphorylation of synapsin I by CaM kinase II may induce the release of insulin from islet cells.	Kumamoto Univ, Sch Med, Dept Pharmacol, Kumamoto 8600811, Japan; Kumamoto Univ, Sch Med, Dept Metab Med, Kumamoto 8600811, Japan; Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Miyamoto, E (corresponding author), Kumamoto Univ, Sch Med, Dept Pharmacol, 2-2-1 Honjo, Kumamoto 8600811, Japan.	emiyamot@gpo.kumamoto-u.ac.jp						AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; ASHCROFT SJH, 1990, CELL SIGNAL, V2, P197, DOI 10.1016/0898-6568(90)90048-F; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; BLOOM FE, 1979, P NATL ACAD SCI USA, V76, P5982, DOI 10.1073/pnas.76.11.5982; CHIN LS, 1994, J BIOL CHEM, V269, P18507; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; DECAMILLI P, 1979, P NATL ACAD SCI USA, V76, P5977; Easom RA, 1997, ENDOCRINOLOGY, V138, P2359, DOI 10.1210/en.138.6.2359; Ebihara K, 1996, ENDOCRINOLOGY, V137, P5255, DOI 10.1210/en.137.12.5255; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HALL FL, 1990, J BIOL CHEM, V265, P6944; HAMAGUCHI K, 1990, DIABETES, V39, P415, DOI 10.2337/diabetes.39.4.415; HARRISON DE, 1986, BIOCHEM J, V237, P191, DOI 10.1042/bj2370191; HUGHES SJ, 1993, BIOCHEM J, V289, P795, DOI 10.1042/bj2890795; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; KATAGIRI H, 1995, J BIOL CHEM, V270, P4963, DOI 10.1074/jbc.270.10.4963; KOONTZ MA, 1993, SYNAPSE, V14, P268, DOI 10.1002/syn.890140405; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; LANDT M, 1982, ARCH BIOCHEM BIOPHYS, V213, P148, DOI 10.1016/0003-9861(82)90449-0; LI GD, 1992, MOL PHARMACOL, V42, P489; LI LA, 1993, P NATL ACAD SCI USA, V90, P1460, DOI 10.1073/pnas.90.4.1460; MANDELL JW, 1992, J NEUROSCI, V12, P1736; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; MATSUMOTO K, 1995, ENDOCRINOLOGY, V136, P3784, DOI 10.1210/en.136.9.3784; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mohlig M, 1997, ENDOCRINOLOGY, V138, P2577, DOI 10.1210/en.138.6.2577; MOORE HPH, 1983, CELL, V35, P531, DOI 10.1016/0092-8674(83)90187-3; MORIYAMA Y, 1995, FEBS LETT, V367, P233, DOI 10.1016/0014-5793(95)00559-R; NAVONE F, 1989, J CELL BIOL, V109, P3425, DOI 10.1083/jcb.109.6.3425; NIKI I, 1993, BIOCHEM BIOPH RES CO, V191, P255, DOI 10.1006/bbrc.1993.1210; ORCI L, 1982, DIABETES, V31, P538, DOI 10.2337/diab.31.6.538; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; RAJAN AS, 1990, DIABETES CARE, V13, P340, DOI 10.2337/diacare.13.3.340; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; Schoch S, 1996, J BIOL CHEM, V271, P3317, DOI 10.1074/jbc.271.6.3317; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; SUDHOF TC, 1990, J BIOL CHEM, V265, P7849; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; TAKAKI R, 1986, IN VITRO CELL DEV B, V22, P120; WATKINS DT, 1991, DIABETES, V40, P1063, DOI 10.2337/diabetes.40.8.1063; Weber E, 1996, J BIOL CHEM, V271, P6963, DOI 10.1074/jbc.271.12.6963; WENHAM RM, 1994, J BIOL CHEM, V269, P4947; WENHAM RM, 1992, BIOCHEM BIOPH RES CO, V189, P128, DOI 10.1016/0006-291X(92)91534-W; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; Yanagihara N, 1996, J BIOL CHEM, V271, P17463, DOI 10.1074/jbc.271.29.17463	52	42	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2053	2059		10.1074/jbc.274.4.2053	http://dx.doi.org/10.1074/jbc.274.4.2053			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890964	hybrid			2022-12-27	WOS:000078185200031
J	Argyris, EG; Vanderkooi, JM; Venkateswaran, PS; Kay, BK; Paterson, Y				Argyris, EG; Vanderkooi, JM; Venkateswaran, PS; Kay, BK; Paterson, Y			The connection domain is implicated in metalloporphyrin binding and inhibition of HIV reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RANDOM PEPTIDE LIBRARIES; PHAGE-DISPLAYED PEPTIDES; NONNUCLEOSIDE INHIBITORS; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; EPITOPE LIBRARY; HEME ANALOGS; IDENTIFICATION; REPLICATION	We have shown that heme and zinc protoporphyrin inhibit both human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) reverse transcriptases (RTs) and, in combination with other nucleoside and non-nucleoside inhibitors, exert an additive effect on HIV-1 RT inhibition. Screening of a phage peptide library against heme resulted in the isolation of a peptide with sequence similarity to sequence 398-407 from the connection subdomain of both HIV-1 and HIV-2 RTs, suggesting that this highly conserved region of HIV RTs corresponds to the binding site for metalloporphyrins and a new site for inhibition of enzyme activity Inclusion of a synthetic peptide corresponding to the exact sequence 398-407 of HIV-1 RT in RT inhibition assays had a protective effect on metalloporphyrin inhibition, as it was able to reverse the inhibitory effect of both metalloporphyrins on HIV-1 RT activity. Furthermore, intrinsic fluorescence assays indicated that these metalloporphyrins bind to synthetic peptide 398-407 as well as to intact dimeric HIV-1 RT. The identification of this novel inhibition site will help to expand our understanding of the rode of action of metalloporphyrins in RT inhibition and will assist in the design and development of more potent metalloporphyrin RT inhibitors for the management of HIV infection.	Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Johnson Res Fdn, Philadelphia, PA 19104 USA; Univ City Sci Ctr, Inst Antiviral Res, Philadelphia, PA 19104 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Wisconsin System; University of Wisconsin Madison	Paterson, Y (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Rm 323,Johnson Pavil 6076,36th & Hamilton Walk, Philadelphia, PA 19104 USA.	yvonne@mail.med.upenn.edu		Paterson, Yvonne/0000-0002-9406-4958	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031841] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM31841] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM NG, 1991, BLOOD REV, V5, P19, DOI 10.1016/0268-960X(91)90004-V; Adey NB, 1996, METHOD MOL CELL BIOL, V6, P34; Adey NB, 1997, BIOCHEM J, V324, P523, DOI 10.1042/bj3240523; AGRAWAL S, 1992, TRENDS BIOTECHNOL, V10, P152, DOI 10.1016/0167-7799(92)90203-8; Arnold E, 1996, Drug Des Discov, V13, P29; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; CRISELL P, 1993, NUCLEIC ACIDS RES, V21, P5251, DOI 10.1093/nar/21.22.5251; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Daniels Dion A., 1996, Methods (Orlando), V9, P494, DOI 10.1006/meth.1996.0057; DECLERCQ E, 1992, AIDS RES HUM RETROV, V8, P119, DOI 10.1089/aid.1992.8.119; DEDMAN JR, 1993, J BIOL CHEM, V268, P23025; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; DING JP, 1995, NAT STRUCT BIOL, V2, P407, DOI 10.1038/nsb0595-407; DIVITA G, 1994, J BIOL CHEM, V269, P13080; DUEWEKE TJ, 1993, P NATL ACAD SCI USA, V90, P4713, DOI 10.1073/pnas.90.10.4713; DYWAB A, 1993, EUR J IMMUNOL, V23, P3189; EISEN HN, 1971, METHODS IMMUNOLOGY I, V3, P395; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; FAN NS, 1995, FEBS LETT, V370, P59, DOI 10.1016/0014-5793(95)00793-9; FOLGORI A, 1994, EMBO J, V13, P2236, DOI 10.1002/j.1460-2075.1994.tb06501.x; Genin MJ, 1996, J MED CHEM, V39, P5267, DOI 10.1021/jm960269m; GOODCHILD J, 1988, P NATL ACAD SCI USA, V85, P5507, DOI 10.1073/pnas.85.15.5507; HAMMER J, 1992, J EXP MED, V176, P1007, DOI 10.1084/jem.176.4.1007; HARRISON J, 1993, BLOOD, V82, P3574; HEIDENREICH O, 1992, J BIOL CHEM, V267, P1904; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; JONCKHEERE H, 1994, J BIOL CHEM, V269, P25255; KAY BK, 1993, GENE, V128, P59, DOI 10.1016/0378-1119(93)90153-T; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lauvrak V, 1997, BIOL CHEM, V378, P1509, DOI 10.1515/bchm.1997.378.12.1509; LUTTON JD, 1991, LEUKEMIA LYMPHOMA, V5, P179, DOI 10.3109/10428199109068123; LUZZAGO A, 1993, GENE, V128, P51, DOI 10.1016/0378-1119(93)90152-S; MARSHALL WS, 1993, SCIENCE, V259, P1564, DOI 10.1126/science.7681216; Moore G. R., 1990, CYTOCHROMES C EVOLUT; MOORE WT, 1993, BIOL MASS SPECTROM, V22, P149, DOI 10.1002/bms.1200220303; NOVOGRODSKY A, 1989, J IMMUNOL, V143, P3981; Olmsted RA, 1996, J VIROL, V70, P3698, DOI 10.1128/JVI.70.6.3698-3705.1996; OLMSTED RA, 1989, P NATL ACAD SCI USA, V86, P8088, DOI 10.1073/pnas.86.20.8088; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; ROBERTS D, 1993, GENE, V128, P67, DOI 10.1016/0378-1119(93)90154-U; ROMERO DL, 1991, P NATL ACAD SCI USA, V88, P8806, DOI 10.1073/pnas.88.19.8806; SAYLE R, 1998, RASMOL VERSION 2 5; SCOTT JK, 1992, P NATL ACAD SCI USA, V89, P5398, DOI 10.1073/pnas.89.12.5398; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Sparks Andrew B., 1996, P227, DOI 10.1016/B978-012402380-2/50015-0; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Staudinger R, 1996, P ASSOC AM PHYSICIAN, V108, P47; TANTILLO C, 1994, J MOL BIOL, V243, P369, DOI 10.1006/jmbi.1994.1665; TUERK C, 1992, P NATL ACAD SCI USA, V89, P6988, DOI 10.1073/pnas.89.15.6988; WEISS G, 1993, P SOC EXP BIOL MED, V202, P470	50	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1549	1556		10.1074/jbc.274.3.1549	http://dx.doi.org/10.1074/jbc.274.3.1549			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880532	hybrid			2022-12-27	WOS:000079956900052
J	de los Santos, T; Hollingsworth, NM				de los Santos, T; Hollingsworth, NM			Red1p, a MEK1-dependent phosphoprotein that physically interacts with Hop1p during meiosis in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; ESCHERICHIA-COLI; PROTEIN; GENE; KINASE; HOMOLOG; DNA; PHOSPHORYLATION	The aptonemal complex (SC) is a proteinaceous structure formed between pairs of homologous chromosomes during prophase I of meiosis, The proper assembly of axial elements (AEs), lateral components of the SC, during meiosis in the yeast, Saccharomyces cerevisiae, is essential for wild-type levels of recombination and for the accurate segregation of chromosomes at the first meiotic division. Genetic experiments have indicated that the stoichiometry between two meiosis-specific components of AEs in S. cerevisiae, HOP1 and RED1, is critical for proper assembly and function of the SC. A third meiosis specific gene, MEK1, which encodes a putative serine/threonine protein kinase, is also important for proper AE function, suggesting that AE formation is regulated by phosphorylation, In this paper, we demonstrate that Mek1p is a functional kinase in vitro and that catalytic activity is an essential part of the meiotic function of Mek1 in vivo. Immunoblot analysis revealed that Red1p is a MEK1-dependent phosphoprotein, Co-immunoprecipitation experiments demonstrated that the interaction between Hop1p and Red1p is enhanced by the presence of MEK1. Thus, MEK1-dependent phosphorylation of Red1p facilitates the formation of Hop1p/Red1p hetero-oligomers, thereby enabling the formation of functional AEs.	SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hollingsworth, NM (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA.	nhollin@notes.cc.sunysb.edu	De+Los+Santos, Teresa/AAU-2840-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050717] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50717, R01 GM050717] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AJIMURA M, 1993, GENETICS, V133, P51; Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; BascomSlack CA, 1997, ADV GENET, V35, P253, DOI 10.1016/S0065-2660(08)60452-6; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; DOBSON MJ, 1994, J CELL SCI, V107, P2749; FRIEDMAN DB, 1994, GENETICS, V136, P449; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Heyting C, 1996, CURR OPIN CELL BIOL, V8, P389, DOI 10.1016/S0955-0674(96)80015-9; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; HOLLINGSWORTH NM, 1993, GENETICS, V133, P785; HOLLINGSWORTH NM, 1989, GENETICS, V121, P445; Hollingsworth NM, 1997, GENETICS, V147, P33; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; HUNTER T, 1991, METHOD ENZYMOL, V200, P3; Kironmai KM, 1998, MOL CELL BIOL, V18, P1424, DOI 10.1128/MCB.18.3.1424; LAMMERS JHM, 1995, CHROMOSOMA, V104, P154, DOI 10.1007/s004120050103; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; LEEM SH, 1992, NUCLEIC ACIDS RES, V20, P449, DOI 10.1093/nar/20.3.449; Maniatis T., 1982, MOL CLONING; MaoDraayer Y, 1996, GENETICS, V144, P71; Neiman AM, 1997, GENETICS, V145, P637; NEIMAN AM, 1994, P NATL ACAD SCI USA, V91, P3398, DOI 10.1073/pnas.91.8.3398; NEIMAN AM, GENETICS, V145, P637; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; ROCKMILL B, 1990, GENETICS, V126, P563; ROCKMILL B, 1991, GENE DEV, V5, P2392, DOI 10.1101/gad.5.12b.2392; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH M, 1985, ANNU REV GENET, V19, P423, DOI 10.1146/annurev.genet.19.1.423; Tarsounas M, 1997, MOL BIOL CELL, V8, P1405, DOI 10.1091/mbc.8.8.1405; VERSHON AK, 1992, MOL CELL BIOL, V12, P3706, DOI 10.1128/MCB.12.9.3706; VONWETTSTEIN D, 1984, ANNU REV GENET, V18, P331, DOI 10.1146/annurev.ge.18.120184.001555; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106	39	87	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1783	1790		10.1074/jbc.274.3.1783	http://dx.doi.org/10.1074/jbc.274.3.1783			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880561	hybrid			2022-12-27	WOS:000079956900081
J	McKay, RA; Miraglia, LJ; Cummins, LL; Owens, SR; Sasmor, H; Dean, NM				McKay, RA; Miraglia, LJ; Cummins, LL; Owens, SR; Sasmor, H; Dean, NM			Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; H-MEDIATED INHIBITION; ICAM-1 MESSENGER-RNA; SIGNAL-TRANSDUCTION; GENE INHIBITION; THERAPEUTIC AGENTS; ENDOTHELIAL-CELLS; PHORBOL ESTERS; OLIGODEOXYNUCLEOTIDES; TRANSLATION	The use of antisense oligonucleotides to inhibit the expression of targeted mRNA sequences is becoming increasingly commonplace. Although effective, the most widely used oligonucleotide modification (phosphorothioate) has some limitations. In previous studies we have described a 20-mer phosphorothioate oligodeoxynucleotide inhibitor of human protein kinase C-alpha expression, In an effort to identify improved antisense inhibitors of protein kinase C expression, a series of 2' modifications have been incorporated into the protein kinase C-alpha targeting oligonucleotide, and the effects on oligonucleotide biophysical characteristics and pharmacology evaluated. The incorporation of 2'-O-(2-methoxy)ethyl chemistry resulted in a number of significant improvements in oligonucleotide characteristics. These include an increase in hybridization affinity toward a complementary RNA (1.5 degrees C per modification) and an increase in resistance toward both 3'-exonuclease and intracellular nucleases, These improvements result in a substantial increase in oligonucleotide potency (>20-fold after 72 h), The most active compound identified was used to examine the role played by protein kinase C-alpha in mediating the phorbol ester-induced changes in c-fos, c-jun, and junB expression in A549 lung epithelial cells, Depletion of protein kinase C-alpha protein expression by this oligonucleotide lead to a reduction in c-jun expression but not c-fos or junB. These results demonstrate that 2'-O-(2-methoxy)ethyl-modified antisense oligonucleotides are 1) effective inhibitors of protein kinase C-alpha expression, and 2) represent a class of antisense oligonucleotide which are much more effective inhibitors of gene expression than the widely used phosphorothioate antisense oligodeoxynucleotides.	ISIS Pharmaceut, Dept Pharmacol, Carlsbad, CA 92008 USA; ISIS Pharmaceut, Dept Mol Pharmacol, Carlsbad, CA 92008 USA; ISIS Pharmaceut, Dept Analyt Phys Chem, Carlsbad, CA 92008 USA; ISIS Pharmaceut, Dept Med Chem, Carlsbad, CA 92008 USA	Isis Pharmaceuticals Inc; Isis Pharmaceuticals Inc; Isis Pharmaceuticals Inc; Isis Pharmaceuticals Inc	Dean, NM (corresponding author), ISIS Pharmaceut, Dept Pharmacol, 2280 Faraday Ave, Carlsbad, CA 92008 USA.							Agrawal Sudhir, 1995, Current Opinion in Biotechnology, V6, P12, DOI 10.1016/0958-1669(95)80003-4; Altmann KH, 1996, BIOCHEM SOC T, V24, P630, DOI 10.1042/bst0240630; Altmann KH, 1996, CHIMIA, V50, P168; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; BOIZIAU C, 1992, BIOCHEM SOC T, V20, P764, DOI 10.1042/bst0200764; BONHAM MA, 1995, NUCLEIC ACIDS RES, V23, P1197, DOI 10.1093/nar/23.7.1197; BORNER C, 1988, P NATL ACAD SCI USA, V85, P2110, DOI 10.1073/pnas.85.7.2110; BUCHNER K, 1995, EUR J BIOCHEM, V228, P211; CHIANG MY, 1991, J BIOL CHEM, V266, P18162; COOK PD, 1991, ANTI-CANCER DRUG DES, V6, P585; CROOKE ST, 1992, ANNU REV PHARMACOL, V32, P329; CROOKE ST, 1996, ADV PHARMACOL, V40, P1; CROOKE ST, 1995, BURGERS MED CHEM DRU, V1, P863; DEAN NM, 1994, P NATL ACAD SCI USA, V91, P11762, DOI 10.1073/pnas.91.24.11762; Dean NM, 1996, BIOCHEM SOC T, V24, P623, DOI 10.1042/bst0240623; Dean NM, 1997, ANTISENSE NUCLEIC A, V7, P229, DOI 10.1089/oli.1.1997.7.229; DEAN NM, 1994, J BIOL CHEM, V269, P16416; DEGITZ K, 1991, J BIOL CHEM, V266, P14024; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DOLNICK BJ, 1991, CANCER INVEST, V9, P185, DOI 10.3109/07357909109044229; Farina AR, 1997, CELL GROWTH DIFFER, V8, P789; Flanagan WM, 1996, NAT BIOTECHNOL, V14, P1139, DOI 10.1038/nbt0996-1139; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; FURDON PJ, 1989, NUCLEIC ACIDS RES, V17, P9193, DOI 10.1093/nar/17.22.9193; GILES RV, 1992, ANTI-CANCER DRUG DES, V7, P37; Gutierrez AJ, 1997, BIOCHEMISTRY-US, V36, P743, DOI 10.1021/bi9620971; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; INOUE H, 1987, FEBS LETT, V215, P327, DOI 10.1016/0014-5793(87)80171-0; IRIBARREN AM, 1990, P NATL ACAD SCI USA, V87, P7747, DOI 10.1073/pnas.87.19.7747; JOHANSSON HE, 1994, NUCLEIC ACIDS RES, V22, P4591, DOI 10.1093/nar/22.22.4591; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KAWASAKI AM, 1993, J MED CHEM, V36, P831, DOI 10.1021/jm00059a007; LAMOND AI, 1993, FEBS LETT, V325, P123, DOI 10.1016/0014-5793(93)81427-2; LARROUY B, 1992, GENE, V121, P189, DOI 10.1016/0378-1119(92)90121-5; LESNIK EA, 1993, BIOCHEMISTRY-US, V32, P7832, DOI 10.1021/bi00081a031; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; Lima WF, 1997, J BIOL CHEM, V272, P18191, DOI 10.1074/jbc.272.29.18191; Lima WF, 1997, J BIOL CHEM, V272, P27513, DOI 10.1074/jbc.272.44.27513; McGraw K, 1997, ANTI-CANCER DRUG DES, V12, P315; McKay RA, 1996, NUCLEIC ACIDS RES, V24, P411, DOI 10.1093/nar/24.3.411; Monia BP, 1996, J BIOL CHEM, V271, P14533, DOI 10.1074/jbc.271.24.14533; MONIA BP, 1993, J BIOL CHEM, V268, P14514; MOULDS C, 1995, BIOCHEMISTRY-US, V34, P5044, DOI 10.1021/bi00015a015; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NIELSEN PE, 1995, ANNU REV BIOPH BIOM, V24, P167, DOI 10.1146/annurev.bb.24.060195.001123; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; QUARTIN RS, 1989, NUCLEIC ACIDS RES, V17, P7253, DOI 10.1093/nar/17.18.7253; SANGHVI YS, 1992, NUCLEIC ACIDS RES S, V27, P133; SHIMAYAMA T, 1993, NUCLEIC ACIDS RES, V21, P2605, DOI 10.1093/nar/21.11.2605; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; STEIN CA, 1993, SCIENCE, V261, P1004, DOI 10.1126/science.8351515; Traub O, 1997, J BIOL CHEM, V272, P31251, DOI 10.1074/jbc.272.50.31251; Ueda E, 1996, J BIOL CHEM, V271, P9790, DOI 10.1074/jbc.271.16.9790; VANDESTOLPE A, 1994, J BIOL CHEM, V269, P6185; VORABERGER G, 1991, J IMMUNOL, V147, P2777; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; WAGNER RW, 1993, SCIENCE, V260, P1510, DOI 10.1126/science.7684856; WALDER RY, 1988, P NATL ACAD SCI USA, V85, P5011, DOI 10.1073/pnas.85.14.5011	60	199	220	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1715	1722		10.1074/jbc.274.3.1715	http://dx.doi.org/10.1074/jbc.274.3.1715			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880552	hybrid			2022-12-27	WOS:000079956900072
J	Attieh, ZK; Mukhopadhyay, CK; Seshadri, V; Tripoulas, NA; Fox, PL				Attieh, ZK; Mukhopadhyay, CK; Seshadri, V; Tripoulas, NA; Fox, PL			Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERRIN-BOUND IRON; RECEPTOR-MEDIATED ENDOCYTOSIS; SACCHAROMYCES-CEREVISIAE; K562 CELLS; MOLECULAR CHARACTERIZATION; TRANSCRIPTIONAL CONTROL; FERRIREDUCTASE ACTIVITY; HL-60 CELLS; FET3 GENE; HEMOCHROMATOSIS	The balance required to maintain appropriate cellular and tissue iron levels has led to the evolution of multiple mechanisms to precisely regulate iron uptake from transferrin and low molecular weight iron chelates. A role for ceruloplasmin (Cp) in vertebrate iron metabolism is suggested by its potent ferroxidase activity catalyzing conversion of Fe2+ to Fe3+, by identification of yeast copper oxidases homologous to Cp that facilitate high affinity iron uptake, and by studies of "aceruloplasminemic" patients who have extensive iron deposits in multiple tissues. We have recently shown that Cp increases iron uptake by cultured HepG2 cells. In this report, we investigated the mechanism by which Cp stimulates cellular iron uptake. Cp stimulated the rate of non-transferrin Fe-55 uptake by iron-deficient K562 cells by 2-3-fold, using a transferrin receptor-independent pathway. Induction of Cp-stimulated iron uptake by iron deficiency was blocked by actinomycin D and cycloheximide, consistent with a transcriptionally induced or regulated transporter. Cp-stimulated iron uptake was completely blocked by unlabeled Fe3+ and by other trivalent cations including A(3+), Ga3+, and Cr3+, but not by divalent cations. These results indicate that Cp utilizes a trivalent cation-specific transporter. Cp ferroxidase activity was required for iron uptake as shown by the ineffectiveness of two ferroxidase-deficient Cp preparations, copper-deficient Cp and thiomolybdate-treated Cp. We propose a model in which iron reduction and subsequent re-oxidation by Cp are essential for an iron uptake pathway with high ion specificity.	Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Fox, PL (corresponding author), Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	foxp@cesmtp.ccf.org			NHLBI NIH HHS [HL52692, HL29582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052692, P01HL029582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Askwith C, 1997, J BIOL CHEM, V272, P401; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Askwith CC, 1998, J BIOL CHEM, V273, P22415, DOI 10.1074/jbc.273.35.22415; BACON BR, 1988, ANN NY ACAD SCI, V526, P155, DOI 10.1111/j.1749-6632.1988.tb55502.x; BRITTON RS, 1994, IRON METABOLISM HLTH, P311; BROCK JH, 1994, IRON METABOLISM HLTH, P353; CHIDAMBARAM MV, 1984, J INORG BIOCHEM, V22, P231, DOI 10.1016/0162-0134(84)85008-4; CHITAMBAR CR, 1992, BLOOD, V80, P505; CIRIOLO MR, 1990, J BIOL CHEM, V265, P11030; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; Crowe A, 1996, BBA-GEN SUBJECTS, V1291, P53, DOI 10.1016/0304-4165(96)00044-X; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; DEJONG G, 1990, CLIN CHIM ACTA, V190, P1, DOI 10.1016/0009-8981(90)90278-Z; DeMaeyer E, 1985, World Health Stat Q, V38, P302; DESILVA DM, 1995, J BIOL CHEM, V270, P1098, DOI 10.1074/jbc.270.3.1098; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; GLAHN RP, 1995, J NUTR, V125, P1833, DOI 10.1093/jn/125.7.1833; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Gutierrez JA, 1997, J CELL BIOL, V139, P895, DOI 10.1083/jcb.139.4.895; HUBER CT, 1970, J BIOL CHEM, V245, P3979; INMAN RS, 1993, J BIOL CHEM, V268, P8521; INMAN RS, 1994, BIOCHEMISTRY-US, V33, P11850, DOI 10.1021/bi00205a022; JORDAN I, 1994, BIOCHEM J, V302, P875, DOI 10.1042/bj3020875; KAPLAN J, 1991, J BIOL CHEM, V266, P2997; Kaplan J, 1996, J CLIN INVEST, V98, P3, DOI 10.1172/JCI118772; Kaplan J, 1996, SCIENCE, V271, P1510, DOI 10.1126/science.271.5255.1510; KATAOKA M, 1985, EXP HEMATOL, V13, P806; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; MORITA H, 1995, ANN NEUROL, V37, P646, DOI 10.1002/ana.410370515; Mukhopadhyay CK, 1998, SCIENCE, V279, P714, DOI 10.1126/science.279.5351.714; Musci G, 1996, J BIOL CHEM, V271, P1972, DOI 10.1074/jbc.271.4.1972; Olakanmi O, 1997, J BIOL CHEM, V272, P2599, DOI 10.1074/jbc.272.5.2599; OSAKI S, 1966, J BIOL CHEM, V241, P2746; PERCIVAL SS, 1988, J TRACE ELEM EXP MED, V1, P63; RANDELL EW, 1994, J BIOL CHEM, V269, P16046; SCHEN RJ, 1966, CLIN CHIM ACTA, V13, P537, DOI 10.1016/0009-8981(66)90253-1; SCHLEGEL R, 1982, P NATL ACAD SCI-BIOL, V79, P2291, DOI 10.1073/pnas.79.7.2291; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; STEIN BS, 1986, J BIOL CHEM, V261, P319; STURROCK A, 1990, J BIOL CHEM, V265, P3139; TEICHMANN R, 1990, J CLIN INVEST, V86, P2145, DOI 10.1172/JCI114953; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YOSHIDA K, 1995, NAT GENET, V9, P267, DOI 10.1038/ng0395-267; Young SP, 1997, FEBS LETT, V411, P93, DOI 10.1016/S0014-5793(97)00478-X; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	48	117	122	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1116	1123		10.1074/jbc.274.2.1116	http://dx.doi.org/10.1074/jbc.274.2.1116			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873059	hybrid			2022-12-27	WOS:000077968500074
J	Barbara, NP; Wrana, JL; Letarte, M				Barbara, NP; Wrana, JL; Letarte, M			Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; SERINE THREONINE KINASE; BONE MORPHOGENETIC PROTEIN-4; RGD-CONTAINING GLYCOPROTEIN; HUMAN ENDOTHELIAL-CELLS; MAD-RELATED PROTEIN; TGF-BETA; I RECEPTORS; BINDING-PROTEIN; ACTIVIN RECEPTOR	Endoglin (CD105) is a transmembrane glycoprotein that binds transforming growth factor (TGF)-beta 1 and -beta 3, and coprecipitates with the Ser/Thr kinase signaling receptor complex by affinity labeling of endothelial and leukemic cells. The present study shows that in addition to TGF-beta 1 and -beta 3, endoglin interacts with activin-A, bone morphogenetic protein (BMP)-7, and BMP-2 but requires coexpression of the respective ligand binding kinase receptor for this association. Endoglin cannot bind ligands on its own and does not alter binding to the kinase receptors. It binds TGF-beta 1 and -beta 3 by associating with the TGF-P type II receptor and interacts with activin-A and BMP-7 via activin type II receptors, ActRII and ActBIIB, regardless of which type I receptor partner is coexpressed. However, endoglin binds BMP-2 by interacting with the ligand binding type I receptors, ALK3 and ALK6. The formation of heteromeric signaling complexes was not altered by the presence of endoglin, although it was coprecipitated with these complexes. Endoglin did not interact with BMP-7 through complexes containing the BMP type II receptor, demonstrating specificity of its action. Our data suggest that endoglin is an accessory protein of multiple kinase receptor complexes of the TGF-beta superfamily.	Hosp Sick Children, Canc & Blood Res Program, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Med Genet & Micorbiol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Letarte, M (corresponding author), Hosp Sick Children, Canc & Blood Res Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Wrana, Jeffrey/F-8857-2013					ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Attisano L, 1996, MOL CELL BIOL, V16, P1066; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Attisano Liliana, 1996, Cytokine and Growth Factor Reviews, V7, P327, DOI 10.1016/S1359-6101(96)00042-1; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; BELLON T, 1993, EUR J IMMUNOL, V23, P2340, DOI 10.1002/eji.1830230943; BUHRING HJ, 1991, LEUKEMIA, V5, P841; Caniggia I, 1997, ENDOCRINOLOGY, V138, P3976, DOI 10.1210/en.138.9.3976; Caniggia I, 1997, ENDOCRINOLOGY, V138, P4977, DOI 10.1210/en.138.11.4977; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CHEIFETZ S, 1988, J BIOL CHEM, V263, P10783; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; EBNER R, 1993, SCIENCE, V260, P1344, DOI 10.1126/science.8388127; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; FRANZEN P, 1995, BIOCHEM BIOPH RES CO, V207, P682, DOI 10.1006/bbrc.1995.1241; FROLIK CA, 1984, J BIOL CHEM, V259, P995; GOUGOS A, 1988, J IMMUNOL, V141, P1925; GOUGOS A, 1992, INT IMMUNOL, V4, P83, DOI 10.1093/intimm/4.1.83; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; IWASAKI S, 1995, J BIOL CHEM, V270, P5476, DOI 10.1074/jbc.270.10.5476; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Jones CM, 1996, CURR BIOL, V6, P1468, DOI 10.1016/S0960-9822(96)00751-8; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; LASTRES P, 1992, EUR J IMMUNOL, V22, P393, DOI 10.1002/eji.1830220216; LASTRES P, 1994, BIOCHEM J, V301, P765, DOI 10.1042/bj3010765; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; Letterio JJ, 1997, CLIN IMMUNOL IMMUNOP, V84, P244, DOI 10.1006/clin.1997.4409; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LIU F, 1995, MOL CELL BIOL, V15, P3479; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; MASSAGUE J, 1987, METHOD ENZYMOL, V146, P174; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MCCARTHY SA, 1993, J BIOL CHEM, V268, P23066; Miyazono K, 1997, INT J HEMATOL, V65, P97; MOREN A, 1992, BIOCHEM BIOPH RES CO, V189, P356, DOI 10.1016/0006-291X(92)91566-9; MULLER G, 1987, P NATL ACAD SCI USA, V84, P5600, DOI 10.1073/pnas.84.16.5600; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakaoka T, 1997, J CLIN INVEST, V100, P2824, DOI 10.1172/JCI119830; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; OETTGEN HC, 1986, NATURE, V320, P272, DOI 10.1038/320272a0; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; Pece N, 1997, J CLIN INVEST, V100, P2568, DOI 10.1172/JCI119800; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Pichuantes S, 1997, TISSUE ANTIGENS, V50, P265, DOI 10.1111/j.1399-0039.1997.tb02870.x; Qu R, 1998, CELL TISSUE RES, V292, P333, DOI 10.1007/s004410051064; Reddi A. Hari, 1997, Cytokine and Growth Factor Reviews, V8, P11, DOI 10.1016/S1359-6101(96)00049-4; ROBERTS AB, 1990, TRANSFORMING GROWTH; Robledo MM, 1996, BRIT J HAEMATOL, V93, P507, DOI 10.1046/j.1365-2141.1996.d01-1698.x; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Shovlin CL, 1997, THROMB HAEMOSTASIS, V78, P145; STJACQUES S, 1994, ENDOCRINOLOGY, V134, P2645, DOI 10.1210/en.134.6.2645; STJACQUES S, 1994, BIOL REPROD, V51, P405, DOI 10.1095/biolreprod51.3.405; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; TENDIJKE P, 1993, ONCOGENE, V8, P2879; Whitman M, 1997, NATURE, V389, P549, DOI 10.1038/39202; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Yamashita H, 1997, EXP CELL RES, V235, P218, DOI 10.1006/excr.1997.3664; YAMASHITA H, 1994, J BIOL CHEM, V269, P1995; Zhang HW, 1996, J IMMUNOL, V156, P565	78	442	466	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					584	594		10.1074/jbc.274.2.584	http://dx.doi.org/10.1074/jbc.274.2.584			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872992	hybrid			2022-12-27	WOS:000077968500007
J	Fischer, Y; Becker, C; Loken, C				Fischer, Y; Becker, C; Loken, C			Purinergic inhibition of glucose transport in cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT VENTRICULAR MYOCYTES; HEART-MUSCLE-CELLS; EXTRACELLULAR ATP; CARDIAC MYOCYTES; FUNCTIONAL EXPRESSION; ADENOSINE-TRIPHOSPHATE; P-2X RECEPTOR; ADIPOSE-CELLS; ION CHANNELS; GLUT4	ATP is known to act as an extracellular signal in many organs. In the heart, extracellular ATP modulates ionic processes and contractile function. This study describes a novel, metabolic effect of exogenous ATP in isolated rat cardiomyocytes, In these quiescent (i.e. noncontracting) cells, micromolar concentrations of ATP depressed the rate of basal, catecholamine stimulated, or insulin-stimulated glucose transport by up to 60% (IC50 for inhibition of insulin-dependent glucose transport, 4 mu M). ATP decreased the amount of glucose transporters (GLUT1 and GLUT4) in the plasma membrane, with a concomitant increase in intracellular microsomal membranes. A similar glucose transport inhibition was produced by P-2 purinergic agonists with the following rank of potencies: ATP approximate to ATP gamma S approximate to 2-methylthio-ATP (P-2Y-selective) > ADP > alpha,beta meATP (P-2X-selective), whereas the P-1 purinoceptor agonist adenosine was ineffective. The effect of ATP was suppressed by the poorly subtype-selective P-2 antagonist pyridoxal-phosphate-6-azophenyl-azophenyl-2',4'-disulfonic acid but, surprisingly, not by the nonselective antagonist suramin nor by the P-2Y-specific Reactive flue 2. Glucose transport inhibition by ATP was not affected by a drastic reduction of the extracellular concentrations of calcium (down to 10(-9) M) or so dium (down to 0 mM), and it was not mimicked by a potassium-induced depolarization, indicating that purinoceptors of the P-2X family (which are nonselective cation channels whose activation leads to a depolarizing sodium and calcium influx) are not involved. Inhibition was specific for the transmembrane transport of glucose because ATP did not inhibit (i) the rate of glycolysis under conditions where the transport step is no longer rate-limiting nor (ii) the rate of [1-C-14]pyruvate decarboxylation. In conclusion, extracellular ATP markedly inhibits glucose transport in rat cardiomyocytes by promoting a redistribution of glucose transporters from the cell surface to an intracellular compartment. This effect of ATP is mediated by P-2 purinoceptors, possibly by a yet unknown subtype of the P-2Y purinoceptor family.	Fac Med, Inst Physiol, D-52057 Aachen, Germany		Fischer, Y (corresponding author), Fac Med, Inst Physiol, Pauwelssstr 30, D-52057 Aachen, Germany.							ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; Babenko AP, 1997, BRIT J PHARMACOL, V120, P631, DOI 10.1038/sj.bjp.0700960; BEAN BP, 1992, TRENDS PHARMACOL SCI, V13, P87, DOI 10.1016/0165-6147(92)90032-2; BONTEMPS F, 1978, BIOCHEM J, V174, P603, DOI 10.1042/bj1740603; BORN GVR, 1984, J PHYSIOL-LONDON, V354, P419, DOI 10.1113/jphysiol.1984.sp015385; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; BURNSTOCK G, 1983, BRIT J PHARMACOL, V79, P211, DOI 10.1111/j.1476-5381.1983.tb10514.x; Burnstock G, 1996, CIBA F SYMP, V198, P1; CHRISTIE A, 1992, J PHYSIOL-LONDON, V445, P369, DOI 10.1113/jphysiol.1992.sp018929; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; DANZIGER RS, 1988, CELL CALCIUM, V9, P193, DOI 10.1016/0143-4160(88)90023-1; Eblenkamp M, 1996, LIFE SCI, V59, P141, DOI 10.1016/0024-3205(96)00270-6; Egert S, 1997, CARDIOVASC RES, V35, P283, DOI 10.1016/S0008-6363(97)00133-8; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FISCHER Y, 1991, LIFE SCI, V49, P1679, DOI 10.1016/0024-3205(91)90310-8; Fischer Y, 1997, BIOCHEM J, V321, P629, DOI 10.1042/bj3210629; FISCHER Y, 1995, ENDOCRINOLOGY, V136, P412, DOI 10.1210/en.136.2.412; Fischer Y, 1996, AM J PHYSIOL-CELL PH, V270, pC1211, DOI 10.1152/ajpcell.1996.270.4.C1211; Fischer Y, 1996, AM J PHYSIOL-CELL PH, V270, pC1204, DOI 10.1152/ajpcell.1996.270.4.C1204; Fischer Y, 1997, J BIOL CHEM, V272, P7085, DOI 10.1074/jbc.272.11.7085; FLEETWOOD G, 1987, BRIT J PHARMACOL, V90, P219, DOI 10.1111/j.1476-5381.1987.tb16843.x; FRIEL DD, 1990, PFLUG ARCH EUR J PHY, V415, P651, DOI 10.1007/BF02584001; GarciaGuzman M, 1996, FEBS LETT, V388, P123, DOI 10.1016/0014-5793(96)00499-1; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; HUE L, 1974, BIOCHEM BIOPH RES CO, V58, P532, DOI 10.1016/S0006-291X(74)80453-5; KANEDA M, 1994, BRIT J PHARMACOL, V111, P1355, DOI 10.1111/j.1476-5381.1994.tb14894.x; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; KOLTER T, 1992, BIOCHEM BIOPH RES CO, V189, P1207, DOI 10.1016/0006-291X(92)92333-S; Lambrecht G, 1996, J AUTON PHARMACOL, V16, P341, DOI 10.1111/j.1474-8673.1996.tb00049.x; LEGSSYER A, 1988, J PHYSIOL-LONDON, V401, P185, DOI 10.1113/jphysiol.1988.sp017157; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; MANCHESTER J, 1994, AM J PHYSIOL, V266, pE326, DOI 10.1152/ajpendo.1994.266.3.E326; MAY JM, 1988, J CELL PHYSIOL, V135, P332, DOI 10.1002/jcp.1041350222; Nicholas RA, 1996, MOL PHARMACOL, V50, P224; Podrasky E, 1997, AM J PHYSIOL-HEART C, V273, pH2380, DOI 10.1152/ajpheart.1997.273.5.H2380; Puceat M, 1996, BIOCHEM J, V318, P723, DOI 10.1042/bj3180723; PUCEAT M, 1991, BIOCHEM J, V274, P55, DOI 10.1042/bj2740055; PUCEAT M, 1991, J PHYSIOL-LONDON, V444, P241, DOI 10.1113/jphysiol.1991.sp018875; SATOH S, 1993, J BIOL CHEM, V268, P17820; SCAMPS F, 1990, CIRC RES, V67, P1007, DOI 10.1161/01.RES.67.4.1007; SCAMPS F, 1994, BRIT J PHARMACOL, V113, P982, DOI 10.1111/j.1476-5381.1994.tb17089.x; Skobel E, 1997, BBA-MOL BASIS DIS, V1362, P128, DOI 10.1016/S0925-4439(97)00060-4; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; SUN DQ, 1994, CIRCULATION, V89, P793, DOI 10.1161/01.CIR.89.2.793; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Vulchanova L, 1996, P NATL ACAD SCI USA, V93, P8063, DOI 10.1073/pnas.93.15.8063; Webb TE, 1996, J AUTON PHARMACOL, V16, P303, DOI 10.1111/j.1474-8673.1996.tb00040.x; WEBB TE, 1993, FEBS LETT, V324, P219, DOI 10.1016/0014-5793(93)81397-I; Wheeler T J, 1989, Prog Clin Biol Res, V292, P349; YAMADA M, 1992, CIRC RES, V70, P477, DOI 10.1161/01.RES.70.3.477; YEH JI, 1995, BIOCHEMISTRY-US, V34, P15523, DOI 10.1021/bi00047a018; Zhang BX, 1996, CIRC RES, V79, P94, DOI 10.1161/01.RES.79.1.94	53	28	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					755	761		10.1074/jbc.274.2.755	http://dx.doi.org/10.1074/jbc.274.2.755			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873012	hybrid			2022-12-27	WOS:000077968500027
J	Lorincz, MC; Parente, MK; Roederer, M; Nolan, GP; Diwu, ZJ; Martin, DIK; Herzenberg, LA; Wolfe, JH				Lorincz, MC; Parente, MK; Roederer, M; Nolan, GP; Diwu, ZJ; Martin, DIK; Herzenberg, LA; Wolfe, JH			Single cell analysis and selection of living retrovirus vector-corrected mucopolysaccharidosis VII cells using a fluorescence-activated cell sorting-based assay for mammalian beta-glucuronidase enzymatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW TRANSPLANTATION; MODIFIED SKIN FIBROBLASTS; MEDIATED GENE-TRANSFER; HEAT-STABLE ANTIGEN; LYSOSOMAL STORAGE; GAUCHER PATIENTS; MOUSE-BRAIN; DEFICIENCY; EXPRESSION; ENZYMES	Mutations in the acid beta-glucuronidase gene lead to systemic accumulation of undegraded glycosaminoglycans in lysosomes and ultimately to clinical manifestations of mucopolysaccharidosis VII (Sly disease). Gene transfer by retrovirus vectors into murine mucopolysaccharidosis VII hematopoietic stem cells or fibroblasts ameliorates glycosaminoglycan accumulation in some affected tissues. The efficacy of gene therapy for mucopolysaccharidosis VII depends on the levels of p-glucuronidase secreted by gene-corrected cells; therefore, enrichment of transduced cells expressing high levels of enzyme prior to transplantation is desirable. We describe the development of a fluorescence-activated cell sorter-based assay for the quantitative analysis of beta-glucuronidase activity in viable cells. Murine mucopolysaccharidosis VII cells transduced with a beta-glucuronidase retroviral vector can be isolated by cell sorting on the basis of beta-glucuronidase activity and cultured for further use. In vitro analysis revealed that sorted cells have elevated levels of beta-glucuronidase activity and secrete higher levels of cross-correcting enzyme than the population from which they were sorted. Transduced fibroblasts stably expressing beta-glucuronidase after subcutaneous passage in the mucopolysaccharidosis VII mouse can be isolated by cell sorting and expanded ex vivo. A relatively high percentage of these cells maintain stable expression after secondary transplantation, yielding significantly higher levels of enzymatic activity than that generated in the primary transplant.	Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Fred Hutchinson Canc Res Ctr, Div Mol Med, Seattle, WA 98019 USA	University of Pennsylvania; Stanford University; Stanford University; Stanford University; Fred Hutchinson Cancer Center	Wolfe, JH (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, 3800 Spruce St, Philadelphia, PA 19104 USA.		Roederer, Mario/G-1887-2011; Nolan, Garry/AAE-7903-2019	Lorincz, Matthew/0000-0003-0885-0467; Nolan, Garry/0000-0002-8862-9043	NATIONAL CANCER INSTITUTE [R35CA042509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042707, R01DK046637] Funding Source: NIH RePORTER; NCI NIH HHS [CA42509] Funding Source: Medline; NIDDK NIH HHS [DK46637, DK42707] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAM MA, 1991, J VIROL, V65, P4985, DOI 10.1128/JVI.65.9.4985-4990.1991; Aran JM, 1996, HUM GENE THER, V7, P2165, DOI 10.1089/hum.1996.7.17-2165; ARTELT P, 1991, GENE, V99, P249, DOI 10.1016/0378-1119(91)90134-W; BELL CE, 1977, J CLIN INVEST, V59, P97, DOI 10.1172/JCI108627; BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010; BIRKENMEIER EH, 1991, BLOOD, V78, P3081; BOWSER R, 1990, J CELL PHYSIOL, V143, P110, DOI 10.1002/jcp.1041430115; Casal ML, 1997, GENE THER, V4, P39, DOI 10.1038/sj.gt.3300352; CONKLIN KF, 1986, MOL CELL BIOL, V6, P3999, DOI 10.1128/MCB.6.11.3999; FEINSTEIN SC, 1982, J MOL BIOL, V156, P549, DOI 10.1016/0022-2836(82)90266-2; FISHMAN WH, 1967, NATURE, V213, P457, DOI 10.1038/213457a0; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; HASKINS ME, 1984, PEDIATR RES, V18, P980, DOI 10.1203/00006450-198418100-00014; HOLLEMANS M, 1981, BIOCHIM BIOPHYS ACTA, V643, P143; Hough MR, 1996, J IMMUNOL, V156, P479; HOUGH MR, 1994, J EXP MED, V179, P177, DOI 10.1084/jem.179.1.177; KNIGHT KR, 1992, J LEUKOCYTE BIOL, V51, P350, DOI 10.1002/jlb.51.4.350; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; LEVVY GA, 1952, BIOCHEM J, V52, P464, DOI 10.1042/bj0520464; Lorincz M, 1996, CYTOMETRY, V24, P321; LORINCZ ML, 1996, BLOOD, V89, P3412; Medin JA, 1996, BLOOD, V87, P1754, DOI 10.1182/blood.V87.5.1754.bloodjournal8751754; Migita M, 1995, P NATL ACAD SCI USA, V92, P12075, DOI 10.1073/pnas.92.26.12075; MOULLIER P, 1993, NAT GENET, V4, P154, DOI 10.1038/ng0693-154; NEUFELD EF, 1970, SCIENCE, V169, P141, DOI 10.1126/science.169.3941.141; Neufeld EF, 1995, METABOLIC MOL BASES, P2465; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; OLSEN I, 1990, EUR J IMMUNOL, V20, P2161, DOI 10.1002/eji.1830201003; OLSEN I, 1981, NATURE, V291, P244, DOI 10.1038/291244a0; PALMER TD, 1991, P NATL ACAD SCI USA, V88, P1330, DOI 10.1073/pnas.88.4.1330; PARKS DR, 1986, HDB EXPT IMMUNOLOGY; PODDA S, 1992, P NATL ACAD SCI USA, V89, P9676, DOI 10.1073/pnas.89.20.9676; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; ROEDERER M, 1987, J CELL PHYSIOL, V131, P200, DOI 10.1002/jcp.1041310209; SANDS MS, 1993, LAB INVEST, V68, P676; SANDS MS, 1994, J CLIN INVEST, V93, P2324, DOI 10.1172/JCI117237; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3; SNYDER EY, 1995, NATURE, V374, P367, DOI 10.1038/374367a0; STLOUIS D, 1988, P NATL ACAD SCI USA, V85, P3150; SUGIMOTO Y, 1994, BIO-TECHNOL, V12, P694, DOI 10.1038/nbt0794-694; SUMNER H, 1991, J IMMUNOL METHODS, V136, P259, DOI 10.1016/0022-1759(91)90012-5; TAYLOR RM, 1994, EXP CELL RES, V214, P606, DOI 10.1006/excr.1994.1298; Taylor RM, 1997, NAT MED, V3, P771, DOI 10.1038/nm0797-771; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952; Wakabayashi M., 1970, METABOLIC CONJUGATIO, P519; WOLFE JH, 1995, GENE THER, V2, P70; WOLFE JH, 1990, P NATL ACAD SCI USA, V87, P2877, DOI 10.1073/pnas.87.8.2877; WOLFE JH, 1992, NATURE, V360, P749, DOI 10.1038/360749a0	52	13	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					657	665		10.1074/jbc.274.2.657	http://dx.doi.org/10.1074/jbc.274.2.657			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872999	hybrid			2022-12-27	WOS:000077968500014
J	Franzoni, L; Nicastro, G; Pertinhez, TA; Oliveira, E; Nakaie, CR; Paiva, ACM; Schreier, S; Spisni, A				Franzoni, L; Nicastro, G; Pertinhez, TA; Oliveira, E; Nakaie, CR; Paiva, ACM; Schreier, S; Spisni, A			Structure of two fragments of the third cytoplasmic loop of the rat angiotensin II AT(1A) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; 3RD INTRACELLULAR LOOP; TYPE-1 RECEPTOR; CIRCULAR-DICHROISM; SYNTHETIC PEPTIDES; COUPLED RECEPTORS; BETA-ADRENOCEPTOR; CONFORMATIONAL-CHANGES; ADRENERGIC-RECEPTOR; REGULATORY PROTEINS	The structural bases that render the third intracellular loop (i3) of the rat angiotensin II AT,, receptor one of the cytoplasmic domains responsible for G-protein coupling are still unknown, The three-dimensional structures of two overlapping peptides mapping the entire i3 loop and shown to differently interact with purified G-proteins have been obtained by simulated annealing calculations, using NMR-derived constraints collected in 70% water/30% trifluoroethanol solution, While the NH2-terminal half, Ni3, residues 213-231, adopts a stable amphipathic alpha-helix, extending over almost the entire peptide, a more flexible conformation is found for the COOH-terminal half, Ci3, residues 227-242, For this peptide, a cis-trans isomerization around the Lys(6)-Pro(7) peptide bond generates two exchanging isomers adopting similar conformations, with an ct-helix spanning from Asn(9) to Ile(15) and a poorly defined NH, terminus. A quite distinct structural organization is found for the sequence EIQKN, common to Ni3 and Ci3, The data do suggest that the extension and orientation of the amphipathic cu-helix, present in the proximal part of i3, may be modulated by the distal part of the loop itself through the Pro(233) residue. A molecular model where this possibility is considered as a mechanism for G-protein selection and coupling is presented.	Univ Parma, Inst Biol Chem, I-43100 Parma, Italy; Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05599970 Sao Paulo, Brazil; Univ Fed Sao Paulo, Dept Biophys, BR-04044020 Sao Paulo, Brazil	University of Parma; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Spisni, A (corresponding author), Univ Parma, Inst Biol Chem, Via Volturno 39, I-43100 Parma, Italy.	aspin@ipruniv.cce.unipr.it	de Oliveira, Eliandre/K-5052-2014; Schreier, Shirley/F-7001-2014; Nakaie, Clovis R./B-3444-2014; Spisni, Alberto/AAY-7778-2020	de Oliveira, Eliandre/0000-0003-4771-5719; 				BALDWIN JM, 1994, CURR OPIN CELL BIOL, V6, P180, DOI 10.1016/0955-0674(94)90134-1; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Bukusoglu G, 1996, MOL CELL BIOL, V16, P4818; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; CHEUNG AH, 1991, FEBS LETT, V279, P277, DOI 10.1016/0014-5793(91)80167-2; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Cilli EM, 1996, J ORG CHEM, V61, P8992, DOI 10.1021/jo9611632; Conchon S, 1997, J BIOL CHEM, V272, P25566, DOI 10.1074/jbc.272.41.25566; CONCHON S, 1994, FEBS LETT, V349, P365, DOI 10.1016/0014-5793(94)00703-9; COTECCHIA S, 1992, J BIOL CHEM, V267, P1633; DALMAN HM, 1991, J BIOL CHEM, V266, P11025; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DONNELLY D, 1994, CURR OPIN STRUC BIOL, V4, P582, DOI 10.1016/S0959-440X(94)90221-6; DYSON HJ, 1992, J MOL BIOL, V226, P819, DOI 10.1016/0022-2836(92)90634-V; DYSON HJ, 1992, J MOL BIOL, V226, P795, DOI 10.1016/0022-2836(92)90633-U; DYSON HJ, 1988, J MOL BIOL, V201, P201, DOI 10.1016/0022-2836(88)90447-0; Eason MG, 1996, J BIOL CHEM, V271, P12826, DOI 10.1074/jbc.271.22.12826; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Franzoni L, 1997, J BIOL CHEM, V272, P9734; GETHER U, 1995, J BIOL CHEM, V270, P28268; GUAN XM, 1995, MOL PHARMACOL, V48, P492; GUIRAMAND J, 1995, J BIOL CHEM, V270, P7354, DOI 10.1074/jbc.270.13.7354; Han HMCB, 1998, MOL ENDOCRINOL, V12, P810, DOI 10.1210/me.12.6.810; Hargrave PA, 1991, CURR OPIN STRUC BIOL, V1, P575, DOI 10.1016/S0959-440X(05)80080-6; HAUSDORFF WP, 1990, J BIOL CHEM, V265, P1388; Hayashida W, 1996, J BIOL CHEM, V271, P21985, DOI 10.1074/jbc.271.36.21985; HIGASHIJIMA T, 1983, FEBS LETT, V152, P227, DOI 10.1016/0014-5793(83)80385-8; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; Inoue Y, 1997, J HYPERTENS, V15, P703, DOI 10.1097/00004872-199715070-00001; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; JIMENEZ MA, 1994, J MOL BIOL, V242, P487; JUNG H, 1995, FEBS LETT, V358, P133, DOI 10.1016/0014-5793(94)01409-T; Jung H, 1996, BIOCHEMISTRY-US, V35, P6399, DOI 10.1021/bi952575s; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kai H, 1998, BIOCHEM J, V332, P781, DOI 10.1042/bj3320781; KOBILKA KB, 1998, ADV PHARMACOL, V42, P470; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Mierke DF, 1996, J AM CHEM SOC, V118, P8998, DOI 10.1021/ja960454p; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; OHYAMA K, 1992, BIOCHEM BIOPH RES CO, V189, P677, DOI 10.1016/0006-291X(92)92254-U; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; PALM D, 1989, FEBS LETT, V254, P89, DOI 10.1016/0014-5793(89)81015-4; Pellegrini M, 1996, BIOPOLYMERS, V40, P653, DOI 10.1002/(SICI)1097-0282(1996)40:6<653::AID-BIP5>3.0.CO;2-V; Qian A, 1998, CELL SIGNAL, V10, P101, DOI 10.1016/S0898-6568(97)00097-1; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Sano T, 1997, J BIOL CHEM, V272, P23631, DOI 10.1074/jbc.272.38.23631; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; SHIRAI H, 1995, HYPERTENSION, V25, P726, DOI 10.1161/01.HYP.25.4.726; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Thompson JB, 1998, J PHARMACOL EXP THER, V285, P216; THURMOD LR, 1996, P NATL ACAD SCI USA, V94, P1715; TSENG MJ, 1995, J BIOL CHEM, V270, P17884, DOI 10.1074/jbc.270.30.17884; WAGNER T, 1995, FEBS LETT, V365, P13, DOI 10.1016/0014-5793(95)00435-C; WALTHO JP, 1993, BIOCHEMISTRY-US, V32, P6337, DOI 10.1021/bi00076a006; WANG CL, 1995, J BIOL CHEM, V270, P16677, DOI 10.1074/jbc.270.28.16677; WESS J, 1989, FEBS LETT, V258, P133, DOI 10.1016/0014-5793(89)81633-3; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yeagle PL, 1997, BIOCHEMISTRY-US, V36, P9649, DOI 10.1021/bi970908a; YEAGLE PL, 1995, BIOCHEMISTRY-US, V34, P14621, DOI 10.1021/bi00045a002; YEAGLE PL, 1995, NAT STRUCT BIOL, V2, P832, DOI 10.1038/nsb1095-832; Yeagle PL, 1997, BIOCHEMISTRY-US, V36, P3864, DOI 10.1021/bi962403a; ZHU BM, 1997, AM J PHYSIOL, V273, P1040	70	36	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					227	235		10.1074/jbc.274.1.227	http://dx.doi.org/10.1074/jbc.274.1.227			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867834	hybrid			2022-12-27	WOS:000077900200034
J	Abbott, DW; Holt, JT				Abbott, DW; Holt, JT			Mitogen-activated protein kinase kinase 2 activation is essential for progression through the G(2)/M checkpoint arrest in cells exposed to ionizing radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; ATAXIA-TELANGIECTASIA CELLS; ABL TYROSINE KINASE; NIH 3T3 CELLS; MAP KINASE; DNA-DAMAGE; C-ABL; CYCLE PROGRESSION; NIH-3T3 CELLS; PHOSPHORYLATION	An increasing body of evidence suggests that mitogen-induced activation of the RAF/ERK signaling pathway is functionally separate from the stress-induced activation of the SEK/JNK/p38 signaling pathway. In general, stress stimuli strongly activate the p38s and the JNKs while only weakly activating ERK1 and ERK2. However, a number of independent groups have now shown that the RAF/ERK signaling pathway is strongly activated by ionizing radiation. In this work, we examine this paradox. We show that both mitogen-activated protein (MAP) kinase kinase 1 (MEK1) and MAP kinase kinase 2 (MEK2) are activated by ionizing radiation. Blockage of this activation through the use of dominant negative MEK2 increases sensitivity of the cell to ionizing radiation and decreases the ability of a cell to recover from the G(2)/M cell cycle checkpoint arrest. Blocking MEK2 activation does not affect double-strand DNA break repair, however, Although MEK1 is activated to a lesser extent by ionizing radiation, expression of a dominant negative MEK1 does not affect radiation sensitivity of the cell, the G(2)/M checkpoint of the cell, or double-strand break repair. Because ionizing radiation leads to a different cell cycle arrest (G(2)/M arrest) than that typically seen with other stress stimuli, and because we have shown that MEK2 can affect G(2)/M checkpoint kinetics, these results provide an explanation for the observation that the MEKs can be strongly activated by ionizing radiation and only weakly activated by other stressful stimuli.	Vanderbilt Univ, Ctr Canc, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Cell Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Holt, JT (corresponding author), Vanderbilt Univ, Ctr Canc, 2220 Pierce Ave S,Rm 659 MRB 2, Nashville, TN 37232 USA.			Abbott, Derek/0000-0003-4387-8094	NATIONAL CANCER INSTITUTE [R01CA051735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA51735] Funding Source: Medline; NIGMS NIH HHS [5T32GM07347] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott DW, 1997, J BIOL CHEM, V272, P32454, DOI 10.1074/jbc.272.51.32454; Abbott DW, 1998, J NATL CANCER I, V90, P978, DOI 10.1093/jnci/90.13.978; Abbott DW, 1997, J BIOL CHEM, V272, P14005, DOI 10.1074/jbc.272.22.14005; Abrieu A, 1997, MOL BIOL CELL, V8, P249, DOI 10.1091/mbc.8.2.249; Abrieu A, 1997, EMBO J, V16, P6407, DOI 10.1093/emboj/16.21.6407; ALESSI DR, 1995, METHOD ENZYMOL, V255, P279; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ALLESSI DR, 1994, EMBO J, V13, P1610; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; BERNHARD EJ, 1995, RADIAT ENVIRON BIOPH, V34, P79, DOI 10.1007/BF01275210; BERNHARD EJ, 1994, RADIAT RES, V140, P193; Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; CHURCH DL, 1995, DEVELOPMENT, V121, P2525; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; DATTA R, 1992, P NATL ACAD SCI USA, V89, P10149, DOI 10.1073/pnas.89.21.10149; deMora JF, 1997, MOL CELL BIOL, V17, P6068, DOI 10.1128/MCB.17.10.6068; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Friedman LS, 1998, CANCER RES, V58, P1338; Fukasawa K, 1997, MOL CELL BIOL, V17, P506, DOI 10.1128/MCB.17.1.506; GOTOH Y, 1995, MOL REPROD DEV, V42, P486, DOI 10.1002/mrd.1080420417; GUAN KL, 1994, CELL SIGNAL, V6, P581, DOI 10.1016/0898-6568(94)90041-8; HAIN J, 1994, CELL SIGNAL, V6, P539, DOI 10.1016/0898-6568(94)90008-6; HALLAHAN DE, 1993, J BIOL CHEM, V268, P4903; Hallahan DE, 1995, J BIOL CHEM, V270, P30303, DOI 10.1074/jbc.270.51.30303; HALLAHAN DE, 1991, P NATL ACAD SCI USA, V88, P2156, DOI 10.1073/pnas.88.6.2156; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Jackson SP, 1996, CANCER SURV, V28, P261; Jhappan C, 1997, NAT GENET, V17, P483, DOI 10.1038/ng1297-483; Jin P, 1996, J CELL BIOL, V134, P963, DOI 10.1083/jcb.134.4.963; Kasid U, 1996, NATURE, V382, P813, DOI 10.1038/382813a0; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; KHARBANDA S, 1994, P NATL ACAD SCI USA, V91, P5416, DOI 10.1073/pnas.91.12.5416; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Lohrer HD, 1996, EXPERIENTIA, V52, P316, DOI 10.1007/BF01919534; Maity A, 1997, INT J RADIAT ONCOL, V37, P639, DOI 10.1016/S0360-3016(96)00598-6; Mansour SJ, 1996, CELL GROWTH DIFFER, V7, P243; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SEGER R, 1994, J BIOL CHEM, V269, P25699; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; SHAFMAN TD, 1995, CANCER RES, V55, P3242; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; SKLAR MD, 1988, SCIENCE, V239, P645, DOI 10.1126/science.3277276; STEVENSON MA, 1994, CANCER RES, V54, P12; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Suy S, 1997, ONCOGENE, V15, P53, DOI 10.1038/sj.onc.1201165; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; VERLHAC MH, 1993, DEV BIOL, V158, P330, DOI 10.1006/dbio.1993.1192; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; WINSTON BW, 1995, P NATL ACAD SCI USA, V92, P1614, DOI 10.1073/pnas.92.5.1614; WU J, 1993, MOL CELL BIOL, V13, P4539, DOI 10.1128/MCB.13.8.4539; YAN MH, 1994, NATURE, V372, P798; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yuan ZM, 1996, NATURE, V382, P272, DOI 10.1038/382272a0; Zanke BW, 1996, J BIOL CHEM, V271, P29876, DOI 10.1074/jbc.271.47.29876; ZHENG CF, 1993, J BIOL CHEM, V268, P11435	72	119	121	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2732	2742		10.1074/jbc.274.5.2732	http://dx.doi.org/10.1074/jbc.274.5.2732			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915804	hybrid			2022-12-27	WOS:000078319500022
J	Siciliano, SJ; Kuhmann, SE; Weng, YM; Madani, N; Springer, MS; Lineberger, JE; Danzeisen, R; Miller, MD; Kavanaugh, MP; DeMartino, JA; Kabat, D				Siciliano, SJ; Kuhmann, SE; Weng, YM; Madani, N; Springer, MS; Lineberger, JE; Danzeisen, R; Miller, MD; Kavanaugh, MP; DeMartino, JA; Kabat, D			A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 ENTRY; ENVELOPE GLYCOPROTEINS; COUPLED RECEPTORS; FUSION; CORECEPTOR; GP120; PROGRESSION; INDIVIDUALS; COFACTOR; RANTES	Like the CCR5 chemokine receptors of humans and rhesus macaques, the very homologous (similar to 98-99% identical) CCR5 of African green monkeys (AGMs) avidly binds beta-chemokines and functions as a coreceptor for simian immunodeficiency viruses. However, AGM CCR5 is a weak coreceptor for tested macrophage-tropic (R5) isolates of human immunodeficiency virus type 1 (HIV-1), Correspondingly, gp120 envelope glycoproteins derived from R5 isolates of HIV-1 bind poorly to AGM CCR5, We focused on a unique extracellular amino acid substitution at the juncture of transmembrane helix 4 (TM4) and extracellular loop 2 (ECL2) (Arg for Gly at amino acid 163 (G163R)) as the likely source of the weak R5 gp120 binding and HIV-1 coreceptor properties of AGM CCR5, Accordingly, a G163R mutant of human CCR5 was severely attenuated in its ability to bind R5 gp120s and to mediate infection by R5 HIV-X isolates. Conversely, the R163G mutant of AGRI CCR5 was substantially strengthened as a coreceptor for HIV-1 and had improved R5 gp120 binding affinity relative to the wild-type AGM CCR5, These substitutions at amino acid position 163 had no effect on chemokine binding pr signal transduction, suggesting the absence of structural alterations. The 2D7 monoclonal antibody has been reported to bind to ECL2 and to block HIV-1. binding and infection. Whereas 2D7 antibody binding to CCR5 was unaffected by the G163R mutation, it was prevented by a conservative ECL2 substitution (K171R), shared between rhesus and AGM CCR5s, Thus, it appears that the 2D7 antibody binds to an epitope that includes Lys-171 and may block HIV-1 infection mediated by CCR5 by occluding an HIV-l-binding site in the vicinity of Gly-163, In summary, our results identify a site for gp120 interaction that is critical for R5 isolates of HIV-1 in the central core of human CCR5, and we propose that this site collaborates with a previously identified region in the CCR5 amino terminus to enable gp120 binding and HIV-1 infections.	Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Merck Res Labs, Antiviral Res, W Point, PA 19486 USA; Merck Res Labs, Immunol & Rheumatol, Rahway, NJ 07065 USA	Oregon Health & Science University; Oregon Health & Science University; Merck & Company; Merck & Company	Kabat, D (corresponding author), Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.				NCI NIH HHS [CA54149, CA67358] Funding Source: Medline; NINDS NIH HHS [NS33270] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA054149, R56CA067358, R01CA067358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033270] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Atchison RE, 1996, SCIENCE, V274, P1924, DOI 10.1126/science.274.5294.1924; Berson JF, 1996, J VIROL, V70, P6288, DOI 10.1128/JVI.70.9.6288-6295.1996; Bieniasz PD, 1997, EMBO J, V16, P2599, DOI 10.1093/emboj/16.10.2599; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; CHEN CA, 1994, CURRENT PROTOCOL SMO, V1; Chen ZW, 1997, J VIROL, V71, P2705, DOI 10.1128/JVI.71.4.2705-2714.1997; CHESEBRO B, 1988, J VIROL, V62, P3779, DOI 10.1128/JVI.62.10.3779-3788.1988; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; COOPER N, 1994, CURRENT PROTOCOLS MO, V2; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dragic T, 1998, J VIROL, V72, P279, DOI 10.1128/JVI.72.1.279-285.1998; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Hill CM, 1998, VIROLOGY, V248, P357, DOI 10.1006/viro.1998.9283; IVEYHOYLE M, 1991, P NATL ACAD SCI USA, V88, P512, DOI 10.1073/pnas.88.2.512; KABAT D, 1994, J VIROL, V68, P2570, DOI 10.1128/JVI.68.4.2570-2577.1994; Kuhmann SE, 1997, J VIROL, V71, P8642, DOI 10.1128/JVI.71.11.8642-8656.1997; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lapham CK, 1996, SCIENCE, V274, P602, DOI 10.1126/science.274.5287.602; LI YX, 1992, J VIROL, V66, P6587, DOI 10.1128/JVI.66.11.6587-6600.1992; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Madani N, 1998, P NATL ACAD SCI USA, V95, P8005, DOI 10.1073/pnas.95.14.8005; Martin KA, 1997, SCIENCE, V278, P1470, DOI 10.1126/science.278.5342.1470; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084, DOI 10.1074/jbc.271.32.19084; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Picard L, 1997, J VIROL, V71, P5003, DOI 10.1128/JVI.71.7.5003-5011.1997; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pretet JL, 1997, AIDS RES HUM RETROV, V13, P1583, DOI 10.1089/aid.1997.13.1583; Rabut GEE, 1998, J VIROL, V72, P3464, DOI 10.1128/JVI.72.4.3464-3468.1998; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; ROLLINS TE, 1988, J BIOL CHEM, V263, P520; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; SICILIANO SJ, 1994, P NATL ACAD SCI USA, V91, P1214, DOI 10.1073/pnas.91.4.1214; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; VANRIPER G, 1993, J EXP MED, V177, P851, DOI 10.1084/jem.177.3.851; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	49	78	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1905	1913		10.1074/jbc.274.4.1905	http://dx.doi.org/10.1074/jbc.274.4.1905			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890944	Green Published, hybrid			2022-12-27	WOS:000078185200011
J	Ahn, S; Maudsley, S; Luttrell, LM; Lefkowitz, RJ; Daaka, Y				Ahn, S; Maudsley, S; Luttrell, LM; Lefkowitz, RJ; Daaka, Y			Src-mediated tyrosine phosphorylation of dynamin is required for beta(2)-adrenergic receptor internalization and mitogen-activated protein kinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; BETA-GAMMA-SUBUNITS; DISTINCT PATHWAYS; GTPASE ACTIVITY; ENDOCYTOSIS; ARRESTIN; FIBROBLASTS; AFFINITY; BINDING; CREB	Some forms of G protein-coupled receptor signaling, such as activation of mitogen-activated protein kinase cascade as well as resensitization of receptors after hormone-induced desensitization, require receptor internalization via dynamin-dependent clathrin-coated pit mechanisms. Here we demonstrate that activation of beta(2)-adrenergic receptors (beta(2)-ARs) leads to c-Src-mediated tyrosine phosphorylation of dynamin, which is required for receptor internalization. Two tyrosine residues, Tyr(231) and Tyr(597), are identified as the major phosphorylation sites. Mutation of these residues to phenylalanine dramatically decreases the c-Src-mediated phosphorylation of dynamin following beta(2)-AR stimulation. Moreover, expression of Y231F/Y597F dynamin inhibits beta(2)-AR internalization and the isoproterenol-stimulated mitogen-activated protein kinase activation. Thus, agonist-induced, c-Src-mediated tyrosine phosphorylation of dynamin is essential for its function in clathrin mediated G protein-coupled receptor endocytosis.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3821, Durham, NC 27710 USA.		Lefkowitz, Robert/AAW-2649-2021; Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019	Maudsley, Stuart/0000-0002-1868-184X; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL16037] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dieffenbach C.W., 1995, PCR PRIMER LAB MANUA; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Foster-Barber A, 1998, P NATL ACAD SCI USA, V95, P4673, DOI 10.1073/pnas.95.8.4673; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; FREEDMAN NJ, 1996, RECENT PROG HORM RES, V51, P219; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; HOLEN I, 1995, J BIOL CHEM, V270, P12823, DOI 10.1074/jbc.270.21.12823; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin HC, 1996, J BIOL CHEM, V271, P27979, DOI 10.1074/jbc.271.45.27979; Lin HC, 1997, J BIOL CHEM, V272, P25999, DOI 10.1074/jbc.272.41.25999; Luttrell LM, 1997, J BIOL CHEM, V272, P31648, DOI 10.1074/jbc.272.50.31648; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; McClure SJ, 1996, MOL MEMBR BIOL, V13, P189, DOI 10.3109/09687689609160598; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; SALAMERO J, 1995, EUR J IMMUNOL, V25, P2757, DOI 10.1002/eji.1830251007; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Ware MF, 1997, J BIOL CHEM, V272, P30185, DOI 10.1074/jbc.272.48.30185; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	35	232	235	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1185	1188		10.1074/jbc.274.3.1185	http://dx.doi.org/10.1074/jbc.274.3.1185			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880482	hybrid			2022-12-27	WOS:000079956900002
J	Field, KA; Holowka, D; Baird, B				Field, KA; Holowka, D; Baird, B			Structural aspects of the association of Fc epsilon RI with detergent-resistant membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASOPHILIC LEUKEMIA-CELLS; IMMUNOGLOBULIN-E-RECEPTOR; HIGH-AFFINITY RECEPTOR; PROTEIN-TYROSINE KINASES; RBL-2H3 MAST-CELLS; IGE RECEPTOR; CYTOPLASMIC DOMAINS; SIGNAL-TRANSDUCTION; MONOCLONAL-ANTIBODY; ANCHORED PROTEINS	We recently showed that aggregation of the high affinity IgE receptor on mast cells, Fc epsilon RI, causes this immunoreceptor to associate rapidly with specialized regions of the plasma membrane, where it is phosphorylated by the tyrosine kinase Lyn, In this study, we further characterize the detergent sensitivity of this association on rat basophilic leukemia-2H3 mast cells, and we compare the capacity of structural variants of Fc epsilon RI and other receptors to undergo this association. We show that this interaction is not mediated by the beta subunit of the receptor or the cytoplasmic tail of the gamma subunit, both of which are involved in signaling. Using chimeric receptor constructs, we found that the ex tracellular segment of the Fc epsilon RI alpha subunit was not sufficient to mediate this association, implicating Fc epsilon RI alpha and/or gamma transmembrane segments. To determine the specificity of this interaction, we compared the association of several other receptors, Interleukin-1 type I receptors on Chinese hamster ovary cells and alpha 4-integrins on rat basophilic leukemia cells showed little or no association with isolated membrane domains, both before and after aggregation on the cells. In contrast, interleukin-2 receptor or (Tac) on Chinese hamster ovary cells exhibited aggregation-dependent membrane domain association similar to Fc epsilon RI, These results provide insights into the structural basis and selectivity of lipid-mediated interactions between certain transmembrane receptors and detergent-resistant membranes.	Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA	Cornell University	Holowka, D (corresponding author), Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA.			Field, Kenneth/0000-0001-7417-4386	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022449] Funding Source: NIH RePORTER; NIAID NIH HHS [AI22449] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBER G, 1991, J BIOL CHEM, V266, P22613; ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; ARREAZA G, 1994, J BIOL CHEM, V269, P19123; Beaven MA, 1996, CURR OPIN IMMUNOL, V8, P766, DOI 10.1016/S0952-7915(96)80002-1; BENHAMOU M, 1992, IMMUNOL TODAY, V13, P195, DOI 10.1016/0167-5699(92)90152-W; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; EISEMAN E, 1992, J BIOL CHEM, V267, P21027; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; FIELD KA, 1999, SIGNAL TRANSDUCTION, P102; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; FRA AM, 1994, J BIOL CHEM, V269, P30745; GALLIS B, 1989, J IMMUNOL, V143, P3235; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; GUO CM, 1995, J BIOL CHEM, V270, P27562, DOI 10.1074/jbc.270.46.27562; GUO N, 1989, J BIOL CHEM, V264, P13267; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; HOLOWKA D, 1983, BIOCHEMISTRY-US, V22, P3466, DOI 10.1021/bi00283a025; ISSEKUTZ TB, 1991, J IMMUNOL, V147, P109; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Juergens Maren, 1995, Journal of Immunology, V155, P5184; KINET JP, 1985, BIOCHEMISTRY-US, V24, P4117, DOI 10.1021/bi00336a046; KINET JP, 1985, BIOCHEMISTRY-US, V24, P7342, DOI 10.1021/bi00346a048; LETOURNEUR F, 1991, P NATL ACAD SCI USA, V88, P8905, DOI 10.1073/pnas.88.20.8905; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; MAO SY, 1992, P NATL ACAD SCI USA, V89, P222, DOI 10.1073/pnas.89.1.222; MENON AK, 1984, J CELL BIOL, V98, P577, DOI 10.1083/jcb.98.2.577; MINAMI Y, 1995, CURR OPIN CELL BIOL, V7, P156, DOI 10.1016/0955-0674(95)80023-9; OLIVER C, 1992, J CELL BIOL, V116, P635, DOI 10.1083/jcb.116.3.635; Parolini I, 1996, BLOOD, V87, P3783, DOI 10.1182/blood.V87.9.3783.bloodjournal8793783; Pierini L, 1996, J CELL BIOL, V134, P1427, DOI 10.1083/jcb.134.6.1427; PRIBLUDA VS, 1994, P NATL ACAD SCI USA, V91, P11246, DOI 10.1073/pnas.91.23.11246; Repetto B, 1996, J IMMUNOL, V156, P4876; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SCHARENBERG AM, 1995, EMBO J, V14, P3385, DOI 10.1002/j.1460-2075.1995.tb07344.x; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; THOMAS JL, 1994, J CELL BIOL, V125, P795, DOI 10.1083/jcb.125.4.795; Vonakis BM, 1997, J BIOL CHEM, V272, P24072, DOI 10.1074/jbc.272.38.24072; WILSON BS, 1995, J BIOL CHEM, V270, P4013, DOI 10.1074/jbc.270.8.4013; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71	46	93	93	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1753	1758		10.1074/jbc.274.3.1753	http://dx.doi.org/10.1074/jbc.274.3.1753			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880557	hybrid			2022-12-27	WOS:000079956900077
J	Heller, LC; Li, Y; Abrams, KL; Rogers, MB				Heller, LC; Li, Y; Abrams, KL; Rogers, MB			Transcriptional regulation of the Bmp2 gene - Retinoic acid induction in F9 embryonal carcinoma cells and Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; RESPONSE ELEMENT; PROMOTER REGION; X RECEPTORS; YEAST; IDENTIFICATION; MOUSE; DIFFERENTIATION; EXPRESSION; APOPTOSIS	Bmp2, a highly conserved member of the transforming growth factor-beta gene family, is crucial for normal development. Retinoic acid, combined with cAMP analogs, sharply induces the Bmp2 mRNA during the differentiation of F9 embryonal carcinoma cells into parietal endoderm, Retinoic acid (RA) also induces the Bmp2 gene in chick limb buds. Since normal Bmp2 expression may require an endogenous retinoid signal and aberrant Bmp2 expression may cause some aspects of RA-induced teratogenesis, we studied the mechanism underlying the induction of Bmp2. Measurements of the Bmp2 mRNA half-life and nuclear run-on assays indicated that RA stimulated the transcription rate of the Bmp2 gene. The results of ribonuclease protection and primer extension assays indicated that Bmp2 transcription started 2,127 nucleotides upstream of the translation start site in F9 cells. To identify genetic elements controlling this transcription rate increase, upstream and downstream genomic sequences flanking the Bmp2 gene were screened using chloramphenicol acetyltransferase reporter genes in F9 cells and beta-galactosidase reporter genes in Saccharomyces cerevisiae that were cotransformed with retinoic acid receptor and retinoid X receptor expression plasmids, RA-dependent transcriptional activation was detected between base pairs -2,373 and -2,316 relative to the translation start site. We also identified a required Sp1 binding site between -2,308 and -2,298, The data indicate that Bmp2 is directly regulated by retinoic acid-bound receptors and Sp1.	Univ S Florida, Dept Biol, Tampa, FL 33620 USA; Univ S Florida, Dept Pharmacol, Tampa, FL 33620 USA; Univ S Florida, Inst Biomol Sci, Tampa, FL 33620 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Rogers, MB (corresponding author), Univ S Florida, Dept Biol, BSF119,4202 E Fowler Ave, Tampa, FL 33620 USA.	rogers@chuma.cas.usf.edu	Heller, Richard/I-6605-2012	Heller, Loree/0000-0001-8084-0787	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD031117] Funding Source: NIH RePORTER; NICHD NIH HHS [R29 HD31117] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEGRETTO EA, 1993, J BIOL CHEM, V268, P26625; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; DARROW AL, 1990, MOL CELL BIOL, V10, P5883, DOI 10.1128/MCB.10.11.5883; FENG JQ, 1994, BBA-GENE STRUCT EXPR, V1218, P221, DOI 10.1016/0167-4781(94)90017-5; Feng JQ, 1997, BBA-GENE STRUCT EXPR, V1350, P47, DOI 10.1016/S0167-4781(96)00178-9; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; Graff JM, 1997, CELL, V89, P171, DOI 10.1016/S0092-8674(00)80196-8; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Gudas Lorraine J., 1994, P443; HALL BL, 1993, P NATL ACAD SCI USA, V90, P6929, DOI 10.1073/pnas.90.15.6929; HEERY DM, 1993, P NATL ACAD SCI USA, V90, P4281, DOI 10.1073/pnas.90.9.4281; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; HOGAN BLM, 1995, NATURE, V376, P210, DOI 10.1038/376210a0; LANGSTON AW, 1992, MECH DEVELOP, V38, P217, DOI 10.1016/0925-4773(92)90055-O; LEHMANN JM, 1992, MOL CELL BIOL, V12, P2976, DOI 10.1128/MCB.12.7.2976; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; LYONS KM, 1990, DEVELOPMENT, V109, P833; Mangelsdorf David J., 1994, P319; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; PADGETT RW, 1993, P NATL ACAD SCI USA, V90, P2905, DOI 10.1073/pnas.90.7.2905; Panariello L, 1996, J BIOL CHEM, V271, P25524, DOI 10.1074/jbc.271.41.25524; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; RIO MC, 1987, P NATL ACAD SCI USA, V84, P9243, DOI 10.1073/pnas.84.24.9243; ROGERS MB, 1992, MOL BIOL CELL, V3, P189, DOI 10.1091/mbc.3.2.189; Rogers MB, 1996, CELL GROWTH DIFFER, V7, P115; ROY DY, 1995, MOL CELL BIOL, V15, P6481; SAMPATH TK, 1993, P NATL ACAD SCI USA, V90, P6004, DOI 10.1073/pnas.90.13.6004; SCHENA M, 1988, SCIENCE, V241, P965, DOI 10.1126/science.3043665; SCHWYTER DH, 1995, MOL CELL BIOL, V15, P3960; STJOHNSTON RD, 1990, GENE DEV, V4, P1114, DOI 10.1101/gad.4.7.1114; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; Taneja R, 1996, P NATL ACAD SCI USA, V93, P6197, DOI 10.1073/pnas.93.12.6197; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Vaahtokari A, 1996, DEVELOPMENT, V122, P121; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; VASIOS GW, 1989, P NATL ACAD SCI USA, V86, P9099, DOI 10.1073/pnas.86.23.9099; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhang HB, 1996, DEVELOPMENT, V122, P2977; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0; Zile MH, 1998, J NUTR, V128, p455S, DOI 10.1093/jn/128.2.455S; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	48	41	44	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1394	1400		10.1074/jbc.274.3.1394	http://dx.doi.org/10.1074/jbc.274.3.1394			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880512	hybrid			2022-12-27	WOS:000079956900032
J	Lee, YJ; Swencki, B; Shoichet, S; Shivdasani, RA				Lee, YJ; Swencki, B; Shoichet, S; Shivdasani, RA			A possible role for the high mobility group box transcription factor Tcf-4 in vertebrate gut epithelial cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; HMG-BOX; INT-1 PROTOONCOGENE; ENDODERM INDUCTION; ALPHA-ENHANCER; GENE; XENOPUS; PROTEIN; DROSOPHILA; LEF-1	The Wingless (Wg)/Wnt signaling pathway activates High Mobility Group (HMG)-box transcription factors of the T-cell Factor (Tcf)/Lymphoid Enhancer Factor (LEF) subfamily and mediates diverse functions in development, possibly including endoderm and gut differentiation. Determinants of tissue specificity in the response to Wg/Wnt signaling remain unknown. We have identified Tcf-4 as the predominant Tcf/LEF factor in the developing mouse gut. During fetal development, Tcf-4 mRNA expression is restricted to gut epithelium and specific regions of the brain, the thalamus and roof of the midbrain. In adults, expression is widespread, with highest levels observed in the liver, an endodermally derived organ, and persists in the gastrointestinal tract. Murine Tcf-4 has multiple RNA splice variants with consequently significant heterogeneity in sequences 3' to the HMG box. Microinjection of mRNA or plasmid DNA encoding Tcf-4 into Xenopus embryos results in ectopic expression of molecular markers of endoderm and differentiated gut epithelium in isolated animal cap explants. Taken together, these findings point to a potentially important function for Tcf-4 in development of the vertebrate gastrointestinal tract.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Shivdasani, RA (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.							Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 1997, CURR OPIN GENET DEV, V7, P683, DOI 10.1016/S0959-437X(97)80017-2; BIRCHMEIER C, 1993, ANNU REV CELL BIOL, V9, P511, DOI 10.1146/annurev.cb.09.110193.002455; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; BRONNER G, 1994, NATURE, V369, P664, DOI 10.1038/369664a0; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cavallo R, 1997, CURR OPIN GENET DEV, V7, P459, DOI 10.1016/S0959-437X(97)80071-8; GAMER LW, 1995, DEV BIOL, V171, P240, DOI 10.1006/dbio.1995.1275; Henry GL, 1998, SCIENCE, V281, P91, DOI 10.1126/science.281.5373.91; HOPPLER S, 1995, EMBO J, V14, P5016, DOI 10.1002/j.1460-2075.1995.tb00184.x; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; JONES EA, 1993, ROUX ARCH DEV BIOL, V202, P233, DOI 10.1007/BF02427884; Kaestner KH, 1997, GENE DEV, V11, P1583, DOI 10.1101/gad.11.12.1583; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; OOSTERWEGEL M, 1993, DEVELOPMENT, V118, P439; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; ROSA F, 1988, SCIENCE, V239, P783, DOI 10.1126/science.3422517; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; SHI YB, 1994, DEV BIOL, V161, P48, DOI 10.1006/dbio.1994.1006; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Suh E, 1996, MOL CELL BIOL, V16, P619; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656	39	40	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1566	1572		10.1074/jbc.274.3.1566	http://dx.doi.org/10.1074/jbc.274.3.1566			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880534	hybrid			2022-12-27	WOS:000079956900054
J	Norwitz, ER; Cardona, GR; Jeong, KH; Chin, WW				Norwitz, ER; Cardona, GR; Jeong, KH; Chin, WW			Identification and characterization of the gonadotropin-releasing hormone response elements in the mouse gonadotropin-releasing hormone receptor gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT GENE; FOLLICLE-STIMULATING-HORMONE; MESSENGER-RIBONUCLEIC-ACID; CELL-SPECIFIC EXPRESSION; ORPHAN NUCLEAR RECEPTOR; STEROIDOGENIC FACTOR-I; PROTEIN-KINASE-C; LUTEINIZING-HORMONE; GNRH RECEPTOR; RAT PITUITARY	The response of the pituitary gonadotrope to gonadotropin-releasing hormone (GnRH) correlates directly with the concentration of GnRH receptors (GnRHR) on the cell surface, which is mediated in part at the level of GnRHR gene expression, Several hormones have been implicated in this regulation, most notably GnRH itself, Despite these observations and the central role that GnRH is known to play in reproductive development and function, the molecular mechanism(s) by which GnRH regulates transcription of the GnRHR gene has not been well elucidated. Previous studies in this laboratory have identified and partially characterized the promoter region of the mouse GnRHR gene and demonstrated that the regulatory elements for tissue-specific expression as well as for GnRH regulation are present within the 1.2-kilobase 5'-flanking sequence. By using deletion and mutational analysis as well as functional transfection studies in the murine gonadotrope-derived alpha T3-1 cell line, we have localized GnRH responsiveness of the mouse GnRHR gene to two DNA sequences at -276/-269 (designated (S) under bar equence (U) under bar nderlying (R) under bar esponsiveness to (G) under bar nRH-2 (SURG-2), which contains the consensus sequence for the activating protein-1-binding site) and -292/-285 (a novel element designated SURG-1), and demonstrated that this response is mediated via protein kinase C. By using the electrophoretic mobility shift assay, we further demonstrate that a member(s) of the Fos/Jun heterodimer superfamily is responsible in part for the DNA-protein complexes formed on SURG-2, using alpha T3-1 nuclear extracts. These data define a bipartite GnRH response element in the mouse GnRHR 5'-flanking sequence and suggest that the activating protein-1 complex plays a central role in conferring GnRH responsiveness to the murine GnRHR gene.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet & Gynecol,Div Maternal Fetal Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Norwitz, ER (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet & Gynecol,Div Maternal Fetal Med, 20 Shattuck St,Rm 1013,GW Thomas Res Bldg, Boston, MA 02115 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD019938, K12HD000849] Funding Source: NIH RePORTER; NICHD NIH HHS [5K12HD00849, R01 HD19938] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALARID ET, 1995, ENDOCRINOLOGY, V136, P1361, DOI 10.1210/en.136.4.1361; ALBARRACIN CT, 1994, ENDOCRINOLOGY, V135, P2300, DOI 10.1210/en.135.6.2300; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BARNHART KM, 1994, MOL ENDOCRINOL, V8, P878, DOI 10.1210/me.8.7.878; BOURNE GA, 1988, MOL CELL ENDOCRINOL, V58, P155, DOI 10.1016/0303-7207(88)90149-9; BRADEN TD, 1991, ENDOCRINOLOGY, V129, P2486, DOI 10.1210/endo-129-5-2486; Bruder JM, 1996, MOL ENDOCRINOL, V10, P35, DOI 10.1210/me.10.1.35; Campion CE, 1996, GENE, V170, P277, DOI 10.1016/0378-1119(96)00042-X; CESNJAJ M, 1994, ENDOCRINOLOGY, V135, P692, DOI 10.1210/en.135.2.692; CHILDS GV, 1987, ENDOCRINOLOGY, V121, P1801, DOI 10.1210/endo-121-5-1801; CLAY CM, 1995, ENDOCRINE, V3, P615, DOI 10.1007/BF02953028; CLAYTON RN, 1989, J ENDOCRINOL, V120, P11, DOI 10.1677/joe.0.1200011; CLAYTON RN, 1981, ENDOCRINOLOGY, V108, P887, DOI 10.1210/endo-108-3-887; CONN PM, 1994, ANNU REV MED, V45, P391, DOI 10.1146/annurev.med.45.1.391; CONN PM, 1979, ENDOCRINOLOGY, V104, P448; Duval DL, 1997, MOL ENDOCRINOL, V11, P1814, DOI 10.1210/me.11.12.1814; FAN NC, 1995, MOL CELL ENDOCRINOL, V107, pR1, DOI 10.1016/0303-7207(94)03460-B; FernandezVazquez G, 1996, MOL ENDOCRINOL, V10, P356, DOI 10.1210/me.10.4.356; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Halvorson LM, 1996, J BIOL CHEM, V271, P6645, DOI 10.1074/jbc.271.12.6645; HAMERNIK DL, 1992, MOL ENDOCRINOL, V6, P1745, DOI 10.1210/me.6.10.1745; HORN F, 1992, MOL CELL BIOL, V12, P2143, DOI 10.1128/MCB.12.5.2143; HORN F, 1991, MOL ENDOCRINOL, V5, P347, DOI 10.1210/mend-5-3-347; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; JACKSON SM, 1995, MOL ENDOCRINOL, V9, P278, DOI 10.1210/me.9.3.278; Kaiser UB, 1998, J BIOL CHEM, V273, P12943, DOI 10.1074/jbc.273.21.12943; KAISER UB, 1993, ENDOCRINOLOGY, V133, P931, DOI 10.1210/en.133.2.931; KAISER UB, 1992, BIOCHEM BIOPH RES CO, V189, P1645, DOI 10.1016/0006-291X(92)90266-N; Kakar SS, 1997, EUR J ENDOCRINOL, V137, P183, DOI 10.1530/eje.0.1370183; KATT JA, 1985, ENDOCRINOLOGY, V116, P2113, DOI 10.1210/endo-116-5-2113; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Lin XW, 1998, ENDOCRINOLOGY, V139, P3896, DOI 10.1210/en.139.9.3896; MARIAN J, 1981, MOL PHARMACOL, V19, P399; MASON DR, 1994, ENDOCRINOLOGY, V135, P1165, DOI 10.1210/en.135.3.1165; McCue JM, 1997, ENDOCRINOLOGY, V138, P3154, DOI 10.1210/en.138.8.3154; Mercer JE, 1995, HUM REPROD UPDATE, V1, P363, DOI 10.1093/humupd/1.4.363; NAOR Z, 1987, BIOCHEM BIOPH RES CO, V148, P1312, DOI 10.1016/S0006-291X(87)80276-0; NAOR Z, 1979, MOL CELL ENDOCRINOL, V14, P191, DOI 10.1016/0303-7207(79)90044-3; NGAN ESW, 1998, 8 END SOC M JUN 24 2; PAPAVASILIOU SS, 1986, P NATL ACAD SCI USA, V83, P4026, DOI 10.1073/pnas.83.11.4026; PERRIN MH, 1993, BIOCHEM BIOPH RES CO, V191, P1139, DOI 10.1006/bbrc.1993.1335; Reinhart J, 1997, MOL CELL ENDOCRINOL, V130, P1, DOI 10.1016/S0303-7207(97)00064-6; ROBERSON MS, 1995, MOL CELL BIOL, V15, P3531; ROBERSON MS, 1994, MOL CELL BIOL, V14, P2985, DOI 10.1128/MCB.14.5.2985; Sambrook J, 1989, MOL CLONING LABORATO; SCHODERBEK WE, 1993, J BIOL CHEM, V268, P3903; STEGER DJ, 1994, MOL CELL BIOL, V14, P5592, DOI 10.1128/MCB.14.8.5592; STOJILKOVIC SS, 1994, ENDOCR REV, V15, P462, DOI 10.1210/er.15.4.462; Strahl BD, 1997, ENDOCRINOLOGY, V138, P2621, DOI 10.1210/en.138.6.2621; STRAHL BD, 1998, 8 END SOC M JUN 24 2; Weck J, 1998, MOL ENDOCRINOL, V12, P451, DOI 10.1210/me.12.3.451; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597; YASIN M, 1995, ENDOCRINOLOGY, V136, P1559, DOI 10.1210/en.136.4.1559; ZHOU W, 1994, DNA CELL BIOL, V13, P605, DOI 10.1089/dna.1994.13.605	55	58	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					867	880		10.1074/jbc.274.2.867	http://dx.doi.org/10.1074/jbc.274.2.867			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873026	hybrid			2022-12-27	WOS:000077968500041
J	Sennequier, N; Wolan, D; Stuehr, DJ				Sennequier, N; Wolan, D; Stuehr, DJ			Antifungal imidazoles block assembly of inducible NO synthase into an active dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; HIGH-LEVEL EXPRESSION; HYDROXY-L-ARGININE; SELECTIVE-INHIBITION; CATALYTIC ACTIVITY; OXYGENASE DOMAIN; ESCHERICHIA-COLI; SUBUNIT DIMERIZATION; REDUCTASE DOMAINS; POTENT INHIBITORS	Cytokine-inducible nitric oxide synthase (iNOS) is a homodimeric enzyme that generates nitric oxide (NO) and L-citrulline from L-arginine (L-Arg) and O-2. The N-terminal oxygenase domain (amino acids 1-498; iNOSox) in each subunit binds heme, L-Arg, and tetrahydrobiopterin (H4B), is the site of NO synthesis, and is responsible for the dimeric interaction, which must occur to synthesize NO. In both cells and purified systems, iNOS dimer assembly is promoted by H4B, L-Arg, and L-Arg analogs. We examined the ability of imidazole and N-substituted imidazoles to promote or inhibit dimerization of heme-containing iNOSox monomers, or to affect iNOS dimerization in cells. Imidazole, 1-phenylimidazole, clotrimazole, and miconazole all bound to the iNOSox monomer heme iron. Imidazole and 1-phenylimidazole promoted iNOSox dimerization, whereas clotrimazole (30 mu M) and miconazole (15 mu M) did not, and instead inhibited dimerization normally promoted by L-Arg and H4B. Clotrimazole also bound to iNOSox dimers in the absence of L-Arg and H4B and caused their dissociation. When added to cells expressing iNOS, clotrimazole (50 mu M) had no effect on MOS protein expression but almost completely inhibited its dimerization and consequent NO synthesis over an 8-h culture period, without affecting calmodulin interaction with MOS. Thus, imidazoles can promote or inhibit dimerization of iNOS both in vitro and in cells, depending on their structure. Bulky imidazoles like clotrimazole block NO synthesis by inhibiting assembly of the iNOS dimer, revealing a new means to control cellular NO synthesis.	Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@cesmtp.ccf.org		Wolan, Dennis/0000-0001-9879-8353	NATIONAL CANCER INSTITUTE [R01CA053914, R29CA053914] Funding Source: NIH RePORTER; NCI NIH HHS [CA53914] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AbuSoud HM, 1997, J BIOL CHEM, V272, P17349, DOI 10.1074/jbc.272.28.17349; ABUSOUD HM, 1995, BIOCHEMISTRY-US, V34, P11167, DOI 10.1021/bi00035a023; ABUSOUD HM, 1995, J BIOL CHEM, V270, P22997, DOI 10.1074/jbc.270.39.22997; Albakri QA, 1996, J BIOL CHEM, V271, P5414, DOI 10.1074/jbc.271.10.5414; BAEK KJ, 1993, J BIOL CHEM, V268, P21120; Bogle RG, 1996, BRIT J PHARMACOL, V117, P1053, DOI 10.1111/j.1476-5381.1996.tb16696.x; BOUCHER JL, 1992, BIOCHEM BIOPH RES CO, V187, P880, DOI 10.1016/0006-291X(92)91279-Y; BOULLERNE AI, 1995, J NEUROIMMUNOL, V60, P117, DOI 10.1016/0165-5728(95)00061-6; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chen PF, 1996, J BIOL CHEM, V271, P14631, DOI 10.1074/jbc.271.24.14631; CHEN PF, 1994, J BIOL CHEM, V269, P25062; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Dweik RA, 1998, J CLIN INVEST, V101, P660, DOI 10.1172/JCI1378; FUKUTO JM, 1995, ANNU REV PHARMACOL, V35, P165, DOI 10.1146/annurev.pharmtox.35.1.165; FURFINE ES, 1994, J BIOL CHEM, V269, P26677; Gachhui R, 1997, BIOCHEMISTRY-US, V36, P5097, DOI 10.1021/bi970331x; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; GARVEY EP, 1994, J BIOL CHEM, V269, P26669; Ghosh DK, 1996, BIOCHEMISTRY-US, V35, P1444, DOI 10.1021/bi9521295; GHOSH DK, 1995, BIOCHEMISTRY-US, V34, P801, DOI 10.1021/bi00003a013; GHOSH DK, 1995, BIOCHEMISTRY-US, V34, P11316, DOI 10.1021/bi00036a003; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Gorren ACF, 1997, BIOCHEMISTRY-US, V36, P4360, DOI 10.1021/bi962381s; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; GROSS SS, 1992, J BIOL CHEM, V267, P25722; HANENBERG H, 1989, DIABETOLOGIA, V32, P126, DOI 10.1007/BF00505185; HEGEMANN L, 1993, J INVEST DERMATOL, V100, P343, DOI 10.1111/1523-1747.ep12470043; HURSHMAN AR, 1995, BIOCHEMISTRY-US, V34, P5627, DOI 10.1021/bi00016a038; KERWIN JF, 1995, J MED CHEM, V38, P4343, DOI 10.1021/jm00022a001; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; KLATT P, 1992, BIOCHEM J, V288, P15, DOI 10.1042/bj2880015; KRONCKE KD, 1995, BIOL CHEM H-S, V376, P327; KUO PC, 1995, FEBS LETT, V360, P10, DOI 10.1016/0014-5793(95)00067-J; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MACNEIL S, 1993, BRIT J DERMATOL, V128, P143, DOI 10.1111/j.1365-2133.1993.tb15143.x; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; MARTIN W, 1986, J PHARMACOL EXP THER, V237, P529; MATSUOKA A, 1994, J BIOL CHEM, V269, P20335; Mayer B, 1995, Adv Pharmacol, V34, P251; MCMILLAN K, 1995, BIOCHEMISTRY-US, V34, P3686, DOI 10.1021/bi00011a025; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; MONCADA S, 1995, FASEB J, V9, P1319, DOI 10.1096/fasebj.9.13.7557022; Moore WM, 1996, J MED CHEM, V39, P669, DOI 10.1021/jm950766n; MURRAY M, 1987, DRUG METAB REV, V18, P55, DOI 10.3109/03602538708998300; NAKANE M, 1993, FEBS LETT, V316, P175, DOI 10.1016/0014-5793(93)81210-Q; NARAYANAN K, 1995, J BIOL CHEM, V270, P11103, DOI 10.1074/jbc.270.19.11103; NATHAN C, 1994, J BIOL CHEM, V269, P13725; NISHIMURA JS, 1995, BIOCHEM BIOPH RES CO, V210, P288, DOI 10.1006/bbrc.1995.1659; ODELL TJ, 1994, SCIENCE, V265, P542, DOI 10.1126/science.7518615; Presta A, 1998, BIOCHEMISTRY-US, V37, P298, DOI 10.1021/bi971944c; PUFAHL RA, 1993, BIOCHEM BIOPH RES CO, V193, P963, DOI 10.1006/bbrc.1993.1719; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P10043, DOI 10.1073/pnas.87.24.10043; RIVEROSMORENO V, 1995, EUR J BIOCHEM, V230, P52; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Sari MA, 1996, BIOCHEMISTRY-US, V35, P7204, DOI 10.1021/bi960087u; Sennequier N, 1996, BIOCHEMISTRY-US, V35, P5883, DOI 10.1021/bi952844e; Siddhanta U, 1996, J BIOL CHEM, V271, P7309, DOI 10.1074/jbc.271.13.7309; Southan GJ, 1995, EUR J PHARM-MOLEC PH, V291, P311, DOI 10.1016/0922-4106(95)90071-3; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; TZENG E, 1995, P NATL ACAD SCI USA, V92, P11771, DOI 10.1073/pnas.92.25.11771; Venema RC, 1997, J BIOL CHEM, V272, P1276, DOI 10.1074/jbc.272.2.1276; WOLFF DJ, 1993, J BIOL CHEM, V268, P9425; WOLFF DJ, 1994, ARCH BIOCHEM BIOPHYS, V314, P360, DOI 10.1006/abbi.1994.1454; WOLFF DJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P293, DOI 10.1006/abbi.1994.1240; Wu CQ, 1996, BIOCHEM BIOPH RES CO, V222, P439, DOI 10.1006/bbrc.1996.0763	72	79	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					930	938		10.1074/jbc.274.2.930	http://dx.doi.org/10.1074/jbc.274.2.930			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873034	hybrid			2022-12-27	WOS:000077968500049
J	Joshi, A; Serpe, M; Kosman, DJ				Joshi, A; Serpe, M; Kosman, DJ			Evidence for (Mac1p)(2)center dot DNA ternary complex formation in Mac1p-dependent transactivation at the CTR1 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; COPPER UPTAKE; TRANSPORT PROTEIN; IRON UPTAKE; YEAST; BINDING; DNA; REPRESSION; REDUCTION	The Mac1 protein in Saccharomyces cerevisiae is required for the expression CTR1 and FRE1, which, respectively, encode the copper permease and metal reductase that participate in copper uptake. Mac1p binds to a core GCTC sequence present as a repeated unit in the promoters of both genes, We show here that Mac1p DNA binding required an intact N-terminal protein domain that includes a likely zinc finger motif, This binding was enhanced by the presence of a TATTT sequence immediately 5' to the core GCTC, in contrast to a TTTTT one. This increased binding was demonstrated clearly in vitro in electrophoretic mobility shift assays that showed Mac1p.DNA complex formation to a single TATTTGCTC element but not to a TTTTTGCTC one, Furthermore, the fraction of Mac1p in a ternary (Mac1p)(2).DNA complex in comparison to a binary Mac1p DNA complex increased when the DNA included two TATTTGCTC elements. A similar increase in ternary complex formation was demonstrated upon homologous mutation of the FRE1 Mac1p-dependent promoter element. The in vivo importance of this ternary complex formation at the CTR1 promoter was indicated by the stronger trans-activity of this promoter mutated to contain two TATTT elements and the attenuated activity of a mutant promoter containing two TTTTT elements that in vitro supported only a weak ternary complex signal in the shift assay. The stronger binding to TATTT appeared due to a more favorable protein contact with adenine in comparison to thymine at this position. An in vivo two-hybrid analysis demonstrated a Mac1D-Mac1p protein-protein interaction. This Mac1p-Mac1p interaction may promote (Mac1p), DNA ternary complex formation at Mac1p-responsive upstream activating sequences.	SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, 140 Farber Hall, 3435 Main St, Buffalo, NY 14214 USA.		Serpe, Michael/T-4176-2019	Serpe, Michael/0000-0002-0161-1087; Serpe, Mihaela/0000-0002-9205-8589; Joshi, Atul/0000-0002-6709-0851	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046787] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46787] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel P. L., 1993, CELLULAR INTERACTION, P153; BUCHMAN C, 1990, MOL CELL BIOL, V10, P4778, DOI 10.1128/MCB.10.9.4778; DAMERON CT, 1993, BIOCHEMISTRY-US, V32, P7294, DOI 10.1021/bi00079a028; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; DANCIS A, 1994, J BIOL CHEM, V269, P25660; DIX DR, 1994, J BIOL CHEM, V269, P26092; DOBI A, 1995, J BIOL CHEM, V270, P10171, DOI 10.1074/jbc.270.17.10171; Farrell RA, 1996, BIOCHEMISTRY-US, V35, P1571, DOI 10.1021/bi9517087; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Graden JA, 1997, P NATL ACAD SCI USA, V94, P5550, DOI 10.1073/pnas.94.11.5550; Graden JA, 1996, BIOCHEMISTRY-US, V35, P14583, DOI 10.1021/bi961642v; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; KNIGHT SAB, 1996, GENE DEV, V10, P1517; Koch KA, 1996, MOL CELL BIOL, V16, P724; KOSMAN DJ, 1993, METAL IONS FUNGI, P1; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Martins LJ, 1998, J BIOL CHEM, V273, P23716, DOI 10.1074/jbc.273.37.23716; Miller J. H, 1972, EXPT MOL GENETICS; SCHMIDT MH, 1992, TRANSCRIPTIONAL REGU, V1, P599; SIKORSKI RS, 1989, GENETICS, V122, P19; Winge DR, 1998, PROG NUCLEIC ACID RE, V58, P165; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; Zhu ZW, 1996, CELL, V87, P459, DOI 10.1016/S0092-8674(00)81366-5; Zhu ZW, 1998, J BIOL CHEM, V273, P1277, DOI 10.1074/jbc.273.3.1277	25	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					218	226		10.1074/jbc.274.1.218	http://dx.doi.org/10.1074/jbc.274.1.218			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867833	hybrid			2022-12-27	WOS:000077900200033
J	Korber, P; Zander, T; Herschlag, D; Bardwell, JCA				Korber, P; Zander, T; Herschlag, D; Bardwell, JCA			A new heat shock protein that binds nucleic acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LAC REPRESSOR; IN-VIVO; NONSPECIFIC-BINDING; DNA INTERACTIONS; CHROMATOGRAPHY; CONSTANTS; ASSAY	We describe the isolation of Hsp15, a new, very abundant heat shock protein that binds to DNA and RNA. Hsp15 is well conserved and related to a number of RNA-binding proteins, including ribosomal protein S4, RNA pseudouridine synthase, and tyrosyl-tRNA synthetase. The region shared between these proteins appears to represent a common, but previously unrecognized, RNA binding motif, Filter binding studies showed that Hsp15 binds to a 17-mer single-stranded RNA with a dissociation constant of 9 mu M in 22.5 mM Hepes, pH 7.0, 5 mM MgCl2. A role of Hsp15 in binding nucleic acids puts this protein into a different functional category from that of many other heat shock proteins that act as molecular chaperones or proteases on protein substrates.	Univ Michigan, Dept Biol, Ann Arbor, MI 48109 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; Stanford University	Bardwell, JCA (corresponding author), Univ Michigan, Dept Biol, Nat Sci Bldg, Ann Arbor, MI 48109 USA.		Korber, Philipp/AAN-7633-2021	Korber, Philipp/0000-0001-7526-6549				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAKER AM, 1995, J BIOL CHEM, V270, P22939, DOI 10.1074/jbc.270.39.22939; BEDOUELLE H, 1986, NATURE, V320, P371, DOI 10.1038/320371a0; BOSCHELLI F, 1982, J MOL BIOL, V162, P267, DOI 10.1016/0022-2836(82)90526-5; Bremer H., 1996, E COLI SALMONELLA CE, V2, P1553; CHUANG SE, 1993, J BACTERIOL, V175, P5242, DOI 10.1128/JB.175.16.5242-5252.1993; COHN EJ, 1943, PROTEINS AMINO ACIDS, P374; DEHASETH PL, 1977, BIOCHEMISTRY-US, V16, P4783, DOI 10.1021/bi00641a004; DEHASETH PL, 1977, BIOCHEMISTRY-US, V16, P4777, DOI 10.1021/bi00641a003; DITTO MD, 1994, J BACTERIOL, V176, P3738, DOI 10.1128/JB.176.12.3738-3748.1994; Donachie W. D., 1987, ESCHERICHIA COLI SAL, P1578; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Gross CA, 1996, ESCHERICHIA COLI SAL, P1382; HA JH, 1992, J MOL BIOL, V228, P252, DOI 10.1016/0022-2836(92)90504-D; HERSCHLAG D, 1994, EMBO J, V13, P2913, DOI 10.1002/j.1460-2075.1994.tb06586.x; HOLLEY RW, 1961, J BIOL CHEM, V236, P200; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; JENSEN DE, 1976, J BIOL CHEM, V251, P7198; Jenuwine ES, 1996, ANAL BIOCHEM, V242, P228, DOI 10.1006/abio.1996.0457; JOHNSON PH, 1977, BIOCHEMISTRY-US, V16, P4217, DOI 10.1021/bi00638a014; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; LOHMAN TM, 1986, J MOL BIOL, V187, P603, DOI 10.1016/0022-2836(86)90338-4; LOHMAN TM, 1980, BIOCHEMISTRY-US, V19, P3561; Lorimer GH, 1996, FASEB J, V10, P5, DOI 10.1096/fasebj.10.1.8566548; Maniatis T., 1989, MOL CLONING LAB MANU; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P13; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; REVZIN A, 1977, BIOCHEMISTRY-US, V16, P4679; Schwarz E, 1996, BIOL CHEM, V377, P411; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TWINING SS, 1984, ANAL BIOCHEM, V143, P30, DOI 10.1016/0003-2697(84)90553-0; VONBOGELEN RA, 1996, ESCHERICHIA COLI SAL, P2067; WAYE MMY, 1983, EMBO J, V2, P1827, DOI 10.1002/j.1460-2075.1983.tb01665.x; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003	38	45	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					249	256		10.1074/jbc.274.1.249	http://dx.doi.org/10.1074/jbc.274.1.249			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867837	hybrid			2022-12-27	WOS:000077900200037
J	Minc, E; de Coppet, P; Masson, P; Thiery, L; Dutertre, S; Amor-Gueret, M; Jaulin, C				Minc, E; de Coppet, P; Masson, P; Thiery, L; Dutertre, S; Amor-Gueret, M; Jaulin, C			The human copper-zinc superoxide dismutase gene (SOD1) proximal promoter is regulated by Sp1, Egr-1, and WT1 via non-canonical binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GROWTH-FACTOR RECEPTOR; CUZN-SUPEROXIDE; DEFICIENT MICE; EXPRESSION; APOPTOSIS; INJURY; TRANSCRIPTION; DEATH; OVEREXPRESSION	Human copper-zinc superoxide dismutase (Cu,Zn-SOD) participates in the control of reactive oxygen intermediate intracellular concentration. In this study, we show that phorbol 12-myristate 13-acetate (PMA) increases Cu,Zn-SOD mRNA expression within 30 min. The sequence between nucleotides -71 and -29 is essential for both basal and PMA-induced gene expression. This region includes an Spl-binding site that is also recognized by a possible Spl-like protein and by Egr-1 in a PMA-inducible manner. Egr-1 and two splicing variants of the Egr-related protein WT1 were able to transactivate the SOD1 promoter in co-transfection experiments. Spl and the possible Sp1-like proteins bind to two overlapping, but distinct sequences. However, Egr-1 and Spl seem to interact with two sites that are either identical or very close to each other. None of these sites fit the consensus sequences previously reported for these proteins. Analysis of various mutants of the SOD1 proximal promoter revealed that the region that binds Spl and Egr-1 is required for both basal and Egr-1-driven expression. Interplay between different members of the Spl family, Egr-1, and different splicing variants of WT1 in the SOD1 proximal promoter may provide clues about the physiological function of Cu,Zn-SOD.	Inst Gustave Roussy, Lab Biol Tumeurs Humaines, CNRS UMR 1598, F-94805 Villejuif, France; Inst Oncol Cellulaire & Mol Humaine, F-93000 Bobigny, France; Ctr Rech, Lab Fournier, F-21121 Daix, France	UNICANCER; Gustave Roussy	Jaulin, C (corresponding author), Inst Gustave Roussy, Lab Biol Tumeurs Humaines, CNRS UMR 1598, Rue Camille Desmoulins, F-94805 Villejuif, France.	cjaulin@igr.fr	Jaulin, Christian/L-9126-2018					Algar EM, 1996, ONCOGENE, V12, P1005; ALLEN RG, 1995, J CELL PHYSIOL, V165, P576; AUWERX JH, 1989, BLOOD, V74, P1807; BILINSKI T, 1985, BIOCHEM BIOPH RES CO, V130, P533, DOI 10.1016/0006-291X(85)90449-8; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DelaTorre R, 1996, EXPERIENTIA, V52, P871; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Haber DA, 1996, MED PEDIATR ONCOL, V27, P453; Harlow E., 1988, ANTIBODIES LAB MANUA; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Inoue N, 1996, CIRC RES, V79, P32, DOI 10.1161/01.RES.79.1.32; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; KIM HT, 1994, BIOCHEM BIOPH RES CO, V201, P1526, DOI 10.1006/bbrc.1994.1877; Kim YH, 1996, J BIOL CHEM, V271, P24539, DOI 10.1074/jbc.271.40.24539; Kondo T, 1997, J NEUROSCI, V17, P4180; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liu CT, 1996, CRIT REV ONCOGENESIS, V7, P101, DOI 10.1615/CritRevOncog.v7.i1-2.70; MADDEN SL, 1993, ANN NY ACAD SCI, V684, P75, DOI 10.1111/j.1749-6632.1993.tb32272.x; MAHESWARAN S, 1995, GENE DEV, V9, P2143, DOI 10.1101/gad.9.17.2143; Menke AL, 1997, CANCER RES, V57, P1353; Murata Y, 1997, FEBS LETT, V409, P41, DOI 10.1016/S0014-5793(97)00477-8; Natesan S, 1997, NATURE, V390, P349, DOI 10.1038/37019; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761; Przedborski S, 1998, NAT GENET, V18, P99, DOI 10.1038/ng0298-99; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Seo SJ, 1996, GENE, V178, P177, DOI 10.1016/0378-1119(96)00383-6; TAN YH, 1973, J EXP MED, V137, P317, DOI 10.1084/jem.137.2.317; VanDriel BEM, 1997, FREE RADICAL BIO MED, V23, P435, DOI 10.1016/S0891-5849(97)00102-0; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709	41	70	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					503	509		10.1074/jbc.274.1.503	http://dx.doi.org/10.1074/jbc.274.1.503			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867871	hybrid			2022-12-27	WOS:000077900200071
J	Zhang, QH; Sakai, T; Nowlen, J; Hayashi, I; Fassler, R; Mosher, DF				Zhang, QH; Sakai, T; Nowlen, J; Hayashi, I; Fassler, R; Mosher, DF			Functional beta 1-integrins release the suppression of fibronectin matrix assembly by vitronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CELL-ADHESION; LYSOPHOSPHATIDIC ACID; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; INTEGRIN ACTIVATION; BINDING-SITE; SYNERGY SITE; RECEPTOR; FIBROBLASTS	beta 1-null GD25 fibroblasts adherent to vitronectin fail to bind the N-terminal 70-kDa matrix assembly domain of fibronectin or to assemble fibronectin (Sakai, T,, Zhang, Q,, Fassler, R., and Mosher, D, F, (1998) J. Cell Biol. 141, 527-538), We have made four observations that extend this finding. First, the presence of vitronectin on a substrate that otherwise can support fibronectin assembly has a dominant-negative effect on assembly. Sec end, the dominant-negative effect is lost when active beta 1A is expressed. Third, beta 1A containing the extracellular D130A inactivating mutation has a dominant-negative effect on fibronectin assembly. Fourth, beta 1-null cells adherent to vitronectin are flat and lack filopodia, whereas beta 1-null cells adherent to fibronectin or beta 1A-expressing cells adherent to either vitronectin or fibronectin are contracted and exhibit numerous filopodia. These results reveal, therefore, that GD25 cells adherent to vitronectin can only assume a shape suitable for assembly of fibronectin when there is a countervailing signal from functional beta 1-integrins.	Univ Wisconsin, Dept Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Lund, Dept Expt Pathol, S-22185 Lund, Sweden	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Lund University	Mosher, DF (corresponding author), Univ Wisconsin, Dept Med, 1300 Univ Ave, Madison, WI 53706 USA.	dfmosher@facstaff.wisc.edu			NHLBI NIH HHS [HL21644] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS JC, 1993, DEVELOPMENT, V117, P1183; AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; AOTA S, 1991, J BIOL CHEM, V266, P15938; AOTA S, 1994, J BIOL CHEM, V269, P24756; ASTERMARK J, 1994, J BIOL CHEM, V269, P3690; BITTORF SV, 1993, J BIOL CHEM, V268, P24838; BOWDITCH RD, 1991, J BIOL CHEM, V266, P23323; BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856; CHECOVICH WJ, 1993, ARTERIOSCLER THROMB, V13, P1662, DOI 10.1161/01.ATV.13.11.1662; Chen F, 1996, J BIOL CHEM, V271, P9084, DOI 10.1074/jbc.271.15.9084; CHEN YP, 1994, J BIOL CHEM, V269, P18307; Christopher RA, 1997, J CELL SCI, V110, P569; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; DZAMBA BJ, 1994, J BIOL CHEM, V269, P19646; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; FOGERTY FJ, 1990, J CELL BIOL, V111, P699, DOI 10.1083/jcb.111.2.699; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Hynes RO, 1990, FIBRONECTINS; KOWALCZYK AP, 1992, J CELL PHYSIOL, V152, P126, DOI 10.1002/jcp.1041520117; LAFLAMME SE, 1994, J CELL BIOL, V126, P1287, DOI 10.1083/jcb.126.5.1287; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LEAHY DJ, 1994, PROTEINS, V19, P48, DOI 10.1002/prot.340190107; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; MCDONALD JA, 1987, J BIOL CHEM, V262, P2957; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; MOSHER DF, 1993, CURR OPIN STRUC BIOL, V3, P214, DOI 10.1016/S0959-440X(05)80155-1; Mosher DF, 1989, FIBRONECTIN; PETERS DMP, 1987, J CELL BIOL, V104, P121, DOI 10.1083/jcb.104.1.121; PLANTEFABER LC, 1989, CELL, V56, P281, DOI 10.1016/0092-8674(89)90902-1; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Ramos JW, 1996, J CELL BIOL, V134, P227, DOI 10.1083/jcb.134.1.227; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; ROSALES C, 1995, BBA-REV CANCER, V1242, P77, DOI 10.1016/0304-419X(95)00005-Z; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563; SEFTOR REB, 1992, P NATL ACAD SCI USA, V89, P1557, DOI 10.1073/pnas.89.5.1557; SHAFFER MC, 1984, J LAB CLIN MED, V103, P783; Tomasini B R, 1991, Prog Hemost Thromb, V10, P269; TOMASINIJOHANSSON BR, 1994, EXP CELL RES, V214, P303, DOI 10.1006/excr.1994.1262; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; WU CY, 1995, J CELL SCI, V108, P821; WU CY, 1995, J CELL SCI, V108, P2511; WU CY, 1993, J BIOL CHEM, V268, P21883; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; YANG JT, 1993, DEVELOPMENT, V119, P1093; Yang JT, 1996, MOL BIOL CELL, V7, P1737, DOI 10.1091/mbc.7.11.1737; Zhang QH, 1996, J BIOL CHEM, V271, P33284, DOI 10.1074/jbc.271.52.33284; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415; ZHANG QH, 1994, J CELL BIOL, V127, P1447, DOI 10.1083/jcb.127.5.1447; ZHANG ZH, 1993, J CELL BIOL, V122, P235, DOI 10.1083/jcb.122.1.235; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	66	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					368	375		10.1074/jbc.274.1.368	http://dx.doi.org/10.1074/jbc.274.1.368			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867852	hybrid			2022-12-27	WOS:000077900200052
J	Crute, BE; Seefeld, K; Gamble, J; Kemp, BE; Witters, LA				Crute, BE; Seefeld, K; Gamble, J; Kemp, BE; Witters, LA			Functional domains of the alpha 1 catalytic subunit of the AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCATALYTIC BETA-SUBUNIT; NIH 3T3 CELLS; GAMMA-SUBUNIT; TRANSFORMATION; IDENTIFICATION; INTERACT; COMPLEX; SITE	The AMP-activated protein kinase is a heterotrimeric enzyme, important in cellular adaptation to the stress of nutrient starvation, hypoxia, increased ATP utilization, or heat shock. This mammalian enzyme is composed of a catalytic a:subunit and noncatalytic beta and gamma subunits and is a member of a larger protein kinase family that includes the SNF1 kinase of Saccharomyces cerevisiae. In the present study, we have identified by truncation and site-directed mutagenesis several functional domains of the alpha 1 catalytic subunit, which modulate its activity, subunit association, and protein turnover. C-terminal truncation of the 548-amino acid (aa) wild-type alpha 1 protein to aa 312 or 392 abolishes the binding of the beta/gamma subunits and dramatically increases protein expression. The full-length wild-type alpha 1 subunit is only minimally active in the absence of co-expressed beta/gamma, and alpha 1(1-392) likewise has little activity. Further truncation to aa 312, however, is associated with a large increase in enzyme specific activity, thus revealing an autoinhibitory sequence between aa 313 and 392. alpha 1(1-312) still requires the phosphorylation of the activation loop Thr-172 for enzyme activity, yet is now independent of the allosteric activator, AMP. The increased levels of protein expression on transient transfection of either truncated a: subunit cDNA are because of a decrease in enzyme turnover by pulse-chase analysis. Taken together, these data indicate that the alpha 1 subunit of AMP-activated protein kinase contains several features that determine enzyme activity and stability. A constitutively active form of the kinase that does not require participation by the noncatalytic subunits provides a unique reagent for exploring the functions of AMP-activated protein kinase.	Dartmouth Med Sch, Dept Med, Endocrine Metab Div, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Biochem, Endocrine Metab Div, Hanover, NH 03755 USA; St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia	Dartmouth College; Dartmouth College; St. Vincent's Institute of Medical Research	Witters, LA (corresponding author), Dartmouth Med Sch, Dept Med, Endocrine Metab Div, Remsen 322, Hanover, NH 03755 USA.	lee.a.witters@dartmouth.edu	Kemp, Bruce/G-9602-2019; Kemp, Bruce E/L-2633-2014; seefeld, kim/J-8127-2014	Kemp, Bruce/0000-0001-6735-5082; Kemp, Bruce E/0000-0001-6735-5082; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035712, T32DK007508] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK07508, DK35712] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BONIFACINO JS, 1996, CURRENT PROTOCOL S10, V2; CHEN BW, 1994, BIOTECHNIQUES, V17, P657; Cheung PCF, 1997, BIOCHEM SOC T, V25, pS668, DOI 10.1042/bst025s668; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; GAO G, 1995, BBA-MOL CELL RES, V1266, P73, DOI 10.1016/0167-4889(94)00222-Z; Gao G, 1996, J BIOL CHEM, V271, P8675, DOI 10.1074/jbc.271.15.8675; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Jiang R, 1997, MOL CELL BIOL, V17, P2099, DOI 10.1128/MCB.17.4.2099; KEMP BE, 1994, TRENDS BIOCHEM SCI, V19, P440, DOI 10.1016/0968-0004(94)90126-0; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Michell BJ, 1996, J BIOL CHEM, V271, P28445, DOI 10.1074/jbc.271.45.28445; MITCHELHILL KI, 1994, J BIOL CHEM, V269, P2361; Mitchelhill KI, 1997, J BIOL CHEM, V272, P24475, DOI 10.1074/jbc.272.39.24475; Ponticos M, 1998, EMBO J, V17, P1688, DOI 10.1093/emboj/17.6.1688; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Spector D.I., 1998, CELL LAB MANUAL, V1; Sprenkle AB, 1997, FEBS LETT, V403, P254, DOI 10.1016/S0014-5793(97)00062-8; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; STAPLETON D, 1994, J BIOL CHEM, V269, P29343; Thornton C, 1997, BIOCHEM SOC T, V25, pS667, DOI 10.1042/bst025s667; YANG XL, 1994, EMBO J, V13, P5878, DOI 10.1002/j.1460-2075.1994.tb06933.x	25	290	296	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35347	35354		10.1074/jbc.273.52.35347	http://dx.doi.org/10.1074/jbc.273.52.35347			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857077	hybrid			2022-12-27	WOS:000077719700095
J	Carrello, A; Ingley, E; Minchin, RF; Tsai, S; Ratajczak, T				Carrello, A; Ingley, E; Minchin, RF; Tsai, S; Ratajczak, T			The common tetratricopeptide repeat acceptor site for steroid receptor-associated immunophilins and Hop is located in the dimerization domain of hsp90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; PROGESTERONE-RECEPTOR; GLUCOCORTICOID RECEPTOR; MOLECULAR-CLONING; ESTROGEN-RECEPTOR; SIGNAL-TRANSDUCTION; MUTATIONAL ANALYSIS; TERMINAL REGION; REACTION CYCLE; IN-VIVO	Structurally related tetratricopeptide repeat motifs in steroid receptor-associated immunophilins and the STI1 homolog, Hop, mediate the interaction with a common cellular target, hsp90, We have identified the binding domain in hsp90 for cyclophilin 40 (CyP40) using a two-hybrid system screen of a mouse cDNA library. All isolated clones encoded the intact carboxyl terminus of hsp90 and overlapped with a common region corresponding to amino acids 558-724 of murine hsp84, The interaction was confirmed in vitro with bacterially expressed CyP40 and deletion mutants of hsp90 beta and was delineated further to a 124-residue COOH-terminal segment of hsp90, Deletion of the conserved MEEVD sequence at the extreme carboxyl terminus of hsp90 precludes interaction with CyP40, signifying an important role for this motif in hsp90 function. We show that CyP40 and Hop display similar interaction profiles with hsp90 truncation mutants and present evidence for the direct competition of Hop and FK506-binding protein 52 with CyP40 for binding to the hsp90 COOH-terminal region. Our results are consistent with a common tetratricopeptide repeat interaction site for Hop and steroid receptor associated immunophilins within a discrete COOH-terminal domain of hsp90. This region of hsp90 mediates ATP-independent chaperone activity, overlaps the hsp90 dimerization domain, and includes structural elements important for steroid receptor interaction.	Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia; Univ Western Australia, Dept Pharmacol, Queen Elizabeth II Med Ctr, Nedlands, WA 6009, Australia; Dept Biochem, Lab Canc Med, Perth, WA 6001, Australia; Univ Western Australia, Dept Biochem, Nedlands, WA 6907, Australia; Mt Sinai Sch Med, Inst Gene Therapy & Mol Med, New York, NY 10030 USA	University of Western Australia; University of Western Australia; University of Western Australia; Icahn School of Medicine at Mount Sinai	Ratajczak, T (corresponding author), Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Verdun St, Nedlands, WA 6009, Australia.	tomr@cyllene.uwa.edu.au	Ingley, Evan/C-2401-2013	Ingley, Evan/0000-0002-8112-9134; Minchin, Rodney/0000-0002-3178-4835				Barent RL, 1998, MOL ENDOCRINOL, V12, P342, DOI 10.1210/me.12.3.342; Beissinger M, 1998, BIOL CHEM, V379, P245; BINART N, 1989, J STEROID BIOCHEM, V34, P369, DOI 10.1016/0022-4731(89)90110-6; BINART N, 1995, BIOCHEM J, V311, P797, DOI 10.1042/bj3110797; BINART N, 1989, BIOCHEM BIOPH RES CO, V159, P140, DOI 10.1016/0006-291X(89)92415-7; BOHEN SP, 1995, SCIENCE, V268, P1303, DOI 10.1126/science.7761850; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; CADEPOND F, 1993, P NATL ACAD SCI USA, V90, P10434, DOI 10.1073/pnas.90.22.10434; Chambraud B, 1996, J BIOL CHEM, V271, P32923, DOI 10.1074/jbc.271.51.32923; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; CSERMELY P, 1993, J BIOL CHEM, V268, P1901; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; CZAR MJ, 1994, J BIOL CHEM, V269, P11155; Dittmar KD, 1997, J BIOL CHEM, V272, P13047, DOI 10.1074/jbc.272.20.13047; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; FRUMAN DA, 1994, FASEB J, V8, P391, DOI 10.1096/fasebj.8.6.7513288; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HICKEY E, 1989, MOL CELL BIOL, V9, P2615, DOI 10.1128/MCB.9.6.2615; HOFFMANN K, 1995, BIOCHEM J, V307, P5, DOI 10.1042/bj3070005; HOHFELD J, 1995, CELL, V83, P589; HONORE B, 1992, J BIOL CHEM, V267, P8485; HUTCHISON KA, 1994, J BIOL CHEM, V269, P5043; JAKOB U, 1994, TRENDS BIOCHEM SCI, V19, P205, DOI 10.1016/0968-0004(94)90023-X; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; JOHNSON JL, 1995, MOL ENDOCRINOL, V9, P670, DOI 10.1210/me.9.6.670; Kay JE, 1996, BIOCHEM J, V314, P361, DOI 10.1042/bj3140361; KIMURA Y, 1995, SCIENCE, V268, P1362, DOI 10.1126/science.7761857; Lassle M, 1997, J BIOL CHEM, V272, P1876, DOI 10.1074/jbc.272.3.1876; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; Meng X, 1996, J CELL SCI, V109, P1677; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; MINAMI Y, 1994, MOL CELL BIOL, V14, P1459, DOI 10.1128/MCB.14.2.1459; MOORE SK, 1987, GENE, V56, P29, DOI 10.1016/0378-1119(87)90155-7; Nair SC, 1997, MOL CELL BIOL, V17, P594, DOI 10.1128/MCB.17.2.594; NEMOTO T, 1995, EUR J BIOCHEM, V233, P1, DOI 10.1111/j.1432-1033.1995.001_1.x; Nemoto T, 1998, BIOCHEM J, V330, P989, DOI 10.1042/bj3300989; Nemoto T, 1997, J BIOL CHEM, V272, P26179, DOI 10.1074/jbc.272.42.26179; OWENSGRILLO JK, 1995, J BIOL CHEM, V270, P20479, DOI 10.1074/jbc.270.35.20479; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; PEATTIE DA, 1992, P NATL ACAD SCI USA, V89, P10974, DOI 10.1073/pnas.89.22.10974; Prapapanich V, 1996, MOL ENDOCRINOL, V10, P420, DOI 10.1210/me.10.4.420; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; RADANYI C, 1994, P NATL ACAD SCI USA, V91, P11197, DOI 10.1073/pnas.91.23.11197; RATAJCZAK T, 1988, BIOCHEM BIOPH RES CO, V151, P1156, DOI 10.1016/S0006-291X(88)80487-X; Ratajczak T, 1996, J BIOL CHEM, V271, P2961, DOI 10.1074/jbc.271.6.2961; RATAJCZAK T, 1993, J BIOL CHEM, V268, P13187; RENOIR JM, 1990, J BIOL CHEM, V265, P10740; RENOIR JM, 1995, P NATL ACAD SCI USA, V92, P4977, DOI 10.1073/pnas.92.11.4977; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SCHWARTZ JA, 1991, MED HYPOTHESES, V35, P140, DOI 10.1016/0306-9877(91)90037-Y; SHAKNOVICH R, 1992, MOL CELL BIOL, V12, P5059, DOI 10.1128/MCB.12.11.5059; SHI Y, 1994, P NATL ACAD SCI USA, V91, P2767, DOI 10.1073/pnas.91.7.2767; SHUE GL, 1994, J BIOL CHEM, V269, P2707; SIMON MC, 1987, MOL CELL BIOL, V7, P2884, DOI 10.1128/MCB.7.8.2884; SMITH DF, 1993, MOL ENDOCRINOL, V7, P1418, DOI 10.1210/me.7.11.1418; SMITH DF, 1993, MOL ENDOCRINOL, V7, P4, DOI 10.1210/me.7.1.4; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; SULLIVAN WP, 1993, J BIOL CHEM, V268, P20373; TAI PKK, 1986, BIOCHEMISTRY-US, V25, P5269, DOI 10.1021/bi00366a043; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; YAMAZAKI M, 1990, AGR BIOL CHEM TOKYO, V54, P3163, DOI 10.1080/00021369.1990.10870468; Young JC, 1997, FEBS LETT, V418, P139, DOI 10.1016/S0014-5793(97)01363-X; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007	77	100	107	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2682	2689		10.1074/jbc.274.5.2682	http://dx.doi.org/10.1074/jbc.274.5.2682			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915798	Green Published, hybrid			2022-12-27	WOS:000078319500016
J	Chen, DS; Rudland, PS; Chen, HL; Barraclough, R				Chen, DS; Rudland, PS; Chen, HL; Barraclough, R			Differential reactivity of the rat S100A4(p9Ka) gene to sodium bisulfite is associated with differential levels of the S100A4 (p9Ka) mRNA in rat mammary epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; MTS1 GENE; DNA-METHYLATION; ELONGATED CELLS; EXPRESSION; METASTASIS; CARCINOGENESIS; HOMOLOGY; BENIGN; TUMORS	Elevated intracellular levels of S100A4, an S100-related calcium-binding protein, induce metastatic capability in benign mammary tumor-derived epithelial cells and in transgenic mice bearing oncogene-induced benign mammary tumors. The S100OA4(p9Ka) gene in rat mammary epithelial cells expressing low levels of S100A4 yields a reduced number of fragments upon digestion with the methylation-sensitive restriction enzyme, HpaII, compared with the gene from high S100A4-expressing cells. Genomic sequencing of two potential regulatory elements in the S100A4 gene, an intronic enhancer and TATA box region, revealed that in low S100A4-expressing cells, most cytosine bases exhibited high levels of resistance to conversion to thymine by sodium bisulfite. In derivative cell lines, which express high levels of S100A4, only a small number of cytosine bases were resistant to treatment with sodium bisulfite. In contrast, cytosine bases in the DNA surrounding an upstream regulatory region, which binds inhibitory GC factor in the low-expressing cell lines, are sensitive to conversion to thymine by sodium bisulfite in both low- and high-expressing cell lines. The results suggest that the rat S100A4 gene is maintained in a different state in the low-expressing cell lines and that this state might be a consequence of the pattern of methylation in this regulated gene that does not contain a CPG island.	Univ Liverpool, Canc Res Fund Lab, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; Univ Liverpool, Polio Res Fund Lab, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool	Barraclough, R (corresponding author), Univ Liverpool, Canc Res Fund Lab, Sch Biol Sci, Life Sci Bldg,POB 147, Liverpool L69 7ZB, Merseyside, England.	brb@liv.ac.uk	Barraclough, Roger/AAH-6516-2020	Barraclough, Roger/0000-0002-7203-1194				Ambartsumian NS, 1996, ONCOGENE, V13, P1621; BARRACLOUGH R, 1984, NUCLEIC ACIDS RES, V12, P8097, DOI 10.1093/nar/12.21.8097; BARRACLOUGH R, 1987, J CELL PHYSIOL, V131, P393, DOI 10.1002/jcp.1041310311; BARRACLOUGH R, 1987, J MOL BIOL, V198, P13, DOI 10.1016/0022-2836(87)90453-0; BARRACLOUGH R, 1982, EUR J BIOCHEM, V129, P335, DOI 10.1111/j.1432-1033.1982.tb07056.x; BARRACLOUGH R, 1984, BIOCHEM BIOPH RES CO, V120, P351, DOI 10.1016/0006-291X(84)91261-0; BENNETT DC, 1978, CELL, V15, P283, DOI 10.1016/0092-8674(78)90104-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen DS, 1997, J BIOL CHEM, V272, P20283, DOI 10.1074/jbc.272.32.20283; Chen DS, 1996, BIOCHEM SOC T, V24, pS352, DOI 10.1042/bst024352s; CLARK SJ, 1995, NAT GENET, V10, P20, DOI 10.1038/ng0595-20; COUNTS JL, 1995, CELL, V83, P13, DOI 10.1016/0092-8674(95)90228-7; DAVIES BR, 1993, ONCOGENE, V8, P999; Davies MPA, 1996, ONCOGENE, V13, P1631; DUNNINGTON DJ, 1983, J NATL CANCER I, V71, P1227; DUNNINGTON DJ, 1984, J NATL CANCER I, V72, P455; DUNNINGTON DJ, 1984, THESIS U LONDON; EBRALIDZE A, 1989, GENE DEV, V3, P1086, DOI 10.1101/gad.3.7.1086; ENGELKAMP D, 1993, P NATL ACAD SCI USA, V90, P6547, DOI 10.1073/pnas.90.14.6547; FEIL R, 1994, NUCLEIC ACIDS RES, V22, P695, DOI 10.1093/nar/22.4.695; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GIBBS FEM, 1995, J HISTOCHEM CYTOCHEM, V43, P169, DOI 10.1177/43.2.7822773; ISSA JPJ, 1993, J NATL CANCER I, V85, P1235, DOI 10.1093/jnci/85.15.1235; KUZNICKI J, 1987, BIOCHEM J, V247, P663, DOI 10.1042/bj2470663; Lloyd BH, 1998, ONCOGENE, V17, P465, DOI 10.1038/sj.onc.1201948; PEDROCCHI M, 1994, INT J CANCER, V57, P684, DOI 10.1002/ijc.2910570513; RAIZIS AM, 1995, ANAL BIOCHEM, V226, P161, DOI 10.1006/abio.1995.1204; Rein T, 1997, J BIOL CHEM, V272, P10021; Sambrook J., 1989, MOL CLONING, pA1; TASHEVA ES, 1994, MOL CELL BIOL, V14, P5636, DOI 10.1128/MCB.14.9.5636; TULCHINSKY E, 1992, P NATL ACAD SCI USA, V89, P9146, DOI 10.1073/pnas.89.19.9146; TULCHINSKY E, 1993, ONCOGENE, V8, P79; TULCHINSKY E, 1995, BBA-GENE STRUCT EXPR, V1261, P243, DOI 10.1016/0167-4781(95)00013-7; WOODCOCK DM, 1987, BIOCHEM BIOPH RES CO, V145, P888, DOI 10.1016/0006-291X(87)91048-5; Zingg JM, 1997, CARCINOGENESIS, V18, P869, DOI 10.1093/carcin/18.5.869	35	13	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2483	2491		10.1074/jbc.274.4.2483	http://dx.doi.org/10.1074/jbc.274.4.2483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891019	hybrid			2022-12-27	WOS:000078185200086
J	Du Yan, S; Shi, YG; Zhu, AP; Fa, J; Zhu, HJ; Zhu, YC; Gibson, L; Stern, E; Collison, K; Al-Mohanna, F; Ogawa, S; Roher, A; Clarke, SG; Stern, DM				Du Yan, S; Shi, YG; Zhu, AP; Fa, J; Zhu, HJ; Zhu, YC; Gibson, L; Stern, E; Collison, K; Al-Mohanna, F; Ogawa, S; Roher, A; Clarke, SG; Stern, DM			Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in A beta-induced cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALZHEIMERS-DISEASE; SCAVENGER RECEPTOR; PROTEIN OXIDATION; AMYLOID PROTEIN; BOVINE LIVER; IN-VITRO; PEPTIDE; EXPRESSION; BRAIN	Endoplasmic reticulum-associated amyloid beta-peptide (A beta)-binding protein (ERAB)/L-3-hydroxyacyl-CoA dehydrogenase type II (HADH II) is expressed at high levels in Alzheimer's disease (AD)-affected brain, binds A beta, and contributes to A beta-induced cytotoxicity. Purified recombinant ERAB/HADH II catalyzed the NADH-dependent reduction of S-acetoacetyl-CoA with a K-m of approximate to 68 mu M and a V-max of approximate to 430 mu mol/min/mg. The contribution of ERAB/HADH II enzymatic activity to A beta-mediated cellular dysfunction was studied by site-directed mutagenesis in the catalytic domain (Y168G/K172G). Although COS cells cotransfected to overexpress wild-type ERAB/HADH II and variant beta-amyloid precursor protein (beta APP(V717G)) showed DNA fragmentation, cotransfection with Y168G/K172G-altered ERAB and beta APP(W717G) was without effect. We thus asked whether the enzyme might recognize alcohol substrates of which the aldehyde products could be cytotoxic; ERAB/HADH II catalyzed oxidation of a variety of simple alcohols (C2-C10) to their respective aldehydes in the presence of NAD(+) and NAD-dependent oxidation of 17 beta-estradiol. Addition of micromolar levels of synthetic A beta(1-40) to purified ERAB/HADH II inhibited, in parallel, reduction of S-acetoacetyl-CoA (K-i approximate to 1.6 mu M), as web as oxidation of 17 beta-estradiol (K-i approximate to 3.2 mu M) and (-)-2-octanol (K-i approximate to 2.6 mu M). Because micromolar levels of A beta were required to inhibit ERAB/HADH II activity, whereas A beta binding to ERAB/HADH II occurred at much lower concentrations (K-m approximate to 40-70 nM), the latter more closely simulating A beta levels within cells, A beta perturbation of ERAB/HADH II was likely to result from mechanisms other than the direct modulation of enzymatic activity. Cells cotransfected to overexpress ERAB/HADH II and beta APP(V717G) generated malondialdehyde-protein and 4-hydroxynonenal-protein epitopes, which were detectable only at the lowest levels in cells overexpressing either ERAB/HADH II or beta APP(V717G) alone. Generation of such toxic aldehydes was not observed in cells contransfected to overexpress Y168G/K172G-altered ERAB and beta APP(V717G). We conclude that the generalized alcohol dehydrogenase activity of ERAB/HADH II is central to the cytotoxicity observed in an A beta-rich environment.	Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Physiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Surg, New York, NY 10032 USA; King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia; Osaka Univ, Dept Anat & Neurosci, Osaka, Japan; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Sun Hlth Res Inst, Haldeman Lab Alzheimers Dis Res, Sun City, AZ 85372 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	Columbia University; Columbia University; Columbia University; King Faisal Specialist Hospital & Research Center; Osaka University; Princeton University; Banner Research; Banner Health; Banner Sun Health Research Institute; University of California System; University of California Los Angeles	Du Yan, S (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, P&S 17-410,630 W 168th St, New York, NY 10020 USA.		Fu, Jin/A-3510-2012	Shi, Yigong/0000-0003-2030-168X	NIA NIH HHS [AG00690, AG11925, AG14103] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG014103, K01AG000690, R01AG011925] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; BONTHRON DT, 1986, NATURE, V324, P270, DOI 10.1038/324270a0; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Du YS, 1997, J NEUROCHEM, V69, P1382; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; ElKhoury J, 1996, NATURE, V382, P716; Furuta S, 1997, BBA-GENE STRUCT EXPR, V1350, P317, DOI 10.1016/S0167-4781(96)00171-6; GILLIGAN DM, 1995, AM J CARDIOL, V75, P264, DOI 10.1016/0002-9149(95)80033-O; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Harlow E., 1988, ANTIBODIES LAB MANUA; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; He XY, 1998, J BIOL CHEM, V273, P10741, DOI 10.1074/jbc.273.17.10741; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; Horie K, 1997, J CLIN INVEST, V100, P2995, DOI 10.1172/JCI119853; KLOTZ IM, 1984, J BIOL CHEM, V259, P60; Kobayashi A, 1996, J BIOCHEM-TOKYO, V119, P775, DOI 10.1093/oxfordjournals.jbchem.a021307; Kuwabara K, 1996, J BIOL CHEM, V271, P5025; Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825; MARK R, 1996, MOL NEUROBIOL, V12, P915; MATTSON MP, 1995, BRAIN RES, V676, P219, DOI 10.1016/0006-8993(95)00148-J; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; PALINSKI W, 1995, ARTERIOSCL THROM VAS, V15, P571, DOI 10.1161/01.ATV.15.5.571; PALINSKI W, 1990, ARTERIOSCLEROSIS, V10, P325, DOI 10.1161/01.ATV.10.3.325; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Roe C. R., 1995, METABOLIC MOL BASES, P1501; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P336, DOI 10.1161/01.ATV.10.3.336; SCHEMBRI MA, 1995, J BACTERIOL, V177, P4501, DOI 10.1128/jb.177.15.4501-4507.1995; Segel IH, 1975, ENZYME KINETICS BEHA; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1995, FASEB J, V9, P366, DOI 10.1096/fasebj.9.5.7896005; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; SMITH MA, 1994, AM J PATHOL, V145, P42; Takeda A, 1996, NEUROSCI LETT, V221, P17, DOI 10.1016/S0304-3940(96)13275-4; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; TEIN I, 1991, ANN NEUROL, V30, P415, DOI 10.1002/ana.410300315; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; Yan SD, 1997, NATURE, V389, P689; YAN SD, 1995, NAT MED, V1, P693, DOI 10.1038/nm0795-693; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	52	98	110	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2145	2156		10.1074/jbc.274.4.2145	http://dx.doi.org/10.1074/jbc.274.4.2145			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890977	Green Published, hybrid			2022-12-27	WOS:000078185200044
J	Petrosino, J; Rudgers, G; Gilbert, H; Palzkill, T				Petrosino, J; Rudgers, G; Gilbert, H; Palzkill, T			Contributions of aspartate 49 and phenylalanine 142 residues of a tight binding inhibitory protein of beta-lactamases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; RESISTANCE; EVOLUTION; SUBSTITUTIONS; CEFTAZIDIME; ANTIBIOTICS; MECHANISM; SELECTION	beta-Lactamases are bacterial enzymes that hydrolyze beta-lactam antibiotics to render them inactive. The beta-lactamase inhibitor protein (BLIP) of Streptomyces clavuligerus, is a potent inhibitor of several beta-lactamases, including the TEM-1 enzyme (K-i = 0.6 nM). Evidence from the TEM-1/BLIP co-crystal suggests that two BLIP residues, Asp-49 and Phe-142, mimic interactions made by penicillin G when bound in the active site of TEM-1. To determine the importance of these two residues, a heterologous expression system for BLIP was established in Escherichia coli. Site-directed mutagenesis was used to change Asp-49 and Phe-142 to alanine, and inhibition constants (K-i) for both mutants were determined. Each mutation increases the K-i for BLIP inhibition of TEM-1 beta-lactamase approximately 100-fold To address how these two positions effect the specificity of beta-lactamase binding, K-i values were determined for the interaction of wild-type BLIP, as well as the D49A and F142A mutants, with two extended spectrum beta-lactamases (the G238S and the E104K TEM variants). Positions 104 and 238 are located in the BLIP/beta-lactamase interface. Interestingly, the three BLIP proteins inhibited the G238S beta-lactamase mutant to the same degree that they inhibited TEM-1, However, wild-type BLIP has a higher K-i for the E104K beta-lactamase mutant, suggesting that interactions between BLIP and beta-lactamase residue Glu-104 are important for wild-type levels of BLIP inhibition.	Baylor Coll Med, Dept Microbiol & Immunol, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Palzkill, T (corresponding author), Baylor Coll Med, Dept Microbiol & Immunol, 1 Baylor Plaza, Houston, TX 77030 USA.		Petrosino, Joseph F./AAF-1621-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032956, R37AI032956, R56AI032956] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32956] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENT R, 1981, P NATL ACAD SCI-BIOL, V78, P4204, DOI 10.1073/pnas.78.7.4204; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Cantu C, 1996, J BIOL CHEM, V271, P22538, DOI 10.1074/jbc.271.37.22538; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DENNIS MS, 1994, J BIOL CHEM, V269, P22129; DORAN JL, 1990, J BACTERIOL, V172, P4909, DOI 10.1128/jb.172.9.4909-4918.1990; DUBOIS SK, 1995, J ANTIMICROB CHEMOTH, V35, P7; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang WZ, 1998, ANTIMICROB AGENTS CH, V42, P2893, DOI 10.1128/AAC.42.11.2893; JACOBY GA, 1991, ANTIMICROB AGENTS CH, V35, P1697, DOI 10.1128/AAC.35.9.1697; Jacoby George A., 1994, Trends in Microbiology, V2, P357, DOI 10.1016/0966-842X(94)90611-4; JORIS B, 1988, BIOCHEM J, V250, P313, DOI 10.1042/bj2500313; Knox JR, 1996, CHEM BIOL, V3, P937, DOI 10.1016/S1074-5521(96)90182-9; MATTHEW M, 1979, J ANTIMICROB CHEMOTH, V5, P349, DOI 10.1093/jac/5.4.349; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; PARKER RH, 1987, INFECT CONT HOSP EP, V8, P36, DOI 10.1017/S0195941700066972; PETIT A, 1995, BIOCHEM J, V305, P33, DOI 10.1042/bj3050033; Petrosino J, 1998, TRENDS MICROBIOL, V6, P323, DOI 10.1016/S0966-842X(98)01317-1; PRADAKAR AS, 1994, GENE, V144, P31; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; SANDERS CC, 1992, CLIN INFECT DIS, V14, P1089, DOI 10.1093/clinids/14.5.1089; SAVES I, 1995, J BIOL CHEM, V270, P18240, DOI 10.1074/jbc.270.31.18240; Sirot D, 1997, ANTIMICROB AGENTS CH, V41, P1322, DOI 10.1128/AAC.41.6.1322; STRYNADKA NCJ, 1994, NATURE, V368, P657, DOI 10.1038/368657a0; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P290, DOI 10.1038/nsb0396-290; TOMASZ A, 1979, ANNU REV MICROBIOL, V33, P113, DOI 10.1146/annurev.mi.33.100179.000553; VENKATACHALAM KV, 1994, J BIOL CHEM, V269, P23444; WIEDEMANN B, 1989, J ANTIMICROB CHEMOTH, V24, P1	31	66	71	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2394	2400		10.1074/jbc.274.4.2394	http://dx.doi.org/10.1074/jbc.274.4.2394			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891008	hybrid			2022-12-27	WOS:000078185200075
J	Thoenges, D; Amler, E; Eckert, T; Schoner, W				Thoenges, D; Amler, E; Eckert, T; Schoner, W			Tight binding of bulky fluorescent derivatives of adenosine to the low affinity E(2)ATP site leads to inhibition of Na+/K+-ATPase - Analysis of structural requirements of fluorescent ATP derivatives with a Koshland-Nemethy-Filmer model of two interacting ATP sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(NA+ + K+)-ATPASE; NUCLEOTIDES; ANALOG; SODIUM; PHOSPHORYLATION; TRIPHOSPHATASE; ADENINE; ENZYMES; STATE; RING	A Koshland-Nemethy-Filmer model of two cooperating ATP sites has previously been shown to explain the kinetics of inhibition of Na+/K+-ATPase (EC 3.6.1.37) by dansylated ATP (Thoenges, D., and Schoner, W. (1997) J. Biol. Chem. 272, 16315-16321), The present work demonstrates that this model adequately describes all types of interactions and kinetics of a number of ATP analogs that differ in their cooperativity of the high and low affinity ATP binding sites of the enzyme. 2',3'-O(2,4,6-trinitrophenyl)ATP binds in a negative cooperative way to the E(1)ATP site (K-d = 0.7 mu M) and to the E(2)ATP site (K-d = 210 mu M), but 3'(2')-O-methylanthraniloyl-ATP in a positive cooperative way with a lower affinity to the E(1)ATP binding site (K-d = 200 mu M) than to the E(2)ATP binding site (K-d = 80 mu M). 3'(2')-O(5-Fluor-2,4-dinitrophenyl)-ATP, however, binds in a noncooperative way, with equal affinities to both ATP binding sites (K-d = 10 mu M). in a research for the structural parameters determining ATP site specificity and cooperativity, we became aware that structural flexibility of ribose is necessary for catalysis, Moreover, puckering of the ring atoms in the ribose is essential for the interaction between ATP sites in Na+/K+-ATPase. A number of derivatives of 2'(3')-O-adenosine with bulky fluorescent substitutes bind with high affinity to the E(2)ATP site and inhibit Na+/K+-ATPase activity. Evidently, an increased number of interactions of such a bulky adenosine with the enzyme protein tightens binding to the E(2)ATP site.	Univ Giessen, Inst Biochem & Endocrinol, Fachbereich Vet Med, D-35392 Giessen, Germany; Univ Giessen, Inst Organ Chem, D-35392 Giessen, Germany; Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague, Czech Republic	Justus Liebig University Giessen; Justus Liebig University Giessen; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Schoner, W (corresponding author), Univ Giessen, Inst Biochem & Endocrinol, Fachbereich Vet Med, Frankfurter Str 100, D-35392 Giessen, Germany.	Wilhelm.Schoner@vetmed.uni-giessen.de	Amler, Evzen/H-3588-2014					ALTONA C, 1972, J AM CHEM SOC, V94, P8205, DOI 10.1021/ja00778a043; BARRIO JR, 1972, BIOCHEM BIOPH RES CO, V46, P597, DOI 10.1016/S0006-291X(72)80181-5; Chaconas G, 1980, Methods Enzymol, V65, P75; CHUAN H, 1989, J BIOL CHEM, V264, P7981; CHUAN H, 1988, J BIOL CHEM, V263, P13003; CORNISHBOWDEN A, 1975, J MOL BIOL, V95, P201, DOI 10.1016/0022-2836(75)90390-3; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; HIRATSUKA T, 1973, BIOCHIM BIOPHYS ACTA, V320, P635, DOI 10.1016/0304-4165(73)90143-8; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KRAUT J, 1988, SCIENCE, V242, P533, DOI 10.1126/science.3051385; Linnertz H, 1997, FEBS LETT, V419, P227, DOI 10.1016/S0014-5793(97)01460-9; LINNERTZ H, 1995, EUR J BIOCHEM, V232, P420, DOI 10.1111/j.1432-1033.1995.tb20827.x; Lovry O.H., 1951, J BIOL CHEM, V193, P265; MOCZYDLOWSKI EG, 1981, J BIOL CHEM, V256, P2357; NEUFELD AH, 1969, J BIOL CHEM, V244, P6493; Obsil T, 1998, FEBS LETT, V426, P297, DOI 10.1016/S0014-5793(98)00373-1; OLSON WK, 1982, J AM CHEM SOC, V104, P270, DOI 10.1021/ja00365a049; PAULS H, 1980, EUR J BIOCHEM, V109, P523, DOI 10.1111/j.1432-1033.1980.tb04824.x; PISZKIEWICZ D, 1971, BIOCHEMISTRY-US, V10, P4544, DOI 10.1021/bi00800a031; POST RL, 1965, J BIOL CHEM, V240, P1437; POST RL, 1972, J BIOL CHEM, V247, P6530; Sanger W., 1984, PRINCIPLES NUCL ACID, P105; SCHAFER G, 1979, EUR J BIOCHEM, V97, P415, DOI 10.1111/j.1432-1033.1979.tb13129.x; SCHEINERBOBIS G, 1993, BIOCHEMISTRY-US, V32, P9592, DOI 10.1021/bi00088a011; SCHEINERBOBIS G, 1987, EUR J BIOCHEM, V168, P123, DOI 10.1111/j.1432-1033.1987.tb13396.x; SCHONER W, 1994, SODIUM PUMP, P332; SCHWARZBAUM PJ, 1995, BBA-BIOMEMBRANES, V1233, P33, DOI 10.1016/0005-2736(94)00229-I; Segel E, 1975, ENZYME KINETICS; Thoenges D, 1997, J BIOL CHEM, V272, P16315, DOI 10.1074/jbc.272.26.16315; Tsuda T, 1998, J BIOL CHEM, V273, P24334, DOI 10.1074/jbc.273.38.24334; Ward DG, 1998, J BIOL CHEM, V273, P14277, DOI 10.1074/jbc.273.23.14277; WOLFENDEN R, 1972, ACCOUNTS CHEM RES, V5, P10, DOI 10.1021/ar50049a002	35	21	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1971	1978		10.1074/jbc.274.4.1971	http://dx.doi.org/10.1074/jbc.274.4.1971			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890953	hybrid			2022-12-27	WOS:000078185200020
J	Gupta, RC; Folta-Stogniew, E; Radding, CM				Gupta, RC; Folta-Stogniew, E; Radding, CM			Human Rad51 protein can form homologous joints in the absence of net strand exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RECA; RECOMBINATION PROTEINS; GENETIC-RECOMBINATION; COMPLEX-FORMATION; YEAST RAD51; ATP HYDROLYSIS; DNA-MOLECULES; IN-VITRO; REPAIR; BINDING	The eukaryotic homologs of RecA protein are central enzymes of recombination and repair, and notwithstanding a high degree of conservation they differ sufficiently from RecA to offer insights into mechanisms and biological roles. The yield of DNA strand exchange reactions driven by both Escherichia coli RecA protein and its human homolog HsRad51 protein was inversely related to the GC content of oligonucleotide substrates, but at any given GC composition, HsRad51 promoted less exchange than RecA. When 40% of bases were GC pairs, the rate constant for strand exchange by HsRad51 was unmeasurable, whereas the rate constants for homologous pairing were unaltered relative to more AT-rich DNA. The ability of HsRad51 to form joints in the absence of net strand exchange was confirmed by experiments in which heterologous blocks at both ends of linear duplex oligonucleotides produced joints that instantly dissociated upon deproteinization These findings suggest that HsRad51 acting alone., human DNA in vivo is a pairing protein that cannot form extensive heteroduplex DNA.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA	Yale University; Yale University	Gupta, RC (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.	rgupta@biomed.med.yale.edu			NIGMS NIH HHS [R37-GM35504] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADZUMA K, 1992, GENE DEV, V6, P1679, DOI 10.1101/gad.6.9.1679; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bazemore LR, 1997, J BIOL CHEM, V272, P14672, DOI 10.1074/jbc.272.23.14672; Bazemore LR, 1997, P NATL ACAD SCI USA, V94, P11863, DOI 10.1073/pnas.94.22.11863; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; BIANCHI M, 1983, CELL, V34, P931, DOI 10.1016/0092-8674(83)90550-0; BIANCHI ME, 1983, CELL, V35, P511, DOI 10.1016/0092-8674(83)90185-X; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; BURNETT B, 1994, J MOL BIOL, V238, P540, DOI 10.1006/jmbi.1994.1313; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; FIRMENICH AA, 1995, MOL CELL BIOL, V15, P1620; Golub EI, 1997, NUCLEIC ACIDS RES, V25, P4106, DOI 10.1093/nar/25.20.4106; GRUSS A, 1991, J BIOL CHEM, V266, P6667; Gupta RC, 1998, P NATL ACAD SCI USA, V95, P9843, DOI 10.1073/pnas.95.17.9843; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; HARTL DL, 1988, BASIC GENETICS, P505; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; HSIEH P, 1992, P NATL ACAD SCI USA, V89, P6492, DOI 10.1073/pnas.89.14.6492; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; KIM JI, 1992, J BIOL CHEM, V267, P16438; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; Li MJ, 1996, P NATL ACAD SCI USA, V93, P10222, DOI 10.1073/pnas.93.19.10222; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Lim DS, 1996, MOL CELL BIOL, V16, P7133; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; PUGH BF, 1987, J BIOL CHEM, V262, P1326; RIDDLES PW, 1985, J BIOL CHEM, V260, P165; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; SHIBATA T, 1981, J BIOL CHEM, V256, P7557; SHIBATA T, 1981, J BIOL CHEM, V256, P7565; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236	42	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1248	1256		10.1074/jbc.274.3.1248	http://dx.doi.org/10.1074/jbc.274.3.1248			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880493	hybrid			2022-12-27	WOS:000079956900013
J	Pregetter, M; Prassl, R; Schuster, B; Kriechbaum, M; Nigon, F; Chapman, J; Laggner, P				Pregetter, M; Prassl, R; Schuster, B; Kriechbaum, M; Nigon, F; Chapman, J; Laggner, P			Microphase separation in low density lipoproteins - Evidence for a fluid triglyceride core below the lipid melting transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SERUM-LIPOPROTEINS; SMALL-ANGLE SCATTERING; HUMAN-PLASMA; OXIDATIVE RESISTANCE; CHOLESTERYL ESTERS; APOLIPOPROTEIN-B; SPIN-LABEL; SURFACE; MEMBRANES; SEQUENCE	The structural organization of the neutral lipid core in human low density lipoproteins (LDL) was investigated in physicochemically defined, distinct human LDL subspecies in the density range of 1.0244-1.0435 g/mg evaluation of the core lipid transition temperature, chemical composition, and the behavior of spin-labeled core lipids. Calorimetric studies were performed on more than 60 LDL preparations, and the transition temperature, which varied between 19 and 32 degrees C, was correlated to the chemical composition and revealed a discontinuity at a critical cholesteryl ester to triglyceride ratio of approximately 7:1. For electron spin resonance studies, several LDL preparations were probed with spin-labeled cholesteryl esters and triglycerides, respectively In LDL with a high triglyceride content, both labels exhibited similar mobility behavior. In contrast, in LDL with only small concentrations of triglycerides, the behavior of labeled cholesteryl esters and labeled triglycerides differed distinctly. The cholesteryl esters were strongly immobilized below the transition temperature, whereas the triglycerides remained fluid throughout the measured temperatures These results suggest that the critical cholesteryl ester to triglyceride mass ratio of 7:1 corresponds to two concentric compartments with a radial ratio of 2:1, where the liquid triglycerides occupy the core, and the cholesteryl esters form the frozen shell. At higher triglyceride contents, the triglyceride molecules insert into the cholesteryl ester shell and depress the peak transition temperature of the LDL core, whereas at lower triglyceride contents, excess cholesteryl esters are dissolved in the core.	Austrian Acad Sci, Inst Biophys & Rontgenstrukturforsch, A-8010 Graz, Austria; Hop Pitie, INSERM, U321, Unite Rech Lipoprot & Atherogenese, F-75654 Paris 13, France; Univ Nat Resources & Appl Life Sci Vienna, Ctr Ultrastruct Res, A-1180 Vienna, Austria; Univ Nat Resources & Appl Life Sci Vienna, Ludwig Boltzmann Inst Mol Nanotechnol, A-1180 Vienna, Austria	Austrian Academy of Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Natural Resources & Life Sciences, Vienna; Ludwig Boltzmann Institute; University of Natural Resources & Life Sciences, Vienna	Laggner, P (corresponding author), Austrian Acad Sci, Inst Biophys & Rontgenstrukturforsch, Steyrergasse 17-6, A-8010 Graz, Austria.	peter.laggner@oeaw.ac.at	Prassl, Ruth/AAE-1523-2021	Kriechbaum, Manfred/0000-0002-3852-4198; Prassl, Ruth/0000-0002-1010-9494; Schuster, Bernhard/0000-0002-2584-204X				ATKINSON D, 1986, ANNU REV BIOPHYS BIO, V15, P403; ATKINSON D, 1977, P NATL ACAD SCI USA, V74, P1042, DOI 10.1073/pnas.74.3.1042; Beisiegel U, 1996, CURR OPIN LIPIDOL, V7, P265, DOI 10.1097/00041433-199610000-00001; BURKS C, 1981, P NATL ACAD SCI-BIOL, V78, P6863, DOI 10.1073/pnas.78.11.6863; CHAPMAN MJ, 1988, J LIPID RES, V29, P442; CRAIG IF, 1982, J BIOL CHEM, V257, P330; DECKELBAUM RJ, 1977, J BIOL CHEM, V252, P744; DECKELBAUM RJ, 1975, SCIENCE, V190, P392, DOI 10.1126/science.170681; DEJAGER S, 1993, J LIPID RES, V34, P295; DESMIDT PC, 1990, CANCER RES, V50, P7476; EKMAN S, 1976, ACTA CHEM SCAND B, V30, P825, DOI 10.3891/acta.chem.scand.30b-0825; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; Gotoh N, 1996, FREE RADICAL RES, V24, P123; GRANOT E, 1985, BIOCHIM BIOPHYS ACTA, V833, P308, DOI 10.1016/0005-2760(85)90203-6; HERAK JN, 1988, CHEM PHYS LIPIDS, V48, P135, DOI 10.1016/0009-3084(88)90141-7; HUBBELL WL, 1971, J AM CHEM SOC, V93, P314; KIVELSON D, 1967, J CHEM PHYS, V46, P3048; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; KOSTNER GM, 1989, HUMAN PLASMA LIPOPRO, V3, P23; KRIEGER M, 1980, J BIOL CHEM, V255, P3330; KVEDER M, 1994, CHEM PHYS LIPIDS, V70, P101, DOI 10.1016/0009-3084(94)90052-3; LAGGNER P, 1978, EUR J BIOCHEM, V84, P227, DOI 10.1111/j.1432-1033.1978.tb12160.x; LAGGNER P, 1995, NATO ADV SCI INST SE, V451, P371; LAGGNER P, 1977, H-S Z PHYSIOL CHEM, V358, P771, DOI 10.1515/bchm2.1977.358.2.771; LAGGNER P, 1984, P NATL ACAD SCI-BIOL, V81, P4389, DOI 10.1073/pnas.81.14.4389; LAGGNER P, 1978, Q REV BIOPHYS, V11, P371, DOI 10.1017/S0033583500002304; LUNDBERG B, 1976, ACTA CHEM SCAND B, V30, P150, DOI 10.3891/acta.chem.scand.30b-0150; LUNDKATZ S, 1986, BIOCHEMISTRY-US, V25, P1562, DOI 10.1021/bi00355a016; Lusa S, 1998, BBA-LIPID LIPID MET, V1389, P112, DOI 10.1016/S0005-2760(97)00164-1; McNamara JR, 1996, J LIPID RES, V37, P1924; Morton RE, 1996, J LIPID RES, V37, P1915; PATEL KM, 1979, LIPIDS, V14, P816, DOI 10.1007/BF02533521; PRIVALOV PL, 1980, PURE APPL CHEM, V52, P479, DOI 10.1351/pac198052020479; SCHUSTER B, 1995, P NATL ACAD SCI USA, V92, P2509, DOI 10.1073/pnas.92.7.2509; SEELIG J, 1970, J AM CHEM SOC, V92, P3881, DOI 10.1021/ja00716a008; SHEN BW, 1977, P NATL ACAD SCI USA, V74, P837, DOI 10.1073/pnas.74.3.837; Small D. M., 1986, PHYSICAL CHEM LIPIDS, P395; SMITH ICP, 1972, BIOLOGICAL APPLICATI, P483; TRELEAVEN WD, 1986, BIOCHIM BIOPHYS ACTA, V877, P198, DOI 10.1016/0005-2760(86)90135-9; WESTESEN K, 1995, J PHARM SCI, V84, P139, DOI 10.1002/jps.2600840204; YANG CY, 1986, NATURE, V323, P738, DOI 10.1038/323738a0; ZECHNER R, 1984, CHEM PHYS LIPIDS, V36, P111, DOI 10.1016/0009-3084(84)90064-1	42	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1334	1341		10.1074/jbc.274.3.1334	http://dx.doi.org/10.1074/jbc.274.3.1334			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880504	hybrid			2022-12-27	WOS:000079956900024
J	Rakemann, T; Niehof, M; Kubicka, S; Fischer, M; Manns, MP; Rose-John, S; Trautwein, C				Rakemann, T; Niehof, M; Kubicka, S; Fischer, M; Manns, MP; Rose-John, S; Trautwein, C			The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TRANSDUCER GP130; ACUTE-PHASE RESPONSE; LIGAND-INDUCED ENDOCYTOSIS; INTERLEUKIN-6 RECEPTOR; LIVER-REGENERATION; IL-6 RECEPTOR; DOWN-REGULATION; TRANSGENIC MICE; STAT FAMILY; GROWTH	Interleukin-6 (IL-6) triggers pivotal pathways in vivo. The designer protein hyper-IL-6 (H-IL-6) fuses the soluble IL-6 receptor (sIL-6R) through an intermediate linker with IL-6. The intracellular pathways that are triggered by H-IL-6 are not defined yet. Therefore, we studied the molecular mechanisms leading to H-IL-6-dependent gene activation. H-IL-6 stimulates haptoglobin mRNA expression in HepG2 cells, which is transcriptionally mediated as assessed by run-off experiments. The increase in haptoglobin gene transcription correlates with higher nuclear translocation of tyrosine-phosphorylated STAT3 and its DNA binding. As H-IL-6 stimulates STAT3-dependent gene transcription, we compared the molecular mechanism between IL-6 and H-IL-6. Transfection experiments were performed with STAT3-dependent luciferase construct. The same amount of H-IL-6 stimulated luciferase activity faster, stronger, and for a longer period of time. Dose response experiments showed that a 10-fold lower dose of H-IL-6 stimulated STAT3-dependent gene transcription comparable with the higher amount of IL-6. Cotransfection with the gp80 and/or gp130 receptor revealed that the effect of H-IL-6 on STAT3-dependent gene transcription is restricted to the gp80/gp130 receptor ratio. High amounts of gp130 increased and high amounts of gp80 decreased the effect on H-IL-6-dependent gene tran. scription. To investigate the in vivo effect of H-IL-6 on gene transcription in the liver, H-IL-6 and IL-6 were injected into C3H mice. H-IL-6 was at least 10-fold more effective in stimulating the DNA binding and nuclear translocation of STAT3, which enhances haptoglobin mRNA and protein expression. Thus H-IL-6 stimulates STAT3-dependent gene transcription in liver cells in vitro and in vivo at least 10-fold more effectively than IL-6. Our results provide evidence that H-IL-6 is a promising designer protein for therapeutic intervention during different pathophysiological conditions also in humans.	Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30625 Hannover, Germany; Johannes Gutenberg Univ Mainz, Sect Pathophysiol, Med Clin 1, Mainz, Germany	Hannover Medical School; Johannes Gutenberg University of Mainz	Trautwein, C (corresponding author), Hannover Med Sch, Dept Gastroenterol & Hepatol, Carl Neuberg Str 1, D-30625 Hannover, Germany.		Rose-John, Stefan/A-7998-2010	Rose-John, Stefan/0000-0002-7519-3279				Baumann H, 1996, J IMMUNOL, V157, P284; Campos SP, 1996, J BIOL CHEM, V271, P24418, DOI 10.1074/jbc.271.40.24418; Ceresa BP, 1996, J BIOL CHEM, V271, P12121, DOI 10.1074/jbc.271.21.12121; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; CRESSMAN DE, 1995, HEPATOLOGY, V21, P1443, DOI 10.1016/0270-9139(95)90068-3; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DITTRICH E, 1994, J BIOL CHEM, V269, P19014; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Graeve L, 1996, FEBS LETT, V399, P131, DOI 10.1016/S0014-5793(96)01305-1; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HIRNO T, 1994, CYTOKINE HDB, P145; HOCKE GM, 1992, MOL CELL BIOL, V12, P2282, DOI 10.1128/MCB.12.5.2282; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MACKIEWICZ A, 1995, ANN NY ACAD SCI, V762, P1; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; NESBITT JE, 1992, J BIOL CHEM, V267, P5739; Niehof M, 1997, MOL CELL BIOL, V17, P3600, DOI 10.1128/MCB.17.7.3600; Peters M, 1997, J IMMUNOL, V159, P1474; Peters M, 1996, J EXP MED, V183, P1399, DOI 10.1084/jem.183.4.1399; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Tajima S, 1996, J EXP MED, V184, P1357, DOI 10.1084/jem.184.4.1357; Trautwein C, 1996, J BIOL CHEM, V271, P22262, DOI 10.1074/jbc.271.36.22262; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; Trautwein C, 1996, GASTROENTEROLOGY, V110, P1854, DOI 10.1053/gast.1996.v110.pm8964411; TRAUTWEIN C, 1994, GUT, V35, P1163, DOI 10.1136/gut.35.9.1163; VANDAM M, 1993, J BIOL CHEM, V268, P15285; Ward LD, 1996, J BIOL CHEM, V271, P20138, DOI 10.1074/jbc.271.33.20138; WEGENKA UM, 1994, MOL CELL BIOL, V14, P3186, DOI 10.1128/MCB.14.5.3186; WEIERGRABER O, 1995, EUR J BIOCHEM, V234, P661, DOI 10.1111/j.1432-1033.1995.661_b.x; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; ZOHLNHOFER D, 1992, FEBS LETT, V306, P219, DOI 10.1016/0014-5793(92)81004-6	40	56	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1257	1266		10.1074/jbc.274.3.1257	http://dx.doi.org/10.1074/jbc.274.3.1257			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880494	hybrid			2022-12-27	WOS:000079956900014
J	Sutrias-Grau, M; Bianchi, ME; Bernues, J				Sutrias-Grau, M; Bianchi, ME; Bernues, J			High mobility group protein 1 interacts specifically with the core domain of human TATA box-binding protein and interferes with transcription factor IIB within the pre-initiation complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; YEAST TFIIA/TBP/DNA COMPLEX; DNA-BINDING; CRYSTAL-STRUCTURE; HMG1 PROTEIN; FACTOR TFIIB; IN-VIVO; CELLS; ACTIVATORS; HOLOENZYME	The high mobility group (HMG) box domain has defined a family of proteins, mostly transcription factors, that specifically interacts with DNA on the minor groove and sharply bends it. The founding member of the family, HMG1, does not specifically recognize regular B-DNA but is recruited to DNA by interaction with other transcription factors and TATA box-binding protein (TBP), However, conflicting effects of HMG1 on transcription have been reported. We show that the interaction between HMG1 and TBP is species specific. This interaction in turn affects the interaction of TBP with transcription factor (TF) LIE and is competed by TFIIA. A primary binding site was mapped to the H2' alpha-helix in the highly conserved core domain of human TBP. On HMG1, the primary binding site was only in the HMG box A, and HMG box A was also sufficient to interact with native TFIID. Both HMG boxes efficiently repressed transcription in vitro as fusions to the Gal4-DNA binding domain. Additionally, HMG box B showed a weak level of activation at very low amounts. These results suggest a general involvement of HMG1 at the early stages of polymerase II transcription that may result in subtle activation or repression of individual genes.	CSIC, Ctr Invest Desenvolupament, Dept Mol & Cellular Biol, Barcelona 08034, Spain; San Raffaele Sci Inst, Dipartimento Ric Biol & Technol, I-20132 Milan, Italy; Univ Milan, Dipartimento Genet & Biol Microorganismi, I-20133 Milan, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan	Bernues, J (corresponding author), CSIC, Ctr Invest Desenvolupament, Dept Mol & Cellular Biol, J Girona 18-26, Barcelona 08034, Spain.		Bernues, Jordi/ABE-8360-2021; Bianchi, Marco Emilio/K-3417-2018	Bernues, Jordi/0000-0001-6218-8254; Bianchi, Marco Emilio/0000-0002-5329-6445				AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; Bernues J, 1996, NUCLEIC ACIDS RES, V24, P2950, DOI 10.1093/nar/24.15.2950; BERNUES J, 1993, EMBO J, V12, P3573, DOI 10.1002/j.1460-2075.1993.tb06031.x; BIANCHI ME, 1991, GENE, V104, P271, DOI 10.1016/0378-1119(91)90261-9; BIANCHI ME, 1992, EMBO J, V11, P1055, DOI 10.1002/j.1460-2075.1992.tb05144.x; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; BIANCHI ME, 1994, DNA PROTEIN STRUCTUR, P177; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; Bryant GO, 1996, GENE DEV, V10, P2491, DOI 10.1101/gad.10.19.2491; Chao DM, 1996, NATURE, V380, P82, DOI 10.1038/380082a0; FALCIOLA L, 1994, NUCLEIC ACIDS RES, V22, P285, DOI 10.1093/nar/22.3.285; Falciola L, 1997, J CELL BIOL, V137, P19, DOI 10.1083/jcb.137.1.19; FERRARI S, 1992, EMBO J, V11, P4497, DOI 10.1002/j.1460-2075.1992.tb05551.x; GE H, 1994, J BIOL CHEM, V269, P17136; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; Hardman CH, 1995, BIOCHEMISTRY-US, V34, P16596, DOI 10.1021/bi00051a007; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; LEE DK, 1992, MOL CELL BIOL, V12, P5189, DOI 10.1128/MCB.12.11.5189; LEE S, 1995, NATURE, V376, P609, DOI 10.1038/376609a0; LOCKER D, 1995, J MOL BIOL, V246, P243, DOI 10.1006/jmbi.1994.0079; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Lu J, 1996, J BIOL CHEM, V271, P33678, DOI 10.1074/jbc.271.52.33678; MAIDONADO E, 1996, NATURE, V381, P86; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; OGAWA Y, 1995, J BIOL CHEM, V270, P9272, DOI 10.1074/jbc.270.16.9272; ONATE SA, 1994, MOL CELL BIOL, V14, P3376, DOI 10.1128/MCB.14.5.3376; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; OSSIPOW V, 1995, CELL, V83, P137, DOI 10.1016/0092-8674(95)90242-2; Pohler JRG, 1998, EMBO J, V17, P817, DOI 10.1093/emboj/17.3.817; READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427; ROBERTS SGE, 1994, NATURE, V371, P717, DOI 10.1038/371717a0; SHYKIND BM, 1995, GENE DEV, V9, P1354, DOI 10.1101/gad.9.11.1354; STELZER G, 1994, MOL CELL BIOL, V14, P4712, DOI 10.1128/MCB.14.7.4712; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tang H, 1996, P NATL ACAD SCI USA, V93, P1119, DOI 10.1073/pnas.93.3.1119; TANSEY WP, 1994, GENE DEV, V8, P2756, DOI 10.1101/gad.8.22.2756; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; ZAWEL L, 1995, ANNU REV BIOCHEM, V64, P533; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x	43	70	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1628	1634		10.1074/jbc.274.3.1628	http://dx.doi.org/10.1074/jbc.274.3.1628			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880542	hybrid			2022-12-27	WOS:000079956900062
J	Grinnell, F; Ho, CH; Lin, YC; Skuta, G				Grinnell, F; Ho, CH; Lin, YC; Skuta, G			Differences in the regulation of fibroblast contraction of floating versus stressed collagen matrices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SKIN FIBROBLASTS; LIGHT-CHAIN PHOSPHORYLATION; BINDING PROTEIN-RHO; EXTRACELLULAR-MATRIX; WOUND CONTRACTION; TYROSINE KINASE; GROWTH-FACTOR; LYSOPHOSPHATIDIC ACID; LATTICE CONTRACTION; ACTIN CYTOSKELETON	To learn more about the regulation of contraction of collagen matrices by fibroblasts, we compared the ability of lysophosphatidic: acid (LPA) and platelet-derived growth factor (PDGF) to stimulate contraction of floating and stressed collagen matrices. In floating collagen matrices, PDGF and LPA stimulated contraction with similar kinetics, but appeared to utilize complementary signaling pathways since contraction obtained by the combination of growth factors exceeded that observed with saturating concentrations of either alone. The PDGF-simulated pathway was selectively inhibited by the protein kinase inhibitor KT5926. In stressed collagen matrices, PDGF and LPA stimulated contraction with different kinetics, with LPA acting rapidly and PDGF acting only after an similar to 1-h lag period. Pertussis toxin, known to block signaling through the Gi class of heterotrimeric G-proteins, inhibited LPA-stimulated contraction of floating but not stressed matrices, suggesting that LPA-stimulated contraction depends on receptors coupled to different G-proteins in floating and stressed matrices. On the other hand, the Rho inhibitor C3 exotransferase blocked contraction of both floating and stressed collagen matrices. These results suggest the possibility that distinct signaling mechanisms regulate contraction of floating and stressed collagen matrices.	Univ Texas, SW Med Sch, Dept Cell Biol & Neurosci, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Grinnell, F (corresponding author), Univ Texas, SW Med Sch, Dept Cell Biol & Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031321, R01GM031321] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM31321] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; BELLOWS CG, 1982, J CELL SCI, V58, P125; Broberg A, 1996, EXP CELL RES, V228, P29, DOI 10.1006/excr.1996.0295; Brock J, 1996, J CELL BIOL, V135, P1097, DOI 10.1083/jcb.135.4.1097; BURRIDGE K, 1981, NATURE, V294, P691, DOI 10.1038/294691a0; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; CLARK RAF, 1989, J CLIN INVEST, V84, P1036, DOI 10.1172/JCI114227; DESMOULIERE A, 1994, CELL MOTIL CYTOSKEL, V29, P195, DOI 10.1002/cm.970290302; Desmouliere A, 1996, MOL CELLULAR BIOL WO, P391; EHRLICH HP, 1991, J CELL PHYSIOL, V146, P1, DOI 10.1002/jcp.1041460102; EHRLICH HP, 1990, TISSUE CELL, V22, P407, DOI 10.1016/0040-8166(90)90070-P; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; GRINNELL F, 1984, J CELL SCI, V66, P51; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; GROSS J, 1995, P NATL ACAD SCI USA, V92, P5982, DOI 10.1073/pnas.92.13.5982; GUIDRY C, 1992, CANCER METAST REV, V11, P45, DOI 10.1007/BF00047602; GUIDRY C, 1985, J CELL SCI, V79, P67; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; HUNT TK, 1979, FUNDAMENTALS WOUND M, P116; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; KOLODNEY MS, 1993, J BIOL CHEM, V268, P23850; KREISBERG JI, 1997, AM J PHYSIOL, V273, pF288; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Langholz O, 1997, EXP CELL RES, V235, P22, DOI 10.1006/excr.1997.3640; LEE TL, 1993, J CELL SCI, V105, P167; Lin YC, 1997, MOL BIOL CELL, V8, P59, DOI 10.1091/mbc.8.1.59; LIN YC, 1995, EXP CELL RES, V221, P73, DOI 10.1006/excr.1995.1354; Lummen G, 1997, N-S ARCH PHARMACOL, V356, P769, DOI 10.1007/PL00005117; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; NAKANISHI S, 1990, MOL PHARMACOL, V37, P482; NARUMIYA S, 1988, J BIOL CHEM, V263, P17255; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pietruck F, 1997, N-S ARCH PHARMACOL, V355, P1; Rayan GM, 1996, J HAND SURG-AM, V21A, P1065, DOI 10.1016/S0363-5023(96)80317-0; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; RUDOLPH R, 1992, WOUND HEALING BIOCH, P96; SCHIRO JA, 1991, CELL, V67, P403, DOI 10.1016/0092-8674(91)90191-Z; SECRIST JP, 1990, J BIOL CHEM, V265, P20394; Skalli O, 1988, MOL CELLULAR BIOL WO, P373; STEINBERG BM, 1980, J CELL BIOL, V87, P304, DOI 10.1083/jcb.87.1.304; STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; TOMASEK JJ, 1992, ANAT REC, V232, P359, DOI 10.1002/ar.1092320305; Zent R, 1998, EXP CELL RES, V240, P134, DOI 10.1006/excr.1998.4008	54	155	157	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					918	923		10.1074/jbc.274.2.918	http://dx.doi.org/10.1074/jbc.274.2.918			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873032	hybrid			2022-12-27	WOS:000077968500047
J	Mauduit, C; Chatelain, G; Magre, S; Brun, G; Benhamed, M; Michel, D				Mauduit, C; Chatelain, G; Magre, S; Brun, G; Benhamed, M; Michel, D			Regulation by pH of the alternative splicing of the stem cell factor pre-mRNA in the testis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; C-KIT LIGAND; SERTOLI CELLS; GERM-CELLS; MESSENGER-RNA; GROWTH-FACTOR; TRANSMEMBRANE FORM; W-LOCUS; EXPRESSION; MOUSE	Proliferation and differentiation of progenitor stem cells are mainly controlled by diffusible and adhesion molecules. Stem cell factor (SCF), an essential regulator of spermatogenesis produced by Sertoli cells, utilize both modes of cell to cell communication. Indeed, SGF exists in soluble (SCFs) and membrane-bound (SCFm) forms, which are required for a complete spermatogenesis, and are generated by alternative splicing of optional exon 6, encoding sites of proteolysis. We show that in the mouse testis, the alternative splicing of SCF is developmentally regulated. SCFs predominates in fetal and neonatal gonads and is then replaced by SCFm in the prepubertal and adult gonads. By sequencing SCF exon 6, we show that the flanking intronic sequences perfectly follow the gt-at rule, suggesting that the basal splicing machinery might not be responsible by itself for exon 6 skipping. Moreover, freshly isolated Sertoli cells mainly express SCFm, but a switch to SCFs occurs after 48 h of culture. We found that this change can be prevented by acidification of the culture medium at pH 6.3 or by addition of lactate. The sustained synthesis of SCFm at low pH was no longer observed in the presence of cycloheximide, suggesting that SCF exon 6 skipping requires de novo protein synthesis. Accordingly, UV cross-linking experiments show that nuclear Sertoli cell protein(s) bind in a sequence-specific manner to exon 6. Together, our data allow the proposal of an integrated mechanism in which the synthesis of lactate by Sertoli cells is used in the same time as an energetic substrate for germ cells and as a promoter of their survival/proliferation through the production of SCFm.	Fac Med Lyon Sud, INSERM, U407, F-69921 Oullins, France; Ecole Normale Super Lyon, Lab Biol Mol & Cellulaire, CNRS, UMR 49, F-69364 Lyon 07, France; Univ Rennes 1, URA256, F-35042 Rennes, France; Univ Paris 06, Reprod Physiol Lab, CNRS, URA 1449, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Mauduit, C (corresponding author), Fac Med Lyon Sud, INSERM, U407, BP 12, F-69921 Oullins, France.	mauduit@sgrisn1.univ-lyon1.fr		Michel, Denis/0000-0002-0643-8025				Allard EK, 1996, BIOL REPROD, V55, P185, DOI 10.1095/biolreprod55.1.185; ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BENAHMED M, 1996, MALE INFERTILITY, P55; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BERNSTEIN SE, 1960, MOUSE NEWS LETT, V23, P33; BORSI L, 1995, J BIOL CHEM, V270, P6243, DOI 10.1074/jbc.270.11.6243; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; BRANNAN CI, 1992, GENE DEV, V6, P1832, DOI 10.1101/gad.6.10.1832; Chabot B, 1996, TRENDS GENET, V12, P472, DOI 10.1016/0168-9525(96)10037-8; DEHBI M, 1992, MOL CELL BIOL, V12, P1490, DOI 10.1128/MCB.12.4.1490; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOLCI S, 1991, NATURE, V352, P809, DOI 10.1038/352809a0; DORRINGTON JH, 1975, MOL CELL ENDOCRINOL, V3, P57, DOI 10.1016/0303-7207(75)90031-3; DYM M, 1995, BIOL REPROD, V52, P8, DOI 10.1095/biolreprod52.1.8; ENDO H, 1994, J BIOL CHEM, V269, P12488; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Gnessi L, 1997, ENDOCR REV, V18, P541, DOI 10.1210/er.18.4.541; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; JUTTE NHPM, 1982, J REPROD FERTIL, V65, P431, DOI 10.1530/jrf.0.0650431; KUO HC, 1991, SCIENCE, V251, P1045, DOI 10.1126/science.1825520; KURODA H, 1989, J CELL PHYSIOL, V139, P329, DOI 10.1002/jcp.1041390215; MANOVA K, 1990, DEVELOPMENT, V110, P1057; MARZIALI G, 1993, DEV BIOL, V157, P182, DOI 10.1006/dbio.1993.1122; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; MOTRO B, 1991, DEVELOPMENT, V113, P1207; NAKAYAMA H, 1988, DEVELOPMENT, V102, P117; Nehar D, 1997, ENDOCRINOLOGY, V138, P1964, DOI 10.1210/en.138.5.1964; ORRURTREGER A, 1990, DEVELOPMENT, V109, P911; Orth JM, 1996, MOL REPROD DEV, V45, P123, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;123::AID-MRD3&gt;3.0.CO;2-V; Petitte JN, 1996, BBA-GENE STRUCT EXPR, V1307, P149, DOI 10.1016/0167-4781(96)00062-0; ROBERTSON DM, 1993, MOL BIOL MALE REPROD, P411; ROBINSON R, 1981, BIOL REPROD, V24, P1032, DOI 10.1095/biolreprod24.5.1032; ROOSENRUNGE EC, 1952, ANN NY ACAD SCI, V55, P574, DOI 10.1111/j.1749-6632.1952.tb26577.x; ROSSI P, 1993, DEV BIOL, V155, P68, DOI 10.1006/dbio.1993.1007; STOLOW DT, 1991, P NATL ACAD SCI USA, V88, P320, DOI 10.1073/pnas.88.2.320; Tarn WY, 1997, TRENDS BIOCHEM SCI, V22, P132, DOI 10.1016/S0968-0004(97)01018-9; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350	42	34	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					770	775		10.1074/jbc.274.2.770	http://dx.doi.org/10.1074/jbc.274.2.770			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873014	hybrid			2022-12-27	WOS:000077968500029
J	Schaefer, G; Akita, RW; Sliwkowski, MX				Schaefer, G; Akita, RW; Sliwkowski, MX			A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; NEU DIFFERENTIATION FACTOR; HUMAN-BREAST-CANCER; FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; MONOCLONAL-ANTIBODIES; EGF RECEPTORS; GENE-PRODUCT; HEREGULIN; THERAPY	ErbB3 is unique among other members of the receptor tyrosine kinase family of growth factor receptors in that its kinase domain is enzymatically impaired. This renders it incapable of transducing a signal in response to ligand binding. However, in conjunction with ErbB2, ErbB3 is a potent mediator of signaling by the growth factor heregulin. Heregulin binding to ErbB3 induces formation of a heterodimeric complex with ErbB2, and this results in transactivation of the ErbB2 kinase. Although interaction between the extracellular domains of these receptors is an essential part of this process, it was not clear whether interaction between the cytoplasmic domains is also necessary for transactivation. By examining the abilities of a series of cytoplasmic domain mutants of ErbE3 to activate ErbB2, we have found a discrete sequence of three amino acid residues (LVI), located at the carboxyl-terminal end of the impaired ErbB3 kinase region, that is obligatory for transactivation. We conclude that formation of a functional ErbB2-ErbB3 signaling complex requires the presence of a specific structural feature within the ErbB3 cytoplasmic domain and suggest that ErbB2 transactivation results from a physical interaction between the cytoplasmic domains of these receptors.	Genentech Inc, S San Francisco, CA 94080 USA; Univ Freiburg, Inst Biol 3, D-79104 Freiburg, Germany	Roche Holding; Genentech; University of Freiburg	Sliwkowski, MX (corresponding author), Genentech Inc, Mail Stop 63, S San Francisco, CA 94080 USA.	marks@gene.com		Schaefer, Gabriele/0000-0001-9727-3555				ALIMANDI M, 1995, ONCOGENE, V10, P1813; BASELGA J, 1994, PHARMACOL THERAPEUT, V64, P127, DOI 10.1016/0163-7258(94)90036-1; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; BASELGA J, 1994, BREAST CANCER RES TR, V29, P127, DOI 10.1007/BF00666188; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; FENDLY BM, 1990, CANCER RES, V50, P1550; Fitzpatrick VD, 1998, FEBS LETT, V431, P102, DOI 10.1016/S0014-5793(98)00737-6; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P2; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Heldin Carl-Henrik, 1996, Cytokine and Growth Factor Reviews, V7, P3, DOI 10.1016/1359-6101(96)00002-0; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; HORAN T, 1995, J BIOL CHEM, V270, P24604, DOI 10.1074/jbc.270.41.24604; HYNES NE, 1993, SEMIN CANCER BIOL, V4, P19; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Klohs Wayne D., 1997, Current Opinion in Oncology, V9, P562, DOI 10.1097/00001622-199711000-00012; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lewis GD, 1996, CANCER RES, V56, P1457; LONARDO F, 1990, New Biologist, V2, P992; MODJTAHEDI H, 1994, INT J ONCOL, V4, P277; OPRESKO LK, 1995, J BIOL CHEM, V270, P4325, DOI 10.1074/jbc.270.9.4325; PABORSKY LR, 1990, PROTEIN ENG, V3, P547, DOI 10.1093/protein/3.6.547; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; PRIGENT S A, 1992, Progress in Growth Factor Research, V4, P1, DOI 10.1016/0955-2235(92)90002-Y; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; Schaefer G, 1997, ONCOGENE, V15, P1385, DOI 10.1038/sj.onc.1201317; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SCHLESSINGER J, 1988, BIOCHEMISTRY-US, V27, P3119, DOI 10.1021/bi00409a002; Sierke SL, 1997, BIOCHEM J, V322, P757, DOI 10.1042/bj3220757; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; TZAHAR E, 1994, J BIOL CHEM, V269, P25226; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; WADA T, 1990, ONCOGENE, V5, P489; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; Worthylake R, 1997, J BIOL CHEM, V272, P8594, DOI 10.1074/jbc.272.13.8594; ZENNER G, 1995, BIOESSAYS, V17, P967, DOI 10.1002/bies.950171110	46	31	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					859	866		10.1074/jbc.274.2.859	http://dx.doi.org/10.1074/jbc.274.2.859			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873025	hybrid			2022-12-27	WOS:000077968500040
J	Osborne, SL; Herreros, J; Bastiaens, PIH; Schiavo, G				Osborne, SL; Herreros, J; Bastiaens, PIH; Schiavo, G			Calcium-dependent oligomerization of synaptotagmins I and II - Synaptotagmins I and II are localized on the same synaptic vesicle and heterodimerize in the presence of calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; HIGH-POLYPHOSPHATE BINDING; PROTEIN-KINASE-C; C2B DOMAIN; NEUROTRANSMITTER RELEASE; PHOSPHOLIPID-BINDING; MEMBRANE-PROTEIN; C-2 DOMAIN; SYNTAXIN; EXOCYTOSIS	Synaptotagmins constitute a large family of membrane proteins characterized by their distinct distributions and different biochemical features. Genetic evidence suggests that members of this protein family are likely to function as calcium sensors in calcium-regulated events in neurons, although the precise molecular mechanism remains ill defined, Here we demonstrate that different synaptotagmin isoforms (Syt I, II, and TV) are present in the same synaptic vesicle population from rat brain cortex. In addition, Syt I and II co-localize on the same small synaptic vesicle (SSV), and they heterodimerize in the presence of calcium with a concentration dependence resembling that of the starting phase of SSV exocytosis (EC50 = 6 +/- 4 mu M). The association between Syt I and Syt II was demonstrated by immunoprecipitation of the native proteins and the recombinant cytoplasmic domains and by using fluorescence resonance energy transfer (FRET), Although a subpopulation of SSV containing Syt I and TV can be isolated, these two isoforms do not show a calcium-dependent interaction, These results suggest that the self-association of synaptotagmins with different calcium binding features may create a variety of calcium sensors characterized by distinct calcium sensitivities. This combinatorial hypothesis predicts that the probability of a single SSV exocytic event is determined, in addition to the gating properties of the presynaptic calcium channels, by the repertoire and relative abundance of distinct synaptotagmin isoforms present on the SSV surface.	Imperial Canc Res Fund, Mol Neuropathobiol Lab, London WC2A 3PX, England; Imperial Canc Res Fund, Cell Biophys Lab, London WC2A 3PX, England	Cancer Research UK; Cancer Research UK	Schiavo, G (corresponding author), Imperial Canc Res Fund, Mol Neuropathobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	g.schiavo@icrf.icnet.uk	Osborne, Shona/C-8290-2009; Herreros, Judit/B-5809-2009	Herreros, Judit/0000-0003-4200-0853; Osborne, Shona/0000-0002-7012-9278; Schiavo, Giampietro/0000-0002-4319-8745				Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; Bastiaens PIH, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P136; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; BRUCK C, 1982, J IMMUNOL METHODS, V53, P313, DOI 10.1016/0022-1759(82)90178-8; BURGER PM, 1989, NEURON, V3, P715, DOI 10.1016/0896-6273(89)90240-7; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Charvin N, 1997, EMBO J, V16, P4591, DOI 10.1093/emboj/16.15.4591; Clegg Robert M., 1995, Current Opinion in Biotechnology, V6, P103, DOI 10.1016/0958-1669(95)80016-6; DAVID P, 1993, FEBS LETT, V326, P135, DOI 10.1016/0014-5793(93)81777-W; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Fukuda M, 1996, J BIOL CHEM, V271, P8430, DOI 10.1074/jbc.271.14.8430; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Goda Y, 1997, P NATL ACAD SCI USA, V94, P769, DOI 10.1073/pnas.94.3.769; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; HARLOW E, 1988, ANTIBODIES LABORATOR, P313; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ibata K, 1998, J BIOL CHEM, V273, P12267, DOI 10.1074/jbc.273.20.12267; Kim K, 1997, P NATL ACAD SCI USA, V94, P14782, DOI 10.1073/pnas.94.26.14782; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; LEVEQUE C, 1994, J BIOL CHEM, V269, P6306; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LITTLETON JT, 1995, TRENDS NEUROSCI, V18, P177; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MARTINMOUTOT N, 1993, J PHYSIOLOGY-PARIS, V87, P37, DOI 10.1016/0928-4257(93)90022-L; MartinMoutot N, 1996, J BIOL CHEM, V271, P6567, DOI 10.1074/jbc.271.12.6567; Marxen M, 1997, NEUROCHEM RES, V22, P941, DOI 10.1023/A:1022414607385; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; Matthews G, 1996, ANNU REV NEUROSCI, V19, P219; METHA PP, 1996, P NATL ACAD SCI USA, V93, P10471; Mochida S, 1997, NEUROSCIENCE, V77, P937; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OCONNOR VM, 1993, FEBS LETT, V326, P255, DOI 10.1016/0014-5793(93)81802-7; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Ponting CP, 1996, PROTEIN SCI, V5, P162; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Rossetto O, 1996, J CELL BIOL, V132, P167, DOI 10.1083/jcb.132.1.167; RuizMontasell B, 1996, EUR J NEUROSCI, V8, P2544, DOI 10.1111/j.1460-9568.1996.tb01548.x; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; SCHIAVO G, 1989, J BIOL CHEM, V264, P7129; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; Schiavo G, 1998, BIOCHEM BIOPH RES CO, V248, P1, DOI 10.1006/bbrc.1998.8527; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Thoidis G, 1998, P NATL ACAD SCI USA, V95, P183, DOI 10.1073/pnas.95.1.183; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; Wiser O, 1997, FEBS LETT, V404, P203, DOI 10.1016/S0014-5793(97)00130-0; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	72	91	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					59	66		10.1074/jbc.274.1.59	http://dx.doi.org/10.1074/jbc.274.1.59			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867811	hybrid			2022-12-27	WOS:000077900200011
J	Goldschmidt-Reisin, S; Kitakawa, M; Herfurth, E; Wittmann-Liebold, B; Grohmann, L; Graack, HR				Goldschmidt-Reisin, S; Kitakawa, M; Herfurth, E; Wittmann-Liebold, B; Grohmann, L; Graack, HR			Mammalian mitochondrial ribosomal proteins - N-terminal amino acid sequencing, characterization, and identification of corresponding gene sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; GUANINE-NUCLEOTIDES; ELONGATION-FACTORS; YEAST; BACTERIAL; SUBUNITS; BINDING; SITE	The integrity of healthy mitochondria is supposed to depend largely on proper mitochondrial protein biosynthesis. Mitochondrial ribosomal proteins (MRPs) are directly involved in this process. To identify mammalian mitochondrial ribosomal proteins and their corresponding genes, we purified mature rat MRPs and determined 12 different N-terminal amino acid sequences. Using this peptide information, data banks were screened for corresponding DNA sequences to identify the genes or to establish consensus cDNAs and to characterize the deduced MRP open reading frames. Eight different groups of corresponding mammalian MRPs constituted from human, mouse, and rat origin were identified. Five of them show significant sequence similarities to bacterial and/or yeast mitochondrial ribosomal proteins. However, MRPs are much less conserved in respect to the amino acid sequence among species than cytoplasmic ribosomal proteins of eukaryotes and bacteria.	Free Univ Berlin, Inst Genet, D-14195 Berlin, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Free University of Berlin; Max Planck Society	Graack, HR (corresponding author), Free Univ Berlin, Inst Genet, Arnimallee 7, D-14195 Berlin, Germany.	graack@zedat.fu-berlin.de						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BRANDA SS, 1995, J BIOL CHEM, V270, P27366, DOI 10.1074/jbc.270.45.27366; CALHILL A, 1995, ANAL BIOCHEM, V232, P47; CZEMPIEL W, 1976, FEBS LETT, V62, P259, DOI 10.1016/0014-5793(76)80070-1; CZEMPIEL W, 1980, THESIS FREE U BERL B; DENSLOW ND, 1989, J BIOL CHEM, V264, P8328; DENSLOW ND, 1988, BIOCHEMISTRY-US, V27, P3521, DOI 10.1021/bi00409a059; DENSLOW ND, 1991, J BIOL CHEM, V266, P9586; Farwell MA, 1996, BBA-GENE STRUCT EXPR, V1309, P122, DOI 10.1016/S0167-4781(96)00118-2; *GCG, 1997, WISC PACK VERS 9 1 O; GRAACK HR, 1991, BIOCHIMIE, V73, P837, DOI 10.1016/0300-9084(91)90063-7; Graack HR, 1998, BIOCHEM J, V329, P433, DOI 10.1042/bj3290433; GRAACK HR, 1992, EUR J BIOCHEM, V206, P373, DOI 10.1111/j.1432-1033.1992.tb16937.x; GROHMANN L, 1989, ENDOCYT CELL RES, V6, P183; GROHMANN L, 1991, FEBS LETT, V284, P51, DOI 10.1016/0014-5793(91)80759-V; Grossman LI, 1996, BIOESSAYS, V18, P983, DOI 10.1002/bies.950181208; HARDY SJ, 1969, BIOCHEMISTRY-US, V18, P2897; KITAKAWA M, 1991, BIOCHIMIE, V73, P813, DOI 10.1016/0300-9084(91)90061-5; Kitakawa M, 1997, EUR J BIOCHEM, V245, P449, DOI 10.1111/j.1432-1033.1997.t01-2-00449.x; KUMAZAWA Y, 1991, BIOCHIM BIOPHYS ACTA, V1090, P167, DOI 10.1016/0167-4781(91)90097-6; LIAO HX, 1989, J BIOL CHEM, V264, P7518; Marty L, 1996, J BIOL CHEM, V271, P11468, DOI 10.1074/jbc.271.19.11468; Muller EC, 1997, CELL MOL LIFE SCI, V53, P34, DOI 10.1007/PL00000578; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; OU JH, 1987, NUCLEIC ACIDS RES, V15, P8919, DOI 10.1093/nar/15.21.8919; PIATYSZEK MA, 1988, NUCLEIC ACIDS RES, V16, P2565, DOI 10.1093/nar/16.6.2565; PIETROMONACO SF, 1991, BIOCHIMIE, V73, P827, DOI 10.1016/0300-9084(91)90062-6; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; SCHWARTZBACH CJ, 1991, J BIOL CHEM, V266, P16324; Shah ZH, 1997, GENE, V204, P55, DOI 10.1016/S0378-1119(97)00521-0; ULBRICH B, 1980, EUR J BIOCHEM, V108, P337, DOI 10.1111/j.1432-1033.1980.tb04728.x; Vladimirov SN, 1996, EUR J BIOCHEM, V239, P144, DOI 10.1111/j.1432-1033.1996.0144u.x; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; White RB, 1998, P NATL ACAD SCI USA, V95, P305, DOI 10.1073/pnas.95.1.305; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Zeviani M, 1997, J BIOENERG BIOMEMBR, V29, P121, DOI 10.1023/A:1022633912917	36	44	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34828	34836		10.1074/jbc.273.52.34828	http://dx.doi.org/10.1074/jbc.273.52.34828			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857009	hybrid			2022-12-27	WOS:000077719700027
J	Mosleh, IM; Huber, LA; Steinlein, P; Pasquali, C; Gunther, D; Meyer, TF				Mosleh, IM; Huber, LA; Steinlein, P; Pasquali, C; Gunther, D; Meyer, TF			Neisseria gonorrhoeae porin modulates phagosome maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN RAB4; GONOCOCCAL-INFECTION; ENDOCYTIC PATHWAY; HUMAN-NEUTROPHILS; EPITHELIAL-CELLS; ENDOSOME FUSION; COMPARTMENTS; COMPLEX; ELECTROPHORESIS; PHAGOLYSOSOMES	The porin (PorB) of Neisseria gonorrhoeae has been implicated in the pathogenesis of this species. Porin is believed to translocate from the bacterial outer membrane into target cell membranes affecting various cell functions. Here we investigated the effect of porin on phagosome maturation. Phagocytosis of latex beads by human macrophages was allowed in the presence or absence of purified porin. Isolation of latex bead-containing phagosomes and subsequent two-dimensional gel electrophoresis revealed substantial differences in the phagosomal protein composition. Immunoblotting detected higher amounts of annexin II and the early endocytic markers Rab5 and transferrin receptor and decreased levels of the late endocytic markers Rab7 and cathepsin D in phagosomes obtained in the presence of porin compared with those obtained in its absence. Furthermore, association of Rab4 with the latex bead-containing phagosomes was revealed by flow cytometry. The amount of this small GTPase was markedly higher in the phagosomes isolated in the presence of porin. The data thus indicate that neisserial porin is itself able to arrest phagosome maturation within macrophages.	Max Planck Inst Infekt Biol, Mol Biol Abt, D-10117 Berlin, Germany; Max Planck Inst Biol, Infekt Biol Abt, D-72076 Tubingen, Germany; Res Inst Mol Pathol, A-1030 Vienna, Austria	Max Planck Society; Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Meyer, TF (corresponding author), Max Planck Inst Infekt Biol, Mol Biol Abt, Monbijoustr 2, D-10117 Berlin, Germany.		Mosleh, Ibrahim/A-1791-2016; Huber, Lukas Alfons/AAM-3499-2021; Meyer, Thomas F. F/J-2485-2013	Mosleh, Ibrahim/0000-0003-1899-4026; Meyer, Thomas F. F/0000-0002-6120-8679; Huber, Lukas Alfons/0000-0003-1116-2120				AlvarezDominguez C, 1996, J BIOL CHEM, V271, P13834, DOI 10.1074/jbc.271.23.13834; BENZ R, 1988, ANNU REV MICROBIOL, V42, P359, DOI 10.1146/annurev.mi.42.100188.002043; BERON W, 1995, TRENDS CELL BIOL, V5, P100, DOI 10.1016/S0962-8924(00)88958-8; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209; BJERKNES R, 1995, INFECT IMMUN, V63, P160, DOI 10.1128/IAI.63.1.160-167.1995; BLAKE MS, 1989, BACTERIAL OUTER MEMB, P377; Bock I, 1997, TRENDS CELL BIOL, V7, P499, DOI 10.1016/S0962-8924(97)01160-4; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; CASEY SG, 1986, INFECT IMMUN, V52, P384, DOI 10.1128/IAI.52.2.384-389.1986; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Clemens DL, 1996, TRENDS MICROBIOL, V4, P113, DOI 10.1016/0966-842X(96)81528-9; DENSEN P, 1978, J CLIN INVEST, V62, P1161, DOI 10.1172/JCI109235; DESJARDINS M, 1995, TRENDS CELL BIOL, V5, P183, DOI 10.1016/S0962-8924(00)88989-8; DESJARDINS M, 1994, J BIOL CHEM, V269, P32194; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; EVANS TC, 1994, BIOCHEMISTRY-US, V33, P13231, DOI 10.1021/bi00249a009; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GOUD B, 1991, Current Opinion in Cell Biology, V3, P626, DOI 10.1016/0955-0674(91)90033-U; HAINES KA, 1991, J CELL BIOL, V114, P433, DOI 10.1083/jcb.114.3.433; HAINES KA, 1988, J BIOL CHEM, V263, P945; HAINES KA, 1990, ADV PROSTAGLANDIN TH, V21, P545; Hall A, 1995, GUIDEBOOK SMALL GTPA, P3; HANIFIN JM, 1970, J CELL BIOL, V46, P97, DOI 10.1083/jcb.46.1.97; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; HART PD, 1991, J EXP MED, V174, P881, DOI 10.1084/jem.174.4.881; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P424, DOI 10.1016/0003-2697(88)90209-6; JOHNSTON KH, 1976, J EXP MED, V143, P741, DOI 10.1084/jem.143.4.741; LAYHSCHMITT G, 1989, ZBL BAKT-INT J MED M, V271, P158; LYNCH EC, 1984, BIOPHYS J, V45, P104, DOI 10.1016/S0006-3495(84)84127-2; MAYORGA LS, 1991, J BIOL CHEM, V266, P6511; PAPINI E, 1994, P NATL ACAD SCI USA, V91, P9720, DOI 10.1073/pnas.91.21.9720; Parton R G, 1991, Semin Cell Biol, V2, P387; Pasquali C, 1997, ELECTROPHORESIS, V18, P2573, DOI 10.1002/elps.1150181413; Pfeffer S R, 1992, Trends Cell Biol, V2, P41, DOI 10.1016/0962-8924(92)90161-F; PITT A, 1992, J CLIN INVEST, V90, P1978, DOI 10.1172/JCI116077; PITT A, 1992, J BIOL CHEM, V267, P126; PIZON V, 1994, J CELL SCI, V107, P1661; RABINOWITZ S, 1992, J CELL BIOL, V116, P95, DOI 10.1083/jcb.116.1.95; REST RF, 1982, INFECT IMMUN, V36, P737, DOI 10.1128/IAI.36.2.737-744.1982; Rudel T, 1996, CELL, V85, P391, DOI 10.1016/S0092-8674(00)81117-4; RYAN KJ, 1990, MED MICROBIOLOGY INT, P343; SANDSTROM EG, 1984, SEX TRANSM DIS, V11, P77, DOI 10.1097/00007435-198404000-00005; SHAFER WM, 1989, ANNU REV MICROBIOL, V43, P121; Sibley L. David, 1993, Seminars in Cell Biology, V4, P335, DOI 10.1006/scel.1993.1040; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; VANDERSLUIJS P, 1991, P NATL ACAD SCI USA, V88, P6313, DOI 10.1073/pnas.88.14.6313; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; WEEL JFL, 1991, RES MICROBIOL, V142, P985, DOI 10.1016/0923-2508(91)90009-Y; WEEL JFL, 1991, J EXP MED, V174, P705, DOI 10.1084/jem.174.3.705; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; ZERIAL M, 1992, METHOD ENZYMOL, V219, P398	55	40	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35332	35338		10.1074/jbc.273.52.35332	http://dx.doi.org/10.1074/jbc.273.52.35332			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857075	Green Published, hybrid			2022-12-27	WOS:000077719700093
J	Penela, P; Ruiz-Gomez, A; Castano, JG; Mayor, F				Penela, P; Ruiz-Gomez, A; Castano, JG; Mayor, F			Degradation of the G protein-coupled receptor kinase 2 by the proteasome pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; BETA(2)-ADRENERGIC RECEPTOR; MULTICATALYTIC PROTEINASE; SYNERGISTIC REGULATION; RAT-LIVER; IN-VIVO; C-ALPHA; INTERNALIZATION; UBIQUITINATION; DESENSITIZATION	GRK2 is a ubiquitous member of the G; protein-coupled receptor kinase (GRK) family and has been shown to play a key role in determining the desensitization and resensitization patterns of a variety of G protein-coupled receptors. In this report, we show that GRK2 is actively degraded by the proteasome proteolytic pathway, unveiling a new mechanism for the rapid regulation of its expression levels. Interestingly, activation of beta(2)-adrenergic receptors (beta(2)AR) markedly increases GRK2 ubiquitination and degradation through the proteasome pathway. In addition, blocking GRK2 degradation notably alters beta(2)AR signaling and internalization, consistent with a relevant physiological role for GRK2 proteasomal degradation. Activity-dependent modulation of GRK2 cellular levels emerges as an important mechanism for modulating the cellular response to agonists acting through G protein coupled receptors.	Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Dept Mol Biol, E-28049 Madrid, Spain; Univ Autonoma Madrid, Fac Med, Dept Bioquim, E-28029 Madrid, Spain; Univ Autonoma Madrid, Fac Med, Inst Invest Biomed, E-28029 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Autonomous University of Madrid	Mayor, F (corresponding author), Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Dept Mol Biol, E-28049 Madrid, Spain.	fmayor@cbm.uam.es	Mayor, Federico/N-7644-2016; Ruiz-Gómez, Ana/H-2092-2015; Ruiz-Gomez, Ana/ABF-3079-2021	Ruiz-Gómez, Ana/0000-0002-1646-3072; Mayor Menendez, Federico/0000-0003-1434-8449; G. Castano, Jose/0000-0002-6579-8442				Aragay AM, 1998, FEBS LETT, V430, P37, DOI 10.1016/S0014-5793(98)00495-5; Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; ARRIBAS J, 1993, J BIOL CHEM, V268, P21165; ARRIBAS J, 1990, J BIOL CHEM, V265, P13969; Bohm SK, 1997, BIOCHEM J, V322, P1; Chuang TT, 1997, EUR J BIOCHEM, V245, P533, DOI 10.1111/j.1432-1033.1997.00533.x; Chuang TT, 1996, TRENDS PHARMACOL SCI, V17, P416, DOI 10.1016/S0165-6147(96)10048-1; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DebBurman SK, 1996, J BIOL CHEM, V271, P22552, DOI 10.1074/jbc.271.37.22552; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gros R, 1997, J CLIN INVEST, V99, P2087, DOI 10.1172/JCI119381; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; HOUGH C, 1994, J NEUROCHEM, V62, P421; JARIELENCONTRE I, 1995, J BIOL CHEM, V270, P11623, DOI 10.1074/jbc.270.19.11623; KONG GH, 1994, J BIOL CHEM, V269, P13084; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Lee HW, 1997, MOL PHARMACOL, V51, P439; Lohse MJ, 1996, KIDNEY INT, V49, P1047, DOI 10.1038/ki.1996.153; Mayor F, 1998, TRENDS CARDIOVAS MED, V8, P234, DOI 10.1016/S1050-1738(98)00008-5; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murga C, 1996, J BIOL CHEM, V271, P985, DOI 10.1074/jbc.271.2.985; Murga C, 1997, FEBS LETT, V409, P24, DOI 10.1016/S0014-5793(97)00476-6; Pitcher JA, 1998, J BIOL CHEM, V273, P12316, DOI 10.1074/jbc.273.20.12316; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; RuizGomez A, 1997, J BIOL CHEM, V272, P9601; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Schlador ML, 1997, J BIOL CHEM, V272, P18882, DOI 10.1074/jbc.272.30.18882; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Tokumoto T, 1997, J CELL BIOL, V138, P1313, DOI 10.1083/jcb.138.6.1313; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; Weissman AM, 1997, IMMUNOL TODAY, V18, P189, DOI 10.1016/S0167-5699(97)84666-X	41	102	104	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35238	35244		10.1074/jbc.273.52.35238	http://dx.doi.org/10.1074/jbc.273.52.35238			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857063	hybrid			2022-12-27	WOS:000077719700081
J	Conger, KL; Liu, JS; Kuo, SR; Chow, LT; Wang, TSF				Conger, KL; Liu, JS; Kuo, SR; Chow, LT; Wang, TSF			Human papillomavirus DNA replication - Interactions between the viral E1 protein and two subunits of human DNA polymerase alpha/primase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN VIRUS-40 DNA; CYCLE-DEPENDENT PHOSPHORYLATION; E2 BINDING-SITES; BOVINE PAPILLOMAVIRUS; T-ANTIGEN; ALPHA-PRIMASE; IN-VITRO; TRANSCRIPTIONAL ACTIVATOR; COMPLEX-FORMATION; TYPE-11 ORIGIN	Papovaviruses are valuable models for the study of DNA replication in higher eukaryotic organisms, as they depend on host factors for replication of their DNA. In this study we investigate the interactions between the human papillomavirus type 11 (HPV-11) origin recognition and initiator protein E1 and human polymerase alpha/primase (pol alpha/primase) subunits, By using a variety of physical assays, we show that both 180- (p180) and 70-kDa (p70) subunits of pol alpha/primase interact with HPV-11 E1, The interactions of E1 with p180 and p70 are functionally different in cell-free replication of an HPV-11 origin-containing plasmid, Exogenously added p180 inhibits both E2-dependent and E2-independent cell-free replication of HPV-11, whereas p70 inhibits E2-dependent but stimulates ES-independent replication. Our experiments indicate that p70 does not physically interact with E2 and suggest that it may compete with E2 for binding to E1, A model of how E2 and p70 sequentially interact with E1 during initiation of viral DNA replication is proposed.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Univ Alabama Birmingham, Sch Med & Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	Stanford University; University of Alabama System; University of Alabama Birmingham	Wang, TSF (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.				NATIONAL CANCER INSTITUTE [R01CA036200, R01CA014835] Funding Source: NIH RePORTER; NCI NIH HHS [CA14835, CA36200] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BONNEANDREA C, 1995, J VIROL, V69, P2341, DOI 10.1128/JVI.69.4.2341-2350.1995; BOROWIEC JA, 1996, DNA REPLICATION EUKA, P545; BREAM GL, 1993, J VIROL, V67, P2655, DOI 10.1128/JVI.67.5.2655-2663.1993; Brush GS, 1995, METHOD ENZYMOL, V262, P522; CHIANG CM, 1992, P NATL ACAD SCI USA, V89, P5799, DOI 10.1073/pnas.89.13.5799; CHIANG CM, 1992, J VIROL, V66, P5224, DOI 10.1128/JVI.66.9.5224-5231.1992; Chow Louise T., 1997, P267; CHOW LT, 1994, INTERVIROLOGY, V37, P150, DOI 10.1159/000150373; COLLINS KL, 1993, EMBO J, V12, P4555, DOI 10.1002/j.1460-2075.1993.tb06144.x; COPELAND WC, 1991, J BIOL CHEM, V266, P22739; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; DEAN FB, 1992, J BIOL CHEM, V267, P14129; DORNREITER I, 1990, EMBO J, V9, P3329, DOI 10.1002/j.1460-2075.1990.tb07533.x; DORNREITER I, 1993, MOL CELL BIOL, V13, P809, DOI 10.1128/MCB.13.2.809; FISHER PA, 1977, J BIOL CHEM, V252, P6528; FOIANI M, 1995, MOL CELL BIOL, V15, P883; FRATTINI MG, 1994, P NATL ACAD SCI USA, V91, P12398, DOI 10.1073/pnas.91.26.12398; Gillette TG, 1998, J VIROL, V72, P5735, DOI 10.1128/JVI.72.7.5735-5744.1998; GRUSSENMEYER T, 1985, P NATL ACAD SCI USA, V82, P7952, DOI 10.1073/pnas.82.23.7952; Hassell J, 1996, DNA REPLICATION EUKA, P639; HIROCHIKA H, 1988, GENE DEV, V2, P54, DOI 10.1101/gad.2.1.54; HOLT SE, 1994, J VIROL, V68, P1094, DOI 10.1128/JVI.68.2.1094-1102.1994; HUGHES FJ, 1993, NUCLEIC ACIDS RES, V21, P5817, DOI 10.1093/nar/21.25.5817; Jenkins O, 1996, J GEN VIROL, V77, P1805, DOI 10.1099/0022-1317-77-8-1805; KUO SR, 1994, J BIOL CHEM, V269, P24058; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; LI R, 1989, GENE DEV, V3, P510, DOI 10.1101/gad.3.4.510; Liu JS, 1998, J BIOL CHEM, V273, P30704, DOI 10.1074/jbc.273.46.30704; LIU JS, 1995, J BIOL CHEM, V270, P27283, DOI 10.1074/jbc.270.45.27283; LIU Y, 1990, J VIROL, V64, P5903, DOI 10.1128/JVI.64.12.5903-5911.1990; LU JZJ, 1993, J VIROL, V67, P7131, DOI 10.1128/JVI.67.12.7131-7139.1993; LUSKY M, 1994, P NATL ACAD SCI USA, V91, P8895, DOI 10.1073/pnas.91.19.8895; LUSKY M, 1993, J BIOL CHEM, V268, P15795; Masterson PJ, 1998, J VIROL, V72, P7407, DOI 10.1128/JVI.72.9.7407-7419.1998; MCBRIDE AA, 1989, P NATL ACAD SCI USA, V86, P510, DOI 10.1073/pnas.86.2.510; MOHR IJ, 1990, SCIENCE, V250, P1694, DOI 10.1126/science.2176744; MURAKAMI Y, 1986, P NATL ACAD SCI USA, V83, P2869, DOI 10.1073/pnas.83.9.2869; MURAKAMI Y, 1986, P NATL ACAD SCI USA, V83, P6347, DOI 10.1073/pnas.83.17.6347; NASHEUER HP, 1991, J BIOL CHEM, V266, P7893; PARK P, 1994, P NATL ACAD SCI USA, V91, P8700, DOI 10.1073/pnas.91.18.8700; Sedman J, 1998, J VIROL, V72, P6893, DOI 10.1128/JVI.72.8.6893-6897.1998; Sedman J, 1996, EMBO J, V15, P5085, DOI 10.1002/j.1460-2075.1996.tb00889.x; Sedman J, 1995, EMBO J, V14, P6218, DOI 10.1002/j.1460-2075.1995.tb00312.x; Sedman T, 1997, J VIROL, V71, P2887, DOI 10.1128/JVI.71.4.2887-2896.1997; SEO YS, 1993, P NATL ACAD SCI USA, V90, P2865, DOI 10.1073/pnas.90.7.2865; SEO YS, 1993, P NATL ACAD SCI USA, V90, P702, DOI 10.1073/pnas.90.2.702; SPALHOLZ BA, 1993, VIROLOGY, V193, P201, DOI 10.1006/viro.1993.1116; Stadlbauer F, 1996, MOL CELL BIOL, V16, P94; STENLUND A, 1996, DNA REPLICATION EUKA, P679; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; SVERDRUP F, 1995, J VIROL, V69, P1319, DOI 10.1128/JVI.69.2.1319-1323.1995; USTAV E, 1993, P NATL ACAD SCI USA, V90, P898, DOI 10.1073/pnas.90.3.898; USTAV M, 1991, EMBO J, V10, P4321, DOI 10.1002/j.1460-2075.1991.tb05010.x; USTAV M, 1991, EMBO J, V10, P449, DOI 10.1002/j.1460-2075.1991.tb07967.x; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; Wang TSF, 1995, METHOD ENZYMOL, V262, P77; WANG TSF, 1996, DNA REPLICATION EUKA, P461; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; West SC, 1996, CELL, V86, P177, DOI 10.1016/S0092-8674(00)80088-4; WILSON VG, 1991, J VIROL, V65, P5314, DOI 10.1128/JVI.65.10.5314-5322.1991; YANG L, 1993, P NATL ACAD SCI USA, V90, P5086, DOI 10.1073/pnas.90.11.5086; YANG L, 1991, NATURE, V353, P628, DOI 10.1038/353628a0; Zou NX, 1998, J VIROL, V72, P3436, DOI 10.1128/JVI.72.4.3436-3441.1998; ZURHAUSEN H, 1994, ANNU REV MICROBIOL, V48, P427, DOI 10.1146/annurev.micro.48.1.427	65	82	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2696	2705		10.1074/jbc.274.5.2696	http://dx.doi.org/10.1074/jbc.274.5.2696			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915800	hybrid			2022-12-27	WOS:000078319500018
J	Shaw-White, JR; Bruno, MD; Whitsett, JA				Shaw-White, JR; Bruno, MD; Whitsett, JA			GATA-6 activates transcription of thyroid transcription factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACTANT PROTEIN-B; FACTOR-I TTF-1; RESPIRATORY EPITHELIAL-CELLS; HEPATOCYTE NUCLEAR FACTOR-3; SECRETORY PROTEIN; GENE; EXPRESSION; LUNG; DIFFERENTIATION; PROMOTER	Thyroid transcription factor-1 (TTF-1) is expressed in respiratory epithelial cells, where it regulates the transcription of target genes expressed in a cell-selective manner. GATA-5 and -6, members of the zinc finger family of transcription factors, are also expressed in various cell types within in the developing lung. In the present work, GrATA-6 mRNA was detected in adult mouse lung, purified mouse type II epithelial cells, and differentiated mouse pulmonary adenocarcinoma cells (MLE-15 cells), being co-expressed with TTF-1 mRNA In order to test whether GATA factors regulated TTF-1 gene transcription, GATA-5 and -6 expression vectors were cotransfected with TTF-1 luciferase expression vector. GATA-6, but not GATA-5, markedly activated TTF-1 gene transcription in HeLa cells. EMSA and supershift analysis with GATA-6 antiserum demonstrated that GATA-6 in MLE-15 cell nuclear extracts bound to an element located 96-101 base pairs from major start of TTF-1 gene transcription. Site directed mutagenesis of the GATA element in the TTF-1 promoter region inhibited transactivation by GATA-6 in HeLa cells. GATA-6 is co-expressed with TTF-1 in the respiratory epithelium in vivo and respiratory epithelial cells in vitro. GATA-6 strongly enhanced activity of the human TTF-1 gene promoter in vitro. These findings support the concept that GATA-6 may play an important role in lung cell differentiation and gene expression, at least in part by altering the expression of TTF-1 and its potential targets.	Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Whitsett, JA (corresponding author), Childrens Hosp, Med Ctr, Div Pulm Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007200] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056387, P50HL056387] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56387] Funding Source: Medline; NICHD NIH HHS [5T32 HD07200] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; ARNONE MI, 1995, J BIOL CHEM, V270, P12048, DOI 10.1074/jbc.270.20.12048; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; BOSHART M, 1992, GENE, V110, P129, DOI 10.1016/0378-1119(92)90456-Y; BRUNO MD, 1995, J BIOL CHEM, V270, P6531, DOI 10.1074/jbc.270.12.6531; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P6294; Davis DL, 1996, MOL ENDOCRINOL, V10, P937, DOI 10.1210/me.10.8.937; Dimaline R, 1997, GASTROENTEROLOGY, V112, P1559, DOI 10.1016/S0016-5085(97)70037-4; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Endo T, 1997, MOL ENDOCRINOL, V11, P1747, DOI 10.1210/me.11.11.1747; Fitzgerald K, 1998, AM J PHYSIOL-GASTR L, V274, pG314, DOI 10.1152/ajpgi.1998.274.2.G314; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P5793, DOI 10.1128/MCB.12.12.5793; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gregory RC, 1996, BLOOD, V87, P1793, DOI 10.1182/blood.V87.5.1793.bloodjournal8751793; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; Hamdan H, 1998, BBA-GENE STRUCT EXPR, V1396, P336, DOI 10.1016/S0167-4781(97)00210-8; HENNIGHAUSEN L, 1987, METHOD ENZYMOL, V152, P721; Ikeda K, 1996, MOL CELL BIOL, V16, P3626; IKEDA K, 1995, J BIOL CHEM, V270, P8108, DOI 10.1074/jbc.270.14.8108; Kalb JM, 1998, DEVELOPMENT, V125, P2171; Kelly SE, 1996, J BIOL CHEM, V271, P6881, DOI 10.1074/jbc.271.12.6881; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Lonigro R, 1996, CELL GROWTH DIFFER, V7, P251; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1997, DEV BIOL, V183, P21, DOI 10.1006/dbio.1996.8485; Nakazato M, 1997, BIOCHEM BIOPH RES CO, V238, P748, DOI 10.1006/bbrc.1997.7383; Oguchi H, 1998, ENDOCRINOLOGY, V139, P1999, DOI 10.1210/en.139.4.1999; Osada H., 1997, Leukemia (Basingstoke), V11, P307; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; Rosoff ML, 1998, J BIOL CHEM, V273, P9124, DOI 10.1074/jbc.273.15.9124; Stahlman MT, 1996, J HISTOCHEM CYTOCHEM, V44, P673, DOI 10.1177/44.7.8675988; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Yan C, 1997, J BIOL CHEM, V272, P17327, DOI 10.1074/jbc.272.28.17327; YAN C, 1995, J BIOL CHEM, V270, P24852, DOI 10.1074/jbc.270.42.24852; Zannini M, 1996, J BIOL CHEM, V271, P2249, DOI 10.1074/jbc.271.4.2249; ZENG X, 1998, IN PRESS J ANAT; Zhang LQ, 1997, BBA-GENE STRUCT EXPR, V1350, P359, DOI 10.1016/S0167-4781(96)00180-7; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	45	75	76	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2658	2664		10.1074/jbc.274.5.2658	http://dx.doi.org/10.1074/jbc.274.5.2658			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915795	hybrid			2022-12-27	WOS:000078319500013
J	Kohler, SA; Menotti, E; Kuhn, LC				Kohler, SA; Menotti, E; Kuhn, LC			Molecular cloning of mouse glycolate oxidase - High evolutionary conservation and presence of an iron-responsive element-like sequence in the mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-HYDROXYACID OXIDASE; FERRITIN MESSENGER-RNA; BINDING-PROTEIN; TRANSLATIONAL REGULATION; SUCCINATE-DEHYDROGENASE; GLYOXYLATE CYCLE; RAT-LIVER; DROSOPHILA-MELANOGASTER; NUCLEOTIDE-SEQUENCE; UNTRANSLATED REGION	Iron regulatory proteins (IRPs) control the synthesis of several proteins in iron metabolism by binding to iron-responsive elements (IREs), a hairpin structure in the untranslated region (UTR) of corresponding mRNAs, Binding of IRPs to IREs in the 5' UTR inhibits translation of ferritin heavy and light chain, erythroid aminolevulinic acid synthase, mitochondrial aconitase, and Drosophila succinate dehydrogenase b, whereas IRP binding to IREs in the 3' UTR of transferrin receptor mRNA prolongs mRNA half-life. To identify new targets of IRPs, we devised a method to enrich IRE-containing mRNAs by using recombinant IRP-1 as an affinity matrix. A cDNA library established fr om enriched mRNA was screened by an RNA-protein band shift assay. This revealed a novel IRE-like sequence in the 3' UTR of a liver-specific mouse mRNA, The newly identified cDNA codes for a protein with high, homology to plant glycolate oxidase (GOX). Recombinant protein expressed in bacteria displayed enzymatic GOX activity. Therefore, this cDNA represents the fil st vertebrate GOX homologue. The IRE-like sequence in mouse GOX exhibited strong binding to IRPs at room temperature. However, it differs from functional IREs by a mismatch in the middle of its upper stem and did not confer iron-dependent regulation in cells.	Swiss Inst Expt Canc Res, Genet Unit, CH-1066 Epalinges, Switzerland	Swiss Institute Experimental Cancer Research	Kuhn, LC (corresponding author), Swiss Inst Expt Canc Res, Genet Unit, 155 Ch Boveresses, CH-1066 Epalinges, Switzerland.	lukas.kuehn@isrec.unil.ch						ANGERMULLER S, 1986, HISTOCHEMISTRY, V85, P403, DOI 10.1007/BF00982670; ASKER H, 1983, BIOCHIM BIOPHYS ACTA, V761, P103, DOI 10.1016/0304-4165(83)90367-7; AU HC, 1995, GENE, V159, P249, DOI 10.1016/0378-1119(95)00162-Y; BARTON HA, 1990, J BIOL CHEM, V265, P7000; BELMOUDEN A, 1993, EUR J BIOCHEM, V214, P17, DOI 10.1111/j.1432-1033.1993.tb17891.x; BOYD D, 1985, J BIOL CHEM, V260, P1755; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chu E, 1996, BIOESSAYS, V18, P191, DOI 10.1002/bies.950180306; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; DAVIS WL, 1990, BIOCHIM BIOPHYS ACTA, V1051, P276, DOI 10.1016/0167-4889(90)90133-X; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Dohan JS, 1940, J BIOL CHEM, V135, P793; DULEY J, 1974, GENETICS, V76, P93; DULEY JA, 1976, EUR J BIOCHEM, V63, P163, DOI 10.1111/j.1432-1033.1976.tb10219.x; Escher CL, 1997, BIOL CHEM, V378, P803; FRY DW, 1979, BIOCHIM BIOPHYS ACTA, V567, P482, DOI 10.1016/0005-2744(79)90134-7; GAO FB, 1994, P NATL ACAD SCI USA, V91, P11207, DOI 10.1073/pnas.91.23.11207; GOOSSEN B, 1992, MOL CELL BIOL, V12, P1959, DOI 10.1128/MCB.12.5.1959; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Gray NK, 1996, P NATL ACAD SCI USA, V93, P4925, DOI 10.1073/pnas.93.10.4925; GUO B, 1994, J BIOL CHEM, V269, P24252; HAILE DJ, 1989, MOL CELL BIOL, V9, P5055, DOI 10.1128/MCB.9.11.5055; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; Henderson ER, 1996, J BIOL CHEM, V271, P4900; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; HIRLING H, 1992, NUCLEIC ACIDS RES, V20, P33, DOI 10.1093/nar/20.1.33; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; KITA K, 1990, BIOCHEM BIOPH RES CO, V166, P101, DOI 10.1016/0006-291X(90)91916-G; KOELLER DM, 1989, P NATL ACAD SCI USA, V86, P3574, DOI 10.1073/pnas.86.10.3574; Kohler SA, 1995, J BIOL CHEM, V270, P30781, DOI 10.1074/jbc.270.51.30781; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUN E, 1954, J BIOL CHEM, V210, P269; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LINDQVIST Y, 1991, J BIOL CHEM, V266, P3198; MCGROARTY E, 1974, ARCH BIOCHEM BIOPHYS, V161, P194, DOI 10.1016/0003-9861(74)90251-3; Melefors O, 1996, BIOCHEM BIOPH RES CO, V221, P437, DOI 10.1006/bbrc.1996.0613; Menotti E, 1998, J BIOL CHEM, V273, P1821, DOI 10.1074/jbc.273.3.1821; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; Poore RE, 1997, AM J PHYSIOL-CELL PH, V272, pC289, DOI 10.1152/ajpcell.1997.272.1.C289; Popov VN, 1996, FEBS LETT, V390, P258, DOI 10.1016/0014-5793(96)00668-0; RICHARDSON K, 1961, J BIOL CHEM, V236, P1280; SCHUMAN M, 1971, BIOCHIM BIOPHYS ACTA, V227, P500, DOI 10.1016/0005-2744(71)90003-9; WEINHOUSE S, 1951, J BIOL CHEM, V191, P707; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; ZHENG LM, 1992, ARCH BIOCHEM BIOPHYS, V299, P356, DOI 10.1016/0003-9861(92)90287-7	51	49	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2401	2407		10.1074/jbc.274.4.2401	http://dx.doi.org/10.1074/jbc.274.4.2401			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891009	hybrid			2022-12-27	WOS:000078185200076
J	Krushel, LA; Cunningham, BA; Edelman, GM; Crossin, KL				Krushel, LA; Cunningham, BA; Edelman, GM; Crossin, KL			NF-kappa B activity is induced by neural cell adhesion molecule binding to neurons and astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; ACTIVATES TRANSCRIPTION; GLUCOCORTICOID RECEPTOR; SIGNALING PATHWAYS; TYROSINE KINASES; GENE-EXPRESSION; ALPHA PROMOTER; INHIBITOR; BRAIN; PHOSPHORYLATION	The neural cell adhesion molecule, N-CAM, is expressed on the surface of astrocytes and neurons, and N-CAM homophilic binding has been shown to alter gene expression in both of these cell types. To determine mechanisms by which N-CAM regulates gene expression, we have analyzed DNA binding of and transcriptional activation by NF-kappa B after N-CAM binding to the cell surface. Addition of purified N-CAM, the recombinant third immunoglobulin domain of N-CAM, or N-CAM antibodies either to neonatal rat forebrain astrocytes or to cerebellar granule neurons increased NF-kappa B/DNA binding activity in nuclear extracts as measured by electrophoretic mobility shift assays. Analysis using supershifting antibodies indicated that, in both cell types, p50 and p65 but not p52, c-Rel, or Rel B were contained in the NF-kappa B-binding complex. NF-kappa B-mediated transcription was increased after N-CAM binding to astrocytes and neurons as demonstrated by the activation of two different luciferase reporter constructs containing NF-kappa B-binding sites. N-CAM binding also resulted in degradation of I kappa B-alpha protein followed by an increase in the levels of I kappa B-alpha mRNA and protein. These results indicate that N-CAM homophilic binding at the cell membrane leads to increased NF-kappa B binding to DNA and transcriptional activation in both neurons and astrocytes. Activation of NF-kappa B, however, did not influence the previously reported ability of N-CAM to inhibit astrocyte proliferation. These observations together support the hypothesis that N-CAM binding activates multiple pathways leading to changes in gene expression in both astrocytes and neurons.	Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA; Inst Neurosci, San Diego, CA 92121 USA; Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Crossin, KL (corresponding author), Scripps Res Inst, Dept Neurobiol, 10550 N Torrey Pines Rd,SBR-14, La Jolla, CA 92037 USA.	kcrossin@scripps.edu			NICHD NIH HHS [HD09635, HD16550] Funding Source: Medline; NINDS NIH HHS [NS/OD 34874] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD009635, R01HD016550, R01HD009635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R55NS034874] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baeuerle PA, 1998, CURR BIOL, V8, pR19, DOI 10.1016/S0960-9822(98)70010-7; Bazzoni G, 1998, TRENDS BIOCHEM SCI, V23, P30, DOI 10.1016/S0968-0004(97)01141-9; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Bowie AG, 1997, J BIOL CHEM, V272, P25941, DOI 10.1074/jbc.272.41.25941; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; CHENG Q, 1994, J BIOL CHEM, V269, P13551; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Crino P, 1998, P NATL ACAD SCI USA, V95, P2313, DOI 10.1073/pnas.95.5.2313; Crockett-Torabi E, 1998, J LEUKOCYTE BIOL, V63, P1; Crossin KL, 1997, P NATL ACAD SCI USA, V94, P2687, DOI 10.1073/pnas.94.6.2687; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DANILOFF JK, 1995, RESTOR NEUROL NEUROS, V7, P137, DOI 10.3233/RNN-1994-7302; DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Doherty P, 1996, PERSPECT DEV NEUROBI, V4, P157; EDELMAN GM, 1991, ANNU REV BIOCHEM, V60, P155, DOI 10.1146/annurev.bi.60.070191.001103; EDELMAN GM, 1992, DEV DYNAM, V193, P2, DOI 10.1002/aja.1001930103; Fields RD, 1996, TRENDS NEUROSCI, V19, P473, DOI 10.1016/S0166-2236(96)30013-1; Freudenthal R, 1998, NEUROSCI LETT, V242, P143, DOI 10.1016/S0304-3940(98)00059-7; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Furukawa K, 1998, J NEUROCHEM, V70, P1876; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GUERRINI L, 1995, P NATL ACAD SCI USA, V92, P9077, DOI 10.1073/pnas.92.20.9077; HALL AV, 1994, J BIOL CHEM, V269, P33082; Hayflick JS, 1998, IMMUNOL RES, V17, P313, DOI 10.1007/BF02786454; HOHASHI N, 1995, INT IMMUNOL, V7, P1851, DOI 10.1093/intimm/7.11.1851; Holst BD, 1998, P NATL ACAD SCI USA, V95, P2597, DOI 10.1073/pnas.95.5.2597; HOLST BD, 1994, J BIOL CHEM, V269, P22245; Imbert V, 1996, J INFLAMM, V46, P65; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; Kamiguchi H, 1997, J NEUROSCI RES, V49, P1, DOI 10.1002/(SICI)1097-4547(19970701)49:1<1::AID-JNR1>3.0.CO;2-H; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; KRUSHEL LA, 1995, P NATL ACAD SCI USA, V92, P4323, DOI 10.1073/pnas.92.10.4323; KRUSHEL LA, 1998, P NATL ACAD SCI USA, V95, P2586; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; LIANG P, 1994, NUCLEIC ACIDS RES, V22, P5763, DOI 10.1093/nar/22.25.5763; Maness PF, 1996, PERSPECT DEV NEUROBI, V4, P169; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; Mattson MP, 1998, INT REV NEUROBIOL, V42, P103, DOI 10.1016/S0074-7742(08)60609-1; MAURO VP, 1994, P NATL ACAD SCI USA, V91, P2868, DOI 10.1073/pnas.91.7.2868; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; Meberg PJ, 1996, MOL BRAIN RES, V38, P179, DOI 10.1016/0169-328X(95)00229-L; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; MOYNAGH PN, 1993, BIOCHEM J, V294, P343, DOI 10.1042/bj2940343; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; PerezOtano I, 1996, GLIA, V16, P306, DOI 10.1002/(SICI)1098-1136(199604)16:4<306::AID-GLIA3>3.0.CO;2-Y; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pompeiano Maria, 1998, P157; Ranheim TS, 1996, P NATL ACAD SCI USA, V93, P4071, DOI 10.1073/pnas.93.9.4071; RATTNER A, 1991, MOL CELL BIOL, V11, P1017, DOI 10.1128/MCB.11.2.1017; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Rose SPR, 1996, J PHYSIOLOGY-PARIS, V90, P387, DOI 10.1016/S0928-4257(97)87926-0; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; SchmidtUllrich R, 1996, DEVELOPMENT, V122, P2117; SCHOLER HR, 1991, TRENDS GENET, V7, P323, DOI 10.1016/0168-9525(91)90422-M; Schousboe A., 1989, DISSECTION TISSUE CU, P203; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SPORNS O, 1995, P NATL ACAD SCI USA, V92, P542, DOI 10.1073/pnas.92.2.542; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Yamada KM, 1997, MATRIX BIOL, V16, P137, DOI 10.1016/S0945-053X(97)90001-9; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; ZHOU H, 1993, J CELL BIOL, V122, P951, DOI 10.1083/jcb.122.4.951	77	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2432	2439		10.1074/jbc.274.4.2432	http://dx.doi.org/10.1074/jbc.274.4.2432			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891013	hybrid			2022-12-27	WOS:000078185200080
J	Verdel, A; Khochbin, S				Verdel, A; Khochbin, S			Identification of a new family of higher eukaryotic histone deacetylases - Coordinate expression of differentiation-dependent chromatin modifiers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE ERYTHROLEUKEMIA-CELLS; MESSENGER-RNA; TRANSCRIPTION; ACETYLATION; ACCUMULATION; TRANSFORMATION; REGULATOR; PROMOTER; H1(0); HDA1	The histone deacetylase domain of almost all members of higher eukaryotic histone deacetylases already identified (HDAC family) is highly homologous to that of yeast RPD3.In this paper we report the cloning of two cDNAs encoding members of a new family of histone deacetylase in mouse that show a better homology to yeast HDA1 histone deacetylase, These cDNAs encode relatively large proteins, presenting an in vitro trichostatin A-sensitive histone deacetylase activity. Interestingly, one, mHDA2, encodes a protein with two putative deacetylase domains, and the other, mHDA1, contains only one deacetylase homology domain, located at the C-terminal half of the protein, Our data showed that these newly identified genes could belong to a network. of genes coordinately regulated and involved in the remodeling of chromatin during cell differentiation. Indeed, the expression of mHDA1 and mHDA2 is tightly linked to the state of cell differentiation, behaving therefore like the histone H1 degrees-encoding gene. Moreover, like histone H1 degrees gene, mHDA1 and mHDA2 gene expression is induced upon deacetylase inhibitor treatment, We postulate the existence of a regulatory mechanism, commanding a coordinate expression of a group of genes involved in the remodeling of chromatin not only during cell differentiation but also after abnormal histone acetylation.	Inst Albert Bonniot, INSERM U309, Fac Med, Lab Biol Mol Cycle Cellulaire, F-38706 La Tronche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Khochbin, S (corresponding author), Inst Albert Bonniot, INSERM U309, Fac Med, Lab Biol Mol Cycle Cellulaire, Domaine de Merci, F-38706 La Tronche, France.	khochbin@ujf-grenoble.fr	Khochbin, Saadi/M-8090-2013; Verdel, André/M-5201-2013	Khochbin, Saadi/0000-0002-0455-0857; VERDEL, Andre/0000-0001-6048-3794				ALISON MR, 1986, PHYSIOL REV, V66, P499, DOI 10.1152/physrev.1986.66.3.499; Bestor TH, 1998, NATURE, V393, P311, DOI 10.1038/30613; BROCARD MP, 1994, EUR J BIOCHEM, V221, P421, DOI 10.1111/j.1432-1033.1994.tb18754.x; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; DePinho RA, 1998, NATURE, V391, P533, DOI 10.1038/35257; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; GIRARDOT V, 1994, EUR J BIOCHEM, V224, P885, DOI 10.1111/j.1432-1033.1994.00885.x; Gorka C, 1998, J BIOL CHEM, V273, P1208, DOI 10.1074/jbc.273.2.1208; Gray SG, 1998, BIOCHEM BIOPH RES CO, V245, P423, DOI 10.1006/bbrc.1998.8449; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; KHOCHBIN S, 1988, J MOL BIOL, V200, P55, DOI 10.1016/0022-2836(88)90333-6; KHOCHBIN S, 1991, FEBS LETT, V283, P65, DOI 10.1016/0014-5793(91)80554-G; KHOCHBIN S, 1993, GENE, V128, P173, DOI 10.1016/0378-1119(93)90560-P; Khochbin S, 1997, FEBS LETT, V419, P157, DOI 10.1016/S0014-5793(97)01423-3; KRESS H, 1986, NUCLEIC ACIDS RES, V14, P7189, DOI 10.1093/nar/14.18.7189; Ladomery M, 1997, GENE, V198, P275, DOI 10.1016/S0378-1119(97)00325-9; LEIPE D, 1997, NUCLEIC ACIDS RES, V18, P3693; Linares-Cruz G, 1998, P NATL ACAD SCI USA, V95, P1131, DOI 10.1073/pnas.95.3.1131; Lusser A, 1997, SCIENCE, V277, P88, DOI 10.1126/science.277.5322.88; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; MEISTRICH ML, 1992, MOL REPROD DEV, V31, P170, DOI 10.1002/mrd.1080310303; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; ROUSSEAU D, 1992, EUR J BIOCHEM, V208, P775, DOI 10.1111/j.1432-1033.1992.tb17247.x; ROUSSEAU D, 1991, J MOL BIOL, V217, P85, DOI 10.1016/0022-2836(91)90613-B; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Wolffe AP, 1996, SCIENCE, V272, P371, DOI 10.1126/science.272.5260.371; Wong JM, 1998, EMBO J, V17, P520, DOI 10.1093/emboj/17.2.520; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	38	210	238	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2440	2445		10.1074/jbc.274.4.2440	http://dx.doi.org/10.1074/jbc.274.4.2440			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891014	hybrid			2022-12-27	WOS:000078185200081
J	Song, XD; Sheppard, HM; Norman, AW; Liu, X				Song, XD; Sheppard, HM; Norman, AW; Liu, X			Mitogen-activated protein kinase is involved in the degradation of p53 protein in the bryostatin-1-induced differentiation of the acute promyelocytic leukemia NB4 cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; ALKALINE-PHOSPHATASE; TERMINAL HYDROLASE; GENE-EXPRESSION; PHOSPHORYLATION; GROWTH; MDM2; INHIBITION; DOMAIN; ACID	Overexpression of mutant p53 has been reported to promote tumorigenicity in several cancers, However, despite its potential importance, the signals regulating mutant p53 protein expression are not known, Here we show that a form of p53 that is incapable of binding DNA is overexpressed in the acute promyelocytic leukemia NB4 cell line, Our results demonstrate that treatment of NB4 cells with bryostatin-1, which induces differentiation in this cell line, leads to hyperphosphorylation of this DNA binding-impaired form of p53 via mitogen-activated protein kinase, After this phosphorylation, the p53 protein is degraded by the ubiquitin/proteasome path:,ay, Furthermore, we show that inhibition of p53 hyperphosphorylation blocks p53 protein degradation and cell differentiation. In addition, inhibition of the ubiquitin/proteasome pathway also blocks p53 protein degradation and cell differentiation. These findings suggest a role for mitogen-activated protein kinase in the degradation of the DNA binding-impaired form of p53 protein and in the bryostatin-induced differentiation observed in this cell line. The implications of these results with respect to the functional significance of p53 phosphorylation and degradation in cell differentiation are discussed.	Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Liu, X (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	xuan.liu@ucr.edu		Sheppard, Hilary/0000-0003-1147-4618	NCI NIH HHS [CA75180-02] Funding Source: Medline; NIDDK NIH HHS [DK09012-034] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA075180, R01CA075180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK009012, R37DK009012] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BHATIA M, 1994, LEUKEMIA, V8, P1744; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; GIANNI M, 1995, BLOOD, V85, P3619, DOI 10.1182/blood.V85.12.3619.bloodjournal85123619; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LANOTTE M, 1991, BLOOD, V77, P1080; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIU X, 1995, MOL CELL BIOL, V15, P6474; LIU X, 1993, MOL CELL BIOL, V13, P3291, DOI 10.1128/MCB.13.6.3291; MILNE DM, 1994, J BIOL CHEM, V269, P9253; Mohammad RM, 1996, ENZYME PROTEIN, V49, P262, DOI 10.1159/000468636; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; SONG X, 1999, IN PRESS LEUKEMIA; Song XD, 1998, ENDOCRINOLOGY, V139, P457, DOI 10.1210/en.139.2.457; Song XD, 1998, LEUKEMIA RES, V22, P69, DOI 10.1016/S0145-2126(97)00054-4; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; SUN XG, 1995, MOL CELL BIOL, V15, P4489; SUN Y, 1993, P NATL ACAD SCI USA, V90, P2827, DOI 10.1073/pnas.90.7.2827; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; ZAMBETTI GP, 1992, GENE DEV, V6, P1143, DOI 10.1101/gad.6.7.1143; ZHANG W, 1994, CANCER RES, V54, P4448	32	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1677	1682		10.1074/jbc.274.3.1677	http://dx.doi.org/10.1074/jbc.274.3.1677			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880547	hybrid			2022-12-27	WOS:000079956900067
J	Tijsterman, M; Brouwer, J				Tijsterman, M; Brouwer, J			Rad26, the yeast homolog of the cockayne syndrome B gene product, counteracts inhibition of DNA repair due to RNA polymerase II transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; EXCISION-REPAIR; COUPLING FACTOR; SYNDROME CELLS; STRAND; ELONGATION; RESOLUTION; DEFICIENT; REMOVAL; DAMAGE	Transcription-coupled DNA repair (TCR) is responsible for the preferential removal of DNA lesions from the transcribed strands of RNA polymerase II transcribed genes. Saccharomyces cerevisiae rad26 mutants and cells from patients suffering from the hereditary disease. Cockayne syndrome display a TCR defective phenotype. Whether this lack of preferential repair has to be explained by a defect in repair or in general transcription is unclear at present. To discriminate between both possibilities, we analyzed repair of UV-induced cyclobutane pyrimidine dimers at single base resolution in yeast cells lacking RAD26, the homolog of the Cockayne syndrome B gene. Disrupting RAD26 affects nucleotide excision repair of transcribed DNA irrespective of the chromatin context, resulting in similar rates of removal for individual cyclobutane pyrimidine dimers throughout the transcribed strand. Notably, repair of transcribed sequences in between core nucleosomal regions is less efficient compared with nontranscribed DNA at these positions, pointing to a nucleotide excision repair impediment caused by blocked RNA polymerase. Our in vivo data demonstrate that the TCR defect in rad26 mutant cells is not due to a general transcription deficiency but results from the inability to release the transcription complex trapped at sites of base damage.	Leiden Univ, Gorlaeus Labs, Leiden Inst Chem, Dept Mol Genet,Med Genet Ctr, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Brouwer, J (corresponding author), Leiden Univ, Gorlaeus Labs, Leiden Inst Chem, Dept Mol Genet,Med Genet Ctr, POB 9502, NL-2300 RA Leiden, Netherlands.		Tijsterman, Marcel/H-5663-2018	Tijsterman, Marcel/0000-0001-8465-9002				Balajee AS, 1997, P NATL ACAD SCI USA, V94, P4306, DOI 10.1073/pnas.94.9.4306; Guzder SN, 1996, J BIOL CHEM, V271, P18314, DOI 10.1074/jbc.271.31.18314; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; LEADON SA, 1993, P NATL ACAD SCI USA, V90, P10499, DOI 10.1073/pnas.90.22.10499; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P11574, DOI 10.1073/pnas.88.24.11574; Tanaka S, 1996, J MOL BIOL, V257, P919, DOI 10.1006/jmbi.1996.0212; Tijsterman M, 1997, P NATL ACAD SCI USA, V94, P8027, DOI 10.1073/pnas.94.15.8027; Tijsterman M, 1996, NUCLEIC ACIDS RES, V24, P3499, DOI 10.1093/nar/24.18.3499; TIJSTERMAN M, 1999, IN PRESS MOL CELL BI; Tu YQ, 1997, J BIOL CHEM, V272, P20747, DOI 10.1074/jbc.272.33.20747; Tu YQ, 1998, MUTAT RES-FUND MOL M, V400, P143, DOI 10.1016/S0027-5107(98)00038-4; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; VERHAGE R, 1994, MOL CELL BIOL, V14, P6135, DOI 10.1128/MCB.14.9.6135; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046	22	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1199	1202		10.1074/jbc.274.3.1199	http://dx.doi.org/10.1074/jbc.274.3.1199			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880486	hybrid			2022-12-27	WOS:000079956900006
J	Hasegawa, J; Osatomi, K; Wu, RF; Uyeda, K				Hasegawa, J; Osatomi, K; Wu, RF; Uyeda, K			A novel factor finding to the glucose response elements of liver pyruvate kinase and fatty acid synthase genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE NUCLEAR FACTOR-4; LOOP-HELIX PROTEIN; CARBOHYDRATE REGULATION; RAT HEPATOCYTES; DNA-BINDING; PRIMARY CULTURE; S14 GENE; EXPRESSION; TRANSCRIPTION; SEQUENCE	Transcription of the liver type pyruvate kinase and lipogenesis enzyme genes is induced by high carbohydrate in liver. We have found a novel protein factor in rat Liver nuclei that binds to the glucose response element (CACGTG motifs) of the pyruvate kinase gene (Liu, Z., Thompson, & S., and Towle, H. C. (1993) J. Biol Chem. 268,12787-12795) and the "insulin response element" of fatty acid synthase gene. The amounts of this DNA-binding protein, termed "glucose response element binding protein" (GRBP) in the nuclear extract, were increased in liver by a high carbohydrate diet and decreased by starvation, high fat, and high protein diet. GRBP also occurs in cytosols of liver and is dependent on carbohydrate. Both the nuclear and the cytosolic GRBP showed similar properties, except the former was more resistant to thermal inactivation than the latter. Kinetics of glucose activation of the cytosolic GRBP in a primary culture of hepatocytes indicated that a half-maximum activation was achieved after 6 h, and glucose concentration required for the maximum activation of the GRBP was approximately 12 mM. Dibutyryl-cAMP, okadaic acid, and forskolin inhibited glucose activation of both GRBP and liver pyruvate kinase transcription. These results suggested that GRBP may be a factor that recognizes the glucose response motif site and may be involved in mediating carbohydrate response of the pyruvate kinase gene.	Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75216 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Uyeda, K (corresponding author), Dallas Vet Affairs Med Ctr, 4500 S Lancaster Rd, Dallas, TX 75216 USA.	kuyeda6400@aol.com						BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARR CS, 1990, MOL CELL BIOL, V10, P4384, DOI 10.1128/MCB.10.8.4384; CASAZZA JP, 1986, BIOCHEM J, V236, P635, DOI 10.1042/bj2360635; COGNET M, 1987, J MOL BIOL, V196, P11, DOI 10.1016/0022-2836(87)90507-9; DECAUX JF, 1989, J BIOL CHEM, V264, P11584; Doiron B, 1996, J BIOL CHEM, V271, P5321, DOI 10.1074/jbc.271.10.5321; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FOUFELLE F, 1995, BIOCHEM J, V308, P521, DOI 10.1042/bj3080521; FOUFELLE F, 1992, J BIOL CHEM, V267, P20543; FRAUCONE OL, 1992, AM J PHYSIOL, V236, pE615; Fukuda H, 1997, EUR J BIOCHEM, V247, P497, DOI 10.1111/j.1432-1033.1997.00497.x; GOODRIDGE AG, 1987, ANNU REV NUTR, V7, P157, DOI 10.1146/annurev.nu.07.070187.001105; GRANNER D, 1990, J BIOL CHEM, V265, P10173; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GUERRA MJMD, 1993, MOL CELL BIOL, V13, P7725, DOI 10.1128/MCB.13.12.7725; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; Kang RJ, 1996, J BIOCHEM-TOKYO, V119, P162; Kaytor EN, 1997, J BIOL CHEM, V272, P7525, DOI 10.1074/jbc.272.11.7525; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LIU ZR, 1993, J BIOL CHEM, V268, P12787; MATSUDA T, 1990, J BIOCHEM-TOKYO, V108, P778, DOI 10.1093/oxfordjournals.jbchem.a123280; Mourrieras F, 1997, BIOCHEM J, V326, P345, DOI 10.1042/bj3260345; MOUSTAID N, 1993, BIOCHEM J, V292, P767, DOI 10.1042/bj2920767; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NISHIMURA M, 1994, J BIOL CHEM, V269, P26100; NISHIMURA M, 1995, J BIOL CHEM, V270, P26341, DOI 10.1074/jbc.270.44.26341; NOGUCHI T, 1987, J BIOL CHEM, V262, P14366; OGAWA N, 1990, MOL CELL BIOL, V10, P2224, DOI 10.1128/MCB.10.5.2224; PRENDERGAST GC, 1991, SCIENCE, V251, P186, DOI 10.1126/science.1987636; PRIPBUUS C, 1995, EUR J BIOCHEM, V230, P309, DOI 10.1111/j.1432-1033.1995.tb20564.x; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; SHIH HM, 1994, J BIOL CHEM, V269, P9380; SHIH HM, 1992, J BIOL CHEM, V267, P13222; THOMPSON KS, 1991, J BIOL CHEM, V266, P8679; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; VAULONT S, 1989, J MOL BIOL, V209, P205, DOI 10.1016/0022-2836(89)90273-8; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; WANG D, 1995, J BIOL CHEM, V270, P28716, DOI 10.1074/jbc.270.48.28716; Yamada K, 1997, BIOCHEM J, V324, P917, DOI 10.1042/bj3240917; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	43	47	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1100	1107		10.1074/jbc.274.2.1100	http://dx.doi.org/10.1074/jbc.274.2.1100			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873057	hybrid			2022-12-27	WOS:000077968500072
J	Lenarcic, B; Turk, V				Lenarcic, B; Turk, V			Thyroglobulin type-1 domains in equistatin inhibit both papain-like cysteine proteinases and cathepsin D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE PROTEIN; AFFINITY CHROMATOGRAPHY; MOLECULAR-CLONING; INVARIANT CHAIN; BINDING; SEQUENCE; PURIFICATION; KININOGEN; CDNA	Equistatin from sea anemone is a protein composed of three thyroglobulin-type 1 domains known to inhibit papain-like cysteine proteinases, papain, and cathepsins B and L, Limited proteolysis was used to dissect equistatin into a first domain, eq d-1, and a combined second and third domain, eq d-2,3, Only the N-terminal domain inhibits papain (K-i = 0.61 nM). Remarkably, equistatin also strongly inhibits cathepsin D with K-i = 0.3 nM but not other aspartic proteinases such as pepsin, chymosin, and HIV-PR. This activity resides on the eq d-2,3 domains (K-i = 0.4 nM). Papain and cathepsin D can be bound and inhibited simultaneously by equistatin at pH 4.5, confirming the physical separation of the two binding sites. Equistatin is the first inhibitor of animal origin known to inhibit cathepsin D, The obtained results demonstrate that the widely distributed thyroglobulin type-1 domains can support a variety of functions.	Jozef Stefan Inst, Dept Biochem & Mol Biol, Ljubljana 1000, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Lenarcic, B (corresponding author), Jozef Stefan Inst, Dept Biochem & Mol Biol, Jamova 39, Ljubljana 1000, Slovenia.	brigita.lenarcic@ijs.si		Lenarcic, Brigita/0000-0002-2508-3776				ALLANDER SV, 1994, J BIOL CHEM, V269, P10891; ALLIEL PM, 1993, EUR J BIOCHEM, V214, P347, DOI 10.1111/j.1432-1033.1993.tb17930.x; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Bevec T, 1996, J EXP MED, V183, P1331, DOI 10.1084/jem.183.4.1331; BLUMBERG S, 1970, EUR J BIOCHEM, V15, P97, DOI 10.1111/j.1432-1033.1970.tb00981.x; BOLANDER ME, 1988, P NATL ACAD SCI USA, V85, P2919, DOI 10.1073/pnas.85.9.2919; BRADFORD HN, 1993, J BIOL CHEM, V268, P26546; BROCKLEHURST K, 1973, BIOCHEM J, V133, P573, DOI 10.1042/bj1330573; DUNN BM, 1984, BIOCHEMISTRY-US, V23, P5241, DOI 10.1021/bi00317a023; FOWLKES JL, 1995, J BIOL CHEM, V270, P27481, DOI 10.1074/jbc.270.46.27481; GRECO WR, 1979, J BIOL CHEM, V254, P2104; KREGAR I, 1977, CROAT CHEM ACTA, V49, P587; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Lenarcic B, 1996, FEBS LETT, V395, P113, DOI 10.1016/0014-5793(96)00984-2; Lenarcic B, 1997, J BIOL CHEM, V272, P13899; Lenarcic B, 1998, J BIOL CHEM, V273, P12682; Lenarcic B, 1998, BIOL CHEM, V379, P105; MALTHIERY Y, 1987, EUR J BIOCHEM, V165, P491, DOI 10.1111/j.1432-1033.1987.tb11466.x; MANN K, 1989, EMBO J, V8, P65, DOI 10.1002/j.1460-2075.1989.tb03349.x; MASON RW, 1986, BIOCHEM J, V240, P285, DOI 10.1042/bj2400285; Molina F, 1996, EUR J BIOCHEM, V240, P125, DOI 10.1111/j.1432-1033.1996.0125h.x; MORABITO MA, 1994, P NATL ACAD SCI USA, V91, P2478, DOI 10.1073/pnas.91.7.2478; MORABITO MA, 1995, P NATL ACAD SCI USA, V92, P6651, DOI 10.1073/pnas.92.14.6651; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; SALVESEN G, 1986, BIOCHEM J, V234, P429, DOI 10.1042/bj2340429; STROP P, 1981, J CHROMATOGR, V207, P55; STRUBIN M, 1986, EMBO J, V5, P3483, DOI 10.1002/j.1460-2075.1986.tb04673.x; SZALA S, 1990, P NATL ACAD SCI USA, V87, P3542, DOI 10.1073/pnas.87.9.3542; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; TURK B, 1995, PROTEIN SCI, V4, P1874, DOI 10.1002/pro.5560040922; VANDERLOGT CPE, 1991, BIOCHEMISTRY-US, V30, P1571, DOI 10.1021/bi00220a018; Yamashita M, 1996, J BIOL CHEM, V271, P1282, DOI 10.1074/jbc.271.3.1282; ZUCKER S, 1985, BIOCHIM BIOPHYS ACTA, V828, P196, DOI 10.1016/0167-4838(85)90057-3	34	84	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					563	566		10.1074/jbc.274.2.563	http://dx.doi.org/10.1074/jbc.274.2.563			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872988	hybrid			2022-12-27	WOS:000077968500003
J	Manifava, M; Sugars, J; Ktistakis, NT				Manifava, M; Sugars, J; Ktistakis, NT			Modification of catalytically active phospholipase d1 with fatty acid in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; D DEFINES; HYDROXYLAMINE	Phospholipase D1 (PLD1) was covalently labeled with H-3 when expressed transiently in COS cells and immunoprecipitated following labeling of the cells with [H-3]-palmitate. Labeling of PLD1 was abolished by treatment with hydroxylamine at neutral pH, indicating that the fatty acid is linked via thioester to the enzyme. In pulse-chase studies the label persisted over a 3-h chase, indicating a slow rate of turnover. A catalytically inactive point mutant of PLD1 that changes serine at position 911 to alanine (S911A) was partially but not entirely redistributed to the cytosol, and it contained no detectable palmitate label. Similarly, N- and C-terminal domain fragments of the protein, encompassing in combination the entire coding region and all expressed to levels comparable with the wild type protein, showed no label with palmitate. Treatment of immunoprecipitated PLD1 with hydroxylamine diminished catalytic activity to background levels in a dose response manner that paralleled the removal of label from [H-3]palmitate-labeled protein. me suggest that modification of PLD1 with palmitate is related to its catalytic activity and may be an important requirement for the function of this enzyme.	Babraham Inst, Dept Signaling, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Ktistakis, NT (corresponding author), Babraham Inst, Dept Signaling, Cambridge CB2 4AT, England.							Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; BROWN HA, 1995, METHOD ENZYMOL, V257, P313; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Ktistakis NT, 1998, BIOESSAYS, V20, P495; LISCOVITCH M, 1995, CELL, V81, P659, DOI 10.1016/0092-8674(95)90525-1; MAGEE AI, 1985, EMBO J, V4, P1137, DOI 10.1002/j.1460-2075.1985.tb03751.x; PEPPERBERG DR, 1995, METHOD ENZYMOL, V250, P348; SINGER WD, 1997, ANNU REV BIOCHEM, V66, P457; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; Welch H, 1998, J BIOL CHEM, V273, P11248, DOI 10.1074/jbc.273.18.11248; ZENG FY, 1995, J BIOL CHEM, V270, P21388, DOI 10.1074/jbc.270.36.21388; Zhao J, 1998, BIOCHEMISTRY-US, V37, P6361, DOI 10.1021/bi980218m	14	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1072	1077		10.1074/jbc.274.2.1072	http://dx.doi.org/10.1074/jbc.274.2.1072			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873053	hybrid			2022-12-27	WOS:000077968500068
J	Medved, LV; Migliorini, M; Mikhailenko, I; Barrientos, LG; Llinas, M; Strickland, DK				Medved, LV; Migliorini, M; Mikhailenko, I; Barrientos, LG; Llinas, M; Strickland, DK			Domain organization of the 39-kDa receptor-associated protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; HUMAN ALPHA-2-MACROGLOBULIN RECEPTOR; HEYMANN NEPHRITIS ANTIGEN; MOLAR HEAT-CAPACITY; PLASMINOGEN-ACTIVATOR; HUMAN FIBRINOGEN; TERMINAL DOMAIN; LIGAND-BINDING; EXPRESSION; SEQUENCE	The 39-kDa receptor-associated protein (RAP) is an endoplasmic reticulum resident protein that binds to the low density lipoprotein receptor-related protein (LRP) as well as certain members of the low density lipoprotein receptor superfamily and antagonizes ligand binding. In order to identify important functional regions of RAP, studies were performed to define the domain organization and domain boundaries of this molecule. Differential scanning calorimetry (DSC) experiments revealed that the process of thermal denaturation of RAP is highly reversible and occurs in a broad temperature range with two well resolved heat absorption peaks. A good fit of the endotherm was obtained with four two-state transitions suggesting these many cooperative domains in the molecule. A number of recombinant fragments of RAP were expressed in bacteria, and their domain composition and stability were characterized by DSC, circular dichroism, and fluorescence spectroscopy. The results confirmed that RAP is composed of four independently folded domains, D1, D2, D3, and D4, that encompass residues 1-92, 93-163, 164-216, and 217-323, respectively. The first and the fourth domains preserved their structure and stability when isolated, whereas the compact structure of the fragment corresponding to D2 seems to be altered when isolated from the parent molecule. Isolated D3 was partially degraded during isolation from bacterial lysates. The isolated D4 was capable of binding with high affinity to LRP whereas neither D1 nor D2 bound. At the same time a fragment containing both D1 and D2 exhibited high affinity binding to LRP. These facts combined with the thermodynamic analysis of the melting process of the fragments containing D1 and D2 indicate that these two domains interact with each other and that the proper folding of the second domain into a native-like active conformation requires presence of the first domain.	Amer Red Cross, Jerome H Holland Lab, Dept Vasc Biol, Rockville, MD 20855 USA; Amer Red Cross, Jerome H Holland Lab, Dept Biochem, Rockville, MD 20855 USA; George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; George Washington Univ, Med Ctr, Inst Biomed Sci, Washington, DC 20037 USA; Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA	American Red Cross; American Red Cross; George Washington University; George Washington University; Carnegie Mellon University	Strickland, DK (corresponding author), Amer Red Cross, Jerome H Holland Lab, Dept Vasc Biol, 15601 Crabbs Branch Way, Rockville, MD 20855 USA.			Medved, Leonid/0000-0002-3665-9849	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050784, P01HL054710, R01HL056051] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54710, HL56051, HL50784, R01 HL056051] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Ellgaard L, 1997, EUR J BIOCHEM, V244, P544, DOI 10.1111/j.1432-1033.1997.00544.x; Filimonov V V, 1982, Mol Biol (Mosk), V16, P551; FURUKAWA T, 1990, J BIOCHEM-TOKYO, V108, P297, DOI 10.1093/oxfordjournals.jbchem.a123197; GASCUEL O, 1988, COMPUT APPL BIOSCI, V4, P357; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HERZ J, 1991, J BIOL CHEM, V266, P21232; JENSEN PH, 1989, FEBS LETT, V255, P275, DOI 10.1016/0014-5793(89)81105-6; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; KANALAS JJ, 1993, J BIOL CHEM, V268, P8188; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; Lindstedt KA, 1997, J BIOL CHEM, V272, P30221, DOI 10.1074/jbc.272.48.30221; MAKHATADZE GI, 1990, J MOL BIOL, V213, P375, DOI 10.1016/S0022-2836(05)80197-4; Medved L, 1997, BIOCHEMISTRY-US, V36, P4685, DOI 10.1021/bi962795l; MEDVED LV, 1995, J BIOL CHEM, V270, P13652, DOI 10.1074/jbc.270.23.13652; MOESTRUP SK, 1990, J BIOL CHEM, V265, P12623; Nielsen PR, 1997, P NATL ACAD SCI USA, V94, P7521, DOI 10.1073/pnas.94.14.7521; NOVOKHATNY V, 1992, J BIOL CHEM, V267, P3878; NOVOKHATNY VV, 1991, J BIOL CHEM, V266, P12994; ORLANDO RA, 1994, P NATL ACAD SCI USA, V91, P3161, DOI 10.1073/pnas.91.8.3161; ORLANDO RA, 1992, P NATL ACAD SCI USA, V89, P6698, DOI 10.1073/pnas.89.15.6698; PIETROMONACO S, 1990, P NATL ACAD SCI USA, V87, P1811, DOI 10.1073/pnas.87.5.1811; Privalov P L, 1986, Methods Enzymol, V131, P4; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; PRIVALOV PL, 1982, J MOL BIOL, V159, P665, DOI 10.1016/0022-2836(82)90107-3; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; SIMONSEN ACW, 1994, FEBS LETT, V354, P279, DOI 10.1016/0014-5793(94)01138-9; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; TOUMADJE A, 1992, ANAL BIOCHEM, V200, P321, DOI 10.1016/0003-2697(92)90473-K; VYSOTCHIN A, 1993, J BIOL CHEM, V268, P8436; WARSHAWSKY I, 1994, J BIOL CHEM, V269, P3325; WARSHAWSKY I, 1995, BIOCHEMISTRY-US, V34, P3404, DOI 10.1021/bi00010a032; WILLIAMS SE, 1994, J BIOL CHEM, V269, P8653; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Yee VC, 1997, STRUCTURE, V5, P125, DOI 10.1016/S0969-2126(97)00171-8	41	39	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					717	727		10.1074/jbc.274.2.717	http://dx.doi.org/10.1074/jbc.274.2.717			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873007	hybrid			2022-12-27	WOS:000077968500022
J	Ratovitski, EA; Alam, MR; Quick, RK; McMillan, A; Bao, C; Kozlovsky, C; Hand, TA; Johnson, RC; Mains, RE; Eipper, BA; Lowenstein, CJ				Ratovitski, EA; Alam, MR; Quick, RK; McMillan, A; Bao, C; Kozlovsky, C; Hand, TA; Johnson, RC; Mains, RE; Eipper, BA; Lowenstein, CJ			Kalirin inhibition of inducible nitric-oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMIDATING MONOOXYGENASE; PEPTIDE-PROCESSING ENZYME; PRO-ACTH-ENDORPHIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; PITUITARY-ADRENAL AXIS; CENTRAL-NERVOUS-SYSTEM; OXYGENASE DOMAIN; MICE LACKING; TYROSINE PHOSPHORYLATION	Nitric oxide (NO) acts as a neurotransmitter. However, excess NO produced from neuronal NO synthase (nNOS) or inducible NOS (iNOS) during inflammation of the central nervous system can be neurotoxic, disrupting neurotransmitter and hormone production and killing neurons. A screen of a hippocampal cDNA library showed that a unique region of the MOS protein interacts with Kalirin, previously identified as an interactor with a secretory granule peptide biosynthetic enzyme. Kalirin associates with iNOS in vitro and in vivo and inhibits iNOS activity by preventing the formation of iNOS homodimers. Expression of exogenous Kalirin in pituitary cells dramatically reduces iNOS inhibition of ACTH secretion. Thus Kalirin may play a neuroprotective role during inflammation of the central nervous system by inhibiting iNOS activity.	Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Lowenstein, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, 950 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	clowenst@welchlink.welch.jhu.edu		Lowenstein, Charles/0000-0003-0485-7514	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL052315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL52315] Funding Source: Medline; NIDA NIH HHS [DA00266] Funding Source: Medline; NIDDK NIH HHS [R01 DK32948] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; Alam MR, 1997, J BIOL CHEM, V272, P12667, DOI 10.1074/jbc.272.19.12667; Alam MR, 1996, J BIOL CHEM, V271, P28636, DOI 10.1074/jbc.271.45.28636; Auernhammer CJ, 1998, ENDOCRINOLOGY, V139, P2201, DOI 10.1210/en.139.5.2201; Ayata C, 1997, J NEUROSCI, V17, P6908; BAEK KJ, 1993, J BIOL CHEM, V268, P21120; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Bredt DS, 1996, P SOC EXP BIOL MED, V211, P41; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Brenman JE, 1997, CURR OPIN NEUROBIOL, V7, P374, DOI 10.1016/S0959-4388(97)80065-7; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Brenner T, 1997, J IMMUNOL, V158, P2940; BRUNETTI L, 1993, LIFE SCI, V53, pPL219, DOI 10.1016/0024-3205(93)90267-7; Colomer V, 1997, HUM MOL GENET, V6, P1519, DOI 10.1093/hmg/6.9.1519; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; CROSS AH, 1994, J CLIN INVEST, V93, P2684, DOI 10.1172/JCI117282; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; DAWSON VL, 1993, J NEUROSCI, V13, P2651; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; DUVILANSKI BH, 1995, P NATL ACAD SCI USA, V92, P170, DOI 10.1073/pnas.92.1.170; Duvilanski BH, 1996, J NEUROENDOCRINOL, V8, P909, DOI 10.1111/j.1365-2826.1996.tb00820.x; EIPPER BA, 1993, PROTEIN SCI, V2, P489; Eissa NT, 1996, J BIOL CHEM, V271, P27184, DOI 10.1074/jbc.271.43.27184; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Ghosh S, 1996, GENE, V176, P249, DOI 10.1016/0378-1119(96)00260-0; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hellermann GR, 1997, J BIOL CHEM, V272, P12030, DOI 10.1074/jbc.272.18.12030; HEVEL JM, 1991, J BIOL CHEM, V266, P22789; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Iadecola C, 1997, J NEUROSCI, V17, P9157; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Katahira M, 1998, ENDOCRINOLOGY, V139, P2414, DOI 10.1210/en.139.5.2414; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; LEE S, 1994, ALCOHOL CLIN EXP RES, V18, P1242, DOI 10.1111/j.1530-0277.1994.tb00112.x; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; LIN RF, 1993, J EXP MED, V178, P643, DOI 10.1084/jem.178.2.643; Lowenstein CJ, 1996, J CLIN INVEST, V97, P1837, DOI 10.1172/JCI118613; LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Mains R E, 1980, Ann N Y Acad Sci, V343, P94, DOI 10.1111/j.1749-6632.1980.tb47245.x; MAINS RE, 1984, ENDOCRINOLOGY, V115, P1683, DOI 10.1210/endo-115-5-1683; MAINS RE, 1981, J CELL BIOL, V89, P21, DOI 10.1083/jcb.89.1.21; MAINS RE, 1981, J BIOL CHEM, V256, P5683; MAINS RE, 1990, TRENDS ENDOCRIN MET, V1, P388, DOI 10.1016/1043-2760(90)90097-M; Mayer B, 1997, BIOCHEMISTRY-US, V36, P8422, DOI 10.1021/bi970144z; Meffert MK, 1996, NEURON, V16, P1229, DOI 10.1016/S0896-6273(00)80149-X; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; MILGRAM SL, 1993, J CELL BIOL, V121, P23, DOI 10.1083/jcb.121.1.23; MITROVIC B, 1994, NEUROSCIENCE, V61, P575, DOI 10.1016/0306-4522(94)90435-9; MITROVIC B, 1994, ANN NY ACAD SCI, V738, P436; MITROVIC B, 1995, NEUROSCIENCE, V65, P531, DOI 10.1016/0306-4522(94)00491-M; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; OKUDA Y, 1995, J NEUROIMMUNOL, V62, P103, DOI 10.1016/0165-5728(95)00114-H; Presta A, 1998, BIOCHEMISTRY-US, V37, P298, DOI 10.1021/bi971944c; Ratovitski EA, 1998, J BIOL CHEM, V273, P3654, DOI 10.1074/jbc.273.6.3654; RIVIER C, 1995, ENDOCRINOLOGY, V136, P3597, DOI 10.1210/en.136.8.3597; RIVIER C, 1994, J NEUROSCI, V14, P1985; SCHNABEL E, 1989, MOL ENDOCRINOL, V3, P1223, DOI 10.1210/mend-3-8-1223; SEILICOVICH A, 1995, P NATL ACAD SCI USA, V92, P3421, DOI 10.1073/pnas.92.8.3421; SEILICOVICH A, 1995, P NATL ACAD SCI USA, V92, P11299, DOI 10.1073/pnas.92.24.11299; SHETA EA, 1994, J BIOL CHEM, V269, P15147; Siddhanta U, 1996, J BIOL CHEM, V271, P7309, DOI 10.1074/jbc.271.13.7309; Song KS, 1997, CELL MOL BIOL, V43, P293; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; StevensTruss R, 1997, BIOCHEMISTRY-US, V36, P12337, DOI 10.1021/bi970973k; STUEHR DJ, 1987, J IMMUNOL, V139, P518; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/S0361-9230(96)00159-1; Turnbull AV, 1996, ENDOCRINOLOGY, V137, P455, DOI 10.1210/en.137.2.455; TZENG E, 1995, P NATL ACAD SCI USA, V92, P11771, DOI 10.1073/pnas.92.25.11771; Venema RC, 1997, J BIOL CHEM, V272, P1276, DOI 10.1074/jbc.272.2.1276; Venema VJ, 1997, BIOCHEM BIOPH RES CO, V236, P155, DOI 10.1006/bbrc.1997.6921; Vodovotz Y, 1996, J EXP MED, V184, P1425, DOI 10.1084/jem.184.4.1425; Volpi R, 1996, NEUROPEPTIDES, V30, P528, DOI 10.1016/S0143-4179(96)90034-7; Wong ML, 1996, NAT MED, V2, P581, DOI 10.1038/nm0596-581; ZHANG J, 1995, ANNU REV PHARMACOL, V35, P213; Zhou Y, 1998, J COMP NEUROL, V394, P496	93	101	105	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					993	999		10.1074/jbc.274.2.993	http://dx.doi.org/10.1074/jbc.274.2.993			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873042	hybrid			2022-12-27	WOS:000077968500057
J	Rosenberger, SF; Finch, JS; Gupta, A; Bowden, GT				Rosenberger, SF; Finch, JS; Gupta, A; Bowden, GT			Extracellular signal-regulated kinase 1/2-mediated phosphorylation of JunD and FosB is required for okadaic acid-induced activator protein 1 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-CELL LINES; C-JUN; TUMOR PROMOTER; TRANSCRIPTIONAL ACTIVATION; MOUSE KERATINOCYTES; BINDING-ACTIVITY; AP-1 ACTIVITY; GROWTH-FACTOR; JB6 CELLS; EXPRESSION	Previously, we reported that in papilloma-producing 308 mouse keratinocytes, the tumor promoter okadaic acid, a serine-threonine phosphatase inhibitor, increased binding of activator protein 1 (AP-1) to a consensus 12-O-tetradecanoylphorbol-18-acetate-responsive element (Rosenberger, S. F., and Bowden, G.T. (1996) Oncogene 12, 2301-2308). In this study, we investigated the correlation between AP-I DNA binding and transactivation and examined molecular mechanisms involved in this process. Using a luciferase reporter driven by region -74 to +63 of the human collagenase gene, we demonstrated induction of AP-1-mediated transcription following okadaic acid treatment. By performing in vitro kinase assays, we found elevated activities of extracellular signal-regulated kinase (ERH) 1/2, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. The ERK-1/2-specific inhibitor PD 98059 completely abrogated okadaic acid-induced AP-1 transactivation without altering AP-1-expression, DNA binding, or complex composition. Phosphorylation analyses indicated that inhibition of ERK-1/2 decreased okadaic acid-elevated phosphorylation of JunD and FosB. To further examine the role of JunD and FosB in okadaic acid-induced AP-1 transactivation, we generated fusion proteins of the DNA-binding domain of the yeast transcription factor Gal4 and the transactivation domain of either JunD or FosB. Cotransfection experiments of these constructs with a Gal4-luciferase reporter demonstrated that both JunD and FosB are required for okadaic acid-induced transcription. Treatment with PD 98059 reduced JunD/FosB-dependent transactivation, suggesting that ERK-1/2-mediated phosphorylation is a critical component in this process.	Univ Arizona, Hlth Sci Ctr, Dept Radiat Oncol, Tucson, AZ 85724 USA	University of Arizona; University of Arizona Health Sciences	Bowden, GT (corresponding author), Univ Arizona, Hlth Sci Ctr, Dept Radiat Oncol, 1501 N Campbell Ave, Tucson, AZ 85724 USA.				NCI NIH HHS [CA40584] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040584] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; AUWERX J, 1991, CELL, V64, P983, DOI 10.1016/0092-8674(91)90322-P; BERNSTEIN LR, 1992, MOL CARCINOGEN, V6, P221, DOI 10.1002/mc.2940060308; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; COFFER P, 1994, ONCOGENE, V9, P911; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOMANN FE, 1994, CELL GROWTH DIFFER, V5, P9; DONG ZG, 1995, INT J ONCOL, V7, P359; Dong ZG, 1997, MOL CARCINOGEN, V19, P204, DOI 10.1002/(SICI)1098-2744(199707)19:3<204::AID-MC8>3.0.CO;2-D; Dong ZG, 1997, J BIOL CHEM, V272, P9962; FROST JA, 1994, P NATL ACAD SCI USA, V91, P3844, DOI 10.1073/pnas.91.9.3844; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HOLLADAY K, 1992, MOL CARCINOGEN, V5, P16, DOI 10.1002/mc.2940050106; HONKANEN RE, 1991, J BIOL CHEM, V266, P6614; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAZO PS, 1992, NUCLEIC ACIDS RES, V20, P343, DOI 10.1093/nar/20.2.343; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MONTECLARO FS, 1993, P NATL ACAD SCI USA, V90, P6726, DOI 10.1073/pnas.90.14.6726; MURATA M, 1982, B JPN SOC SCI FISH, V48, P549; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rosenberger SF, 1996, ONCOGENE, V12, P2301; RYSECK RP, 1991, ONCOGENE, V6, P533; SASSA T, 1989, BIOCHEM BIOPH RES CO, V159, P939, DOI 10.1016/0006-291X(89)92199-2; Skinner M, 1997, MOL CELL BIOL, V17, P2372, DOI 10.1128/MCB.17.5.2372; STRICKLAND JE, 1988, CANCER RES, V48, P165; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; TACHIBANA K, 1981, J AM CHEM SOC, V103, P2469, DOI 10.1021/ja00399a082; Wang HL, 1996, ONCOGENE, V13, P2639; WATTS RG, 1995, MOL CARCINOGEN, V13, P27, DOI 10.1002/mc.2940130106; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	38	53	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1124	1130		10.1074/jbc.274.2.1124	http://dx.doi.org/10.1074/jbc.274.2.1124			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873060	hybrid			2022-12-27	WOS:000077968500075
J	Chang, JY				Chang, JY			Denatured states of tick anticoagulant peptide - Compositional analysis of unfolded scrambled isomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANIDINE-HYDROCHLORIDE DENATURATION; RIBONUCLEASE-A; CONTAINING PROTEINS; FACTOR-XA; INHIBITOR; UREA; STABILITY; NMR; TAP; HIRUDINS	In the presence of denaturant and thiol catalyst, a disulfide-containing protein denatures and converts to a mixture of scrambled isomers, which can be purified and structurally characterized. Scrambled isomers adopt a different conformation and a varied extent of unfolding. Their relative concentration (composition) signals the state of unfolding of the denatured protein and is determined by the denaturing condition. In this report, tick anticoagulant peptide (TAP) (60 amino acids and 3 disulfides) has been denatured in the presence of urea, guanidine hydrochloride, guanidine thiocyanate, organic solvents, and at elevated temperature. The recoveries of scrambled TAP were analyzed. The results demonstrate that each denaturing condition generates a unique structure (composition of scrambled species) of denatured TAP. Among various species of scrambled TAP, the beads-form species contains the smallest disulfide loop and appears to represent the most extensively unfolded state. The yield of the beads-form species as a fraction of the total denatured TAP is invariably determined by the strength of the denaturing condition.	Univ Texas, Inst Mol Med, Res Ctr Prot Chem, Houston, TX 77030 USA	University of Texas System	Chang, JY (corresponding author), Univ Texas, Inst Mol Med, Res Ctr Prot Chem, 2121 W Holcome Blvd, Houston, TX 77030 USA.	rchang@imm2.imm.uth.tmc.edu						AMIR D, 1988, BIOCHEMISTRY-US, V27, P8889, DOI 10.1021/bi00425a003; ANTUCH W, 1994, FEBS LETT, V352, P251, DOI 10.1016/0014-5793(94)00941-4; BIERZYNSKI A, 1982, J MOL BIOL, V162, P173, DOI 10.1016/0022-2836(82)90167-X; Blundell TL, 1996, NATURE, V384, P23; CHANG JY, 1991, ANAL BIOCHEM, V197, P52, DOI 10.1016/0003-2697(91)90354-V; CHANG JY, 1995, J BIOL CHEM, V270, P11992, DOI 10.1074/jbc.270.20.11992; Chang JY, 1997, J BIOL CHEM, V272, P69; Chang JY, 1996, BIOCHEMISTRY-US, V35, P11702, DOI 10.1021/bi9606915; CHANG JY, 1995, J BIOL CHEM, V270, P25661; CHANG JY, 1991, J BIOL CHEM, V266, P10839; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; GREENE RF, 1974, J BIOL CHEM, V249, P5388; HOURY WA, 1995, NAT STRUCT BIOL, V2, P495, DOI 10.1038/nsb0695-495; KUWAJIMA K, 1979, BIOCHEMISTRY-US, V18, P878, DOI 10.1021/bi00572a022; LIEPINSH E, 1994, J AM CHEM SOC, V116, P9670, DOI 10.1021/ja00100a036; LIMWILBY MSL, 1995, PROTEIN SCI, V4, P178; MCWHERTER CA, 1986, BIOCHEMISTRY-US, V25, P1951, DOI 10.1021/bi00356a018; PACE CN, 1990, BIOCHEMISTRY-US, V29, P2564, DOI 10.1021/bi00462a019; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; RODER H, 1988, NATURE, V335, P700, DOI 10.1038/335700a0; SARDANA M, 1991, J BIOL CHEM, V266, P13560; Shirley B A, 1995, Methods Mol Biol, V40, P177; SHORTLE D, 1989, BIOCHEMISTRY-US, V28, P936, DOI 10.1021/bi00429a003; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; TANFORD C, 1966, J BIOL CHEM, V241, P1921; TANFORD C, 1967, J AM CHEM SOC, V89, P5023, DOI 10.1021/ja00995a034; TANFORD C, 1970, ADV PROTEIN CHEM, V21, P1; TIMASHEFF SN, 1990, PROTEIN STRUCTURE PR, P331; Volkin D.B., 1989, PROTEIN FUNCTION PRA, P1; WAXMAN L, 1990, SCIENCE, V248, P593, DOI 10.1126/science.2333510; ZALE SE, 1986, BIOCHEMISTRY-US, V25, P5432, DOI 10.1021/bi00367a014	34	42	43	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					123	128		10.1074/jbc.274.1.123	http://dx.doi.org/10.1074/jbc.274.1.123			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867819	hybrid			2022-12-27	WOS:000077900200019
J	Woodard, RL; Anderson, MG; Dynan, WS				Woodard, RL; Anderson, MG; Dynan, WS			Nuclear extracts lacking DNA-dependent protein kinase are deficient in multiple round transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; INITIATION-FACTOR TFIIF; STRAND BREAK REPAIR; V(D)J RECOMBINATION; PREINITIATION COMPLEX; CATALYTIC SUBUNIT; KU AUTOANTIGEN; GENE; BINDING; PHOSPHORYLATION	We have compared levels of in vitro transcription in nuclear extracts from DNA-dependent protein kinase (DNA-PK)-deficient and DNA-PK-containing Chinese hamster ovary cell lines. DNA-PK-deficient cell lines are radiosensitive mutants lacking either the catalytic subunit or the 80-kDa subunit of the Ku protein regulatory component. Extracts from DNA-PK-deficient cell lines had a 2-7-fold decrease in the level of in vitro transcription when compared with matched controls. This decrease was observed with several promoters. Transcription could be restored to either of the deficient extracts by addition of small amounts of extract from the DNA-PK-containing cell lines. Transcription was not restored by addition of purified DNA-PK catalytic subunit, Ru protein, or individually purified general transcription factors. We conclude that extracts from DNA-PK-deficient cells lack a positively acting regulatory factor or a complex of factors not readily reconstituted with individual proteins. We have also investigated the mechanistic defect in the deficient extracts and have found that the observed differences in transcription levels between Ku-positive and Ru-negative cell lines can be attributed solely to a greater ability of the Ru-positive nuclear extracts to carry out secondary initiation events subsequent to the first round of transcription.	Med Coll Georgia, Inst Mol Med & Genet, Program Gene Regulat, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Dynan, WS (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Program Gene Regulat, 1120 15th St, Augusta, GA 30912 USA.			Dynan, William/0000-0002-4045-5662	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035866] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 35866] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASO T, 1992, NATURE, V355, P461, DOI 10.1038/355461a0; Barnes G, 1997, P NATL ACAD SCI USA, V94, P867, DOI 10.1073/pnas.94.3.867; BECKER PB, 1991, P NATL ACAD SCI USA, V88, P4109, DOI 10.1073/pnas.88.10.4109; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; Chen FQ, 1996, MUTAT RES-DNA REPAIR, V362, P9, DOI 10.1016/0921-8777(95)00026-7; COLLINS AR, 1993, MUTAT RES, V293, P99, DOI 10.1016/0921-8777(93)90062-L; CONAWAY JW, 1992, J BIOL CHEM, V267, P10142; Dikstein R, 1996, CELL, V84, P781, DOI 10.1016/S0092-8674(00)81055-7; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; DVIR A, 1993, J BIOL CHEM, V268, P10440; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; GETTS RC, 1994, J BIOL CHEM, V269, P15981; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Huang JR, 1997, J BIOL CHEM, V272, P26009, DOI 10.1074/jbc.272.41.26009; JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; KITAJIMA S, 1994, J BIOL CHEM, V269, P29970; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Lei L, 1998, MOL CELL BIOL, V18, P2130, DOI 10.1128/MCB.18.4.2130; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; MOROZOV VE, 1994, J BIOL CHEM, V269, P16684; Muller C, 1998, NUCLEIC ACIDS RES, V26, P1382, DOI 10.1093/nar/26.6.1382; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Oelgeschlager T, 1998, MOL CELL, V1, P925, DOI 10.1016/S1097-2765(00)80092-1; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; OZER J, 1994, GENE DEV, V8, P2324, DOI 10.1101/gad.8.19.2324; PETERSON MG, 1991, NATURE, V354, P369; PETERSON S, 1995, P NATL ACAD SCI USA, V92, P2934; PETERSON SR, 1992, GENE DEV, V6, P426, DOI 10.1101/gad.6.3.426; PETERSON SR, 1995, J BIOL CHEM, V270, P1449, DOI 10.1074/jbc.270.3.1449; RATHMELL WK, 1994, P NATL ACAD SCI USA, V91, P7623, DOI 10.1073/pnas.91.16.7623; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; SMIDER V, 1994, SCIENCE, V266, P288, DOI 10.1126/science.7939667; SUWA A, 1994, P NATL ACAD SCI USA, V91, P6904, DOI 10.1073/pnas.91.15.6904; SZENTIRMAY MN, 1991, P NATL ACAD SCI USA, V88, P10691, DOI 10.1073/pnas.88.23.10691; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; WALKER AI, 1985, EMBO J, V4, P139, DOI 10.1002/j.1460-2075.1985.tb02328.x; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964	50	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					478	485		10.1074/jbc.274.1.478	http://dx.doi.org/10.1074/jbc.274.1.478			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867868	hybrid			2022-12-27	WOS:000077900200068
J	Lupher, ML; Rao, N; Lill, NL; Andoniou, CE; Miyake, S; Clark, EA; Druker, B; Band, H				Lupher, ML; Rao, N; Lill, NL; Andoniou, CE; Miyake, S; Clark, EA; Druker, B; Band, H			Cbl-mediated negative regulation of the Syk tyrosine kinase - A critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; PROTOONCOGENE C-CBL; OF-FUNCTION MUTATION; EGF RECEPTOR; IN-VIVO; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; T-LYMPHOCYTES; V-CBL; PROTEIN	The proto-oncogene product Cbl has emerged as a potential negative regulator of the Syk tyrosine kinase; however, the nature of physical interactions between Cbl and Syk that are critical for this negative regulation remains unclear. Here we show that the phosphotyrosine-binding (PTB) domain within the N-terminal transforming region of Cbl (Cbl-N) binds to phosphorylated Tyr(323) in the linker region between the Src homology 2 and kinase domains of Syk, confirming recent results by another laboratory using the yeast two-hybrid approach (Deckert, M., Elly, C., Altman, A. and Liu, Y. C. (1998) J. Biol. Chem. 273, 8867-8874). A PTB domain-inactivating point mutation (G306E), corresponding to a loss-of-function mutation in the Caenorhabditis elegans Cbl homologue SLI-1, severely compromised Cbl-N/Syk binding in vitro and Cbl/Syk association in transfected COS-7 cells. Using heterologous expression in COS-7 cells, we investigated the role of Cbl PTB domain binding to Syk Tyr(323) in the negative regulation of Syk. Co expression of Cbl with Syk in COS-7 cells led to a dose-dependent decrease in the autophosphorylated pool of Syk and in phosphorylation of an in vivo substrate, CD8-zeta Unexpectedly, these effects were largely due to the loss of Syk protein. Both the decrease in Syk and CD8-zeta phosphorylation and reduction in Syk protein levels were blocked by either G306E mutation in Cbl or by Y323F mutation in Syk. These results demonstrate a critical role for the Cbl PTB domain in the recruitment of Cbl to Syk and in Cbl-mediated negative regulation of Syk.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Lymphocyte Biol Sect, Dept Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle; Oregon Health & Science University	Band, H (corresponding author), Smith Bldg,Rm 538C,1 Jimmy Fund Way, Boston, MA 02115 USA.	hband@rics.bwh.harvard.edu	Andoniou, Christopher/B-6296-2013; Clark, Edward/K-3462-2012	Druker, Brian/0000-0001-8331-8206; Clark, Edward A/0000-0001-8061-5475; Andoniou, Christopher/0000-0003-0566-3180	NATIONAL CANCER INSTITUTE [R01CA076118] Funding Source: NIH RePORTER; NCI NIH HHS [CA76118] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; BLAKE TJ, 1992, ONCOGENE, V7, P757; BLAKE TJ, 1991, ONCOGENE, V6, P653; Bonita DP, 1997, MOL CELL BIOL, V17, P4597, DOI 10.1128/MCB.17.8.4597; Borg JP, 1996, MOL CELL BIOL, V16, P6229; BOWTELL DDL, 1995, ONCOGENE, V11, P1561; CAMBIER JC, 1995, J IMMUNOL, V155, P3281; CANTLEY LC, 1994, J CELL SCI, P121; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; DEFRANCO AL, 1995, CURR OPIN CELL BIOL, V7, P163, DOI 10.1016/0955-0674(95)80024-7; FitzerAttas CJ, 1997, J BIOL CHEM, V272, P8551, DOI 10.1074/jbc.272.13.8551; FLIER JS, 1989, NEW ENGL J MED, V321, P1383, DOI 10.1056/NEJM198911163212007; Fournel M, 1996, J EXP MED, V183, P301, DOI 10.1084/jem.183.1.301; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141, DOI 10.1074/jbc.270.32.19141; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Hime GR, 1997, ONCOGENE, V14, P2709, DOI 10.1038/sj.onc.1201223; HOU D, 1994, J BIOL CHEM, V269, P14244; Kong GH, 1996, MOL CELL BIOL, V16, P5026; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; LAW CL, 1994, J BIOL CHEM, V269, P12310; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; Li SC, 1997, P NATL ACAD SCI USA, V94, P7204, DOI 10.1073/pnas.94.14.7204; Lupher ML, 1998, INT J BIOCHEM CELL B, V30, P439, DOI 10.1016/S1357-2725(97)00075-7; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; MARCILLA A, 1995, J BIOL CHEM, V270, P9115, DOI 10.1074/jbc.270.16.9115; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Miyake S, 1997, CRIT REV ONCOGENESIS, V8, P189, DOI 10.1615/CritRevOncog.v8.i2-3.30; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Ota Y, 1996, J EXP MED, V184, P1713, DOI 10.1084/jem.184.5.1713; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Panchamoorthy G, 1996, J BIOL CHEM, V271, P3187, DOI 10.1074/jbc.271.6.3187; PAOLINI R, 1993, EMBO J, V12, P779, DOI 10.1002/j.1460-2075.1993.tb05712.x; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; SPITS H, 1983, HYBRIDOMA, V2, P423, DOI 10.1089/hyb.1983.2.423; TANAKA S, 1993, MOL CELL BIOL, V13, P4409, DOI 10.1128/MCB.13.7.4409; Taylor N, 1997, BLOOD, V89, P388, DOI 10.1182/blood.V89.2.388; Thien CBF, 1997, ONCOGENE, V14, P2239, DOI 10.1038/sj.onc.1201193; Ueno H, 1997, J BIOL CHEM, V272, P8739, DOI 10.1074/jbc.272.13.8739; Wang Y, 1996, J BIOL CHEM, V271, P17, DOI 10.1074/jbc.271.1.17; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; Zhao QH, 1996, MOL CELL BIOL, V16, P6765; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zoller KE, 1997, J IMMUNOL, V158, P1650	52	152	154	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35273	35281		10.1074/jbc.273.52.35273	http://dx.doi.org/10.1074/jbc.273.52.35273			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857068	hybrid			2022-12-27	WOS:000077719700086
J	Min, KS; Liu, XB; Fabritz, J; Jaquette, J; Abell, AN; Ascoli, M				Min, KS; Liu, XB; Fabritz, J; Jaquette, J; Abell, AN; Ascoli, M			Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the lutropin/choriogonadotropin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEYDIG TUMOR-CELLS; HUMAN CHORIO-GONADOTROPIN; LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; BETA-ADRENERGIC-RECEPTOR; LUTEINIZING-HORMONE; MEDIATED ENDOCYTOSIS; BETA(2)-ADRENERGIC RECEPTOR; CYTOPLASMIC TAIL; INDUCED PHOSPHORYLATION; INDUCED DESENSITIZATION	Previous results from this laboratory suggested that the same active conformation of the lutropin/choriogonadotropin receptor (LHR) is involved in the stimulation of G proteins and in triggering the internalization of the bound agonist, We have now analyzed two naturally occurring, constitutively active mutants of the human LHR, These mutations were introduced into the rat LHR (rLHR) and are designated L435R and D556Y, Cells expressing rLHR-D556Y bind human choriogonadotropin (hCG) with normal affinity, exhibit a 25-fold increase in basal cAMP and respond to hCG with a normal increase in cAMP accumulation. This mutation does not affect the internalization of the free receptor, but it enhances the internalization of the agonist-occupied receptors similar to 3-fold. Cells expressing rLHR-L435R also bind hCG with normal affinity, exhibit a 47-fold increase in basal cAMP, and do not respond to hCG with a further increase in cAMP accumulation. This mutation enhances the internalization of the free and agonist-occupied receptors similar to 2- and similar to 17-fold, respectively, We conclude that the state of activation of the rLHR can modulate its basal and/or agonist-stimulated internalization. Since the internalization of hCG is involved in the termination of hCG actions, we suggest that the lack of responsiveness detected in cells expressing rLHR-L435R is due to the fast rate of internalization of the bound hCG. The finding that membranes expressing rLHR-L435R (a system where internalization does not occur) respond to hCG with an increase in adenylyl cyclase activity supports this suggestion.	Univ Iowa, Dept Pharmacol, Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Physiol & Biophys, Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Ascoli, M (corresponding author), Univ Iowa, Dept Pharmacol, Coll Med, 2-319A BSB, Iowa City, IA 52242 USA.	mario-ascoli@uiowa.edu			NCI NIH HHS [CA-40629] Funding Source: Medline; NIDDK NIH HHS [DK-25295] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abell AN, 1997, J BIOL CHEM, V272, P14586, DOI 10.1074/jbc.272.23.14586; ASCOLI M, 1984, J CELL BIOL, V99, P1242, DOI 10.1083/jcb.99.4.1242; ASCOLI M, 1982, J BIOL CHEM, V257, P13306; ASCOLI M, 1987, ENDOCRINOLOGY, V120, P1161, DOI 10.1210/endo-120-3-1161; ASCOLI M, 1978, P NATL ACAD SCI USA, V75, P99, DOI 10.1073/pnas.75.1.99; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Beau I, 1997, J BIOL CHEM, V272, P5241, DOI 10.1074/jbc.272.8.5241; BERLIN CM, 1965, MOL PHARMACOL, V1, P149; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEUNG AH, 1990, MOL PHARMACOL, V37, P775; Dhanwada KR, 1996, MOL ENDOCRINOL, V10, P544, DOI 10.1210/me.10.5.544; Fabritz J, 1998, BIOCHEMISTRY-US, V37, P664, DOI 10.1021/bi972355+; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; HIPKIN RW, 1993, MOL ENDOCRINOL, V7, P823, DOI 10.1210/me.7.7.823; HIPKIN RW, 1995, MOL ENDOCRINOL, V9, P151, DOI 10.1210/me.9.2.151; HIPKIN RW, 1992, MOL ENDOCRINOL, V6, P2210, DOI 10.1210/me.6.12.2210; HOELSCHER SR, 1991, ENDOCRINOLOGY, V128, P2837, DOI 10.1210/endo-128-6-2837; HUNYADY L, 1995, J BIOL CHEM, V270, P9702, DOI 10.1074/jbc.270.17.9702; HUNYADY L, 1994, J BIOL CHEM, V269, P24798; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kosugi S, 1996, J BIOL CHEM, V271, P31813, DOI 10.1074/jbc.271.50.31813; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Latronico AC, 1998, J CLIN ENDOCR METAB, V83, P2435, DOI 10.1210/jc.83.7.2435; LAUE L, 1995, P NATL ACAD SCI USA, V92, P1906, DOI 10.1073/pnas.92.6.1906; Lazari RDM, 1998, J BIOL CHEM, V273, P18316, DOI 10.1074/jbc.273.29.18316; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LLOYD CE, 1983, J CELL BIOL, V96, P521, DOI 10.1083/jcb.96.2.521; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; REN Q, 1993, J BIOL CHEM, V268, P16483; ROCHE PC, 1985, LUTEINIZING HORMONE, P17; SANCHEZYAGUE J, 1993, ENDOCRINOLOGY, V132, P1007, DOI 10.1210/en.132.3.1007; SEGALOFF DL, 1981, J BIOL CHEM, V256, P1420; SEGALOFF DL, 1993, ENDOCR REV, V14, P324, DOI 10.1210/er.14.3.324; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; SHENKER A, 1998, G PROTEINS DIS, P139; SZEKERS PG, 1997, MOL PHARM, V53, P759; VANAILUUTHI MT, 1992, BIOCHEMISTRY-US, V31, P8377; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; WANG H, 1991, J BIOL CHEM, V266, P780; Wang Z, 1997, MOL ENDOCRINOL, V11, P183, DOI 10.1210/me.11.2.183; Wang Z, 1996, MOL ENDOCRINOL, V10, P748, DOI 10.1210/me.10.6.748; WESTPHAL RS, 1995, MOL PHARMACOL, V48, P200; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; WILEY HS, 1982, J BIOL CHEM, V257, P4222; WILEY HS, 1981, CELL, V25, P433, DOI 10.1016/0092-8674(81)90061-1; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005; ZHU HY, 1995, MOL ENDOCRINOL, V9, P141, DOI 10.1210/me.9.2.141	53	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34911	34919		10.1074/jbc.273.52.34911	http://dx.doi.org/10.1074/jbc.273.52.34911			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857020	hybrid			2022-12-27	WOS:000077719700038
J	Price-Schiavi, SA; Carraway, CAC; Fregien, N; Carraway, KL				Price-Schiavi, SA; Carraway, CAC; Fregien, N; Carraway, KL			Post-transcriptional regulation of a milk membrane protein, the sialomucin complex (ascites sialoglycoprotein (ASGP)-1/ASGP-2, Rat Muc4), by transforming growth factor beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; RECONSTITUTED BASEMENT-MEMBRANE; CASEIN GENE-EXPRESSION; ADENOCARCINOMA CELLS; MOLECULAR-CLONING; ALVEOLAR MORPHOGENESIS; EXTRACELLULAR-MATRIX; GLYCOPROTEIN COMPLEX; TRANSGENIC MICE; DIFFERENTIATION	Sialomucin complex (SMC, Rat Muc4) is a heterodimeric glycoprotein complex consisting of a mucin subunit ASGP-1 (ascites sialoglycoprotein-1) and a transmembrane subunit ASGP-8, which can act as a ligand for the receptor tyrosine kinase ErbB2. SMC is highly expressed on the surface of ascites 13762 rat mammary adenocarcinoma cells, approximately 100 times the level in lactating mammary gland and 10(4) times that in virgin mammary gland. SMC is sharply increased at mid-pregnancy in a manner similar to beta-casein. Unlike beta-casein, SMC appears to be regulated posttranscriptionally. Its transcript is present in both virgin and pregnant mammary tissue, and SMC synthesis is induced rapidly in cultured primary mammary epithelial cells from either normal pregnant or virgin rats. SMC protein, but not transcript, levels are significantly reduced when mammary cells are cultured in Matrigel, a reconstituted basement membrane which stimulates casein expression. SMC precursor is synthesized in Matrigel at a 10-fold lower rate. Matrigel has no effect on either the level of SMC or its transcript in cultured 13762 mammary tumor cells. The Matrigel effect on primary mammary and 13762 cells is mimicked by transforming growth factor beta, a component associated with this complex matrix. These results indicate that SMC is a novel product of normal mammary gland and milk, which is post-transcriptionally regulated by transforming growth factor beta in normal mammary gland, but not in 13762 mammary adenocarcinoma cells.	Univ Miami, Sch Med, Dept Cell Biol & Anat, Miami, FL 33101 USA; Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami; University of Miami	Carraway, KL (corresponding author), Univ Miami, Sch Med, Dept Cell Biol R124, POB 016960, Miami, FL 33101 USA.				NATIONAL CANCER INSTITUTE [R01CA052498, P30CA014395] Funding Source: NIH RePORTER; NCI NIH HHS [CA52498, CA14395] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGGELER J, 1991, J CELL SCI, V99, P407; BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223; CARRAWAY K L, 1991, Glycobiology, V1, P131, DOI 10.1093/glycob/1.2.131; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; CARRAWAY KL, 1979, J CELL BIOL, V83, P529, DOI 10.1083/jcb.83.3.529; CARRAWAY KL, 1986, MOL CELL BIOCHEM, V72, P109; CHEN LH, 1989, CELL REGUL, V1, P45, DOI 10.1091/mbc.1.1.45; Daniel C. W., 1987, The mammary gland. Development, regulation, and function., P3; DARCY KM, 1991, EXP CELL RES, V196, P49, DOI 10.1016/0014-4827(91)90455-4; EMERMAN JT, 1977, P NATL ACAD SCI USA, V74, P4466, DOI 10.1073/pnas.74.10.4466; HOWARD SC, 1982, JNCI-J NATL CANCER I, V69, P33; HULL SR, 1990, BIOCHEM J, V265, P121, DOI 10.1042/bj2650121; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; Juang SH, 1996, ONCOGENE, V12, P1033; Komatsu M, 1997, J BIOL CHEM, V272, P33245, DOI 10.1074/jbc.272.52.33245; LEE EYH, 1984, J CELL BIOL, V98, P146, DOI 10.1083/jcb.98.1.146; LEE EYHP, 1985, P NATL ACAD SCI USA, V82, P1419, DOI 10.1073/pnas.82.5.1419; LI ML, 1987, P NATL ACAD SCI USA, V84, P136, DOI 10.1073/pnas.84.1.136; LIN CQ, 1995, J CELL BIOL, V129, P1115, DOI 10.1083/jcb.129.4.1115; LIN CQ, 1993, FASEB J, V7, P737, DOI 10.1096/fasebj.7.9.8330681; McNeer RR, 1998, J CELL PHYSIOL, V176, P110, DOI 10.1002/(SICI)1097-4652(199807)176:1<110::AID-JCP13>3.3.CO;2-U; McNeer RR, 1998, BIOCHEM J, V330, P737, DOI 10.1042/bj3300737; MCNEER RR, 1997, THESIS U MIAMI; MCNEER RR, 1997, FRONT BIOSCI, V2, P449; MERCIER JC, 1993, J DAIRY SCI, V76, P3079, DOI 10.3168/jds.S0022-0302(93)77647-X; Mieth M, 1990, GROWTH FACTORS, V4, DOI 10.3109/08977199009011005; Nollet S, 1998, BIOCHEM J, V332, P739, DOI 10.1042/bj3320739; PITTIUS CW, 1988, MOL ENDOCRINOL, V2, P1027, DOI 10.1210/mend-2-11-1027; PORCHET N, 1991, BIOCHEM BIOPH RES CO, V175, P414, DOI 10.1016/0006-291X(91)91580-6; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; ROBINSON SD, 1993, J CELL BIOL, V120, P245, DOI 10.1083/jcb.120.1.245; Rossi EA, 1996, J BIOL CHEM, V271, P33476, DOI 10.1074/jbc.271.52.33476; ROSSI EA, 1996, THESIS U MIAMI; SAKAKURA T, 1982, REGULATORY MECH BREA, P383; SHENG Z, 1990, J BIOL CHEM, V265, P8505; SHENG ZQ, 1992, J BIOL CHEM, V267, P16341; SHERBLOM AP, 1980, J BIOL CHEM, V255, P2051; SHERBLOM AP, 1980, J BIOL CHEM, V255, P783; STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; TAKETANI Y, 1983, P NATL ACAD SCI-BIOL, V80, P1646, DOI 10.1073/pnas.80.6.1646; TAKETANI Y, 1983, FEBS LETT, V152, P256, DOI 10.1016/0014-5793(83)80391-3; TOPPER YJ, 1980, PHYSIOL REV, V60, P1049, DOI 10.1152/physrev.1980.60.4.1049; WU K, 1994, J BIOL CHEM, V269, P11950	44	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35228	35237		10.1074/jbc.273.52.35228	http://dx.doi.org/10.1074/jbc.273.52.35228			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857062	hybrid			2022-12-27	WOS:000077719700080
J	Tsukuba, T; Bond, JS				Tsukuba, T; Bond, JS			Role of the COOH-terminal domains of meprin A in folding, secretion, and activity of the metalloendopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; ENDOPLASMIC-RETICULUM; ALPHA-SUBUNIT; CHROMOSOMAL LOCALIZATION; SUBSTRATE-SPECIFICITY; BETA-SUBUNIT; RAT MEPRIN; MAM DOMAIN; DEGRADATION; EXPRESSION	Secreted forms of the cu subunit of recombinant mouse meprin A include an NH2-terminal prosequence, a catalytic domain, and three COOH-terminal domains designated as MAM (meprin, A-5 protein, receptor protein-tyrosine phosphatase mu), MATH (meprin and TRAF homology), and AM (after MATH). In this study, the importance of these COOH-terminal domains for biosynthesis of secreted, activable forms of the protease was investigated. Transcripts of the meprin subunit truncated after the protease (alpha(1-275)), MAM (alpha(1-452)), and MATH (alpha(1-528)) domains or with individual domains deleted (Delta MAM, Delta MATH, and Delta AM), were transfected into human embryonic kidney 293 cells. The wild-type subunit, Delta MATH, Delta AM, alpha(1-452), and alpha(1-528) were secreted into the media, although the Delta AM mutant was secreted at very low levels. The Delta MATH and alpha(1-452) mutants were not activable by Limited proteolysis. The alpha(1-528) mutant was as active as wild-type meprin cu against a bradykinin substrate, but had no activity against azocasein, and it, as all other mutants, was more vulnerable to extensive degradation by proteases than the wild-type protein. Pulse-chase experiments revealed that the Delta MAM and alpha(1-275) mutants were rapidly degraded within cells. Treatment with lactacystin, a specific inhibitor of the proteasome, significantly decreased the degradation, indicating that the mutants lacking the MAM domain are degraded by the proteasome as misfolded proteins. These results indicate that the MAM domain is necessary for correct folding and transport through the secretory pathway, the MATH domain is required for folding of an activable zymogen, and the AM domain is important for activity against proteins and efficient secretion of the protein. The work demonstrates the interdependence of the domains for correct folding of an activable, stable, mature enzyme.	Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Bond, JS (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.		Tsukuba, Takayuki/I-9542-2018	Tsukuba, Takayuki/0000-0003-3322-1339	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019691, R37DK019691, R56DK019691] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 19691] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BECKMANN G, 1993, TRENDS BIOCHEM SCI, V18, P40, DOI 10.1016/0968-0004(93)90049-S; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Chestukhin A, 1997, J BIOL CHEM, V272, P3153, DOI 10.1074/jbc.272.6.3153; Chevallier S, 1996, BIOCHEM J, V317, P731, DOI 10.1042/bj3170731; Dietrich JM, 1996, J BIOL CHEM, V271, P2271, DOI 10.1074/jbc.271.4.2271; DUMERMUTH E, 1993, FEBS LETT, V335, P367, DOI 10.1016/0014-5793(93)80421-P; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; GORBEA CM, 1993, J BIOL CHEM, V268, P21035; Hahn D, 1997, EUR J BIOCHEM, V247, P933, DOI 10.1111/j.1432-1033.1997.00933.x; HIGUCH, 1990, PCR PROTOCOLS GUIDE, P177; JIANG WP, 1993, J BIOL CHEM, V268, P10380; JIANG WP, 1992, J BIOL CHEM, V267, P9185; Johnson GD, 1997, J BIOL CHEM, V272, P28126, DOI 10.1074/jbc.272.44.28126; JOHNSON GD, 1992, J BIOL CHEM, V267, P13505; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Marchand P, 1996, J BIOL CHEM, V271, P24236, DOI 10.1074/jbc.271.39.24236; MARCHAND P, 1994, J BIOL CHEM, V269, P15388; MARCHAND P, 1995, J BIOL CHEM, V270, P5449, DOI 10.1074/jbc.270.10.5449; McGee TP, 1996, J BIOL CHEM, V271, P25630, DOI 10.1074/jbc.271.41.25630; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; STEINER DF, 1992, J BIOL CHEM, V267, P23435; STOCKER W, 1995, PROTEIN SCI, V4, P823; Tang J, 1998, ARCH BIOCHEM BIOPHYS, V349, P192, DOI 10.1006/abbi.1997.0453; Uren AG, 1996, TRENDS BIOCHEM SCI, V21, P244, DOI 10.1016/S0968-0004(96)30022-4; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WOLZ RL, 1995, METHOD ENZYMOL, V248, P325; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; ZONDAG GCM, 1995, J BIOL CHEM, V270, P14247, DOI 10.1074/jbc.270.24.14247	38	42	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35260	35267		10.1074/jbc.273.52.35260	http://dx.doi.org/10.1074/jbc.273.52.35260			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857066	hybrid			2022-12-27	WOS:000077719700084
J	Bannenberg, G; Dahlen, SE; Luijerink, M; Lundqvist, G; Morgenstern, R				Bannenberg, G; Dahlen, SE; Luijerink, M; Lundqvist, G; Morgenstern, R			Leukotriene C-4 is a tight-binding inhibitor of microsomal glutathione transferase-1 - Effects of leukotriene pathway modifiers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-LIPOXYGENASE ACTIVATING PROTEIN; S-TRANSFERASE; RAT; IDENTIFICATION; SYNTHASE; SUBSTRATE; PURIFICATION; ANTAGONIST; POTENT; ENZYME	Microsomal glutathione transferase-1 (MGST-1) is an abundant protein that catalyzes the conjugation of electrophilic compounds with glutathione, as well as the reduction of lipid hydroperoxides, Here we report that leukotriene C-4 is a potent inhibitor of MGST-1. Leukotriene C-4 was found to be a tight-binding inhibitor, with a K-i of 5.4 nM for the unactivated enzyme, and 9.2 nM for the N-ethylmaleimide activated enzyme, This is the first tight-binding inhibitor characterized for this enzyme, Leukotriene C-4 was competitive with respect to glutathione and non-competitive toward the second substrate, CDNB, Analysis of stoichiometry supports binding of one molecule of inhibitor per homotrimer, Leukotrienes A(4), D-4, and E-4 were much weaker inhibitors of the purified enzyme (by at least 3 orders of magnitude), Leukotriene C-4 analogues, which have been developed as antagonists of leukotriene receptors, were found to display varying degrees of inhibition of MGST-1, In particular, the cysteinyl-leukotriene analogues SKF 104,353, ONO-1078, and BAYu9773 were strong inhibitors (IC50 values: 0.13, 3.7, and 7.6 mu M, respectively), In view of the partial structural similarity between MGST-1, leukotriene C-4 synthase, and 5-lipoxygenase activating protein (FLAP), it was of interest that leukotriene C-4 synthesis inhibitors (which antagonize FLAP) also displayed significant inhibition (e.g. IC50 for BAYx1005 was 58 mu M). In contrast, selective 5-lipoxygenase inhibitors such as zileuton only marginally inhibited activity at high concentrations (500 mu M). Our discovery that leukotriene C-4 and drugs developed based on its structure are potent inhibitors of MGST-1 raises the possibility that MGST-1 influences the cellular processing of leukotrienes. These findings may also have implications for the effects and side-effects of drugs developed to manipulate leukotrienes.	Karolinska Inst, Inst Environm Med, Div Biochem Toxicol, SE-17177 Stockholm, Sweden; Karolinska Inst, Inst Environm Med, Div Expt Asthma & Allergy Res, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Morgenstern, R (corresponding author), Karolinska Inst, Inst Environm Med, Div Biochem Toxicol, Box 210, SE-17177 Stockholm, Sweden.		Morgenstern, Ralf/GZH-0158-2022; Bannenberg, Gerard/AAF-6216-2020	Bannenberg, Gerard/0000-0001-7763-6224				ANDERS MW, 1994, ADV PHARM, V27; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BACH MK, 1987, BIOCHEM PHARMACOL, V36, P1461, DOI 10.1016/0006-2952(87)90111-0; Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9; COTGREAVE IA, 1986, J BIOCHEM BIOPH METH, V13, P231, DOI 10.1016/0165-022X(86)90102-8; DEJONG JL, 1988, J BIOL CHEM, V263, P8430; DIXON M, 1972, BIOCHEM J, V129, P197, DOI 10.1042/bj1290197; FORDHUTCHINSON AW, 1994, ANN NY ACAD SCI, V744, P78, DOI 10.1111/j.1749-6632.1994.tb52725.x; GOFFINET AM, 1989, EUR J PHARMACOL, V161, P99, DOI 10.1016/0014-2999(89)90186-6; HAY DWP, 1987, J PHARMACOL EXP THER, V243, P474; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HEBERT H, 1995, EMBO J, V14, P3864, DOI 10.1002/j.1460-2075.1995.tb00058.x; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; HOLGATE ST, 1997, SRS LEUKOTRIENES DAW; Jakobsson PJ, 1997, J BIOL CHEM, V272, P22934, DOI 10.1074/jbc.272.36.22934; Jakobsson PJ, 1996, J BIOL CHEM, V271, P22203, DOI 10.1074/jbc.271.36.22203; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIER I, 1994, J BIOL CHEM, V269, P27807; M PG, 1995, ADV DRUG METABOLISM, P407; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; METTERS KM, 1994, J BIOL CHEM, V269, P12816; MORGENSTERN R, 1979, BIOCHEM BIOPH RES CO, V87, P657, DOI 10.1016/0006-291X(79)92009-6; MORGENSTERN R, 1989, BIOCHEM J, V260, P577, DOI 10.1042/bj2600577; MORGENSTERN R, 1982, EUR J BIOCHEM, V128, P243; MORGENSTERN R, 1983, EUR J BIOCHEM, V134, P591, DOI 10.1111/j.1432-1033.1983.tb07607.x; MORGENSTERN R, 1988, J BIOL CHEM, V263, P6671; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; MOSIALOU E, 1995, ARCH BIOCHEM BIOPHYS, V320, P210, DOI 10.1016/0003-9861(95)90002-0; MOSIALOU E, 1993, BIOCHEM PHARMACOL, V45, P1645, DOI 10.1016/0006-2952(93)90305-G; PETERSGOLDEN M, 1993, BIOCHEM BIOPH RES CO, V196, P147, DOI 10.1006/bbrc.1993.2227; SNYDER DW, 1987, J PHARMACOL EXP THER, V243, P548; SODERSTROM M, 1995, PROTEIN EXPRES PURIF, V6, P352, DOI 10.1006/prep.1995.1046; SUN FF, 1986, J BIOL CHEM, V261, P8540; Sun TH, 1997, BIOCHEM J, V326, P193, DOI 10.1042/bj3260193; Surapureddi S, 1996, BIOCHEM BIOPH RES CO, V229, P388, DOI 10.1006/bbrc.1996.1815; WEINANDER R, 1994, J BIOL CHEM, V269, P71; WEINANDER R, 1996, GLUTATHIONE S TRANSF, P49; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935	38	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1994	1999		10.1074/jbc.274.4.1994	http://dx.doi.org/10.1074/jbc.274.4.1994			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890956	hybrid			2022-12-27	WOS:000078185200023
J	Greenfield, B; Wang, WC; Marquardt, H; Piepkorn, M; Wolff, EA; Aruffo, A; Bennett, KL				Greenfield, B; Wang, WC; Marquardt, H; Piepkorn, M; Wolff, EA; Aruffo, A; Bennett, KL			Characterization of the heparan sulfate and chondroitin sulfate assembly sites in CD44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE RECEPTOR; BREFELDIN-A; DIRECTED MUTAGENESIS; PROTEOGLYCAN; BIOSYNTHESIS; BINDING; MIGRATION; EXONS; V3	Isoforms of CD44 are differentially modified by the glycosaminoglycans (GAGs) chondroitin sulfate (CS), heparan sulfate (HS), and keratan sulfate. GAG assembly occurs at serines followed by glycines (SG), but not all SG are utilized. Seven SG motifs are distributed in five CD44 exons, and in this paper we identify the HS and CS assembly sites that are utilized in CD44. Not. all the CD44 SG sites are modified. The SGSG motif in CD44 exon V3 is the only HS assembly site; this site is also modified with CS, HS and CS attachment at that site was eliminated by mutation of the serines in the V3 motif to alanine (AGAG), Exon E5 is the only other CD44 exon that supports GAG assembly and is modified with CS. Using a number of recombinant CD44 protein fragments we show herein that the eight amino acids located downstream of the SGSG site in V3 are responsible for the specific addition of HS to this site. If the eight amino acids located downstream from the first SIG site in CD44 exon E5 are exchanged with those located downstream of the SGSG site in exon V3, the SG site in E5 becomes modified with HS and CS, Likewise if the eight amino acids found downstream from the first SG in E5 are placed downstream from the SGSG in V3, this site is modified with CS but not HS. We also show that these sequences cannot direct the modification of CD44 with; HS from a distance. Constructs containing CD44 exon V3 in which the SGSG motif was mutated to AGAG were not modified with HS even though they contained other SG motifs. Thus, a number of sequence and structural requirements that dictate GAG synthesis on CD44 have been identified.	Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ 08543 USA; Univ Washington, Dept Dermatol, Seattle, WA 98105 USA	Bristol-Myers Squibb; University of Washington; University of Washington Seattle	Bennett, KL (corresponding author), Bristol Myers Squibb Pharmaceut Res Inst, POB 4000, Princeton, NJ 08543 USA.	bennettk@bms.com			NIAMS NIH HHS [AR 21557] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BENNETT KL, 1995, J CELL BIOL, V131, P1623, DOI 10.1083/jcb.131.6.1623; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; FRANSSON LA, 1992, BIOCHIM BIOPHYS ACTA, V1137, P287, DOI 10.1016/0167-4889(92)90149-6; FRITZ TA, 1994, J BIOL CHEM, V269, P300; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; HARDY MR, 1989, METHOD ENZYMOL, V179, P76; Henke CA, 1996, J CLIN INVEST, V97, P2541, DOI 10.1172/JCI118702; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; KINSELLA MG, 1986, J CELL BIOL, V102, P679, DOI 10.1083/jcb.102.3.679; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; MANN DM, 1990, J BIOL CHEM, V265, P5317; MARESH GA, 1994, ARCH BIOCHEM BIOPHYS, V311, P95, DOI 10.1006/abbi.1994.1213; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; Piepkorn M, 1997, BIOCHEM J, V327, P499, DOI 10.1042/bj3270499; SPIRO RC, 1991, J CELL BIOL, V115, P1463, DOI 10.1083/jcb.115.5.1463; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; UHLINHANSEN L, 1993, J BIOL CHEM, V268, P17370; Wolff EA, 1999, J BIOL CHEM, V274, P2518, DOI 10.1074/jbc.274.4.2518; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295; ZHANG LJ, 1995, J BIOL CHEM, V270, P27127, DOI 10.1074/jbc.270.45.27127	23	58	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2511	2517		10.1074/jbc.274.4.2511	http://dx.doi.org/10.1074/jbc.274.4.2511			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891022	hybrid			2022-12-27	WOS:000078185200089
J	Nicodeme, E; Benoist, F; McLeod, R; Yao, ZM; Scott, J; Shoulders, CC; Grand-Perret, T				Nicodeme, E; Benoist, F; McLeod, R; Yao, ZM; Scott, J; Shoulders, CC; Grand-Perret, T			Identification of domains in apolipoprotein B100 that confer a high requirement for the microsomal triglyceride transfer protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; B-CONTAINING LIPOPROTEINS; HEPG2 CELLS; ENDOPLASMIC-RETICULUM; IMMUNOELECTRON MICROSCOPY; LIPID RECRUITMENT; MCA-RH7777 CELLS; HEPATOMA-CELLS; MESSENGER-RNA; SECRETION	The microsomal triglyceride transfer protein (MTP) is required for the assembly and secretion of apoB-containing lipoproteins, To investigate the role of MTP in lipoprotein assembly, we determined the ability of carboxyl-terminally truncated forms of apoB to be secreted from cells treated with the MTP inhibitor 4'-bromo-3'-methylmetaqualone (Benoist, F., Nicodeme, E., and Grand-Ferret, T. (1996) Eur. J. Biochem. 240, 713-720). In Caco-2 and mhAT3F cells that produce apoB100 and apoB48, the inhibitor preferentially blocked apoB100 secretion. When the inhibitor was tested on McARH7777 cells stably transfected with cDNAs encoding human apoB100, apoB72, apoB53, apoB29, and apoB18, the secretion of apoB100, apoB72, and apoB53 was preferentially impaired relative to apoB48 and shorter forms. To delineate the region between apoB48 and apoB53 that has a high requirement for MTP, we used puromycin to generate a range of truncated forms of apoB in HepG2 cells. The secretion of apoB53 and longer forms of apoB was markedly affected by low concentrations of the MTP inhibitor (similar to 1 mu M), whereas apoB51 and smaller forms of apoB were only affected at higher concentrations (> 10 mu M). The size-related sensitivity to MTP inhibitor was not due to late processing or retention, since the same result was observed when nascent lipoproteins were isolated from the endoplasmic reticulum. The MTP inhibitor did not alter the density of the secreted lipoproteins, indicating that each apoB polypeptide requires a minimally defined amount of lipid to attain a secretable conformation, Our results suggest that the folding of the domain between apoB51 and apoB53 has a high requirement for lipid, This domain is predicted to form amphipathic alpha-helices and to bind lipid reversibly, It proceeds and is followed by rigid amphipathic beta-sheets that are predicted to associate with lipid irreversibly, We speculate that these domains enable apoB to switch from a stable lipid-poor conformation in apoB48 to another lipid-rich conformation in apoB100 during lipoprotein assembly.	Lab Glaxo Wellcome, Ctr Rech, F-91951 Les Ulis, France; Univ Ottawa, Inst Heart, Lipoprot & Atherosclerosis Grp, Ottawa Civic Hosp, Ottawa, ON K1Y 4E9, Canada; Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Mol Med Grp, London W12 0NN, England	GlaxoSmithKline; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa Heart Institute; Imperial College London	Grand-Perret, T (corresponding author), Lab Glaxo Wellcome, Ctr Rech, 25 Ave Quebec,ZA Courtaboeuf, F-91951 Les Ulis, France.	tgp28876@GlaxoWellcome.co.uk	McLeod, Roger/F-8014-2015	McLeod, Roger/0000-0002-6740-5569				ANTOINE B, 1992, EXP CELL RES, V200, P175, DOI 10.1016/S0014-4827(05)80086-2; BELLQUINT J, 1981, BIOCHEM BIOPH RES CO, V99, P700, DOI 10.1016/0006-291X(81)91800-3; Benoist F, 1996, EUR J BIOCHEM, V240, P713, DOI 10.1111/j.1432-1033.1996.0713h.x; BENOIST F, 1995, J LIPID RES, V36, P2243; Benoist F, 1997, J BIOL CHEM, V272, P20435, DOI 10.1074/jbc.272.33.20435; BONNARDEL JA, 1995, J BIOL CHEM, V270, P28892, DOI 10.1074/jbc.270.48.28892; BOREN J, 1992, J BIOL CHEM, V267, P9858; BOREN J, 1994, J BIOL CHEM, V269, P25879; CHAN L, 1992, J BIOL CHEM, V267, P25621; CHATTERTON JE, 1995, J LIPID RES, V36, P2027; CHATTERTON JE, 1991, J BIOL CHEM, V266, P5955; Chauhan V, 1998, BIOCHEMISTRY-US, V37, P3735, DOI 10.1021/bi9718853; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; DELOOF H, 1987, J LIPID RES, V28, P1445; ELLSWORTH JL, 1986, J LIPID RES, V27, P858; FISCHER EA, 1997, J BIOL CHEM, V272, P20424; Gibbons Geoffrey F., 1994, Current Opinion in Lipidology, V5, P191, DOI 10.1097/00041433-199405030-00006; GIBBONS GF, 1994, J LIPID RES, V35, P1801; GORDON DA, 1994, P NATL ACAD SCI USA, V91, P7628, DOI 10.1073/pnas.91.16.7628; Gordon DA, 1997, CURR OPIN LIPIDOL, V8, P131, DOI 10.1097/00041433-199706000-00002; Gordon DA, 1996, J BIOL CHEM, V271, P33047, DOI 10.1074/jbc.271.51.33047; GRANHAM DL, 1991, BIOCHEMISTRY-US, V30, P5616; Gretch DG, 1996, J BIOL CHEM, V271, P8682, DOI 10.1074/jbc.271.15.8682; Haghpassand M, 1996, J LIPID RES, V37, P1468; Jamil H, 1998, J LIPID RES, V39, P1448; JANERO DR, 1983, J BIOL CHEM, V258, P4496; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIPER JM, 1994, J BIOL CHEM, V269, P21951; LEVRAT F, 1993, EXP CELL RES, V209, P307, DOI 10.1006/excr.1993.1315; LINTON MF, 1993, J LIPID RES, V34, P521; McLeod RS, 1996, J BIOL CHEM, V271, P18445, DOI 10.1074/jbc.271.31.18445; MCLEOD RS, 1994, J BIOL CHEM, V269, P2852; Mehran M, 1997, IN VITRO CELL DEV-AN, V33, P118; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; Patel SB, 1996, J BIOL CHEM, V271, P18686, DOI 10.1074/jbc.271.31.18686; PEASE RJ, 1990, J BIOL CHEM, V265, P553; PEASE RJ, 1991, NATURE, V353, P448, DOI 10.1038/353448a0; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; RICCI B, 1995, J BIOL CHEM, V270, P14281, DOI 10.1074/jbc.270.24.14281; SAKATA N, 1993, J BIOL CHEM, V268, P22967; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674, DOI 10.1161/01.ATV.14.10.1674; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; Shelness GS, 1996, J LIPID RES, V37, P408; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; SPRING DJ, 1992, J LIPID RES, V33, P233; SPRING DJ, 1992, J BIOL CHEM, V267, P14839; SWIFT LL, 1995, J LIPID RES, V36, P395; Tran K, 1998, J BIOL CHEM, V273, P7244, DOI 10.1074/jbc.273.13.7244; van Greevenbroek MMJ, 1998, J LIPID RES, V39, P173; Wang S, 1996, J BIOL CHEM, V271, P14124, DOI 10.1074/jbc.271.24.14124; Wang YW, 1997, J BIOL CHEM, V272, P12272, DOI 10.1074/jbc.272.19.12272; WETTERAU JR, 1992, SCIENCE, V258, P999; YANG CY, 1990, P NATL ACAD SCI USA, V87, P5523, DOI 10.1073/pnas.87.14.5523; YANG CY, 1989, ARTERIOSCLEROSIS, V9, P96, DOI 10.1161/01.ATV.9.1.96; YAO ZM, 1991, J BIOL CHEM, V266, P3300; YOUNG SG, 1990, CIRCULATION, V80, P219	57	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1986	1993		10.1074/jbc.274.4.1986	http://dx.doi.org/10.1074/jbc.274.4.1986			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890955	hybrid			2022-12-27	WOS:000078185200022
J	Kuze, K; Graves, P; Leahy, A; Wilson, P; Stuhlmann, H; You, GF				Kuze, K; Graves, P; Leahy, A; Wilson, P; Stuhlmann, H; You, GF			Heterologous expression and functional characterization of a mouse renal organic anion transporter in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; N-LINKED GLYCOSYLATION; RAT-KIDNEY; CLONING; SECRETION; CATIONS; TUBULE	Organic anion transporters play an essential role in eliminating a wide range of organic anions including endogenous compounds, xenobiotics, and their metabolites from kidney thereby preventing their potentially toxic effects within the body. The goal of this study was to extend our previous study on the functional characterization and posttranslational modification of a mouse kidney organic anion transporter (mOAT), in a mammalian cell system, COS-7 cells. The transporter-mediated p-aminohippurate (PAH) uptake was saturable, probenecid-sensitive, and inhibited by a wide range of organic anions including vitamins, antihypertensive drugs, anti-tumor drugs, and anti-inflammatory drugs, Tunicamycin, an inhibitor of asparagine-linked glycosylation, significantly inhibited the transport activity. Immunofluorescence provided evidence that most of the protein remained in the intracellular compartment in tunicamycin-treated cells. Diethyl pyrocarbonate (DEPC), a histidine residue-specific reagent, completely blocked PAH transport. The inhibitory effect by DEPC was significantly protected (90%) by pretreating the cells with excess unlabeled PAH, suggesting that the histidine residues may be close to the PAH binding sites. Finally, in situ mRNA localization was studied in postnatal mouse kidney. The expression was observed in proximal tubules throughout development. We conclude that COS-7 cells may be useful in pharmacological and molecular biological studies of this carrier. The carbohydrate moieties are necessary for the proper trafficking of mOAT to the plasma membrane, and histidine residues appear to be important for the transport function.	CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	You, GF (corresponding author), CUNY Mt Sinai Sch Med, Dept Med, 1 Gustave L Levy Pl, New York, NY 10029 USA.			Stuhlmann, Heidi/0000-0001-7217-768X				ASANO T, 1991, J BIOL CHEM, V266, P24632; Bendayan R, 1996, PHARMACOTHERAPY, V16, P971; Berndt WO, 1998, TOXICOL PATHOL, V26, P52, DOI 10.1177/019262339802600107; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER BM, 1996, KIDNEY, V8, P608; BRENNER BM, 1996, KIDNEY, V8, P1680; DEAS J, 1989, BRAIN RES, V483, P84, DOI 10.1016/0006-8993(89)90037-1; FEUGEAS JP, 1990, BIOCHIM BIOPHYS ACTA, V1030, P60, DOI 10.1016/0005-2736(90)90238-J; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HORSTER M, 1970, AM J PHYSIOL, V219, P1061, DOI 10.1152/ajplegacy.1970.219.4.1061; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; LUNDBLAD RL, 1984, CHEM REAGENTS PROTEI, V2, P1; Miles E W, 1977, Methods Enzymol, V47, P431; Moller J. V., 1983, PHARMACOL REV, V34, P315; OTT RJ, 1992, J BIOL CHEM, V267, P133; PRITCHARD JB, 1993, PHYSIOL REV, V73, P765, DOI 10.1152/physrev.1993.73.4.765; RENNICK B, 1961, AM J PHYSIOL, V201, P743, DOI 10.1152/ajplegacy.1961.201.4.743; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; SOKOL PP, 1988, J BIOL CHEM, V263, P7118; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; TATE CG, 1994, J BIOL CHEM, V269, P26303; Terada T, 1996, FEBS LETT, V394, P196, DOI 10.1016/0014-5793(96)00952-0; ULLRICH KJ, 1988, AM J PHYSIOL, V254, pF453, DOI 10.1152/ajprenal.1988.254.4.F453; ULLRICH KJ, 1987, PFLUG ARCH EUR J PHY, V409, P229, DOI 10.1007/BF00583470; Wolff NA, 1997, FEBS LETT, V417, P287, DOI 10.1016/S0014-5793(97)01304-5; YOU GF, 1993, NATURE, V365, P844, DOI 10.1038/365844a0; YUSUFI ANK, 1988, J BIOL CHEM, V263, P13683	27	61	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1519	1524		10.1074/jbc.274.3.1519	http://dx.doi.org/10.1074/jbc.274.3.1519			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880528	hybrid			2022-12-27	WOS:000079956900048
J	Lehmann, U; Brocke, P; Dittmer, J; Nordheim, A				Lehmann, U; Brocke, P; Dittmer, J; Nordheim, A			Characterization of the human elk-1 promoter - Potential role of a downstream intronic sequence for elk-1 gene expression in monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEX FACTORS; ETS TRANSCRIPTION FACTORS; MAP KINASE PATHWAYS; DNA-BINDING; DIFFERENTIATION; EXTRACTION; ACTIVATION; SIGNALS; CELLS; EGR-1	To characterize the human elk-1 promoter, we mapped the transcriptional start site and isolated elk-1-specific genomic phage clones that contained extensive upstream and downstream sequences. A TATA-like motif was identified immediately upstream of the transcriptional start site. Functional analyses of DNA fragments containing the TATA element and the identification of a DNase I-hypersensitive chromatin site (HS 1) in close proximity to the TATA box suggest that the identified TATA motif is important for elk-1 transcription in vivo, Sequences upstream and downstream from the TATA box were found to contribute to elk-1 promoter activity. A second hypersensitive site (HS 2) was identified within the first intron in pre-monocytic cells, which express Elk-1 only when differentiating to monocytes. In a variety of other cell types, which display a constitutive Elk-1 expression, HS 2 did not exist, suggesting that inducibility of elk-1 expression is associated with the presence of HS 2. Egr-1 and the serum response factor were found to interact specifically with the intronic sequence at +265 and +448, respectively. Because Egr-1 mRNA and protein levels were observed to increase significantly before induction of elk-1 expression, we propose that Egr-1 is important for the regulation of elk-1 transcription in differentiating monocytes.	Univ Tubingen, Inst Zellbiol, Mol Biol Abt, D-72076 Tubingen, Germany; Med Hsch Hannover, Inst Mol Biol, D-30623 Hannover, Germany	Eberhard Karls University of Tubingen; Hannover Medical School	Nordheim, A (corresponding author), Univ Tubingen, Inst Zellbiol, Mol Biol Abt, Morgenstelle 15, D-72076 Tubingen, Germany.		Dittmer, Juergen/G-1160-2011					ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Ausubel FM, 1988, MOL REPROD DEV; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTY B, 1989, MOL CELL BIOL, V9, P4889, DOI 10.1128/MCB.9.11.4889; DIAMOND L, 1992, CURRENT PROTOCOL S17, V1; Dittmer J, 1998, BBA-REV CANCER, V1377, pF1, DOI 10.1016/S0304-419X(97)00039-5; GHYSDAEL J, 1997, ONCOGENES TRANSCRIPT, V1, P29; GILMAN MZ, 1988, GENE DEV, V2, P394, DOI 10.1101/gad.2.4.394; HIPSKIND RA, 1994, GENE DEV, V8, P1803, DOI 10.1101/gad.8.15.1803; JANKNECHT R, 1992, NUCLEIC ACIDS RES, V20, P3317, DOI 10.1093/nar/20.13.3317; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; JANZ M, 1994, HUM GENET, V94, P442, DOI 10.1007/BF00201610; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; Sambrook J., 2002, MOL CLONING LAB MANU; SEYFERT VL, 1989, MOL CELL BIOL, V9, P2083, DOI 10.1128/MCB.9.5.2083; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; Strahl T, 1996, P NATL ACAD SCI USA, V93, P11563, DOI 10.1073/pnas.93.21.11563; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; TAKEDA K, 1982, CANCER RES, V42, P5152; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; VASYLYK B, 1993, EUR J BIOCHEM, V211, P7; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WASYLYK B, 1997, TRANSCRIPTION FACTOR, P251; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740	32	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1736	1744		10.1074/jbc.274.3.1736	http://dx.doi.org/10.1074/jbc.274.3.1736			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880555	hybrid			2022-12-27	WOS:000079956900075
J	Yue, TL; Ni, J; Romanic, AM; Gu, JL; Keller, P; Wang, CL; Kumar, S; Yu, GL; Hart, TK; Wang, XK; Xia, ZG; DeWolf, WE; Feuerstein, GZ				Yue, TL; Ni, J; Romanic, AM; Gu, JL; Keller, P; Wang, CL; Kumar, S; Yu, GL; Hart, TK; Wang, XK; Xia, ZG; DeWolf, WE; Feuerstein, GZ			TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells - Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; FAMILY PROTEASES; FACTOR-ALPHA; MAP KINASE; DEATH; EXPRESSION; ANGIOGENESIS; INHIBITOR; REQUIRES; JNK	TL1 is a recently discovered novel member of the tumor necrosis factor (TNF) cytokine family. TL1 is abundantly expressed in endothelial cells, but its function is not known. The present study was undertaken to explore whether TL1 induces apoptosis in endothelial cells and if so, to explore its mechanism of action. Cultured bovine pulmonary artery endothelial cells (BPAEC) exposed to TL1 showed morphological (including ultrastructural) and biochemical features characteristic of apoptosis. TL1-induced apoptosis in BPAEC was a time- and concentration-dependent process (EC50 = 72 ng/ml). The effect of TL1 was not inhibited by soluble TNF receptors 1 or 2. TL1 up-regulated Fas expression in BPAEC at 8 and 24 h after treatment, and significantly activated stress-activated protein kinase (SAPK) and p38 mitogen-activated protein kinase (p38 MAPK). The peak activities of SAPK and p38 MAPK in TL1-treated BPAEC were increased by 9- and 4-fold, respectively. TL1-induced apoptosis in the BPAEC was reduced by expression of a dominant-interfering mutant of c-Jun (62.8%, p < 0.05) or by a specific p38 inhibitor, SB203580 (1-10 mu M) dose-dependently. TL1 also activated caspases in BPAEC, and TL1-induced apoptosis in BPAEC was significantly attenuated by the caspase inhibitor, ZVAD-fluromethyl-ketone, The major component activated by TL1 in BPAEC was caspase 3, which was based on substrate specificity and immunocytochemical analysis. These findings suggest that TL1 may act as an autocrine factor to induce apoptosis in endothelial cells via activation of multiple signaling pathways, including stress protein kinases as well as certain caspases.	SmithKline Beecham Pharmaceut, Dept Cardiovasc Pharmacol, King Of Prussia, PA 19046 USA; SmithKline Beecham Pharmaceut, Dept Mol Recognit, King Of Prussia, PA 19046 USA; SmithKline Beecham Pharmaceut, Dept Toxicol, King Of Prussia, PA 19046 USA; SmithKline Beecham Pharmaceut, Dept Bone Cartilage, King Of Prussia, PA 19046 USA; Human Genome Sci Inc, Rockville, MD 20850 USA; Univ Washington, Dept Environm Hlth, Seattle, WA 98195 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Human Genome Sciences Inc; University of Washington; University of Washington Seattle	Yue, TL (corresponding author), SmithKline Beecham Pharmaceut, Dept Cardiovasc Pharmacol, King Of Prussia, PA 19406 USA.							BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Bryant D, 1998, CIRCULATION, V97, P1375, DOI 10.1161/01.CIR.97.14.1375; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; Karsan A, 1998, TRENDS CARDIOVAS MED, V8, P19, DOI 10.1016/S1050-1738(97)00126-6; Kumar S, 1996, J BIOL CHEM, V271, P30864, DOI 10.1074/jbc.271.48.30451; Li YG, 1997, BIOTECHNIQUES, V23, P1026, DOI 10.2144/97236bm12; MARTIN SJ, 1995, CELL, V82, P1; Martins LM, 1997, J BIOL CHEM, V272, P7421, DOI 10.1074/jbc.272.11.7421; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Ni J, 1997, J BIOL CHEM, V272, P10853; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; POLUNOVSKY VA, 1994, EXP CELL RES, V214, P584, DOI 10.1006/excr.1994.1296; Reed JC, 1996, J CELL BIOCHEM, V60, P23, DOI 10.1002/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.3.CO;2-3; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Tan KB, 1997, GENE, V204, P35, DOI 10.1016/S0378-1119(97)00509-X; THOMBERRY NA, 1992, NATURE, V356, P768; VERJEIJ M, 1995, NATURE, V380, P75; Wang JM, 1998, TRENDS CARDIOVAS MED, V8, P169, DOI 10.1016/S1050-1738(98)00006-1; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; Wilson DJ, 1996, EUR J IMMUNOL, V26, P989, DOI 10.1002/eji.1830260505; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yue TL, 1997, MOL PHARMACOL, V51, P951, DOI 10.1124/mol.51.6.951; Yue TL, 1998, J MOL CELL CARDIOL, V30, P495, DOI 10.1006/jmcc.1997.0614; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X	30	101	116	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1479	1486		10.1074/jbc.274.3.1479	http://dx.doi.org/10.1074/jbc.274.3.1479			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880523	hybrid			2022-12-27	WOS:000079956900043
J	Nuchprayoon, I; Shang, J; Simkevich, CP; Luo, ML; Rosmarin, AG; Friedman, AD				Nuchprayoon, I; Shang, J; Simkevich, CP; Luo, ML; Rosmarin, AG; Friedman, AD			An enhancer located between the neutrophil elastase and proteinase 3 promoters is activated by Sp1 and an Ets factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GA-BINDING PROTEIN; TRANSCRIPTION FACTOR; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; MURINE MYELOPEROXIDASE; CELL-DIFFERENTIATION; CD11B PROMOTER; CONTROL REGION; MYELOID CELLS; C-MYB	The adjacent neutrophil elastase, proteinase 3, and azurocidin genes encode serine proteases expressed specifically in immature myeloid cells. Subclones of a 17-kilobase (kb) murine neutrophil elastase genomic clone were assessed for their ability to stimulate the neutrophil elastase promoter in 32D cl3 myeloid cells. Region -9.3 to -7.3 kb stimulated transcription 7-fold, whereas other genomic segments were inactive. This enhancer is located in the second intron of the proteinase-3 gene and so may regulate more than one gene in the myeloid protease cluster. Deletional analysis of the enhancer identified several segments which activated the neutrophil elastase and thymidine kinase promoters 3-6-fold. The most active segment was a 220 base pair region centered at -8.6 kb, which activated transcription 31-fold. This segment contains an Sp1 consensus site, which bound Sp1, flanked by two Ets family consensus sequences, which bound PU.1, GABP, and an Ets factor present in myeloid cell extracts. Mutation of the Sp1-binding site reduced enhancer activity 8-fold in 32D cl3 cells, and mutation of either or both Ets-binding sites reduced activity 3-4-fold. Sp1 activated the distal enhancer 5-fold, GABP 8-fold, and the combination 8-fold in Schneider cells.	Johns Hopkins Univ, Ctr Oncol, Div Pediat Oncol, Baltimore, MD 21287 USA; Brown Univ, Dept Med, Div Hematol, Providence, RI 02906 USA; Miriam Hosp, Div Hematol Oncol, Providence, RI 02906 USA	Johns Hopkins University; Johns Hopkins Medicine; Brown University; Lifespan Health Rhode Island; Miriam Hospital	Friedman, AD (corresponding author), Johns Hopkins Univ, Ctr Oncol, Div Pediat Oncol, Rm 3-109,600 N Wolfe St, Baltimore, MD 21287 USA.			Nuchprayoon, Issarang/0000-0002-4014-5082	NHLBI NIH HHS [HL51388] Funding Source: Medline; NIDDK NIH HHS [R29DK44728] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK044728] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHNE B, 1994, J BIOL CHEM, V269, P17794; Baum C, 1997, J VIROL, V71, P6323, DOI 10.1128/JVI.71.9.6323-6331.1997; Belaaouaj K, 1997, MAMM GENOME, V8, P5, DOI 10.1007/s003359900337; BOTTINGER EP, 1994, MOL CELL BIOL, V14, P2604; CARTER RS, 1994, J BIOL CHEM, V269, P4381; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P1006, DOI 10.1093/nar/22.6.1006; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN HM, 1993, J BIOL CHEM, V268, P8230; Costa MW, 1996, BIOCHEMISTRY-US, V35, P8662, DOI 10.1021/bi952801y; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DITTMER J, 1994, J BIOL CHEM, V269, P21428; Ford AM, 1996, P NATL ACAD SCI USA, V93, P10838, DOI 10.1073/pnas.93.20.10838; FOURET P, 1989, J EXP MED, V169, P833, DOI 10.1084/jem.169.3.833; Friedman AD, 1996, CURR TOP MICROBIOL, V211, P149; Friedman AD, 1996, LEUKEMIA RES, V20, P809, DOI 10.1016/S0145-2126(96)00035-5; FRIEDMAN AD, 1991, BLOOD, V78, P2426; GEGONNE A, 1993, EMBO J, V12, P1169, DOI 10.1002/j.1460-2075.1993.tb05758.x; GOLDHAMER DJ, 1992, SCIENCE, V256, P538, DOI 10.1126/science.1315077; HAMANN L, 1994, MOL CELL BIOL, V14, P5786, DOI 10.1128/MCB.14.9.5786; Heydemann A, 1996, MOL CELL BIOL, V16, P1676; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; Nuchprayoon I, 1997, BLOOD, V89, P4546, DOI 10.1182/blood.V89.12.4546; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; Olsen J, 1997, BIOCHEM J, V322, P899, DOI 10.1042/bj3220899; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; POGULIS RJ, 1993, J BIOL CHEM, V268, P2493; ROSMARIN AG, 1989, BLOOD, V73, P131; ROSMARIN AG, 1995, P NATL ACAD SCI USA, V92, P801, DOI 10.1073/pnas.92.3.801; ROSMARIN AG, 1995, J BIOL CHEM, V270, P23627, DOI 10.1074/jbc.270.40.23627; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; SADASIVAN E, 1994, J BIOL CHEM, V269, P4725; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SAGOH T, 1988, ARCH BIOCHEM BIOPHYS, V262, P599, DOI 10.1016/0003-9861(88)90411-0; SAVAGNER P, 1995, DNA CELL BIOL, V14, P501, DOI 10.1089/dna.1995.14.501; SCHAUFELE F, 1990, J BIOL CHEM, V265, P17189; Sturrock A, 1996, J BIOL CHEM, V271, P32392, DOI 10.1074/jbc.271.50.32392; TAKAHASHI H, 1988, J BIOL CHEM, V263, P2543; VALTIERI M, 1987, J IMMUNOL, V138, P3829; VANZONNEVELD AJ, 1988, P NATL ACAD SCI USA, V85, P5525; YOSHIMURA K, 1992, BLOOD, V79, P2733; ZHANG DE, 1994, J IMMUNOL, V153, P3276; ZHANG DE, 1994, J BIOL CHEM, V269, P11425; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; ZIMMER M, 1992, P NATL ACAD SCI USA, V89, P8215, DOI 10.1073/pnas.89.17.8215	45	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1085	1091		10.1074/jbc.274.2.1085	http://dx.doi.org/10.1074/jbc.274.2.1085			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873055	hybrid			2022-12-27	WOS:000077968500070
J	Williger, BT; Ho, WT; Exton, JH				Williger, BT; Ho, WT; Exton, JH			Phospholipase D mediates matrix metalloproteinase-9 secretion in phorbol ester-stimulated human fibrosarcoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; ARF PROTEINS; PURIFICATION; ACTIVATION; TRANSPORT; COLLAGEN; REQUIRES; COATOMER; BINDING; TUMOR	Phospholipase D (PLD) has been implicated in vesicle trafficking in the Golgi and hence secretion. In this study, we show that the secretion of matrix metalloproteinase-9 (MMP-9) from HT 1080 human fibrosarcoma cells was stimulated by phorbol 12-myristate 13-acetate in a time- and dose dependent manner that involved protein kinase C. The phorbol ester also increased PLD activity in the cells. Evidence that PLD was involved in the stimulation of MMP-9 secretion was provided by the observations that the secretion of MMP-9 was stimulated by the introduction of short-chain phosphatidic acid (PA) into the growth medium and that inhibition of PA production by 1-propanol inhibited secretion, Using a short-chain diacylglycerol we excluded the possibility that MMP-9 secretion was induced by diacylglycerol formed from PA by phosphatidic acid phosphatase. Furthermore, propranolol, an inhibitor of this enzyme, had no effect on secretion induced by either phorbol 12-myristate 13-acetate or PA. The data presented here indicate that activation of protein kinase C increases MMP-9 secretion in HT 1080 cells and implicate PLD and PA formation in the effect.	Vanderbilt Univ, Howard Hughes Med Inst, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University	Exton, JH (corresponding author), Vanderbilt Univ, Howard Hughes Med Inst, Sch Med, Nashville, TN 37232 USA.	john.exton@mcmail.vanderbilt.edu						BALLIN M, 1988, BIOCHEM BIOPH RES CO, V154, P832, DOI 10.1016/0006-291X(88)90215-X; Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; DONALDSON JG, 1994, CURR OPIN CELL BIOL, V6, P527, DOI 10.1016/0955-0674(94)90072-8; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Ella KM, 1997, BIOCHEM MOL BIOL INT, V41, P715; Exton JH, 1997, J BIOL CHEM, V272, P15579, DOI 10.1074/jbc.272.25.15579; Goldberg G I, 1992, Matrix Suppl, V1, P25; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; KAHN RA, 1993, CELL, V75, P1045, DOI 10.1016/0092-8674(93)90314-G; KOUL O, 1987, ARCH BIOCHEM BIOPHYS, V253, P453, DOI 10.1016/0003-9861(87)90199-8; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; LIOTTA LA, 1979, P NATL ACAD SCI USA, V76, P2268, DOI 10.1073/pnas.76.5.2268; LIOTTA LA, 1981, BIOCHEMISTRY-US, V20, P100, DOI 10.1021/bi00504a017; MACKAY AR, 1992, INVAS METAST, V12, P168; MOSS J, 1995, J BIOL CHEM, V270, P12327, DOI 10.1074/jbc.270.21.12327; OKADA Y, 1992, J BIOL CHEM, V267, P21712; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; West MA, 1997, J CELL BIOL, V138, P1239, DOI 10.1083/jcb.138.6.1239	22	69	73	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					735	738		10.1074/jbc.274.2.735	http://dx.doi.org/10.1074/jbc.274.2.735			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873009	hybrid			2022-12-27	WOS:000077968500024
J	de Bernard, S; Misrahi, M; Huet, JC; Beau, I; Desroches, A; Loosfelt, H; Pichon, C; Pernollet, JC; Milgrom, E				de Bernard, S; Misrahi, M; Huet, JC; Beau, I; Desroches, A; Loosfelt, H; Pichon, C; Pernollet, JC; Milgrom, E			Sequential cleavage and excision of a segment of the thyrotropin receptor ectodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-ALPHA; TSH RECEPTOR; METALLOPROTEASE INHIBITORS; MATRIX METALLOPROTEINASES; CONVERTING-ENZYME; HORMONE-RECEPTOR; IL-6 RECEPTOR; TNF-ALPHA	The thyrotropin (TSH) receptor belongs to a subfamily of G protein-coupled receptors, which also includes luteinizing hormone and follicle-stimulating hormone receptors, The TSH receptor (TSHR) differs from the latter by the presence of an additional specific segment in the C-terminal part of its ectodomain. We show here that this insertion is excised in the majority of receptor molecules. Preparation of specific monoclonal antibodies to this region, microsequencing, enzyme-linked immunosorbent assay, and immunoblot studies have provided insight into the mechanisms of this excision, In the human thyroid gland, N termini of the transmembrane receptor beta subunit were found to be phenylalanine 366 and leucines 370 and 378, In transfected L cells a variety of other more proximal N termini were found, probably corresponding to incomplete excisions, The most extreme N terminus was observed to lie at Ser-314, These observations suggest that after initial cleavage at Ser-314 the inserted fragment of TSHR is progressively clipped out by a series of cleavage reactions progressing up to amino acids 366-378, The impossibility of recovering the excised fragment from purified receptor, cell membranes, or culture medium supports this interpretation, The cleavage enzyme has previously been shown to be inhibited by BB-2116, an inhibitor of matrix metalloproteases, However, we show here that it is unaffected by tissue inhibitors of metalloproteases. The cleavage enzyme is very similar to TACE (tumor necrosis factor Lu-converting enzyme) in both these characteristics. However, incubation of the TSH receptor with the purified recombinant catalytic domain of TACE, co transfection of cells with TACE and TSHR expression vectors, and the use of mutated Chinese hamster ovary cells in which TACE is inactive suggested that the TSHR cleavage enzyme is different from TACE, TACE and TSHR cleavage enzyme may thus possibly be related but different members of the adamalysin family of metzincin metalloproteases.	Hop Bicetre, INSERM U135, Unite Rech Hormones & Reprod, F-94275 Le Kremlin Bicetre, France; INRA, Unite 377, F-78352 Jouy En Josas, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Milgrom, E (corresponding author), Hop Bicetre, INSERM U135, Unite Rech Hormones & Reprod, 3eme Niveau, F-94275 Le Kremlin Bicetre, France.	milgrom@infobiogen.fr	Desroches-Castan, Agnes/AAA-4557-2019; Beau, Isabelle/M-4423-2017; Castan, Agnes/AAS-2580-2021	Beau, Isabelle/0000-0002-3352-6813; Castan, Agnes/0000-0002-3301-9504				Arribas J, 1997, J BIOL CHEM, V272, P17160, DOI 10.1074/jbc.272.27.17160; ARRIBAS J, 1995, J CELL BIOL, V128, P433, DOI 10.1083/jcb.128.3.433; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; BAN T, 1992, ENDOCRINOLOGY, V131, P815, DOI 10.1210/en.131.2.815; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 1996, BIOCHEM BIOPH RES CO, V225, P400, DOI 10.1006/bbrc.1996.1186; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; BRAKEBUSCH C, 1994, J BIOL CHEM, V269, P32488; CHAZENBALK GD, 1994, J BIOL CHEM, V269, P32209; Chazenbalk GD, 1997, ENDOCRINOLOGY, V138, P2893, DOI 10.1210/en.138.7.2893; CHENG HJ, 1994, MOL BIOL CELL, V5, P943, DOI 10.1091/mbc.5.9.943; Couet J, 1996, BIOCHEMISTRY-US, V35, P14800, DOI 10.1021/bi961359w; Couet J, 1996, J BIOL CHEM, V271, P4545; ENDO T, 1992, BIOCHEM BIOPH RES CO, V187, P887, DOI 10.1016/0006-291X(92)91280-4; FRAZIER AL, 1990, MOL ENDOCRINOL, V4, P1264, DOI 10.1210/mend-4-8-1264; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Graves PN, 1996, ENDOCRINOLOGY, V137, P3915, DOI 10.1210/en.137.9.3915; GROSSMAN RF, 1995, THYROID, V5, P101, DOI 10.1089/thy.1995.5.101; HARFST E, 1994, MOL CELL ENDOCRINOL, V102, P77, DOI 10.1016/0303-7207(94)90100-7; Kakinuma A, 1997, J BIOL CHEM, V272, P28296, DOI 10.1074/jbc.272.45.28296; LIBERT F, 1989, BIOCHEM BIOPH RES CO, V165, P1250, DOI 10.1016/0006-291X(89)92736-8; LOOSFELT H, 1992, P NATL ACAD SCI USA, V89, P3765, DOI 10.1073/pnas.89.9.3765; Merlos-Suarez A, 1998, J BIOL CHEM, V273, P24955, DOI 10.1074/jbc.273.38.24955; MIGAKI GI, 1995, J EXP MED, V182, P549, DOI 10.1084/jem.182.2.549; MISRAHI M, 1990, BIOCHEM BIOPH RES CO, V166, P394, DOI 10.1016/0006-291X(90)91958-U; MISRAHI M, 1994, EUR J BIOCHEM, V222, P711, DOI 10.1111/j.1432-1033.1994.tb18916.x; Misrahi M, 1997, HANDB EXP PHARM, V128, P33; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; MULLBERG J, 1994, J IMMUNOL, V152, P4958; MULLBERG J, 1995, J IMMUNOL, V155, P5198; NAGAYAMA Y, 1989, BIOCHEM BIOPH RES CO, V165, P1184, DOI 10.1016/0006-291X(89)92727-7; Parvathy S, 1997, BIOCHEM J, V327, P37, DOI 10.1042/bj3270037; POTTER E, 1994, BIOCHEM BIOPH RES CO, V205, P361, DOI 10.1006/bbrc.1994.2673; RUSSO D, 1991, MOL ENDOCRINOL, V5, P1607, DOI 10.1210/mend-5-11-1607; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SMITH BR, 1988, ENDOCR REV, V9, P106, DOI 10.1210/edrv-9-1-106; Tanaka K, 1998, J BIOL CHEM, V273, P1959, DOI 10.1074/jbc.273.4.1959; Tang P, 1996, BIOCHEMISTRY-US, V35, P8226, DOI 10.1021/bi952183l; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Vecchi M, 1997, J CELL BIOL, V139, P995, DOI 10.1083/jcb.139.4.995; WEETMAN AP, 1994, ENDOCR REV, V15, P788, DOI 10.1210/er.15.6.788; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; ZHONG ZY, 1994, J BIOL CHEM, V269, P627	43	73	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					101	107		10.1074/jbc.274.1.101	http://dx.doi.org/10.1074/jbc.274.1.101			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867816	Green Published, hybrid			2022-12-27	WOS:000077900200016
J	Waters, TR; Gallinari, P; Jiricny, J; Swann, PF				Waters, TR; Gallinari, P; Jiricny, J; Swann, PF			Human thymine DNA glycosylase binds to apurinic sites in DNA but is displaced by human apurinic endonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; POLYMERASE-BETA; HELA-CELLS; MISMATCH BINDING; NUCLEAR EXTRACTS; MAMMALIAN-CELLS; BOVINE TESTIS; G.T MISPAIRS; PURIFICATION; MECHANISM	In vitro, following the removal of thymine from a GT mismatch, thymine DNA glycosylase binds tightly to the apurinic site it has formed. It can also bind to an apurinic site opposite S(6)-methylthioguanine ((SMe)G) or opposite any of the remaining natural DNA bases. It will therefore bind to apurinic sites formed by spontaneous depurination, chemical attack, or other glycosylases, In the absence of magnesium, the rate of dissociation of the glycosylase from such complexes is so slow (k(off) 1.8 - 3.6 x 10(-5) s(-1); i.e. half-life between 5 and 10 h) that each molecule of glycosylase removes essentially only one molecule of thymine, In the presence of magnesium, the dissociation rates of the complexes with C.AP and (SMe)G.AP are increased more than 20-fold, allowing each thymine DNA glycosylase to remove more than one uracil or thymine from C.U and( SMe)G.T mismatches in DNA. In contrast, magnesium does not increase the dissociation of thymine DNA glycosylase from G.AP sites sufficiently to allow it to remove more than one thymine from G.T mismatches. The bound thymine DNA glycosylase prevents human apurinic endonuclease 1 (HAP1) cutting the apurinic site, so unless the glycosylase was displaced, the repair of apurinic sites would be very slow. However, HAP1 significantly increases the rate of dissociation of thymine DNA glycosylase from apurinic sites, presumably through direct interaction with the bound glycosylase, This effect is concentration-dependent and at the probable normal concentration of HAP1 in cells the dissociation would be fast. This interaction couples the first step in base excision repair, the glycosylase, to the second step, the apurinic endonuclease. The ether proteins involved in base excision repair, polymerase beta, XRCC1, and DNA ligase III, do not affect the dissociation of thymine DNA glycosylase from the apurinic site.	UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England; Ist Ric Biol Mol P Angeletti, I-00040 Pomezia, Italy; Inst Med Radiobiol, CH-8008 Zurich, Switzerland	University of London; University College London; Merck & Company	Waters, TR (corresponding author), UCL, Dept Biochem & Mol Biol, Gower St, London WC1E 6BT, England.	t.waters@biochem.ucl.ac.uk	Gallinari, Paola/ABE-8238-2021					Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; BARZILAY G, 1995, NAT STRUCT BIOL, V2, P561, DOI 10.1038/nsb0795-561; BARZILAY G, 1995, BIOESSAYS, V17, P713, DOI 10.1002/bies.950170808; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; CAREY J, 1991, METHOD ENZYMOL, V208, P103; DUGUID JR, 1995, CANCER RES, V55, P6097; EHRLICH M, 1990, MUTAT RES, V238, P277, DOI 10.1016/0165-1110(90)90019-8; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; GRIFFIN S, 1994, BIOCHEMISTRY-US, V33, P4787, DOI 10.1021/bi00182a006; KANE CM, 1981, J BIOL CHEM, V256, P3405; Krokan HE, 1997, BIOCHEM J, V325, P1; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Lawley P D, 1966, Prog Nucleic Acid Res Mol Biol, V5, P89, DOI 10.1016/S0079-6603(08)60232-9; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LONG KS, 1995, BIOCHEMISTRY-US, V34, P8885, DOI 10.1021/bi00027a041; NEDDERMANN P, 1993, J BIOL CHEM, V268, P21218; NEDDERMANN P, 1994, P NATL ACAD SCI USA, V91, P1642, DOI 10.1073/pnas.91.5.1642; Neddermann P, 1996, J BIOL CHEM, V271, P12767, DOI 10.1074/jbc.271.22.12767; Nicholl ID, 1997, BIOCHEMISTRY-US, V36, P7557, DOI 10.1021/bi962950w; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Scharer OD, 1997, P NATL ACAD SCI USA, V94, P4878, DOI 10.1073/pnas.94.10.4878; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; SIBGHATULLAH, 1995, BIOCHEMISTRY-US, V34, P6869, DOI 10.1021/bi00020a034; SibghatUllah, 1996, BIOCHEMISTRY-US, V35, P12926, DOI 10.1021/bi961022u; Singer B, 1997, CHEM RES TOXICOL, V10, P713, DOI 10.1021/tx970011e; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Waters TR, 1997, BIOCHEMISTRY-US, V36, P2501, DOI 10.1021/bi9621573; WERNER M, 1991, BIOCHEMISTRY-US, V30, P5832, DOI 10.1021/bi00238a004; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0; Wilson DM, 1997, NUCLEIC ACIDS RES, V25, P933, DOI 10.1093/nar/25.5.933; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; XU YZ, 1992, ANAL BIOCHEM, V204, P185, DOI 10.1016/0003-2697(92)90159-5	38	216	221	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					67	74		10.1074/jbc.274.1.67	http://dx.doi.org/10.1074/jbc.274.1.67			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867812	hybrid			2022-12-27	WOS:000077900200012
J	Beilharz, T; Suzuki, CK; Lithgow, T				Beilharz, T; Suzuki, CK; Lithgow, T			A toxic fusion protein accumulating between the mitochondrial membranes inhibits protein assembly in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAUSES INCREASED ESCAPE; SACCHAROMYCES-CEREVISIAE; YEAST MITOCHONDRIA; ESCHERICHIA-COLI; INNER MEMBRANE; PRECURSOR PROTEINS; CYTOCHROME-C; MFT1 GENE; ATP; DEGRADATION	When overexpressed in Saccharomyces cerevisiae, beta-galactosidase fusion proteins directed to the mitochondria are toxic, preventing growth of yeast cells on non-fermentable carbon sources (Emr. S. D., Vassarotti, A., Garrett, J., Geller, B. L., Takeda, M., and Douglas, M. G. (1986) J, Cell Biol. 102, 523-533), We show that such fusion proteins interfere with the assembly of respiratory complexes in the mitochondrial inner membrane, without blocking protein translocation. The gene YME1, encoding an ATP-dependent metalloprotease of the mitochondrial inner membrane, acts as a suppressor of this defect; a 3-fold overexpression of Yme1p is sufficient to restore respiratory complex assembly and mitochondrial function. Detailed knowledge of the topology and effect of the toxic beta-galactosidase fusion proteins will permit the identification and characterization of components that control protein sorting and protein assembly within the mitochondrial inner membrane.	La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	La Trobe University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lithgow, T (corresponding author), La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia.		Lithgow, Trevor J/H-5925-2017; Beilharz, Traude/O-5457-2019; Beilharz, Traude/I-1438-2014	Lithgow, Trevor J/0000-0002-0102-7884; Beilharz, Traude/0000-0002-8942-9502; Beilharz, Traude/0000-0002-8942-9502				AKIYAMA Y, 1994, J BIOL CHEM, V269, P5218; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; BASSFORD PJ, 1979, J BACTERIOL, V139, P19, DOI 10.1128/JB.139.1.19-31.1979; Beilharz T, 1997, FEBS LETT, V407, P220, DOI 10.1016/S0014-5793(97)00349-9; Brachmann CB, 1998, YEAST, V14, P115; Cartwright P, 1997, J BIOL CHEM, V272, P5320, DOI 10.1074/jbc.272.8.5320; DOUGLAS MG, 1984, P NATL ACAD SCI-BIOL, V81, P3983, DOI 10.1073/pnas.81.13.3983; EMR SD, 1986, J CELL BIOL, V102, P523, DOI 10.1083/jcb.102.2.523; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GARDEL C, 1987, J BACTERIOL, V169, P1286, DOI 10.1128/jb.169.3.1286-1290.1987; GARRETT JM, 1991, MOL GEN GENET, V225, P483, DOI 10.1007/BF00261691; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Guelin E, 1996, FEBS LETT, V381, P42, DOI 10.1016/0014-5793(96)00074-9; Hanekamp T, 1996, MOL CELL BIOL, V16, P2764; KIINO DR, 1990, J BACTERIOL, V172, P185, DOI 10.1128/JB.172.1.185-192.1990; KUMAMOTO C, 1983, J BACTERIOL, V154, P254; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; MACCECCHINI ML, 1979, P NATL ACAD SCI USA, V76, P343, DOI 10.1073/pnas.76.1.343; NAKAI T, 1995, MOL CELL BIOL, V15, P4441; OLIVER DB, 1981, CELL, V25, P2765; PEARCE DA, 1995, J BIOL CHEM, V270, P20879, DOI 10.1074/jbc.270.36.20879; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHATZ PJ, 1990, ANNU REV GENET, V24, P215, DOI 10.1146/annurev.ge.24.120190.001243; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; THORSNESS PE, 1993, MOL CELL BIOL, V13, P5418, DOI 10.1128/MCB.13.9.5418; TZAGOLOFF A, 1994, J BIOL CHEM, V269, P26144; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; Weber ER, 1996, MOL BIOL CELL, V7, P307, DOI 10.1091/mbc.7.2.307	29	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35268	35272		10.1074/jbc.273.52.35268	http://dx.doi.org/10.1074/jbc.273.52.35268			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857067	hybrid			2022-12-27	WOS:000077719700085
J	Jing, NJ; Hogan, ME				Jing, NJ; Hogan, ME			Structure-activity of tetrad-forming oligonucleotides as a potent anti-HIV therapeutic drug	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 INTEGRASE; NMR-SPECTROSCOPY; DNA APTAMER; IN-VITRO; INHIBITION; ASSIGNMENT; ANALOGS; PROTEIN	Recently, we have described the design and characterization of oligonucleotides containing only G and T bases, i.e. T30695 and T30177, that are potent inhibitors of human immunodeficiency virus type 1 (HIV-1) replication in culture (Jing, N,, Rando, R, F,, Pommier, Y,, and Hogan, M, E, (1997) Biochemistry 36, 12498-12505), To understand that observation and to rationalize the generally high thermal stability of oligonucleotide folding for these compounds, we have used NMR methods, coupled to molecular modeling, to obtain a high resolution structure model for T30695, which is the most potent of the integrase inhibitors that have been identified thus far. Modeling and NMR data obtained in the presence of Li+ ions show that T30695 assumes an intramolecular fold with a distorted G-octet core and a set of three open, partially disordered loops. This is referred to as Li+-form structure. The NMR-based model suggests that, upon coordination with three K+ equivalents, the central G-octet becomes more regular and that the loop domains become orderly and compact. This is referred to as K+-form structure. Based upon the assay of inhibition of HIV-1 integrase, T30695 demonstrated a strong inhibition of HIV-1 integrase activity as the K+-form structure, but a poor inhibition of HIV-1 integrase activity as the Li+-form structure. The structure/activity analysis suggests that the K+-induced conformation transition of the tetrad-forming oligonucleotides, such as T30695 and T30177, plays a key role in inhibition of HIV-1 integrase activity.	Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Genometrix Inc, The Woodlands, TX 77381 USA	Baylor College of Medicine	Jing, NJ (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	njing@bcm.tmc.edu; mhogan@bcm.tmc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032894] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32-HL-07676] Funding Source: Medline; NIAID NIH HHS [R01 AI32894] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CUSHMAN M, 1995, J MED CHEM, V38, P443, DOI 10.1021/jm00003a007; DAVIS DG, 1985, J AM CHEM SOC, V107, P2820, DOI 10.1021/ja00295a052; DECLERCQ E, 1995, J MED CHEM, V38, P2491, DOI 10.1021/jm00014a001; Feigon J, 1995, METHOD ENZYMOL, V261, P225; Jing NJ, 1997, J BIOMOL STRUCT DYN, V15, P573, DOI 10.1080/07391102.1997.10508967; Jing NJ, 1997, BIOCHEMISTRY-US, V36, P12498, DOI 10.1021/bi962798y; KANG C, 1992, NATURE, V356, P126, DOI 10.1038/356126a0; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025; MAZUMDER A, 1994, P NATL ACAD SCI USA, V91, P5771, DOI 10.1073/pnas.91.13.5771; Mazumder A, 1996, BIOCHEMISTRY-US, V35, P13762, DOI 10.1021/bi960541u; Mazumder A, 1996, MOL PHARMACOL, V49, P621; MAZUMDER A, 1995, BIOCHEMISTRY-US, V34, P15111, DOI 10.1021/bi00046a018; MOUSCADET JF, 1994, J BIOL CHEM, V269, P21635; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; RANDO RF, 1995, J BIOL CHEM, V270, P1754, DOI 10.1074/jbc.270.4.1754; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; SKLENAR V, 1986, FEBS LETT, V208, P94, DOI 10.1016/0014-5793(86)81539-3; VINK C, 1993, TRENDS GENET, V9, P433, DOI 10.1016/0168-9525(93)90107-S; WANG KY, 1993, BIOCHEMISTRY-US, V32, P1899, DOI 10.1021/bi00059a003; WUTHRICH K, 1986, NMR PROTEINS NUCL AC, P53	21	141	146	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34992	34999		10.1074/jbc.273.52.34992	http://dx.doi.org/10.1074/jbc.273.52.34992			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857031	hybrid			2022-12-27	WOS:000077719700049
J	Aikawa, J; Esko, JD				Aikawa, J; Esko, JD			Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/N-sulfotransferase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TREACHER-COLLINS SYNDROME; SULFATE SULFOTRANSFERASE; MOUSE; BIOSYNTHESIS; LOCALIZATION; GENE; PURIFICATION; PROTEIN	N-Deacetylation and N-sulfation of N-acetylglucosamine residues in heparan sulfate and heparin initiate a series of chemical modifications that ultimately lead to oligosaccharide sequences with specific ligand binding properties. These reactions are catalyzed by GlcNAc N-deacetylase/N-sulfotransferase (NDST), a monomeric enzyme with two catalytic activities. Two genes encoding NDST isozymes have been described, one from rat liver (NDST1) and another from murine mastocytoma (NDST2), Both isozymes are expressed in tissues in varying amounts, but their relative contribution to heparan sulfate formation in any one tissue is unknown. We now report the identification of a third member of the NDST family, designated NDST3, A full-length cDNA clone (3.2 kilobase pairs) encoding a 873-amino acid protein was obtained from a human fetal/infant brain cDNA library, Human NDST3 (hNDST3) has a nucleotide sequence homologous but not identical to hNDST1 and NDST2. The deduced amino acid sequence shows 70% and 65% amino acid identity to that of hNDST1 and NDST2, respectively. A soluble chimera of hNDST3 and protein A exhibited both N-deacetylase and M-sulfotransferase activity, confirming its enzymatic identity, Northern blot analysis of human fetal brain poly(A)(+) RNA showed a single transcript of 6.4 kilobase pairs, Reverse transcription polymerase chain reaction analysis revealed more restricted tissue expression of hNDST3 than hNDST1 and NDST2, and high levels in brain, liver, and kidney. Analysis of Chinese hamster ovary cells revealed expression of NDST1 and NDST2, but not NDST3. In a Chinese hamster ovary cell mutant exhibiting reduced N-sulfotransferase activity and reduced sulfation of heparan sulfate (Bame, K. J., and Esko, J, D, (1989) J, Biol. Chem, 264, 8059-8065), expression of NDST1 was greatly reduced, but NDST2 was expressed normally, suggesting that both enzymes are involved in heparan sulfate assembly, The discovery of multiple NDST isozymes suggests that the assembly of heparan sulfate is much complicated than previously appreciated.	Univ Calif San Diego, Div Cellular & Mol Med, Glycobiol Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Esko, JD (corresponding author), 9500 Gilman Dr,CMM-E 1055, La Jolla, CA 92093 USA.		Aikawa, Jun-ichi/D-3357-2017	Aikawa, Jun-ichi/0000-0003-2250-8756	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL53745] Funding Source: Medline; NIGMS NIH HHS [GM33063] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAME KJ, 1994, BIOCHEM J, V303, P81, DOI 10.1042/bj3030081; BAME KJ, 1991, J BIOL CHEM, V266, P10287; BAME KJ, 1989, J BIOL CHEM, V264, P8059; BAME KJ, 1991, J BIOL CHEM, V266, P12461; BRANDAN E, 1988, J BIOL CHEM, V263, P2417; Cheung WF, 1996, BIOCHEMISTRY-US, V35, P5250, DOI 10.1021/bi952325b; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Conrad H. E., 1998, HEPARIN BINDING PROT; DIXON J, 1995, GENOMICS, V26, P239, DOI 10.1016/0888-7543(95)80206-2; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; Gladwin AJ, 1996, GENOMICS, V32, P471, DOI 10.1006/geno.1996.0145; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; Humphries DE, 1998, BIOCHEM J, V332, P303, DOI 10.1042/bj3320303; Humphries DE, 1997, BIOCHEM J, V325, P351, DOI 10.1042/bj3250351; Kakuta Y, 1998, TRENDS BIOCHEM SCI, V23, P129, DOI 10.1016/S0968-0004(98)01182-7; KJELLEN L, 1992, ADV EXP MED BIOL, V313, P107; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; LYON M, 1994, J BIOL CHEM, V269, P11208; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MANDON E, 1994, J BIOL CHEM, V269, P11729; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; SHAPER JH, 1992, CURR OPIN STRUC BIOL, V2, P701; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; Veugelers M, 1997, GENOMICS, V40, P24, DOI 10.1006/geno.1996.4518; WEI Z, 1993, P NATL ACAD SCI USA, V90, P3885, DOI 10.1073/pnas.90.9.3885	28	120	125	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2690	2695		10.1074/jbc.274.5.2690	http://dx.doi.org/10.1074/jbc.274.5.2690			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915799	hybrid			2022-12-27	WOS:000078319500017
J	Shin, HW; Takatsu, H; Mukai, H; Munekata, E; Murakami, K; Nakayama, K				Shin, HW; Takatsu, H; Mukai, H; Munekata, E; Murakami, K; Nakayama, K			Intermolecular and interdomain interactions of a dynamin-related GTP-binding protein, Dnm1p/Vps1p-like protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COATED VESICLE FORMATION; ENDOCYTOSIS; MUTANT; YEAST; ASSEMBLES; RINGS	Dnm1p/Vps1p-like protein (DVLP) is a mammalian member of the dynamin GTPase family, which is classified into subfamilies on the basis of the structural similarity. Mammalian dynamins constitute the dynamin subfamily. DVLP belongs to the Vps1 subfamily, which also includes yeast Vps1p and Dnm1p, Typical structural features that discriminate between members of the Vps1 and dynamin subfamilies are that the former lacks the pleckstrin homology and Pro-rich domains. Dynamin exists as tetramers under physiological salt conditions, whereas under low salt conditions, it can polymerize into spirals that resemble the collar structures seen at the necks of constricted coated pits. In this study, we found that DVLP is also oligomeric, probably tetrameric, under physiological salt conditions and forms sedimentable large aggregates under low salt conditions. The data indicate that neither the pleckstrin homology nor Pro-rich domain is required for the self-assembly. Analyses using the two-hybrid system and coimmunoprecipitation show that the N-terminal region containing the GTPase domain and a domain (DVH1) conserved across members of the dynamin and Vps1 subfamilies, can interact with the C-terminal region containing another conserved domain (DVH2), The data on the interdomain interaction of DVLP is compatible with the previous reports on the interdomain interaction of dynamin, Thus, the self-assembly mechanism of DVLP appears to resemble that of dynamin, suggesting that DVLP may also be involved in the formation of transport vesicles.	Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Gene Expt Ctr, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Nakayama, K (corresponding author), Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan.		Shin, Hye-Won/P-5398-2018; Nakayama, Kazuhisa/ABF-2924-2020	Shin, Hye-Won/0000-0002-9138-9554; Nakayama, Kazuhisa/0000-0001-7701-7183				Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Damke H, 1996, FEBS LETT, V389, P48, DOI 10.1016/0014-5793(96)00517-0; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; GAMMIE AE, 1995, J CELL BIOL, V130, P553, DOI 10.1083/jcb.130.3.553; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Imoto M, 1998, J CELL SCI, V111, P1341; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kamimoto T, 1998, J BIOL CHEM, V273, P1044, DOI 10.1074/jbc.273.2.1044; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Lin HC, 1997, J BIOL CHEM, V272, P25999, DOI 10.1074/jbc.272.41.25999; LIU JP, 1995, ENDOCR REV, V16, P590, DOI 10.1210/er.16.5.590; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; ROTHMAN JH, 1990, CELL, V61, P1063, DOI 10.1016/0092-8674(90)90070-U; Shin HW, 1997, J BIOCHEM-TOKYO, V122, P525; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TORII S, 1995, J BIOL CHEM, V270, P11574, DOI 10.1074/jbc.270.19.11574; TUMA PL, 1995, J BIOL CHEM, V270, P26707, DOI 10.1074/jbc.270.44.26707; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; VALLEE RB, 1995, TRENDS CELL BIOL, V5, P43, DOI 10.1016/S0962-8924(00)88937-0; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Warnock DE, 1997, MOL BIOL CELL, V8, P2553, DOI 10.1091/mbc.8.12.2553; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779	24	61	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2780	2785		10.1074/jbc.274.5.2780	http://dx.doi.org/10.1074/jbc.274.5.2780			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915810	hybrid			2022-12-27	WOS:000078319500028
J	Zhou, YC; Waxman, DJ				Zhou, YC; Waxman, DJ			Cross-talk between Janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPAR alpha) signaling pathways - Growth hormone inhibition of PPAR alpha transcriptional activity mediated by STAT5b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED RAT HEPATOCYTES; RESPONSE ELEMENT; THYROID-HORMONE; PROTEIN-KINASE; BETA-OXIDATION; FATTY-ACIDS; TYROSINE PHOSPHORYLATION; DIFFERENTIAL ACTIVATION; GLUCOCORTICOID RECEPTOR; CLOFIBRATE-INDUCTION	Hepatic peroxisome proliferation induced by structurally diverse non-genotoxic carcinogens is mediated by the nuclear receptor peroxisome proliferator-activated receptor (PPAR alpha) and can be inhibited by growth hormone (GH), GH-stimulated Janus kinase-signal transducer and activator of transcription 5b (JAK2/ STAT5b) signaling and the PPAR activation pathway were reconstituted in COS-1 cells to investigate the mechanism for this GH inhibitory effect. Activation of STAT5b signaling by either GH or prolactin inhibited, by up to 80-85%, ligand-induced, PPAR alpha-dependent reporter on. GH failed to inhibit 15-deoxy-Delta(12,14)-prostaglandin-J(2)-stimulated gene transcription mediated by an endogenous COS-1 PPAR-related receptor, GH inhibition of PPAR alpha activity required GH receptor and STAT5b and was not observed using GH-activated STAT1 in place of STAT5b, GH inhibition was not blocked by the mitogen-activated protein kinase pathway inhibitor PD98059, STAT5b-PPAR alpha protein-protein interactions could not be detected by anti-STAT5b supershift analysis of PPAR alpha-DNA complexes. The GH inhibitory effect required the tyrosine phosphorylation site (Tyr-699) of STAT5b, an intact STAT5b DNA binding domain, and the presence of a COOH-terminal transactivation domain. Moreover, GH inhibition was reversed by a COOH-terminal-truncated, dominant-negative STAT5b mutant. STAT5b must thus be nuclear and transcriptionally active to mediate GH inhibition of PPAR alpha activity, suggesting an indirect inhibition mechanism, such as competition for an essential PPAR alpha co-activator or STAT5b-dependent synthesis of a more proximal PPARa inhibitor. The cross-talk between STAT5b and PPAR alpha signaling pathways established by these findings provides new insight into the mechanisms of hormonal and cytokine regulation of hepatic peroxisome proliferation.	Boston Univ, Dept Biol, Div Cell & Mol Biol, Boston, MA 02215 USA	Boston University	Waxman, DJ (corresponding author), Boston Univ, Dept Biol, Div Cell & Mol Biol, 5 Cummington St, Boston, MA 02215 USA.	djw@bio.bu.edu		Waxman, David/0000-0001-7982-9206	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007381] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES07381] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BEADLING C, 1994, EMBO J, V13, P5605, DOI 10.1002/j.1460-2075.1994.tb06898.x; BILLESTRUP N, 1990, P NATL ACAD SCI USA, V87, P7210, DOI 10.1073/pnas.87.18.7210; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Brun RP, 1997, CURR OPIN LIPIDOL, V8, P212, DOI 10.1097/00041433-199708000-00004; Camp HS, 1997, J BIOL CHEM, V272, P10811; CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074; CAMPBELL GS, 1995, J BIOL CHEM, V270, P3974, DOI 10.1074/jbc.270.8.3974; Cella N, 1998, MOL CELL BIOL, V18, P1783, DOI 10.1128/MCB.18.4.1783; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CHU RY, 1995, P NATL ACAD SCI USA, V92, P11593, DOI 10.1073/pnas.92.25.11593; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; GALA RR, 1991, P SOC EXP BIOL MED, V198, P513; Gebert CA, 1997, MOL ENDOCRINOL, V11, P400, DOI 10.1210/me.11.4.400; Gonzalez FJ, 1997, ADV EXP MED BIOL, V422, P109; GREEN S, 1994, MOL CELL ENDOCRINOL, V100, P149, DOI 10.1016/0303-7207(94)90294-1; GRONOWSKI AM, 1994, J BIOL CHEM, V269, P7874; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; HOWELL BW, 1989, MOL CELL BIOL, V9, P2928, DOI 10.1128/MCB.9.7.2928; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; JEDLITSCHKY G, 1993, ADV ENZYME REGUL, V33, P181; Kawashima H, 1997, ARCH BIOCHEM BIOPHYS, V347, P148, DOI 10.1006/abbi.1997.0342; KAWASHIMA Y, 1989, BIOCHEM J, V261, P595, DOI 10.1042/bj2610595; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Lechner J, 1997, J BIOL CHEM, V272, P20954, DOI 10.1074/jbc.272.33.20954; LEDWITH BJ, 1993, MOL CARCINOGEN, V8, P20, DOI 10.1002/mc.2940080107; LEE SST, 1995, MOL CELL BIOL, V15, P3012; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; LOIU X, 1997, GENE DEV, V11, P179; Love DW, 1998, ENDOCRINOLOGY, V139, P1965, DOI 10.1210/en.139.4.1965; Luo GY, 1997, J BIOL CHEM, V272, P26841, DOI 10.1074/jbc.272.43.26841; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Miyamoto T, 1997, J BIOL CHEM, V272, P7752, DOI 10.1074/jbc.272.12.7752; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; MUERHOFF AS, 1992, J BIOL CHEM, V267, P19051; MUI AL, 1995, EMBO J, V14, P2005; MUKHTAR H, 1989, XENOBIOTICA, V19, P151, DOI 10.3109/00498258909034687; PALMER CNA, 1994, J BIOL CHEM, V269, P18083; PALMER CNA, 1995, J BIOL CHEM, V270, P16114, DOI 10.1074/jbc.270.27.16114; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; Peters JM, 1996, MOL PHARMACOL, V50, P67; Ram PA, 1996, J BIOL CHEM, V271, P5929, DOI 10.1074/jbc.271.10.5929; Rao MS, 1996, ANN NY ACAD SCI, V804, P573, DOI 10.1111/j.1749-6632.1996.tb18646.x; SATO T, 1995, BBA-LIPID LIPID MET, V1256, P327, DOI 10.1016/0005-2760(95)00040-J; SCHOONJANS K, 1995, J BIOL CHEM, V270, P19269, DOI 10.1074/jbc.270.33.19269; Schoonjans K, 1997, CURR OPIN LIPIDOL, V8, P159, DOI 10.1097/00041433-199706000-00006; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; Smit LS, 1997, ENDOCRINOLOGY, V138, P3426, DOI 10.1210/en.138.8.3426; STEINEGER HH, 1994, EUR J BIOCHEM, V225, P967, DOI 10.1111/j.1432-1033.1994.0967b.x; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; SU CC, 1996, ANNU REV PHYSIOL, V58, P187; SUGIYAMA H, 1994, BIOCHEM PHARMACOL, V47, P918, DOI 10.1016/0006-2952(94)90494-4; SUNDSETH SS, 1992, J BIOL CHEM, V267, P3915; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; WAHLI W, 1995, CHEM BIOL, V2, P261, DOI 10.1016/1074-5521(95)90045-4; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; WEIGENT DA, 1992, BRAIN BEHAV IMMUN, V6, P365, DOI 10.1016/0889-1591(92)90035-M; Weigent DA, 1996, PHARMACOL THERAPEUT, V69, P237, DOI 10.1016/0163-7258(96)00001-0; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; YAMADA J, 1995, RES COMMUN MOL PATH, V90, P173; YAMADA J, 1994, ARCH BIOCHEM BIOPHYS, V315, P555, DOI 10.1006/abbi.1994.1536; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975; ZHANG BW, 1993, J BIOL CHEM, V268, P12939; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zhang ZX, 1997, J BIOL CHEM, V272, P30607, DOI 10.1074/jbc.272.49.30607; ZHU YJ, 1993, J BIOL CHEM, V268, P26817; Zhu YJ, 1996, GENE EXPRESSION, V6, P185; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	82	103	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2672	2681		10.1074/jbc.274.5.2672	http://dx.doi.org/10.1074/jbc.274.5.2672			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915797	hybrid			2022-12-27	WOS:000078319500015
J	Oue, S; Okamoto, A; Yano, T; Kagamiyama, H				Oue, S; Okamoto, A; Yano, T; Kagamiyama, H			Redesigning the substrate specificity of an enzyme by cumulative effects of the mutations of non-active site residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ASPARTATE-AMINOTRANSFERASE; ESCHERICHIA-COLI; TYROSINE AMINOTRANSFERASE; DIRECTED MUTAGENESIS; IN-VITRO; EVOLUTION; REFINEMENT; MECHANISM; PROGRAM; SPACE	Directed evolution was used to change the substrate specificity of aspartate aminotransferase, A mutant enzyme with 17 amino acid substitutions was generated that; shows a 2.1 x 10(6)-fold increase in the catalytic efficiency (k(cat)/K-m) for a non-native substrate, valine, The absorption spectrum of the bound coenzyme, pyridoxal 5'-phosphate, is also changed significantly by the mutations. interestingly, only one of the 17 residues appears to be able to contact the substrate, and none of them interact with the coenzyme. The three-dimensional structure of the mutant enzyme complexed with a valine analog, isovalerate (determined to 2.4-Angstrom resolution by x-ray crystallography), provides insights into how the mutations affect substrate binding, The active site is remodeled; the subunit interface is altered, and the enzyme domain that encloses the substrate is shifted by the mutations. The present results demonstrate clearly the importance of the cumulative effects of residues remote from the active site and represent a new line of approach to the redesign of enzyme activity.	Osaka Med Coll, Dept Biochem, Takatsuki, Osaka 5698686, Japan	Osaka Medical College	Kagamiyama, H (corresponding author), Osaka Med Coll, Dept Biochem, Takatsuki, Osaka 5698686, Japan.	med001@art.osaka-med.ac.jp						BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BONE R, 1989, NATURE, V339, P191, DOI 10.1038/339191a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Christen P, 1985, TRANSAMINASES; CRONIN CN, 1988, BIOCHEMISTRY-US, V27, P4572, DOI 10.1021/bi00412a052; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; HAYASHI H, 1989, BIOCHEM BIOPH RES CO, V159, P337, DOI 10.1016/0006-291X(89)92443-1; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; HERMES JD, 1990, P NATL ACAD SCI USA, V87, P696, DOI 10.1073/pnas.87.2.696; HIGASHI T, 1990, J APPL CRYSTALLOGR, V23, P253, DOI 10.1107/S0021889890002461; INOUE Y, 1989, J BIOL CHEM, V264, P9673; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; JENKINS WT, 1957, J AM CHEM SOC, V79, P2655, DOI 10.1021/ja01567a086; KARMEN A, 1955, J CLIN INVEST, V34, P126, DOI 10.1172/JCI103055; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; MALASHKEVICH VN, 1995, NAT STRUCT BIOL, V2, P548, DOI 10.1038/nsb0795-548; MCPHALEN CA, 1992, J MOL BIOL, V227, P197, DOI 10.1016/0022-2836(92)90691-C; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; OKAMOTO A, 1994, J BIOCHEM, V116, P95, DOI 10.1093/oxfordjournals.jbchem.a124509; ONUFFER JJ, 1995, PROTEIN SCI, V4, P1750, DOI 10.1002/pro.5560040910; Patten PA, 1996, SCIENCE, V271, P1086, DOI 10.1126/science.271.5252.1086; Quemeneur E, 1998, NATURE, V391, P301, DOI 10.1038/34687; Shao ZX, 1996, CURR OPIN STRUC BIOL, V6, P513, DOI 10.1016/S0959-440X(96)80117-5; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; WILKS HM, 1988, SCIENCE, V242, P1541, DOI 10.1126/science.3201242; YANO T, 1993, BIOCHEMISTRY-US, V32, P1810, DOI 10.1021/bi00058a015; Yano T, 1998, P NATL ACAD SCI USA, V95, P5511, DOI 10.1073/pnas.95.10.5511; YANO T, 1991, J BIOL CHEM, V266, P6079; Zhang JH, 1997, P NATL ACAD SCI USA, V94, P4504, DOI 10.1073/pnas.94.9.4504	35	145	153	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2344	2349		10.1074/jbc.274.4.2344	http://dx.doi.org/10.1074/jbc.274.4.2344			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891001	hybrid			2022-12-27	WOS:000078185200068
J	Peng, SB; Li, XJ; Crider, BP; Zhou, ZM; Andersen, P; Tsai, SJ; Xie, XS; Stone, DK				Peng, SB; Li, XJ; Crider, BP; Zhou, ZM; Andersen, P; Tsai, SJ; Xie, XS; Stone, DK			Identification and reconstitution of an isoform of the 116-kDa subunit of the vacuolar proton translocating ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICLE H+-ATPASE; GENE ENCODES; PUMP; POLYPEPTIDE; CLONING; ACIDIFICATION; COMPARTMENTS; EXPRESSION; PROTEIN; COMPLEX	We have identified a cDNA encoding an isoform of the 116-kDa subunit of the bovine vacuolar proton translocating ATPase. The predicted protein sequence of the new isoform, designated a,, consists of 854 amino acids with a calculated molecular mass of 98,010 Pa; it has approximately 50% identity to the original isoform (a(1)) we described (Peng, S.-B., Crider, B. P., Xie, X. S., and Stone, D.K. (1994) J. Biol. Chem. 269, 17262-17266). Sequence comparison indicates that the a(2) isoform is the bovine homologue of a 116-kDa polypeptide identified in mouse as an immune regulatory factor (Lee, C.-K., Ghoshal, K., and Beaman, K.D. (1990) Mol. Immunol. 27, 1137-1144). The bovine a(1) and a(2) isoforms share strikingly similar structures with hydrophilic amino-terminal halves that are composed of more than 30% charged residues and hydrophobic carboxyl-terminal halves that contain 6-8 transmembrane regions, Northern blot analysis demonstrates that isoform a(2) is highly expressed in lung, kidney, and spleen. To determine the possible role of the a(2) isoform in vacuolar proton pump function, we purified from bovine lung a vacuolar pump proton channel (V-o) containing isoform a(2). This V-o conducts bafilomycin-sensitive proton flow after reconstitution and acid activation, and supports proton pumping activity after assembly with the catalytic sector (V-1) of vacuolar-type proton translocating ATPase (V-ATPase) and sub-58-kDa doublet, a 50-57-kDa polypeptide heterodimer required for V-ATPase function. These data indicate that the a(2) isoform of the 116-kDa polypeptide functions as part of the proton channel of V-ATPases.	Univ Texas, SW Med Ctr, Dept Internal Med, Div Mol Transport, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Stone, DK (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Mol Transport, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.				NIDDK NIH HHS [DK-33627] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033627] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON RGW, 1988, J CELL BIOL, V106, P539, DOI 10.1083/jcb.106.3.539; BAUERLE C, 1993, J BIOL CHEM, V268, P12749; CRIDER BP, 1994, J BIOL CHEM, V269, P17379; Crider BP, 1997, J BIOL CHEM, V272, P10721; FERNANDEZ JM, 1991, BIOPHYS J, V59, P1022, DOI 10.1016/S0006-3495(91)82317-7; GLUCK S, 1982, J BIOL CHEM, V257, P9230; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; KANE PM, 1989, J BIOL CHEM, V264, P19236; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE CK, 1990, MOL IMMUNOL, V27, P1137; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; PARRY RV, 1989, J BIOL CHEM, V264, P20025; Peng SB, 1996, J BIOL CHEM, V271, P3324, DOI 10.1074/jbc.271.6.3324; PENG SB, 1994, J BIOL CHEM, V269, P27778; PENG SB, 1994, J BIOL CHEM, V269, P17262; PERIN MS, 1991, J BIOL CHEM, V266, P3877; PUOPOLO K, 1991, J BIOL CHEM, V266, P24564; Sambrook J., 2002, MOL CLONING LAB MANU; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; STONE DK, 1988, KIDNEY INT, V33, P403; SUDHOF TC, 1989, P NATL ACAD SCI USA, V86, P6067, DOI 10.1073/pnas.86.16.6067; TAKASE K, 1994, J BIOL CHEM, V269, P11037; Togashi K, 1997, IMMUNOL LETT, V55, P139, DOI 10.1016/S0165-2478(97)02698-9; VANHILLE B, 1993, J BIOL CHEM, V268, P7075; WANG SY, 1988, J BIOL CHEM, V263, P17638; XIE XS, 1986, J BIOL CHEM, V261, P2492; XIE XS, 1994, J BIOL CHEM, V269, P25809; XIE XS, 1986, P NATL ACAD SCI USA, V83, P8913, DOI 10.1073/pnas.83.23.8913; XIE XS, 1988, J BIOL CHEM, V263, P9859; YAMASHIRO DJ, 1984, J CELL BIOCHEM, V26, P231, DOI 10.1002/jcb.240260404; Zhou ZM, 1998, J BIOL CHEM, V273, P5878, DOI 10.1074/jbc.273.10.5878	33	44	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2549	2555		10.1074/jbc.274.4.2549	http://dx.doi.org/10.1074/jbc.274.4.2549			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891027	hybrid			2022-12-27	WOS:000078185200094
J	Wadgaonkar, R; Phelps, KM; Haque, Z; Williams, AJ; Silverman, ES; Collins, T				Wadgaonkar, R; Phelps, KM; Haque, Z; Williams, AJ; Silverman, ES; Collins, T			CREB-binding protein is a nuclear integrator of nuclear factor-kappa B and p53 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; INDUCED APOPTOSIS; CELL-DEATH; E-SELECTIN; INHIBITION; COACTIVATORS; SUPPRESSION; PROMOTERS; RECEPTORS; P300/CBP	Transcriptional coactivators may function as nuclear integrators by coordinating diverse signaling events. Here we show that the p65 (RelA) component of nuclear factor-kappa B (NF-kappa B) and p53 mutually repress each other's ability to activate transcription. Additionally, tumor necrosis factor-activated NP-kappa B is inhibited by UV light-induced p53. Both p65 and p53 depend upon the coactivator CREB-binding protein (CBP) for maximal activity. Increased levels of the coactivator relieve p53-mediated repression of NF-kappa B activity and p65-mediated repression of p53-dependent gene expression. Nuclear competition for limiting amounts of CBP provides a novel mechanism for altering the balance between the expression of NF-kappa B-dependent proliferation or survival genes and p53-dependent genes involved in cell cycle arrest and apoptosis.	Brigham & Womens Hosp, Dept Pathol, Div Vasc Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Collins, T (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Vasc Res, 221 Longwood Ave, Boston, MA 02115 USA.	tcollins@bustoff.bwh.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035716, P01HL036028, R37HL035716] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 35716, HL45462, P0 HL 36028] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; Bertrand F, 1998, J BIOL CHEM, V273, P2931, DOI 10.1074/jbc.273.5.2931; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; GINSBERG D, 1991, P NATL ACAD SCI USA, V88, P9979, DOI 10.1073/pnas.88.22.9979; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lane DP, 1997, TRENDS BIOCHEM SCI, V22, P372, DOI 10.1016/S0968-0004(97)01119-5; Lee CW, 1998, ONCOGENE, V16, P2695, DOI 10.1038/sj.onc.1201818; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; MIYASHITA T, 1995, CELL, V80, P293; Parvin JD, 1998, CURR OPIN GENET DEV, V8, P565, DOI 10.1016/S0959-437X(98)80012-9; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	38	168	173	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1879	1882		10.1074/jbc.274.4.1879	http://dx.doi.org/10.1074/jbc.274.4.1879			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890939	hybrid			2022-12-27	WOS:000078185200006
J	Zen, Q; Cottman, M; Truskey, G; Fraser, R; Telen, MJ				Zen, Q; Cottman, M; Truskey, G; Fraser, R; Telen, MJ			Critical factors in basal cell adhesion molecule/Lutheran-mediated adhesion to laminin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP GLYCOPROTEIN; IMMUNOGLOBULIN SUPERFAMILY; SURFACE GLYCOPROTEIN; BINDING-SITES; INTEGRIN; DOMAINS; ERYTHROCYTES; PROTEINS; ANTIGENS; COMPLEX	Basal cell adhesion molecule (B-CAM) and Lutheran (LU) are two spliceoforms of a single immunoglobulin superfamily protein containing five Ig domains and comprise the sickle (SS) red cell receptor for laminin. We have now analyzed laminin binding to murine erythroleulremia cells transfected with various human B-CAM/LU constructs. B-CAM and LU bound equally well to laminin, indicating that the longer cytoplasmic tail of LU is not required for binding. However, binding of soluble laminin did require the presence of the membrane-proximal fifth immunoglobulin superfamily (IgSF) domain of LU, while deletion of IgSF domains 1, 2, 3, or 4 individually or together did not abrogate laminin binding. Under flow conditions, MEL cells expressing B-CAM, LU, and LU lacking domains 1, 2, 3, or 4 adhered to immobilized laminin with critical shear stresses over 10 dynes/cm(2). However, MEL cells expressing LU lacking domain 5 bound to laminin poorly (critical shear stress = 2.3 dynes/cm(2)). Moreover, expression of only IgSF domain 5 of LU was sufficient to mediate MEL cell adhesion to immobilized laminin (critical shear stress >10 dynes/cm(2)). Finally, Scatchard analysis showed that SS red cells had an average of 67% more B-CAM/LU than normal red cells, and low density red cells from sickle cell disease patients expressed 40-55% more B-CAM/LU than high density SS red cells. B-CAM/LU copy number thus may also play a role in the abnormal adhesion of SS red cells to laminin.	Duke Univ, Med Ctr, Div Hematol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Duke Comprehens Sickle Cell Ctr, Durham, NC 27710 USA; Duke Univ, Sch Engn, Durham, NC 27710 USA; Glasgow & W Scotland Blood Transfus Serv, Glasgow, Lanark, Scotland	Duke University; Duke University; Duke University	Zen, Q (corresponding author), Duke Univ, Med Ctr, Div Hematol, Box 2615, Durham, NC 27710 USA.	qinzen@acpub.duke.edu	Truskey, George A/B-2215-2012; Truskey, George/AAB-7793-2021	Truskey, George A/0000-0002-6885-4489; Truskey, George/0000-0002-6885-4489; Telen, Marilyn/0000-0003-3809-1780	NHLBI NIH HHS [R01 HL58939] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058939] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bowen MA, 1997, EUR J IMMUNOL, V27, P1469, DOI 10.1002/eji.1830270625; CAMPBELL IG, 1994, CANCER RES, V54, P5761; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; El Nemer W, 1998, J BIOL CHEM, V273, P16686; Embury Stephen H., 1994, P311; Engvall E, 1996, J CELL BIOCHEM, V61, P493; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Giancotti FG, 1996, J CELL SCI, V109, P1165; HEBBEL R, 1997, SICKL CELL DIS 21 CE, P109; Hillery CA, 1996, BLOOD, V87, P4879, DOI 10.1182/blood.V87.11.4879.bloodjournal87114879; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Karecla PI, 1996, J BIOL CHEM, V271, P30909, DOI 10.1074/jbc.271.48.30909; Klickstein LB, 1996, J BIOL CHEM, V271, P23920, DOI 10.1074/jbc.271.39.23920; KRAMER RH, 1994, METHOD ENZYMOL, V245, P129; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWENTHAL JW, 1985, J IMMUNOL, V135, P3988; MERCURIO AM, 1991, BIOESSAYS, V13, P169; MOEBIUS U, 1993, P NATL ACAD SCI USA, V90, P8259, DOI 10.1073/pnas.90.17.8259; Newham P, 1997, J BIOL CHEM, V272, P19429, DOI 10.1074/jbc.272.31.19429; Parsons SF, 1997, BLOOD, V89, P4219, DOI 10.1182/blood.V89.11.4219; PARSONS SF, 1995, P NATL ACAD SCI USA, V92, P5496, DOI 10.1073/pnas.92.12.5496; Rahuel C, 1996, BLOOD, V88, P1865; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SOWEMIMOCOKER SO, 1989, AM J HEMATOL, V31, P263, DOI 10.1002/ajh.2830310409; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; TELEN MJ, 1984, BLOOD, V64, P599; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204	28	65	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					728	734		10.1074/jbc.274.2.728	http://dx.doi.org/10.1074/jbc.274.2.728			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873008	hybrid			2022-12-27	WOS:000077968500023
J	Laitusis, AL; Brostrom, MA; Brostrom, CO				Laitusis, AL; Brostrom, MA; Brostrom, CO			The dynamic role of GRP78/BiP in the coordination of mRNA translation with protein processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-REGULATED PROTEIN; INITIATION-FACTOR 2-ALPHA; GH3 PITUITARY-CELLS; ENDOPLASMIC-RETICULUM; ADP-RIBOSYLATION; HEAT-SHOCK; MOLECULAR CHAPERONE; GENE-TRANSCRIPTION; SECRETORY PROTEINS; EUKARYOTIC CELLS	The role of GRP78/BiP in coordinating endoplasmic reticular (ER) protein processing with mRNA translation was examined in GH(3) pituitary cells. ADP-ribosylation of GRP78 and eukaryotic initiation factor (eIF)-2 alpha phosphorylation were assessed, respectively, as indices of chaperone inactivation and the inhibition of translational initiation. Inhibition of protein processing by ER stress (ionomycin and dithiothreitol) resulted in GRP78 deribosylation and eIF-2 phosphorylation, Suppression of translation relative to ER protein processing (cycloheximide) produced approximately 50% ADP-ribosylation of GRP78 within 90 min without eIF-2 phosphorylation, ADP-ribosylation was reversed in 90 min by cycloheximide removal in a manner accelerated by ER stressors. Cycloheximide sharply reduced eIF-2 phosphorylation in response to ER stressors for about 30 min; sensitivity returned as GRP78 became increasingly ADP-ribosylated, Reduced sensitivity of eIF-2 to phosphorylation appeared to derive from the accumulation of free, unmodified chaperone as proteins completed processing without replacements. Prolonged (24 h) incubations with cycloheximide resulted in the selective loss of the ADP-ribosylated form of GRP78 and increased sensitivity of eIF-2 phosphorylation in response to ER stressors. Brefeldin A decreased ADP-ribosylation of GRP78 in parallel with increased eIF-2 phosphorylation, The cytoplasmic stressor, arsenite, which inhibits translational initiation through eIF-2 phosphorylation without affecting the ER, also produced ADP-ribosylation of GRP78.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Brostrom, CO (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	brostrom@umdnj.edu						BANASIK M, 1994, MOL CELL BIOCHEM, V138, P185, DOI 10.1007/BF00928461; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Brostrom CO, 1996, J BIOL CHEM, V271, P24995, DOI 10.1074/jbc.271.40.24995; BROSTROM MA, 1995, J BIOL CHEM, V270, P4127, DOI 10.1074/jbc.270.8.4127; CARLSSON L, 1983, P NATL ACAD SCI-BIOL, V80, P4664, DOI 10.1073/pnas.80.15.4664; CHIN KV, 1987, J BIOL CHEM, V262, P16509; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HAAS IG, 1991, CURR TOP MICROBIOL, V167, P71; HENDERSHOT LM, 1988, MOL CELL BIOL, V8, P4250, DOI 10.1128/MCB.8.10.4250; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; KIM PS, 1992, J CELL BIOL, V118, P541, DOI 10.1083/jcb.118.3.541; KIM YK, 1987, J CELL PHYSIOL, V133, P553, DOI 10.1002/jcp.1041330317; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laitusis AL, 1998, ARCH BIOCHEM BIOPHYS, V354, P270, DOI 10.1006/abbi.1998.0712; LEDFORD BE, 1986, EUR J BIOCHEM, V161, P661, DOI 10.1111/j.1432-1033.1986.tb10491.x; LEDFORD BE, 1994, MOL CELL BIOCHEM, V138, P141, DOI 10.1007/BF00928456; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; LENO GH, 1989, EUR J BIOCHEM, V186, P205, DOI 10.1111/j.1432-1033.1989.tb15196.x; LENO GH, 1990, FEBS LETT, V276, P29, DOI 10.1016/0014-5793(90)80499-9; LEUSTEK T, 1991, ARCH BIOCHEM BIOPHYS, V289, P256, DOI 10.1016/0003-9861(91)90469-Y; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; LODISH HF, 1990, J BIOL CHEM, V265, P10893; MELLOR H, 1994, FEBS LETT, V350, P143, DOI 10.1016/0014-5793(94)00756-X; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; PROSTKO CR, 1992, J BIOL CHEM, V267, P16751; PROSTKO CR, 1991, J BIOL CHEM, V266, P19790; RESENDEZ E, 1986, J CELL BIOL, V103, P2145, DOI 10.1083/jcb.103.6.2145; SANDERS SL, 1992, CELL, V69, P353, DOI 10.1016/0092-8674(92)90415-9; STADDON JM, 1992, J BIOL CHEM, V267, P25239; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063	34	66	72	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					486	493		10.1074/jbc.274.1.486	http://dx.doi.org/10.1074/jbc.274.1.486			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867869	hybrid			2022-12-27	WOS:000077900200069
J	Tao, W; Deschenes, RJ; Fassler, JS				Tao, W; Deschenes, RJ; Fassler, JS			Intracellular glycerol levels modulate the activity of Sln1p, a Saccharomyces cerevisiae two-component regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION PATHWAY; ESCHERICHIA-COLI-LACZ; OSMOTIC-STRESS; CELL-CYCLE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; TRANSCRIPTION FACTOR; YEAST SACCHAROMYCES; GENE DISRUPTION; MESSENGER-RNA	The HOG mitogen-activated protein kinase pathway mediates the osmotic stress response in Saccharomyces cerevisiae, activating genes like GPD1 (glycerol phosphate dehydrogenase), required for survival under hyperosmotic conditions. Activity of this pathway is regulated by Sln1p, a homolog of the "two-component" histidine kinase family of signal transduction molecules prominent in bacteria. Sln1p also regulates the activity of a Hog1p-independent pathway whose transcriptional output can be monitored using an Mcm1p-dependent lacZ reporter gene. The relationship between the two Sln1p branches is unclear, however, the requirement for unphosphorylated pathway intermediates in Hog1p pathway activation and for phosphorylated intermediates in the activation of the Mcm1p reporter suggests that the two Sln1p branches are reciprocally regulated. To further investigate the signals and molecules involved in modulating Sln1p activity, we have screened for new mutations that elevate the activity of the Mcm1p-dependent lacZ reporter gene. We find that loss of function mutations in FPS1, a gene encoding the major glycerol transporter in yeast activates the reporter in a SLN1-dependent fashion. We propose that elevated intracellular glycerol levels in the fps1 mutant shift Sln1p to the phosphorylated state and trigger the Sln1-dependent activity of the Mcm1 reporter. These observations are consistent with a model in which Sln1p autophosphorylation is triggered by a hypo-osmotic stimulus and indicate that the Sln1p osmosensor is tied generally to osmotic balance, and may not specifically sense an external osmolyte.	Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Fassler, JS (corresponding author), Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA.	jan-fassler@uiowa.edu	Deschenes, Robert J/E-4926-2010	Deschenes, Robert J/0000-0001-8325-4257	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056719] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056719-02, R01 GM056719] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Attfield PV, 1997, NAT BIOTECHNOL, V15, P1351, DOI 10.1038/nbt1297-1351; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BLOMBERG A, 1989, J BACTERIOL, V171, P1087, DOI 10.1128/jb.171.2.1087-1092.1989; Blomberg A, 1997, YEAST, V13, P529; BREWSTER JL, 1994, YEAST, V10, P425, DOI 10.1002/yea.320100402; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; COSTIGAN C, 1992, MOL CELL BIOL, V12, P1162, DOI 10.1128/MCB.12.3.1162; DALE JE, 1986, PLANT PHYSL TREATISE, V9, P1; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; deMaranon IM, 1996, BIOCHEM BIOPH RES CO, V227, P519, DOI 10.1006/bbrc.1996.1539; Fassler JS, 1997, J BIOL CHEM, V272, P13365, DOI 10.1074/jbc.272.20.13365; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Gray WM, 1996, MOL CELL BIOL, V16, P347; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; GUSTIN MC, 1988, SCIENCE, V242, P762, DOI 10.1126/science.2460920; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; KUO MH, 1994, MOL CELL BIOL, V14, P348, DOI 10.1128/MCB.14.1.348; LARSON GP, 1983, GENE, V22, P31, DOI 10.1016/0378-1119(83)90061-6; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; LEE KS, 1992, MOL CELL BIOL, V12, P4396; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; MAGER WH, 1993, MOL MICROBIOL, V10, P253, DOI 10.1111/j.1365-2958.1993.tb01951.x; Nevoigt E, 1997, FEMS MICROBIOL REV, V21, P231, DOI 10.1111/j.1574-6976.1997.tb00352.x; ORTEGA JKE, 1989, BIOPHYS J, V56, P465, DOI 10.1016/S0006-3495(89)82694-3; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Philips J, 1997, J CELL BIOL, V138, P961, DOI 10.1083/jcb.138.5.961; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; PURVIS IJ, 1987, NUCLEIC ACIDS RES, V15, P7951, DOI 10.1093/nar/15.19.7951; PURVIS IJ, 1987, NUCLEIC ACIDS RES, V15, P7963, DOI 10.1093/nar/15.19.7963; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sherman F., 1986, METHODS YEAST GENETI, P163; SHIMIZU J, 1994, MOL GEN GENET, V242, P641, DOI 10.1007/BF00283417; SIKORSKI RS, 1989, GENETICS, V122, P19; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; Sutherland FCW, 1997, J BACTERIOL, V179, P7790, DOI 10.1128/jb.179.24.7790-7795.1997; TORRES L, 1991, MOL MICROBIOL, V5, P2845, DOI 10.1111/j.1365-2958.1991.tb01993.x; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; YU GY, 1995, J BIOL CHEM, V270, P8739, DOI 10.1074/jbc.270.15.8739; YU GY, 1993, MOL CELL BIOL, V13, P63, DOI 10.1128/MCB.13.1.63	50	58	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					360	367		10.1074/jbc.274.1.360	http://dx.doi.org/10.1074/jbc.274.1.360			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867851	Green Accepted, hybrid			2022-12-27	WOS:000077900200051
J	Asante-Appiah, E; Seeholzer, SH; Skalka, AM				Asante-Appiah, E; Seeholzer, SH; Skalka, AM			Structural determinants of metal-induced conformational changes in HIV-1 integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 INTEGRASE; PHOTO-CROSS-LINKING; RETROVIRAL INTEGRASE; DNA-BINDING; CATALYTIC DOMAIN; ZINC-BINDING; PROTEIN; MULTIMERIZATION; IDENTIFICATION; SEQUENCES	Human immunodeficiency virus type 1 (HIV-1) integrase (IN) undergoes a reversible metal-induced conformational change that activates the enzyme (Asante-Appiah, E., and Skalka, A. M. (1997) J. Biol. Chem. 272, 16196-16205), In this report, key structural features that mediate this conformational change have been identified by site-directed mutagenesis, limited proteolysis, and mass spectrometry studies. The results reveal two separable metal-induced effects, One depends on residues in the N-terminal domain (amino acids 1-50) and a C-terminal tail (amino acids 274-288) and is detected by increased resistance of the full-length protein to proteolytic digestion. This effect appears to depend on metal binding at an undefined location distinct from the known sites in the N-terminal and catalytic core domains. The second conformational change depends on metal binding at the active site in the catalytic core domain, Substitution of acidic residues Asp(64) Or Glu(152) in the catalytic core D,D(35)E motif or truncation of the Src homology 3 (SH3)-like domain in the C-terminal region of the enzyme abolishes this metal-induced change. Comparison of tryptic digests of an HIV-1 IN derivative competent for metal-induced conformational change and a conformation-defective D64N derivative identified specific regions in HIV-1 IN that are affected by this second change. A region in the N terminus that spans Lys(14), an extended loop and the adjacent region in the core domain (including lysines 136, 156, and 160 and Arg(173)), and residues at the C terminus beyond the SH3-like domain all become less accessible to proteolysis in the conformation-competent protein. In contrast, a region that encompasses Lys(258) in the putative DNA binding groove of the SHE-like domain becomes more sensitive to proteolysis in the presence of Mn2+. The results are consistent with a model in which the binding of the metal ion by residues of the D,D(35)E motif elicits specific changes in all three domains of HIV-1 IN, inducing the restructuring of the enzyme for catalytic competence.	Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Skalka, AM (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 7701 Burholme Ave, Philadelphia, PA 19111 USA.				NATIONAL CANCER INSTITUTE [R01CA071515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI040721, R01AI040385] Funding Source: NIH RePORTER; NCI NIH HHS [CA71515] Funding Source: Medline; NIAID NIH HHS [AI40385, AI40721] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrake MD, 1996, J BIOL CHEM, V271, P19633, DOI 10.1074/jbc.271.33.19633; Asante-Appiah E, 1997, ANTIVIR RES, V36, P139, DOI 10.1016/S0166-3542(97)00046-6; Asante-Appiah E, 1998, PROTEIN EXPRES PURIF, V12, P105, DOI 10.1006/prep.1997.0818; AsanteAppiah E, 1997, J BIOL CHEM, V272, P16196, DOI 10.1074/jbc.272.26.16196; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BEAVIS RC, 1998, PROTEIN ANAL WORKSHE; BIZUBBENDER D, 1994, AIDS RES HUM RETROV, V10, P1105, DOI 10.1089/aid.1994.10.1105; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; BUJACZ G, 1995, J MOL BIOL, V253, P333, DOI 10.1006/jmbi.1995.0556; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; BURKE CJ, 1992, J BIOL CHEM, V267, P9639; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; DRELICH M, 1992, VIROLOGY, V188, P459, DOI 10.1016/0042-6822(92)90499-F; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Eijkelenboom APAM, 1997, CURR BIOL, V7, P739, DOI 10.1016/S0960-9822(06)00332-0; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; ELLISON V, 1995, J BIOL CHEM, V270, P3320, DOI 10.1074/jbc.270.7.3320; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; FAYET O, 1990, MOL MICROBIOL, V4, P1771, DOI 10.1111/j.1365-2958.1990.tb00555.x; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Heuer TS, 1997, BIOCHEMISTRY-US, V36, P10655, DOI 10.1021/bi970782h; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; JOHNSON MS, 1986, P NATL ACAD SCI USA, V83, P7648, DOI 10.1073/pnas.83.20.7648; KHAN E, 1991, NUCLEIC ACIDS RES, V19, P851, DOI 10.1093/nar/19.4.851; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KULKOSKY J, 1995, VIROLOGY, V206, P448, DOI 10.1016/S0042-6822(95)80060-3; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; LAFEMINA RL, 1992, J VIROL, V66, P7414, DOI 10.1128/JVI.66.12.7414-7419.1992; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; PURASLUTZKE RA, 1994, NUCLEIC ACIDS RES, V22, P4125; VINCENT KA, 1993, J VIROL, V67, P425, DOI 10.1128/JVI.67.1.425-437.1993; VINK C, 1993, NUCLEIC ACIDS RES, V21, P1419, DOI 10.1093/nar/21.6.1419; Wolfe AL, 1996, J VIROL, V70, P1424, DOI 10.1128/JVI.70.3.1424-1432.1996; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	40	51	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35078	35087		10.1074/jbc.273.52.35078	http://dx.doi.org/10.1074/jbc.273.52.35078			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857042	hybrid			2022-12-27	WOS:000077719700060
J	Cheng, YJ; Lotan, R				Cheng, YJ; Lotan, R			Molecular cloning and characterization of a novel retinoic acid-inducible gene that encodes a putative G protein-coupled receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL DIFFERENTIATION; ACTIVATION FUNCTION AF-2; NUCLEAR RECEPTORS; CARCINOMA-CELLS; MESSENGER-RNA; CO-REPRESSOR; HUMAN GENOME; HUMAN HEAD; SEQUENCE; CANCER	The effects of retinoids such as all-trans-retinoic acid (ATRA) on cell growth, differentiation, and apoptosis are thought to be mediated by nuclear retinoid receptors, which are involved in ligand-dependent transcriptional activation of target genes. Using differential display, we identified the cDNA of a novel gene, designated retinoic acid-inducible gene 1 (RAIG1), which was induced by ATRA in the squamous carcinoma cell line UMSCC-22B, Two RAIG1 transcripts of 2.4 and 6.8 kilobase pairs, respectively, have the same ORF that encodes a 357-amino acid polypeptide. RAIG1 mRNA is expressed at high level in fetal and adult lung tissues. Induction of RAIG1 expression by ATRA is rapid (within 2 h) and dose-dependent in the range between 1 nM to 1 mu M. The constitutive RAIG1 mRNA levels, which were low in three of five head and neck and four of six lung cancer cell lines, increased after ATRA treatment in most cell lines. The deduced RAIG1 protein sequence contains seven transmembrane domains, characteristic of G protein-coupled receptors, A fusion protein of RAIG1 and the green fluorescent protein was localized in the cell surface membrane and perinuclear vesicles in transiently transfected cells. RAIG1 was mapped to chromosome 12p12.3-p13, Our results provide novel evidence for a possible interaction between retinoid and G protein signaling pathways.	Univ Texas, Md Anderson Canc Ctr, Dept Tumor Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Lotan, R (corresponding author), Univ Texas, Md Anderson Canc Ctr, Dept Tumor Biol, Houston, TX 77030 USA.	rlotan@notes.mdacc.tmc.edu			NATIONAL CANCER INSTITUTE [U19CA068437, P01CA052051, P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALDWIN JM, 1994, CURR OPIN CELL BIOL, V6, P180, DOI 10.1016/0955-0674(94)90134-1; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; GALVINPARTON PA, 1990, J BIOL CHEM, V265, P17771; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; HONG WK, 1986, NEW ENGL J MED, V315, P1501, DOI 10.1056/NEJM198612113152401; HONG WK, 1990, NEW ENGL J MED, V323, P795, DOI 10.1056/NEJM199009203231205; Hong WK, 1997, SCIENCE, V278, P1073, DOI 10.1126/science.278.5340.1073; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; JETTEN AM, 1990, INT J CANCER, V45, P195, DOI 10.1002/ijc.2910450135; Jho EH, 1997, J BIOL CHEM, V272, P24468, DOI 10.1074/jbc.272.39.24468; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRAUTER K, 1995, NATURE, V377, P321; KURIE JM, 1994, BBA-MOL CELL RES, V1222, P88, DOI 10.1016/0167-4889(94)90028-0; KWIATKOWSKI TJ, 1990, NUCLEIC ACIDS RES, V18, P7191, DOI 10.1093/nar/18.23.7191; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LeDouarin B, 1997, BIOCHEM SOC T, V25, P605, DOI 10.1042/bst0250605; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LOTAN R, 1994, CANCER RES, V54, pS1987; Lotan R, 1997, ENVIRON HEALTH PERSP, V105, P985, DOI 10.2307/3433315; Lotan R, 1996, FASEB J, V10, P1031, DOI 10.1096/fasebj.10.9.8801164; LOVE JM, 1994, CURR OPIN CELL BIOL, V6, P825, DOI 10.1016/0955-0674(94)90051-5; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Minucci S, 1996, CURR OPIN GENET DEV, V6, P567, DOI 10.1016/S0959-437X(96)80085-2; MORRISSKAY G, 1993, BIOESSAYS, V15, P9, DOI 10.1002/bies.950150103; MorrissKay GM, 1996, FASEB J, V10, P961, DOI 10.1096/fasebj.10.9.8801178; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; ONATE SA, 1995, SCIENCE, V270, P1354; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shalinsky DR, 1997, CANCER RES, V57, P162; Sporn M.B., 1994, RETINOIDS BIOL CHEM; Stadel JM, 1997, TRENDS PHARMACOL SCI, V18, P430, DOI 10.1016/S0165-6147(97)01117-6; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; Tarasova NI, 1997, J BIOL CHEM, V272, P14817, DOI 10.1074/jbc.272.23.14817; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wahle E, 1997, PROG NUCLEIC ACID RE, V57, P41, DOI 10.1016/S0079-6603(08)60277-9; Wang Y., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P275; WATKINS DC, 1992, SCIENCE, V258, P1373, DOI 10.1126/science.1455234; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Zahn S, 1997, EUR J IMMUNOL, V27, P935, DOI 10.1002/eji.1830270420; ZOU CP, 1994, CANCER RES, V54, P5479	47	115	126	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35008	35015		10.1074/jbc.273.52.35008	http://dx.doi.org/10.1074/jbc.273.52.35008			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857033	hybrid			2022-12-27	WOS:000077719700051
J	Horton, MR; McKee, CM; Bao, G; Liao, F; Farber, JM; Hodge-DuFour, J; Pure, E; Oliver, BL; Wright, TM; Noble, PW				Horton, MR; McKee, CM; Bao, G; Liao, F; Farber, JM; Hodge-DuFour, J; Pure, E; Oliver, BL; Wright, TM; Noble, PW			Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines Mig and interferon-inducible protein-10 in mouse macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY FIBROSIS; NECROSIS-FACTOR-ALPHA; BRONCHOALVEOLAR LAVAGE FLUID; NITRIC-OXIDE SYNTHASE; FACTOR KAPPA-B; ALVEOLAR MACROPHAGES; GENE-EXPRESSION; IFN-GAMMA; MURINE MACROPHAGES; T-LYMPHOCYTES	Hallmarks of chronic inflammation and tissue fibrosis are increased influx of activated inflammatory cells, mediator release, and increased turnover and production of the extracellular matrix (ECM). Recent evidence has suggested that fragments of the ECM component hyaluronan play a role in chronic inflammation by inducing macrophage expression of chemokines. Interferon-gamma (IFN-gamma), an important regulator of macrophage functions, has been shown to induce the C-X-C chemokines Mig and IP-10. These chemokines affect T-cell recruitment and inhibit angiogenesis. The purpose of this investigation was to determine the effect of hyaluronan (HA) on IFN-gamma-induced Mig and IP-10 expression in mouse macrophages. We found a marked synergy between HA and IFN-gamma on Mig and IP-10 mRNA and protein expression in mouse macrophages. This was most significant with Mig, which was not induced by HA alone. The synergy was specific for HA, was not dependent on new protein synthesis, was not mediated by tumor necrosis factor-cy, was selective for Mig and IP-10, and occurred at the level of gene transcription. These data suggest that the ECM component HA may influence chronic inflammatory states by working in concert with IFN-gamma to alter macrophage chemokine expression.	Yale Univ, Sch Med, Dept Vet Affairs Connecticut Healthcare Syst, Pulm Sect, W Haven, CT 06516 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; Wistar Inst, Pittsburgh, PA 15261 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); The Wistar Institute; University of Pennsylvania; Yale University	Noble, PW (corresponding author), Yale Univ, Sch Med, Dept Vet Affairs Connecticut Healthcare Syst, Pulm Sect, 950 Campbell Ave,111A, W Haven, CT 06516 USA.	paul.noble@yale.edu	Liao, Fang/S-7021-2018		NHLBI NIH HHS [R01HL60539, K11HL02880, 5F32HL09614-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060539, F32HL009614, K11HL002880] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amichay D, 1996, J IMMUNOL, V157, P4511; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Asensio VC, 1997, J VIROL, V71, P7832, DOI 10.1128/JVI.71.10.7832-7840.1997; BALAZS EA, 1967, ARTHRITIS RHEUM, V10, P357, DOI 10.1002/art.1780100407; BJERMER L, 1989, THORAX, V44, P126, DOI 10.1136/thx.44.2.126; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; CARRE PC, 1991, J CLIN INVEST, V88, P1802, DOI 10.1172/JCI115501; CLARK RAF, 1988, J BIOL CHEM, V263, P12115; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Ebnet K, 1996, ANN NY ACAD SCI, V797, P107, DOI 10.1111/j.1749-6632.1996.tb52953.x; FARBER JM, 1993, BIOCHEM BIOPH RES CO, V192, P223, DOI 10.1006/bbrc.1993.1403; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; FLESCH IEA, 1994, INT IMMUNOL, V6, P693, DOI 10.1093/intimm/6.5.693; GAULDIE J, 1993, THORAX, V48, P931, DOI 10.1136/thx.48.9.931; GAZZINIELLI RT, 1992, J IMMUNOL, V148, P1752; GREENBERG M, 1995, CURRENT PROTOCOLS MO, V1; GUYER NB, 1995, J IMMUNOL, V155, P3472; HALLGREN R, 1985, BRIT MED J, V290, P1778, DOI 10.1136/bmj.290.6484.1778; HANCE AJ, 1975, AM REV RESPIR DIS, V112, P657; HIDENORI K, 1996, CELL, V87, P1069; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Horton MR, 1998, J IMMUNOL, V160, P3023; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; LASKIN DL, 1994, AM J RESP CELL MOL, V10, P58, DOI 10.1165/ajrcmb.10.1.8292381; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LAZAAR AL, 1994, J EXP MED, V180, P807, DOI 10.1084/jem.180.3.807; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Lokuta MA, 1996, J BIOL CHEM, V271, P13731, DOI 10.1074/jbc.271.23.13731; LUSTER AD, 1993, J EXP MED, V178, P1057, DOI 10.1084/jem.178.3.1057; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; MARTINET Y, 1987, NEW ENGL J MED, V317, P202, DOI 10.1056/NEJM198707233170404; MBAWUIKE IN, 1989, J LEUKOCYTE BIOL, V46, P119, DOI 10.1002/jlb.46.2.119; McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Narumi S, 1997, J IMMUNOL, V158, P5536; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; OHMORI Y, 1994, J IMMUNOL, V153, P2204; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; RENNARD SI, 1981, P NATL ACAD SCI-BIOL, V78, P7147, DOI 10.1073/pnas.78.11.7147; ROM WN, 1988, J CLIN INVEST, V82, P1685, DOI 10.1172/JCI113781; STRIETER RM, 1995, SHOCK, V4, P155, DOI 10.1097/00024382-199509000-00001; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; VANGURI P, 1990, J BIOL CHEM, V265, P15049; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; WONG P, 1994, MOL CELL BIOL, V14, P914, DOI 10.1128/MCB.14.2.914; WRIGHT TM, 1991, J EXP MED, V173, P417, DOI 10.1084/jem.173.2.417	52	146	151	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35088	35094		10.1074/jbc.273.52.35088	http://dx.doi.org/10.1074/jbc.273.52.35088			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857043	hybrid			2022-12-27	WOS:000077719700061
J	Li, XQ; Zhao, XN; Fang, Y; Jiang, X; Duong, T; Fan, C; Huang, CC; Kain, SR				Li, XQ; Zhao, XN; Fang, Y; Jiang, X; Duong, T; Fan, C; Huang, CC; Kain, SR			Generation of destabilized green fluorescent protein transcription reporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ORNITHINE DECARBOXYLASE; INTRACELLULAR DEGRADATION; GENE-EXPRESSION; MAMMALIAN-CELLS; CODON USAGE; PROTEOLYSIS; PROTEASES; MUTATIONS; ENZYME	The green fluorescent protein (GFP) is a widely used reporter in gene expression and protein localization studies. GFP is a stable protein; this property allows its accumulation and easy detection in cells. However, this stability also limits its application in studies that require rapid reporter turnover. We created a destabilized GFP for use in such studies by fusing amino acids 422-461 of the degradation domain of mouse ornithine decarboxylase (MODC) to the C-terminal end of an enhanced variant of GFP (EGFP), The fusion protein, unlike EGFP, was unstable in the presence of cycloheximide and had a fluorescence half-life of 2 h, Western blot analysis indicated that the fluorescence decay of EGFP-MODC-(422-461) was correlated with degradation of the fusion protein. We mutated key amino acids in the PEST sequence of EGFP-MODC-(422-461) and identified several mutants with variable half-lives. The suitability of destabilized EGFP as a transcription reporter was tested by linking it to NF kappa B binding sequences and monitoring tumor necrosis factor cu-mediated NF kappa B activation. We obtained time course induction and dose response kinetics similar to secreted alkaline phosphatase obtained in transfected cells. This result did not occur when unmodified EGFP was used as the reporter. Because of its autofluorescence, destabilized EGFP can be used to directly correlate gene induction with biochemical change, such as NF kappa B translocation to the nucleus.	CLONTECH Labs Inc, Palo Alto, CA 94303 USA		Li, XQ (corresponding author), CLONTECH Labs Inc, 1020 E Meadow Circle, Palo Alto, CA 94303 USA.	xqli@clontech.com						ABRAMS SB, 1998, CIRCADIAN RHYTHMS AR, P24; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BERCOVICH Z, 1989, J BIOL CHEM, V264, P15949; CHALFIE M, 1995, PHOTOCHEM PHOTOBIOL, V62, P651, DOI 10.1111/j.1751-1097.1995.tb08712.x; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; GHODA L, 1990, J BIOL CHEM, V265, P11823; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOTTESMAN S, 1992, MICROBIOL REV, V56, P592, DOI 10.1128/MMBR.56.4.592-621.1992; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; INOUYE S, 1994, FEBS LETT, V351, P211, DOI 10.1016/0014-5793(94)00859-0; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; PAPAVASSILIOU AG, 1992, SCIENCE, V258, P1941, DOI 10.1126/science.1470918; PHILLIPS MA, 1987, J BIOL CHEM, V262, P8721; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; Rechsteiner M, 1990, Semin Cell Biol, V1, P433; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; ROSENBERGHASSON Y, 1989, EUR J BIOCHEM, V185, P469, DOI 10.1111/j.1432-1033.1989.tb15138.x; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592	34	598	640	1	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34970	34975		10.1074/jbc.273.52.34970	http://dx.doi.org/10.1074/jbc.273.52.34970			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857028	hybrid			2022-12-27	WOS:000077719700046
J	Saragovi, HU; Zheng, WH; Maliartchouk, S; DiGugliemo, GM; Mawal, YR; Kamen, A; Woo, SB; Cuello, AC; Debeir, T; Neet, KE				Saragovi, HU; Zheng, WH; Maliartchouk, S; DiGugliemo, GM; Mawal, YR; Kamen, A; Woo, SB; Cuello, AC; Debeir, T; Neet, KE			A TrkA-selective, fast internalizing nerve growth factor-antibody complex induces trophic but not neuritogenic signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING; PC12 CELLS; SYMPATHETIC NEURONS; HIGH-AFFINITY; PROTOONCOGENE PRODUCT; BIOLOGICAL-ACTIVITIES; RETROGRADE SIGNAL; CARBOXYL-TERMINUS; NGF; DIFFERENTIATION	Nerve growth factor (NGF) is a neurotrophin that induces neuritogenic and trophic signals by binding to TrkA and/or p75 receptors. We report a comparative study of the binding, internalization, and biological activity of NGF versus that of NGF in association with an anti-NGF monoclonal antibody (mAb NGF30), directed against the C termini of NGF. NGF mAb complexes do not bind p75 effectively but bind TrkA with high affinity. After binding, NGF mAb complexes stimulate internalization faster and to a larger degree than NGF. NGF.mAb-induced activation of TrkA, Shc, and MAPK is transient compared with NGF-induced activation; yet NGF and NGF mAb afford identical trophic responses. In contrast, NGF induces Suc-1-associated neurotrophic activating protein phosphorylation and neuritogenic differentiation, but NGF mAb does not. Thus, an absolute separation of trophic and neuritogenic function is seen for NGF.mAb, suggesting that biological response modifiers of neurotrophins can afford ligands with selected activities.	McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Oncol Canc Ctr, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Cell Biol, Montreal, PQ H3G 1Y6, Canada; Natl Res Council, Biotechnol Res Inst, Montreal, PQ H3G 1Y6, Canada; Finch Univ Hlth Sci Chicago Med Sch, Dept Biol Chem, N Chicago, IL 60064 USA	McGill University; McGill University; McGill University; National Research Council Canada; Chicago Medical School	Saragovi, HU (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Drummond St,1320, Montreal, PQ H3G 1Y6, Canada.	Uri@pharma.mcgill.ca	Cuello, A. Claudio/N-8211-2015	Cuello, Claudio/0000-0003-2143-2745	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024380] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24380] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; BATISTATOU A, 1991, J CELL BIOL, V115, P461, DOI 10.1083/jcb.115.2.461; Beattie EC, 1996, COLD SPRING HARB SYM, V61, P389; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; BROWN VI, 1991, DNA CELL BIOL, V10, P399, DOI 10.1089/dna.1991.10.399; Canossa M, 1996, J BIOL CHEM, V271, P5812, DOI 10.1074/jbc.271.10.5812; Carter BD, 1997, NEURON, V18, P187, DOI 10.1016/S0896-6273(00)80259-7; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; COUNTAWAY JL, 1990, J BIOL CHEM, V265, P3407; Dechant G, 1997, J NEUROSCI, V17, P5281; DRINKWATER CC, 1993, J BIOL CHEM, V268, P23202; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; Gargano N, 1997, J NEUROSCI RES, V50, P1; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HEASLEY LE, 1992, MOL BIOL CELL, V3, P545, DOI 10.1091/mbc.3.5.545; HEFTI F, 1985, NEUROSCIENCE, V14, P55, DOI 10.1016/0306-4522(85)90163-0; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IBANEZ CF, 1994, J NEUROBIOL, V25, P1349, DOI 10.1002/neu.480251104; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KENIGSBERG RL, 1991, J IMMUNOL METHODS, V136, P247, DOI 10.1016/0022-1759(91)90011-4; Kruttgen A, 1997, J BIOL CHEM, V272, P29222, DOI 10.1074/jbc.272.46.29222; KULLANDER K, 1994, J NEUROSCI RES, V39, P195, DOI 10.1002/jnr.490390210; Kullander K, 1997, J BIOL CHEM, V272, P9300; LESAUTEUR L, 1995, J BIOL CHEM, V270, P6564, DOI 10.1074/jbc.270.12.6564; LeSauteur L, 1996, J NEUROSCI, V16, P1308; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LUO Y, 1992, J BIOL CHEM, V267, P12275; MacDonald JIS, 1996, MOL CELL NEUROSCI, V7, P371, DOI 10.1006/mcne.1996.0027; Maliartchouk S, 1997, J NEUROSCI, V17, P6031; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; Meakin SO, 1997, J NEUROCHEM, V69, P954; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; NANDURI J, 1994, J NEUROSCI RES, V37, P433, DOI 10.1002/jnr.490370402; NEBREDA AR, 1991, SCIENCE, V252, P558, DOI 10.1126/science.1850550; PENG X, 1995, NEURON, V15, P395, DOI 10.1016/0896-6273(95)90043-8; PEREZ P, 1995, MOL CELL NEUROSCI, V6, P97, DOI 10.1006/mcne.1995.1010; RABIN SJ, 1993, MOL CELL BIOL, V13, P2203, DOI 10.1128/MCB.13.4.2203; RAFFIONI S, 1995, J BIOL CHEM, V270, P7568, DOI 10.1074/jbc.270.13.7568; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Ross GM, 1997, NAT MED, V3, P872, DOI 10.1038/nm0897-872; Ross GM, 1998, EUR J NEUROSCI, V10, P890, DOI 10.1046/j.1460-9568.1998.00094.x; Shamovsky IL, 1996, J AM CHEM SOC, V118, P9743, DOI 10.1021/ja9611194; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Torcia M, 1996, CELL, V85, P345, DOI 10.1016/S0092-8674(00)81113-7; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; WINDISCH JM, 1995, J BIOL CHEM, V270, P28133; Woo SB, 1998, PROTEIN SCI, V7, P1006; Woo SB, 1996, J BIOL CHEM, V271, P24433, DOI 10.1074/jbc.271.40.24433; Yamada M, 1996, J NEUROSCI RES, V43, P355, DOI 10.1002/(SICI)1097-4547(19960201)43:3<355::AID-JNR10>3.0.CO;2-4; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240; Yoon SO, 1997, J BIOL CHEM, V272, P23231, DOI 10.1074/jbc.272.37.23231	56	81	100	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34933	34940		10.1074/jbc.273.52.34933	http://dx.doi.org/10.1074/jbc.273.52.34933			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857023	hybrid			2022-12-27	WOS:000077719700041
J	Eckhart, L; Ban, J; Ballaun, C; Weninger, W; Tschachler, E				Eckhart, L; Ban, J; Ballaun, C; Weninger, W; Tschachler, E			Reverse transcription-polymerase chain reaction products of alternatively spliced mRNAs form DNA heteroduplexes and heteroduplex complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR FAMILY; RNA; PCR; QUANTIFICATION; IDENTIFICATION; PROTEINS; DEATH	Reverse transcription-polymerase chain reaction (RT-PCR) is frequently used to simultaneously detect mRNA isoforms, which are generated by alternative splicing. Here we characterize two previously unrecognized RT-PCR products of vascular endothelial growth factor (VEGF) RNA. DNA products with apparent sizes of 600 and 1200 base pairs (bp) were detected at high cycle numbers. Heat denaturation of the smaller product and subsequent reannealing revealed that it was a heteroduplex consisting of two different DNA strands. These were identified by DNA sequencing as the amplification products of two VEGF transcripts, i.e. VEGF(121) and VEGF(165), which differ by the presence of one exon, S1 nuclease analysis showed that this exon is bulged out as a single-stranded loop. Purified heteroduplexes in solution were found to form a 1200-bp DNA product which could be reconverted into 600-bp DNA heteroduplexes by mild denaturation at 70 degrees C. These findings suggest that this product is formed by base pairing of complementary heteroduplex loops and represents a novel four-stranded DNA structure.	Univ Vienna, Sch Med, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria; Ctr Rech & Invest Epiderm & Sensorielle, F-92521 Sur Seine, France; Inst Canc Res, Bratislava 83391, Slovakia	University of Vienna; Slovak Academy of Sciences	Tschachler, E (corresponding author), Univ Vienna, Sch Med, Dept Dermatol, Div Immunol Allergy & Infect Dis, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	Erwin.Tschachler@akh-wien.ac.at		Tschachler, Erwin/0000-0002-0248-1798; Eckhart, Leopold/0000-0002-5645-2036				BALLAUN C, 1995, J INVEST DERMATOL, V104, P7, DOI 10.1111/1523-1747.ep12613450; BECKERANDRE M, 1989, NUCLEIC ACIDS RES, V17, P9437, DOI 10.1093/nar/17.22.9437; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; CHARNOCKJONES DS, 1993, BIOL REPROD, V48, P1120, DOI 10.1095/biolreprod48.5.1120; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; GREGORIAN RS, 1995, J MOL BIOL, V248, P968, DOI 10.1006/jmbi.1995.0275; Henley WN, 1996, BIOCHEM BIOPH RES CO, V226, P113, DOI 10.1006/bbrc.1996.1319; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; Mujeeb A, 1998, NAT STRUCT BIOL, V5, P432, DOI 10.1038/nsb0698-432; PARSONS CA, 1995, EMBO J, V14, P5736, DOI 10.1002/j.1460-2075.1995.tb00260.x; Poltorak Z, 1997, J BIOL CHEM, V272, P7151, DOI 10.1074/jbc.272.11.7151; ROBERTS RG, 1994, PCR PRACTICAL APPROA, V1, P51; Robinson CA, 1997, GENE, V198, P1, DOI 10.1016/S0378-1119(97)00305-3; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578	14	41	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2613	2615		10.1074/jbc.274.5.2613	http://dx.doi.org/10.1074/jbc.274.5.2613			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915788	hybrid			2022-12-27	WOS:000078319500006
J	Aizawa, T; Fujitani, N; Hayakawa, Y; Ohnishi, A; Ohkubo, T; Kumaki, Y; Kawano, K; Hikichi, K; Nitta, K				Aizawa, T; Fujitani, N; Hayakawa, Y; Ohnishi, A; Ohkubo, T; Kumaki, Y; Kawano, K; Hikichi, K; Nitta, K			Solution structure of an insect growth factor, growth-blocking peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SITE-DIRECTED MUTAGENESIS; SPECTROSCOPY; HEMOLYMPH; IDENTIFICATION; ARMYWORM; SPECTRA; LARVAE	Growth-blocking peptide (GBP) is an insect growth factor consisting of 25 amino acid residues that retards the development of lepidopteran larvae at high concentration while it stimulates larval growth at low concentration. In this study, we determined the solution structure of GBP by two-dimensional H-1 NMR spectroscopy. The structure contains a short segment of double-stranded beta-sheet involving residues 11-13 and 19-21 and a type-II beta-turn in the loop region (residues 8-11), whereas the N and C termini are disordered. This is the first report of the three-dimensional structure of the peptiderigic insect growth factor, and the structure of the well defined region of GBP was found to share similarity with that of the C-terminal domain of the epidermal growth factor (EGF). Because GBP has been reported to stimulate DNA synthesis of not only insect cells but also human keratinocyte cells at the same level with EGF, the structural similarity between GBP and EGF may lead to the interaction of GBP to EGF receptor.	Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Toyama 9300194, Japan; Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan; Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan	University of Toyama; Hokkaido University; Hokkaido University	Kawano, K (corresponding author), Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, 2630 Sugitani, Toyama 9300194, Japan.		Kawano, Keiichi/F-5265-2011; Fujitani, Naoki/A-4072-2012; Aizawa, Tomoyasu/F-5278-2011	Aizawa, Tomoyasu/0000-0001-9134-7576; Fujitani, Naoki/0000-0002-4035-7317; Ohnishi, Atsushi/0000-0003-1213-4439				BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BRUNGER AT, 1992, XPLOR VERSION 3 1; Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; DUDGEON TJ, 1990, FEBS LETT, V261, P392, DOI 10.1016/0014-5793(90)80600-N; ENGLER DA, 1990, FEBS LETT, V271, P47, DOI 10.1016/0014-5793(90)80368-S; Hayakawa Y, 1998, BIOCHEM BIOPH RES CO, V250, P194, DOI 10.1006/bbrc.1998.8959; HAYAKAWA Y, 1990, J BIOL CHEM, V265, P10813; HAYAKAWA Y, 1991, J BIOL CHEM, V266, P7982; HAYAKAWA Y, 1995, FEBS LETT, V376, P185, DOI 10.1016/0014-5793(95)01273-7; HAYAKAWA Y, 1994, J BIOCHEM-TOKYO, V115, P15, DOI 10.1093/oxfordjournals.jbchem.a124291; HAYAKAWA Y, 1993, INSECT BIOCHEM MOLEC, V23, P225, DOI 10.1016/0965-1748(93)90003-B; HAYAKAWA Y, 1995, MOL MECH INSECT META, P55; KOHDA D, 1992, BIOCHEMISTRY-US, V31, P11928, DOI 10.1021/bi00162a036; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; Noguchi H, 1997, FEBS LETT, V413, P157, DOI 10.1016/S0014-5793(97)00848-X; Ohnishi A, 1995, INSECT BIOCHEM MOLEC, V25, P1121, DOI 10.1016/0965-1748(95)00054-2; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; SKINNER WS, 1991, J BIOL CHEM, V266, P12873; Wuthrich K, 1986, NMR PROTEINS NUCL AC; ZUIDERWEG ERP, 1986, J MAGN RESON, V70, P336, DOI 10.1016/0022-2364(86)90020-X	21	37	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1887	1890		10.1074/jbc.274.4.1887	http://dx.doi.org/10.1074/jbc.274.4.1887			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890941	hybrid			2022-12-27	WOS:000078185200008
J	Doi, Y; Itoh, M; Yonemura, S; Ishihara, S; Takano, H; Noda, T; Tsukita, S; Tsukita, S				Doi, Y; Itoh, M; Yonemura, S; Ishihara, S; Takano, H; Noda, T; Tsukita, S; Tsukita, S			Normal development of mice and unimpaired cell adhesion cell motility actin-based cytoskeleton without compensatory up-regulation of ezrin or radixin in moesin gene knockout	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROFIBROMATOSIS-2 TUMOR-SUPPRESSOR; TYROSINE KINASE SUBSTRATE; EPIDERMAL GROWTH-FACTOR; EMBRYONIC STEM-CELLS; ERM FAMILY MEMBERS; MEMBRANE ASSOCIATION; TERMINAL DOMAIN; PROTEIN FAMILY; CDNA SEQUENCE; BINDING-SITE	Ezrin/radixin/moesin (ERM) proteins are general cross-linkers between the plasma membrane and actin filaments. Because their expression is regulated in a tissue-specific manner, each ERM protein has been proposed to have unique functions. On the other hand, experiments at the cellular level and in vitro have suggested their functional redundancy. To assess the possible unique functions of ERM proteins in vivo, the moesin gene located on the X chromosome was disrupted by gene targeting in embryonic stem cells. Male mice hemizygous for the mutation as well as homozygous females were completely devoid of moesin but developed normally and were fertile, with no obvious histological abnormalities in any of the tissues examined. In the tissues of the mutant mice, moesin completely disappeared without affecting the expression levels or subcellular distribution of ezrin and radixin, Also, in platelets, fibroblasts, and mast cells isolated from moesin-deficient mice, targeted disruption of the moesin gene did not affect their ERM-dependent functions, i.e. platelet aggregation, stress fiber/focal contact formation of fibroblasts, and microvillar formation of mast cells, without compensatory up-regulation of ezrin or radixin, These findings favor the notion that ERM proteins are functionally redundant at the cellular as well as the whole body level.	Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 606, Japan; Osaka Univ, Sch Med, Dept Internal Med 2, Suita, Osaka 565, Japan; Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Toshima Ku, Tokyo 170, Japan; Tohoku Univ, Sch Med, Dept Mol Genet, Sendai, Miyagi 980, Japan; Kyoto Univ, Coll Med Technol, Sakyo Ku, Kyoto 606, Japan	Kyoto University; Osaka University; Japanese Foundation for Cancer Research; Tohoku University; Kyoto University	Tsukita, S (corresponding author), Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 606, Japan.	atsukita@mfour.med.kyoto-u.ac.jp; atsukita@mfour.med.kyoto-u.ac.jp	Noda, Tetsuo/B-1667-2016					AMIEVA MR, 1994, EXP CELL RES, V210, P140, DOI 10.1006/excr.1994.1021; AMIEVA MR, 1995, EXP CELL RES, V219, P180, DOI 10.1006/excr.1995.1218; ARPIN M, 1994, CURR OPIN CELL BIOL, V6, P136, DOI 10.1016/0955-0674(94)90127-9; BERRYMAN M, 1995, J CELL BIOL, V131, P1231, DOI 10.1083/jcb.131.5.1231; BERRYMAN M, 1993, J CELL SCI, V105, P1025; BRETSCHER A, 1983, J CELL BIOL, V97, P425, DOI 10.1083/jcb.97.2.425; BRETSCHER A, 1989, J CELL BIOL, V108, P921, DOI 10.1083/jcb.108.3.921; Bretscher A, 1997, J CELL SCI, V110, P3011; Bretscher A, 1993, CURR OPIN CELL BIOL, V5, P653, DOI 10.1016/0955-0674(93)90136-E; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; EDWARDS KA, 1994, P NATL ACAD SCI USA, V91, P4589, DOI 10.1073/pnas.91.10.4589; FRANCK Z, 1993, J CELL SCI, V105, P219; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FUNAYAMA N, 1991, J CELL BIOL, V115, P1039, DOI 10.1083/jcb.115.4.1039; GARY R, 1993, P NATL ACAD SCI USA, V90, P10846, DOI 10.1073/pnas.90.22.10846; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; GOULD KL, 1986, J CELL BIOL, V102, P660, DOI 10.1083/jcb.102.2.660; GOULD KL, 1989, EMBO J, V8, P4133, DOI 10.1002/j.1460-2075.1989.tb08598.x; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; HUNTER T, 1981, CELL, V24, P741, DOI 10.1016/0092-8674(81)90100-8; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; KISHINO T, 1994, CYTOGENET CELL GENET, V66, P167, DOI 10.1159/000133692; Kondo T, 1997, J CELL BIOL, V139, P749, DOI 10.1083/jcb.139.3.749; LANKES W, 1988, BIOCHEM J, V251, P831, DOI 10.1042/bj2510831; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; MAGENDANTZ M, 1995, J BIOL CHEM, V270, P25324, DOI 10.1074/jbc.270.43.25324; Martin M, 1997, MOL BIOL CELL, V8, P1543, DOI 10.1091/mbc.8.8.1543; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PAKKANEN R, 1987, J HISTOCHEM CYTOCHEM, V35, P809, DOI 10.1177/35.8.3298422; PESTONJAMASP K, 1995, MOL BIOL CELL, V6, P247, DOI 10.1091/mbc.6.3.247; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Roy C, 1997, J BIOL CHEM, V272, P20088, DOI 10.1074/jbc.272.32.20088; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; SATO N, 1992, J CELL SCI, V103, P131; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SCHWARTZALBIEZ R, 1995, EUR J CELL BIOL, V67, P189; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; TSUKITA S, 1989, J CELL BIOL, V108, P2369, DOI 10.1083/jcb.108.6.2369; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; TURUNEN O, 1989, J BIOL CHEM, V264, P16727; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Vaheri A, 1997, CURR OPIN CELL BIOL, V9, P659, DOI 10.1016/S0955-0674(97)80119-6; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; WILGENBUS KK, 1993, GENOMICS, V16, P199, DOI 10.1006/geno.1993.1159; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; YONEMURA S, 1993, J CELL BIOL, V120, P437, DOI 10.1083/jcb.120.2.437	62	134	137	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2315	2321		10.1074/jbc.274.4.2315	http://dx.doi.org/10.1074/jbc.274.4.2315			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890997	hybrid			2022-12-27	WOS:000078185200064
J	Jiang, XM; Fitzgerald, M; Grant, CM; Hogg, PJ				Jiang, XM; Fitzgerald, M; Grant, CM; Hogg, PJ			Redox control of exofacial protein thiols/disulfides by protein disulfide isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; EXOCRINE PANCREATIC-CELLS; LUMINAL ER PROTEINS; HAMSTER OVARY CELLS; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; PROTEINDISULFIDE ISOMERASE; MULTIFUNCTIONAL PROTEIN; PROLYL 4-HYDROXYLASE; HUMAN-LYMPHOCYTES	Protein disulfide isomerase (PDI) facilitates proper folding and disulfide bonding of nascent proteins in the endoplasmic reticulum and is secreted by cells and associates with the cell surface, We examined the consequence of over- or underexpression of PDI in HT1080 fibrosarcoma cells for the redox state of cell-surface protein thiols/disulfides. Overexpression of PDI resulted in 3.6-4.2-fold enhanced secretion of PDI and 1.5-1.7-fold increase in surface-bound PDI. Antisense-mediated underexpression of PDI caused 38-53% decreased secretion and 10-33% decrease in surface-bound PDI. Using 5,5'-dithio-bis(2-nitrobenzoic acid) to measure surface protein thiols, a 41-50% increase in surface thiols was observed in PDI-overexpressing cells, whereas a 29-33% decrease was observed in underexpressing cells. Surface thiol content was strongly correlated with cellular (r = 0.998) and secreted (r = 0.969) PDI levels. The pattern of exofacial protein thiols was examined by labeling with the membrane-impermeable thiol reactive compound, 3-(N-maleimidylpropionyl)biocytin. Fourteen identifiable proteins on HT1080 cells were labeled with 3-(N-maleimidylpropionyl)biocytin. The intensity of labeling of 11 proteins was increased with overexpression of PDI, whereas the intensity of labeling of 3 of the 11 proteins was clearly decreased with underexpression of PDI, These findings indicated that secreted PDI was controlling the redox state of existing exofacial protein thiols or reactive disulfide bonds.	Univ New S Wales, Ctr Thrombosis & Vasc Res, Sch Pathol, Sydney, NSW 2052, Australia; Univ New S Wales, CRC Food Ind Innovat, Dept Biochem, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Hogg, PJ (corresponding author), Univ New S Wales, Ctr Thrombosis & Vasc Res, Sch Pathol, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au	Fitzgerald, Melinda/C-4235-2011	Fitzgerald, Melinda/0000-0002-4823-8179; Hogg, Philip/0000-0001-6486-2863; Grant, Chris/0000-0002-0616-6576				AKAGI S, 1988, J HISTOCHEM CYTOCHEM, V36, P1069, DOI 10.1177/36.8.3292644; BALAZS M, 1986, BIOCHEM BIOPH RES CO, V140, P999, DOI 10.1016/0006-291X(86)90734-5; BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6; BULLEID NJ, 1993, ADV PROTEIN CHEM, V44, P125, DOI 10.1016/S0065-3233(08)60566-5; CHEN K, 1992, BLOOD, V79, P2226; CHENG SY, 1987, J BIOL CHEM, V262, P11221; Couet J, 1996, BIOCHEMISTRY-US, V35, P14800, DOI 10.1021/bi961359w; DORNER AJ, 1990, J BIOL CHEM, V265, P22029; ESSEX DW, 1995, BLOOD, V86, P2168, DOI 10.1182/blood.V86.6.2168.bloodjournal8662168; FARQUHAR R, 1991, GENE, V108, P81, DOI 10.1016/0378-1119(91)90490-3; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; Hotchkiss KA, 1996, BIOCHEMISTRY-US, V35, P9761, DOI 10.1021/bi9603938; INGALLS HM, 1986, P NATL ACAD SCI USA, V83, P4779, DOI 10.1073/pnas.83.13.4779; KATZ BA, 1986, J BIOL CHEM, V261, P5480; KIVIRIKKO KI, 1989, FASEB J, V3, P1609, DOI 10.1096/fasebj.3.5.2537773; KRONING H, 1994, SCAND J IMMUNOL, V39, P346, DOI 10.1111/j.1365-3083.1994.tb03384.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERT N, 1983, BIOCHEM J, V213, P225, DOI 10.1042/bj2130225; Lawrence DA, 1996, J LEUKOCYTE BIOL, V60, P611, DOI 10.1002/jlb.60.5.611; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; MirandaVizuete A, 1996, J BIOL CHEM, V271, P19099, DOI 10.1074/jbc.271.32.19099; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NOIVA R, 1992, J BIOL CHEM, V267, P3553; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; RAO ASMK, 1993, P NATL ACAD SCI USA, V90, P2950, DOI 10.1073/pnas.90.7.2950; ROFFMAN E, 1986, BIOCHEM BIOPH RES CO, V136, P80, DOI 10.1016/0006-291X(86)90879-X; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; ROSEN A, 1995, INT IMMUNOL, V7, P625, DOI 10.1093/intimm/7.4.625; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; RYSER HJP, 1991, J BIOL CHEM, V266, P18439; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Stathakis P, 1997, J BIOL CHEM, V272, P20641, DOI 10.1074/jbc.272.33.20641; Tager M, 1997, EXP HEMATOL, V25, P601; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P9728, DOI 10.1021/bi00104a023; Wolvetang EJ, 1996, CELL GROWTH DIFFER, V7, P1315; YOSHIMORI T, 1990, J BIOL CHEM, V265, P15984	41	161	165	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2416	2423		10.1074/jbc.274.4.2416	http://dx.doi.org/10.1074/jbc.274.4.2416			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891011	hybrid			2022-12-27	WOS:000078185200078
J	Tomita, S; Ozaki, T; Taru, H; Oguchi, S; Takeda, S; Yagi, Y; Sakiyama, S; Kirino, Y; Suzuki, T				Tomita, S; Ozaki, T; Taru, H; Oguchi, S; Takeda, S; Yagi, Y; Sakiyama, S; Kirino, Y; Suzuki, T			Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; CYTOPLASMIC DOMAIN; MESSENGER-RNA; BETA-PROTEIN; KINASE-C; DISEASE; PHOSPHORYLATION; CDNA; PEPTIDE; SITES	A novel protein, human X11-like (human X11L), contains a phosphotyrosine interaction (PI) domain and two PDZ domains and displays 55.2% amino acid homology with the human X11 (human X11), The PI domain of human X11L interacts with a sequence containing the NPXY motif found in the cytoplasmic domain of Alzheimer's amyloid precursor protein. A construct lacking the carboxyl-terminal domain, which comprises two PDZ domains (N + PI), enhances PI binding to APP, whereas another construct lacking an amino-terminal domain relative to PI domain (PI + C) suppresses PI binding to APP. Overexpression of full-length human X11L (N + PI + C) in cells that express APP695 stably decreased the secretion of A beta 40 but not that of A beta 42. However, overexpression of the PI domain alone and the N + PI construct in cells did not affect the secretion of AP despite their ability to bind to the cytoplasmic domain of Alzheimer's amyloid precursor protein. These observations suggest that the amino-terminal domain regulates PI binding to APP and that the carboxyl-terminal domain containing PDZ motifs is essential to modulate APP processing. Because expression of the human X11L gene is specific to brain, the present observations should contribute to shedding light on the molecular mechanism of APP processing in Alzheimer's disease.	Univ Tokyo, Bunkyo Ku, Lab Neurobiophys, Sch Pharmaceut Sci, Tokyo 1130033, Japan; Chiba Canc Ctr, Div Biochem, Chuou Ku, Res Inst, Chiba 2600801, Japan; Biooriented Technol Res Adv Inst, Minato Ku, Tokyo 1050001, Japan	University of Tokyo; Chiba Cancer Center	Suzuki, T (corresponding author), Univ Tokyo, Bunkyo Ku, Lab Neurobiophys, Sch Pharmaceut Sci, Hongo 7-3-1, Tokyo 1130033, Japan.	tsuzuki@mayqueen.f.u-tokyo.ac.jp	Taru, Hidenori/B-7059-2009; Suzuki, Toshiharu/B-5342-2013					AMENTA F, 1991, MECH AGEING DEV, V61, P249, DOI 10.1016/0047-6374(91)90059-9; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Charest A, 1996, J BIOL CHEM, V271, P8424, DOI 10.1074/jbc.271.14.8424; Chow NW, 1996, J BIOL CHEM, V271, P11339, DOI 10.1074/jbc.271.19.11339; DESAUVAGE F, 1989, SCIENCE, V245, P651, DOI 10.1126/science.2569763; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; DUCLOS F, 1993, P NATL ACAD SCI USA, V90, P109, DOI 10.1073/pnas.90.1.109; DUCLOS F, 1995, MAMM GENOME, V6, P57, DOI 10.1007/BF00350899; Duilio A, 1998, BIOCHEM J, V330, P513, DOI 10.1042/bj3300513; FEILOTTER HE, 1994, NUCLEIC ACIDS RES, V22, P1502, DOI 10.1093/nar/22.8.1502; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; GANDY S, 1988, P NATL ACAD SCI USA, V85, P6218, DOI 10.1073/pnas.85.16.6218; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Haass C, 1997, NEURON, V18, P687, DOI 10.1016/S0896-6273(00)80309-8; HARDING A, 1984, HEREDITARY ATAXIAS R; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Iijima K, 1998, BIOCHEM J, V330, P29, DOI 10.1042/bj3300029; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KOO EH, 1994, J BIOL CHEM, V269, P17386; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McLoughlin DM, 1996, FEBS LETT, V397, P197; Neve RL, 1996, TRENDS NEUROSCI, V19, P371, DOI 10.1016/S0166-2236(96)30011-8; NORSTEDT C, 1993, J BIOL CHEM, V268, P608; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; Sambrook J., 2002, MOL CLONING LAB MANU; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; SUZUKI T, 1992, NEUROSCIENCE, V48, P755, DOI 10.1016/0306-4522(92)90264-3; Suzuki T, 1997, BIOCHEMISTRY-US, V36, P4643, DOI 10.1021/bi962618k; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TARTAKOFF AM, 1983, J CELL BIOL, V97, P1243, DOI 10.1083/jcb.97.4.1243; Tomita S, 1998, J BIOL CHEM, V273, P19304, DOI 10.1074/jbc.273.30.19304; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; VIRTANEN I, 1980, J CELL BIOL, V85, P429, DOI 10.1083/jcb.85.2.429; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	55	140	146	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2243	2254		10.1074/jbc.274.4.2243	http://dx.doi.org/10.1074/jbc.274.4.2243			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890987	hybrid			2022-12-27	WOS:000078185200054
J	Dai, Y; Wensink, PC; Abeles, RH				Dai, Y; Wensink, PC; Abeles, RH			One protein, two enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE SALVAGE PATHWAY; KLEBSIELLA-PNEUMONIAE; CARBON-MONOXIDE	Two enzymes, designated, E-2 and E-2', catalyze different oxidation reactions of an aci-reductone intermediate in the methionine salvage pathway. E-2 and E-2', overproduced in Escherichia coli from the same gene, have the same protein component. E-2 and E-2' are separable on an anion exchange column or a hydrophobic column. Their distinct catalytic and chromatographic properties result from binding different metals. The apo enzyme, obtained after metal is removed from either enzyme, is catalytically inactive. Addition of Ni2+ or Co2+ to the apo-protein yields E-2 activity. E-2' activity is obtained when Fe2+ is added. Production in intact E. coli of E-2 and E-2' depends on the availability of the corresponding metals. These observations suggest that the metal component dictates reaction specificity.	Brandeis Univ, Dept Biochem, Waltham, MA 02453 USA	Brandeis University	Abeles, RH (corresponding author), Brandeis Univ, Dept Biochem, 415 South St, Waltham, MA 02453 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM012633] Funding Source: NIH RePORTER; NIGMS NIH HHS [2 R01 GM12633] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON EH, 1946, P NATL ACAD SCI USA, V32, P120, DOI 10.1073/pnas.32.5.120; AULD DS, 1995, METHOD ENZYMOL, V248, P228; BALAKRISHNAN R, 1993, J BIOL CHEM, V268, P24792; BERGENHEM N, 1989, BIOCHIM BIOPHYS ACTA, V998, P277, DOI 10.1016/0167-4838(89)90285-9; Brann DW, 1997, NEUROENDOCRINOLOGY, V65, P385, DOI 10.1159/000127201; COLEMAN JE, 1983, J BIOL CHEM, V258, P386; FURFINE ES, 1988, J BIOL CHEM, V263, P9598; MYERS RW, 1993, J BIOL CHEM, V268, P24785; SCHLENK F, 1983, ADV ENZYMOL RAMB, V54, P195; SHAPIRO SK, 1981, BIOCHEM BIOPH RES CO, V102, P302, DOI 10.1016/0006-291X(81)91521-7; TRACKMAN PC, 1981, J BIOL CHEM, V258, P6717; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Weiner M. P., 1994, STRATEGIES, V7, P41; Williams-Ashman H., 1981, POLYAMINES BIOL MED, P43; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; WRAY JW, 1995, J BIOL CHEM, V270, P3147, DOI 10.1074/jbc.270.7.3147; WRAY JW, 1993, J BIOL CHEM, V268, P21466; YUNG KH, 1982, BIOCHEM BIOPH RES CO, V104, P771, DOI 10.1016/0006-291X(82)90704-5	18	125	129	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1193	1195		10.1074/jbc.274.3.1193	http://dx.doi.org/10.1074/jbc.274.3.1193			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880484	hybrid			2022-12-27	WOS:000079956900004
J	Peytavi, R; Hong, SS; Gay, B; d'Angeac, AD; Selig, L; Benichou, S; Benarous, R; Boulanger, P				Peytavi, R; Hong, SS; Gay, B; d'Angeac, AD; Selig, L; Benichou, S; Benarous, R; Boulanger, P			HEED, the product of the human homolog of the murine eed gene, binds to the matrix protein of HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BACULOVIRUS-INFECTED CELLS; GREEN FLUORESCENT PROTEIN; RNA-POLYMERASE-III; EXTRA SEX COMBS; GAG PRECURSOR; NONDIVIDING CELLS; NUCLEAR IMPORT; TRANSCRIPTIONAL ACTIVATION; PREINTEGRATION COMPLEXES	heed, the human homolog of mouse eed and Drosophila esc, two members of the trithorax (trx) and Polycomb group (Pc-G) of genes, was isolated by screening an activated lymphocyte cDNA library versus the immunodeficiency virus type 1 (HIV-1) MA protein used as a bait in,two hybrid system in yeast. The human EED protein (HEED) had 99.5% identity with the mouse EED protein and contained seven WD repeats. Two heed gene transcripts were identified, with a putative 407-nucleotide-long intron, giving rise to two HEED protein isoforms of 535 and 494 residues in length, respectively. The shorter HEED isoform, originated from the unspliced message, lacked the seventh WD repeat, HEED was found to bind to MA protein in vitro, as efficiently as in vivo in yeast cells, Site-directed mutagenesis and phage biopanning suggested that the interaction between HEED and IMA involved the N-terminal region of the MA protein, including the first polybasic signal, in a MA conformation-dependent manner. In the HEED protein, however, two discrete linear MA-binding motifs were identified within residues 388-403, overlapping the origin of the fifth WD repeat. Deletion of the C-terminal 41 residues of HEED, spanning the seventh WD repeat, as in the 494-residue HEED protein, was detrimental to HEED-MA interaction in vivo, suggesting the existence of another C-terminal binding site and/or a conformational role of the REED C-terminal domain in the MA-HEED interaction. MA and HEED proteins co-localized within the nucleus of co-transfected human cells and of recombinant baculovirus co-infected insect cells. This and the failure of HEED to bind to uncleaved GAG precursor suggested a role of HEED at the early stages of virus infection, rather than late in the virus life cycle.	Fac Med Montpellier, Inst Biol, Lab Virol Mol & Pathogenese Virale, CNRS,UMR 5812, F-34060 Montpellier, France; Fac Med Cochin, Lab Interact Mol Hote Pathogene, INSERM, CJF 97 03, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Boulanger, P (corresponding author), Fac Med Montpellier, Inst Biol, Lab Virol Mol & Pathogenese Virale, CNRS,UMR 5812, 2 Blvd Henri 4, F-34060 Montpellier, France.	pboulang@infobiogen.fr	Hong, Saw See/M-9818-2017	Hong, Saw See/0000-0001-8871-0901; Benichou, Serge/0000-0003-3602-3530				Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Bouhamdan M, 1996, J VIROL, V70, P697, DOI 10.1128/JVI.70.2.697-704.1996; Boulanger P, 1996, CURR TOP MICROBIOL, V214, P237; Bukrinskaya AG, 1996, P NATL ACAD SCI USA, V93, P367, DOI 10.1073/pnas.93.1.367; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Cannon PM, 1997, J VIROL, V71, P3474, DOI 10.1128/JVI.71.5.3474-3483.1997; CARRIERE C, 1995, J VIROL, V69, P2366; Carteau S, 1997, J VIROL, V71, P6225, DOI 10.1128/JVI.71.8.6225-6229.1997; Casella CR, 1997, VIROLOGY, V228, P294, DOI 10.1006/viro.1996.8355; CHALKER DL, 1992, GENE DEV, V6, P117, DOI 10.1101/gad.6.1.117; CHAZAL N, 1994, J VIROL, V68, P111, DOI 10.1128/JVI.68.1.111-122.1994; CHAZAL N, 1995, J VIROL, V69, P365, DOI 10.1128/JVI.69.1.365-375.1995; CRAIGIE R, 1992, TRENDS GENET, V8, P187, DOI 10.1016/0168-9525(92)90223-Q; Craven RC, 1996, CURR TOP MICROBIOL, V214, P65; CRAWFORD S, 1984, J VIROL, V49, P909, DOI 10.1128/JVI.49.3.909-917.1984; Denisenko ON, 1997, MOL CELL BIOL, V17, P4707, DOI 10.1128/MCB.17.8.4707; Devine SE, 1996, GENE DEV, V10, P620, DOI 10.1101/gad.10.5.620; El Kharroubi A, 1998, MOL CELL BIOL, V18, P2535, DOI 10.1128/MCB.18.5.2535; FACKE M, 1993, J VIROL, V67, P4972; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Freed EO, 1997, CELL, V88, P171, DOI 10.1016/S0092-8674(00)81836-X; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; GALLAY P, 1995, CELL, V80, P379, DOI 10.1016/0092-8674(95)90488-3; GALLAY P, 1995, CELL, V83, P569, DOI 10.1016/0092-8674(95)90097-7; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUTJAHR T, 1995, EMBO J, V14, P4296, DOI 10.1002/j.1460-2075.1995.tb00104.x; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; HONG SS, 1993, J VIROL, V67, P2787, DOI 10.1128/JVI.67.5.2787-2798.1993; Hong SS, 1997, EMBO J, V16, P2294, DOI 10.1093/emboj/16.9.2294; HONG SS, 1995, EMBO J, V14, P4714, DOI 10.1002/j.1460-2075.1995.tb00153.x; HUANG I, 1998, J GEN VIROL, V79, P1069; JEANG KT, 1993, J BIOL CHEM, V268, P24940; Jones CA, 1998, MOL CELL BIOL, V18, P2825, DOI 10.1128/MCB.18.5.2825; KAIN SR, 1995, BIOTECHNIQUES, V19, P650; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kiernan RE, 1998, J VIROL, V72, P4116, DOI 10.1128/JVI.72.5.4116-4126.1998; Krausslich HG, 1996, CURR TOP MICROBIOL, V214, P25; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; MOORE JH, 1993, CELL, V73, P1007; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; PAL R, 1990, AIDS RES HUM RETROV, V6, P721, DOI 10.1089/aid.1990.6.721; Pirrotta V, 1997, CURR OPIN GENET DEV, V7, P249, DOI 10.1016/S0959-437X(97)80135-9; RHEE SS, 1991, EMBO J, V10, P535, DOI 10.1002/j.1460-2075.1991.tb07980.x; RHEE SS, 1990, CELL, V63, P77, DOI 10.1016/0092-8674(90)90289-Q; ROYER M, 1992, J VIROL, V66, P3230, DOI 10.1128/JVI.66.5.3230-3235.1992; Royer M, 1997, J GEN VIROL, V78, P131, DOI 10.1099/0022-1317-78-1-131; SANDMEYER SB, 1990, ANNU REV GENET, V24, P491; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Trono D, 1997, CELL, V88, P173, DOI 10.1016/S0092-8674(00)81837-1; VALVERDE V, 1992, J GEN VIROL, V73, P639, DOI 10.1099/0022-1317-73-3-639; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WANG CT, 1993, J VIROL, V67, P7067, DOI 10.1128/JVI.67.12.7067-7076.1993; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Yang TT, 1996, GENE, V173, P19, DOI 10.1016/0378-1119(95)00781-4; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992; YUAN X, 1993, J VIROL, V67, P6387, DOI 10.1128/JVI.67.11.6387-6394.1993; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994; ZOU S, 1995, P NATL ACAD SCI USA, V92, P920, DOI 10.1073/pnas.92.3.920; Zou S, 1997, P NATL ACAD SCI USA, V94, P7412, DOI 10.1073/pnas.94.14.7412	72	41	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1635	1645		10.1074/jbc.274.3.1635	http://dx.doi.org/10.1074/jbc.274.3.1635			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880543	hybrid			2022-12-27	WOS:000079956900063
J	Piedagnel, R; Murphy, G; Ronco, PM; Lelong, B				Piedagnel, R; Murphy, G; Ronco, PM; Lelong, B			Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGENASE GELATINASE; TISSUE INHIBITOR; HUMAN FIBROBLASTS; EPITHELIAL-CELLS; GENE-EXPRESSION; PLASMA-MEMBRANE; TRANSCRIPTION; RAT; ACTIVATION; TUBULE	We analyzed the expression and regulation of matrix metalloproteinase 2 (MMP2) and MMP9 gelatinases in a rabbit kidney collecting duct principal cell line (RC.S-VtsA58) (Prie, D., Ronco, P. M., Baudouin, B., Geniteau-Legendre, M., Antoine, M., Piedagnel, R., Estrade, S., Lelongt, B., Verroust, P. J., Cassingena, R., and Vandewalle, A. (1991) J. Cell Biol. 113, 951-962) infected with the temperature-sensitive (ts) SV40 strain tsA58, At the permissive temperature (33 degrees C), cells produced only MMP2. Shifting cells to a nonpermissive temperature (39.5 degrees C) induced a marked increase in total gelatinolytic activity due to an increase of MMP2 and an induction of MMP9 synthesis. This effect was attributed to large-T inactivation at 39.5 degrees C because it was abolished by re-infecting the cells with wild-type SV40 strain LP, Run-on experiments showed that negative regulation of MMP2 and MMP9 by large-T was transcriptional and posttranscriptional, respectively. MMP2 and MMP9 were also produced by primary cultures of collecting duct cells. In rabbit kidney, both MMP2 and MMP9 were almost exclusively expressed in collecting duct cells, where an unexpected apical localization was observed. Arginine vasopressin and epidermal growth factor, which exert opposite hydroosmotic effects in the collecting duct, also exhibited contrasted effects on MMP9 synthesis. Epidermal growth factor increased but arginine vasopressin suppressed MMP9 at a posttranscriptional level, whereas MMP2 was not affected. These results suggest a specific physiological role of MMP2 and MMP9 in principal cells of renal collecting duct.	Hop Tenon, INSERM, U489, F-75020 Paris, France; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of East Anglia	Piedagnel, R (corresponding author), Hop Tenon, INSERM, U489, F-75020 Paris, France.	remi.piedagnel@tnn.ap-hop-paris.fr	lelongt, brigitte/N-3746-2017; Ronco, Pierre/AAC-8390-2022; Piedagnel, Remi/C-7427-2017	lelongt, brigitte/0000-0002-9308-8798; Piedagnel, Remi/0000-0002-5931-1271				Basset P, 1997, MATRIX BIOL, V15, P535, DOI 10.1016/S0945-053X(97)90028-7; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; BREYER MD, 1988, J CLIN INVEST, V82, P1313, DOI 10.1172/JCI113732; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; DAVIES M, 1988, BIOCHEM J, V251, P431; DELANY AM, 1992, J CELL BIOCHEM, V50, P400, DOI 10.1002/jcb.240500409; Douglas DA, 1997, J PROTEIN CHEM, V16, P237, DOI 10.1023/A:1026348808069; FINI ME, 1994, J BIOL CHEM, V269, P28620; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FRISCH SM, 1990, MOL CELL BIOL, V10, P6524, DOI 10.1128/MCB.10.12.6524; FRISCH SM, 1990, ONCOGENE, V5, P75; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; GIJBELS K, 1993, J NEUROSCI RES, V36, P432, DOI 10.1002/jnr.490360409; GRANTHAM JJ, 1966, AM J PHYSIOL, V211, P255, DOI 10.1152/ajplegacy.1966.211.1.255; Hansell EJ, 1995, BIOCHEM CELL BIOL, V73, P373, DOI 10.1139/o95-045; HARENDZA S, 1995, J BIOL CHEM, V270, P18786, DOI 10.1074/jbc.270.32.18786; HARRIS RC, 1989, AM J PHYSIOL, V256, pF1117, DOI 10.1152/ajprenal.1989.256.6.F1117; HIBBS MS, 1987, J CLIN INVEST, V80, P1644, DOI 10.1172/JCI113253; HIPPS DS, 1991, BIOL CHEM H-S, V372, P287, DOI 10.1515/bchm3.1991.372.1.287; Ito A, 1996, J BIOL CHEM, V271, P14657, DOI 10.1074/jbc.271.25.14657; JOHNSON R, 1992, J AM SOC NEPHROL, V2, P1388; KOJRO E, 1995, J BIOL CHEM, V270, P6476, DOI 10.1074/jbc.270.12.6476; Kondapaka SB, 1997, INT J CANCER, V70, P722, DOI 10.1002/(SICI)1097-0215(19970317)70:6<722::AID-IJC15>3.3.CO;2-5; KUMAR R, 1994, SEMIN NEPHROL, V14; LeGoas F, 1997, GENE, V185, P169, DOI 10.1016/S0378-1119(96)00604-X; Lelongt B, 1997, J CELL BIOL, V136, P1363, DOI 10.1083/jcb.136.6.1363; Logan SK, 1996, MATRIX BIOL, V15, P81, DOI 10.1016/S0945-053X(96)90149-3; LOVETT DH, 1983, KIDNEY INT, V23, P342, DOI 10.1038/ki.1983.25; LYONS JG, 1993, J BIOL CHEM, V268, P19143; McMillan JI, 1996, J CLIN INVEST, V97, P1094, DOI 10.1172/JCI118502; MEHUL B, 1994, J BIOL CHEM, V269, P18250; Mertens PR, 1997, J BIOL CHEM, V272, P22905, DOI 10.1074/jbc.272.36.22905; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; MINTY AJ, 1983, J MOL BIOL, V167, P77, DOI 10.1016/S0022-2836(83)80035-7; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MURAHASHI N, 1992, BIOTECHNOL APPL BIOC, V16, P152; MURPHY G, 1989, BIOCHEM J, V258, P463, DOI 10.1042/bj2580463; MURPHY G, 1982, BIOCHEM J, V203, P209, DOI 10.1042/bj2030209; MURPHY G, 1981, BIOCHEM J, V199, P807, DOI 10.1042/bj1990807; Nguyen M, 1998, J BIOL CHEM, V273, P5400, DOI 10.1074/jbc.273.9.5400; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; NORMAN JT, 1995, EXP NEPHROL, V3, P88; ORCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109; PIEDAGNEL R, 1994, J BIOL CHEM, V269, P17469; Price JT, 1996, EUR J CANCER, V32A, P1977, DOI 10.1016/0959-8049(96)00207-9; PRIE D, 1991, J CELL BIOL, V113, P951, DOI 10.1083/jcb.113.4.951; PRIE D, 1994, AM J PHYSIOL, V266, pC1628, DOI 10.1152/ajpcell.1994.266.6.C1628; QUINN CO, 1990, J BIOL CHEM, V265, P22342; Sato H, 1996, J BIOCHEM-TOKYO, V119, P209; Sawicki G, 1997, NATURE, V386, P616, DOI 10.1038/386616a0; Schaefer L, 1996, KIDNEY INT, V49, P75, DOI 10.1038/ki.1996.10; SCHAFER JA, 1990, AM J PHYSIOL, V259, pF823, DOI 10.1152/ajprenal.1990.259.5.F823; SINGH AK, 1995, EXP NEPHROL, V3, P355; Somasundaram K, 1996, P NATL ACAD SCI USA, V93, P3088, DOI 10.1073/pnas.93.7.3088; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; TANAKA K, 1995, CANCER RES, V55, P2927; TAUC M, 1992, BIOL CELL, V76, P55, DOI 10.1016/0248-4900(92)90195-7; TEGTMEYER P, 1972, J VIROL, V10, P591, DOI 10.1128/JVI.10.4.591-598.1972; TEZUKA K, 1994, J BIOL CHEM, V269, P15006; Turck J, 1996, J BIOL CHEM, V271, P15074, DOI 10.1074/jbc.271.25.15074; Ueda M, 1997, INT J CANCER, V72, P1027, DOI 10.1002/(SICI)1097-0215(19970917)72:6<1027::AID-IJC18>3.0.CO;2-1; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; van der Zee E, 1998, J PERIODONTAL RES, V33, P65; VANDEWALLE A, 1989, J CELL PHYSIOL, V141, P203, DOI 10.1002/jcp.1041410128; Vincenti MP, 1996, CRIT REV EUKAR GENE, V6, P391, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.40; Vu TH, 1998, BIOL EXTRAC, P115; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; YAMADA T, 1995, KIDNEY INT, V48, P745, DOI 10.1038/ki.1995.346	70	44	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1614	1620		10.1074/jbc.274.3.1614	http://dx.doi.org/10.1074/jbc.274.3.1614			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880540	hybrid			2022-12-27	WOS:000079956900060
J	Qian, ZJ; Okuhara, D; Abe, MK; Rosner, MR				Qian, ZJ; Okuhara, D; Abe, MK; Rosner, MR			Molecular cloning and characterization of a mitogen-activated protein kinase-associated intracellular chloride channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELLS; EXPRESSION; KIDNEY; CONDUCTANCE; LYMPHOCYTES; GENE; P64	ERK7, a member of the mitogen-activated protein kinase family, has a carboxyl-terminal tail that is required for ERK7 activation, cellular localization, and its ability to inhibit DNA synthesis. To identify proteins that interact With ERK7, we utilized a yeast two-hybrid screen with the COOH-terminal tail of ERK7 as bait and isolated the cDNA for a novel protein termed CLIC3. The interaction between CLIC3 and ERK7 in mammalian cells was confirmed by co-immunoprecipitation. CLIC3 has significant homology to human intracellular chloride channels 1 (NCC27/CLIC1) and 2 and bovine kidney chloride channel p64, Like NCC27/CLIC1, CLIC3 is predominantly localized in the nucleus and stimulates chloride conductance when expressed in cells, Taken together, these results suggest that CLIC3 is a new member of the human CLIC family. The observed interaction between CLIC3 and ERK7 is the first demonstration of a stable complex between a protein that activates chloride ion transport and a member of the mitogen-activated protein kinase family of signal transducers. The specific association of CLIC3 with the COOH-terminal tail of ERK7 suggests that CLIC3 may play a role in the regulation of cell growth.	Univ Chicago, Dept Pharmacol & Physiol Sci, Chicago, IL 60637 USA; Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Rosner, MR (corresponding author), Univ Chicago, Dept Pharmacol & Physiol Sci, 947 E 58th St, Chicago, IL 60637 USA.				NHLBI NIH HHS [HL56399, HL03867] Funding Source: Medline; NINDS NIH HHS [NS33858] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033858] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE MK, 1994, AM J RESP CELL MOL, V11, P577, DOI 10.1165/ajrcmb.11.5.7946386; ABE MK, 1999, IN PRESS MOL CELL BI; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; Cobb M H, 1996, Adv Pharmacol, V36, P49, DOI 10.1016/S1054-3589(08)60576-1; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Duncan RR, 1997, J BIOL CHEM, V272, P23880, DOI 10.1074/jbc.272.38.23880; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Heiss NS, 1997, GENOMICS, V45, P224, DOI 10.1006/geno.1997.4922; Holmes TC, 1997, J NEUROSCI, V17, P8964; HONG T, 1996, J NEUROSCI, V16, P1581; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Krapivinsky G, 1998, J BIOL CHEM, V273, P10811, DOI 10.1074/jbc.273.18.10811; KRAPIVINSKY GB, 1994, CELL, V76, P439, DOI 10.1016/0092-8674(94)90109-0; KUO WL, 1991, MOL ENDOCRINOL, V5, P1467, DOI 10.1210/mend-5-10-1467; Kuo WL, 1996, MOL CELL BIOL, V16, P1458; KYTE J, 1982, J MOL BIOL, V157, P106; LANDRY D, 1993, J BIOL CHEM, V268, P14948; LANDRY DW, 1989, SCIENCE, V244, P1469, DOI 10.1126/science.2472007; LANDRY DW, 1987, J GEN PHYSIOL, V90, P779, DOI 10.1085/jgp.90.6.779; Lepple-Wienhues A, 1998, J CELL BIOL, V141, P281, DOI 10.1083/jcb.141.1.281; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; NEHER E, 1992, METHOD ENZYMOL, V207, P123; PAULMICHL M, 1992, NATURE, V356, P238, DOI 10.1038/356238a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; STRANGE K, 1991, AM J PHYSIOL, V260, pF225, DOI 10.1152/ajprenal.1991.260.2.F225; Szabo I, 1998, P NATL ACAD SCI USA, V95, P6169, DOI 10.1073/pnas.95.11.6169; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593; Wildering WC, 1995, J NEUROPHYSIOL, V74, P2778, DOI 10.1152/jn.1995.74.6.2778; WORRELL RT, 1989, AM J PHYSIOL, V256, pC1111, DOI 10.1152/ajpcell.1989.256.6.C1111; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	34	102	109	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1621	1627		10.1074/jbc.274.3.1621	http://dx.doi.org/10.1074/jbc.274.3.1621			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880541	hybrid			2022-12-27	WOS:000079956900061
J	Sarkar, SN; Bandyopadhyay, S; Ghosh, A; Sen, GC				Sarkar, SN; Bandyopadhyay, S; Ghosh, A; Sen, GC			Enzymatic characteristics of recombinant medium isozyme of 2 '-5 ' oligoadenylate synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; 2'-5'-OLIGOADENYLATE SYNTHETASE; 2-5A SYNTHETASE; PROTEIN-KINASE; 2',5'-OLIGOADENYLATE SYNTHETASE; N-MYRISTOYLATION; BINDING DOMAIN; 100-KDA FORMS; HUMAN-CELLS; INTERFERON	P69 is an isozyme of the medium size class of human 2'-5' oligoadenylate synthetases. In this study, recombinant P69 was expressed and used for enzymological and structural investigations. Bacterially expressed P69 was inactive whereas the same protein expressed in insect cells was highly active. Whether this difference could be due to differential post-translational modifications of the protein was investigated. Mutations of appropriate residues showed that myristoylation of the protein was not necessary for enzyme activity. In contrast, inhibition of glycosylation of P69, by tunicamycin treatment of the insect cells, produced an enzymatically inactive protein, Recombinant P69 produced in insect cells was purified by affinity chromatography. It was a dimeric glycoprotein, very stable and completely dependent on double stranded (ds) RNA for activity. The enzyme catalyzed the non-processive synthesis of 2'5'-linked oligoadenylate products containing up to 30 residues, 2'-O-Methylated dsRNA was incapable of activating P69 and a 25-base pair dsRNA was as effective as larger dsRNA. This expression system will be useful for large scale production of P69 and its mutants for structural studies.	Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Biol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Sen, GC (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Biol, 9500 Euclid Ave,NC20, Cleveland, OH 44195 USA.		Sarkar, Saumendra N/B-5038-2011	Sarkar, Saumendra N/0000-0002-2850-6121	NCI NIH HHS [CA-68782, CA-62220] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA062220, R01CA068782] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bandyopadhyay S, 1998, BIOCHEMISTRY-US, V37, P3824, DOI 10.1021/bi972848e; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; Borgese N, 1996, J CELL BIOL, V135, P1501, DOI 10.1083/jcb.135.6.1501; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; DEICHAITE I, 1988, MOL CELL BIOL, V8, P4295, DOI 10.1128/MCB.8.10.4295; Desai SY, 1997, J INTERF CYTOK RES, V17, P531, DOI 10.1089/jir.1997.17.531; DESAI SY, 1995, J BIOL CHEM, V270, P3454, DOI 10.1074/jbc.270.7.3454; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133; Ghosh A, 1997, J BIOL CHEM, V272, P15452, DOI 10.1074/jbc.272.24.15452; Ghosh A, 1997, J BIOL CHEM, V272, P33220, DOI 10.1074/jbc.272.52.33220; GHOSH SK, 1991, J BIOL CHEM, V266, P15293; GRIBAUDO G, 1991, J VIROL, V65, P1748, DOI 10.1128/JVI.65.4.1748-1757.1991; HOVANESSIAN AG, 1988, J BIOL CHEM, V263, P4945; HOVANESSIAN AG, 1991, J INTERFERON RES, V11, P199, DOI 10.1089/jir.1991.11.199; ICHII Y, 1986, NUCLEIC ACIDS RES, V14, P10117, DOI 10.1093/nar/14.24.10117; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; JUSTESEN J, 1980, P NATL ACAD SCI-BIOL, V77, P4618, DOI 10.1073/pnas.77.8.4618; MAITRA RK, 1994, VIROLOGY, V204, P823, DOI 10.1006/viro.1994.1601; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Marie I, 1997, EUR J BIOCHEM, V248, P558, DOI 10.1111/j.1432-1033.1997.t01-1-00558.x; MARIE I, 1990, J BIOL CHEM, V265, P18601; MARIE I, 1992, J BIOL CHEM, V267, P9933; MIELE MB, 1991, J INTERFERON RES, V11, P33, DOI 10.1089/jir.1991.11.33; OREILLY D, BACULOVIRUS EXPRESSI; PATEL RC, 1992, J BIOL CHEM, V267, P7671; ROQUEMORE EP, 1994, METHOD ENZYMOL, V230, P443; Ruddon RW, 1997, J BIOL CHEM, V272, P3125, DOI 10.1074/jbc.272.6.3125; RUTHERFORD MN, 1991, NUCLEIC ACIDS RES, V19, P1917, DOI 10.1093/nar/19.8.1917; VILCEK J, 1996, FIELDS VIROLOGY, P375; XIE RL, 1995, J BIOL CHEM, V270, P23212, DOI 10.1074/jbc.270.39.23212	30	50	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1848	1855		10.1074/jbc.274.3.1848	http://dx.doi.org/10.1074/jbc.274.3.1848			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880569	hybrid			2022-12-27	WOS:000079956900089
J	Vassilev, A; Ozer, Z; Navara, C; Mahajan, S; Uckun, FM				Vassilev, A; Ozer, Z; Navara, C; Mahajan, S; Uckun, FM			Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; CELL-DEATH; SRC-FAMILY; INDUCED APOPTOSIS; CD19 RECEPTOR; TNF RECEPTOR; PROTEIN; FAS; DOMAIN; LEUKEMIA	Bruton's tyrosine kinase (BTK) is a member of the Src-related Tec family of protein tyrosine kinases, Mutations in the btk gene have been linked to severe developmental blocks in human B-cell ontogeny leading to X-linked agammaglobulinemia. Here, we provide unique biochemical and genetic evidence that BTK is an inhibitor of the Fas/APO-1 death-inducing signaling complex in B-lineage lymphoid cells. The Src homology 2, pleckstrin homology (PH), and kinase domains of BTK are all individually important and apparently indispensable, but not sufficient, for its function as a negative regulator of Fas-mediated apoptosis, BTK associates with Fas via its kinase and PH domains and prevents the FAS-FADD interaction, which is essential for the recruitment and activation of FLICE by Fas during the apoptotic signal. Fas-resistant DT-40 lymphoma B-cells rendered BTK-deficient through targeted disruption of the btk gene by homologous recombination knockout under went apoptosis after Fas ligation, but wild-type DT-40 cells or BTK deficient DT-40 cells reconstituted with wild-type human btk gene did not. Introduction of an Src homology 2 domain, a PH domain, or a kinase domain mutant human btk gene into BTK-deficient cells did not restore the resistance to Fas-mediated apoptosis. introduction of wild type BTK protein by electroporation rendered BTK-deficient DT-40 cells resistant to the apoptotic effects of Fas Ligation, BTK deficient RAMOS-1 human Burkitt's leukemia cells underwent apoptosis after Fas ligation, whereas BTK-positive NALM-6-UM1 human B-cell precursor leukemia cells expressing similar levels of Fas did not. Treatment of the anti-Fas-resistant NALM-6-UM1 cells with the leflunomide metabolite analog alpha-cyano-beta-methyl-beta-hydroxy-N-(2, 5-dibromophenyl)propenamide, a potent inhibitor of BTK, abrogated the BTK-Fas association without affecting the expression levels of BTK or Fas and rendered them sensitive to Fas-mediated apoptosis, The ability of BTK to inhibit the pro-apoptotic effects of Fas ligation prompts the hypothesis that apoptosis of developing B-cell precursors during normal E-cell ontogeny may be reciprocally regulated by Fas and BTK.	Hughes Inst, Dept Immunol, Parker Hughes Canc Ctr, Mol Signal Transduct Lab, St Paul, MN 55113 USA; Hughes Inst, Dept Mol Biol, St Paul, MN 55113 USA; Hughes Inst, Dept Biochem, St Paul, MN 55113 USA		Uckun, FM (corresponding author), Hughes Inst, Dept Immunol, Parker Hughes Canc Ctr, Mol Signal Transduct Lab, 2665 Long Lake Rd,Suite 330, St Paul, MN 55113 USA.		Navara, Christopher/C-2813-2011	Uckun, Fatih M./0000-0001-9334-183X	NATIONAL CANCER INSTITUTE [U01CA072157] Funding Source: NIH RePORTER; NCI NIH HHS [U01-CA-72157] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson JS, 1996, P NATL ACAD SCI USA, V93, P10966, DOI 10.1073/pnas.93.20.10966; Atkinson EA, 1996, J BIOL CHEM, V271, P5968, DOI 10.1074/jbc.271.11.5968; BERGLUND DL, 1991, CYTOMETRY, V12, P64, DOI 10.1002/cyto.990120109; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dibirdik I, 1998, J BIOL CHEM, V273, P4035, DOI 10.1074/jbc.273.7.4035; FISCHER GH, 1995, CELL, V81, P935; Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Kawakami Y, 1997, P NATL ACAD SCI USA, V94, P3938, DOI 10.1073/pnas.94.8.3938; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; LINETTE GP, 1994, CURR OPIN CELL BIOL, V6, P809, DOI 10.1016/0955-0674(94)90049-3; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; RAWLINGS DJ, 1994, IMMUNOL REV, V138, P105, DOI 10.1111/j.1600-065X.1994.tb00849.x; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Schlottmann KE, 1996, J LEUKOCYTE BIOL, V60, P546, DOI 10.1002/jlb.60.4.546; SCHULZEOSTHOFF K, 1994, EMBO J, V13, P4587, DOI 10.1002/j.1460-2075.1994.tb06780.x; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; TSUKADA S, 1994, J BIOL CHEM, V269, P10217; UCKUN FM, 1995, SCIENCE, V267, P886, DOI 10.1126/science.7531365; Uckun FM, 1996, J BIOL CHEM, V271, P6389, DOI 10.1074/jbc.271.11.6389; Uckun FM, 1998, CLIN CANCER RES, V4, P901; UCKUN FM, 1993, J BIOL CHEM, V268, P21172; Uckun FM, 1996, SCIENCE, V273, P1096, DOI 10.1126/science.273.5278.1096; Uckun FM, 1997, BLOOD, V89, P3769, DOI 10.1182/blood.V89.10.3769.3769_3769_3777; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; VIHINEN M, 1995, IMMUNOL TODAY, V16, P460, DOI 10.1016/0167-5699(95)80027-1; WADDICK KG, 1993, RADIAT RES, V136, P313, DOI 10.2307/3578542; Wang JY, 1996, J EXP MED, V184, P831, DOI 10.1084/jem.184.3.831; WHYLLIE AH, 1980, INT REV CYTOL, V68, P251; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604	47	114	178	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1646	1656		10.1074/jbc.274.3.1646	http://dx.doi.org/10.1074/jbc.274.3.1646			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880544	hybrid			2022-12-27	WOS:000079956900064
J	Hmama, Z; Knutson, KL; Herrera-Velit, P; Nandan, D; Reiner, NE				Hmama, Z; Knutson, KL; Herrera-Velit, P; Nandan, D; Reiner, NE			Monocyte adherence induced by lipopolysaccharide involves CD14, LFA-1, and cytohesin-1 - Regulation by Rho and phosphatidylinositol 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING-PROTEIN; DIFFICILE TOXIN-B; KINASE C-ZETA; BACTERIAL LIPOPOLYSACCHARIDE; LEUKOCYTE ADHESION; T-CELL; PHOSPHOINOSITIDE 3-KINASE; KLEBSIELLA-PNEUMONIAE; VASCULAR ENDOTHELIUM; NEUTROPHIL ADHERENCE	Mechanisms regulating lipopolysaccharide (LPS)-induced adherence to intercellular adhesion molecule (ICAM)-1 were examined using THP-1 cells transfected with CD14-cDNA (THP-1wt). THP-1wt adherence to ICAM-1 was LPS dose-related, time-dependent, and inhibited by antibodies to either CD14 or leukocyte function associated antigen (LFA)-1, but was independent of any change in the number of surface expressed LFA-1 molecules. A potential role for phosphatidylinositol (PI) 3-kinase (PI 3-kinase) in LPS-induced adherence was examined using the PI 3-kinase inhibitors LY294002 and Wortnaannin. Both inhibitors selectively attenuated LPS-induced, but not phorbol 12-myristate 13-acetate-induced adherence, Inhibition by these agents was unrelated to any changes in either LPS binding to or LFA-1 expression by THP-1wt cells. LPS-induced adherence was also abrogated in U937 cells transfected with a dominant negative mutant of of PI 3-kinase. Toxin B from Clostridium difficile, an inhibitor of the Rho family of GTP-binding proteins, abrogated both PI-3 kinase activation and adherence induced by LPS. Cytohesin-1, a phosphatidylinositol 3,4,5-triphosphate-regulated adaptor molecule for LFA-1 activation, was found to be expressed in THP-1wt cells. In addition, treatment of THP-1wt with cytohesin-1 antisense attenuated LPS-induced adherence. These findings suggest a model in which LPS induces adherence through a process of "inside-out" signaling involving CD14, Rho, and PI 3-kinase. This converts low avidity LFA-1 into an active form capable of increased binding to ICAM-1. This change in LFA-1 appears to be cytohesin-1-dependent.	Univ British Columbia, Fac Med & Sci, Vancouver Hosp & Hlth Sci Ctr, Res Inst,Dept Med,Div Infect Dis, Vancouver, BC V5Z 3J5, Canada; Univ British Columbia, Fac Med & Sci, Vancouver Hosp & Hlth Sci Ctr, Res Inst,Dept Microbiol & Immunol, Vancouver, BC V5Z 3J5, Canada; Univ Mohamed Ben Abdallah, Fac Sci Dhar Mahraz, Immunol Lab, Atlas Fes, Morocco	University of British Columbia; University of British Columbia; Sidi Mohamed Ben Abdellah University of Fez	Reiner, NE (corresponding author), Univ British Columbia, Div Infect Dis, Rm 452D,2733 Heather St, Vancouver, BC V5Z 3J5, Canada.	ethan@unixg.ubc.ca						BEEKHUIZEN H, 1993, J IMMUNOL, V150, P950; BEVILACQUA MP, 1994, ANNU REV MED, V45, P361, DOI 10.1146/annurev.med.45.1.361; BEVILACQUA MP, 1985, J CLIN INVEST, V76, P2003, DOI 10.1172/JCI112200; Capodici C, 1998, J IMMUNOL, V160, P1901; CROSS MJ, 1995, J BIOL CHEM, V270, P25352, DOI 10.1074/jbc.270.43.25352; DUSTIN ML, 1991, ANNU REV IMMUNOL, V9, P27, DOI 10.1146/annurev.iy.09.040191.000331; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Gomez J, 1997, J IMMUNOL, V158, P1516; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; HASLETT C, 1997, AM REV RESPIR DIS, V136, P9; HerreraVelit P, 1996, J IMMUNOL, V156, P1157; HerreraVelit P, 1997, J BIOL CHEM, V272, P16445, DOI 10.1074/jbc.272.26.16445; HMAMA Z, 1992, IMMUNOBIOLOGY, V186, P183, DOI 10.1016/S0171-2985(11)80249-4; HMAMA Z, 1994, INFECT IMMUN, V62, P1520, DOI 10.1128/IAI.62.5.1520-1527.1994; JUST I, 1994, J BIOL CHEM, V269, P10706; JUST I, 1994, J CELL SCI, V107, P1653; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Kundra A, 1998, J BIOL CHEM, V273, P3848, DOI 10.1074/jbc.273.7.3848; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Laudanna C, 1997, J BIOL CHEM, V272, P24141, DOI 10.1074/jbc.272.39.24141; LIU L, 1992, BIOCHIM BIOPHYS ACTA, V1132, P75, DOI 10.1016/0167-4781(92)90055-5; LIU MK, 1994, J IMMUNOL, V153, P2642; LOLLO BA, 1993, J BIOL CHEM, V268, P21693; LUB M, 1995, IMMUNOL TODAY, V16, P479, DOI 10.1016/0167-5699(95)80031-X; Nandan D, 1997, J IMMUNOL, V158, P1095; OWEN CA, 1992, J LEUKOCYTE BIOL, V51, P400, DOI 10.1002/jlb.51.4.400; PHILIPS MR, 1988, J CLIN INVEST, V82, P495, DOI 10.1172/JCI113623; POHLMAN TH, 1986, J IMMUNOL, V136, P4548; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; Schmidt M, 1998, J BIOL CHEM, V273, P7413, DOI 10.1074/jbc.273.13.7413; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shimizu Y, 1996, IMMUNOL TODAY, V17, P565, DOI 10.1016/S0167-5699(96)10061-X; Shimizu Y, 1995, J CELL BIOL, V131, P1867, DOI 10.1083/jcb.131.6.1867; SMEDLY LA, 1986, J CLIN INVEST, V77, P1233, DOI 10.1172/JCI112426; SMITH CW, 1988, J CLIN INVEST, V82, P1746, DOI 10.1172/JCI113788; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; TOKER A, 1995, J BIOL CHEM, V270, P29525, DOI 10.1074/jbc.270.49.29525; TOMINAGA T, 1993, J CELL BIOL, V120, P1529, DOI 10.1083/jcb.120.6.1529; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WALLIS WJ, 1985, J IMMUNOL, V135, P2323; Ward SG, 1996, IMMUNOL TODAY, V17, P187, DOI 10.1016/0167-5699(96)80618-9; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; ZHANG J, 1993, J BIOL CHEM, V268, P22251; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	50	81	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1050	1057		10.1074/jbc.274.2.1050	http://dx.doi.org/10.1074/jbc.274.2.1050			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873050	hybrid			2022-12-27	WOS:000077968500065
J	Iiboshi, Y; Papst, PJ; Kawasome, H; Hosoi, H; Abraham, RT; Houghton, PJ; Terada, N				Iiboshi, Y; Papst, PJ; Kawasome, H; Hosoi, H; Abraham, RT; Houghton, PJ; Terada, N			Amino acid-dependent control of p70(s6k) - Involvement of tRNA aminoacylation in the regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; TRANSFER-RNA SYNTHETASE; ACTIVATED PROTEIN-KINASE; SINGLE-POINT MUTATION; TRANSLATIONAL CONTROL; SIGNALING PATHWAY; PHAS-I; PHOSPHORYLATION; RAPAMYCIN; INITIATION	In human T-lymphoblastoid cells, downstream signaling events of mammalian target of rapamycin (mTOR), including the activity of p70(s6k) and phosphorylation of eukaryotic initiation factor 4E-binding protein 1, were dependent on amino acid concentration in the culture media, whereas other growth-related protein kinases were not. Amino acid-induced p70(s6k) activation was completely inhibited by rapamycin but only partially inhibited by wortmannin. Moreover, amino acid concentration similarly affected the p70(s6k) activity, which was dependent on a rapamycin-resistant mutant (S2035I) of mTOR. These data indicate that mTOR is required for amino acid-dependent activation of p70(s6k). The mechanism by which amino acids regulate p70(s6k) activity was further explored: 1) amino acid alcohols, which inhibit aminoacylation of tRNA by their competitive binding to tRNA synthetases, suppressed p70(s6k) activity; 2) suppression of p70(s6k) by amino acid depletion was blocked by cycloheximide or puromycin, which inhibit utilization of aminoacylated tRNA in cells; and 3) in cells having a temperature-sensitive mutant of histidyl tRNA synthetase, p70(s6k) was suppressed by a transition of cells to a nonpermissible temperature, which was partially restored by addition of high concentrations of histidine. These results indicate that suppression of tRNA aminoacylation is able to inhibit p70(s6k) activity. Deacylated tRNA may be a factor negatively regulating p70(s6k).	Natl Jewish Med & Res Ctr, Div Basic Sci, Dept Pediat, Denver, CO 80206 USA; St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; Mayo Clin & Mayo Fdn, Dept Immunol & Pharmacol, Rochester, MN 55905 USA	National Jewish Health; St Jude Children's Research Hospital; Mayo Clinic	Terada, N (corresponding author), Natl Jewish Med & Res Ctr, Div Basic Sci, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.				NCI NIH HHS [CA-64685, CA-23099] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA064685, P01CA023099] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; BANDI HR, 1993, J BIOL CHEM, V268, P4530; BANERJEE P, 1990, P NATL ACAD SCI USA, V87, P8550, DOI 10.1073/pnas.87.21.8550; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; DOUGLASS EC, 1987, CYTOGENET CELL GENET, V45, P148, DOI 10.1159/000132446; Fox HL, 1998, AM J PHYSIOL-CELL PH, V274, pC206, DOI 10.1152/ajpcell.1998.274.1.C206; Fukushima K, 1996, GENES CELLS, V1, P1087, DOI 10.1046/j.1365-2443.1996.d01-225.x; HAMILTON TA, 1976, BIOCHIM BIOPHYS ACTA, V435, P362, DOI 10.1016/0005-2787(76)90202-1; HANSEN BS, 1972, J BIOL CHEM, V247, P3854; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HASELTINE WA, 1973, P NATL ACAD SCI USA, V70, P1564, DOI 10.1073/pnas.70.5.1564; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kawasome H, 1998, P NATL ACAD SCI USA, V95, P5033, DOI 10.1073/pnas.95.9.5033; KILBERG MS, 1994, FASEB J, V8, P13, DOI 10.1096/fasebj.8.1.8299885; KOLTER R, 1982, ANNU REV GENET, V16, P113, DOI 10.1146/annurev.ge.16.120182.000553; KUMAKURA T, 1995, LIFE SCI, V57, P75; LIN TA, 1995, J BIOL CHEM, V270, P18531, DOI 10.1074/jbc.270.31.18531; Motomura S, 1996, GENES CELLS, V1, P1101, DOI 10.1046/j.1365-2443.1996.d01-227.x; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; PESTKA S, 1971, ANNU REV MICROBIOL, V25, P487, DOI 10.1146/annurev.mi.25.100171.002415; PROUD CG, 1992, CURR TOP CELL REGUL, V32, P243; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; REINHARD C, 1992, P NATL ACAD SCI USA, V89, P4052, DOI 10.1073/pnas.89.9.4052; Sugiyama H, 1997, ONCOGENE, V15, P443, DOI 10.1038/sj.onc.1201207; SUSA M, 1989, CELL, V57, P817, DOI 10.1016/0092-8674(89)90796-4; TERADA N, 1992, BIOCHEM BIOPH RES CO, V186, P1315, DOI 10.1016/S0006-291X(05)81549-9; TERADA N, 1993, J BIOL CHEM, V268, P12062; THOMPSON LH, 1978, SOMAT CELL GENET, V4, P423, DOI 10.1007/BF01538864; vonManteuffel SR, 1996, P NATL ACAD SCI USA, V93, P4076, DOI 10.1073/pnas.93.9.4076; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; WEK RC, 1994, TRENDS BIOCHEM SCI, V19, P491, DOI 10.1016/0968-0004(94)90136-8; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK SA, 1995, MOL CELL BIOL, V15, P4497; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744	48	178	181	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1092	1099		10.1074/jbc.274.2.1092	http://dx.doi.org/10.1074/jbc.274.2.1092			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873056	hybrid, Green Submitted			2022-12-27	WOS:000077968500071
J	Kasibhatla, S; Genestier, L; Green, DR				Kasibhatla, S; Genestier, L; Green, DR			Regulation of Fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; PROTEASOME REGULATION; SIGNAL-TRANSDUCTION; PROTEINS; GENE; JNK; IDENTIFICATION; HYBRIDOMAS; INHIBITION; PRECURSOR	T cell receptor engagement activates transcription factors important for cytokine gene regulation. additionally, this signaling pathway also leads to activation-induced apoptosis in T lymphocytes that is dependent on FasL transcription and expression. Here we demonstrate that nuclear factor kappa B (NF-kappa B), which is involved in the transcriptional regulation of many cytokine genes expressed in activated lymphocytes, also plays a role in T cell activation-induced FasL expression. Inhibition of NF-kappa B activity in a T cell hybridoma leads to decreased FasL expression and apoptosis upon T cell receptor stimulation. We identified the NF-kappa B site in the FasL promoter that contributes to such regulation. Co-expression of p65 (Rel A) with the FasL promoter enhanced its activity, and co-expression of I kappa B dramatically inhibited the inducible promoter activity. In contrast, the transcription factor AP-1 is not required for activation-induced FasL promoter activity, These results define a role for NF-kappa B in mediating FasL expression during T cell activation.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Kasibhatla, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	skasibhatla@liai.org	Genestier, Laurent/H-6443-2016; Green, Douglas R/N-8083-2018	Genestier, Laurent/0000-0002-0527-4583; Green, Douglas R/0000-0002-7332-1417	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052735, R37GM052735] Funding Source: NIH RePORTER; NCI NIH HHS [CA69831] Funding Source: Medline; NIA NIH HHS [AG 00252-01] Funding Source: Medline; NIGMS NIH HHS [GM 52735] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; Bauer MKA, 1998, J BIOL CHEM, V273, P8048, DOI 10.1074/jbc.273.14.8048; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Brunner T, 1996, INT IMMUNOL, V8, P1017, DOI 10.1093/intimm/8.7.1017; Brunner T, 1996, Behring Inst Mitt, P161; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Cui HL, 1997, P NATL ACAD SCI USA, V94, P7515, DOI 10.1073/pnas.94.14.7515; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; FINCO TS, 1995, IMMUNITY, V3, P263, DOI 10.1016/1074-7613(95)90112-4; HENKEL T, 1992, CELL, V68, P1121, DOI 10.1016/0092-8674(92)90083-O; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; IVANOV V, 1997, ONCOGENE, V22, P2455; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; KASIBHATLA S, 1993, J IMMUNOL, V151, P3140; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Lin SC, 1998, MOL CELL BIOL, V18, P5523, DOI 10.1128/MCB.18.9.5523; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Mariani SM, 1998, EUR J IMMUNOL, V28, P1492, DOI 10.1002/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.0.CO;2-X; Matsui K, 1997, EUR J IMMUNOL, V27, P2269, DOI 10.1002/eji.1830270922; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; ROSSETTE C, 1995, J CELL BIOL, V128, P1111; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shibuya H, 1989, INT IMMUNOL, V1, P43, DOI 10.1093/intimm/1.1.43; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Williams MS, 1996, J IMMUNOL, V157, P2395	46	233	235	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					987	992		10.1074/jbc.274.2.987	http://dx.doi.org/10.1074/jbc.274.2.987			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873041	hybrid			2022-12-27	WOS:000077968500056
J	Conlan, RS; Gounalaki, N; Hatzis, P; Tzamarias, D				Conlan, RS; Gounalaki, N; Hatzis, P; Tzamarias, D			The Tup1-Cyc8 protein complex can shift from a transcriptional co-repressor to a transcriptional co-activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GLUCOSE REPRESSION; YEAST; EXPRESSION; DOMAIN; GENE; MITOCHONDRIA; ALPHA-2; NUCLEUS; TPR	Cyc8(Ssn6)-Tup1, a general co-repressor complex, is recruited to promoter DNA via interactions with DNA-binding regulatory proteins and inhibits the transcription of many different yeast genes, Previous studies have established that repression function of the complex is performed by one subunit of the complex, the Tup1 protein, and requires specific components of the RNA polymerase II holoenzyme such as Sine and Rgr1, in this study we test the transcriptional activity of the Cyc8 subunit using a LexA operator-containing reporter, We show that a LexA-Cyc8 hybrid stimulates transcription when expressed in a tup1 Delta, a sin4 Delta, or a rgr1 Delta strain, suggesting that transcriptional activation is an intrinsic property of the Cyc8-Tup1 co-repressor. In support of this notion we demonstrate that Cyc8-Tup1 has a dual function on CIT2, a gene encoding a citrate synthase that is expressed upon mitochondrial dysfunction, First, we show that Cyc8-Tup1 is tethered to CIT2 promoter by interacting with the activation domain of Rtg3, a bHLH/L-Zip DNA-binding transactivator of CIT2. Next we demonstrate that Cyc8-Tup1 activates CIT2 transcription in response to mitochondrial dysfunction, and this stimulatory effect is mediated by Cyc8, In contrast, basal (noninduced) expression of this gene is inhibited by Tup1, These findings establish a positive role for the Cyc8-Tup1 complex in transcription and support a model by which specific metabolic signals may convert the Cyc8-Tup1 transcriptional co-repressor to a co-activator of certain promoters.	Inst Mol Biol & Biotechnol, Fdn Res & Technol, Iraklion, Crete, Greece		Tzamarias, D (corresponding author), Inst Mol Biol & Biotechnol, Fdn Res & Technol, POB 71110, Iraklion, Crete, Greece.	Tzamarias@imbb.forth.gr		Conlan, Robert/0000-0002-2562-3461				Carrico PM, 1998, GENETICS, V148, P637; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; HERSCHBACH BM, 1994, NATURE, V370, P309, DOI 10.1038/370309a0; Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110; KAMENS J, 1990, MOL CELL BIOL, V10, P2840, DOI 10.1128/MCB.10.6.2840; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; KOS W, 1995, BBA-GENE STRUCT EXPR, V1264, P79, DOI 10.1016/0167-4781(95)00127-3; Kuchin S, 1998, MOL CELL BIOL, V18, P1163, DOI 10.1128/MCB.18.3.1163; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; LEWIN AS, 1990, MOL CELL BIOL, V10, P1399, DOI 10.1128/MCB.10.4.1399; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Ozcan S, 1997, YEAST, V13, P127; Roberts SM, 1997, GENETICS, V147, P451; ROTH SY, 1995, CURR OPIN GENET DEV, V5, P168, DOI 10.1016/0959-437X(95)80004-2; Rothermel BA, 1997, J BIOL CHEM, V272, P19801, DOI 10.1074/jbc.272.32.19801; ROTHERMEL BA, 1995, J BIOL CHEM, V270, P29476, DOI 10.1074/jbc.270.49.29476; SAKAI A, 1990, MOL CELL BIOL, V10, P4130, DOI 10.1128/MCB.10.8.4130; SCHULTZ J, 1990, MOL CELL BIOL, V10, P4744, DOI 10.1128/MCB.10.9.4744; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; SMITH RL, 1995, GENE DEV, V9, P2903, DOI 10.1101/gad.9.23.2903; TZAMARIAS D, 1995, GENE DEV, V9, P821, DOI 10.1101/gad.9.7.821; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; WAHI M, 1995, GENETICS, V140, P79; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; WILLIAMS FE, 1991, MOL CELL BIOL, V11, P3307, DOI 10.1128/MCB.11.6.3307; ZHANG L, 1994, GENETICS, V136, P813	35	71	72	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					205	210		10.1074/jbc.274.1.205	http://dx.doi.org/10.1074/jbc.274.1.205			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867831	hybrid			2022-12-27	WOS:000077900200031
J	Magert, HJ; Cieslak, A; Alkan, O; Luscher, B; Kauffels, W; Forssmann, WG				Magert, HJ; Cieslak, A; Alkan, O; Luscher, B; Kauffels, W; Forssmann, WG			The golden hamster aphrodisin gene - Structure, expression in parotid glands of female animals, and comparison with a similar murine gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOCALIN PROTEIN FAMILY; PROSTAGLANDIN-D SYNTHASE; LIGAND CARRIER PROTEINS; ETS-RELATED PROTEIN; VOMERONASAL ORGAN; APOLIPOPROTEIN-D; MOLECULAR-CLONING; VAGINAL DISCHARGE; PERIPHERAL-NERVE; BINDING PROTEIN	The so-called lipocalins are a family of extracellular proteins that are known to typically fulfill tasks as transport proteins for small hydrophobic molecules. However, in the last decade, a large diversity has been described concerning their functions, for example as enzymes, immunomodulators, or proteins involved in coloration and pheromone action. Aphrodisin belongs to those lipocalins, which are of significant importance for the pheromonal stimulation of copulatory behavior in male hamsters, We recently succeeded in characterizing the corresponding cDNA and demonstrated the expression of the aphrodisin gene in the vagina, uterus, and Bartholin's glands of female hamsters, Here we report the structure of the aphrodisin gene and the functionality of its promoter region. We further compare the aphrodisin gene to the related gene for mouse odorant binding protein la, indicating similar functions of their products. As a novelty, we show that the aphrodisin gene, in addition to the above-mentioned tissues, is also expressed in female hamster parotid glands. In contradiction to the results expected, we finally demonstrate that aphrodisin already occurs in vaginal discharge before the female animals reach fertility. These findings may lead to the identification of as yet unknown aphrodisin functions.	Lower Saxony Inst Peptide Res, D-30625 Hannover, Germany; Hannover Med Sch, Dept Mol Biol, D-30625 Hannover, Germany; Hannover Med Sch, Dept Gynecol & Obstet, D-30625 Hannover, Germany	Hannover Medical School; Hannover Medical School	Magert, HJ (corresponding author), Lower Saxony Inst Peptide Res, Feodor Lynen Str 31, D-30625 Hannover, Germany.		Luscher, Bernhard/A-7330-2011	Luscher, Bernhard/0000-0002-9622-8709				ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Bartholomew C, 1997, ONCOGENE, V14, P569, DOI 10.1038/sj.onc.1200864; BISHOP RE, 1995, J BIOL CHEM, V270, P23097, DOI 10.1074/jbc.270.39.23097; BLAKER M, 1993, BIOCHIM BIOPHYS ACTA, V1172, P131, DOI 10.1016/0167-4781(93)90279-M; BOYLES JK, 1990, J BIOL CHEM, V265, P17805; CLANCY AN, 1984, PHYSIOL BEHAV, V33, P653, DOI 10.1016/0031-9384(84)90386-X; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; FLOWER DR, 1994, FEBS LETT, V354, P7, DOI 10.1016/0014-5793(94)01078-1; Flower DR, 1996, BIOCHEM J, V318, P1; FLOWER DR, 1995, TRENDS BIOCHEM SCI, V20, P498, DOI 10.1016/S0968-0004(00)89116-1; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; GUTTNER J, 1993, WORTERBUCH VERSUCHST; HENZEL WJ, 1988, J BIOL CHEM, V263, P16682; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; HO IC, 1990, SCIENCE, V250, P814, DOI 10.1126/science.2237431; IGARASHI M, 1992, P NATL ACAD SCI USA, V89, P5376, DOI 10.1073/pnas.89.12.5376; Kroner C, 1996, NEUROREPORT, V7, P2989, DOI 10.1097/00001756-199611250-00038; Kruhoffer M, 1997, CELL TISSUE RES, V287, P153; MAGERT HJ, 1995, P NATL ACAD SCI USA, V92, P2091, DOI 10.1073/pnas.92.6.2091; MONTIBLOCH L, 1991, J STEROID BIOCHEM, V39, P573, DOI 10.1016/0960-0760(91)90255-4; MORAN DT, 1991, J STEROID BIOCHEM, V39, P545, DOI 10.1016/0960-0760(91)90251-Y; MORROW DM, 1994, AM J PATHOL, V145, P1485; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAGATA A, 1991, P NATL ACAD SCI USA, V88, P4020, DOI 10.1073/pnas.88.9.4020; Pardigol A, 1996, BIOCHEM BIOPH RES CO, V224, P638, DOI 10.1006/bbrc.1996.1078; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; PERKINS AS, 1991, DEVELOPMENT, V111, P479; PEVSNER J, 1988, SCIENCE, V241, P336, DOI 10.1126/science.3388043; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RAO VN, 1992, ONCOGENE, V7, P65; RILEY CT, 1984, J BIOL CHEM, V259, P3159; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHMALE H, 1990, NATURE, V343, P366, DOI 10.1038/343366a0; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; SINGER AG, 1990, CHEM SENSES, V15, P199, DOI 10.1093/chemse/15.2.199; SINGER AG, 1986, J BIOL CHEM, V261, P3323; Soderholm J, 1997, LEUKEMIA, V11, P352, DOI 10.1038/sj.leu.2400584; SPREYER P, 1990, EMBO J, V9, P2479, DOI 10.1002/j.1460-2075.1990.tb07426.x; STEENSAS LJ, 1991, J STEROID BIOCH MOL, V39, P553; URADE Y, 1989, J BIOL CHEM, V264, P1041	41	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					444	450		10.1074/jbc.274.1.444	http://dx.doi.org/10.1074/jbc.274.1.444			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867863	hybrid			2022-12-27	WOS:000077900200063
J	Weissmann, C				Weissmann, C			Molecular genetics of transmissible spongiform encephalopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CREUTZFELDT-JAKOB-DISEASE; SCRAPIE PRION PROTEIN; FOLLICULAR DENDRITIC CELLS; TRANSGENIC MICE; STRAIN VARIATION; PRP ISOFORMS; BIOLOGY; NEURODEGENERATION; PROPAGATION; AMYLOIDOSES		Univ Zurich, Inst Mol Biol, Abt 1, CH-8057 Zurich, Switzerland	University of Zurich	Weissmann, C (corresponding author), Univ Zurich, Inst Mol Biol, Abt 1, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	weissma@molbio.unizh.ch						AIZAWA SI, 1990, J MOL BIOL, V211, P673, DOI 10.1016/0022-2836(90)90064-S; ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; ASAKURA S, 1966, J MOL BIOL, V16, P302, DOI 10.1016/S0022-2836(66)80174-2; Baker H. F., 1992, Neurodegeneration, V1, P3; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; BOLTON DC, 1991, J GEN VIROL, V72, P2905, DOI 10.1099/0022-1317-72-12-2905; Brandner S, 1996, P NATL ACAD SCI USA, V93, P13148, DOI 10.1073/pnas.93.23.13148; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BROWN P, 1991, LANCET, V337, P1019, DOI 10.1016/0140-6736(91)92670-W; BRUCE ME, 1992, E H S NEURO, P497; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; CHESEBRO B, 1985, NATURE, V315, P331, DOI 10.1038/315331a0; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DICKINSON AG, 1969, GENET RES, V13, P213, DOI 10.1017/S0016672300002895; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; GAJDUSEK DC, 1988, J NEUROIMMUNOL, V20, P95; GOLDFARB LG, 1994, PHILOS T R SOC B, V343, P379, DOI 10.1098/rstb.1994.0032; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KIMBERLIN RH, 1980, J GEN VIROL, V51, P183, DOI 10.1099/0022-1317-51-1-183; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; MCBRIDE PA, 1992, J PATHOL, V168, P413, DOI 10.1002/path.1711680412; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; PRUSINER SB, 1993, PHILOS T R SOC B, V339, P239, DOI 10.1098/rstb.1993.0022; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; WEISSMANN C, 1991, NATURE, V349, P569, DOI 10.1038/349569a0; Weissmann C, 1996, FEBS LETT, V389, P3, DOI 10.1016/0014-5793(96)00610-2; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; WILESMITH JW, 1991, SEMINARS VIROLOGY, V2, P239; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	50	144	152	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					3	6		10.1074/jbc.274.1.3	http://dx.doi.org/10.1074/jbc.274.1.3			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867802	hybrid			2022-12-27	WOS:000077900200002
J	Chang, CCY; Lee, CYG; Chang, ET; Cruz, JC; Levesque, MC; Chang, TY				Chang, CCY; Lee, CYG; Chang, ET; Cruz, JC; Levesque, MC; Chang, TY			Recombinant acyl-CoA : cholesterol acyltransferase-1 (ACAT-1) purified to essential homogeneity utilizes cholesterol in mixed micelles or in vesicles in a highly cooperative manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; PROTEIN-KINASE-C; BILIARY LIPID SYSTEMS; COENZYME-A; RADIATION INACTIVATION; MOLECULAR-CLONING; APOLIPOPROTEIN-B; RECONSTITUTION; LIPOSOMES; ENZYMES	Acyl-coenzyme A:cholesterol acyltransferase (ACAT) is an integral membrane protein located in the endoplasmic reticulum. It catalyzes the formation of cholesteryl esters from cholesterol and long-chain fatty acyl coenzyme A. The first gene encoding the enzyme, designated as ACAT-I, was identified in 1993 through an expression cloning approach, We isolated a Chinese hamster ovary cell line that stably expresses the recombinant human ACAT-1 protein bearing an N-terminal hexahistidine tag. We purified this enzyme approximately 7000-fold from crude cell extracts by first solubilizing the cell membranes with the zwitterionic detergent 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, then proceeding with an ACAT-1 monoclonal antibody affinity column and an immobilized metal affinity column. The final preparation is enzymologically active and migrates as a single band at 54 kDa on SDS-polyacrylamide gel electrophoresis. Pure ACAT-1 dispersed in mixed micelles containing sodium taurocholate, phosphatidylcholine, and cholesterol remains catalytically active. The cholesterol substrate saturation curves of the enzyme assayed either in mixed micelles or in reconstituted vesicles are both highly sigmoidal. The oleoyl-coenzyme A substrate saturation curves of the enzyme assayed under the same conditions are both hyperbolic. These results support the hypothesis that ACAT is an allosteric enzyme regulated by cholesterol.	Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA; Univ British Columbia, Dept Obstet & Gynecol, Androl Lab, Vancouver, BC V6T 2B5, Canada	Dartmouth College; University of British Columbia	Chang, TY (corresponding author), Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA.		Chang, Ellen/E-3168-2010; Chang, Ellen/G-5700-2010	Chang, Ta-Yuan/0000-0002-3249-0468	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060306, R01HL036709, R37HL036709] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 60306, HL 36709] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BILLHEIMER JT, 1990, J BIOL CHEM, V265, P8632; BISHOP JE, 1980, ANAL BIOCHEM, V106, P344, DOI 10.1016/0003-2697(80)90531-X; CABRAL DJ, 1989, HDB PHYSL 6, V3, P621; CADIGAN KM, 1988, J LIPID RES, V29, P1683; Cao GQ, 1996, J BIOL CHEM, V271, P14642, DOI 10.1074/jbc.271.24.14642; CAREY MC, 1978, J CLIN INVEST, V61, P998, DOI 10.1172/JCI109025; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; CARR TP, 1995, J LIPID RES, V36, P25; CASES S, 1997, CIRCULATION S1, V96, P230; CHANG CCY, 1995, J BIOL CHEM, V270, P29532; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; CHANG TY, 1981, ANAL BIOCHEM, V116, P298, DOI 10.1016/0003-2697(81)90360-2; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; CHANG TY, 1983, ENZYMES, V16, P523; DAVIS JM, 1982, J IMMUNOL METHODS, V50, P161, DOI 10.1016/0022-1759(82)90222-8; DOOLITTLE GM, 1982, BIOCHIM BIOPHYS ACTA, V713, P529, DOI 10.1016/0005-2760(82)90313-7; DOOLITTLE GM, 1982, BIOCHEMISTRY-US, V21, P674, DOI 10.1021/bi00533a014; ERICKSON SK, 1994, J LIPID RES, V35, P763; GOODMAN DS, 1964, J BIOL CHEM, V239, P1335; HASAN MT, 1991, SOMAT CELL MOLEC GEN, V17, P513, DOI 10.1007/BF01233175; Khelef N, 1998, J BIOL CHEM, V273, P11218, DOI 10.1074/jbc.273.18.11218; Koshland DE, 1998, SCIENCE, V280, P852, DOI 10.1126/science.280.5365.852; Lee O, 1998, J LIPID RES, V39, P1722; MATHUR SN, 1983, BIOCHIM BIOPHYS ACTA, V751, P401, DOI 10.1016/0005-2760(83)90299-0; MAZER NA, 1983, BIOCHEMISTRY-US, V22, P426, DOI 10.1021/bi00271a029; MAZER NA, 1980, BIOCHEMISTRY-US, V19, P601, DOI 10.1021/bi00545a001; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Meiner VL, 1998, J BIOL CHEM, V273, P1064, DOI 10.1074/jbc.273.2.1064; Miyazaki A, 1998, ARTERIOSCL THROM VAS, V18, P1568, DOI 10.1161/01.ATV.18.10.1568; MUKHERJEE S, 1958, J BIOL CHEM, V230, P91; NEWTON AC, 1989, J BIOL CHEM, V264, P14909; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4667, DOI 10.1021/bi00134a019; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4661, DOI 10.1021/bi00134a018; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; SANKARAM MB, 1991, P NATL ACAD SCI USA, V88, P8686, DOI 10.1073/pnas.88.19.8686; SHI SP, 1989, BIOCHIM BIOPHYS ACTA, V982, P187, DOI 10.1016/0005-2736(89)90054-0; STANGE EF, 1985, CHOLESTEROL ABSORPTI, P121; STURLEY SL, 1997, CIRCULATION S1, V96, P411; SUCKLING KE, 1985, J LIPID RES, V26, P647; TABAS I, 1995, CURR OPIN LIPIDOL, V6, P260, DOI 10.1097/00041433-199510000-00004; TANAKA M, 1993, J BIOL CHEM, V268, P12713; VENTIMIGLIA JB, 1986, ANAL BIOCHEM, V157, P323, DOI 10.1016/0003-2697(86)90633-0; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WILSON MD, 1994, J LIPID RES, V35, P943; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Yu CJ, 1996, J BIOL CHEM, V271, P24157, DOI 10.1074/jbc.271.39.24157	47	103	107	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35132	35141		10.1074/jbc.273.52.35132	http://dx.doi.org/10.1074/jbc.273.52.35132			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857049	hybrid			2022-12-27	WOS:000077719700067
J	Cheng, W; Bullitt, E; Bhattacharyya, L; Brewer, CF; Makowski, L				Cheng, W; Bullitt, E; Bhattacharyya, L; Brewer, CF; Makowski, L			Electron microscopy and X-ray diffraction studies of Lotus tetragonolobus A isolectin cross-linked with a divalent Lewis(x) oligosaccharide, an oncofetal antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CONCANAVALIN-A; 3-DIMENSIONAL STRUCTURE; QUATERNARY STRUCTURE; SOYBEAN AGGLUTININ; ANIMAL LECTINS; LEGUME LECTIN; BINDING; COMPLEX; CELLS	The interactions of lectins with multivalent carbohydrates often leads to the formation of highly ordered cross-linked lattices that are amenable to structural studies. A particularly well ordered, two-dimensional lattice is formed from fucose-specific isolectin A from Lotus tetragonolobus cross-linked with difucosyllacto-N-neohexaose, an oligosaccharide possessing the Lewis(x) determinant, which is an oncofetal antigen. A combination of electron microscopy, x-ray diffraction, simulation of electron micrographs, and molecular model building was used to determine the relative positions of the tetrameric lectin and bivalent carbohydrate within the lattice. X-ray diffraction from unoriented pellets was used to determine the lattice dimensions and analysis of electron micrographs was used to determine the lattice symmetry. Molecular models of the lattice were constructed based on the known structure of the jack bean lectin concanavalin A and the high degree of sequence homology between the two lectins. Using the symmetry and dimensions of the lattice and its appearance in filtered electron micrographs, molecular models were used to determine the orientation of the lectin in the lattice, and to define the range of lectin-oligosaccharide interactions consistent with the structural data. The present study provides the first description of a highly ordered, two-dimensional, cross-linked lattice between a tetravalent lectin and a bivalent carbohydrate.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Immunol, Bronx, NY 10461 USA; Boston Univ, Dept Phys, Boston, MA 02215 USA; Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Boston University; State University System of Florida; Florida State University	Brewer, CF (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.			Bullitt, Esther/0000-0003-2447-6209	NCI NIH HHS [CA-16054, P30 CA13330] Funding Source: Medline; NIGMS NIH HHS [GM-29829] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA016054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029829] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen H. J., 1992, GLYCOCONJUGATES COMP; ALLEN HJ, 1977, CARBOHYD RES, V58, P253, DOI 10.1016/S0008-6215(00)84352-9; BANERJEE R, 1994, P NATL ACAD SCI USA, V91, P227, DOI 10.1073/pnas.91.1.227; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BECKER JW, 1989, T AM CRYSTALLOGR ASS, V25, P37; BHATTACHARYYA L, 1990, BIOCHEMISTRY-US, V29, P7523, DOI 10.1021/bi00484a022; BHATTACHARYYA L, 1987, J BIOL CHEM, V262, P1294; BOURNE Y, 1994, NAT STRUCT BIOL, V1, P863, DOI 10.1038/nsb1294-863; BOURNE Y, 1990, PROTEINS, V8, P365, DOI 10.1002/prot.340080410; BOURNE Y, 1994, STRUCTURE, V2, P209, DOI 10.1016/S0969-2126(00)00022-8; BREWER CF, 1996, CHEMTRACTS BIOCH MOL, V6, P165; Brockhausen I., 1997, GLYCOPROTEINS HUMAN; CABRALLILLY D, 1991, BIOPHYS J, V59, P805, DOI 10.1016/S0006-3495(91)82293-7; CARRAWAY KL, 1989, BIOCHIM BIOPHYS ACTA, V988, P147, DOI 10.1016/0304-4157(89)90017-8; CHUNG KN, 1989, SCIENCE, V243, P192, DOI 10.1126/science.2911732; DELBAERE LTJ, 1993, J MOL BIOL, V230, P950, DOI 10.1006/jmbi.1993.1212; DESSEN A, 1995, BIOCHEMISTRY-US, V34, P4933, DOI 10.1021/bi00015a004; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; EDELMAN GM, 1972, P NATL ACAD SCI USA, V69, P2580, DOI 10.1073/pnas.69.9.2580; EDELMAN GM, 1976, SCIENCE, V192, P218, DOI 10.1126/science.769162; EDMONDS BT, 1990, CELL MOTIL CYTOSKEL, V17, P106, DOI 10.1002/cm.970170206; EINSPAHR H, 1986, J BIOL CHEM, V261, P6518; Ginsburg V., 1984, BIOL CARBOHYDRATES; GUPTA D, 1994, BIOCHEMISTRY-US, V33, P7495, DOI 10.1021/bi00190a001; HAKOMORI S, 1984, ANNU REV IMMUNOL, V2, P103, DOI 10.1146/annurev.iy.02.040184.000535; Hamelryck TW, 1996, J BIOL CHEM, V271, P20479, DOI 10.1074/jbc.271.34.20479; HARDMAN KD, 1972, BIOCHEMISTRY-US, V11, P4910, DOI 10.1021/bi00776a006; KALB AJ, 1968, BIOCHIM BIOPHYS ACTA, V168, P532; KOBATA A, 1992, GLYCOCONJUGATES COMP, P33; KONAMI Y, 1990, FEBS LETT, V268, P281, DOI 10.1016/0014-5793(90)81028-M; Konstantinov KN, 1996, AM J PATHOL, V148, P25; KOOIJMAN R, 1989, J CELL BIOL, V109, P1677, DOI 10.1083/jcb.109.4.1677; Lee X, 1998, J BIOL CHEM, V273, P6312, DOI 10.1074/jbc.273.11.6312; Liener I.E., 1986, LECTINS PROPERTIES F; LORIS R, 1993, BIOCHEMISTRY-US, V32, P8772, DOI 10.1021/bi00085a007; LOTAN R, 1988, ANN NY ACAD SCI, V551, P385, DOI 10.1111/j.1749-6632.1988.tb22372.x; MONSIGNY M, 1988, BIOCHIMIE, V70, P1633, DOI 10.1016/0300-9084(88)90299-4; NICOLSON GL, 1976, BIOCHIM BIOPHYS ACTA, V457, P57, DOI 10.1016/0304-4157(76)90014-9; Olsen LR, 1997, BIOCHEMISTRY-US, V36, P15073, DOI 10.1021/bi971828+; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; PHILLIPS WC, 1985, METHOD ENZYMOL, V114, P316; REEKE GN, 1975, J BIOL CHEM, V250, P1525; REEKE GN, 1986, SCIENCE, V234, P1108, DOI 10.1126/science.3775378; REEKE GN, 1986, CURR TOP MICROBIOL I, V139, P35; SABESAN S, 1992, J AM CHEM SOC, V114, P8363, DOI 10.1021/ja00048a004; SAHA SK, 1994, CARBOHYD RES, V254, P157; SHAANAN B, 1991, SCIENCE, V254, P862, DOI 10.1126/science.1948067; STEVEN AC, 1980, P NATL ACAD SCI-BIOL, V77, P4721, DOI 10.1073/pnas.77.8.4721; STEWART M, 1988, J ELECTRON MICR TECH, V9, P301, DOI 10.1002/jemt.1060090403; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Wright CS, 1996, STRUCTURE, V4, P1339, DOI 10.1016/S0969-2126(96)00141-4; WRIGHT CS, 1992, J BIOL CHEM, V267, P14345; YARIV J, 1967, NATURE, V215, P890, DOI 10.1038/215890a0	54	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35016	35022		10.1074/jbc.273.52.35016	http://dx.doi.org/10.1074/jbc.273.52.35016			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857034	hybrid			2022-12-27	WOS:000077719700052
J	Mahnke-Zizelman, DK; Tullson, PC; Sabina, RL				Mahnke-Zizelman, DK; Tullson, PC; Sabina, RL			Novel aspects of tetramer assembly and N-terminal domain structure and function are revealed by recombinant expression of human AMP deaminase isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; RAT MUSCLE; CLONING; MYOSIN; AMINOHYDROLASE; SEQUENCE; ISOZYMES; BINDING; GENE; PURIFICATION	AMP deaminase isoforms purified from endogenous sources display smaller than predicted subunit molecular masses, whereas baculoviral expression of human AMPD1 (isoform M) and AMPD3 (isoform E) cDNAs produces full-sized recombinant enzymes, However, nearly 100 N-terminal amino acid residues are cleaved from each recombinant polypeptide during storage at 4 degrees C, Expression of N-truncated cDNAs (Delta L96AMPD1 and Delta M90AMPD3) produces stable recombinant enzymes exhibiting subunit molecular masses and kinetic properties that are similar to those reported for purified isoforms M and E, Conversely, wild type recombinant isoforms display significantly higher K-m(app) values in the absence of ATP, Gel filtration analysis demonstrates native tetrameric structures for all recombinant proteins, except the wild type AMPD1 enzyme, which forms aggregates of tetramers that disperse upon cleavage of N-terminal residues at 4 degrees C, These data: 1) confirm that available literature on AMP deaminase is likely derived from N-truncated enzymes and 2) are inconsistent with a new model proposing native trimeric structure of an N-truncated rabbit skeletal muscle AMP deaminase (Ranieri-Rags, M,, Montali, U., Ronca, F. Sabbatini, A., Brown, P. E., Moir, A. J. G., and Raggi, A. (1997) Biochem. J, 326, 641-648), N-terminal residues also influence actomyosin-binding properties of the enzyme, which are enhanced and suppressed by AMPD1 and AMPD3 sequences, respectively. Finally, co-expression of AMPD1 and AMPD3 recombinant polypeptides produces tetrameric enzymes with either isoform-specific or mixed subunits, and also reveals that tetramer assembly is driven by relative polypeptide abundance with no apparent preference for like subunits.	Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; SUNY Hlth Sci Ctr, Dept Physiol, Syracuse, NY 13210 USA	Medical College of Wisconsin; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Sabina, RL (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.				NIAMS NIH HHS [AR-21617] Funding Source: Medline; NIDDK NIH HHS [DK-50902] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR021617, R01AR021617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050902] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASHBY B, 1977, J BIOL CHEM, V252, P1869; BAUSCHJURKEN MT, 1995, ARCH BIOCHEM BIOPHYS, V321, P372, DOI 10.1006/abbi.1995.1407; BAUSCHJURKEN MT, 1992, J BIOL CHEM, V267, P22407; Chilson OP, 1997, COMP BIOCHEM PHYS B, V116, P371, DOI 10.1016/S0305-0491(96)00270-2; COFFEE CJ, 1975, J BIOL CHEM, V250, P6653; GROSS M, 1994, BIOCHEM BIOPH RES CO, V205, P1010, DOI 10.1006/bbrc.1994.2767; KORETZ JF, 1993, ARCH BIOCHEM BIOPHYS, V304, P305, DOI 10.1006/abbi.1993.1354; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOH E, 1996, CIRCULATION S1, V94, P434; MahnkeZizelman DK, 1996, BBA-GENE STRUCT EXPR, V1306, P75, DOI 10.1016/0167-4781(95)00231-6; MahnkeZizelman DK, 1996, BBA-GENE STRUCT EXPR, V1308, P122, DOI 10.1016/0167-4781(96)00089-9; MahnkeZizelman DK, 1997, BIOCHEM J, V326, P521, DOI 10.1042/bj3260521; MAHNKEZIZELMAN DK, 1992, J BIOL CHEM, V267, P20866; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MORISAKI H, 1993, J CLIN INVEST, V91, P2275, DOI 10.1172/JCI116455; MORISAKI T, 1990, J BIOL CHEM, V265, P11482; Nathans G R, 1978, Methods Enzymol, V51, P497; ODRISCOLL D, 1976, BIOCHEM SOC T, V4, P928, DOI 10.1042/bst0040928; OGASAWARA N, 1975, BIOCHIM BIOPHYS ACTA, V403, P530, DOI 10.1016/0005-2744(75)90081-9; OGASAWARA N, 1982, BIOCHIM BIOPHYS ACTA, V714, P298; OGASAWARA N, 1977, BIOCHEM BIOPH RES CO, V79, P671, DOI 10.1016/0006-291X(77)91164-0; OGASAWARA N, 1975, FEBS LETT, V58, P245, DOI 10.1016/0014-5793(75)80270-5; OGASAWARA N, 1984, INT J BIOCHEM, V16, P269, DOI 10.1016/0020-711X(84)90099-5; OGASAWARA N, 1978, BIOCHIM BIOPHYS ACTA, V524, P442, DOI 10.1016/0005-2744(78)90182-1; RANIERIRAGGI M, 1990, BIOCHEM J, V272, P755, DOI 10.1042/bj2720755; RANIERIRAGGI M, 1980, BIOCHEM J, V189, P367, DOI 10.1042/bj1890367; RanieriRaggi M, 1997, BIOCHEM J, V326, P641, DOI 10.1042/bj3260641; RONCA F, 1994, BBA-PROTEIN STRUCT M, V1209, P123, DOI 10.1016/0167-4838(94)90147-3; RUNDELL KW, 1992, AM J PHYSIOL, V263, pC287, DOI 10.1152/ajpcell.1992.263.2.C287; RUNDELL KW, 1992, AM J PHYSIOL, V263, pC294, DOI 10.1152/ajpcell.1992.263.2.C294; SABINA RL, 1992, NEUROLOGY, V42, P170, DOI 10.1212/WNL.42.1.170; SABINA RL, 1990, J BIOL CHEM, V265, P9423; SABINA RL, 1985, METABOLIC GENETIC BA, P1769; SHIRAKI H, 1979, BIOCHIM BIOPHYS ACTA, V566, P335, DOI 10.1016/0005-2744(79)90037-8; SOTERIOU A, 1993, J CELL SCI, V104, P119; STANKIEWICZ A, 1979, COMP BIOCHEM PHYS B, V62, P363, DOI 10.1016/0305-0491(79)90104-4; STANKIEWICZ A, 1981, INT J BIOCHEM, V13, P1177, DOI 10.1016/0020-711X(81)90211-1; SWAIN JL, 1982, AM J PHYSIOL, V242, P818; VANKUPPEVELT TH, 1994, J HISTOCHEM CYTOCHEM, V42, P861, DOI 10.1177/42.7.8014469; Wang XD, 1997, GENE, V188, P285, DOI 10.1016/S0378-1119(96)00818-9; YUN SL, 1978, J BIOL CHEM, V253, P404	41	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35118	35125		10.1074/jbc.273.52.35118	http://dx.doi.org/10.1074/jbc.273.52.35118			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857047	hybrid			2022-12-27	WOS:000077719700065
J	Vakiani, E; Luz, JG; Buck, J				Vakiani, E; Luz, JG; Buck, J			Substrate specificity and kinetic mechanism of the insect sulfotransferase, retinol dehydratase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; RAT-LIVER; PHENOL SULFOTRANSFERASE; MOLECULAR-CLONING; HYDROXYSTEROID SULFOTRANSFERASE; CYTOSOLIC SULFOTRANSFERASES; ESTROGEN SULFOTRANSFERASE; ARYL SULFOTRANSFERASE; SULFATING FORM; HUMAN-BRAIN	Spodoptera frugiperda retinol dehydratase catalyzes the conversion of retinol to the retro-retinoid anhydroretinol. It shares sequence homology with the family of mammalian cytosolic sulfotransferases and provides the first link between sulfotransferases and retinol metabolism. In this study the enzymatic properties of retinol dehydratase were examined using bacterially expressed protein. We show that retinol dehydratase can catalyze the transfer of the sulfonate moiety to small phenolic compounds and exhibits many functional similarities to the mammalian cytosolic sulfotransferases. The bisubstrate reaction that it catalyzes between retinol and the universal sulfonate donor 3'-phosphoadenosine 5'-phosphosulfate seems to involve ternary complex formation and to proceed via a Random Bi Bi mechanism. In addition to the low nanomolar K-m value for free retinol, retinol dehydratase is strongly inhibited by retinol metabolites, suggesting a preference for retinoids. Conversely, a number of tested mammalian cytosolic sulfotransferases do not utilize retinol, indicating that retinol is not a general substrate for sulfotransferases.	Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Cornell University	Buck, J (corresponding author), Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pharmacol, 1300 York Ave, New York, NY 10021 USA.				NATIONAL EYE INSTITUTE [T32EY007138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048022] Funding Source: NIH RePORTER; NEI NIH HHS [T32EY07138] Funding Source: Medline; NIDDK NIH HHS [DK48022] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BUCK J, 1991, SCIENCE, V254, P1654, DOI 10.1126/science.1749937; BUCK J, 1993, J EXP MED, V178, P675, DOI 10.1084/jem.178.2.675; CHATTERJEE B, 1987, J BIOL CHEM, V262, P822; CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1; DUFFEL MW, 1981, J BIOL CHEM, V256, P1123; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; FALANY JL, 1995, J STEROID BIOCHEM, V52, P35, DOI 10.1016/0960-0760(94)00147-E; FOLDES A, 1973, BIOCHIM BIOPHYS ACTA, V327, P365, DOI 10.1016/0005-2744(73)90419-1; GILBERT LI, 1980, ANNU REV PHYSIOL, V42, P493, DOI 10.1146/annurev.ph.42.030180.002425; Grun F, 1996, J BIOL CHEM, V271, P16135, DOI 10.1074/jbc.271.27.16135; HOFFMANN C, 1994, RETINOIDS BIOL CHEM, P387; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; LOVE JM, 1994, CURR OPIN CELL BIOL, V6, P825, DOI 10.1016/0955-0674(94)90051-5; MCCLEAN SW, 1982, CLIN CHEM, V28, P693; NAGATA K, 1993, J BIOL CHEM, V268, P24720; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; NOY N, 1990, BIOCHEMISTRY-US, V29, P3878, DOI 10.1021/bi00468a012; OGURA K, 1989, BIOCHEM BIOPH RES CO, V165, P168, DOI 10.1016/0006-291X(89)91050-4; OGURA K, 1990, BIOCHEM BIOPH RES CO, V166, P1494, DOI 10.1016/0006-291X(90)91036-R; OZAWA S, 1990, NUCLEIC ACIDS RES, V18, P4001, DOI 10.1093/nar/18.13.4001; PENNINGS EJM, 1978, BIOCHEM J, V173, P299, DOI 10.1042/bj1730299; RungeMorris MA, 1997, FASEB J, V11, P109, DOI 10.1096/fasebj.11.2.9039952; Sakakibara Y, 1995, J BIOL CHEM, V270, P30470, DOI 10.1074/jbc.270.51.30470; SINGER SS, 1980, CAN J BIOCHEM CELL B, V58, P660, DOI 10.1139/o80-092; SINGER SS, 1985, BIOCH PHARM TOXICOLO, V1, P95; VAKIANI E, 1998, HDB EXPT PHARM RETIN; Varin L, 1997, FASEB J, V11, P517, DOI 10.1096/fasebj.11.7.9212075; VARIN L, 1992, J BIOL CHEM, V267, P1858; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WATABE T, 1994, CHEM-BIOL INTERACT, V92, P87, DOI 10.1016/0009-2797(94)90056-6; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; WHITTEMORE RM, 1986, ARCH BIOCHEM BIOPHYS, V249, P464, DOI 10.1016/0003-9861(86)90023-8; WHITTEMORE RM, 1985, BIOCHEMISTRY-US, V24, P2477, DOI 10.1021/bi00331a013; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	34	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35381	35387		10.1074/jbc.273.52.35381	http://dx.doi.org/10.1074/jbc.273.52.35381			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857081	hybrid			2022-12-27	WOS:000077719700099
J	Jacquemin, P; Lannoy, VJ; Rousseau, GG; Lemaigre, FP				Jacquemin, P; Lannoy, VJ; Rousseau, GG; Lemaigre, FP			OC-2, a novel mammalian member of the ONECUT class of homeodomain transcription factors whose function in liver partially overlaps with that of hepatocyte nuclear factor-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE-ROD DYSTROPHY; HOMEOBOX GENE; MATCH-BOX; EXPRESSION; CUT; ALIGNMENT; PROTEIN; DOMAIN; DIFFERENTIATION; PHOTORECEPTOR	Transcription factors of the ONECUT class, whose prototype is hepatocyte nuclear factor (HNF)-6, are characterized by the presence of a single cut domain and by a peculiar homeodomain (Lannoy, V. J., Burglin, T. R., Rousseau, G. G., and Lemaigre, F. P. (1998) J. Biol. Chem, 273, 13552-13562), We report here the identification and characterization of human OC-2, the second mammalian member of this class. The OC-2 gene is located on human chromosome 18, The distribution of OC-2 mRNA in humans is tissue-restricted, the strongest expression being detected in the liver and skin. The amino acid sequence of OC-2 contains several regions of high similarity to HNF-6, The recognition properties of OC-2 for binding sites present in regulatory regions of liver-expressed genes differ from, but overlap with, those of HNF 6. Like HNF-6, OC-2 stimulates transcription of the hnf-3 beta gene in transient transfection experiments, suggesting that OC-2 participates in the network of transcription factors required for liver differentiation and metabolism.	Univ Catholique Louvain, Sch Med, Hormone & Metab Res Unit, B-1200 Brussels, Belgium; Christian de Duve Inst Cellular Pathol, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Lemaigre, FP (corresponding author), Univ Catholique Louvain, Sch Med, Hormone & Metab Res Unit, Ave Hippocrate 75, B-1200 Brussels, Belgium.	lemaigre@horm.ucl.ac.be	Jacquemin, Patrick/ABA-7932-2021	Lemaigre, Frederic/0000-0002-3609-434X				ADES SE, 1994, BIOCHEMISTRY-US, V33, P9187, DOI 10.1021/bi00197a022; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDRES V, 1994, GENE DEV, V8, P245, DOI 10.1101/gad.8.2.245; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BULLA GA, 1994, MOL CELL BIOL, V14, P7086, DOI 10.1128/MCB.14.11.7086; Burglin Thomas R., 1994, P25; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; DEPIEREUX E, 1992, COMPUT APPL BIOSCI, V8, P501; Depiereux E, 1997, COMPUT APPL BIOSCI, V13, P249; DUBOULE D, 1994, GUIDEBOOK HOMEOBOX G; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; HARADA R, 1994, J BIOL CHEM, V269, P2062; Jacquemin P, 1997, J BIOL CHEM, V272, P12928, DOI 10.1074/jbc.272.20.12928; KENYON C, 1994, CELL, V78, P175, DOI 10.1016/0092-8674(94)90288-7; KORNBERG TB, 1993, J BIOL CHEM, V268, P26813; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; Landry C, 1997, DEV BIOL, V192, P247, DOI 10.1006/dbio.1997.8757; Lannoy VJ, 1998, J BIOL CHEM, V273, P13552, DOI 10.1074/jbc.273.22.13552; Lemaigre FP, 1996, P NATL ACAD SCI USA, V93, P9460, DOI 10.1073/pnas.93.18.9460; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Papadimitrakopoulou VA, 1998, CLIN CANCER RES, V4, P539; Rastegar M, 1998, BIOCHEM J, V334, P565, DOI 10.1042/bj3340565; Rausa F, 1997, DEV BIOL, V192, P228, DOI 10.1006/dbio.1997.8744; Samadani U, 1996, MOL CELL BIOL, V16, P6273; Spath GF, 1997, MOL CELL BIOL, V17, P1913; Spath GF, 1998, J CELL BIOL, V140, P935, DOI 10.1083/jcb.140.4.935; Stepchenko AG, 1997, NUCLEIC ACIDS RES, V25, P2847, DOI 10.1093/nar/25.14.2847; TREISMAN J, 1992, BIOESSAYS, V14, P145, DOI 10.1002/bies.950140302; Vaisse C, 1997, DIABETES, V46, P1364, DOI 10.2337/diabetes.46.8.1364; WARBURG M, 1991, AM J MED GENET, V39, P288, DOI 10.1002/ajmg.1320390309; Wolberger C, 1996, CURR OPIN STRUC BIOL, V6, P62, DOI 10.1016/S0959-440X(96)80096-0; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G	36	86	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2665	2671		10.1074/jbc.274.5.2665	http://dx.doi.org/10.1074/jbc.274.5.2665			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915796	hybrid			2022-12-27	WOS:000078319500014
J	Casado, M; Vallet, VS; Kahn, A; Vaulont, S				Casado, M; Vallet, VS; Kahn, A; Vaulont, S			Essential role in vivo of upstream stimulatory factors for a normal dietary response of the fatty acid synthase gene in the liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX-LOOP-HELIX; STEROL REGULATORY ELEMENT; LEUCINE ZIPPER PROTEIN; TRANSGENIC MICE; TRANSCRIPTION FACTOR; RAT HEPATOCYTES; MESSENGER-RNA; EXPRESSION; BINDING; PROMOTER	In the liver, transcription of several genes encoding lipogenic and glycolytic enzymes, in particular the gene for fatty acid synthase (FAS), is known to be stimulated by dietary carbohydrates. The molecular dissection of the FAS promoter pointed out the critical role of an E box motif, located at position -65 with respect to the start site of transcription, in mediating the glucose- and insulin-dependent regulation of the gene. Upstream stimulatory factors (USF1 and USF2) and sterol response element binding protein 1 (SREBP1) were shown to be able to interact in vitro with this E box. However, to date, the relative contributions of USFs and SREBP1 ex vivo remain controversial. To gain insight into the specific roles of these factors in vivo, we have analyzed the glucose responsiveness of hepatic FAS gene expression in USF1 and USF2 knock-out mice. In both types of mouse lines, defective in either USF1 or USF2, induction of the FAS gene by refeeding a carbohydrate rich diet was severely delayed, whereas expression of SBEBP1 was almost normal and insulin response unchanged. Therefore, USF transactivators, and especially USF1/USF2 heterodimers, seem to be essential to sustain the dietary induction of the FAS gene in the liver.	Inst Cochin Genet Mol, INSERM U129, Unite Rech Physiol & Pathol Genet & Mol, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Vaulont, S (corresponding author), Inst Cochin Genet Mol, INSERM U129, Unite Rech Physiol & Pathol Genet & Mol, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	vaulont@cochin.inserm.fr	Casado, Marta/L-2078-2014; Vaulont, Sophie/O-6732-2017	Casado, Marta/0000-0001-6457-4650; 				Athanikar JN, 1998, P NATL ACAD SCI USA, V95, P4935, DOI 10.1073/pnas.95.9.4935; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; COUPE C, 1990, AM J PHYSIOL, V258, pE126, DOI 10.1152/ajpendo.1990.258.1.E126; CUIF MH, 1992, MOL CELL BIOL, V12, P4852, DOI 10.1128/MCB.12.11.4852; FOUFELLE F, 1995, BIOCHEM J, V308, P521, DOI 10.1042/bj3080521; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Guan GM, 1997, J BIOL CHEM, V272, P10295; GUERRA MJMD, 1993, MOL CELL BIOL, V13, P7725, DOI 10.1128/MCB.13.12.7725; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; KATSURADA A, 1990, EUR J BIOCHEM, V190, P427, DOI 10.1111/j.1432-1033.1990.tb15592.x; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; LITTLEWOOD TD, 1995, PROTEIN PROFILE, V2, P621; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Moriizumi S, 1998, GENE EXPRESSION, V7, P103; Mourrieras F, 1997, BIOCHEM J, V326, P345, DOI 10.1042/bj3260345; MOUSTAID N, 1994, J BIOL CHEM, V269, P5629; PRIPBUUS C, 1995, EUR J BIOCHEM, V230, P309, DOI 10.1111/j.1432-1033.1995.tb20564.x; SEMENKOVICH CF, 1993, J BIOL CHEM, V268, P6961; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Soncini M, 1995, J BIOL CHEM, V270, P30339, DOI 10.1074/jbc.270.51.30339; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Vallet VS, 1997, J BIOL CHEM, V272, P21944, DOI 10.1074/jbc.272.35.21944; Vallet VS, 1998, J BIOL CHEM, V273, P20175, DOI 10.1074/jbc.273.32.20175; Viollet B, 1996, J BIOL CHEM, V271, P1405, DOI 10.1074/jbc.271.3.1405; WANG D, 1995, J BIOL CHEM, V270, P28716, DOI 10.1074/jbc.270.48.28716; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; WOLF SS, 1994, BIOCHEM BIOPH RES CO, V203, P943, DOI 10.1006/bbrc.1994.2273; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	35	111	112	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2009	2013		10.1074/jbc.274.4.2009	http://dx.doi.org/10.1074/jbc.274.4.2009			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890958	hybrid			2022-12-27	WOS:000078185200025
J	Jorda, L; Coego, A; Conejero, V; Vera, P				Jorda, L; Coego, A; Conejero, V; Vera, P			Genomic cluster containing four differentially regulated subtilisin-like processing protease genes is in tomato plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEAT; PROPROTEIN CONVERTASE; ARABIDOPSIS-THALIANA; FUNCTIONAL DOMAINS; EXPRESSION; PATHOGENESIS; ENDOPROTEASES; FAMILY; IDENTIFICATION; LOCALIZATION	Screening of a genomic library from tomato plants (Lycopersicon. esculentum) with a cDNA probe encoding a subtilisin-like protease (PR-P69) that is induced at the transcriptional level following pathogen attach (Tornero, P., Conejero, V., and Vera, P. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 6332-6337) resulted in the isolation of a cluster of genomic clones that comprise a tandem of four different subtilisin-like protease genes (P69A, P69B, P69C, and P69D). Sequence analyses and comparison of the encoded proteins revealed that all are closely related (79 to 88% identity), suggesting that all are derived from a common ancestral gene. mRNA expression analysis as well as studies of transgenic plants transformed with promoter-beta-glucuronidase fusions for each of these genes revealed that the four genes exhibit differential transcriptional regulation and expression patterns, P69A and P69D are expressed constitutively, but with different expression profiles during development, whereas the P69B and P69C genes show expression following infection with Pseudomonas syringae and are also up-regulated by salicylic acid. We propose that these four P69-like proteases, as members of a complex gene family of plant subtilisin-like proteases, may be involved in a number of specific proteolytic events that occur in the plant during development and/or pathogenesis.	Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Vera, P (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Camino Vera S-N, Valencia 46022, Spain.	vera@ibmcp.upv.es	Conejero, Vicente/H-9027-2015; Jordá, Lucía/H-5429-2015	Conejero, Vicente/0000-0002-3516-350X; Jordá, Lucía/0000-0002-1660-3469; Vera, Pablo/0000-0002-7787-7519; Coego Gonzalez, Alberto/0000-0002-2459-4291				Alexander CM, 1991, CELL BIOL EXTRACELLU, P255; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; Chen Wen-Tien, 1992, Current Opinion in Cell Biology, V4, P802; DIXON RA, 1990, ANNU REV PLANT PHYS, V41, P339, DOI 10.1146/annurev.pp.41.060190.002011; ENYEDI AJ, 1992, CELL, V70, P879, DOI 10.1016/0092-8674(92)90239-9; Glazer A., 1971, ENZYMES, P501; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KINOSHITA T, 1992, P NATL ACAD SCI USA, V89, P4693, DOI 10.1073/pnas.89.10.4693; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LIANG XW, 1992, P NATL ACAD SCI USA, V89, P11046, DOI 10.1073/pnas.89.22.11046; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; PAUTOT V, 1993, P NATL ACAD SCI USA, V90, P9906, DOI 10.1073/pnas.90.21.9906; RIBEIRO A, 1995, PLANT CELL, V7, P785, DOI 10.1105/tpc.7.6.785; Ryan CA, 1981, BIOCH PLANTS, P321; Schaller A, 1996, PLANT MOL BIOL, V31, P1073, DOI 10.1007/BF00040725; SCHALLER A, 1994, P NATL ACAD SCI USA, V91, P11802, DOI 10.1073/pnas.91.25.11802; SEIDAH NG, 1992, MOL ENDOCRINOL, V6, P1559, DOI 10.1210/me.6.10.1559; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; Siezen RJ, 1997, PROTEIN SCI, V6, P501; STEINER DF, 1992, J BIOL CHEM, V267, P23435; Taylor AA, 1997, PLANT J, V12, P1261, DOI 10.1046/j.1365-313x.1997.12061261.x; Tornero P, 1996, P NATL ACAD SCI USA, V93, P6332, DOI 10.1073/pnas.93.13.6332; Tornero P, 1997, J BIOL CHEM, V272, P14412, DOI 10.1074/jbc.272.22.14412; Tornero P, 1996, PLANT J, V9, P639, DOI 10.1046/j.1365-313X.1996.9050639.x; Tornero P, 1996, PLANT J, V10, P315, DOI 10.1046/j.1365-313X.1996.10020315.x; VERA P, 1989, PLANT PHYSIOL, V91, P119, DOI 10.1104/pp.91.1.119; VERA P, 1988, PLANT PHYSIOL, V87, P58, DOI 10.1104/pp.87.1.58; VERA P, 1989, PHYSIOL MOL PLANT P, V34, P323, DOI 10.1016/0885-5765(89)90029-5; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; YAMAGATA H, 1994, J BIOL CHEM, V269, P32725; ZHOU A, 1995, J BIOL CHEM, V270, P21509, DOI 10.1074/jbc.270.37.21509	32	124	132	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2360	2365		10.1074/jbc.274.4.2360	http://dx.doi.org/10.1074/jbc.274.4.2360			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891003	hybrid			2022-12-27	WOS:000078185200070
J	Scheiffele, P; Rietveld, A; Wilk, T; Simons, K				Scheiffele, P; Rietveld, A; Wilk, T; Simons, K			Influenza viruses select ordered lipid domains during budding from the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR STOMATITIS-VIRUS; GPI-ANCHORED PROTEINS; SEMLIKI-FOREST VIRUS; DETERGENT INSOLUBILITY; BIOLOGICAL-MEMBRANES; ALKALINE-PHOSPHATASE; TRANSMEMBRANE DOMAIN; TRANSPORT VESICLES; CELL-MEMBRANES; MDCK CELLS	During the budding of enveloped viruses from the plasma membrane, the lipids are not randomly incorporated into the envelope, but virions seem to have a lipid composition different from the host membrane. Here, we have analyzed Lipid assemblies in three different viruses: fowl plague virus (FPV) from the influenza virus family, vesicular stomatitis virus (VSV), and Semliki Forest virus (SFV). Analysis of detergent extractability of proteins, cholesterol, phosphoglycerolipids, and sphingomyelin in virions showed that FPV contains high amounts of detergent-insoluble complexes, whereas such complexes are largely absent from VSV or SFV. Cholesterol depletion from the viral envelope by methyl-beta-cyclodextrin results in increased solubility of sphingomyelin and of the glycoproteins in the FPV envelope. This biochemical behavior suggest that so-called raft-lipid domains are selectively incorporated into the influenza virus envelope. The "fluidity" of the FPV envelope, as measured by the fluorescence polarization of diphenylhexatriene, was significantly lower than compared with VSV or SFV. Furthermore, influenza virus hemagglutinin incorporated into the envelope of recombinant VSV was largely detergent-soluble, indicating the depletion of raft-lipid assemblies from this membrane. The results provide a model for lipid selectivity during virus budding and support the view of lipid rafts as cholesterol-dependent, ordered domains in biological membranes.	European Mol Biol Lab, Cell Biol Programme, D-69012 Heidelberg, Germany; European Mol Biol Lab, Struct Biol Programme, D-69012 Heidelberg, Germany; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Max Planck Society	Simons, K (corresponding author), European Mol Biol Lab, Cell Biol Programme, Postfach 102209, D-69012 Heidelberg, Germany.			Simons, Kai/0000-0002-9231-9996				Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; BENNETT MK, 1988, EMBO J, V7, P4075, DOI 10.1002/j.1460-2075.1988.tb03301.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Cadd TL, 1997, BIOESSAYS, V19, P993, DOI 10.1002/bies.950191109; CERNEUS DP, 1993, J BIOL CHEM, V268, P3150; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; FULLER SD, 1995, CELL, V81, P715, DOI 10.1016/0092-8674(95)90533-2; Hailstones D, 1998, J LIPID RES, V39, P369; HANADA K, 1995, J BIOL CHEM, V270, P6254, DOI 10.1074/jbc.270.11.6254; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; Jin H, 1997, EMBO J, V16, P1236, DOI 10.1093/emboj/16.6.1236; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kretzschmar E, 1997, J VIROL, V71, P5982, DOI 10.1128/JVI.71.8.5982-5989.1997; Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Lafont F, 1998, J CELL BIOL, V142, P1413, DOI 10.1083/jcb.142.6.1413; LENARD J, 1974, BIOCHIM BIOPHYS ACTA, V344, P51, DOI 10.1016/0304-4157(74)90008-2; Lin SS, 1998, J CELL BIOL, V142, P51, DOI 10.1083/jcb.142.1.51; LIPOWSKY R, 1993, BIOPHYS J, V64, P1133, DOI 10.1016/S0006-3495(93)81479-6; LUAN P, 1995, BIOCHEMISTRY-US, V34, P9874, DOI 10.1021/bi00031a008; LUAN P, 1994, BIOCHEMISTRY-US, V33, P4483, DOI 10.1021/bi00181a007; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; NAIM HY, 1992, J VIROL, V66, P7585, DOI 10.1128/JVI.66.12.7585-7588.1992; NAIM HY, 1993, J VIROL, V67, P4831, DOI 10.1128/JVI.67.8.4831-4841.1993; PARASASSI T, 1993, BIOCHIM BIOPHYS ACTA, V1153, P143, DOI 10.1016/0005-2736(93)90399-K; PESSIN JE, 1980, J BIOL CHEM, V255, P9044; RENKONEN O, 1971, VIROLOGY, V46, P318, DOI 10.1016/0042-6822(71)90033-X; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; SANKARAM MB, 1991, P NATL ACAD SCI USA, V88, P8686, DOI 10.1073/pnas.88.19.8686; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; SILBERKANG M, 1983, J BIOL CHEM, V258, P8503; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SKIBBENS JE, 1989, J CELL BIOL, V108, P821, DOI 10.1083/jcb.108.3.821; THOMPSON TE, 1985, ANNU REV BIOPHYS BIO, V14, P361, DOI 10.1146/annurev.biophys.14.1.361; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; VAZ WLC, 1993, CURR OPIN STRUC BIOL, V3, P482, DOI 10.1016/0959-440X(93)90071-R	47	357	371	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2038	2044		10.1074/jbc.274.4.2038	http://dx.doi.org/10.1074/jbc.274.4.2038			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890962	hybrid			2022-12-27	WOS:000078185200029
J	Guerini, D; Garcia-Martin, E; Gerber, A; Volbracht, C; Leist, M; Merino, CG; Carafoli, E				Guerini, D; Garcia-Martin, E; Gerber, A; Volbracht, C; Leist, M; Merino, CG; Carafoli, E			The expression of plasma membrane Ca2+ pump isoforms in cerebellar granule neurons is modulated by Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+-INDUCED DEPOLARIZATION; MESSENGER-RNA; CALCIUM-PUMP; ENDOPLASMIC-RETICULUM; RECEPTOR SUBUNITS; SKELETAL-MUSCLE; RAT-BRAIN; CELLS; CA2+-ATPASE; ATPASE	Plasma membrane Ca2+ ATPase (PMCA) pump isoforms 2, 3, and 1CII are expressed in large amounts in the cerebellum of adult rats but only minimally in neonatal cerebellum. These isoforms were almost undetectable in rat neonatal cerebellar granule cells 1-3 days after plating, but they became highly expressed after 7-9 days of culturing under membrane depolarizing conditions (25 mM KCl). The behavior of isoform 4 was different: it was clearly detectable in adult cerebellum but was down-regulated by the depolarizing conditions in cult-red cells. 25 mM KCl-activated L-type Ca2+ channels, significantly increasing cytosolic Ca2+. Changes in the concentration of Ca2+ in the culturing medium affected the expression of the pumps. L-type Ca2+ channel blockers abolished both the up-regulation of the PMCA1CII, 2, and 3 isoforms and the down-regulation of PMCA4 isoform, When granule cells were cultured in high concentrations of N-methyl-D-aspartic acid, a condition that increased cytosolic Ca2+ through the activation of glutamate operated Ca2+ channels, up regulation of PMCA1CII, 2, and 3 and down-regulation of PMCA4 was also observed. The activity of the isoforms was estimated by measuring the phosphoenzyme inter mediate of their reaction cycle: the up-regulated isoforms, the activity of which was barely detectable at plating time, accounted far a large portion of the total PMCA activity of the cells. No up-regulation of the sarcoplasmic/endoplasmic reticulum calcium pump was induced by the depolarizing conditions.	Swiss Fed Inst Technol, Inst Biochem, CH-8092 Zurich, Switzerland; Univ Extremadura, Dept Bioquim & Biol Mol, E-06080 Badajoz, Spain; Univ Konstanz, Dept Toxicol, D-78465 Constance, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidad de Extremadura; University of Konstanz	Carafoli, E (corresponding author), Swiss Fed Inst Technol, Inst Biochem, Univ Str 16, CH-8092 Zurich, Switzerland.		Leist, Marcel/D-2133-2010; Gutierrez-Merino, Carlos/K-4574-2014; Carafoli, Ernesto/K-5192-2016; García-Martin, Elena/H-9828-2016	Leist, Marcel/0000-0002-3778-8693; Gutierrez-Merino, Carlos/0000-0003-3673-7007; Carafoli, Ernesto/0000-0002-7826-0094; García-Martin, Elena/0000-0002-8094-046X; Volbracht, Christiane/0000-0002-5748-9981				ADAMO HP, 1992, BIOCHEM J, V283, P355, DOI 10.1042/bj2830355; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5; BALAZS R, 1988, DEV BRAIN RES, V40, P269, DOI 10.1016/0165-3806(88)90139-3; BESSHO Y, 1994, NEURON, V12, P87, DOI 10.1016/0896-6273(94)90154-6; BORKE JL, 1989, AM J PHYSIOL, V257, pC341, DOI 10.1152/ajpcell.1989.257.2.C341; BOVOLIN P, 1992, J NEUROCHEM, V59, P62, DOI 10.1111/j.1471-4159.1992.tb08876.x; BRANDT P, 1992, J BIOL CHEM, V267, P4376; BURGOYNE RD, 1995, TRENDS NEUROSCI, V18, P191, DOI 10.1016/0166-2236(95)93900-I; BURK SE, 1992, J BIOL CHEM, V267, P19683; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; CARAFOLI E, 1993, TRENDS CARDIOVAS MED, V3, P177, DOI 10.1016/1050-1738(93)90003-O; CARMICHAEL J, 1987, CANCER RES, V47, P943; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONDORELLI DF, 1993, J NEUROCHEM, V61, P2133, DOI 10.1111/j.1471-4159.1993.tb07451.x; CURRAN T, 1987, ONCOGENE, V2, P79; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; ENYEDI A, 1994, J BIOL CHEM, V269, P41; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; FOLETTI D, 1995, FASEB J, V9, P670, DOI 10.1096/fasebj.9.8.7768360; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GALLIN WJ, 1995, CURR OPIN NEUROBIOL, V5, P367, DOI 10.1016/0959-4388(95)80050-6; GALLO V, 1987, J NEUROSCI, V7, P2203; GarciaMartin E, 1996, BBA-BIOMEMBRANES, V1280, P257, DOI 10.1016/0005-2736(95)00294-4; GREEB J, 1989, J BIOL CHEM, V264, P18569; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUERINI D, 1995, J BIOL CHEM, V270, P14643, DOI 10.1074/jbc.270.24.14643; HAMMES A, 1994, FASEB J, V8, P428, DOI 10.1096/fasebj.8.6.8168693; Henderson CE, 1996, CURR OPIN NEUROBIOL, V6, P64, DOI 10.1016/S0959-4388(96)80010-9; HILFIKER H, 1994, J BIOL CHEM, V269, P26178; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; KEETON TP, 1995, BIOCHEM J, V306, P779, DOI 10.1042/bj3060779; KEETON TP, 1993, J BIOL CHEM, V268, P2740; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; RESINK A, 1995, J NEUROCHEM, V64, P558; REUTER H, 1995, NEURON, V15, P1077, DOI 10.1016/0896-6273(95)90096-9; Sambrook J., 2002, MOL CLONING LAB MANU; SARKADI B, 1986, J BIOL CHEM, V261, P9552; Schulz JB, 1996, J NEUROSCI, V16, P4696; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; Seiz Preiano Brigitta, 1996, Biochemistry, V35, P7946, DOI 10.1021/bi9527404; SIEBERT PD, 1992, NATURE, V359, P557, DOI 10.1038/359557a0; Silos-Santiago Inmaculada, 1995, Current Opinion in Neurobiology, V5, P42, DOI 10.1016/0959-4388(95)80085-9; Stauffer TP, 1997, BRAIN RES, V748, P21, DOI 10.1016/S0006-8993(96)01282-6; STAUFFER TP, 1993, J BIOL CHEM, V268, P25993; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; Thomas A.P., 1991, CELLULAR CALCIUM PRA, P1; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; WUYTACK F, 1989, BIOCHEM J, V264, P765, DOI 10.1042/bj2640765; ZACHARIAS DA, 1995, MOL BRAIN RES, V28, P263, DOI 10.1016/0169-328X(94)00215-Z; Zacharias DA, 1996, CURR BIOL, V6, P1642, DOI 10.1016/S0960-9822(02)70788-4	54	97	97	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1667	1676		10.1074/jbc.274.3.1667	http://dx.doi.org/10.1074/jbc.274.3.1667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880546	hybrid, Green Submitted			2022-12-27	WOS:000079956900066
J	Motta, MC; Caretti, G; Badaracco, GF; Mantovani, R				Motta, MC; Caretti, G; Badaracco, GF; Mantovani, R			Interactions of the CCAAT-binding trimer NF-Y with nucleosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-BINDING; NUCLEAR FACTOR-Y; CBF-DNA COMPLEX; FACILITATED BINDING; HISTONE FOLD; TRANSLATIONAL POSITION; FUNCTIONAL DOMAINS; CHROMATIN; PROTEIN; PROMOTER	NF-Y is a sequence-specific evolutionary conserved activator binding to CCAAT boxes with high affinity and specificity. It is a trimer formed by NF-YA and two putative histone-like subunits, NF-YB and NF-YC, showing similarity to histones H2B and H2A, respectively. We investigated the relationships between NF-Y and chromatin using an Artemia franciscana chromatin assembly system with plasmids containing the Major Histo-Compatibility complex class II Ea promoter. The NF-Y trimer, but not single subunits, protects the Y box in the presence of reconstituted chromatin, and it can bind the target sequence during and after assembly. Using reconstitution assays with purified chicken histones, we show that NF-Y associates with preformed nucleosomes. Translational analysis of various Ea fragments of identical length in which the CCAAT box is at different positions indicated that the lateral fragment was slightly more prone to NF-Y binding. In competition experiments, NF-Y is able to prevent formation of nucleosomes significantly. These data support the idea that NF-Y is a gene-specific activator with a built-in capacity to interface with chromatin structures.	Univ Milan, Dipartimento Genet & Biol Microrganismi, I-20133 Milan, Italy; Univ Milan, Dipartimento Biol Strutturale & Funz, I-21100 Varese, Italy	University of Milan; University of Milan	Mantovani, R (corresponding author), Univ Milan, Dipartimento Genet & Biol Microrganismi, Via Celoria 26, I-20133 Milan, Italy.		Motta, Maria Cristina M/I-3140-2014		Telethon [E.0582] Funding Source: Medline	Telethon(Fondazione Telethon)		ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; ALMOUZNI G, 1990, EMBO J, V9, P573, DOI 10.1002/j.1460-2075.1990.tb08145.x; ARENTS G, 1995, P NATL ACAD SCI USA, V92, P11170, DOI 10.1073/pnas.92.24.11170; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P2685, DOI 10.1093/nar/23.14.2685; Bellorini M, 1997, GENE, V193, P119, DOI 10.1016/S0378-1119(97)00109-1; Bellorini M, 1997, NUCLEIC ACIDS RES, V25, P2174, DOI 10.1093/nar/25.11.2174; Blomquist P, 1996, J BIOL CHEM, V271, P153, DOI 10.1074/jbc.271.1.153; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; BURLEY SL, 1997, ANNU REV BIOCHEM, V65, P769; Cairns BR, 1998, TRENDS BIOCHEM SCI, V23, P20, DOI 10.1016/S0968-0004(97)01160-2; CAMERINIOTERO RD, 1976, CELL, V8, P333, DOI 10.1016/0092-8674(76)90145-8; CHEN H, 1994, EMBO J, V13, P380, DOI 10.1002/j.1460-2075.1994.tb06272.x; Currie RA, 1998, J BIOL CHEM, V273, P1430, DOI 10.1074/jbc.273.3.1430; Dooley KA, 1998, J BIOL CHEM, V273, P1349, DOI 10.1074/jbc.273.3.1349; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; GODDE JS, 1995, NUCLEIC ACIDS RES, V23, P4557, DOI 10.1093/nar/23.22.4557; GOPPELDT A, 1996, EMBO J, V15, P305; HAYES JJ, 1992, P NATL ACAD SCI USA, V89, P1229, DOI 10.1073/pnas.89.4.1229; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Jackson SM, 1998, J LIPID RES, V39, P767; Kim IS, 1996, MOL CELL BIOL, V16, P4003; LANDSBERGER N, 1995, MOL CELL BIOL, V15, P6013; LI BY, 1994, J BIOL CHEM, V269, P7756; LI Q, 1993, GENE DEV, V7, P2471, DOI 10.1101/gad.7.12a.2471; LI XY, 1992, NUCLEIC ACIDS RES, V20, P1087, DOI 10.1093/nar/20.5.1087; Liberati C, 1998, J BIOL CHEM, V273, P16880, DOI 10.1074/jbc.273.27.16880; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; Motta MC, 1998, J BIOL CHEM, V273, P18028, DOI 10.1074/jbc.273.29.18028; Ng KW, 1997, EMBO J, V16, P2072, DOI 10.1093/emboj/16.8.2072; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; READ CM, 1985, BIOCHEMISTRY-US, V24, P4435, DOI 10.1021/bi00337a027; REITH W, 1994, P NATL ACAD SCI USA, V91, P554, DOI 10.1073/pnas.91.2.554; RONCHI A, 1995, NUCLEIC ACIDS RES, V23, P4565, DOI 10.1093/nar/23.22.4565; SchildPoulter C, 1996, NUCLEIC ACIDS RES, V24, P4751, DOI 10.1093/nar/24.23.4751; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; Sinha S, 1996, MOL CELL BIOL, V16, P328; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; SVAREN J, 1994, J BIOL CHEM, V269, P9335; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; VETTESEDADEY M, 1994, MOL CELL BIOL, V14, P970, DOI 10.1128/MCB.14.2.970; VIVILLE S, 1991, J IMMUNOL, V146, P3211; WALTER PP, 1995, MOL CELL BIOL, V15, P6178; WECHSLER DS, 1994, MOL CELL BIOL, V14, P4097, DOI 10.1128/MCB.14.6.4097; WORKMAN JL, 1991, CELL, V64, P533, DOI 10.1016/0092-8674(91)90237-S; WRIGHT KL, 1995, J BIOL CHEM, V270, P20978, DOI 10.1074/jbc.270.36.20978; XING YY, 1993, EMBO J, V12, P4647, DOI 10.1002/j.1460-2075.1993.tb06153.x	55	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1326	1333		10.1074/jbc.274.3.1326	http://dx.doi.org/10.1074/jbc.274.3.1326			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880503	hybrid			2022-12-27	WOS:000079956900023
J	Rebouillat, D; Hovnanian, A; Marie, I; Hovanessian, AG				Rebouillat, D; Hovnanian, A; Marie, I; Hovanessian, AG			The 100-kDa 2 ',5 '-oligoadenylate synthetase catalyzing preferentially the synthesis of dimeric pppA2 ' p5 ' A molecules is composed of three homologous domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; ENCEPHALOMYOCARDITIS VIRUS-INFECTION; INTERFERON-TREATED CELLS; HUMAN 2-5A SYNTHETASE; OLIGO-A SYNTHETASE; PROTEIN-SYNTHESIS; 2'-5'-OLIGOADENYLATE SYNTHETASE; CONSTITUTIVE EXPRESSION; 2-5A-DEPENDENT RNASE; ACTIVATED ENZYMES	The 2-5A synthetases represent a family of proteins implicated in the mechanism of the antiviral action of interferon. When activated by double-stranded RNA, these proteins polymerize ATP into 2'-5'-linked oligomers with the general formula pppA(2'p5'A)(n), n greater than or equal to 1. Three forms of human 2-5A synthetases have been described corresponding to proteins of 40/46 (p40/p46), 69/71 (p69/p71), and 100 kDa (p100). Here we describe the molecular cloning and characterization of p100. By screening a cDNA expression library with a specific p100 polyclonal antibody, we first isolated 590-nucleotide cDNA fragment which was subsequently used to isolate the full-length 6365-nucleotide cDNA. This cDNA recognizes a distinct interferon-induced messenger RNA of 7 kilobases. It has an open reading frame encoding a protein of 1087 amino acids including the sequence of seven peptides obtained by microsequencing of the natural p100 protein, which was purified from interferon-treated human cells. p100 is composed of three adjacent domains, each homologous to the previously defined catalytic unit of 350 amino acids, which is present as one unit in p40/p46 and as two units in p69/p71. The recombinant p100 synthesized preferentially dimeric 2',5'-oligoadenylate molecules and displayed parameters for maximum enzyme activity similar to the natural p100. These results confirm that the enzymatic activity of p100 is distinct compared with that of p40/p46 and p69/p71.	Inst Pasteur, Unite Virol & Immunol Cellulaire, CNRS, ERS 572, F-75724 Paris 15, France; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oxford; Wellcome Centre for Human Genetics	Hovanessian, AG (corresponding author), Inst Pasteur, Unite Virol & Immunol Cellulaire, CNRS, ERS 572, 28 Rue Dr Roux, F-75724 Paris 15, France.	arahovan@pasteur.fr	Hovnanian, Alain/I-4711-2017	Hovnanian, Alain/0000-0003-3412-7512; Marie, Isabelle/0000-0002-3091-7624				Ball L.A., 1979, REGULATION MACROMOLE, P303; Bandyopadhyay S, 1998, BIOCHEMISTRY-US, V37, P3824, DOI 10.1021/bi972848e; BENECH P, 1985, NUCLEIC ACIDS RES, V13, P1267; BENECH P, 1985, EMBO J, V4, P2249, DOI 10.1002/j.1460-2075.1985.tb03922.x; Besse S, 1998, EXP CELL RES, V239, P379, DOI 10.1006/excr.1997.3908; CARMOFONSECA M, 1992, J CELL BIOL, V117, P1, DOI 10.1083/jcb.117.1.1; CASTORA FJ, 1991, J INTERFERON RES, V11, P143, DOI 10.1089/jir.1991.11.143; CAYLEY PJ, 1982, EUR J BIOCHEM, V122, P601; CHEBATH J, 1987, J BIOL CHEM, V262, P3852; CHEBATH J, 1987, NATURE, V330, P587, DOI 10.1038/330587a0; CLEMENS MJ, 1978, CELL, V13, P565, DOI 10.1016/0092-8674(78)90329-X; COCCIA EM, 1990, VIROLOGY, V179, P228, DOI 10.1016/0042-6822(90)90292-Y; DUBOIS MF, 1990, VIROLOGY, V179, P591, DOI 10.1016/0042-6822(90)90126-C; Ghosh A, 1997, J BIOL CHEM, V272, P33220, DOI 10.1074/jbc.272.52.33220; Ghosh Arundhati, 1997, Journal of Interferon and Cytokine Research, V17, pS51; Hartmann R, 1998, NUCLEIC ACIDS RES, V26, P4121, DOI 10.1093/nar/26.18.4121; HASSEL BA, 1993, EMBO J, V12, P3297, DOI 10.1002/j.1460-2075.1993.tb05999.x; HOVANESSIAN AG, 1977, NATURE, V268, P537, DOI 10.1038/268537a0; HOVANESSIAN AG, 1979, P NATL ACAD SCI USA, V76, P3261, DOI 10.1073/pnas.76.7.3261; HOVANESSIAN AG, 1987, EMBO J, V6, P1273, DOI 10.1002/j.1460-2075.1987.tb02364.x; HOVANESSIAN AG, 1988, J BIOL CHEM, V263, P4945; HOVANESSIAN AG, 1991, J INTERFERON RES, V11, P199, DOI 10.1089/jir.1991.11.199; HOVANESSIAN AG, 1980, VIROLOGY, V101, P81, DOI 10.1016/0042-6822(80)90485-7; Hovnanian A, 1998, GENOMICS, V52, P267, DOI 10.1006/geno.1998.5443; JUSTESEN J, 1980, P NATL ACAD SCI-BIOL, V77, P4618, DOI 10.1073/pnas.77.8.4618; JUSTESEN J, 1985, BIOCHIMIE, V67, P651, DOI 10.1016/S0300-9084(85)80207-8; KERR IM, 1987, J INTERFERON RES, V7, P505, DOI 10.1089/jir.1987.7.505; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; KIMCHI A, 1981, EUR J BIOCHEM, V114, P5; KIMCHI A, 1981, FEBS LETT, V134, P212, DOI 10.1016/0014-5793(81)80604-7; Kon N, 1996, J BIOL CHEM, V271, P19983, DOI 10.1074/jbc.271.33.19983; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KRUST B, 1982, VIROLOGY, V120, P240, DOI 10.1016/0042-6822(82)90022-8; Latham KE, 1996, ONCOGENE, V12, P827; LENGYEL P, 1982, ANNU REV BIOCHEM, V51, P251, DOI 10.1146/annurev.bi.51.070182.001343; Li XL, 1998, J VIROL, V72, P2752, DOI 10.1128/JVI.72.4.2752-2759.1998; Maitra RK, 1998, J VIROL, V72, P1146, DOI 10.1128/JVI.72.2.1146-1152.1998; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; Marie I, 1997, EUR J BIOCHEM, V248, P558, DOI 10.1111/j.1432-1033.1997.t01-1-00558.x; MARIE I, 1990, J INTERFERON RES, V10, P571, DOI 10.1089/jir.1990.10.571; MARIE I, 1990, J BIOL CHEM, V265, P18601; MARIE I, 1992, J BIOL CHEM, V267, P9933; MARIE I, 1989, BIOCHEM BIOPH RES CO, V160, P580, DOI 10.1016/0006-291X(89)92472-8; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; NILSEN TW, 1982, J BIOL CHEM, V257, P4593; Rebouillat D, 1998, EUR J BIOCHEM, V257, P319, DOI 10.1046/j.1432-1327.1998.2570319.x; RYSIECKI G, 1989, J INTERFERON RES, V9, P649, DOI 10.1089/jir.1989.9.649; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O; SAUNDERS ME, 1985, EMBO J, V4, P1761, DOI 10.1002/j.1460-2075.1985.tb03848.x; SCHMIDT A, 1979, P NATL ACAD SCI USA, V76, P4788, DOI 10.1073/pnas.76.10.4788; SEN GC, 1992, J BIOL CHEM, V267, P5017; SENGUPTA DN, 1989, NUCLEIC ACIDS RES, V17, P969, DOI 10.1093/nar/17.3.969; SPERLING J, 1991, P NATL ACAD SCI USA, V88, P10377, DOI 10.1073/pnas.88.23.10377; STARK GR, 1979, NATURE, V278, P471, DOI 10.1038/278471a0; WILLIAMS BRG, 1979, NATURE, V282, P582, DOI 10.1038/282582a0; WILLIAMS BRG, 1978, NATURE, V276, P88, DOI 10.1038/276088a0; WILLIAMS BRG, 1985, 2 5A SYSTEM; WITT PL, 1993, J INTERFERON RES, V13, P17, DOI 10.1089/jir.1993.13.17; YANG K, 1981, J BIOL CHEM, V256, P9324; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D	61	57	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1557	1565		10.1074/jbc.274.3.1557	http://dx.doi.org/10.1074/jbc.274.3.1557			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880533	hybrid			2022-12-27	WOS:000079956900053
J	Zheng, XL; Lu, DS; Sadler, JE				Zheng, XL; Lu, DS; Sadler, JE			Apical sorting of bovine enteropeptidase does not involve detergent-resistant association with sphingolipid-cholesterol rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DARBY CANINE KIDNEY; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEIN; INFLUENZA-VIRUS HEMAGGLUTININ; POLARIZED EPITHELIAL-CELLS; MDCK CELLS; MEMBRANE-PROTEINS; SURFACE TRANSPORT; PLASMA-MEMBRANE; BREFELDIN-A; ENTEROKINASE	Enteropeptidase is a heterodimeric type II membrane protein of the brush border of duodenal enterocytes. In this location, enteropeptidase cleaves and activates trypsinogen, thereby initiating the activation of other intestinal digestive enzymes. Recombinant bovine enteropeptidase was sorted directly to the apical surface of polarized Madin-Darby canine kidney cells. Replace ment of the cytoplasmic and signal anchor domains with a cleavable signal peptide (mutant proenteropeptidase lacking the amino-terminal signal anchor domain (dSA-BEK)) caused apical secretion. The additional aminoterminal deletion of a mucin-like domain (HL-BEK) resulted in secretion both apically and basolaterally, Further deletion of the noncatalytic heavy chain (L-BEK) resulted in apical secretion. Thus enteropeptidase appears to have at least three distinct sorting signals as follows: the light chain (L-BEK) directs apical sorting, addition of most of the heavy chain (HL-BEK) inhibits apical sorting, and addition of the mucin-like domain (dSA-BEK) restores apical sorting. Inhibition of N-linked glycosylation with tunicamycin or disruption of microtubules with colchicine caused L-BEK to be secreted equally into apical and basolateral compartments, whereas brefeldin A caused basolateral secretion of L-BEK. Full-length BEK was not found in detergent-resistant raft domains of Madin-Darby canine kidney cells or baby hamster kidney cells. These results suggest epical sorting of enteropeptidase depends on N-linked glycosylation of the serine protease domain and an amino-terminal segment that includes an O-glycosylated mucin-like domain and three potential N-glycosylation sites. In contrast to many apically targeted proteins, enteropeptidase does not form detergent-resistant associations with sphingolipid-cholesterol rafts.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med,Div Hematol & Oncol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst,Barnes Jewish Hosp, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Barnes-Jewish Hospital; Howard Hughes Medical Institute; Washington University (WUSTL)	Sadler, JE (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med,Div Hematol & Oncol, 660 S Euclid Ave,Box 8022, St Louis, MO 63110 USA.	esadler@im.wustl.edu	Zheng, X. Long/ABD-7362-2021; Sadler, Evan/D-8556-2011	Zheng, X. Long/0000-0003-1680-5295; Sadler, J. Evan/0000-0001-5705-469X	NIDDK NIH HHS [DK50053] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050053] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alonso MA, 1997, J BIOL CHEM, V272, P30748, DOI 10.1074/jbc.272.49.30748; ARREAZA G, 1995, J BIOL CHEM, V270, P23641, DOI 10.1074/jbc.270.40.23641; Beau I, 1997, J BIOL CHEM, V272, P5241, DOI 10.1074/jbc.272.8.5241; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Fiedler K, 1996, J CELL SCI, V109, P271; Graichen R, 1996, J BIOL CHEM, V271, P15854, DOI 10.1074/jbc.271.27.15854; GRANT D, 1986, INT J PANCREATOL, V1, P167; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Gut A, 1998, EMBO J, V17, P1919, DOI 10.1093/emboj/17.7.1919; HADORN B, 1969, LANCET, V1, P812; HAMMOND JB, 1977, AM J DIG DIS, V22, P182, DOI 10.1007/BF01072274; HANADA K, 1995, J BIOL CHEM, V270, P6254, DOI 10.1074/jbc.270.11.6254; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; HARLOW E, 1988, ANTIBODIES LAB MANUA, V1, P92; HAWORTH JC, 1971, J PEDIATR-US, V78, P481, DOI 10.1016/S0022-3476(71)80231-7; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Keller P, 1997, J CELL SCI, V110, P3001; KITAMOTO Y, 1995, BIOCHEMISTRY-US, V34, P4562, DOI 10.1021/bi00014a008; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; LAVALLIE ER, 1993, J BIOL CHEM, V268, P23311; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LOW SH, 1992, J CELL BIOL, V118, P51, DOI 10.1083/jcb.118.1.51; LOW SH, 1991, J BIOL CHEM, V266, P17729; Lu D., 1998, HDB PROTEOLYTIC ENZY, P50; Lu DS, 1997, J BIOL CHEM, V272, P31293, DOI 10.1074/jbc.272.50.31293; Marzolo MP, 1997, P NATL ACAD SCI USA, V94, P1834, DOI 10.1073/pnas.94.5.1834; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; MATSUSHIMA M, 1994, J BIOL CHEM, V269, P19976; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; Nichols BL, 1998, J BIOL CHEM, V273, P3076, DOI 10.1074/jbc.273.5.3076; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PARCZYK K, 1991, FEBS LETT, V278, P267, DOI 10.1016/0014-5793(91)80132-M; PARCZYK K, 1989, J BIOL CHEM, V264, P16837; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; RINDLER MJ, 1987, J CELL BIOL, V104, P231, DOI 10.1083/jcb.104.2.231; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SKIBBENS JE, 1989, J CELL BIOL, V108, P821, DOI 10.1083/jcb.108.3.821; WAGNER M, 1995, EUR J CELL BIOL, V67, P84; WANDINGERNESS A, 1990, J CELL BIOL, V111, P987, DOI 10.1083/jcb.111.3.987; Yahagi N, 1996, BIOCHEM BIOPH RES CO, V219, P806, DOI 10.1006/bbrc.1996.0315; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Yuan X, 1998, AM J PHYSIOL-GASTR L, V274, pG342, DOI 10.1152/ajpgi.1998.274.2.G342	45	54	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1596	1605		10.1074/jbc.274.3.1596	http://dx.doi.org/10.1074/jbc.274.3.1596			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880538	hybrid			2022-12-27	WOS:000079956900058
J	Volkmer, E; Karnitz, LM				Volkmer, E; Karnitz, LM			Human homologs of Schizosaccharomyces pombe Rad1, Hus1, and Rad9 form a DNA damage-responsive protein complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; CHECKPOINT; GENE; KINASE; YEAST	DNA damage activates cell cycle checkpoints in yeast and human cells. In the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe checkpoint-deficient mutants have been characterized, and the corresponding genes have been cloned. Searches for human homologs of S. pombe rad1, rad9, and hus1 genes identified the potential human homologs hRad1, hRad9, and hHus1; however, Little is known about the roles of these proteins in human cells. The present studies demonstrate that hRad1 and hHus1 associate in a complex that interacts with a highly modified form of hRad9, but hHus1 and hRad1 do not associate with hRad17. In addition to being a key participant in complex formation, hRad9 is phosphorylated in response to DNA damage. Together, these results suggest that hRad9, hRad1, and hHus1 are central components of a DNA damage-responsive protein complex in human cells.	Mayo Clin & Mayo Fdn, Div Radiat Oncol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Karnitz, LM (corresponding author), Mayo Clin & Mayo Fdn, Div Radiat Oncol, 200 1st St SW,13 Guggenheim, Rochester, MN 55905 USA.	karnitz.larry@mayo.edu						Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; CARR AM, 1994, INT J RADIAT BIOL, V66, pS133, DOI 10.1080/09553009414551961; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Freire R, 1998, GENE DEV, V12, P2560, DOI 10.1101/gad.12.16.2560; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Kostrub CF, 1998, EMBO J, V17, P2055, DOI 10.1093/emboj/17.7.2055; Lieberman HB, 1996, P NATL ACAD SCI USA, V93, P13890, DOI 10.1073/pnas.93.24.13890; LONG KE, 1994, GENE, V148, P155, DOI 10.1016/0378-1119(94)90250-X; Longhese MP, 1998, EMBO J, V17, P5525, DOI 10.1093/emboj/17.19.5525; Longhese MP, 1997, EMBO J, V16, P5216, DOI 10.1093/emboj/16.17.5216; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Parker AE, 1998, J BIOL CHEM, V273, P18340, DOI 10.1074/jbc.273.29.18340; Parker AE, 1998, J BIOL CHEM, V273, P18332, DOI 10.1074/jbc.273.29.18332; Paulovich AG, 1997, CELL, V88, P315, DOI 10.1016/S0092-8674(00)81870-X; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Udell CM, 1998, NUCLEIC ACIDS RES, V26, P3971, DOI 10.1093/nar/26.17.3971; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Weinert T, 1997, SCIENCE, V277, P1450, DOI 10.1126/science.277.5331.1450; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8	25	173	180	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					567	570		10.1074/jbc.274.2.567	http://dx.doi.org/10.1074/jbc.274.2.567			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872989	hybrid			2022-12-27	WOS:000077968500004
J	Westphal, RS; Coffee, RL; Marotta, A; Pelech, SL; Wadzinski, BE				Westphal, RS; Coffee, RL; Marotta, A; Pelech, SL; Wadzinski, BE			Identification of kinase-phosphatase signaling modules composed of p70 S6 kinase-protein phosphatase 2A (PP2A) and p21-activated kinase-PP2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; SERINE/THREONINE PHOSPHATASE-1; TYROSINE PHOSPHORYLATION; AFFINITY-CHROMATOGRAPHY; ENDOPLASMIC-RETICULUM; TUMOR-ANTIGEN; MITOGEN; PURIFICATION; COMPLEX; YEAST	A growing body of evidence indicates that regulation of protein-serine/threonine phosphatase 2A (PP2A) involves its association with other cellular and viral proteins in multiprotein complexes. PP2A-containing protein complexes may exist that contribute to PP2A's important regulatory role in many cellular processes. To identify such protein complexes, PP2A was partially purified from rat brain soluble extracts following treatment with a reversible cross-linker to stabilize large molecular size forms of PP2A. Compared with native (uncross-linked) PP2A, cross-linked PP2A revealed an enrichment of p70 S6 kinase and two pal-activated kinases (PAK1 and PAK3) in the PP2A complex, indicating these kinases may associate with PP2A. The existence of protein kinase-PP2A complexes in rat brain soluble ex tracts was further substantiated by the following results: 1) independent immunoprecipitation of the kinases revealed that PP2A co-precipitated with p70 S6 kinase and the two PAR isoforms; 2) glutathione S-transferase fusion proteins of p70 S6 kinase and PAK3 each isolated PP2A; and 3) PAK3 and p70 S6 kinase bound to microcystin-Sepharose tan affinity resin for PP2A-PP1). Cumulatively, these findings provide evidence for association of PP2A with p70 S6 kinase, PAK1, and PARS in the context of the cellular environment. Moreover, together with the recent reports describing associations of PP2A with Ca2+/calmodulin-dependent protein kinase IV (Westphal, R. S., Anderson, K. A, Means, A. R., and Wadzinski, B. E. (1998) Science 280, 1258-1261) and casein kinase II alpha (Heriche, J. K, Lebrin, F., Rabilloud, T., Leroy, D., Chambaz, E. M., and Goldberg, Y. (1997) Science 278, 952-955), the present data provide compelling evidence for the existence of protein kinase-PP2A signaling modules as a new paradigm for the control of various intracellular signaling cascades.	Vanderbilt Univ, Med Ctr, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada	Vanderbilt University; University of British Columbia	Wadzinski, BE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Sch Med, 424 MRB1, Nashville, TN 37232 USA.	brian.wadzinski@mcmail.vanderbilt.edu		Coffee, Lane/0000-0003-0059-0461	NCI NIH HHS [CA68585] Funding Source: Medline; NIDDK NIH HHS [DK20593] Funding Source: Medline; NIGMS NIH HHS [GM51366] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051366, R01GM051366] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andjelkovic N, 1996, EMBO J, V15, P7156, DOI 10.1002/j.1460-2075.1996.tb01107.x; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BALLOU LM, 1988, J BIOL CHEM, V263, P1188; Campos M, 1996, J BIOL CHEM, V271, P28478, DOI 10.1074/jbc.271.45.28478; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CHOI KY, 1994, CELL, V78, P499; Colbran RJ, 1997, J NEUROCHEM, V69, P920; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; FAVRE B, 1994, J BIOL CHEM, V269, P16311; FERRARI S, 1993, J BIOL CHEM, V268, P16091; FERRARI S, 1994, CRIT REV BIOCHEM MOL, V29, P385, DOI 10.3109/10409239409083485; Fuhrer DK, 1996, BIOCHEM BIOPH RES CO, V224, P289, DOI 10.1006/bbrc.1996.1023; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; GUO H, 1993, J BIOL CHEM, V268, P11193; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; JAKES S, 1988, BIOCHIM BIOPHYS ACTA, V967, P11, DOI 10.1016/0304-4165(88)90182-1; Kawabe T, 1997, NATURE, V385, P454, DOI 10.1038/385454a0; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KLEINBERGER T, 1993, J VIROL, V67, P7556, DOI 10.1128/JVI.67.12.7556-7560.1993; Kowluru A, 1996, ENDOCRINOLOGY, V137, P2315, DOI 10.1210/en.137.6.2315; MARCUS S, 1994, P NATL ACAD SCI USA, V91, P7762, DOI 10.1073/pnas.91.16.7762; MOORHEAD G, 1994, FEBS LETT, V356, P46, DOI 10.1016/0014-5793(94)01232-6; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; NISHIWAKI S, 1991, FEBS LETT, V279, P115, DOI 10.1016/0014-5793(91)80264-4; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PITCHER JA, 1995, P NATL ACAD SCI USA, V92, P8343, DOI 10.1073/pnas.92.18.8343; PRINTEN JA, 1994, GENETICS, V138, P609; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; SAITO T, 1995, BIOCHEMISTRY-US, V34, P7376, DOI 10.1021/bi00022a010; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Strack S, 1997, MOL BRAIN RES, V49, P15, DOI 10.1016/S0169-328X(97)00117-4; Strack S, 1998, J COMP NEUROL, V392, P515; Tudan C, 1998, BIOCHEM J, V331, P531, DOI 10.1042/bj3310531; WALTER G, 1990, P NATL ACAD SCI USA, V87, P2521, DOI 10.1073/pnas.87.7.2521; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258	46	170	175	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					687	692		10.1074/jbc.274.2.687	http://dx.doi.org/10.1074/jbc.274.2.687			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873003	hybrid			2022-12-27	WOS:000077968500018
J	Chen, AP; Davis, BH				Chen, AP; Davis, BH			UV irradiation activates JNK and increases alpha I(I) collagen gene expression in rat hepatic stellate cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; C-JUN; PROTEIN-KINASE; BINDING-PROTEIN; RETINOIC ACID; TRANSCRIPTION; PROMOTER; RECEPTORS; PHOSPHORYLATION; SUPPRESSION	Hepatic stellate cells (HSCs) become activated into myofibroblast-like cells during the early stages of hepatic injury associated with fibrogenesis, The subsequent dysregulation of alpha I(I) collagen gene expression is a central pathogenetic step during the development of cirrhosis, Our recent study in rat HSCs (Davis, B. H., Chen, A., and Beno, D. (1996) J, Biol, Chem. 271, 11039-11042) found that ERK1,3 activation might be required for maximal alpha I(I) collagen gene expression. However, the role of the parallel JNK cascade in regulating alpha I(I) collagen gene expression was unknown. In this study, we initially found that UV irradiation of HSCs activated JNK but not ERK1,2, Furthermore, UV irradiation increased endogenous alpha I(I) collagen mRNA abundance and stimulated alpha I(I) collagen gene transcription in HSCs, The effect of the activation of JNK and Jun on alpha I(I) collagen gene expression was further evaluated via transfection of chloramphenicol acetyltransferase reporter plasmids with various sizes of truncated 5' upstream promoter sequence (UPS) of the alpha I(I) collagen gene, This revealed that dominant negative transcription factor JUN suppressed alpha(I) collagen gene transcription in HSCs maintained in media with 20% serum and constitutively activated JUN increased alpha I(I) collagen gene transcription in HSCs cultured in media with 0.4% serum. UV activated JNK utilized a distal GC box in the 5'-UPS of the collagen gene to regulate gene transcription. This observation was confirmed by site-directed mutagenesis. In co-transfection experiments, the col-chloramphenicol acetyltransferase reporter with a mutagenized GC box was not suppressed by dn-JUN and was not stimulated by activated JUN or by UV irradiation. Southwestern blotting analyses and gel shift assays with basic transcription element-binding protein antiserum suggested that the GC box was bound by basic transcription element-binding protein, a recently described DNA binding protein. In conclusion, the current study combined with our previous report suggests that ERK1,2 and JNK cascades regulate alpha I(I) collagen expression in HSCs through different regions of the 5'-UPS of the gene. The distal GC box in the 5'-UPS of the alpha I(I) collagen gene may play a central role in receiving extracellular signals through the JNK pathway.	Univ Chicago, Med Ctr, Dept Med, Gastroenterol Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center	Davis, BH (corresponding author), Univ Chicago, Med Ctr, Dept Med, Gastroenterol Sect, 5841 S Maryland Ave,MC 4076, Chicago, IL 60637 USA.	bhdavis@medicine.bsd.uchicago.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK040223, P30DK042086, K08DK002022] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK40223, DK42086, DK02022] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANESKIEVICH BJ, 1992, MOL CELL BIOL, V12, P4862, DOI 10.1128/MCB.12.11.4862; ARMENDARIZBORUNDA J, 1994, BIOCHEM J, V304, P817, DOI 10.1042/bj3040817; BEDALOV A, 1994, J BIOL CHEM, V269, P4903; BRENNER DA, 1989, NUCLEIC ACIDS RES, V17, P6055, DOI 10.1093/nar/17.15.6055; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BROWN PH, 1993, ONCOGENE, V8, P877; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chen AP, 1996, J BIOL CHEM, V271, P25994, DOI 10.1074/jbc.271.42.25994; CROMBUGGHE BD, 1991, ANN RHEUM DIS, V50, P872; Davis BH, 1996, J BIOL CHEM, V271, P11039, DOI 10.1074/jbc.271.19.11039; DAVIS BH, 1991, BIOCHEM J, V278, P43, DOI 10.1042/bj2780043; DAVIS BH, 1987, J BIOL CHEM, V262, P10280; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; FRIEDMAN SL, 1994, J BIOL CHEM, V269, P10551; GENOVESE C, 1984, BIOCHEMISTRY-US, V23, P6210, DOI 10.1021/bi00320a049; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hormuzdi SG, 1998, MOL CELL BIOL, V18, P3368, DOI 10.1128/MCB.18.6.3368; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; KOBAYASHI A, 1995, J BIOCHEM-TOKYO, V117, P91, DOI 10.1093/oxfordjournals.jbchem.a124727; LASKIN DL, 1990, SEMIN LIVER DIS, V10, P293, DOI 10.1055/s-2008-1040485; MEYER DH, 1992, HEPATOLOGY, V16, P204, DOI 10.1002/hep.1840160131; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Poulos JE, 1997, AM J PHYSIOL-GASTR L, V273, pG804, DOI 10.1152/ajpgi.1997.273.4.G804; RIPPE RA, 1989, MOL CELL BIOL, V9, P2224, DOI 10.1128/MCB.9.5.2224; RITZENTHALER JD, 1993, J BIOL CHEM, V268, P13625; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Shapiro PS, 1996, J BIOL CHEM, V271, P5750, DOI 10.1074/jbc.271.10.5750; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Wang TH, 1998, J BIOL CHEM, V273, P4928, DOI 10.1074/jbc.273.9.4928; Weiner JK, 1998, J BIOL CHEM, V273, P15913, DOI 10.1074/jbc.273.26.15913; YAN MH, 1994, NATURE, V372, P798	34	61	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					158	164		10.1074/jbc.274.1.158	http://dx.doi.org/10.1074/jbc.274.1.158			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867824	hybrid			2022-12-27	WOS:000077900200024
J	Tong, Y; Quirion, R; Shen, SH				Tong, Y; Quirion, R; Shen, SH			Cloning and characterization of a novel mammalian PP2C isozyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SERINE THREONINE PHOSPHATASES; MOLECULAR-CLONING; SIGNAL-TRANSDUCTION; AFFINITY-CHROMATOGRAPHY; SEQUENCE SIMILARITY; CELLULAR FUNCTION; GENE-EXPRESSION; FISSION YEAST; KINASE	PP2C is a structurally diversified protein phosphatase family with a wide range of functions in cellular signal transduction. A novel PP2C subtype, designated PP2C delta, was identified from a rat cDNA clone, which encodes a protein of 392 amino acid residues. While PP2C delta shares approximately 30% sequence identity in its catalytic domain with the mammalian PP2C, it lacks a SO-residue carboxyl-terminal sequence conserved in mammalian PP2C. Northern blot analysis showed that PP2C delta is widely expressed in rat tissues. The transcription of the PP2C delta gene was activated in response to stress, such as the addition of ethanol to the culture medium or UV irradiation of cells. Recombinant PP2C delta purified from bacteria exhibited a potent Mn2+-dependent serine/threonine phosphatase activity. Unlike other members of the PP2C family, the activity of PP2C delta was inhibited, rather than stimulated, by Mg2+. Transfection with PP2C delta resulted in inhibition of cell growth, precluding generation of stable 293 or CHO transfectants. Using a modified tetracycline-regulated PP2C delta-GFP dicistronic expression cassette, it was revealed that overexpression of PP2C delta blocked cell cycle progression and arrested cells at early S phase, resulting in inhibition of DNA synthesis and leading to cell death. These results suggest that PP2C delta plays a role in regulation of cell cycle progression via dephosphorylation of its substrates whose appropriate phosphorylation states might be crucial for cell proliferation.	Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr, Verdun, PQ H4H 3R2, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada	National Research Council Canada; McGill University; McGill University	Shen, SH (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	shi.shen@nrc.ca			ACF HHS [AF095927] Funding Source: Medline	ACF HHS		Barak I, 1996, MOL MICROBIOL, V19, P1047, DOI 10.1046/j.1365-2958.1996.433963.x; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; BOHMANN D, 1990, CANCER CELL-MON REV, V2, P337; BOUCHARD P, 1994, J BIOL CHEM, V269, P19585; BRONDELLO JM, 1995, ONCOGENE, V10, P1895; BURNS JM, 1993, J BIOL CHEM, V268, P17155; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1989, J BIOL CHEM, V264, P21435; COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DUMONT Y, 1990, EUR J PHARMACOL, V191, P501, DOI 10.1016/0014-2999(90)94189-5; Gaits F, 1997, J BIOL CHEM, V272, P17873, DOI 10.1074/jbc.272.28.17873; GOLBERG J, 1995, NATURE, V376, P745; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GOUY M, 1989, MOL BIOL EVOL, V6, P109; Guthridge MA, 1997, MOL CELL BIOL, V17, P5485, DOI 10.1128/MCB.17.9.5485; JOHNSON LN, 1993, ANNU REV BIOPH BIOM, V22, P199, DOI 10.1146/annurev.bb.22.060193.001215; KATO S, 1995, ARCH BIOCHEM BIOPHYS, V318, P387, DOI 10.1006/abbi.1995.1244; KLUMPP S, 1994, J BIOL CHEM, V269, P32774; KOBAYASHI T, 1993, BIOCHEM BIOPH RES CO, V195, P484, DOI 10.1006/bbrc.1993.2069; KUROSAWA M, 1994, J PHARMACOL TOXICOL, V31, P135, DOI 10.1016/1056-8719(94)90075-2; LABBE D, 1994, FEBS LETT, V356, P351, DOI 10.1016/0014-5793(94)01305-5; LAWSON JE, 1993, BIOCHEMISTRY-US, V32, P8987, DOI 10.1021/bi00086a002; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; MANN DJ, 1992, BIOCHIM BIOPHYS ACTA, V1130, P100, DOI 10.1016/0167-4781(92)90471-B; MASSAGUE J, 1992, CURR OPIN GENET DEV, V2, P228; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; MITCHELL DM, 1995, FEBS LETT, V368, P148, DOI 10.1016/0014-5793(95)00626-K; Mosser DD, 1997, BIOTECHNIQUES, V22, P150, DOI 10.2144/97221rr02; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; SCHONTHAL AH, 1995, SEMIN CANCER BIOL, V6, P239, DOI 10.1006/scbi.1995.0031; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; SHEN SH, 1991, J BIOL CHEM, V266, P1058; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SHIOZAKI K, 1995, EMBO J, V14, P492, DOI 10.1002/j.1460-2075.1995.tb07025.x; SHIOZAKI K, 1994, MOL CELL BIOL, V14, P3742, DOI 10.1128/MCB.14.6.3742; SHIOZAKI K, 1994, CELL MOL BIOL RES, V40, P241; SILVA OBDE, 1988, FEBS LETT, V242, P106, DOI 10.1016/0014-5793(88)80995-5; SPRAGUE GF, 1991, TRENDS GENET, V7, P393, DOI 10.1016/0168-9525(91)90262-O; STONE JM, 1994, SCIENCE, V266, P793, DOI 10.1126/science.7973632; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Su L, 1996, J BIOL CHEM, V271, P10385, DOI 10.1074/jbc.271.17.10385; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; TAMURA S, 1989, P NATL ACAD SCI USA, V86, P1796, DOI 10.1073/pnas.86.6.1796; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; TERASAWA T, 1993, ARCH BIOCHEM BIOPHYS, V307, P342, DOI 10.1006/abbi.1993.1598; Tong Y, 1995, MOL BRAIN RES, V34, P303, DOI 10.1016/0169-328X(95)00176-S; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; Travis SM, 1997, FEBS LETT, V412, P415, DOI 10.1016/S0014-5793(97)00837-5; WENK J, 1992, FEBS LETT, V297, P135, DOI 10.1016/0014-5793(92)80344-G; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Wolf CM, 1997, EXP CELL RES, V230, P22, DOI 10.1006/excr.1996.3401	58	51	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35282	35290		10.1074/jbc.273.52.35282	http://dx.doi.org/10.1074/jbc.273.52.35282			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857069	hybrid			2022-12-27	WOS:000077719700087
J	Habib, A; FitzGerald, GA; Maclouf, J				Habib, A; FitzGerald, GA; Maclouf, J			Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; AGONIST-DEPENDENT PHOSPHORYLATION; PROSTAGLANDIN H-2 RECEPTORS; HUMAN-BLOOD-PLATELETS; A(2) RECEPTOR; 8-EPI PROSTAGLANDIN-F2-ALPHA; ADENYLYL-CYCLASE; IN-VIVO; ACTIVATION; DESENSITIZATION	A single gene encodes the human thromboxane receptor (TP), of which there are two identified splice variants, cu and beta. Both isoforms are rapidly phosphorylated in response to thromboxane agonists when overexpressed in human embryonic kidney 293 cells; this phenomenon is only slightly altered by inhibitors of protein kinase C. Pharmacological studies have defined two classes of TP in human platelets; sites that bind the agonist I-BOP with high affinity support platelet shape change. Low affinity sites, which irreversibly bind the antagonist GR 32191, transduce platelet activation and aggregation. Isoform-specific antibodies permitted detection of TP alpha, but not TP beta, from human platelets, although mRNA for both isoforms is present. A broad protein band of 50-60 kDa, reflecting the glycosylated receptor, was phosphorylated upon activation of platelets for 2 min with I-BOP, This was a rapid (similar to 30 s) and transient (maximum, 2-4 min) event and was inhibited by TP antagonists. Both arachidonic acid and low concentrations of collagen stimulated TP alpha phosphorylation, which was blocked by cyclooxygenase inhibition or TP antagonism, Blockade of the low affinity TP sites with GR 32191 prevented I-BOP-induced TP alpha phosphorylation. This coincided with agonist-induced platelet aggregation and activation but not shape change, Also, activation of these sites with the isoprostame iPF(2 alpha)-III induced platelet shape change but not TP alpha phosphorylation. Heterologous TP phosphorylation was observed in aspirin-treated platelets exposed to thrombin, high concentrations of collagen, and the calcium ionophore A 23187. Both homologous and heterologous agonist-induced phosphorylation of endogenous TP alpha was blocked by protein kinase C inhibitors. TP alpha was the only isoform detectably translated in human platelets, This appeared to correspond to the activation of the low affinity site defined by the antagonist GR 32191 and not activated by the high affinity agonist, iPF(2 alpha)-III. Protein kinase C played a more important role in agonist-induced phosphorylation of native TP alpha in human platelets than in human embryonic kidney 293 cells overexpressing recombinant TP alpha.	Hop Lariboisiere, Inst Federatif Rech Circulat Lariboisiere, U348 INSERM, F-75010 Paris, France; Univ Penn, Ctr Expt Therapeut, Philadelphia, PA 19104 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania	Habib, A (corresponding author), Hop Lariboisiere, Inst Federatif Rech Circulat Lariboisiere, U348 INSERM, 2 Rue Ambroise Pare, F-75010 Paris, France.	aida.habib@inserm.lrb.ap-hop-paris.fr	FitzGerald, Garret A/A-4222-2010; Habib, Aida/H-8647-2019	Habib, Aida/0000-0001-6027-0043	NHLBI NIH HHS [HL5400] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allan CJ, 1996, J PHARMACOL EXP THER, V277, P1132; BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cb.04.110188.002201; Blackman SC, 1998, J BIOL CHEM, V273, P475, DOI 10.1074/jbc.273.1.475; BORG C, 1994, J BIOL CHEM, V269, P6109; BOUVIER M, 1995, BIOCHEM SOC T, V23, P577, DOI 10.1042/bst0230577; DANGELO DD, 1994, J PHARMACOL EXP THER, V271, P1034; Diviani D, 1996, J BIOL CHEM, V271, P5049; DORN GW, 1991, AM J PHYSIOL, V260, pH327, DOI 10.1152/ajpheart.1991.260.2.H327; FUKUNAGA M, 1997, AM J PHYSIOL, V272, pF447; FUNK CD, 1993, MOL PHARMACOL, V44, P934; GAILANI D, 1990, BRIT J HAEMATOL, V74, P192, DOI 10.1111/j.1365-2141.1990.tb02565.x; GOMEZ J, 1992, INT REV CYTOL, V137B, P1; Habib A, 1997, J BIOL CHEM, V272, P7191, DOI 10.1074/jbc.272.11.7191; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; Hirata T, 1996, J CLIN INVEST, V97, P949, DOI 10.1172/JCI118518; KIM SO, 1992, BIOCHEM PHARMACOL, V43, P313; Kinsella BT, 1997, J PHARMACOL EXP THER, V281, P957; Kunapuli P, 1997, J BIOL CHEM, V272, P27147, DOI 10.1074/jbc.272.43.27147; MORROW JD, 1992, PROSTAGLANDINS, V44, P155, DOI 10.1016/0090-6980(92)90077-7; MURRAY R, 1990, J BIOL CHEM, V265, P21670; MURRAY R, 1989, P NATL ACAD SCI USA, V86, P124, DOI 10.1073/pnas.86.1.124; NEGISHI M, 1993, J BIOL CHEM, V268, P26067; ODA A, 1992, J BIOL CHEM, V267, P20075; OKWU AK, 1994, BBA-MOL CELL RES, V1221, P83, DOI 10.1016/0167-4889(94)90220-8; OKWU AK, 1992, J PHARMACOL EXP THER, V262, P238; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; PRADELLES P, 1985, ANAL CHEM, V57, P1170, DOI 10.1021/ac00284a003; Pratico D, 1996, J BIOL CHEM, V271, P14916, DOI 10.1074/jbc.271.25.14916; PUMIGLIA KM, 1992, BIOCHEM J, V286, P441, DOI 10.1042/bj2860441; RAYCHOWDHURY MK, 1994, J BIOL CHEM, V269, P19256; Rokach J, 1997, PROSTAG OTH LIPID M, V54, P853, DOI 10.1016/S0090-6980(97)00184-6; Shattil SJ, 1997, J CLIN INVEST, V100, pS91; SMITH WL, 1992, AM J PHYSIOL, V263, P181; Smyth EM, 1996, J BIOL CHEM, V271, P33698, DOI 10.1074/jbc.271.52.33698; TARDIF M, 1993, J IMMUNOL, V150, P3534; TYERS M, 1988, NATURE, V333, P470, DOI 10.1038/333470a0; USHIKUBI F, 1989, J BIOL CHEM, V264, P16496; VazquezPrado J, 1997, J BIOL CHEM, V272, P27330, DOI 10.1074/jbc.272.43.27330; VEZZA R, 1993, BLOOD, V82, P2704; VOURETCRAVIARI V, 1995, J BIOL CHEM, V270, P8367, DOI 10.1074/jbc.270.14.8367; YIN K, 1994, J PHARMACOL EXP THER, V270, P1192	41	113	114	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2645	2651		10.1074/jbc.274.5.2645	http://dx.doi.org/10.1074/jbc.274.5.2645			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915793	hybrid			2022-12-27	WOS:000078319500011
J	Spinelli, SL; Kierzek, R; Turner, DH; Phizicky, EM				Spinelli, SL; Kierzek, R; Turner, DH; Phizicky, EM			Transient ADP-ribosylation of a 2 '-phosphate implicated in its removal from ligated tRNA during splicing in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-I INTRONS; TRANSFER-RNA; WHEAT-GERM; SACCHAROMYCES-CEREVISIAE; ELONGATION FACTOR-2; MECHANISM; LIGASE; RIBOSE; TOXIN; SITE	The last step of tRNA splicing in yeast is catalyzed by Tpt1 protein, which transfers the S'-phosphate from ligated tRNA to NAD to produce ADP-ribose 1 "-2 "-cyclic phosphate (Appr>p), Structural and functional TPT1 homologs are found widely in eukaryotes and, surprisingly, also in Escherichia coli, which does not have this class of tRNA splicing. To understand the possible roles of the Tpt1 enzymes as well as the unusual use of NAD, the reaction mechanism of the E, coli homolog KptA was investigated. We show here that KptA protein removes the 2'-phosphate from RNA via an intermediate in which the phosphate is ADP-ribosylated followed by a presumed transesterification to release the RNA and generate Appr>p, The intermediate was characterized by analysis of its components and their linkages, using various labeled substrates and cofactors, Because the yeast and mouse Tpt1 proteins, like KptA protein, can catalyze the conversion of the KptA-generated intermediate to both product and the original substrate, these enzymes likely use the same reaction mechanism. Step 1 of this reaction is strikingly similar to the ADP-ribosylation of proteins catalyzed by a number of bacterial toxins.	Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA; Univ Rochester, Dept Chem, Rochester, NY 14627 USA; Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland	University of Rochester; University of Rochester; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Phizicky, EM (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	eric_phizicky@urmc.rochester.edu	Schroeder, Susan/D-3946-2011	Kierzek, Ryszard/0000-0002-7644-0016	NIGMS NIH HHS [GM22939, GM52347] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022939, R01GM052347] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Belfort M, 1997, CELL, V89, P1003, DOI 10.1016/S0092-8674(00)80287-1; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Culver GM, 1997, J BIOL CHEM, V272, P13203, DOI 10.1074/jbc.272.20.13203; CULVER GM, 1994, J BIOL CHEM, V269, P24928; CULVER GM, 1993, SCIENCE, V261, P206, DOI 10.1126/science.8392224; EDMONDS C, 1989, BIOCHEM J, V261, P113, DOI 10.1042/bj2610113; FERAT JL, 1993, NATURE, V364, P358, DOI 10.1038/364358a0; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; Gomes I, 1997, BIOCHEM BIOPH RES CO, V237, P588, DOI 10.1006/bbrc.1997.7193; GREER CL, 1983, CELL, V33, P899, DOI 10.1016/0092-8674(83)90032-6; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; IGLEWSKI BH, 1977, INFECT IMMUN, V15, P138, DOI 10.1128/IAI.15.1.138-144.1977; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; KlemanLeyer K, 1997, CELL, V89, P839, DOI 10.1016/S0092-8674(00)80269-X; KONARSKA M, 1981, NATURE, V293, P112, DOI 10.1038/293112a0; LASKI FA, 1983, J BIOL CHEM, V258, P1974; LITTLE JW, 1972, ANAL BIOCHEM, V48, P217, DOI 10.1016/0003-2697(72)90184-4; LUDDEN PW, 1994, MOL CELL BIOCHEM, V138, P123, DOI 10.1007/BF00928453; LykkeAndersen J, 1997, EMBO J, V16, P6290, DOI 10.1093/emboj/16.20.6290; MCCRAITH SM, 1991, J BIOL CHEM, V266, P11986; MOSS J, 1977, J BIOL CHEM, V252, P2455; NISHIKURA K, 1981, J MOL BIOL, V145, P405, DOI 10.1016/0022-2836(81)90212-6; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; PENYIGE A, 1990, FEMS MICROBIOL LETT, V69, P293; PHIZICKY EM, 1992, J BIOL CHEM, V267, P4577; PICK L, 1986, J BIOL CHEM, V261, P6694; POPE MR, 1985, P NATL ACAD SCI USA, V82, P3173, DOI 10.1073/pnas.82.10.3173; PRICE SR, 1987, PYRIDINE NUCLEOTIDE, P513; REINHOLDHUREK B, 1992, NATURE, V357, P173, DOI 10.1038/357173a0; ROWEN JW, 1951, J BIOL CHEM, V193, P497; SCHWARTZ RC, 1983, J BIOL CHEM, V258, P8374; SEKINE A, 1989, J BIOL CHEM, V264, P8602; SKORKO R, 1981, EUR J BIOCHEM, V116, P317, DOI 10.1111/j.1432-1033.1981.tb05336.x; Spinelli SL, 1997, RNA, V3, P1388; Spinelli SL, 1998, P NATL ACAD SCI USA, V95, P14136, DOI 10.1073/pnas.95.24.14136; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; UEDA K, 1990, ADP RIBOSYLATING TOX, P525; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; VANDOP C, 1984, J BIOL CHEM, V259, P696; VANNESS BG, 1980, J BIOL CHEM, V255, P710; WEST RE, 1985, J BIOL CHEM, V260, P4428; XU MQ, 1990, SCIENCE, V250, P1566, DOI 10.1126/science.2125747; ZATMAN LJ, 1953, J BIOL CHEM, V200, P197; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410	45	50	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2637	2644		10.1074/jbc.274.5.2637	http://dx.doi.org/10.1074/jbc.274.5.2637			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915792	hybrid			2022-12-27	WOS:000078319500010
J	Czech, MP; Corvera, S				Czech, MP; Corvera, S			Signaling mechanisms that regulate glucose transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INSULIN-RECEPTOR SUBSTRATE-1; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION; 3T3-L1 ADIPOCYTES; SKELETAL-MUSCLE; NITRIC-OXIDE; GLUT4 TRANSLOCATION; PHOSPHOINOSITIDE 3-KINASE; HOMOLOGY DOMAINS; RAT ADIPOCYTES; GROWTH-FACTOR		Univ Massachusetts, Med Ctr, Dept Cell Biol, Worcester, MA 01655 USA; Univ Massachusetts, Med Ctr, Dept Biochem & Mol Biol, Worcester, MA 01655 USA; Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Med Ctr, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	Michael.Czech@ummed.edu						ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; AVRUCH J, 1988, MOL CELL BIOCHEM, V182, P31; Balon TW, 1997, J APPL PHYSIOL, V82, P359, DOI 10.1152/jappl.1997.82.1.359; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Brozinick JT, 1998, J BIOL CHEM, V273, P14679, DOI 10.1074/jbc.273.24.14679; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; BURGUERA B, 1994, BIOCHEM J, V300, P781, DOI 10.1042/bj3000781; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; CHARRONMJ, 1999, J BIOL CHEM, V274, P3253; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; Coffer PJ, 1998, BIOCHEM J, V335, P1; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Cortright RN, 1997, CAN J APPL PHYSIOL, V22, P519, DOI 10.1139/h97-033; Corvera S, 1996, SEMIN CELL DEV BIOL, V7, P249, DOI 10.1006/scdb.1996.0033; CZECH MP, 1992, TRENDS BIOCHEM SCI, V17, P197, DOI 10.1016/0968-0004(92)90266-C; Etgen GJ, 1997, DIABETES, V46, P1915, DOI 10.2337/diabetes.46.11.1915; Farah S, 1998, J BIOL CHEM, V273, P4740, DOI 10.1074/jbc.273.8.4740; Fischer Y, 1996, AM J PHYSIOL-CELL PH, V270, pC1211, DOI 10.1152/ajpcell.1996.270.4.C1211; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; Frevert EU, 1998, J BIOL CHEM, V273, P25480, DOI 10.1074/jbc.273.39.25480; Guilherme A, 1998, J BIOL CHEM, V273, P33119, DOI 10.1074/jbc.273.50.33119; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Han XX, 1998, AM J PHYSIOL-ENDOC M, V274, pE700, DOI 10.1152/ajpendo.1998.274.4.E700; Hansen PA, 1997, AM J PHYSIOL-ENDOC M, V273, pE28, DOI 10.1152/ajpendo.1997.273.1.E28; HAUSDORFF SF, 1994, J BIOL CHEM, V269, P21391; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Heijnen HFG, 1997, J CELL BIOL, V138, P323, DOI 10.1083/jcb.138.2.323; HELLERHARRISON RA, 1995, J BIOL CHEM, V270, P24442, DOI 10.1074/jbc.270.41.24442; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Inoue G, 1998, J BIOL CHEM, V273, P11548, DOI 10.1074/jbc.273.19.11548; ISAKOFF SJ, 1995, P NATL ACAD SCI USA, V92, P10247, DOI 10.1073/pnas.92.22.10247; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; JULLIEN D, 1995, METABOLISM, V44, P18; Kaburagi Y, 1997, J BIOL CHEM, V272, P25839, DOI 10.1074/jbc.272.41.25839; Kapur S, 1997, DIABETES, V46, P1691, DOI 10.2337/diabetes.46.11.1691; KARUAM P, 1997, J BIOL CHEM, V272, P6163; KASUGA M, IN PRESS MOL CELL BI; Kishi K, 1998, DIABETES, V47, P550, DOI 10.2337/diabetes.47.4.550; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; KLARLUND JK, 1995, J BIOL CHEM, V270, P23421, DOI 10.1074/jbc.270.40.23421; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V208, P985, DOI 10.1006/bbrc.1995.1431; KOZMA L, 1993, P NATL ACAD SCI USA, V90, P4460, DOI 10.1073/pnas.90.10.4460; LAVAN BE, 1993, J BIOL CHEM, V268, P5921; LUI F, 1998, MOL CELL BIOCHEM, V182, P73; MANCHESTER J, 1994, P NATL ACAD SCI USA, V91, P4644, DOI 10.1073/pnas.91.11.4644; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; MASSAGUE J, 1980, P NATL ACAD SCI-BIOL, V77, P7137, DOI 10.1073/pnas.77.12.7137; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; Okada S, 1998, EMBO J, V17, P2554, DOI 10.1093/emboj/17.9.2554; OKADA T, 1994, J BIOL CHEM, V269, P3568; Olefsky JM, 1999, J BIOL CHEM, V274, P1863, DOI 10.1074/jbc.274.4.1863; OmatsuKanbe M, 1996, BIOCHEM J, V315, P25, DOI 10.1042/bj3150025; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; QUON MJ, 1994, J BIOL CHEM, V269, P27920; Roberts CK, 1997, AM J PHYSIOL-ENDOC M, V273, pE220, DOI 10.1152/ajpendo.1997.273.1.E220; Rocchi S, 1998, MOL ENDOCRINOL, V12, P914, DOI 10.1210/me.12.7.914; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; Sharma PM, 1997, MOL CELL BIOL, V17, P7386, DOI 10.1128/MCB.17.12.7386; Shimizu Y, 1996, BIOCHEM J, V314, P485, DOI 10.1042/bj3140485; SMITH U, 1984, J BIOL CHEM, V259, P8758; Staubs PA, 1998, J BIOL CHEM, V273, P25139, DOI 10.1074/jbc.273.39.25139; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Tanaka K, 1997, EUR J BIOCHEM, V245, P512, DOI 10.1111/j.1432-1033.1997.00512.x; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; VanRenterghem B, 1998, J BIOL CHEM, V273, P29942, DOI 10.1074/jbc.273.45.29942; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; VOLLENWEIDER P, 1999, IN PRESS MOL CELL BI; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Young ME, 1997, BIOCHEM J, V322, P223, DOI 10.1042/bj3220223; Zierath JR, 1998, J BIOL CHEM, V273, P20910, DOI 10.1074/jbc.273.33.20910	78	422	442	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					1865	1868		10.1074/jbc.274.4.1865	http://dx.doi.org/10.1074/jbc.274.4.1865			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890935	hybrid			2022-12-27	WOS:000078185200002
J	Owada, S; Larsson, O; Arkhammar, P; Katz, AI; Chibalin, AV; Berggren, PO; Bertorello, AM				Owada, S; Larsson, O; Arkhammar, P; Katz, AI; Chibalin, AV; Berggren, PO; Bertorello, AM			Glucose decreases Na+,K+-ATPase activity in pancreatic beta-cells - An effect mediated via Ca2+-independent phospholipase A(2) and protein kinase C-dependent phosphorylation of the alpha-subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID METABOLISM; SINGLE POTASSIUM CHANNELS; FREE CA2+ CONCENTRATION; INSULIN-SECRETION; B-CELLS; ISLETS; RAT; ACTIVATION; RELEASE; CA-2+	In the pancreatic beta-cell, glucose-induced membrane depolarization promotes opening of voltage-gated L-type Ca2+ channels, an increase in cytoplasmic free Ca2+ concentration ([Ca2+](i)), and exocytosis of insulin. Inhibition of Na+, K+-ATPase activity by ouabain leads to beta-cell membrane depolarization and Ca2+ influx. Because glucose-induced beta-cell membrane depolarization cannot be attributed solely to closure of ATP-regulated K+ channels, we investigated whether glucose regulates other transport proteins, such as the Na+,K+-ATPase. Glucose inhibited Na+,K+-ATPase activity in single pancreatic islets and intact beta-cells. This effect was reversible and required glucose metabolism. The inhibitory action of glucose was blocked by pretreatment of the islets with a selective inhibitor of a Ca2+-independent phospholipase A(2). Arachidonic acid, the hydrolytic product of this phospholipase A(2), also inhibited Na+,K+-ATPase activity, This effect, like that of glucose, was blocked by nordihydroguaiaretic acid, a selective inhibitor of the lipooxygenase metabolic pathway, but not by inhibitors of the cyclooxygenase or cytochrome P450-monooxygenase pathways. The lipooxygenase product 12(S)-HETE (12-S-hydroxyeicosatetranoic acid) inhibited Na+,K(+-)ATPase activity, and this effect, as well as that of glucose, was blocked by bisindolylmaleimide, a specific protein kinase C inhibitor. Moreover, glucose increased the state of alpha-subunit phosphorylation by a protein kinase C-dependent process. These results demonstrate that glucose inhibits Na+,K+-ATPase activity in beta-cells by activating a distinct intracellular signaling network. Inhibition of Na+,K+-ATPase activity may thus be part of the mechanisms whereby glucose promotes membrane depolarization, an increase in [Ca2+](i), and thereby insulin secretion in the pancreatic beta-cell.	Karolinska Inst, Karolinska Hosp, Dept Mol Med, Rolf Luft Ctr Diabet Res L6B 01, S-17176 Stockholm, Sweden; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Novo Nordisk AS, DK-2860 Soeborg, Denmark	Karolinska Institutet; Karolinska University Hospital; University of Chicago; Novo Nordisk	Bertorello, AM (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Mol Med, Rolf Luft Ctr Diabet Res L6B 01, S-17176 Stockholm, Sweden.	alejan@enk.ks.se		Chibalin, Alexander/0000-0002-6339-6271; Berggren, Per-Olof/0000-0001-8991-413X				ARKHAMMAR P, 1994, J BIOL CHEM, V269, P2743; ASHCROFT FM, 1988, J PHYSIOL-LONDON, V400, P501, DOI 10.1113/jphysiol.1988.sp017134; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; ATWATER I, 1975, J PHYSIOL-LONDON, V247, P56; BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; Bertorello AM, 1995, NEWS PHYSIOL SCI, V10, P253; BERTORELLO AM, 1990, NATURE, V347, P386, DOI 10.1038/347386a0; BERTORELLO AM, 1991, P NATL ACAD SCI USA, V88, P11359, DOI 10.1073/pnas.88.24.11359; BERTORELLO AM, 1993, AM J PHYSIOL, V265, pF743, DOI 10.1152/ajprenal.1993.265.6.F743; BOZEM M, 1988, PFLUG ARCH EUR J PHY, V413, P147, DOI 10.1007/BF00582524; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASTEELS R, 1981, SMOOTH MUSCLE ASSESS, P105; Chibalin AV, 1998, J BIOL CHEM, V273, P8814, DOI 10.1074/jbc.273.15.8814; Chibalin AV, 1997, AM J PHYSIOL-CELL PH, V273, pC1458, DOI 10.1152/ajpcell.1997.273.5.C1458; FORDHUTCHINSON AW, 1979, J PHARM PHARMACOL, V31, P868, DOI 10.1111/j.2042-7158.1979.tb13687.x; GRAPENGIESSER E, 1993, ARCH BIOCHEM BIOPHYS, V300, P372, DOI 10.1006/abbi.1993.1050; GRONDA CM, 1989, METHOD FIND EXP CLIN, V11, P341; GROSS RW, 1993, BIOCHEMISTRY-US, V32, P327, DOI 10.1021/bi00052a041; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HANSSON A, 1986, BIOCHEM BIOPH RES CO, V134, P1215, DOI 10.1016/0006-291X(86)90380-3; HAZEN SL, 1991, J BIOL CHEM, V266, P14526; HAZEN SL, 1991, J BIOL CHEM, V266, P5629; HELLMAN B, 1995, ANN NY ACAD SCI, V13, P541; HENQUIN JC, 1982, J PHYSIOL-LONDON, V332, P529, DOI 10.1113/jphysiol.1982.sp014429; HENQUIN JC, 1984, EXPERIENTIA, V40, P1043, DOI 10.1007/BF01971450; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; KINDMARK H, 1991, FEBS LETT, V291, P310, DOI 10.1016/0014-5793(91)81309-V; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LERNMARK A, 1974, DIABETOLOGIA, V10, P431, DOI 10.1007/BF01221634; LEVIN SR, 1978, J CLIN INVEST, V62, P692, DOI 10.1172/JCI109177; MCPHAIL LC, 1984, SCIENCE, V224, P622, DOI 10.1126/science.6231726; METZ SA, 1985, P NATL ACAD SCI USA, V82, P198, DOI 10.1073/pnas.82.1.198; MIDDLETON JP, 1993, J BIOL CHEM, V268, P15958; NILSSON T, 1987, BIOCHEM J, V248, P329, DOI 10.1042/bj2480329; NILSSON T, 1988, J BIOL CHEM, V263, P1855; Nowicki S, 1997, J CLIN INVEST, V99, P1224, DOI 10.1172/JCI119279; OMATA K, 1992, AM J PHYSIOL, V262, pF8, DOI 10.1152/ajprenal.1992.262.1.F8; Ominato M, 1996, J MEMBRANE BIOL, V152, P235, DOI 10.1007/s002329900101; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; RANDLE PJ, 1993, DIABETOLOGIA, V36, P269, DOI 10.1007/BF00400227; SHANNON VR, 1992, AM J PHYSIOL, V263, pE828, DOI 10.1152/ajpendo.1992.263.5.E828; SHEARMAN MS, 1989, FEBS LETT, V243, P177, DOI 10.1016/0014-5793(89)80125-5; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; TURK J, 1989, BIOCHIM BIOPHYS ACTA, V1001, P16, DOI 10.1016/0005-2760(89)90301-9; TURK J, 1988, DIABETES, V37, P992, DOI 10.2337/diabetes.37.7.992; TURK J, 1984, BIOCHIM BIOPHYS ACTA, V794, P125, DOI 10.1016/0005-2760(84)90305-9; WOLF BA, 1991, BIOCHEMISTRY-US, V30, P6372, DOI 10.1021/bi00240a004; YNGST DR, 1988, ANNU REV PHYSIOL, V50, P291; ZAITSEV SV, 1995, P NATL ACAD SCI USA, V92, P9712, DOI 10.1073/pnas.92.21.9712; ZAWALICH WS, 1990, MOL CELL ENDOCRINOL, V70, P119, DOI 10.1016/0303-7207(90)90152-X	52	60	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2000	2008		10.1074/jbc.274.4.2000	http://dx.doi.org/10.1074/jbc.274.4.2000			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890957	hybrid			2022-12-27	WOS:000078185200024
J	Shih, ML; Lin, FB; Scott, JD; Wang, HY; Malbon, CC				Shih, ML; Lin, FB; Scott, JD; Wang, HY; Malbon, CC			Dynamic complexes of beta(2)-adrenergic receptors with protein kinases and phosphatases and the role of gravin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; PHOSPHORYLATION SITES; SCAFFOLD PROTEIN; A431 CELLS; DESENSITIZATION; LOCALIZATION; AGONIST; PATHWAYS; INSULIN	Signals mediated by G-protein-linked receptors display agonist-induced attenuation and recovery involving both protein kinases and phosphatases, The role of protein kinases and phosphatases in agonist-induced attenuation and recovery of beta-adrenergic receptors was explored by two complementary approaches, antisense RNA suppression and co-immunoprecipitation of target elements. Protein phosphatases 2A and 2B are associated with the unstimulated receptor, the latter displaying a transient decrease followed by a 2-fold increase in the levels of association at 30 min following challenge with agonist. Protein kinase A displays a robust, agonist-induced association with beta-adrenergic receptors over the same period. Suppression of phosphatases 2A and 2B with antisense RNA or inhibition of their activity with calyculin A and FK506, respectively, blocks resensitization following agonist removal Recycling of receptors to the plasma membrane following agonist-promoted sequestration is severely impaired by loss of either phosphatase 2B or protein kinase C. In addition, loss of protein kinase C diminishes association of phosphatase 2B with beta-adrenergic receptors. Overlay assays performed with the RII subunit of protein kinase A and co-immunoprecipitations reveal proteins of the A kinase-anchoring proteins (AKAP) family, including AKAP250 also known as gravin, associated with the beta-adrenergic receptor. Suppression of gravin expression disrupts recovery from agonist-induced desensitization; confirming the role of gravin in organization of G-protein-linked signaling complexes. The Ht31 peptide, which blocks AKAP protein-protein interactions, blocks association of beta-adrenergic receptors with protein kinase A. These data are the first to reveal dynamic complexes of beta-adrenergic receptors with protein kinases and phosphatases acting via an anchoring protein, gravin.	SUNY Stony Brook, Univ Med Ctr, Dept Mol Pharmacol, Diabet & Metab Dis Res Program, Stony Brook, NY 11794 USA; Vollum Inst, Howard Hughes Med Inst, Portland, OR 97201 USA; SUNY Stony Brook, Univ Med Ctr, Dept Physiol & Biophys, Diabet & Metab Dis Res Program, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Malbon, CC (corresponding author), SUNY Stony Brook, Univ Med Ctr, Dept Mol Pharmacol, Diabet & Metab Dis Res Program, Stony Brook, NY 11794 USA.		malbon, craig/ABF-3604-2020					Baltensperger K, 1996, J BIOL CHEM, V271, P1061, DOI 10.1074/jbc.271.2.1061; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; GALVINPARTON P, 1995, METHODS MOL GENETICS; Gray PC, 1997, J BIOL CHEM, V272, P6297, DOI 10.1074/jbc.272.10.6297; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; KAROOR V, 1995, J BIOL CHEM, V270, P25305, DOI 10.1074/jbc.270.43.25305; KINCAID RL, 1988, P NATL ACAD SCI USA, V85, P8983, DOI 10.1073/pnas.85.23.8983; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KONG GH, 1994, J BIOL CHEM, V269, P13084; LIGGETT SB, 1989, MOL PHARMACOL, V36, P641; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PIPPIG S, 1993, J BIOL CHEM, V268, P3201; PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; SAMBROOK J, 1989, ANAL GNEOMIC DNA SO; SHIH ML, 1994, P NATL ACAD SCI USA, V91, P12193, DOI 10.1073/pnas.91.25.12193; Stone S R, 1988, Adv Exp Med Biol, V231, P559; UHLER MD, 1986, J BIOL CHEM, V261, P5360; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WANG HY, 1989, BIOCHEM J, V263, P519, DOI 10.1042/bj2630519; WANG HY, 1989, BIOCHEM J, V263, P533, DOI 10.1042/bj2630533; WATKINS DC, 1992, SCIENCE, V258, P1373, DOI 10.1126/science.1455234; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671	27	172	182	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1588	1595		10.1074/jbc.274.3.1588	http://dx.doi.org/10.1074/jbc.274.3.1588			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880537	hybrid			2022-12-27	WOS:000079956900057
J	Zhao, XF; Aplan, PD				Zhao, XF; Aplan, PD			The hematopoietic transcription factor SCL binds the p44 subunit of TFIIH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; T-CELL LEUKEMIA; DNA-BINDING; IN-VIVO; ENHANCER-BINDING; GENE-PRODUCT; ID PROTEINS; TAL-1 GENE; ASSOCIATION; DIFFERENTIATION	SCL is a basic domain helix-loop-helix (bHLH) oncoprotein that is involved in T-cell acute lymphoblastic leukemia as well as in normal hematopoiesis. Although it is believed that SCL functions as a tissue-specific transcription factor, no molecular mechanism has thus far been identified for this putative function. In this report, we show that SCL interacts with p44, a subunit of the basal transcription factor TFIIH, The minimal region of SCL that interacts with p44 was mapped to a 101-amino acid sequence that includes, hut is not limited to, the bHLH, region; the SCL-binding site of p44 is located in the carboxyl-terminal half of p44. This interaction was confirmed by glutathione S-transferase fusion protein pull-down assays and a co-immunoprecipitation assay. As analyzed with a yeast two-hybrid system, p44 interacts specifically with SCL, but not with the other class A or B bHLH proteins tested. E2A did not compete with p44 for SCL binding, as demonstrated by an in vitro binding assay. These findings document a previously unsuspected interaction between SCL and a subunit of the basal transcription factor TFIIH, suggesting a potential means by which SCL might modulate transcription.	Roswell Pk Canc Inst, Dept Pediat, Buffalo, NY 14263 USA; Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; SUNY Buffalo, Dept Pediat, Buffalo, NY 14222 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Aplan, PD (corresponding author), Roswell Pk Canc Inst, Dept Pediat, Buffalo, NY 14263 USA.	paplan@sc3101.med.buffalo.edu	Aplan, Peter D/K-9064-2016		NATIONAL CANCER INSTITUTE [P30CA016056, R29CA067177] Funding Source: NIH RePORTER; NCI NIH HHS [CA16056-21, CA67177-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adamczewski JP, 1996, EMBO J, V15, P1877, DOI 10.1002/j.1460-2075.1996.tb00538.x; Aplan PD, 1997, EMBO J, V16, P2408, DOI 10.1093/emboj/16.9.2408; APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; APLAN PD, 1990, MOL CELL BIOL, V10, P6426, DOI 10.1128/MCB.10.12.6426; BEGLEY CG, 1992, P NATL ACAD SCI USA, V89, P38, DOI 10.1073/pnas.89.1.38; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; BERNARD O, 1991, ONCOGENE, V6, P1477; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; ELWOOD NJ, 1994, LEUKEMIA, V8, P106; FINGER LR, 1989, P NATL ACAD SCI USA, V86, P5039, DOI 10.1073/pnas.86.13.5039; Goldfarb AN, 1996, J BIOL CHEM, V271, P2683, DOI 10.1074/jbc.271.5.2683; GOLDFARB AN, 1995, BLOOD, V85, P465; HATEBOER G, 1993, P NATL ACAD SCI USA, V90, P8489, DOI 10.1073/pnas.90.18.8489; Heller H, 1998, NUCLEIC ACIDS RES, V26, P2112, DOI 10.1093/nar/26.9.2112; HSU HL, 1991, MOL CELL BIOL, V11, P3037, DOI 10.1128/MCB.11.6.3037; HSU HL, 1994, MOL CELL BIOL, V14, P1256, DOI 10.1128/MCB.14.2.1256; HUMBERT S, 1994, EMBO J, V13, P2393, DOI 10.1002/j.1460-2075.1994.tb06523.x; Izraeli S, 1997, CELL GROWTH DIFFER, V8, P1171; JAYNES JB, 1988, MOL CELL BIOL, V8, P62, DOI 10.1128/MCB.8.1.62; Kornberg RD, 1996, TRENDS BIOCHEM SCI, V21, P325, DOI 10.1016/0968-0004(96)20021-0; Larson RC, 1996, EMBO J, V15, P1021, DOI 10.1002/j.1460-2075.1996.tb00439.x; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Mahajan MA, 1996, ONCOGENE, V12, P2343; MAHESWARAN S, 1994, MOL CELL BIOL, V14, P1147, DOI 10.1128/MCB.14.2.1147; Marinoni JC, 1997, EMBO J, V16, P1093, DOI 10.1093/emboj/16.5.1093; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; PULFORD K, 1995, BLOOD, V85, P675, DOI 10.1182/blood.V85.3.675.bloodjournal853675; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SHIMAMOTO T, 1995, BLOOD, V86, P3173; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; TAPSCOTT SJ, 1991, J CLIN INVEST, V87, P1133, DOI 10.1172/JCI115109; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; VORONOVA AF, 1994, P NATL ACAD SCI USA, V91, P5952, DOI 10.1073/pnas.91.13.5952; WADMAN I, 1994, EMBO J, V13, P4831, DOI 10.1002/j.1460-2075.1994.tb06809.x; WADMAN IA, 1994, ONCOGENE, V9, P3713; WANG S, 1988, Microsurgery, V9, P10, DOI 10.1002/micr.1920090104; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; Zhao XF, 1998, BBA-MOL CELL RES, V1448, P109, DOI 10.1016/S0167-4889(98)00129-3	51	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1388	1393		10.1074/jbc.274.3.1388	http://dx.doi.org/10.1074/jbc.274.3.1388			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880511	hybrid			2022-12-27	WOS:000079956900031
J	Qian, XL; O'Rourke, DM; Fei, ZZ; Zhang, HT; Kao, CC; Greene, MI				Qian, XL; O'Rourke, DM; Fei, ZZ; Zhang, HT; Kao, CC; Greene, MI			Domain-specific interactions between the p185(neu) and epidermal growth factor receptor kinases determine differential signaling outcomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIH 3T3 CELLS; NEU-ONCOGENE; EGF RECEPTOR; HUMAN-BREAST; INTERMOLECULAR ASSOCIATION; TYROSINE PHOSPHORYLATION; NEUREGULIN RECEPTOR; CARDIAC DEVELOPMENT; CARCINOMA-CELLS; POINT MUTATION	We expressed the epidermal growth factor receptor (EGFR) along with mutant p185(neu) proteins containing the rat transmembrane point mutation. The work concerned the study of the contributions made by various p185(neu) subdomains to signaling induced by a heterodimeric ErbB complex. Go-expression of full-length EGFR and oncogenic p185(neu) receptors resulted in an increased EGF-induced phosphotyrosine content of p185(neu), increased cell proliferation to limiting concentrations of EGF, and increases in both EGF-induced MAPK and phosphatidylinositol 3-kinase (PI 3-kinase) activation. Intracellular domain-deleted p185(neu) receptors (T691stop neu) were able to associate with full-length EGFR, but induced antagonistic effects on EGF-dependent EGF receptor down-regulation, cell proliferation, and activation of MAPK and PI 3-kinase pathways. Ectodomain-deleted p185(neu) proteins (T Delta 5) were unable to physically associate with EGFR, and extracellular domain-deleted p185(neu) forms failed to augment activation of MAPK and PI 3-kinase in response to EGF. Association of EGFR with a carboxyl-terminally truncated p185(neu) mutant (TAPstop) form did not increase transforming efficiency and phosphotyrosine content of the TAPstop species, and proliferation of EGFR TAPstop-co-expressing cells in response to EGF was similar to cells containing EGFR only. Thus, neither cooperative nor inhibitory effects were observed in cell Lines co-expressing either T Delta 5 or TAPstop mutant proteins. Unlike the formation of potent homodimer assemblies composed of oncogenic p185"'", the induction of signaling from p185(neu) EGFR heteroreceptor assemblies requires the ectodomain for Ligand-dependent physical association and intracellular domain contacts for efficient intermolecular kinase activation.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Greene, MI (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 252 John Morgan Bldg,36th & Hamilton Walk, Philadelphia, PA 19104 USA.		O'Rourke, Donald/AAC-3376-2021	Zhang, Hongtao/0000-0001-9173-0049; O'Rourke, Donald/0000-0002-8479-7314				AKIYAMA T, 1988, MOL CELL BIOL, V8, P1019, DOI 10.1128/MCB.8.3.1019; ALIMANDI M, 1995, ONCOGENE, V10, P1813; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; Bergeron JJM, 1995, BIOSCIENCE REP, V15, P411, DOI 10.1007/BF01204345; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; Cohen BM, 1996, J BIOL CHEM, V271, P4813; DECKER SJ, 1989, J BIOL CHEM, V264, P9204; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DOUGALL WC, 1994, ONCOGENE, V9, P2109; Dougall WC, 1996, DNA CELL BIOL, V15, P31, DOI 10.1089/dna.1996.15.31; DREBIN JA, 1984, NATURE, V312, P545, DOI 10.1038/312545a0; FEDI P, 1994, MOL CELL BIOL, V14, P492, DOI 10.1128/MCB.14.1.492; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; GOLDMAN R, 1990, BIOCHEMISTRY-US, V29, P11024, DOI 10.1021/bi00502a002; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KOKAI Y, 1989, CELL, V58, P287, DOI 10.1016/0092-8674(89)90843-X; KOKAI Y, 1988, P NATL ACAD SCI USA, V85, P5389, DOI 10.1073/pnas.85.15.5389; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; LEVEA CM, 1993, RECEPTOR, V3, P293; MIKAMI Y, 1992, P NATL ACAD SCI USA, V89, P7335, DOI 10.1073/pnas.89.16.7335; Moscatello DK, 1998, J BIOL CHEM, V273, P200, DOI 10.1074/jbc.273.1.200; Moscatello DK, 1996, ONCOGENE, V13, P85; MYERS JN, 1992, RECEPTOR, V2, P1; O'Rourke DM, 1998, ONCOGENE, V16, P1197, DOI 10.1038/sj.onc.1201635; ORourke DM, 1997, P ASSOC AM PHYSICIAN, V109, P209; ORourke DM, 1997, P NATL ACAD SCI USA, V94, P3250, DOI 10.1073/pnas.94.7.3250; PELES E, 1993, BIOESSAYS, V15, P815, DOI 10.1002/bies.950151207; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; PRUSS RM, 1977, P NATL ACAD SCI USA, V74, P3918, DOI 10.1073/pnas.74.9.3918; QIAN XL, 1995, ONCOGENE, V10, P211; QIAN XL, 1994, ONCOGENE, V9, P1507; QIAN XL, 1994, P NATL ACAD SCI USA, V91, P1500, DOI 10.1073/pnas.91.4.1500; QIAN XL, 1992, P NATL ACAD SCI USA, V89, P1330, DOI 10.1073/pnas.89.4.1330; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; SAMANTA A, 1994, P NATL ACAD SCI USA, V91, P1711, DOI 10.1073/pnas.91.5.1711; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SEGATTO O, 1990, New Biologist, V2, P187; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; Wang ZX, 1996, SCIENCE, V272, P1935, DOI 10.1126/science.272.5270.1935; WEINER DB, 1989, ONCOGENE, V4, P1175; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; Zhang K, 1996, J BIOL CHEM, V271, P3884	59	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					574	583		10.1074/jbc.274.2.574	http://dx.doi.org/10.1074/jbc.274.2.574			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9872991	hybrid			2022-12-27	WOS:000077968500006
J	Tong, JF; McCarthy, TV; MacLennan, DH				Tong, JF; McCarthy, TV; MacLennan, DH			Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RYANODINE RECEPTOR GENE; MUSCLE SARCOPLASMIC-RETICULUM; HUMAN SKELETAL-MUSCLE; SUSCEPTIBLE PIGS; RYR1 MUTATION; COS-1 CELLS; CA-2+; CALCIUM; IDENTIFICATION; SUBSTITUTION	Malignant hyperthermia (MH) and central core disease (CCD) mutations were introduced into full-length rabbit Ca2+ release channel (RYR1) cDNA, which was then expressed transiently in HEK-293 cells. Resting Ca2+ concentrations were higher in HEK-293 cells expressing homotetrameric CCD mutant RyR1 than in cells expressing homotetrameric MH mutant RyR1, Cells expressing homotetrameric CCD or MR mutant RyR1 exhibited lower maximal peak amplitudes of caffeine-induced Ca2+ release than cells expressing wild type RyR1, suggesting that MR and CCD mutants might be "weaky." In cells expressing homotetrameric wild type or mutant RyR1, the amplitude of 10 mM caffeine-induced Ca2+ release was correlated significantly with the amplitude of carbachol- or thapsigarsn-induced Ca2+ release, indicating that maximal drug-induced Ca2+ release depends on the size of the endoplasmic reticulum Ca2+ store. The content of endogenous sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2b (SERCA2b), measured by enzyme-linked immunosorbent assay, Ca-45(2+) uptake, and confocal microscopy, was increased in HEK-293 cells expressing mild type or mutant RyR1, supporting the view that endoplasmic reticulum Ca2+ storage capacity is increased as a compensatory response to an enhanced Ca2+ leak. When heterotetrameric (1:1) combinations of MH/CCD mutant and wild type RyR1 were expressed together with SERCA1 to enhance Ca2+ reuptake, the amplitude of Ca2+ release in response to low concentrations of caffeine and halothane was higher than that observed in cells expressing wild type RyR1 and SERCA1, In Ca2+-free medium, MH/CCD mutants were more sensitive to caffeine than wild type RyR1, indicating that caffeine hypersensitivity observed with a variety of MH/CCD mutant RyR1 proteins is not dependent on extracellular Ca2+ concentration.	Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5G 1L6, Canada; Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cork, Ireland	University of Toronto; University of Toronto; University College Cork	MacLennan, DH (corresponding author), Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	david.maclennan@utoronto.ca		McCarthy, Tommie/0000-0003-4884-6972				AIREY JA, 1990, J BIOL CHEM, V265, P14187; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN SRW, 1993, BIOCHEMISTRY-US, V32, P3743, DOI 10.1021/bi00065a029; Chen SRW, 1997, BIOPHYS J, V73, P1904, DOI 10.1016/S0006-3495(97)78221-3; CLARKE DM, 1993, J BIOL CHEM, V268, P18359; DENBOROUGH MA, 1973, BMJ-BRIT MED J, V1, P272, DOI 10.1136/bmj.1.5848.272; DUBOWITZ V, 1960, LANCET, P23; FILL M, 1990, BIOPHYS J, V57, P471, DOI 10.1016/S0006-3495(90)82563-7; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; GROUP EM, 1984, BRIT J ANAESTH, V56, P1267; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3450; HAWKES MJ, 1992, J BIOL CHEM, V267, P6702; HAYASHI K, 1989, MUSCLE NERVE, V12, P95, DOI 10.1002/mus.880120203; IAIZZO PA, 1988, PFLUG ARCH EUR J PHY, V411, P648, DOI 10.1007/BF00580861; IAIZZO PA, 1989, CELL CALCIUM, V10, P151, DOI 10.1016/0143-4160(89)90069-9; KEATING KE, 1994, HUM MOL GENET, V3, P1855, DOI 10.1093/hmg/3.10.1855; Keating KE, 1997, J MED GENET, V34, P291, DOI 10.1136/jmg.34.4.291; LARACH MG, 1989, ANESTH ANALG, V69, P511; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; LOPEZ JR, 1986, MUSCLE NERVE, V9, P85; LOPEZPADRINO JR, 1994, MALIGNANT HYPERTHERM, P133; Lynch PJ, 1997, ANESTHESIOLOGY, V86, P620, DOI 10.1097/00000542-199703000-00014; MA J, 1988, SCIENCE, V242, P99, DOI 10.1126/science.2459777; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MACLENNAN DH, 1995, SOC GEN PHY, V50, P89; MACLENNAN DH, 1995, CURR OPIN NEUROL, V8, P397, DOI 10.1097/00019052-199510000-00013; MACLENNAN DH, 1996, MOL BIOL MEMBRANE TR, P181; Manning BM, 1998, AM J HUM GENET, V62, P599, DOI 10.1086/301748; MARTONOSI A, 1982, ANNU REV PHYSIOL, V44, P337, DOI 10.1146/annurev.ph.44.030182.002005; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; NELSON TE, 1983, ANESTH ANALG, V62, P545; NELSON TE, 1988, CELL CALCIUM, V9, P257, DOI 10.1016/0143-4160(88)90006-1; OBRIEN PJ, 1986, CAN J VET RES, V50, P318; Owen VJ, 1997, AM J PHYSIOL-CELL PH, V272, pC203, DOI 10.1152/ajpcell.1997.272.1.C203; PHILLIPS MS, 1994, HUM MOL GENET, V3, P2181, DOI 10.1093/hmg/3.12.2181; QUANE KA, 1994, GENOMICS, V23, P236, DOI 10.1006/geno.1994.1483; QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51; QUANE KA, 1994, HUM MOL GENET, V3, P471, DOI 10.1093/hmg/3.3.471; Quane KA, 1997, BRIT J ANAESTH, V79, P332, DOI 10.1093/bja/79.3.332; Querfurth HW, 1998, BIOCHEM J, V334, P79, DOI 10.1042/bj3340079; ROUFA D, 1981, BIOCHIM BIOPHYS ACTA, V674, P225, DOI 10.1016/0304-4165(81)90380-9; SHOMER NH, 1995, MUSCLE NERVE, V18, P1167, DOI 10.1002/mus.880181013; SHY GM, 1956, BRAIN, V79, P610, DOI 10.1093/brain/79.4.610; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332; Tripathy A, 1996, BIOPHYS J, V70, P2600, DOI 10.1016/S0006-3495(96)79831-4; ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	48	151	153	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					693	702		10.1074/jbc.274.2.693	http://dx.doi.org/10.1074/jbc.274.2.693			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873004	hybrid			2022-12-27	WOS:000077968500019
J	York, SJ; Arneson, LS; Gregory, WT; Dahms, NM; Kornfeld, S				York, SJ; Arneson, LS; Gregory, WT; Dahms, NM; Kornfeld, S			The rate of internalization of the mannose 6-phosphate/insulin-like growth factor II receptor is enhanced by multivalent ligand binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							6-PHOSPHATE RECEPTOR; LYSOSOMAL-ENZYMES; IGF-II; MANNOSE-6-PHOSPHATE RECEPTORS; CYTOPLASMIC DOMAIN; BETA-GALACTOSIDASE; GOLGI-COMPLEX; LOCALIZATION; CELLS; ENDOCYTOSIS	The cation-independent mannose 6-phosphate/insulin-like growth factor II receptor (M6GP/IGF-II receptor) undergoes constitutive endocytosis, mediating the internalization of two unrelated classes of ligands, mannose 6-phosphate (Man-6-P)-containing acid hydrolases and insulin-like growth factor II (IGF-II). To determine the role of ligand valency in M6P/IGF-II receptor-mediated endocytosis, we measured the internalization rates of two ligands, beta-glucuronidase (a homotetramer bearing multiple Man-6-P moieties) and IGF-II. We found that beta-glucuronidase entered the cell similar to 3-4-fold faster than IGF-II. Unlabeled beta-glucuronidase stimulated the rate of internalization of I-125-IGF-II to equal that of I-125-beta-glucuronidase, but a bivalent synthetic tripeptide capable of occupying both Man-6-P-binding sites on the M6P/IGF-II receptor simultaneously did not. A mutant receptor with one of the two Man-6-P-binding sites inactivated retained the ability to internalize beta-glucuronidase faster than IGF-II. Thus, the increased rate of internalization required a multivalent ligand and a single Man-6-P-binding site on the receptor. M6P/IGF-II receptor solubilized and purified in Triton X-100 was present as a monomer, but association with beta-glucuronidase generated a complex composed of two receptors and one beta-glucuronidase. Neither IGF-II nor the synthetic peptide induced receptor dimerization. These results indicate that intermolecular cross-linking of the M6P/IGF-II receptor occurs upon binding of a multivalent ligand, resulting in an increased rate of internalization.	Washington Univ, Sch Med, Div Hematol, St Louis, MO 63110 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Washington University (WUSTL); Medical College of Wisconsin	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Div Hematol, 660 S Euclid Ave,Campus Box 8125, St Louis, MO 63110 USA.				NCI NIH HHS [CA08759-30] Funding Source: Medline; NHLBI NIH HHS [T32 HL07088] Funding Source: Medline; NIDDK NIH HHS [DK42667] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA008759, R37CA008759] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042667, R56DK042667, R29DK042667] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACKERS GK, 1967, J BIOL CHEM, V242, P3237; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAULKE T, 1987, J CELL BIOL, V104, P1735, DOI 10.1083/jcb.104.6.1735; BROWN WJ, 1986, J CELL BIOL, V103, P1235, DOI 10.1083/jcb.103.4.1235; BROWN WJ, 1984, P NATL ACAD SCI-BIOL, V81, P5135, DOI 10.1073/pnas.81.16.5135; BROWN WJ, 1984, J CELL BIOL, V99, P320, DOI 10.1083/jcb.99.1.320; CASTELLINO FJ, 1968, BIOCHEMISTRY-US, V7, P2207, DOI 10.1021/bi00846a025; CHRISTENSEN MK, 1994, J CHEM SOC P1, V1, P1299; CLARKE S, 1975, J BIOL CHEM, V250, P5459; COLLAWN JF, 1993, J BIOL CHEM, V268, P21686; DAHMS NM, 1993, J BIOL CHEM, V268, P5457; Denzer K, 1997, BIOCHEM J, V326, P497, DOI 10.1042/bj3260497; DISTLER JJ, 1991, J BIOL CHEM, V266, P21687; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; FIRE E, 1991, J CELL BIOL, V115, P1585, DOI 10.1083/jcb.115.6.1585; FORMISANO S, 1983, ARCH BIOCHEM BIOPHYS, V227, P351, DOI 10.1016/0003-9861(83)90463-0; FRANCIS GL, 1993, BIOCHEM J, V293, P713, DOI 10.1042/bj2930713; Franzyk H, 1997, BIOORGAN MED CHEM, V5, P21, DOI 10.1016/S0968-0896(96)00194-0; GARMROUDI F, 1994, J BIOL CHEM, V269, P26944; GEUZE HJ, 1985, J CELL BIOL, V101, P2253, DOI 10.1083/jcb.101.6.2253; HERBERTSSON H, 1995, BBA-GEN SUBJECTS, V1244, P191, DOI 10.1016/0304-4165(94)00223-K; HILLEREHFELD A, 1995, BBA-REV BIOMEMBRANES, V1241, P177, DOI 10.1016/0304-4157(95)00004-B; HOFLACK B, 1987, J BIOL CHEM, V262, P123; JADOT M, 1992, J BIOL CHEM, V267, P11069; JIN M, 1989, J BIOL CHEM, V264, P7675; JOHNSON KF, 1990, P NATL ACAD SCI USA, V87, P10010, DOI 10.1073/pnas.87.24.10010; KIESS W, 1988, J BIOL CHEM, V263, P9339; KIESS W, 1990, EUR J BIOCHEM, V190, P71, DOI 10.1111/j.1432-1033.1990.tb15547.x; KIESS W, 1989, J BIOL CHEM, V264, P4710; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KYLE JW, 1988, J BIOL CHEM, V263, P16230; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; LOBEL P, 1988, J BIOL CHEM, V263, P2563; MACDONALD RG, 1988, SCIENCE, V239, P1134, DOI 10.1126/science.2964083; Marron-Terada PG, 1998, J BIOL CHEM, V273, P22358, DOI 10.1074/jbc.273.35.22358; MORGAN DO, 1987, NATURE, V329, P301, DOI 10.1038/329301a0; PERDUE JF, 1983, J BIOL CHEM, V258, P7800; PFEFFER SR, 1987, J CELL BIOL, V105, P229, DOI 10.1083/jcb.105.1.229; Roberts DL, 1998, CELL, V93, P639, DOI 10.1016/S0092-8674(00)81192-7; SADLER JE, 1979, J BIOL CHEM, V254, P4434; SCHMIDT B, 1995, J BIOL CHEM, V270, P14975, DOI 10.1074/jbc.270.25.14975; SHIPLEY JM, 1993, J BIOL CHEM, V268, P12193; SIEGEL A, 1966, BIOCHIM BIOPHYS ACTA, V113, P346; SOBER HA, 1968, HDB BIOCH, pC10; STEIN M, 1987, BIOL CHEM H-S, V368, P937, DOI 10.1515/bchm3.1987.368.2.937; TONG PY, 1988, J BIOL CHEM, V263, P2585; TONG PY, 1989, J BIOL CHEM, V264, P7962	47	85	94	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1164	1171		10.1074/jbc.274.2.1164	http://dx.doi.org/10.1074/jbc.274.2.1164			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873065	hybrid			2022-12-27	WOS:000077968500080
J	Huber, M; Izzi, L; Grondin, P; Houde, C; Kunath, T; Veillette, A; Beauchemin, N				Huber, M; Izzi, L; Grondin, P; Houde, C; Kunath, T; Veillette, A; Beauchemin, N			The carboxyl-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE-1 PECAM-1; GROWTH-FACTOR RECEPTOR; ANTIGEN GENE FAMILY; SH2-CONTAINING PHOSPHOTYROSINE PHOSPHATASE; CYTOPLASMIC DOMAIN; CARCINOEMBRYONIC ANTIGENS; INTERCELLULAR-ADHESION; SH2 DOMAIN; C-CAM; ENDOGENOUS SUBSTRATE	Biliary glycoprotein (Bgp, C-CAM, or CD66a) is an immunoglobulin-like cell adhesion molecule and functions as a tumor suppressor protein. We have previously shown that the Bgp1 isoform responsible for inhibition of colonic, liver, prostate, and breast tumor cell growth contains within its cytoplasmic domain two tyrosine residues positioned in immunoreceptor tyrosine-based inhibition motif (ITIM) consensus sequences. Moreover, we determined that these residues, upon phosphorylation, associate with the protein-tyrosine phosphatase SHP-1. In this report, we have further evaluated the structural bases of the association of Bgp1 with Tyr phosphatases. First, we demonstrate that Bgp1 also associates with the SHP-2 Tyr phosphatase, but not with an unrelated Tyr phosphatase, PTP-PEST, Association of Bgp1 and SHP-2 involves the Tyr residues within the Bgp1 ITIM sequences, Val at position +3 relative to the second Tyr (Tyr-515), and the SHP-2 N-terminal SH2 domain. In addition, our results indicate that residues +4, +5, and +6 relative to Tyr-515 in the Bgp1 cytoplasmic domain play a significant role in these interactions, as their deletion reduced Bgp1 Tyr phosphorylation and association with SHP-1 and SHP-2 by as much as 80%. Together, these results indicate that both SHP-1 and SHP-2 interact with the Bgp1 cytoplasmic domain via ITIM-like sequences. Furthermore, they reveal that the C-terminal amino acids of Bgp1 are critical for these interactions.	McGill Univ, Ctr Canc, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3G 1Y6, Canada; Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	McGill University; McGill University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Beauchemin, N (corresponding author), McGill Univ, Ctr Canc, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	nicoleb@med.mcgill.ca		Kunath, Tilo/0000-0002-8805-7356				BARNETT TR, 1989, J CELL BIOL, V108, P267, DOI 10.1083/jcb.108.2.267; Beauchemin N, 1998, CELL ADHES COMMUN S, V5, P155; Beauchemin N, 1997, ONCOGENE, V14, P783, DOI 10.1038/sj.onc.1200888; BRUMMER J, 1995, ONCOGENE, V11, P1649; Burshtyn DN, 1997, J BIOL CHEM, V272, P13066, DOI 10.1074/jbc.272.20.13066; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Cao MY, 1998, J BIOL CHEM, V273, P15765, DOI 10.1074/jbc.273.25.15765; CASE RD, 1994, J BIOL CHEM, V269, P10467; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; CHEUNG PH, 1993, J BIOL CHEM, V268, P24303; COUTELIER JP, 1994, EUR J IMMUNOL, V24, P1383, DOI 10.1002/eji.1830240622; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; DELISSER HM, 1994, J CELL BIOL, V124, P195, DOI 10.1083/jcb.124.1.195; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991; Edwards GM, 1998, J BIOL CHEM, V273, P9495, DOI 10.1074/jbc.273.16.9495; Famiglietti J, 1997, J CELL BIOL, V138, P1425, DOI 10.1083/jcb.138.6.1425; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; FORMISANO P, 1995, J BIOL CHEM, V270, P24073, DOI 10.1074/jbc.270.41.24073; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; HSIEH JT, 1995, CANCER RES, V55, P190; Hunter I, 1996, BIOCHEM J, V320, P847, DOI 10.1042/bj3200847; Jackson DE, 1997, J BIOL CHEM, V272, P24868, DOI 10.1074/jbc.272.40.24868; Jackson DE, 1997, J BIOL CHEM, V272, P6986, DOI 10.1074/jbc.272.11.6986; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kunath T, 1995, ONCOGENE, V11, P2375; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; LEUSCH HG, 1991, INFECT IMMUN, V59, P2051, DOI 10.1128/IAI.59.6.2051-2057.1991; LIN SH, 1995, BIOCHEM J, V311, P239, DOI 10.1042/bj3110239; Luo WP, 1997, ONCOGENE, V14, P1697, DOI 10.1038/sj.onc.1200999; MCCUAIG K, 1992, CELL GROWTH DIFFER, V3, P165; Moller MJ, 1996, INT J CANCER, V65, P740, DOI 10.1002/(SICI)1097-0215(19960315)65:6<740::AID-IJC5>3.0.CO;2-Z; NAJJAR SM, 1993, J BIOL CHEM, V268, P1201; NEDELLEC P, 1995, EUR J BIOCHEM, V231, P104, DOI 10.1111/j.1432-1033.1995.tb20676.x; NEDELLEC P, 1994, J VIROL, V68, P4525; Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; OCKLIND C, 1982, J BIOL CHEM, V257, P6788; ODIN P, 1987, EXP CELL RES, V171, P1, DOI 10.1016/0014-4827(87)90246-1; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; Pei DH, 1996, P NATL ACAD SCI USA, V93, P1141, DOI 10.1073/pnas.93.3.1141; REESJONES RW, 1985, J BIOL CHEM, V260, P4461; Rojas M, 1996, CELL GROWTH DIFFER, V7, P655; ROJAS M, 1990, CELL GROWTH DIFFER, V1, P527; Ruff SJ, 1997, J BIOL CHEM, V272, P1263, DOI 10.1074/jbc.272.2.1263; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIPPEL CJ, 1994, J BIOL CHEM, V269, P19539; SKUBITZ KM, 1995, J IMMUNOL, V155, P5382; SOUTHERN PJ, 1982, J MOL APPL GENET, V1, P314; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; TOMIC S, 1995, J BIOL CHEM, V270, P21277, DOI 10.1074/jbc.270.36.21277; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; TORRES RM, 1992, J IMMUNOL, V149, P2641; Turbide C, 1997, CANCER RES, V57, P2781; VALLEJO AN, 1994, PCR METH APPL, V4, pS123; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; WATT SM, 1994, BLOOD, V84, P200; Wikstrom K, 1996, EXP CELL RES, V227, P360, DOI 10.1006/excr.1996.0285; Wong L, 1996, J BIOL CHEM, V271, P20981, DOI 10.1074/jbc.271.35.20981; YAN HC, 1995, J BIOL CHEM, V270, P23672, DOI 10.1074/jbc.270.40.23672; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687	67	144	152	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					335	344		10.1074/jbc.274.1.335	http://dx.doi.org/10.1074/jbc.274.1.335			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867848	hybrid			2022-12-27	WOS:000077900200048
J	Rzigalinski, BA; Willoughby, KA; Hoffman, SW; Falck, JR; Ellis, EF				Rzigalinski, BA; Willoughby, KA; Hoffman, SW; Falck, JR; Ellis, EF			Calcium influx factor, further evidence it is 5,6-epoxyeicosatrienoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CA2+ STORES; PROTEIN-KINASE-C; ARACHIDONIC-ACID; EPOXYEICOSATRIENOIC ACIDS; CYTOSOLIC CALCIUM; INOSITOL TRISPHOSPHATE; ENDOTHELIAL-CELLS; VASCULAR TONE; ENTRY; EPOXYGENASE	We present evidence in astrocytes that 5,6-epoxyeicosatrienoic acid, a cytochrome P450 epoxygenase metabolite elite of arachidonic acid, may be a component of calcium influx factor, the elusive link between release of Ca2+ from intracellular stores and capacitative Ca2+ influx. Capacitative influx of extracellular Ca2+ was inhibited by blockade of the two critical steps in epoxyeicosatrienoic acid synthesis: release of arachidonic acid from phospholipid stores by cytosolic phospholipase A(2) and cytochrome P450 metabolism of arachidonic acid. AAOCF(3), which inhibits cytosolic phospholipase A(2), blocked thapsigargin-stimulated release of arachidonic acid as well as thapsigargin-stimulated elevation of intracellular free calcium. Inhibition of P450 arachidonic acid metabolism with SKF525A econazole, or N methyl sulfonyl-6-(2-propargyloxyphenyl)hexanamide, a substrate inhibitor of P450 arachidonic acid metabolism, also blocked thapsigargin-stimulated Ca2+ influx. Nano- to picomolar 5,6-epoxyeicosatrienoic acid induced [Ca2+](i) elevation consistent with capacitative Ca2+ influx. We have previously shown that 5,6-epoxyeicosatrienoic acid is synthesized and released by astrocytes, When 5,6-epoxyeicosatrienoic acid was applied to the rat brain surface, it induced vasodilation, suggesting that calcium influx factor may also serve a paracrine function. In summary, our results suggest that 5,6-epoxyeicosatrienoic acid may be a component of calcium influx factor and may participate in regulation of cerebral vascular tone.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Univ Texas, SW Med Ctr, Dept Biochem & Pharmacol, Dallas, TX 75235 USA	Virginia Commonwealth University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Rzigalinski, BA (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, POB 980613, Richmond, VA 23298 USA.	brzigali@hsc.vcu.edu	Hoffman, Stuart/CAF-7908-2022	Falck, John/0000-0002-9219-7845	NHLBI NIH HHS [HL-57869] Funding Source: Medline; NINDS NIH HHS [NS-07288, NS-27214] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027214] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alkayed NJ, 1996, AM J PHYSIOL-HEART C, V271, pH1541, DOI 10.1152/ajpheart.1996.271.4.H1541; Alkayed NJ, 1997, STROKE, V28, P1066, DOI 10.1161/01.STR.28.5.1066; ALONSO MT, 1991, BIOCHEM J, V280, P783, DOI 10.1042/bj2800783; ALVAREZ J, 1992, J BIOL CHEM, V267, P11789; AMRUTHESH SC, 1992, J NEUROCHEM, V58, P503, DOI 10.1111/j.1471-4159.1992.tb09749.x; AMRUTHESH SC, 1993, J NEUROCHEM, V61, P150, DOI 10.1111/j.1471-4159.1993.tb03550.x; BAEZ SILVIO, 1966, J APPL PHYSIOL, V21, P299; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; CAPDEVILA J, 1988, ARCH BIOCHEM BIOPHYS, V261, P257, DOI 10.1016/0003-9861(88)90340-2; CHEN G, 1991, AM J PHYSIOL, V260, pH1888, DOI 10.1152/ajpheart.1991.260.6.H1888; FASOLATO C, 1993, J BIOL CHEM, V268, P20737; FASOLATO C, 1994, TRENDS PHARMACOL SCI, V15, P77, DOI 10.1016/0165-6147(94)90282-8; FITZPATRICK FA, 1989, PHARMACOL REV, V40, P229; GARLAND CJ, 1995, TRENDS PHARMACOL SCI, V16, P23, DOI 10.1016/S0165-6147(00)88969-5; GEBREMEDHIN D, 1992, AM J PHYSIOL, V263, pH519, DOI 10.1152/ajpheart.1992.263.2.H519; GRAIER WF, 1995, J PHYSIOL-LONDON, V482, P259, DOI 10.1113/jphysiol.1995.sp020515; HARDER DR, 1995, J VASC RES, V32, P79, DOI 10.1159/000159080; HARDER DR, 1994, AM J PHYSIOL, V266, pH2098, DOI 10.1152/ajpheart.1994.266.5.H2098; HARDER DR, 1991, BLOOD VESSELS, V28, P290; HECKER M, 1994, J PHYSIOL-LONDON, V481, P407, DOI 10.1113/jphysiol.1994.sp020449; Hoebel BG, 1997, BRIT J PHARMACOL, V121, P1579, DOI 10.1038/sj.bjp.0701304; Hoffman SW, 1997, STROKE, V28, P844, DOI 10.1161/01.STR.28.4.844; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Komalavilas P, 1996, J BIOL CHEM, V271, P21933, DOI 10.1074/jbc.271.36.21933; KOSTYUK P, 1994, NEUROSCIENCE, V63, P381, DOI 10.1016/0306-4522(94)90537-1; LAMB RG, 1997, J NEUROCHEM, V68, P289; Leffler CW, 1997, AM J PHYSIOL-HEART C, V273, pH333, DOI 10.1152/ajpheart.1997.273.1.H333; MADHUN ZT, 1991, J CLIN INVEST, V88, P456, DOI 10.1172/JCI115325; MALCOLM KC, 1992, J BIOL CHEM, V267, P19854; MCGIFF JC, 1991, ANNU REV PHARMACOL, V31, P339, DOI 10.1146/annurev.pa.31.040191.002011; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; MOCHIZUKIODA N, 1993, J NEUROCHEM, V61, P1882, DOI 10.1111/j.1471-4159.1993.tb09830.x; NAGAO T, 1992, J PHYSL, V56, P170; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; Petersen OH, 1996, NEWS PHYSIOL SCI, V11, P13; POENIE M, 1990, CELL CALCIUM, V11, P85, DOI 10.1016/0143-4160(90)90062-Y; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; RIENDEAU D, 1994, J BIOL CHEM, V269, P15619; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Rzigalinski BA, 1996, BBA-LIPID LIPID MET, V1299, P342, DOI 10.1016/0005-2760(95)00224-3; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; RZIGALINSKI BA, 1997, J CEREB BLOOD FLO S1, V17, pS717; SHAH J, 1988, BIOCHEM J, V250, P617, DOI 10.1042/bj2500617; SHIVACHAR AC, 1995, J NEUROCHEM, V65, P338; SHUTTLEWORTH TJ, 1992, CELL CALCIUM, V13, P541, DOI 10.1016/0143-4160(92)90034-P; THASTRUP O, 1994, AGENTS ACTIONS, V43, P187, DOI 10.1007/BF01986687; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; TUCKER RW, 1990, CELL CALCIUM, V11, P201, DOI 10.1016/0143-4160(90)90071-2; Wang MH, 1998, J PHARMACOL EXP THER, V284, P966; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; [No title captured]	55	117	122	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					175	182		10.1074/jbc.274.1.175	http://dx.doi.org/10.1074/jbc.274.1.175			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867827	hybrid			2022-12-27	WOS:000077900200027
J	Chen, YH; Sinha, K; Perumal, K; Gu, J; Reddy, R				Chen, YH; Sinha, K; Perumal, K; Gu, J; Reddy, R			Accurate 3 ' end processing and adenylation of human signal recognition particle RNA and Alu RNA in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEAR-RNA; PROTEIN TRANSLOCATION; 7SL RNA; ENDOPLASMIC-RETICULUM; ELONGATION ARREST; SEQUENCE; DNA; PRECURSORS; BINDING; SRP9/14	Human signal recognition particle (SRP) RNA is transcribed by RNA polymerase III and terminates with -GU-CUCUCTUUOH on its 3' end. Our previous studies showed that the three terminal uridylic acid residues of human SRP RNA are post-transcriptionally removed and a single adenylic acid residue is added, resulting in a 3' end sequence of-GUCUCUA(OH) (Sinha, K.M., Gu, J., Chen. Y., and Reddy, R. (1998) J. Biol, Chem, 273, 6853-6859), In this study we show that the Alu RNA, corresponding to the 5' and 3' ends of SRP RNA, is also accurately processed and adenylated in vitro. Alu RNAs containing 7 or II additional nucleotides on the 3' end were accurately processed and then adenylated, Deletion analysis showed that an 87-nucleotide-long motif comprising of the 5' and 3' ends, including stem IV of the Alu RNA, is sufficient and necessary for the 3' end processing and adenylation, A 73-nucleotide-long construct with deletion of stem IV, required for the binding of SRP 9/14-kDa proteins, was neither processed nor adenylated, The adenylated Alu RNA as well as adenylated SRP RNA were bound to the SRP 9/14-kDa heterodimer and were immunoprecipitated by specific antibodies. A significant fraction of SRP RNA in the nucleoli was found to be processed and adenylated. These data are consistent with nascent SRP and/or Alu RNAs first binding to SRP 9/14-kDa protein heterodimer, followed by the removal of extra sequence on the 3' end and then the addition of one adenylic acid residue in the nucleus, before transport into the cytoplasm.	Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine	Reddy, R (corresponding author), Baylor Coll Med, Dept Pharmacol, 1 Baylor Plaza, Houston, TX 77030 USA.	rreddy@bcm.tmc.edu	Gu, Jian/Q-4780-2018	Gu, Jian/0000-0003-3499-0973	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052901] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-52901] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birse DEA, 1997, EMBO J, V16, P3757, DOI 10.1093/emboj/16.13.3757; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; DEVEGVAR HEN, 1990, MOL CELL BIOL, V10, P3365, DOI 10.1128/MCB.10.7.3365; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FISCHER U, 1991, J CELL BIOL, V113, P705, DOI 10.1083/jcb.113.4.705; Gu J, 1997, J BIOL CHEM, V272, P21989, DOI 10.1074/jbc.272.35.21989; GUNDELFINGER ED, 1983, NUCLEIC ACIDS RES, V11, P7363, DOI 10.1093/nar/11.21.7363; HERNANDEZ N, 1985, EMBO J, V4, P1827, DOI 10.1002/j.1460-2075.1985.tb03857.x; Huang Q, 1997, MOL CELL BIOL, V17, P7178, DOI 10.1128/MCB.17.12.7178; Jacobson MR, 1998, P NATL ACAD SCI USA, V95, P7981, DOI 10.1073/pnas.95.14.7981; KLEINSCHMIDT AM, 1987, MOL CELL BIOL, V7, P3131, DOI 10.1128/MCB.7.9.3131; LI WY, 1982, J BIOL CHEM, V257, P5136; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; MADORE SJ, 1984, J CELL BIOL, V99, P1140, DOI 10.1083/jcb.99.3.1140; NG DTW, 1994, CURR OPIN CELL BIOL, V6, P510, DOI 10.1016/0955-0674(94)90069-8; PARKER KA, 1989, METHOD ENZYMOL, V180, P454; Powers T, 1996, NATURE, V381, P191, DOI 10.1038/381191a0; ROTHBLUM LI, 1977, BIOCHEMISTRY-US, V16, P4716, DOI 10.1021/bi00640a028; Sarrowa J, 1997, MOL CELL BIOL, V17, P1144, DOI 10.1128/MCB.17.3.1144; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIEGEL V, 1988, TRENDS BIOCHEM SCI, V13, P314, DOI 10.1016/0968-0004(88)90127-2; SIEGEL V, 1985, J CELL BIOL, V100, P1913, DOI 10.1083/jcb.100.6.1913; Silberklang M, 1979, Methods Enzymol, V59, P58; Sinha KM, 1998, J BIOL CHEM, V273, P6853, DOI 10.1074/jbc.273.12.6853; STEITZ JA, 1989, METHOD ENZYMOL, V180, P468; STRUB K, 1991, MOL CELL BIOL, V11, P3949, DOI 10.1128/MCB.11.8.3949; ULLU E, 1984, EMBO J, V3, P3303, DOI 10.1002/j.1460-2075.1984.tb02294.x; ULLU E, 1982, NUCLEIC ACIDS RES, V10, P2209, DOI 10.1093/nar/10.7.2209; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; ULLU E, 1982, CELL, V29, P195, DOI 10.1016/0092-8674(82)90103-9; WALTER P, 1983, J CELL BIOL, V97, P1693, DOI 10.1083/jcb.97.6.1693; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Weichenrieder O, 1997, RNA, V3, P1262; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WEINER AM, 1980, CELL, V22, P209, DOI 10.1016/0092-8674(80)90169-5; WENDELBURG BJ, 1992, MOL CELL BIOL, V12, P4132, DOI 10.1128/MCB.12.9.4132; WIEBEN ED, 1985, J MOL BIOL, V183, P69, DOI 10.1016/0022-2836(85)90281-5; WOLIN SL, 1989, J CELL BIOL, V109, P2617, DOI 10.1083/jcb.109.6.2617; XE XP, 1994, J CELL SCI, V107, P903; YANG H, 1992, MOL CELL BIOL, V12, P1553, DOI 10.1128/MCB.12.4.1553; ZIEVE G, 1977, BIOCHEMISTRY-US, V16, P4520, DOI 10.1021/bi00639a029; ZIEVE GW, 1988, J MOL BIOL, V199, P259, DOI 10.1016/0022-2836(88)90312-9	43	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35023	35031		10.1074/jbc.273.52.35023	http://dx.doi.org/10.1074/jbc.273.52.35023			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857035	hybrid			2022-12-27	WOS:000077719700053
J	Silverman, MA; Benard, O; Jaaro, H; Rattner, A; Citri, Y; Seger, R				Silverman, MA; Benard, O; Jaaro, H; Rattner, A; Citri, Y; Seger, R			CPG16, a novel protein serine/threonine kinase downstream of cAMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; ACTIVATION; CELLS; GENES; CREB; LTP	Gene expression is necessary for the formation and consolidation of long term memory in both Invertebrates and vertebrates. Here, we describe the expression and characterization of candidate plasticity gene 16 (cpg16), a protein serine/threonine kinase that was previously isolated from rat hippocampus as a plasticity-related gene. CPG16, when expressed in and purified from bacteria and COS7 cells, was only capable of autophosphorylation and phosphorylation of myelin basic protein but failed to phosphorylate many other peptides and proteins in in vitro phosphorylation assays. Recombinant CPG16, when overexpressed and purified from COS7 cells, had a relatively low level of autophosphorylation activity. This activity was significantly stimulated when cAMP-elevating agents (forskolin, 8-bromo-cAMP) were added to the cells but not by any other extracellular stimuli tested, e.g. serum, phorbol esters, and a calcium ionophore, Although the stimulation of CPG16 activity was inhibited by the cAMP-dependent protein kinase inhibitor H-89, it did not serve as a direct substrate for this kinase, This suggests that CPG16 may be activated by a cAMP-stimulated protein kinase cascade. Immunolocalization studies in COS7 and NIH-3T3 cells showed mostly cytoplasmic localization of CPG16 that turned partially nuclear upon stimulation with 8-bromo-cAMP. Moreover, overexpression of CPG16 seems to partially inhibit cAMP-stimulated activity of the transcription factor CREB (cAMP response element-binding protein), suggesting its involvement in the down-regulation of cAMP-induced transcription. Thus, CPG16 is a protein serine/threonine kinase that may be involved in a novel signaling pathway downstream of cAMP dependent protein kinase.	Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Seger, R (corresponding author), Oregon Hlth & Sci Univ, CROET, L606,3181 SW Sam Jackson Rd, Portland, OR 97201 USA.	bmseger@weizmann.weizmann.ac.il	Jaaro-Peled, Hanna/D-1046-2012	Jaaro-Peled, Hanna/0000-0002-8950-391X; Silverman, Michael A./0000-0001-6967-4917; Rattner, Amir/0000-0001-9542-6212				Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; des Portes V, 1998, CELL, V92, P51; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hevroni D, 1998, J MOL NEUROSCI, V10, P75, DOI 10.1007/BF02737120; HUNTER T, 1991, METHOD ENZYMOL, V200, P3; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; Johnson LN, 1997, ADV SEC MESS PHOSPH, V31, P11; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KEOWN WA, 1990, METHOD ENZYMOL, V185, P527, DOI 10.1016/0076-6879(90)85043-N; Levi NL, 1998, MOL ENDOCRINOL, V12, P815, DOI 10.1210/me.12.6.815; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Sadot E, 1998, J NEUROCHEM, V70, P428; SEGER R, 1994, J BIOL CHEM, V269, P25699; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240	28	51	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2631	2636		10.1074/jbc.274.5.2631	http://dx.doi.org/10.1074/jbc.274.5.2631			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915791	hybrid			2022-12-27	WOS:000078319500009
J	Gao, TY; Chien, AJ; Hosey, MM				Gao, TY; Chien, AJ; Hosey, MM			Complexes of the alpha(1C) and beta subunits generate the necessary signal for membrane targeting of class C L-type calcium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNELS; SH3 DOMAIN; IDENTIFICATION; ROLES; ALPHA(1)-SUBUNIT; DIHYDROPYRIDINE; ALPHA(2)DELTA; EXPRESSION; INCREASES; RECEPTOR	In the present study, we investigated the role of channel subunits in the membrane targeting of voltage-dependent L-type calcium channel complexes. We co-expressed the calcium channel pore-forming alpha(1C) Subunit with different accessory beta subunits in HEK-tsA201 cells and examined the subcellular localization of the channel subunits by immunohistochemistry using confocal microscopy and whole-cell radioligand binding studies. While the pore-forming alpha(1C) subunit exhibited perinuclear staining when expressed alone, and several of the wild-type and mutant beta subunits also exhibited intracellular staining, co-expression of the alpha(1C) subunit with either the wild-type beta(2a) subunit, a palmitoylation-deficient beta(2a)(C3S/C4S) mutant or three other nonpalmitoylated beta isoforms (beta(1b), beta(3), and beta(4) subunits) resulted in the redistribution of both the alpha(1C) and beta subunits into clusters along the cell surface. Furthermore, the redistribution of calcium channel complexes to the plasma membrane was observed when alpha(1C) was co-expressed with an N- and C-terminal truncated mutant beta(2a) containing only the central conserved regions. However, when the alpha(1C) subunit was co-expressed with an alpha(1)beta interaction-deficient mutant, beta(2a)BID(-), we did not observe formation of the channels at the plasma membrane. In addition, an Src homology 3 motif mutant of beta(2a) that was unable to interact with the alpha(1C) subunit also failed to target channel complexes to the plasma membrane. Interestingly, co-expression of the pore-forming alpha(1C) subunit with the largely peripheral accessory alpha(2)delta subunit was ineffective in recruiting alpha(1C) to the plasma membrane, while codistribution of all three subunits was observed when beta(2a) was co-expressed with the alpha(1C) and alpha(2)delta subunits, Taken together, our results suggested that the signal necessary for correct plasma membrane targeting of the class C L-type calcium channel complexes is generated as a result of a functional interaction between the alpha(1) and beta subunits.	Northwestern Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Chicago, IL 60611 USA	Northwestern University	Hosey, MM (corresponding author), Northwestern Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, 303 E Chicago Ave,S215, Chicago, IL 60611 USA.				NHLBI NIH HHS [HL23306] Funding Source: Medline; NIMH NIH HHS [MH10770] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL023306, R37HL023306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH010770] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; BRUST PF, 1993, NEUROPHARMACOLOGY, V32, P1089, DOI 10.1016/0028-3908(93)90004-M; CARL SL, 1995, J CELL BIOL, V129, P673, DOI 10.1083/jcb.129.3.673; Chien AJ, 1998, J BIOL CHEM, V273, P23590, DOI 10.1074/jbc.273.36.23590; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; De Waard M, 1996, Ion Channels, V4, P41; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gurnett CA, 1997, J BIOL CHEM, V272, P18508, DOI 10.1074/jbc.272.29.18508; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; Hosey MM, 1996, TRENDS CARDIOVAS MED, V6, P265, DOI 10.1016/S1050-1738(96)00109-0; Josephson IR, 1996, BIOPHYS J, V70, P1285, DOI 10.1016/S0006-3495(96)79685-6; Kamp TJ, 1996, J PHYSIOL-LONDON, V492, P89, DOI 10.1113/jphysiol.1996.sp021291; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; MITTERDORFER J, 1994, FEBS LETT, V352, P141, DOI 10.1016/0014-5793(94)00938-4; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PEREZREYES E, 1995, KIDNEY INT, V48, P1111, DOI 10.1038/ki.1995.395; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Puri TS, 1997, BIOCHEMISTRY-US, V36, P9605, DOI 10.1021/bi970500d; QIN N, 1998, BIOPHYS J, V74, P102; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; VANDAELE S, 1987, BIOCHEMISTRY-US, V26, P5, DOI 10.1021/bi00375a002; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YU HT, 1992, SCIENCE, V258, P1665, DOI 10.1126/science.1280858	29	102	106	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2137	2144		10.1074/jbc.274.4.2137	http://dx.doi.org/10.1074/jbc.274.4.2137			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890976	hybrid			2022-12-27	WOS:000078185200043
J	Booden, MA; Baker, TL; Solski, PA; Der, CJ; Punke, SG; Buss, JE				Booden, MA; Baker, TL; Solski, PA; Der, CJ; Punke, SG; Buss, JE			A non-farnesylated Ha-Ras protein can be palmitoylated and trigger potent differentiation and transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE LOCALIZATION; NERVE GROWTH-FACTOR; POLYBASIC DOMAIN; NEURONAL DIFFERENTIATION; PHEOCHROMOCYTOMA CELLS; PC12 CELLS; BINDING; PRENYLATION; P21RAS; RAF-1	Ha-Ras undergoes post-translational modifications (including attachment of farnesyl and palmitate) that culminate in localization of the protein to the plasma membrane. Because palmitate is not attached without prior farnesyl addition, the distinct contributions of the two lipid modifications to membrane attachment or biological activity have been difficult to examine. To test if palmitate is able to support these crucial functions on its own, novel C terminal mutants of Ha-Ras were constructed, retaining the natural sites for palmitoylation, but replacing the C-terminal residue of the CAAX signal for prenylation with six lysines, Both the Ext61L and ExtWT proteins were modified in a dynamic fashion by palmitate, without being farnesylated; bound to membranes modestly (40% as well as native Ha-Ras); and retained appropriate GTP binding properties. Ext61L caused potent transformation of NIH 3T3 cells and, unexpectedly, an exaggerated differentiation of PC12 cells, Ext61L with the six lysines but lacking palmitates was inactive. Thus, farnesyl is not needed as a signal for palmitate attachment or removal, and a combination of transient palmitate modification and basic residues can support Ha-Ras membrane binding and two quite different biological functions. The roles of palmitate can therefore be independent of and distinct from those of farnesyl. Reciprocally, if membrane association can be sustained largely through palmitates, farnesyl is freed to interact with other proteins.	Iowa State Univ, Dept Biochem, Ames, IA 50011 USA; Iowa State Univ, Dept Zool & Genet, Ames, IA 50011 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	Iowa State University; Iowa State University; University of North Carolina; University of North Carolina Chapel Hill	Buss, JE (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 3212 Mol Biol Bldg, Ames, IA 50011 USA.			Buss, Janice/0000-0002-8086-265X; Der, Channing/0000-0002-7751-2747	NCI NIH HHS [CA51890] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA051890] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; BHATTACHARYA S, 1995, P NATL ACAD SCI USA, V92, P2984, DOI 10.1073/pnas.92.7.2984; BUSS JE, 1989, SCIENCE, V243, P1600, DOI 10.1126/science.2648572; BUSS JE, 1986, MOL CELL BIOL, V6, P116, DOI 10.1128/MCB.6.1.116; CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P3323; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; DARCANGELO G, 1993, MOL CELL BIOL, V13, P3146, DOI 10.1128/MCB.13.6.3146; Drugan JK, 1996, J BIOL CHEM, V271, P233, DOI 10.1074/jbc.271.1.233; Dudler T, 1996, J BIOL CHEM, V271, P11541, DOI 10.1074/jbc.271.19.11541; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; GHOMASHCHI F, 1995, BIOCHEMISTRY-US, V34, P11910, DOI 10.1021/bi00037a032; GIBBS JB, 1993, J BIOL CHEM, V268, P7617; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Hu CD, 1995, J BIOL CHEM, V270, P30274, DOI 10.1074/jbc.270.51.30274; JACKSON JH, 1994, P NATL ACAD SCI USA, V91, P12730, DOI 10.1073/pnas.91.26.12730; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; KATO K, 1992, P NATL ACAD SCI USA, V89, P6403, DOI 10.1073/pnas.89.14.6403; KOHL NE, 1994, P NATL ACAD SCI USA, V91, P9141, DOI 10.1073/pnas.91.19.9141; KURODA Y, 1993, SCIENCE, V259, P683, DOI 10.1126/science.8430318; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; Liu L, 1996, J BIOL CHEM, V271, P23269, DOI 10.1074/jbc.271.38.23269; Luo ZJ, 1997, MOL CELL BIOL, V17, P46, DOI 10.1128/MCB.17.1.46; MITCHELL DA, 1994, J BIOL CHEM, V269, P21540; MUMBY S M, 1990, Methods (Orlando), V1, P216, DOI 10.1016/S1046-2023(05)80320-2; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; PORFIRI E, 1994, J BIOL CHEM, V269, P22672; Roy S, 1997, J BIOL CHEM, V272, P20139, DOI 10.1074/jbc.272.32.20139; Schroeder H, 1997, BIOCHEMISTRY-US, V36, P13102, DOI 10.1021/bi9709497; Siddiqui AA, 1998, J BIOL CHEM, V273, P3712, DOI 10.1074/jbc.273.6.3712; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; Willumsen BM, 1996, ONCOGENE, V13, P1901; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	40	55	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1423	1431		10.1074/jbc.274.3.1423	http://dx.doi.org/10.1074/jbc.274.3.1423			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880516	hybrid, Green Published			2022-12-27	WOS:000079956900036
J	Dunham, TD; Farrens, DL				Dunham, TD; Farrens, DL			Conformational changes in rhodopsin - Movement of helix F detected by site-specific chemical labeling and fluorescence spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; TRANSMEMBRANE HELICES; SIGNAL-TRANSDUCTION; CYTOPLASMIC LOOPS; ACTIVATION; CYSTEINE; MUTANTS; MUTATION; REGION; RELEASE	A recent proposal for the formation of functionally active rhodopsin has placed critical importance on a movement of one of its transmembrane helices (Farrens, D. L., Altenbach, C., Yang, K., Hubbell, W. L., and Khorana, H. G. (1996) Science 274, 768-770), We investigated this hypothesis using a series of eight rhodopsin mutants containing single reactive cysteine residues in the region (helix F) where movement was previously detected. The cysteine mutants were studied in two ways, by measuring their reactivity to a cysteine-specific reagent (PyMPO-maleimide), and by labeling the cysteines with a fluorescent label (monobromobimane) followed by fluorescence spectroscopic analysis. The chemical reactivity data showed sequence-specific variations in reactivity for the mutants in the dark state, resulting in a pattern suggestive of an cu helix. Interestingly, only upon photoactivation to the MII form did residues found on the inner "face" of this helix react with the PyMPO-maleimide. The ability of the dark state mutants to react with the fluorescent label monobromobimane followed a similar pattern, Furthermore, fluorescence measurements indicate that a bimane label on the inner face of the helix (at V250C) detects changes in the polarity of its environment and accessibility to a fluorescence quenching agent upon MII formation. Viewed together, the data provide further direct evidence that rhodopsin activation involves a conformational change at helix F.	Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University	Farrens, DL (corresponding author), Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Dr, Portland, OR 97201 USA.				NEI NIH HHS [R01 EY12095-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012095] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acharya S, 1996, J BIOL CHEM, V271, P25406, DOI 10.1074/jbc.271.41.25406; Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Butler SL, 1998, BIOCHEMISTRY-US, V37, P10746, DOI 10.1021/bi980607g; Cai KW, 1997, P NATL ACAD SCI USA, V94, P14267, DOI 10.1073/pnas.94.26.14267; ERNST OP, 1995, J BIOL CHEM, V270, P10580, DOI 10.1074/jbc.270.18.10580; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P8812, DOI 10.1021/bi00027a033; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; JAVITCH JA, 1994, P NATL ACAD SCI USA, V91, P10355, DOI 10.1073/pnas.91.22.10355; KARNIK SS, 1993, P NATL ACAD SCI USA, V90, P40, DOI 10.1073/pnas.90.1.40; KHORANA HG, 1992, J BIOL CHEM, V267, P1; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Konopka JB, 1996, P NATL ACAD SCI USA, V93, P6764, DOI 10.1073/pnas.93.13.6764; KOSOWER EM, 1986, J PHYS CHEM-US, V90, P5552, DOI 10.1021/j100280a014; Kostenis E, 1997, BIOCHEMISTRY-US, V36, P1487, DOI 10.1021/bi962554d; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LIU J, 1995, P NATL ACAD SCI USA, V92, P11642, DOI 10.1073/pnas.92.25.11642; Liu J, 1996, J BIOL CHEM, V271, P6172, DOI 10.1074/jbc.271.11.6172; OLIVEIRA L, 1994, TRENDS PHARMACOL SCI, V15, P170, DOI 10.1016/0165-6147(94)90137-6; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Pogozheva ID, 1997, BIOPHYS J, V72, P1963, DOI 10.1016/S0006-3495(97)78842-8; RESEK JF, 1993, BIOCHEMISTRY-US, V32, P12025, DOI 10.1021/bi00096a012; RESEK JF, 1994, P NATL ACAD SCI USA, V91, P7643, DOI 10.1073/pnas.91.16.7643; RIDGE KD, 1995, BIOCHEMISTRY-US, V34, P8804, DOI 10.1021/bi00027a032; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Yang K, 1996, BIOCHEMISTRY-US, V35, P12464, DOI 10.1021/bi960848t; ZHANG DQ, 1993, J MED CHEM, V36, P934, DOI 10.1021/jm00059a021	35	156	158	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1683	1690		10.1074/jbc.274.3.1683	http://dx.doi.org/10.1074/jbc.274.3.1683			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880548	hybrid			2022-12-27	WOS:000079956900068
J	Hall, MC; Matson, SW				Hall, MC; Matson, SW			The Escherichia coli MutL protein physically interacts with MutH and stimulates the MutH-associated endonuclease activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTED MISMATCH REPAIR; GENE-PRODUCT; HELICASE-II; INVITRO; REQUIREMENT; PMS1	All possible pairwise combinations of UvrD, MutL, MutS, and MutH were tested using the yeast two-hybrid system to identify potential interactions involving mismatch repair proteins. A two-hybrid screen previously identified a physical interaction between MutL and UvrD. Although several other known interactions were not observed, a novel interaction between MutL and MutH was detected. A series of truncations from the NH2 and COOH termini of MutL demonstrated that the COOH-terminal 218 amino acids were sufficient for the two hybrid interaction with MutH. Removal of a small number of residues from either the NH2 or COOH termini of MutH eliminated the two-hybrid interaction with MutL. Protein affinity chromatography experiments confirmed that MutL, but not MutS, physically associates with MutH. Furthermore, MutL greatly stimulated the d(GATC)-specific endonuclease activity of MutH in the absence of MutS and a mispaired base. Stimulation of the MutH-associated endonuclease activity by MutL was dependent on ATP binding but not ATP hydrolysis. Further stimulation of this reaction by MutS required the presence of a DNA mismatch and a hydrolyzable form of ATP. These results suggest that MutL activates the MutH associated endonuclease activity through a physical interaction during methyl-directed mismatch repair in Escherichia coli.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Matson, SW (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.		Hall, Mark C./D-1698-2011	Hall, Mark/0000-0001-6429-2506	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033476] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-33476] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AU KG, 1992, J BIOL CHEM, V267, P12142; Ausubel FM, 1995, CURRENT PROTOCOLS MO, V1; COOPER DL, 1993, J BIOL CHEM, V268, P11823; Dao V, 1998, J BIOL CHEM, V273, P9202, DOI 10.1074/jbc.273.15.9202; FISCHER H, 1980, J BIOL CHEM, V255, P7956; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; GRILLEY M, 1993, J BIOL CHEM, V268, P11830; Hall MC, 1998, EMBO J, V17, P1535, DOI 10.1093/emboj/17.5.1535; KAISERROGERS KA, 1991, THESIS U N CAROLINA, P66; KRAMER W, 1989, J BACTERIOL, V171, P5339, DOI 10.1128/jb.171.10.5339-5346.1989; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LU AL, 1983, P NATL ACAD SCI-BIOL, V80, P4639, DOI 10.1073/pnas.80.15.4639; MENDONCA VM, 1993, J BACTERIOL, V175, P461; Miller JH, 1972, EXPT MOL GENETICS, P201; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; NEVERS P, 1975, MOL GEN GENET, V139, P233, DOI 10.1007/BF00268974; PROLLA TA, 1994, MOL CELL BIOL, V14, P407, DOI 10.1128/MCB.14.1.407; PUKKILA PJ, 1983, GENETICS, V104, P571; Sambrook J., 2002, MOL CLONING LAB MANU; SANCAR A, 1993, SCIENCE, V259, P1415, DOI 10.1126/science.8451638; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; SU SS, 1988, J BIOL CHEM, V263, P6829; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; WELSH KM, 1987, J BIOL CHEM, V262, P15624; Worth L, 1998, J BIOL CHEM, V273, P23176, DOI 10.1074/jbc.273.36.23176; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197	27	132	135	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1306	1312		10.1074/jbc.274.3.1306	http://dx.doi.org/10.1074/jbc.274.3.1306			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880500	Green Published, hybrid			2022-12-27	WOS:000079956900020
J	Motoya, S; Kitamura, K; Matsuda, A; Maizel, AL; Yamamoto, H; Takeda, A				Motoya, S; Kitamura, K; Matsuda, A; Maizel, AL; Yamamoto, H; Takeda, A			Interaction between CD45-AP and protein-tyrosine kinases involved in T cell receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN RECEPTOR; PHOSPHOTYROSINE PHOSPHATASE; LYMPHOCYTE DEVELOPMENT; MICE LACKING; ZETA-CHAIN; ZAP-70; LCK; ACTIVATION; PHOSPHORYLATION; P56(LCK)	CD45-AP associates specifically with CD45, a protein-tyrosine phosphatase essential for antigen receptor mediated signal transduction CD45 modulates the activity of Src family protein-tyrosine kinases involved at the onset of antigen receptor-mediated signaling by dephosphorylating their regulatory tyrosyl residues. We have shown that lymphocyte responses to antigen receptor stimulation are impaired in CD45-AP-null mice. To examine the possibility that CD45-AP coordinates the interaction between CD45 and its substrates, we investigated the associations of CD45-AP with several protein tyrosine kinases. Endogenous CD45-AP coimmunoprecipitated with Lck and ZAP-70 in both CD45-positive T cells and their CD45-negative variants after stimulation by antigen receptor ligation, Concomitantly, CD45 coimmunoprecipitated with Lck and ZAP-70 after T cell receptor-mediated stimulation of CD45-positive cells. Recombinant CD45-AP exhibited specific binding to Lck and ZAP-70 protein tyrosine kinases, but not to Fyn or Csk, in lysates of both CD45 positive and -negative T cells. Specific interactions were demonstrated between the respective recombinant proteins as well. These results demonstrate that CD45-AP associates directly and selectively with Lck and ZAP-70 in response to T cell receptor-mediated stimulation The associations of CD45-AP with Lck and ZAP-70 may mediate the functional interactions of these kinases with CD45 during antigen receptor stimulation.	Boston Univ, Roger Williams Med Ctr, Dept Pathol, Providence, RI 02908 USA	Boston University; Roger Williams Medical Center	Takeda, A (corresponding author), Boston Univ, Roger Williams Med Ctr, Dept Pathol, 825 Chalkstone Ave, Providence, RI 02908 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048188] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 48188] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; BURNS CM, 1994, J BIOL CHEM, V269, P13594; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1994, J IMMUNOL, V152, P4758; Doro U, 1996, MOL CELL BIOL, V16, P4996; DUPLAY P, 1994, J EXP MED, V179, P1163, DOI 10.1084/jem.179.4.1163; FURUKAWA T, 1994, P NATL ACAD SCI USA, V91, P10928, DOI 10.1073/pnas.91.23.10928; Gervais FG, 1997, J BIOL CHEM, V272, P12754, DOI 10.1074/jbc.272.19.12754; GERVAIS FG, 1995, MOL CELL BIOL, V15, P2393; Goldman F, 1997, J IMMUNOL, V158, P2017; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; HAUGHN L, 1992, NATURE, V358, P328, DOI 10.1038/358328a0; HURLEY TR, 1993, MOL CELL BIOL, V13, P1651, DOI 10.1128/MCB.13.3.1651; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KITAMURA K, 1995, J BIOL CHEM, V270, P21151, DOI 10.1074/jbc.270.36.21151; KITAMURA K, 1997, EUR J IMMUNOL, V27, P388; Kong GH, 1996, MOL CELL BIOL, V16, P5026; LEE O, 1987, P NATL ACAD SCI USA, V84, P1374; Matsuda A, 1998, J EXP MED, V187, P1863, DOI 10.1084/jem.187.11.1863; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; MUSTELIN T, 1994, IMMUNITY, V1, P351, DOI 10.1016/1074-7613(94)90065-5; MUSTELIN T, 1995, EUR J IMMUNOL, V25, P942, DOI 10.1002/eji.1830250413; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; MUSTELIN T, 1992, EUR J IMMUNOL, V22, P1173, DOI 10.1002/eji.1830220510; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; Ng DHW, 1996, J BIOL CHEM, V271, P1295, DOI 10.1074/jbc.271.3.1295; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; ROSS SE, 1994, BIOCHEM BIOPH RES CO, V198, P88, DOI 10.1006/bbrc.1994.1013; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; RUDD CE, 1994, IMMUNOL TODAY, V15, P225, DOI 10.1016/0167-5699(94)90248-8; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; SCHRAVEN B, 1994, J BIOL CHEM, V269, P29102; Shimizu Y, 1997, AM J HEMATOL, V54, P1, DOI 10.1002/(SICI)1096-8652(199701)54:1<1::AID-AJH1>3.0.CO;2-1; SHIROO M, 1992, EMBO J, V11, P4887, DOI 10.1002/j.1460-2075.1992.tb05595.x; SPRINGER T, 1978, EUR J IMMUNOL, V8, P539, DOI 10.1002/eji.1830080802; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; TAKEDA A, 1992, J BIOL CHEM, V267, P16651; TAKEDA A, 1994, J BIOL CHEM, V269, P2357; TING AT, 1995, J BIOL CHEM, V270, P16415, DOI 10.1074/jbc.270.27.16415; TONKS N K, 1988, Biochemistry, V27, P8695, DOI 10.1021/bi00424a001; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VOLAREVIC S, 1992, J EXP MED, V176, P835, DOI 10.1084/jem.176.3.835; WEIL R, 1995, J BIOL CHEM, V270, P2791, DOI 10.1074/jbc.270.6.2791; Yamasaki S, 1996, MOL CELL BIOL, V16, P7151; Zhang J, 1998, J IMMUNOL, V160, P1148; Zhao QH, 1996, MOL CELL BIOL, V16, P6765	52	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1407	1414		10.1074/jbc.274.3.1407	http://dx.doi.org/10.1074/jbc.274.3.1407			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880514	hybrid			2022-12-27	WOS:000079956900034
J	Pellacani, A; Chin, MT; Wiesel, P; Ibanez, M; Patel, A; Yet, SF; Hsieh, CM; Paulauskis, JD; Reeves, R; Lee, ME; Perrella, MA				Pellacani, A; Chin, MT; Wiesel, P; Ibanez, M; Patel, A; Yet, SF; Hsieh, CM; Paulauskis, JD; Reeves, R; Lee, ME; Perrella, MA			Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1 beta in vascular smooth muscle cells - Role in activation of inducible nitric oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IFN-BETA GENE; EPIDERMAL GROWTH-FACTOR; HMG-I/Y GENE; CHROMOSOMAL-PROTEINS; TRANSFORMING GROWTH-FACTOR-BETA-1; VIRUS INDUCTION; MESSENGER-RNA; INTERFERON GENE; SEPTIC SHOCK	Nonhistone chromosomal proteins of the high mobility group (HMG) affect the transcriptional regulation of certain mammalian genes. For example, HMG-I(Y) controls cytokine-mediated promoters that require transcription factors, such as nuclear factor-kappa B, for maximal expression. Even though a great deal is known about how HMG-I(Y) facilitates expression of other genes, less is known about the regulation of HMG-I(Y) itself, especially in cells in primary culture. Therefore we investigated the effect of endotoxin and the cytokine interleukin-1 beta on HMG-I(Y) expression in vascular smooth muscle cells. Induction of HMG-I(Y) peaked after 48 h of interleukin-1 beta stimulation (6.2-fold) in cells in primary culture, and this increase in mRNA corresponded to an increase in HMG-I(Y) protein. Moreover, immunohistochemical staining revealed a dramatic increase in HMG-I(Y) protein expression in vascular smooth muscle cells after endotoxin stimulation in vivo. This increase in HMG-I(Y) expression (both in vitro and in vivo) mirrored an up-regulation of inducible nitric oxide synthase, a cytokine-responsive gene. The functional significance of this coinduction is underscored by our finding that HMG-I(Y) potentiated the response of inducible nitric oxide synthase to nuclear factor-kappa B transactivation Taken together, these studies suggest that induction of HMG-I(Y), and subsequent transactivation of iNOS, may contribute to a reduction in vascular tone during endotoxemia and other systemic inflammatory processes.	Harvard Univ, Sch Publ Hlth, Cardiovasc Biol Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; Washington State Univ, Dept Biochem & Biophys, Pullman, WA 99164 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Washington State University	Perrella, MA (corresponding author), Harvard Univ, Sch Publ Hlth, Cardiovasc Biol Lab, 667 Huntington Ave, Boston, MA 02115 USA.		Yet, Shaw-Fang/B-1067-2010; Yet, Shaw-Fang/O-8583-2019	Yet, Shaw-Fang/0000-0001-9097-3962	NHLBI NIH HHS [HL03745, HL03194] Funding Source: Medline; NIGMS NIH HHS [GM53249] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053249] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEASLEY D, 1994, AM J PHYSIOL, V266, pR1197, DOI 10.1152/ajpregu.1994.266.4.R1197; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; BONE RC, 1992, JAMA-J AM MED ASSOC, V268, P3452, DOI 10.1001/jama.268.24.3452; BUSSEMAKERS MJG, 1991, CANCER RES, V51, P606; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; CHIAPPETTA G, 1995, ONCOGENE, V10, P1307; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; Fedele M, 1996, CANCER RES, V56, P1896; FEN Z, 1993, BIOCHEMISTRY-US, V32, P7932, DOI 10.1021/bi00082a014; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; GIANCOTTI V, 1993, EUR J BIOCHEM, V213, P825, DOI 10.1111/j.1432-1033.1993.tb17825.x; GIANCOTTI V, 1985, CANCER RES, V45, P6051; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; GROSSCHEDL R, 1995, CURR OPIN CELL BIOL, V7, P362, DOI 10.1016/0955-0674(95)80091-3; GUNTHER S, 1982, J CELL BIOL, V92, P289, DOI 10.1083/jcb.92.2.289; Holth LT, 1997, DNA CELL BIOL, V16, P1299, DOI 10.1089/dna.1997.16.1299; JOHNSON KR, 1990, EXP CELL RES, V187, P69, DOI 10.1016/0014-4827(90)90118-T; JOHNSON KR, 1988, J BIOL CHEM, V263, P18338; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; LEE ME, 1990, J BIOL CHEM, V265, P10446; LEWIS H, 1994, MOL CELL BIOL, V14, P5701, DOI 10.1128/MCB.14.9.5701; LUNDBERG K, 1989, BIOCHIM BIOPHYS ACTA, V1009, P277, DOI 10.1016/0167-4781(89)90113-9; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; OGRAM SA, 1995, J BIOL CHEM, V270, P14235, DOI 10.1074/jbc.270.23.14235; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; PERRELLA MA, 1994, J BIOL CHEM, V269, P14595; Perrella MA, 1996, J BIOL CHEM, V271, P13776, DOI 10.1074/jbc.271.23.13776; Perrella MA, 1996, P NATL ACAD SCI USA, V93, P2054, DOI 10.1073/pnas.93.5.2054; Pierce LM, 1996, TOXICOL APPL PHARM, V138, P1, DOI 10.1006/taap.1996.9999; REEVES R, 1990, J BIOL CHEM, V265, P8573; Sambrook J., 2002, MOL CLONING LAB MANU; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SIRSJO A, 1994, FEBS LETT, V338, P191, DOI 10.1016/0014-5793(94)80363-3; THANOS D, 1995, MOL CELL BIOL, V15, P152, DOI 10.1128/MCB.15.1.152; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; WEGNER M, 1990, BIOCHEM BIOPH RES CO, V166, P1110, DOI 10.1016/0006-291X(90)90981-R; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; WOOD LD, 1995, NUCLEIC ACIDS RES, V23, P4210, DOI 10.1093/nar/23.20.4210; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yet SF, 1998, J BIOL CHEM, V273, P10530, DOI 10.1074/jbc.273.17.10530; YOSHIZUMI M, 1995, MOL CELL BIOL, V15, P3266	52	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1525	1532		10.1074/jbc.274.3.1525	http://dx.doi.org/10.1074/jbc.274.3.1525			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880529	hybrid			2022-12-27	WOS:000079956900049
J	Dempsey, LA; Sun, H; Hanakahi, LA; Maizels, N				Dempsey, LA; Sun, H; Hanakahi, LA; Maizels, N			G4 DNA binding by LR1 and its subunits, nucleolin and hnRNP D, a role for G-G pairing in immunoglobulin switch recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUADRUPLEX NUCLEIC-ACIDS; YEAST GENE-PRODUCT; TELOMERIC DNA; G-QUARTET; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; BLOOMS-SYNDROME; RNA; PROTEIN; TRANSCRIPTION	The immunoglobulin heavy chain switch regions contain multiple runs of guanines on the top (nontemplate) DNA strand. Here we show that LR1, a B cell-specific, duplex DNA binding factor, binds tightly and specifically to synthetic oligonucleotides containing G-G base pairs (K-D less than or equal to 0.25 nM). LR1 also binds to single-stranded G-rich sequences (K-D approximate to 10 nM). The two subunits of LR1, nucleolin and hnRNP D, bind with high affinity to 64 DNA (K-D = 0.4 and 0.5 nM respectively). LR1 therefore contains two independent 64 DNA binding domains. We propose that LRI binds with G-G-paired structures that form during the transcription of the S regions that is prerequisite to recombination in vivo. Interactions of donor and acceptor S regions with subunits of the LR1 could then juxtapose the switch regions for recombination.	Yale Univ, Dept Biochem & Mol Biophys, New Haven, CT 06520 USA; Yale Univ, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University	Maizels, N (corresponding author), Yale Univ, Dept Biochem & Mol Biophys, 266 Whitney Ave, New Haven, CT 06520 USA.	nancy.maizels@yale.edu		Dempsey, Laurie/0000-0002-3304-796X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039799, F32GM015948] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM039799, R01 GM39799, GM15948] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761; BRYS A, 1994, P NATL ACAD SCI USA, V91, P4915, DOI 10.1073/pnas.91.11.4915; BULFONEPAUS S, 1995, P NATL ACAD SCI USA, V92, P8293, DOI 10.1073/pnas.92.18.8293; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; COBIANCHI F, 1993, NUCLEIC ACIDS RES, V21, P949, DOI 10.1093/nar/21.4.949; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Dempsey LA, 1998, GENOMICS, V49, P378, DOI 10.1006/geno.1998.5237; Dempsey LA, 1998, J BIOL CHEM, V273, P29224, DOI 10.1074/jbc.273.44.29224; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Ellis NA, 1996, HUM MOL GENET, V5, P1457, DOI 10.1093/hmg/5.Supplement_1.1457; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; FANG SH, 1993, EXP CELL RES, V208, P48, DOI 10.1006/excr.1993.1221; FRANTZ JD, 1995, J BIOL CHEM, V270, P9413, DOI 10.1074/jbc.270.16.9413; FRANTZ JD, 1995, J BIOL CHEM, V270, P20692, DOI 10.1074/jbc.270.35.20692; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2014; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; GIRALDO R, 1994, P NATL ACAD SCI USA, V91, P7658, DOI 10.1073/pnas.91.16.7658; GIRALDO R, 1994, EMBO J, V13, P2411, DOI 10.1002/j.1460-2075.1994.tb06526.x; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; Li MJ, 1997, MOL IMMUNOL, V34, P201, DOI 10.1016/S0161-5890(97)00028-X; LIU ZP, 1994, CELL, V77, P1083, DOI 10.1016/0092-8674(94)90447-2; LIU ZP, 1993, P NATL ACAD SCI USA, V90, P3157, DOI 10.1073/pnas.90.8.3157; LIU ZP, 1995, P NATL ACAD SCI USA, V92, P6002, DOI 10.1073/pnas.92.13.6002; Maxam A M, 1980, Methods Enzymol, V65, P499; MUNROE SH, 1992, P NATL ACAD SCI USA, V89, P895, DOI 10.1073/pnas.89.3.895; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; PONTIUS BW, 1990, P NATL ACAD SCI USA, V87, P8403, DOI 10.1073/pnas.87.21.8403; PORTMAN DS, 1994, EMBO J, V13, P213, DOI 10.1002/j.1460-2075.1994.tb06251.x; REABAN ME, 1994, J BIOL CHEM, V269, P21850; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; SEN D, 1992, BIOCHEMISTRY-US, V31, P65, DOI 10.1021/bi00116a011; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Shamoo Y, 1997, NAT STRUCT BIOL, V4, P215, DOI 10.1038/nsb0397-215; Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; SUNDQUIST WI, 1993, CURR BIOL, V3, P893, DOI 10.1016/0960-9822(93)90229-H; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; WEISMANSHOMER P, 1993, J BIOL CHEM, V268, P3306; WEISMANSHOMER P, 1994, BIOCHEM BIOPH RES CO, V205, P305, DOI 10.1006/bbrc.1994.2665; WILLIAMS M, 1991, GENE DEV, V5, P2353, DOI 10.1101/gad.5.12a.2353; WILLIAMS M, 1993, J BIOL CHEM, V268, P13731; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I	49	142	149	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1066	1071		10.1074/jbc.274.2.1066	http://dx.doi.org/10.1074/jbc.274.2.1066			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873052	hybrid			2022-12-27	WOS:000077968500067
J	Halse, R; Rochford, JJ; McCormack, JG; Vandenheede, JR; Hemmings, BA; Yeaman, SJ				Halse, R; Rochford, JJ; McCormack, JG; Vandenheede, JR; Hemmings, BA; Yeaman, SJ			Control of glycogen synthesis in cultured human muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; EPIDERMAL GROWTH-FACTOR; RAT SKELETAL-MUSCLE; SYNTHASE KINASE-3; PHOSPHOINOSITIDE 3-KINASE; INSULIN; ACTIVATION; INHIBITION; RAPAMYCIN; HEPATOCYTES	The regulation of glycogen synthesis and associated enzymes was studied in human myoblasts and myotubes maintained in culture. Both epidermal growth factor (EGF) and insulin stimulated glycogen synthesis approximately 2-fold, this stimulation being accompanied by a rapid and stable activation of the controlling enzyme glycogen synthase (GS). EGF also caused inhibition of glycogen synthase kinase 3 (GSK-3) and activation of the alpha isoform of protein kinase B (PKB) with the time-course and magnitude of its effects being similar to those induced by insulin. An inhibitor of the mitogen-activated protein (MAP) kinase pathway did not prevent stimulation of GS by EGF, suggesting that this pathway is not essential for the effect. A partial decrease in the fold activation of GS was, however, observed when p70(S6k) activation was blocked with rapamycin, suggesting a contribution of this pathway to the control of GS by either hormone. Wortmannin, a selective inhibitor of phosphatidylinositol 3'-kinase (PI-3 kinase) completely blocked the effects of both EGF and insulin in these cells. These results demonstrate that EGF, like insulin, activates glycogen synthesis in muscle, acting principally via the PKB/GSK-3 pathway but with a contribution from a rapamycin-sensitive component that lies downstream of PI-3 kinase.	Univ Newcastle Upon Tyne, Sch Med, Sch Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Katholieke Univ Leuven, Adfeling Biochem, Fac Geneeskunde, B-3000 Louvain, Belgium; Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark; Univ Basel, Friedrich Miescher Inst, CH-4056 Basel, Switzerland	Newcastle University - UK; KU Leuven; Novo Nordisk; Friedrich Miescher Institute for Biomedical Research; University of Basel	Yeaman, SJ (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Sch Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.			Rochford, Justin/0000-0002-5020-4939				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Azpiazu I, 1996, J BIOL CHEM, V271, P5033; BORTHWICK AC, 1995, BIOCHEM BIOPH RES CO, V210, P738, DOI 10.1006/bbrc.1995.1721; COHEN P, 1993, BIOCHEM SOC T, V21, P555, DOI 10.1042/bst0210555; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; Cross DAE, 1997, FEBS LETT, V406, P211, DOI 10.1016/S0014-5793(97)00240-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; GLADHAUG IP, 1992, DIGEST DIS SCI, V37, P233, DOI 10.1007/BF01308177; GUINOVART JJ, 1979, FEBS LETT, V106, P284, DOI 10.1016/0014-5793(79)80515-3; Hurel SJ, 1996, BIOCHEM J, V320, P871, DOI 10.1042/bj3200871; Lin Tai-An, 1994, Journal of Biological Chemistry, V269, P21255; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; Peak M, 1998, DIABETOLOGIA, V41, P16, DOI 10.1007/s001250050861; PEAK M, 1994, EUR J BIOCHEM, V221, P529, DOI 10.1111/j.1432-1033.1994.tb18765.x; SAITO Y, 1994, BIOCHEM J, V303, P27, DOI 10.1042/bj3030027; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; Shepherd PR, 1996, J MOL ENDOCRINOL, V17, P175, DOI 10.1677/jme.0.0170175; SHEPHERD PR, 1995, BIOCHEM J, V305, P25, DOI 10.1042/bj3050025; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; SUTHERLAND C, 1994, FEBS LETT, V338, P37, DOI 10.1016/0014-5793(94)80112-6; Welsh GI, 1997, ANAL BIOCHEM, V244, P16, DOI 10.1006/abio.1996.9838; YANG LJ, 1993, J BIOL CHEM, V268, P3739	24	51	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					776	780		10.1074/jbc.274.2.776	http://dx.doi.org/10.1074/jbc.274.2.776			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873015	hybrid			2022-12-27	WOS:000077968500030
J	Henle, ES; Han, ZX; Tang, N; Rai, P; Luo, YZ; Linn, S				Henle, ES; Han, ZX; Tang, N; Rai, P; Luo, YZ; Linn, S			Sequence-specific DNA cleavage by Fe2+-mediated fenton reactions has possible biological implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; OXIDATIVE STRESS; STRAND BREAKS; NITROGEN MUSTARDS; ELECTRON-TRANSFER; DAMAGE; IRON; SITE; MECHANISM; CELLS	Preferential cleavage sites have been determined for Fe2+/H2O2-mediated oxidations of DNA. In 50 mM H2O2, preferential cleavages occurred at the nucleoside 5' to each of the dG moieties in the sequence RGGG, a sequence found in a majority of telomere repeats. Within a plasmid containing a (TTAGGG)(81) human telomere insert, 7-fold more strand breakage occurred in the restriction fragment with the insert than in a similar-sized control fragment. This result implies that telomeric DNA could protect coding DNA from oxidative damage and might also link oxidative damage and iron load to telomere shortening and aging. In micromolar H2O2, preferential cleavage occurred at the thymidine within the sequence RTGR, a sequence frequently found to be required in promoters for normal responses of many procaryotic and eucaryotic genes to iron or oxygen stress. Computer modeling of the interaction of Fe2+ with RTGR in B-DNA suggests that due to steric hindrance with the thymine methyl, Fe2+ associates in a specific manner with the thymine flipped out from the base stack so as to allow an octahedrally-oriented coordination of the Fe2+ with the three purine N-7 residues. Fe2+-dependent changes in NMR spectra of duplex oligonucleotides containing ATGA versus those containing AUGA or A(5m)CGA were consistent with this model.	Univ Calif Berkeley, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Linn, S (corresponding author), Univ Calif Berkeley, Div Biochem & Mol Biol, Berkeley, CA 94720 USA.	slinn@socrates.berkeley.edu		Rai, Priyamvada/0000-0001-7822-7553	NIEHS NIH HHS [P30ES01896, T32ES070075] Funding Source: Medline; NIGMS NIH HHS [R37GM19020] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019020] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABSALON MJ, 1995, BIOCHEMISTRY-US, V34, P2065, DOI 10.1021/bi00006a029; [Anonymous], 1984, PRINCIPLES NUCL ACID; BERTONCINI CRA, 1995, NUCLEIC ACIDS RES, V23, P2995, DOI 10.1093/nar/23.15.2995; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; CHEVION M, 1988, FREE RADICAL BIO MED, V5, P27, DOI 10.1016/0891-5849(88)90059-7; CLAYSON DB, 1994, MUTAT RES, V317, P25, DOI 10.1016/0165-1110(94)90010-8; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; DERVAN PB, 1986, SCIENCE, V232, P464, DOI 10.1126/science.2421408; ENRIGHT HU, 1992, NUCLEIC ACIDS RES, V20, P3341, DOI 10.1093/nar/20.13.3341; GOLDSTEIN S, 1993, FREE RADICAL BIO MED, V15, P435, DOI 10.1016/0891-5849(93)90043-T; GRADY DL, 1992, P NATL ACAD SCI USA, V89, P1695, DOI 10.1073/pnas.89.5.1695; Hall DB, 1996, NATURE, V382, P731, DOI 10.1038/382731a0; Harrison L, 1997, MUTAT RES-DNA REPAIR, V385, P159, DOI 10.1016/S0921-8777(97)00053-0; HARTLEY JA, 1990, BIOCHEMISTRY-US, V29, P2985, DOI 10.1021/bi00464a014; HENDERSON E, 1995, TELOMERES, P11; Henle ES, 1997, J BIOL CHEM, V272, P19095, DOI 10.1074/jbc.272.31.19095; HENNER WD, 1982, J BIOL CHEM, V257, P1750; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; KALNIK MW, 1990, J BIOL CHEM, V265, P636; KANEKO M, 1994, FREE RADICAL RES, V20, P229, DOI 10.3109/10715769409147519; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Koppenol W., 1994, FREE RADICAL DAMAGE, V28, P3; KUHNLEIN U, 1976, P NATL ACAD SCI USA, V73, P1169, DOI 10.1073/pnas.73.4.1169; LUO HZ, 1994, METHOD ENZYMOL, V234, P51; Luo YZ, 1996, J BIOL CHEM, V271, P21167, DOI 10.1074/jbc.271.35.21167; LUO YZ, 1994, P NATL ACAD SCI USA, V91, P12438, DOI 10.1073/pnas.91.26.12438; MARTINEZBALBAS MA, 1995, NUCLEIC ACIDS RES, V23, P2464, DOI 10.1093/nar/23.13.2464; MATTES WB, 1986, NUCLEIC ACIDS RES, V14, P2971, DOI 10.1093/nar/14.7.2971; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MELLO AC, 1991, MUTAT RES, V251, P109, DOI 10.1016/0027-5107(91)90220-I; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; Moinova HR, 1998, J BIOL CHEM, V273, P14683, DOI 10.1074/jbc.273.24.14683; MORDEN KM, 1990, BIOCHEMISTRY-US, V29, P8835, DOI 10.1021/bi00489a047; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Oikawa S, 1996, BIOCHEMISTRY-US, V35, P4584, DOI 10.1021/bi9527000; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; PEZZANO H, 1980, CHEM REV, V80, P366; Plum GE, 1995, BIOCHEMISTRY-US, V34, P16148, DOI 10.1021/bi00049a030; PULLMAN A, 1981, Q REV BIOPHYS, V14, P289, DOI 10.1017/S0033583500002341; ROBERTS RJ, 1995, CELL, V82, P9, DOI 10.1016/0092-8674(95)90046-2; RODRIGUEZ H, 1995, J BIOL CHEM, V270, P17633, DOI 10.1074/jbc.270.29.17633; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; SAGRIPANTI JL, 1989, J BIOL CHEM, V264, P1729; SAITO I, 1995, J AM CHEM SOC, V117, P6406, DOI 10.1021/ja00128a050; SAMUNI A, 1983, EUR J BIOCHEM, V137, P119, DOI 10.1111/j.1432-1033.1983.tb07804.x; Sissoeff I, 1976, Prog Biophys Mol Biol, V31, P165; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; TERRON A, 1993, COMMENTS INORG CHEM, V14, P63; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; WINK DA, 1994, P NATL ACAD SCI USA, V91, P6604, DOI 10.1073/pnas.91.14.6604; YAMAZAKI I, 1991, J AM CHEM SOC, V113, P7588, DOI 10.1021/ja00020a021	53	275	287	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					962	971		10.1074/jbc.274.2.962	http://dx.doi.org/10.1074/jbc.274.2.962			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873038	hybrid			2022-12-27	WOS:000077968500053
J	Wu, CY; Robertson, DHL; Hubbard, SJ; Gaskell, SJ; Beynon, RJ				Wu, CY; Robertson, DHL; Hubbard, SJ; Gaskell, SJ; Beynon, RJ			Proteolysis of native proteins - Trapping of a reaction intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR URINARY PROTEINS; MASS-SPECTROMETRY; PHEROMONE BINDING; MAXIMUM-ENTROPY; MUS-MUSCULUS; TRYPSIN; MOUSE	When limited proteolysis of the mouse major urinary proteins by trypsin was stopped by rapid denaturation of the proteinase, a covalent adduct of the two proteins was observed. The formation of this complex required active trypsin, was favored at low pH, and could be reversed by the addition of covalent or non-covalent trypsin inhibitors. Electrospray mass spectrometry of the complex demonstrated that it was an acyl-enzyme complex, formed after an unusual exopeptidase attack on the C-terminal-Arg-Glu-OH sequence by trypsin. The complex could sequester over 50% of the trypsin in a digestion mixture, and as anticipated, the protein was an effective trypsin inhibitor.	Univ Manchester, Inst Sci & Technol, Dept Biomol Sci, Manchester M60 1QD, Lancs, England; Univ Manchester, Inst Sci & Technol, Michael Barber Ctr Mass Spectrometry, Manchester M60 1QD, Lancs, England	University of Manchester; University of Manchester	Beynon, RJ (corresponding author), Univ Manchester, Inst Sci & Technol, Dept Biomol Sci, POB 88, Manchester M60 1QD, Lancs, England.	r.beynon@umist.ac.uk	Hubbard, Simon J/B-9006-2009; Beynon, Robert J/K-1408-2014	Beynon, Robert J/0000-0003-0857-495X; Hubbard, Simon/0000-0002-8601-9524				AKO H, 1972, BIOCHEM BIOPH RES CO, V47, P1402, DOI 10.1016/0006-291X(72)90228-8; ASHTON DS, 1994, BIOCHEM BIOPH RES CO, V199, P694, DOI 10.1006/bbrc.1994.1284; BACCHINI A, 1992, EXPERIENTIA, V48, P419, DOI 10.1007/BF01923448; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; CHOWDHURY SK, 1990, RAPID COMMUN MASS SP, V4, P81, DOI 10.1002/rcm.1290040305; CHRISTENSEN S, 1995, J BIOL CHEM, V270, P14859, DOI 10.1074/jbc.270.25.14859; CHUNG SY, 1994, J AGR FOOD CHEM, V42, P623, DOI 10.1021/jf00039a004; ELLISON D, 1995, PROTEIN SCI, V4, P1337, DOI 10.1002/pro.5560040709; EVERSHED RP, 1993, RAPID COMMUN MASS SP, V7, P882, DOI 10.1002/rcm.1290071005; FERRIGE AG, 1992, RAPID COMMUN MASS SP, V6, P707, DOI 10.1002/rcm.1290061115; FINLAYSON JS, 1963, J NATL CANCER I, V31, P91; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; FLOWER DR, 1994, FEBS LETT, V354, P7, DOI 10.1016/0014-5793(94)01078-1; Fontana A, 1997, FOLD DES, V2, pR17, DOI 10.1016/S1359-0278(97)00010-2; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; KASAI K, 1992, J CHROMATOGR, V597, P3, DOI 10.1016/0021-9673(92)80092-9; KASCHE V, 1989, PROTEOLYTIC ENZYMES, P125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; Robertson D, 1998, J CHEM ECOL, V24, P1127, DOI 10.1023/A:1022434300449; Robertson DHL, 1996, BIOCHEM J, V316, P265, DOI 10.1042/bj3160265; ROBERTSON DHL, 1993, J CHEM ECOL, V19, P1405, DOI 10.1007/BF00984885; Summerfield SG, 1997, J MASS SPECTROM, V32, P225, DOI 10.1002/(SICI)1096-9888(199702)32:2<225::AID-JMS471>3.0.CO;2-#; Wilmouth RC, 1997, NAT STRUCT BIOL, V4, P456, DOI 10.1038/nsb0697-456	25	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1108	1115		10.1074/jbc.274.2.1108	http://dx.doi.org/10.1074/jbc.274.2.1108			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873058	hybrid			2022-12-27	WOS:000077968500073
J	Connelly, MA; Klein, SM; Azhar, S; Abumrad, NA; Williams, DL				Connelly, MA; Klein, SM; Azhar, S; Abumrad, NA; Williams, DL			Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPROTEIN-A-I; PLASMA-MEMBRANE; GENE FAMILY; RAT; CELLS; EXPRESSION; METABOLISM; IDENTIFICATION; TRANSPORT; DELIVERY	Scavenger receptor BI (SR-BI) mediates the selective uptake of high density lipoprotein (HDL) cholesteryl ester (CE), a process by which HDL CE is taken into the cell without internalization and degradation of the HDL particle. The biochemical mechanism by which SR-BI mediates the selective uptake of HDL CE is poorly understood. Given that CE transfer will occur to some extent from HDL to protein-free synthetic membranes, one hypothesis is that the role of SR-BI is primarily to tether HDL close to the cell surface to facilitate CE transfer from the particle to the plasma membrane. In the present study, this hypothesis was tested by comparing the selective uptake of HDL CE mediated by mouse SR-BI (mSR-BI) with that mediated by rat CD36 (rCD36), a closely related class B scavenger receptor. Both mSR-BI and rCD36 bind HDL with high affinity, and both receptors mediate HDL CE selective uptake. However, SR-BI mediates selective uptake of HDL CE with a 7-fold greater efficiency than rCD36, HDL CE selective uptake mediated by rCD36 is dependent on HDL binding to the receptor, since a mutation that blocks HDL binding also blocks HDL CE selective uptake. These data lead us to hypothesize that one component of HDL CE selective uptake is the tethering of HDL particles to the cell surface. To explore the molecular domains responsible for the greater efficiency of selective uptake by mSR-BI, we compared binding and selective uptake among mSR-BI, scavenger receptor BII, and various chimeric receptors formed from mSR-BI and rCD36. The results show that the extracellular domain of mSR-BI is essential for efficient HDL CE uptake, but the C-terminal cytoplasmic tail also has a major influence on the selective uptake process.	SUNY Stony Brook, Ctr Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Physiol & Biophys, Ctr Med, Stony Brook, NY 11794 USA; Vet Affairs Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Williams, DL (corresponding author), SUNY Stony Brook, Ctr Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058012, R01HL032868] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58012, HL32868] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; AZHAR S, 1989, J LIPID RES, V30, P1799; AZHAR S, 1990, BIOCHIM BIOPHYS ACTA, V1047, P148, DOI 10.1016/0005-2760(90)90041-U; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; CALVO D, 1995, GENOMICS, V25, P100, DOI 10.1016/0888-7543(95)80114-2; Calvo D, 1998, J LIPID RES, V39, P777; CALVO D, 1993, J BIOL CHEM, V268, P18929; Dorahy DJ, 1996, BIOCHEM J, V319, P67, DOI 10.1042/bj3190067; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; GLASS C, 1985, J BIOL CHEM, V260, P744; GLOMSET JA, 1968, J LIPID RES, V9, P155; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; GWYNNE JT, 1980, J BIOL CHEM, V255, P875; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILLER GJ, 1975, LANCET, V1, P16; MORRISON JR, 1994, J BIOL CHEM, V269, P13911; OBERT S, 1994, MOL CELL BIOL, V14, P1333, DOI 10.1128/MCB.14.2.1333; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; REAVEN E, 1984, J CLIN INVEST, V74, P1384, DOI 10.1172/JCI111549; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rigotti A, 1996, J BIOL CHEM, V271, P33545, DOI 10.1074/jbc.271.52.33545; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; STEIN Y, 1983, BIOCHIM BIOPHYS ACTA, V752, P98, DOI 10.1016/0005-2760(83)90237-0; Temel RE, 1997, P NATL ACAD SCI USA, V94, P13600, DOI 10.1073/pnas.94.25.13600; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241; Webb NR, 1997, J LIPID RES, V38, P1490	31	177	182	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					41	47		10.1074/jbc.274.1.41	http://dx.doi.org/10.1074/jbc.274.1.41			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867808	hybrid			2022-12-27	WOS:000077900200008
J	Hu, CD; Kariya, K; Okada, T; Qi, XD; Song, CH; Kataoka, T				Hu, CD; Kariya, K; Okada, T; Qi, XD; Song, CH; Kataoka, T			Effect of phosphorylation on activities of Rap1A to interact with Raf-1 and to suppress Ras-dependent Raf-1 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE DISSOCIATION STIMULATOR; CYSTEINE-RICH REGION; PROTEIN-KINASE; HA-RAS; HUMAN-NEUTROPHILS; BINDING; FIBROBLASTS; MEMBERS; ZINC; GENE	Rap1A is phosphorylated by cAMP-dependent protein kinase (PRA), and this phosphorylation has been shown to modulate its interaction with other proteins. However, it is not known whether Rap1A phosphorylation is involved in regulation of its cellular functions, including suppression of Ras-dependent Raf-l activation. We have previously shown that this suppressive activity of Rap1A is attributable to its greatly enhanced ability to bind to the cysteine-rich region (CRR, residues 152-184) of Raf-l compared with that of Ras, Here, we show that phosphorylation of Rap1A by PKA abolished its binding activity to CRR, Furthermore, a mutant Rap1A(S180E), whose sole PKA phosphorylation residue, Ser-180, was substituted by an acidic residue, Glu, to mimic its phosphorylated form, failed to suppress Ras-dependent Raf-l activation in COS-7 cells. These results indicate that the CRR binding activity and the Ras-suppressive function of Rap1A can be modulated through phosphorylation and suggest that Rap1A may function as a PKA-dependent regulator of Raf-l activation, not merely as a suppressor.	Kobe Univ, Sch Med, Dept Physiol 2, Chuo Ku, Kobe, Hyogo 6500017, Japan	Kobe University	Kataoka, T (corresponding author), Kobe Univ, Sch Med, Dept Physiol 2, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kataoka@kobe-u.ac.jp	song, chunhua/K-7882-2016; song, chunhua/K-7882-2016	song, chunhua/0000-0001-7563-0339; song, chunhua/0000-0002-4081-2543				ALBRIGHT CF, 1993, EMBO J, V12, P339, DOI 10.1002/j.1460-2075.1993.tb05662.x; BOKOCH GM, 1993, BIOCHEM J, V289, P17, DOI 10.1042/bj2890017; BOKOCH GM, 1991, SCIENCE, V254, P1794, DOI 10.1126/science.1763330; BRTVA TR, 1995, J BIOL CHEM, V270, P9809, DOI 10.1074/jbc.270.17.9809; BURGERING BMT, 1995, TRENDS BIOCHEM SCI, V20, P18, DOI 10.1016/S0968-0004(00)88944-6; CHENG HC, 1986, J BIOL CHEM, V261, P989; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; GHOSH S, 1994, J BIOL CHEM, V269, P30785; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; HOFER F, 1994, P NATL ACAD SCI USA, V91, P11089, DOI 10.1073/pnas.91.23.11089; Hu CD, 1997, J BIOL CHEM, V272, P11702, DOI 10.1074/jbc.272.18.11702; Hu CD, 1995, J BIOL CHEM, V270, P30274, DOI 10.1074/jbc.270.51.30274; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483, DOI 10.1128/MCB.14.11.7483; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KURODA Y, 1993, SCIENCE, V259, P683, DOI 10.1126/science.8430318; LEROSEY I, 1991, BIOCHEM BIOPH RES CO, V175, P430, DOI 10.1016/0006-291X(91)91582-W; Luo ZJ, 1997, MOL CELL BIOL, V17, P46, DOI 10.1128/MCB.17.1.46; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; NASSAR N, 1998, NATURE, V375, P554; NODA M, 1993, BIOCHIM BIOPHYS ACTA, V1155, P97, DOI 10.1016/0304-419X(93)90024-7; QUILLIAM LA, 1991, J IMMUNOL, V147, P1628; QUINN MT, 1989, NATURE, V342, P198, DOI 10.1038/342198a0; Roy S, 1997, J BIOL CHEM, V272, P20139, DOI 10.1074/jbc.272.32.20139; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; Tamada M, 1997, ONCOGENE, V15, P2959, DOI 10.1038/sj.onc.1201582; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1	29	49	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					48	51		10.1074/jbc.274.1.48	http://dx.doi.org/10.1074/jbc.274.1.48			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867809	hybrid			2022-12-27	WOS:000077900200009
J	Moyano, JV; Carnemolla, B; Albar, JP; Leprini, A; Gaggero, B; Zardi, L; Garcia-Pardo, A				Moyano, JV; Carnemolla, B; Albar, JP; Leprini, A; Gaggero, B; Zardi, L; Garcia-Pardo, A			Cooperative role for activated alpha 4 beta 1 integrin and chondroitin sulfate proteoglycans in cell adhesion to the heparin III domain of fibronectin - Identification of a novel heparin and cell binding sequence in repeat III5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLASMA FIBRONECTIN; FN-C/H-V; SYNTHETIC PEPTIDE; MONOCLONAL-ANTIBODY; MELANOMA ADHESION; REGION; RECOGNITION; FIBROBLASTS; RECEPTOR; PROGENITORS	We recently reported that the heparin (Hep) III domain of fibronectin contains the H2 cell adhesion site in repeat III5 which binds activated alpha 4 integrins, We have now further characterized the heparin and cell binding activities of this domain. A recombinant fragment containing repeats III4-III5 (FN-III4-5) induced Jurkat cell adhesion upon integrin activation with Mn2+ or TS2/16 monoclonal antibody (anti-beta 1). Adhesion of Mn2+ treated cells to FN-III4-5 or FN-IIIB fragments was inhibited by chondroitinase ABC and ACII but not by the anti-alpha 4 monoclonal antibody HP2/1, In contrast, HP2/1 completely blocked adhesion of TS2/16-treated cells while chondroitinase had a partial (FN-III4-5) or minor (FN-III5) effect. Thus, the role of each receptor depended on the stimulus used to activate alpha 4 beta 1, The combination of HP2/1 and chondroitinase at dilutions which did not inhibit when used individually abolished adhesion of Mn2+ or TS2/16-treated cells to both fragments, indicating a cooperative effect between alpha 4 beta 1 and chondroitin sulfate proteoglycans (CSPG). Furthermore, we have identified a 20-amino acid sequence in III5 (HBP/III5) which binds heparin and induces cell adhesion via CSPG exclusively. Although soluble HBP/III5 was a poor inhibitor, when combined with H2, it abolished adhesion to FN-III4-5 and FN-III5 fragments. These results establish that adhesion to the Rep III domain involves the cooperation of activated alpha 4 beta 1 and CSPG and show that HBP/III5 is a novel heparin and CSPG-binding site contributing to cell adhesion to this domain.	CSIC, Ctr Invest Biol, Dept Inmunol, E-28006 Madrid, Spain; Ist Nazl Ric Canc, Cell Biol Lab, I-16132 Genoa, Italy; CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Genoa; IRCCS AOU San Martino IST; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Garcia-Pardo, A (corresponding author), CSIC, Ctr Invest Biol, Dept Inmunol, Velazquez 144, E-28006 Madrid, Spain.		Garcia Pardo, Angeles/G-5987-2015	Garcia Pardo, Angeles/0000-0001-5577-2954				AOTA S, 1994, J BIOL CHEM, V269, P24756; ARROYO AG, 1993, J BIOL CHEM, V268, P9863; BeauvaisJouneau A, 1997, EXP CELL RES, V233, P1, DOI 10.1006/excr.1997.3554; BORSI L, 1987, J CELL BIOL, V104, P595, DOI 10.1083/jcb.104.3.595; Bultmann H, 1998, J BIOL CHEM, V273, P2601, DOI 10.1074/jbc.273.5.2601; CLARK RAF, 1988, J BIOL CHEM, V263, P12115; DRAKE SL, 1992, J CELL BIOL, V117, P1331, DOI 10.1083/jcb.117.6.1331; GARCIAPARDO A, 1990, J IMMUNOL, V144, P3361; GIMOND C, 1997, INTEGRIN LIGAND INTE; GOLD LI, 1983, BIOCHEMISTRY-US, V22, P4113, DOI 10.1021/bi00286a019; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; HAYASHI M, 1982, J BIOL CHEM, V257, P5263; Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Hynes RO, 1990, FIBRONECTINS; IIDA J, 1995, CANCER RES, V55, P2177; IIDA J, 1992, J CELL BIOL, V118, P431, DOI 10.1083/jcb.118.2.431; Iida J, 1998, J BIOL CHEM, V273, P5955, DOI 10.1074/jbc.273.10.5955; Kato K, 1997, BIOCHEM BIOPH RES CO, V239, P205, DOI 10.1006/bbrc.1997.7259; Lundell BI, 1997, LEUKEMIA, V11, P822, DOI 10.1038/sj.leu.2400653; MASUMOTO A, 1993, J BIOL CHEM, V268, P228; MCCARTHY JB, 1988, BIOCHEMISTRY-US, V27, P1380, DOI 10.1021/bi00404a044; MOORADIAN DL, 1993, INVEST OPHTH VIS SCI, V34, P153; MORRIS R, 1980, METHOD ENZYMOL, V70, P159; MOULD AP, 1994, J BIOL CHEM, V269, P27224; MOULD AP, 1990, J BIOL CHEM, V265, P4020; MOULD AP, 1991, J BIOL CHEM, V266, P3579; MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x; Moyano JV, 1997, J BIOL CHEM, V272, P24832, DOI 10.1074/jbc.272.40.24832; Obara M, 1997, FEBS LETT, V412, P48, DOI 10.1016/S0014-5793(97)00737-0; SANCHEZAPARICIO P, 1993, J IMMUNOL, V150, P3506; SANCHEZAPARICIO P, 1994, J CELL BIOL, V126, P271, DOI 10.1083/jcb.126.1.271; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; SIRI A, 1986, EUR J BIOCHEM, V154, P533, DOI 10.1111/j.1432-1033.1986.tb09431.x; VERFAILLIE CM, 1994, BLOOD, V84, P1802; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; WOODS A, 1993, MOL BIOL CELL, V4, P605, DOI 10.1091/mbc.4.6.605; WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x; Zhang QH, 1996, J BIOL CHEM, V271, P33284, DOI 10.1074/jbc.271.52.33284; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	40	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					135	142		10.1074/jbc.274.1.135	http://dx.doi.org/10.1074/jbc.274.1.135			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867821	hybrid, Green Published			2022-12-27	WOS:000077900200021
J	Postic, C; Shiota, M; Niswender, KD; Jetton, TL; Chen, YJ; Moates, JM; Shelton, KD; Lindner, J; Cherrington, AD; Magnuson, MA				Postic, C; Shiota, M; Niswender, KD; Jetton, TL; Chen, YJ; Moates, JM; Shelton, KD; Lindner, J; Cherrington, AD; Magnuson, MA			Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; DEPENDENT DIABETES-MELLITUS; IMPAIRED INSULIN-SECRETION; TRANSGENIC MICE; CHRONIC HYPERGLYCEMIA; HEPATIC GLUCOKINASE; HEXOKINASE-I; COPY NUMBER; EXPRESSION; YOUNG	Glucokinase (GR) gene mutations cause diabetes mellitus in both humans and mouse models, but the pathophysiological basis is only partially defined. We have used cre-loxP technology in combination with gene targeting to perform global, beta cell-, and hepatocyte-specific gene knock-outs of this enzyme in mice. Gene targeting was used to create a triple-loxed gk allele, which was converted by partial or total Cre-mediated recombination to a conditional allele lacking neomycin resistance, or to a null allele, respectively. beta cell- and hepatocyte-specific expression of Cre was achieved using transgenes that contain either insulin or albumin promoter/enhancer sequences. By intercrossing the transgenic mice that express Cre in a cell-specific manner with mice containing a conditional gk allele, we obtained animals with either a beta cell or hepatocyte-specific knock-out of GK, Animals either globally deficient in GK, or lacking GK just in beta cells, die within a few days of birth from severe diabetes. Mice that are heterozygous null for GK, either globally or just in the beta cell, survive but are moderately hyperglycemic, Mice that lack GR only in the liver are only mildly hyperglycemic but display pronounced defects in both glycogen synthesis and glucose turnover rates during a hyperglycemic clamp. Interestingly, hepatic GK knock-out mice also have impaired insulin secretion in response to glucose. These studies indicate that deficiencies in both beta cell and hepatic GK contribute to the hyperglycemia of MODY-2.	Vanderbilt Univ, Med Ctr, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Sch Med, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Magnuson, MA (corresponding author), Vanderbilt Univ, Med Ctr, Sch Med, Dept Mol Physiol & Biophys, 723 Light Hall, Nashville, TN 37232 USA.	mark.magnuson@mcmail.vanderbilt.edu	Lindner, Jill/K-5511-2012; Magnuson, Mark/AAY-7172-2021; Postic, Catherine/P-2271-2017; Magnuson, Mark A/B-1335-2009	Lindner, Jill/0000-0002-8897-7494; Magnuson, Mark/0000-0002-8824-6499; Postic, Catherine/0000-0002-1875-6960; Magnuson, Mark A/0000-0002-8824-6499	NCI NIH HHS [CA68485] Funding Source: Medline; NIDDK NIH HHS [DK42612, DK42502] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042612] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; BALI D, 1995, J BIOL CHEM, V270, P21464, DOI 10.1074/jbc.270.37.21464; Barzilai N, 1996, DIABETES, V45, P1329, DOI 10.2337/diabetes.45.10.1329; BERGMEYER HU, 1984, METHOD ENZYMAT AN, P163; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; BOUWENS L, 1992, ENZYME, V46, P155, DOI 10.1159/000468782; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; EFRAT S, 1994, P NATL ACAD SCI USA, V91, P2051, DOI 10.1073/pnas.91.6.2051; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; HAGER J, 1994, DIABETES, V43, P730, DOI 10.2337/diabetes.43.5.730; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; HOGAN B, 1994, MANIPULATING MOUSE E, P293; JETTON TL, 1994, J BIOL CHEM, V269, P3641; JETTON TL, 1992, P NATL ACAD SCI USA, V89, P2619, DOI 10.1073/pnas.89.7.2619; Kellendonk C, 1996, NUCLEIC ACIDS RES, V24, P1404, DOI 10.1093/nar/24.8.1404; Keppler D., 1984, METHOD ENZYMAT AN, V6, P11; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; LEAHY JL, 1988, J CLIN INVEST, V81, P1407, DOI 10.1172/JCI113470; LEAHY JL, 1992, DIABETES CARE, V15, P442, DOI 10.2337/diacare.15.3.442; LEAHY JL, 1987, DIABETES, V36, P459, DOI 10.2337/diabetes.36.4.459; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Moates JM, 1997, GENOMICS, V45, P185, DOI 10.1006/geno.1997.4936; Niswender KD, 1997, J BIOL CHEM, V272, P22564, DOI 10.1074/jbc.272.36.22564; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; Niswender KD, 1997, BIOCHEM SOC T, V25, P113, DOI 10.1042/bst0250113; ODoherty RM, 1996, J BIOL CHEM, V271, P20524, DOI 10.1074/jbc.271.34.20524; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; POSTIC C, 1995, GENOMICS, V29, P740, DOI 10.1006/geno.1995.9943; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Seoane J, 1996, J BIOL CHEM, V271, P23756, DOI 10.1074/jbc.271.39.23756; STOFFEL M, 1992, P NATL ACAD SCI USA, V89, P7698, DOI 10.1073/pnas.89.16.7698; SUN F, 1993, J CLIN INVEST, V92, P1174, DOI 10.1172/JCI116687; Tappy L, 1997, DIABETES, V46, P204, DOI 10.2337/diabetes.46.2.204; Terauchi Y, 1995, J BIOL CHEM, V270, P30253, DOI 10.1074/jbc.270.51.30253; TRENT DF, 1984, DIABETES, V33, P170, DOI 10.2337/diabetes.33.2.170; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Velho G, 1997, DIABETOLOGIA, V40, P217, DOI 10.1007/s001250050666; Velho G, 1996, J CLIN INVEST, V98, P1755, DOI 10.1172/JCI118974; VELHO G, 1992, LANCET, V340, P1162; Velho G, 1997, DIABETES METAB, V23, P34; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; WANG H, 1997, NAT BIOTECHNOL, V15, P239; ZOUALI H, 1993, DIABETES, V42, P1238, DOI 10.2337/diabetes.42.9.1238	57	983	1006	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					305	315		10.1074/jbc.274.1.305	http://dx.doi.org/10.1074/jbc.274.1.305			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867845	hybrid			2022-12-27	WOS:000077900200045
J	Puskas, F; Marcolongo, P; Watkins, SL; Mandl, J; Allan, BB; Houston, P; Burchell, A; Benedetti, A; Banhegyi, G				Puskas, F; Marcolongo, P; Watkins, SL; Mandl, J; Allan, BB; Houston, P; Burchell, A; Benedetti, A; Banhegyi, G			Conformational change of the catalytic subunit of glucose-6-phosphatase in rat liver during the fetal-to-neonatal transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSOMAL GLUCOSE-6-PHOSPHATASE; ENDOPLASMIC-RETICULUM; MEMBRANE TOPOLOGY; P-GLYCOPROTEIN; GLUCOSE; ENZYME; SYSTEM; PHOSPHATE; PERMEABILITY; INVOLVEMENT	The glucose-6-phosphatase system was investigated in fetal rat liver microsomal vesicles. Several observations indicate that the orientation of the catalytic subunit is different in the fetal liver in comparison with the adult form: (i) the phosphohydrolase activity was not latent using glucose-6-phosphate as substrate, and in the case of other phosphoesters it was less latent; (ii) the intravesicular accumulation of glucose upon glucose-6-phosphate hydrolysis was lower; (iii) the size of the intravesicular glucose-6-phosphate pool was independent of the glucose-6-phosphatase activities; (iv) antibody against the loop containing the proposed catalytic site of the enzyme inhibited the phosphohydrolase activity in fetal but not in adult rat liver microsomes. Glucose-6-phosphate, phosphate, and glucose uptake could be detected by both light scattering and/or rapid filtration method in fetal liver microsomes; however, the intravesicular glucose-6-phosphate and glucose accessible spaces were proportionally smaller than in adult rat liver microsomes. These data demonstrate that the components of the glucose-6-phosphatase system are already present, although to a lower extent, in fetal liver, but they are functionally uncoupled by the extravesicular orientation of the catalytic subunit.	Univ Siena, Ist Patol Gen, I-53100 Siena, Italy; Semmelweis Univ, Dept Med Chem, H-1444 Budapest, Hungary; Univ Dundee, Ninewells Hosp & Med Sch, Dept Obstet & Gynaecol, Dundee DD1 9SY, Scotland	University of Siena; Semmelweis University; University of Dundee	Benedetti, A (corresponding author), Univ Siena, Ist Patol Gen, Viale Aldo Moro, I-53100 Siena, Italy.	benedetti@unisi.it	Bánhegyi, Gábor/A-1476-2014; Burchell, Ann/B-7475-2008; Marcolongo, Paola/AAG-5260-2019	Marcolongo, Paola/0000-0001-9330-8570	Telethon [E.0638] Funding Source: Medline	Telethon(Fondazione Telethon)		Annabi B, 1997, BIOCHEM BIOPH RES CO, V236, P808, DOI 10.1006/bbrc.1997.6979; ARION WJ, 1980, J BIOL CHEM, V255, P396; ARION WJ, 1975, MOL CELL BIOCHEM, V6, P75, DOI 10.1007/BF01732001; ATKINS SL, 1995, BIOCH SOC T S, V23, P436; Banhegyi G, 1997, J BIOL CHEM, V272, P13584, DOI 10.1074/jbc.272.21.13584; BANHEGYI G, 1998, IN PRESS ARCH BIOCH; BURCHELL A, 1989, LANCET, V2, P291; BURCHELL A, 1990, FASEB J, V4, P2978, DOI 10.1096/fasebj.4.12.2168325; BURCHELL A, 1988, FEBS LETT, V242, P153, DOI 10.1016/0014-5793(88)81005-6; Burchell A, 1996, BIOL REPROD, V55, P298, DOI 10.1095/biolreprod55.2.298; BURCHELL A, 1988, BIOL NEONATE, V54, P107; BURCHELL A, 1990, CLIN CHEM, V36, P1633; Chatelain F, 1998, DIABETES, V47, P882, DOI 10.2337/diabetes.47.6.882; Chen Y-T, 1995, METABOLIC MOL BASES, P935; FORSYTH RJ, 1993, BIOCHEM J, V294, P145, DOI 10.1042/bj2940145; FOSTER JD, 1997, P SOC EXP BIOL MED, V203, P274; FULCERI R, 1995, BIOCHEM J, V307, P391, DOI 10.1042/bj3070391; FULCERI R, 1994, ARCH BIOCHEM BIOPHYS, V309, P43, DOI 10.1006/abbi.1994.1081; Gamberucci A, 1996, MOL MEMBR BIOL, V13, P103, DOI 10.3109/09687689609160583; Girard J, 1998, BIOCHEM SOC T, V26, P69, DOI 10.1042/bst0260069; GONZALEZMUJICA F, 1993, BIOCHEM SOC T, V22, pS39; Hemrika W, 1997, FEBS LETT, V409, P317, DOI 10.1016/S0014-5793(97)00530-9; HENNE V, 1986, FEBS LETT, V202, P267, DOI 10.1016/0014-5793(86)80699-8; HUME R, 1995, J CLIN ENDOCR METAB, V80, P1960, DOI 10.1210/jc.80.6.1960; Hume R, 1996, HISTOCHEM J, V28, P141, DOI 10.1007/BF02331419; HUME R, 1993, ARCH DIS CHILD, V68, P202, DOI 10.1136/adc.68.2.202; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Levy D, 1996, Essays Biochem, V31, P49; Marcolongo P, 1996, BIOCHEM BIOPH RES CO, V219, P916, DOI 10.1006/bbrc.1996.0333; McIntosh Kerry, 1996, Biochemical Society Transactions, V24, p243S; MEISSNER G, 1988, METHOD ENZYMOL, V157, P417; NORDLIE RC, 1985, ENZYMES BIOL MEMBR, P349; OJCIUS DM, 1991, TRENDS BIOCHEM SCI, V16, P225, DOI 10.1016/0968-0004(91)90090-I; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; POSTIC C, 1994, AM J PHYSIOL, V266, pE548, DOI 10.1152/ajpendo.1994.266.4.E548; TAKAHASHI T, 1981, BIOCHIM BIOPHYS ACTA, V672, P165, DOI 10.1016/0304-4165(81)90390-1; WADDELL ID, 1988, BIOCHEM J, V255, P471, DOI 10.1042/bj2550471; WADDELL ID, 1991, BIOCHEM J, V275, P133, DOI 10.1042/bj2750133; ZHANG JT, 1991, J BIOL CHEM, V266, P18224; ZHANG JT, 1993, J BIOL CHEM, V268, P15101	40	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					117	122		10.1074/jbc.274.1.117	http://dx.doi.org/10.1074/jbc.274.1.117			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867818	Green Published, hybrid			2022-12-27	WOS:000077900200018
J	Tabor, H				Tabor, H			Prions of mammals and fungi minireview series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review									NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Tabor, H (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA.							Liebman SW, 1999, J BIOL CHEM, V274, P1181, DOI 10.1074/jbc.274.3.1181; Weissmann C, 1999, J BIOL CHEM, V274, P3, DOI 10.1074/jbc.274.1.3; Wickner RB, 1999, J BIOL CHEM, V274, P555, DOI 10.1074/jbc.274.2.555	3	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					1	1		10.1074/jbc.274.1.1	http://dx.doi.org/10.1074/jbc.274.1.1			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867801	hybrid			2022-12-27	WOS:000077900200001
J	Wu, MH; Hancock, REW				Wu, MH; Hancock, REW			Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; BACTERICIDAL ACTIVITY; SKIN; CELLS; FROG; PERMEABILIZATION; ANTIBIOTICS; POLYMYXIN; MECHANISM	Bactenecin, a 12-amino acid cationic antimicrobial peptide from bovine neutrophils, has two cysteine residues, which form one disulfide bond, making it a cyclic molecule. To study the importance of the disulfide bond, a linear derivative Bac2S was made and the reduced form (linear bactenecin) was also included in this study. Circular dichroism spectroscopy showed that bactenecin existed as a type I p-turn structure regardless of its environment, while the reduced form and linear bactenecin adopted different conformations according to the lipophilicity of the environment. Bactenecin was more active against the Gram-negative wild type bacteria Escherichia coli, Pseudomonas aeruginosa, and Salmonella typhimurium than its linear derivative and reduced form, while all three peptides were equally active against the outer membrane barrier-defective mutants of the first two bacteria. Only the two linear peptides showed activity against the Gram-positive bacteria Staphylococcus epidermidis and Enterococcus facaelis, Bactenecin interacted well with the outer membrane and its higher affinity for E. coli UB1005 lipopolysaccharide and improved ability to permeabilize the outer membrane seemed to account for its better antimicrobial activity against Gram-negative bacteria. The interaction of bactenecin with the cytoplasmic membrane was determined by its ability to dissipate the membrane potential by using the fluorescence probe 3,3-dipropylthiacarbocyanine and an outer membrane barrier-defective mutant E, coli DC2, It was shown that the linear derivative and reduced form were able to dissipate the membrane potential at much lower concentrations than bactenecin despite the similar minimal inhibitory concentrations of all three against this barrier-defective mutant.	Univ British Columbia, Dept Immunol & Microbiol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Hancock, REW (corresponding author), Univ British Columbia, Dept Immunol & Microbiol, Vancouver, BC V6T 1Z3, Canada.	bob@cmdr.ubc.ca	Barenkamp, Stephen J./I-9390-2019; Hancock, Robert E. W./E-1145-2013	Barenkamp, Stephen J./0000-0002-3054-8910; Hancock, Robert E. W./0000-0001-5989-8503				Amsterdam D., 1991, ANTIBIOTICS LAB MED, P72; ANGUS BL, 1982, ANTIMICROB AGENTS CH, V21, P299, DOI 10.1128/AAC.21.2.299; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; CHRISTENSEN B, 1988, P NATL ACAD SCI USA, V85, P5072, DOI 10.1073/pnas.85.14.5072; CLARK DP, 1994, J BIOL CHEM, V269, P10849; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Fehlbaum P, 1996, P NATL ACAD SCI USA, V93, P1221, DOI 10.1073/pnas.93.3.1221; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; GANZ T, 1987, BACTERIA HOST CELL I, P3; GHAZI A, 1981, FEBS LETT, V125, P197, DOI 10.1016/0014-5793(81)80717-X; Hancock R E, 1995, Adv Microb Physiol, V37, P135, DOI 10.1016/S0065-2911(08)60145-9; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; LETELLIER L, 1979, EUR J BIOCHEM, V102, P441, DOI 10.1111/j.1432-1033.1979.tb04259.x; LOH B, 1984, ANTIMICROB AGENTS CH, V19, P777; MAYER LD, 1985, BIOCHIM BIOPHYS ACTA, V817, P193, DOI 10.1016/0005-2736(85)90084-7; MOORE RA, 1986, ANTIMICROB AGENTS CH, V29, P496, DOI 10.1128/AAC.29.3.496; MORIKAWA N, 1992, BIOCHEM BIOPH RES CO, V189, P184, DOI 10.1016/0006-291X(92)91542-X; Perczel A., 1996, CIRCULAR DICHROISM C, P285; PIERS KL, 1994, MOL MICROBIOL, V12, P951, DOI 10.1111/j.1365-2958.1994.tb01083.x; Qu XD, 1997, INFECT IMMUN, V65, P636, DOI 10.1128/IAI.65.2.636-639.1997; RADERMACHER SW, 1993, J NEUROSCI RES, V36, P657, DOI 10.1002/jnr.490360606; RICHMOND MH, 1976, ANTIMICROB AGENTS CH, V10, P215, DOI 10.1128/AAC.10.2.215; ROMEO D, 1988, J BIOL CHEM, V263, P9573; SAWYER JG, 1988, INFECT IMMUN, V56, P693, DOI 10.1128/IAI.56.3.693-698.1988; SCHINDLER PRG, 1975, ANTIMICROB AGENTS CH, V8, P95, DOI 10.1128/AAC.8.1.95; Silvestro L, 1997, BIOCHEMISTRY-US, V36, P11452, DOI 10.1021/bi9630826; SIMMACO M, 1993, FEBS LETT, V324, P159, DOI 10.1016/0014-5793(93)81384-C; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; SKERLAVAJ B, 1990, INFECT IMMUN, V58, P3724, DOI 10.1128/IAI.58.11.3724-3730.1990; SPIKER S, 1980, ANAL BIOCHEM, V108, P263, DOI 10.1016/0003-2697(80)90579-5; Sprott G. Dennis, 1994, P72; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; SUZUKI S, 1995, BIOCHEM BIOPH RES CO, V212, P249, DOI 10.1006/bbrc.1995.1963; TAMAMURA H, 1993, CHEM PHARM BULL, V41, P978; VENYAMINOV YS, 1996, CIRCULAR DICHROISM, P65; WESTERHOFF HV, 1989, P NATL ACAD SCI USA, V86, P6597, DOI 10.1073/pnas.86.17.6597	39	288	297	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					29	35		10.1074/jbc.274.1.29	http://dx.doi.org/10.1074/jbc.274.1.29			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867806	hybrid			2022-12-27	WOS:000077900200006
J	Gomelsky, M; Kaplan, S				Gomelsky, M; Kaplan, S			AppA, a redox regulator of photosystem formation in Rhodobacter sphaeroides 2.4.1, is a flavoprotein - Identification of a novel FAD binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHESIS GENE-EXPRESSION; HISTIDINE KINASE; RHODOBACTER-SPHAEROIDES-2.4.1; MUTANT; PPSR; BACTERIOCHLOROPHYLL; COMPLEMENTATION; REPRESSOR; PROTEINS	The AppA protein is required for increased photosystem gene expression upon transition of the facultatively photoheterotrophic bacterium Rhodobacter sphaeroides 2.4.1 from aerobic to anaerobic photosynthetic conditions. AppA shows no obvious similarity to proteins with established function. Genetic evidence suggests that its effect is exerted through modulation of the activity of the repressor PpsR, which controls expression of multiple photosystem genes. To gain insight into the nature of AppA involvement in redox-dependent photosystem gene expression, the appA gene was overexpressed in Escherichia coli, AppA was produced as insoluble inclusion bodies. The purified inclusion bodies were found to contain FAD, By overexpressing various deletion derivatives, we were able to localize the region of AppA sufficient for FAD binding to approximately 120 aminoterminal residues. To assess the role of FAD binding in AppA function, we constructed an AppA derivative lacking the entire FAD binding domain. Surprisingly, this derivative complemented the AppA null mutant undergoing transition from aerobic to anaerobic photosynthetic growth conditions almost to the same extent as the full-length AppA protein. When the sequence of the amino-terminal portion of AppA was examined, it was shown not to contain any known flavin binding motifs, However, two open reading frames of unknown function, showing significant similarity to the amino terminus of AppA, were identified, i.e. Synechocystis sp, Sr11694 and E. coli F403, The latter gene was amplified and overexpressed in E, coli, and the partially purified F403 protein was found to contain FAD as a cofactor. We have therefore concluded that the amino terminus of AppA represents a novel FAD binding domain present in a small group of bacterial proteins. The binding of FAD by AppA may be the first clue as to how this regulatory protein is involved in redox-regulated reactions.	Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System	Kaplan, S (corresponding author), Univ Texas, Sch Med, Dept Microbiol & Mol Genet, 6431 Fannin St, Houston, TX 77030 USA.	skaplan@utmmg.med.uth.tmc.edu	gomelsky, mark/F-6209-2010	Gomelsky, Mark/0000-0003-4077-3932	NIGMS NIH HHS [GM15590] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; DAVIS J, 1988, J BACTERIOL, V170, P320, DOI 10.1128/jb.170.1.320-329.1988; ERASO JM, 1995, J BACTERIOL, V177, P2695, DOI 10.1128/jb.177.10.2695-2706.1995; ERASO JM, 1994, J BACTERIOL, V176, P32, DOI 10.1128/JB.176.1.32-43.1994; Fazekar A. G., 1971, METHODS ENZYMOL    B, V18B, P385; GOMELSKY M, 1995, MICROBIOL-UK, V141, P1805, DOI 10.1099/13500872-141-8-1805; GOMELSKY M, 1995, J BACTERIOL, V177, P4609, DOI 10.1128/jb.177.16.4609-4618.1995; GOMELSKY M, 1995, J BACTERIOL, V177, P1634, DOI 10.1128/jb.177.6.1634-1637.1995; Gomelsky M, 1997, J BACTERIOL, V179, P128, DOI 10.1128/jb.179.1.128-134.1997; GOMELSKY M, 1998, IN PRESS PHOTOTROPHI; Hill S, 1996, P NATL ACAD SCI USA, V93, P2143, DOI 10.1073/pnas.93.5.2143; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; KILEY PJ, 1988, MICROBIOL REV, V52, P50, DOI 10.1128/MMBR.52.1.50-69.1988; KOZIOL J., 1971, Methods in Enzymology, V18B, P253, DOI 10.1016/S0076-6879(71)18089-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1982, MOL CLONING; Pemberton JM, 1998, MICROBIOL-UK, V144, P267, DOI 10.1099/00221287-144-2-267; PENFOLD RJ, 1994, J BACTERIOL, V176, P2869, DOI 10.1128/JB.176.10.2869-2876.1994; PLOUX O, 1995, BIOCHEMISTRY-US, V34, P4159, DOI 10.1021/bi00013a003; Ponnampalam SN, 1997, J BIOL CHEM, V272, P18391, DOI 10.1074/jbc.272.29.18391; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Zeilstra-Ryalls J, 1998, J BACTERIOL, V180, P2801, DOI 10.1128/JB.180.11.2801-2809.1998; ZEILSTRARYALLS JH, 1995, J BACTERIOL, V177, P6422, DOI 10.1128/jb.177.22.6422-6431.1995	24	104	109	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35319	35325		10.1074/jbc.273.52.35319	http://dx.doi.org/10.1074/jbc.273.52.35319			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857073	hybrid			2022-12-27	WOS:000077719700091
J	Schwoebel, ED; Talcott, B; Cushman, I; Moore, MS				Schwoebel, ED; Talcott, B; Cushman, I; Moore, MS			Ran-dependent signal-mediated nuclear import does not require GTP hydrolysis by Ran	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; PORE COMPLEX; NUCLEOTIDE-BINDING; RCC1 PROTEIN; IDENTIFICATION; RAN/TC4; TRANSPORT; SUBSTRATE; RANGAP1; NUCLEOPORINS	Nuclear import of classical nuclear localization sequence-containing proteins involves the assembly of an import complex at the cytoplasmic face of the nuclear pore complex (NPC) followed by movement of this complex through the NPC and release of the import substrate into the nuclear interior. This process has historically been thought to require nucleotide hydrolysis as a source of energy. We found, using hydrolysis-resistant GTP analogs and a mutant Ran unable to hydrolyze GTP, that transport of classical nuclear localization sequence containing substrate through the NPC and release of the substrate into the nucleus did not require hydrolysis of GTP by Ran. In fact, for movement of this type of import substrate into the nuclear interior we did not observe a requirement for hydrolysis of any nucleotide triphosphate. We did, however, find that a pool of free GTP (or its structural equivalent) must be added, probably because the GDP Ran that is added must be converted to GTP Ran during the import process. We found that a requirement for GTP hydrolysis can be restored to an import mixture consisting of recombinant import factors by the addition of RCC1, the Ran guanine nucleotide exchange factor.	Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	Baylor College of Medicine	Moore, MS (corresponding author), Baylor Coll Med, Dept Cell Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	mmoore@bcm.tmc.edu			NIGMS NIH HHS [F32 GM19231-01, R01 GM53678] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053678, F32GM019231] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; ADAM SA, 1998, CELLS LAB MANUAL, V1; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; CHI NC, 1995, J CELL BIOL, V130, P265, DOI 10.1083/jcb.130.2.265; DASSO M, 1994, EMBO J, V13, P5732, DOI 10.1002/j.1460-2075.1994.tb06911.x; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; LEHMEIER B, 1992, J BIOTECHNOL, V23, P153, DOI 10.1016/0168-1656(92)90089-R; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; MOORE MS, 1992, CELL, V69, P939, DOI 10.1016/0092-8674(92)90613-H; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Moore MS, 1998, J BIOL CHEM, V273, P22857, DOI 10.1074/jbc.273.36.22857; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P2008, DOI 10.1073/pnas.92.6.2008; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; REN MD, 1995, MOL CELL BIOL, V15, P2117; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; SCHLENSTEDT G, 1995, P NATL ACAD SCI USA, V92, P225, DOI 10.1073/pnas.92.1.225; SEINO H, 1992, J CELL SCI, V102, P393; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x	31	93	93	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35170	35175		10.1074/jbc.273.52.35170	http://dx.doi.org/10.1074/jbc.273.52.35170			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857054	hybrid			2022-12-27	WOS:000077719700072
J	Whitby, MC; Dixon, J				Whitby, MC; Dixon, J			Substrate specificity of the SpCCE1 Holliday junction resolvase of Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-WAY DNA JUNCTION; CRUCIFORM CUTTING ENDONUCLEASE; ESCHERICHIA-COLI; RUVC PROTEIN; SACCHAROMYCES-CEREVISIAE; GENETIC-RECOMBINATION; IN-VITRO; MITOCHONDRIAL-DNA; ENZYME CCE1; RESOLUTION	SpCCE1 from Schizosaccharomyces pombe is an endonuclease that resolves Holliday junctions in vitro. SpCCE1 also binds and cleaves a range of other DNAs (Y-junction; flap; and flayed, nicked, and partial duplexes) with varying efficiency. Cleavage sites are always 3' of thymine nucleotides positioned at or close to the branch point or strand interruption. SpCCE1's favored substrate is the X-junction. Up to two dimers of SpCCE1 can bind concurrently to the same X-junction at its crossover point. From mixing experiments of SpCCE1 and the Escherichia coli RuvA protein, we show that each dimer of SpCCE1 binds to a different face of the X-junction and that both are seemingly competent for strand cleavage. We propose that this provides a mechanism whereby SpCCE1 can scrutinize all four junction strands simultaneously for cleavable thymine nucleotides. SpCCE1 appears to resolve X-junctions by a nick and counter-nick mechanism. Therefore, to ensure a high probability of bilateral strand cleavage, SpCCE1 has a relatively long lifetime on X-junctions. This mechanism has the drawback of limiting dissociation from noncleavable junctions. We discuss why this might not be a problem in vivo.	Univ Oxford, Dept Biochem, Microbiol Unit, Oxford OX1 3QU, England	University of Oxford	Whitby, MC (corresponding author), Univ Oxford, Dept Biochem, Microbiol Unit, S Parks Rd, Oxford OX1 3QU, England.			Whitby, Matthew/0000-0003-0951-3374				Bennett RJ, 1996, P NATL ACAD SCI USA, V93, P12217, DOI 10.1073/pnas.93.22.12217; BENNETT RJ, 1993, CELL, V74, P1021, DOI 10.1016/0092-8674(93)90724-5; BENNETT RJ, 1995, J MOL BIOL, V252, P213, DOI 10.1006/jmbi.1995.0489; BENSON FE, 1994, J BIOL CHEM, V269, P5195; BHATTACHARYYA A, 1991, J MOL BIOL, V221, P1191, DOI 10.1016/0022-2836(91)90928-Y; Chan SN, 1997, J BIOL CHEM, V272, P14873, DOI 10.1074/jbc.272.23.14873; Chan SN, 1998, NUCLEIC ACIDS RES, V26, P1560, DOI 10.1093/nar/26.7.1560; DUCKETT DR, 1995, J MOL BIOL, V246, P95, DOI 10.1006/jmbi.1994.0069; DUCKETT DR, 1990, EMBO J, V9, P583, DOI 10.1002/j.1460-2075.1990.tb08146.x; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; DUNDERDALE HJ, 1991, NATURE, V354, P506, DOI 10.1038/354506a0; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; EZEKIEL UR, 1993, MOL GEN GENET, V240, P414, DOI 10.1007/BF00280395; HAN ZY, 1994, CHROMOSOMA, V103, P162, DOI 10.1007/BF00368008; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; KLEFF S, 1988, EMBO J, V7, P1527, DOI 10.1002/j.1460-2075.1988.tb02972.x; KLEFF S, 1992, EMBO J, V11, P699, DOI 10.1002/j.1460-2075.1992.tb05102.x; Kupfer C, 1996, EUR J BIOCHEM, V238, P77, DOI 10.1111/j.1432-1033.1996.0077q.x; LLOYD RG, 1993, NUCLEIC ACIDS RES, V21, P1719, DOI 10.1093/nar/21.8.1719; LOCKSHON D, 1995, CELL, V81, P947, DOI 10.1016/0092-8674(95)90014-4; MACALPINE DM, 1998, BIOCHEMISTRY-US, V95, P6739; Mahdi AA, 1996, J MOL BIOL, V257, P561, DOI 10.1006/jmbi.1996.0185; Maxam A M, 1980, Methods Enzymol, V65, P499; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MURCHIE AIH, 1993, J MOL BIOL, V233, P77, DOI 10.1006/jmbi.1993.1486; Oram M, 1998, NUCLEIC ACIDS RES, V26, P594, DOI 10.1093/nar/26.2.594; PARSONS CA, 1990, J BIOL CHEM, V265, P9285; PARSONS CA, 1995, NATURE, V374, P375, DOI 10.1038/374375a0; Pohler JRG, 1996, J MOL BIOL, V260, P678; POTTMEYER S, 1992, J MOL BIOL, V223, P607, DOI 10.1016/0022-2836(92)90977-R; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Shah R, 1997, EMBO J, V16, P1464, DOI 10.1093/emboj/16.6.1464; SHAH R, 1994, CELL, V79, P853, DOI 10.1016/0092-8674(94)90074-4; SHARPLES GJ, 1994, EMBO J, V13, P6133, DOI 10.1002/j.1460-2075.1994.tb06960.x; Shida T, 1996, J BIOL CHEM, V271, P26105, DOI 10.1074/jbc.271.42.26105; SIGMAN DS, 1991, METHOD ENZYMOL, V208, P414; SOLARO PC, 1993, J MOL BIOL, V230, P868, DOI 10.1006/jmbi.1993.1207; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAKAHAGI M, 1994, J BIOL CHEM, V269, P15132; Whitby MC, 1997, J MOL BIOL, V272, P509, DOI 10.1006/jmbi.1997.1286; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; White MF, 1997, J MOL BIOL, V269, P647, DOI 10.1006/jmbi.1997.1097; White MF, 1996, J MOL BIOL, V257, P330, DOI 10.1006/jmbi.1996.0166; White MF, 1997, MOL CELL BIOL, V17, P6465, DOI 10.1128/MCB.17.11.6465; White MF, 1997, J MOL BIOL, V266, P122, DOI 10.1006/jmbi.1996.0795	45	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35063	35073		10.1074/jbc.273.52.35063	http://dx.doi.org/10.1074/jbc.273.52.35063			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857040	hybrid			2022-12-27	WOS:000077719700058
J	Gazit, E; Sauer, RT				Gazit, E; Sauer, RT			Stability and DNA binding of the Phd protein of the phage P1 plasmid addiction system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; ARC REPRESSOR; ESCHERICHIA-COLI; OPERATOR DNA; BACTERIOPHAGE-P1; MAINTENANCE; PROPHAGE; GENES	The plasmid addiction module of bacteriophage P1 encodes two proteins, Dec, a toxin that is stable to proteolytic degradation, and Phd, the toxin's antidote that is proteolytically unstable. Phd has been shown to autoregulate its expression by specific DNA binding. Here, we investigate the secondary structure and thermal stability of Phd, the effect of operator DNA binding on the structure and stability of Phd, and the stoichiometry, affinity, and cooperativity of Phd binding to operator subsites and intact operator DNA, Phd folds as a monomer at low temperatures or in the presence of osmolytes but exists predominantly in an unfolded conformation at 37 degrees C. The native state of Phd is stabilized by operator binding. Two Phd monomers bind to each operator subsite, and four monomers bind to the intact operator, The subsite binding reaction shows a second-order dependence on protein concentration and monomer-bound DNA species are unpopulated, suggesting that two Phd molecules bind cooperatively to each operator subsite. In intact operator binding experiments, both dimer-bound and tetramer-bound DNA species are populated, and binding occurs at protein concentrations similar to those required for subsite binding, suggesting that there is no significant dimer-dimer cooperativity.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 68-571, Cambridge, MA 02139 USA.		Gazit, Ehud/C-3715-2011; Gazit, Ehud/M-8026-2019; Gazit, Ehud/AHE-9332-2022	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Sauer, Robert/0000-0002-1719-5399	NIAID NIH HHS [AI-15706, AI-16892] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015706, R01AI015706, R01AI016892] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BOWIE JU, 1989, BIOCHEMISTRY-US, V28, P7139, DOI 10.1021/bi00444a001; BRENSTEIN RJ, 1989, NONLIN MACINTOSH; BROWN BM, 1993, BIOCHEMISTRY-US, V32, P1354, DOI 10.1021/bi00056a022; BROWN BM, 1990, BIOCHEMISTRY-US, V29, P11189, DOI 10.1021/bi00503a006; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Holcik M, 1997, MICROBIOL-SGM, V143, P3403, DOI 10.1099/00221287-143-11-3403; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; LOH SM, 1988, GENE, V66, P259, DOI 10.1016/0378-1119(88)90362-9; Magnuson P, 1996, J BIOL CHEM, V271, P18705, DOI 10.1074/jbc.271.31.18705; MERELO JJ, 1994, NEUROCOMPUTING, V6, P443, DOI 10.1016/0925-2312(94)90021-3; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; PHILLIPS SEV, 1989, NATURE, V341, P711, DOI 10.1038/341711a0; RAUMANN BE, 1994, NATURE, V367, P754, DOI 10.1038/367754a0; ROSNER JL, 1972, VIROLOGY, V49, P679; Tyndall C, 1997, MOL MICROBIOL, V23, P729, DOI 10.1046/j.1365-2958.1997.2531622.x; VERSHON A K, 1986, Proteins Structure Function and Genetics, V1, P302, DOI 10.1002/prot.340010404; VERSHON AK, 1987, J MOL BIOL, V195, P323, DOI 10.1016/0022-2836(87)90653-X; VERSHON AK, 1987, J MOL BIOL, V195, P311, DOI 10.1016/0022-2836(87)90652-8; Wang AJ, 1997, BIOCHEMISTRY-US, V36, P9101, DOI 10.1021/bi970247h; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528; YOUNG C, 1985, P NATL ACAD SCI USA, V82, P7374, DOI 10.1073/pnas.82.21.7374	26	58	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2652	2657		10.1074/jbc.274.5.2652	http://dx.doi.org/10.1074/jbc.274.5.2652			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915794	hybrid			2022-12-27	WOS:000078319500012
J	Roobol, A; Sahyoun, ZP; Carden, MJ				Roobol, A; Sahyoun, ZP; Carden, MJ			Selected subunits of the cytosolic chaperonin associate with microtubules assembled in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-COMPLEX POLYPEPTIDE-1; MOLECULAR CHAPERONES; BRAIN MICROTUBULES; CYTOPLASMIC CHAPERONIN; EUKARYOTIC CYTOSOL; TUBULIN; PROTEIN; ATPASE; GROEL; IDENTIFICATION	The molecular chaperone activities of the only known chaperonin in the eukaryotic cytosol (cytosolic chaperonin containing T-complex polypeptide 1 (CCT)) appear to be relatively specialized; the main folding substrates in vivo and in vitro are identified as tubulins and actins. CCT is unique among chaperonins in the complexity of its hetero-oligomeric structure, containing eight different, although related, gene products. In addition to their known ability to bind to and promote correct folding of newly synthesized and denatured tubulins, we show here that CCT subunits alpha, gamma, zeta, and theta also associated with in vitro assembled microtubules, i.e. behaved as microtubule-associated proteins. This nucleotide-dependent association between microtubules and CCT polypeptides (K-d similar to 0.1 mu M CCT subunit) did not appear to involve whole oligomeric chaperonin particles, but rather free CCT subunits. Removal of the tubulin COOH termini by subtilisin digestion caused all eight CCT subunits to associate with the microtubule polymer, thus highlighting the non-chaperonin nature of the selective CCT subunit association with normal microtubules.	Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	University of Kent	Roobol, A (corresponding author), Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England.	A.Roobol@ukc.ac.uk	Carden, Martin/D-4135-2019	Carden, Martin/0000-0002-0609-4605				AMOS LA, 1977, J CELL BIOL, V72, P642, DOI 10.1083/jcb.72.3.642; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; BLOCH MA, 1995, J CELL SCI, V108, P3541; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brown CR, 1996, J BIOL CHEM, V271, P824, DOI 10.1074/jbc.271.2.824; BROWN CR, 1993, J CELL BIOL, V120, P1101, DOI 10.1083/jcb.120.5.1101; BULINSKI JC, 1980, J CELL BIOL, V87, P802, DOI 10.1083/jcb.87.3.802; BULINSKI JC, 1993, MICROTUBULES, P167; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Dobrzynski JK, 1996, BIOCHEMISTRY-US, V35, P15870, DOI 10.1021/bi961114j; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; GREEN LAD, 1989, J BIOL CHEM, V264, P15210; JOB D, 1982, BIOCHEMISTRY-US, V21, P509, DOI 10.1021/bi00532a015; KIM H, 1979, J CELL BIOL, V80, P266, DOI 10.1083/jcb.80.2.266; KIM S, 1994, TRENDS BIOCHEM SCI, V19, P543, DOI 10.1016/0968-0004(94)90058-2; KUBOTA H, 1994, CURR BIOL, V4, P89, DOI 10.1016/S0960-9822(94)00024-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASEK RJ, 1985, NATURE, V316, P645, DOI 10.1038/316645a0; Lewis SA, 1996, J CELL BIOL, V132, P1, DOI 10.1083/jcb.132.1.1; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; LINGAPPA JR, 1994, J CELL BIOL, V125, P99, DOI 10.1083/jcb.125.1.99; Liou AKF, 1997, EMBO J, V16, P4311, DOI 10.1093/emboj/16.14.4311; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MCBURNEY MW, 1988, J NEUROSCI, V8, P1063; MEJILLANO MR, 1991, J BIOL CHEM, V266, P657; MURPHY DB, 1975, P NATL ACAD SCI USA, V72, P2696, DOI 10.1073/pnas.72.7.2696; NAPOLITANO EW, 1985, J CELL BIOL, V101, P1323, DOI 10.1083/jcb.101.4.1323; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; ROOBOL A, 1993, J NEUROCHEM, V60, P2327, DOI 10.1111/j.1471-4159.1993.tb03524.x; ROOBOL A, 1995, J CELL SCI, V108, P1477; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; SANCHEZ C, 1994, ARCH BIOCHEM BIOPHYS, V310, P428, DOI 10.1006/abbi.1994.1188; SCHIFF PB, 1981, BIOCHEMISTRY-US, V20, P3247, DOI 10.1021/bi00514a041; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SHPETNER HS, 1988, J CELL BIOL, V107, P1001, DOI 10.1083/jcb.107.3.1001; SLOBODA RD, 1975, P NATL ACAD SCI USA, V72, P177, DOI 10.1073/pnas.72.1.177; SOARES H, 1994, J BIOL CHEM, V269, P29299; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; Stoldt V, 1996, YEAST, V12, P523, DOI 10.1002/(SICI)1097-0061(199605)12:6<523::AID-YEA962>3.3.CO;2-3; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; VALLEE RB, 1986, METHOD ENZYMOL, V134, P104; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0	51	48	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2408	2415		10.1074/jbc.274.4.2408	http://dx.doi.org/10.1074/jbc.274.4.2408			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891010	hybrid			2022-12-27	WOS:000078185200077
J	Tanaka, K; Chazenbalk, GD; McLachlan, SM; Rapoport, B				Tanaka, K; Chazenbalk, GD; McLachlan, SM; Rapoport, B			Thyrotropin receptor cleavage at site 1 involves two discontinuous segments at each end of the unique 50-amino acid insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TSH RECEPTOR; EXTRACELLULAR DOMAIN; ECTODOMAIN; CELLS; REGION; CHAIN	Among the glycoprotein hormone receptors, only the thyrotropin receptor (TSHR) cleaves (at two sites) into disulfide-linked A and B subunits, A 50-amino acid insertion unique to the TSHR ectodomain (residues 317-366) plays no role in ligand binding or signal transduction, but its deletion abrogates cleavage at Site 1, closely upstream of the insertion. We sought to define the region within the 50-amino acid tract involved in TSHR cleavage at Site 1. Mutation of small segments within this region previously failed to prevent cleavage at Site 1., We, therefore, divided the 50-amino acid insertion into quartiles and deleted each one individually (TSHR residues 317-327, 328-338, 339-350, and 351-362), As determined by covalent cross-linking of I-125-TSH to, intact cells expressing the mutant receptors, none of these deletions prevented TSHR cleavage at Site 1., Neither did larger deletions of quartiles 1 + 2, 2 + 3, and 3 + 4. However, qualitative differences in the extent of receptor cleavage suggested that quartiles 1 and 4 were playing a greater role in cleavage at Site 1 than were the middle two quartiles, In support of this hypothesis, deletion of these two discontinuous segments almost completely eliminated TSHR cleavage at Site 1. In conclusion, intramolecular cleavage at Site 1 requires the presence of the N-terminal and C-terminal quartiles of the 50-amino acid insertion unique to the TSHR. Taken together with previous observations, our data suggest that this tract may provide a discontinuous binding site for a protease that clips the TSHR at Site 1.	Cedars Sinai Res Inst, Autoimmune Dis Unit, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90045 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rapoport, B (corresponding author), Cedars Sinai Med Ctr, 8700 Beverly Blvd,Suite B-131, Los Angeles, CA 90048 USA.				NIDDK NIH HHS [DK19289] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019289] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Black RA, 1996, BIOCHEM BIOPH RES CO, V225, P400, DOI 10.1006/bbrc.1996.1186; Chazenbalk GD, 1997, ENDOCRINOLOGY, V138, P2893, DOI 10.1210/en.138.7.2893; Couet J, 1996, BIOCHEMISTRY-US, V35, P14800, DOI 10.1021/bi961359w; Couet J, 1996, J BIOL CHEM, V271, P4545; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; Fosang AJ, 1998, FEBS LETT, V430, P186, DOI 10.1016/S0014-5793(98)00667-X; FURMANIAK J, 1987, FEBS LETT, V215, P316, DOI 10.1016/0014-5793(87)80169-2; Kakinuma A, 1996, ENDOCRINOLOGY, V137, P2664, DOI 10.1210/en.137.7.2664; Kakinuma A, 1997, J BIOL CHEM, V272, P28296, DOI 10.1074/jbc.272.45.28296; KOSUGI S, 1992, BIOCHEM BIOPH RES CO, V189, P1754, DOI 10.1016/0006-291X(92)90281-O; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOOSFELT H, 1992, P NATL ACAD SCI USA, V89, P3765, DOI 10.1073/pnas.89.9.3765; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; RUSSO D, 1991, MOL ENDOCRINOL, V5, P1607, DOI 10.1210/mend-5-11-1607; RUSSO D, 1992, ENDOCRINOLOGY, V130, P2135, DOI 10.1210/en.130.4.2135; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Tanaka K, 1998, J BIOL CHEM, V273, P1959, DOI 10.1074/jbc.273.4.1959; WADSWORTH HL, 1990, SCIENCE, V249, P1423, DOI 10.1126/science.2169649	19	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2093	2096		10.1074/jbc.274.4.2093	http://dx.doi.org/10.1074/jbc.274.4.2093			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890969	hybrid			2022-12-27	WOS:000078185200036
J	Black, AR; Jensen, D; Lin, SY; Azizkhan, JC				Black, AR; Jensen, D; Lin, SY; Azizkhan, JC			Growth/cell cycle regulation of Sp1 phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SP1; DEPENDENT PROTEIN-KINASE; REDUCTASE GENE PROMOTER; COA CARBOXYLASE GENE; DNA-BINDING ACTIVITY; VIRUS TYPE-1 TAT; DIHYDROFOLATE-REDUCTASE; CELL-CYCLE; ELEMENT-BINDING; SP1-MEDIATED TRANSCRIPTION	Sp1 sites can mediate growth/cell cycle induction of dihydrofolate reductase in late G(1) (Jensen, D. E., Black, A. R. Swick, A. G., and Azizkhan, J. C. (1997) J. Cell. Biochem, 67, 24-31). To investigate mechanisms underlying this induction, effects of serum stimulation on regulation of Sp1 were examined. In Balb/c 3T3 cells, serum stimulation did not affect Sp1 synthesis or the relative binding of Sp1 family members to DNA; however, it did result in a rapid, similar to 2-fold increase in Sp1 levels and an similar to 3-fold increase in specific Sp1 phosphorylation in midG(1). In normal human diploid fibroblasts, serum stimulation also increased Sp1 phosphorylation in mid-G(1) but did not affect Sp1 levels. Therefore, Sp1 phosphorylation is regulated in a growth/cell cycle-dependent manner which correlates temporally with induction of dihydrofolate reductase transcription. Further studies revealed a kinase activity specifically associated with Sp1 in a growth-regulated manner. This activity is distinct from purified kinases previously shown to phosphorylate Sp1 in vitro and phosphorylates Sp1 between amino acids 612 and 678 in its C terminus, a region also phosphorylated in mid-G, in vivo. Therefore, this study indicates that phosphorylation of the C terminus of Sp1 may play a role in the cell cycle regulation of its transcriptional activity.	Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Azizkhan, JC (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	azizkhan@sc3101.med.buffalo.edu			NCI NIH HHS [CA 16056] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alliston TN, 1997, MOL ENDOCRINOL, V11, P1934, DOI 10.1210/me.11.13.1934; Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Athanikar JN, 1997, MOL CELL BIOL, V17, P5193, DOI 10.1128/MCB.17.9.5193; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; Birnbaum MJ, 1995, BIOCHEMISTRY-US, V34, P16503, DOI 10.1021/bi00050a034; BLACK AR, 1996, PEZCOLLER FDN J, V3, P4; BOCHNER BR, 1982, ANAL BIOCHEM, V122, P100, DOI 10.1016/0003-2697(82)90257-3; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CHEN LI, 1994, MOL CELL BIOL, V14, P4380, DOI 10.1128/MCB.14.7.4380; CHEN XR, 1992, ONCOGENE, V7, P1805; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Cole EG, 1997, NUCLEIC ACIDS RES, V25, P3705, DOI 10.1093/nar/25.18.3705; Daniel S, 1996, J BIOL CHEM, V271, P14692, DOI 10.1074/jbc.271.25.14692; DATTA PK, 1995, MOL CELL BIOL, V15, P5444; EASTMAN HB, 1991, P NATL ACAD SCI USA, V88, P8572, DOI 10.1073/pnas.88.19.8572; Good LF, 1996, J CELL PHYSIOL, V168, P580, DOI 10.1002/(SICI)1097-4652(199609)168:3<580::AID-JCP10>3.0.CO;2-3; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Ihn H, 1997, NUCLEIC ACIDS RES, V25, P3712, DOI 10.1093/nar/25.18.3712; JACKSON S, 1993, ADV SEC MESS PHOSPH, V28, P279; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; JEANG KT, 1993, J VIROL, V67, P6224, DOI 10.1128/JVI.67.10.6224-6233.1993; JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108; Jensen DE, 1997, J CELL BIOCHEM, V67, P24, DOI 10.1002/(SICI)1097-4644(19971001)67:1<24::AID-JCB3>3.0.CO;2-Y; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KIM SJ, 1992, MOL CELL BIOL, V12, P2455, DOI 10.1128/MCB.12.6.2455; Kumar AP, 1997, NUCLEIC ACIDS RES, V25, P2012, DOI 10.1093/nar/25.10.2012; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; LI JM, 1995, J BIOL CHEM, V270, P26750, DOI 10.1074/jbc.270.45.26750; Lin SY, 1996, MOL CELL BIOL, V16, P1668; MAJELLO B, 1994, NUCLEIC ACIDS RES, V22, P4914, DOI 10.1093/nar/22.23.4914; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; MILTENBERGER RJ, 1995, CELL GROWTH DIFFER, V6, P549; MOMOI K, 1992, MOL ENDOCRINOL, V6, P1682, DOI 10.1210/me.6.10.1682; Nevins JR, 1997, J CELL PHYSIOL, V173, P233, DOI 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F; Noe V, 1997, EUR J BIOCHEM, V249, P13, DOI 10.1111/j.1432-1033.1997.00013.x; Prowse DM, 1997, J BIOL CHEM, V272, P1308, DOI 10.1074/jbc.272.2.1308; PYERIN W, 1987, BIOL CHEM H-S, V368, P215, DOI 10.1515/bchm3.1987.368.1.215; RAPAPORT E, 1982, J CELL PHYSIOL, V110, P318, DOI 10.1002/jcp.1041100317; Rohlff C, 1997, J BIOL CHEM, V272, P21137, DOI 10.1074/jbc.272.34.21137; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; SIF S, 1993, ONCOGENE, V8, P2501; Slansky JE, 1996, CURR TOP MICROBIOL, V208, P1; STOCCHI V, 1987, ANAL BIOCHEM, V167, P181, DOI 10.1016/0003-2697(87)90150-3; Studzinski GP, 1996, CANCER RES, V56, P5513; SWICK AG, 1989, NUCLEIC ACIDS RES, V17, P9291, DOI 10.1093/nar/17.22.9291; TALHA S, 1985, EXP CELL RES, V158, P311, DOI 10.1016/0014-4827(85)90456-2; Tommasi S, 1997, J BIOL CHEM, V272, P30483, DOI 10.1074/jbc.272.48.30483; UDVADIA AJ, 1995, P NATL ACAD SCI USA, V92, P3953, DOI 10.1073/pnas.92.9.3953; Wells J, 1996, MOL CELL BIOL, V16, P634; White LA, 1997, J NEUROSCI RES, V47, P242, DOI 10.1002/(SICI)1097-4547(19970201)47:3<242::AID-JNR2>3.0.CO;2-I; YIEH L, 1995, P NATL ACAD SCI USA, V92, P6102, DOI 10.1073/pnas.92.13.6102; Yokono M, 1998, BIOCHEMISTRY-US, V37, P6824, DOI 10.1021/bi9727646; Zhang SY, 1997, ARCH BIOCHEM BIOPHYS, V338, P227, DOI 10.1006/abbi.1996.9809	60	153	156	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1207	1215		10.1074/jbc.274.3.1207	http://dx.doi.org/10.1074/jbc.274.3.1207			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880488	hybrid			2022-12-27	WOS:000079956900008
J	Kupriyanova, TA; Kandror, KV				Kupriyanova, TA; Kandror, KV			Akt-2 binds to Glut4-containing vesicles and phosphorylates their component proteins in response to insulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; RAT ADIPOSE-CELLS; GLUCOSE-TRANSPORTER GLUT4; STIMULATED TRANSLOCATION; GLUCOSE-TRANSPORTER-4 TRANSLOCATION; GLUT4-ENRICHED VESICLES; INTRINSIC ACTIVITY; 3T3-L1 ADIPOCYTES; SKELETAL-MUSCLE; SER/THR KINASE	Glut4-containing vesicles immunoadsorbed from primary rat adipocytes possess endogenous protein kinase activity and phosphorylation substrates. Phosphorylation of several vesicle proteins including Glut4 itself is rapidly activated by insulin. Wortmannin blocks the effect of insulin when added to cells in vivo prior to insulin administration. By means of MonoQ chromatography and Western blot analysis, vesicle-associated protein kinase is identified as Akt-2, a lipid-binding protein kinase involved in insulin signaling. Akt-2 is found to be recruited to Glut4-containing vesicles in response to insulin.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Kandror, KV (corresponding author), Boston Univ, Sch Med, Dept Biochem, K401,715 Albany St, Boston, MA 02118 USA.			Kandror, Konstantin/0000-0002-8601-9313	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052057] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK52057] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; BEGUM N, 1993, J BIOL CHEM, V268, P3352; BELL GI, 1993, J BIOL CHEM, V268, P19161; BIRNBAUM MJ, 1992, INT REV CYTOL, V137A, P239; CAIN CC, 1992, J BIOL CHEM, V267, P11681; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; Cohen P, 1997, FEBS LETT, V410, P3, DOI 10.1016/S0014-5793(97)00490-0; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; CORMONT M, 1993, J BIOL CHEM, V268, P19491; CORMONT M, 1994, EUR J BIOCHEM, V219, P1081, DOI 10.1111/j.1432-1033.1994.tb18591.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DELVECCHIO RL, 1991, J BIOL CHEM, V266, P13278; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; HellerHarrison RA, 1996, J BIOL CHEM, V271, P10200, DOI 10.1074/jbc.271.17.10200; Hirling H, 1996, P NATL ACAD SCI USA, V93, P11945, DOI 10.1073/pnas.93.21.11945; JAMES DE, 1989, P NATL ACAD SCI USA, V86, P8368, DOI 10.1073/pnas.86.21.8368; JAMES DE, 1985, AM J PHYSIOL, V248, pE567, DOI 10.1152/ajpendo.1985.248.5.E567; JAMES DE, 1994, J CELL BIOL, V126, P1123, DOI 10.1083/jcb.126.5.1123; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; KANDROR K, 1994, J BIOL CHEM, V269, P138; Kandror KV, 1996, AM J PHYSIOL-ENDOC M, V271, pE1, DOI 10.1152/ajpendo.1996.271.1.E1; Kandror KV, 1998, BIOCHEM J, V331, P829, DOI 10.1042/bj3310829; Kandror KV, 1996, J BIOL CHEM, V271, P21703, DOI 10.1074/jbc.271.36.21703; Kandror KV, 1996, SEMIN CELL DEV BIOL, V7, P269, DOI 10.1006/scdb.1996.0035; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x; KUBLAOUI B, 1995, J BIOL CHEM, V270, P59, DOI 10.1074/jbc.270.1.59; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE JC, 1990, J BIOL CHEM, V265, P2324; Lee W, 1997, J BIOL CHEM, V272, P21427, DOI 10.1074/jbc.272.34.21427; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; PIPER RC, 1993, J BIOL CHEM, V268, P16557; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; REUSCH JEB, 1993, J BIOL CHEM, V268, P3348; RODBELL M, 1964, J BIOL CHEM, V239, P375; SCHURMANN A, 1992, BIOCHEM J, V285, P223, DOI 10.1042/bj2850223; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SMITH RM, 1991, P NATL ACAD SCI USA, V88, P6893, DOI 10.1073/pnas.88.15.6893; STEPHENS JM, 1995, ENDOCR REV, V16, P529, DOI 10.1210/er.16.4.529; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Tanti JF, 1997, ENDOCRINOLOGY, V138, P2005, DOI 10.1210/en.138.5.2005; THOIDIS G, 1993, J BIOL CHEM, V268, P11691; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; vanderKaay J, 1997, J BIOL CHEM, V272, P5477, DOI 10.1074/jbc.272.9.5477; Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299; Wang WC, 1996, J CELL BIOL, V135, P415, DOI 10.1083/jcb.135.2.415; Waters SB, 1997, J BIOL CHEM, V272, P23323, DOI 10.1074/jbc.272.37.23323; Wijkander J, 1997, J BIOL CHEM, V272, P21520, DOI 10.1074/jbc.272.34.21520	58	93	99	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1458	1464		10.1074/jbc.274.3.1458	http://dx.doi.org/10.1074/jbc.274.3.1458			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880520	hybrid			2022-12-27	WOS:000079956900040
J	Stephanou, A; Isenberg, DA; Nakajima, K; Latchman, DS				Stephanou, A; Isenberg, DA; Nakajima, K; Latchman, DS			Signal transducer and activator of transcription-1 and heat shock factor-1 interact and activate the transcription of the Hsp-70 and Hsp-90 beta gene promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-6; PROTEINS; EXPRESSION; RESPONSES; PATHWAY; NF-IL6; FAMILY; STRESS; CELLS	We have previously demonstrated that interleukin-6 (IL-6) increases the levels of the heat shock protein 90 (Hsp-90) and activates the Hsp-90 beta promoter via the IL-6-activated transcription factors NF-IL6 and signal transducer and activator of transcription-3 (STAT-3). Here, we show that interferon-gamma (IFN-gamma) treatment increases the levels of Hsp-70 and Hsp-90 and also enhances the activity of the Hsp-70 and Hsp-90 beta promoters with these effects being dependent on activation of the STAT-1 transcription factor by IFN-gamma, These effects were not seen in a STAT-1-deficient cell line, indicating that IFN-gamma modulates HsP induction via a STAT-1-dependent pathway. The effect of IFN-gamma/STAT-1 was mediated via a short region of the Hsp-70/Hsp-90 promoters, which also mediates the effects of NF-IL6 and STAT-3 and can bind STAT-1, This region also contains a binding site for the stress activated transcription factor HSF-1. We show that STAT-1 and HSF-1 interact with one another via a protein-protein interaction and produce a strong activation of transcription, which is in contrast to our previous finding that STAT-3 and HSF-1 antagonize one another. To our knowledge this is the first report of HSF-1 interacting directly via a protein-protein interaction with another transcription factor. Such protein-protein interactions and the binding of a number of different stress and cytokine-activated transcription factors to a short region of the Hsp-90 and Hsp-70 gene promoters are likely to play,very important role in Hsp gene activation by non-stressful stimuli and the integration of these responses with the stress response of these genes.	UCL, Windyer Inst Med Sci, Dept Mol Pathol, London W1P 6DB, England; UCL, Windyer Inst Med Sci, Dept Med, London W1P 6DB, England; Osaka Univ, Sch Med, Dept Mol Oncol, Biomed Res Ctr, Suita, Osaka 565, Japan	University of London; University College London; University of London; University College London; Osaka University	Stephanou, A (corresponding author), UCL, Windyer Inst Med Sci, Dept Mol Pathol, 46 Cleveland St, London W1P 6DB, England.			Isenberg, David/0000-0001-9514-2455				AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Cahill CM, 1996, J BIOL CHEM, V271, P24874; DARNELL JE, 1994, SCIENCE, V264, P1414; DENT CL, 1993, TRANSCRIPTION FACTOR, P1; GANTER U, 1989, EMBO J, V8, P3773, DOI 10.1002/j.1460-2075.1989.tb08554.x; HAIRE RN, 1988, J CELL BIOL, V106, P883, DOI 10.1083/jcb.106.3.883; Jurivich D.A., 1994, BIOL HEAT SHOCK PROT, P417; KANIEISHII C, 1997, SCIENCE, V277, P246; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schumann RR, 1996, MOL CELL BIOL, V16, P3490; Stephanou A, 1998, BIOCHEM J, V330, P189, DOI 10.1042/bj3300189; Stephanou A, 1997, BIOCHEM J, V321, P103, DOI 10.1042/bj3210103; TWOMEY BM, 1993, CLIN EXP IMMUNOL, V93, P178; YELLON DM, 1992, J MOL CELL CARDIOL, V24, P113, DOI 10.1016/0022-2828(92)93148-D	20	111	114	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1723	1728		10.1074/jbc.274.3.1723	http://dx.doi.org/10.1074/jbc.274.3.1723			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880553	hybrid			2022-12-27	WOS:000079956900073
J	Choi, IG; Bang, WG; Kim, SH; Yu, YG				Choi, IG; Bang, WG; Kim, SH; Yu, YG			Extremely thermostable serine-type protease from Aquifex pyrophilus - Molecular cloning, expression, and characterization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYROCOCCUS-FURIOSUS; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; SUBTILISIN-E; GEN-NOV; STABILITY; PROKARYOTES; QUANTITIES; PROTEINASE; BACTERIA	A gene encoding a serine-type protease has been cloned from Aquifex pyrophilus using a sequence tag containing the consensus sequence of proteases as a probe, Sequence analysis of the cloned gene reveals an open reading frame of 619 residues that has three canonical residues (Asp-140, His-184, and Ser-502) that form the catalytic site of serine-type proteases, The size of the mature form (43 kDa) and its localization in the cell wall fraction indicate that both the NH2- and COOH-terminal sequences of the protein are processed during maturation. When the cloned gene is expressed in Escherichia coli, it is weakly expressed as active and processed forms. The pH optimum of this protease is very broad, and its activity is completely inactivated by phenylmethylsulfonyl fluoride. The half-life of the protein is 6 h at 105 degrees C, suggesting that it is one of the most heat-stable proteases, The cysteine residues in the mature form may form disulfide bonds that are responsible for the strong stability of this protease, because the thermostability of the protein is significantly reduced in the presence of reducing reagent.	Korea Inst Sci & Technol, Struct Biol Ctr, Seoul 136791, South Korea; Korea Univ, Dept Agr Chem, Seoul 136701, South Korea; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Korea Institute of Science & Technology (KIST); Korea University; University of California System; University of California Berkeley	Yu, YG (corresponding author), Korea Inst Sci & Technol, Struct Biol Ctr, POB 131, Seoul 136791, South Korea.	ygy@kistmail.kist.re.kr	Choi, In-Geol/F-3152-2013	Choi, In-Geol/0000-0001-7403-6274				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARRETT AJ, 1961, METHOD ENZYMOL, V244, P19; Bauer MW, 1996, ADV PROTEIN CHEM, V48, P271; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; Choi IG, 1997, EXTREMOPHILES, V1, P125, DOI 10.1007/s007920050025; COWAN DA, 1987, BIOCHEM J, V247, P121, DOI 10.1042/bj2470121; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; EGGEN R, 1990, FEMS MICROBIOL LETT, V71, P17; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; IKEMURA H, 1987, J BIOL CHEM, V262, P7859; Kessler S W, 1981, Methods Enzymol, V73, P442; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; Lim JH, 1997, FEBS LETT, V406, P142, DOI 10.1016/S0014-5793(97)00262-7; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; Mayr J, 1996, CURR BIOL, V6, P739, DOI 10.1016/S0960-9822(09)00455-2; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OLSON GJ, 1994, J BACTERIOL, V176, P1; PETERS J, 1995, J MOL BIOL, V245, P385, DOI 10.1006/jmbi.1994.0032; Sambrook J., 2002, MOL CLONING LAB MANU; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SLOMA A, 1991, J BACTERIOL, V173, P6889, DOI 10.1128/jb.173.21.6889-6895.1991; STETTER KO, 1983, SYST APPL MICROBIOL, V4, P535, DOI 10.1016/S0723-2020(83)80011-3; Stetter KO, 1996, FEMS MICROBIOL REV, V18, P149, DOI 10.1111/j.1574-6976.1996.tb00233.x; TAKAGI H, 1990, J BIOL CHEM, V265, P6874; TERADA I, 1990, J BIOL CHEM, V265, P6576; VOLKL P, 1994, PROTEIN SCI, V3, P1329; Voorhorst WGB, 1997, PROTEIN ENG, V10, P905, DOI 10.1093/protein/10.8.905; VOS P, 1989, J BIOL CHEM, V264, P13579; WISHART DS, 1994, COMPUT APPL BIOSCI, V10, P121; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9; [No title captured]	35	34	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					881	888		10.1074/jbc.274.2.881	http://dx.doi.org/10.1074/jbc.274.2.881			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873027	hybrid			2022-12-27	WOS:000077968500042
J	Han, YQ; Weinman, S; Boldogh, I; Walker, RK; Brasier, AR				Han, YQ; Weinman, S; Boldogh, I; Walker, RK; Brasier, AR			Tumor necrosis factor-alpha-inducible I kappa B alpha proteolysis mediated by cytosolic m-calpain - A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CELLS; DEGRADATION; HEPATOCYTES; CALPASTATIN; INHIBITOR; FAMILY; SYSTEM; ACID; FOS	The cytokine tumor necrosis factor alpha (TNF-alpha) induces expression of inflammatory gene networks by activating cytoplasmic to nuclear translocation of the nuclear factor-kappa B (NF-kappa B) transcription factor. NF-kappa B activation results from sequential phosphorylation and hydrolysis of the cytoplasmic inhibitor, I kappa B alpha, through the 26 S proteasome, Here, we show a parallel proteasome-independent pathway for cytokine-inducible I kappa B alpha proteolysis in HepG2 liver cells mediated by cytosolic calcium-activated neutral protease (calpains). Pretreatment with either calpain- or proteasome-selective inhibitors partially blocks up to 50% of TNF-alpha-inducible I kappa B alpha proteolysis; pretreatment with both is required to completely block I kappa B alpha proteolysis. Similarly, in transient cotransfection assays, expression of the specific inhibitor, calpastatin, partially blocks TNF-alpha-inducible NF-kappa B-dependent promoter activity and I kappa B alpha proteolysis. In TNF-alpha-stimulated cells, a rapid (within 1 min), 2.2-fold increase in cytosolic calpain proteolytic activity is measured using a specific fluorescent assay. Inducible calpain proteolytic activity occurs coincidentally with the particulate-to-cytosol redistribution of the catalytic m-calpain subunit into the I kappa Ba alpha compartment, Addition of catalytically active m-calpain into broken cells was sufficient to produce ligand-independent I kappa B alpha proteolysis and NF-kappa B translocation. As additional evidence for calpain-dependent I kappa B alpha proteolysis and NF-kappa B activation, we demonstrate that this process occurs in a cell line (ts20b) deficient in the ubiquitin-proteasome pathway, Following inactivation of the temperature-sensitive ubiquitin-activating enzyme, I kappa B alpha proteolysis occurs in a manner sensitive only to calpain inhibitors. Our results demonstrate that TNF-alpha activates cytosolic calpains, a parallel pathway that degrades I kappa B alpha and activates NF-kappa B activation independently of the ubiquitin-proteasome pathway.	Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Phys & Biophys, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Brasier, AR (corresponding author), Univ Texas, Med Branch, Dept Internal Med, 301 Univ Blvd,MRB 8-138, Galveston, TX 77555 USA.	arbrasie@utmb.edu	Weinman, Steven/E-7012-2011		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NHLBI NIH HHS [NHLBI55630] Funding Source: Medline; NIEHS NIH HHS [P30ES06676] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Arora AS, 1996, J CELL PHYSIOL, V167, P434, DOI 10.1002/(SICI)1097-4652(199606)167:3<434::AID-JCP7>3.0.CO;2-Q; Arthur JSC, 1996, BBA-PROTEIN STRUCT M, V1293, P201, DOI 10.1016/0167-4838(95)00243-X; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; BRASIER AR, 1990, EMBO J, V9, P3933, DOI 10.1002/j.1460-2075.1990.tb07614.x; BUROKERKILGORE M, 1993, ANAL BIOCHEM, V208, P387, DOI 10.1006/abio.1993.1066; Carillo S, 1996, BIOCHEM J, V313, P245, DOI 10.1042/bj3130245; Chakrabarti AK, 1996, J NEUROSCI RES, V44, P374; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; ETO A, 1995, J BIOL CHEM, V270, P25115, DOI 10.1074/jbc.270.42.25115; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; HALL TG, 1987, J BIOL CHEM, V262, P10537; Han YQ, 1997, J BIOL CHEM, V272, P9825; HIRAI S, 1991, FEBS LETT, V287, P57, DOI 10.1016/0014-5793(91)80015-U; Jamaluddin M, 1998, J VIROL, V72, P4849, DOI 10.1128/JVI.72.6.4849-4857.1998; LANE RD, 1992, EXP CELL RES, V203, P5, DOI 10.1016/0014-4827(92)90033-5; MAGLOVA LM, 1995, HEPATOLOGY, V22, P637; Mellgren RL, 1996, J BIOL CHEM, V271, P15568, DOI 10.1074/jbc.271.26.15568; MELLONI E, 1986, J BIOL CHEM, V261, P4101; Michetti M, 1996, FEBS LETT, V392, P11, DOI 10.1016/0014-5793(96)00775-2; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; MURACHI T, 1984, BIOCHEM SOC SYMP, P149; PADMANABHAN R, 1993, METHOD ENZYMOL, V218, P637; Pahl HL, 1996, CURR OPIN CELL BIOL, V8, P340, DOI 10.1016/S0955-0674(96)80007-X; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pariat M, 1997, MOL CELL BIOL, V17, P2806, DOI 10.1128/MCB.17.5.2806; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROSSER BG, 1993, J BIOL CHEM, V268, P23593; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; TSUJINAKA T, 1988, BIOCHEM BIOPH RES CO, V153, P1201, DOI 10.1016/S0006-291X(88)81355-X; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Xie HQ, 1997, J NEUROCHEM, V69, P1020; Zhang WL, 1996, J BIOL CHEM, V271, P18825, DOI 10.1074/jbc.271.31.18825	38	210	224	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					787	794		10.1074/jbc.274.2.787	http://dx.doi.org/10.1074/jbc.274.2.787			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873017	hybrid			2022-12-27	WOS:000077968500032
J	Hayes, KL; Tracy, PB				Hayes, KL; Tracy, PB			The platelet high affinity binding site for thrombin mimics hirudin, modulates thrombin-induced platelet activation, and is distinct from the glycoprotein Ib-IX-V complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-THROMBIN; QUICK-I; RECEPTOR; DYSTHROMBIN; IDENTIFICATION; PROTEINS; DEFECT	The platelet high affinity binding site for thrombin appears to be described by a classical receptor-ligand interaction that is distinct from the platelet thrombin receptor/substrate, PAR-1. However, the identification and function of the high affinity binding site with respect to its physiological importance have continued to dude investigators. Prior studies using two mutant thrombins suggested that thrombin interaction with the platelet high affinity binding site is mediated through an extensive portion of the thrombin molecule involving residues within the substrate binding pocket and the anion binding exosite (Leong, L., Henriksen, R. A, Kermode, J. C., Rittenhouse, S. E., and Tracy, P. B. (1992) Biochemistry 31, 2567-2575) and may mimic a thrombin-hirudin interaction. To test this hypothesis, an anti-hirudin peptide antibody (anti-hirpeptide Ab) was raised against a peptide mimicking the COOH terminus of hirudin. The Ab recognized adherent platelets and those in suspension as determined by enzyme-linked immunosorbent assay and immunofluorescence microscopy, respectively. I-125-Thrombin binding to platelets was inhibited in the presence of the anti-hirpeptide Ab in a dose-dependent manner with maximal inhibition >90%. Analyses of data from binding studies of I-125-thrombin to platelets at a fixed Ab concentration indicated that the anti-hirpeptide Ab inhibited the high affinity binding interaction exclusively. In addition, thrombin-induced increases in platelet [Ca2+](i) were enhanced by blocking the high affinity binding site with the Ab due to redistribution of the agonist to PAR-1. Thrombin Quick I-induced platelet calcium mobilization was unaffected by the presence of the Ab, consistent with the inability of thrombin Quick I to bind to the high affinity site. Even though glycoprotein (GP) Ib contains a hirudin-like region within the cr subunit, the postulated high affinity binding site, direct binding of I-125-thrombin could not be demonstrated to transfected Chinese hamster ovary and L cells expressing the GP Ib-IX-V complex Furthermore, an anti-GP Ib Ab, raised to the peptide region proposed as the thrombin high affinity site, did not enhance thrombin-induced platelet calcium mobilization. The anti-hirpeptide Ab recognized a population of platelet membrane proteins distinct from PAR-1 and GP Ib by three-color immunofluorescence using confocal microscopy. These combined studies demonstrate that the high affinity binding site for thrombin is a unique platelet protein distinct from GP Ib which modulates the effective thrombin concentration localized at the human platelet surface.	Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont	Tracy, PB (corresponding author), Univ Vermont, Coll Med, Dept Biochem, Given Bldg C409, Burlington, VT 05405 USA.			Leong, Lilley/0000-0003-1041-0110	NHLBI NIH HHS [HL-46703, F32 HL-09376] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009376, P01HL046703] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAJAJ SP, 1981, PREP BIOCHEM, V11, P394; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Bradford HN, 1997, BLOOD, V90, P1508, DOI 10.1182/blood.V90.4.1508.1508_1508_1515; CHURCH WR, 1988, J BIOL CHEM, V263, P6259; DEGAN SJF, 1983, BIOCHEMISTRY-US, V22, P2087; DEMARCO L, 1991, J BIOL CHEM, V266, P23776; DEMARCO L, 1994, J BIOL CHEM, V269, P6478; Dong JF, 1997, BLOOD, V89, P4355, DOI 10.1182/blood.V89.12.4355; FENTON JW, 1977, CHEM BIOL THROMBIN, P43; Greco NJ, 1996, BIOCHEMISTRY-US, V35, P915, DOI 10.1021/bi951504q; Greco NJ, 1996, BIOCHEMISTRY-US, V35, P906, DOI 10.1021/bi951503y; HARMON JT, 1986, J BIOL CHEM, V261, P3224; HARMON JT, 1985, BIOCHEMISTRY-US, V24, P58, DOI 10.1021/bi00322a010; HAYES KL, 1994, J BIOL CHEM, V269, P28606; HENRIKSEN RA, 1983, J BIOL CHEM, V258, P3717; HENRIKSEN RA, 1988, BIOCHEMISTRY-US, V27, P9160, DOI 10.1021/bi00426a013; HENRIKSEN RA, 1987, J BIOL CHEM, V262, P4664; JAKUBOWSKI JA, 1990, BLOOD, V75, P399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEONG L, 1992, BIOCHEMISTRY-US, V31, P2567, DOI 10.1021/bi00124a017; LIU LW, 1991, J BIOL CHEM, V266, P16977; LOPEZ JA, 1994, J BIOL CHEM, V269, P23716; LOPEZ JA, 1991, J BIOL CHEM, V266, P12851; Mann K G, 1976, Methods Enzymol, V45, P123; MARTIN BM, 1976, BIOCHEMISTRY-US, V15, P4886, DOI 10.1021/bi00667a021; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; OWEN W G, 1973, Thrombosis Research, V3, P705, DOI 10.1016/0049-3848(73)90017-0; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; SHUMAN MA, 1976, BLOOD, V47, P43; STONE SR, 1991, BIOCHEMISTRY-US, V30, P6392, DOI 10.1021/bi00240a007; STONE SR, 1987, BIOCHEMISTRY-US, V26, P4617, DOI 10.1021/bi00389a004; TAM SW, 1979, J BIOL CHEM, V254, P8723; TOLLEFSEN DM, 1974, J BIOL CHEM, V249, P2646; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0	35	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					972	980		10.1074/jbc.274.2.972	http://dx.doi.org/10.1074/jbc.274.2.972			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873039	hybrid			2022-12-27	WOS:000077968500054
J	Markus, M; Benezra, R				Markus, M; Benezra, R			Two isoforms of protein disulfide isomerase alter the dimerization status of E2A proteins by a redox mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING ACTIVITY; LOOP-HELIX PROTEINS; PHOSPHOLIPASE-C-ALPHA; PSBA MESSENGER-RNA; B-CELL DEVELOPMENT; NF-KAPPA-B; TRANSCRIPTION FACTOR; IMMUNOGLOBULIN ENHANCER; MOLECULAR-CLONING; HEAVY-CHAIN	We have shown previously that E2A helix-loop-helix proteins spontaneously form an intermolecular disulfide cross-link that is required for stable homodimer binding to DNA (Benezra, R. (1994) Cell 79, 1057-1067). These homodimers are important for the development of B lymphocytes but are not present in other cell lineages. We have purified two proteins that are capable of regulating the formation of this disulfide bond and found them to be members of the protein disulfide isomerase (PDI) family. By regulating the formation of the disulfide cross-link, these proteins are capable of regulating the dimerization state of E proteins. PDI-mediated reduction appears to dissociate E protein homodimers and favors heterodimer formation with other basic helix-loop-helix proteins in both a purified protein system and in cellular extracts. These studies suggest that PDI may play an important role in the regulation of E2A transcription factor dimerization and the development of the B lymphocyte lineage.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Benezra, R (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.	r-benezra@ski.mskcc.org			NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056425] Funding Source: NIH RePORTER; NCI NIH HHS [P30-CA-08748] Funding Source: Medline; NIGMS NIH HHS [GM56425, GM-07739] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABATE C, 1990, CELL GROWTH DIFFER, V1, P455; ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ABATE C, 1990, P NATL ACAD SCI USA, V87, P1032, DOI 10.1073/pnas.87.3.1032; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BENEZRA R, 1994, CELL, V79, P1057, DOI 10.1016/0092-8674(94)90036-1; BENNETT CF, 1988, NATURE, V334, P268, DOI 10.1038/334268a0; BLANAR MA, 1992, SCIENCE, V256, P1014, DOI 10.1126/science.1589769; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CHENG SY, 1987, J BIOL CHEM, V262, P11221; Choi JK, 1996, EMBO J, V15, P5014, DOI 10.1002/j.1460-2075.1996.tb00881.x; CHRISTY BA, 1991, P NATL ACAD SCI USA, V88, P1815, DOI 10.1073/pnas.88.5.1815; Clive DR, 1996, CELL BIOCHEM FUNCT, V14, P49, DOI 10.1002/cbf.638; CORDLE SR, 1991, MOL CELL BIOL, V11, P1734, DOI 10.1128/MCB.11.3.1734; CORNELIUSSEN B, 1991, J VIROL, V65, P6084, DOI 10.1128/JVI.65.11.6084-6093.1991; DANON A, 1991, EMBO J, V10, P3993, DOI 10.1002/j.1460-2075.1991.tb04974.x; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DESPREZ PY, 1995, MOL CELL BIOL, V15, P3398; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; FORNES MW, 1994, ANDROLOGIA, V26, P87; Galter Dagmar, 1994, European Journal of Biochemistry, V221, P639; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; Hauser CR, 1996, J BIOL CHEM, V271, P1486, DOI 10.1074/jbc.271.3.1486; HAYASHI T, 1993, J BIOL CHEM, V268, P11380; HENTHORN P, 1990, NUCLEIC ACIDS RES, V18, P678, DOI 10.1093/nar/18.3.678; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; HIRANO N, 1994, BIOCHEM BIOPH RES CO, V204, P375, DOI 10.1006/bbrc.1994.2469; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; JACOBS Y, 1994, MOL CELL BIOL, V14, P4087, DOI 10.1128/MCB.14.6.4087; JAVAUX F, 1991, NUCLEIC ACIDS RES, V19, P1121, DOI 10.1093/nar/19.5.1121; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; JOHNSON E, 1992, J BIOL CHEM, V267, P14412; KADESCH T, 1992, IMMUNOL TODAY, V13, P31, DOI 10.1016/0167-5699(92)90201-H; KADESCH T, 1993, CELL GROWTH DIFFER, V4, P49; Kim JM, 1997, SCIENCE, V278, P1954, DOI 10.1126/science.278.5345.1954; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; KULLIK I, 1995, J BACTERIOL, V177, P1285, DOI 10.1128/jb.177.5.1285-1291.1995; KUMAR S, 1992, MOL CELL BIOL, V12, P3094, DOI 10.1128/MCB.12.7.3094; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LIN H, 1991, MOL CELL BIOL, V11, P267, DOI 10.1128/MCB.11.1.267; LISTER J, 1995, J BIOL CHEM, V270, P17939, DOI 10.1074/jbc.270.30.17939; Lui M, 1996, ANAL BIOCHEM, V241, P156, DOI 10.1006/abio.1996.0393; MAYFIELD SP, 1994, J CELL BIOL, V127, P1537, DOI 10.1083/jcb.127.6.1537; MORRIS JI, 1988, BIOCHIM BIOPHYS ACTA, V949, P169, DOI 10.1016/0167-4781(88)90080-2; MURRAY SS, 1992, J BONE MINER RES, V7, P1131; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nakshatri H, 1996, J BIOL CHEM, V271, P28784, DOI 10.1074/jbc.271.46.28784; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; OHTANI H, 1993, HISTOCHEMISTRY, V100, P423, DOI 10.1007/BF00267822; PARK CW, 1992, J BIOL CHEM, V267, P15642; PERREAULT SD, 1984, DEV BIOL, V101, P160, DOI 10.1016/0012-1606(84)90126-X; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; PONGUBALA JMR, 1991, MOL CELL BIOL, V11, P1040, DOI 10.1128/MCB.11.2.1040; ROBERTS VJ, 1993, P NATL ACAD SCI USA, V90, P7583, DOI 10.1073/pnas.90.16.7583; SARTORELLI V, 1992, P NATL ACAD SCI USA, V89, P4047, DOI 10.1073/pnas.89.9.4047; SAWADA S, 1993, MOL CELL BIOL, V13, P5620, DOI 10.1128/MCB.13.9.5620; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHAKNOVICH R, 1992, MOL CELL BIOL, V12, P5059, DOI 10.1128/MCB.12.11.5059; SHEN CP, 1995, MOL CELL BIOL, V15, P4518; SHOJI W, 1994, J BIOL CHEM, V269, P5078; SHUE GL, 1994, J BIOL CHEM, V269, P2707; Sloan SR, 1996, MOL CELL BIOL, V16, P6900; SRIVASTAVA SP, 1993, BIOCHEM BIOPH RES CO, V193, P971, DOI 10.1006/bbrc.1993.1720; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; TASANEN K, 1988, J BIOL CHEM, V263, P16218; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; THAYER MJ, 1993, P NATL ACAD SCI USA, V90, P6483, DOI 10.1073/pnas.90.14.6483; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WILSON RB, 1991, MOL CELL BIOL, V11, P6185, DOI 10.1128/MCB.11.12.6185; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317; Yohn CB, 1996, MOL CELL BIOL, V16, P3560; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	87	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1040	1049		10.1074/jbc.274.2.1040	http://dx.doi.org/10.1074/jbc.274.2.1040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873049	hybrid			2022-12-27	WOS:000077968500064
J	Takayama, S; Xie, ZH; Reed, JC				Takayama, S; Xie, ZH; Reed, JC			An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC PROTEIN BAG-1; CELL DEATH ACTIVITY; DNAJ HOMOLOG; REACTION CYCLE; IMPORT; YDJ1P; BCL-2; HIP	Heat Shock Protein 70 kDa (Hsp70) family molecular chaperones play critical roles in protein folding and trafficking in all eukaryotic cells, The mechanisms by which Hsp70 family chaperones are regulated, however, are only partly understood. BAG-1 binds the ATPase domains of Hsp70 and Hsc70, modulating their chaperone activity and functioning as a competitive antagonist of the co-chaperone Hip. We describe the identification of a family of BAG-1-related proteins from humans (BAG-2, BAG-3, BAG-4, BAG-5), the invertebrate Caenorhabditis elegans (BAG-I, BAG-a), and the fission yeast Schizosaccharomyces pombe (BAG-1A, BAG-1B), These proteins all contain a conserved similar to 45-amino acid region near their C termini (the BAG domain) that binds Hsc70/Hsp70, but they differ widely in their N-terminal domains. The human BAG-1, BAG-2, and BAG-3 proteins bind with high affinity (K-D congruent to 1-10 nM) to the ATPase domain of Hsc70 and inhibit its chaperone activity in a Hip-repressible manner. The findings suggest opportunities for specification and diversification of Hsp70/ Hsc70 chaperone functions through interactions with various BAG-family proteins.	Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jreed@burnham-inst.org			NATIONAL CANCER INSTITUTE [R01CA067329] Funding Source: NIH RePORTER; NCI NIH HHS [CA-67329] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bardelli A, 1996, EMBO J, V15, P6205, DOI 10.1002/j.1460-2075.1996.tb01009.x; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; CHEETHAM M, 1998, BIOCHEM J, V284, P469; Clevenger CV, 1997, MOL ENDOCRINOL, V11, P608, DOI 10.1210/me.11.5.608; DanenVanOorschot AAAM, 1997, APOPTOSIS, V2, P395, DOI 10.1023/A:1026409808732; Ellis RJ, 1997, CURR BIOL, V7, pR531, DOI 10.1016/S0960-9822(06)00273-9; Froesch BA, 1998, J BIOL CHEM, V273, P11660, DOI 10.1074/jbc.273.19.11660; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Gebauer M, 1997, FEBS LETT, V417, P109, DOI 10.1016/S0014-5793(97)01267-2; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HOHFELD J, 1995, CELL, V83, P589; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Kanazawa M, 1997, J BIOCHEM-TOKYO, V121, P890; Kullmann M, 1998, J BIOL CHEM, V273, P14620, DOI 10.1074/jbc.273.23.14620; Liu R, 1998, J BIOL CHEM, V273, P16985, DOI 10.1074/jbc.273.27.16985; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Prapapanich V, 1998, MOL CELL BIOL, V18, P944, DOI 10.1128/MCB.18.2.944; Schulz JB, 1997, J NEUROCHEM, V69, P2075; Stuart JK, 1998, J BIOL CHEM, V273, P22506, DOI 10.1074/jbc.273.35.22506; Sudol M, 1996, TRENDS BIOCHEM SCI, V21, P161, DOI 10.1016/0968-0004(96)30018-2; Takaoka A, 1997, ONCOGENE, V14, P2971, DOI 10.1038/sj.onc.1201147; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Takayama S, 1998, CANCER RES, V58, P3116; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Terada K, 1997, J CELL BIOL, V139, P1089, DOI 10.1083/jcb.139.5.1089; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Xie ZH, 1998, BIOCHEMISTRY-US, V37, P6410, DOI 10.1021/bi973052i; Zeiner M, 1997, EMBO J, V16, P5483, DOI 10.1093/emboj/16.18.5483; ZHONG T, 1993, CELL, V73, P1175, DOI 10.1016/0092-8674(93)90646-8	34	399	427	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					781	786		10.1074/jbc.274.2.781	http://dx.doi.org/10.1074/jbc.274.2.781			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873016	hybrid			2022-12-27	WOS:000077968500031
J	Chanson, M; Mollard, P; Meda, P; Suter, S; Jongsma, HJ				Chanson, M; Mollard, P; Meda, P; Suter, S; Jongsma, HJ			Modulation of pancreatic acinar cell to cell coupling during ACh-evoked changes in cytosolic Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE; EXOCRINE PANCREAS; CALCIUM-ENTRY; NITRIC-OXIDE; AMYLASE SECRETION; PROTEIN-KINASE; GAP-JUNCTIONS; OSCILLATIONS; COMMUNICATION; DEPLETION	The temporal changes in cytosolic free Ca2+ ([Ca2+](i)), Ca2+-dependent membrane currents (I-m), and gap junctional current (I-j) elicited by acetylcholine (ACh) were measured in rat pancreatic acinar cells using digital imaging and dual perforated patch-clamp recording. ACh (50 nM-5 mu M) increased [Ca2+](i) and evoked I-m currents without altering I-j in 19 of 37 acinar cell pairs. Although [Ca2+], rose asynchronously in cells comprising a cluster, the delay of the [Ca2+](i) responses decreased with increasing ACh concentrations, Perfusion of inositol 1,4,5-trisphosphate (IP3) into one cell of a cluster resulted in [Ca2+](i) responses in neighboring cells that were not necessarily in direct contact with the stimulated one. This suggests that extensive coupling between acinar cells provides a pathway for cell-to-cell diffusion of Ca2+-releasing signals. Strikingly, maximal (1-5 mu M) ACh concentrations reduced I-j by 69 +/- 15% (n = 9) in 25% of the cell pairs subjected to dual patch-clamping. This decrease occurred shortly after the I, peak and was prevented by incubating acinar cells in a Ca2+ free medium, suggesting that uncoupling was subsequent to the initiation of the Ca2+-mobilizing responses. Depletion of Ca2+-sequestering stores by thapsigargin resulted in a reduction of intercellular communication similar to that observed with ACh. In addition, ACh-induced uncoupling was prevented by blocking nitric oxide production with L-nitro-arginine and restored by exposing acinar cells to dibutyryl cGMP. The results suggest that ACh-induced uncoupling and capacitative Ca2+ entry are regulated concurrently. Closure of gap junction channels may occur to functionally isolate nearby cells differing in their intrinsic sensitivity to ACh and thereby to allow for sustained activity of groups of secreting cells.	Univ Utrecht, Dept Med Physiol & Sport Med, NL-3508 TA Utrecht, Netherlands; CCIPE, INSERM, U469, F-34094 Montpellier, France; Univ Geneva, Dept Morphol, CH-1211 Geneva, Switzerland; Univ Geneva, Dept Pediat, CH-1211 Geneva 14, Switzerland	Utrecht University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Geneva; University of Geneva	Chanson, M (corresponding author), HUG, Dept Pediat, Lab Clin Invest 3, POB 14,Micheli Du Crest 24, CH-1211 Geneva 14, Switzerland.	Marc.Chanson@hcuge.ch		Chanson, Marc/0000-0001-8104-2090				BAHNSON TD, 1993, J BIOL CHEM, V268, P10808; BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; BERLIN RD, 1993, CELL CALCIUM, V14, P379, DOI 10.1016/0143-4160(93)90042-5; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BOSCO D, 1994, J CELL PHYSIOL, V160, P378, DOI 10.1002/jcp.1041600219; BOSCO D, 1988, AM J PHYSIOL, V254, pG664, DOI 10.1152/ajpgi.1988.254.5.G664; CHANSON M, 1988, AM J PHYSIOL, V255, pC699, DOI 10.1152/ajpcell.1988.255.5.C699; CHANSON M, 1989, J CELL PHYSIOL, V139, P147, DOI 10.1002/jcp.1041390121; CHANSON M, 1993, PROG CELL R, V3, P199; Chanson M, 1998, J CELL BIOL, V141, P1267, DOI 10.1083/jcb.141.5.1267; CHANSON M, 1991, AM J PHYSIOL, V261, pC28; CHIONO M, 1995, J BIOL CHEM, V270, P1149, DOI 10.1074/jbc.270.3.1149; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Guerineau NC, 1998, J BIOL CHEM, V273, P10389, DOI 10.1074/jbc.273.17.10389; GUKOVSKAYA A, 1994, AM J PHYSIOL, V266, pG350, DOI 10.1152/ajpgi.1994.266.3.G350; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; IWATSUKI N, 1978, J PHYSIOL-LONDON, V274, P81, DOI 10.1113/jphysiol.1978.sp012135; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Lu CB, 1997, J PHYSIOL-LONDON, V499, P689, DOI 10.1113/jphysiol.1997.sp021961; MARUYAMA Y, 1993, EMBO J, V12, P3017, DOI 10.1002/j.1460-2075.1993.tb05970.x; MEDA P, 1986, J CELL BIOL, V103, P475, DOI 10.1083/jcb.103.2.475; MEDA P, 1987, P NATL ACAD SCI USA, V84, P4901, DOI 10.1073/pnas.84.14.4901; MEDA P, 1988, MODERN CELL BIOL, V7, P353; MOLLARD P, 1995, P NATL ACAD SCI USA, V92, P3065, DOI 10.1073/pnas.92.7.3065; NATHANSON MH, 1992, J BIOL CHEM, V267, P18118; NEYTON J, 1985, NATURE, V317, P331, DOI 10.1038/317331a0; NGEZAHAYO A, 1993, PFLUG ARCH EUR J PHY, V422, P413, DOI 10.1007/BF00374302; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; PANDOL SJ, 1990, J BIOL CHEM, V265, P12846; PAREKH AB, 1995, P NATL ACAD SCI USA, V92, P7907, DOI 10.1073/pnas.92.17.7907; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; PETERSEN CCH, 1991, FEBS LETT, V284, P113, DOI 10.1016/0014-5793(91)80774-W; PETERSEN OH, 1975, J PHYSIOL-LONDON, V247, P461, DOI 10.1113/jphysiol.1975.sp010941; PUTNEY JW, 1993, CELL, V75, P199, DOI 10.1016/0092-8674(93)80061-I; Sanderson MJ, 1996, NEWS PHYSIOL SCI, V11, P262, DOI 10.1152/physiologyonline.1996.11.6.262; SOMOGYI R, 1988, PFLUG ARCH EUR J PHY, V412, P54, DOI 10.1007/BF00583731; STAUFFER PL, 1993, J BIOL CHEM, V268, P19769; TAKENSKWAK BR, 1992, PFLUG ARCH EUR J PHY, V422, P198, DOI 10.1007/BF00370421; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; TOESCU EC, 1992, EMBO J, V11, P1623, DOI 10.1002/j.1460-2075.1992.tb05208.x; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; WILLEMS PHGM, 1993, CELL CALCIUM, V14, P145, DOI 10.1016/0143-4160(93)90084-J; XU X, 1995, J BIOL CHEM, V270, P29169, DOI 10.1074/jbc.270.49.29169; XU X, 1994, J BIOL CHEM, V269, P12645; Yule David I., 1994, P1447; Yule DI, 1996, AM J PHYSIOL-CELL PH, V271, pC1285, DOI 10.1152/ajpcell.1996.271.4.C1285; YULE DI, 1991, CELL CALCIUM, V12, P145, DOI 10.1016/0143-4160(91)90016-8	50	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					282	287		10.1074/jbc.274.1.282	http://dx.doi.org/10.1074/jbc.274.1.282			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867842	hybrid			2022-12-27	WOS:000077900200042
J	Huh, KH; Wenthold, RJ				Huh, KH; Wenthold, RJ			Turnover analysis of glutamate receptors identifies a rapidly degraded pool of the N-methyl-D-aspartate receptor subunit, NR1, in cultured cerebellar granule cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROMERIC NMDA RECEPTORS; K+-INDUCED DEPOLARIZATION; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; PROTEIN-KINASE-C; RAT-BRAIN; ACETYLCHOLINE-RECEPTOR; SURFACE EXPRESSION; FUNCTIONAL EXPRESSION; ENDOPLASMIC-RETICULUM	The Plumber, composition, and location of receptors in neurons are critically important factors in determining the neuron's response to neurotransmitters. The functional expression of receptors appears to be regulated both generally, at the level of transcription or translation, and locally, at the level of the individual synapse, A key component in the regulation of any protein is its turnover rate, which, measured in half-lives, ranges from a few minutes to several days. In the present study, we measured the turnover rates of subunits of N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors, the two major ionotropic glutamate receptors, using cultured cerebellar granule cells. Turnover rates for NR1, NR2A/B, GluR2/3, and GluR4 subunits were determined by pulse-chase labeling of cells with [S-35]methionine. Half-lives were found to be 18 +/- 5 h and 23 +/- 8 h for the AMPA receptor subunits GluR2/3 and GluR4, respectively, and 16 +/- 5 h for NR2A. The NR1 subunit showed a biphasic decay with half-lives of 2 and 34 h for the rapidly and slowly degraded populations, respectively, Splice variants of the NR1 subunit with different carboxyl-terminal cassettes, C2 and C2', showed similar biphasic degradation patterns, To further characterize the rapidly degraded pool of NR1, surface receptors were labeled by biotinylation, and half-lives of the biotinylated proteins were determined, All surface NR1 was slowly degraded with a pattern similar to that of NR2A, GluR2/3, and GluR4, suggesting that the rapidly degraded pool is confined to the cytoplasm and not assembled with NR2 subunits, A significant amount of NR1 was not immunoprecipitated by NR2 subunit-specific antibodies after solubilization with deoxycholate. This unassembled pool, but not the assembled one, was greatly diminished following treatment of cycloheximide for 5 h, indicating that the rapidly degraded pool of NR1 is not assembled with NR2, These results show that MMDA and AMPA receptors have similar turnover rates, but NMDA receptors have a separate pool of NR1 subunits that is rapidly degraded and accounts for most of the intracellular pool.	NIDCD, Neurochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Huh, KH (corresponding author), NIDCD, Neurochem Lab, NIH, Bldg 36,Rm 5D08, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000003, Z01DC000003] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BESSHO Y, 1994, NEURON, V12, P87, DOI 10.1016/0896-6273(94)90154-6; Bi XN, 1997, J NEUROCHEM, V68, P1484; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; BOECKMAN FA, 1994, NEUROSCI LETT, V173, P189, DOI 10.1016/0304-3940(94)90180-5; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; BROSE N, 1993, J BIOL CHEM, V268, P22663; BULLER AL, 1994, J NEUROSCI, V14, P5471; Centrella M, 1996, J BIOL CHEM, V271, P18616, DOI 10.1074/jbc.271.31.18616; Chazot PL, 1997, J NEUROCHEM, V68, P507; Chazot PL, 1995, MOL MEMBR BIOL, V12, P331, DOI 10.3109/09687689509072435; CLAUDIO T, 1989, J CELL BIOL, V108, P2277, DOI 10.1083/jcb.108.6.2277; CONDORELLI DF, 1993, J NEUROCHEM, V61, P2133, DOI 10.1111/j.1471-4159.1993.tb07451.x; DIDIER M, 1994, EUR J NEUROSCI, V6, P1536, DOI 10.1111/j.1460-9568.1994.tb00544.x; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; DURAND GM, 1992, P NATL ACAD SCI USA, V89, P9359, DOI 10.1073/pnas.89.19.9359; GALLO W, 1992, P NATL ACAD SCI USA, V79, P7919; Garner CC, 1996, TRENDS CELL BIOL, V6, P429, DOI 10.1016/S0962-8924(96)10036-2; Gorter JA, 1997, J NEUROSCI, V17, P6179; GRIMWOOD S, 1995, J NEUROCHEM, V64, P525; HACK NJ, 1995, DEV BRAIN RES, V87, P55, DOI 10.1016/0165-3806(95)00054-H; Hall RA, 1997, J NEUROCHEM, V68, P625; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huh K. H., 1997, Society for Neuroscience Abstracts, V23, P935; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JONES KA, 1991, NEURON, V7, P593, DOI 10.1016/0896-6273(91)90372-7; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Lau LF, 1996, J BIOL CHEM, V271, P21622, DOI 10.1074/jbc.271.35.21622; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Mammen AL, 1997, J NEUROSCI, V17, P7351; McIlhinney RAJ, 1996, NEUROSCIENCE, V70, P989, DOI 10.1016/0306-4522(95)00419-X; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; PETRALIA RS, 1994, J NEUROSCI, V14, P667; PETRALIA RS, 1997, IONOTROPIC GLUTAMATE, P219; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; RESINK A, 1995, J NEUROCHEM, V64, P558; ROSS AF, 1991, J CELL BIOL, V113, P623, DOI 10.1083/jcb.113.3.623; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; SATO K, 1993, NEUROSCIENCE, V52, P515, DOI 10.1016/0306-4522(93)90403-3; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SHENG M, 1996, NEURON, V17, P759; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; STOLLBERG J, 1987, J NEUROSCI, V7, P1809; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510; Tiedge H, 1996, J NEUROSCI, V16, P7171; Vallano ML, 1996, J NEUROSCI, V16, P631; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WATANABE M, 1993, J COMP NEUROL, V338, P377, DOI 10.1002/cne.903380305; WATNAABE M, 1992, NEUROREPORT, V3, P1138; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhao HM, 1997, J NEUROCHEM, V68, P1041	71	209	214	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					151	157		10.1074/jbc.274.1.151	http://dx.doi.org/10.1074/jbc.274.1.151			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867823	hybrid			2022-12-27	WOS:000077900200023
J	Park, EA; Song, S; Vinson, C; Roesler, WJ				Park, EA; Song, S; Vinson, C; Roesler, WJ			Role of CCAAT enhancer-binding protein beta in the thyroid hormone and cAMP induction of phosphoenollolpyruvate carboxykinase gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; GTP GENE; C/EBP-ALPHA; ORPHAN RECEPTORS; RESPONSE ELEMENT; DNA-BINDING; COUP-TF; PHOSPHOENOLPYRUVATE; PROMOTER; ACTIVATION	Transcription of the gene for phosphoenolpyruvate carboxykinase (PEPCK) is stimulated by thyroid hormone (T-3) and cAMP. Two DNA elements in the PEPCK promoter are required for T-3 responsiveness including a thyroid hormone response element and a binding site called P3(I) for the CCAAT enhancer-binding protein (C/EBP). Both the alpha and beta isoforms of C/EBP are highly expressed in the liver. C/EBP alpha contributes to the liver-specific expression and cAMP responsiveness of the PEPCK gene. In this study, we examined the ability of C/EBP beta when bound to the P3(I) site to regulate PEPCK gene expression. We report that C/EBP beta can stimulate basal expression and participate in the induction of PEPCK gene transcription by T-3 and cAMP. The cAMP-responsive element-binding protein and API proteins that contribute to the induction by cAMP are not involved in the stimulation by T-3. A small region of the transactivation domain of C/EBP beta is sufficient for the stimulation of basal expression and cAMP responsiveness. Our results suggest that C/EBP alpha and C/EBP beta are functionally interchangeable when bound to the P3(I) site of the PEPCK promoter.	Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Pharmacol, Memphis, TN 38163 USA; Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; NCI, Biochem Lab, NIH, Bethesda, MD 20892 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Saskatchewan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Park, EA (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Pharmacol, 874 Unioin Ave, Memphis, TN 38163 USA.	epark@utmem1.utmem.edu			NIDDK NIH HHS [DK-46399] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046399] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; BANIAHMAD A, 1993, P NATL ACAD SCI USA, V90, P8832, DOI 10.1073/pnas.90.19.8832; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Croniger C, 1997, J BIOL CHEM, V272, P26306, DOI 10.1074/jbc.272.42.26306; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Jump DB, 1997, J BIOL CHEM, V272, P27778, DOI 10.1074/jbc.272.44.27778; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KRYLOV D, 1995, EMBO J, V14, P5329, DOI 10.1002/j.1460-2075.1995.tb00217.x; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Lee Y, 1997, MOL CELL BIOL, V17, P2745, DOI 10.1128/MCB.17.5.2745; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; LEE YH, 1997, MOL CELL BIOL, V17, P3028; Li H, 1998, J BIOL CHEM, V273, P5948, DOI 10.1074/jbc.273.10.5948; LIU HC, 1994, MOL ENDOCRINOL, V8, P1021, DOI 10.1210/me.8.8.1021; LIU JS, 1991, J BIOL CHEM, V266, P19095; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MCKNIGHT SL, 1989, GENE DEV, V3, P2021, DOI 10.1101/gad.3.12b.2021; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; MITCHELL J, 1994, MOL ENDOCRINOL, V8, P585, DOI 10.1210/me.8.5.585; MURRAY MB, 1988, J BIOL CHEM, V263, P12770; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; NERLOV C, 1994, GENE DEV, V8, P350, DOI 10.1101/gad.8.3.350; Nizielski SE, 1996, AM J PHYSIOL-REG I, V270, pR1005, DOI 10.1152/ajpregu.1996.270.5.R1005; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; ONATE SA, 1995, SCIENCE, V270, P1354; PARK EA, 1995, BIOCHEM J, V309, P913, DOI 10.1042/bj3090913; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; PARK EA, 1993, J BIOL CHEM, V268, P613; Park EA, 1997, BIOCHEM J, V322, P343, DOI 10.1042/bj3220343; PATEL YM, 1994, J BIOL CHEM, V269, P5619; ROESLER WJ, 1995, J BIOL CHEM, V270, P8225, DOI 10.1074/jbc.270.14.8225; Roesler WJ, 1996, J BIOL CHEM, V271, P8068, DOI 10.1074/jbc.271.14.8068; Roesler WJ, 1998, J BIOL CHEM, V273, P14950, DOI 10.1074/jbc.273.24.14950; Scott DK, 1998, MOL ENDOCRINOL, V12, P482, DOI 10.1210/me.12.4.482; Scott DK, 1996, J BIOL CHEM, V271, P6260, DOI 10.1074/jbc.271.11.6260; Scott DK, 1996, J BIOL CHEM, V271, P31909, DOI 10.1074/jbc.271.50.31909; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; SUTHERLAND JA, 1992, GENE DEV, V6, P1810, DOI 10.1101/gad.6.9.1810; VOZ ML, 1992, MOL CELL BIOL, V12, P3991, DOI 10.1128/MCB.12.9.3991; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Wang JC, 1996, MOL ENDOCRINOL, V10, P794, DOI 10.1210/me.10.7.794; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x	50	51	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					211	217		10.1074/jbc.274.1.211	http://dx.doi.org/10.1074/jbc.274.1.211			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867832	hybrid			2022-12-27	WOS:000077900200032
J	Richardson, A; van der Vies, SM; Keppel, F; Taher, A; Landry, SJ; Georgopoulos, C				Richardson, A; van der Vies, SM; Keppel, F; Taher, A; Landry, SJ; Georgopoulos, C			Compensatory changes in GroEL/Gp31 affinity as a mechanism for Allele-specific genetic interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONIN ATPASE CYCLE; ESCHERICHIA-COLI; BACTERIOPHAGE MORPHOGENESIS; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; GROES; BACTERIAL; MUTATIONS; 2.8-ANGSTROM; POLYPEPTIDE	Previous work has shown that the GroEL-GroES interaction is primarily mediated by the GroES mobile loop. In bacteriophage T4 infection, GroES is substituted by the gene 31-encoded cochaperonin, Gp31. Using a genetic selection scheme, we have identified a new set of mutations in gene 31 that affect interaction with GroEL; all mutations result in changes in the mobile loop of Gp31, Biochemical analyses reveal that the mobile loop mutations alter the affinity between Gp31 and GroEL, most likely by modulating the stability of the GroEL-bound hairpin conformation of the mobile loop. Surprisingly, mutations in groEL that display allele-specific interactions with mutations in gene 31 alter residues in the GroEL intermediate domain, distantly located from the mobile loop binding site. The observed patterns of genetic and biochemical interaction between GroES or Gp31 and GroEL point to a mechanism of genetic allele specificity based on compensatory changes in affinity of the protein-protein interaction. Mutations studied in this work indirectly alter affinity by modulating a folding transition in the Gp31 mobile loop or by modulating a hinged conformational change in GroEL.	Univ Geneva, Dept Biochim Med, CH-1211 Geneva, Switzerland; Tulane Univ, Sch Med, Dept Biochem, New Orleans, LA 70112 USA	University of Geneva; Tulane University	Richardson, A (corresponding author), Univ Geneva, Dept Biochim Med, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	Alexandra.Richardson@medicine.unige.ch	Landry, Samuel/AAK-5778-2020	Landry, Samuel/0000-0002-4082-0543				BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1995, NAT STRUCT BIOL, V2, P1083, DOI 10.1038/nsb1295-1083; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Fenton WA, 1997, PROTEIN SCI, V6, P743; GEORGOPOULOS C, 1992, TRENDS BIOCHEM SCI, V17, P295, DOI 10.1016/0968-0004(92)90439-G; GEORGOPOULOS CP, 1972, NATURE-NEW BIOL, V239, P38, DOI 10.1038/newbio239038a0; Goldsmith SC, 1997, NAT STRUCT BIOL, V4, P708, DOI 10.1038/nsb0997-708; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; HOHN T, 1979, J MOL BIOL, V129, P359, DOI 10.1016/0022-2836(79)90501-1; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; KEPPEL F, 1990, GENE, V86, P19, DOI 10.1016/0378-1119(90)90109-5; KOONIN EV, 1995, TRENDS BIOCHEM SCI, V20, P14, DOI 10.1016/S0968-0004(00)88941-0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LAEMMLI UK, 1970, J MOL BIOL, V47, P69, DOI 10.1016/0022-2836(70)90402-X; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Landry SJ, 1996, P NATL ACAD SCI USA, V93, P11622, DOI 10.1073/pnas.93.21.11622; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; McEvoy MM, 1998, P NATL ACAD SCI USA, V95, P7333, DOI 10.1073/pnas.95.13.7333; MINOR DL, 1994, NATURE, V371, P264, DOI 10.1038/371264a0; PARKINSON JS, 1979, P NATL ACAD SCI USA, V76, P2390, DOI 10.1073/pnas.76.5.2390; REPOILA F, 1994, EMBO J, V13, P4181, DOI 10.1002/j.1460-2075.1994.tb06736.x; Richardson A, 1998, TRENDS BIOCHEM SCI, V23, P138, DOI 10.1016/S0968-0004(98)01193-1; ROMAN SJ, 1992, J BACTERIOL, V174, P6247, DOI 10.1128/JB.174.19.6247-6255.1992; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sandrock TM, 1997, GENETICS, V147, P1635; SIBANDA BL, 1991, METHOD ENZYMOL, V202, P59; SOCKETT H, 1992, J BACTERIOL, V174, P793, DOI 10.1128/jb.174.3.793-806.1992; TILLY K, 1981, P NATL ACAD SCI-BIOL, V78, P1629, DOI 10.1073/pnas.78.3.1629; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; WANG Z, 1992, PROTEIN SCI, V1, P522; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Welch M, 1998, NAT STRUCT BIOL, V5, P25, DOI 10.1038/nsb0198-25; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; ZEILSTRARYALLS J, 1993, J BACTERIOL, V175, P1134, DOI 10.1128/JB.175.4.1134-1143.1993; ZEILSTRARYALLS J, 1994, J BACTERIOL, V176, P6558, DOI 10.1128/JB.176.21.6558-6565.1994	44	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					52	58		10.1074/jbc.274.1.52	http://dx.doi.org/10.1074/jbc.274.1.52			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867810	hybrid, Green Published			2022-12-27	WOS:000077900200010
J	Yan, C; Takahashi, M; Okuda, M; Lee, JD; Berk, BC				Yan, C; Takahashi, M; Okuda, M; Lee, JD; Berk, BC			Fluid shear stress stimulates big mitogen-activated protein kinase 1 (BMK1) activity in endothelial cells - Dependence on tyrosine kinases and intracellular calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE ANION RELEASE; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTORS; NITRIC-OXIDE; MAP KINASE; FLOW; SRC; PHOSPHORYLATION; EXPRESSION; ADHESION	Mitogen-activated protein (MAP) kinases including ERK1/2 and JNK play an important role in shear stress-mediated gene expression in endothelial cells (EC). A new MAP kinase termed big MAP kinase 1 (BMK1/ERK5) has been shown to phosphorylate and activate the transcription factor MEF2C, which is highly expressed in EC, To determine the effects of shear stress on BMK1, bovine aortic EC were exposed to steady laminar flow (shear stress = 12 dynes/cm(2)). Flow activated BMK1 within 10 min with peak activation at 60 min (7.1 +/- 0.6-fold) in a force-dependent manner. Flow was the most powerful activator of BMK1, significantly greater than H2O2 or sorbitol. An important role for non-Src tyrosine kinases in flow-mediated BMK1 activation was demonstrated by inhibition with herbimycin A, but not with the Src inhibitor PP1 or overexpression of kinase-inactive c-Src. BMK1 activation was calcium-dependent as shown by inhibition with 1,2-bis(2-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid/acetoxymethyl ester or thapsigargin, As shown by specific inhibitors or activators, flow-mediated BMK1 activation was not regulated by the following: intracellular redox state; intracellular NO; protein kinase A, C, or G; calcium/calmodulin-dependent kinase; phosphatidylinositol 3-kinase; or arachidonic acid metabolism. In summary, flow potently stimulates BMK1 in EC by a mechanism dependent on a tyrosine kinase(s) and calcium mobilization, but not on c-Src, redox state, or NO production.	Univ Rochester, Cardiol Unit, Rochester, NY 14642 USA; Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	University of Rochester; University of Washington; University of Washington Seattle; Scripps Research Institute	Berk, BC (corresponding author), Univ Rochester, Cardiol Unit, POB 679, Rochester, NY 14642 USA.			Yan, Chen/0000-0002-1397-6358; Berk, Bradford/0000-0002-2767-4115	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049192, P01HL018645, T32HL007828] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL49192, T32HL07828, HL18645] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abe J, 1998, TRENDS CARDIOVAS MED, V8, P59, DOI 10.1016/S1050-1738(97)00133-3; Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; ABE J, 1996, CIRCULATION, V94, P280; Berk BC, 1995, J BIOMECH, V28, P1439, DOI 10.1016/0021-9290(95)00092-5; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Corson MA, 1996, CIRC RES, V79, P984, DOI 10.1161/01.RES.79.5.984; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; GHIGO D, 1993, AM J PHYSIOL, V265, P728; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HOLLAND JA, 1990, J CELL PHYSIOL, V143, P21, DOI 10.1002/jcp.1041430104; Howard AB, 1997, AM J PHYSIOL-CELL PH, V272, pC421, DOI 10.1152/ajpcell.1997.272.2.C421; HSIEH HJ, 1993, J CELL PHYSIOL, V154, P143, DOI 10.1002/jcp.1041540118; Ishida T, 1997, ANN NY ACAD SCI, V811, P12, DOI 10.1111/j.1749-6632.1997.tb51984.x; Ishida T, 1996, CIRC RES, V79, P310, DOI 10.1161/01.RES.79.2.310; Jalali S, 1998, ARTERIOSCL THROM VAS, V18, P227, DOI 10.1161/01.ATV.18.2.227; Jo H, 1997, J BIOL CHEM, V272, P1395, DOI 10.1074/jbc.272.2.1395; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kawakatsu H, 1996, J BIOL CHEM, V271, P5680, DOI 10.1074/jbc.271.10.5680; KINNULA VL, 1992, AM J RESP CELL MOL, V6, P175, DOI 10.1165/ajrcmb/6.2.175; LAN QX, 1994, BIOCHEM BIOPH RES CO, V201, P950, DOI 10.1006/bbrc.1994.1794; LAURINDO FRM, 1994, CIRC RES, V74, P700, DOI 10.1161/01.RES.74.4.700; Laursen JB, 1997, CIRCULATION, V95, P588, DOI 10.1161/01.CIR.95.3.588; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Li YS, 1996, MOL CELL BIOL, V16, P5947; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; MATSUBARA T, 1986, J CELL PHYSIOL, V127, P207, DOI 10.1002/jcp.1041270203; Pearce MJ, 1996, BIOCHEM BIOPH RES CO, V218, P500, DOI 10.1006/bbrc.1996.0089; ROSEN GM, 1984, P NATL ACAD SCI-BIOL, V81, P7269, DOI 10.1073/pnas.81.23.7269; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Takahashi M, 1997, J VASC RES, V34, P212, DOI 10.1159/000159225; Takahashi M, 1996, J CLIN INVEST, V98, P2623, DOI 10.1172/JCI119083; Traub O, 1997, J BIOL CHEM, V272, P31251, DOI 10.1074/jbc.272.50.31251; TRAUB O, 1999, IN PRESS MECH FORCES; TSENG H, 1995, CIRC RES, V77, P869, DOI 10.1161/01.RES.77.5.869	39	151	154	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					143	150		10.1074/jbc.274.1.143	http://dx.doi.org/10.1074/jbc.274.1.143			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867822	hybrid			2022-12-27	WOS:000077900200022
J	Ren, Y; Li, R; Zheng, Y; Busch, H				Ren, Y; Li, R; Zheng, Y; Busch, H			Cloning and characterization of GEF-H1, a microtubule-associated guanine nucleotide exchange factor for Rac and Rho GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; GTP-BINDING PROTEINS; ACTIN STRESS FIBERS; STRUCTURAL SIMILARITIES; ACTIVATING-PROTEIN; EXPRESSION CLONING; GDP/GTP EXCHANGE; FAMILY GTPASES; CDC42 GTPASES; DBL FAMILY	The Rho-related small GTPases are critical elements involved in regulation of signal transduction cascades from extracellular stimuli to cell nucleus and cytoskeleton, The Dbl-like guanine nucleotide exchange factors (GEF) have been implicated in direct activation of these GTPases. Here we have identified a new member of the Dbl family, GEF-H1, by screening a human HeLa cell cDNA library. GEF-H1 encodes a 100-kDa protein containing the conserved structural array of a Dbl homology domain in tandem with a pleckstrin homology domain and is most closely related to the lfc oncogene, but additionally it contains a unique coiled-coil domain at the carboxyl terminus, Biochemical analysis reveals that GEF-H1 is capable of stimulating guanine nucleotide exchange of Rac and Rho but is inactive toward Cdc42, TC10, or Ras, Moreover, GEF-H1 binds to Rac and Rho proteins in both the GDP- and guanosine 5'-3-O-(thio)triphosphate-bound states without detectable affinity for Cdc42 or Ras. Immunofluorescence reveals that GEF-H1 colocalizes with microtubules through the carboxyl-terminal coiled-coil domain. Overexpression of GEF-H1 in COS-7 cells results in induction of membrane ruffles. These results suggest that GEF-H1 may have a direct role in activation of Rac and/or Rho and in bringing the activated GTPase to specific target sites such as microtubules.	Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; Univ Tennessee, Dept Biochem, Memphis, TN 38163 USA	Baylor College of Medicine; University of Tennessee System; University of Tennessee Health Science Center	Ren, Y (corresponding author), Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA.		Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074	NIGMS NIH HHS [GM53943] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053943] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Best A, 1996, J BIOL CHEM, V271, P3756; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Brill S, 1996, MOL CELL BIOL, V16, P4869; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; HART MJ, 1994, J BIOL CHEM, V269, P62; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MOSTELLER RD, 1994, MOL CELL BIOL, V14, P1104, DOI 10.1128/MCB.14.2.1104; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Olson MF, 1997, ONCOGENE, V15, P2827, DOI 10.1038/sj.onc.1201594; PASTERIS NG, 1994, CELL, V79, P669; QUILLIAM LA, 1995, BIOESSAYS, V17, P309; REDDY AB, 1989, CANCER RES, V49, P1763; Ren Y, 1996, PROTEIN EXPRES PURIF, V7, P212, DOI 10.1006/prep.1996.0029; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sambrook J., 2002, MOL CLONING LAB MANU; SHERWOOD SW, 1994, EXP CELL RES, V215, P373, DOI 10.1006/excr.1994.1354; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; TOKSOZ D, 1994, ONCOGENE, V9, P621; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; WHITEHEAD I, 1995, J BIOL CHEM, V270, P18388, DOI 10.1074/jbc.270.31.18388; Whitehead IP, 1996, J BIOL CHEM, V271, P18643, DOI 10.1074/jbc.271.31.18643; WICHE G, 1991, J CELL BIOL, V114, P83, DOI 10.1083/jcb.114.1.83; Zheng Y, 1996, J BIOL CHEM, V271, P19017, DOI 10.1074/jbc.271.32.19017	34	238	249	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					34954	34960		10.1074/jbc.273.52.34954	http://dx.doi.org/10.1074/jbc.273.52.34954			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857026	hybrid			2022-12-27	WOS:000077719700044
J	Pessin, JE; Thurmond, DC; Elmendorf, JS; Coker, KJ; Okada, S				Pessin, JE; Thurmond, DC; Elmendorf, JS; Coker, KJ; Okada, S			Molecular basis of insulin-stimulated GLUT4 vesicle trafficking - Location! Location! Location!	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GLUCOSE-TRANSPORTER GLUT4; RAT ADIPOSE-CELLS; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 3-KINASE; SKELETAL-MUSCLE; SUBCELLULAR-LOCALIZATION; INTRACELLULAR GLUT4; POTENTIAL ROLE; TRANSLOCATION		Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Pessin, JE (corresponding author), Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	Jeffrey-Pessin@uiowa.edu						Al-Hasani H, 1998, J BIOL CHEM, V273, P17504, DOI 10.1074/jbc.273.28.17504; ANDO A, 1994, EMBO J, V13, P3033, DOI 10.1002/j.1460-2075.1994.tb06602.x; BALDINI G, 1991, J BIOL CHEM, V266, P4037; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Baron V, 1998, ENDOCRINOLOGY, V139, P3034, DOI 10.1210/en.139.6.3034; Bennett MK, 1997, CURR OPIN NEUROBIOL, V7, P316, DOI 10.1016/S0959-4388(97)80058-X; BURANT CF, 1992, J BIOL CHEM, V267, P14523; Calakos N, 1996, PHYSIOL REV, V76, P1; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Charron MJ, 1999, J BIOL CHEM, V274, P3253, DOI 10.1074/jbc.274.6.3253; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; Chen D, 1997, J BIOL CHEM, V272, P27401, DOI 10.1074/jbc.272.43.27401; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Cormont M, 1996, MOL CELL BIOL, V16, P6879; CORMONT M, 1993, J BIOL CHEM, V268, P19491; CORVERA S, 1994, J CELL BIOL, V126, P979, DOI 10.1083/jcb.126.4.979; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; CZECH MP, 1993, J BIOL CHEM, V268, P9187; CZECH MP, 1993, J CELL BIOL, V123, P127, DOI 10.1083/jcb.123.1.127; CZECH MP, 1995, ANNU REV NUTR, V15, P441, DOI 10.1146/annurev.nu.15.070195.002301; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Garippa RJ, 1996, J BIOL CHEM, V271, P20660, DOI 10.1074/jbc.271.34.20660; Goda Y, 1997, P NATL ACAD SCI USA, V94, P769, DOI 10.1073/pnas.94.3.769; HANEY PM, 1991, J CELL BIOL, V114, P689, DOI 10.1083/jcb.114.4.689; HANEY PM, 1995, J CELL BIOL, V129, P641, DOI 10.1083/jcb.129.3.641; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; HOLMAN GD, 1994, BIOESSAYS, V16, P753, DOI 10.1002/bies.950161010; HUDSON AW, 1993, J CELL BIOL, V122, P579, DOI 10.1083/jcb.122.3.579; HUDSON AW, 1992, J CELL BIOL, V116, P785, DOI 10.1083/jcb.116.3.785; JHUN BH, 1992, J BIOL CHEM, V267, P17710; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Kandror KV, 1996, AM J PHYSIOL-ENDOC M, V271, pE1, DOI 10.1152/ajpendo.1996.271.1.E1; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kishi K, 1996, J BIOL CHEM, V271, P26561, DOI 10.1074/jbc.271.43.26561; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; KLIP A, 1994, FASEB J, V8, P43, DOI 10.1096/fasebj.8.1.8299889; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Lee W, 1997, J BIOL CHEM, V272, P21427, DOI 10.1074/jbc.272.34.21427; MARSH BJ, 1995, J CELL BIOL, V130, P1081, DOI 10.1083/jcb.130.5.1081; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; Mora S, 1997, BIOCHEM J, V324, P455, DOI 10.1042/bj3240455; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; NISHIMURA H, 1993, J BIOL CHEM, V268, P19246; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Rao AW, 1998, J BIOL CHEM, V273, P25450, DOI 10.1074/jbc.273.39.25450; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; RODNICK KJ, 1992, J BIOL CHEM, V267, P6278; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; SATOH S, 1993, J BIOL CHEM, V268, P17820; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Sevilla L, 1997, ENDOCRINOLOGY, V138, P3006, DOI 10.1210/en.138.7.3006; Shepherd PR, 1997, BIOCHEM SOC T, V25, P978, DOI 10.1042/bst0250978; SHIBATA H, 1995, J BIOL CHEM, V270, P11489, DOI 10.1074/jbc.270.19.11489; Shibata H, 1996, J BIOL CHEM, V271, P9704, DOI 10.1074/jbc.271.16.9704; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SMITH RM, 1991, P NATL ACAD SCI USA, V88, P6893, DOI 10.1073/pnas.88.15.6893; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; VERHEY KJ, 1995, J CELL BIOL, V130, P1071, DOI 10.1083/jcb.130.5.1071; Volchuk A, 1998, J BIOL CHEM, V273, P8169, DOI 10.1074/jbc.273.14.8169; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; Wang WC, 1996, J CELL BIOL, V135, P415, DOI 10.1083/jcb.135.2.415; Waters SB, 1997, J BIOL CHEM, V272, P23323, DOI 10.1074/jbc.272.37.23323; Yang J, 1996, BIOCHEM J, V313, P125, DOI 10.1042/bj3130125; YANG J, 1993, J BIOL CHEM, V268, P4600; YEH JI, 1995, J BIOL CHEM, V270, P2107, DOI 10.1074/jbc.270.5.2107	80	336	345	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	1999	274	5					2593	2596		10.1074/jbc.274.5.2593	http://dx.doi.org/10.1074/jbc.274.5.2593			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	161ZB	9915783	hybrid			2022-12-27	WOS:000078319500001
J	Periasamy, M; Reed, TD; Liu, LH; Ji, Y; Loukianov, E; Paul, RJ; Nieman, ML; Riddle, T; Duffy, JJ; Doetschman, T; Lorenz, JN; Shull, GE				Periasamy, M; Reed, TD; Liu, LH; Ji, Y; Loukianov, E; Paul, RJ; Nieman, ML; Riddle, T; Duffy, JJ; Doetschman, T; Lorenz, JN; Shull, GE			Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAGE HEART-FAILURE; PIG SMOOTH-MUSCLE; SARCOPLASMIC-RETICULUM; CA-2+-ATPASE GENE; MOLECULAR-CLONING; PHOSPHOLAMBAN GENE; PRESSURE OVERLOAD; ATPASE GENE; CA-2+ PUMP; EXPRESSION	The sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene encodes both SERCA2a, the cardiac sarcoplasmic reticulum Ca2+ pump, and SERCA2b, which is expressed in all tissues. To gain a better understanding of the physiological functions of SERCA2, we used gene targeting to develop a mouse in which the promoter and 5' end of the gene were eliminated, Mating of heterozygous mutant mice yielded wild-type and heterozygous offspring; homozygous mutants were not observed. RNase protection, Western blotting, and biochemical analysis of heart samples showed that SERCA2 mRNA was reduced by similar to 45% in heterozygous mutant hearts and that SERCA2 protein and maximal velocity of Ca2+ uptake into the sarcoplasmic reticulum were reduced by similar to 35%, Measurements of cardiovascular performance via transducers in the left ventricle and right femoral artery of the anesthetized mouse revealed reductions in mean arterial pressure, systolic ventricular pressure, and the absolute values of both positive and negative dP/dt in heterozygous mutants. These results demonstrate that two functional copies of the SERCA2 gene are required to maintain normal levels of SERCA2 mRNA, protein, and Ca2+ sequestering activity, and that the deficit in Ca2+ sequestering activity due to the loss of one copy of the SERCA2 gene impairs cardiac contractility and relaxation.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Cellular & Mol Physiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Shull, GE (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Bethesda Ave,ML 524, Cincinnati, OH 45267 USA.	shullge@ucmail.uc.edu	Loukianov, Evgeny/AAC-9794-2022	Periasamy, Muthu/0000-0001-8834-5975	NHLBI NIH HHS [HL52318, HL41496] Funding Source: Medline; NIDDK NIH HHS [DK50594] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL052318, P01HL041496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK050594, R01DK050594] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARAI M, 1993, CIRC RES, V72, P463, DOI 10.1161/01.RES.72.2.463; ARAI M, 1994, CIRC RES, V74, P555, DOI 10.1161/01.RES.74.4.555; CHU G, 1996, CIRC RES, V81, P485; DELABASTIE D, 1990, CIRC RES, V66, P554, DOI 10.1161/01.RES.66.2.554; DUDOV KP, 1984, CELL, V37, P457, DOI 10.1016/0092-8674(84)90376-3; EGGERMONT JA, 1990, BIOCHEM J, V271, P649, DOI 10.1042/bj2710649; EGGERMONT JA, 1990, BIOCHEM J, V266, P901; FELDMAN AM, 1993, CIRC RES, V73, P184, DOI 10.1161/01.RES.73.1.184; GANIM JR, 1992, CIRC RES, V71, P1021, DOI 10.1161/01.RES.71.5.1021; GUNTESKIHAMBLIN AM, 1988, J BIOL CHEM, V263, P15032; GWATHMEY JK, 1987, CIRC RES, V61, P70, DOI 10.1161/01.RES.61.1.70; HARRER JM, 1995, BIOTECHNIQUES, V18, P995; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; He HP, 1997, J CLIN INVEST, V100, P380, DOI 10.1172/JCI119544; KOMURO I, 1989, J CLIN INVEST, V83, P1102, DOI 10.1172/JCI113989; KRANIAS EG, 1985, BIOCHEM J, V226, P113, DOI 10.1042/bj2260113; LANGER GA, 1992, FASEB J, V6, P893, DOI 10.1096/fasebj.6.3.1310947; LIMAS CJ, 1987, CARDIOVASC RES, V21, P601, DOI 10.1093/cvr/21.8.601; Liu LH, 1997, J BIOL CHEM, V272, P30538, DOI 10.1074/jbc.272.48.30538; Lorenz JN, 1997, AM J PHYSIOL-HEART C, V273, pH2826, DOI 10.1152/ajpheart.1997.273.6.H2826; LORENZ JN, 1997, AM J PHYSIOL, V272, pH1167; Loukianov E, 1998, CIRC RES, V83, P889; Luo WS, 1996, CIRC RES, V78, P839, DOI 10.1161/01.RES.78.5.839; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; LYTTON J, 1988, J BIOL CHEM, V263, P15024; LYTTON J, 1989, J BIOL CHEM, V264, P7059; MATSUI H, 1995, AM J PHYSIOL-CELL PH, V268, pC252, DOI 10.1152/ajpcell.1995.268.1.C252; MERCADIER JJ, 1990, J CLIN INVEST, V85, P305, DOI 10.1172/JCI114429; NAGAI R, 1989, P NATL ACAD SCI USA, V86, P2966, DOI 10.1073/pnas.86.8.2966; PAGANI ED, 1984, AM J PHYSIOL, V247, P909; SOLARO RJ, 1974, CIRC RES, V34, P531, DOI 10.1161/01.RES.34.4.531; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443; TAKAHASHI T, 1992, J CLIN INVEST, V90, P927, DOI 10.1172/JCI115969; WANKERL M, 1995, J MOL MED-JMM, V73, P487	34	195	201	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2556	2562		10.1074/jbc.274.4.2556	http://dx.doi.org/10.1074/jbc.274.4.2556			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891028	hybrid			2022-12-27	WOS:000078185200095
J	Trejo, J; Coughlin, SR				Trejo, J; Coughlin, SR			The cytoplasmic tails of protease-activated receptor-1 and substance P receptor specify sorting to lysosomes versus recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET THROMBIN RECEPTOR; COUPLED RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; PROTEOLYTIC MECHANISM; BETA-ARRESTIN; RESENSITIZATION; ENDOCYTOSIS; INTERNALIZATION; SEQUESTRATION; CELLS	The G protein-coupled receptor (GPCR) for thrombin, protease-activated receptor-1 (PAR1), is activated when thrombin cleaves its amino-terminal exodomain. The irreversibility of this proteolytic mechanism raises the question of how desensitization and resensitization are accomplished for thrombin signaling. PAR1 is phosphorylated, uncoupled from signaling, and internalized after activation like classic GPCRs, However, unlike classic GPCRs, which internalize and recycle, activated PAR1 is sorted to lysosomes. To identify the signals that specify the distinct sorting of PAR1, we constructed chimeras between PAR1 and the substance P receptor. Wild-type substance P receptor internalized and recycled after activation; PAR1 bearing the cytoplasmic tail of the substance P receptor (P/S) behaved similarly. By contrast, wild-type PAR1 and a substance P receptor bearing the cytoplasmic tail of PAR1 (S/P) sorted to lysosomes after activation, Consistent with these observations, PARI and the S/P chimera were effectively downregulated by their respective agonists as assessed by both receptor protein levels and signaling. Substance P receptor and the P/S chimera showed little down-regulation. These data suggest that the cytoplasmic tails of PAR1 and substance P receptor specify their distinct intracellular sorting patterns after activation and internalization. Moreover, by altering the trafficking fates of PARI and substance P receptor, one can dictate the efficiency with which a cell maintains responsiveness to PAR1 or substance P receptor agonists over time.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, HSE-1300,Box 0130,505 Parnassus Ave, San Francisco, CA 94143 USA.	shaun_coughlin@quickmail.ucsf.edu		TREJO, JOANN/0000-0003-4405-6228	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044907, R01HL059202] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL59202, HL44907] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CHEN J, 1994, J BIOL CHEM, V269, P16041; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; COUGHLIN SR, 1994, TRENDS CARDIOVAS MED, V4, P77, DOI 10.1016/1050-1738(94)90013-2; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GRADY EF, 1995, MOL BIOL CELL, V6, P509, DOI 10.1091/mbc.6.5.509; HEIN L, 1994, J BIOL CHEM, V269, P27719; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; HOXIE JA, 1993, J BIOL CHEM, V268, P13756; HUNG DT, 1992, J CELL BIOL, V116, P827, DOI 10.1083/jcb.116.3.827; HUNG DT, 1992, J CLIN INVEST, V89, P1350, DOI 10.1172/JCI115721; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; ISHII K, 1994, J BIOL CHEM, V269, P1125; ISHII K, 1993, J BIOL CHEM, V268, P9780; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Krueger KM, 1997, J BIOL CHEM, V272, P5; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; Nanevicz T, 1996, J BIOL CHEM, V271, P702, DOI 10.1074/jbc.271.2.702; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Reaves BJ, 1996, J CELL SCI, V109, P749; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; Trejo J, 1996, J BIOL CHEM, V271, P21536, DOI 10.1074/jbc.271.35.21536; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; WOOLKALIS MJ, 1995, J BIOL CHEM, V270, P9868, DOI 10.1074/jbc.270.17.9868; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649; YU SS, 1993, J BIOL CHEM, V268, P337	32	138	142	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2216	2224		10.1074/jbc.274.4.2216	http://dx.doi.org/10.1074/jbc.274.4.2216			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9890984	hybrid			2022-12-27	WOS:000078185200051
J	Yamada, K; Shimada, T; Kondo, M; Nishimura, M; Hara-Nishimura, I				Yamada, K; Shimada, T; Kondo, M; Nishimura, M; Hara-Nishimura, I			Multiple functional proteins are produced by cleaving Asn-Gln bonds of a single precursor by vacuolar processing enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING PUMPKIN COTYLEDONS; SODIUM DODECYL-SULFATE; AMINO-ACID SEQUENCES; SP SEED GLOBULIN; MOLECULAR CHARACTERIZATION; ARABIDOPSIS-THALIANA; GEL-ELECTROPHORESIS; PLANT-CELLS; CDNA; INHIBITORS	Precursor-accumulating vesicles mediate transport of the precursors of seed proteins to protein storage vacuoles in maturing pumpkin seeds. We isolated the precursor-accumulating vesicles and characterized a 100-kDa component (PV100) of the vesicles. Isolated cDNA for PV100 encoded a 97,310-Da protein that was composed of a hydrophobic signal peptide and the following three domains: an 11-kDa Cys-rich domain with four CXXXC motifs, a 34-kDa Arg/Glu-rich domain composed of six homologous repeats, and a 56-kDa vicilin-like domain. Both immunocytochemistry and immunoblots with anti-PV100 antibodies showed that <10-kDa proteins and the 50-kDa vicilin-like protein were accumulated in the vacuoles, To identify the mature proteins derived from PV100, soluble proteins of the vacuoles were separated, and their molecular structures were determined. Mass spectrometry and peptide sequencing showed that two Cys-rich peptides, three Arg/Glu-rich peptides, and the vicilin-like protein were produced by cleaving Asn-Gln bonds of PV100 and that all of these proteins had a pyroglutamate at their NH,termini, To clarify the cleavage mechanism, in vitro processing of PV100 was performed with purified vacuolar processing enzyme (VPE), Taken together, these results suggested that VPE was responsible for cleaving Asn-Gln bonds of a single precursor, PV100, to produce multiple seed proteins. It is likely that the Asn-Gln stretches not only provide cleavage sites for VPE but also produce aminopeptidase-resistant proteins. We also found that the Cys-rich peptide functions as a trypsin inhibitor. Our findings suggested that PV100 is converted into different functional proteins, such as a proteinase inhibitor and a storage protein, in the vacuoles of seed cells.	Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 444, Japan; Grad Univ Adv Studies, Dept Mol Biomech, Sch Life Sci, Okazaki, Aichi 444, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Hara-Nishimura, I (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 444, Japan.	ihnishi@nibb.ac.jp		Nishimura, Mikio/0000-0001-7960-9721				AKAZAWA T, 1985, ANNU REV PLANT PHYS, V36, P441; ATKINSON AH, 1993, PLANT CELL, V5, P203, DOI 10.1105/tpc.5.2.203; BECKER C, 1995, EUR J BIOCHEM, V228, P456, DOI 10.1111/j.1432-1033.1995.tb20284.x; BEDNAREK SY, 1991, PLANT CELL, V3, P1195, DOI 10.1105/tpc.3.11.1195; Cechova D, 1976, Methods Enzymol, V45, P806, DOI 10.1016/S0076-6879(76)45074-7; CHLAN CA, 1986, PLANT MOL BIOL, V7, P475, DOI 10.1007/BF00020331; CHRISPEELS MJ, 1991, ANNU REV PLANT PHYS, V42, P21, DOI 10.1146/annurev.pp.42.060191.000321; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; FUKASAWA T, 1988, PLANT CELL PHYSIOL, V29, P339; Hara-Nishimura I, 1998, PLANT CELL, V10, P825, DOI 10.1105/tpc.10.5.825; Hara-Nishimura I, 1998, J PLANT PHYSIOL, V152, P668, DOI 10.1016/S0176-1617(98)80028-X; HARADA JJ, 1989, PLANT CELL, V1, P415, DOI 10.1105/tpc.1.4.415; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; HARANISHIMURA I, 1987, PLANT PHYSIOL, V85, P440, DOI 10.1104/pp.85.2.440; HARANISHIMURA I, 1991, FEBS LETT, V294, P89, DOI 10.1016/0014-5793(91)81349-D; HARANISHIMURA I, 1985, PLANT PHYSIOL, V77, P747, DOI 10.1104/pp.77.3.747; HARANISHIMURA I, 1982, PLANT PHYSIOL, V70, P699, DOI 10.1104/pp.70.3.699; HARANISHIMURA I, 1993, PLANT CELL, V5, P1651, DOI 10.1105/tpc.5.11.1651; HARANISHIMURA I, 1995, J PLANT PHYSL, V145, P932; Hiraiwa N, 1997, EUR J BIOCHEM, V246, P133, DOI 10.1111/j.1432-1033.1997.00133.x; HOLWERDA BC, 1992, PLANT CELL, V4, P307, DOI 10.1105/tpc.4.3.307; INOUE K, 1995, PLANT J, V7, P235, DOI 10.1046/j.1365-313X.1995.7020235.x; INOUE K, 1995, PLANT MOL BIOL, V28, P1089, DOI 10.1007/BF00032669; KINOSHITA T, 1995, PLANT MOL BIOL, V29, P81, DOI 10.1007/BF00019120; Kinoshita T, 1995, PLANT CELL PHYSIOL, V36, P1555; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MATSUOKA K, 1991, P NATL ACAD SCI USA, V88, P834, DOI 10.1073/pnas.88.3.834; MCHENRY L, 1992, PLANT MOL BIOL, V18, P1173, DOI 10.1007/BF00047720; MORI H, 1991, EUR J BIOCHEM, V197, P331, DOI 10.1111/j.1432-1033.1991.tb15915.x; NAISBITT GH, 1988, PLANT PHYSIOL, V88, P770, DOI 10.1104/pp.88.3.770; NEUHAUS JM, 1991, P NATL ACAD SCI USA, V88, P10362, DOI 10.1073/pnas.88.22.10362; NG JD, 1993, PLANT PHYSIOL, V101, P713, DOI 10.1104/pp.101.3.713; NISHIMURA M, 1993, PROTOPLASMA, V175, P131, DOI 10.1007/BF01385011; OHMIYA M, 1980, PLANT CELL PHYSIOL, V21, P157; Okita TW, 1996, ANNU REV PLANT PHYS, V47, P327, DOI 10.1146/annurev.arplant.47.1.327; Park SS, 1997, FEBS LETT, V400, P103, DOI 10.1016/S0014-5793(96)01367-1; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shimada T, 1997, PLANT CELL PHYSIOL, V38, P1414, DOI 10.1093/oxfordjournals.pcp.a029138; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WATSON MD, 1988, BIOCHEM J, V251, P857, DOI 10.1042/bj2510857; WIECZOREK M, 1985, BIOCHEM BIOPH RES CO, V126, P646, DOI 10.1016/0006-291X(85)90233-5	42	88	90	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	1999	274	4					2563	2570		10.1074/jbc.274.4.2563	http://dx.doi.org/10.1074/jbc.274.4.2563			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	159QL	9891029	hybrid			2022-12-27	WOS:000078185200096
J	Liebman, SW; Derkatch, IL				Liebman, SW; Derkatch, IL			The yeast [PSI+] prion: Making sense of nonsense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CHAIN RELEASE FACTORS; DE-NOVO APPEARANCE; SACCHAROMYCES-CEREVISIAE; SUP35 PROTEIN; IN-VITRO; DETERMINANT; GENE; PROPAGATION; TRANSLATION; INHERITANCE		Univ Illinois, Dept Biol Sci, Mol Biol Lab, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Liebman, SW (corresponding author), Univ Illinois, Dept Biol Sci, Mol Biol Lab, Chicago, IL 60607 USA.				NIGMS NIH HHS [R01 GM056350] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056350] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; BORKHSENIUS AS, 1995, DOKL AKAD NAUK, V353, P553; Buckingham RH, 1997, MOL MICROBIOL, V24, P449, DOI 10.1046/j.1365-2958.1997.3711734.x; CHARNOFF YO, 1995, SCIENCE, V268, P890; CHERNOFF YO, 1992, YEAST, V8, P489, DOI 10.1002/yea.320080702; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; COX B, 1994, CURR BIOL, V4, P744, DOI 10.1016/S0960-9822(00)00167-6; Cox Brian, 1993, P219; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1998, P NATL ACAD SCI USA, V95, P2400, DOI 10.1073/pnas.95.5.2400; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; DOEL SM, 1994, GENETICS, V137, P659; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Frolova L, 1996, RNA, V2, P334; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Gagny B, 1998, GENETICS, V149, P1763; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; JeanJean O, 1996, CR ACAD SCI III-VIE, V319, P487; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Kochneva-Pervukhova NV, 1998, CURR GENET, V34, P146, DOI 10.1007/s002940050379; Kochneva-Pervukhova NV, 1998, EMBO J, V17, P5805, DOI 10.1093/emboj/17.19.5805; KUSHNIROV VV, 1990, YEAST, V6, P461, DOI 10.1002/yea.320060603; LIEBMAN SW, 1979, J BACTERIOL, V139, P1068, DOI 10.1128/JB.139.3.1068-1071.1979; LIEBMAN SW, 1980, GENETICS, V95, P49; LIEBMAN SW, 1980, J BACTERIOL, V143, P1527, DOI 10.1128/JB.143.3.1527-1529.1980; LIEBMAN SW, 1984, CURR GENET, V8, P567, DOI 10.1007/BF00395701; Lindquist S, 1997, CELL, V89, P495, DOI 10.1016/S0092-8674(00)80231-7; LUND PM, 1981, GENET RES, V37, P173, DOI 10.1017/S0016672300020140; NEWNAM GP, 1999, IN PRESS MOL CELL BI, V19; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, MOL CELL BIOL, V17, P2798, DOI 10.1128/MCB.17.5.2798; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Pel HJ, 1998, RNA, V4, P47; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; Schirmer EC, 1997, P NATL ACAD SCI USA, V94, P13932, DOI 10.1073/pnas.94.25.13932; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Tikhomirova VL, 1996, CURR GENET, V30, P44, DOI 10.1007/s002940050098; Tuite MF, 1996, TRENDS GENET, V12, P467, DOI 10.1016/0168-9525(96)10045-7; TUITE MF, 1982, PLASMID, V8, P103, DOI 10.1016/0147-619X(82)90048-8; TUITE MF, 1980, GENETICS, V95, P611; VINCENT A, 1994, GENETICS, V138, P597; Weissmann C, 1999, J BIOL CHEM, V274, P3, DOI 10.1074/jbc.274.1.3; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1999, J BIOL CHEM, V274, P555, DOI 10.1074/jbc.274.2.555; Wickner RB, 1996, CURR TOP MICROBIOL, V207, P147; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; YOUNG CSH, 1971, HEREDITY, V26, P413, DOI 10.1038/hdy.1971.52; YOUNG CSH, 1972, HEREDITY, V28, P189, DOI 10.1038/hdy.1972.24; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	56	77	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1181	1184		10.1074/jbc.274.3.1181	http://dx.doi.org/10.1074/jbc.274.3.1181			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880481	hybrid			2022-12-27	WOS:000079956900001
J	Schiltz, RL; Mizzen, CA; Vassilev, A; Cook, RG; Allis, CD; Nakatani, Y				Schiltz, RL; Mizzen, CA; Vassilev, A; Cook, RG; Allis, CD; Nakatani, Y			Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLTRANSFERASE ACTIVITY; RNA-POLYMERASE; YEAST GCN5P; IN-VIVO; TRANSCRIPTION; ACTIVATION; CBP; COMPLEX; E1A; REQUIREMENTS	A number of transcriptional coactivators possess intrinsic histone acetylase activity, providing a direct link between hyperacetylated chromatin and transcriptional activation. We have determined the core histone residues acetylated in vitro by recombinant p300 and PCAF within mononucleosomes. p300 specifically acetylates all sites of histones H2A and H2B known to be acetylated in bulk chromatin in vivo but preferentially acetylates lysines 14 and 18 of histone H3 and lysines 5 and 18 of histone H4. PCAF primarily acetylates lysine 14 of H3 but also less efficiently acetylates lysine 8 of H4. PCAF in its native form, which is present in a stable multimeric protein complex lacking p300/CBP, primarily acetylates H3 to a monoacetylated form, suggesting that PCAF-associated polypeptides do not alter the substrate specificity. These distinct patterns of acetylation by the p300 and PCAF may contribute to their differential roles in transcriptional regulation.	NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA; Univ Rochester, Dept Biol, Rochester, NY 14627 USA; Baylor Coll Med, Dept Microbiol & Immunol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Rochester; Baylor College of Medicine	Nakatani, Y (corresponding author), NICHHD, Lab Mol Growth Regulat, NIH, Bldg 6,Rm 416, Bethesda, MD 20892 USA.							ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; BANNO Y, 1984, REV INFECT DIS S1, V6, P11; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kaufman PD, 1996, CURR OPIN CELL BIOL, V8, P369, DOI 10.1016/S0955-0674(96)80012-3; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lee JS, 1996, MOL CELL BIOL, V16, P4312; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Mizzen CA, 1998, CELL MOL LIFE SCI, V54, P6, DOI 10.1007/s000180050121; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; Owen-Hughes Thomas, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P403; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Roth SY, 1996, CELL, V87, P5, DOI 10.1016/S0092-8674(00)81316-1; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; SOBEL RE, 1994, J BIOL CHEM, V269, P18576; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; THORNE AW, 1990, EUR J BIOCHEM, V193, P701, DOI 10.1111/j.1432-1033.1990.tb19390.x; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Varga-Weisz PD, 1998, CURR OPIN CELL BIOL, V10, P346, DOI 10.1016/S0955-0674(98)80010-0; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; WEST MHP, 1980, BIOCHEMISTRY-US, V19, P3238, DOI 10.1021/bi00555a022; Wu C, 1997, J BIOL CHEM, V272, P28171, DOI 10.1074/jbc.272.45.28171; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	43	328	340	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1189	1192		10.1074/jbc.274.3.1189	http://dx.doi.org/10.1074/jbc.274.3.1189			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880483	hybrid			2022-12-27	WOS:000079956900003
J	van den Elsen, J; Vandeputte-Rutten, L; Kroon, J; Gros, P				van den Elsen, J; Vandeputte-Rutten, L; Kroon, J; Gros, P			Bactericidal antibody recognition of meningococcal PorA by induced fit - Comparison of liganded and unliganded Fab structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHINOVIRUS NEUTRALIZING ANTIBODY; NEISSERIA-MENINGITIDIS; CRYSTAL-STRUCTURE; STRUCTURE REFINEMENT; ANTIGEN INTERACTIONS; MAXIMUM-LIKELIHOOD; COMPLEX; PROGRAM; PEPTIDE; EPITOPE	MN12H2 is a bactericidal antibody directed against outer membrane protein PorA epitope P1.16 of Neisseria meningitidis. Binding of MN12H2 to PorA at the meningococcal surface activates the classical complement pathway resulting in bacterial lysis, We have deter mined the crystal structure of the unliganded MN12H2 Fab fragment in two different crystal forms and compared it with the structure of the Fab in complex with a P1.16-derived peptide. The unliganded Fabs have elbow bend angles of 155 degrees and 159 degrees, whereas the liganded Fab has a more closed elbow bend of 143 degrees, Substantial differences in quaternary and tertiary structure of the antigen binding site are observed between the unliganded and liganded MN12H2 Fab structures that can be attributed to peptide binding. The variable light and heavy chain interface of the liganded Fab is twisted by a 5 degrees rotation along an axis approximately perpendicular to the plane of the interface. Hypervariable loops H1, H2, and framework loop FR-HS follow this rotation. The hypervariable loop H3 undergoes conformational changes but remains closely linked to hypervariable loop L1. In Fab-peptide structures, the MN12H2 binding site is narrowed upon peptide binding due to the formation of a "false floor" mediated by arginine residue 101 of the light chain. These results indicate that PorA epitope P1.16 of N. meningitidis is recognized by the complement-activating antibody MN12H2 through induced fit, allowing the formation of a highly complementary immune complex.	Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Crystal & Struct Chem, NL-3584 CH Utrecht, Netherlands	Utrecht University	Gros, P (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Crystal & Struct Chem, Padualaan 8, NL-3584 CH Utrecht, Netherlands.		van den Elsen, Jean/D-9274-2011; Gros, Piet/I-5569-2016; Gros, Piet/AAD-6452-2019	Gros, Piet/0000-0002-7782-2585; Gros, Piet/0000-0002-7782-2585; van den Elsen, Jean/0000-0002-0367-1956				Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; GHIARA JB, 1994, SCIENCE, V264, P82, DOI 10.1126/science.7511253; HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302; JISKOOT W, 1991, J IMMUNOL METHODS, V138, P273, DOI 10.1016/0022-1759(91)90176-G; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabat E. A., 1991, SEQUENCES PROTEINS I, V1; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MILAGRES LG, 1994, INFECT IMMUN, V62, P4419, DOI 10.1128/IAI.62.10.4419-4424.1994; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; RINI JM, 1993, P NATL ACAD SCI USA, V90, P6325, DOI 10.1073/pnas.90.13.6325; STANFIELD RL, 1990, SCIENCE, V248, P721; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Tormo J, 1995, PROTEINS, V23, P491, DOI 10.1002/prot.340230404; TORMO J, 1994, EMBO J, V13, P2247, DOI 10.1002/j.1460-2075.1994.tb06506.x; vandenElsen JMH, 1997, PROTEINS, V29, P113; vandenElsen JMH, 1997, BIOCHEMISTRY-US, V36, P12583, DOI 10.1021/bi9700431; vandenElsen JMH, 1997, ANAL BIOCHEM, V247, P382, DOI 10.1006/abio.1997.2064; VANDERLEY P, 1991, INFECT IMMUN, V59, P2963, DOI 10.1128/IAI.59.9.2963-2971.1991; VanDerVoort ER, 1996, INFECT IMMUN, V64, P2745, DOI 10.1128/IAI.64.7.2745-2751.1996; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WILSON IA, 1993, CURR OPIN STRUC BIOL, V3, P113, DOI 10.1016/0959-440X(93)90210-C; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4	32	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1495	1501		10.1074/jbc.274.3.1495	http://dx.doi.org/10.1074/jbc.274.3.1495			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880525	hybrid			2022-12-27	WOS:000079956900045
J	Zhao, SM; Somerville, RL				Zhao, SM; Somerville, RL			Isolated operator binding and ligand response domains of the TyrR protein of Haemophilus influenzae associated to reconstitute functional repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GENE; PURIFICATION; TRYPTOPHAN; EXPRESSION; TYROSINE	Highly purified preparations of the TyrR protein of Haemophilus influenzae Rd undergo specific and limited proteolytic cleavage during storage at 4 degrees C to generate two fragments of 28 and 8 kDa, Under nondenaturing conditions, the two fragments remain tightly associated. Nicked TyrR is identical to full-length TyrR in its operator binding characteristics. The 8-kDa fragment containing amino acid residues 258-318 was separated from the 28-kDa fragment (residues 1-257) by gel filtration chromatography in the presence of 4 M urea. Upon renaturation, this fragment bound to operator with an affinity similar to that of full-length TyrR but was unresponsive to Ligands that normally modulate operator binding (gamma-S-ATP and L-tyrosine), It was not possible to renature the urea-treated 28-kDa fragment. Highly purified soluble preparations of truncated TyrR containing residues 1-257 were obtained after the overexpression of a shortened form of the tyrR gene via a specific plasmid construct. By several criteria, this species had native secondary and tertiary structure. The 28-kDa fragment was unable to bind to operator but could reconstitute nicked TyrR when added to the renatured 8-kDa fragment, as shown by physical properties and responsiveness to cofactors in operator binding. When either the 28- or 8-kDa species was expressed in vivo, there was no detectable operator binding, as evaluated using a lacZ reporter system driven by the repressible aroF promoter. When the two fragments were co-expressed in a common cytoplasm, an operator-binding species was formed, as demonstrated through par tial restoration of repression capability.	Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Somerville, RL (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022131] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM22131] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARGAET VP, 1994, J BIOL CHEM, V269, P5171; CORNISH EC, 1986, J BIOL CHEM, V261, P403; CUI JS, 1993, J BACTERIOL, V175, P303, DOI 10.1128/JB.175.1.303-306.1993; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; HEATWOLE VM, 1991, J BACTERIOL, V173, P3601, DOI 10.1128/jb.173.11.3601-3604.1991; Miller J.H., 1972, EXPT MOL GENETICS; PITTARD AJ, 1991, MOL MICROBIOL, V5, P1585, DOI 10.1111/j.1365-2958.1991.tb01904.x; SOMERVILLE RL, 1991, BIOCHEM BIOPH RES CO, V181, P1056, DOI 10.1016/0006-291X(91)92044-K; YANG J, 1993, J BACTERIOL, V175, P1767, DOI 10.1128/JB.175.6.1767-1776.1993; Zhu Q, 1997, PROTEIN EXPRES PURIF, V10, P237, DOI 10.1006/prep.1997.0757	10	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1999	274	3					1842	1847		10.1074/jbc.274.3.1842	http://dx.doi.org/10.1074/jbc.274.3.1842			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	190HL	9880568	hybrid			2022-12-27	WOS:000079956900088
J	Eickelberg, O; Roth, M; Lorx, R; Bruce, V; Rudiger, J; Johnson, M; Block, LH				Eickelberg, O; Roth, M; Lorx, R; Bruce, V; Rudiger, J; Johnson, M; Block, LH			Ligand-independent activation of the glucocorticoid receptor by beta(2)-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-HORMONE RECEPTORS; GENE-EXPRESSION; GROWTH-FACTOR; PHOSPHORYLATION; PROTEIN; FORMOTEROL; SALMETEROL; CALMODULIN; BINDING; ASTHMA	The glucocorticoid receptor (GR) is a ubiquitously expressed transcription factor present in most cell types. Upon ligand binding, the GR is activated and translocates into the nucleus where it transmits the anti-inflammatory actions of glucocorticoids. Here, we describe the ligand-independent activation of GR by the beta(2)-adrenergic receptor (beta(2)-AR) agonists, salbutamol and salmeterol, in primary human lung fibroblasts and vascular smooth muscle cells. Immunohistochemistry demonstrated expression of GR and the beta(2)-AR by fibroblasts and vascular smooth muscle cells. Treatment of the cells with the beta(2)-AR agonists, salbutamol or salmeterol, resulted in translocation of GR into the nucleus beginning at 30 min, as shown by immunohistochemistry and Western blotting of cytosolic and nuclear cell extracts. In comparison, activation of GR induced by the corticosteroids dexamethasone and fluticasone occurred at the same time after treatment (30 min) but resulted in a more complete depletion of GR from the cytosolic compartment. Electrophoretic mobility shift assays confirmed that nuclear GR, activated by both beta(2)-AR agonists and glucocorticoids, actively bound to the GR consensus sequence (GR element). Functional activation of the GR was confirmed by a Luciferase reporter gene assay, using a GR driven promoter fragment from the p21((WAF1/CIP1)) gene. The effects of the beta(2)-AR agonists, salbutamol and salmeterol, were dependent upon binding to the beta(2)-AR, because blocking of beta(2)-AR with propranolol abrogated GR activation. GR activation appeared to involve cAMP, In summary, these data show that beta(2)-AR agonists are potent activators of GR, Ligand-independent activation of GR by beta(2)-AR agonists may substantially mediate the anti-inflammatory actions of these drugs observed in vitro and in vivo.	Univ Hosp Vienna, Dept Internal Med 4, A-1090 Vienna, Austria; Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; Glaxo Wellcome Res & Dev Ltd, Dept Resp Commercial Strategy, Stockley Pk UB11 1BU, Middx, England	University Hospital Vienna; University of Basel; GlaxoSmithKline	Block, LH (corresponding author), Univ Hosp Vienna, Dept Internal Med 4, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.		Roth, Michael/H-8657-2019; Eickelberg, Oliver/A-5461-2013	Roth, Michael/0000-0002-8139-2821; Eickelberg, Oliver/0000-0001-7170-0360				BALUK P, 1994, AM J PHYSIOL, V266, pL461, DOI 10.1152/ajplung.1994.266.4.L461; BARNES PJ, 1995, NEW ENGL J MED, V332, P868, DOI 10.1056/NEJM199503303321307; BARNES PJ, 1982, NATURE, V299, P444, DOI 10.1038/299444a0; BARNES PJ, 1995, AM J RESP CRIT CARE, V152, P125; BODWELL JE, 1991, J BIOL CHEM, V266, P7549; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Calleja C, 1998, NAT MED, V4, P92, DOI 10.1038/nm0198-092; Cha HH, 1998, J BIOL CHEM, V273, P1998, DOI 10.1074/jbc.273.4.1998; COLLINS S, 1988, J BIOL CHEM, V263, P9067; DAHLMANWRIGHT K, 1994, P NATL ACAD SCI USA, V91, P1619, DOI 10.1073/pnas.91.5.1619; DAVIS C, 1982, J APPL PHYSIOL, V53, P1080, DOI 10.1152/jappl.1982.53.5.1080; DEFRANCO DB, 1991, MOL ENDOCRINOL, V5, P1215, DOI 10.1210/mend-5-9-1215; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eickelberg O, 1997, AM J RESP CRIT CARE, V156, P1987, DOI 10.1164/ajrccm.156.6.9704112; ELDEIRY WS, 1995, CANCER RES, V55, P2910; ERJEFALT I, 1991, AM REV RESPIR DIS, V144, P788, DOI 10.1164/ajrccm/144.4.788; GEHRING U, 1993, J STEROID BIOCHEM, V45, P183, DOI 10.1016/0960-0760(93)90140-R; GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3; GRONEMEYER H, 1992, FASEB J, V6, P2524, DOI 10.1096/fasebj.6.8.1592204; HADCOCK JR, 1988, P NATL ACAD SCI USA, V85, P8415, DOI 10.1073/pnas.85.22.8415; HOECK W, 1989, J BIOL CHEM, V264, P14396; HU JM, 1994, MOL ENDOCRINOL, V8, P1709, DOI 10.1210/me.8.12.1709; KARIN M, 1993, EUR J CLIN PHARM S1, V45, P9; Katzenellenbogen JA, 1996, MOL ENDOCRINOL, V10, P119, DOI 10.1210/me.10.2.119; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; MCCREA KE, 1993, BRIT J PHARMACOL, V110, P619, DOI 10.1111/j.1476-5381.1993.tb13856.x; MENDEL DB, 1986, J BIOL CHEM, V261, P3758; MIGLIACCIO A, 1984, P NATL ACAD SCI-BIOL, V81, P5921, DOI 10.1073/pnas.81.19.5921; Nauck M, 1997, AM J RESP CELL MOL, V16, P398, DOI 10.1165/ajrcmb.16.4.9115750; NIJKAMP FP, 1992, PHYSIOL REV, V72, P323, DOI 10.1152/physrev.1992.72.2.323; NING YM, 1995, BIOCHEM BIOPH RES CO, V208, P48, DOI 10.1006/bbrc.1995.1303; ORTI E, 1993, J BIOL CHEM, V268, P7779; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; PETERS MJ, 1995, EUR J PHARM-MOLEC PH, V289, P275, DOI 10.1016/0922-4106(95)90104-3; Ramalingam A, 1997, MOL ENDOCRINOL, V11, P577, DOI 10.1210/me.11.5.577; Roth M, 1996, P NATL ACAD SCI USA, V93, P5478, DOI 10.1073/pnas.93.11.5478; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Tanaka H, 1996, J IMMUNOL, V156, P1601; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Webster JC, 1997, J BIOL CHEM, V272, P9287; WHELAN CJ, 1993, BRIT J PHARMACOL, V110, P613, DOI 10.1111/j.1476-5381.1993.tb13855.x; Woolcock A, 1996, AM J RESP CRIT CARE, V153, P1481, DOI 10.1164/ajrccm.153.5.8630590	44	308	330	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1005	1010		10.1074/jbc.274.2.1005	http://dx.doi.org/10.1074/jbc.274.2.1005			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873044	hybrid			2022-12-27	WOS:000077968500059
J	Hatada, S; Kuziel, W; Smithies, O; Maeda, N				Hatada, S; Kuziel, W; Smithies, O; Maeda, N			The influence of chromosomal location on the expression of two transgenes in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; C-III GENE; HAPTOGLOBIN GENE; STEM-CELLS; MOUSE; INTEGRATION; ELEMENT; REGION; MUTAGENESIS; DISRUPTION	We have generated mice having a single copy of the human haptoglobin gene (Hp(2)), driven by its natural promoter, and a neomycin resistance gene (Neo), driven by a herpes simplex thymidine kinase promoter with polyoma enhancers, inserted into two defined chromosomal locations, the Hprt locus on the X-chromosome and the apolipoprotein (apo) AI-CIII gene cluster on chromosome 9. The haptoglobin promoter is highly specialized in its tissue of action; the viral promoter has few restrictions. The apoAI-CIII gene is naturally active in only two tissues, whereas the Hprt gene region is ubiquitously active. Expression of both transgenes at substantial levels was achieved only (a) when the transgenes were inserted into the genome close to a known tissue-specific enhancer/locus control region in the apoAI-CIII gene cluster, and (b) when known conditions for function of their promoters were met. The specificities of the two chromosomal regions and of the two promoters are preserved, but their interactions are not specific. Ne conclude that transgenes are affected by locus-related enhancers in the same manner as nearby endogenous genes. Our experiments reinforce the usefulness of using gene targeting to direct single-copy transgenes to appropriate chromosomal locations.	Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Maeda, N (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, CB 7525,Brinkhous Bullitt Bldg, Chapel Hill, NC 27599 USA.				NIGMS NIH HHS [GM37567, GM20069] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020069, R01GM020069, R01GM037567] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALSHAWI R, 1990, MOL CELL BIOL, V10, P1192, DOI 10.1128/MCB.10.3.1192; BISAHA JG, 1995, J BIOL CHEM, V270, P19979, DOI 10.1074/jbc.270.34.19979; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; CONNELL GE, 1959, BIOCHEM J, V72, P115, DOI 10.1042/bj0720115; DARMIENTO J, 1992, CELL, V71, P955, DOI 10.1016/0092-8674(92)90391-O; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; KREUZER J, 1994, J HYPERTENS, V12, P113; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MAEDA N, 1985, J BIOL CHEM, V260, P6698; MAEDA N, 1991, AM J HUM GENET, V49, P158; MAEDA N, 1994, J BIOL CHEM, V269, P23610; MARTINEZ A, 1995, BIOCHEM BIOPH RES CO, V208, P309, DOI 10.1006/bbrc.1995.1339; MEISLER MH, 1992, TRENDS GENET, V8, P341, DOI 10.1016/0168-9525(92)90278-C; NTAMBI JM, 1992, J BIOL CHEM, V267, P10925; OLIVIERO S, 1987, EMBO J, V6, P1905, DOI 10.1002/j.1460-2075.1987.tb02450.x; PALMITER PD, 1986, ANNU REV GENET, V20, P459; REID LH, 1991, MOL CELL BIOL, V11, P2769, DOI 10.1128/MCB.11.5.2769; SABATH DE, 1990, GENE, V91, P185, DOI 10.1016/0378-1119(90)90087-8; Sambrook D.J., 1989, MOL CLONING LAB MANU; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; SORIANO P, 1987, GENE DEV, V1, P366, DOI 10.1101/gad.1.4.366; SPANAKIS E, 1993, NUCLEIC ACIDS RES, V21, P3809, DOI 10.1093/nar/21.16.3809; STIEF A, 1989, NATURE, V341, P343, DOI 10.1038/341343a0; TALBOT D, 1989, NATURE, V338, P352, DOI 10.1038/338352a0; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; WALSH A, 1993, J LIPID RES, V34, P617; WANG A, 1990, ARTICLES URBAN EC, P21; WILLIAMSON R, 1992, P NATL ACAD SCI USA, V89, P7134, DOI 10.1073/pnas.89.15.7134; YANG FM, 1993, GENOMICS, V18, P374, DOI 10.1006/geno.1993.1478; ZANNIS VI, 1991, ADV EXP MED BIOL, V285, P1	30	26	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					948	955		10.1074/jbc.274.2.948	http://dx.doi.org/10.1074/jbc.274.2.948			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873036	hybrid, Green Published			2022-12-27	WOS:000077968500051
J	John, CM; Schneider, H; Griffiss, JM				John, CM; Schneider, H; Griffiss, JM			Neisseria gonorrhoeae that infect men have lipooligosaccharides with terminal N-acetyllactosamine repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL LIPOOLIGOSACCHARIDES; GONOCOCCAL LIPOOLIGOSACCHARIDE; HUMAN GLYCOSPHINGOLIPIDS; MONOCLONAL-ANTIBODIES; MASS-SPECTROMETRY; LIPOPOLYSACCHARIDES; HETEROGENEITY; MENINGITIDIS; EXPRESSION; EPITOPE	Infectious Neisseria gonorrhoeae make relatively large lipooligosaccharides (LOS) that structurally re resemble human glycosphingolipids. MS11mkC is an LOS variant of N. gonorrhoeae strain MS11 which was isolated from men at the onset of dysuria (Schneider, H., Griffiss, J. M., Boslego, J. W., Hitchcock, P. J., Zahos, K. M., and Apicella, M. A (1991) J. Exp. Med 174, 1601-1605). Delayed extraction matrix-assisted laser desorption and ionization and electrospray ionization mass spectrometry of O-deacylated MS11mkC LOS produced ions consistent with known LOS which have lacto-N-neotetraose (Gal beta 1-->4GlcNAc beta 1-->3Gal beta 1-->4Glc; paraglobosyl; monoclonal antibodies (mAbs) 1B2(+) and 06B4(+)) and GalNAc-->lacto-N-neotetraose (gangliosyl; mAb 1-1-M+) oligosaccharides. Ion peaks for a larger LOS which also bound mAb 1B2 indicated the addition of a hexose (+162 Da) to gangliosyl LOS or the addition of a hexose and a N-acetylhexosamine (+365 Da) to paraglobosyl LOS. Analysis of HF-treated and O-deacylated LOS revealed three major components present in a phosphoethanolamine (PEA)(0) and a PEA(1) series. Digestion of MS11mkC LOS by beta-N-acetylhexosaminidase and beta-galactosidase, alone and sequentially, combined with mAb binding patterns, confirmed the presence of a nonreducing terminal repeating LacNAc ((Gal beta 1-->4GlcNAc)(2)) on the largest LOS, rather than a parallel oligosaccharide structure.	Univ Calif San Francisco, Ctr Immunochem, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94121 USA; Walter Reed Army Med Ctr, Walter Reed Army Inst Res, Dept Bacterial Dis, Washington, DC 20307 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Walter Reed National Military Medical Center	John, CM (corresponding author), VA Med Ctr, 111W1,4150 Clement St, San Francisco, CA 94121 USA.	cjohn@vacom.ucsf.edu.net			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021620] Funding Source: NIH RePORTER; NCRR NIH HHS [RR01614] Funding Source: Medline; NIAID NIH HHS [AI21620] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APICELLA MA, 1994, METHOD ENZYMOL, V235, P242; Banerjee A, 1998, P NATL ACAD SCI USA, V95, P10872, DOI 10.1073/pnas.95.18.10872; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Erwin AL, 1996, J EXP MED, V184, P1233, DOI 10.1084/jem.184.4.1233; Gibson BW, 1997, J AM SOC MASS SPECTR, V8, P645, DOI 10.1016/S1044-0305(97)00042-1; GIBSON BW, 1993, J BACTERIOL, V175, P2702, DOI 10.1128/JB.175.9.2702-2712.1993; GIBSON BW, 1989, P NATL ACAD SCI USA, V86, P17, DOI 10.1073/pnas.86.1.17; GRIFFISS JM, 1988, REV INFECT DIS, V10, pS287; GRIFFISS JM, 1995, TRENDS GLYCOSCI GLYC, V7, P461, DOI 10.4052/tigg.7.461; Griffiss JM, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P179; Gulati S, 1996, J INFECT DIS, V174, P1223, DOI 10.1093/infdis/174.6.1223; HOLMES KK, 1970, AM J EPIDEMIOL, V91, P170, DOI 10.1093/oxfordjournals.aje.a121125; JOHN CM, 1991, J BIOL CHEM, V266, P19303; KERWOOD DE, 1992, BIOCHEMISTRY-US, V31, P12760, DOI 10.1021/bi00166a008; LI SC, 1975, J BIOL CHEM, V250, P6786; MANDRELL RE, 1992, INFECT IMMUN, V60, P3017, DOI 10.1128/IAI.60.7.3017-3020.1992; MANDRELL RE, 1991, J BACTERIOL, V173, P2823, DOI 10.1128/JB.173.9.2823-2832.1991; MANDRELL RE, 1988, J EXP MED, V168, P107, DOI 10.1084/jem.168.1.107; PHILLIPS NJ, 1990, BIOMED ENVIRON MASS, V19, P731, DOI 10.1002/bms.1200191112; SCHNEIDER H, 1995, J INFECT DIS, V172, P180, DOI 10.1093/infdis/172.1.180; SCHNEIDER H, 1982, J GEN MICROBIOL, V128, P13; SCHNEIDER H, 1984, INFECT IMMUN, V45, P544, DOI 10.1128/IAI.45.3.544-549.1984; Schneider H, 1996, J INFECT DIS, V173, P1422, DOI 10.1093/infdis/173.6.1422; SCHNEIDER H, 1991, J EXP MED, V174, P1601, DOI 10.1084/jem.174.6.1601; SWANSON J, 1987, J EXP MED, V165, P1344, DOI 10.1084/jem.165.5.1344; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; YAMASAKI R, 1991, MOL IMMUNOL, V28, P1233, DOI 10.1016/0161-5890(91)90010-H; YAMASAKI R, 1994, J BIOL CHEM, V269, P30345; YAMASAKI R, 1991, BIOCHEMISTRY-US, V30, P10566, DOI 10.1021/bi00107a028; YOUNG WW, 1981, J BIOL CHEM, V256, P967	31	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					1017	1025		10.1074/jbc.274.2.1017	http://dx.doi.org/10.1074/jbc.274.2.1017			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873046	hybrid			2022-12-27	WOS:000077968500061
J	Membrillo-Hernandez, J; Coopamah, MD; Anjum, MF; Stevanin, TM; Kelly, A; Hughes, MN; Poole, RK				Membrillo-Hernandez, J; Coopamah, MD; Anjum, MF; Stevanin, TM; Kelly, A; Hughes, MN; Poole, RK			The flavohemoglobin of Escherichia coli confers resistance to a nitrosating agent, a "nitric oxide releaser," and paraquat and is essential for transcriptional responses to oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOGLOBIN-LIKE PROTEIN; MANGANESE SUPEROXIDE-DISMUTASE; FLAVOHAEMOGLOBIN HMP; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; PHYSIOLOGICAL-FUNCTION; BACTERIAL HEMOGLOBIN; YEAST HEMOGLOBIN; OXYGEN; OXIDOREDUCTASE	Escherichia coli possesses a flavohemoglobin (Hmp), product of hmp, the first microbial globin gene to be sequenced and characterized at the molecular level. Although related proteins occur in numerous prokaryotes and eukaryotic microorganisms, the function(s) of these proteins have been elusive. Here we report construction of a defined hmp mutation and its use to probe Hmp function. As anticipated from up-regulation of hmp expression by nitric oxide (NO), S-nitrosoglutathione (GSNO) or sodium nitroprusside (SNP), the hmp mutant is hypersensitive to these agents. The hmp promoter is more sensitive to SNP and S-nitroso-N-penicillamine (SNAP) than is the soxS promoter, consistent with the role of Hmp in protection from reactive nitrogen species. Additional functions for Hmp are indicated by (a) parallel sensitivity of the hmp mutant to the redox-cycling agent, paraquat, (b) inability of the mutant to upregulate fully the soxS and sodA promoters in response to oxidative stress caused by paraquat, GSNO and SNP, and (c) failure of the mutant to accumulate reduced paraquat radical after anoxic growth. We conclude that Hmp plays a role in protection from nitrosating agents and NO-related species and oxidative stress. This protective role probably involves direct detoxification of those species and sensing of NO-related and oxidative stress.	Univ Sheffield, Krebs Inst Biomolec Res, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Univ London Kings Coll, Div Life Sci, London W8 7AH, England; Univ London Kings Coll, Dept Chem, London WC2R 2LS, England	University of Sheffield; University of London; King's College London; University of London; King's College London	Poole, RK (corresponding author), Univ Sheffield, Krebs Inst Biomolec Res, Dept Mol Biol & Biotechnol, Firth Court,Western Bank, Sheffield S10 2TN, S Yorkshire, England.	r.poole@sheffield.ac.uk	Membrillo-Hernández, Jorge/AAN-4996-2021; anjum, muna/C-5213-2011	Membrillo-Hernández, Jorge/0000-0001-7650-8116; Kelly, Andrew/0000-0002-1536-7134				ANDREWS SC, 1992, FEBS LETT, V302, P247, DOI 10.1016/0014-5793(92)80452-M; Anjum MF, 1998, FEMS MICROBIOL LETT, V166, P219, DOI 10.1111/j.1574-6968.1998.tb13893.x; BIANCHI V, 1995, J BACTERIOL, V177, P4528, DOI 10.1128/jb.177.15.4528-4531.1995; BIANCHI V, 1993, J BACTERIOL, V175, P1590, DOI 10.1128/JB.175.6.1590-1595.1993; Buisson N, 1998, J BIOL CHEM, V273, P9527, DOI 10.1074/jbc.273.16.9527; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COMPAN I, 1993, J BACTERIOL, V175, P1687, DOI 10.1128/JB.175.6.1687-1696.1993; COOPER CE, 1994, BIOCHEM SOC T, V22, P709, DOI 10.1042/bst0220709; CRAMM R, 1994, J BIOL CHEM, V269, P7349; Crawford MJ, 1998, J BIOL CHEM, V273, P12543, DOI 10.1074/jbc.273.20.12543; CRAWFORD MJ, 1995, J BIOL CHEM, V270, P6991, DOI 10.1074/jbc.270.12.6991; DAWSON RMC, 1986, DATA BIOCH RES, P350; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; DIKSHIT KL, 1989, J GEN MICROBIOL, V135, P2601; DIKSHIT RP, 1992, ARCH BIOCHEM BIOPHYS, V293, P241, DOI 10.1016/0003-9861(92)90391-9; Eaves DJ, 1998, MOL MICROBIOL, V28, P205, DOI 10.1046/j.1365-2958.1998.00792.x; ESCHENBRENNER M, 1994, BIOCHEM BIOPH RES CO, V198, P127, DOI 10.1006/bbrc.1994.1018; FAVEY S, 1995, MICROBIOL-UK, V141, P863, DOI 10.1099/13500872-141-4-863; FEE JA, 1980, BIOCHEM INT, V1, P304; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; GARDNER PR, 1993, J BIOL CHEM, V268, P12958; GAUDU P, 1994, EUR J BIOCHEM, V226, P459, DOI 10.1111/j.1432-1033.1994.tb20070.x; GAUDU P, 1994, J BIOL CHEM, V269, P8182; GIACOMINI A, 1992, FEMS MICROBIOL LETT, V100, P87, DOI 10.1111/j.1574-6968.1992.tb05687.x; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Hardison R, 1998, J EXP BIOL, V201, P1099; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; Hidalgo E, 1997, TRENDS BIOCHEM SCI, V22, P207, DOI 10.1016/S0968-0004(97)01068-2; IOANNIDIS N, 1992, BIOCHEM J, V288, P649, DOI 10.1042/bj2880649; IWAASA H, 1992, J MOL BIOL, V227, P948, DOI 10.1016/0022-2836(92)90236-D; JONES RW, 1977, BIOCHEM J, V260, P10478; KHOSLA C, 1989, J MOL BIOL, V210, P79, DOI 10.1016/0022-2836(89)90292-1; KUSHNER SR, 1971, P NATL ACAD SCI USA, V68, P824, DOI 10.1073/pnas.68.4.824; LaCelle M, 1996, J BACTERIOL, V178, P3803, DOI 10.1128/jb.178.13.3803-3808.1996; LIOCHEV SI, 1994, P NATL ACAD SCI USA, V91, P1328, DOI 10.1073/pnas.91.4.1328; Macheroux P, 1998, BIOCHEM J, V332, P413, DOI 10.1042/bj3320413; Membrillo-Hernandez J, 1997, FEMS MICROBIOL LETT, V155, P179, DOI 10.1111/j.1574-6968.1997.tb13875.x; Membrillo-Hernandez J, 1998, MOL MICROBIOL, V29, P1101, DOI 10.1046/j.1365-2958.1998.01000.x; MembrilloHernandez J, 1997, MOL GEN GENET, V254, P599, DOI 10.1007/s004380050457; MembrilloHernandez J, 1997, J BACTERIOL, V179, P3164, DOI 10.1128/jb.179.10.3164-3170.1997; MembrilloHernandez J, 1996, FEBS LETT, V382, P141, DOI 10.1016/0014-5793(96)00154-8; Miller J.H., 1972, EXPT MOL GENETICS; NUNOSHIBA T, 1995, INFECT IMMUN, V63, P794, DOI 10.1128/IAI.63.3.794-798.1995; NUNOSHIBA T, 1993, P NATL ACAD SCI USA, V90, P9993, DOI 10.1073/pnas.90.21.9993; OSHINO R, 1973, EUR J BIOCHEM, V35, P23, DOI 10.1111/j.1432-1033.1973.tb02805.x; PLAMANN MD, 1983, GENE, V14, P9; Poole RK, 1996, J BACTERIOL, V178, P5487, DOI 10.1128/jb.178.18.5487-5492.1996; Poole RK, 1997, MICROBIOL-SGM, V143, P1557, DOI 10.1099/00221287-143-5-1557; POOLE RK, 1994, P ROY SOC B-BIOL SCI, V255, P251, DOI 10.1098/rspb.1994.0036; POOLE RK, 1994, ANTON LEEUW INT J G, V65, P289, DOI 10.1007/BF00872215; Poole RK, 1996, MICROBIOL-SGM, V142, P1141, DOI 10.1099/13500872-142-5-1141; RIGGS AF, 1991, AM ZOOL, V31, P535; Sambrook J., 2002, MOL CLONING LAB MANU; STAUFFER GV, 1981, GENE, V14, P63, DOI 10.1016/0378-1119(81)90148-7; VASUDEVAN SG, 1991, MOL GEN GENET, V226, P49, DOI 10.1007/BF00273586; WAKABAYASHI S, 1986, NATURE, V331, P633; Zhao XJ, 1996, J BIOL CHEM, V271, P25131, DOI 10.1074/jbc.271.41.25131; ZHU H, 1992, P NATL ACAD SCI USA, V89, P5015, DOI 10.1073/pnas.89.11.5015	58	131	133	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					748	754		10.1074/jbc.274.2.748	http://dx.doi.org/10.1074/jbc.274.2.748			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873011	hybrid			2022-12-27	WOS:000077968500026
J	Nicoll, DA; Ottolia, M; Lu, LY; Lu, YJ; Philipson, KD				Nicoll, DA; Ottolia, M; Lu, LY; Lu, YJ; Philipson, KD			A new topological model of the cardiac sarcolemmal Na+-Ca2+ exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; NA-CA EXCHANGER; DYNAMIC PROPERTIES; MOLECULAR-CLONING; SIGNAL SEQUENCE; STEADY-STATE; EXPRESSION; LOCALIZATION; PURIFICATION; MYOCYTES	The current topological model of the Na+-Ca2+ exchanger consists of II transmembrane segments with extracellular loops a, c, e, g, i, and k and cytoplasmic loops b, d, f, h, and j, Cytoplasmic loop f, which plays a role in regulating the exchanger, is large and separates the first five from the last six transmembrane segments. We have tested this topological model by mutating residues near putative transmembrane segments to cysteine and then examining the effects of intracellular and extracellular applications of sulfhydryl-modifying reagents on exchanger activity. To aid in our topological studies, we also constructed a cysteineless Na+-Ca2+ exchanger. This mutant is fully functional in Na+ gradient-dependent Ca-45(2+) uptake measurements and displays wild-type regulatory properties. It is concluded that the 15 endogenous cysteine residues are not essential for either activity or regulation of the exchanger. Our data support the current model by placing loops c and e at the extracellular surface and loops d, j, and l at the intracellular surface. However, the data also support placing Ser-788 of loop h at the extracellular surface and Gly-837 of loop i at the intracellular surface, To account for these data, we propose a revision of the model that places transmembrane segment 6 in cytoplasmic loop f. Additionally, we propose that putative transmembrane segment 9 does not span the membrane, but may form a "P-loop"-like structure.	Univ Calif Los Angeles, Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nicoll, DA (corresponding author), Univ Calif Los Angeles, Sch Med, Cardiovasc Res Labs, MRL 3645, Los Angeles, CA 90095 USA.	dnicoll@mednet.ucla.edu			NHLBI NIH HHS [HL49101] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049101] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACETO JF, 1992, ARCH BIOCHEM BIOPHYS, V298, P553, DOI 10.1016/0003-9861(92)90449-7; Agre P, 1998, J BIOL CHEM, V273, P14659, DOI 10.1074/jbc.273.24.14659; BERS DM, 1991, EXCITATION CONTRACTI; BOYD D, 1990, CELL, V62, P1031, DOI 10.1016/0092-8674(90)90378-R; Braun P, 1997, J BIOL CHEM, V272, P29566, DOI 10.1074/jbc.272.47.29566; Cook O, 1998, BBA-BIOMEMBRANES, V1371, P40, DOI 10.1016/S0005-2736(97)00272-1; Doering AE, 1998, J BIOL CHEM, V273, P778, DOI 10.1074/jbc.273.2.778; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DURKIN JT, 1991, ARCH BIOCHEM BIOPHYS, V290, P369, DOI 10.1016/0003-9861(91)90553-U; GOLDMAN WF, 1994, J NEUROSCI, V14, P5834; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P905, DOI 10.1085/jgp.100.6.905; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; HRYSHKO LV, 1993, BIOCHIM BIOPHYS ACTA, V1151, P35, DOI 10.1016/0005-2736(93)90068-B; KOFUJI P, 1992, AM J PHYSIOL, V263, pC1241, DOI 10.1152/ajpcell.1992.263.6.C1241; KOHMOTO O, 1994, CIRC RES, V74, P550, DOI 10.1161/01.RES.74.3.550; KOMURO I, 1992, P NATL ACAD SCI USA, V89, P4769, DOI 10.1073/pnas.89.10.4769; LEE SL, 1994, J BIOL CHEM, V269, P14849; LEVI AJ, 1994, AM J PHYSIOL, V266, pH1422, DOI 10.1152/ajpheart.1994.266.4.H1422; LI ZP, 1991, J BIOL CHEM, V266, P1014; LI ZP, 1992, J BIOL CHEM, V267, P7828; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; PHILIPSON KD, 1988, BIOCHIM BIOPHYS ACTA, V945, P298, DOI 10.1016/0005-2736(88)90492-0; PIERCE GN, 1986, J MEMBRANE BIOL, V94, P217, DOI 10.1007/BF01869717; PORZIG H, 1993, AM J PHYSIOL, V265, pC748, DOI 10.1152/ajpcell.1993.265.3.C748; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; REEVES JP, 1986, J BIOL CHEM, V261, P4948; SAHINTOTH M, 1995, BIOCHEM BIOPH RES CO, V212, P968, DOI 10.1006/bbrc.1995.2064; Santacruz-Toloza LK, 1998, BIOPHYS J, V74, pA197; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Wasserstrom JA, 1996, J PHYSIOL-LONDON, V493, P529, DOI 10.1113/jphysiol.1996.sp021401	36	169	174	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	1999	274	2					910	917		10.1074/jbc.274.2.910	http://dx.doi.org/10.1074/jbc.274.2.910			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155WC	9873031	hybrid			2022-12-27	WOS:000077968500046
J	Hall, AJ; Vos, HL; Bertina, RM				Hall, AJ; Vos, HL; Bertina, RM			Lipopolysaccharide induction of Tissue Factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappa B nuclear translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR GENE-EXPRESSION; FACTOR MESSENGER-RNA; MONOCYTIC CELLS; C-JUN; THROMBOPLASTIN ACTIVITY; ACTIVATOR PROTEIN-1; BINDING-ACTIVITY; ENDOTOXIN; KINASE; PROMOTER	Tissue Factor (TF) gene expression is transiently induced in human monocytic THP-1 cells by lipopolysaccharide (LPS), We characterized the transcription factor complexes binding to the TF gene promoter LPS response element (LRE) (-220 to -172), which contains binding sites for nuclear factor kappa B (NF kappa B) and activator protein 1 (AP1) transcription factors, and examined the nature of the activation of these factors during a 24-h time course of LPS stimulation, We found proteolysis of the cytoplasmic inhibitory protein I kappa B alpha and nuclear translocation of the NF kappa B/Rel family proteins p65 and c-Rel, corresponding to the transient binding of a p65/c-Rel heterodimer to the KB-like site of the LRE, AP1 binding to the LRE was found to be constitutive, with the majority of the AP1 complexes being JunD/Fra-1 heterodimers, A change in the activation state of the AP1 complexes was, however, found to be transient, as determined by JunD phosphorylation of AP1 bound to the proximal binding site. This directly correlates to the transient activation of Jun N-terminal kinase (SAPK/ JNK), These data indicate that LPS induction of TF gene expression in monocytic THP-1 cells is regulated by both the transient phosphorylation of Jun-family proteins and the nuclear translocation and transient binding of NF kappa B/Rel proteins.	Univ Leiden Hosp, Haemostasis & Thrombosis Res Ctr, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC)	Hall, AJ (corresponding author), Royal Hallamshire Hosp, Div Med & Mol Genet, Floor M, Sheffield S10 2JF, S Yorkshire, England.	a.j.hall@sheffield.ac.uk	Bertina, Rogier/AGQ-5246-2022					BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Bird TA, 1997, J BIOL CHEM, V272, P32606, DOI 10.1074/jbc.272.51.32606; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND K, 1991, MOL CELL BIOL, V11, P4732, DOI 10.1128/MCB.11.9.4732; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONKLING PR, 1988, BLOOD, V72, P128; CONSONNI R, 1995, THROMB HAEMOSTASIS, V74, P904; CORDLE SR, 1993, J BIOL CHEM, V268, P11803; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DOKTER WHA, 1993, BLOOD, V81, P337; DONOVANPELUSO M, 1994, J BIOL CHEM, V269, P1361; DRABER P, 1989, J CELL SCI, V92, P519; DRAKE TA, 1989, AM J PATHOL, V134, P1087; EDGINGTON TS, 1991, THROMB HAEMOSTASIS, V66, P67; GREGORY SA, 1989, MOL CELL BIOL, V9, P2752, DOI 10.1128/MCB.9.6.2752; Groupp ER, 1996, J BIOL CHEM, V271, P12423, DOI 10.1074/jbc.271.21.12423; HAYASHI T, 1993, J BIOL CHEM, V268, P26790; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; Luque I, 1998, MOL CELL BIOL, V18, P1213, DOI 10.1128/MCB.18.3.1213; LYBERG T, 1981, BIOCHEM J, V194, P699, DOI 10.1042/bj1940699; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; NIEMETZ J, 1977, BLOOD, V49, P947; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; Oeth P, 1997, ARTERIOSCL THROM VAS, V17, P365, DOI 10.1161/01.ATV.17.2.365; OETH PA, 1994, MOL CELL BIOL, V14, P3772, DOI 10.1128/MCB.14.6.3772; OSTERUD B, 1983, THROMB HAEMOSTASIS, V49, P5; PARRY GCN, 1995, ARTERIOSCL THROM VAS, V15, P612, DOI 10.1161/01.ATV.15.5.612; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; Sambrook J., 2002, MOL CLONING LAB MANU; Suzuki YJ, 1995, BIOCHEM MOL BIOL INT, V36, P241; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; VANDERLOGT CPE, 1992, THROMB HAEMOSTASIS, V67, P272; VICKLICKY V, 1982, CELL BIOL INT REP, V6, P725; Vogt P K, 1990, Adv Cancer Res, V55, P1, DOI 10.1016/S0065-230X(08)60466-2	38	55	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					376	383		10.1074/jbc.274.1.376	http://dx.doi.org/10.1074/jbc.274.1.376			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867853	hybrid			2022-12-27	WOS:000077900200053
J	Mio, T; Yamada-Okabe, T; Arisawa, M; Yamada-Okabe, H				Mio, T; Yamada-Okabe, T; Arisawa, M; Yamada-Okabe, H			Saccharomyces cerevisiae GNA1, an essential gene encoding a novel acetyltransferase involved in UDP-N-acetylglucosamine synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; N-ACETYLGLUCOSAMINE-1-PHOSPHATE URIDYLTRANSFERASE; STREPTOTHRICIN ACETYLTRANSFERASE; NUCLEOTIDE-SEQUENCE; ACTIVE-SITE; YEAST; TRANSCRIPTION; ACETYLATION; IDENTIFICATION; MUTAGENESIS	The Saccharomyces cerevisiae gene, YFL017C, for a putative acetyltransferase was characterized, Disruption of YFL017C was lethal, leading to a morphology similar to those caused by the depletion of AGM1 or UAP1, the genes encoding phospho-N-acetylglucosamine mutase and UDP-N-acetylglucosamine pyrophosphorylase, respectively. This implies the involvement of YFLO17C in UDP-N-acetylglucosamine synthesis. The recombinant protein for YFL017C displayed phosphoglucosamine acetyltransferase activities in vitro and utilized glucosamine B-phosphate as the substrate. When incubated with Agm1p and Uap1p, the Yfl017c protein produced UDP-N-acetylglucosamine from glucosamine B-phosphate, These results indicate that YFL017C specifies glucosamine-6-phosphate acetyltransferase; therefore, the gene was designated GNA1 (glucosamine-6-phosphate acetyltransferase). In addition, whereas bacterial phosphoglucosamine acetyltransferase and UDP-N-acetylglucosamine pyrophosphorylase activities are intrinsic in a single polypeptide, they are encoded by distinct essential genes in yeast. When the sequence of ScGnalp was compared with those of other acetyltransferases, Ile(97), Glu(98), Val(102), Gly(112), Leu(115), Ile(116), Phe(142), Tyr(143), and Gly(147) were found to be highly conserved. When alanine was substituted for these amino acids, the enzyme activity for the substituted Phe(142) or Tyr(143) enzymes was severely diminished, Although the activity of Y143A was too low to perform kinetics, F142A displayed a significantly increased K-m value for acetyl-CoA, suggesting that the Phe(142) and Tyr(143) residues are essential for the catalysis.	Nippon Roche Res Ctr, Dept Mycol, Kanagawa 2478530, Japan; Yokohama City Univ, Sch Med, Dept Hyg, Yokohama, Kanagawa 2360004, Japan	Roche Holding; Yokohama City University	Yamada-Okabe, H (corresponding author), Nippon Roche Res Ctr, Dept Mycol, 200 Kajiwara, Kanagawa 2478530, Japan.	hisafumi.okabe@roche.com						BORJIGIN J, 1995, NATURE, V378, P783, DOI 10.1038/378783a0; CABIB E, 1982, ANNU REV BIOCHEM, V51, P763, DOI 10.1146/annurev.bi.51.070182.003555; Coleman CS, 1996, BIOCHEM J, V316, P697, DOI 10.1042/bj3160697; DIEKMAN AB, 1994, BIOL REPROD, V50, P1087, DOI 10.1095/biolreprod50.5.1087; DOBROGOS.WJ, 1968, J BACTERIOL, V95, P578, DOI 10.1128/JB.95.2.578-584.1968; DUTKAMALEN S, 1988, BIOCHIMIE, V70, P287, DOI 10.1016/0300-9084(88)90073-9; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Freese EB, 1970, J BACTERIOL, V101, P1046, DOI 10.1128/JB.101.3.1046-1062.1970; Gehring AM, 1996, BIOCHEMISTRY-US, V35, P579, DOI 10.1021/bi952275a; GRANT DM, 1989, NUCLEIC ACIDS RES, V17, P3978, DOI 10.1093/nar/17.10.3978; HannecartPokorni E, 1997, ANTIMICROB AGENTS CH, V41, P314, DOI 10.1128/AAC.41.2.314; HASHIMOTOGOTOH T, 1995, GENE, V152, P271, DOI 10.1016/0378-1119(94)00750-M; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; HOFMANN M, 1994, EUR J BIOCHEM, V221, P741, DOI 10.1111/j.1432-1033.1994.tb18787.x; HOLTJE JV, 1985, MOL CYTOLOGY ESCHERI, P77; HORINOUCHI S, 1987, J BACTERIOL, V169, P1929, DOI 10.1128/jb.169.5.1929-1937.1987; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; JACOB J, 1994, FEMS MICROBIOL LETT, V120, P13; KULKARNI MS, 1994, J BIOL CHEM, V269, P13141; Lin RY, 1996, GENES CELLS, V1, P923, DOI 10.1046/j.1365-2443.1996.d01-215.x; Lu L, 1996, J BIOL CHEM, V271, P18920, DOI 10.1074/jbc.271.31.18920; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; MenginLecreulx D, 1996, J BIOL CHEM, V271, P32, DOI 10.1074/jbc.271.1.32; MENGINLECREULX D, 1993, J BACTERIOL, V175, P6150, DOI 10.1128/JB.175.19.6150-6157.1993; Meyer UA, 1997, ANNU REV PHARMACOL, V37, P269, DOI 10.1146/annurev.pharmtox.37.1.269; Mio T, 1998, J BIOL CHEM, V273, P14392, DOI 10.1074/jbc.273.23.14392; PARK JT, 1987, ESCHERICHIA COLI SAL, V1, P663; RAETZ CRH, 1987, ESCHERICHIA COLI SAL, V1, P498; RANDERATH K, 1965, ANAL BIOCHEM, V13, P575, DOI 10.1016/0003-2697(65)90356-8; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Sambrook J., 1989, MOL CLONING LAB MANU, V1; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; WALKER JE, 1984, BIOCHEM J, V224, P799, DOI 10.1042/bj2240799; Wang-Gillam A, 1998, J BIOL CHEM, V273, P27055, DOI 10.1074/jbc.273.42.27055; WATZELE G, 1989, J BIOL CHEM, V264, P8753; WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847; Wolf E, 1998, CELL, V94, P439, DOI 10.1016/S0092-8674(00)81585-8; WU DH, 1995, J BIOL CHEM, V270, P29111, DOI 10.1074/jbc.270.49.29111; WU HC, 1971, J BACTERIOL, V105, P455, DOI 10.1128/JB.105.2.455-466.1971; Xiao L, 1996, BIOCHEM J, V313, P691, DOI 10.1042/bj3130691; YamadaOkabe T, 1996, MICROBIOL-UK, V142, P2515, DOI 10.1099/00221287-142-9-2515	42	84	93	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					424	429		10.1074/jbc.274.1.424	http://dx.doi.org/10.1074/jbc.274.1.424			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867860	hybrid			2022-12-27	WOS:000077900200060
J	Tian, Y; Ke, S; Denison, MS; Rabson, AB; Gallo, MA				Tian, Y; Ke, S; Denison, MS; Rabson, AB; Gallo, MA			Ah receptor and NF-kappa B interactions, a potential mechanism for dioxin toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; ARYL-HYDROCARBON RECEPTOR; ALPHA-NAPHTHOFLAVONE; TRANSCRIPTIONAL ACTIVATION; GLUCOCORTICOID RECEPTOR; INDUCIBLE EXPRESSION; HUMAN HEPATOCYTES; INDUCED APOPTOSIS; PRIMARY CULTURE; CYP1A1 GENE	The Ah receptor (AhR) mediates many of the toxic responses induced by polyhalogenated and polycyclic hydrocarbons (PAHs) which are ubiquitous environmental contaminants causing toxic responses in human and wildlife. NF-kappa B is a pleiotropic transcription factor controlling many physiological functions adversely affected by PAHs, including immune suppression, thymus involution, hyperkeratosis, and carcinogenesis. Here, we show physical interaction and mutual functional repression between AhR and NF-kappa B, This mutual repression may provide an underlying mechanism for many hitherto poorly understood PAM-induced toxic responses, and may also provide a mechanistic explanation for alteration of xenobiotic metabolism by cytokines and compounds that regulate NF-kappa B.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Community Med, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA; Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Canc Inst New Jersey, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California Davis; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Gallo, MA (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Community Med, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA.	gallo@umdnj.edu			NCI NIH HHS [CA69281] Funding Source: Medline; NIEHS NIH HHS [ES05022, ES07072] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007072] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BARKER CW, 1992, J BIOL CHEM, V267, P8050; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BLANK JA, 1987, MOL PHARMACOL, V32, P168; BOUCHER PD, 1995, MOL CELL BIOL, V15, P5144; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Carver LA, 1997, J BIOL CHEM, V272, P11452; DENIS M, 1988, J BIOL CHEM, V263, P18520; DENISON MS, 1988, P NATL ACAD SCI USA, V85, P2528, DOI 10.1073/pnas.85.8.2528; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; FUKUDA Y, 1992, BIOCHEM BIOPH RES CO, V184, P960, DOI 10.1016/0006-291X(92)90684-D; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; GASIEWICZ TA, 1991, MOL PHARMACOL, V40, P607; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; GHEZZI P, 1986, BIOCHEM BIOPH RES CO, V136, P316, DOI 10.1016/0006-291X(86)90912-5; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; JAISWAL AK, 1994, J BIOL CHEM, V269, P14502; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kobayashi A, 1996, J BIOL CHEM, V271, P12310, DOI 10.1074/jbc.271.21.12310; Kobayashi A, 1997, J BIOCHEM, V122, P703; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; LUSSKA A, 1993, J BIOL CHEM, V268, P6575; Ma Q, 1997, J BIOL CHEM, V272, P8878; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; MERCHANT M, 1993, TOXICOL APPL PHARM, V120, P179, DOI 10.1006/taap.1993.1101; MERCHANT M, 1990, ARCH BIOCHEM BIOPHYS, V281, P84, DOI 10.1016/0003-9861(90)90416-V; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; MUNTANERELAT J, 1995, HEPATOLOGY, V22, P1143; Palvimo JJ, 1996, J BIOL CHEM, V271, P24151, DOI 10.1074/jbc.271.39.24151; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; POLAND A, 1976, J BIOL CHEM, V251, P4936; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; RUBEN SM, 1992, MOL CELL BIOL, V12, P444, DOI 10.1128/MCB.12.2.444; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; SILKWORTH JB, 1984, TOXICOL APPL PHARM, V75, P156, DOI 10.1016/0041-008X(84)90086-3; Staples JE, 1998, J IMMUNOL, V160, P3844; STEIN B, 1995, MOL CELL BIOL, V15, P4971; SWANSON HI, 1995, J BIOL CHEM, V270, P26292, DOI 10.1074/jbc.270.44.26292; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Whitlock JP, 1996, FASEB J, V10, P809, DOI 10.1096/fasebj.10.8.8666157; WILHELMSSON A, 1990, EMBO J, V9, P69, DOI 10.1002/j.1460-2075.1990.tb08081.x; Zhang LY, 1998, J BIOL CHEM, V273, P5174, DOI 10.1074/jbc.273.9.5174	55	308	312	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	1999	274	1					510	515		10.1074/jbc.274.1.510	http://dx.doi.org/10.1074/jbc.274.1.510			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	154QP	9867872	hybrid			2022-12-27	WOS:000077900200072
J	Fradette, J; Germain, L; Seshaiah, P; Coulombe, PA				Fradette, J; Germain, L; Seshaiah, P; Coulombe, PA			The type I keratin 19 possesses distinct and context-dependent assembly properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; INTERMEDIATE FILAMENTS; GENE-EXPRESSION; HAIR-FOLLICLES; MERKEL CELLS; STEM-CELLS; EPITHELIAL-CELLS; TRANSGENIC MICE; CULTURED-CELLS; HUMAN-SKIN	Keratins (K), the cytoplasmic intermediate filament (IF) proteins of epithelial cells, are encoded by a multigene family and expressed in a tissue- and differentiation-specific manner. In human skin, keratinocytes of the basal layer of epidermis and the outer root sheath of hair follicles express K5 and K14 as their main keratins. A small subpopulation of basal cells exhibiting stem-cell Like characteristics express, in addition, K19. At 40 kDa, this keratin is the smallest LF protein due to an exceptionally short carboxyl-terminal domain. We examined the assembly properties of K19 and contrasted them to K14 in vitro and in vivo. Relative to K5-K14, we find that K5-K19 form less stable tetramers that polymerize into shorter and narrower Ifs in vitro. When transiently coexpressed in cultured baby hamster kidney cells, the K5 and K19 combination fails to form a filamentous array, whereas the K5-K14 and K8-K19 ones readily do so. Transient expression of K19 in the epithelial cell lines T51B-Ni and A431 results in its integration into the endogenous keratin network with minimal if any perturbation. Collectively, these results indicate that K19 possesses assembly properties that are distinct from those of K14 and suggest that it may impart unique properties to the basal cells expressing it in skin epithelia.	Hop St Sacrement, Lab Organogenese Expt, LOEX, Quebec City, PQ G1S 4L8, Canada; Univ Laval, Dept Surg, Ste Foy, PQ G1K 7P4, Canada; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA	Laval University; Laval University; Johns Hopkins University; Johns Hopkins University	Germain, L (corresponding author), Hop St Sacrement, Lab Organogenese Expt, LOEX, 1050 Chemin St Foy, Quebec City, PQ G1S 4L8, Canada.	lucie.germain@chg.ulaval.ca		Germain, Lucie/0000-0001-8883-6491; Fradette, Julie/0000-0002-1851-5112	NIAMS NIH HHS [AR44232] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044232] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALBERS K, 1987, J CELL BIOL, V105, P791, DOI 10.1083/jcb.105.2.791; BADER BL, 1986, EMBO J, V5, P1865, DOI 10.1002/j.1460-2075.1986.tb04438.x; BADER BL, 1990, DIFFERENTIATION, V45, P109, DOI 10.1111/j.1432-0436.1990.tb00464.x; BADER BL, 1991, J CELL BIOL, V115, P1293, DOI 10.1083/jcb.115.5.1293; BARTEK J, 1986, EUR J CANCER CLIN ON, V22, P1441, DOI 10.1016/0277-5379(86)90077-5; BARTEK J, 1985, INT J CANCER, V36, P299, DOI 10.1002/ijc.1985.36.3.299; BLESSING M, 1993, J CELL BIOL, V120, P743, DOI 10.1083/jcb.120.3.743; BLOUIN R, 1992, BIOCHEM CELL BIOL, V70, P1, DOI 10.1139/o92-001; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; CHOU CF, 1993, J CELL SCI, V105, P433; COLLIN C, 1992, EXP CELL RES, V202, P132, DOI 10.1016/0014-4827(92)90412-2; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COULOMBE PA, 1989, J CELL BIOL, V109, P2295, DOI 10.1083/jcb.109.5.2295; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; Coulombe PA, 1993, CURR OPIN CELL BIOL, V5, P17, DOI 10.1016/S0955-0674(05)80004-3; ECKERT RL, 1988, P NATL ACAD SCI USA, V85, P1114, DOI 10.1073/pnas.85.4.1114; EICHNER R, 1986, J CELL BIOL, V102, P1767, DOI 10.1083/jcb.102.5.1767; Fradette J, 1995, BIOCHEM CELL BIOL, V73, P635, DOI 10.1139/o95-070; FRANKE WW, 1978, CYTOBIOLOGIE, V17, P392; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Fuchs E, 1997, MOL BIOL CELL, V8, P189, DOI 10.1091/mbc.8.2.189; GERMAIN L, 1993, BURNS, V19, P99, DOI 10.1016/0305-4179(93)90028-7; HATZFELD M, 1990, J CELL SCI, V97, P317; HEID HW, 1988, DIFFERENTIATION, V37, P137, DOI 10.1111/j.1432-0436.1988.tb00805.x; Hofmann I, 1997, EUR J CELL BIOL, V72, P122; Hutton E, 1998, J CELL BIOL, V143, P487, DOI 10.1083/jcb.143.2.487; KARTASOVA T, 1993, J CELL BIOL, V120, P1251, DOI 10.1083/jcb.120.5.1251; Ku NO, 1997, J BIOL CHEM, V272, P33197, DOI 10.1074/jbc.272.52.33197; KU NO, 1994, J CELL BIOL, V127, P161, DOI 10.1083/jcb.127.1.161; LACOUR JP, 1991, BRIT J DERMATOL, V125, P535, DOI 10.1111/j.1365-2133.1991.tb14790.x; LANE EB, 1991, ANN NY ACAD SCI, V642, P197; LAVKER RM, 1982, SCIENCE, V215, P1239, DOI 10.1126/science.7058342; LERSCH R, 1989, MOL CELL BIOL, V9, P3685, DOI 10.1128/MCB.9.9.3685; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; LU X, 1990, CELL, V62, P681, DOI 10.1016/0092-8674(90)90114-T; LUSSIER M, 1989, GENE, V85, P435, DOI 10.1016/0378-1119(89)90437-X; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; MCCORMICK MB, 1993, J CELL BIOL, V122, P395, DOI 10.1083/jcb.122.2.395; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; Michel M, 1996, J CELL SCI, V109, P1017; MOLL I, 1994, CELL TISSUE RES, V277, P131, DOI 10.1007/s004410050140; MOLL R, 1982, DIFFERENTIATION, V22, P25, DOI 10.1111/j.1432-0436.1982.tb01220.x; MOLL R, 1984, DIFFERENTIATION, V28, P136, DOI 10.1111/j.1432-0436.1984.tb00277.x; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; OGUIN WM, 1990, CELLULAR MOL BIOL IN, P301; Oosawa F., 1975, THERMODYNAMICS POLYM; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035; PALADINI RD, 1995, BIOCHEM BIOPH RES CO, V215, P517, DOI 10.1006/bbrc.1995.2495; PARAMIO JM, 1994, EXP CELL RES, V215, P319, DOI 10.1006/excr.1994.1348; Paramio JM, 1997, J CELL SCI, V110, P1099; QUINLAN RA, 1982, P NATL ACAD SCI-BIOL, V79, P3452, DOI 10.1073/pnas.79.11.3452; RORKE EA, 1992, J INVEST DERMATOL, V98, P17, DOI 10.1111/1523-1747.ep12494161; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; ROYAL I, 1995, EXP CELL RES, V220, P171, DOI 10.1006/excr.1995.1303; STASIAK PC, 1989, J INVEST DERMATOL, V92, P707, DOI 10.1111/1523-1747.ep12721500; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; Stewart M, 1993, CURR OPIN CELL BIOL, V5, P3, DOI 10.1016/S0955-0674(05)80002-X; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SU L, 1993, J ORAL PATHOL MED, V22, P183, DOI 10.1111/j.1600-0714.1993.tb01054.x; TAKAHASHI K, 1995, J BIOL CHEM, V270, P18581, DOI 10.1074/jbc.270.31.18581; Wawersik M, 1997, J BIOL CHEM, V272, P32557, DOI 10.1074/jbc.272.51.32557; WILSON AK, 1992, J CELL BIOL, V119, P401, DOI 10.1083/jcb.119.2.401; WU YJ, 1981, CELL, V25, P627, DOI 10.1016/0092-8674(81)90170-7	66	36	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1998	273	52					35176	35184		10.1074/jbc.273.52.35176	http://dx.doi.org/10.1074/jbc.273.52.35176			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151KR	9857055	hybrid			2022-12-27	WOS:000077719700073
